{"title": "PDF", "author": "PDF", "url": "https://aaap.memberclicks.net/assets/WPDC/wpdcproceedings_2002.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "id": "PDF", "license": "PDF", "body": "PDF", "comments": "PDF", "commentsbody": "PDF", "raw_text": "PDF", "text": "i  xx  \n \n \n \n \n    \nMEMORIAS DE LA XXVII CONVENCION ANUAL DE LA \nASOCIACION NACIONAL DE ESPECIALISTAS EN \nCIENCIAS AVICOLAS  \n \n \nPROCEEDINGS OF THE FIFTY -FIRST  \nWESTERN POULTRY DISEASE CONFERENCE  \n \n \n \n \n \n \n \n        MESA DIRECTIVA \n   GESTION 2001- 2002 \n \nPresidente      Dr.Juli\u00e1n C arrillo Valadez  \n \nVice presidente y Tesorero    Dr. Fernando de la Colina  \n \nSecretario      Dr. Roberto Se\u00f1as C.  \n \nRelaciones Comerciales    Dr. Sergio Higuera  \n       Dr. Miguel A. Romero  \n \nCoordinador WPDC     Dr. Ernesto Soto P. \n \nComit\u00e9 Cient\u00edfico     Dr. Jos\u00e9 A.  Quintana  \n      Dr. Carlos L\u00f3pez Coello \n      Dr. Ricardo Cuetos  \n      Dr. Susano Medina  \n      Dr. Guillermo Tellez  \n \nMembres\u00edas      Dra. Cecilia Rosario C.  \n \nComit\u00e9 Editorial     Dr. Victor Mireles  \n \nComit\u00e9 Pro fondos     Dr. David Sarfati  \n      Dr. Francisco B\u00e1ez  \n  Relaciones Internacionales    Dr. Marco A.Rebollo \nDr. Marco Quiroz  \n      Dr.Luis Etcharren  \n        \nRelaciones Nacionales               Dr. Arturo Suazo Orozco \n      Dr. Antonio Ortiz  \n \nVocales      Dr. Carlos Sanchez Widmanm  \n      Dr. Jos\u00e9 Manuel Arriol a \n      Dr. Jos\u00e9 Jesus Gomez  \n       Dr. Jes\u00fas Corona  \n       Dr. Mauricio Gonzalez  \n       Dr. Jesus Bernal  \n       Dr.Jos\u00e9 Quesada Fox  \n \nEstatutos      Dr. Bernardo Lozano  \n      Dra. Martha Silva  \n \nComit\u00e9 Ex Presidentes    Dra. Maritza Tamayo   \n \nGerente Administrativo    Lic. Felipe Nu\u00f1ez  \n     \n  \nExpresidentes ANECA  Periodo  \n  \nMVZ. Benjam\u00edn Lucio Mart\u00ednez  1970 -1972  \nMVZ. Jos\u00e9 Antonio Villase\u00f1or Michel  1972 -1973  \nMVZ. Alejandro Cuadra Germ\u00e1n  1973 -1974  \nMVZ. Miguel Angel M\u00e1rquez Ru\u00edz  1974 -1976  \nMVZ. Antonio Berna Sant os 1976 -1977  \nMVZ. Jorge Basurto Bello  1977 -1979  \nMVZ. Angel Mosqueda Taylor  1979 -1980  \nMVZ. Miguel \u00c1ngel M\u00e1rquez Ru\u00edz  1980 -1981  \nMVZ. Luis Villase\u00f1or Michel  1981 -1982  \nMVZ. Carlos L\u00f3pez Coello  1982 -1983  \nMVZ. Francisco Javier Aranda Torres  1983 -1984  \nMVZ.  Jorge Basurto Bello  1984 -1985  \nMVZ. Jorge Basurto Bello  1985 -1986  \nMVZ. Bernardo Lozano Dubernard  1986 -1987  \nMVZ. Manuel Golzarri Moreno  1987 -1988  \nMVZ. David Sarfati Mizrahi  1988 -1989  \nMVZ. Manuel Benegas Vilchis  1989 -1990  \nMVZ. Martha Silva Maldonado  1990-1991  \nMVZ. Jos\u00e9 Antonio Varona Beascoechea  1991 -1992  \nMVZ. Eduardo Lucio Decanini  1992 -1993  \nMVZ. Francisco B\u00e1ez Medina  1993 -1994  \nMVZ. Hugo Galicia B  1994 -1995  \nMVZ. Ricardo Salado Carbajal  1995 -1996  \nMVZ. Jos\u00e9 Antonio Varona Beascoechea  1996 -1997  \nMVZ . Guillermo T\u00e9llez Isa\u00edas.  1997 -1998  \nMVZ. Agust\u00edn Torres  1998 -1999  \nMVZ. Guillermo Luna O.  1999 -2000  \nMVZ. Maritza Tamayo Salmoran  2000 -2001  \n  \n \n          ACTUAL PRESIDENT: MVZ Julian Carrillo Valadez 2001 -2002 \n \n     \n ANECA gratefully thanks the following S pecial Sponsors for their \nsupport of this Convention:  \n \n3P S A  \nAlpharma  Animal Health  \nAlta Tecnolog\u00eda Industrial  \nALLTECH de M\u00e9xico  \nAnglo Corp S. A. de C. V.  \nArgos Ferpac S. A. de C . V. Bayer de M\u00e9xico S. A. de C. V. Biotecnolog\u00eda Industrial S. A. de  C. V.  BM Editores S. A. De C . V.  Boehringer Ingelheim  \nBios\u00edntesis Laboratorios  Collins Divisi\u00f3n Veterinaria  \nECO M\u00e9xico Sanidad Animal, S. A. de C. V.  Ediciones Pecuarias  \nEuroplast S. A. de  C. V.  Fort Dodge Animal Health S. de R L de C V  \nGarc\u00eda Cornej o \nIntervet de M\u00e9xico S. A. de C. V.  Investigaci\u00f3n Aplicada S. A. de C V  \nLaboratorio AVI - MEX S. A.   de C. V. \nLaboratorios   Sanfer S. A. de C. V.  \nLaboratorios BIODECI  \nLaboratorios Gortie S. A. de C.V. Lubing Mesoamericana  \nMerial M\u00e9xico  \nMidia Relaciones  \nNovartis Salud Animal S. A. de C. V.  \nPharmacia & Upjohn  \nPISA Agropecuaria S A de C V  \nPremezclas de M\u00e9xico  \nPurina S. A. De C. V.  \nSchering \u2013 Plough  S. A. de C. V.  \nSynbiotics  \nV\u00e9toquinol de M\u00e9xico S. A. de C . V.  \nVrot S. A. de C . V.  Elanco Animal Health  Kemia S. A. de C. V.  \n           \n \n \n \n \n  \n \n \n \n \n \n           \n \n \n>>>>>>>>>>>>>>\n  \n \n* \n    \n \n \n \nLUBING   MESO    MERICANA    \n                    S.A.   DE   C.V.  \n  \n \n \n \n           \n  \n   \n \n \n \n        \n  \n \n \n   ECO MEXICO  \n  Sanidad Animal,S.A. De C.V.       \n \nPROLOGO  \n \n \nEstimados amigos, La Asociaci\u00f3n Nacional de Especialistas en Ciencias Av\u00edcolas (ANECA) se enorgullece en ofrecer a todos nuestros socios el m\u00e1ximo evento que es nuestra XXVII Convenci\u00f3n Anual y que en esta ocasi\u00f3n se enaltece por llevarse en conjunto con la 51a. Convenci\u00f3n de la Western Poultr y Disease Conference (WPDC) esto le da una gran importancia \npuesto que tenemos excelentes ponencias y ponentes de talla internacional.    Cabe se\u00f1alar que el poder llevar a cabo un evento de esta magnitud nos obliga a las dos   Organizaciones a cumplir con  cada uno de los detalles para lograr nuestro objetivo final  que es \nel \u00e9xito de nuestra convenci\u00f3n.    Es importante tambi\u00e9n se\u00f1alar que durante el desarrollo de nuestra convenci\u00f3n, debemos aprovechar la experiencia de cada uno de los ponentes , as\u00ed mismo  como mexicanos mostrar \ntodas nuestras capacidades desde t\u00e9cnicas hasta  de cordialidad.  \n   Estamos seguros que este evento nos comprometer\u00e1 a todos los mexicanos en seguir capacitandonos y actualizandonos con eventos de \u00e9sta calidad, tambi\u00e9n estamos conve ncidos  sin \nlugar a duda que el \u00e9xito de nuestra Convenci\u00f3n de ANECA y WPDC se logra por el trabajo en equipo tanto de esta mesa directiva de ANECA como todo el comit\u00e9 de la WPDC.  \n   En ANECA seguiremos trabajando por llevar a cada socio  la actualizaci\u00f3n y capacitaci\u00f3n con la \ncalidad y organizaci\u00f3n que siempre nos ha caracterizado, como lo es este evento.  \n   Les deseamos que nuestra Convenci\u00f3n, las Ponencias y estas Memorias  cubran con todas las expectativas, que ustedes se han marcado, as\u00ed que aprovechem os al m\u00e1ximo el trabajo de todos \nlos ponentes que  plasmaron su mejor esfuerzo.        \n    ATENTAMENTE \n \n                MESA DIRECTIVA \n                       2001- 2002 \n       \n     \n  \n \n \nPREFACE  \n \n   \nDear friends, The National Association of Specialists in Poultry  Sciences (ANECA) is proud to \noffer all our members the maximum event that is our XXVII Annual Convention, and that in this occasion it is ennobled to be held in conjunction with the 51\nst meeting of the Western Poultry \nDisease Conference (WPDC). This gives  it great importance, since we have excellent papers and \npresenters of international size.     \n   It must be emphasized that the ability to carry out such an event of this magnitude requires both \norganizations to work together to complete every detail in o rder to achieve our final objective: \nthe success of our convention.   \n It is also important to point out that during the convention we should take advantage of the experience of each one of the presenters; likewise as Mexicans, to display all of our capaci ties \u2013 \nfrom our technical ability to our cordiality.   \n     We are sure that this event will commit us to all the Mexicans in continuing to qualify and upgrade us with events of this quality. We are also undoubtedly convinced that the success of our Convention of ANECA and WPDC is achieved by the teamwork displayed by this board of directors of ANECA as well as the WPDC Executive Committee.   \n     In ANECA we will continue working to deliver to each member the update and training with the quality and organi zation that has always characterized us through this event.   \n     It is our desire that our Convention, the presentations, and these proceedings fulfil your every \nexpectation.  May we take full advantage of the work of all these presenters who have brought together their best efforts for our enlightenment.  \n       \n          SINCERELY   \n   \n                 BOARD OF DIRECTORS   \n                       2001- 2002   \n     \n \n       \nDEDICATORIA AL DR. CARLOS SANCHEZ WIDMANN  \n \nNaci\u00f3 el 27 de octubre de 1936, en la ciudad de M\u00e9xico D.F. Estudio en la Escuela Nacional \nde Medicina Veterinaria, Universidad Nacional Aut\u00f3noma de M\u00e9xico, siendo la segunda \ngeneraci\u00f3n de Ciudad Universitaria (1956- 1960). Teniendo como compa\u00f1eros al Dr. Alejandro \nCuadra, Dr. Fabi\u00e1n Ubi\u00f1a, Dr. Enrique Salinas Aguilera entre otros.  \nSu inter\u00e9s por las aves se remonta a antes de entrar a a la facultad de Medicina Veterinaria, \nya que por los a\u00f1os 50\u00b4s, su t\u00edo fue avicultor de gallina de postura con 18,000 aves y algo de \npollo de engorda, pero desgraciada mente en esa \u00e9poca apareci\u00f3 una de las enfermedades que mas \nestragos ha causado en M\u00e9xico como es el Newcastle y los oblig\u00f3 a retirarse del negoci\u00f3 av\u00edcola.  \nEl  Dr. S\u00e1nchez Widmann inici\u00f3 su propio negocio en el a\u00f1o de 1962 con 20, 000 pollos de \nengorda en  la zona de Chimalhuacan y  al mismo tiempo fue asesor t\u00e9cnico externo de la \nempresa Alimentos Industriales (AISA) de 1959 a 1962. Posteriormente, de 1962 a 1964 fue \nasesor de Alimentos Malta, para luego regresar a AISA hasta el a\u00f1o de 1994. Tambi\u00e9n en esa  \nd\u00e9cada fue asesor de Laboratorios Vinelad trabajando junto con el Dr. Alejandro Cuadra y el Dr. Miguel Angel Marquez.  \nPara los a\u00f1os 70\u00b4s,  se asocia con el Dr. Jos\u00e9 Garcia para engorda de pollo durante dos a\u00f1os. \nPosteriormente en los 80\u00b4s tambi\u00e9n se asoci a con el Sr. Juan Antonio S\u00e1nchez Barse con una \nproducci\u00f3n de 90,000 pollos de engorda y con el Sr. Arturo Gilio con 60,000 pollos de engorda en la zona de Zumpango, Estado de M\u00e9xico. \nY es justo durante esa d\u00e9cada cuando el Lic. Ra\u00fal Canales lo induce a un irse a la Asociaci\u00f3n \nde Avicultores del Valle de M\u00e9xico, ocupando el cargo de Presidente de Consejo en el per\u00edodo de 1982 a 1986, y seg\u00fan lo permiten los estatutos, toma cargo de Secretario General del Consejo en la Uni\u00f3n Nacional de Avicultores (UNA) de 1983 a 1988. \nEn 1988, se asocia con el Sr. Alfonso Larey  para la producci\u00f3n de 450,000 pollos de \nengorda en la zona del Lago de Guadalupe, terminando en 1996, debido a dos causas: por un lado la crisis de la devaluaci\u00f3n de la moneda en M\u00e9xico, y por otro l a crisis de la escasez del \ngrano. Pero permanece en la UNA como Gerente General, puesto que ocupa a la fecha, en donde su principal funci\u00f3n es el enlace de aspectos t\u00e9cnicos, sanitarios y productivos con la SAGARPA y en la Secretaria de Asistencia particip a en la elaboraci\u00f3n de normas relacionadas con la \nactividad av\u00edcola.  \nActualmente tambi\u00e9n es miembro del Comit\u00e9 Nacional de Sanidad Animal (CONASA), \nenfermedades de las aves, desde 1990.  \nAs\u00ed mismo ha participado dentro de algunos consejos de ANECA, siendo V ocal o miembro \ndel Comit\u00e9 Cient\u00edfico.  \n      \n     \n Dentro del \u00e1rea de asesor\u00edas, ha participado con varias empresas av\u00edcolas, entre ellas:  \n \n\u2022 Agropecuaria El Avi\u00f3n (actualmente)  \n\u2022 Av\u00edcola Nochistongo  \n\u2022 Av\u00edcola Sim\u00f3n Bolivar  \n\u2022 Propollo \n\u2022 Alcer  \n   \nActualmente continua part icipando en la avicultura con 200,000 pollos de engorda en la \nzona de Texcoco, Estado de M\u00e9xico.  \nA lo largo de su trayectoria, al Dr. S\u00e1nchez Widmann le ha tocado ver y participar en los \nprocesos de consolidaci\u00f3n y crecimiento de la industria av\u00edcola desde  sus inicios, y actualmente \nen la concentraci\u00f3n de la misma.  \nSin duda alguna el Dr. Carlos S\u00e1nchez Widmann, ha sido un ejemplo para las nuevas \ngeneraciones de M\u00e9dicos Veterinarios, ya que mas all\u00e1 de cuidar la salud de las aves, ha demostrado que los M\u00e9dic os Veterinarios tenemos la capacidad de encabezar puestos tanto \npol\u00edticos, como administrativos, e incluso empresariales.  \n \nFELICIDADES DR. CARLOS S\u00c1NCHEZ WIDMANN  \n        \n  \nDEDICATION OF THE XXVII ANECA CONVENTION TO DR. CARLOS SANCHEZ \nWIDMANN  \n   \nDr. Carlos S anchez Widmann was born October 27, 1936 in Mexico City D. F. He studied at \nthe National School of Veterinary Medicine, Autonomous National University of Mexico, where he was in the 2\nnd generation from 1956 to 1960. His associates were Dr. Alejandro Cuadra , Dr. \nFabi\u00e1n Ubi\u00f1a, Dr. Enrique Salinas Aguilera, among others.  \nHis interest in poultry dates back before entering Veterinary School. In the 50\u00b4s he worked \nwith his uncle as a poultry producer of 18,000 hens. Unfortunately during that time one of the awful  illnesses appeared in Mexico: Newcastle Disease. This forced them to retire from the \npoultry business.  \nIn 1962 Dr. Sanchez Widmann began his own business in Chimalhuacan with 20,000 \nchickens. He served as external technical advisor for the AISA Company fr om 1959 to 1962. \nThen from 1962 to 1964 he was technical advisor for Malta, afterward returning to AISA until 1994. Also during that decade he acted as technical advisor for Vineland Laboratories, working together with Dr. Alejandro Cuadra and Dr. Miguel A ngel Marquez.  \nDuring the 70\u00b4s he partnered with Dr. Jos\u00e9 Garcia to raise chickens for two years; then later \non in the 80\u00b4s he associated with Mr. Juan Antonio Sanchez Barse, producing 90,000 chickens; and with Mr. Arturo Gilio producing 60,000 chickens in the Zumpango, State of Mexico area.  \nIt was during the \u201880\u2019s, that the Layer Raul Canales induced him to join the Association of \nthe Valley of Mexico, occupying the president's advisory position from 1982 to 1986; and according to what the statutes allowed , he took the general secretary's advisory position in the \nNational Union of Poultry Producers  (UNA) from 1983 to 1988. \nIn 1988 he worked with Mr. Alfonso Larrey producing 450,000 chickens in the area of \nGuadalupe Lake, State of Mexico. They had to quit r aising chickens in 1996 due to two causes: \n1) the crisis of the devaluation in Mexico and 2) a grain shortage crisis. However, he continued on as General Manager of National Union of Poultry Producers (UNA), which position he presently holds, where his mai n function is in the connection of technical aspects, sanitariums, \nand production with the Mexican Authorities (SAGARPA), and as Attendance Secretary he participates in the elaboration of norms related to poultry activity.  \nFrom 1990 to the present he has a lso been a member of the National Committee of Animal \nHealth (CONASA), Diseases of Poultry. Likewise, he has participated in various advisory positions of ANECA as well as serving as a member, Vocal , and as a member of the scientific \ncommittee.  \n       \n      \nWithin the area of advisory, he has participated with several poultry companies, among \nthem:   \nAgropecuaria  El Avion (at the moment)   Av\u00edcola Nochistongo   \nAv\u00edcola Sim\u00f3n Bol\u00edvar    \nProductora  de Propollo   \nAvicola Alcer   \nHe currently continues to be an active poultry producer, raising 200,000 chickens in the \nTexcoco area.   \nDuring his career Dr. Carlos Sanchez Widmann has played an integral role in the \nconsolidation and growth of the poultry industry from its beginnings. He continues to do the same.   \nUndoubtedly Dr. Carlos Sanchez Widmann has been an example for the new generations of \nveterinarians now finding themselves with the responsibility of caring for poultry health. He has demonstrated that veterinarians have the capacity to head influential poli tical, administrative, and \neven managerial positions. Congratulations!!!!!!  Dr. Carlos Sanchez Widmann.      \nDEDICATION OF THE ANECA/WPDC JOINT MEETING TO  \nDR. HIRAM LASHER  \n \nThe joint meeting of the XXVII Convenci\u00f3n Anual ANECA and the 51st Western Poultry \nDisease Conference is proudly dedicated to Dr. Hiram Lasher for his many contributions to the \npoultry industry in Mexico, the USA and throughout the world. \n Dr. Lasher obtained his DVM from Cornell University in 1942 and began providing routine \ndiagnostic se rvice to independent poultry farms in the Eastern and Central New York area. He \nthen took a position as an extension veterinarian in Delaware with the State Board of Agriculture \nfocusing on poultry pathology and disease control. \nIn 1950, Dr. Lasher establi shed the Delaware Poultry Laboratories, which specialized in \npoultry diagnostics and production of poultry vaccines. This business eventually became Sterwin Laboratories from which Dr. Lasher retired in 1979. Subsequently, he established a new company, Int ercontinental Biologics in Millsboro, Delaware. This company was subsequently \nacquired and renamed Intervet America, Inc. Some of Dr. Lasher\u2019s accomplishments include the production of the first vaccines for use against tenosynovitis and infectious bursal disease, the first commercial production of vaccines using JMK and Holland strains of infectious bronchitis virus, and the first tissue -culture fowl pox vaccine.  \nDr. Lasher is still actively consulting throughout the world as President of Lasher \nAssociates , Inc.  \nDr. Lasher is a strong supporter of new students and researchers in the field of avian \nmedicine. He and his brother, the late William Lasher of Sunrise Farms, have been long -time \ncontributors to the Western Poultry Disease Conference and the annual conferences of ANECA, and were the first Benefactor contributors to WPDC. Dr. Lasher has been honored with numerous awards and is past recipient of the American Association of Avian Pathologists\u2019 C. A. Bottorff Award, an award that he helped establish and fund. Additionally, Dr. Lasher has received well -deserved recognition for his public service to the Delmarva Poultry Industry and to \nthe State of Delaware, its people and government.      51ST WESTERN POULTRY DISEASE CONFERENCE OFFICERS  \n \nWPDC President           \nDr. Ken Takeshita        \nLohmann Animal Health International  \n4759 Ridgeview Lane             \nVacaville, CA  95688  \n \nProgram Chair     \nDr. Barbara Daft         \nCalifornia Animal Health & Food  \n Safety Laboratory System \u2013  San Bernardino  \n105 W. Central Ave .  \nSan Bernardino, CA  82408  \nProgram Chair -elect  \nDr. David Willoughby  \nCalifornia Department of Food & Ag 3800 Cornucopia Way, Suite F  \nModesto, CA  95350     Proceedings Editor  \nDr. David Frame, Utah State University  \nCooperative Extension USU Turkey Resea rch Center  \n325 West 100 North Ephraim, UT  84627  \n \nSecretary -  Treasurer  \nDr. Richard P. Chin California Animal Health & Food Safety  \n Laboratory System -  Fresno  \n2789 S. Orange Ave.  \nFresno, CA  93725   \n     \nContributions Co- Chairs  \nDr. A. S. Rosenwald & Dr. Ke n Takeshita  \nWestern Poultry Disease Conference  \nP.O. Box 1531 Davis, CA  95617- 1531           \nwpdcontribution@cs.com\n \nThe Proceedings  of the 51st Western Poultry Disease Conference and XXVII Convenci\u00f3n \nAnnual A NECA are not  refereed, but are presented as a service and a source of information to \nthose attending the conference and to others who wish to gain some insight as to the information \npresented.  Copies of the Proceedings are available in either hardcopy or electronic (CD) \nformats.  Currently, we are only able to accept payments by check.  \n \nCopies of these Proceedings are available from:  Dr. R. P. Chin             \nCAHFS -Fresno                    \nUniversity of California, Davis  \n2789 S. Orange Ave.  \nFresno, CA  93725  \nrpchin@ucdavic.edu  \nPrice per copy (includes shipping & handling):  US$20.00 for USA shipment. \nUS$17.00 for AAAP members and orders of 5 or more for      \nUSA.  \nUS$21.00 for Canada and Mexico. US$23.00 for all other countries. Add an additional US$6.00 for airmail.  \nMake checks payable to: UC Regents  \n Still available\u2026  \n50\nth WPDC Anniversary  CD- ROM .  Copies can be purchased from the AAAP. Phone: 610- 444-4282,  \n610-444-5800- ext.2714. Fax: 610- 925-8106. aaap@vet.upenn.edu.  \nWeb: http://cahpwww.nbc.upenn.edu/~aaap/index.html      WESTERN POULTRY DISEASE CONFERENCE (WPDC) HISTORY  \n \n \n PRESIDENT  PROGRAM CHAIR DEDICATION  RECOGNITION  \n \n 1st WPDC \u2013 1952   A. S. Rosenwald   \n 2nd WPDC \u2013 1953  P. D. DeLay  A. S. Rosenwa ld \n 3rd WPDC \u2013 1954  C. M. Hamilton  Kermit Schaaf  \n 4th WPDC \u2013 1955  E. M. Dickinson  W. H. Armstrong  \n 5th WPDC \u2013 1956  D. E. Stover  E. E. Jones  \n 6th WPDC \u2013 1957  D. V. Zander  H. E. Adler  \n 7th WPDC \u2013 1958  H. E. Adler  E. E. Jones  \n 8th WPDC \u2013 1959  R. D. Conrad  L. G. Raggi  \n 9th WPDC \u2013 1960  L. G. Raggi  A. S. Rosenwald  \n10th WPDC \u2013 1961  A. S. Rosenwald  D. V. Zander  \n11th WPDC \u2013 1962  D. V. Zander  R. V. Lewis  \n12th WPDC \u2013 1963  R. V. Lewis  Walter H. Hughes  \n13th WPDC \u2013 1964  W. H. Hughes  Bryan Mayeda  \n14th WPDC \u2013 1965  B. Mayed a R. Yamamoto  \n15th WPDC \u2013 1966  R. Yamamoto  David S. Clark  \n1st sign of Contributors  \n16th WPDC \u2013 1967  D. S. Clark  Roscoe Balch  \n17th WPDC \u2013 1968  R. Balch  Richard McCapes  \n18th WPDC \u2013 1969  R. McCapes  Dean C. Young \n19th WPDC \u2013 1970  D. C. Young  W. J. Mathey  \n  4th Poultry Health Sym. (PHS)    1st combined WPDC & PHS, 1st listing of distinguished members  \n20th WPDC \u2013 1971  W. J. Mathey  Ramsay Burdett  \n  5th PHS \n21st WPDC \u2013 1972  R. Burdett  Marion Hammarlund  \n  6th PHS \n22nd WPDC \u2013 1973  M. Hammerlund  G. W. Peterson  \n  7th PHS \n23rd WPDC \u2013 1974  G. W. Peterson  Craig Riddell \n  8th PHS \n24th WPDC \u2013 1975  C. Riddell  Ralph Cooper  \n  9th PHS \n25th WPDC \u2013 1976  R. Cooper  Gabriel Galvan  \n  10th PHS  \n26th WPDC \u2013 1977  G. Galvan  Don H. Helfer  Hector Bravo  \n  11th PHS \n27th WPDC \u2013 1978  D. H. Helfe r Art Bickford  \n  12th PHS \n28th WPDC \u2013 1979  A. Bickford J. W. Dunsing  \n  13th PHS \n29th WPDC \u2013 1980  J. W. Dunsing (WPDC)  G. Yan Ghazikhanian  P. P. Levine  \n  14th PHS \n  5th ANECA  Angel Mosqueda T. (ANECA)  \n30th WPDC \u2013 1981  G. Y. Ghazikhanian  Mahesh Kumar  \n  15th PHS \n31st WPDC \u2013 1982  M. Kumar  Robert Schock  \n  16th PHS \n32nd WPDC \u2013 1983  R. Schock  George B. E. West  \n33rd WPDC \u2013 1984  G. B. E. West  Gregg J. Cutler  \n34th WPDC \u2013 1985  G. J. Cutler  Don W. Waldrip   Bryan Mayeda  \n35th WPDC \u2013 1986  D. W. Waldrip(WPDC) Duncan A. McM artin (WPDC)  J. A. Allen  \n      PRESIDENT  PROGRAM CHAIR DEDICATION  RECOGNITION  \n \n  11th ANECA  Jorge Basurto(ANECA) Mario Padron (ANECA)  A. Tellez \u2013  G. Rode  \n36th WPDC \u2013 1987  D. A. McMartin  Marcus M. Jensen  \n37th WPDC \u2013 1988  M. M. Jensen  Barry Kelly  A. S. Rosenwald  \n38th WPDC \u2013 1989  B. Kelly  Masakazu Matsumoto   Louise Williams  \n  \n \n39TH WPDC \u2013 1990  M. Matsumoto  Jeanne M. Smith   Dean Young \n40th WPDC \u2013 1991  J. M. Smith (WPDC)  Richard P. Chin (WPDC)  A. S. Rosenwald  \n  16th ANECA  Martha Silva M.(ANECA) David Sarfati M.(ANEC A)A. S. Rosenwald  \n41st WPDC \u2013 1992  R. P. Chin  Rocky J. Terry  Marcus Jensen  Henry E. Adler  \n        (posthumous)  \n      R. A. Bankowski  \n      C. E. Whiteman  \n42nd WPDC \u2013 1993  R. J. Terry  A. S. Dhillon  W. W. Sadler  Royal A. Bagley  \n43rd WPDC \u2013 1994  A. S. Dhillo n Hugo A. Medina   G. B. E. West   \n44th WPDC \u2013 1995  H. A. Medina  David D. Frame  W. M. Dungan  A. J. DaMassa  \n     (posthumous)  Gabriel Galvan  \n    Walter F. Hughes  \n    W. D. Woodward  \n    R. Yamamoto  \n45th WPDC \u2013 1996  D. D. Frame (WPDC)   Mark Bland (WPDC)  Don Zan der (WPDC)  Pedro Villegas  \n  21st ANECA  R. Salado C.(ANECA) G. Tellez I. (ANECA)  M. A. Marquez (ANECA)  Ben Lucio M.  \n    Mariano Salem  \n    Victor Mireles  \n    Craig Riddell \n46th WPDC \u2013 1997  Mark Bland  James Andreasen, Jr.  Bryan Mayeda  Roscoe Balch  \n    Paul D eLay  \n    J. W. Dunsing  \n    Don Helfer  \n    D. E. Stover  \n47th WPDC \u2013 1998  J. Andreasen, Jr.  H. L. Shivaprasad  W. J. Mathey  Marcus Jensen  \n    Duncan Martin  \n48th WPDC \u2013 1999  H. L. Shivaprasad  R. Keith McMillan  \n49th WPDC \u2013 2000  R. K. McMillan  Patricia Wakenell  R. P. Chin  Ralph Cooper  \n    Robert Tarbell  \n50th WPDC \u2013 2001  P. Wakenell  Ken Takeshita   Don Bell  \n    Art Bickford  \n51st WPDC \u2013 2002  K. Takeshita  Barbara Daft  Hiram Lasher  \n \n52nd WPDC \u2013 2002     B. Daft   David H. Willoughby      SPECIAL ACKNOWLEDGMENTS  \n \nThe Wester n Poultry Disease Conference (WPDC) is honored to acknowledge the many \ncontributions to the Conference.  These contributions provide support for outstanding participants and to help pay for some of the costs of the Conference. Over 30 organizations, compan ies and individuals have given substantial financial support. Many companies and \norganizations, including some that also contribute, send speakers at no expense to the Conference.  We thank all these people, and acknowledge their support and contribution. \nWe are extremely pleased to acknowledge three contributors at the Benefactor level. They \nare the American Association of Avian Pathologists, Intervet, Inc., and Merial, Inc. Once again, our distinguished Patrons, Donors, Sustaining Members, and Friends of the Conference are listed on the following pages.  We greatly appreciate their generosity and say thanks to them and their representatives.  \nThe WPDC is especially grateful to Dr. Ernesto Soto, Dr. Victor Mireles and Dr. Julian \nCarrillo for their hard work and efforts into the planning and organization of this joint meeting. \nThanks and appreciations are due to Dr. Barbara Daft, for accepting the responsibilities of \nProgram Chair for this joint meeting. Barbara, Victor and Ernesto have put together an excelle nt \nprogram, with an impressive array of international speakers and poster presenters. With more than 200 titles submitted, dual sessions for both oral and posters were necessary in order to fit as many titles as possible into the program. We thank all the presenters for their time and effort in making this an outstanding program.  \nMany have provided special services that contribute to the continued success of this \nconference. The WPDC would like to thank Ms. Nicole Gibson and the Center for Avian Biology for  their secretarial support to Dr. \u201cRosy\u201d Rosenwald and Dr. Ken Takeshita; Jo Anne \nAllen, Yvette Velasquez, Judy Brooks, Jan McCarthy, and the University of California, Veterinary Medicine Extension/Public Programs for administering the contributions and \nfinancial services; Dr. Rosenwald for once again garnering the outstanding contributions; and to \nall others who contributed to the program and conference.  \nThis year, we are especially appreciative of Ms. Robin Sanchez for handling the registration \nand admini strative duties of this conference. Robin didn\u2019t know what she was getting into \nespecially with a joint meeting in Mexico this year. Dr. Chin is grateful for her patience and hard work with this international conference.  \nWe thank Dr. David Frame for editing and producing an outstanding Proceedings of this \njoint meeting. Dr. Frame is indebted to Ms. Sherry Nielson, Senior Secretary of The Utah State University Turkey Research Center, for her seemingly endless hours of proofreading and formatting the Proceedings for publication.  In addition, we must acknowledge the contributions of ANECA for collecting the papers submitted in Spanish and to Dr. Victor Mireles for his translation of all summaries, both Spanish and English papers. We express our gratitude to al l \nauthors who submitted manuscripts \u2013 especially those who followed the instructions and \nsubmitted their papers on time!  We again acknowledge and thank Ms. Rebecca Dodson and Ominpress, Madison, Wisconsin, for the handling and printing of this year\u2019s Proc eedings. Once \nagain, we thank Bruce Patrick (Graphic Communications, Brigham Young University) for the cover design.  \n \n      WPDC SPECIAL RECOGNITION AWARDS  \n \nAt this year\u2019s conference, the WPDC is pleased to present its Special Recognition Award to \nthe followin g companies for their many years of financial contribution and support to the \nconference. We are especially proud to honor these companies from Latin America during this \njoint meeting. The 2002 Awardees are:  \n \nBachoco S.A. de C.V.  \n \nProductos Toledano S.A.  \n xxi  xx 2002 BENEFACTORS  \n \nAMERICAN ASSOCIATION OF AVIAN PATHOLOGIST S \nKennett Square, PA  \n \nEMBREX , INC \nResearch Triangle Park, NC  \n \nINTERVET  \nBoxmeer, The Netherlands  \n \nMERIAL SELECT, INC.  \nGainesville, GA  \n \n2002 PATRONS  \n \nCobb- Vantress  \nSiloam Springs, AR  \n \nIDEXX Labs,  Inc. \nWestbrook, ME  \n \nLohman Animal Health International  \nGainesville, GA   \nNippon Biologicals, Inc.  \nTokyo, Japan  \n \nSunrise Farms, Inc.  \nCatskill, NY  \n \nSynbiotics Corporation  \nSan Diego, CA  \n \n \n2002 DONORS  \n \nAlltech Biotechnology Centre, Inc.  \nGuelph, ON, Canada  \n \nBachoco S.A. de C.V.  \nCelaya, GTO, Mexico  \n \nBayer Corporation  \nShawnee Mission, KS  \n \nBiomune Co.  \nLenexa, KS  \n \nBoehringer Ingelheim Vetmedica, S.A. de C.V.  \nGuadalajara, Jalisco, Mexico  \n \nCharles River SPAFAS  \nNorth Franklin, CT  \n \nCutler & Associates  \nMoorpark, CA  \n \nHy-Line International  \nDallas Center, IA  Jones -Hamilton Co. \u2013  PLT  \nSalisbury, MD  \n \nLasher Associates, Inc.  \nMillsboro, DE  \n \nPerdue Farms, Inc.  \nSalisbury, MD  \n \nProductos Toledano S.A.  \nPanama City, Panama  \n \nArnold & Jo Rosenwald  \nDavis, CA  \n \nShaver -Hubbard ISA  \nCambri dge, ON, Canada  \n \nTyson de Mexico  \nGomez Palacio, DGO, Mexico  \n \nVeterinary Service, Inc.  \nSalida, CA\n       \n \n2002 SUSTAINING MEMBERS  \n \nAviagen North America  \nHuntsville, AL  \n \nFort Dodge Animal Health  \nOverland Park, KS  \n \nFoster Poultry Farms  \nLivingston, CA  \n \nGemperle Enterprises, Inc.  \nTurlock, CA  \n \nJ.S. West Milling Company  \nModesto, CA  \n \nMerrill\u2019s Poultry Farms, Inc.  \nPaul, ID  \n \nMoroni Feed Company, Inc.  \nMoroni, UT   \nNicholas Turkey Breeding Farms, Inc . \nSonoma, CA  \n \nNovus International, Inc.  \nSt. Charles, MO  \n \nOrlopp Turkey B reeding Farms  \nOrosi, CA  \n \nPacific Egg and Poultry Association  \nSacramento, CA  \n \nPreserve International  \nTurlock, CA  \n \nSchering -Plough Animal Health/ASL  \nUnion, NJ  \n \nWalco International, Inc.  \nCeres, CA  \n \n \n2002 FRIENDS OF THE CONFERENCE  \n \nAgri Stats, Inc.  \nFort Way ne, IN  \n \nCalifornia Poultry Federation, Inc.  \nModesto, CA  \n \nConsortium of California Poultry Extension  \nVeterinarians  \nDavis, CA   \nM. A. Hammarlund, DVM  \nRiverside, CA  \n \nBryan Mayeda, DVM  \nSacramento, CA  \n \nInternational Poultry Production  \nEast Yorkshire, UK  \n     Minut es of the 50th WPDC Annual Business Meeting \n \nPresident Wakenell called the meeting to order on Sunday, 25 March 2001, at 12:00 PM, at \nthe Memorial Union II, University of California, Davis, California. There were approximately 30 \npeople in attendance.  \n \nAPP ROVAL OF 49TH WPDC BUSINESS MEETING MINUTES  \n \nThe minutes from the 49th WPDC business meeting were reviewed and a motion was carried \nto approve them as printed in the Proceedings of the 50th WPDC.  \n \nANNOUNCEMENTS  \n \nPresident Wakenell acknowledged all the cont ributors; in particular, those contributing at \nthe Super Sponsor level, which included the American Association of Avian Pathologists, Merial -Select and International Poultry Production. She also thanked all the contributors for their \ngenerous donations. P resident Wakenell acknowledged the efforts of the current WPDC officers. \nIt was noted that Dr. Wakenell was incorrectly listed as the Program Chair on the page of WPDC officers in the Proceedings.  \n \nREPORT OF THE SECRETARY- TREASURER    \n \nDr. R. Chin presente d the Secretary -Treasurer report. There were 237 registrants for the 49\nth \nWPDC. At the end of the 1998- 99 fiscal year, contributions for the 49th WPDC were $31,950 \nand income from the meeting was $21,455.02. There were expenses of $45,515.56 for the meetin g with a net gain of $7,889.46. The current balance in the WPDC account is $55,705.45. \nDr. Chin estimates a net gain of about $2400 for the 2001 meeting.  \n \nREPORT OF THE PROCEEDINGS EDITOR  \n \nDr. D. Frame presented the Proceedings Editor report. In general, t he production of the \nProceedings went well with all papers being submitted by E -mail. Total expenses for preparing \nand printing the Proceedings were $5910.40. There were 700 Proceedings printed, each with 202 pages, for a cost of $8.44/copy. There are stil l problems with authors not following the \ndirections, in particular, problems with formatting, length and number of tables. Dr. Frame said this was a good learning experience and has prepared him and his secretarial support (Sherry Nielson) to be ready for  next year\u2019s meeting in Mexico. He will work on developing instructions \nthat address the length and number of tables.  \n \nREPORT OF THE LOCAL ARRANGEMENTS COORDINATOR \n \nDr. C. Cardona commented on the difficult planning this year with the meeting being held at  \nUCD. Previously, when the meeting was held at UCD, it was much smaller. Prior to the start of this year\u2019s meeting, we had 346 people registered. She also mentioned the difficulty in working \nwith the present coordinating group and suggested we consider a proposal from the School of     Veterinary Medicine Public Programs for future meetings. It was agreed that Dr. Cardona should \nlook at other organizations for coordinating future meetings. \n \nOLD BUSINESS  \n \nDr. R. Chin reported that the WPDC completed reimbursement to Dr. Rosenwald for his \nprevious out -of-pocket expenses at the WPDC meeting in Cancun.  \n \nNEW BUSINESS  \n \nPresident Wakenell reported that the WPDC Executive Committee did not have a \nnomination for Program Chair -elect of the 52nd WPDC in 2003. Three people were asked and \nsaid they would think about it. It was agreed that President Wakenell would continue talking with these three individuals and report if one agreed to accept the position. (Note: Dr. Dave Willoughby accepted the Program Chair -elect.) Presiden t Wakenell nominated the  \nfollowing officers for 2001- 2002:  \n Program Chair: Dr. Barbara Daft  \nPresident: Dr. Ken Takeshita  \nLocal Arrangement Coordinator: Dr. Carol Cardona  \nContributions Chair: Dr. Ken Takeshita  \nProceedings Editor: Dr. David Frame  \nSecretary -Treasurer: Dr. Rich Chin  \n(Program Chair- elect: Dr. David Willoughby)  \nNominations for all offices were closed and all nominees were approved unanimously.  \nIt was announced that the 51\nst WPDC, in 2002, would be held in conjunction with ANECA \nin Puerto Vallarta, Mexico in 2002. ANECA will be represented by Dr. Ernesto Soto as the Scientific Program Chair, and Dr. Julian Carrillo as the President for ANECA. \nIt was moved, seconded and approved to have the 52\nnd WPDC, in Sacramento, on March 9-\n11, 2003. \nThere was a  discussion on when the WPDC Proceedings should be produced as CD\u2019s and/or \nhard copies. After much discussion, Dr. J. Jeffrey proposed that a CD version of the proceedings \nbe produced every 5 years, in conjunction with the joint meeting with ANECA. The CD would \ncontain the 4 previous years and that year\u2019s proceedings. This proposal was seconded and approved. In addition, it was moved, seconded and approved that ANECA and WPDC make a CD for the 2002 meeting that will be in Puerto Vallarta, Mexico.  \nPresident Wakenell passed the presidency to Dr. Ken Takeshita. President Takeshita thanked outgoing President Wakenell for her service to WPDC and adjourned the meeting at 12:40 PM.      \n \n \n \n    \nMEMORIAS DE LA XXVII CONVENCION ANUAL DE LA \nASOCIACION NACIONAL DE ESPECI ALISTAS EN CIENCIAS \nAVICOLAS  \n \n \nPROCEEDINGS OF THE FIFTY -FIRST  \nWESTERN POULTRY DISEASE CONFERENCE  \n \n \n CONTENIDO \n \nTABLE OF CONTENTS \n \nNota:  Ambas presentaciones (oral y poster) se enlistan a continuaci\u00f3n por autor en orden alfab\u00e9tico.  El orden de las \nponencias se realiz\u00f3 de acuerdo al Prog rama Cient\u00edfico de la Convenci\u00f3n XXVII ANECA \u2013 51st WPDC. \n \nNote: Both the oral and poster presentations of the 51st WPDC \u2013 XXVII ANECA are listed below in alphabetical \narrangement by presenting author.  Authors and titles of all papers scheduled for presentation at the con ference are \nlisted.  \nAUTOR  TITULO                                 PAGINA \nPRESENTER  TITLE            PAGE \n \nACEVES, M. Cin\u00e9tica de la absorci\u00f3n, transporte y depo sici\u00f3n de pigmento carotenoide en pollo  \nde engorda \n Kinetics of caroteoind pigment absorption, transportation, and deposition in broilers ............................ 235  \n ALLAN, B.  A model for the horizontal transfer of Campylobacter jejuni in poultry  \n \nUn modelo para la transferencia horizontal de Campylobacter jejuni  en aves..................................... 240 \n ALMAZA, Y. Mecanismos de patogenicidad de Escherichia coli  aviar como l\u00ednea de investigaci\u00f3n: \nAdherencia a prote\u00ednas de la matriz extracelular \n Pathogenicity mechanisms of avian Escherichia coli  as a research line: Adhesion to extracellular  \n matrix proteins............................................................................................................... 238 \n ALONSO, F.  El comportamiento de las importaciones de carne de pollo en el periodo 1994-1999  \nen el marco del tlcan \n Broiler meat imports within the North American free trade agreement (NAFTA): 1994-1999 .................. 227 \n ALVAREZ, R. T. Efecto de la edad en la mineralizaci\u00f3n del cascar\u00f3n de huevos de gallinas criollas gen \ncuello desnudo (Na) heterocigotas (Nana) y su comparaci\u00f3n con la estirpe comercial babcock B-380, durante el primer ciclo de postura \n Effect of age on egg shell mineralization of native, naked neck (Na gene), heterocygous (Nana), and  \n babcock B-380 hen eggs during the first laying cycle ................................................................. 239 \n AMBROSE, N. S. Case report: Defective down in a commercial broiler flock  \nPlum\u00f3n defectuoso en una parvada comer cial de pollo de engorda .................................................. 172 \n ANDERSON, A.  The human health consequences of antimicr obial use in poultry  \nConsecuencias del uso de antimicrobianos en aves, sobre la salud humana ............................................1 \n ARUMUGASWAMI, V. Redefining a latency model for Marek\u2019s disease virus (MDV)  \nRedefinici\u00f3n de un modelo de latencia para el virus de la enfermedad de Marek ................................. 123 \n AVAKIAN, A.  In ovo administration of Marek\u2019s disease vaccine: Importance of vaccine deposition  \nsite in the fertile egg \nAdministraci\u00f3n In ovo de la vacuna contra la enfermedad de Marek: Importancia del sitio donde queda \ndepositada lavacuna en el huevo fertile .................................................................................. 119 \n BARRI, C. Caracterizaci\u00f3n histopa tologica en enc\u00e9falos de pollos libres de pat\u00f3genos espec\u00edficos \nexperimentalmente infectados con el virus de la enfermedad de newcastle cepa chimalhuac\u00e1n  \n \nBrain histopathological c haracterization of specific pathogen free (SPF) chickens experimentally \n infected with Newcastle disease virus, chimalhuac\u00e1n strain .................................................................... ............241 BECKMAN, B.   Feeding early maturing commercial layers  \n Alimentaci\u00f3n de ponedoras comerciales de madurez temprana  ......................................................... 159 \n \nBELL, D.  New technology for the poultry industry -  The essential components of sci ence and \neconomics  \n Nueva tecnolog\u00eda para la industria av\u00edcola \u2013  Los componentes esenciales de la ciencia y la econom\u00eda  ........ 229 \n \nBENNETT, R. S.  The isolation and characterization of an avian pneumovirus isolate from Canada geese  .. 105 \n \nBLACKALL, P.   Characterisa tion of Indian isolates of H aemophilus paragallinarum   \n Caracterizaci\u00f3n de aislamientos de Haemophilus paragallinarum  en la India  ......................................... 58 \n \nBLACKMORE, C.  A statistical prototype for establishing new histopathology cut off scores in the  \nevaluation of infectious bursal disease vaccine efficacy  \n Prototipo estad\u00edstico para establecer nuevas calificaciones histopatol\u00f3gicas y clasificar claramente  \n los resultados, en la evaluaci\u00f3n de la eficacia de las vacunas contra la infecci\u00f3n de la bolsa de fabricio  ......... 45 \n \nBLAND, M.  C. Case report: A severe infectious coryza infection in a multiple age layer complex in \nCentral California  \n Iinforme de un caso severo de coriza infecciosa en un complejo de postura con parvadas de edades  \n m\u00faltiples en la regi\u00f3n  Central de California  .................................................................................. 56 \n BOCHKOV, Y. A.  Demonstration of avian pneumovirus infection in chickens in Russia  \nDemostraci\u00f3n de la infecci\u00f3n de pollos con el neumovirus aviar ( APV) en Rusia  ................................... 242 \n BOULIANNE, M.  S. Enteritidis  surveillance program in layers in Quebec  \n \nPrograma de vigil ancia de S. Enteritidis  (SE) en ponedoras en Quebec  ................................................. 15 \n BOUZOUBAA, K.  Studies on predominant diseases in poultry backyard flocks in Morocco \n(Khenifra region)  \n Estudios sobre las enfermedades predominantes en las parvadas de traspatio  \n en Marruecos (regi\u00f3n  de Kenifra)  ................................................................................... 243 \n BYRD, J. A.  \nEffect of experimental chlorate compound (ECP) on Salmonella  contamination of poultry  ............ 9 \n \nCABRIALES, J.  Comportamiento de la eliminaci\u00f3n de ooquistes como herramienta en la evaluaci\u00f3n  \nde una vacuna contra la coccidiosis aviar en aves reproductoras  \n Oocyst shedding as a tool in the evaluation of a coccidial vaccine in breeders  ...................................... 134 \n \nCALLISON, S. A.  Creation of a novel infectious bronchitis virus S1 gene library by DNA shuffling  \n Creaci\u00f3n de una nueva colecci\u00f3n del gene S1 del vir us de la bronquitis infecciosa mediante la  \n combinaci\u00f3n aleatoria del ADN  .................................................................................................. 74 \n CAMACHO, D.  Dietas formuladas a prote\u00edna ideal y restricci\u00f3n alimenticia, sobre la hiperplasia e \nhipertrofia del tejido graso abdominal en pollos de engorda  \nEffect of ideal prot ein-formulated diets and feed restriction on fat pad hyperplasia and hypertrophy  \nin broilers  ........................................................................................................................... 170 \n  \nCAMPOGARRIDO, R.  Impacto de la P asteurella haemolytica en parvadas comerciales  \nThe impact of P asteruella haemolytica on commercial flocks  ............................................................ 84 \n \nCANO, M.   Situaci\u00f3n y oportunidad de la producci\u00f3n de huevo organico en un sistema rural  \nde la sierra norte de Puebla \n Status and opportunities of organic egg production in a rural system in the northern sierra of Puebla  .......... 244 \n CAPUA, I.  Strategies for the control of avian influenza in Italy  ....................................................... 147 \n \n CARDONA, C.   Neuropathology associated with H aemoproteus lophortyx infection in Bobwhite quail  \n Neuropatolog\u00eda asociada con la infecci\u00f3n por H aemoproteus lophortyx  en codornices  \n bobwhite  ............................................................................................................................ 246 \n \nCASTELLANOS, N. L.  Amplification o f the il -2 gene of total chicken spleen cells in a Salmonella gallinarum  \ninfection  .......................................................................................................................... 247 \n   \nCERDA, R.   Eficacia del 3 -acetil 4\u201d -isovaleril tartrato de tilosina en el tratamiento de la  \nenfermedad respiratoria cr\u00f3nica (Mycoplasma allisepticum ) \nEfficacy of 3 -acetyl, 4\u201d- isovaleryl tylosine tartrate (AIV) in the treatment of chronic respiratory disease \n(Mycoplasma gallisepticum ) .................................................................................................... 212 \n \nCERVANTES, H.  Incidence of pathological conditions in clinically normal broilers from different  \n regions of the USA  ......................................................................................................... 220 \n \nCERVANTES , R. Aplicaci\u00f3n de una cut\u00edcula artificial en huevos incubados de avestruz  \n Application of an artificial cuticle  to ostrich hatching eggs  ............................................................. 248 \n \nCERVANTES, R.  Determinaci\u00f3n del peso \u00f3ptimo de incubaci\u00f3n en huevos de avestruz  \n Determination of optimum egg we ight in ostrich hatching eggs  ........................................................ 250 \n \nCHAPA, B.  Hallazgos macrosc\u00f3picos y microscopicos en aves con problemas de despigmentacion \ntrabajo experimental  \n Gross and microscopic findings in poultry with poor pigmentation -  Experimental work  ......................... 252 \n \nCHAPMAN, D. H.  The use of feed additives in broiler chickens in the USA  \nUso de aditivos alimenticios en pollo de engorda en EE.UU.  .......................................................................... 219 \n \nCHARLES, M.   Aspectos relevantes del proceso de coagulaci\u00f3n en las aves  \n Relevant aspects of the blood clotting process in birds .................................................................... 156 \n \nCHIN, R. P. Neisseria sp.  \u2013 A novel bacterium of poultry  .................................................................  254 \n CLARK, S.  Disk -diffusion testing of reference and poultry veterinary bacterial isolates for \nsusceptibility to Aureomycin \uf8e8 (Chlortetracycline)  \n Prueba de difusi\u00f3n en disco para determinar la suscept ibilidad a la Aureomicina\u00ae (Clortetraciclina)  \n de aislamientos bacterianos de referencia y de casos  ...................................................................... 255 \n COOKSON, K.\n A Comparison of 3 live Salmonella vaccines against group C and D Salmonella challenge  \n Comparaci\u00f3n de 3 vacunas vivas de Salmonella contra  el desaf\u00edo con Salmonella  de los gripos C y D  .......... 12 \n \nCOOPER, G.   Hexamita meleagridis  infection in chukar partridges associated with high mortality  \nand intracellular trophozoites  \n Infecci\u00f3n con Hexamita meleagridis  en perdices chukar, asociada con alta morta lidad y trofozo\u00edtos \nintracelulares  ....................................................................................................................... 174 \n \nCORONA, J.   Evaluaci\u00f3n de mortalidad, lesiones ent\u00e9ricas y coccidiosis en pollos de engorda  \ntratados con exclusi\u00f3n competitiva y toltrazuril  \n Evaluation of mortality, enteric lesions, and coccidiosis in chickens tre ated with competitive  \n exclusion and toltrazur  ........................................................................................................... 137 \n CORTES, C. A.  Digestibilidad aparente ileal de proteina y aminoacidos en pollos de engorda con la \nadicion de fitasa en la dieta  \n \nApparent ileal digestibility of proteins and aminoacids in broilers after  addition of phytase to the diet  ........ 161 \n \nCORTES, P.   The role of Marek\u2019s disease viral IL -8 in viral pathogenesis  \n El papel de la interleucina 8 del virus de la enfermedad de Marek en la patogenia de la enfermedad   .......... 122 CUMMINGS, T.  Antibiotic use in food anim al medicine: The quiet voice of reason in the  \nantibiotic resistance debate  \nEl Uso de antibi\u00f3ticos en la medicina de los animals productores de alimentos para el hombre: La callada  \nvoz de la raz\u00f3n en el debatede la resistencia a los antibioticos  .............................................................. 1  \n \nCUPIT T, D. Darkling beetle [ alphitobius diaperinus panzer   (coleoptera: tenebrionidae )] Control  \nin Australian broilers \u2212enhancing food safety  \n Control del escarabajo negro ( alphitobius diaperinus panzer  [coleoptera : tenebrionidae ]) en pollos de  \n engorda Austral ianos: favoreciendo la seguridad alimentaria .............................................................. 32 \n DAVILA, V.   The effect of Nobilis Cox ATM\u00ae, avian coccidiosis vaccine, on pigmentation  and productive parameters in broilers  \n \nThe effect of Nobilis Cox ATM\u00ae, avian coccidiosis vaccine, on skin pigmentation and productive parameters  \n in broilers  ........................................................................................................................... 256 \n DHILLON, A. S.  High mortality in layers as a result of clostridial enteritis  .............................................. 175 \n DONOGHUE, D.   Transfer of food borne bacterial pathogens: Investigating potential modes of infection  \nin turkeys  \nTransferencia de  bacterias pat\u00f3genas de origen alimentario: Investigaci\u00f3n de los modos potenciales de  \ninfecci\u00f3n en pavos  ........................................................................................................................................... 259 \n ECKROADE, R.  Using geographic information system (GIS) technology to determine the location of commercial poultry flocks, support industry and li ve bird market system companies, \ndealers and markets in Pennsylvania  \n \nUso de la tecnolog\u00eda del sistema de informaci\u00f3n geogr\u00e1fica ( GIS)  para determinar la ubicaci\u00f3n de  \n las parvadas comerciales y apoyar a la industria, las compa\u00f1\u00edas, distribuidores y los m ercados  \n de aves vivas en Pennsylvania  .................................................................................................. 146 \n ESCAMILLA, J.                Protecci\u00f3n conferida por vacunas emulsionadas contra un aislamiento local del virus  \n               de gumboro  \n \nProtection with oil emulsion vaccines against challenge with local IBD V isolates  ................................... 47 \n \nESCORCIA, M.   El virus de influenza aviar. \u00bfPotencial pand\u00e9mico? (Revisi\u00f3n bibliogr\u00e1fica)  \nAvian influenza virus:  Pandemic  potential? (A bibliographic review)  ........................................................... 261 \n  \nESQUIVEL, P.   SEXADO DE AVESRUCES  \n Sex determination in ostriches  .................................................................................................. 262 \n FADLY , A. Influence of Marek\u2019s disease vaccines on the response of commercial broiler breeder \nchickens to infection with subgroup J avian leukosis virus  \n \nInfluencia de las vacunas contra la enfermedad de Marek sobre la respuesta de las reproductoras pesadas  \n a la infecci\u00f3n con el virus de la leucosis aviar, subgrupo  J ............................................................... 129 \n \nFERENC, R.  Diagnostic pathology and ultrastructure of Avian diseases  ............................................ 223 \n \nFERNANDEZ, A. I.   Efecto de una vacuna comercial de coccidia sobre el tipo de especie presente despu\u00e9s  \nde un desaf\u00edo  pat\u00f3geno en pollos de engorda  \n Effect of a coccidial commercial vaccine on the Eimeria species present after a pathogenic challenge in  \n broilers  .............................................................................................................................. 266 \n \nFERNANDEZ, P.  Revision critica de la coriza infecciosa  \n Infectious coryza: a critical review  .................................................................................................................... 66 \n \nFERNAND EZ, R.  Identificaci\u00f3n de virus de la enfermedad de gumboro en el Per\u00fa por elisa de  \ncaptura de ant\u00edgeno  \n Identification of infectious bursal disease virus in Peru using antigen capture ELISA  ............................. 263 FIERRO, J. A.   Compatabilidad de un adsorbente organoaluminos ilicato de Micotoxinas con  \naditivos quimicos  \n Compatibility of a Mycotoxin adsorbing organic aluminum silicate with chemical additives  .................... 269 \n \nFUENTE, M.  Efecto de la adici\u00f3n de fitasa como fuente  de f\u00f3sforo inorg\u00e1nico en dietas para gallinas de postura  \n The effect of phytase addition as a source of inorganic phosphorous in layer diets  .................................  162 \n GALLAZZI, D.  Effects  of the vaccination and normal avian gut flora (NAGF) application on  \nSalmonella enteritidis/S. gallinarum  control in commercial layers in Italy  \n Efectos de la vacunaci\u00f3n y de la aplicaci\u00f3n de flora intestinal av\u00edcola normal (NAGF) sobre el control  \n de Salmonella enteritidis/S. gallinarum  en ponedoras comerciales, en  ................................................ 270 \n GARCIA, A.   Presencia de H aemophilus paragallinarum  NAD independiente en M\u00e9xico  \nThe presence of NAD -independent H aemophilus paragallinarum in Mexico  ......................................... 59 \n GARCIA, A.   Efecto de Ocratoxina A, urea y amprolio sobre la pigmentaci\u00f3n en pollo de engorda  \n \nEffect of Ochratoxin A (OA), urea, and amprolium on skin pigmentation in broilers  .............................. 204 \n \nGARCIA, A.  Evaluaci\u00f3n de la capacidad de secuestro in vitro  de Ocratoxina A por diferentes \nsecuestrantes comerciales utilizados en M\u00e9xico  \n Evaluation of the in vitro  effectiveness on Ochratoxin A (OA) of different Mycotoxin binders  used  \n in Mexico  ........................................................................................................................... 271 \n \nGAR CIA, A.   Evaluaci\u00f3n de secuestrantes de micotoxinas para reducir la toxicidad en dietas para   \npollo de engorda contaminadas con cultivos de Aspergillus ochraceus y fusarium \ntricinctum  productores de Ocratoxina A y toxina T -2 \n Evaluation of mycotoxin binde rs to decrease toxicity in broiler diets contaminated with  \n Ochratoxin A -/T-2 toxin -producing Aspergillus ochraceus and fusarium tricinctum  cultures  .................... 274 \n GARCIA, I.   Evaluaci\u00f3n de la calidad de absorentes amoniacos  \n Quality evaluation of ammonia absorbent s .................................................................................. 209 \n GARCIA, J                        Caracterizaci\u00f3n de un aislamiento mexicano de un virus de gumboro  \n \nCharacterization of a mexican infectious bursal disease virus (IBDV) isolate  ......................................... 46 \n GAY, M.  Evaluaci\u00f3n experimental de una vacuna atenuada contra la bro nquitis infecciosa  \nserotipo BL56  \n \nExperimental evaluation of an atenuated infectious bronchitis vaccine, serotype BL -56 ............................ 75 \n GAZDZINSKI, P.  Venereal colibacillosis  (acute vaginitis) in turkey breeder hens  \n \nColibacilosis ven\u00e9rea (vaginitis aguda) en pavas reproductoras  ......................................................... 176 \n GELB, J.  Inactivated virus vaccination for controlling the nephropathogenic PA/wolgemuth/98 \nstrain of infectious bronchitis virus  \nVacunaci\u00f3n con virus inactivado para el control de la cepa neuropat\u00f3gena PA/wolgemuth/98 del virus de la \nbronquitis infecciosa .......................................................................................................................................... 70 \n \nGILBERT, R.  Autogeneous IBD vaccines: techniques for isolating \u201cNew\u201d IBD strains which  \n are not protected by maternal immunity  ........................................................................... 53 \n \nGOMIS, S.   Stimulation of the immune system of broilers against cellulitis / colibacillosis  \n Est\u00edmul o del aparato inmunocompetente de los pollos de engorda contra la celulitis/colibacilosis  ................ 42 \n \nGONZALEZ, C.   Coriza infecciosa, inmunidad y resistencia bacteriana a los antibi\u00f3ticos  \nInfectious coryza (CI): Immunity and bacterial antibiotic resistance   .................................................... 63 \n GONZALEZ, E.   Patrones de resistencia antibi\u00f3tica en P asteurella haemolytica  aviar  \n Antibiotic resistence pattern of avian Pasteurella haemolytica  ........................................................... 87 \n \nGUENTHER, R.   New variety of Ornithobacterium rhinotracheale  \n Una nueva variedad de Ornithobacterium rhyno tracheale  ............................................................... 277 \n \nGUERRERO, R.   El codex, seguridad alimentaria, y el comercio internacional  \n The codex alimentarius, food safety, and international trade  .............................................................. 37 \n \nGUSTAFSON, C.  In ovo technology meeting the challenges of today and tomorrow  \n La tecnolog\u00eda In ovo  satisface los retos de hoy y del manana  .............................................................. 20 \n \nHADDAD, E.  Safety and efficacy of a novel Newcastle disease vaccine administered In ovo to  \nSPF and commercial broiler birds  \n Seguridad y eficacia de una nueva vacuna contra la enfermedad de Newcastle administrada In ovo  a aves  \n SPF y a pollos de engorda comerciales  ....................................................................................... 101 \n HAFEZ, H. M.  Pre- and post - harvest approaches to reduce Salmonella in poultry meat production:  \n Review  ................................................................................................................................ 4 \n \nHAFEZ, H. M.\n  Re-emergence of fowl pox in Germany  \n Resurgimiento de la viruela aviar en A lemania  ............................................................................... 28 \n \nHEINS MILLER, S.  Proven triculitis/poor feed conversion:  A case study  ..................................................... 177 \n \nHERNANDEZ, V. X.  Evaluaci\u00f3n de una vacuna de Eimeria tenella, E. acervulina y E. maxima  en pollo  \nde engorda  \n Evaluation of an Eim eria tenella/E. acervulina/E. maxima  vaccine in broilers  ...................................... 278 \n HOWELL, L.   Use of diclazuril for the prevention of coccidiosis in turkeys  \n \nEl uso del diclazuril para la prevenci\u00f3n de la coccidiosis en pavos  ..................................................... 140 \n HUERTA, J.   Caracterizaci\u00f3n molecular del virus bronquitis infecciosa  \n Molecular ch aracterization of infectious bronchitis virus  .................................................................  280 \n HUFF, G. R.  The influence of behavior and environmental enrichment on resistance of turkeys to Escherichia coli respiratory infection  \n Influencia del comportamiento y del enriquecimiento del ambiente sobre  la resistencia de los pavos  \n a la infecci\u00f3n respiratoria por E scherichia coli  ............................................................................. 282 \n HUFF, W.  Studies on the use of bacteriophage aerosol sprays to prevent E. coli respiratory disease  \nin poultry  \nEstudios sobre el uso de aspersiones de bacteri\u00f3fagos para p revenir la enfermedad respiratoria causada por \nEscherichia coli  en aves  ........................................................................................................... 41 \n INGALLS, F.   Analisis de la rentabilidad en la comercializacion de pollo en M\u00e9xico  \n A profitability analysis of broiler trade in Mexico  ......................................................................... 283 \n JACKWOOD, M.  Advances in diagnosis of I BV using real -time RT -PCR \n \nAvances en el diagn\u00f3stico de la bronquitis infecciosa usando la reacci\u00f3n en cadena con  \n polimerasa y transcriptasa inversa (RT -PCR) de tiempo real  .............................................................. 69 \n JACOBS, A.  An emerging immunotype (variant type B) of H aemophilus paragallinarum : Serotyping \nand vaccination -challenge experiments  \n \nUn nuevo inmunotipo (tipo variante B) de H aemophilus paragallinarum:  Serotipificaci\u00f3n y experimentos  \n de vacunaci\u00f3n y desaf\u00edo  ........................................................................................................... 62 \n JUAREZ, M.  Caracterizaci\u00f3n biol\u00f3gica de cuatro cepas velog\u00e9nicas y un a lentog\u00e9nica del virus de la \nenfermedad de Newcastle  \n Biological characterizatiohn of one lentogenic and four velogenic strains of Newcastle disease virus  ........... 79 \n \nJUAREZ, M.  Captura de ant\u00edgeno contra el virus de leucosis aviar en distintos \u00f3rganos de pollo  \nde engorda  \n Antigen capture against avian leukosis virus in different broiler organs  .............................................. 130 \n JUAREZ, M. A.  Evaluaci\u00f3n de una cut\u00edcula artificial sobre la p\u00e9rdida de humedad e incubabilidad en \nhuevos de aves leghorn de segundo ciclo  \n Evaluation of an artificia l cuticle on moisture and hatchability loss in the eggs of second -cycle  \n leghorn hens  ........................................................................................................................ 284 \n \nKAPCZYNSKI, D.  Immune function following vaccination with an inactivated avian pneumovirus vaccine  \n La funci\u00f3n inmune despu\u00e9s de la aplicaci\u00f3n de una vacuna inactiv ada contra el neumovirus aviar  ............. 287 \n KELLY, B. J.   Fluoroquinolone use in poultry in the USA:  Impact on public health ?  \nEl uso de las fluoroquinolonas en la industria av\u00edcola estadounidense \u2013  \u00bfImpacto sobre la salud p\u00fablica?  ....... 29 \n KLEVEN, S.\n  Recent developm ents in Mycoplasma diagnosis and control  \n Desarrollos recientes en el diagn\u00f3stico de M ycoplasma  y su control   ................................................. 109 \n LECHUGA, M.  T\u00e9cnicas para la evaluaci\u00f3n del tama\u00f1o de la bolsa de fabricio y su relaci\u00f3n con el  \nestado de salud de la parvada  \n \nTechniques fo r bursal size evaluation and its relationship with flock health status  ................................... 43 \n LEDESMA, N.   Diferenciaci\u00f3n de aislamientos del virus de anemia infecciosa en M\u00e9xico  \n \nDifferentiation of chicken anemia virus strains isolated in Mexico ....................................................... 55 \n LEE, M.    Vaccine potent ial of core LPS of avian Escherichia coli  \n El potencial del lipopolisac\u00e1rido ( LPS) central de Escherichia coli  aviar como vacuna  ........................... 288 \n LIMA, A.  Cambios hematologicos en aves infectadas con la cepa 73688 altamente patogena del virus de infeccion de bolsa de fabricio  \n Hematological changes in birds infected with highly pathogenic 73688 strain, infectious bursal disease  \n (IBD) virus  ......................................................................................................................... 290 \n LOBANOV, V. A.  Application of the PCR to detect chicken anemia virus genome  \n Aplicaci\u00f3n de la reacci\u00f3n en cadena con polimer asa (PCR) para detectar el genoma del virus de la anemia  \n del pollo  ............................................................................................................................. 292 \n \nLOPES, V.   Ornithobacterium rhinotracheale : Its survival over time and temperature in poultry  \nlitter  \n Ornithobacterium rhinotrachaels (ort):  Su supervivencia ante el tiempo y la tem peratura en la  \n cama av\u00edcola  ......................................................................................................................... 90 \n \nLOPEZ, B.   Efecto de la estirpe genetica, sexo y algunas practicas de manejo sobre los parametros  \nde produccion en el pollo de engorda  \n Effect of the strain, sex, and management practices  on broiler production parameters  ............................. 293 \n LOPEZ, C. C.   Efecto de la temperatura de crianza sobre el emplume de pollos de engorda  \nmachos y hembras  \n \nThe effect of brooding temperature on feather development in male and female broilers  ......................... 192 \n \nLOPEZ, C. C.   Mtodolog\u00eda para evaluar excretas de pol lo \n Methodology for fecal evaluation .............................................................................................. 206 \n LOUGOVSKAIA, N. N.  Enzyme -linked immunosorbent assay using peptide specific antibodies for detection \nof avian infectious bronchitis virus  \nEnsayo de inmunoabsorci\u00f3n ligado a enzimas usando anticuerpos espec\u00edficos co ntra p\u00e9ptidos para la  \ndetecci\u00f3n del virus de la bronquitis infecciosa  ................................................................................................ 294 \n \nLU, H.  Persistence and immune response of a Pennsylvania nephropathogenic strain of IBV  \nin SPF chickens  \n Persistencia y respuesta inmune de una cepa nefropat\u00f3gena del virus de la b ronquitis infecciosa en pollos  \n libres de pat\u00f3genos espec\u00edficos ( SPF) en Pennsylvania  ..................................................................... 71 \n \nMANIN, T. B.   Characterization of ND virus isolate from recent outbreak in central region of Russia  \n Caracterizaci\u00f3n de un aislamiento del virus de la enfermedad de newcastle de un brote reciente en la  \n regi\u00f3n central de Rusia  ........................................................................................................... 295 \n \nMARQUEZ, M. A.  Prevalencia e identificaci\u00f3n de serogrupos y serovariedades de Haemophilus \nparagallinarum  en gallinas de postura en M\u00e9xico  \n Prevalence and identification of Haemophilus para gallinarum serogroups y serovars in commercial  \n layers in Mexico  ..................................................................................................................... 60 \n MARQUEZ, R.   Evaluaci\u00f3n  in vivo  de la capacidad inhibitoria de las micotoxicosis en aves  \nalimentadas con dietas contaminadas con aflatoxinas, Ocratoxina A y  toxina T -2 con la \nadici\u00f3n de  levaduras  Saccharomyces cereveisiae y con mananglucanoligosacaridos \n(Safmannan \nmr) \n In vitro evaluation of the mycotixicosis inhibitory activity of the addition of Saccharomyces cereveisiae  \n yeast and mannan oligosaccharides (Safmannantm) in birds fe d aflatoxin -, Ochratoxin A -, and  \n T-2 toxin - contaminated feeds  .................................................................................................. 202 \n \nMARRUFO, D.  Evaluaci\u00f3n de la aplicaci\u00f3n de una vacuna inactivada contra el virus de la bronquitis infecciosa por aspersi\u00f3n en una parvada de pollo de engorda  \n Evaluation of a spray -given , killed, infectious bronchitis virus (IBV) vaccine in a broiler flock  ................ 295 \n MARSH JOHNSON, T.\n Impact of poultry house air quality on human health \n Impacto de la calidad del aire en las casetas av\u00edcolas sobre la salud humana  ........................................ 187 \n MARTINEZ, J. F.  \u201cEvaluaci\u00f3n de par\u00e1metros productivos y grado de pigmentaci\u00f3n en pollos de engorda \nvacunados contra coccidiosis (Nobilis Cox ATM\u00ae) y medicados con Salinomicina  (Sacox \u00ae).\u201d \n Evaluation of productive parameters and skin pigmentation of coccidia -vaccinated (Nobilis  \n Cox ATM\u00ae)/Salinomycin -treated (Sacox\u00ae) broilers  ..................................................................... 297 \n MATA, S.  \n Manejo para la ponedora comercial  \nManaging the commercial layer  ...................................................................................................................... 190 \n \nMC DOUGALD, L. R.  Control of histomoniasis in chickens and turkeys  \n Control de la histomoniasis en pollos y pavos  .............................................................................. 142 \n \nMC KEE , S. R. Low levels of electron beam irradiation improve poultry meat safety but alter meat quality  \n La radiaci\u00f3n con un haz de electrons de bajo nivel mejora la seguridad de la carne de ave pero modifica su \ncalidad  .................................................................................................................................  36 \n \nMEDINA, H.  Experiences with killed oil emulsion Newcastle disease virus vaccine on day old  \nturkey poults in the Midwest (USA)  \n Experiencias con una vacuna inactivada y emulsionada en aceite, elaborada con el virus de la enfermedad de \nNewcastle para uso en pavipollos de un d\u00eda en el medio oes te Estadounidense ............................................... 103 \n \n  MEDINA, J. C.   Aseguramiento de calidad en determinar el nivel de vitamina A en alimentos  \nbalanceados  \n Quality assurance in the quantification of vitamin A in finished feeds  ................................................ 164 \n \nMENDEZ, G.   An\u00e1lisis comparativo de antibiogramas r ealizados en aislamientos de Escherichia coli  \nDurante el periodo 1996 \u2013  2001  \n Compatarive analysis of sensitivity tests using Escherichia coli  isolates: 1996 \u2013  2001 ............................ 299 \n \nMERINO, R.  Uso del ensayo ELISA para detectar anticuerpos contra el virus de Influenza Aviar en \nyema de huevo y establecer el estado de infecci\u00f3n/vacunaci\u00f3n en gallinas de postura  \n Use of ELISA test to detect avian influenza virus (AIV) antibodies in egg yolks and to establish  \n infection/ vaccination status in laying hens  .................................................................................... 16 \n \nMERINO, R.   Uso del ensayo ELISA para detectar anticuerpos contra Salmonella enteritidis  en  \nyema de huevo y establecer el estado de infeccion en gallinas de postura \nThe use of ELISA to detect Salmonella enteritidis  (SE) antibodies in the yolk sac,  \n and to establish infection status in laying hens  .............................................................................. 154 \n \nMIRANDE, A.   Reduction of Salmonella in the United States poultry industry through vaccination  \n Reduccion de Salmonella  en la industria avicola de los Estados Unidos a traves de la vacunacion  ................. 7 \n \nMIREYA, J.  Estudio serol \u00f3gico y morfol\u00f3gico de adenocarcinomas abdominales en gallinas \nreproductoras semipesadas  \n Serological/morphological study of abdominal adenocarcinomas in semi -heavy breeders  .............................. 301 \n \nMONCADA, L. B.  Epizootiolog\u00eda de la leucosis mieloide subgrupo \u201cJ\u201d en aves s emiligeras y criollas del \nNorte de Puebla \nEpidemiology of myeloid leukosis subgroup \u201cJ\u201d in semi -heavy and native hens in Northern Puebla  ............. 302 \n  \nMONDAL, S. P.   A preliminary report on a rapid test for the detection of infectious bronchitis virus  \n Reporte pr eliminar de una prueba r\u00e1pida para la detecci\u00f3n del virus de la bronquitis infecciosa  .................. 68 \n MOORE, K. M.\n  Efficacy and safety of a recombinant fowl poxvirus containing laryngotracheitis genes  \n Eficacia y seguridad de un poxvirus recombinante conteniendo gene s de laringotraqueitis  ......................... 21 \n \nMORALES, L. R.  Efecto del 25 hidroxicolecalciferol (25 -(OH)D 3) en los par\u00e1metros productivos e \ninmunidad de pollos de engorda  \n Effect of 25 hydroxy -chole -calciferol (25 -(OH)D 3) on productive parameters and immunity of broilers ...... 303 \n MUNOZ, J.   Uniformidad en alimentos balanceados  \n Balanced feed uniformity  ........................................................................................................ 168 \n \nMUNOZ, J.   Lo que se debe conocer de las evaluaciones de adsorbentes de micotoxinas  \n What we should know about mycotoxin binders  ........................................................................... 304 \n \nMUNOZ, P.  Evaluacion de proteccion contr a la enfermedad de Newcastle ante un desafio, utilizando \ndiferentes calendarios de vacunacion  \n Protection against challenge using different Newcastle disease vaccination programs schedules .................. 98 \n MURILLO, M. A.\n Experiencia de tres a\u00f1os con el uso de  una vacu na termosensible de Mycoplasma  \nsynoviae  \n Three -year experience using a temperature- sensitive Mycoplasma synoviae (ms) vaccine  ........................ 305 \n \nNAGARAJA, K. V.  Serodiagnosis of Salmonella enteritidis  infection in poultry ............................................ 13 \n \n NASCIMENTO, E.  Serologic responses and recovery of Mycoplasma gallisepticum  in SPF  \n vaccinated chickens  ........................................................................................................ 307 \n \nOJKIC, D.   Phylogenetic analysis of Ontario infectious bronchitis virus isolates  \n An\u00e1lisis filogen\u00e9tico de aislamientos del virus de la bronquitis infecciosa en Ontario  .... 73 \n \nORTEGA, D.   Patog\u00e9nesis molecular de infecciones provenientes de S almonella spp  \n Molecular pathogenesis of S almonella spp  infections  ..................................................................... 308 \n \nORTIZ, A.   Bienestar y productividad en la industria av\u00edcola  \n Welfare and productivity in the poultry industry  ........................................................................... 309 \n \nORTIZ, M.  Caracterizaci\u00f3n molecular de aislamientor mexicanos del virus de la enfermedad de newcastle:  1997- 2001  \n Molecular characterization of mexican newcastle disease virus (NDV) isolates,  \n 1997 \u2013 2001  ....................................................................................................................... 77 \n \nOWENS, C. M.  Screening broilers with halothane and succinylchol ine to identify birds prone to \ndeveloping pale, soft, exudative (PSE) meat  \n An\u00e1lisis del pollo de engorda con halotano y succinilcolina para identificar a los individuos  \n susceptibles al desarrollo de carne p\u00e1lida, suave y exudativa ( PSE) ................................................... 310 \n \nPAGES -MANTE , A. Utilizaci\u00f3n de prote\u00ednas recombinantes en una vacuna inactivada contra la  enfermedad de gumboro  \n \nThe use of recombinant proteins in a killed, infectious bursal disease virus (IBDV) vaccine  ....................... 52 \n PARCELLS, M.   Characterization of vv+MDVs having mutation s in glycoprotein L (gL)  \n Caracterizaci\u00f3n de los virus muy virulentos de la enfermedad de marek que presentan mutaciones  \n en la glucoprote\u00edna L (gL)  ....................................................................................................... 311 \n \nPRADO, R.  Efecto de edad de la reproductora en peso de huevo, p\u00e9rdida de humedad, mortalidad \nembri\u00f3ni ca, tiempo de reposo, y viabilidad de progenitura durante la primera semana  \nde vida  \n Effect of breeder age on egg weight, moisture loss, embryo mortality, resting time, and first week  \n broiler livability  ................................................................................................................... 312 \n PRIGGE, J.   Characterization of the Marek\u2019s d isease virus phosphoprotein 38 (pp38) gene family  \n \nCaracterizaci\u00f3n de la familia del gene de la fosfoprote\u00edna 38 (pp38) del virus de la enfermedad de Marek  ... 125 \n QUEZADA, T.   Aseguramiento de calidad en determinar el nivel de vitamina A en alimentos  \nbalanceados  \nQuality assurance in the quantification of vitamin A in finished feeds  ................................................ 166 \n QUINTANA, J.   Efecto de dos r\u00e9gimenes alimenticios en reproductoras pesadas  \nEffect of  two broiler breeder feeding programs (Hubbard)  .............................................................. 313 \n \nQUINTANA, J.   Productividad en repr oductoras de consumo incrementado de alimento \n Productivity of broiler breeders with a higher feed intake (Avian farms)  ............................................. 314 \n \nQUINTANA, J.   Determinaci\u00f3n de hormonas sexuales y tiroidens en muestras de suero implementando  \nun m\u00e9todo radio immuno an\u00e1lisis humano  \n Detection of sexual and tyroid hormones in broiler breeder serum  using human radio immuno  ................ 318 \n \nQUINTERO, M. T.  Primer hallazgo en m\u00e9xico del \u00e1caro  Yerygocrusolichus chanayi en guajolotes de  M\u00e9xico  \n \nFirst report in Mexico of the mite Pterygocrusoli chus chanayi  in turkeys  ........................................... 145 QUINTERO, T.  Primer hallazgo en m\u00e9xico del \u00e1caro P terygocrusolichus chanayi en guajolotes de \nM\u00e9xico  \n First report in Mexico of the mite Pterygocrusolichus chanayi  in turkeys  ........................................... 321 \n \nRAMIREZ, G.   Cambios hematol\u00f3gicos en aves legh orn infectadas con el virus H5N2 de influenza  \naviar de alta patogenicidad  \n Hematological changes in leghorn birds infected with highly pathogenic H5N2 avian influenza virus  ........ 150 \n \nRATH, N.   Modulation of phagocyte function by ovotransferrin, a chicken acute  phase protein \n Modulaci\u00f3n de la funci\u00f3n de los fagocitos por la ovotransferrina, prote\u00edna de fase aguda en el pollo  .......... 322 \n RAVIV, Z.   Magnesium intoxication in broiler breeder chicks  \n Intoxicaci\u00f3n con magnesio en pollas reproductoras pesadas  ............................................................. 178 \n \nREBOLLEDO,  P. El efecto de humedad incubatoria en los par\u00e1metros productivos del pollo          \n The effect of incubation humidity on hatchability and embryo mortality, and on major broiler  \n productive parameters  ............................................................................................................ 187 \n \nREIMERS, N.   Gastric intussusception in laying hens \n Intususcepci\u00f3n en ponedoras  ................................................................................................... 180 \n \nREVELO, U.   Enfermedad de Marek en pollo de engorda informe de un caso  \n Marek\u2019s disease (MD) in broilers: A case report  ........................................................................... 323 \n REYNNELLS, R.  Animal welfare and related issues  \nEl bienestar de los animales y aspectos rela cionados  ...................................................................... 113 \n ROSARIO, C.   Deteriminaci\u00f3n de la sensibilidad a antibi\u00f3ticos de diferentes cepas de E.  coli  \n \nDetermination of antibiotic sensitivity of different Escherichia coli strain  ........................................... 214 \n RUBIO, E.  Comparaci\u00f3n del uso de un inmunoestimulante y de un com puesto antiestr\u00e9s en la \nrespuesta inmunol\u00f3gica contra la enfermedad de Newcastle en pollo de engorda y su \nefecto sobre la productividad de la parvada  \n \nComparison of one immunostimulant and one anti -stress compound on the immune rsponse to  \n Newcastle disease, and their effect on broiler productivity  .................................................................  95 \n \nSALAZAR, G.   Manejo de los desechos en la industria av\u00edcola (Estudio recapitulativo)  \n Waste management in the poultry industry (A summary report)  ........................................................ 325 \n \nSALEM, M.  Estudio de una serie de casos de cuadro de com plejo respiratorio temprano en pollos  \nde engorda  \n Study of a series of cases of early respiratory complex in broilers  ..................................................... 182 \n SANDER, J.   A study of P seudomonas aeruginosa contamination in a commercial poultry hatchery  \n Eestudio de contaminaci\u00f3n con Pseud omonas aeruginosa  en una incubadora comercial  ......................... 184 \n SEFTON, T.   Comparison of survey data on antibiotic growth promotants and responses to  \nalternatives  \nComparaci\u00f3n de los datos de una encuesta sobre los promotores antibi\u00f3ticos del crecimiento y las  \nrespuesta s a otras alternatives  .................................................................................................. 326 \n \nSENTIES -CUE, G.  An unusual case of mycoplasma synoviae infection in broiler chickens  \nUn caso inusual de infecci\u00f3n con mycoplasma synoviae  (ms) en pollo de engorda  .................................. 91 \n SERRATOS, J.\n  Interacci\u00f3n genotipo -ambiente en una linea de aves productora de huevo comercial  \n Genotype:  Environment interaction in a commerciallayer strain .................................................................... 197 SHARMA, J.   Disease control by multivalent In ovo vaccines  \n Control de enfermedades mediante vacunas multivalentes In Ovo  ....................................................... 19 \n \nSHIVAPRASAD, H. L.  An outbr eak of inclusion body hepatitis in broiler chickens  \n Un brote de hepatitis con cuerpos de inclusi\u00f3n en pollo de engorda  ................................................... 181 \n \nSIVANANDAN, V.  La vacunaci\u00f3n como un m\u00e9todo de control P asteurella haemolytica  en aves  \n Vaccination as a control method of P asteure lla haemolytica  in poultry  ................................................. 89 \n \nSOMMER, F.   Mortality problems in hatcheries: Have they disappeared due to modern technology?  \n Problemas de mortalidad en la incubadora: \u00bfHan desaparecido gracias a la tecnolog\u00eda moderna?  .............. 185 \n \nSORIANO, V. E.  Caracterizacion g enomica de ornithobacterium rhinotracheale  mediante la tecnica  \nde ERIC -PCR \n ERIC -PCR genomic characterization of haemophilus paragllinarum  ................................................... 57 \n SORIANO, V. E.\n Aislamiento y caracterizacion de Ornithobacterium rhinotracheale  obtenido de pavos \ncon enfermedad  corizoide  \n Isolation and characterization of Ornithobacterium rhinotracheale from turkeys with a coryza -like  \n infection  ............................................................................................................................. 328 \n SOSA, A.   Ealuacion comparativa invitro de dos antimicrobianos a base de fosfomicina utilizando  \nla tecnica de mic contra diversas especies bacterianas  \n In vitro comparison of two fosfomycin -based antimicrobials using the minimum inhibitory concentration  \n (MIC) technique against different bacterial species  ........................................................................ 217 \n \nSOTO, E.   In vitro evaluation of various antibiotic against Mycoplasma synoviae  \n In vitro  microbiological determination of the susceptibility of mycoplasma synoviae to five antimicrobials  . 329 \n TEJEDA, G. R.   Efecto en la cantidad de pigmento sint\u00e9tico en plasma de pollo de engorda despu\u00e9s de   \nla vacunaci\u00f3n contra Eimeria ace rvulina, E. maxima , E. mivati y  E. tenella  y tratado   \ncon toltrazuril  \nSynthetic pigment plasma levels in broilers after Eimeria acervulina, E. maxima, E. mivati, and E. tenella  \nvaccination and treatment with toltrazuril .................................................................................... 330 \n  \nTHRONE -STEINLAGE, S. Case re port:  Zygomycosis in layer pullets and cockerels  \nZigomicosis en pollas para postura y gallos j\u00f3venes  ....................................................................... 182 \n \nTOSCANO, A.   Determinacion del da\u00f1o a la bolsa de fabricio causada por la aplicaci\u00f3n de  \nvacunas a virus vivo con cepas intermedias, asi como la prot eccion al desafio  \n Intermediate live vaccine virus -associated bursal damage and protection against challenge  ........................ 49 \n \nTRIPATHY, D. N.  Future of new generation of virus -vectored vaccines for efficient poultry production  \n El futuro de una nueva generaci\u00f3n de vacu nas que utilizan virus como vectores, para la producci\u00f3n  \n av\u00edcola eficiente  ..................................................................................................................... 22 \n \nTRUETA, R.   Analisis de la situaci\u00f3n de la avicultura Mexicana y Norteamericana productora de  \ncarne de ave en el periodo 1990 -1999  \n Analysis of the Mexican and the US broiler  industries: 1990 -1999 .................................................... 224 \n TSAI, H. J.   Complete  VP1 nucleotide sequences of field goose and muscovy duck parvovirus  \nisolates and their attenuated derivatives  \n Secuencias completas de los nucle\u00f3tidos VP1 de aislamientos de campo de parvovirus de gansos y  patos  \n rusos, y sus derivados atenuados  ............................................................................................... 332 \n \n \n VALDIVIA, A.  Reducci\u00f3n de la intoxicaci\u00f3n alimentaria con aflatoxina B 1 en pollo de engorda m ediante \nN-acetilciste\u00edna  \n Decreased dietary aflatoxin B 1 (AFB 1) toxicity using N -acetyl -cysteine (NAC) in broilers ...................... 200 \n \nVALLADARES, J. C.  Productividad y respuesta serol\u00f3gica de reproductoras con exposiciones vacunales  \ny/o de campo a M ycoplasma gallisepticum y Mycoplasma synoviae  \nProductivity and serological response of broiler breeders after field and/or vaccine exp osure to M ycoplasma \ngallisepticum (MG) and M ycoplasma synoviae  (MS) ....................................................................... 92 \n \nVALLADARES, J. C.  Detecci\u00f3n de la miopat\u00eda pectoral profunda bajo dos sistemas de manejo de carga y embarque en pollo de engorda  \n Deep pectoral myopathy (DPM) in broilers using two cat ching/shipping systems  .................................. 194 \n \nVAZQUEZ, D.  Frecuencia en el diagn\u00f3stico de las enfermedades aviares en el laboratorio de \ndiagn\u00f3sticos cl\u00ednicos veterinarios durante los dos \u00faltimos a\u00f1os.  \n Frequency of poultry disease diagnostics in diagn\u00f3sticos cl\u00ednicos veteri narios in recent years  ................... 333 \n \nVAZQUEZ, M. E.  Aislamiento e identificaci\u00f3n de Pasteurella haemolytica  aviar  \n Isolation and identification of P asteurella haemolytica aviar  Isolation and identification of P. haemolytica  ... 82 \n \nVEGA, C.   Monitoreo de salud gastro -intestinal  en el pollo de engorda  \n Monitoring the gastrointestinal (GI) health in broilers  .................................................................... 132 \n \nVELAYUDHAN, B.  Wild birds and their role in the epidemiology of avian pneumovirus (APV) infection in domestic birds  \n \nAs aves silvestres y sus papel en la epizoo tiolog\u00eda de la infecci\u00f3n con el neumovirus aviar ( APV) en  \n aves dom\u00e9sticas  .................................................................................................................... 106 \n VOLKOVA, M. A.  Indirect enzyme -linked immunosorbent assay for the quantitative detection of  \nantibodies to avian adenovirus group 1 serotype 4  \n Ensayo de inmunoabsorci\u00f3n liga do a enzimas indirecto para la detecci\u00f3n  cuantitativa de anticuerpos  \n contra el adenovirus aviar, serotipo 4, grupo 1  .............................................................................. 335 \n VOLKOVA, M. A.  Development of liquid -phase blocking enzyme -linked immunosorbent assay for the \nquantitative detection of avian adeno virus  group 1 serotype 4  \nDesarrollo de un ensayo de inmunoabsorci\u00f3n ligado a enzimas de bloqueo en fase l\u00edquida para la detecci\u00f3n \ncuantitativa de adenovirus aviar serotipo 4, grupo 1  ....................................................................... 336 \n \nWHITFILL, C.   Virus antibody complex vaccines: Present and future  \n Complejos virus -anticuerpo usados como vacunas: Presente y futuro  ................................................... 25 \n \nWITTER, R. L.   Susceptibility of adult chickens to Marek\u2019s disease  \n Susceptibilidad de los pollos adultos a la enfermedad de Marek  ........................................................ 127 \n \nWOOLCOCK, P.  Isolation of low pathogenicity avian  influenza virus (h6n2) from chickens in  \nCalifornia, 2000- 2001  \n Aislamiento de un virus de la influenza aviar de baja patogenicidad (h6n2) de pollos en California,  \n 2000 -2001 .......................................................................................................................... 152 \n \nZHAO, S.  Characterization of antibiotic resistance of campylobacter isolat ed from retail  \npoultry meats  \nCaracterizaci\u00f3n de la resistencia a los antibi\u00f3ticos de aislamientos de campylobacter  de carne de ave  \npara venta Al menudeo  ...................................................................................................................................... 38 PRESENTACIONES ADICIONALES \n \nADDITIONAL PRESENTATIONS \n \n \nAUTOR  TITULO                    PAGINA \nPRESENTER TITLE                         PAGE \n \nHERRERA, J. A. Criopreservaci\u00f3n y evaluaci\u00f3n fisiol\u00f3gica de los espermatozoides de aves \nCryo-preservation and physiological evaluation of poultry sperm cells ............................................. 337 \n LUCIO, E. Evaluaci\u00f3n de vacunas inactivadas contra influenza aviar  \n Evaluation of killed avian influenza (IA) vaccines ..................................................................... 338 \n RATCLIFF, J. Organic chicken production  \n Avicultura org\u00e1nica ......................................................................................................... 342 \n  \n  \n1 THE HUMAN HEALTH CONSEQUENCES OF ANTIMICROBIAL \nUSE IN POULTRY  \n \nCONSECUENCIAS DEL USO DE ANTIMICROBIANOS EN AVES, SOBRE LA \nSALUD HUMANA  \n \nAlicia D. Anderson, DVM, MPH  \n \nRESUMEN  \nEl creciente uso de agentes antimicrobianos para \nprop\u00f3sitos agropecuarios ha caus ado preocupaciones \nacerca el impacto de estos usos sobre la salud humana. \nLos esfuerzos para mitigar el efecto del aumento de la \nresistencia requieren la colaboraci\u00f3n de varios \nsegmentos de la comunidad, incluyendo a los \ngranjeros, los m\u00e9dicos veterinarios , la industria \nfarmac\u00e9utica y el sector de la salud p\u00fablica. En esta \npresentaci\u00f3n revisaremos informaci\u00f3n reciente del \nNARMS  y otras actividades de la investigaci\u00f3n \naplicada, as\u00ed como datos similares procedentes de Europa, relacionados con las consecuencia s sobre la \nsalud p\u00fablica del uso de antimicrobianos en aves.  \n \nThe increased use of antimicrobial agents for \nagricultural purposes has caused concern regarding the impact these uses have on human health.  Extensive agricultural use of antimicrobial agents i ncreases the \nrisk of human bacterial pathogens, which have food \nanimal reservoirs, developing cross -resistance to drugs \napproved for use in human medicine.  As resistant bacteria become more prevalent, the potential for increased incidences, more severe in fections, and \ntreatment failures in foodborne illnesses is \nconsiderable.  Efforts to mitigate the effect of \nincreasing resistance require collaboration by several \npartners, including the farming, veterinary, \npharmaceutical, and public health communities.  Such \nresistance is tracked through the National \nAntimicrobial Resistance Monitoring System \n(NARMS) at the Centers for Disease Control and \nPrevention. This presentation will review recent data \nfrom NARMS and other applied research activities, as \nwell as sim ilar data from Europe related to human \nhealth consequences of antimicrobial use in poultry.\n  \nANTIBIOTIC USE IN FO OD ANIMAL MEDICINE: THE QUIET \nVOICE OF REASON IN T HE ANTIBIOTIC RESISTANCE DEBATE  \n \nEL USO DE ANTIBI\u00d3TICOS EN LA MEDICINA DE LOS ANIMALES \nPRODUCTORES DE ALIMENTOS PARA EL HOMBRE: LA CALLADA VOZ \nDE LA RAZ\u00d3N EN EL DEBATE DE LA RESISTENCIA A LOS ANTIBI\u00d3TICOS  \n \nTimothy S. Cummings, DVM, MS, ACPV  \n \nClinical Poultry Professor, College of Veterinary Medicine, Mississippi State University  \n \nRESUMEN  \nEl uso de antibi\u00f3ticos en los animales de granja y \nsu impacto subsecuente en los patrones de resistencia \nentre los pat\u00f3genos que afectan al humano no es un \ndebate nuevo. Mientras que actualmente se est\u00e1n \nrealizando numerosos proyectos de investigaci\u00f3n e iniciativ as para ayudar a llenar los vac\u00edos de \ninformaci\u00f3n, es necesario poner en tela de juicio la \nsimplista creencia de que la prohibici\u00f3n de cualquier \nporci\u00f3n del uso de antibi\u00f3ticos en la medicina de los animales productores de alimentos para el hombre, \nvaya a frenar o dar marcha atr\u00e1s con la tendencia actual \ndel incremento de la resistencia de los pat\u00f3genos \nbacterianos que afectan al ser humano. En esta presentaci\u00f3n citaremos hallazgos recientes y \npertinentes que justifican el uso continuo de \nantibi\u00f3ticos en la  medicina de estos animales y que \nayudan a enfocar la atenci\u00f3n hacia otros factores de \nriesgo que m\u00e1s probablemente contribuyan para la existencia de este problema.  \n The topic concerning antibiotic use in farm \nanimals and subsequent impact on the resistanc e \npatterns in human pathogens is not a new debate, \nbeginning in the 1960s. The issue has been raised \nseveral times since then without any definitive \nconclusion being reached. As we\u2019re all aware, the latest \nflare-up came when the EU began the process to ban   \n  \n2 certain, long established growth promotant antibiotics \nfrom use in animal feeds. The EU invoked the \n\u201cprecautionary principle\u201d to justify its position despite \nthe lack of scientific data to support their concerns. In \ndoing so, they essentially ignored the report of their \nown committee of experts (SCAN) which concluded \nthat there was no justification to take action at the time. It should also be noted that this debate came at a time \nwhen food safety issues were at an all time high in \nEurope due to other unre lated concerns.  \nAs a result, the debate became headlines in the \nUS with much activity being initiated. There have been \npositions taken by individuals and agencies/groups on both sides of the issue with data being used to support \neach sides\u2019 point of view, but there has been some \nsharp debate on the validity and conclusions of certain \nreports. In reality, it appears that the question is still \nvery much unanswered, as the topic is a very complex \nmatter. While research projects, risk assessments, and prudent u se guidelines for antibiotic use in animals and \nhumans have been initiated worldwide and are to be \ncommended, the simplistic belief that the banning of \nany portion of antibiotic use in food animal medicine \nwill halt or reverse the current trend towards ant ibiotic \nresistance patterns in human medicine is not rational \nand must be challenged.  \nThe theoretical hazard to human public health \nrelated to antibiotic use in animals revolves around the \ntransfer of resistant bacteria from animals to humans \nlargely throu gh the food chain. In order for resistant \nanimal bacteria to successfully transmit through the \nfood chain, they must develop resistance and survive a \nmyriad of obstacles throughout the production, \nprocessing, transportation, storage, and cooking of the \nfood source. Even if a resistant bacterium of animal \norigin survived to the point of being consumed by a human, the bacteria would have to contend with various enteric defenses to prevent their survival and \nmultiplication to the point of causing disease or \nallowing the transfer of resistance factors. Attempts to \nestimate the chances of this risk have been offered, and \nwhile there is much debate about the legitimacy of \nthese risk assessment models, critical thinking of the \nfacts as we currently know them points  towards other \ncauses besides antibiotic use in animals as having \nmuch more of an impact in causing resistance in human \npathogens/commensals.    \nThe two antibiotics used in food animal \nproduction which have received the most attention in \nthe current debate are the fluoroquinolones and \nvirginiamycin. The fluoroquinolones are a therapeutic \nclass of antibiotics approved for use in poultry via the \nwater, whereas virginiamycin is a feed additive \nantibiotic used to enhance performance in poultry, swine, and cattle. It should be noted that very real \ndifferences exists when discussing this topic with regard to the therapeutic use of antibiotics via injection \nor water versus those used for performance \nenhancement in the feed as different organisms are \ntargeted. Also recognize there are other antibiotic uses \nin veterinary medicine which have attracted concern, \nbut we will primarily focus on these two groups of \nantibiotics.  \nThe virginiamycin debate evolves around \nEnterococcal  infections in humans, which has become \nan i mportant pathogen in immunosuppressed \nindividuals and a potential nosocomial complication in \npost-operative patients. The initial concern involved \nVancomycin resistance development by these \norganisms (VRE), which at the time was one of the few remaining ef ficacious antibiotics against Enterococcal  \ninfections approved for use in humans. Vancomycin is \na glycopeptide class antibiotic. Avoparcin, a growth \npromotant antibiotic used in Europe at the time, was \nremoved from the market in 1997 because of its \nrelated ness to Vancomycin. On the other hand, \nVancomycin resistance was much more prevalent in \nthe US where Avoparcin had never been used. This \nwould put the VRE resistance problem in the US \nsquarely on human clinical use of Vancomycin as the primary instigator o f glycopeptide resistance in the \nStates, since Vancomycin had been approved for use \nthere.  \nShortly afterwards, a new product, Synercid, was \nbeing reviewed for treatment of human Enterococcal  \ninfections in certain countries. It belonged to the \nstreptogramin  class of antibiotics.  Virginiamycin, also \na streptogramin antibiotic, had been in use in the \nworldwide animal market for over 25 years with little \nevidence of streptogramin resistance to date, yet it \nbecame the next target. It should be noted that \nentero cocci resistance data is often reported as a group, \nbut needs to be differentiated by species due to the \nnatural resistance of certain species to different \nantibiotics. For instance, E. fecalis  is naturally more \nresistant to virginiamycin, but is often inc luded in \nrelevancy data pertaining to this issue. This is of vital \nimportance when attempting to draw accurate \nconclusions from the data pool. Unfortunately, most \nlabs do not or can not speciate Enterococcal  infections \ndue to the technical expertise requir ed to do so.   \nIn one very large, yet little cited clinical study by \nJones et al which involved over 28,000 human clinical \nisolates from 200 different medical centers in the US \nand Canada, found streptogramin resistance to be 0.2% \nin the E. faecium  isolate s. This is a highly significant \nstudy in that it involved over 1,000 E. faecium  isolates \nfrom a clinical setting. Thus, there is meaningful \nevidence that streptogramin resistance in human clinical isolates of Enterococcus  was miniscule in the \nUS despite d ecades of virginiamycin use by the poultry \nindustry. Similarly, pristinamycin, another human  \n  \n3 streptogramin approved for use in France since 1973, \nhas been used along with virginiamycin for decades \nwithout any unusual rates of streptogramin resistance \ndevel opment in that country.  \nWith regard to the fluoroquinolones, the concern \nrevolves around treatment for Campylobacter  \ninfections in humans. Campylobacter  has been the \nleading cause of food borne enteric illness in humans, \nwith the disease being self limiti ng in the vast majority \nof infected individuals. However, infections in humans \nhas been markedly decreasing over recent years, due in \npart to the new HACCP regulations implemented in the \nmid 1990\u2019s. Fluoroquinolones are considered to be an efficacious ther apeutic drug for Campylobacter \ninfections in humans although the organism remains \nhighly sensitive to the macrolides as well. Since the \nfluoroquinolones were also approved for use in poultry \nin the mid 1990\u2019s, there were concerns that this would \nresult in an increase in therapeutic failures in humans \ndue to resistant strains of Campylobacter  originating \nfrom poultry meat consumption.  \nThis was one impetus for the establishment of the \nNational Antimicrobial Resistance Monitoring System \n(NARMS) in 1996, which  is a collaboration among \nCDC, FDA, and the USDA to monitor antimicrobial \nresistance in human enteric bacteria. The most recent \nNARMS FoodNet data indicates that overall \nfluoroquinolone resistance rates in human Campylobacter isolates actually decreased sl ightly in \n2000 back to 1998 baseline levels. In addition, the 1999 NARMS resistant C. jejuni chicken isolate data held steady at 9.4% vs 9.3% in 1998, hence resistance \ndoes not appear to be on the increase despite use of the \nantibiotic in the poultry indus try. \nAs alluded to earlier, a risk assessment model was \ndeveloped by David Vose to estimate the human health \nimpact of fluoroquinolone resistant Camplyobacter \ninfections associated with the consumption of chicken. \nAlthough the model had some merit, there w ere serious \nshortcomings according to other experts in risk \nassessment which called into question its results which significantly overestimated the number of individuals \nwho could be affected by use of fluoroqiunolones in \npoultry. Irregardless, CVM propose d to withdraw the \nfluoroquinolones from use in poultry, and the matter \ncurrently is awaiting an opportunity for hearing \n(NOOH) to be announced  \nSeemingly, other areas of concern beg scrutiny \nbefore attempting to enact regulatory action against \nantibiotic us age in animals. For example, the impact of \nforeign travel should not be overlooked. In one study \n(Smith et al), 70% of the resistant Campylobacter  \nisolates from people was related to foreign travel or prior use of a fluoroquinolone. In addition, the debate  \nalways centers around resistant bacteria being passed \nfrom animals to man, but who is asking about the other way around? There remains the distinct possibility that \ncertain pathogens containing resistant factors may be \nentering the animal microflora and/o r environment \nfrom human exposure (Kinde et al). Finally, there is mounting evidence that certain strains of bacteria tend \nto be host specific and do not colonize other animal \nspecies (Johnson et al, 2000), making it less likely for resistance factors to b e transferred.     \nVarious governmental and independent \norganizations have weighed in on the matter, but most have agreed that there is simply not enough \ninformation to draw any conclusion. The 1998 National \nResearch Council Report, The General Accounting \nOffice Report of 1999, the SCAN Opinions, and the \nHAN Foundation Report of 1999 fall into this category. \nThe consensus was that while use of drugs in food \nanimals does have some concerns, the evidence to date \ndoes not constitute an immediate public health concern. \nHaving said this, the WHO organization recently \nissued new guidelines to \u201cslow the growth of microbes \nresistant to commonly used antimicrobials\u201d which \nincluded calling for mandatory prescriptions for all \nantibiotics used to control diseases in ani mals and the \ncessation of the use of antimicrobials to promote \nanimal growth.  \nThis is not to say that the use of antibiotics in \nfood or companion animal poses no risk to the human medicine sector, as resistance development/transfer in \nbacteria is a real occurence. However, there needs to be \nmore scientific evidence or at least a concensus in the scientific community to justify any further regulatory \naction. All currently approved antibiotics in animal \nproduction play far too important a role in maintaining \nanimal health and performance to simply remove them \nfrom use based upon perceived risks. Various \nresistance surveillance projects have been funded and other research studies are underway to help fill in the \ndata gaps, but it will take time to begin to get a \nreasonable chance for meaningful answers. Hopefully, \nthe true risk factors at stake will be elucidated, as this issue is much too important to human and animal \nhealth for wrong associations to be made.  \n \nREFERENCES  \n1. Johnson, Judith A. AVMA/AAAP abstract \nat the annual convention. 2000.  \n2. Jones, R. et al. Antimicrobial activity of \nquinupristin/dalfopristin tested against over 28,000 \nrecent clinical isolates from 200 medical centers in the \nUnited States and Canada. Diagn Microbiol Infect Dis \n30:437- 451. 1998.  \n3. Kinde, H. et al. Sewage effluent: likely \nsource of Salmonella enteritidis phage type 4 infection in a commercial chicken layer flock in southern \nCalifornia. Avian Dis 40:672- 676. 1996.   \n  \n4 4. Smith, K. E. et al. Quinolone -resistant \nCampylobacter jejuni infections in Minnesota, 1992-1998. New England J Med 340:1525- 1532. 1999.\n \nPRE-  AND POST - HARVEST APPROACHES T O REDUCE \nSALMONELLA  IN POULTRY MEAT PROD UCTION: REVIEW  \n \nHafez Mohamed Hafez  \n \nInstitute of Poultry Diseases, Free University Berlin, Koserstr. 21, 14195 Berlin, Germany  \n \nSUMMARY  \nThe significant increase in the number of reported \nfoodborne outbreaks world- wide has altered the view \nof food safety. The fact that processing plants have not \nbeen able to effectively reduce the pathogenic bacteria \nin poultry product s, mean that every effort must be \nmade to reduce foodborne pathogen infection and / or \ncontamination of the live birds before dispatch to \nprocessing plants. In general the major strategy to \ncontrol Salmonella should include: stamping out \ninfected breeder f lock, Good Animal Husbandry \nPractices (GAHPs) and logistic slaughtering. In the \nprocessing plants the machine design must permit easy \nand thorough cleaning and disinfection. Several \ndevelopments and modifications to reduce the \ncontamination were introduced  and some are still in \nfurther modification. It is essential to incorporate \neducation programs by all people involved throughout \nthe poultry production chain.  \nPoultry and poultry products have repeatedly \nbeen implicated as a source of Salmonella  infection  for \nhumans. The significant increase in the number of reported foodborne outbreaks world- wide has altered \nthe view of food safety. It has become clear that current legislation alone is not enough, and industry accepted a greater share of responsibilities for the quality and \nsafety of the food product from farm -to-fork. Different \nsystems of Hazard analysis critical control points \n(HACCP) to identify, evaluate and control microbial \nhazards have been integrated at different production \nlevels, in which each li nk of the food chain can be \ncarefully analyzed to demonstrate where and how \nspecific hazards can be introduced.  \n \nPre-harvest approach  \nThe fact that processing plants have not been able \nto effectively reduce the pathogenic bacteria in poultry \nproducts, mea n that every effort must be made to \nreduce foodborne pathogen infection and / or \ncontamination of the live birds before dispatch to \nprocessing plants. In general the major strategy to control Salmonella should include: Cleaning the \nproduction chain from the top by stamping out infected flock; hatching egg sanitation, preventing introduction and spread at the farm through Good Animal Husbandry Practices (GAHPs).  \nThe major strategy to control Salmonella  in \npoultry should be directed to clean the production \nchain from the top to prevent Salmonella introduction \nthrough breeder flocks. Control measures to prevent \nintroduction and spread of Salmonella infection in \nbreeder flocks should be concentrated on high standards of animal management accompanied with \nbacter iological and serological monitoring of the flocks \n(22). Guidelines on cleaning, disinfection and vector control in Salmonella infected poultry flocks have been \nprovided by WHO (1). Salmonella  control programs \ntoward S. Typhimurium  and S. Enteritidis  in chicken \nbreeder flocks were adopted in the European Union by \nthe Zoonoses Directive (92/117/EEC). These measures \nmust be coupled with meticulous attention at all stages of hatching egg production and sanitation (9). Different \napproaches have been used to red uce the contamination \nof feed ingredients as well as finished feed (10,19). To \nmaintain the hygienic quality of finished feed, cleaning \nand inspection programs for feed transportation \nvehicles must be applied. Also several feed additives  \nsuch as short chai n organic acids  (formic acid, \npropionic acid) can be used for decontamination as well as for prevention of recontamination of feed (3,12) Other feed additives such as carbohydrates (lactose, \nmannose, galactose, saccharose) which are able to \ninfluence the c aecal environment by increasing the \namount of acid produced by bacterial fermentation thus decreasing the pH, have been found to reduce \nSalmonella colonization (13). In addition, certain \nantimicrobial products  can be used as feed additives \nto prevent and t o reduce shedding, but not to treat \nclinical Salmonellosis  in poultry. The use of probiotics  \nin chickens was reviewed by (2,14). It is also generally \nknown, that Competitive Exclusion (CE)  in \ncombination with conventional hygienic measures has \nbeen shown t o be very effective as a preventive \nmeasure against Salmonella, Campylobacter  and E. \ncoli O157H7 colonization in poultry (17,20). In \naddition, different live and inactivated vaccines  were \ndeveloped and used in aim to control clinical \nSalmonellosis  as in case of S. Gallinarum  and to reduce \nSalmonella shedding and colonization especially by S.  \n  \n5 Typhimurium  and S. Enteritidis  infections. However, a \nfew number of vaccine are currently commercial \navailable. Also, in birds previously infected with a field \nSalmonel la strain, the vaccine did not eliminate the \ninfection, but may reduce the number of carriers (8,16). \nRecently, we carried out field trails using live and \ninactivated vaccines. In  12 commercial layer flocks \nkept on farms with floor and/or free range rearin g \nform, with S. Enteritidis  history, The birds were \nvaccinated twice with S. Enteritidis  live vaccine \n(Salmovac SE\uf6da, DT Impfstoffwerk, Dessau -Tornau \nGmbH, Germany) at 2nd and 16th days of age via \ndrinking water (the vaccine is licenced in Germany since mid  2000) and then once between 15\nth and 16th \nweeks of age with inactivated S. Enteritidis  vaccine \n(Salenvac\uf6da, Intervet). The results indicate, that the \napplied of live and inactivated vaccines together with \nimprovement in the production hygiene, have been \nremarkably successful and have resulted in a marked \ndecline in Salmonella at least in the first 7 vaccinated \nflocks. In birds previously infected with a field \nSalmonella strain (at 1st day of age), the vaccine did not \neliminate the infection. It seems to be,  that the use of \nthe vaccine might sends the wrong message, since the \nSalmonella detection rates were increased in the last \nfour vaccinated flocks (8). In conclusion vaccination \nmust be considered as an important support to good \nhygiene and husbandry pract ices in all production \nsystems.  \n \nHYGIENIC CATCHING AND TRANSPORT  \nCurrently, there is no legislation or obligation for \ntesting meat poultry flocks for Salmonella  before \nslaughtering. However, the fact remains that processing plants have not been able to eff ectively reduce the \nincidents of pathogenic bacteria in poultry products. This facts has forced several companies in Europe to \nchanges the slaughter and processing system towards \nthe logistic slaughtering of the flocks with a known \nstatus based on the hist ory of individual farm and the \nresults of a bacteriological examination before \nslaughtering in order to improve the quality and reduce \nthe cross contamination during the processing (7). \nFood should be withheld from the birds for several \nhours before the pl anned slaughter time to reduce the \namount of subsequent defecation. In general, \nequipment used in collecting live birds on the farm \nmust also be adequately cleaned and disinfected before re-use. It is essential that loading and transport of the \nbirds is ca rried out by trained personnel, who handle \nthe birds carefully and do not cause them distress. There are primarily two systems used for \ntransportation, with either loose containers for the birds \nor containers that are fixed to the vehicle. Fixed \nequipment is more difficult to clean and disinfect properly after use. Also the introduction of steam cleaning failed to improve the situation (15).  \nPost-harvest approach. Although the \nmicrobiological quality of poultry meat is determined by the health status of th e live birds, a great deal of \nattention must be given to limiting cross -contamination \nduring processing. In aim to reduce the further contamination during the processing regular schedules \nof cleaning and disinfection of the equipment and plant \nare essential for maintaining sanitary condition \nrequired to reduce contamination. Machine design must \npermit easy and thorough cleaning. Several \ndevelopment and modifications to reduce the contamination during processing and packaging were \nintroduced and some are sti ll in further modification \n(4,5,21). In all approaches to the development of new \nprocessing technology environmental saving aspects \nmust be considered. The amount of water, detergents \nand chemical used should be optimized (18).  \nSince the success of any saf e food program on the \nfarm and processing plant depends on personal \nsanitation, it is essential to incorporate education \nprograms about microorganisms, modes of \ntransmission as well as awareness of the reasons \nbehind such control programs by all people inv olved \nthroughout the poultry production chain. In the farm -\nto-fork concept, post processing food handling is very \nimportant in reduction of foodborne infections. Effective education programs must also be \nimplemented to increase public awareness and the \nnecessary measures to be taken for protection against \nmicrobial contamination in food products. Finally, \ndevelopment and application of acceptable methods for \nend-product decontamination and preservation must be \nprogressed and/ or re -evaluated (11).  \n \nREFEREN CES  \n1. Anon. World Health Organization \nGuidelines on cleaning, disinfection and vector control \nin Salmonella infected poultry flocks. WHO/ Geneva. \nZoon 94.1 72. 1994.  \n2. Barrow,  P.A. Probiotics for chickens. In: \nFuller R (ed) Probiotics. Chapman Hall, London. p.  1-\n8. 1992a.  \n3. Berchieri, A. and P.A. Barrow. Reduction in \nIncidence of Experimental Fowl Typhoid by Incorporation of a Commercial Formic -Acid \nPreparation (Bio -Add\n\uf8ea) into Poultry Feed. Poultry \nScience 75, 339 -341. (1996  \n4. Bolder, N. M. Safety and economic aspects \nof modified atmosphere packaging (MAP) of poultry \nproducts. In: Flair No.6 11. Contamination with \npathogens in relation to processing and marketing of \nproducts. Ed. L\u00f6pfe, J., Kan, C.A. and Mulder, \nR.W.A.W., COVP -DLO Het Spelderholt, p. 89- 94. \n1993.   \n  \n6 5. Farber, J.M. Microbiological aspects of \nmodified atmosphere packaging technology -A. review. \nJournal of Food Protection, 54, 58- 70. 1991  \n6. Hafez, H.M. Poultry meat and food safety: \nPre- and post -harvest approaches to reduce foodborne \npathogens. World\u2019s Poultry Science Journal 55: 269 -\n280. 1999.  \n7. Hafez, H.M. and A. Mazaheri. \nBacteriological investigation on salmonella in meat \nturkey flocks. Proceedings of the 3rd  International \nsymposium on turkey diseases, Berlin.(Ed. H.M. Hafez \n- ISBN 3 -930511- 92-4). pp. 319 \u2013  325. 2000.  \n8. Hafez, H.M., A. Mazaheri, and A. Edel. \nTrials on the efficacy of Salmonella Enteritidis  life and \ninactivated vaccine in layer flocks under field \ncondition. Proceedings of the 50th Western Poultry \nDisease conference, Davis, California, USA. 2001P  31-\n32. \n9. Hafez, H.M., S. Jodas, J. K\u00f6sters and H. \nSchmidt. Treatment of Salmonella enteritidis  \nartificially contaminated hatching eggs with Pressure Differential Dipping (PDD) using antibiotics. Archiv \nfuer Gefluegelkunde. 59:69- 73. 1995.  \n10. H\u00e4ggblom, P. Monit oring and control of \nSalmonella in animal feed. Proceedings of International \ncourse on Salmonella control in animal production and \nproducts. A presentation of the Swedish Salmonella  \nProgramme. WHO. Ed. Bengtson S. O., p. 127 -137. \n1993.   \n11. Hinton, M.H. and J.  Corry. The \ndecontamination of carcass meat. In: COST Action 97 - \n5. Poultry and food safety. Ed. Nagy, B. and Mulder, R.W.A.W  European communities ISBN 92- 828-3609-\n6, pp. 23 -  31.1998.  \n12. Hinton, M. and G.C. Mead. Control of \nSalmonella infections in broiler chickens. In: In: Flair \nNo.6 5. Zoonoses control in Europe Ed. Mulder, \nR.W.A.W. and Lan, C.A. COVP -DLO Het Spelderholt, \npp. 25- 27. 1991a.  \n13. Hinton, M. and G.C. Mead. Opinion. \nSalmonella control in poultry: the need for the \nsatisfactory evaluation of probiotics for this purpose. \nLetters in Applied Microbiology, 13, 49- 50. 1991b.  14. Huis in\u00b4t Veld, J.H. Probiotics and the \ncontrol of pathogens: what do we know? In: COST \nAction 97 - 5. Poultry and food safety. Ed. Nagy, B. and \nMulder, R.W.A.W., European communities I SBN 92 -\n828-3609- 6, pp. 103- 108. 1998.  \n15. Mead, G. C. Critical control of major \npathogens in poultry. In: COST Action 97 - 6. Safe \nchicken for the next century. Ed. M. Hakkinen, L. Nuotio, E. Nurmi and Mead, G.C., European \ncommunities ISBN 92- 828-3669- X, pp. 6 -12. 1998.  \n16. Meyer, H., U. Methner, G., Martin and G. \nSteinbach. Control of Salmonella infection in poultry \nfarm: competitive exclusion, vaccination and \nantimicrobial treatment: In: COST Action 97 - 5. \nPoultry and food safety. Ed. Nagy, B. and Mulder, \nR.W.A.W European communities ISBN 92- 828-3609-\n6, pp. 115- 122. 1998.  \n17. Mulder, R.W.A.W. Probiotics and \ncompetitive exclusion microflora against Salmonella. \nWorld Poultry Misset Salmonella Special, May, pp. 30 -\n32. 1996a  \n18. Mulder, R.W.A.W. The impact of slaughter \ntechnol ogies on microbial contamination of poultry \nmeat. World Poultry Misset Salmonella Special, May, \npp. 44- 46. 1996b.  \n19. Renggli, F. Preventing an on -farm infection \nthrough proper feed treatment. World Poultry Misset Salmonella Special, May, pp. 34 -35. 1996  \n20. Schne itz, C. and E. Nurmi. Competitive \nexclusion in poultry production. In: American Association of Avian Pathologists (ed.) Proceeding of \nEnteric Disease Control. 39\nth Annual Meeting. \nLouisville, KY, pp. 44- 55. 1996.  \n21. Stals, P. Slaughter and dressing of poultry. \nIn: Concerted Action CT94 -1456-  Factors affecting the \nmicrobial quality of meat. 2. Slaughter and Dressing. \nEd. Hinton, M.H. and Rowlings, C. Published by \nUniversity of Bristol Press, UK. ISBN 0 86292 4367, \npp.99- 106. 1996.  \n22. Wray, C. and R.H. Davies. Guid elines on \ndetection and monitoring of Salmonella infected \npoultry flocks with particular reference to Salmonella \nEnteritidis . World Health Organization Veterinary \nPublic Health Unit. WHO/Zoon 94.173, Geneva. 1994.\n \n \n  \n \n    \n  \n7 REDUCTION OF SALMONELLA IN THE UNI TED STATES \nPOULTRY INDUSTRY THROUGH VACCINATION  \n \nREDUCCION DE SALMONELLA EN LA INDUSTRIA AVICOLA DE LOS \nESTADOS UNIDOS A TRAVES DE LA VACUNACION  \n \nArmando Mirand\u00e9 y Joan Leonard  \n \nBiomune Co., Lenexa, Kansas, E.U.A. \n \nRESUMEN  \nLas vacunas contra salmonella co ntin\u00faan siendo \nel m\u00e9todo mas efectivo para controlar la salmonelosis \nen la industria av\u00edcola. Experiencias de campo han \ndemostrado consistentemente que la vacunaci\u00f3n de \nreemplazos para pollos y pavos reproductores y de \npollas para postura con bacterinas de salmonella, \ncontrola la salmonella tanto en ponedoras comerciales como en reproductoras y su progenie. La vacunaci\u00f3n de pollos con la vacuna viva tiene las expectativas de \nser una intervenci\u00f3n efectiva cuando se requiera de una \nacci\u00f3n correctiva inmediata y tambi\u00e9n en donde exista \nla necesidad de una protecci\u00f3n temprana, adem\u00e1s de servir como primovacunaci\u00f3n para la administraci\u00f3n de \nla bacterina. Datos sobre resultados de campo de \nproductores en los E.U.A. ser\u00e1n presentados para \nilustrar los efectos de la  vacunaci\u00f3n contra salmonella.  \n \nCurrent food safety regulations aimed at reducing \nthe incidence of human salmonellosis in the United \nStates have been directed extensively towards the \npoultry industry, including both the meat and egg sectors. In the commercial egg industry there is zero \ntolerance for Salmonella enteritidis  (SE) in table eggs \nsince the early 1990\u2019s. There are indications that this \nsituation will soon expand to include Salmonella \ntyphimurium  as well because of serious public health \nconcerns ov er the multiple antibiotic resistance pattern \nof the definite type 104 (DT 104). The United States Department of Agriculture (USDA) established a \nmicrobiological standard for broilers in 1998 allowing \na maximum of 11 Salmonella sp. positive broiler \ncarcass es out of a series of 51 broilers at the \ncompletion of processing (21.5%). This figure is expected to drop to 7.5% in the year 2003 and efforts \nto reduce further the microbiological load of poultry \nproducts, including turkey meat, are likely to continue \neven if \u201ckill -step\u201d interventions, such as the in -shell \npasteurization of eggs or the gamma irradiation of \nmeat, are routinely adopted. Not surprising, \ninterventions in the area of food safety are already \nbranching to poultry industries in countries where the \nexport of poultry products is vital, i.e. Brazil.  To comply with these rules the U.S. poultry \nindustry has been forced to modify certain management \npractices to reduce bacterial load, in general, and in particular to apply interventions aimed specificall y at \nreducing the prevalence of salmonella. It is now clear that control of poultry foodborne pathogens involves an \napproach of multiple interventions at multiple levels of \nthe food chain.  \nOne of the most successful and cost -effective \ninterventions to cont rol Salmonella in poultry has been \nthe use of vaccines. Data are presented from actual \nfield results obtained by producers in the U.S. with the \nuse of Salmonella vaccines produced by Biomune Co.  \n Chicken and turkey breeders have long relied on \noil-based au togenous inactivated vaccines (bacterins) \nmade with isolates specific to a farm or company \nlocation.  Their past use in an operation tended to be \nsporadic, however, due to growing demands from \nintegrators for a cleaner product during the last 4 years, \nsalm onella bacterin use has gained wider acceptance as \npart of a routine vaccination program. Data generated by breeders obtained with the use of Salmonella \nvaccines are often difficult to collect because of the \nresistance of these companies to share sensitive  \ninformation, especially as it relates to baseline values on the prevalence of certain types of Salmonella within \nthe organization. However, the following information \nwas provided and illustrates the control of a group D \nSalmonella in a breeder operation.  \nThis broiler breeder company eliminated a group \nD Salmonella from its operation with the use of \nautogenous bacterin when other measures had failed. Although SE and other invasive group D Salmonellae  \nsuch as Salmonella gallinarum  and S. pullorum  were \nnot p revalent, chicks serologically and culture positive \nat hatch to group D Salmonella presented export \nmarketing problems for this producer. The Salmonella  \nvaccination program consisted of vaccinating breeder \nstock pullets on known positive farms with two dos es \nof an autogenous Salmonella bacterin at 12 and 18 \nweeks of age. The incidence of Salmonella was \nmonitored by monthly environmental cultures of all \nvaccinated breeder flocks and meconium cultures of every hatch comprising more than 1500 cultures per  \n  \n8 mont h. Results were compared with the previous year\u2019s \nprevalence on known positive farms. Reduction of \ngroup D Salmonella in chicks was evident the first year \nafter vaccination began as young pullets replaced older, \nnon-vaccinated hens. Elimination of the group D \nSalmonella from the breeder chicks at hatch and from \nthe operation occurred shortly after all breeders had been vaccinated twice and has continued for more than \nsix years.  \nA turkey integrator had been troubled with an \ninsidious problem with Salmonella arizonae (SA). SA \nappears sporadically as a problem in the turkey \nindustry, although it belongs to serogroup K, a group rarely found in poultry. This integrator was recovering \nSA only occasionally from growing replacement \nbreeders but it rapidly disseminated vertically through \negg transmission into the meat birds. The overall \nprevalence of SA in commercial poults was 60%, as \ndetermined by culture of early -death embryos from \neggs candled at 7 days of incubation. A Salmonella \nvaccination program, consisting o f two doses of an \nautogenous SA bacterin at 18 and 26 weeks of age, was \nimplemented.  A year after this program was initiated \nthe prevalence of SA in poult embryos fluctuates at \nlevels consistently under 10%.  \nThe broiler industry has experienced a dramatic  \nincrease in the use of Salmonella bacterins in breeders \nduring the past years, obviously as a result of the new regulations enacted by USDA, also known as the Mega \nReg.  Typically, bacterins used are oil -based \nautogenous products showing very good results  at both \nthe breeder and broiler (post -processing) level. It is \nimperative to be patient and not abandon the program if the prevalence of Salmonella does not drop \nsignificantly within the first three to six months. It will take a full year for all the breeders in a complex to be \nreplaced with vaccinated pullets and before major progress is achieved at the processing plant, but it will \nwork!  \nThese bacterins can be produced with adjuvants \nthat are less tissue reactive to add flexibility in the \nvaccination pro gram particularly when commercial \ncholera bacterins are being injected subcutaneously in \nthe neck. However, it has been demonstrated that \ngranuloma formation at the injection site is necessary for any inactivated, adjuvanted vaccine to provide \nadequate, lo ng-term protection. Words of caution are \nthat a Salmonella vaccination program with bacterins \nthat are too mild and non -reactive could result in a poor \nimmune response and subsequent failure to reduce \nsalmonella infection and lead to a waste of money and time. Two doses are always recommended.  \nThe ability of a commercial SE bacterin, \nLayermune SE, to reduce the incidence of total Salmonellae  in broiler chickens at processing was \nevaluated by an integrator. Since contamination at this integrator\u2019s plant was determined to be of Salmonella  \ngroups B and C, but not group D, Layermune SE was also evaluated for cross -protection. An advantage of a \ncommercial versus an autogenous vaccine is the fact that with a commercial bacterin, isolates have been \ncarefully select ed and thoroughly tested for their \nimmunogenicity (ability to induce an immune \nresponse).  \nThe field study consisted of vaccinating all pullets \nat 10 and 18 weeks of age in one complex for one year. A separate complex with a comparable rate of \nSalmonella contamination in processed broiler flocks \nserved as the non -vaccinated control. No other \nintervention aimed specifically at reducing Salmonella  \nwas instituted at either complex during the trial. Six \nbroiler farms were designated as \u201cstudy flocks\u201d and \nreceived new litter for placement of the first flocks \nonly. These study farms were divided in half and each \nhalf received broiler chicks from the corresponding \ngroup of breeders. Broilers on each farm were \nevaluated for Salmonella contamination in three \nconsecuti ve grow -outs during the year by culturing \ncecae from 30 birds from each flock at the processing plant. The incidence of Salmonella positive broilers in \nthe vaccinated complex was 7.1%, compared to 36.0% \nthe previous year. Incidence of Salmonella in broiler s \nfrom the control, non -vaccinated complex was 26.7%, \ncompared to 28.0% the year before. Breeder vaccination significantly reduced the number of \nbroilers with intestinal contamination by effectively reducing Salmonella shed from breeder hen to egg and, \ntherefore, from hatchery to broiler.  \nThe use of live Salmonella vaccines in the U.S. is \nmore recent and there are fewer field studies than with \nbacterins. Data are presented from results obtained by a \nbroiler complex on the Eastern Shore of the U.S. where Salmune, a chemically mutated Salmonella \ntyphimurium  live vaccine, was successfully used in an \neffort to reduce a high level of Salmonella contamination of broilers at the processing plant. This field study involved 16 million broilers over an 11-\nweek period.  Salmune has protection claims of the \nintestine and internal organs against the most common \nserotypes in the U.S., including types of serogroups B, \nC and D. Only one dose by spray is required and data \nhave shown that the vaccine organism does not persist in the environment or vaccinated chickens.  \nSalmonella monitoring data of this broiler \ncomplex showed that during the three months prior to \nvaccination, the average prevalence of Salmonella at \nthe processing plant was at 22.5%, 11.4% and 14.6%, \nrespectively,  as measured by the company\u2019s whole -bird \ncarcass rinse test. This plant was at risk of being out of \ncompliance. During the three months following the \nprocessing of broilers vaccinated with Salmune the \nprevalence of total Salmonella decreased to a monthly  \n  \n9 average of 6.8%, 5.0% and 2.3%, respectively. These \nwere the lowest levels of Salmonella reported in this \nplant since the carcass rinse testing was implemented. \nTotal Salmonella  levels at the same plant during the \nsame months the previous year were at 6.5%,  7.9% and \n12.1%, respectively, suggesting that the reduction \nobserved was independent of seasonal variation. Very importantly, this overall reduction at the plant was \nachieved without compromising productive \nperformance of broilers as determined by a lower  \naverage adjusted caloric conversion per pound in \nvaccinated broilers during the 11 -week trial than in \nnon-vaccinated broilers during five weeks before and \nfive weeks after the trial.  \nIn the commercial egg industry the use of \nLayermune SE in the State of P ennsylvania has \nprovided the largest, most comprehensive and standardized vaccine field trial ever conducted in \nlayers. Pennsylvania has 23 million layers and more than 90% are enrolled in the State\u2019s egg quality -\nassurance program (PEQAP). PEQAP is conside red the \npremier egg quality program in the country mainly because of the intensity of environmental testing for \nSE. It is also being used as the model for a national \nmandatory program that will be enacted soon by the \nFood and Drug Administration. Under PEQ AP SE -\npositive environmental samples within a flock result in the testing of eggs. SE -positive eggs result in the \nmandatory diversion into the breaker market \n(pasteurization) with heavy economic loss. Thus, it is \nimperative for the egg producer to maintain  a SE -\nnegative environment.  \nThe effects of SE vaccination have been \nmonitored in PEQAP flocks since 1997. The State Department of Agriculture conducts all the SE testing, \nenvironmental and eggs, and collects, summarizes and analyzes the data. PEQAP flocks follow standard \nmanagement guidelines relating to cleaning and \ndisinfection, rodent control and biosecurity, making \ncomparisons between contemporary flocks much more \nrelevant. All pullets in the PEQAP study have been \ninjected at 13 weeks of age with one do se of \nLayermune SE or Layermune 3 (in combination with \nNewcastle disease and infectious bronchitis virus) by \nthe same servicing company, thus facilitating the \nidentification and follow -up of the flocks.  \nCumulative results of SE prevalence in PEQAP \nflocks f rom 1997 to 2000, include 1,005 non -\nvaccinated flocks representing 57.4 million layers, with \nSE-positive eggs found in 7.9% of flocks. The percent \nof SE -positive environmental samples was 2.20% with \n12.6% of flocks having a SE -positive environment. \nDuring this period there were 182 vaccinated flocks \ncomprising 15.9 million layers. Vaccinated flocks with \nSE-positive eggs were 0.55%. The percent of SE -\npositive environmental samples was 0.24% with 3.3% of flocks having a SE -positive environment. These \nfigures indicate a reduction of SE prevalence of 93%, \n89% and 74% in eggs, environmental samples and flocks, respectively. This reduction in SE is greater than that reported in the United Kingdom two years \nafter mandatory vaccination with a bacterin was \nimplemente d. \nLayermune SE is the most thoroughly tested \nsalmonella vaccine in the market because it was the \nfirst of its type to be licensed by the USDA and by regulatory authorities in many other countries. It has \nbeen subjected to a high degree of scrutiny by \nindependent researchers and governments and, most \nimportantly, it has been used without disappointment in \nmore chickens around the world under the most varied \nset of circumstance than any other SE bacterin.\n \nEFFECT OF EXPERIMENT AL CHLORATE COMPOUND (ECP) ON \nSALMONELLA CONTAMINATION OF POU LTRY  \n \nJ.A. Byrd2, R.C. Anderson, and D.J. Nisbet  \n \nU.S. Department of Agriculture, Agricultural Research Service,Southern Plains Agricultural Research Center,  \n2881 F&B Road, College Station, Texas 77845  \nBYRD@FFSRU.TAMU.EDU  \n \nABS TRACT  \nE. coli and Salmonella are members of the family \nEnterobacteriacea , a common commensal family of \nbacteria.  Salmonella  and E. coli have a nitrate \nreductase enzyme that allows respiration in anaerobic conditions.  Nitrate reductase can also co -metabol ize \nchlorate to chlorite ion which will kill the bacteria. \nThis study was performed to investigate the effect of \nchlorate on cecal Salmonella  typhimurium  (ST) recovery in poultry.  Broilers or turkeys provided a \nchlorate solution in the drinking water had significantly \nlower populations and incidence of crop and cecal \nSalmonella compared to the controls.  This study \nsuggests that incorporation of chlorate in the drinking \nwater prior to slaughter can reduce Salmonella  \ncontamination in broilers.   \n  \n10 INTRODUCTION  \nSalmonella and Escherichia coli O157:H7 are \nimport food borne pathogens of concerns to the meat \nindustries in the U.S.(1,2,3,4).  These bacteria are \nmembers of the family Enterobacteriaceae  that also \nincludes some of the most pathogenic bacteria most often  encountered in human disease outbreaks \nincluding Shigella, Klebsiella , and Yersinia (5).  Most \nmembers of the family Enterobacteriaceae possess \nrespiratory nitrate reductase activity (5,6).  Respiratory nitrate reductase functions to conserve electrons vi a \nelectron transport phosphorylation (6,7).  One interesting fact that has been reported was respiratory nitrate reductase also co -metabolizes chlorate to \nchlorite which is cytotoxic to the bacterium (6).  The \nnitrate reductase bacteria built up toxic leve ls of \nchlorite and eventually die.  In vitro  and in vivo  studies \nin cattle rumen contents indicate that chlorate \nsignificantly reduced E. coli O157:H7  populations and \ndid not alter the total anaerobic bacterial counts (8,9).  Similarly, sodium chlorate sig nificantly reduced pigs \ncecal concentrations of Salmonella typhimurium  but \nnot potentially beneficial anaerobes (10).  Since sodium chlorate effectively reduced E. coli O157:H7 and Salmonella typhimurium in bovine and swine \nspecies, we conducted a study to  determine whether \nchlorate will selectively inhibit Salmonella in day -of-\nhatch chicks.      \n \nMATERIALS AND METHODS  \nExperimental Design Two hundred day -of-hatch \nbroiler chicks were obtained from a commercial \nhatchery, divided into 4 groups of 50, and placed in \nround floor pens on clean pine shavings at a density of \n0.33 ft\n2/bird.  The chicks were maintained under \ncontinuous lighting and provided free access to water and unmedicated corn -soybean meal -based broiler \nstarter ration that met or exceeded the level s of critical \nnutrients recommended by the National Research \nCouncil (11).  The paper liners from chick transport \nboxes and feed samples were cultured for Salmonella \nas described previously  (12,13).  \nOn Day 1, chicks (25) of each group was \nchallenged with 10\n8-109 cfu novobiocin (NO) and \nnalidixic acid (NA) resistant S. typhimurium (Seeders) and placed in the pen with the remaining unchallenged \nchicks (Contacts).  One hour later, a reconstituted competitive exclusion (CE) product (PREEMPT\ntm) was \nadministered  by oral gavage (0.25 mL) to Group 2 and \n4.  After additional hour, chicks were provided either distilled water or  experimental chlorate product (ECP; \nECP is equivalent to a 15 mM chlorate ion concentration; groups 3 and 4) for 4 days.  After this period, all chicks were provided free access to water \nuntil termination of the experiment.On day 3, \napproximately 48h post -CE treatment, 10 chicks in each group were randomly selected and euthanized by \ncervical dislocation.  The concentration of volatile fatty \nacids (VFA) (acetic + propionic + butyric + isobutyric \n+ valeric + isovaleric) in the caecal contents were \ndetermined by gas liquid chromatography as reported \npreviously (14).  \nRecovery of Salmonella .  On Day 10, all chicks \nwere killed by cervical dislocation and evaluated for Salmonella colonization.  Cecal contents were \naseptically collected from a cecum of each chick, \nserially diluted and spread -plated on NO/NA BGA, \nincubated for 24 hours at 37\noC, and the number of \ncolony forming units of  Salmonella was determined \nand expressed as log 10 Salmonella /g cecal contents.  \nCecal contents that were negative at a 100 fold dilution \non BGA plates but were positive at a 10 fold dilution \non BGA plating were assigned 1.50 log 10 Salmonella /g \ncecal contents (14,15).  \n \nRESULTS AND DISCUSSION  \nSeeder or Contact chicks given ECP in the \ndrinking water or CE, had decreased cecal Salmonella  \nincidence and lower number of Salmonella cfu \nrecovered was statistically ( P < 0.05) lower than the \ncontrols or CE treated (T able 1).  Seeders or Contacts \nchicks had significantly lower numbers of cecal \nSalmonella cfu recovered and lower incidence of \nSalmonella recovered as compared to the controls.  \nChicks provided the combination of ECP and CE had \nsignificantly lower numbers o f Salmonella cfu \nrecovered from the ceca and the incidence detected in \nthe cecal as compared to the controls.  Furthermore, the \ncombination of ECP and CE was not significantly \ndifferent from the ECP alone with the exception on \nnon-challenged chicks provide d ECP alone.  ECP alone \nor in combination with CE provided to broiler chicks 3 \ndays prior to sampling did not significantly effect the \ncecal volatile fatty acid populations compared to the \ncontrols or the CE treated (data not shown).  \nThe data in the prese nt study suggest that ECP \nprovided in the drinking water during the first 4 days of \nlife may reduce the incidence and the population of \nSalmonella in newly hatched chicks.  In addition, data \nsuggest that ECP will not adversely affect the \nmicrobial population naturally found in the gastrointestinal tract or artificially introduced in CE. \nThese data suggest that ECP treatment may be a \npractical preharvest intervention strategy.  Because poultry have access to water during the initial \nplacement or during the f eed withdrawal period and \nECP can be administered in the drinking water, ECP \ncould have an impact on the pathogen load during \ngrow -out or that will be transported to the processing \nplant.  The reduction of foodborne pathogens entering \nthe processing plant should reduce pathogen \ncontamination on the final product.   \n  \n11 The use of ECP in a preharvest program will still \nneed to be further investigated to maximize its \neffectiveness in a commercial setting.  Chlorate has \nbeen approved for use in low concentrations in \nveterinary and human medicine and has been used \npreviously in toothpaste in Europe (16).  The lethal \ndose of chlorate in humans has been determined to be 1 g/kg body weight (16). Studies demonstrated that \nchlorate significantly reduced E. coli  O157:H7  an d \nSalmonella typhimurium  DT104  in gastrointestinal \ncontents while not significantly alter normal total culturable anaerobic bacteria counts suggesting that \nchlorate supplementation maybe a viable strategy to reduce foodborne pathogens that posses nitrate \nreductase enzyme. Government regulations (Pathogen \nReduction Act) have brought a need for cost efficient \napproaches to reducing food borne pathogens without \ndramatically altering present management techniques. \nThe results of the present study suggest a pos sible \nmeans to reduce food borne pathogens that can be \nincorporated into existing commercial management \nprocedures.   \n(Mention of a trade name, proprietary product, or \nspecific equipment does not constitute a guarantee or \nwarranty by the U.S. Department of  Agriculture and \ndoes not imply its approval to the exclusion of other \nproducts that may be suitable.)  \n \nREFERENCES  \n1. Doyle, M., Escherichia coli O157:H7 -  the \nnemesis of the cattle industry.  Beef Safetey \nSymposium: Emerging microbial pathogens and issues \nin beef. National Beef Cattle Association Greenwood \nVillage, Co. pp. 42 -45.1998.  \n2. Hogue, A., Akkina, J., Angulo, F., Johnson, \nR., Petersen, K., Saini, P. and Schlosser, W. S. \ntyphimurium DT104 situation report.   Proc. Beef Safety Symposium: Emerging microbia l pathogens and \nissues in beefNational Beef Cattle Association. \nGreenwood Village, Co.  pp 13- 23. 1998.  \n3. Wells, S., Fedorka -Cray, P. J., Besser, T., \nMcDonough, P. and Smith, B.  E. coli O157 and Salmonella, status on U.S. dairy operations. p. 1 -8 In \nNAHMS ' 96 Nationasl Animal Health Monitoring \nsystem. pp. 1 -8. 1999.  \n4. Woteki, C. E.  The food safety research \nagenda -emerging microbial pathogens and issuesIn \nBeef Safety symposium, emerging microbial pathogens \nand issues in beef. National Cattlemen's Beef \nAssociat ion, Greenwood Village, Col. pp 1- 5. 1998  \n5. Brenner, D. J. \u201cEnterobacteriaceae\u201d In: \nKrieg, N. R. and Holt, J. G. (eds.) Bergey's manual of \nsystemic bacteriology., Vol. 1. The Williams & \nWilkins Co., Baltimore. pp. 408- 420. 1998.  6. Stewart, V. Nitrate respiration in relation to \nfacultative metabolism in enterobacteria.  Micro.Reviews  52:190- 232. 1988.   \n7. Cole, J. A. \u201cAssimilatory and dissimilatory \nreduction of nitrogen to ammonia.\u201d In\n: Cole, J. A. and \nFerguson, S. J. (eds.) The nitrogen and sulfur cycles. Cambri dge University Press, Cambridge.  pp. 281- 329. \n1988.  \n8. Anderson, R.C., Buckley, S.A., Callaway, \nT.R., Genovese, K.J., Kubena, L.F., Harvey, R.B., and \nNisbet, D.J. Effect of sodium chlorate administration \non Salmonella typhimurium concentrations in weaned \npig gut.  J. Food Protect. 64:255- 258. 2001.  \n9. Callaway, T. R., Anderson, R. C., Anderson, \nT. J., Poole, T. L., Bischoff, K. M., Kubena, L. F. and \nNisbet, D. J.  Escherichia coli O157:H7 becomes \nresistant to sodium chlorate in pure culture, but not in \nmixed cul ture in vivo.   J. Applied Micro.  91:1 -8. 2001  \n10. Anderson, R. C., Buckley, S. A., Callaway, T. \nR., Genovese, K. J., Kubena, L. F., Harvey, R. B. and \nNisbet, D. J. Effect of sodium chlorate on Salmonella \nsv. typhimurium concentrations in the pig gut. In:  \nLindberg, J. E. and Ogle, B. (eds.) Digestive \nPhysiology of Pigs. CABI Publishing, Wallingford, \nUK, pp. 308- 310. 2001.  \n11. National Research Council. Nutrient \nRequirements of Domestic Animals. Nutrient Requirement of Poultry.  9th Rev. Edition. Natl.  Aca d. \nSci., Washington, DC. 1994.  \n12.  Andrews, W.H., V.R. Bruce, G. June, F. \nSatchell, and P. Sherrod.  Salmonella . in : \nBacteriological Analytical Manual.  7th ed. Association \nOfficial Analytical Chemists, Arlington, VA pp 51 -69 \n1992.  \n13. Corrier, D.E., D.J. Nisbet, C.M. Scanlan, A.G. \nHollister, D.J. Caldwell, L.A. Thomas, B.M. Hargis, T. \nTomkins, and J.R. DeLoach.  Treatment of commercial broiler chickens with a characterized culture of cecal \nbacteria to reduce salmonellae colonization.  Poultry \nSci. 74:1093- 1101. 1995.  \n14. Corrier, D.E., D.J. Nisbet, A.G. Hollister, \nC.M. Scanlan, B.M. Hargis, and J.R. DeLoach .  \nDevelopment of defined cultures of indigenous cecal \nbacteria to control salmonellosis in broiler chicks.  \nPoultry Sci. 72:1164- 1168. 1993.  \n15. Corrie r, D.E., D.J. Nisbet, C.M. Scanlan, A.G. \nHollister, and J.R. DeLoach.  Control of Salmonella typhimurium  colonization in broiler chicks with a \ncontinuous -flow characterized mixed culture of cecal \nbacteria. Poultry Sci. 74:916 -924. 1995.  \n16.  Cosmetic Ingre dient Review Panel.  Final \nreport on the safety assessment of potassium chlorate.  \nJ. Am. College Toxicology 14:221- 23l. 1995.  \n \n  \n  \n12 Table 1.   Effect of an experimental chlorate compound (ECP) provided in the drinking water and competitive \nexclusion culture ( CE) during the first 4 days on Salmonella typhimurium  cecal colonization in broilers chicks (two \ntrials)1.  \nGroups  Salmonella  challenged (Seeders)  Non- Salmonella  challenged (Contacts)  \n \n Log 10 Salmonella  \nper gram cecal contents  Salmonella  positive  \nchicks  \nper total chicks (%)B Log 10 Salmonella  \nper gram cecal \ncontents  Salmonella  positive  \nchicks per total chicks \n(%)B \nControl  \n 5.37 + 0.98A2 40/40 (100)A 3.94 + 2.15A 33/39 (84.6)A \nCE-gavage  \n 4.21 + 2.05B 35/40 (87.5)B 1.31 + 2.08B 13/39 (33)B \nECP  \n 1.71 + 2.31C 16/39 (41)C 0.42 + 0.97C 7/40 (15)B \nCE + ECP  \n 1.76 + 2.37C 15/40 (37.5)C 0.07 + 0.45C 1/40 (2.5)C \n1ECP is equivalent to a 15 mM chlorate ion concentration  \n2Mean  \u00b1  standard deviation  \na-cMean values within the same column with no common superscripts di ffer significantly ( P < 0 .05).  \n \nA COMPARISON OF 3 LI VE SALMONELLA VACCINES AGAINST \nGROUP C AND D SALMONELLA CHALLENGE  \n \nCOMPARACI\u00d3N DE 3 VACUNAS VIVAS DE SALMONELA CONTRA EL \nDESAF\u00cdO CON SALMONELA DE LOS GRUPOS C Y D  \n \nK.C. Cookson and H. Fan.   \n \nFort Dodge Animal Health, Inc., Overland Park, Kansas.  \n \nRESUMEN  \nEn EE.UU. actualmente existen tres vacunas \nvivas de Salmonella typhimurium,  a saber Salmune de \nBiomune, Megan Vac- 1 de Megan y Poulvac ST de \nFort Dodge. Este trabajo se realiz\u00f3 para comparar los \ntres p roductos bajo condiciones id\u00e9nticas. Ninguna de \nlas aves reaccion\u00f3 ante la prueba en placa para S. \npullorum  a los 14 ni a los 42 d\u00edas de edad. En el \nestudio de desaf\u00edo SK,  la ganancia de peso antes y \ndespu\u00e9s del desaf\u00edo fue de la siguiente manera: \nSalmune (541, 87), Megan Vac -1 (545, 78), Poulvac \nST (579, 107) y testigos (533, 115). En el estudio de desaf\u00edo SE la ganancia de peso antes y despu\u00e9s del \ndesaf\u00edo fue: Salmune (547, 85), Megal Vac- 1 (515, \n103), Poulvac ST (554, 105) y testigos (530, 99).  \n \nINTRODUCTION  \nThere are three live Salmonella typhimurium  (ST) \nvaccines currently available in the U.S. poultry \nmarket \u2014Biomune\u2019s Salmune, Megan\u2019s MaganVac -1 \nand Fort Dodge\u2019s Poulvac ST.  Because each of these \nvaccines is derived from a different field isolate and \neach was attenuated by the modification of different \nproperties of the parent strain, these vaccines potentially may be quite different in the way they \nbehave (1,2,4).  This study was conducted in order to \ncompare all three products under identical conditio ns. \n \nMATERIALS AND METHODS  \nDay old SPF pullets were housed in Horsfall \nisolator units until the termination of the study at 49 \ndays.  Vaccinate groups were given a single dose of \nlive ST by course spray at day of age, then they received a second dose by dr inking water at 14 days of \nage.  At 14 and 42 days of age, ten birds from each group were bled for Pullorum plate testing.  At 42 days of age, all birds were challenged by 1.0 ml oral gavage \nwith virulent strains of either Salmonella kentucky  (SK) \nor Salmo nella enteritidis  (SE).  The SK challenge titer \nwas 1.7x10\n6 colony forming units (CFU)/dose and the \nSE challenge titer was 3.6x107 CFU/dose.  One week \npost challenge, all birds were sacrificed and cultured \nfor salmonella.  Organ pools consisted of liver, s pleen \nand kidney.  Intestinal pools consisted of sections of duodenum, jejunum and ileum.  Body weights (grams) were taken at 1, 42 and 49 days of age.   \n  \n13 RESULTS  \nNo birds reacted on the Pullorum plate test at \neither 14 or 42 days of age.  In the SK challenge  study, \nthe pre -challenge and post -challenge weight gains were \nas follows:  Salmune (541, 87), MeganVac -1 (545, 78), \nPoulvac ST (579, 107) and Controls (533, 115).  In the \nSE challenge study, the pre -challenge and post -\nchallenge weight gains were:  Salmune  (547, 85), \nMeganVac1 (515, 103), Poulvac ST (554, 105) and \nControls (530, 99). However, none of these differences \nwere significant.  The re- isolation results post \nchallenge are summarized in Table 1 below.  \n \nDISCUSSION  \nAlthough there were no significant pr e-challenge \nweight differences between vaccinates and controls, it is interesting that vaccinate weights were numerically \nhigher in 5 out of 6 groups.  This is consistent with \npreviously published work (1,3), which at least \ndemonstrates the safety of the l ive ST products \nregarding weight gains.  The results also showed that \nSK and SE did not affect the non- vaccinates\u2019 body \nweights in the seven day post -challenge period.  In this \nlimited study, none of the vaccines caused Pullorum \nplate reactions 2 weeks aft er the day of age vaccination \nor 4 weeks after the 14 day vaccination.  However, \nmore extensive field testing should be conducted on \nthese products before ruling out their potential to cause \nfalse positive reactions.  \nAll vaccine groups showed a significant  reduction \nof SK and SE re -isolation from the internal organs post \nchallenge compared to the non -vaccinated controls.  In addition, Poulvac ST showed reductions in intestinal \nre-isolations of SE and cecal re -isolations of both \nchallenge strains, while the other products did not.  \nTitration of the vaccines indicated that they were all potent at the time of vaccination.  Finally, it must be \nnoted that in order to compare all three vaccines under \nidentical conditions, Salmune was not given according to label r ecommendations.  Thus, based on this study \nno comments can be made about the relative efficacy \nof Salmune given by day of age spray alone.  \n \nREFERENCES  \n1. Alderton, M.R., K.J. Fahey, and P.J. Coloe.  \nHumeral reponses and salmonellosis protection in \nchickens gi ven a vitamin- dependent salmonella \ntyphimurium mutant.  Avian Dis. 35:435- 442. 1991.  \n2. Barbezange, C., F. Humbert, V. Rose, F. \nLalande, and G. Salvat.  Some safety aspects of salmonella vaccines for poultry:  distribution and \npersistence of three salmonella typhimurium live \nvaccines.  Avian Dis. 44:968 -976.  2000.  \n3. Coloe, P.J., N.L Gerraty, W. Christopher, \nM.R. Alderton, and S.C. Smith.  Vaccination of poultry with salmonella typhimurium STM -1.  Laboratory and \nfield evaluations.  Proc. 43\nrd  West. Po. Dis. Con f.  37 -\n39.  1994.  \n4. Hassan, J.O., and R. Curtis III.  Efficacy of a \nlive avirulent salmonella typhimurium vaccine in \npreventing colonization and invasion of laying hens by \nsalmonella typhimurium and salmonella enteritidis.  \nAvian Dis.  41:783- 791.  1997.  \n    \nTable 1.   Re-isolation rates 7 days post challenge with S. kentucky and  S. enteritidis.  \nVaccine \nGroup   S. kentucky challenge  S. enteritidis challenge  \nOrgan pool  intestine  cecum  organ pool  intestine  cecum  \nSalmune  7/23*  20/23  12/23    9/25*  23/25  23/25 \nMaganVac -1 8/25*  25/25  22/25       10/24*  24/24  23/24  \nPoulvac ST  2/23*  19/23     7/23*    2/25*    18/25*    17/25*  \nControl      14/21  21/21        14/21       23/24  23/24  23/24  \n* denotes a significant difference from control group (Chi -square test, p<0.05)      \n \n SERODIAGNOSIS OF SALMONELLA ENTERITIDIS  INFECTION  \nIN POULTRY  \n \nKakambi V. Nagaraja, Professor  \n \nCollege of Veterinary Medicine, Department of Veterinary PathoBiology,  \nUniversity of Minnesota, St.Paul, MN  55108  \n \nSalmonellosis is the  most common fo odborne \ninfectious disease of humans reported in the US.  The \nincidence of cases of SE in humans in the US began to \nrise in the late 1970s, and later it became the leading \nserotype responsible for food poisoning in US.  A number of disease outbreaks from S E infection in \nhumans have been traced to the consumption of SE contaminated eggs. To the producers of the eggs, SE is \nan important economic as well as public health issue.  \nIt is estimated that 0.01% of all shell eggs contain SE,  \n  \n14 and the percentage may be  even higher in some parts of \nUS (8).  The presence of SE in chickens and its \ntransmission through table eggs into human food chain \nhighlights the need for specific test to identify SE \ninfected chickens and to eliminate them from the flock.  \nPreharvest food  safety is the most important \ncomponent of an effective prevention and control strategy for SE infection.  Many control strategies have \nbeen implemented to reduce the prevalence of SE \ninfection in poultry with the ultimate aim of reducing \nSE outbreaks in h umans.  Successful implementation \nof control measures requires rapid, specific and inexpensive methods of detection of birds infected with SE.  Current methods for the detection of SE infection \nin chickens rely primarily on conventional \nbacteriologic cultu re.  This procedure is relatively \nslow, often taking up to 3 to 4 days to provide even a \npresumptive diagnosis.  More importantly, birds \ninfected with Salmonella may not excrete the organism \neveryday and with this intermittent shedding, \ntraditional bacteriologic culture methods generally \nhave a low sensitivity.  \nThe detection of antibodies specific to the \nbacterium can provide an alternate method for \nassessing the presence of infection.  Several serological \nmethods such as serum plate agglutination (2,3), \nmicroagglutination (15), microantiglobulin tests (6), \nELISA (7,12,14) have previously been employed for \nthe detection of SE infection in poultry.  The major \nproblem with these assays is that they lack either the \nsensitivity or the specificity to detect SE infected birds, or the tests are too difficult to perform in a routine \nlaboratory or at field setting (1).  This has precluded \nthe widespread application of these tests for the \ndetection of SE infection.  \nEgg yolk has been recognized as an excellent \nsource o f antibodies.  Only a small proportion of eggs \nfrom infected flocks may be positive for  Salmonella on \nculture and the examination of large number of eggs \nfor evidence of infection by culture is impractical.  \nAlternatively, detection of antibodies in eggs f rom SE \ninfected birds does not involve physical handling of \nbirds and is economical.  \nSE produces at least four distinct fimbriae: \nSEF14, SEF17, SEF18 and SEF21 (4,5,9,10).  The \nSEF14 fimbriae is a uniquely specific structure consists \nof repeating subunits with a molecular mass of 14,300 \n(10).  The gene sefA , encoding SEF14 has been shown \nto have limited distribution among Salmonella \nserotypes belonging to serogroup- D.  SEF14 fimbriae \nare present in S. enteritidis , S. dublin, S. moscow  and S. \nblegdam  (11).  Though, many of the serogroup -D \nSalmonella such as S. typhi , S. gallinarum  and \nS.pullorum  possess the intact gene, they fail to express \nSEF14 fimbriae (13).  We evaluated rSEF14 fimbrial antigen of \nEnteritidis for specific detection of Enteritidis infected  \nchickens using the latex agglutination test (LAT) and ELISA.  RSEF 14 antigen was highly specific in \nidentifying birds infected with Enteritidis.  Sera from \nchickens infected with closely related serogroup -D \nSalmonella and other avian pathogens did not re act \nwith rSEF14 antigen.  The rSEF14 antigen identified antibodies in serum of 88% of chickens during first two \nweeks of infection, and 100% of the birds \nsubsequently.  The Enteritidis specific antibodies were \ndetected in egg yolk as early as 6 days post i nfection in \nrSEF14 -ELISA.  Our results suggest that rSEF14 based \nassays could be used as a screening tests for detection of Enteritidis antibodies and would overcome the \ncross- reactions observed with existing serological tests.  \n \nREFERENCES  \n1. Barrow PA (1994) Serological diagnosis of \nSalmonella serotype enteritidis  infection in poultry by \nELISA and other tests.  Int J Food Microbiol  21: 55 -\n68. \n2. Chart H, Rowe B, Baskerville A, Humphrey \nTJ (1990a) Serological tests for Salmonella enteritidis  \nin chickens.  Vet Re c 126: 20. \n3. Chart H, Rowe B, Baskerville A, Humphrey \nTJ (1990b) Serological tests for Salmonella enteritidis  \nin chickens.  Vet Rec 126: 92. \n4. Clouthier SC, Collinson SK, Kay WW \n(1994) Unique fimbriae -like structures encoded by \nsefD of the SEF14 fimbrial gene cluster of Salmonella \nenteritidis .  Mol Microbiol  12: 893- 903. \n5. Collinson SK, Emody L, Muller KH, Trust \nTJ, Kay WW (1991) Purification and characterization \nof thin, aggregative fimbriae from Salmonella \nenteritidis .  J Bacteriol  173: 4773- 4781.  \n6. Cooper GL, Ni cholas RAJ, Bracewell CD \n(1989) Serological and bacteriological investigations of \nchickens from flocks naturally infected with \nSalmonella enteritidis .  Vet Record  125: 567- 572. \n7. Kim CJ, Nagaraja KV, Pomeroy BS (1991) \nEnzyme -linked immunosorbent assay for th e detection \nof Salmonella enteritidis  infection in chickens.  Am J \nVet Res  52: 1069- 1074.  \n8. Mason J, Ebel E (1992) USDA -APHIS \nSalmonella enteritidis  control program.  In Proceeding \nof the symposium on the diagnosis and control of \nsalmonella. Ed GH Snoeyenbos .  Richmond, Virginia; \nUS Animal Health Association, pp78.  \n9. Muller KH, Collinson SK, Trust TJ, Kay \nWW (1991) Type 1 fimbriae of Salmonella enteritidis . \nJ Bacteriol  173: 4765- 4772.  \n10. Thorns CJ, Sojka MG, Chase D (1990) \nDetection of a novel fimbrial structure o n the surface of \nSalmonella enteritidis by using a monoclonal antibody.  \nJ Clin Microbiol 28: 2409- 2414.   \n  \n15 11. Thorns CJ, Sojka MG, McLaren IM, Dibb -\nFuller M (1992) Characterization of monoclonal \nantibodies against a fimbrial structure of Salmonella \nenteritidis  and certain other serogroup D salmonellae \nand their application as serotyping reagents. Res Vet \nSci 53: 300 -308. \n12. Timoney JF, Sikora N, Shivaprasad HL, \nOpitz M (1990) Detection of antibody to Salmonella enteritidis  by a gm flagellin -based ELISA.  Vet Rec  \n127: 18-19. \n13. Turcotte C, Woodward MJ (1993) Cloning, \nDNA nucleotide sequence and distribution of the gene encoding SEF14, a fimbrial antigen of Salmonella \nenteritidis . J Gen Microbiol  139: 1477- 1485.  \n14. Van Zijderveld FG, Van Bemmel AMV, \nAnakotta J (1992) Compar ison of four different \nenzyme -linked immunosorbent assays for serological \ndiagnosis of Salmonella enteritidis  infections in \nexperimentally infected chickens.  J Clin Microbiol 30: \n2560- 2566.  \n15. Williams JE, Whittemore AD (1971) \nSerological diagnosis of pullor um disease with the \nmicroagglutination system.  Appl Microbiol  21: 394-\n399.\n \nSALMONELLA ENTERITID IS SURVEILLANCE PROGRAM  \nIN LAYERS IN QUEBEC  \n \nPROGRAMA DE VIGILANCIA DE SALMONELLA ENTERITIDIS  (SE) EN \nPONEDORAS EN QUEBEC  \n \nM. Boulianne1 and D. Frenette2 \n \n1Department of Clinical Sciences, Faculty of Veterinary Medicine, University of Montreal, P.O. Box 5000,  \nSt-Hyacinthe, Qc J2S 7C6 Canada, 2F\u00e9d\u00e9ration des Producteurs d\u2019Oeufs de Consommation du Qu\u00e9bec, 555 \nRolland -Therrien Bvld, Longueuil, Qc J4H 3Y9 Canada  \n \nRESUMEN  \nEn 1996, despu\u00e9s de un brote de infecci\u00f3n por SE \nPT 4 en la provincia de Quebec, el Consejo del Huevo \ninici\u00f3 un programa de vigilancia y erradicaci\u00f3n de SE. \nEste enfoque de \u201ctolerancia cero\u201d implica la \ncolaboraci\u00f3n de numerosos participantes de los \nsectores privado y gubernamental, para asegurar el seguimiento profundo del sistema de producci\u00f3n de \nhuevo. La detecci\u00f3n de Salmonella a todos los niveles \nde producci\u00f3n se combina con un r\u00edgido c\u00f3digo de \npr\u00e1cticas que debe obedecer el avicultor para poder comercializar su huevo.  \n \nPARTNERS OF THE PROGRAM  \nThe egg production in Canada is managed by a \nsupply management system, where producers must \nacquire quotas in order to produce. This system allows \nproducers to benefit from a price based on production costs.   It is national and production is predicted \naccording to consumption. In the province of Quebec, \nthere are one hundred table egg producers owning a \ntotal of  3,4 millions laying hens. All producers are \nmembers of the Quebec Egg Board and pay a levy \nbased on numbers of layers, hence eggs produced. Part \nof this money has been redirected to the provincial \nsurveillance program and a special national \ncompensation fund covers losses when a flock is found \npositive.   The SE surveillance and eradication program al so \ninvolves the collaboration of various governmental \npartners; the Provincial Ministries of Health, of \nAgriculture and Fisheries, and the federal Canadian \nFood Inspection Agency (CFIA), each with a well -\ndefined scope of intervention. Industry partners, su ch \nas the Quebec Eggs Graders Association, the Quebec \nHatcheries Association and the Faculty of Veterinary \nMedicine of the University of Montreal are also \nessential to the program. Each of these partners have a \nwell-defined role and level of intervention in the \nsurveillance program as well as in the case of a SE outbreak.  \n \nDETECTION TESTS  \nDetection tests are conducted at all levels of \nproduction. Primary breeders (grandparents) are \nalready tested monthly by genetic companies (serology \nand environment tests) , but an added monthly \nenvironment testing is performed in every breeder \nflocks (parents). Every hatched lot is sampled at the \nhatchery via fluff and/or meconium, and pullet houses \nare tested twice (environment tests) over the 19 -week -\ngrowing -period. All layer flocks are tested a minimum \nof four times during the lay cycle, the first test being conducted before 23 weeks of age. Depending on \nvarious criteria, such as presence of a multi -age barn, \nsome flocks will be sampled a minimum of six times a \nyear. If t he previous flock was housed in a SE -positive  \n  \n16 barn, the two subsequent flocks will be tested at least \nsix times during the laying period, with a special \nattention devoted to the first months of laying.  \nFluff and/or meconium samples are the \nresponsibility o f the hatcher, while environment tests in \ngrowing and laying houses are conducted by Quebec \nEgg Board agents. Egg graders are part of a combined industry -CFIA testing program. All samples are \nanalysed in a provincial laboratory of the Ministry of \nAgricultu re and Fisheries with a Salmonella  isolation \nprotocol including delayed secondary enrichment.  \n \nPRODUCER\u2019S CODE OF PRACTICE  \nThe producer must comply to a series of \npreventive measures for his eggs to be sent to a certified grading station for marketing purp oses. Any \nderogation to the conditions stipulated in the Quebec \nEgg Board prevention program automatically diverts \neggs to the breaker, at the price paid for industrial product. For example, the producer must contract \nservices of a certified professional p est exterminator, \ncleaning and disinfection must be done according to \nEgg Board standards, premises and their immediate \nenvironment must be kept clean at all times, eggs must \nbe placed daily in a 12C cold room, etc\u2026  \n CHAIN OF ACTION IN CASE OF A SE -\nPOSITIV E RESULT  \nIf a fluff/meconium sample or an environment \ntest of a pullet house is SE -positive, birds will be \ndestroyed.  \nIn case of a group D Salmonella  positive sample \nfrom a laying barn, suspected eggs are located at grading stations, all eggs originating f rom the \nsuspected flock are seized. Upon final bacteriological \nresults, if found positive, they will be routed to a \nbreaker for pasteurization. Multiple environment tests \nare then conducted in the SE -positive barn along with \nblood sampling.  If one or more  sample is found \npositive, eggs will be diverted to further processing until slaughter.  If the flock represents a risk to other \nnearby flocks, it will be immediately destroyed.  \n \nCONCLUSIONS  \nThis program has been highly successful in that it \nbrought together various industry and government \npartners and lead to the design of a sensible and well -\ndefined intervention program in case of a SE outbreak. \nFurthermore, there has been no single human case of \nSE foodborne poisoning related to table egg consumption of in the province of Quebec since the \nestablishment of the program in 1997.\n \nUSO DEL ENSAYO ELISA PARA DETECTAR ANTICUERPOS \nCONTRA EL VIRUS DE I NFLUENZA AVIAR EN YE MA DE HUEVO \nY ESTABLECER EL ESTA DO DE INFECCI\u00d3N/VACUNACI\u00d3N EN \nGALLINAS DE POSTURA  \n \nUSE OF ELIS A TEST TO DETECT AVIAN INFLUENZA VIRUS (AIV) \nANTIBODIES IN EGG YOLKS AND TO ESTABLISH INFECTION/ \nVACCINATION STATUS IN LAYING HENS  \n \nR Merino*, LY Guti\u00e9rrez, VR Tejeda y JA Quintana  \n \nDepartamento de Producci\u00f3n Animal: aves, FMVZ, UNAM, M\u00e9xico  \n \nSUMMARY  \nThe ELISA test had a kappa value of 0.67 as \ncompared with HI in the detection of AIV antibodies in \nserum samples. Specificity and sensitivity of HI, \nELISA, and AGP for AIV antibody detection in \npositive and negative egg yolk samples were: HI: 87% \nand 100% respectively; ELISA: 100% and 100% respectively. AGP did not detect any positive samples. \nELISA is adequate to detect AIV antibodies in egg \nyolk samples, in order to learn about \nvaccination/infection status in layer flocks.  \n RESUMEN  \nEl ensayo ELISA tuvo un va lor de Kappa de 0.67 \ncomparada con HI  para detectar anticuerpos contra \nInfluenza aviar en muestras de suero. La especificidad \ny sensibilidad de HI, ELISA y PGA para detectar \nanticuerpos contra Influenza Aviar en muestras de yema de huevo positivas y negat ivas fueron: HI: 87% y \n100% respectivamente, ELISA: 100% y 100% respectivamente. La PGA no detect\u00f3 muestras \npositivas. El ensayo ELISA es adecuado para detectar \nanticuerpos contra Influenza Aviar en muestras de \nyema de huevo, para conocer el estado de vacu naci\u00f3n -  \n  \n17 infecci\u00f3n en las parvadas de las cuales procede el \nhuevo.  \n \nINTRODUCCI\u00d3N  \nLa Influenza Aviar (IA) es un padecimiento \ninfeccioso de las aves, causado por un virus de Influenza del tipo \"A\" perteneciente a la familia Orthomyxoviridae. En M\u00e9xico, la Uni\u00f3n Nacional de \nAvicultores  calcul\u00f3 las p\u00e9rdidas monetarias del sector \nav\u00edcola durante el brote de Influenza Aviar de alta \npatogenicidad, diciembre 1994 -  mayo 1995, en 49 \nmillones de d\u00f3lares (Flores, 1995). Las pruebas serol\u00f3gicas m\u00e1s utilizadas en M\u00e9xico son Inhibici\u00f3n de la Hemoaglutinaci\u00f3n (HI, siglas en ingl\u00e9s), y \nPrecipitaci\u00f3n en Gel Agar (PGA). La prueba de HI es \necon\u00f3mica y r\u00e1pida (Jawetz,1992). La PGA es una \nt\u00e9cnica simple y de gran utilidad que se basa en el \nprincipio de que cuando el ant\u00edgeno y el anticuerpo se \ndifunden en un medio semis\u00f3lido (agar), forman complejos inmunitarios estables que se pueden analizar \nvisualmente (Stites,1996; Cottral, 1978). La prueba \nELISA (Enzyme -Linked Immunosorbent Assay) es \naltamente sensible, espec\u00edfica y r\u00e1pida;  se basa en el \nuso de ant\u00edgenos o anticuerpos marcados con una \nenzima, de forma que los conjugados resultantes \ntengan actividad tanto inmunol\u00f3gica como enzim\u00e1tica, \npuede ser utilizada para la determinaci\u00f3n serol\u00f3gica de \nanticuerpos de manera secuencial y m ejorar la \ntitulaci\u00f3n de estos (Rubio, 1993).  \n La detecci\u00f3n y cuantificaci\u00f3n de anticuerpos en \nmuestras de yema de huevo, contra diversos agentes virales y bacterianos, ha demostrado alta sensibilidad y \nespecificidad. Las ventajas del an\u00e1lisis serol\u00f3gico a  \npartir de yema de huevo son el f\u00e1cil embarque, \nausencia de riesgos biol\u00f3gicos, el huevo no requiere \nrefrigeraci\u00f3n (en cortos periodos de tiempo), la \nrecolecci\u00f3n es muy sencilla, los proveedores nuevos de huevo pueden ser analizados f\u00e1cilmente, sitio centr al \nde recolecci\u00f3n (por ejemplo, la planta incubadora), los \nresultados se obtienen antes del nacimiento de los \npollitos, pueden representar un promedio de 6 d\u00edas de producci\u00f3n de anticuerpos por parte de las \nreproductoras, puede conocerse el estado de infecci\u00f3n / \nvacunaci\u00f3n de las aves de las cuales procede el huevo \n(Venne, 1995).  \nLos objetivos del trabajo fueron calcular el valor \nde Kappa de la prueba ELISA comparada con HI, para detectar anticuerpos de Influenza Aviar en muestras de \nsuero, y determinar la sensibilidad, especificidad y el \nvalor predictivo positivo y negativo de ELISA, HI y \nPGA para detectar anticuerpos contra influenza aviar en yema de huevo procedente de gallinas que \nestuvieron en contacto con el ant\u00edgeno, ya sea vacunal \no no.  \n MATERIAL Y M \u00c9TODOS  \nAnt\u00edgeno de Influenza Aviar para la \nPrecipitaci\u00f3n en agar. El ant\u00edgeno se prepar\u00f3 \nmediante la inoculaci\u00f3n 5 huevos embrionados, de 9 d\u00edas de edad, en la cavidad amnioalantoidea con 0.2 ml \nde virus vivo de influenza Aviar H5N2. Despu\u00e9s de 72 \nhoras se  obtuvieron las membranas corioalantoideas, se \nlavaron con PBS, fueron maceradas y guardadas en \ncongelaci\u00f3n hasta su uso.  \nObtenci\u00f3n de las muestras. Se utilizaron 90 \nmuestras de sueros de aves de diferentes edades y 15 muestras de huevo f\u00e9rtil de diferente s procedencias \n(n=60): Grupo negativo \"A\": Gallinas SPF, Grupo \npositivo \"B\": Gallinas vacunadas contra Influenza Aviar, Grupo sospechoso \"C\": Gallinas sospechosas de \nun brote de Influenza Aviar y Grupo desconocido \"D\": \nGallinas con situaci\u00f3n desconocida.  \nDetecci\u00f3n de anticuerpos anti Influenza Aviar \nen suero y yema, con la t\u00e9cnica de Inhibici\u00f3n de la \nHemoaglutinaci\u00f3n (HI), m\u00e9todo . Los sueros fueron \ndiluidos 1:5 y las yemas 1:10; se realizaron diluciones \ndobles seriadas en una microplaca de titulaci\u00f3n, de \nfondo en \"v\", donde se coloc\u00f3 previamente ant\u00edgeno de \nInfluenza H5N2 inactivado (4 UHA), diluido en PBS y \nse incub\u00f3 por 30 minutos. Posteriormente, a cada pozo \nse agregaron 50 l de gl\u00f3bulos rojos de gallina al 0.5% y \nse incub\u00f3 nuevamente por 30 minutos. Tra nscurrido el \ntiempo de incubaci\u00f3n se realiz\u00f3 la lectura. Las \nmuestras fueron consideradas positivas cuando \npresentaron t\u00edtulo de inhibici\u00f3n de la hemoaglutinaci\u00f3n igual o superior a 10.  \nDetecci\u00f3n de los t\u00edtulos de anticuerpos anti -\nInfluenza Aviar en suero y yema por ELISA.  \nSe uso un kit comercial ELISA (AIV ELISA kit, \nSynbiotics Corporation) que tiene placas de microtitulaci\u00f3n revestidas con una cepa del virus de Influenza Aviar. La t\u00e9cnica ELISA se llev\u00f3 a cabo \ncomo describe el fabricante. Las muestras fueron \nconsideradas positivas cuando presentaron t\u00edtulo \nELISA igual o mayor a 570.  \nPrueba de Precipitaci\u00f3n en Gel de Agar: Se \nutilizaron cajas Petri con gel de agar (PBS + 1% agarosa, 5 mm espesor) con un orificio al centro y \ncinco alrededor de manera equidis tante. En el centro se \ncoloc\u00f3 el ant\u00edgeno, como control positivo se utiliz\u00f3 un \nantisuero de Influenza Aviar con t\u00edtulo de 1280; como control negativo se us\u00f3 antisuero de ENC. En los pozos \nrestantes de cada caja se colocaron las muestras de \nyema de huevo di luidas 1:10. Las cajas se colocaron en \nuna c\u00e1mara h\u00fameda y se incubaron por 24 horas a temperatura ambiente y se realiz\u00f3 la lectura de \nresultados. Las muestras se consideraron positivas \ncuando formaron una l\u00ednea de precipitaci\u00f3n blanquecina entre el pozo d el ant\u00edgeno y el pozo de la \nmuestra.   \n  \n18 Valor de Kappa, sensibilidad, especificidad y \nvalores predictivos: Se obtuvieron de acuerdo con las \nf\u00f3rmulas descritas en otros trabajos.  \n \nRESULTADOS Y DISCUSI\u00d3N \nEn las noventa muestras de suero evaluadas por \nHI (4 UHA ) y por ELISA los resultados fueron: 22 \nsueros positivos por ambas t\u00e9cnicas, 4 fueron positivos (+) por ELISA  y negativos (- ) por HI, 3 ELISA (- ) y \nHI (+), 61 fueron negativos en ambas pruebas. El valor de Kappa fue 0.67, excelente (cuadro 1).  \nLas muestr as de yema de huevo de los 4 grupos \nresultaron negativas a la presencia de anticuerpos, con la prueba PGA, por lo tanto no se calcularon \nsensibilidad, especificidad o valores predictivos. Los \nresultados de HI y ELISA fueron: Grupo A HI \npositivos 2/15, ELIS A  positivos 0/15; Grupo B HI \npositivos 15/15, ELISA positivos 15/15. ELISA mostr\u00f3 \n100% de sensibilidad, especificidad, valor predictivo \npositivo y valor predictivo negativo para la detecci\u00f3n de anticuerpos contra Influenza Aviar en los grupos A \ny B, respe ctivamente (cuadro 2). El HI demostr\u00f3 baja \nespecificidad y valor predictivo negativo (87%), y alta \nsensibilidad y valor predictivo positivo(100%) para detectar anticuerpos en los grupos (A) y (B) \nrespectivamente (cuadro 2).  \nLos resultados del Grupo C (HI positivos 13/15, \nELISA positivos 15/15) y del Grupo D (HI positivos 7/15, ELISA positivos 8/15) demuestran que los huevos proceden de aves que estuvieron en contacto \ncon el virus de la influenza aviar. En el caso del grupo \nC se sospechaba de un brote de IA , por lo que el \nresultado serol\u00f3gico confirma el diagn\u00f3stico. Se \ndesconoce la situaci\u00f3n epidemiol\u00f3gica del grupo D, por \nlo tanto no es posible determinar si los anticuerpos \nencontrados en la yema son la respuesta inmunol\u00f3gica a un programa de vacunaci\u00f3n, o  a una exposici\u00f3n de \ncampo.  \n \nCONCLUSIONES  \nEl ensayo ELISA mostr\u00f3 un valor excelente de \nkappa (0.67), as\u00ed como alta sensibilidad, especificidad y valor predictivo para identificar muestras positivas \ncomo positivas y negativas como negativas, con \nrespecto a la prueba de HI. El ELISA es de utilidad \npara identificar anticuerpos contra el virus de Influenza Aviar en muestras de yema de huevo procedentes de \ngallinas que tuvieron contacto con el ant\u00edgeno.  \n Las muestras de huevo son una fuente adecuada \npara detectar anticuerpos contra el virus de la influenza \naviar, y determinar el estado de vacunaci\u00f3n / infecci\u00f3n \nde las parvadas de las cuales proceden.  \n Se recomienda llevar a cabo m\u00e1s estudios para \nestablecer la relaci\u00f3n entre los t\u00edtulos de anticuerpos obtenidos por las pruebas HI y ELISA.  \n \nREFERENCIAS  \nDisponibles con el autor.  \n \nCuadro 1. Concordancia entre ELISA y HI para detectar anticuerpos contra IA en muestras de suero  \n  Resultado ELISA   \n  + - Total  \n Resultado      +  22 3 25 \n HI                   - 4 61 65 \n Total  26 64 90 \nKappa  = (22+61) -  (7.51 * + 45.51 **) / (90 -  45.51) = 0.67  \n \nCuadro 2. Sensibilidad y especificidad de ELISA y HI para detectar anticuerpos contra IA en muestras de \nyema de huevo  \n Grupo   Grupo  \n A (-) B (+)   A (-) B (+)  \nResultado        + 0 15 Resultado        +  2 15 \nELISA             - 15 0 HI                    - 13 0 \n      \nSensibilidad    =                       (15 / 15) x 100 = 100 %  (15 / 15) x 100 = 100 %  \nEspecificidad =                       (15 / 15) x 100 = 100 %  (13 / 15) x  100 = 87 %  \nValor predictivo positivo       (15 / 15) x 100 = 100 %  (15 / 15) x 100 = 100 %  \nValor predictivo negativo  =  (15 / 15) x 100 = 100 %  (13 / 15) x 100 = 87 %  \n \n \n  \n  \n  \n19 DISEASE CONTROL BY M ULTIVALENT IN OVO  VACCINES  \n \nCONTROL DE ENFERMEDADES MEDIANTE VACUNAS  \nMULTIVALENTES IN OVO \n \nJagdev M. Sharma  \n \nVeterinary PathoBiology, College of Veterinary Medicine, University of Minnesota, St. Paul, MN  \n \nRESUMEN  \nSe combinaron varias vacunas elaboradas con \nvirus activos disponibles comercialmente para obtener \nuna sola vacuna multivalente (MV) para aplicaci\u00f3n in \novo. Esta vacuna, que conten\u00eda los serotipos 1, 2 y 3 \ndel virus de la enfermedad de Marek, una cepa intermedia del virus de la infecci\u00f3n de la bolsa de \nFabricio y un virus de viruela aviar recombinante que \nconten\u00eda inserciones de genes del virus de la \nenfermedad de Newcastle (rFPV -NDV), se administr\u00f3 \na los huevos de pollo de engorda comerciales y libres \nde pat\u00f3genos espec\u00edficos ( SPF) a los 18 d\u00edas de \nincubaci\u00f3n. La vacuna indujo anticuerpos contra todos los a nt\u00edgenos virales. Los pollos vacunados estuvieron \nprotegidos contra el desaf\u00edo virulento con los virus de la enfermedad de Marek, de la enfermedad de \nNewcastle, de la infecci\u00f3n de la bolsa de Fabricio y de \nla viruela aviar. El \u00e9xito de la MV bajo condicion es \nexperimentales y de campo ampl\u00eda la utilidad de la \ntecnolog\u00eda in ovo para la avicultura.  \n \nSeveral commercially available live viral vaccines \nwere combined into a single multivalent in ovo vaccine \n(MV). The MV, containing serotypes 1, 2 and 3 of \nMarek\u2019s disease virus (MDV), an intermediate \ninfectious bursal disease virus (IBDV), and recombinant fowl pox virus containing inserts of Newcastle disease virus genes (rFPV -NDV), was \nadministered at embryonation day 18 in SPF and commercial broiler eggs.  The vaccine induced antibodies against all viral antigens.  Vaccinated \nchickens were protected against challenge with virulent \nMDV, NDV, IBDV and FPV.   The successful use of \nMV under experimental and field conditions expands \nthe usefulness of the in ovo technolo gy for poultry.          \nThe In ovo vaccination system has been in \ncommercial use in broilers for the last several years.  \nAlthough Marek\u2019s disease (MD) vaccine is by far the \nmost common vaccine delivered in ovo, experimental \nstudies have shown that live viral vaccines against a number of other common poultry diseases may also be \ndelivered in ovo (Wakenell and Sharma, 1986; Sharma, \n1986; Ahmad and Sharma, 1992; Reddy et al., 1996; \nHaddad et al.,  1997; Rautenschlein et al., 2000).  The \nin ovo technology has also been used experimentally in turkeys (Fadly and Nazerian, 1989; Ahmad and Sharma, 1993; Rautenschlein et al., 2000).  \nRecently, we examined the possibility of \ncombining several commercially available live viral vaccines into a single multivalent in ovo vaccine (MV, \nGagic et al.,  1999).  The following vaccine viruses \nwere combined:  turkey herpesvirus (HVT), SB1 strain of Marek\u2019s disease virus (SB1 -MDV), B2 strain of \ninfectious bursal disease virus (B2- IBDV) and \nrecombinant fowl pox virus (FPV) vector con taining \ninserts of Newcastle disease virus (NDV) HN and F \ngenes (rFPV -NDV). This MV, containing one \ncommercially recommended dose of each of the five \nviruses, was inoculated in a single injection in specific -\npathogen -free eggs at embryonation day 18.  Chic kens \nhatching from MV -injected eggs developed persistent \nviremia with the three serotypes of MDV, antibodies \nagainst the viral antigens present in the mixture and \nwere resistant to challenge with virulent MDV, NDV, IBDV and FPV.    \nThe efficacy of the MV w as also examined in a \nfield trial in commercial broilers. Approximately twenty thousand broiler eggs were inoculated with MV \nwith an automatic egg -injection machine.  The \nremaining eggs, approximately 125 thousand, were \ninoculated with HVT alone, the routi nely used in ovo \nvaccine at the hatchery.  Chickens hatching from the \nMV-inoculated eggs were placed in a barn, adjacent to \nfive barns that housed the chickens that hatched from the HVT -inoculated eggs. The relative performance \nvalues for the MV - and the H VT-vaccinated groups \nrespectively were as follows:   % livability, 92.04 vs \n92.95- 95.22; average daily weight gain, 0.1085 lbs. vs \n0.1072- 0.1151 lbs.; and % total condemnation at \nprocessing, 0.68 vs 0.61- 0.80.  Chickens from the MV - \nand the HVT -vaccinated groups were challenged with \nvirulent viruses under laboratory conditions.  The \nrelative resistance of the MV - and the HVT -vaccinated \ngroups respectively was as follows: MDV and IBDV, \n100% for both groups; NDV, 81% vs 19%; FPV, 86% \nvs 0%.  The successful us e of MV under experimental \nand field conditions expands the usefulness of the in \novo technology for poultry.          \n \n \n  \n  \n20 RERFERENCES  \n1. Ahmad, J., and J. M. Sharma.  Evaluation of \na modified -live virus vaccine administered in ovo to \nprotect chickens against N ewcastle disease.  Am. J. \nVet. Res. 53:1999- 2004.  1992.  \n2. Ahmad, J., and J. M. Sharma.  Protection \nagainst hemorrhagic enteritis and Newcastle disease in \nturkeys by embryo vaccination  with monovalent and \nbivalent vaccines.  Avian Dis. 37:485 -491. 1993.  \n3. Fadly, A.M. and K. Nazerian. Hemorrhagic \nenteritis of turkeys: influence of maternal antibodies and age at exposure. Avian Dis. 33:778- 786. 1989  \n4. Gagic, M., C., St. Hill and J.M. Sharma. In \novo Vaccination of Specific Pathogen Free Chickens \nwith Vaccines Conta ining Multiple Agents. Avian Dis.  \n43:293- 301. 1999.  \n5. Haddad, E.E., C.E. Whitfill, A.P. Avakian, \nC. A. Ricks, P.D. Andrews, J.A. Thoma and P.S. \nWakenell. Efficacy of a novel infectious bursal disease \nvirus immune complex vaccine in broiler chickens . \nAvian D is. 41:882- 889. 1997.  6. Rautenschlein, S., J.M. Sharma, B Winslow, \nJ. McMillen, D. Junker, and M. Cochran.  Embryo vaccination of turkeys against Newcastle disease \ninfection with recombinant fowlpox constructs \ncontaining interferons as adjuvants.  Vaccine 18 :426-\n433. 2000.  \n7. Reddy, S. K., J. M. Sharma, J. Ahmad, D. N. \nReddy, J. McMillen, S. Cook, M. Wild, and R. \nSchwartz. Protective efficacy of a recombinant \nherpesvirus of turkeys as an in ovo vaccine against \nNewcastle and Marek's diseases in specific pathogen \nfree chickens.  Vaccine 14:469 -478. 1996.  \n8. Sharma, J. M.  Embryo vaccination of \nspecific -pathogen -free chickens with infectious bursal \ndisease virus: Tissue distribution of the vaccine virus \nand protection of hatched chickens against disease.  \nAvian Dis. 30 :776- 780. 1986.  \n9. Wakenell, P. S., and J. M. Sharma.  Chicken \nembryonal vaccination with avian infectious bronchitis \nvirus.  Am. J. Vet. Res. 47:933 -938.  1986.  \n \nIN OVO TECHNOLOGY MEETING THE CHALLENGES OF TODAY \nAND TOMORROW  \n \nLA TECNOLOG\u00cdA IN OVO  SATISFACE LOS RETOS DE HOY  \nY DEL MA\u00d1ANA  \n \nCheryl R. GustafsonA, Chris Williams A, Sean Bryan A, Todd Radford A, Bill Stuart A, Nancy Privette A,  \nDexter Smith A, and Stacey Neuman A \n \nAEmbrex, Inc., 1040 Swabia Ct., Research Triangle Park, NC, 27709  \n \nRESUMEN  \nLa tecn olog\u00eda de inyecci\u00f3n del huevo ha pasado \nde las instalaciones de investigaci\u00f3n a la industria av\u00edcola con el desarrollo comercial del sistema de \ninyecci\u00f3n in ovo Inovoject\n\u00ae. Este sistema fue dise\u00f1ado \npara administrar vacunas al embri\u00f3n en desarrollo, pero ahora se han creado nuevos dispositivos para dar valor \nagregado a la tecnolog\u00eda existente. Un sistema de \ndetecci\u00f3n de la viabilidad del embri\u00f3n o \u201caparato de \novoscop\u00eda\u201d funciona con un dispositivo de remoci\u00f3n (sistema Egg Remover\n\u00ae) que identifica \nautom\u00e1tica mente a los embriones vivos y muertos. Los \ndatos recolectados se pueden usar como una fuente de \ninformaci\u00f3n para eliminar del proceso todos los huevos \nno viables antes de la inyecci\u00f3n, como una ayuda para la colocaci\u00f3n del pollo reci\u00e9n nacido y para resolv er \nproblemas de operaci\u00f3n de la incubadora.  \n \nEgg injection technology advanced from the \nresearch laboratories of the US Department of \nAgriculture to the poultry industry with the development of a commercial in ovo  injection system. \nThe first commercial in ovo delivery system \n(Inovoject\n\uf8e8 system) was designed to apply Marek\u2019s \ndisease vaccine to the developing embryo in the egg. \nFollowing its inception in 1992, the commercial \napplication of Marek\u2019s disease vaccine in ovo has \ngrown to encompass over 85% of the broiler chickens produced in North America, representing more than 8 \nbillion eggs annually. Additionally, commercialization \nto date has been initiated in 31 countries worldwide, with more than 500 individual machines in operation. \nThe success of the in ovo injection system is due to \nmany factors; however, three technical application \nprinciples drive the technology. One, the in ovo \ninjection system serves to deliver to the embryo \nbiologically active vaccines at the earliest possible time \nof embryonic develop ment, thereby preparing the chick \nimmunologically for the grow -out period prior to \nhatching. Two, the application is a mass application on an individual dosage basis, allowing for uniform \napplication at a rapid rate. Three, the needle and egg  \n  \n21 punch are sanitized between each injection. Building \non these basic principles, the application of the \ntechnology has grown and expanded throughout the \nglobal commercial poultry industry.  \nNew in ovo system development has been focused \non an egg viability detection sys tem or \u2018candler\u2019 that \nautomatically identifies the live and dead embryos \nduring the injection and transfer process. This \nprocedure (Egg Remover \uf8e8 system) fits with the \ncurrent egg injection systems in broiler and breeder \nhatcheries, and can add value in several ways. Once the \nviability of the incubated egg is identified, the data can \nbe used as an information source to control vaccine \ndelivery to only viable embryos, and similarly, to remove non -viable eggs from the process before egg \ninjection. In a large scale week -on, week -off trial in \nNorth America involving 9.5M eggs, removal of non-viable eggs resulted in increased hatch and decreased \nculls. This trend was observed in chicks from broiler breeder birds greater than 40 weeks of age.  \nThe Identifier or can dling component is the basis \nfor which this technology works. The system uses rapid \npulses of light (IR) to determine whether an egg is \nclear (infertile or early dead), or contains a developed \nembryo. Many individual pulses are evaluated per egg to determi ne viability. The candling information that is \ncollected by the Identifier has been examined closely. The perceived light levels have been correlated to \ndifferent stages of embryonic development. Almost no \nlight is perceived by the system when a beam is \ndirected through a live embryo. In contrast, a large \namount of light is perceived when an infertile egg is scanned. What is intriguing is the variation in light \nlevels that is perceived by scanning embryos that have \ndied during incubation. Levels of light ca n be \ndelineated and correlated to the developmental period \nthat embryonic death occurs, especially embryonic \ndays one through eight. These levels are not as clearly \ndefined as the live and infertile, however, there is continued work with the system to refi ne its \ncapabilities. Additional incorporation of thermal \nimaging technology has shown good promise of \nincorporation into the candling/identification system. \nThermal imaging is able to differentiate between live \nembryos and middle and late dead embryos, as well as \ncontaminated \u2018black\u2019 rots.  \nThe Identifier collects and collates information \nthat can be accessed through various screens found on the control box. These information screens are used to \nverify accurate operation, give immediate data on \nscanned eggs,  summarize accumulated data, trouble \nshoot the scanning process, and can serve as a tool for the hatchery manager. Data can be collated during \noperation into groups such as by incubator or by \nbreeder flock. During operation, the individual \nincubator flat is shown on the screen, as well as a cumulative total viability for the individual breeder \nflock. This information can obviously be used to help \nthe manager predict subsequent hatch by flock or \nmachine, and therefore serve to help manage the \nplacement of th e hatched chicks. The data is also very \nuseful as a troubleshooting device for incubator \noperation.\n \nEFFICACY AND SAFETY OF A RECOMBINANT FOWL POXVIRUS \nCONTAINING LARYNGOTRACHEITIS GENES  \n \nEFICACIA Y SEGURIDAD DE UN POXVIRUS RECOMBINANTE \nCONTENIENDO GENES DE LARINGOTRAQUEITIS  \n \nKristi M. Moore, Jennifer R. Davis, Yoshinari Tsuzaki, David R. Hout, Motoyuki Esaki, Takashi Okuda,  \nand Joan D. Leonard   \n \nRESUMEN  \nLaringotraqueitis infecciosa (ILT) es una \nenfermedad viral aguda del tracto respiratorio de las aves.  Los m\u00e9todos de control actuales del ILT en \u00e1reas \nde la producci\u00f3n intensiva de las aves de corral \nincluyen el uso de vacunas vivas modificadas. Dentro \nde las desventajas de las vacunas vivas modificadas de ILT es que estas vacunas pueden  revertir a la \nvirulencia y causar la enfermedad en aves susceptibles. \nEn un esfuerzo de producir una vacuna m\u00e1s segura de \nILT usando ingenier\u00eda gen\u00e9tica, un Poxvirus \nrecombinante (FP) conteniendo genes del ILT fue dise\u00f1ado con el fin de limitar las desventajas de las vacu nas vivas modificads de ILT. Dos genes que \nexpresan los ant\u00edgenos protectores dominantes del ILT fueron aislados de cepas virulentas del campo de ILT. \nEstos dos genes de ILT fueron insertados en el genoma \nde una vacuna de FP, que mantuvo las caracter\u00edsticas \nde la vacuna de FP y adem\u00e1s demostr\u00f3 protecci\u00f3n \ncontra ILT. Esta vacuna recombinante es segura para el \nuso en aves y es eficaz contra el desaf\u00edo de FP y de \nILT. Adem\u00e1s, esta vacuna redujo la diseminaci\u00f3n del \nvirus de desaf\u00edo de ILT del grupo vacunado al grupo de \nno vacunados. En una prueba de duraci\u00f3n de  \n  \n22 inmunidad, que lleg\u00f3 hasta las 32 semanas de edad, \n\u00e9sta vacuna mostr\u00f3 protecci\u00f3n contra desaf\u00edo de ILT y \nFP y la proteccci\u00f3n contra ILT fue estadisticamente \nsimilar a la de una vacuna commercial de FP usada \ncomo control.  \nInfectious laryngotracheitis (LT) is an acute viral \ndisease of the respiratory tract of chickens. Current LT control methods in areas of intensive poultry \nproduction include the use of modified- live vaccines. \nDisadvantages of modified -live LT vaccines include \ninduction of latency and spread to susceptible chickens with the potential to revert to a more virulent form \ncausing disease.  In an effort to produce a safer LT vaccine through genetic engineering, a recombinant \nFowl Poxvirus (FP) con taining LT genes was designed \nto limit the disadvantages of modified -live LT vaccines. Two genes expressing key protective LT antigens were isolated from virulent field strains of LT. \nThese two LT genes were inserted into the genome of a \nFP vaccine, which maintained the characteristics of the \nFP vaccine and gained protection against LT.  This \nrecombinant vaccine is safe for use in chickens and is \nefficacious against FP and LT challenge. In addition, this vaccine reduced spread of LT challenge virus from \nvaccinates to non -vaccinated, co -mingled chickens.  In \na duration of immunity trial, this vaccine showed \nprotection against LT and FP challenge through 32 \nweeks of age and FP protection was statistically similar \nto a commercial FP vaccine.  \n(A full \u2013length article will be submitted to Avian \nDiseases  for peer review).  \n \nFUTURE OF NEW GENERATION OF VIRUS -VECTORED \nVACCINES FOR EFFICIENT POULTRY PRODUCTION \n \nEL FUTURO DE UNA NUEVA GENERACI\u00d3N DE VACUNAS QUE UTILIZAN \nVIRUS COMO VECTORES, PARA LA PRODUCCI\u00d3N AV\u00cdCOLA EFICIENTE  \n \nDeoki N. Tripathy  \n \nDepartment of Veterinary Pathobiology, College of Veterinary Medicine,  \nUniversity of Illinois, Urbana, Illinois 61802  \n \nRESUMEN  \nLa industria av\u00edcola ha realizado progresos \nsignificativos en la eficiencia productiva gracias a \ninnovadoras pr\u00e1cticas de manejo y al uso con \nregularidad de vacunas para reducir las p\u00e9rdidas asociadas con las enfermedades. Tradicionalmente, el desarrollo de vacunas implica el uso de microorganismos tanto activos modificados (atenuados) como inactivados. D e manera ideal, la \nindustria av\u00edcola deber\u00eda contar con vacunas econ\u00f3micas y efectivas que requieran menos frecuencia de manejo de las aves. Las vacunas de esta naturaleza se pueden dise\u00f1ar incorporando genes espec\u00edficos que codifiquen para los ant\u00edgenos protectivos de los pat\u00f3genos, en el genoma de un veh\u00edculo vivo. A medida que se ha modificado la estructura de la industria av\u00edcola, tambi\u00e9n ha venido aumentando la importancia de la necesidad de contar con vacunas \ncosteables para la prevenci\u00f3n de enfermedades. En este sentido es muy promisoria una nueva generaci\u00f3n de vacunas elaboradas a base de vectores.  \n The poultry industry has made significant \nprogress in production efficiency due to innovative management practices and the regular use of vaccines to red uce disease- related losses. Prevention of diseases \nthrough vaccination has been shown to be extremely beneficial, in decreasing not only mortality and morbidity but also the cost of animal production   Vaccines, therefore, represent one of the most importa nt tools available for disease prevention.  In \naddition to providing protection, vaccines also reduce the spread of infection. In recent years poultry production has changed from a large number of small farms to a relatively few large operations. Because o f \nthe intensive nature of production units, contagious diseases can spread rapidly and the economic \nconsequences can be devastating.  Despite the regular \nvaccination of poultry, disease outbreaks still continue to occur frequently. Currently, live viral va ccines e.g., \nNewcastle disease, infectious laryngotracheitis, fowlpox, infectious bursal disease, avian encephalomyelitis, infectious bronchitis, as well as several killed vaccines are used.   Without the protective effect of these vaccines, the industry w ould \nnot be where it is today.   In order to reduce the cost of production and administration, some of these vaccines are administered in combination with others.  \nThe traditional approach to vaccine development \ninvolves the use of both modified -live (atte nuated) and  \n  \n23 inactivated microorganisms.   Attenuated vaccines are \ngenerally preferred since they provide immunity of a longer duration and are more easily produced. However, they often pose the threat of reversion to virulence and often need to be maintained at the correct passage level. Attaining the balance between maximum immunogenicity and minimum virulence for the host does involve some risk. Since conventional vaccines \nare developed to some extent by \"trial and error\" and without knowledge of their ge netic make -up, reaching \nthe desired levels of induced protective immunity and reduced virulence may enable the \"vaccine\" to revert to a more virulent form under field conditions.   Moreover, different strains of a vaccine (produced by separate biological companies) may exhibit a varied potential for reversion to virulence. Furthermore, in vivo recombination of different attenuated strains may \nresult in the generation of a strain that is more virulent than its parents. Although these concerns are unwarranted  when using inactivated or subunit \nvaccines, frequent administration is required and killed vaccines are more expensive than live ones.    While \nvaccines are usually efficacious in eliciting a protective \nimmune response in the host, none still can be claim ed \nto be perfect.   \nRealizing the impact and importance of vaccines \nfor the prevention and control of diseases, research on all aspects of vaccination against human and animal diseases has increased considerably in recent years.  In spite of the fact that vaccines are popular interventions for the prevention of diseases due to their relatively low costs, limited efforts have been made towards \nproducing a new generation of effective poultry \nvaccines.  Ideally, the poultry industry would like to have effectiv e vaccines that require less frequent \nhandling of the birds and are inexpensive.   Currently, administration of a large number of individual vaccines involves frequent handling of the birds, which stresses them and also increases the cost of labor. One way  to \nreduce these problems would be the production of vaccines capable of providing protection against multiple pathogens.   Such vaccines can be designed by incorporating specific genes that encode for protective antigens of pathogens into the genome of a live carrier.   Since in such a live vectored vaccine only the protective antigen(s) of a pathogen are presented to the immune system of the host, chances of reversion to virulence are eliminated and the beneficial properties of both live and killed vaccin es are retained.  \nUsing current molecular methods it has become \npossible to uncover the biological pathways which are needed by pathogens to survive in their respective hosts.  Moreover, genes encoding protective antigens of pathogens as well as those assoc iated with their virulence can be easily identified.    The availability of \nsuch information can be used to overcome the \nlimitations of traditional approaches in designing a new \ngeneration of effective vaccines. While protective antigens can be expressed either by bacterial or viral vectors, the later are preferred because foreign genes are expressed authentically by them. While the genomes of several viral vectors e.g., poxviruses, baculoviruses, herpesviruses and adenoviruses, have been manipulated to ena ble expression of foreign \nproteins, larger viruses like herpes and pox have an advantage in that they can accommodate a substantial \namount of foreign genetic material. When considering herpes viruses as vaccine vectors, it is important to remember their po tential for delayed persistence and \noncogenesis.  Thus for the generation of poultry \nvaccines, avipox viruses like fowlpox or pigeonpox \nvirus are more advantageous than other vectors.   \nOne of the major advantages for viral -vectored \nvaccines is their abili ty to elicit a protective cell -\nmediated immune response as well as a humoral immune response to the antigen delivered by the vector.  However, in the case of modified viral vectors, the main safety concern is whether the vector itself is virulent and capab le of producing clinical disease in \nthe host.   Concerns about the use of fowlpox virus as an expression vector are unwarranted since attenuated live fowlpox virus vaccines of chicken embryo or \nculture origin have been used in commercial poultry \nfor more t han 70 years. Additionally, the extensive \nexperience obtained with fowlpox virus as a live vaccine, its restricted host range, large genome capable of accommodating substantial amounts of foreign DNA and inability to induce oncogenic transformation are desirable features for its potential use as a vector for \nimmunization against important pathogens.  The basic requirements to develop a viral vectored vaccine are: a cell culture system which will support the growth of the virus; sites within the genome of the virus which are non -essential for growth, transcriptional regulatory \nelements (promoters) necessary for optimal expression of the foreign genes; a procedure for inserting the foreign gene into the non -essential locus and a method \nof identifying the recom binant viruses.  \nThe first recombinant fowlpox virus expressing a \nspecific protein from an avian pathogen, in this case avian influenza virus was generated in late 1980s. Subsequently,  fowlpox virus vaccines capable of expressing protective antigens of  N ewcastle disease, \nMarek\u2019s disease, infectious laryngotracheitis, and  infectious bursal disease viruses were generated.  In each instance, immunization of susceptible birds with such recombinants resulted in the development of specific antibodies and prote ction to subsequent  \n  \n24 challenge with the respective pathogen (Tripathy, \n1996).  \nIn developing a new generation of vaccines it is \nimportant to consider:  \n(a) efficacy, (b) safety and  (c) cost.  Currently, \ntwo commercial fowlpox virus vectored vaccines express ing either avian influenza or Newcastle disease \nvirus genes are available. Results of experimental and \nfield studies with these vaccines revealed that they are \nsafe and efficacious.  In this regard, the fowlpox virus vectored avian influenza vaccine has been used extensively in Mexico.  Although a similar vaccine designed to protect against Newcastle Disease virus has been available in the US for sometime, it has not been routinely used by the poultry industry.  One of the reasons for its limited use has be en its high cost as \ncompared to the rather inexpensive conventional vaccines. Based on the current prices of poultry meat and eggs, the industry cannot afford an expensive vaccine even if it is highly effective and superior to current conventional ones.  T herefore, the \nmanufacturers must consider the cost of any new \nvaccines.  Another concern has been that the immunity \ngenerated against fowlpox virus after initial \nvaccination may prevent the subsequent use of a similar recombinant containing gene(s) of diff erent \npathogens as an immunizing agent in the same animal.  To circumvent this problem several other avianpox viruses e.g. quailpox, canarypox and condorpox could be developed as ideal vaccines for reimmunization since these viruses are antigenically disti nct from \nfowlpox virus.   \nFowlpox virus has certain biological attributes for \nits use as a vector. These include its host specificity, mild pathogenicity and low transmissibility (Tripathy and Reed, 1997).  In addition, because it can accommodate large amo unt of foreign DNA into its \ngenome without loss of viability, this virus could simultaneously express antigens from several pathogens and thus serve as a polyvalent vaccine.    \nI feel that avianpox virus vectored vaccines can \nbe developed at a reasonable p rice if genes from \nmultiple pathogens can be incorporated into the fowlpox virus genome.  To obtain such a vector, several non -essential regions in the genome of fowlpox \nvirus as well as strong virus specific promoters are required. Until recently only a f ew non -essential \nregions had been identified in the fowlpox virus genome and a limited number of homologous promoters were available.  Recently, we have shown \nthat fowlpox virus contains many genes which are not \nessential for its multiplication (Srinivasan , et al, 2001).  \nSuch loci could be effectively used for the insertion of various genes from multiple pathogens. Previously, in lieu of homologous fowlpox virus promoters, heterologous vaccinia virus regulatory elements were \nused in creating recombinant fo wlpox virus vaccines.    \nHowever, realizing the importance of using \nhomologous promoters, we have recently identified several fowlpox virus promoters and determined their efficacy.  Use of such homologous promoters should allow optimal expression of foreig n proteins.  \nIt is very encouraging to survey the wealth of \ngenetic information on various poultry pathogens that  has become available in last 10 years.  For example, the complete nucleotide sequence of a vaccine- like \nfowlpox virus has been determined (Af onso et al, \n2000).  Moreover, several non -essential regions and \ntranscriptional regulatory elements in the fowlpox virus genome have been evaluated.   Additionally, several \ngenes associated with virus virulence and prolonged \npersistence have been identified. This information will be valuable in designing an ideal vaccine against fowlpox.    Likewise, genes from several poultry pathogens, which encode for specific protective antigens have been identified.  Now, it will be possible to develop a polyvalent fow lpox virus vectored vaccine \nincorporating genes of several respiratory pathogens.   Since fowlpox virus infects the upper respiratory tract of chickens, such vaccines may eventually be administered ocularly or orally.  Similar recombinant vaccines expressi ng multiple antigens can be designed \nfor subcutaneous, intramuscular or in ovo  \nadministration.   \nAlthough fowlpox virus currently appears to be \nthe predominant vector, the avipoxviruses are a diverse group of viruses infecting a variety of birds. Therefore , \nit is possible that in the near future, monovalent or polyvalent recombinant vaccines using other avian poxviruses, e.g. canarypox, pigeonpox, quailpox, psittacinepox, sparrowpox or condorpox viruses, will be created for use in commercial poultry.  \nAs th e structure of poultry industry has changed \nfrom small to large units and the efficiency of production has improved significantly, the need for cost-effective vaccines for the prevention of diseases \nhas become increasingly important.  In this regard, a new generation of vectored vaccines for which the \nbasic technology has already been established holds \ngreat promise.  Such vaccines appear to have a great \nfuture role in efficient poultry production.   \n \nREFERENCES  \n1. Afonso, C. L., E. R. Tulman, Z., Lu,, L. \nZsak , G. F.  Kutish, and D. L. Rock.. The genome of \nfowlpox virus. J. Virol.  74, 3815- 3831. 2000.  \n2. Srinivasan, V., W. M.  Schnitzlein and D. N. \nTripathy.  Fowlpox virus encodes a novel DNA repair  \n  \n25 enzyme, CPD -Photolyase, that restores infectivity of \nUV light dam aged virus. J. Virol.  75, 1681- 1688. 2001.  \n3. Tripathy, D. N. Fowlpox Virus Vectored \nVaccines for Control of Poultry Diseases.  Proc. XX World's Poultry Congress, New Delhi, India, \nSeptember 2 -5; Volume  II 497- 503. 1996.  \n4. Tripathy, D. N. and W. M. Reed. Pox.  In:  \nDiseases of Poultry.  10th ed., eds Calnek, B. W. et al.  Iowa State, University Press, Ames, IA, pp 643 -659. \n1997.\n  \nVIRUS -ANTIBODY COMPLEX VACCINES:  \nPRESENT AND FUTURE  \n \nCOMPLEJOS VIRUS -ANTICUERPO USADOS COMO VACUNAS:  \nPRESENTE Y FUTURO  \n \nCraig E. W hitfill A, Alan P. Avakian A, Eid E. Haddad A, Michael P. Martin A, \nJan-Kees van den Wijngaard A, and Nick J. Chettle B \n \nA Embrex, Inc. PO Box, 13989, Research Triangle Park, NC, USA, 27709; B Central Veterinary Laboratory, New \nHaw, Weybridge, Surrey, UK, KT15 3NB  \n  \nRESUMEN  \nSe ha creado una nueva tecnolog\u00eda para el \ndesarrollo de vacunas utilizando un antisuero \nespec\u00edfico mezclado, en la proporci\u00f3n correcta, con un \nvirus infeccioso para formar un complejo inmune \nvirus -anticuerpo. Se desarroll\u00f3 una vacuna para la \nprevenci\u00f3n de la infecci\u00f3n de la bolsa de Fabricio y se est\u00e1 usando actualmente en el campo, en todo el \nmundo. En este ejemplo se utiliza una vacuna \nintermedia plus contra esta enfermedad para generar \nuna vacuna con el complejo virus -anticuerpo. \nPresentaremos una selecci\u00f3n de los estudios realizados \npara documentar las caracter\u00edsticas de la vacuna \ncomplejo virus de la infecci\u00f3n de la bolsa de Fabricio -\nanticuerpo, administrada in ovo  a pollos libres de \npat\u00f3genos espec\u00edficos y a pollos de engorda, \ninclu yendo su seguridad, las pruebas de eficacia y sus \nefectos ante niveles variables de anticuerpos maternos.  \n \nSUMMARY  \nA new vaccine technology has been developed \nusing specific antiserum mixed in the appropriate ratio with an infectious vaccine virus to form a virus -\nantibody immune complex.  With this technology, a vaccine for the prevention of Infectious Bursal Disease Virus (IBDV) has been developed and used in the field \nworldwide.  In this example, an intermediate plus \nIBDV vaccine virus is used to generate a virus -\nantibody complex vaccine.  Selections from the studies \nperformed documenting IBDV -antibody complex \nvaccine characteristics when given (in ovo) to SPF and broiler chickens are presented including safety trials, \nefficacy trials, and vaccine efficacy  with varying \nmaternal antibody levels.  In ovo (in the egg) has become an accepted route \nfor delivery of vaccines to chickens worldwide. The \nfirst commercial vaccines shown to be safe and \neffective for in ovo administration were for Marek\u2019s \ndisease virus (7, 8, 14).  Administration of vaccines in \novo may be advantageous through improved \ninoculation consistency and decreased labor costs.  In \novo preventative vaccination for other poultry diseases \nrequires the development of safe and effective vaccines \nsuita ble for in ovo administration.  \nVaccination around day 18 of embryonic \ndevelopment correlates with the rise in maternal \nantibody levels in the chick (4).  In ovo vaccines \ntherefore need to withstand the neutralizing effects of \nhigh maternal antibodies to b e protective.  More potent \nvaccine viruses may be able to overcome maternal antibodies, but are unsafe in birds with lower levels of maternal antibody.  Research has shown that the \naddition of specific antiserum to a more potent vaccine \nvirus at an appropr iate ratio creates a virus -antibody \ncomplex without neutralization of the vaccine virus \n(1,3,11,12).  The resulting virus -antibody complex \nvaccine modifies the timing of vaccine virus release \nand remains safe to administer to birds with lower maternal antibody levels.  \nVery virulent strains of IBDV started to emerge \nin the 1980\u2019s (9).  The rise of these virulent strains prompted the need for IBDV vaccines that could work \nin the presence of high maternal antibody levels that \nwould have eliminated conventiona l vaccines if given \nat an early age.  The virus -antibody complex vaccine \ntechnology has been very successfully used with 3 \ndifferent IBDV vaccine strains: 2512, V877, and MB.  \nData presented here and in other papers (1,11,12)  \n  \n26 demonstrate the safety and eff icacy of IBDV -antibody \ncomplex vaccines.  \n \nMATERIALS AND METHODS  \nExperiment 1.   SPF eggs were either vaccinated \nwith 1000 EID 50 of IBDV strain 2512 (13) complexed \nwith 240 units of specific antiserum, vaccinated with \n1000 EID 50 of IBDV strain 2512 alone, or  \nunvaccinated at 18 days of incubation (in ovo).  Gross \nand histological examination was performed on the \nbursae of 5 birds/group on days 1, 3, 5, 7, 13, 22, and \n29 of age.  Bursae were evaluated grossly for signs of \nedema or atrophy and were given a mean histological \nscore ranging from 0 -5 as previously reported (5); 5 = \nextensive destruction, 0 = no lesions.  Ten birds per \ngroup were bled and then challenged via intramuscular \ninjection with 100 CID 50 of vvIBDV strain DV86 on \nday 28 of age.  Birds were evaluated 4 days post -\nchallenge for gross signs of acute bursal infection.  \nExperiment 2.   SPF eggs were either vaccinated \nwith 100 EID 50 of IBDV strain 2512 complexed with \n24 units of specific antiserum at 18 days of incubation \n(in ovo) or unvaccinated.  150 eggs per group were \nused.  Birds were challenged via eye drop with 100 \nEID 50 IBDV STC challenge strain from the United \nStates Department of Agriculture (USDA) on day 29 of \nage.  Birds were evaluated grossly 3 days post -\nchallenge for signs of acute bursal i nfection and bursa \nbody weight ratios.  Blood was collected at termination \n(ELISA for anti -IBDV antibodies).  \nExperiment 3.   Broiler eggs were either \nvaccinated with the IBDV -antibody complex vaccine at \n18 days of incubation (in ovo) or unvaccinated.  Birds  \nwere challenged via eye drop with 100 EID 50 IBDV \nSTC challenge strain from the USDA on day 35 of age.  Birds were evaluated grossly 3 days post -challenge for \nsigns of acute bursal infection and bursa to body \nweight ratios. Blood was collected at termination \n(ELISA for anti -IBDV antibodies).  \nExperiment 4.   Eggs from 4 broiler breeder \nflocks were vaccinated with the IBDV -antibody \ncomplex vaccine at 18 days of incubation (in ovo).  \nBlood was collected from birds within each group at \nhatch.  Blood collection a nd gross evaluation of the \nbursae for atrophy and edema associated with the \nvaccine virus were made from 12 -20 birds per group at \neach sampling (weeks 3, 4, 5, and 6 of age).  Idexx, Inc. performed IBDV ELISA titers.  \n \nRESULTS AND DISCUSSI ON \nExperiment 1.  In SPF chickens, 1000 EID\n50 \nIBDV strain 2512 alone caused reduced hatchability, gross bursal changes starting day 1, 15% post -hatch \nmortality, and 100% clinical depression in remaining birds.  Complete bursal destruction was observed \nhistologically by day 5 of age.  Chickens vaccinated with the IBDV -antibody complex IBDV vaccine had a \nnormal hatch, no post -hatch mortality, and no clinical \ndepression.  Mild bursal atrophy was observed in 1/5 birds on day 5 and mild to moderate atrophy in 100% \nat day 7.  Histologically, bursal changes are observed \nwith the complex vaccine, but bursal lesion scores were \nconsistently lower from day 5 to day 29 by 0.5- 2.0 \nranks on the mean histology score.  \nIn ovo administration of IBDV vaccine virus 2512 \nat 1000 EID\n50 was not saf e without the addition of \nspecific antiserum.  By complexing the vaccine virus \nwith specific antiserum, in ovo administration of the \nvaccine was safe and delayed the onset of gross bursal changes approximately 5 -7 days consistent with \nprevious findings (2) .  Delay in bursal changes may \nhave occurred due to a delayed or slowed viral replication.   \nPre-challenge ELISA antibody titers and post-\nchallenge protection were used to evaluate efficacy in \nexperiment 1.  At day 28 of age, mean antibody titers \nfor the c ontrols, IBDV vaccine virus alone, and IBDV -\nantibody complex vaccine groups were 111, 174, and 2633, respectively.  In the control group 0/10 birds \nwere protected from day 28 challenge compared to \n10/10 birds from the IBDV -antibody complex vaccine \ngroup.  Although none of the birds in the vaccine virus \nalone group had clinical signs of bursal disease after challenge, complete destruction in this group of the bursal lymphoid tissue necessary for challenge virus \nreplication made bursal changes difficult to de fine.   \nExperiment 2.   In SPF birds, bursa to body \nweight ratios for the unchallenged controls, challenged \ncontrols and challenged IBDV -antibody complex \ngroups were 6.32gm, 5.12gm, and 1.41gm, respectively \non day 32.  Between the challenge on day 29 and st udy \ntermination on day 32, body weight gain for the unchallenged controls (45.69gm) and the challenged IBDV- antibody complex group (43.08gm) were similar \nand statistically different from the challenged controls (-1.90gm).  Both challenged and unchallenged control \ngroups had a day 32 IBDV ELISA geometric mean titer (GMT) of 1.  Challenged IBDV -antibody complex \ngroup had a day 32 GMT of 851.  The vaccine virus in \nthe IBDV -antibody complex group replicates in the \nbursa to stimulate immunity as evidenced by bur sal \natrophy from the bursa to body weight ratios.  \nProtection to challenge therefore is evaluated by body weight gain comparison to unchallenged controls, \nelevated antibody titers, and acute clinical signs of \nIBDV.  The IBDV- antibody complex group was 100%  \nprotected to viral challenge (positive controls 0% \nprotected) based on these criteria.  \nExperiment 3.   In broilers, bursa to body weight \nratios for the unchallenged controls, challenged controls, unchallenged vaccinates, and challenged \nvaccinate groups wer e 2.27gm, 2.79gm, 0.97gm, and  \n  \n27 0.75gm, respectively on day 38 (3 days post -\nchallenge).  Unchallenged and challenged control \ngroups had day 38 GMT of 1 and 2, respectively.  \nUnchallenged and challenged IBDV -antibody complex \ngroups had day 38 GMT of 3631 and 2697, \nrespectively.  Bursal atrophy occurred in all of the \nbirds in the vaccinate group but atrophy did not significantly change in severity with IBDV challenge.  \nProtection to challenge therefore is evaluated by \nelevated antibody titers and acute clinical  signs of \nIBDV including bursal edema and hemorrhage.  The \nIBDV- antibody complex group was 100% protected to \nviral challenge (positive controls 0% protected) based \non these criteria.  \nExperiment 4.   Mean IBDV maternal antibody \nlevels at hatch for the 4 groups of broilers were 7427 (Flock A), 5560 (Flock B), 3911 (Flock C), and 3042 \n(Flock D).  Flocks were further defined based on their \nmaternal antibody levels as very high, high, moderate (+), and moderate, respectively.  Antibody levels \nthroughout experiment 4 are shown in figure 1.  Bursal \nevaluation at week 3 showed 10% of Flock A were \neffected compared to 40% in Flock D (groups B and C \nnot tested).  Week 4 bursae were 35%, 55%, 100%, and \n90% effected in Flocks A, B, C, and D, respectively.  \nWeek 5 bursae were 89%, 90%, and 100% effected in \nFlocks A, B, and C, respectively (group D not tested).  Birds with higher levels of maternal antibodies (Flocks A and B) had an immune response (Fig. 1) and grossly \ninfected bursae that occurred later than birds with \nlower levels of maternal antibodies (Flocks C and D).  \nData from experiment 4 suggests that the IBDV -\nantibody complex vaccine given in ovo replicates and \nprotects birds when maternal antibody levels decrease \nand that even very high levels of maternal immunity \n(Flock A) would not interfere with the vaccine \nefficacy.  \nConventional water and spray methods of IBDV \nvaccination can be less efficacious due to maternal \nimmunity (5, 6, 10).  A single virus -antibody complex \nvaccine given in ovo or at hatch is able to wo rk with \nmaternal antibodies eliminating the guesswork of conventional multiple vaccine schedules and reducing \nthe risk of disease from a field challenge.  In ovo \nvaccination also provides a more uniform vaccination strategy than water/spray administration.  \n \nCONCLUSIONS  \nBroilers given a single vaccination are able to \ndevelop and effective immune response with a wide range of maternal antibody levels.  Vaccine virus is delayed approximately 5 -7 days in birds with no \nmaternal antibodies and is most likely due to the \nantiserum component of the vaccine.   Vaccine virus replication in the bursal lymphoid cells of a broiler bird \nis delayed based on maternal antibody levels.  Virus -antibody complex vaccine technology provides for the \nfirst time a safe and effective means to vaccinate \nbroilers for IBDV in the hatchery via a single \ninoculation.  \n \nREFERENCES  \n1. Haddad E. E., C. E. Whitfill, A. P. Avakian, \nC. A. Ricks, P. D. Andrews, J. A. Thoma and P. S. \nWakenell. Efficacy of a novel infectious bursal disease \nvirus immune c omplex vaccine in broiler chickens. \nAvian Dis. 41:882- 889. 1997.  \n2. Jeurissen, S. H. M., E. M. Janse, P. R. \nLehrbach, E. E. Haddad, A. Avakian and C. E. \nWhitfill. The working mechanism of an immune \ncomplex vaccine that protects chickens against \ninfectious bur sal disease. Immunology 95:494- 500. \n1998.  \n3. Kelemen, M., K. Forgach, J. Ivan, V. Palya, \nT. Suveges, B. Toth and J. Meszaros. Pathological and \nimmunological study of an in ovo complex vaccine \nagainst infectious bursal disease. Acta Vet. Hun. \n48:443- 454. 2000.  \n4. Kowalczyk, K., J. Daiss, J. Halpern and T. \nF. Roth. Quantitation of maternal -fetal IgG transport in \nthe chicken. Immunology 54:755- 758. 1985.  \n5. Muskett, J. C., I. G. Hopkins, K. R. \nEdwards, D. H. Thornton. Comparison of two \ninfectious bursal disease vaccine strains: Efficacy and \npotential hazards in susceptible and maternally immune birds. Vet. Rec. 104:332- 334. 1979.  \n6. Tsukamoto, K., N. Tanimura, S -i. Kakita, K. \nOta, M. Mase, K. Imai and H. Hihara. Efficacy of three \nlive vaccines against highly virulent infec tious bursal \ndisease virus in chickens with or without maternal \nantibodies. Avian Dis. 39:218 -229. 1995.  \n7. Sarma, G., W. Greer, R.P. Gildersleeve, \nD.L. Murray, and A.M. Miles. Field safety and efficacy of in ovo administration of HVT and SB -1 bivalent \nMarek\u2019 s disease vaccine in commercial broilers. Avian \nDis. 39:211- 217. 1995.  \n8. Sharma, J.M., and R.L. Witter. Embryo \nvaccination against Marek\u2019s disease with serotypes 1, \n2, and 3 vaccines administered singly or in \ncombination. Avian Dis. 27:453 -463. 1983.  \n9. van den  Berg, T. P., M. Gonze and G. \nMeulemans. Acute infectious bursal disease in poultry: \nisolation and characterization of a highly virulent \nstrain. Avian Pathol. 20:133 -143. 1991.  \n10. van den Berg, T. P. and G. Meulemans. \nAcute infectious bursal disease in poultr y: protection \nafforded by maternally derived antibodies and interference with live vaccination. Avian Pathol. \n20:409- 421. 1991.  \n11. Whitfill, C.E., E. E. Haddad, C. A. Ricks, J. \nK. Skeeles, L. A. Newberry, J. N. Beasley, P. D. \nAndrews, J. A. Thoma and P. S. Wa kenell.  \n  \n28 Determination of optimum formulation of a novel \ninfectious bursal disease virus (IBDV) vaccine \nconstructed by mixing bursal disease antibody with \nIBDV. Avian Dis. 39:687- 699. 1995.  \n12. van den Wijngaard, J -K, A. Avakian, C. \nWhitfill and E. Haddad. In o vo IBD vaccinations \nsurpass conventional approach. World Poultry \u2013 \nElsevier Special: Gumboro. pp. 16- 17. 2001.  13. Winterfield, R. W. and H. L. Thacker. \nImmune response and pathogenicity of different strains \nof infectious bursal disease virus applied as vaccin es. \nAvian Dis. 22:721- 731. 1978.  \n14. Zhang, Y. and J. M. Sharma. Early \nposthatch protection against Marek\u2019s disease in chickens vaccinated in ovo with a CVI988 serotype 1 \nvaccine. Avian Dis. 45:639 -645. 2001\n. \n \n \nRE-EMERGENCE OF FOWL POX IN GERMANY  \n \nRESURGIMIE NTO DE LA VIRUELA AVIAR EN ALEMANIA \n \nHafez, H.M., D. L\u00fcschow, C. Prusas and T. Hoffmann  \n \nInstitute of Poultry Diseases, Free University Berlin, Koserstr. 21, 14195 Berlin  \n \nRESUMEN  \nEn las granjas av\u00edcolas de Alemania con sistemas \nde explotaci\u00f3n intensiva n o se ha visto la infecci\u00f3n con \nel virus de la viruela aviar durante los \u00faltimos 25 a\u00f1os \ny no se ha utilizado ninguna vacuna. No obstante, en los \u00faltimos dos a\u00f1os se presentaron varios brotes de \nviruela primero en parvadas de postura mantenidas \nbajo un sist ema de pastoreo libre, y despu\u00e9s en \nparvadas de pollos y pavos bajo explotaci\u00f3n convencional. El presente trabajo describe el \ndiagn\u00f3stico y la posible aplicaci\u00f3n de las herramientas \nbiol\u00f3gicas moleculares para la caracterizaci\u00f3n de las \ncepas aisladas. Se r ealizaron las primeras \ninvestigaciones con enzimas de restricci\u00f3n sobre el producto de la reacci\u00f3n en cadena con polimerasa (PCR ) usando las endonucleasas EcoRV y NlaIII. No \nse encontraron diferencias en los patrones de la ruptura \ncausada por el tratamient o enzim\u00e1tico entre 11 cepas \nde campo de pollos y 2 cepas de campo de pavos.  \n \nFowl pox is a disease of chickens and turkeys \nwith a world -wide distribution. It has been responsible for considerable economic problems to the poultry industry.  Because of diffe rence in management, \nhygiene and vaccination regime in different areas the \nincidence of this disease in commercial poultry is \nvariable. In Europe the trend away from intensive \nrearing to alternative rearing has been increases \nremarkably and resulted in re -emerging of important \npoultry diseases of the past. In Germany infection with \nfowl poxvirus (FPV) have never been seen for the past \n25 years in poultry farms with intensive rearing system \nand no vaccine was used. In the last two years several \noutbreaks of fowl pox were firstly observed in layer \nflocks kept free range rearing system (2,3). Thereafter \nfurther outbreaks were detected in broiler breeder flocks as well as in turkey breeder flocks. The birds \nexhibited nodular lesions on comb, wattles, eyelids, \nand at the corner of the mouth. In addition, diphtheritic \nlesions on mucous membrane of mouth and larynx were detected. The symptoms were accompanied with \ndrop in egg production and increasing mortality. The \nmortality rates were 5.5% to 16%, within 8 weeks a fter \nthe onset of clinical signs. The present paper describes \n \n  \n29 the diagnosis and the possible application of molecular \nbiological tools for detection and characterization of \nthe isolated strains.  \nIn the present investigations tissues (cutaneous \nnodules on t he head and/or cloacae) and mucous \nmembrane lesions were used for virus isolation in \nembryonated chicken eggs  (5) and for detection of FPV-DNA in polymerase chain reaction (4). Poxvirus \nwas diagnosed in 13 poultry flocks. 7 of 13 pox \npositive samples were  derived from layer, 4 from \nbroiler breeders and 2 from turkey breeder flocks.  \nFrom 12 out 13 examined cases, poxvirus was \nisolated on the chorioallantoic membrane (CAM) of 11 \ndays old SPF - embryonated chicken eggs. The isolated \nvirus was identified using agar gel precipitation test \n(AGP) and / or electron microscopy (EM) examination of CAM. In one case, the isolation of the virus on \nCAM revealed negative result. However, electron \nmicroscopy examination of suspected lesions revealed positive results.  \nIn ad dition, the diagnosis was verified using \npolymerase chain reaction. FPV -PCR was performed \nusing specific primers describes by Lee and Lee (4). \nFPV specific DNA was detected in all 13 cases. \nAdditionally, in 6 cases the PCR was performed \ndirectly from skin lesions and in 2 cases from trachea \nlesions. In all case positive results were obtained and \nconfirmed by virus isolation.   \nThe specificity of the FPV -DNA amplification \nwas confirmed by restriction enzyme analysis. PCR -\nproducts were cleaved with restriction  endonucleases \nEcoRV and NlaIII. Based on published FPV -DNA \nsequence data (1) both enzymes showed the expected \ncleavage patterns in the case of fowlpox virus. \nFurthermore no differences in cleavage patterns were \nidentified between chickens and turkey isola tes.  \nThe results of the present study indicate the re -\nemerging of fowlpox in Germany, where infections have never been recorded for the past 25 years. The diagnosis was carried out using conventional methods \nand confirmed by polymerase chain reaction. PCR  \nseem to be a fast and sensitive technique for the routine diagnosis and direct detection of FPV specific DNA \nfrom the lesions. Further investigations by restriction \nenzyme analysis showed no differences in cleavage patterns; for this reason, it was not ab le to distinguish \nbetween fowl poxvirus and turkey poxvirus.  \n \nREFERENCES  \n1. Binns, M.M., M.E.G . Boursnell, F.M. \nTomley, and J. Campbell. Analysis of the fowlpox \nvirus gene encoding the 4b core polypeptide and demonstration that it possesses efficient promote r \nsequences. Virology 170: 288- 291. 1989.  \n2. Hafez, H. M., A., Mazaheri and C. Prusas. \nRe-emerging of some infectious diseases in layer \nflocks kept alternative rearing systems. Proceedings of the 49\nth Western Poultry Diseases Conference, March \n5-7, 2000. Sacr amento, CA. USA. pp. 68 -69. \n3. Hafez, H.M., A. Mazaheri, C. Prusas, K., \nB\u00f6hland, M. P\u00f6ppel, and D.Schulze. Aktuelle Gefl\u00fcgelkrankheiten bei Legehennen i m \nZusammenhang mit alternativen Haltungs systemen. \nTier\u00e4rztl. Prax. 29: 168 -174. 2001.  \n4. Lee, L.H. and K.H. Le e. Application of the \npolymerase chain reaction for the diagnosis of fowl poxvirus infection. J. Virol. Methods 63: 113- 119. \n1997.  \n5. Tripathy , D.N.  and W.M.  Reed.  Pox. In: \nSwayne, D.E:, Glisson, J.R., Jackwood, M.W. Pearson, J.E. and Reed, W.M. (eds.). A la boratory manual for \nthe isolation and identification of avian pathogens, 4th ed. American Association of Avian Pathologists, Kennet Square, PA, 137 -140. 1998.  \n \nFLUOROQUINOLONE USE IN POULTRY IN THE U.S.A.  \nIMPACT ON PUBLIC HEALTH ?  \n \nEL USO DE LAS FLUOROQUINOLONAS EN LA INDUSTRIA AV\u00cdCOLA \nESTADOUNIDENSE \u2013 \u00bfIMPACTO SOBRE LA SALUD P\u00daBLICA?  \n \nB.J. Kelly, D. Copeland, M. Vaughn  \n \nBayer Animal Health, 9009 W. 67 th Street, Merriam, KS 66202  \n \nRESUMEN  \nEn octubre de 2000, el Centro para la Medicina \nVeterinaria ( CVM ) entabl\u00f3 un Aviso de Oportunidad de \nAudiencia ( NOOH) con la intenci\u00f3n de retirar las \nfluoroquinolonas del mercado av\u00edcola. Las evidencias de respaldo para esta acci\u00f3n fueron: 1) La informaci\u00f3n \ngenerada por una evaluaci\u00f3n del riesgo patrocinada por \nel CVM,  2) La informaci\u00f3n publicada por Smith et al.  \n(11) y  3) Un informe sobre la elevaci\u00f3n en la \nincidencia de Campylobacter  \u201cR\u201d en el Sistema  \n  \n30 Nacional Estadounidense de Monitoreo de la \nResistencia a los Antimicrobianos ( NARMS ) en seres \nhumanos, de 1998 (13.1%) a 1999 (17.6%). Una \nprofunda revisi\u00f3n de esta informaci\u00f3n, de las \nreferencias pertinentes que aparecen en la literatura y la \ninformaci\u00f3n publicada recientemente por Bayer \nAnimal Health y expertos externos, demuestra que no hay un riesgo identificable para la  salud p\u00fablica \nasociado con el uso de las fluoroquinolonas en aves \ndesde finales de 1995 hasta la fecha. De hecho, la \nrevisi\u00f3n de toda la informaci\u00f3n disponible sugiere que \nexisten otros factores de mayor importancia \nconducentes a la ocurrencia de Campylobacter  \nresistente a las fuoroquinolonas entre las personas, en \nEstados Unidos, y que las aves no contribuyen m\u00e1s que \notros tipos de carnes o alimentos.  \n \nSUMMARY  \nIn October of 2000, the Food and Drug \nAdministration\u2019s (FDA) Center for Veterinary \nMedicine (CVM ) filed a Notice of Opportunity for \nHearing (NOOH) with the intent to remove \nfluoroquinolones (FQ\u2019s) from the market for use in \npoultry. The underlying premise of the NOOH was that \nuse of FQ\u2019s in poultry resulted in the selection for and \ntransfer of FQ res istant Campylobacter jejuni   (Campy) \nfrom poultry live operations onto processed poultry products which, if improperly cooked or handled, could result in FQ resistant Campy infections in people.  \nThese infections might not respond to FQ therapy  (if a \nFQ w as chosen for therapy) thereby resulting in an \nadverse outcome to the treatment.  An adverse outcome \nwas considered to be an additional two days of diarrhea \nsymptoms in persons for whom all these conditions \nwere met (9). The supporting evidence for this action \nwas; 1) information generated from a CVM sponsored \nrisk assessment, 2) information reported by Smith et. al. (12 ), and 3) a rise in the occurrence of resistant \nCampylobacter in people from 1998 (13.1%) to 1999 \n(17.6%) as reported by the National Anti microbial \nResistance Monitoring System (NARMS) (2,Table 1). \nAn in depth review of this information, relevant \nliterature, and newly released data by the U.S. \ngovernment, along with evaluations conducted by \nindependent experts, demonstrate no identifiable ri sk to \npublic health associated with the use of \nfluoroquinolones in poultry. In fact, the review of all \navailable information suggests that there are other \nmajor drivers of FQ resistant Campy occurrence in \npeople in the U.S. and that poultry is no more a \ncontributor than other meat or food types.  Therefore, \nthe removal of FQ\u2019s for use in poultry would have no \nmeasurable impact on the occurrence of FQ resistant \nCampy infections in people in the US.  However, such action would deny veterinarians use of the mo st \neffective compound available to reduce suffering and death in poultry, and would hinder their ability to \nassure that healthy animals enter the food supply.  \n \nOVERVIEW  \nTemporal trends in the U.S. relating Campy \nresistance in people to that in poultry are  incomplete \nbut suggest that there is no relationship.  \nFluoroquinolones were first approved for use in poultry \nin late 1995.  The NARMS program did not begin to \ncollect Campy data until 1997 so there is no valid \nbaseline for comparison of resistance level s prior to FQ \nuse in poultry.  FQ\u2019s have been approved for use in people since the mid -1980\u2019s. Resistance levels in \nhuman isolates of 12% were reported as early as 1992-\n1995 in Wisconsin by Kiehlbauch (8) and \napproximately 6% resistance was seen in Minneso ta \nresidents in late 1995 (12). These levels of resistance \nare not surprising since it has been established in the \nliterature that use of FQ\u2019s in people (1) or poultry (6) \nwho are colonized with Campy can select for clones \nwith reduced susceptibility. This  is due to the fact that \na single point mutation can occur in Campy resulting in \nreduced susceptibility. Other enterobacteriacae require \nseveral mutational events to confer reduced susceptibility or resistance. Comparing the most \ncurrent 2000 NARMS data wi th yearly data starting in \n1997 demonstrates no significant difference between \nyears by Chi -squared analysis (P 0.11) (Table 1). This \nprovides strong evidence that the 1999 data point does not represent a trend of increasing resistance and verifies no impa ct on human resistant Campy \ninfections during the first four years of FQ use in \npoultry.  The NARMS data for poultry during this \nsame period show that the level of resistant Campy has \nremained low and stable at around 10% (13,14, Table \n1). Most importantly , based on a study of Minnesota \nresidents, (12) it is estimated that 70% of all resistant \nCampy infections are related to travel outside the U.S. \nor to prior use of a FQ. The reported human NARMS \ndata remain unadjusted for these major risk factors and, therefore, do not reflect the rate of domestically \nacquired resistant infection.   \nIt is also instructive to note that the rate of \nincrease in FQ resistant Campy in Minnesota residents \nthat began prior to the approval of FQs for poultry did \nnot change after a pproval (12) and more recently has, \nin fact, actually started to decline (10). If chicken were \nthe main driver of human Campy infections (both \nsusceptible and resistant) then, with chicken \nconsumption increasing at the annual rate of 2.5%, it \nwould be logi cal to conclude that the Campy \noccurrence rate in the U.S. would be increasing. The Centers for Disease Control and Prevention (CDC) data bear significantly on this point. For the fourth year in a \nrow, the incidence of human Campy infection has \ndropped. In  1997 the occurrence rate was 24.7/100,000  \n  \n31 and in 2000 it was 15.7/100,000 (2, Table 1). This \nrepresents a 36% reduction in human Campy \ninfections.  Food Safety and Inspection Service (FSIS) \ndata also corroborate this conclusion. They report that \nboth prev alence of carcass contamination and Campy \nCFU per carcass are decreasing (5, Table 1).  \nRecent large scale case- control studies conducted \nby CDC  indicate that chicken or poultry meat eaten \noutside the home carry no greater risk than any other \nmeat with re gard to Campy infection (4).  The risk of \nCampy infections appears to be associated with the \nrestaurant and not the meat.  Interestingly, chicken or \npoultry meat consumed inside the home shows no risk for Campy occurrence (4).  Approximately half of the \nchicken consumed in the U.S. is prepared and eaten at \nhome.  Friedman et.al.(4) are the first to suggest that \nfast and slow food restaurants may play an important \nrole in disseminating Campy infections among people. \nTheir findings are important because they define vastly reduced risk associated with poultry cooked in the \nhome versus outside the home (Odds Ratio 0.5 vs 2.4). \nThey also reaffirm the large risk associated with \nforeign travel and describe a much lower Campy risk \nassociated with poultry than do pre vious studies.  The \nCVM risk assessment does not take into account these \nrecent studies on Campy and it greatly overestimates \nthe likely contribution of chicken to the overall \nincidence of Campy in people. Even if these exaggerated assumptions were correct , the risk the \nFDA accepts for bottled drinking water would be greater than that estimated for fluoroquinolone use in poultry.  \nThe apparent minor role of chicken in the \ntransmission of resistant Campy can be explained by the sequential chain of events that  must occur for an \ninfection to result. For example, retail store surveys estimate that 20% of poultry products may contain resistant Campy (P=0.2) (14), while molecular \ngenotyping studies estimate that about 20% of the \nCampy that colonize birds are also able to colonize \nhumans (P=0.2) (3). If the two events are independent, the probability of a chicken origin resistant infection in \npeople is 0.2 X 0.2 = 0.04. Additionally, the literature \nestablishes that a threshold dose of Campy required to \ncause patent i nfection is about 300 -  500 organisms. \nRecent FSIS data suggest that most freshly processed \npoultry are at, or below, this threshold level (5), and \ntypical cooking is estimated to reduce the pathogen \nload by 99.99%. This makes the overall chance that a \nchicken origin, FQ resistant organism will be \nresponsible for infection a remote one.  \nIt is interesting to note that even in the face of FQ \n\u201cresistant\u201d infections, it has been reported that 38 out \nof 39 patients responded successfully to FQ treatment (12).  Macrolide antibiotics such as erythromicin and azithromicin remain the drugs of choice for known \nCampy infections in many parts of the world.   \n \nCONCLUSION  \nThere are no current data which suggest that \npoultry is the predominate or even a significant source  \nof FQ resistant Campy infections in people in the U.S. \nAlthough it is clear that FQ resistant Campy can be \nselected for in the poultry grow out environment, the \nlow selective pressures due to infrequent and prudent \nuse in conjunction with decreasing carcass \ncontamination rates, appear to result in no detectable \neffects on Campy resistance in people. Most of the \noccurrence is clearly related to foreign travel and prior \nuse of FQ\u2019s. The influence of other factors such as \ncontamination of foods by infected pe ople, \ncontamination of surface waters, streams and reservoirs \nas well as the roll of domestic pets are unknown and \nshould be further investigated. It is also apparent that \ntypical Odds Ratios for Campy risk associated with \npoultry in previous studies are i ncorrect and no longer \npertinent in the modern HACCP Food Safety era.   \n  \nREFERENCES  \n1. Adler -Mosca, H. and M. Altwegg. 1991. \nFluoroquinolone resistance in Campylobacter jejuni  \nand Campylobacter coli  isolated from human faeces in \nSwitzerland. J. Infect. 23:34 1-342. \n2. Anonymous.  CDC Online, \u201cNARMS\u201d.  \nLocated on the CDC website at: http://www.cdc.gov/narms  \n3. Clow, K., S. F. Park, P.R. Hawtin and D. G. \nNewell. 1998. The genotypic comparison of Campylobacter jejuni  strains from humans and poultry.  \nCost Action 97 Pat hogenic micro -organism in poultry \nand eggs.  No. 4.  Development of monitoring procedures, rapid detection methods and techniques.  \nMolecular epidemiology of campylobacter and \nsalmonella.  (eds.) A. Aspan and R.W.A.W. Mulder.  \nEuropean Commission, Brussels , p. 25 -31. \n4. Friedman, C., S. Reddy, M. Samuel, R. \nMarcus, J. Bender, S. Desai, B. Shiferaw, D. Helfrick, M. Carter, B. Anderson, M. Hoekstra and the EIP \nFoodNet Working Group. 2000. Risk factors for \nsporadic Campylobacter  infections in the United \nStates: a  case-controlled study in FoodNet sites, p. 149-\n150. Second International Conference on Emerging Infectious Diseases, Atlanta, GA.  \n5. Food Safety & Inspection Service. \nNovember, 2000. Personal communication.  \n6. Jacobs -Reitsma, W., Kan. C., and Bolder, N. \nThe Ind uction of Quinolone Resistance in \nCampylobacte r Bacteria in Broilers by Quinolone \nTreatment. Letters in App Micro. 1994. 19:228- 231.   \n7. Eating chicken or turkey outside the home \nassociated with domestically acquired fluroquinolone - \n  \n32 resistant Campylobacter  infections: a FoodNet case \ncontrol study, p. 150- 151. Second International \nConference on Emerging Infectious Diseases, Atlanta, \nGA.  \n8. Kiehlbauch, J. A., M. H. Simon and J. M. \nMakowski. 1996. Use of filtration to isolate \nCampylobacter  and related organisms fro m stools, p. \n47-49. In D. G. Newell, J. M. Ketley and R. A. \nFeldman (eds.), Campylobacters, Helicobacters, and \nRelated Organisms. Plenum Press, New York, NY.  \n9. Marano, N., D. Vugia, T. Fiorentino, S. \nSegler, M. Carter, H. Kassenborg, K. Smith, S. Zansky, \nK. Hollinger, F. Angulo, and the EIP FoodNet \nWorking Group. 2000. Fluoroquinolone resistant \nCampylobacter causes longer duration of diarrhea than \nfluoroquinolone susceptible Campylobacter strains in \nFoodNet sites. Second International Conference on \nEmerging I nfectious Diseases, Atlanta, GA.  \n10. Minnesota Dept. of Public Health. Website; \nwww.health.state.mn.us. Antimicrobial susceptibilities of selected pathogens; 2000, 1999 & 1998.  11. Piddock, L. J. V.. 1999. Implications for \nhuman health. J. Antimicrob. Chemother. 44 (Suppl. \nA). \n12. Smith, K. E., J. M. Besser, C. W. Hedberg, \nF. T. Leano, J. B. Bender, J. H. Wicklund, B. P. \nJohnson, K. A. Moore, M. T. Osterholm and the \nInvestigation Team. 1999. Quinolone -resistant \nCampylobacter jejuni  infections in Minnesota, 1992-\n1998. New England J. Med. 340:1525- 1532.  \n13. U.S. Department of Agriculture, \nAgricultural Research Service. 1998. Preliminary data: \nNARMS National antimicrobial resistance monitoring \nsystem: enteric bacteria -animal Campylobacter  isolate \nreport. Athens, GA.  \n14. U.S. Dep artment of Agriculture, \nAgricultural Research Service. 2000. Preliminary data: NARMS National antimicrobial resistance monitoring \nsystem: enteric bacteria -animal Campylobacter  isolate \nreport. Athens, GA.. \n \nTable 1.   Important figures on Campy occurrences  \nYear  Human Cases per  \n100,000  Human \u201cR\u201d  \nCampy %  Poultry \u201cR\u201d  \nCampy %  FSIS Carcass  \nPrevalence/CFU  \n1996 or before  23.5   88%/21mpn in  \ncarcass wash  \n1997  24.7 12.9   \n1998  21.4**  13.1 9.4  \n1999  17.3**  17.6 9.3  \n2000  15.7 14.3*  10.4 82%/5mpn in  \ncarcass wash  \n*preliminary data  \n**original 5 Food Net sites  \n \nDARKLING BEETLE [ ALPHITOBIUS DIAPERINUS  PANZER \n(COLEOPTERA: TENEBRIONIDAE)] CONTROL IN AUSTRALIAN \nBROILERS \u2212ENHANCING FOOD SAFETY  \n \nCONTROL DEL ESCARABAJO NEGRO (ALPHITOBIUS DIAPERINUS  \nPANZER [COLEOPTERA: TENEBR IONIDAE]) EN POLLOS DE ENGORDA \nAUSTRALIANOS: FAVORECIENDO LA SEGURIDAD ALIMENTARIA  \n \nTrevor Anthony Lambkin and Damien Aaron Cupitt  \n \n Entomology Building, Queensland Department of Primary Industries, 80 Meiers Road, Indooroopilly, Qld 4068 \nAustralia, Email: Trevor.Lambkin@dpi.qld.gov.au \n \nRESUMEN  \nDisertaremos sobre el estado de la plaga por \nAlphitobius diaperinus  y las enfermedades con \u00e9l \nasociadas en los sistemas de pollo de engorda en \nAustralia. Se observ \u00f3 que el piretroide ciflutr\u00edn tiene poco o ning\u00fan efecto sobre el control de las \npoblaciones subterr\u00e1neas del escarabajo que se ocultan en los pisos de arcilla despu\u00e9s de limpiar las casetas, y \nque este insecticida no inhibi\u00f3 la reinfestaci\u00f3n de la \ncama nu eva con el citado escarabajo. Se registraron  \n  \n33 poblaciones de aproximadamente 10 adultos vivos por \nlitro de arcilla en estos pisos debajo de los comederos y \nbebederos despu\u00e9s de haber aplicado el insecticida.  \n \nINTRODUCTION  \nThe darkling or black beetle, Alphi tobius diaperinus  \n(Panzer) is a common cosmopolitan insect pest of \npoultry houses, in particular broiler sheds and egg \nbarns (22, 27, 29).  The species is believed to originate \nin tropical east Africa (2) and occurs naturally in bird \nand bat nests where it  feeds on droppings and animal \nparts such as feathers and carcasses (1, 13, 21).  Because of its natural association with animals, in particular birds, this tropical species is well suited to \nthe warm humid conditions that occur in heated or \ninsulated poul try sheds and other intensive livestock \nhouses.  It is also known to occur in animal feeds \nwithin these systems (26).  Despite A. diaperinus  being \na common and ubiquitous poultry farm insect in \nAustralia (16), no Australian research has previously \nbeen und ertaken to determine the pest\u2019s abundance, \nbehaviour, insecticide resistance and control.  We \ncommenced a research project i n 1998 to investigate \nthe pest in Australian broiler systems.  These investigations have concentrated on determining and \nquantifying insecticide resistance in farm populations, \ndetermining the efficacy in situ  of a registered \npyrethroid (cyfluthrin WP), studying the distribution of beetle populations in a range of broiler shed types and \ntrialing novel control strategies.  In this paper  we \ndiscuss the pest\u2019s status and disease association, report \non the efficacy of cyfluthrin WP in tunnel -ventilated \nand conventional clay- floored broiler sheds, and \noutline potential strategies for the management of A. diaperinus .  \n \nPEST STATUS  \nSkewes and Munroe (1991) (25) believed that \nproduction losses from A. diaperinus  infestations were \ndifficult to recognise.  Despite this, the US ( 23) and \nAustralian chicken meat industries have identified the main issues associated with beetle infestations to be \nthreats to the production of safe food and the reduction \nof production costs.  More specifically in Australia \nthese issues are:  \n\u2022 Farm hygeine, biosecurity and consumer \nwelfare - A. diaperinus  is a vector of a range of avian \ndiseases and is a bio -security risk on farms, and for the \nproduction of safe food.  As well, disposal of bio-\nsecure litter and its use for horticulture is an important \nenvironmental issue.  \n\u2022 Traditional control has been with \ninsecticides - A. diaperinus  has developed high \nresistance to fenitroth ion in some areas of Australia \nand is known to already have some resistance to \ncyfluthrin.  Alternatives to insecticide control are preferred to further ensure safe food production and \ndisposal of environmentally friendly litter.  \n\u2022 Damage to shed structure from tunnelling \nlarvae and adults - When pest numbers are high, adults \nand larvae of A. diaperinus  tunnel into shed structures \nand cause damage, particularly to the compacted clay floors of sheds.  \nIn the US, concerns are similar, with disease \nlosses (9), fe ed inefficiency (23), poultry house and \ninsulation damage (11), and environmental hazards \n(14) being the most important.  \n \nDISEASE ASSOCIATION  \nAll stages of A. diaperinus  act as reservoirs or \nexternal carriers for a number of avian diseases and \nparasites.  The pest is known to transmit acute leucosis \n(9, 17), Marek\u2019s (24), infectious bursal disease \n[Gumboro] (19), enteritis [enterovirus and rotavirus] \n(8, 12), Salmonella spp and Escherichia coli  bacteria \n(7, 5, 6, 12, 18, 20), coronavirus (28) and fungi spp (5).  \nA. diaperinus  is also an intermediate host for the \ntapeworms Choanotaenia infundibulum  and Raillietina \nresticulus  (3, 10), and the protozoan Eimeria  sp. that \ncauses intestinal coccidiosis (12). The pest is also a \nlow-level transmitter of Newcastle disease and fowl -\npox virus (4).  \n \nPYRETHROID EFFICACY STUDY  \nFor some time the Australian broiler industry has \nsuspected that, in clay -floored broiler sheds re -\ninfestations of new litter by A. diaperinus  mainly \noriginate from the pest harbouring in clay floors .  It has \nalso suspected that the larval stage burrows into clay floors only when mature, just prior to pupation.  These \nsuspicions have led industry to question the efficacy of \ncyfluthrin WP in controlling subterranean populations.  \nMaterials and Methods.  We conducted a study \nto determine the efficacy of cyfluthrin WP in \ncontrolling populations below ground by comparing \nthe life -stage profiles of  A. diaperinus  and their \nmortalities in clay floors before and after insecticide \napplication in brooder sections of six clay -floored \nbroiler sheds ie three conventional and three tunnel -\nventilated.  Because A.  diaperinus  varies in it\u2019s \nresistance to cyfluthrin (15), the insecticide character \nof pest populations was determined by screening each with a cyfluthrin discr iminating dose [D dose](15). \nOnly populations with similar cyfluthrin resistances were chosen for the study.  Core clay samples were \ncollected and all beetle life -stages, dead and alive, \nbefore and after applications were counted and \nmortalities before and  after were compared to \ndetermine any insecticide efficacy.  Two transects were \nmade within the brooder sections across the width of \nthe sheds and sample points were under feeder and \ndrinker lines that these transects crossed.  Because  \n  \n34 anecdotal evidence s uggested that higher beetle \nnumbers occurred in these areas, this was used to select \ntransect and sample point positions.  \nSampling was undertaken in each shed at the end \nof a batch before litter removal and again after clean -\nout and insecticide application , before introducing the \nnew brood.  Two core samples were collected from \nunder each feeder and drinker ie in total per shed 16 \nunder drinkers and 8 under feeders.  Core samples of \n0.86L ie 75mm diameter, 200mm deep were collected \nwith a motorised auger.  A. diaperinus  stages from \nlarvae to adult were counted and mortality of each life-stage was recorded.  Therefore in total 124 core samples were collected from the brooder sections of six \nclay-floored broiler sheds that had pest populations \nwith roughly equal cyfluthrin resistance.  Results from \nall samples before and after insecticide applications \nwere combined and mean numbers of alive and dead of \nthe four stages collected ie larvae, pre- pupae, pupae \nand adults were determined (see Table).  \nResults and Disc ussion. For cyfluthrin to have \neffect on populations in the clay, it was expected that mortality of all stages of A diaperinus would rise \nsignificantly after insecticide application.  The data (see Table) indicates the contrary, with no significant \nincreas e in mortality after insecticide application.  The \nresults also indicate that all stages from larvae to adults occur in the clay floors.  Furthermore the life- stage \nprofiles of live insects before and after insecticide \napplication indicate that between sam ple dates, \ndevelopment from larvae through to adults progressed \nunhindered despite applications of insecticide.  \nApproximately 10 days after litter removal almost all \nimmature stages that had been below ground developed \nto adults, indicating that larvae pr esent were mostly \npenultimate ie mature and ready to pupate.  As well, the total number of all stages (21.11 insects) before removing litter and spraying was larger than after \n(10.73 insects).  These data strongly suggest that \nremoval of old litter removes  all stages, and no further \nlarvae enter the clay floor.  By the second sample date \nalmost all immature stages had developed through to \nadults and had most likely emigrated out of the clay \nfloor into the new litter.  Recent measurements of \nbrooder clay tem peratures in Queensland broiler sheds \nhave indicated that temperatures stay relatively \nconstant at around 30 \u00b0C (Lambkin and Cupitt: research \nin progress).  At this temperature, it is known that \npenultimate larvae develop through to adults in less \nthan 10 d ays (30). The results from our studies \ncorrelated positively with this (30) and indicated that \nalmost all immature stages had developed to adults \nover the study period. This strongly suggested that only \nlarvae close to pupation had entered the clay floors.  \nIn summary, the analyses of these data suggest \nthat cyfluthrin has little or no effect on A. diaperinus  in broiler shed clay floors between clean -outs.  Also, \napplying the insecticide on the ground does not inhibit development below ground or the emigrati on of newly \nemerged adults out of the clay into new litter.  Furthermore, the analyses suggests that the feeding \nstages of the pest\u2019s life cycle are found only above \nground in litter, and larvae only enter clay floors to pupate.  Also alarming is the substantially large \npopulation of approximately 10 live adult A. diaperinus  \nper litre of clay that survives underground under \ndrinkers and feeders after insecticide application of \nclay floors.  These insects would readily infest new \nlitter.   \n \nCONCLUSIONS  \nThe e cology of A. diaperinus and its ability to \nvector avian pathogens and parasites makes its control \nhigh priority attempting to maintain broiler farm \nhygiene and bio -security.  The ineffectiveness of \ncyfluthrin WP as described, questions its continued use.  This research data suggest that applications of \ncyfluthrin WP in eastern Australian broiler sheds do \nlittle to prevent infestations of new litter from previous \nbatches.  Furthermore, moderate levels of cyfluthrin resistance already in some populations in s outheast \nQueensland indicate that continued applications of \ncyfluthrin will increase resistance.  In our current \nproject using the same sampling methodology we are \ndetermining the spatial and temporal variability and \ndistribution of the pest in a range of Australian broiler \nshed types.  These studies will provide baseline data of \npest numbers and distributions in clay and concrete \nfloored conventional and tunnel -ventilated broiler \nsheds.  As well, we are laboratory trialing a \ndiatomaceous earth and re- looki ng at a borate \nformulation as potential litter treatments.  In summary \nour research is aimed at defining the parameters that \ncontrol A. diaperinus , developing more strategic, \nefficient and responsible uses for existing insecticides \nand trialing non -insecticide control methods.  \n \nACKNOWLEDGEMENTS  \nWe thank the chicken meat growers of \nQueensland and New South Wales for their \ncooperation during our field studies.  Financial \nassistance was provided by the Rural Industries Research and Development Cooperation, an d the \nFarming Systems Institute and Intensive Livestock Industries of the Queensland Department of Primary \nIndustries.  \n \nREFERENCES  \n1. Arshad, M., G.A. Jan, and A. Khattack. \nInsect fauna of birds\u2019 nests of N.W.F.P . Bulletin of \nZoology Pakistan, 2: 1- 7. 1984.   \n  \n35 2. Bayer. Understanding the darkling beetle \n(Alphitobius diaperinus). Bayer Poultry Technical \nBulletin. 1995.  \n3. Case, A.A., and J.E. Ackert. New \nintermediate hosts of fowl cestodes. Kansas Academy of Science, 43: 393- 396. 1940.  \n4. De Las Casas, E., P.K. Harein, D. R. \nDeshmukh, and B.S. Pomeroy. Relationship between the lesser mealworm, fowl pox, and Newcastle disease \nvirus in poultry. Journal of Economic Entomology, 69: \n775-779. 1976.  \n5. De Las Cases, E., P.K. Harien and B.S. \nPomeroy. Bacteria and fungi within the less er \nmealworm collected from poultry brooder houses. \nEntomops 1, 27- 30. 1972.  \n6. De Las Casas, E., P.K. Harein, M.D. York, \nand B.S. Pomeroy. Escherichia coli  serotypes isolated \nfrom within the lesser mealworm and evaluated for \nvirulence. Annals of the Entomolog ical Society of \nAmerica, 67(6): 967- 970. 1974.  \n7. De Las Casas, E., B.S. Pomeroy, and P.K. \nHarein. Infection and quantitative recovery of Salmonella typhimurium  and Escherichia coli  from \nwithin the lesser mealworm, Alphitobius diaperinus (Panzer). Poultry Sci ence, 47: 1871- 1875. 1968.  \n8. Despins, J.L., R.C. Axtell, D.V. Rives, J.S. \nGuy, and M.D. Ficken. Transmission of enteric pathogens of turkeys by darkling beetle larva (Alphitobius diaperinus ). Journal of Applied Poultry \nResearch, 3(1): 61 -65. 1994.  \n9. Eidson, C. S., S.C. Schmittle, J.B. Lal, and \nR.B. Goode. Role of the darkling beetle. Poultry \nScience, 44: 1366- 1367. 1965.  \n10. Elowni, E.E. and S. Elbihari. Natural and \nexperimental infection of the beetle, Alphitobius \ndiaperinus  (Coleoptera: Tenebrionidae) with \nChoanot aenia infundibulum  and other chicken \ntapeworms. Veterinary Science Communications, 3: \n171-173. 1979.  \n11. Geden, C.J., and R.C. Axtell. Factors \naffecting climbing and tunneling behavior of the lesser \nmealworm (Coleoptera: Tenebrionidae). Journal of \nEconomic Ent omology, 80(6): 1197- 1204. 1987.  \n12. Goodwin, M.A. and W.D. Waltman. \nTransmission of Emeria , viruses, and bacteria to \nchicks:  Darkling beetles ( Alphitobius diaperinus ) as \nvectors of pathogens . Journal of Applied Poultry \nResearch, 5(1) 51 -55. 1996.  \n13. Hicks EA. C heck -list and bibliography on \nthe occurrence of insects in birds' nests. The Iowa State \nCollege Press, Iowa. 682 pages. 1959.  \n14. Jerrard, P.C., and K.B. Wildey. Beetle \nplague from deep pit muck spreading. Poultry World, 131: 20- 21. 1980.  \n15. Lambkin, T.A Investigations into the \nmanagement of the darkling beetle. A report for the Rural Industries Research and Development \nCorporation. RIRDC, publication number 01/151 \nOnline. 2001.  \n16. Lambkin, T.A. and M.C. Cameron. Darkling \nbeetle control, current difficulties and futu re prospects. \nProceedings from the 11\nth Australian Poultry and Feed \nConvention. 10- 13 October 1999 Gold Coast, \nQueensland.  184 -192. 1999.  \n17. Lancaster, J.L. Jnr. and J.S. Simco. Biology \nof the lesser mealworm, a suspected reservoir of avian leucosis. Arkansa s Experiment Station, Series 159: \n12pp. 1967.  \n18. M\ncAllister, J.C., C.D. Steelman, and J.K. \nSkeeles. Reservoir competence of the lesser mealworm \n(Coleoptera: Tenebrionidae) for Salmonella \ntyphimurium  (Eubacteriales:  Enterobacteriaceae). \nJournal of Medical Ent omology, 31(3): 369- 372. 1994.  \n19. McAllister, J.C., C.D. Steelman, L.A. \nNewberry, and J.K . Skeeles. Isolation of infectious \nbursal disease virus from the lesser mealworm, \nAlphitobius diaperinus  (Panzer). Poultry Science  74, \n45-49.  1995.  \n20. McAllister, J.C., C.D . Steelman, J.K. \nSkeeles, L.A. Newberry, and E.E. Gbur. Reservoir \ncompetence of Alphitobius diaperinus  (Coleoptera: \nTenebrionidae) for Escherichia coli  (Eubacteriales:  \nEnterobacteriaceae). Journal of Medical Entomology, \n33(6): 983- 987. 1996.  \n21. McFarlane, J. A. The carnivorous beetles of \nthe Ithunda caves, Kenya. Studies of Speleology, 2:149- 158. 1971.  \n22. Pfeiffer, D.G. and R.C. Axtell. Coleoptera of \npoultry manure in caged layer houses in North Carolina. Environmental Entomology, 9: 21 -28. 1980.  \n23. Scarborough, A. How to deal with darkling \nbeetles. Broiler Industry, 48 -49. 1988.  \n24. Schmittle, S.C. Leukosis \u2013 New or changed \ndisease? Poultry Tribune, 72: 32- 34.1966.  \n25. Skewes, P.A. and J.L. Munroe. Research \nnote: The effects of darkling beetles on broiler performance. Poult ry Science, 70: 1034- 1036. 1991.  \n26. Smith, L.B. Occurrence of the depressed \nflour beetle, Palorus subdepressus  (Coleoptera: \nTenebrionidae), in Canada.  Canadian Entomologist, \n107(1): 109. 1975.  \n27. Turner, E.C. Jnr. Structural and litter peats. \nPoultry Science, 6 5(4): 644- 648. 1986.  \n28. Watson, D.W., J.S. Guy, and S.M. \nStringham. Limited transmission of turkey coronavirus \nin young turkeys by adult Alphitobius diaperinus \n(Coleoptera: Tenebrionidae). Journal of Medical \nEntomology, 37(3): 480- 483. 2000.  \n29. Weaver, J.E. and V.A. Kondo. Laboratory \nevaluation on insect growth regulators in producing lesser mealworm mortality and egg infertility. Journal \nof Agricultural Entomology, 4(3): 233 -245. 1987.   \n  \n36 30. Wilson, T.H., and F.D. Miner. Influence of \ntemperature on development of the lesser mealworm Alphitobius diaperinus . Journal of the Kansas \nEntomological Society 42, 294- 303. 1969.  \n \nTable 1.  Mean numbers (n=124) of A. diaperinus  per litre of clay collected from under feeders and drinkers from \nsix clay -floored broiler sheds (3 tunne l-ventilated and 3 conventional) before and after cyfluthrin WP application \n(mean time between sampling was 10.3 days)  \nLife stage  Before cyfluthrin WP application  After cyfluthrin WP application  \nNumber dead/L  Number alive/L  Number dead/L  Number alive/L  \nLarvae  0.79 7.21 0.18 0.36 \nPre-pupae  0.38 2.08 0.14 0.17 \nPupae  1.29 1.57 1.22 0.92 \nAdults  3.48 10.25  5.13 9.28 \nTotals (all stages)  5.94 21.11  6.67 10.73  \n \nLOW LEVELS OF ELECTRON BEAM IRRADIATION IMPROVE \nPOULTRY MEAT SAFETY BUT ALTER MEAT QUALITY  \n \nLA RADIACI\u00d3N CON UN HAZ DE ELECTRONES DE BAJO NIVEL MEJORA \nLA SEGURIDAD DE LA CARNE DE AVE PERO MODIFICA SU CALIDAD  \n \nS. R. McKee and S. J Lewis  \n \nDepartment of Food Science and Technology, University of Nebraska- Lincoln, Lincoln, NE  68583 -0919 \n \nRESUMEN  \nLa rad iaci\u00f3n con un haz de electrones es una \nherramienta para reducir los pat\u00f3genos de origen alimentario. Debido a que se ha demostrado que esta \nradiaci\u00f3n incrementa la oxidaci\u00f3n de los l\u00edpidos, es \nimportante observar tanto la seguridad como la calidad de los a limentos radiados. Nosotros evaluamos el \nefecto de 2 dosis de radiaci\u00f3n (1.0 y 1.8 KGY) sobre la \ncalidad y la seguridad de la carne de pechuga. La \nradiaci\u00f3n se aplic\u00f3 a los paquetes de 4 filetes de \npechuga y fue suficiente para destruir a todos los pat\u00f3gen os. Los grupos de clientes que participaron \ncomo catadores sugirieron que la carne de ave reci\u00e9n \nirradiada no era diferente de los testigos, pero la carne \nque se irradi\u00f3, se congel\u00f3 y se almacen\u00f3 durante 14 \u00f3 \n28 d\u00edas recibi\u00f3 menores calificaciones de sabor , textura \ny aceptaci\u00f3n general.  \n Irradiation is known to be an effective means of \ndestroying food- borne pathogens in food product.  \nHowever, depending on the type of irradiation and dose level applied, food quality characteristics can be negatively impacted.  The purpose of this study was to \ndetermine the effect of electron beam irradiation at 1.0 \nand 1.8 KGY on the safety and quality of packaged boneless, skinless poultry breast.   Packaged breast \nfillets in groups of 10 were irradiated at 1.0 KGy and \n1.8 KGy and 10 packages were maintained as a non -irradiated control group.  Four breast fillets in a covered/polystyrene tray constituted one sample.  The \nexperiment was conducted in triplicate.  Packages were \nsampled after storage for 0, 14, and 28 days at 0\no C.  \nMicrobial evaluation included sampling for \nSalmonella,  Campylobacter, aerobic populations, \ncoliforms, psychrotrophs, and generic E. coli.  \nEvaluation of product quality was determined using \nconsumer taste panels and degree of lipid oxidation as \ndeterm ined by TBAR analysis.  Irradiation at 1.0 and \n1.8 KGY effectively destroyed all bacteria except for \naerobic populations.  However, aerobic populations in \nboth the 1.0 and 1.8 KGy treatments were significantly \nreduced compared to non- irradiated control sam ples.  \nSensory panel results indicated that at day 0 there were no differences in any of the quality attributes tested \nbetween the control and irradiated samples.  By day 14, \npanelists ranked texture and flavor slightly lower in \nboth irradiated groups compared to controls.  By day \n28, irradiated treatment groups were ranked less \ndesirable for flavor, texture, and overall acceptability.  \nLipid oxidation increased with both storage time and \nlevel of irradiation.  The increase in lipid oxidation was \nlikely ass ociated with the decrease in flavor rankings in \nthe taste panel.   \n \n(Present research will be published as a full -length \narticle in Poultry Science).  \n \n  \n  \n37 EL CODEX, SEGURIDAD ALIMENTARIA, Y EL COMERCIO \nINTERNACIONAL  \n \nTHE CODEX ALIMENTARIUS, FOOD SAFETY,  \nAND INTERNATIONAL TRADE  \n \nRaul J. Guerrero, D.V.M., M.S. \n \nElanco Animal Health, 2001 West Main Street, Greenfield, Indiana 46140 -USA \n \nSUMMARY  \nCodex Alimentarius is an international \norganization that in recent years has become very \nimportant since its decision s and recommendations are \ntaken as a reference by the World Trade Organization \nin the solution of international food trade litigation \nprocedures. One hundred and sixty five countries are \ninnate Codex members, and they dictate internationally \nused standards , directions, and norms to protect human \nhealth, and to assure faithful practices in the trade of foods. It is in the best interest of developing countries \nbeing represented in the Codex meetings, for them to \nexpress their opinions and to aid in the decisi on-\nmaking process, on the basis of scientific criteria that \nreflect countries\u2019 will to produce larger amounts of \nquality, non -hazardous, affordable,  nutritious foods  \n \n Son miembros natos del Codex 165 paises que \ndeterminan estandares, directrices y norma s de uso \ninternacional para proteger la salud humana y asegurar \npracticas leales en el comercio de alimentos.  \nEs importante para los paises en desarrollo estar \nrepresentados en las reuniones del Codex para poder expresar su opini\u00f3n y ayudar a la toma de decisiones \nbasadas en criterios cient\u00edficos que reflejen la voluntad \nde los paises de producir mayor cantidad de alimentos nutritivos, de buena calidad, que no representen un \npeligro para la salud humana y que esten al alcance de \nla economia de la poblaci\u00f3n.  \nEl Codex Alimentarius es una organizaci\u00f3n \nintergubernamental establecida en 1962,  que tiene el \nsoporte directo de la Organizaci\u00f3n Mundial de \nAgricultura y Alimentaci\u00f3n (FAO) y la Organizaci\u00f3n Mundial de la Salud (OMS). El Codex fue creado con \nla finalida d principal de tener un organismo \ninternacional que establezca normas y estandares \ninternacionales en alimentos, a fin de proteger la salud \nde la poblaci\u00f3n y facilitar el comercio internacional de \nalimentos.  \nEl numero de miembros natos del Codex con voz \ny voto es de 165 paises miembros de las Naciones \nUnidas y mas de 125 organizaciones internacionales gubernamentales y no gubernamentales que participan como observadores, con voz y sin voto.  La importancia del Codex radica en que los \nestandares establecidos  por este grupo son \nconsiderados por los paises miembros pudiendo ser incorporados en sus legislaciones locales. De igual manera la Organizaci\u00f3n Mundial de Comercio (OMC) \nreconoce las normas y estandares establecidos en \nCodex para dirimir casos de disputas  internacionales en \ncomercio de alimentos. Debido a este \u00faltimo hecho es \nque en a\u00f1os recientes las decisiones del Codex se han \nconvertido en asuntos de suma importancia para prevenir posibles confrontaciones de paises \nimportadores y exportadores de aliment os. Por esta \nraz\u00f3n es sumamente importante que tanto el sector \noficial como el de las industrias privadas de cada pais \nesten representados en las reuniones de los diferentes \ncomites del Codex para asegurar que los puntos de vista e intereses del pais sean considerados en la toma \nde decisiones en el ambito del Codex.  \nLas decisiones en Codex se toman por consenso \npor lo cual es necesario que los delegados manifiesten la opini\u00f3n de su pais durante las discusiones, para \nayudar a formar consenso, particularment e en casos de \nasuntos que son controversiales. La delegaci\u00f3n que no \nmanifiesta su posici\u00f3n no es tomada en cuenta para \nestablecer consenso y tomar decisiones.  \nDesde hace pocos a\u00f1os en que la OMC designa al \nCodex como una de las organizaciones de referencia, \nlas discusiones y toma de decisiones en Codex se han vuelto muy importantes por ser posibles puntos de \nconsulta para la resoluci\u00f3n de futuros problemas de \ncomercio internacional de alimentos.  \nEl proceso para la adopci\u00f3n de estandares tiene 8 \npasos establ ecidos y dependiendo de la naturaleza del \nproducto en cuesti\u00f3n, puede demorar 4 a\u00f1os o mas.  \nLa Comisi\u00f3n del Codex es el ente maximo del \nCodex y se reune cada dos a\u00f1os alternando entre Roma \ny Ginebra para considerar en estas reuniones la \nadopci\u00f3n de normas,  directrices y estandares \npropuestos por los diferentes comites. El Codex \nconsidera criterios objetivos con fundamento cient\u00edfico \ncomo base para la toma de sus decisiones, aunque \nmuchas veces se pretenden introducir intereses \npoliticos y economicos que interfieren y entorpecen el \nproceso del Codex.   \n  \n38 El Codex funciona sobre la base de Comites por \nmateria o producto, 13 de los cuales son muy activos; sus recomendaciones son consideradas en la Comisi\u00f3n \ndel Codex para su adopci\u00f3n en el sistema del Codex.\n \nCHARACTERIZATION OF ANTIBI OTIC RESISTANCE OF \nCAMPYLOBACTER ISOLATED FROM RETAIL  POULTRY MEATS  \n \nCARACTERIZACI\u00d3N DE LA RESISTENCIA A LOS ANTIBI\u00d3TICOS DE \nAISLAMIENTOS DE CAMPYLOBACTER DE CARNE DE AVE PARA VENTA \nAL MENUDEO  \n \nB. Ge2, J. Meng2, D. G. White1, P. F. McDe rmott1, R. D. Walker1, and S. Zhao1* \n \n1Division of Animal and Food Microbiology / Office of Research, Center for Veterinary Medicine,  \nFood & Drug Administration, Laurel, MD 20708; 2Department of Nutrition and Food Science,  \nUniversity of Maryland, College  Park, MD 20742  \n \nRESUMEN  \nSe obtuvieron aislamientos de Campylobacter  \n(191 de C. jejuni,  147 de C. coli  y 31 de otras especies \ndel mismo g\u00e9nero) a partir de canales crudas de pollo y \npechugas de pavo, usando el m\u00e9todo de diluci\u00f3n en \nagar, determinando su resistencia a 7 agentes \nantimicrobianos, a saber: cloranfenicol, ciprofoxacina, \ndoxiciclina, eritromicina, gentamicina, \u00e1cido nalid\u00edxico y tetraciclina. La resistencia m\u00e1s com\u00fan entre estos \naislamientos de Campylobacter  fue a la tetraciclina \n(75.9%), segui da de la doxiciclina (72.8%), la \neritromicina (43.7%), el \u00e1cido nalid\u00edxico (33.1%) y la ciprofloxacina (28.8%). No se demostr\u00f3 resistencia de \nninguno de los aislamientos a la gentamicina. C. coli  \nmostr\u00f3 tasas de resistencia mayores a la eritromicina, la \nciprofloxacina y el \u00e1cido nalid\u00edxico que C. jejuni \n(P<0.05) y, asimismo, los aislamientos procedentes de \npavo mostraron tasas de resistencia significativamente mayores (P<0.05) que los aislamientos de pollo, a \ntodos los agentes antimicrobianos probados, exce pto a \nla gentamicina. Este estudio mostr\u00f3 que los \naislamientos de Campylobacter  resistentes a los \nantimicrobianos usados para el tratamiento de la \ninfecci\u00f3n por Campylobacter  en humanos son comunes \nen las carnes de ave para venta al menudeo.  \n \nABSTRACT  \nCamp ylobacter is the most common cause of \nbacterial gastroenteritis in the United States, mainly transmitted through food. Resistance to antimicrobials \nused for the treatment of campylobacterosis has increased. The present study investigated antimicrobial \nresistance among Campylobacter  isolates recovered \nfrom retail raw meats from 1999 -2000 in the Greater \nWashington Area.  All 369 Campylobacter  isolates \n(191 C. jejuni, 147 C. coli , and 31 other \nCampylobacter ), from retail raw chicken carcasses and \nturkey breast s, were determined using agar dilution method to seven antimicrobial agents: \nchloramphenicol, ciprofloxacin, doxycycline, \nerythromycin, gentamicin, nalidixic acid, and \ntetracycline. The most common resistance among the Campylobacter  isolates was to tetracy cline (76%), \nfollowed by doxycycline (73%), erythromycin (44%), nalidixic acid (33%), and ciprofloxacin (29%). Two C. coli from turkey were resistant to chloramphenicol. \nNone of the isolates demonstrated resistance to gentamicin. C. coli  exhibited higher r esistant rates to \nerythromycin, ciprofloxacin, and nalidixic acid than C. \njejuni (p<0.05), and isolates from turkey also showed \nsignificantly higher resistant rates (p<0.05) than \nisolates from chicken to all the antimicrobial agents \ntested except for genta micin. Multi -drug resistance was \ncommonly observed, with 81 % of the isolates resistant \nto \u2265 2, and 25% to \u2265  4 antimicrobials.  Campylobacter  \nisolates resistant to antimicrobial agents used for \ntreating Campylobacter infection in humans are \ncommon in retail  poultry meats from the greater \nWashington DC area.   \n \nINTRODUCTION  \nCampylobacter  species, primarily Campylobacter \njejuni and Campylobacter coli , are recognized as a \nleading cause of human gastroenteritis worldwide, with \nan estimated 2.4 million cases each year in the United \nStates (1). Campylobacter  is considered mainly a \nfoodborne pathogen, with raw or undercooked poultry \nserving as an important source of Campylobacter  \ninfection in human (2). Contaminated milk, water, \npork, beef, lamb, and seafood also con tribute to human \ninfections. Campylobacteriosis is usually a mild to \nmoderate self -limiting diarrheal disease, however, \nsevere and prolonged cases of enteritis, bacteremia, \nseptic arthritis, and other extra -intestinal infections also \noccur.\n C. jejuni has a lso been identified as the \npredominant cause of antecedent infection in Guillain - \n  \n39 Barr\u00e9 syndrome (GBS) (3). When antibiotics are \nrecommended for treatment of patients with severe, \nprolonged, or relapsing campylobacteriosis, \nerythromycin or a fluoroquinolone  such as \nciprofloxacin, are the drugs of choice (4). Tetracycline, \ndoxycycline, and chloramphenicol are sometimes listed \nas alternative drugs for treatment. Serious systemic infections may also be treated with an aminoglycoside \nsuch as gentamicin. However,  an increasing number of \nCampylobacter  strains resistant to several of these \ndrugs have been isolated from clinical samples in many countries, which compromised the effectiveness of \nantibiotic treatment in Campylobacter  infections.  \nThere is a growing concern that veterinary use of \nantimicrobials in food animals can select for resistant \nCampylobacter  strains, which may subsequently be \ntransmitted to humans through the food chain (5,6). \nHowever, only a few reports have examined the current \ntrend of antimicrob ial susceptibility of Campylobacter  \nisolated from healthy animals or retail meats. In this \nstudy, the antimicrobial susceptibilities of 369 \nCampylobacter  isolates recovered from retail poultry \nmeats of the greater Washington DC area, were \ndetermined.  \n \nMAT ERIALS & METHODS  \nCampylobacter  isolates and species \nidentification.  A total of 369 Campylobacter  isolates \n(191 C. jejuni, 147 C. coli , and 31 other \nCampylobacter ) were obtained from a retail meat \nsurvey in the greater Washington DC area conducted \nfrom Aug ust 1999 to July 2000. C. jejuni  ATCC 33560 \nwas used as the quality control (QC) organism for \nantimicrobial susceptibility testing.  \nA multiplex PCR assay based on two separate \nPCRs of Linton\n23 was developed for the identification \nof C. jejuni and C. coli  simultaneously. Primers HIP \n400F (5' -GAAGAGGGTTTGGGTGGTG- 3') and HIP \n1134R (5' -AGCTAGCTTCGCATAATAACTTG -3') \nwere used for C. jejuni, whereas primers CC18F (5' -\nGGTATGATTTCTACAAAGCGAG -3') and CC519R \n(5'-ATAAAAGACTATCGTCGCGTG- 3') were for C. \ncoli.   \nAntimicrobial susceptibility testing.  Seven \nantimicrobial agents were used: chloramphenicol, ciprofloxacin, doxycycline, erythromycin, gentamicin, \nnalidixic acid, and tetracycline. Ten double dilutions \nwere tested. Concentration ranges of the antimicrobial \nagents we re 0.25- 128, 0.03- 16, 0.125- 64, 0.125- 64, \n0.06- 32, 0.5- 256, and 0.125- 64 \u00b5g/ml respectively for \nthe antimicrobial agents.  \nCampylobacter  isolates were grown on Trypticase \nsoy agar base supplemented with 5% sheep blood and \nincubated for 40- 48 hr in a microaerobic atmosphere \n(5% O\n2, 10% CO 2, and 85% N 2) at 42oC. Suspensions \nof the organisms were prepared in 3 ml of Mueller -Hinton II broth and adjusted to a turbidity of 0.5 \nMcFarland. Mueller -Hinton agar plates, supplemented \nwith 5% defibrinated sheep blood and appropriate \nconcentrations of the antimicrobial agents, were prepared and inoculated with Campylobacter  cell \nsuspensions, using a Cathra replicator (Oxoid Inc., \nOgdensburg, NY) with 1 mm pins. The plates were \nincubated at 37\noC in the same microaerobic atm osphere \nfor 48 h. The MICs of antimicrobials were recorded as \nthe lowest concentration of the antimicrobial agent that \ncompletely inhibited Campylobacter growth on the agar plates.  \nMIC breakpoints defined by NCCLS for members \nof the family Enterobacteriaceae were employed, with \nthe exception of erythromycin. These breakpoints were \nthat used by the National Antimicrobial Resistance \nMonitoring System (NARMS); chloramphenicol 32 \n\u00b5g/ml, ciprofloxacin 4 \u00b5g/ml, doxycycline 16 \u00b5g/ml, \nerythromycin 8 \u00b5g/ml, gentami cin 16 \u00b5g/ml, nalidixic \nacid 32 \u00b5 g/ml, and tetracycline 16 \u00b5 g/ml.  \n \nRESULTS & DISCUSSION S \nThe MIC distributions of 369 Campylobacter  \nisolates for each antimicrobial agent are summarized in \nTable 1. Two (0.5%) C. coli  isolates, recovered from \ntwo turkey samp les, showed an MIC of 32 \u00b5g/ml for \nchloramphenicol. For ciprofloxacin, MIC ranged from 0.06 \u00b5g/ml to >16 \u00b5g/ml with no isolates having an MIC of 4 or 8 \u00b5g/ml. For doxycycline, the majority of \nthe isolates had an MIC \u2265  32 \u00b5g/ml. For erythromycin, \n44% of the  isolates showed an MIC \u2265 8 \u00b5g/ml, with \n101 isolates having an MIC of 8 \u00b5g/ml. For \ngentamicin, all the isolates had an MIC \u2264  2 \u00b5g/ml, with \nmost of them clustered at MIC of 0.5 or 1 \u00b5g/ml. For \nnalidixic acid, 33% of the isolates had an MIC \u2265  32 \n\u00b5g/ml. For t etracycline, the majority of the isolates had \nan MIC \u2265  64 \u00b5g/ml.     \nDependent upon type of antimicrobial agents, \nmost Campylobacter  isolated from retail raw meats \nwere resistant to at least one antimicrobial.  The most \ncommon resistance was to tetracyclin e (76%), followed \nclosely by doxycycline (73%), then erythromycin \n(44%), nalidixic acid (33%), and ciprofloxacin (29%). \nTwo isolates of C. coli  recovered from turkey meats \nshowed resistant to chloramphenicol. However, none \nof the Campylobacter  isolates dem onstrated resistance \nto gentamicin. Cross -resistances between ciprofloxacin \nand nalidixic acid, and between doxycycline and tetracycline were commonly observed. All the \nciprofloxacin -resistant Campylobacter  (109 isolates) \nwere resistant to nalidixic acid, and all the doxycycline \nresistant Campylobacter  (275 isolates) were resistant to \ntetracycline.  \nComparing the resistances among C. jejuni and C. \ncoli isolates, C. coli  isolates exhibited much greater  \n  \n40 resistant rates to erythromycin (61% verses 33%), \nciprof loxacin (38% verses 21%), and nalidixic acid \n(41% verses 26%) than C. jejuni  (p<0.05), whereas the \nresistant rates to tetracycline and doxycycline were comparable among C. jejuni and C. coli  isolates \n(p>0.05). Percentage resistance to each antimicrobial agent among the 369 Campylobacter  isolates also \ndiffered as to types of meat samples from which the \norganisms were recovered. Noticeably, turkey isolates \nhad significantly greater resistant rates (p<0.05) than \nchicken isolates to all the antimicrobial agents  tested \nexcept for gentamicin where there was no resistance among all the isolates.  \nMulti -drug resistance was commonly observed, \nwith 91% of the isolates resistant to at least 1 antimicrobial agent tested, 81% to at least \n2antimicrobial agents, 40% to at least 3, 25% to at least \n4, and 17% to at least 5 antimicrobials tested. Two C. \ncoli isolates  (0.5%), both recovered from turkey meat \nsamples, were resistant to six antimicrobial agents \nexcept gentamicin. Thirty- three Campylobacter  isolates \n(9%), however, were susceptible to all seven \nantimicrobial agents tested.  The study revealed that Campylobacter  isolates resistant to antimicrobial \nagents used for treating Campylobacter infection in \nhumans were common in retail poultry meats from the greater Washington  DC area.  Surveillance on \nantimicrobial resistance of  Campylobacter  needs to \ninclude retail meats, particularly poultry meats.  \n \nTable 1. Distribution of MICs, MIC\n50, and MIC 90 for each antimicrobial agent tested among all 369 Campylobacter  \nretail meat iso lates.  \nAgents  % isolates with MIC ( \u00b5g/ml) of  MIC 50 MIC 90 \n 0.03 0.06 0.125  0.25 0.5 1 2 4 8 16 >16 32 >32 64 >64 128 >128  256 >256  \u00b5g/ml \u00b5g/ml \nCML       10 50 32 8  0.5*        4 8 \nCIP  2 18 21 20 10 1    *   5 24         0.5 >16 \nDOX    2 5 6 8 5 0.3 2 5*  24  44 0.3     32 64 \nERY      0.3 6 18 32 27* 6  2  0.3 10     4 32 \nGEN    2 15 52 28 2   *          0.5 1 \nNAL         15 38 13  3*  2  9  17 3 8 256 \nTET    4 5 5 6 3 0.8 0.5*  2  10 63     >64 >64 \nNote: Highlighted are the 10 dilution ranges tested in  the agar dilution.  \n* NCCLS resistant breakpoints.  \n** NARMS resistant breakpoint  \n \nREFERENCES  \n1. Mead PS, Slutsker L, Dietz V, McCaig LF, \nBresee JS, Shapiro C, Griffin PM and Tauxe RV, \nFood- Related Illness and Death in the United States.  \nEmerg Infect Dis 5: 607-625, 1999.  \n2. Jacobs -Reitsma W. Campylobacter in the \nfood supply.  In: Campylobacter (Eds. Nachamkin I \nand Blaser MJ), pp. 467 -482. ASM press, Washington, \nD. C., 2000.  \n3. Blaser MJ, Epidemiologic and clinical \nfeatures of Campylobacter jejuni infections. J In fect \nDis 176 Suppl 2:S103- 5, 1997.  \n4. Nachamkin I, Engberg J and Aarestrup FM, \nDiagnosis and antimicrobial susceptibility of Campylobacter  spp. In:  Campylobacter  (Eds. \nNachamkin I and Blaser MJ), pp. 45 -66. ASM press, \nWashington, D. C., 2000.  \n5. Aaerstrup FM, N ielsen EM, Madsen M and \nEngberg J, Antimicrobial susceptibility patterns of  thermophilic Campylobacter spp. From humans, pigs, \ncattle and broilers in Denmark.  Antimicrob Agents \nChemother 41:2244- 50, 1997.  \n6. Threfall EJ, Ward LR, Frost JA and Willshaw \nGA, The emergence and spread of antibiotic resistance \nin food- borne bacteria.  Int J Food Microbiol 62: 1- 5, \n2000.\n \n \n \n \n \n  \n  \n41 STUDIES ON THE USE OF BACTERIOPHAGE AEROSOL SPRAYS \nTO PREVENT E. COLI  RESPIRATORY DISEASE IN POULTRY  \n \nESTUDIOS SOBRE EL USO DE ASPERSIONES DE BACTERI\u00d3FAGOS PARA \nPREVENIR LA ENFERMEDAD RESPIRATORIA CAUSADA POR \nESCHERICHIA COLI EN AVES  \n \nW. E. Huff, G. R. Huff, N. C. Rath, J. M. Balog, and A. M. Donoghue  \n \nUSDA, Agricultural Research Service, Poultry Production and Product Safety Research Unit  \nCenter of Excellence for Poultry Science, University of Arkansas, Fayetteville, Arkansas 72701  \n \nRESUMEN  \nSe realizaron tres estudios para determinar la \neficacia del bacteri\u00f3fago administrado mediante \naerosol para prevenir la enfermedad respiratoria \ncausada por E. coli.  En los estudios 1 y 2 se present\u00f3 \nuna significativa disminuci\u00f3n en la mortalidad cuando las aves se desafiaron inmediatamente despu\u00e9s de \nhaber recibido el aerosol  con el bacteri\u00f3fago. En el estudio 3 la infecci\u00f3n preexistente por E. coli caus\u00f3 \nalta mortalidad en los testigos mientras que no se \nobserv\u00f3 mortalidad en las aves asperjadas con el \nbacteri\u00f3fago. Estos datos sugieren que la administraci\u00f3n de bacteri\u00f3fagos en aerosol puede ser \nuna manera pr\u00e1ctica de prevenir y tratar enfermedades \nbacterianas en las aves.  \n \nSUMMARY  \nThree studies were conducted to determine the \nefficacy of bacteriophage administered as an aerosol \nspray to prevent E. coli respiratory disease.  There was \na significant decrease in mortality in Study 1 and 2 \nwhen the birds w ere challenged immediately after \nbeing sprayed with the bacteriophage.  In Study 3 a pre-existing E. coli infection caused high mortality in \nthe controls, while no abnormal mortality was observed \nin the birds sprayed with bacteriophage.  These data \nsuggest  that the administration of bacteriophage as an \naerosol spray may be a practical way to prevent and \ntreat bacterial diseases in poultry.  \n \nINTRODUCTION  \n Colibacillosis is a serious problem in poultry \nproduction causing mortality and condemnations.  There is  a real need to find alternatives to antibiotic use \nfor the prevention and treatment of colibacillosis in \npoultry production.  Bacteriophage were independently \ndiscovered by Twort (1915) and d\u2019Herelle (1917) and are viruses that infect and can kill bacteri a.  The \nobjective of these studies was to determine if \nbacteriophage could prevent an  E. coli respiratory \ninfection in broiler chickens by exposing the birds to an aerosol bacteriophage spray prior to challenging the \nbirds.  \n \nMATERIALS AND METHODS  \nBacteriop hage were isolated to an E. coli  \n(serotype 02) and two bacteriophage isolates were selected for these studies. The bacteriophage were amplified by growing the phage on soft agar overlay \nplates, which were flooded with PBS, periodically \nswirled, and harvest ed.  Three studies were conducted \nto determine the efficacy of administering two \nbacteriophage, designated SPRO2 and DAF6, via an \naerosol spray, to protect broiler chickens from an air sac challenge of E. coli.  Study 1 consisted of 9 treatments with 3 rep licate pens of 10 birds per pen.  \nThree treatments consisted of an untreated control, birds exposed to an aerosol spray of PBS at 7 days of \nage, and birds exposed to an aerosol spray of the two \nbacteriophage (3.6 x 10\n7 and 4.6 x 107 pfu per mL of \nDAF6 and SPR02, respectively). Three treatments \nconsisted of an aerosol spray of PBS at 7 days of age \nand challenging the birds with 5.6 x 104 cfu of E. coli  \ninjected into the thoracic air sac at either 7, 8 or 10 days of age.  The final three treatments consisted of an \naerosol spray containing 3.6 x 10\n7 and 4.6 x 107 pfu per \nmL of the bacteriophage DAF6 and SPR02, \nrespectively, and challenging the birds with E. coli  at 7, \n8, or 10 days of age as described above.  In Study 2 the \ntiter of the 2 bacteriophage was incr eased providing 2.6 \nX 108 pfu per mL of SPRO2 and 2.35 X 109 pfu per ml \nof DAF6, while the E. coli  challenge was 6.12 X104.  \nIn addition, instead of a PBS control, we prepared a \ncontrol by flooding soft agar overlay plates made with \nE. coli without the vir us and harvesting as described \nabove to provide a control for any bacterial debris effects in these studies.  Study 3 was identical to Study \n2 except for differences in bacteriophage titers, with \nbacteriophage SPR02 at 1.88 X 10\n8 pfu per mL, and \nDAF6 at 3. 60 X 108 pfu per mL, and the E. coli \nchallenge was 6.85 X 104cfu. \nThe birds and feed were weighed each week.  \nAny birds that died were weighed, the severity of  \n  \n42 airsaculitis was scored (Huff et al., 1998), the liver and \nairsac were cultured with sterile swabs and plated on \nMacConkey\u2019s agar, with isolates compared to the \ninoculum culture based on colony morphology.  The \nliver, heart, spleen, and bursa of Fabricius were excised \nand weighed.  When the birds were 3 wk of age they \nwere killed by cervical dislocat ion, and necropsied as \ndescribed for the mortalities.  \n \nRESULTS AND DISCUSSION \nBody weights of the birds at 2 weeks of age were \nsignificantly (P \u2264  .05) decreased from controls in all E. \ncoli challenged birds sprayed with diluent or \nbacteriophage in all 3 st udies.  These data indicate that \nthe bacteriophage spray treatment did not provide \ncomplete protection to the birds challenged with an air \nsac inoculation of 104 cfu of E. coli.  However, there \nwas substantial protection of the birds based on \nmortality.  I n Study 1, mortality was significantly \nreduced from 60% to 30% when the birds were challenged with E. coli immediately after being \nsprayed with the two bacteriophage.  In Study 2, the \nbacteriophage titers in the spray were the highest of the \nthree studies conducted.  In Study 2, there was a \nsignificant decrease in mortality from 63% to 7% in the birds challenged with E. coli immediately after the \nbacteriophage spray treatment, and a significant decrease in mortality from 40% to 3% in the birds that \nwere challenged 3 days after being treated with the \nbacteriophage spray.  These data demonstrate, as might \nbe expected, that there is a correlation between the \namount of bacteriophage administered and the degree of protection provided to the birds.  These data als o \nsuggest that the protection provided to the birds by the \nbacteriophage spray was of some duration, with birds \nprotected by an E. coli challenge 3 days after \nbacteriophage spray administration.  In Study 3, there \nwas a significant decrease in mortality fr om 63% to 27% in the birds challenged immediately after \nbacteriophage administration and in those challenged a \nday after bacteriophage administration (73% versus \n37%).  Possibly the most important data collected in \nStudy 3 was unplanned.  Mortality in the untreated \ncontrols and the birds that received only the diluent spray was unexpectedly high at 20% and 27%, respectively.  The mortality in these control birds was \nprimarily caused by airsaculitis, and an E. coli could be \nisolated from the lesions.  The mo rtality of the birds \nthat received only the bacteriophage spray was significantly less than the mortality of the other \ncontrols (3%).  We were able to determine that the E. coli isolated from these control birds was not our \nchallenge culture and was suscep tible to only one of \nthe bacteriophage in the aerosol spray.  We believe the mortality that occurred in these control treatments was \ncaused by an indigenous E. coli and the birds were \ncompletely protected by the bacteriophage spray.  These data clearly ind icate that bacteriophage can \nprovide an alternative to antibiotics, and that spray \nadministration of bacteriophage may be a practical way \nto treat poultry in production facilities.  \n \nREFERENCES  \n1. d\u2019Herelle, F., 1917.  Sur un microbe \ninvisible antagonists des bacilles dysenteriques .  \nComptes rendus de L\u2019Academie des Sciences de Paris  165:373- 375. \n2. Huff, G. R., W. E. Huff, J. M. Balog, and N. \nC. Rath, 1998.  The effects of dexamethasone immunosuppression on turkey osteomyelitis complex \nin an experimental Escheri chia coli  respiratory \ninfection.  Poultry Sci.  77:654 -661. \n3. Twort, F. W., 1915.  An investigation on the \nnature of ultramicroscopic viruses.  Lancet 2:1241 - \n1243.\n \nSTIMULATION OF THE I MMUNE SYSTEM OF BROI LERS \nAGAINST CELLULITIS /  COLIBACILLOSIS  \n \nEST\u00cdMULO D EL APARATO INMUNOCOMPETENTE DE LOS POLLOS DE \nENGORDA CONTRA LA CELULITIS/COLIBACILOSIS  \n \nSusantha Gomis1, Dale Godson 2, Lorne Babiuk 1, Brenda Allan 1, Rolf Hecker3, and Andrew Potter1 \n \n1 Veterinary Infectious Disease Organization, 120 Veterinary Road, Sas katoon, SK. Canada S7N 5E3.  \n2 Dept. of Veterinary Microbiology, University of Saskatchewan, Saskatoon, SK, Canada  \n3 Qiagen GmbH, Hilden, Germany  \n \nRESUMEN  \nSe ha demostrado que los oligonucle\u00f3tidos \nsint\u00e9ticos del \u00e1cido desoxirribonucleico bacteriano que contienen motivos CpG (CpG -DNA) son agentes \ninmunoprotectores efectivos en modelos de laboratorio en animales. El objetivo de este trabajo fue investigar  \n  \n43 el efecto del CpG -DNA en un modelo de \ncelulitis/colibacilosis en pollos. El grupo testigo que no \nrecibi\u00f3 el CpG -DNA tuvo una tasa de supervivencia \ndel 15% mientras que los grupos que s\u00ed lo recibieron \npor inyecci\u00f3n subcut\u00e1nea o intramuscular, presentaron \ntasas de supervivencia significativamente m\u00e1s \nelevadas. De la misma manera, el tama\u00f1o de la lesi\u00f3n causada por la celulitis fue significativamente menor en \nel grupo que recibi\u00f3 el CpG -DNA por v\u00eda subcut\u00e1nea \n(p<0.01). Este estudio demostr\u00f3 que el CpG -DNA tiene \nefectos protectores tanto locales como sist\u00e9micos en el \npollo.  \n \nSynthetic bacterial DNA oligonucleotide s \ncontaining CpG motifs (CpG -DNA) have been shown to be effective immunoprotective agents in laboratory \nanimal models. The objective of this study was to \ninvestigate the effect of CpG -DNA in a disease model \nof cellulitis / colibacillosis in chickens. The c ontrol \ngroup of birds that received no CpG -DNA had a \nsurvival rate of 15%. In contrast, groups that received CpG -DNA by subcutaneous or intramuscular injection \nhad significantly higher survival rates. As well, the size \nof the cellulitis lesion was signific antly smaller in the \ngroup that received CpG -DNA by the subcutaneous \nroute (p<0.01). This study demonstrated that CpG -\nDNA had both localized and systemic \nimmunoprotective effects in chickens.  \n  \nT\u00c9CNICAS PARA LA EVA LUACI\u00d3N DEL TAMA\u00d1O DE LA BOLSA \nDE FABRICI O Y SU RELACI\u00d3N CON EL ESTADO DE SALUD  \nDE LA PARVADA \n \nTECHNIQUES FOR BURSAL SIZE EVALUATION AND ITS RELATIONSHIP \nWITH FLOCK HEALTH STATUS  \n \nMario Lechuga G.  \n \nFort Dodge Animal Health  \n  \nSUMMARY  \nThe purpose of this paper is to demonstrate the \nimportance of bursal size as an indicator of the immune \nstatus of the flock. Three techniques to evaluate the size of the bursa of Fabricius are discussed, together with the relationships that exist among them. Similarly, \nwe offer a model to generate \u2013through a data bas e\u2013 a \nbursal size standard to be used as the basis for the clinical prognosis of flocks\u2019 immune status . \n \nRESUMEN  \nEl objetivo de este trabajo es demostrar la \nimportancia del tama\u00f1o de la Bolsa de Fabricio (BF) \ncomo indicador del estado inmunol\u00f3gico de la par vada, \nas\u00ed como mostrar tres t\u00e9cnicas para la evaluaci\u00f3n del \ntama\u00f1o de la BF y la relaci\u00f3n  que existe entre ellas. \nAs\u00ed mismo, ofrecer un modelo para generar, a trav\u00e9s de un banco de datos, un est\u00e1ndar de tama\u00f1os de la bolsa \nde fabricio, y en base a este, h acer un \u201cpron\u00f3stico\u201d \ncl\u00ednico del estado inmune de la parvada.  \n \nMATERIAL Y M\u00c9TODO  \nEste es un trabajo de campo, en que se dio \nseguimiento a 8 parvadas de pollo de engorda, \nmidiendo el tama\u00f1o de la BF a los 28 d\u00edas de edad y, \nposteriormente, se evalu\u00f3 la mor talidad de cada \nparvada.  Para medir la BF se puede utilizar un vernier, \nseguir la t\u00e9cnica de Rountree o utilizar el burs\u00f3metro, \nsiendo estas dos m\u00e1s objetivas, pues facilitan el an\u00e1lisis \nde los datos obtenidos.   \nVernier. Es un instrumento de precisi\u00f3n que  \npuede dar medidas en cent\u00edmetros, d\u00e9cimas y cent\u00e9simas de cent\u00edmetro.  \nInmunovaloraci\u00f3n de Rountree .  Esta t\u00e9cnica se \nbasa en que el di\u00e1metro de la Bolsa de Fabricio representa un porcentaje del tama\u00f1o del tarso, medidos \ncon Vernier (Se divide el di\u00e1metro  de la bolsa entre el \ntama\u00f1o del tarso) y se ubican en una de tres categor\u00edas : \n1) 20 o mayor; 2) 16 a 19.9 y; 3) menor a 16.  La \ninterpretaci\u00f3n es: grupo 1 es bueno, grupo 2 es regular \ny, grupo 3 es malo.  \nBurs\u00f3metro . Es una regla de pl\u00e1stico con ocho \nperforaciones de diferente di\u00e1metro, graduada del uno \nal ocho; para utilizar el burs\u00f3metro, se extrae la Bolsa \nde Fabricio y, el di\u00e1metro por donde la bolsa pase m\u00e1s \nf\u00e1cilmente, indicar\u00e1 el grupo al que pertenece. A los 28 \nd\u00edas de edad,  bolsas en el grupo 4 e s malo, grupo 5 es \nregular, grupo 6 es bueno y, grupo 7 es excelente.  \n \nRESULTADOS  \nLos resultados se resumen en la tabla 1.  \n  \n  \n44 DISCUSI\u00d3N  \nLos resultados obtenidos con el burs\u00f3metro van \nde la mano con los obtenidos con el Vernier y con la \nt\u00e9cnica de Rountree.  El Burs\u00f3metro tiene relaci\u00f3n \ndirecta con la inmunovaloraci\u00f3n de Rountree.  \nExiste una relaci\u00f3n directa entre el tama\u00f1o de la \nBolsa de Fabricio y el estado de salud de la parvada.  \nEs Importante hacer una medici\u00f3n objetiva para \ndejar el m\u00e9todo del tanteo.  \nLas t\u00e9cnicas de Rontree y el Burs\u00f3metro ofrecen \nuna medici\u00f3n objetiva para evaluar el tama\u00f1o de la \nBolsa de fabricio.  La t\u00e9cnica del Burs\u00f3metro es m\u00e1s sencilla que el \nVernier y la de Rountree, y por lo tanto, m\u00e1s pr\u00e1ctica. Observando los resultados obtenidos con el \nBurs\u00f3metro, se ver\u00e1 tiene su equivalente a la t\u00e9cnica de \nRountree, sin embargo, esta \u00faltima surgi\u00f3 de medir \nbolsas, tarsos y aplicar varias f\u00f3rmulas matem\u00e1ticas, a \ndiferencia del Burs\u00f3metro, que pudo obtener las mismas conclusiones, \u00fanicamente pasan do la Bolsa de \nFabricio por   una perforaci\u00f3n.  \nEl generar una base de datos en cuanto al tama\u00f1o \nde la bolsa de fabricio y su relaci\u00f3n con la salud de las parvadas facilitar\u00e1 y mejorar\u00e1 la toma de decisiones.\n \nTabla 1.  Resultados obtenidos con las diferent es t\u00e9cnicas y su relaci\u00f3n con la salud de la parvada, tomando como \npar\u00e1metro de esta, el porcentaje de mortalidad final.  \n \nNo. Parvada  Di\u00e1metro de la bolsa \nde Fabricio   \nRountree   \nBurs\u00f3metro   \n% mortalidad  \n1 1.88 21.9 7 2.04 \n2 1.75 20.64  6 1.7 \n3 1.66 20.00  6 3.59 \n4 1.66 19.80  6 3.29 \n5 1.24 14.15  5 4.00 \n6 1.15 14.00  4 1.63 \n7 1.10 13.41  4 5.43 \n8 1.07 13.39  4 6.79 \n \nREFERENCIAS  \n1. Glick. . Normal growth of the Bursa of \nFabricius in chickens. Poultry Science 35:843 -851. \n1956.  \n2. Kuney D.R., A.A. Bickford, D.D. B ell. The \nsignificance of bursal size survey, Proceedengs of 29th  \nWestern Poultry Disease Conference and 14th Poultry \nHealth Simposia. Pp 44- 46. 1980  3. Ulloa Jorge H. Caracterizaci\u00f3n del \ndesarrollo de la Bolsa de Fabricio, Timo y Bazo en \npollos Broilers. XVI  Congreso Latinoamericano de \nAvicultura, Per\u00fa. 1999.  \n4. L.A. Mazariegos, Lukert P.D. and John \nBrown.. Pathogenicity and inmunosupresive properties \nof Infectious Bursal Disease \u201cintermediate\u201d strains. Avian Diseases 34:203- 208. 1990.  \n \n \n   \n \n   \n \n  \n \n   \n  \n45 A STATISTI CAL PROTOTYPE FOR ESTABLISHING NEW \nHISTOPATHOLOGY CUT OFF SCORES IN THE EVALUATION OF \nINFECTIOUS BURSAL DISEASE VACCINE EFFICACY  \n \nPROTOTIPO ESTAD\u00cdSTICO PARA ESTABLECER NUEVAS \nCALIFICACIONES HISTOPATOL\u00d3GICAS Y CLASIFICAR CLARAMENTE \nLOS RESULTADOS, EN LA EVALUACI\u00d3N DE LA EFICACIA DE LAS \nVACUNAS CONTRA LA INFECCI\u00d3N DE LA BOLSA DE FABRICIO  \n \nCraig BlackmoreA, Ken TakeshitaB, Joseph GiambroneC, and Patricia WakenellA \n \nADepartment of Population, Health and Reproduction, School of Veterinary Medicine,  \nUniversity o f California, Davis, CA 95616  \nBLohmann Animal Health International, 4759 Ridgeview Lane, Vacaville, CA  95688  \nCPoultry Science Dept., Auburn University, AL  36849                   \n         \nRESUMEN  \nEl m\u00e9todo de desaf\u00edo de pollos desarrollado en \nAuburn uti liza las proporciones entre el peso de la \nbolsa de Fabricio y el peso corporal, adem\u00e1s de la \ncalificaci\u00f3n histopatol\u00f3gica para evaluar la eficacia de las vacunas mediante inmunidad pasiva, comparando \nlos resultados conjuntos de la proporci\u00f3n entre el peso \nde la bolsa y el peso corporal, y el porcentaje de \nprotecci\u00f3n histopatol\u00f3gica de cada parvada (grupo) \ninvolucrada. Menos de un 20% de protecci\u00f3n se \nconsidera \u201cmalo\u201d, del 20 al 50% de protecci\u00f3n se considera \u201cregular\u201d y m\u00e1s del 50% de protecci\u00f3n se \nconsider a \u201cbueno\u201d. Este estudio intenta establecer \nnuevos niveles de separaci\u00f3n para clasificar los \nresultados de la calificaci\u00f3n histopatol\u00f3gica con base \nen los valores existentes de 20% y 50%, establecidos \npara las proporciones entre el peso de la bolsa y el pes o \ncorporal, usando varios m\u00e9todos estad\u00edsticos.  \n Data on passive immunity efficacy was collected \non 146 breeder flocks from five years of the Auburn University Infectious Bursal Disease virus chick \nchallenge. Each flock was given a different \ncombination of  IBDV vaccines and fell into 1 of 3 \nclassifications, young flocks (<40 weeks), middle -aged \nflocks (41- 50 weeks) and old flocks (>50 weeks). 50 \n(unvaccinated) day old chicks were received from each flock and segregated according to how they were to be \nchall enged. After two weeks 20 chicks from each flock \nwere challenged with standard (APHIS) Infectious Bursal Disease virus, 20 challenged with a variant (Var E) Infectious Bursal Disease virus and 10 were left as \ncontrols. Seven days post challenge the birds w ere \nsacrificed. Bursal to bodyweight ratios and histopathology scores were used to derive the percent \npassive protection provided from both the standard and \nvariant challenges. These percentages were then combined to create an overall percent protection. \nProtection was considered \u201cgood\u201d if 50% or more of \nthe flock remained unaffected, \u201cfair\u201d if 20% to 50% \nwere unaffected and \u201clow\u201d if less than 20% were \nunaffected.  \nThe purpose of our investigation was to establish \na highly prototypical method for finding ne w \u201ccut off\u201d \npoints for histopathology scores to be used in IBDV \nvaccine efficacy trials. Currently, these \u201ccut off\u201d scores are based on the old parameters of 20% and 50% used \nfor bursal to bodyweight scoring.  \nFurthermore, we hope to use the information \ndiscovered to plan and execute further studies which \nexplore the relationship between bursal to bodyweight ratio and histopathology.  \nUtilization of regression analysis, the Archetti and \nHorsfall equation, fitted line plots and correlation were \nimportant to c onstructing new \u201ccut off\u201d points for \nhistopathology scores. The results are preliminary, and \nfurther studies are necessary. However, in light of the \ninformation obtained a number of ancillary studies will \nbe performed, including use of other variables as predictors.\n  \n \n \n   \n  \n46 CARACTERIZACI\u00d3N DE UN AISLAMIENTO MEXICANO  \nDE UN VIRUS DE GUMBO RO \n \nCHARACTERIZATION OF A MEXICAN INFECTIOUS BURSAL DISEASE \nVIRUS (IBDV) ISOLATE  \n \nJuan Garc\u00eda- Garc\u00eda1, Manuel Gay1, Alejandro Su\u00e1rez1, Jorge Escamilla1, Mar\u00eda E. Aranda1, \nErne sto Soto1,  David Sarfati1, Agust\u00edn Morales2 y Bernardo Lozano1. \n \n1Laboratorio Avi -Mex, S.A. de C.V., M\u00e9xico. 2Diagn\u00f3sticos Cl\u00ednicos Veterinarios S. A. de C. V. M\u00e9xico  \n \nSUMMARY  \nOne virus was isolated from a commercial broiler \nflock with a health problem characterized by a low \nweight gain, and a moderate mortality rate. Farm is \nlocated in the state of Mexico. Agar gel \nimmunodiffusion, SPF bird inoculation, virus recovery, \nelectron microscopy, and RT -PCR -RFLP analyses \nallowed for the characterization of this  isolate as an \nIBDV. This virus belongs to molecular group number \n6. The original isolate has been called IBF -0596.  \n \nRESUMEN  \nA partir de un problema sanitario en pollo de \nengorda, caracterizado por baja ganancia de peso y mortalidad moderada, en una granja comercial \nlocalizada en el Estado de M\u00e9xico, se logr\u00f3 aislar un \nvirus que mediante las pruebas de inmunodifusi\u00f3n en \nagar, inoculaci\u00f3n en aves SPF, re- aislamiento viral, \nmicroscop\u00eda electr\u00f3nica y RT -PCR -RFLP se identific\u00f3 \ncomo un virus de la infecci\u00f3n de l a bolsa de Fabricio, \nperteneciente al grupo molecular seis, el aislamiento \noriginal fue denominado IBF -0596.  \n \nINTRODUCCI\u00d3N  \nLa enfermedad de Gumboro \u00f3 enfermedad de la \nbolsa de Fabricio es causada por un virus perteneciente \na la familia Birnaviridae, que se  caracteriza por ser un \npadecimiento agudo y altamente contagioso en aves \nj\u00f3venes causando principalmente por lesiones severas \nen la bursa, que se inician con un proceso inflamatorio \ny que culminan con atrofia, lo que induce un estado \nsevero de inmunosupre si\u00f3n en las aves afectadas (5). \nEn los Estados Unidos de Norteam\u00e9rica se ha descrito \nla emergencia de diferentes cepas variantes de este  \nvirus durante los \u00faltimos 20 a\u00f1os (2).  \nLa hetereogenidad gen\u00e9tica determinada en un \nsegmento de 743 pares de bases de l gen que codifica \npara la prote\u00edna VP -2, ha sido utilizada para identificar \na los aislamientos y colocarlos en diferentes grupos \nmoleculares (2, 3, 4). El segmento es amplificado por \nPCR y se somete a restricci\u00f3n por el m\u00e9todo de \nJackwood.  Este procedimi ento acomoda a los virus en \nseis grupos moleculares. En los grupos 1 y 2 se insertan  virus variantes, en los grupos 3 y 4 se insertan  virus cl\u00e1sicos y en los grupos 5 y 6 se clasifican a virus no definidos. El procedimiento adem\u00e1s  se considera adecuado para predecir el tipo antig\u00e9nico de los virus y \nlas variantes que se a\u00edslan en pollos vacunados con las cepas tradicionales de referencia (2, 3).   \nEl objetivo del presente estudio fue el de \nidentificar y caracterizar a un virus de Gumboro denominado IBF -0596, aislado de aves vacunadas, para \ndeterminar sus propiedades biol\u00f3gicas y el grupo molecular al que corresponde mediante la prueba del \npolimorfismo de la longitud de los fragmentos de \nrestricci\u00f3n (RFLP) del gen VP2.  \n \nMATERIAL Y M\u00c9TODOS  \nEn 1996, se trans portaron al laboratorio pollos de \nengorda, procedentes de una granja del Estado de \nM\u00e9xico, con problemas de baja ganancia de peso y \nmortalidad moderada. Las aves fueron sacrificadas y a \nla necropsia se tom\u00f3 una porci\u00f3n de tejido de \naproximadamente 1cm\n3 de espesor de cada una de las \nbolsas, mismas que se colocaron en una soluci\u00f3n de \nformalina al 10 % amortiguada para estudios de \nhistopatolog\u00eda. Con el resto de las bolsas se elaboraron \nmacerados independientes adicionando a cada bolsa \nsoluci\u00f3n amortiguada de fosfatos (PBS), pH 7.2, en \nproporci\u00f3n 1:10 (v/v). Los macerados, posteriormente se centrifugaron a 4,000 X g durante 5 minutos, los sobrenadantes  se mezclaron y fueron congelados a \u2013\n70C hasta su uso.  \nEl sobrenadante se titul\u00f3 y se utiliz\u00f3 para infectar \naves SPF de tres semanas de edad conteniendo 10\n4.5 \nDIP50%/mL. Tres d\u00edas despu\u00e9s del desaf\u00edo se sacrificaron a las aves y se determino la relaci\u00f3n peso \nde bolsa/ peso corporal. Las bolsas se trataron de la \nmisma forma que el inoculo original y el sobrenadante final se someti\u00f3 a diversas pruebas.  \n \nRESULTADOS Y DISCUSI \u00d3N \n Las lesiones histopatol\u00f3gicas observadas en la \nporci\u00f3n de la bolsa analizada concuerdan \nadecuadmente con las reportadas en la literatura, que  \n  \n47 incluye depleci\u00f3n de c\u00e9lulas linfoides, necrosis y  una \nreacci\u00f3n inflamatoria casi inadvertible.  \n El sobrenadante obtenido del macerado de las \nbolsas de las aves SPF dio reacci\u00f3n positiva en la \nprueba de Inmunodifusi\u00f3n en agar (IDA) con un \nantisuero de referencia espec\u00edfico al virus de la \ninfecci\u00f3n de la b olsa de Fabricio, preparado \npreviamente en el laboratorio. El sobrenadante se llev\u00f3 \nal microscopio electr\u00f3nico en el cual se observaron \npart\u00edculas virales con caracter\u00edsticas propias de los \nvirus de la familia Birnaviridae. En una prueba para \nidentificar la presencia de otros virus el sobrenadante \nse administr\u00f3 en aves SPF en las que se midieron la presencia de anticuerpos para otros pat\u00f3genos aviares \nresultando negativos. Se realizaron pruebas \nmicrobiol\u00f3gicas para determinar la presencia de \nbacterias, levaduras, hongos y micoplasmas sembrando \nen medios apropiados resultando negativo el \ncrecimiento.  \n Muestras del sobrenadante inicial y del obtenido \ndespu\u00e9s de la infecci\u00f3n en pollos SPF se colocaron en \nuna soluci\u00f3n de fenol -cloroformo -alcohol isoam\u00edlico \ncon el prop\u00f3sito de inactivar al virus pero de conservar \nsu  \u00e1cido nucleico viral. La mezcla se envi\u00f3 a \ncaracterizar a un laboratorio de an\u00e1lisis moleculares en \nUSA. Por medio del estudio de polimorfismo en el \nlargo de los segmentos de restricci\u00f3n utilizando la \nenzima BstN1 se observaron tres bandas, la primera de \n424 kilopares de bases (Kpb), la segunda de 172 Kpb y \nla tercera de 119 Kpb. Al someter el segmento original \namplificado a la digesti\u00f3n con la enzima MboI se observaron dos fragmentos, uno de 362 Kpb y otro de \n229 Kpb. Sin embargo, al someter el segmento \namplificado a la digesti\u00f3n con la enzima Ssp1 no se observaron bandas, lo que indica la inhabilidad de esta enzima para fragmentar al amplic\u00f3n (2).  \nEstos resultados concuerdan con los trabajos de \nJackw ood en 1999, quien reporta virus aislados en \nM\u00e9xico y que se distribuyen en diferentes pa\u00edses de Am\u00e9rica latina y el Caribe con este patr\u00f3n que \npertenece al grupo molecular seis y que es diferente al de las cepas vacunales tradicionales. En un trabajo \nadicional de esta convenci\u00f3n se determina la capacidad \ninmunol\u00f3gica de estos sobrenadantes para su uso en la \nprevenci\u00f3n y control de la enfermedad.  \n \nREFERENCIAS  \n1. Jakwood, D. J. y Sommer, S. E.  Genetic \nheterogeneity in the VP2 of infectious bursal disease \nvirus es detected in commercially reared chickens. \nAvian Dis. 42: 321- 339 1998  \n2. Jakwood, D. J. y Sommer, S. E. Restriction \nfragment length polymorphisms in the VP2 gene of \ninfectious bursal disease virus outside the United \nStates. Avian Dis. 43: 310 -314 1999  \n3. Jackwood, D. J., Jackwood, R. J. y Sommer, \nS. E. Identification and comparison of point mutations associated with neutralizing epitope in classic and variant infectious bursal disease viruses Virus Res.  49: \n131-137 1997  \n4. Ismail, N. M. y Saif, Y. M Immunogeneci ty \nof infectious bursal disease viruses in chickens Avian disease 35: 460- 469 1991.  \n5. Rosales A. G., Villegas, P., Lukert, P. D., \nFletcher, O. J., Mohamed, M. A. y Brown, J. Pathogenecity of recent isolates of Infectious Bursal \nDisease virus in Specific -pathogen. Free chickens: \nProtection conferred by an interemediate vaccine \nstrain. Avian Dis. 33: 729.734, 1989.  \n \nPROTECCI\u00d3N CONFERIDA POR VACUNAS EMULSIONADAS \nCONTRA UN AISLAMIENT O LOCAL DEL VIRUS DE  GUMBORO  \n \nPROTECTION WITH OIL EMULSION VACCINES AGAINST CHAL LENGE \nWITH LOCAL INFECTIOUS BURSAL DISEASE VIRUS (IBDV) ISOLATES  \n \nManuel Gay1,  Jorge Escamilla1*, Alejandro Su\u00e1rez1, Ernesto Soto1, Bernardo Lozano1, David Sarfati1,  \nDiana V\u00e1zquez2, Agust\u00edn Morales2 y  Juan Garc\u00eda -Garc\u00eda1. \n \n1Laboratorio Avi -Mex, S.A. de C.V., M\u00e9xico, 2Diagn\u00f3sticos Cl\u00ednicos Veterinarios S.A. de C.V., M\u00e9xico  \n \nSUMMARY  \nThis paper presents the results of the evaluation \nof 3 oil emulsion IBDV vaccines for their ability to \nconfer protection after experimental challenge. Two \ncommercial and one experimental vaccines were tested. \nThe experimental vaccine was prepared with a virus isolated from Mexican broilers in 1996.   Immunogenicity results show that all 3 vaccines were able to induce adequate immune responses, but only \nthe experimental vaccine was able to confer protection \nafter challenge with the homologous isolate, and to \nprevent gross and microscopic lesions in challenged \nbirds.   \n  \n48 RESUMEN  \nEn el presente trabajo se presentan los resultados \nde la evaluaci\u00f3n de tres vacunas emulsionadas contra \nGum boro, sobre su capacidad de conferir protecci\u00f3n al \ndesaf\u00edo experimental. Se probaron dos vacunas \ncomerciales y una experimental elaborada con un virus \naislado de pollos de engorda en M\u00e9xico en 1996. Los \nresultados de inmunogenicidad indican que todas las \nvacunas fueron capaces de inducir una adecuada \nrespuesta de anticuerpos, pero solamente la vacuna \nexperimental fue capaz de conferir protecci\u00f3n al \ndesaf\u00edo con el aislamiento hom\u00f3logo, evitando la \npresencia de lesiones macrosc\u00f3picas y microsc\u00f3picas en las av es desafiadas.  \n \nINTRODUCCI\u00d3N  \nLa  enfermedad de Gumboro (IBF) representa un \nserio problema para la avicultura comercial, debido a que da lugar a un estado de inmunodepresi\u00f3n que \npuede interferir con la respuesta inmune esperada, \ninducida por los programas de vacunaci\u00f3n, as\u00ed como a \nla inadecuada respuesta a infecciones que normalmente \nlas aves sanas pueden f\u00e1cilmente resolver (1, 2, 3, 5, 6).  \n La evoluci\u00f3n constante observada en estos virus \nha dado como resultado la presencia de cuasi -especies, \nque pueden va riar en su comportamiento biol\u00f3gico \ntanto de patogenicidad como antigenicidad. En a\u00f1os \nanteriores fue detectada la presencia en M\u00e9xico de un \nvIBF perteneciente al grupo gen\u00e9tico seis, determinado \nposteriormente por pruebas de restricci\u00f3n en el largo de los fragmentos (RFLP por sus siglas en ingl\u00e9s), por lo \nque fue necesario evaluar la capacidad protectora de las \nvacunas emulsionadas comerciales disponibles y una \nexperimental para prevenir la infecci\u00f3n y las manifestaciones cl\u00ednicas que causa esta cepa \ndenom inada IBF -0596 (3, 4, 5).  \n \nMATERIAL Y M\u00c9TODOS  \nAves: Para cada vacuna se emplearon 20 pollitos \ncomerciales de engorda, de 10 d\u00edas de edad, libres de \nanticuerpos contra IBF. Dos grupos de 20 pollos se \nutilizaron como testigos y no se vacunaron; uno de \nellos fue infectado y se utiliz\u00f3 como grupo control \npositivo. El otro permaneci\u00f3 como grupo control \nnegativo.  \nVacunas:  \n\u2022 Vacuna emulsionada, laboratorio comercial A  \n\u2022 Vacuna emulsionada, laboratorio comercial B  \n\u2022 Vacuna emulsionada, experimental, \nconteniendo la cepa ASM97 (derivada del \naislamiento original IBF -0596),  elaborada en \nbolsa de Fabricio.  \nInmunizaci\u00f3n: La aplicaci\u00f3n de vacunas se realiz\u00f3 \npor v\u00eda subcut\u00e1nea, en la porci\u00f3n media y posterior del \ncuello, a raz\u00f3n 0.5 ml de cada vacuna por pollo. La inmunizaci\u00f3n se realiz\u00f3 a los diez d\u00edas de edad del \npollo.  \nDesaf\u00edo: A los 31 d\u00edas de edad del pollo (21 d\u00edas \nposvacunaci\u00f3n), los grupos vacunados y un grupo control no vacunado fueron desafiados con 0.05 ml v\u00eda \nocular y con 0.05 ml v\u00eda cloaca con el aislamiento \norigina l denominado inicialmente IBF -0596 \nconteniendo 10\n4.5 DIP50%/ml,  elaborada en bolsa de \nFabricio.  \nMuestras: Se obtuvieron muestras de suero de \ntodas las aves a los 14 y 21 d\u00edas posvacunaci\u00f3n (previo desaf\u00edo) para determinar el nivel promedio de \nanticuerpos de cada uno de los grupos para el virus de \nIBF mediante  la prueba de ELISA. Al s\u00e9ptimo d\u00eda posdesaf\u00edo se sacrificaron las aves de todos los grupos \nexperimentales desafiados y controles. Se separaron las \nbolsas de Fabricio, se obtuvo el peso promedio de el las \npara cada uno de los grupos y  se colocaron en una soluci\u00f3n de formalina al 10% para estudios \nhistol\u00f3gicos.    \n \nRESULTADOS Y DISCUSI \u00d3N \nLos resultados de potencia e inmunogenicidad, \nevaluados a trav\u00e9s de la prueba de ELISA indirecta y de los pesos promedio de las bolsas de Fabricio de cada uno de los grupos experimentales, se resumen en el \nCuadro 1.  \nLos resultados de inmunogenicidad, determinados \npor el t\u00edtulo promedio de anticuerpos de cada uno de \nlos grupos experimentales, indican que la respuesta a la \nvacunaci\u00f3n fue similar para las tres vacunas en estudio \ntanto a los 14 como a los 21 d\u00edas despu\u00e9s de la \naplicaci\u00f3n de las vacunas.  \nLos resultados del peso promedio de las bolsas de \nFabricio, para cada uno de los grupos, indican que \nsolamente la vacuna experimental fue capaz de conferir \nprotecci\u00f3n al desaf\u00edo con la cepa original denominada \nIBF-0596, mientras que las vacunas comerciales \nevaluadas no fueron capaces de proteger al desaf\u00edo ya que su peso promedio fue igual o muy cercano al \nobservado en el grupo control desafiado.  \nLos estudios histol\u00f3gicos indican que el 100% de \nlas bolsas de Fabricio de las aves inmunizadas con la \nvacuna experimental no mostraron lesiones sugestivas \nal virus de IBF, mientras que el 100% de las bolsas de Fabricio de los grupos inm unizados con las vacunas \ncomerciales presentaron lesiones histol\u00f3gicas de IBF en diversos grados, de manera similar a lo observado en el grupo control desafiado.   \n \nCONCLUSIONES  \nLas vacunas comerciales empleadas en esta \ninvestigaci\u00f3n, inducen una adecuada respuesta de \nanticuerpos, detectable  por la prueba de ELISA; sin embargo, no fueron capaces de conferir protecci\u00f3n a  \n  \n49 las lesiones en la bursa, cuando se desafiaron con la \ncepa original IBF -0596.  \nLa vacuna experimental conteniendo la cepa \nASM 97 indujo una  adecuada respuesta de anticuerpos \ny confiri\u00f3 protecci\u00f3n del 100% al desaf\u00edo con la cepa hom\u00f3loga (IBF -0596), indicando que su mosaico \nantig\u00e9nico de protecci\u00f3n es diferente al de las cepas tradicionales utilizadas en las vacunas comerciales para \nla prevenci\u00f3n de la enfermedad de Gumboro.  \n \nCuadro 1.    Resultados de la prueba de inmunogenicidad y potencia de tres vacunas administradas en pollos \nde engorda, libres de anticuerpos contra IBF y desafiados con  la cepa IBF -0596.  \n \nVacuna  ELISA 14 d\u00edas  \nPromedio geom\u00e9trico  ELISA 21 d\u00edas  \nPromedio geom\u00e9trico  Peso promedio de             \nbolsas de Fabricio             \n7 d\u00edas post -desaf\u00edo  Lesiones \nhistol\u00f3gicas \nsugestivas de IBF  \nComercial A  431 1496  0.31g  + \nComercial B  325 1230  0.38g  + \nExp. Cepa ASM97  573 2571  0.71g  - \nControl  positivo  228 226 0.31g  + \nControl negativo  225 225 0.69g  - \n \nREFERENCIAS  \n1. Jackwood, D.J., Sommer, S.E.  and Odor, E.  \nCorrelation of enzyme -linked immunosorbent assay \ntiters with protection against infectious bursal disease virus.  Avian Dis. 43 : 189- 97. 1999.   \n2. Kumar, D.V.M. and  Boclair, M.S. Avances \nen la Producci\u00f3n de Biol\u00f3gicos Contra la Enfermedad \nde Gumboro. Memorias del Quinto Curso de \nActualizaci\u00f3n Avimex. M\u00e9xico. Enfermedad de \nGumboro. 15- 20. 1993.  \n3. Lasher H. and Shane , S.W.  Infectious  \nBursal Disease.  World\u2019s Poultry Science Journal. Vol. 50. 1994.  4. Lukert,P.D., y Y.M. Saif.. Infectious Bursal \nDisease. En Diseases of Poultry. D\u00e9cima edici\u00f3n. Editado por Calnek, B.W., Barnes, H,J., Beard, C.W., McDougald, L. Y M. Saif. Editorial Board f or the \nAmerican Association of Avian Pathologists. Iowa State University Press.721 -738.1997.  \n5. Rosenberger, J.K  The Role of IBD in \nImmunosuppression, Increase in Susceptibility to other Infectious Diseases. World Poultry, Special. December 1994.  \n6. Shane, S. L a enfermedad de Gumboro en \nPollo de Engorda.  Memorias del Quinto Curso de \nActualizaci\u00f3n Avimex. Enfermedad de Gumboro. 37 -\n44. 1993.  \n \nDETERMINACION DEL DA\u00d1O A LA BOLSA DE FABRICIO \nCAUSADA POR LA APLICACI\u00d3N DE VACUNAS A VIRUS VIVO \nCON CEPAS INTERMEDIAS, AS I COMO LA PROTECCION AL \nDESAFIO  \n \nINTERMEDIATE LIVE VACCINE VIRUS -ASSOCIATED BURSAL DAMAGE \nAND PROTECTION AGAINST CHALLENGE  \n \nToscano C. Arnulfo; Jim\u00e9nez P. Alma; Rodr\u00edguez G. Elizabeth; G\u00f3mez V. Edna; Chapa B. Joaqu\u00edn  \n \nLaboratorio de Biolog\u00eda de Investigaci \u00f3n Aplicada S.A de C.V.  \nTehuac\u00e1n, Puebla, Mexico. 7 Norte 416. Col. Centro. C.P. 75700  \n \nRESUMEN  \nSe evaluaron 2 vacunas de Gumboro, para \ndeterminar el da\u00f1o que causan a la Bolsa de Fabricio \n(BF), comparar la respuesta inmune humoral por la \nprueba de ELISA;  microsc\u00f3picamente por las pruebas de Histopatolog\u00eda  e Inmunoperoxidasa observar el \ngrado de lesi\u00f3n que presentan las BF. Se realiz\u00f3 la \nprueba de Indice Bursal (IB), para ver si entre el IB y la \nrespuesta inmune humoral presenta relaci\u00f3n con \nlesiones burs ales.  De acuerdo a los resultados  \n  \n50 obtenidos,  la dos vacunas  resultaron ser cepas \nintermedias y  protegen al desaf\u00edo.    \n \nINTRODUCCION  \nLa enfermedad infecciosa de la bolsa, es una \nenfermedad viral aguda y altamente contagiosa, que \nnormalmente afecta a av es j\u00f3venes, se caracteriza por \nda\u00f1o severo en la BF. Las aves son m\u00e1s susceptibles a \nla infecci\u00f3n cl\u00ednica de 3 a 6 semanas de edad, aunque \nla ocurrencia de la enfermedad se ha reportado entre 2 \ny 15 semanas de edad.  Las aves que son susceptibles y \nque pre sentan lesiones a las 2 semanas de edad, son \ninfectadas subcl\u00ednicamente, pero la infecci\u00f3n \nnormalmente presenta inmunosupresi\u00f3n prolongada \ngrave.  \nEl mecanismo de la inmunosupresi\u00f3n no esta \ncompletamente entendido, pero se presume que resulta en destrucci\u00f3n  linfocitaria y degeneraci\u00f3n de la bolsa. \nMedidas efectivas para controlar la IBF, son necesarias \npor el efecto de infecci\u00f3n temprana en el sistema \ninmune. La infecci\u00f3n temprana de IBF disminuye la \nrespuesta a la vacunaci\u00f3n e incrementa la \nsusceptibilidad a otras infecciones. Hoy en d\u00eda hay dos \nm\u00e9todos de prevenir el da\u00f1o de IBF en el sistema inmune.  \n1) Inmunizaci\u00f3n de parvadas reproductoras, de \nmodo tal que se transmita inmunidad de los progenitores hacia su progenie. Tales anticuerpos maternos protegen al po llo de infecciones \ninmunosupresivas tempranas, y normalmente protegen de 1 a 3 semanas (inmunidad pasiva).  \n2) Las aves j\u00f3venes pueden ser inmunizadas \npor vacunaci\u00f3n, con vacunas a virus vivo de IBF \n(inmunidad activa).  \nLas cepas llamadas \u201cIntermedias\u201d son \nactualmente las m\u00e1s populares y/o utilizadas. Estas \npueden ser usadas en pollos con inmunidad maternal \nalta, ya que estas cepas son capaces de superar altos \nniveles de inmunidad maternal a diferencia de las cepas \natenuadas. Sin embargo estas cepas intermedias var\u00edan \nen cuanto a antigenicidad, virulencia y por \nconsiguiente, provocan en mayor o menor grado \ninmunodepresi\u00f3n por inducir atrofia en la BF que es \ndonde se replica el virus, as\u00ed como la producci\u00f3n del \nnivel de anticuerpos depende de la antigenicidad de l a \nvacuna y de la capacidad de respuesta del sistema \ninmune.  \nDe acuerdo a lo anterior, el presente trabajo se \nrealiz\u00f3, con el siguiente objetivo.  \n \nOBJETIVOS  \na) Determinar el da\u00f1o que provocan las cepas \nvacunales (intermedias) a la Bolsa de Fabricio (BF), \npor s \u00ed mismas.  b) Comparar la respuesta inmune humoral \ncontra Infecci\u00f3n de la Bolsa de Fabricio (IBF), producida por cada vacuna.  \nc) Cuantificar el grado de lesiones bursales \nmicrosc\u00f3picamente, por medio de pruebas \nHistopatolog\u00eda (HP) e Inmunoperoxidasa (IP).  \nd) Correla cionar las lesiones bursales, entre el \nIndice Bursal  (IB) y la respuesta inmune humoral de IBF. \n \nMATERIAL Y METODOS  \nCepas Vac\u00fanales : Para dicha prueba, se \nutilizaron 2 vacunas comerciales contra la IBF, \nconocidas como cepas \u201cIntermedias\u201d. Estas vacunas se  \nidentificaron como grupos B y C.  \nLa cepa Edgar del virus de la IBF, se utilizo como \nun virus virulento (control positivo), para compararla con las cepas vac\u00fanales \u201cIntermedias\u201d. Este control \npositivo se identifico como grupo D. Tambi\u00e9n se \nincluy\u00f3 un grupo  E, al cu\u00e1l no se le aplic\u00f3 ninguna \nvacuna, ni virus virulento (control negativo).  \nAves : Para cada grupo se utiliz\u00f3 40 aves Libres \nde Pat\u00f3genos Espec\u00edficos (LPE) de 14 d\u00edas de edad. \nCada grupo de aves se coloc\u00f3 en diferentes unidades de aislamiento tipo Ho rsfall Bauer, a presi\u00f3n negativa, \nprovistas de agua y alimento Add Libitum.  \nA los 14 d\u00edas de edad, se vacunaron las 40 aves \nde los grupos B y C, con diferentes vacunas, a raz\u00f3n de \nuna dosis por ave, v\u00eda ocular, una gota en el ojo (0.03 \nml), as\u00ed como tambi\u00e9 n las aves del grupo D, se \ninfectaron con el virus virulento de IBF (cepa Edgar), \ncon una dosis de   10\n4 DIE 50/ml.  \nCinco aves de cada grupo y a diferentes tiempos \n(17, 21, 28, 35, 40, 45, 50 y 55 d\u00edas de edad respectivamente), se sangraron para realizar p ruebas \nserol\u00f3gicas ELISA as\u00ed como tambi\u00e9n se sacrificaron, \npara cosechar la BF y determinar \u00e9l IB, as\u00ed como \nrealizar pruebas de HP e IP, para evaluar el grado de \nda\u00f1o microsc\u00f3picamente.  \nA los 35 d\u00edas de edad (21 d\u00edas post -vacunaci\u00f3n \n(DPV)) se desafiaron las aves vacunadas de los grupos \nB y C, al igual que las aves del grupo D (control \npositivo) se infectaron nuevamente con el virus \nvirulento de IBF (cepa Edgar), con una dosis de 10\n4 \nDIE 50/ml. \n \nRESULTADOS  \nGrupo B:  En la prueba de ELISA, presento \nserolog\u00eda positiva a IBF (respuesta inmune humoral) \ndurante los MPV, alcanzando t\u00edtulos arriba de 2000, \nsimilar a los t\u00edtulos del grupo D (control positivo); a los 5, 10 y 15 DPD, los t\u00edtulos tienden a bajar, esto debido \na que hay una neutralizaci\u00f3n de los t\u00edtulos vac \u00fanales \nhacia el virus de desaf\u00edo, y a los 20 DPD tienden a \nincrementarse nuevamente. A los 14 DPD, las BF \npresentan un IB muy bajo (0.2) aunque a los 21 DPV  \n  \n51 se recuperan (0.8), sin embargo a partir de los 10 DPD \nhasta el termino de la prueba las BF present an un IB \nregular (0.6). Microsc\u00f3picamente durante toda la \nprueba tanto por HP como por IP, las BF no presentan \nlesiones, ni positividad, a excepci\u00f3n, que a los 10 DPD, \npor HP solamente algunas BF presentan lesiones en \nfase cr\u00f3nica regenerativa.  \nGrupo C:  En la prueba de ELISA, presento \nserolog\u00eda positiva a IBF (respuesta inmune humoral) \ndurante los MPV, alcanzando t\u00edtulos arriba de 2000, \nsimilar a los t\u00edtulos del grupo D; durante los MPD los \nt\u00edtulos se mantienen e inclusive se incrementan (cerca \nde 4000), ig ual que los t\u00edtulos del grupo D. A los 14 \nDPD, las BF presentan un IB bajo (0.4); y durante los \nMPD las BF presentan un IB de regular a normal (de \n0.7 a 1.2) hasta los 15 DPD, pero a los 20DPD \nnuevamente presentan un IB bajo. Microsc\u00f3picamente \ntanto por HP  como por IP, las BF a los 3 y 7 DPV no \npresentan lesiones, ni tinci\u00f3n positiva, pero a los 14 y \n21 DPV algunas BF presentan lesiones en fase \nsubaguda y fase regenerativa; durante los MPD por IP, \nlas BF no presentan tinci\u00f3n positiva, al igual que por IP \nno presentaron lesiones, a excepci\u00f3n, que a los 15 DPD \nalgunas BF presentan lesiones en fase cr\u00f3nica regenerativa.   \nGrupo D:  Durante toda la prueba hubo serolog\u00eda \npositiva a IBF, alcanzando t\u00edtulos arriba de 4000, debido al virus de desaf\u00edo; as\u00ed como tambi\u00e9 n por IB las \nBF a partir de los 7 d\u00edas post -infecci\u00f3n (DPI) hasta el \nfinal de la prueba  presentaron IB muy bajo (de 0.2 a 0.4). Microsc\u00f3picamente, durante los monitoreos post -\ninfecci\u00f3n (MPI) por HP, las BF presentan lesiones que \nvan desde fase aguda, suba guda y cr\u00f3nica regenerativa; \nal igual que por IP, las BF presentan tinci\u00f3n positiva a \nexcepci\u00f3n de los 2 \u00faltimos monitoreos, ya que la \ntinci\u00f3n resulto negativa.  \nGrupo E:  Durante toda la prueba, no presento \nserolog\u00eda positiva a IBF, ya que no se le aplic\u00f3 n inguna \nvacuna, ni virus de desaf\u00edo (control negativo); las BF presentan un IB normal durante toda la prueba (1.0). \nMicrosc\u00f3picamente por HP las BF no presentan ninguna lesi\u00f3n al igual que por IP, no presentan tinci\u00f3n \npositiva a IBF.  \n \nDISCUSION Y CONCLUSIONES  \nLas cepas vac\u00fanales intermedias contra la IBF, \nson actualmente las m\u00e1s populares y/o utilizadas, pero estas cepas pueden variar en cuanto a antig\u00e9nicidad y virulencia . De acuerdo a los resultados obtenidos, las \nvacunas de los grupos B y C resultaron se r vacunas \nrealmente intermedias, aunque la vacuna del grupo C, microsc\u00f3picamente por HP e IP y por IB resulto ser \nuna cepa un poco m\u00e1s agresiva , ya que a los 14 y 21 \nDPV presentaron lesiones en fase subaguda y regenerativa, tinci\u00f3n positiva e IB de bajo a regular.  \nEl conocimiento del efecto o da\u00f1o de las vacunas \nsobre el tejido de la BF puede ser de utilidad para determinar el momento de la vacunaci\u00f3n y las vacunas \nde elecci\u00f3n.  \nDe acuerdo a los objetivos planteados en el \npresente trabajo, se establece que:  \na) La vacuna del grupo C, microsc\u00f3picamente, \nprovoca un da\u00f1o moderado a la BF, por la aplicaci\u00f3n \nde la misma.  \nb) La respuesta inmune humoral de las vacunas \nde los grupos B y C fue muy similar.  \nc) Microsc\u00f3picamente las lesiones bursales \npost-vacunaci\u00f3n, fueron nega tivas, a excepci\u00f3n del \ngrupo C que a los 14 DPV presento un da\u00f1o moderado \ntanto por HP como por IP; y las BF de los grupos B y \nC, presentaron da\u00f1o por HP pero en fase cr\u00f3nica con regeneraci\u00f3n del tejido linfoide y por HP fueron \nnegativos.  \nd) No existe una cor relaci\u00f3n entre las pruebas \nde Elisa e IB con las pruebas de HP e IP, ya que en algunos  \nmonitoreos tanto post -vacunaci\u00f3n como post -desaf\u00edo, \nlas BF presentan un IB bajo o regular y los t\u00edtulos por la prueba de ELISA se incrementan, con esto se podr\u00eda \ndecir q ue la disminuci\u00f3n del IB es debido al  \nincremento en los t\u00edtulos a causa del virus vacunal o \ndel virus de desaf\u00edo, sin embargo por las pruebas de HP \ne IP, las BF de los 2 grupos vacunados y del grupo control positivo, poco a poco se va regenerando el \ntejido linfoide conforme pasa el tiempo.  \n En conclusi\u00f3n, las vacunas de los grupos B y C, \nson cepas realmente intermedias, ya que las dos \nvacunas presentaron seroconversi\u00f3n en las aves, as\u00ed \ncomo tambi\u00e9n ambas vacunas son capaces de proteger \na las aves ante un d esaf\u00edo contra la IBF.  \n \nNOTA: Bibliograf\u00eda y mayor informaci\u00f3n al \npresente trabajo, disponible con el autor.  \n \n \n \n    \n  \n52 UTILIZACI\u00d3N DE PROTE\u00cdNAS RECOMBINANTES E N UNA \nVACUNA INACTIVADA CONTRA LA ENFERMEDAD DE \nGUMBORO  \n \nTHE USE OF RECOMBINANT PROTEINS IN A KILLED, INFECTIOUS \nBURSAL DISEASE VIRUS (IBDV) VACCINE  \n \nSaubi, NA.; Mart\u00ednez -Torrecuadrada, J.L.B; Casal, IB; Vela, C.B Pag\u00e8s -Mant\u00e9, A.A; Espu\u00f1a, E.A \n \nA Laboratorios Hipra, S.A. -  Avda. La Selva, 135 \u2013  17170 AMER (Girona) Spain.  \nB INGENASA - C/Hnos .Garc\u00eda Noblej as 41, 4  -  28037 Madrid Spain.  \n \nSUMMARY  \nFrom a series of IBDV recombinant proteins \nobtained in a baculovirus, experimental vaccines have \nbeen prepared in order to determine which protein is \nmore antigenic. Once candidate proteins were selected, \na test was performed to determine the amount of \nprotein necessary for the vaccine to fulfill the \nrequirements of the European Pharmacopoeia.  \n \nRESUMEN  \nA partir de una serie de prote\u00ednas recombinantes \ndel virus de la enfermedad de Gumboro (IBDV), \nobtenidas en baculo virus, se han preparado unas \nvacunas experimentales para determinar cual de las \nprote\u00ednas es m\u00e1s antig\u00e9nica. Una vez seleccionadas las \nprote\u00ednas candidatas, se ha realizado una prueba para \ndeterminar la cantidad de prote\u00edna necesaria para que la \nvacuna cum pla los requerimientos de la Farmacopea \nEuropea.  \n \nINTRODUCCI\u00d3N  \nEl uso de vacuna recombinantes inactivadas \nfrente la enfermedad de Gumboro (IBD) puede ser de gran utilidad en el futuro siempre que su inocuidad y \npotencia sean buenas para el control de esta importante enfermedad. Las dudas t\u00e9cnicas que aparecen son: ver primero qu\u00e9 prote\u00ednas constitucionales se deben \nutilizar, cual es el contenido de las mismas y cual es su \npotencia si se compara con vacunas inactivadas \ncl\u00e1sicas de IBD siguiendo las directrices de la \nFarmacopea Europea.  \nExisten dos objetivos importantes en este estudio: \nprimero determinar cual de las tres prote\u00ednas \nrecombinantes seleccionadas VP2, VPX y poliprote\u00edna \nson \u00f3ptimas para la elaboraci\u00f3n de una vacuna \ninactivada de IBD. Segundo, cu\u00e1l  es la dosis m\u00ednima de \nla prote\u00edna recombinante en una dosis vacunal que \nproteja las aves.  \n \nMATERIAL Y M\u00c9TODOS  \nSe han utilizado tres prote\u00ednas recombinantes, \nexpresadas en el sistema baculovirus: VP2, VPX y Poliprote\u00edna (VP2 -VP3-VP4). , Aves: se han utiliz ado \npollitas SPF de 4 semanas de edad libres de IBD. Se alojaron en condiciones de aislamiento completo para \nevitar cualquier tipo de contagio que pudiera interferir \nla prueba. Vacunas: Se prepararon vacunas tipo W/O \n(water in oil), con la misma composici\u00f3 n que la vacuna \ninactivada comercial descrita a continuaci\u00f3n. Para la \ndeterminaci\u00f3n de la prote\u00edna  m\u00e1s inmunog\u00e9nica, se \nprepararon vacunas con 25 \u00b5g de prote\u00edna. Para la determinaci\u00f3n de la dosis vacunal, se prepararon \nvacunas con 9 \u00b5g, 3 \u00b5g y 1 \u00b5g de prote\u00edna.  Las \nvacunas se administraron por v\u00eda subcut\u00e1nea,  a raz\u00f3n de 0,5 ml de vacuna por ave. Cada una de las vacunas \nse prob\u00f3 en un lote de 10 animales. Se utiliz\u00f3 una \nvacuna de IBD inactivada comercial (HIPRAGUMBORO -BPL2) para la comparaci\u00f3n de \nlos resu ltados. Protocolo: A las 4 semanas de edad, las \naves se referenciaron individualmente y se tom\u00f3 una muestra de sangre de cada una de ellas. Se vacunaron \ncon las diferentes vacunas, y a los 28 d\u00edas post -\ninoculaci\u00f3n se procedi\u00f3 a tomar una muestra de sangre,  \npara la determinaci\u00f3n de anticuerpos por \nsueroneutralizaci\u00f3n (m\u00e9todo requerido por la \nFarmacopea Europea para el control de lote de vacunas \ninactivadas contra IBDV), y se realiz\u00f3 una infecci\u00f3n \nexperimental con un IBDV de alta virulencia \n(vvIBDV), cepa Gir ona, a raz\u00f3n de 0,2 ml de \nsuspensi\u00f3n v\u00edrica por animal, por v\u00eda oral. Se valoraron los datos cl\u00ednicos, postraci\u00f3n, plumas hirsutas, \nmotilidad y muerte post- infecci\u00f3n experimental, y a los \n10 d\u00edas del enfrentamiento con el vvIBDV se procedi\u00f3 \nal estudio post -mortem de los animales, que \ncomprend\u00eda el estudio macrosc\u00f3pico de las lesiones y \nel an\u00e1lisis de la relaci\u00f3n de pesos entre la Bolsa de \nFabricio (BF) y el Peso corporal (BW), BF/BW*1000.  \n \nRESULTADOS  \nLos resultados de protecci\u00f3n obtenidos en la \nprueba de s elecci\u00f3n de prote\u00edna muestran que las \nmejores candidatas son la VP2 (ning\u00fan animal muerto, s\u00f3lo un animal con atrofia grave de la BF, t\u00edtulo de sueroneutralizaci\u00f3n por encima de 100.000 Unidades  \n  \n53 de Farmacopea Europea, UFE), seguido de la \npoliprote\u00edna (ning \u00fan animal muerto, 2 animales con \nlesiones graves (BF/BWx1000 < 2) de la BF y t\u00edtulo de \nsueroneutralizaci\u00f3n entre 50.000 y 100.000 UFE). La \nprote\u00edna que  descartamos es la VPX (ning\u00fan animal \nmuerto, 3 animales con lesiones graves de BF y un \nt\u00edtulo sueroneut ralizante de 12000 UFE). Los \nresultados de la vacuna comercial de referencia, \nHIPRAGUMBORO BPL2, son similares a los \nobtenidos con 25 \u00b5g VP2 (ning\u00fan animal muerto, un \nanimal con lesi\u00f3n grave en la BF, t\u00edtulo \nsueroneutralizante de 51200 UFE) Respecto a la p rueba \nde evaluaci\u00f3n de la dosis vacunal los resultados \nobtenidos demuestran que la dosis de 3 \u00b5g de VP2 son \nsuficientes para satisfacer los requerimientos de la \nFarmacopea Europea.  \n \nDISCUSI\u00d3N  \nTal como hemos podido constatar en este estudio \nel uso de las subunidades antig\u00e9nicas es interesante \ndentro de las posibilidades de profilaxis en avicultura.  Pero consideramos en este caso validar adem\u00e1s \neste tipo de vacunas directamente en aves con anticuerpos pasivos de IBD y a la vez su uso en \nreproductoras, con el  fin de conocer mejor los \nest\u00edmulos pasivos de inmunidad y su catabolismo para \nintentar neutralizar los casos subcl\u00ednicos de IBD en \nbrotes tal como ha ocurrido con el uso de vacunas inactivadas que utilizan ant\u00edgeno completo.  \n \nREFERENCIAS  \n1. European  Pharmaco poeia 1997 (monograf\u00eda \n1997:0960).  \n2. Mart\u00ednez -Torrecuadrada, JL, L\u00e1zaro, B; \nRodr\u00edguez, JF; Casal, JI. \"Antigenic properties and \ndiagnostic potential of baculovirus expressed Infectious \nBursal Disease Virus proteins VPX and VP3\", \npublicado en el Clin. Diagn. Lab. Immunol. 2000 Jul; \n7(4):645- 651 \n3. Pag\u00e8s -Mant\u00e9, A. \u201cCin\u00e9tica de anticuerpos \nfrente a la enfermedad de Gumboro (IBD). Estudio evolutivo mediante una prueba de ELISA indirecta. \nTesis Doctoral. 1990. Universidad de Zaragoza.  \n \nAUTOGENEOUS IBD VACCINES: TECH NIQUES FOR ISOLATING  \n\u201cNEW\u201d IBD STRAINS WHICH ARE NOT PROTECTE D BY \nMATERNAL IMMUNITY  \n \nRobinette A. Gilbert, DVM, MAM, Diplomate ACPV  \n \nMerial Select, PO Drawer 2497, Gainesville, GA 30503  \n \nInfectious Bursal Disease (IBD) causes millions \nof dollars in losses  to the poultry industry in the USA. \nThese IBD strains do not cause high mortality as \nstrains in other countries. However, these IBD strains \ntypically cause either permanent, or more commonly, \ntemporary immunosuppression that results in poor \nperformance, p oor feed conversions, and increased \nsusceptibility to other diseases.  IBD vaccination began in the late 1960\u2019s, with classic strains of IBD. By the \nearly 1980\u2019s, the clinical picture for IBD had changed and the classic IBD vaccine programs began to fail. \nVariant IBD strains were being isolated. These strains \nwere shown to easily break through the classic vaccine \nprograms. Once variant IBD vaccines were added to the breeder and broiler vaccination program, bird \nhealth improved. There is recent evidence that  the IBD \nstrains are changing once again. Several poultry \nintegrators are seeing early IBD challenges despite the \nuse of both breeder and broiler IBD vaccines. The \ncurrent IBD vaccine programs are not protecting these flocks as well as they have in the pas t. As in the 1960\u2019s \nand 1980\u2019s, integrators seek other options to protect \ntheir flocks. One option is to isolate the \u201cnew\u201d IBD strains that break through the maternal immunity and \nproduce an autogeneous vaccine that will protect \nagainst these strains. The methods outlined below were \nused to isolate these \u201cnew\u201d IBD strains in a poultry \noperation and, determine if they were candidates for an \nautogeneous IBD vaccine.  \nClinical signs that suggest a \u201cnew\u201d IBD \nvariant . The occurrence of any of the following \nclinical signs in a poultry operation that has a solid \nbreeder and broiler IBD vaccination program would \nsuggest the presence of a \u201cnew\u201d IBD variant.  \n1. Bursal infection or atrophy occurs early \n(before 17 days of age).  \n2. Broiler performance and feed conversions \ndeteriorate despite good management on the farms.  \n3. Miscellaneous bird health issues are present \non the farm due to possible immunosuppression from \nIBD.  \nSetting up a monitoring program in the \noperation.  \n1. Remove all broiler IBD vaccines. Do not use \nIBD vaccines ( hatchery or field administration) in \nflocks where the bursae will be collected. This will  \n  \n54 confirm when the IBD challenge breaks through the \nmaternal immunity without the possibility of \ninterference from live broiler IBD vaccines.  \n2. Screen as many farms as po ssible. Special \nemphasis should be placed on well managed, poor performing farms and farms with a history of an early \nIBD challenge.  \n3. Bursal collection -  Collect bursae at both 12 \nand 17 days of age (two collections per farm).  \nTypically, five (5) birds per  farm at each collection age \nare sufficient. The bursae should be split with one -half \nbeing placed in 10% neutral buffered formalin (for \nhistopathology), and one -half in a sterile bag (for \nPCR). The bursas in the formalin jars should be kept at \nroom temper ature and the bursas in the sterile bags \nshould be kept frozen.  \n4. Each farm should have two formalin jars \nand two sterile frozen bags. The labels should contain \nthe following information: farm name, age at collection (12 or 17 day collection), and the date.   \nHistopathology and virus isolation results that \nsuggest a \u201cnew\u201d IBD variant  \n1. Since PCR (polymerase chain reaction) \nanalysis is relatively expensive, histopathology is used as a screening tool. Histopathological results usually \nreveal one of three findings : \na. Normal or slight variations in follicular \nsize \nb. Acute or sub -acute follicular necrosis  \nc. Chronic follicular necrosis  \n2. Samples that show acute or sub -acute \nfollicular necrosis (suggesting that virus is actively \nreplicating) are selected and the frozen paired samples \nare sent for PCR analysis.  \n3. PCR analysis is used to characterize the \nvirus isolates into molecular groups. This test is helpful \nin determining if the virus is a vaccine strain (used previously on the farm) or if it is a wild IBD virus. \nPCR analysis is also used to characterize new isolates \nthat do not fit into the current molecular groups. The \ncurrent vaccines may not protect against these \u201cnew\u201d pattern IBD viruses.  \nProgeny challenge on the IBD candidates.  Once \nan isolate that is suspected of breaki ng through \nmaternal immunity is identified, progeny challenge is done to confirm that current breeder programs will not \nprotect against the isolate.  1. Progeny for the challenge study are selected \nfrom breeder flocks vaccinated with two live priming \nvaccines (classic and variant), plus one hot live classic \npriming vaccine. The live vaccines are followed by two inactivated bursal -derived vaccines, containing classic \nand variant IBD strains. Progeny are selected from a number of different breeder flocks. Fifty one -day-old \nchicks from each of the breeder flocks are sent to the \nlaboratory.  \n2. The progeny are housed in isolators for 14 \ndays.  \n3. At 14 days, twenty birds from each breeder \nsource are challenged with the variant E strain (positive \ncontrol) and twenty birds from each breeder source are challenged with the \u201cnew\u201d isolate (test group). Ten \nbirds from each breeder source are left unchallenged \n(negative control).  \n4. At 21 days, all the birds are sacrificed and \nthe bursa/body weight (BBW) ratios are recorded for \neach bird. The BBW ratios are calculated for each \nindividual bird using the following formula.  \nBBW ratio = [bursa weight (in grams)/body \nweight (in grams) ] x 1000. The mean BBW ratio and \nthe standard deviations ( 2\nSD) are determined for the \nnegative control gro up of each flock. The benchmark \nBBW ratios are established by subtracting the two SD from the mean BBW ratio.   \n5. A BBW ratio of each individual bird is \ncompared to the benchmark standard for the group. If \nthe BBW ratio is less than the benchmark standard, \nthen the bird is classified as unprotected. If the BBW \nratio is equal to or greater than the benchmark \nstandard, then the bird is classified as protected.  The \nother factor that is assessed is whether the individual bursa has gross lesions indicating active infection \n(without atrophy). If this is the case, then the bird is classified as unprotected, regardless of the BBW ratio. The level of protection is calculated as a percentage \nusing the formula:  \n (Number of birds classified as protected / \nNumber of birds  in the group) x 100  \n6. The following is an example of the results \nfrom a progeny challenge study on a \u201cnew\u201d IBD strain.  \n7.    \u201cNew\u201d IBD isolates with numerous moderate \nand poor group ratings should be considered as candidates for a potential autogeneous vaccine.  \n \n \n \n \n \n  \n \n  \n  \n55  \nFlock #  \n(see note below)  Percent Protected  \nVariant E  \u201cNew\u201d IBD Strain  \n1 100 11 \n2 95 47 \n3 90 26 \n4 95 60 \n5 100 68 \n6 74 67 \n7 65 0 \n8 95 0 \n9 100 53 \n10 100 63 \nThe protection ratings are as follows:  \n<20%  = Poor  \n20-50% = Moderate  \n>50%  =  Good  \n \nDIFERENCIACI\u00d3N DE AISLAMIENTOS DEL VIRUS DE ANEMIA \nINFECCIOSA EN M\u00c9XICO  \n \nDIFFERENTIATION OF CHICKEN ANEMIA VIRUS STRAINS ISOLATED  \nIN MEXICO  \n \nLedesma MNA*, Huerta LBA, Alonso MRB, Fehervari BTA y Tellez IGA. \n \n A Departamento de Producci\u00f3n Animal:Av es FMVZ UNAM  \nB Laboratorio de Gen\u00e9tica Molecular FMVZ UNAM  \n \nSUMMARY  \nThe chicken anemia virus was isolated in Mexico \nin 1993. Nevertheless, given the difficulties that the \nisolation represents, little information has been \nobtained about the characteristics  of these isolates. The \npurpose of this paper was to differentiate \u2013 using \npolymerase chain reaction (PCR) and restriction fragment length polymorfism (RFLP) \u2013 10 isolates \nobtained in the Poultry Pathology Laboratory, \nDepartment of Animal Production: Poultry , Faculty of \nVeterinary Medicine and Animal Husbandry, The \nNational Autonomous University of Mexico \n(Laboratorio de Patolog\u00eda Aviar, Departamento de \nProducci\u00f3n Animal: Aves, de la Facultad de Medicina \nVeterinaria y Zootecnia de la Universidad Nacional \nAut\u00f3 inoma de M\u00e9xico ), during 2001. Results showed \ngenomic differences between Mexican isolates, which \ncan be related with the clinical differences observed in \nthe field. Further, full sequence studies are required in order to dtermine more accurately genomic \ndifferences/similarities.    \n \n \n RESUMEN  \nEl virus de anemia infecciosa fue aislado en \nM\u00e9xico en 1993, sin embargo dadas las dificultades de \naislamiento, se tiene poca informaci\u00f3n acerca de las \ncaracter\u00edsticas de estos virus. El objetivo del presente trabajo fue diferenciar por medio de PCR y RFLP 10 \naislamientos obtenidos en el Laboratorio de Patolog\u00eda Aviar del Departamento de Producci\u00f3n Animal: Aves de la FMVZ UNAM durante 2001.  \nA partir de macerados de timo y m\u00e9dula \u00f3sea de \naves remitidas para diagn\u00f3stico al Departamento de \nProducci\u00f3n Animal Aves de la FMVZ UNAM y que al \nser inoculados en aves libres de pat\u00f3genos espec\u00edficos \nde 1 d\u00eda reprodujeron el cuadro cl\u00ednico caracte\u00edstico de anemia infecciosa, fue extra\u00eddo el DNA total mediante \nun buffer de lisis con prote\u00ednasa K y SDS y posterior \ntratamiento con Fenol- cloroformo- alcohhol isoam\u00edlico. \nEl DNA fue precipitado con etanol, resuspendido en \nagua y congelado hasta su utilizaci\u00f3n.  \nFueron empleados los iniciadores 5\u00b4GAC TGT \nAAG ATG GCA AGA CGA GCT C3\u00b4 (Sentido) y 5\u00b4GGC TGA AGG ATC CCT CAT TC3\u00b4 (Reversa) \nque amplifican un fragmento de 675 pb \ncorrespondiente al extremo amino terminal del gene  \n  \n56 para la prote\u00edna viral VP1. Los productos de PCR \nfueron corridos en geles de agarosa al 1% y te\u00f1idos con \nbromuro de etidio. Las bandas fueron cortadas y \npurificadas mediante la t\u00e9cnica de \u201cperlas\u201d, y \nposteriormente digeridas con las enzimas HaeIII y \nHinfI. Los productos de digesti\u00f3n fueron corridos en geles de poliacrilamida al 1% y te\u00f1idos con plata.  \nDe los diez casos estudiad os, con la enzima  \nHaeIII, 2 aislamientos fueron compatibles con la cepa \nde referencia Cux -1 encontrandose los fragmentos \nesperados de 238, 161, 113, 67, y 58 pares de bases. \nLos 8 aislamientos restantes, presentaron diferencias \ncon respecto de las cepas descritas previamente. Mediante el uso de esta enzima los aismientos pudieron \nser separados en 6 grupos.  \nCon la enzima HinfI, los virus pudieron ser \nseparados en 5 grupos, sin embargo no hubo relaci\u00f3n \ncon los hallazgos de la enzima Hae III. Estos resultados \nmuestran que existen diferencias en los genomas de los \nvirus aislados en M\u00e9xico, lo cual podr\u00eda tener relaci\u00f3n con los diferentes cuadros que ser encuentran en \ncampo. Se requieren sin embargo mas estudios en los \nque sea posible secuenciar el genoma completo  para \nestablecer diferencias  o similitudes mas precisas.  \n \n(El art\u00edculo completo ser\u00e1 presentado para su \npublicaci\u00f3n en la revista Avian Diseases ). \n \nCASE REPORT: A SEVERE INFECTIOUS CORYZA INFECTION IN \nA MULTIPLE AGE LAYER COMPLEX IN CENTRAL CALIFORNIA  \n \nINFORME DE UN CASO SEVERO DE CORIZA INFECCIOSA EN  \nUN COMPLEJO DE POSTURA CON PARVADAS DE EDADES M\u00daLTIPLES EN \nLA REGI\u00d3N  CENTRAL DE CALIFORNIA  \n \nBland, M.C. AB, A, A. Bickford A, B.R., CharltonA, G. L. Cooper A, F. Sommer A, G. Cutler B \n \nA California Animal Health Food Safety Laboratory, Turlock Branch, University of California \n\u2013 Davis, 1550 N. Soderquist Av., P. O. Box 1522, Turlock CA 95381  \nB Cutler Associates P. O. Box 1042 Moorpark, CA 93020  \n \nRESUMEN  \nSe present\u00f3 un brote de coriza infecciosa en 4 \nparvadas de ponedoras \u2013 en un complejo con edades \nm\u00faltiples \u2013 durante un per\u00edodo de 13 semanas a partir \nde enero del 2000. Los signos cl\u00ednicos incluyeron inflamaci\u00f3n facial, sinusal y palpebral, tos, estertores, depresi\u00f3n severa y anorexia. La mortalidad vari\u00f3 del 8 \nal 64% y la producci\u00f3n de huevo cay\u00f3 de un promedio \nde 77% a tan solo 15%. Disertaremos sobre diversas pr\u00e1cticas de manejo, incluyendo la vacunaci\u00f3n de las \nparvadas susceptibles en presencia del brote.  \n \nThe first week of January 2001, a large multi -age \nlayer complex located in the Central Valley of \nCalifornia became infected with Haemophilus paragallinarum  (Infectious Coryza).   Complex \u201cA\u201d is \na large facility of five environmental buildings housing \napproximately 389,000 layers ages 67 to 104 weeks. \nLocat ed nearby is complex b, a second but smaller \ncomplex operated by the same company, consisting of \nsix \u201cCalifornia Woody Style\u201d buildings housing \napproximately 180,000 layers, About a half kilometer \nseparates the two complexes.  Neither facility had a \nhistor y or clinical signs of Infectious Coryza.  \nClinical signs began in building 7, (Complex A) \nin a flock of 95 week -old layers.  Signs included severe depression, loss of appetite, respiratory distress (rales, \nsnicking, swollen sinuses) and increased mortality . \nApproximately 15 \u2013  20 % of the flock was initially \ninvolved.  Mortality increased from 0.3 to 31.7 % per \nweek in 3 weeks.  Total mortality over an 8 -week \nperiod was approximately 48 %.  Egg production \ndropped from 75 to 15.7 % over a 3- week period.  Feed  \nconsumption dropped from 26 lbs to 10 lbs per 100 \nbirds in 2 weeks.  \nBirds were submitted to the California Animal \nHealth Food Safety lab in Turlock.  Gross lesions consisted of swollen sinuses containing yellow caseous \nexudate, mucoid tracheitis, periton itis, and swollen \nkidneys. H. Paragallinarum  was isolated from the \nsinuses and airsacs.  Isolated from the trachea were Ornithobacterium rhinotracheale  and Pasteurella \nhemolytica -like bacteria and from the sinus  Pasteurella \ngallinarum and Mycoplasma sp. (n ot typable). Virus \nwas not isolated from the trachea or cecal tonsil.  Serology for Avian Influenza (AGID) was negative.  \nPaired serology (ELISA) showed no increase in titers \nto Newcastle Disease or Infectious Bronchitis. Birds \nwere serologically (Plate ag glutination and ELISA) \npositive to MG and MS.  \nThe flock was medicated for ten days with \nchlorotetracycline in the feed and erythromycin in the  \n  \n57 water.  However, medication did not reduce mortality \nor slow the progress of the disease. The following \nmanagemen t protocols were implemented in the \naffected flock (building 7) as well as the adjacent flock \n(building 8) in an attempt to mitigate the spread of the \ndisease to the adjacent flocks in complex A as well as \ncomplex B.  \nBuilding 8 was medicated with the same \nmedications as the affected flock (building 7).  It was \nrecommended that the affected flock be marketed; \nhowever the owner felt that this was not a viable \noption.  We reviewed a number of biosecurity issues \nwith complex employees including, keeping equipme nt \nand movement of employees separated between the \ntwo complexes as well as the rest of the flocks located \nin the back units as much as possible.  Feed and egg \ntrucks were advised to visit complex B first before \nproceeding to Complex A.  Mortality was to be picked \nup and disposed separately between the two complexes as well as from the other flocks in the complex A.  \nWithin two weeks the adjacent flock in building 8 \nbegan to exhibit clinical signs of Coryza. Mortality increased from 0.3 to 16 % per week in 6 weeks.  Total \nmortality over a 10 -week period was 43 %.  Egg \nproduction dropped from 74 to 22 % over a 5- week period.  Feed consumption dropped from 24 lbs to 11 lbs per 100 birds in 2 weeks.   \nFlocks housed in buildings 11 and 12 (complex \nA) were vaccina ted 5 weeks after the initial infection in \nbuilding 7 with a killed Coryza Bacterin in an effort to reduce clinical signs from the oncoming Coryza.  \nHowever, approximately 6 and 10 weeks after the initial infection (1 and 5 weeks post vaccination with \nthe killed Coryza vaccine) flocks housed in buildings \n11 and 12 started showing signs of respiratory distress.  \nClinical signs were not as severe in the vaccinated \nflocks as compared to flocks housed in buildings 7 and \n8.  Total mortality was 22 and 9 %, egg production \ndropped to 25 and 33 % respectively and the duration \nof clinical signs was shorter.  \nAll incoming pullet flocks that were to be housed \nin complex \u201cA\u201d were to be vaccinated twice as pullets with a killed Coryza vaccine.   No new clinical cases of \nCoryza have been observed on either the front or back \nunits.   Further investigations did not reveal a source for the Coryza, although the Coryza spread through \ncomplex A very slowly (total of 13 weeks), complex B \nnever broke with the disease.  We were unab le to \nserotype the Haemophilus paragallinarum isolate.  \n \nCARACTERIZACION GENOMICA DE ORNITHOBACTERIUM \nRHINOTRACHEALE MEDIANTE LA TECNICA DE ERIC- PCR  \n \nERIC-PCR GENOMIC CHARACTERIZATION OF  \nHAEMOPHILUS PARAGLLI NARUM   \n \nSoriano VE1, RP Fern\u00e1ndez2 y PJ Blackall3 \n \n 1Departamento de Investigaci\u00f3n y Desarrollo Av\u00edcola, Bios\u00edntesis Laboratorios SA. Toluca 50130, M\u00e9xico.  \n2Centro de Investigaci\u00f3n y Estudios Avanzados en Salud Animal, FMVZ -UAEM. Toluca 50000, M\u00e9xico.  \n3Queensland Department of Primary Industries, Agency for Food and Fibre Science, Animal Research Institute, \nYeerongpilly 4105, Australia.  \n \nSUMMARY  \nThe genomes of reference strains and field \nisolates of H. paragallinarum were typified in \naccordance with Kume\u2019s typifying scheme, using the \nERIC -PCR test. A to tal of 9 amplicone factors were \nobserved, corresponding to each reference strain (A -1 \nto C -4). Fifteen isolates showing 8 different patterns \nwere also included in the study.   \nRESUMEN  \nSe tipificaron gen\u00f3micamente cepas de referencia \ny aislamientos de Ornit hobacterium rhinotracheale  \nmediante la prueba de ERIC -PCR. Se observaron seis \npatrones de amplicones entre las cepas de referencia y cuatro para los aislamientos. El empleo de esta prueba permiti\u00f3 establecer las relaciones gen\u00f3micas y \nepizootiol\u00f3gicas entr e las cepas de O. rhinotracheale . \nEste estudio reporta el an\u00e1lisis de la distribuci\u00f3n \nde variabilidad de secuencias ERIC (Enterobacterial \nRepetitive Intergenic Concensus) en el ADN \ncromos\u00f3mico de cepas de referencia y aislamientos de \nOrnithobacterium rhinotracheale  empleando una \nprueba de PCR. El prop\u00f3sito del estudio fue establecer \nla diversidad gen\u00e9tica de este microorganismo.  \nLa variaci\u00f3n gen\u00e9tica de O. rhinotracheale  ha \nsido evaluada mediante la prueba de electroforesis enzim\u00e1tica multilocus (MLEE), PCR  basado en las \nsecuencias repetitivas (REP -PCR), secuencia del gen \n16 ARNr (1) y RAPD (2).   \n  \n58 Secuencias de ADN repetitivas han sido descritas \npara eubacterias. Las secuencias ERIC son altamente \nconservadas al nivel de secuencia de nucle\u00f3tidos, pero \nla localizaci\u00f3n cromosomal difiere entre especies o \ncepas. Las secuencias ERIC son de 126 bp \naproximadamente y parecen estar restrictas a regiones \ntranscritas del genoma, tanto en regiones interg\u00e9nicas de operones policistr\u00f3nicos como en regiones no \ntranscritas (3) . \nSe incluyeron nueve cepas de referencia de O. \nrhinotracheale  (A - I), las cuales mostraron seis \npatrones de amplicones ERIC. Asimismo, se \nincluyeron 10 aislamientos obtenidos de casos cl\u00ednicos (4), los cuales mostraron 4 patrones diferentes.  \nLa prueba de ERIC -PCR es una t\u00e9cnica que \nestablece diferencias intraespecie en O. rhinotracheale , \npermitiendo ser empleada en estudios tanto de \nrelaciones gen\u00e9ticas, as\u00ed como de relaciones \nepizootiol\u00f3gicas, de este microorganismo.  \n REFERENCIAS  \n1. Amonsin, A., Wellehan , F. X., Li, L. L., \nvandamme, P., Lindeman, C., Edman, M., Robinson, \nR. A., and V. Kapur. Molecular epidemiology of \nOrnithobacterium rhinotracheale. J. Clin. Microbiol. \n35:2894- 2898. 1997.  \n2. Hung, A. L., and A. Alvarado. Molecular \ninvestigation of Ornitho bacterium rhinotracheale \noutbreaks in commercial poultry. Proc. 50th West. \nPoult. Dis. Conf. Davis, California. pp. 109- 110. 2001.  \n3. Lupski, J. R., and G. M. Weinstock. Short \ninterspersed repetitive DNA sequences in prokaryotic \ngenomes. J. Bacteriol. 174: 4525- 4529. 1992.  \n4. Soriano, V. E., Longinos, G. M., Navarrete, \nG. M., and R. P. Fern\u00e1ndez. Characterization and \nadherence tests of Ornithobacterium rhinotracheale isolates from Mexico. Proc. 49th West. Poult. Dis. \nConf. Sacramento, California. p. 50. 2000.  \n \n(Al art\u00edculo completo se publicar\u00e1 en Avian Diseases ). \n \nCHARACTERISATION OF INDIAN ISOLATES OF  \nHAEMOPHILUS PARAGALLINARUM   \n \nCARACTERIZACI\u00d3N DE AISLAMIENTOS DE HAEMOPHILUS \nPARAGALLINARUM  EN LA INDIA  \n \nS. Tongaonkar1, S.G. Deshmukh1 and P.J. Blackall2 \n \n1Vaccine R & D, Poultry Diagnostic and Research Centre, Venkateshwara Hatcheries Ltd, Pune, India  \n2Agency for Food and Fibre Sciences, Queensland Department of Primary Industries, Animal Research Institute, \nYeerongpilly, Australia  \n \nRESUMEN  \nNo se conocen lo s tipos de Haemophilus \nparagallinarum  que causan brotes de coriza infecciosa \nen la avicultura de la India, lo cual representa una \nimportante limitaci\u00f3n para el desarrollo de vacunas a nivel nacional. Se realiz\u00f3 la serotipificaci\u00f3n de ocho \naislamientos de H . paragallinarum  en Australia e \nIndia, usando la prueba de inhibici\u00f3n de la \nhemaglutinaci\u00f3n con antisueros de conejo de alto \nt\u00edtulo. Todos los aislamientos usados en este estudio se \nconfirmaron como positivos a H. paragallinarum  \nmediante la reacci\u00f3n en cad ena con polimerasa ( PCR ). \nEncontramos que cuatro aislamientos eran del serovar \nA y cuatro del serovar C, no logrando identificar \nninguno del serovar B. El \u00e9xito de esta colaboraci\u00f3n \npermitir\u00e1 el desarrollo de vacunas completamente \ncaracterizadas contra la coriza infecciosa, a nivel nacional, con base en los aislamientos de H. \nparagallinarum  obtenidos en la India , al servicio de la \nindustria av\u00edcola de dicho pa\u00eds.  \n Infectious coryza (IC) is an acute respiratory \ndisease of chickens caused by Haemophilus \nparagallinarum  (2).  The greatest economic losses \nassociated with this disease result from poor growth \nperformance in growing birds and marked reduction \n(10\u201340%) in egg production in layers (2).  The most \ncommonly used serological classification scheme for \nH. p aragallinarum  is the Page scheme, which \nrecognizes serovars A, B, and C (2). The importance of \nthe Page serotyping scheme is that inactivated vaccines provide serovar -specific protection (2).  \nThere was no knowledge about the types of H. \nparagallinarum  present in Indian poultry.  This is a \nmajor limitation to the development of national \nvaccines.   Hence, a collaborative research program \nbetween the Bacteriology Research Laboratory and the research laboratories of the Venkateshwara Hatcheries \nLtd Group was c ommenced.   \nA total of eight Indian isolates were serotyped at \nboth the Bacteriology Research Laboratory in Australia and at the Venkateshwara Hatcheries Ltd Group in  \n  \n59 India.  The serotyping was done using a \nhaemagglutination inhibition test with high titre  rabbit \nantisera as previously described (1).  All of the isolates \nused in this study were confirmed as H. paragallinarum  \nby the HP -2 PCR as previously described (3).  \nWe found that four isolates were serovar A and \nfour isolates were serovar C \u2013 no isolates  of serovar B \nwere identified.  This successful collaboration will \nallow the development of fully characterised, national \ninfectious coryza vaccines based on Indian isolates of \nH. paragallinarum . \n \nREFERENCES  \n1. Blackall, P. J., L. E. Eaves, and G. Aus. \nSeroty ping of Haemophilus paragallinarum  by the Page scheme: comparison of the use of agglutination \nand hemagglutination -inhibition tests. Avian Dis. \n34:643- 645. 1990.  \n2. Blackall, P. J., M. Matsumoto, and R. \nYamamoto. Infectious coryza. In: Diseases of Poultry, 10th ed. B. W. Calnek, H. J. Barnes, C. W. Beard, L. R. \nMcDougald, and Y. M. Saif, eds. Iowa State University Press, Ames, Iowa. pp. 179 -190. 1997.  \n3. Chen, X., J. K. Miflin, P. Zhang, and P. J. \nBlackall. Development and application of DNA probes \nand PCR tests for Haemophilus paragallinarum\n. Avian \nDis. 40:398 -407. 1996.  \n \nPRESENCIA DE HAEMOPHILUS PARAGALLINARUM  NAD \nINDEPENDIENTE EN M\u00c9X ICO  \n \nTHE PRESENCE OF NAD-INDEPENDENT HAEMOPHILUS \nPARAGALLINARUM IN MEXICO  \n \n1 Alejandro Garc\u00eda F., 2 Patrick Blackall., 3Enrique A ngulo \n \n1Laboratorios Avilab., 2Department of Primary Industries Queensland Australia., 3Cl\u00ednico de campo.  \n \nSUMMARY  \nNAD- independent H. paragallinarum causes \ninfectious coryza in poultry. This disease is \neconomically important. Mexican strains of this patho gen were identified using polymerase chain \nreaction (PCR) and biochemical tests. When \nsusceptible birds were inoculated with these isolates, \nthey developed typical infectious coryza. Two serovars \nwere identified in accordance with Page\u2019s \nclassification, i. e.: B (PUMA), and C (AZUL y ORO). \nSerovar C has only been reported in South Africa and \nnow in Mexico. Serovar B had not been reported in the \nworld before. This is the first report of serovar B (PUMA) of NAD -independent H. paragallinarum.  \n \nRESUMEN  \nHaemophi lus paragallinarum NAD independiente \ncausa Coriza Infecciosa aviar,  siendo esta de importancia  econ\u00f3mica. Mediante PCR y bioqu\u00edmicas \nse identificaron dos cepas mexicanas de Haemophilus \nparagallinarum NAD independientes. Cuando estas se \ninocularon en aves  susceptibles, se presento el cuadro \ncaracter\u00edstico de Coriza.  Se identificaron dos \nserovares de Page, uno de ellos el B (PUMA)  y C \n(AZUL y ORO). El serovar C se ha reportado solo en \nSud\u00e1frica y ahora en M\u00e9xico. No hay reportes en el \nmundo del serovar B, siendo esta investigaci\u00f3n la \nprimera que demuestra la presencia de este serovar de \nHaemophilus paragallinarum  NAD independiente \n(PUMA).  \n \n(El trabaj\u00f3 completo se publicar\u00e1 en la revista Avian \nDiseases ).\n \n \n   \n \n  \n  \n60 PREVALENCIA E IDENTI FICACI\u00d3N DE SEROGRUP OS Y \nSEROVARIEDADES DE HAEMOPHILUS PARAGALLINARUM  EN \nPONEDORAS COMERCIALE S DE POSTURA EN M\u00c9XI CO \n \nPREVALENCE AND IDENTIFICATION OF HAEMOPHILUS \nPARAGALLINARUM SEROGROUPS Y SEROVAR S IN COMMERCIAL \nLAYERS IN MEXICO \n \nMiguel A. M\u00e1rquez A, Juan Luis Garc\u00eda A, y  Pomposo Fern\u00e1ndez B \n                                        \nA Boehringer Ingelheim Vetmedica, Guadalajara, Jalisco, M\u00e9xico, BCentro de Investigaci\u00f3n  y Estudios Avanzados \nen Salud Animal, Facultad de Medicina Veterinaria y Zootecnia. Universidad Aut\u00f3noma del Estado de M\u00e9xico  \nmmarquez@gua.boehringer -ingelheim.com  \n \nSUMMARY  \nTwenty six Mexican suspected isolates of H. \nparagallinarum  obtained from laying hens  were \nserotypified using the hemagglutination inhibition test \nand following Kume\u2019s scheme. Twenty two (84.6%) \nisolates were positive to H. paragallinarum.  Eight \n(36.36%) of these isolates corresponded to serogroup \nA, 8 (36.36%) to serogroup B  and 6 (27.27%) to \nserogroup C. Prevailing serovars were A -1, A-2, B-1, \nand C -2.The considerable increase of Serogroup B is \nremarkable and surprising. In addition to the 22 isolates H. paragallinarum , 3 (11.5%) islolates were identified \nas Pasteurella avium , and one sample (3.8%) was \npositive to Ornythobacterium rhinotracheale . \n \nRESUMEN  \nEmpleando el Esquema de Kume, se \nserotipificaron por medio de la Prueba de Inhibici\u00f3n de \nla Hemoaglutinaci\u00f3n,  veinte y seis aislamientos de \nHaemophilus paragallinarum  (H. pg.) hechos en \nM\u00e9xico, a partir de gallinas en postura. Veintidos de \nellos, fueron positivos a H. pg . (84.6 %), de los cuales , \nocho correspondieron al  Serogrupo A (36.36 %), ocho \nal Serogrupo B (36.36 %) y seis al Serogrupo C (27.27 \n%). Las serovariedades predominantes fueron: A -1, A-\n2, B -1 y C -2. Es remarcable y sorprendente el \nconsiderable aumento de la presencia del Serogrup o B. \nAdem\u00e1s de los veintidos  aislamientos de H. pg ., tres   \naislamientos se identificaron como Pasteurella avium \n(11.5 %) y una muestra result\u00f3 positiva  a \nOrnithobacterium rhinotracheale (3.8%).  \n \nINTRODUCCI\u00d2N  \nLa Coriza Infecciosa\n  (CI) es una enfermedad  \naguda del tracto respiratorio superior de la gallina \ndomestica, ocasionada por el Haemophilus \nparagallinarum (H. pg) . La CI se encuentra \nampliamente distribuida en la avicultura industrial \nmundial. Su impacto econ\u00f3mico es gran importancia ya que provoca un aumento del porcentaje de aves \neliminadas durante el periodo de crianza y desarrollo y \nadem\u00e1s, en gallinas adultas puede disminuir  la \nproducci\u00f3n de huevo entre un 10 y 40 % (4) . \nEl H. paragallinarum , es un microorganismo \ninm\u00f3vil, con tendencia a formar f ilamentos, gram \nnegativo y de tinci\u00f3n bipolar, que puede poseer o no \nc\u00e1psula. El H. pg. requiere de factores de crecimiento \ncomo Nicotinamida Adenina Dinucle\u00f3tido (Factor V). \nSin embargo, desde 1992 se han reportado aislamientos \nde H. pg.  independientes de NAD en Africa del Sur; \ngenerando el temor de que los inmun\u00f3genos elaborados \ncon cepas cl\u00e1sicas de H. pg.  NAD -dependientes no \nconfieran una protecci\u00f3n suficiente (1,2,3). \nA lo largo de los a\u00f1os se han realizado varias \nclasificaciones del H. pg.  basadas en su estructura \nantig\u00e9nica. Page clasific\u00f3 los aislamientos en \nSerogrupos A, B y C  mediante pruebas de aglutinaci\u00f3n \nen placa. Kume, utilizando la t\u00e9cnica de Inhibici\u00f3n de \nla Hemoaglutinaci\u00f3n identific\u00f3 los serogrupos  I, II, III \ny 7 hemoaglutininas  o serovariedades. Una octava y novena serovariedad han sido reconocidas en Australia. \nRecientemente, Blackall propuso una modificaci\u00f3n de \nla clasificaci\u00f3n de Kume, en la cual,  se utiliza en \nprimera instancia la clasificaci\u00f3n de Page en base de \nSerogrupos y poste riormente en orden progresivo, a las \n9 hemoaglutininas identificadas hasta ahora, ordenadas de la siguiente manera  : A1, A2, A3, A4; B1; C1, C2, \nC3 y C4.  Esta nueva clasificaci\u00f3n es muy flexible y \npr\u00e1ctica, ya que permite la incorporaci\u00f3n de nuevas \nhemoag lutininas.  \nDebido a que las bacterinas absorbidas en \nhidr\u00f3xido de aluminio \u00f3 emulsionadas en aceite, actualmente empleadas en el campo incluyen los serogrupos  A, B y C de Page de H. pg.  m\u00e1s \ncom\u00fanmente identificados a nivel internacional, y a \npesar de que se ha reportado inmunidad cruzada entre \nlos serogrupos A y C con el serogrupo B,  a este \u00faltimo  \nse le considera un serogrupo emergente\n   bajo la  \n  \n61 sospecha de poseer subtipos, ya que se ha encontrado \nen algunos pa\u00edses ( Africa del Sur, Alemania, \nArgentina y M\u00e9xico) con incidencia y prevalencia \ncrecientes (2,3) . Por esta raz\u00f3n se consider\u00f3  relevante, \nrealizar un estudio epizotiol\u00f3gico para determinar los serogrupos y las serovariedades prevalentes, en casos \nrecientes de CI, en las principales explotaciones  de \ngallinas de postura  de diversas zonas av\u00edcolas de \nM\u00e9xico; adem\u00e1s de, evaluar la posibilidad de agregar \ncepas locales a las vacunas existentes para obtener una \nmayor protecci\u00f3n  \n \nOBJETIVOS  \n1. Identificar la presencia de H. paragallinarum  \nen distintas \u00e1r eas    geogr\u00e1ficas     de M\u00e9xico a partir de   \ncuadros cl\u00ednicos corizoides, observados en gallinas con  signolog\u00eda respiratoria y baja de producci\u00f3n, \nobservados a lo largo del 2000 y del 2001.  \n2.  Determinar el serogrupo y la serovariedad de \nlos aislamientos obtenidos durante el presente estudio.  \n  \nMATERIAL Y M\u00c9TODOS  \n Los espec\u00edmenes objeto de este estudio, fueron \nremitidos para su estudio al Centro de Investigaci\u00f3n y \nEstudios Avanzados en Salud Animal  (CIESA) de la Facultad de Medicina Veterinaria y Zootecnia de la \nUniversidad Aut\u00f3noma del Estado de M\u00e9xico  \n \nMATERIAL BIOL\u00d3GICO  \nCepas bacterianas .- Se utilizaron las cepas de \nreferencia 221,  2403, HP -  14 ; 2671 ; H-18 , Modesto, \nSA - 3 y HP - 60, correspondientes a los serovares  A -\n1,  A -2, A-3, A-4 ; B-1 ; C-1, C-2, C-3 y C -4  de H, \nparagallinarum , respectivamente. Dichas cepas fueron \nfacilitadas al MVZ Pomposo Fern\u00e1ndez Rosas  con \nfines de investigaci\u00f3n  por el Dr. Patrick  J. Blackall \ndel Animal Research Institute, Queensland Department \nof Primary Industri es, Agency for Food and Fibre \nSciences,  Yeerongpilly, Queensland , 4105, Australia  \n Se estudiaron veinte y seis muestras procedentes \nde diferentes parvadas de gallinas ponedoras presentando cuadros corizoides.  \nMedios de cultivo .- Se utiliz\u00f3 Agar Sangre (1 0% \nsangre de ovino) para el aislamiento de H. paragallinarum , y  Staphylococcus epidermis como \ncolonia nodriza. Se emple\u00f3, adem\u00e1s, el medio TM/SN reportado por Blackall et al. 1990  \nAntisueros .- Los antisueros correspondientes a \nlas cepas de referencia fuer on obtenidos del CIESA.  \nLos eritrocitos fijados con glutaraldeh\u00eddo, se prepararon de acuerdo con la t\u00e9cnica descrita por Blackall et al.. 1990.  \nElaboraci\u00f3n de las hemoaglutininas .- Cultivos  \nen TM/SN de 24 hs. de cada cepa de referencia y los aislamientos  de H. paragallinarum  fueron lavados y \nsuspendidos en una soluci\u00f3n de tiocianato de potasio. La soluci\u00f3n fue ajustada a una densidad \u00f3ptica de 1.6 a \n650 nanometros, equivalente a 1 x 10\n10 bacterias / ml y \nsonicada por 30 segundos (60% de pulsos de salida).  El \npaquete bacteriano fue lavado con PBS resuspendido a una densidad \u00f3ptica de 1 x 6 a 650 nanometros \n(Blackall et al, 1990)  \nPrueba de la Hemoaglutinaci\u00f3n .- La actividad \nhemoaglutinante de cada cepa de referencia y aislamiento se determin\u00f3 mediante diluciones dobles \nseriadas en PBS. Se adicionaron  vol\u00famenes iguales de \nla suspensi\u00f3n de eritrocitos al 1%. Despu\u00e9s de la \nincubaci\u00f3n por 30 minutos, el t\u00edtulo de unidades \nhemoaglutinantes (UH) fue le\u00eddo como el rec\u00edproco de \nla diluci\u00f3n m\u00e1xima que mostr\u00f3 completa  \nhemoaglutinacion (Blackall et al, 1990).  \nEliminaci\u00f3n de las hemoaglutininas \ninespec\u00edficas .- Para la eliminaci\u00f3n de la \nhemoaglutininas inespecificas se utiliz\u00f3 una suspensi\u00f3n de eritrocitos fijados con glutaraldeh\u00eddo al 10%.  \nAbsorci\u00f3n de antisueros .- La ab sorci\u00f3n de \nantisueros de las cepas de referencia se realiz\u00f3 \ndiluyendo estos, en 1:40 en PBS y la hemoaglutinina \nfue ajustada a 64 UH y el volumen fue cinco veces el \ndel suero a absorver, la hemoaglutinina fue ajustada y centrifugada y se elimin\u00f3 el sobrenadante. El paquete \nbacteriano (hemoaglutinina) fue resuspendido en el \nantisuero a absorber. La suspensi\u00f3n fue mantenida \ndurante dos horas a temperatura ambiente y doce horas \na 4 \n0 C. La suspensi\u00f3n fue centrifugada y el \nsobrenadante, ya como antisuero absorb ido, fue \nconservado en congelaci\u00f3n hasta su utilizaci\u00f3n.  \nAsignaci\u00f3n de los aislamientos a los serogrupos \nde Kume .- Se llevo a cabo con los antisueros sin \nabsorber, mediante la Prueba de la Inhibici\u00f3n de la Hemoaglutinaci\u00f3n. La asignaci\u00f3n de la hemoaglutini na \nde un aislamiento a su correspondiente serogrupo, fue \nrealizada  considerando el titulo m\u00e1s alto de \nanticuerpos inhibidores de la hemoaglutinaci\u00f3n,  \nmostrado en las columnas o filas de los antisueros \npertenecientes a los serogrupos  A, B \u00f3 C (Blackall et \nal, 1990)  \nAsignaci\u00f3n de los aislamientos a las \nserovariedades de Kume. -  Se realiz\u00f3 con los \nantisueros previamente absorbidos, mediante la Prueba de Inhibici\u00f3n de la Hemoaglutinaci\u00f3n . La asignaci\u00f3n \nde la hemoaglutinina de un aislamiento a su correspondi ente serovariedad, fue realizada \nconsiderando el titulo m\u00e1s alto de anticuerpos inhibidores de la hemoaglutinaci\u00f3n, mostrado en las \ncolumnas o filas del antisuero absorbido.  \n \nRESULTADOS  \nBacteriolog\u00eda ..- De los 26 casos/aislamientos \nestudiados, se obtuvier on los siguientes resultados.  \nDos casos fueron positivos a m\u00e1s de un \nmicroorganismo.   \n  \n62 Veinte y dos muestras fueron positivas a H. \nparagallinarum  ( 84.6%).  \nTres aislamientos se identificaron como \nPasteurella avium  (11.5%).  \nUna muestra result\u00f3 ser positiva a \nOrnithobacterium rhinotracheale . (3.8%)  \nSerolog\u00eda  de los veinte y dos aislamientos de \nH. paragallinarum  \nDeterminaci\u00f3n del serogrupo .- Ocho \naislamientos correspondieron al  Serogrupo A (36.36 \n%) , ocho al Serogrupo B (36.36 %), seis al Serogrupo \nC (27.27 %).   \nDeterminaci\u00f3n de la serovariedad .- Siete \naislamientos se identificaron como serovariedad A -1,  \nuno como A -2 , cinco como B -1, seis como C- 2 \n \nDISCUSI\u00d3N  \n1.  Los resultados de la serotipificaci\u00f3n de veinte \ny seis  aislamientos  de H. paragallinarum  obtenidos \nde  diferentes regiones de la Rep\u00fablica Mexicana, muestran que  las serovariedades predominantes  son:  \nA-1, A -2 ; B-1 y  C -2, de manera similar a los \nresultados obtenidos por Soriano et al, 2001 (4), quien \nidentific\u00f3  las mismas serovariedades.  Desde  otro \npunto de vista los resultados obtenidos en este trabajo muestran  que la  serovariedad A -1 es la m\u00e1s frecuente, \nseguida de la C -2 y en menor proporci\u00f3n  la \nserovariedad B -1.  \n \nCONCLUSIONES  \nLos brotes de Coriza Infecciosa ocurridos en \nparvadas inm unizadas con bacterinas bi o trivalentes, \npodr\u00edan estar siendo ocasionados por serovariedades de \nH. paragallinarum,  que no est\u00e1n contenidas en los \ninmun\u00f3genos utilizados.  Los resultados obtenidos en el presente estudio, \nmuestran la necesidad de realizar un   diagn\u00f3stico \nbacteriol\u00f3gico y bioqu\u00edmico preciso, tomando en \ncuenta que existen otras agentes bacterianos  \nmorfol\u00f3gicamente similares, como es el caso del \nHaemophilus spp, Ornithobacetrium  rhinotracheale  y \nPasteurella spp \n  \nRECOMENDACIONES  \nSe recomienda continuar con  la b\u00fasqueda de  \naislamientos de H. paragallinarum , con el fin de \ndefinir la  prevalencia de las distintas serovariedades presentes en M\u00e9xico y en el Continente Americano. Sugerimos, asimismo, continuar con este estudio \nempleando pruebas de B iolog\u00eda Molecular, que \npermitan un conocimiento mas detallado del agente \ncausal .  \n  \nREFERENCIAS  \n1. Blackall, P. J. (1989). The Avian \nHaemophili. A review. Clin Microbiol Review. 1989; \n2: 270- 277..  \n2. Horner, R. F., Bishop, G. C., & Haw, C. \n(1992). An upper respi ratory disease of commercial \nchickens resembling infectious coriza, but caused by a \nV-factor independent bacterium. Avian Pathology. 21: \n421-427 \n3. Mouahid, M., Bisgaard, M., Morley, A. J.,  \nMutters, R. & Mannheim, W. (1992) Occurrence of V -\nfactor (NAD) indep endent strains of Haemophilus \nparagallinarum . Veterinary Microbiology. 31:363- 368. \n4. Soriano, V. E., P.J. Blackall, S.M. Dabo, G. \nTellez; G.A. Garc\u00eda Delgado, and R.P. Fern\u00e1ndez. \nSerotyping of  H. paragallinarum  isolates from M\u00e9xico \nby the Kume Hemagglutinin Scheme. Avian Dis \n45:680- 683.\n \nAN EMERGING IMMUNOTYPE (VARIANT TYPE B) OF \nHAEMOPHILUS PARAGALLINARUM : SEROTYPING AND \nVACCINATION- CHALLENGE EXPERIMENTS  \n \nUN NUEVO INMUNOTIPO (TIPO VARIANTE B) DE HAEMOPHILUS \nPARAGALLINARUM: SEROTIPIFICACI\u00d3N Y EXPERIMENTOS DE \nVACUNACI\u00d3N Y DESAF\u00cdO  \n \nAnton A. C. Jacobs, Karin vd Berg and Aris Malo  \n \nIntervet International BV, P.O. Box 31, 5830 AA Boxmeer, The Netherlands  \n  \nRESUMEN  \nHemos probado varios aislamientos de \nHaemophilus paragallinarum  procedentes de brotes de \ncoriza en p arvadas bien vacunadas en Ecuador, Argentina, Estados Unidos y Zimbabwe. La mayor\u00eda de \nlos aislamientos apareci\u00f3 como intipificable ante la \nprueba de inhibici\u00f3n de la hemaglutinaci\u00f3n, en \nocasiones mostrando alg\u00fan nivel de reacci\u00f3n cruzada  \n  \n63 con el serotipo B . Las bacterinas comerciales \ntrivalentes que existen en el mercado no protegieron \ncontra el desaf\u00edo con dichas cepas. En contraste, una \nvacuna experimental tetravalente con adyuvante oleoso \nque conten\u00eda una de las cepas intipificables (variante \ntipo B) par eci\u00f3 ser inmunog\u00e9nica despu\u00e9s de una \nvacunaci\u00f3n contra todos estos aislamientos de campo y \ncontra las cepas de los serotipos A, B y C. En \nconclusi\u00f3n, se confirm\u00f3 la existencia de una nuevo \ninmunotipo (tipo variante B) de H. paragallinarum  y \nparece que una vacuna tetravalente con adyuvante \noleoso es la mejor opci\u00f3n en la batalla contra estos \nnuevos aislamientos de campo.  \n \nABSTRACT  \nOutbreaks of Infectious Coryza are reported from \ndifferent countries despite routine vaccination against \nthis disease. This could  be an indication that new \nserotype(s) of Haemophilus paragallinarum  have \nevolved. In our experiments, several field isolates from vaccinated flocks were tested. These included strains \nfrom Ecuador (3 strains), Argentina (2 strains) the \nUnited States (1 strain), and Zimbabwe (1 strain). \nExcept for one Ecuadorian type C strain, all other \nisolates appeared untypable in the hemagglutination \ninhibition (HI) test, sometimes showing some level of \ncross- reaction to serotype B of H. paragallinarum . \nThis suggests th at these strains may be considered \nvariants of such serotype and most probably constitute \na new immunotype. Existing inactivated commercial \ntrivalent vaccines did not protect against challenge with these strains. In contrast, an experimental tetravalent \noil adjuvant vaccine, containing one of the untypable \n(variant type B) strains, appeared immunogenic after \none vaccination against all isolates. The efficacy of the \nnew experimental tetravalent vaccine was further tested \nin layer chickens under field conditi ons. Layer \nchickens were vaccinated in the rearing period at 8w \nand at 16w of age or were left unvaccinated. \nVaccinates and controls were challenged with type A, \nB, C and variant type B at 25 or 45 weeks of age. After \nthe challenges good protection was found against all \nfour immunotypes.  \nSimilar variant type B strains have been described \npreviously by Terzolo et al (Avian Pathol. 26:365- 376. \n1997) who tested strains from Argentina. These authors \nalso indicated that existing commercial vaccines were \nnot eff ective against the local isolates. The fact that we \nisolated similar strains in other South -American \ncountries as well as in the USA and Zimbabwe \nindicates that the variant strains are emerging and \nspreading and have reached the North -American and \nAfrican continent. In conclusion, the existence of a \nnew emerging immunotype (variant type B) of H. paragallinarum  was confirmed and a tetravalent (oil \nadjuvant) vaccine including variant type B seems to be \nthe best choice in the battle against the new field \nisola tes. \n \n(A full report of the study will be submitted to Avian \nPathology ).\n \nCORIZA INFECCIOSA,  INMUNIDAD Y RESISTENCIA \nBACTERIANA A LOS ANTIBI\u00d3TICOS  \n \nINFECTIOUS CORYZA (CI): IMMUNITY AND BACTERIAL  \nANTIBIOTIC RESISTANCE  \n \nEnrique Gonz\u00e1lez E., Daniel Marrufo V ., Eduardo Lucio D.  \n \nInvestigaci\u00f3n Aplicada S.A. de C.V. Tehuac\u00e1n Pue. M\u00e9xico . \n \nSUMMARY  \nCI outbreaks were reported in an egg -producing \ncompany in Mexico starting at week 20, and for up to 3 different occasions prior to production peak. As a \ncomplicating f actor of these outbreaks, Haemophilus \nparagallinarum isolates were resistant to the majority \nof the antibiotics tested. In an attempt to correct the problem, bacterins containing serotypes A, B, and C of \nH. paragallinarum were prepared. Different adjuvant \ncombinations were assayed. Once the best bacterin was \nselected, birds were immunized. Together with a decreased incidence of the outbreaks, a higher bacterial sensitivity to antimicrobials was also observed.  \n \nRESUMEN  \nEn una empresa productora de Huevo en M\u00e9xico, \nse reportaron brotes de Coriza Infecciosa (CI)  desde la semana 20 y hasta en tres ocasiones antes o despu\u00e9s de \nllegar al pico de producci\u00f3n, la agravante de estos \nbrotes fue que los aislamientos de Haemopilus \nparagallinarum (H.paragallinarum)  eran  resistentes a \nla mayor\u00eda de los antibi\u00f3ticos probados . Para corregir \nel problema se elaboraron bacterinas conteniendo los  \n  \n64 serotipos A, B y C de H. paragallinarum ensay\u00e1ndose \ndiferentes combinaciones de adyuvantes. Una vez \nelegida la mejor bacterina, se in munizaron las aves y \njunto con la disminuci\u00f3n de los brotes, se observ\u00f3 \nmayor susceptibilidad bacteriana a los antibi\u00f3ticos.  \n \nINTRODUCCI\u00d3N  \nEn una empresa productora de huevo para plato \nde la zona centro de M\u00e9xico se reportaron brotes de \n(CI) recurrentes qu e se presentaban desde la semana 20 \nde edad, repiti\u00e9ndose hasta en tres ocasiones antes de \nllegar al pico de producci\u00f3n o despu\u00e9s del mismo, con \nla agravante de que las bacterias aisladas como H. paragallinarum mostraron una resistencia del 98% a \nlos antib i\u00f3ticos utilizados en los antibiogramas \nempleados en el laboratorio (cuadro 1).  \nEn nuestra propia experiencia observamos que la \nresistencia bacteriana hac\u00eda que las aves no respondieran adecuadamente a los  tratamientos, siendo necesario medicar hasta 10 o  15 d\u00edas para tener \nresultados aceptables. En la empresa en la que se \nrealiz\u00f3 el estudio se consideraban \u201ceficaces\u201d los \nbiol\u00f3gicos contra (CI) utilizados, sin embargo con la \npresencia de los brotes se tuvieron que analizar nuevas \nf\u00f3rmulas de productos biol \u00f3gicos que pudieran servir \npara solucionar la problem\u00e1tica de la empresa desde el \npunto de vista inmunol\u00f3gico, y que al mismo tiempo \npermitiera reducir la necesidad de tratamiento con antibi\u00f3ticos y/o hacerlos m\u00e1s eficientes.  \nEn un trabajo previo se ensay aron tres bacterinas \ncontra H. paragallinarum  conteniendo los serotipos \nABC en combinaciones de aceite, aceite con un \nadyuvante oleoso especial de Investigaci\u00f3n Aplicada \nS.A. (IASA) y otra elaborada con el adyuvante oleoso \nespecial sin aceite.  \nComo result ado de esa evaluaci\u00f3n se observ\u00f3 que \nla mejor combinaci\u00f3n fue la de aceite con adyuvante especial y se dio inicio a un programa de inmunizaci\u00f3n \ncon el fin de evaluar la respuesta inmune y la respuesta \na los tratamientos que permitiera evitar el uso \nindiscr iminado de antibi\u00f3ticos.  \nTomando en cuenta que la bacterina contra (CI) \nutilizada hasta ese momento era elaborada con \naislamientos de H.  paragallinarum serotipos A y C \nemulsionados, \u00e9sta se compar\u00f3 con la bacterina \nemulsionada elaborada con los serotipos ABC y el \nadyuvante especial de IASA.  \nMaterial y M\u00e9todo:  se inmunizaron con la \nbacterina contra Coriza infecciosa Coribact ABC \nalrededor de tres millones de aves en un per\u00edodo de un \na\u00f1o en diferentes granjas de la empresa problema, lo que se reporta en est e estudio es el resultado de \n250,000 aves alojadas en una granja de postura localizada en un n\u00facleo de edades m\u00faltiples en el cual se hab\u00edan tenido brotes complicados de (CI).  Vacunaci\u00f3n: se inmuniz\u00f3 contra (CI)  con 0.5 ml \nde Coribact ABC por la v\u00eda subcut \u00e1nea en la parte \nmedia posterior del cuello a las 4, 10 y 16 semanas de \nedad y se realiz\u00f3 el traspaso de crianza a postura a las \n17 semanas.  \nSerolog\u00eda: se colectaron muestras de suero para \nevaluar la respuesta inmune hacia (CI).  \nAntibiogramas: de los aisla mientos de H. \nparagallinarum  se realiz\u00f3 sensibilidad a antibi\u00f3ticos \nutiliz\u00e1ndose sensidiscos para 14 antibi\u00f3ticos evaluando el halo de inhibici\u00f3n producido por los mismos, \ncatalog\u00e1ndolos como Sensibles (S)  Moderados (M)  y \nResistentes (R).  \n \nRESULTADOS  \nUn a\u00f1o despu\u00e9s de iniciado el programa de \ninmunizaci\u00f3n con la bacterina de IASA, a\u00fan se \nobservan brotes de (CI) pero ahora se presentan de una \nforma muy benigna afectando solamente del 10 al 15 % \nde la parvada y la respuesta a los antibi\u00f3ticos es r\u00e1pida \nfluctuando entre 24 y 72 hrs. En ese tiempo se observa \nuna franca mejor\u00eda de las aves seguida del control total \nde la enfermedad, tambi\u00e9n los aislamientos de (CI) se \nhan vuelto sensibles a la mayor\u00eda de los antibi\u00f3ticos 71.4% (cuadro 1) facilitando el tratamie nto y haciendo \nposible que el huevo llegue al consumidor final con la \ncalidad que marcan las normas de salud.  \n \nDISCUSI\u00d3N  \nCuando se logra un esquema de inmunizaci\u00f3n \nefectivo, se obtienen mejores par\u00e1metros productivos y \nse reduce considerablemente la necesi dad de utilizar \nantibi\u00f3ticos que lejos de solucionar efectivamente los \nproblemas, coadyuvan en el fomento de la resistencia \nbacteriana, el incremento de los costos de producci\u00f3n y \nponen riesgo la salud de los consumidores. Como observaci\u00f3n de campo se apre cia que cuando se \nestablece una buena inmunidad y las aves responden \nadecuadamente al desaf\u00edo, la necesidad del uso de \nantibi\u00f3ticos es m\u00ednima y las bacterias presentes en la zona o granja de m\u00faltiples edades tienden a ser \nnuevamente sensibles a los antibi\u00f3 ticos a los que ya \neran resistentes, esto \u00faltimo lo hemos podido observar \nconsistentemente aunque hace falta llevar a cabo \nestudios de mayor profundidad encaminados a entender \nlos mecanismos de resistencia de bacterias como H. paragallinarum.  Con este an\u00e1l isis se pretende hacer \nnotar que ya es tiempo de que en la industria av\u00edcola Mexicana se establezcan nexos entre las estrategias de \ncrianza, desarrollo y producci\u00f3n de las aves y el control \nen el uso de antibi\u00f3ticos ya que, como se pudo observar \nen el pres ente trabajo, el hecho de no contar con \nbacterinas y/o vacunas adecuadas a las necesidades de \nlas aves, repercute negativamente en el uso de los \nantibi\u00f3ticos, en los costos de producci\u00f3n y en la salud \nde los consumidores. El costo m\u00e1s alto de no tomar  \n  \n65 acciones preventivas puede darse si el consumidor o el \ncomercializador se niegan a comprar productos con \nresiduos antibi\u00f3ticos.  \n      \nCONCLUSI\u00d3N  \nEn este experimento el uso de la bacterina \nCoribact ABC con el adyuvante especial otorg\u00f3 los \nsiguientes beneficios:  \n\u2022 Reducci\u00f3n en el n\u00famero de brotes \nsufrido por cada parvada.  \u2022 Disminuci\u00f3n del % de aves afectadas \ndurante el desaf\u00edo as\u00ed como el nivel de lesiones.  \n\u2022 Amplia reducci\u00f3n del uso de antibi\u00f3ticos con el consecuente ahorro econ\u00f3mico.  \n\u2022 Cepas de (CI) aisladas un a\u00f1o despu\u00e9s de \nla misma zona que las resistentes del \ncuadro 1 mostraron una  mayor susceptibilidad a los antibi\u00f3ticos.  \nCuando se presentaron los brotes, se observ\u00f3 una \nrespuesta r\u00e1pida y efectiva de las aves al tratamiento.\n Comportamiento de campo de las dos ba cterinas probadas y resultado de los antibiogramas antes y despues del \nuso de las mismas.  \nBacterina vs. \nCoriza  \nSerotipos A y \nC. a\u00f1o 2000  Bact. IASA vs. \nCoriza  serotipos \nABC+ adyuvante \nespecial. a\u00f1o 2001   \nAntimicrobian\no \n  \nAntibiograma   \n06/2000 **   \nAntibio grama  \n12/2001 ***  \nNo. \nbrotes/parvada  No. \nbrotes/parvada   H. \nparagallinarum*  H. \nparagallinarum*  \n3 1 Ac. Nalidixico  R R \n  Amoxicilina  R S \n% de aves \nafectadas  % de aves \nafectadas  Ampicilina  R R \n70-80 en cada \nbrote  10-15 una sola \nvez Ceftiofur  R R \n  Enrofloxacina  R S \nResp. al \ntratamiento.  Resp. al \ntratamiento  Fosfomicina  R S \nMala 10 -15 \nd\u00edas Buena 24 -72 \nhrs. Furazolidona  R S \n  Linco+Especti\nno. R S \nResp. \nserol\u00f3gica  Resp. \nserol\u00f3gica  Gentamicina  R S \nRegular MG \n10 Buena MG 20  Florfenicol  R S \n  Nitrofu razona  R S \nInadecuado  \ntiempo  de \nretiro de \nAntibi\u00f3ticos / \nhuevo.  Adecuado  \ntiempo de \nretiro de \nAntibi\u00f3ticos / \nhuevo.  Penicilina  R R \nAlto (1)  Muy bajo / \nnulo (1)  Tetraciclina  M S \n  Sulfa+trimetop\nrim R S \n*Interpretaci\u00f3n: S= Sensible.  M= Moderado.  R= Res istente.  \n** Aislamiento de H. paragallinarum  antes del cambio de bacterina.  \n*** Aislamiento de H. paragallinarum  despu\u00e9s del cambio de bacterina.  \n \nREFERENCIAS  \n1. Sumano L\u00f3pez, H., y L. Ocampo Camberos \n1987. Farmacocinetica comparativa de tres combinaciones  de sulfonamidas + trimetoprim en \npollas Leghorn sanas y en pollas con Coriza Infecciosa. Vet. M\u00e9xico 18:21 \u2013  26. \n  \n  \n66 REVISION CRITICA DE LA CORIZA INFECCIOSA  \n \nINFECTIOUS CORYZA: A CRITICAL REVIEW  \n \nFern\u00e1ndez RP1, Longinos GM1, Vel\u00e1squez QE1 y VE Soriano2 \n \n1Centro de Investigaci\u00f3n y Estudios Avanzados en Salud Animal, FMVZ -UAEM. Toluca 50000, M\u00e9xico.  \n2Departamento de Investigaci\u00f3n y Desarrollo Av\u00edcola, Bios\u00edntesis Laboratorios SA. Toluca 50130, M\u00e9xico.  \n \nSUMMARY  \nThis paper refers to the most recent publication s \non infectious coryza and its causative agent, H. \nparagallinarum . It critically reviews recently identified \naspects related with both pathogenicity mechanisms \nand virulence factors. Similarly, the serological typing \nschemes of H. paragallinarum  are correl ated with the \nbiologic products used in the prevention of the disease. \nDespite the technological progress, the advantages of \nthe traditional identification of the bacterium are \nmentioned.  \n \nRESUMEN  \nEl presente trabajo aborda las publicaciones m\u00e1s \nrecientes concernientes con la coriza infecciosa y el \nagente causal, H. paragallinarum . Revisa de manera \ncr\u00edtica los aspectos relacionados con los mecanismos \nde patogenicidad y factores de virulencia recientemente \nidentificados. Asimismo, se relacionan los esquemas de \nserotipificaci\u00f3n de este agente con los productos biol\u00f3gicos empleados para la prevenci\u00f3n de esta \nenfermedad. No obstante el avance tecnol\u00f3gico, se \nmencionan las ventajas de la identificaci\u00f3n tradicional de H. paragallinarum . \n \nINTRODUCCI\u00d3N  \nLa coriza inf ecciosa (CI) es una enfermedad \nreconocida por el alto impacto en la industria av\u00edcola al nivel mundial (4). En M\u00e9xico, se presenta de forma \nenzo\u00f3tica en zonas av\u00edcolas densamente pobladas. Se \nha registrado retraso del crecimiento y p\u00e9rdida de peso en pollo  de engorda, incrementando la edad de salida al \nmercado. De forma similar, en gallinas de postura se ha \ninformado una reducci\u00f3n en la producci\u00f3n de huevo de \nm\u00e1s del 50%.  \nPropiedades bioqu\u00edmicas.  Las reacciones de \ncatalasa y oxidasa, negativa y positiva res pectivamente, \nson caracter\u00edsticas uniformes en H. paragallinarum . En \nun estudio que incluy\u00f3 40 aislamientos de  H. \nparagallinarum  obtenidos de casos cl\u00ednicos en M\u00e9xico, \ntodos los aislamientos produjeron \u00e1cido a partir de glucosa y manosa, pero no de galacto sa, lactosa, \ntrehalosa y xilosa.  La producci\u00f3n de \u00e1cido a partir de \nmanitol, maltosa y sucrosa fue variable, lo que permiti\u00f3 \nel reconocimiento de 4 biovares bioqu\u00edmicos (7).  Clasificaci\u00f3n serol\u00f3gica.  Page en 1962 (13), \nidentific\u00f3 los serovares A, B y C mediante la prueba de \naglutinaci\u00f3n en placa. Posteriormente, Kume et al. , \n(11) identificaron 7 serovares empleando la prueba de \ninhibici\u00f3n de la hemoaglutinaci\u00f3n (IH). Con base en el \nempleo de esta prueba es posible identificar los tres \nserovares de Page. Co n la identificaci\u00f3n de dos nuevos \nserovares, Blackall et al.  (3) combinaron los esquemas \nde serotipificaci\u00f3n anteriores, quedando de la siguiente \nmanera: A -1 a A -4, B-1 y C -1 a C -4. Con base en este \nesquema, se han reconocido los serovares A -1, B-1 y \nC-2 en Estados Unidos de Am\u00e9rica; A -4, C-2 y C -4 en \nAustralia; A -1, B-1, C-2 y C -3 en Sud\u00e1frica; A -1 y C -1 \nen Jap\u00f3n; A -3 en Brasil y, A -1, A -2, B -1 y C -2 en \nAlemania y M\u00e9xico (16).  \nPatogenia.  Bacterias de H. paragallinarum \ncarentes de ant\u00edgenos hemoaglutinantes  no fueron \ninmunog\u00e9nicas  y no produjeron signos cl\u00ednicos de CI \nen aves desafiadas (19). Con base en la consideraci\u00f3n \nde que la adherencia bacteriana es el primer paso en el \nproceso de infecci\u00f3n,  Fern\u00e1ndez et al.  (8) demostraron \nla adherencia  in vitro  de  H. paragallinarum  a c\u00e9lulas \nepiteliales traqueales de pollo. En un estudio posterior, las ant\u00edgenos hemoaglutinantes (hemoaglutininas) se reconocieron como las adhesinas que median esta \nadherencia (12).  \nPor otra parte, se reconocieron que los receptores \ncelulares para las adhesinas de H. paragallinarum  son \nde tipo polisac\u00e1rido en naturaleza, siendo la manosa el \nprincipal componente (14).  \nFactores de virulencia.  Sawata et al.  (15) \nreportaron que la c\u00e1psula es una estructura importante \nen la virulencia de H. paragallinarum . La infiltraci\u00f3n \nde c\u00e9lulas cebadas en pollos inoculados con cepas \ncapsuladas, indica que estas c\u00e9lulas pueden ser las \nresponsables de los signos de coriza por la activaci\u00f3n \nde mediadores farmacol\u00f3gicos.  \nLa resistencia a los antimicrobiano s es \nconsiderado un factor de virulencia importante. En un \nestudio que incluy\u00f3 las nueve cepas de referencia de H. \nparagallinarum y 22 aislamientos de M\u00e9xico, se \nobserv\u00f3 que el 100% de los microorganismos fueron \nresistentes ( \u2265 16 \u00b5/mL) a varias sulfonamidas y \ntrimetoprim, 50% a la amoxicilina, 30% a la \noxitetraciclina, 15% a la gentamicina y 2% a la \nenrofloxacina. Las concentraciones m\u00ednimas  \n  \n67 inhibitorias fueron obtenidas mediante la t\u00e9cnica de \nmicrodiluci\u00f3n en caldo. Se desconoce si las diferencias \nen la resistencia son debidas a pl\u00e1smidos (18).  \nUn aspecto relevante en la biolog\u00eda de H. \nparagallinarum  es la identificaci\u00f3n de cepas \nindependientes del NAD (dinucle\u00f3tido de adenina \nnicotinamida). Estudios posteriores mostraron que esta caracter\u00edstica est\u00e1 mediad a por pl\u00e1smidos y que pueden \nser conferidos a cepas dependientes del NAD (6).  \nInmunogenicidad.  Como se mencion\u00f3 \nanteriormente, las hemoaglutininas son los principales \nant\u00edgenos inmunog\u00e9nicos de H. paragallinarum , que \ninducen la producci\u00f3n de anticuerpos IH . Kume et al.  \n(10) mostraron que t\u00edtulos s\u00e9ricos de anticuerpos IH mayores a 1:20 confirieron protecci\u00f3n en pollos \ndesafiados de forma hom\u00f3loga. En un estudio realizado \npor este grupo de investigaci\u00f3n, se mostr\u00f3 que los \nanticuerpos IH presentes en suero y en lavados \ntraqueales, inhibieron la adherencia in vitro  a c\u00e9lulas \nepiteliales traqueales de pollo (12). Este estudio \nmuestra que los anticuerpos s\u00e9ricos IH act\u00faan como \nanticuerpos neutralizantes de las adhesinas de H. \nparagallinarum . \nDiagn\u00f3stico.  No obsta nte el avance tecnol\u00f3gico, \nel aislamiento bacteriol\u00f3gico sigue siendo la \nherramienta m\u00e1s importante, ya que permite la \nmanipulaci\u00f3n del agente con fines de estudios \nantig\u00e9nicos y serol\u00f3gicos, que pueden guiar en el empleo de productos biol\u00f3gicos. La prueba  de la \nreacci\u00f3n en cadena por la polimerasa (PRC), es la prueba mas r\u00e1pida y espec\u00edfica para la identificaci\u00f3n de H. paragallinarum , tanto de cepas independientes del \nNAD, como dependientes de \u00e9ste. Esta t\u00e9cnica fue \ndesarrollada en China y ha sido transfer ida con \u00e9xito a  \nSud\u00e1frica y M\u00e9xico (2). Con fines de caracterizaci\u00f3n molecular, se han utilizado las pruebas de an\u00e1lisis de \nendonucleasas de restricci\u00f3n, ribotipificaci\u00f3n y ERIC -\nPCR (1).  \nEl diagn\u00f3stico diferencial de la CI debe realizarse \nprincipalmente c on otras enfermedades respiratorias de \norigen bacterianao. Bragg et al, (5) report\u00f3 el aislamiento de Pasteurella avium  y P. volantium  a \npartir de brotes corizoides en pollos de engorda. Estas \nbacterias se consideraban como agentes no patog\u00e9nicos \npara las aves. De forma similar, debe considerarse como diferencial la infecci\u00f3n por Ornithobacterium \nrhinotracheale , el cual se ha reportado como causante \nde un cuadro corizoide con mortalidad significativa en pollos.  \nInmunizaci\u00f3n.  B\u00e1sicamente, en el mercado \ninternacional existen productos biol\u00f3gicos que \ncontienen los serovares A y C (bivalentes) y los serovares A, B y C (trivalentes). Jacobs et al.  (9) \nmostraron que bacterinas bivalentes administradas en \npollos, no confirieron protecci\u00f3n cruzada ante el \ndesaf\u00edo co n una cepa de H. paragallinarum  perteneciente al serovar B. Sin embargo, en otro \nestudio se mostr\u00f3 una protecci\u00f3n del 100% en aves \ninmunizadas de forma bivalente y desafiadas con una \ncepa del serovar B (17). Con base en estas \ndiscrepancias, la investigaci\u00f3 n de este grupo est\u00e1 \nenfocada en la determinaci\u00f3n del grado de protecci\u00f3n cruzada entre los nueve serovares hemoaglutinantes del esquema de Kume. En este sentido, la prueba de IH \npuede ser la principal herramienta para la evaluaci\u00f3n \ndel estado inmune humor al en aves inmunizadas con \nestos biol\u00f3gicos.  \nLos resultados obtenidos en las pruebas de \nadherencia in vitro  de H. paragallinarum  a c\u00e9lulas \nepiteliales traqueales de pollo, orientan nuevas \nhip\u00f3tesis en la inmunizaci\u00f3n de aves susceptibles, \nempleando ant\u00edgenos inactivados administrados por la \nv\u00eda nasal.  \n \nREFERENCIAS  \n1. Blackall, P. J. Infectious coryza: overview \nof the disease and new diagnostic options: Clin. \nMicrobiol. Reviews. 12:627- 632. 1999.  \n2. Blackall, P. J. Infectious coryza. Proc. XVII \nCong.. Latinoam. Av icult. Guatemala. pp. 4 -13. 2001.  \n3. Blackall, P. J., L. E. Eaves and D. G. \nRogers. Proposal of a new serovar and altered nomenclature of Haemophilus paragallinarum in the \nKume hemagglutinin scheme. J. Clin. Microbiol. \n28:1185- 1187. 1990.  \n4. Blackall, P. J., M. Matsumoto and R. \nYamamoto. Infectious coryza. In: Diseases of poultry, 10th ed. B.W. Calnek, Beard and Y. M. Saif eds. Iowa \nState University Press, Ames. pp. 179 -190. 1997.  \n5. Bragg, R. R., J. M. Greyling and J. A. \nVerschoor. Isolation and identification of N AD-\nindependence bacteria from chickens with symptoms \nof infectious coryza. Avian Pathol. 26:595- 606. 1997.  \n6. Bragg, R. R., L. Coetzee  and J. A. \nVerschoor. Plasmid -encoded NAD independence in \nsome South African isolates of Haemophilus paragallinarum. Onders.  J. Vet. Res. 60:147- 152. 1993.  \n7. Fern\u00e1ndez, R. P., G. A. Garc\u00eda- Delgado, G. \nP. Ochoa and V. E. Soriano. Characterization of \nHaemophilus paragallinarum isolates from Mexico. \nAvian Pathol. 29:473- 476. 2000.  \n8. Fern\u00e1ndez, R. P., G. A. Garc\u00eda- Delgado, and \nSoriano V. E. Adherence of Haemophilus \nparagallinarum to chicken tracheal epithelial cells. \nProc. Haem., Actino., an Past. Intern. Conf., Acapulco, \nMexico. Pp 51. 1996.  \n9. Jacobs A. A. A., W. Cuenen and P. K. \nStorm. Efficacy of a trivalent Haemophilus \nparagallinarum vaccine compared to bivalent vaccines. \nVet. Microbiol. 32:43 -49. 1992.  \n10. Kume, K., A. Sawata and T. Nakai. \nClearance on the challenge organisms from the upper  \n  \n68 respiratory tract of chickens injected with an \ninactivated Haemophilus paragallinarum vaccine. Jpn.  \nJ. Vet. Sci. 46:843- 850. 1984.  \n11. Kume K., A. Sawata, T. Nakai and M. \nMatsumoto. Serological classification of Haemophilus \nparagallinarum with a hemagglutinin system. J. Clin. \nMicrobiol. 17:958- 964. 1983.  \n12. Longinos, G. M. y G. P. Navarrete. Efecto \nde los anticuerpos inhibidores de la hemoaglutinacion \nsobre la adherencia in vitro de Haemophilus \nparagallinarum a c\u00e9lulas epiteliales traqueales de pollo. \nMVZ Tesis. Universidad Aut\u00f3noma del Estado de \nM\u00e9xico, M\u00e9xico.  2001.  \n13. Page L. A. Haemophilus infections in \nchick ens. I. Characteristics of 12 Haemophilus  isolates \nrecovered from diseased chickens. Am. J. Vet. Res. 23:85- 95. 1962.  \n14. S\u00e1nchez, S. A. efecto del tratamiento de \nHaemophilus paragallinarum con varios carbohidratos y N-acetil -D-glucosamina sobre la adherencia in vitro a \nc\u00e9lulas epiteliales traqueales de polo. MVZ Tesis. \nUniversidad Aut\u00f3noma del Estado de M\u00e9xico, M\u00e9xico. \n2000.  \n15. Sawata, A., T. Nakai, K. Kume, H. \nYoshikawa and T. Yoshikawa. Lesions induced in the respiratory tract of chickens by encapsulated or non -\nencapsulated variants of Haemophilus paragallinarum. Am. J. Vet. Res. 46:1185- 1191. 1985.  \n16. Soriano, V. E., P. J. Blackall, S. M. Dabo, \nG. I. T\u00e9llez, G. A. Garc\u00eda- Delgado and R. P. \nFern\u00e1ndez. Serotyping of Haemophilus paragallinarum isolates from Mexico by the Kume hemagglutinin scheme. Avian Dis. 45:680- 683. 2001a.  \n17. Soriano, V. E., R. P. Fern\u00e1ndez, G. A. \nGarc\u00eda- Delgado y G. P. Ochoa. Evaluaci\u00f3n de sod \nprotocolos de bacterinizaci\u00f3n de gallinas de postura \nmediante detecci\u00f3n de anticuerpos inhibidores de la \nhemoaglutinaci\u00f3n y protecci\u00f3n ante un desaf\u00edo \ncontrolado con Haemophilus paragallinarum. Vet. \nM\u00e9x. 32:145- 148. 2001b.  \n18. Vel\u00e1squez, Q. E. Susceptibilidad in vitro de \naislamientos de Haemophilus paragallinarum a antimicrobianos. MVZ Tesis. Universidad Aut\u00f3noma \ndel Estado de M\u00e9xico, M\u00e9xico. 2002.  \n19. Yamaguchi, T., M. Kobayashi, S. Masaki \nand Y. Iritani. Isolation and characterization of a \nHaemophilus paragallinarum mutant lacks of \nhemagglutinin antigen. Avian Dis. 37970 -976. 1993.  \n \nA PRELIMINARY REPORT  ON A RAPID TES T FOR THE \nDETECTION OF INFECTI OUS BRONCHITIS VIRUS  \n \nREPORTE PRELIMINAR DE UNA PRUEBA R\u00c1PIDA PARA LA DETECCI\u00d3N \nDEL VIRUS DE LA BRONQUITIS INFECCIOSA  \n \nShankar P. Mondal1, Carol Cardona2 \n \n1Comparative Pathology, University of California , DAVIS, DAVIS, CA  95616  \n2Veterinary Medicine Extension, Surge III, Rm. 1383, University of California, Davis, Davis, CA  95616  \n \nRESUMEN  \nEs importante contar con procedimientos \ndiagn\u00f3sticos r\u00e1pidos para el control de la bronquitis \ninfecciosa, enfermedad altamente contagiosa q ue \nrepresenta una amenaza de gran importancia para la \nsustentabilidad de la industria av\u00edcola. En este estudio desarrollamos una prueba r\u00e1pida y sencilla para \ntipificar los aislamientos del virus de la bronquitis \ninfecciosa. Las muestras se amplificaron mediante \nreacci\u00f3n en cadena con polimerasa y transcriptasa \ninversa ( RT-PCR ) en una membrana. Las sondas, \ngeneradas a partir de un panel de diferentes serotipos \ndel virus en regiones selectas del genoma, se \nhibridizaron individualmente a la membrana y se \ndetectaron por colorimetr\u00eda. Usando este m\u00e9todo es \nposible distinguir entre los diferentes serotipos, incluso en reacciones que contienen cepas m\u00faltiples del virus \nde la bronquitis infecciosa.  \nRapid diagnostic procedures are especially \nimportant in controlling  infectious bronchitis, an acute \nand highly contagious disease, and a major threat to the \nsustainability of the poultry industry.  In this study, we \nhave developed a simple and rapid test for typing infectious bronchitis virus  (IBV) isolates.  Samples \nwere amplified with RT -PCR and immobilized on a \nmembrane.  Probes were generated from a panel of \nIBVs of different serotypes in selected regions of the genome.  The probes were then individually hybridized \nto the membrane and detected colorimetrically.  Using  \nthis method, isolates of different serotypes could be \ndistinguished even in reactions containing multiple \nIBV strains.  This method will provide a rapid and \nreliable method of diagnosing field isolates.   \n  \n69 ADVANCES IN DIAGNOSIS OF IBV USING REAL -TIME RT- PCR  \n \nAVANCES EN EL DIAGN\u00d3STICO DE LA BRONQUITIS INFECCIOSA \nUSANDO LA REACCI\u00d3N EN CADENA CON POLIMERASA Y \nTRANSCRIPTASA INVERSA (RT-PCR) DE TIEMPO REAL  \n \nMark W. Jackwood, Deborah A. Hilt, and Scott A. Callison  \n \nPoultry Diagnostic and Research Center, Departmen t of Avian Medicine, College of Veterinary  Medicine  \nUniversity of Georgia, Athens, GA 30602 USA  \n \nRESUMEN  \nSe han desarrollado t\u00e9cnicas moleculares para \nidentificar con rapidez el serotipo de los virus de la \nbronquitis infecciosa involucrados en brotes de enfermedad en las v\u00edas respiratorias altas, para poder \nvacunar adecuadamente a los pollos. El objetivo de esta \ninvestigaci\u00f3n fue desarrollar un m\u00e9todo molecular m\u00e1s \nr\u00e1pido para la identificaci\u00f3n del tipo de vacuna contra \nla bronquitis infecciosa usando la RT -PCR  y la \ntransferencia de energ\u00eda de resonancia de fluorescencia \n(FRET ), que utiliza donadores y sondas de detecci\u00f3n. \nLogramos distinguir entre los tipos Massachusetts y \nArkansas del virus, lo cual refleja una falta de \ncoincidencia de cuatro pares de bases con la sonda de \ndetecci\u00f3n. Las faltas de coincidencia de uno o dos  pares de bases con la sonda de detecci\u00f3n no fueron \ndistinguibles con las sondas y las condiciones del \namortiguador empleadas en este trabajo.  \n \nSUMMARY  \nMolecular techniques have been d eveloped to \nrapidly identify the serotype of infectious bronchitis \nviruses (IBV) involved in an upper -respiratory disease \noutbreak so that the chickens can be properly \nvaccinated. The goal of this research was to develop a more rapid molecular method for i dentification of \nvaccine type IBV using real -time reverse transcriptase -\npolymerase chain reaction (RT -PCR), and fluorescence \nresonance energy transfer (FRET), which utilizes donor and detection probes. We were able to distinguish \nbetween Mass and Ark type viruses, which reflects a 4 \nbase pair mismatch with the detection probe. One or \ntwo base pair mismatches with the detection probe \nwere not distinguishable using those probes and buffer \nconditions.  \nInfectious bronchitis is a highly contagious upper -\nrespirat ory tract disease in chickens that is \ncharacterized by coughing, sneezing, tracheal rales, swollen sinuses, and watery eyes. The disease is caused \nby a group III coronavirus, which is designated \ninfectious bronchitis virus (IBV). Different serotypes of IBV  occur and do not cross protect, making it \nimportant to rapidly identify the serotype of the virus involved in an outbreak so that the birds can be \nproperly vaccinated.  \nMany laboratories including ours have developed \nmolecular techniques to identify IBV. T hose \ntechniques determine molecular type, which correlates \nwith the serotype of the virus. They are based on \nsequence differences located in hypervariable regions \nof the S1 subunit of the spike glycoprotein gene. It has been our experience that most of the  IBV isolates \nobtained from the field are the same type as the viruses \nthat were used to vaccinate the birds. The goal of this \nresearch was to develop a more rapid molecular \nmethod for identification of those vaccine type \ninfectious bronchitis viruses usin g real -time reverse \ntranscriptase -polymerase chain reaction (RT -PCR). \nThe LightCycler\ntm (Roche diagnostics Corporation, \nIndianapolis, IN) is a real -time PCR instrument that \nmeasures the amplified product as it is being produced in the reaction. Detection o f the disease agent and \nidentification of the virus is almost immediate through \nthe use of fluorescent dyes and DNA probes.  \nRT-PCR Product. We designed a set of primers \nthat amplify a 382 base pair product in the \nhypervariable region of the S1 gene of IBV.  That \nprimer set amplified the Beaudette, Mass 41, Ark DPI, Ark 99, GA variant, Mass 41, Beaudette, Conn, Fla \n18288, GA98, Iowa, NE 95, and DE072 strains of IBV \nand a field isolate of IBV designated 18046. Typically \nthe reaction takes about 1 hour to compl ete and 32 \nsamples can be tested in each run. Taking advantage of  \nthe sequence differences between different serotypes of \nIBV in this 382 base pair amplicon, we attempted to \nidentify the above IBV strains using a melting curve \nanalysis. Unfortunately the results were not \nreproducible. Many factors including enzyme activity, \nminor variations in salt concentration, and the amount of PCR product, made it difficult to reproduce the \nresults from one run to the next. Thus, a complete set \nof reference viruses had  to be run each time a field \nvirus was to be identified.  \nFluorescence Resonance Energy Transfer \n(FRET). The FRET technique utilizes two probes; an \nanchor or donor probe, which is conjugated to  \n  \n70 fluorescein, and a detection probe conjugated to a red \nfluoresc ent dye (LightCyclertm Red 640). Fluorescein \non the anchor probe emits a green fluorescent light \nwhen it is excited by the ultra violet light source in the \nLightCyclertm. When that probe comes into close \nproximity with the detection probe, by hybridizing t o \nthe PCR product, energy from the green fluorescent \nlight is transferred to and excites the red dye which \nthen emits light at 640 nm. After each round of \namplification, the probes are allowed to anneal to the \nproduct and the reaction is monitored for ligh t emitted \nby the red dye at 640 nm. Taking into consideration base pair mismatches in the 382 base pair RT -PCR \nproduct, we designed and utilized two probes in a \nmelting curve analysis to identify the presence of \nspecific IBV types. The detection probe was made \nidentical to the Mass sequence. Based on our \npreliminary data, it is possible to distinguish between \nIBV types with as little as 4 base pair mismatches (two A-T and two G -C) with the detection probe. The Mass \ntype virus melting temperature for the per fectly \nmatched probe averaged 38.27 C whereas the Ark type \nmelting temperature was 34.88 C reflecting the 4 base \npair mismatch. However, detection of 1 or 2 A -T \nmismatches (Fla and Conn respectively) was not possible under the current conditions. It should  be \nemphasized that these results are specific for this set of \nprobes and buffer conditions. Other probes and \nstringency conditions may yield more or less sensitive \nresults.  \nThere is a temperature spread of almost 4 C \ndegrees between 0 (Mass) and 4 (Ark) b ase pair \nmismatches. Theoretically, we ought to be able to \ndetect less than a 4 base pair mismatch, however; the \nnumber of hydrogen bonds between A -T and G -C base \npairs are different and important, and need to be \nconsidered along with buffer conditions whe n \nexamining the sensitivity of the assay.  \n \nINACTIVATED VIRUS VACCINATION FOR CONTROLLING THE \nNEPHROPATHOGENIC PA/ WOLGEMUTH/98 STRAIN OF \nINFECTIOUS BRONCHITI S VIRUS  \n \nVACUNACI\u00d3N CON VIRUS INACTIVADO PARA EL CONTROL DE LA CEPA \nNEUROPAT\u00d3GENA PA/WOLGEMUTH/98 DEL VIRUS  \nDE LA BRONQUITIS INFECCIOSA  \n \nJ. Gelb, Jr.A, B. S. LadmanA, C. R. PopeA, A. F. ZieglerB, T. SwieczkowskiC and J. M. CallahanA \n \nADepartment of Animal and Food Sciences, University of Delaware, Newark, DE 19717 -1303  \nBLasher Laboratory, Research and Education Center, University of Delaware, Georgetown, DE 19947  \nCLohmann Animal Health International, Waterville, ME 04903 -0255  \n \nRESUMEN  \nSe evalu\u00f3 la protecci\u00f3n proporcionada por la \nvacunaci\u00f3n con virus inactivado contra el desaf\u00edo con \nun virus virulento nefropat\u00f3geno de la bronquitis \ninfecciosa ( NIBV ). Despu\u00e9s de la primera inmunizaci\u00f3n \ncon vacunas atenuadas, los pollos Leghorn libres de \npat\u00f3genos espec\u00edficos recibieron vacunas en emulsi\u00f3n \noleosa que conten\u00edan cepas Massachusetts y Arkansas \no el aislamiento NIBV  PA/Wolgemuth/98 del virus de \nla bronquitis infecciosa. Ambas vacunas inactivadas indujeron respuestas anamn\u00e9sicas de anticuerpos \ns\u00e9ricos de magnitud similar; no obstante, las aves que \nrecibieron la vacuna aut\u00f3gena PA/Wolgemuth/98 \nestuvieron mejor pr otegidas contra el desaf\u00edo con el \nNIBV  en comparaci\u00f3n con los pollos vacunados con el \nproducto heter\u00f3logo inactivado que conten\u00eda las cepas \nMassachusetts y Arkansas. La evaluaci\u00f3n de la protecci\u00f3n se bas\u00f3 en el reaislamiento del virus a partir \nde la tr\u00e1quea y el ri\u00f1\u00f3n, y en la patolog\u00eda microsc\u00f3pica renal, adem\u00e1s de la tinci\u00f3n del ant\u00edgeno espec\u00edfico del virus de la bronquitis infecciosa.  \n \nABSTRACT  \nAn experiment was performed to assess the \nprotection provided by inactivated virus vaccination \nagainst challe nge with a virulent nephropathogenic \ninfectious bronchitis virus (NIBV).  The challenge \nstrain used was PA/Wolgemuth/98, an isolate \nrecovered from commercial broilers during an NIBV \noutbreak in Pennsylvania from 1997 -2000.  Following \na priming immunization  with attenuated IBV vaccines, \nspecific pathogen free (SPF) chickens were given either an oil emulsion vaccine containing inactivated IBV strains Massachusetts (Mass) and Arkansas (Ark) \nor an autogenous vaccine prepared from NIBV \nPA/Wolgemuth/98.   \nBoth in activated vaccines induced an anamnestic \nserum antibody response of similar magnitude in the  \n  \n71 chickens.  However, birds receiving the autogenous \nPA/Wolgemuth/98 vaccine were better protected \nagainst homologous virulent NIBV challenge \ncompared to chickens gi ven the heterologous Mass and \nArk combination inactivated vaccine.  Assessment of \nprotection following challenge was based on several \ncriteria; virus reisolation from trachea and kidney, and renal microscopic pathology and IBV -specific antigen \ndeposition.  The findings of this study suggest that maximum \nprotection to NIBV may be achieved by using an autogenous inactivated vaccine prepared from the same \nstrain that exists in the field in chickens initially primed \nwith live attenuated IBV.  \n \n(The full -length ar ticle of this paper will be submitted \nto Avian Diseases  for publication).  \n \nPERSISTENCE AND IMMUNE RESPONSE OF A PENNSYLVANIA \nNEPHROPATHOGENIC STRAIN OF IBV IN SPF CHICKENS  \n \nPERSISTENCIA Y RESPUESTA INMUNE DE UNA CEPA NEFROPAT\u00d3GENA \nDEL VIRUS DE LA BRONQUITIS INFECCIOSA EN POLLOS LIBRES DE \nPAT\u00d3GENOS ESPEC\u00cdFICOS (SPF ) EN PENNSYLVANIA  \n \nH. Lu, Q. Yang, J. Liu, T. Ward  \n \nAnimal Diagnostic Laboratory, Center for Veterinary Diagnostics and Investigation  \nThe Pennsylvania State University, University Park, PA 16801 \ntel: (814)863- 4369;  fax: (814)865- 4717;  email: hxl15@psu.edu  \n \nRESUMEN  \nEvaluamos la patogenicidad y la respuesta \ninmune de una nueva cepa nefropat\u00f3gena de Pennsylvania del virus de la bronquitis infecciosa \n(npIVB) en pollos SPF.  Observamos los signos \nrespiratorios caracter\u00edsticos y 25% de mortalidad \ncuando las aves se infectaron a los 2 d\u00edas de edad. \nDespu\u00e9s de inoculado, este virus se reaisl\u00f3 mediante \nimprontas cloacales durante un per\u00edodo de 114 d\u00edas. \nCuando inoculamos aves de 12 semanas de edad con el \ncitado virus no se observaron signos cl\u00ednicos ni \nmortalidad, pero el virus inoculado persisti\u00f3 en las tonsilas cecales y los ri\u00f1ones de estas aves durante un per\u00edodo de 9 semanas. Los pollos SPF  expuestos \npreviamente a esta cepa nefropat\u00f3gena de Pennsylvani a \nestuvieron protegidos contra la infecci\u00f3n cl\u00ednica cuando se desafiaron con el virus de la bronquitis infecciosa nefropat\u00f3gena.  \n \nSUMMARY  \nThe pathogenicity and immune response of a \nnovel Pennsylvania nephropathogenic strain of infectious bronchitis virus (npIBV) were evaluated in SPF chickens. Characteristic respiratory signs and a 25% mortality were produced when birds were infected \nat 2 days of age. The inoculated npIBV was isolated \nfrom cloacal swabs over a 114 day period. When 12 -\nweek old birds  were in oculated with npIBV, clinical \nsigns or mortality were not observed, but the inoculated virus persisted in the cecal tonsils and kidneys of such birds for a period of 9 weeks. SPF chickens previously exposed to the PA npIBV were protected against clinical i nfection when challenged by npIBV.  \nA novel nephropathogenic strain of infectious \nbronchitis virus (npIBV) was isolated from poultry \nlocated in Pennsylvania (PA) at the Animal Diagnostic \nLaboratory (ADL) of Penn State University in 1997. \nThe initial isolation was made from birds from a 12-day old broiler flock which had experienced high morbidity and mortality due to kidney failures. The \nisolate was diagnosed as an untypeable strain of IBV \nby monoclonal antibody (Mab) -based IFA (4) at the \nADL, and was furth er characterized at Dr. Jack Gelb\u2019s \nLaboratory, University of Delaware (1) , as a novel \nstrain of IBV by the sequencing of the S1 gene \nassociated with IBV isolates. This novel npIBV has \nbeen consistently isolated from clinical cases of broiler \nand layer chi ckens in PA and was also isolated from \nnormal commercial layer flocks using SPF sentinel chickens (2).  In our ongoing studies of the npIBV, observations obtained from clinical trials are presented \non evaluations in SPF birds of its pathogenicity and \nimmun e response.  \n \nMATERIALS AND METHODS  \nVirus and SPF chicken. The PA npIBV was \ninitially isolated from broiler chickens at the ADL, \nPenn State University in 1997. Specific -pathogen- free \n(SPF) White leghorn chicks were hatched at our \nlaboratory from SPF eggs re ceived from Charles River, \nSPAFAS at North Franklin, Connecticut.   \n  \n72 Experiment design. Two experiments were done \nusing the npIBV in SPF chickens at 12 -weeks old \n(trial- 1) and 5- days old (trial- 2), respectively.  Birds \nwere inoculated by a combination of eye and nasal \ndrops and oral administration which contained 1000 \nELD 50 in 0.5 ml dose per bird. All inoculated birds \nwere housed in negative pressure isolators and \nobserved daily for clinical signs. In trial -1, two birds \nwere sacrificed biweekly; cecal tonsil s, kidneys, \ntrachea and lung were collected for virus isolation using embryonating chicken eggs (3).  In trial -2, \ncloacal swabs were collected on a weekly or biweekly basis for virus isolation; blood samples were drawn in a 2-3 week interval to evaluate th e immune response by a \ncommercial IDEXX ELISA Kit (IDEXX Laboratories \nInc, Westbrook, ME).  An additional experiment (trial -\n3) was conducted by a challenge (1000 ELD\n50 in 0.5 \nml dose per bird) of the inoculated birds at 4 weeks \nwith the same npIBV. The cha llenge study was \nconducted following protocols established for standard vaccine challenge procedures (3).    \n \nRESULTS  \nIn observations from trial -1, clinical signs were \nnot observed on birds inoculated at 12- weeks old. \nHowever, the inoculated npIBV was cons istently \nisolated from the cecal tonsils and kidneys of sacrificed birds over a period of 9 weeks and thereafter the virus \nwas not isolated.  \nIn trial- 2, characteristic respiratory signs of \ngasping, sneezing and head shaking were observed during the first 2  weeks inoculation; 4 out of 16 birds \ndied due to IBV infection within 3 weeks. The npIBV \nwas successfully isolated from cloacal swabs from \nthese birds in 13 subsequent samplings over a period of 114 days. Thereafter, it was not isolated in 5 additional \nsamplings of 8 weeks duration.  \nIn trial- 3, 15 SPF chickens exposed at 5 weeks to \nnpIBV were all protected against challenge by the \nnpIBV at 4 weeks subsequent to the initial npIBV \nexposure. The challenge npIBV infected all 15 control \nbirds not previously exp osed to virus.  \n \nDISCUSSION  \nThe results from these experimental trials \ndemonstrate that the npIBV is highly pathogenic or \nvirulent to baby chicks.  In such chicks, npIBV \nproduced characteristic respiratory signs and 25% mortality.  Furthermore, npIBV affected about one \nthird of surviving birds as measured by stunted growth and continual shedding of virus in fecal materials for \n114 days. The npIBV infected chickens of all ages.  It \npersisted in cecal tonsils and kidneys of infected adult \nchickens for 9 weeks , but no clinical disease was \nobserved. The fact that the npIBV was found more \noften in young chickens than in adult chickens suggests \nthat the immune system of baby chicks may not recognize the virus as successfully as that of adult \nbirds.  \nAn additional f inding indicates that birds over 5 -\nweeks old exposed to the npIBV are able to develop a successful and protective immune response to exposure \nby the same virus. The findings of antibody levels in the serum samples collected from these bird trials have \nyet to be completed.  In additional projected studies, \nvaccine challenge studies using known commercial \nIBV vaccines will be done to further evaluate the cross \nprotection of such vaccines to the emergence and \nspread of the npIBV.  \n \nREFERENCES  \n1. Ladman, B.S., J. Gelb Jr., W. A. Nix, C.R. \nPope, and B.F. Kingham. Characterization of a novel \nnephropathogenic infectious bronchitis virus isolated \nfrom chickens in Pennsylvania. Proc. 71\nst Northeastern \nConf. On Avian Dis., Blacksburg, VA, p.38, 1999.  \n2. Lu, H., Q. Yang, T. Ward, P. Dunn, and D. \nWeinstock. Isolation and characterization of multiple strains of infectious bronchitis virus (IBV) from a commercial layer farm. 138\nth AVMA Annual \nConvention, Boston, MA. Proc. AAAP/AVMA Scientific Program, p. 32, July 2001.  \n3. Gelb, J.  Jr., and M. W. Jackwood. Infectious \nbronchitis. In: A Laboratory Manual for the Isolation and Identification of Avian Pathogens, 4th. ed., D.E. \nSwayne, J.R. Glisson, M.W. Jackwood, J.E. Pierson \nand W.M. Reed, eds. American Assoc. Avian Pathologists. pp. 169 -174. 1998.  \n4. Karaca, K., S. Naqi, and J. Gelb. Production \nand characterization of monoclonal antibodies to three infectious bronchitis virus serotypes. Avian Dis. 36: 903-915. 1992.  \n \nACKNOWLEDGMENTS  \nThis research was supported by the Pennsylvania \nDepartment of Agriculture and 2000 Pennsylvania \nPoultry Industry Research Check -Off Program.  \n \n(Complete results from this study will be submitted for \npublication in Avian Diseases ). \n \n \n \n  \n  \n73 PHYLOGENETIC ANALYSI S OF ONTARIO INFECTI OUS \nBRONCHITIS VIRUS ISOLATES  \n \nAN\u00c1LIS IS FILOGEN\u00c9TICO DE AISLAMIENTOS DEL VIRUS DE LA \nBRONQUITIS INFECCIOSA EN ONTARIO \n \nDavor Ojkic and Brian Binnington  \n \nAnimal Health Laboratory, University of Guelph, Guelph, Ontario, N1H 6R8, Canada  \n \nRESUMEN  \nSe amplificaron los fragmentos 5\u2019 de la secuencia  \nde la prote\u00edna de la esp\u00edcula de 39 aislamientos de \ncampo del virus de la bronquitis infecciosa procedentes de Ontario, Canad\u00e1, mediante reacci\u00f3n en cadena con \npolimerasa y transcriptasa inversa. Se determinaron las \nsecuencias de nucle\u00f3tidos de estos frag mentos que \nconten\u00edan las regiones hipervariables S1 y se \nsometieron a an\u00e1lisis filogen\u00e9tico para examinar el \ngrado de relaci\u00f3n de los aislamientos de campo de Ontario con secuencias S1 conocidas del virus de la \nbronquitis infecciosa. Los resultados del an\u00e1lisis \nfilogen\u00e9tico sugirieron que estos aislamientos se \npueden dividir en tres grupos generales: (1) Virus \nsimilares a los vacunales, (2) Aislamientos similares o \nrelacionados con las variantes del virus de la bronquitis infecciosa descritas en EE.UU. y (3 ) Aislamientos \nespec\u00edficos de Ontario.  \n Infectious bronchitis virus (IBV) is a very \ncontagious chicken pathogen. Although the primary target for virus replication is the respiratory tract some IBV strains target the intestinal tract, kidneys or the \noviduct . IBV often undergoes genetic changes, \ngenerating serological variants that may escape the \nvaccine -induced immunity. The S1 portion of the spike \nprotein (S) gene is responsible for the induction of neutralizing antibodies (1). The changes causing the antigenic variation occur most frequently within the \"hypervariable\" region of S1.  The 5\u2019 fragments of the S gene sequences from \nthirty -nine field isolates of IBV from Ontario, Canada \nwere amplified by RT -PCR as described by Kingham \net al.  (2). Nucleotide sequ ences of the amplified \nsegments containing the S1 hypervariable regions were \ndetermined.  Amino acid sequences of these fragments were subjected to phylogenetic analysis to examine the \nrelatedness of Ontario field isolates between \nthemselves and their simi larity to other known IBV S1 \ngene sequences.  The results of phylogenetic analysis \nsuggested that these isolates could be divided into three \ngeneral groups: (i) vaccine -like viruses, (ii) isolates \nsimilar or related to variant IBVs described in the USA \nand (iii) Ontario -specific isolates.  \n \nREFERENCES  \n1. Cavanah, D., and Davis P.J. Amino acids \nwithin hypervariable region I of avian coronavirus IBV \nspike glycoprotein are associated with neutralization \nepitopes. Virus Res 11: 141- 150. 1988.  \n2. Kingham, B.E., Keele r, C.L., Nix, W.A., \nLadman, B.S., and Gelb, J. Identification of avian infectious bronchitis virus by direct automated cycle \nsequencing of the S -1 gene. Avian Dis. 44: 325- 335. \n2000.\n \n \n(A full -length article will be submitted for publication \nin Avian Diseas es). \n \n \n  \n \n   \n \n  \n  \n74 CREATION OF A NOVEL INFECTIOUS BRONCHITI S VIRUS  \nS1 GENE LIBRARY BY D NA SHUFFLING  \n \nCREACI\u00d3N DE UNA NUEVA COLECCI\u00d3N DEL GENE S1 DEL VIRUS DE LA \nBRONQUITIS INFECCIOSA MEDIANTE LA COMBINACI\u00d3N ALEATORIA \nDEL ADN  \n \nScott A. Callison, Mark W. Jackwo od and Deborah A. Hilt  \n \nDepartment of Avian Medicine, College of Veterinary Medicine, The University of Georgia, Athens, GA 30602  \n \nRESUMEN  \nNo existe todav\u00eda ninguna vacuna contra el virus \nde la bronquitis infecciosa con amplia protecci\u00f3n \ncruzada y es suma mente necesario contar con un \nproducto as\u00ed. En un esfuerzo por acelerar el proceso de \ncrear nuevas vacunas con la m\u00e1xima posibilidad de \nproteger en forma cruzada, informamos sobre el uso de \nla combinaci\u00f3n aleatoria del ADN (\u201c barajarlo\u201d) para \ncrear una nueva biblioteca de genes S1. Despu\u00e9s de \neste proceso los nuevos genes S1 resultantes se usaron \ncomo plantilla de inicio para una segunda ronda de \ncombinaci\u00f3n al azar o clonaci\u00f3n del ADN. Se \ndetermin\u00f3 la secuencia de las regiones hipervariables del gene S1 de varios clones de cada ronda de \ncombinaciones aleatorias. El an\u00e1lisis m\u00e1s profundo de \nestos clones determinar\u00e1 sus caracter\u00edsticas serol\u00f3gicas \ny su utilidad para crear una nueva vacuna capaz de \nproteger contra la bronquitis infecciosa.  \n \nA cross protective I nfectious Bronchitis Virus \n(IBV) vaccine does not exist and remains sorely \nneeded.  Current procedures for new vaccine \ndevelopment require a great deal of time and good \nfortune to produce a vaccine with favorable antigenic \nproperties.  In an effort to expe dite the process of \ncreating new vaccines with the maximum possibility of \nbeing cross protective, we report the use of DNA \nshuffling to create a novel S1 gene library.  In short, \nDNA shuffling requires three steps:  1) the random fragmentation of similar o r homologous pieces of \nDNA, 2) the consequent reassembly of the fragments into novel recombinants by primerless PCR, and 3) amplification of full -length recombinants by normal \nPCR to produce DNA that can be cloned or used as template for another round of D NA shuffling.  \nBriefly, RT -PCR was used to amplify the S1 gene \nfrom four serologically distinct IBV strains:  Massachusetts 41, Arkansas DPI, Connecticut 46, and \nDelaware 072.  The S1 genes were subjected to DNA \nshuffling and the resultant novel S1 genes we re used as \ntemplate for another round of DNA shuffling or cloned.  \nIn total, three rounds of DNA shuffling were completed \nto produce the final novel S1 gene library.  \nThe S1 gene hypervariable regions were \nsequenced for several clones from each round of \nshuffling.  The degree of recombination increased with \neach reiterative cycle of DNA shuffling.  Several \nclones from the last round of DNA shuffling have an \nopen -reading frame that contain sequence elements \nfrom each of the donor strains, indicating their cod ing \npotential for a spike glycoprotein that may induce cross \nprotective antibodies.  Further analysis of these clones \nwill determine their serological characteristics and \nusefulness in creating a cross protective vaccine for \nIBV.  \n \n(These findings will be s ubmitted for publication in \nVirus Research ). \n \n \n \n \n   \n \n  \n  \n75 EVALUACI\u00d3N EXPERIMENTAL DE UNA VACUNA AT ENUADA \nCONTRA LA BRONQUITIS  INFECCIOSA SEROTIPO BL56  \n \nEXPERIMENTAL EVALUATION OF AN ATTENUATED INFECTIOUS \nBRONCHITIS VACCINE, SEROTYPE BL-56  \n \nManuel Gay, Mar\u00eda E . Aranda,  Bernardo Lozano, Ernesto Soto, Alejandro Su\u00e1rez, David Sarfati,  \nJorge Escamilla y Juan Garc\u00eda -Garc\u00eda.  \n \nLaboratorio Avi -Mex, S.A. de C.V., M\u00e9xico  \n \nSUMMARY  \nThis research evaluated the ability of a live, \nattenuated, infectious bronchitis virus (VB I), serotype \nBL56 vaccine, for the protection against the \ndevelopment of lesions after challenge with VBI, DS57 strain. DS57 features important differences with \nserotype BL56 in the S1 protein amino acid sequence. \nVaccine BL56 conferred 100% protection aga inst \nchallenge with VBI DS57. VBI DS57is closely related \nwith serotype UNAM -97, since nearly a 100% \nhomology exists between both. This result determined \nserotype BL56 as a protectotype of VBI DS57.  \n \nRESUMEN  \nEn este estudio se evalu\u00f3 la capacidad de una \nvacuna a virus vivo, elaborada con un virus de \nbronquitis infecciosa (VBI) serotipo BL56 atenuado, para conferir protecci\u00f3n a la presentaci\u00f3n de lesiones al \ndesaf\u00edo con  VBI denominado DS57 el cual difiere de \nmanera importante en la secuencia de amino\u00e1cidos d e \nla prote\u00edna S1 del serotipo BL56. La vacuna BL56 \nconfiri\u00f3 protecci\u00f3n del 100% al desaf\u00edo con VBI DS57 \nque est\u00e1 estrechamente relacionado con el serotipo \nUNAM -97 con una homolog\u00eda en su secuencia de \namino\u00e1cidos cercana al 100%. Este resultado determina \nal serotipo BL56 como un protectotipo del VBI DS57.  \n \nINTRODUCCI\u00d3N  \nEn los \u00faltimos a\u00f1os las investigaciones sobre el \nagente etiol\u00f3gico de la bronquitis infecciosa (BI) se \nhan centrado en el estudio de la prote\u00edna de superficie \n(S) que constituye proyecciones e n la superficie del \nvirus. Esta prote\u00edna reviste gran importancia ya que \ncontiene determinantes antig\u00e9nicos que inducen la \nformaci\u00f3n de anticuerpos neutralizantes y adem\u00e1s \ndeterminan el serotipo o una variante  (1,2,3,4,5). Por tal raz\u00f3n, la gran diversidad de serotipos y variantes del \nVBI esta dada por la relativa facilidad con que se \nmodifica la secuencia de amino\u00e1cidos a nivel de la prote\u00edna S1. Sin embargo, es importante se\u00f1alar que la \nnucleoprote\u00edna  (N) que se encuentra asociada al \ngenoma del virus, ha sido se\u00f1alada como altamente \nantig\u00e9nica y de gran importancia en la respuesta inmunol\u00f3gica  de las aves hacia los VBI. Esto puede dar respuesta a los denominados protectotipos del VBI, \nen donde virus con  una diferencia importante en la \nsecuenciaci\u00f3n de amino\u00e1cidos de la prote\u00edna S1 pueden \ndar reacciones de neutralizaci\u00f3n cruzada en grado \nimportante.   \nEn M\u00e9xico reportamos en 1998 el aislamiento y \ncaracterizaci\u00f3n, mediante pruebas de Inmunoflorescencia Indirecta, VSN, RT -PCR, RT -\nPCR- RFLP y secuenciaci\u00f3n d e amino\u00e1cidos ,  de un \nnuevo serotipo del  VBI al que se le denomin\u00f3 BL56 \n(6). Este virus se atenu\u00f3 en nuestro laboratorio de \nInvestigaci\u00f3n y Desarrollo y se demostr\u00f3 su inocuidad, \nsu pureza, su no reversi\u00f3n a la virulencia mediante  \npases seriados en poll os SPF de cuatro semanas de \nedad y  su potencia al desaf\u00edo con VBI hom\u00f3logo \nvirulento (2 ).  \nEl objetivo de la presente investigaci\u00f3n fue \nevaluar nuestra vacuna atenuada BL56 frente al desaf\u00edo \ncon un VBI que aislamos en 1999 al que denominamos \nDS57, mismo que est\u00e1 estrechamente relacionado con \nel serotipo UNAM -97 con una homolog\u00eda en su \nsecuencia deducida de amino\u00e1cidos cercana al 100% \n(Gelb, J. comunicaci\u00f3n personal, 2000 ).  \n \nMATERIAL Y M\u00c9TODOS  \nAves: Se emplearon tres grupos, cada uno de ellos \ncon treinta a ves SPF de un d\u00eda de edad.  \nVacunas: elaborada con virus activo, atenuado, \nserotipo BL56  \nInmunizaci\u00f3n:  \n\u2022 Grupo 1, control negativo no desafiado.  \n\u2022 Grupo 2, control positivo no vacunado y \ndesafiado.  \n\u2022 Grupo 3, con aplicaci\u00f3n de una dosis de \nvacuna al d\u00eda de edad ( 0.03 ml v\u00eda ocular 10\n5.3 \nDIEP 50%/ml).  \n\u2022 Grupo 4, con aplicaci\u00f3n de dos dosis iguales a las del grupo 3 al d\u00eda y a los diez d\u00edas de edad.  \nNota. -  Cada uno de los grupos se mantuvieron en \nunidades de aislamiento independientes hasta el desaf\u00edo.   \n  \n76 Desaf\u00edo: Los g rupos 2, 3 y 4 fueron desafiados a \nlos 35 d\u00edas de edad con 0.06 ml v\u00eda ocular de VBI \nserotipo DS57 conteniendo 106.13 DIEP 50%/ml.  \nObtenci\u00f3n de muestras biol\u00f3gica: A los 42 d\u00edas de \nedad (siete d\u00edas despu\u00e9s del desaf\u00edo) se sacrificaron \naves de cada grupo para observaci\u00f3n de lesiones a la \nnecropsia (aerosaculitis, peritonitis, friabilidad de los ri\u00f1ones) y para obtenci\u00f3n de \u00f3rganos para histolog\u00eda \n(tr\u00e1quea, pulm\u00f3n y ri\u00f1ones).   \nCoeficiente de Lesiones (CL):  Con base en la \nescala de lesiones del 0 al 3 (donde el 0 representa sin \nlesi\u00f3n y el 3 el mayor grado de lesi\u00f3n), se obtuvo el CL de cada grupo que resulta de sumar el grado de lesi\u00f3n \nindividual.  \n \nRESULTADOS Y DISCUSI \u00d3N \nLos resultados de potencia evaluados a trav\u00e9s de \nlas lesiones macrosc\u00f3picas se resumen e n el Cuadro 1. \nLos resultados de potencia, se correlacionan directamente con las observaciones microsc\u00f3picas, \nvaloradas a trav\u00e9s de estudios histopatol\u00f3gicos donde \nel CL para el grupo control positivo fue de 87 para \ntraqueas, 72 para pulmones y 87 para ri\u00f1 ones, mientras \nque para los grupos vacunados fue pr\u00e1cticamente de 0 en todos los casos.  \nAmbos resultados se\u00f1alan que la vacuna atenuada \nelaborada con el serotipo BL56 fue capaz de conferir \nuna protecci\u00f3n del 100% a la presentaci\u00f3n de lesiones \nproducidas e n el grupo control no vacunado y \ndesafiado con el serotipo DS57, lo que indica que el serotipo BL56 corresponde a un protectotipo para el VBI DS57.  \nPor otra parte esta investigaci\u00f3n concuerda con \nlos resultados de trabajos anteriores realizados por \nnuestro  laboratorio de Investigaci\u00f3n y Desarrollo en \ncuanto a que la presentaci\u00f3n de lesiones macrosc\u00f3picas y microsc\u00f3picas en sacos a\u00e9reos, peritoneo, ri\u00f1ones, \npulmones y traqueas, sirven como un indicador \npr\u00e1ctico para medir la protecci\u00f3n que confieren las \nvacu nas contra la BI  que pueden ser causadas o \ninducida por la acci\u00f3n directa del VBI sobre los epitelios.  \n CONCLUSIONES  \n1. La vacuna atenuada del VBI elaborada con \nel serotipo BL56 confiri\u00f3 protecci\u00f3n cruzada del 100% \ncontra el VBI serotipo DS57, por lo que se  determina \nque corresponde a un protectotipo hacia la cepa \nheter\u00f3loga de desaf\u00edo.  \n2. La pr\u00e1cticamente ausencia de lesiones antes \ndel desaf\u00edo en las aves vacunados con la cepa atenuada BL56 confirman su  inocuidad.  \n3. Las lesiones macrosc\u00f3picas y microsc\u00f3picas \ndesencadenadas por el desaf\u00edo del VBI son un \nindicador pr\u00e1ctico para la evaluaci\u00f3n de vacunas contra \nla BI.  \n \nREFERENCIAS  \n1. Cavanagh, D. y S.A. Naqi. Infectious \nbronchitis. En Diseases of Poultry. D\u00e9cima edici\u00f3n. \nEditado por Calnek, B.W., Barnes, H,J., Beard, C .W., \nMcDougald, L. Y M. Saif. Editorial Board for the American Association of Avian Pathologists. Iowa \nState University Press.511 -526.1997.  \n2. Gay, G.M., Su\u00e1rez, A., Lozano, B., Soto, E., \nSarfati, D., Escamilla, J., Alvarado, C. y A. Morales. Avances en la pr evenci\u00f3n de la bronquitis infecciosa en \nM\u00e9xico. Memorias del XII Curso de Actualizaci\u00f3n \nAvimex. M\u00e9xico.38 -51. 2000  \n3. Gelb, J. Jr.  Bronquitis infecciosa.  Vineland \nUpdate. 1990.  \n4. Gelb, J.Jr.  Variant IBV serotypes in \ncommercial chicken in the United States an d Canada \nand approaches to their control.  II International Symposium on Infectious Bronchitis. \nRauschholzhausen, Germany, June 3 -  6, 1991.  \n5. Gelb, J.Jr., Rossenberg, J.K., Odor, E.M. y M. \nSalem.  Bronquitis Infecciosa: Una actualizaci\u00f3n. La \nimportancia de cepas variantes en los programas de \nvacunaci\u00f3n.  Tecnolog\u00eda Avipecuaria. A\u00f1o 7, No. 73.  \n6. Lozano, B., Gay, M., Sarfati, D., Soto, E., \nSuarez, A., Aranda, M.E., Escamilla, J., Hern\u00e1ndez, M., y J. Garc\u00eda- Garc\u00eda. Aislamiento e identificaci\u00f3n de \nuna posible vari ante o nuevo serotipo de la bronquitis \ninfecciosa en M\u00e9xico. Memorias del X Curso de \nActualizaci\u00f3n Avimex, M\u00e9xico. 80 -91. 1998.  \n Cuadro 1.    Lesiones macrosc\u00f3picas en sacos a\u00e9reos, peritoneo y ri\u00f1ones antes y siete d\u00edas despu\u00e9s del desaf\u00edo con el serotip o DS57 (treinta aves por grupo).  \n CL ANTES DEL DESAF\u00cdO*  CL 7 D\u00cdAS POSTDESAF\u00cdO*  \nAerosaculitis  Peritonitis  Ri\u00f1\u00f3n \nfriable  Aerosaculitis  Peritonitis  Ri\u00f1\u00f3n \nfriable  \n1. Control negativo  0 0 0 4 0 0 \n2. Control positivo  2 0 0 84 72 86 \n3. BL56 (una aplicaci\u00f3n)  2 0 0 6 0 0 \n4. BL56 (dos aplicaciones)  0 0 0 4 0 0 \n(*) Individualmente el 0 indica sin lesiones y el 3 indica el grado mayor de lesiones.  En grupo de 30 aves la escala es de 0 a 90.   \n  \n77  \nCARACTERIZACI\u00d3N MOLECULAR DE AISLAMIENTOS \nMEXICANOS DEL VIRUS DE LA ENFERMEDAD DE NEWCASTLE:  \n1997- 2001  \n \nMOLECULAR CHARACTERIZATION OF MEXICAN NEWCASTLE DISEASE \nVIRUS (NDV) ISOLATES, 1997\u2013 2001  \n \nOrtiz N.M1., Feh\u00e9rv\u00e1ri T1., Huerta L.B.J1., Lomniczi B2., Ledesma, N1., Hargis, B3., Alonso, R4., T\u00e9llez G1 \n \n1Departamento de Produc ci\u00f3n Animal: Aves. Facultad de Medicina Veterinaria y Zootecnia, Universidad Nacional \nAut\u00f3noma de M\u00e9xico. M\u00e9xico D.F. 04510  \n2Veterinary Medical Research Institute of Hungarian Academy of Science. H -1519 Budapest, P.O. Box, Hungary \n3Poultry Health Research Laboratory.  Department of Poultry Science Fayetteville, Arkansas 72701 Office  \n4Departamento de Gen\u00e9tica, Laboratorio de Gen\u00e9tica Molecular. Facultad de Medicina Veterinaria y Zootecnia, \nUniversidad Nacional Aut\u00f3noma de M\u00e9xico  \n \nSUMMARY  \nDetermination of th e molecular characteristics of \nsome NDV\u2019s through restriction analysis using 7 \nreference strains: 5 velogenic viscerotropic strains (Ishii, Chimalhuac\u00e1n, Miyadera, Quer\u00e9taro, and \nTorre\u00f3n), 2 lentogenic strains (LaSota and Queensland \nV4); and  19 NDV positiv e isolates.  Using reverse \ntranscription -polymerase chain reaction (RT -PCR) one \n1,349 bp fragment corresponding to one fraction of the F gen was amplified. Fragments were digested with restriction enzymes (BstoI, HinfI and RsaI) to \ndetermine electrophoreti c patterns. Results: Torre\u00f3n \n6/19 (31.5%), Chimalhuac\u00e1n 1/19 (5%), LaSota 4/19 \n(21.5%) y 8/19 (31.5%) showed electrophoretic \npatterns different from those of the reference strains.  \n \nRESUMEN  \n Determinaci\u00f3n de las caracter\u00edsticas moleculares \nde algunos viru s de la ENC mediante el an\u00e1lisis de \nrestricci\u00f3n utilizando 7 cepas de referencia:  5 \nvelog\u00e9nicas viscerotropicas (Ishii, Chimalhuacan, \nMiyadera, Quer\u00e9taro, y Torre\u00f3n), 2 lentog\u00e9nicas (La \nSota y Queensland V4); y 19 aislamientos positivos a \nla ENC.  Mediante la RT -PCR se  amplific\u00f3 un \nfragmento de 1349 pb correspondiente a una fracci\u00f3n \ndel gen F.  Los fragmentos fueron digeridos por \nenzimas de restricci\u00f3n  (BstoI, HinfI y RsaI) para \ndeterminar los patrones electrofor\u00e9ticos (PEs).  \nResultados: Torre\u00f3n 6/19 (31.5%), Chimalhuacan 1/19 \n(5%), La Sota 4/19 (21.5%) y 8/19 (31.5%) tuvieron PEs distintos a las cepas de referencia.  \n \nINTRODUCCI\u00d3N  \nLa enfermedad de Newcastle (ENC) es una \nenfermedad altamente contagiosa tanto en aves j\u00f3venes como adultas ocasionando mortali dad elevada.  La \ninfecci\u00f3n que ahora denominamos ENC se conoce desde 1926, a\u00f1o en que se registro el primer brote en la \nisla de Java (ahora parte de Indonesia), y poco despu\u00e9s \nen la regi\u00f3n de Newcastle -upon -Tyne, Inglaterra.  Se \nconsidera que, desde que se reconoci\u00f3 por primera vez \nesta enfermedad se han presentado cuando menos 4 \npanzootias en el mundo.   \nActualmente estamos siendo testigos de la cuarta \npanzootia, pues desde 1991 se ha venido \nincrementando la incidencia de una serie de brotes caracterizados  por la presencia de un virus velog\u00e9nico \nmuy virulento que causa principalmente la forma \nrespiratoria y ocasionalmente la viscerotr\u00f3pica.   \nEn M\u00e9xico, fue notificada por primera vez en \n1946. Desgraciadamente a pesar del control de la \nenfermedad con el uso de vacunas y m\u00e9todos \nzoosanitarios, las cepas virulentas extremadamente \npat\u00f3genas est\u00e1n a\u00fan presentes en la Rep\u00fablica \nMexicana.  El 29 de marzo del 2000 se hizo la \ndenuncia de un nuevo brote de la ENC velog\u00e9nico en la Comarca Lagunera resultando positivas 83 granjas \ncomerciales con una poblaci\u00f3n de 13 500 160 aves; \nestim\u00e1ndose el costo del brote en 250 millones de \npesos.  \nEl agente causal de la ENC es un virus clasificado \ncomo miembro de la superfamilia Mononegavirales  en \nla Familia Paramyxoviridae .  Esta fa milia de virus se \ndivide en dos subfamilias: Paramyxovirinae y \nPneumovirinae .  En 1993, el Comit\u00e9 Internacional de \nla Taxonom\u00eda Viral reordena el g\u00e9nero paramyxovirus  \ny coloc\u00f3 al virus de Newcastle (VNC) en el g\u00e9nero \nRubulavirus  entre los Paramyxovirinae . El virus consta \nde un amplio rango de hospedadores con 27 a 30 \n\u00f3rdenes de aves que se han reportado infectadas con el \nvirus de la ENC.  La envoltura de este virus consta de \npolaridad negativa con un genoma de RNA de cadena sencilla con 15 156 nucle\u00f3tidos, cuyo genoma codifica \n6 prote\u00ednas estructurales: hemoaglutinina - \n  \n78 neuraminidasa (HN), fusi\u00f3n (F), matriz (M), fosforilasa \n(P), nucleoprote\u00edna (NP) y polimerasa (L).  De acuerdo \na la versi\u00f3n m\u00e1s reciente de la clasificaci\u00f3n de los \nvirus, los paramixovirus avia res constan de 9 serotipos \ndel PMV -1 al PMV -9.  Los virus del PMV -2 al PMV -9 \nse pueden encontrar en muchas aves dom\u00e9sticas y \nsilvestres, pero no se relacionan con la enfermedad de Newcastle.  \n El VNC se identifica f\u00e1cilmente mediante el uso \nde la prueba de inhibici\u00f3n de la hemoaglutinaci\u00f3n, mediante la utilizaci\u00f3n de anticuerpos espec\u00edficos.  \nCuando el virus se pone en presencia del anticuerpo, \neste es capaz de neutralizar la propiedad de los virus de aglutinar los eritrocitos, por el bloqueo del sitio de \nuni\u00f3n del virus al eritrocito.  \n Los anticuerpos en el suero de aves se pueden \nidentificar mediante m\u00e9todo serol\u00f3gico como inhibici\u00f3n de la hemoaglutinaci\u00f3n, seroneutralizaci\u00f3n y \nla prueba de ELISA.  Otras t\u00e9cnicas de laboratorio que pueden ser de utilidad pa ra la identificaci\u00f3n del VNC \nson la fijaci\u00f3n del complemento, inmunodifusi\u00f3n en \ngel, las cuales detectan ant\u00edgeno soluble e inactivo.  \n Las pruebas de reacci\u00f3n de anticuerpos \nmonoclonales (Acm) y la transcriptasa reversa \u2013  \nreacci\u00f3n en cadena de la polimeras a (RT -PCR) \nproducto del gen de fusi\u00f3n del VNC indica que al \nmenos tres genotipos diferentes (II, III y IV) fueron \nresponsables de las epizootias.  Sin embargo en la actualidad no se conoce con seguridad a que genotipo \npertenecen las cepas viscerotr\u00f3picas q ue se encuentran \nafectando las diferentes regiones de nuestro pa\u00eds.  \n La efectividad de las medidas de control puede \nser improvisada en el origen de la  rapidez de los brotes ambiguamente identificados.  La identificaci\u00f3n de las \ncepas es de gran  importanci a en los pa\u00edses donde se  \nutilizan diferentes vacunas con cepas vivas, para establecer la identidad de la vacuna.  Conjuntando esfuerzos en d\u00e9cadas pasadas se ha logrado introducir \nm\u00e9todos de identificaci\u00f3n y diferenciaci\u00f3n.  Estas \nt\u00e9cnicas se han basado e n las propiedades virales del \nvirus tales como la patogenicidad \u00f3 la formaci\u00f3n de \nplacas, propiedades f\u00edsico -qu\u00edmicas, tales como la \ntermoestabilidad y el an\u00e1lisis de polip\u00e9ptidos u \noligonucle\u00f3tidos estructurales.  Obteni\u00e9ndose los \nmejores resultados para la identificaci\u00f3n y diferenciaci\u00f3n de las cepas de la ENC con el an\u00e1lisis de \nAcm.  Este m\u00e9todo establece 10 grupos antig\u00e9nicos de \nlos cuales 5 incluyen cepas virulentas (velog\u00e9nicas).  \nEsta fue la primera clasificaci\u00f3n de cepas de la ENC en \ndonde las cepas  comparten propiedades antig\u00e9nicas y \nepizootiol\u00f3gicas.  As\u00ed mismo, basados en la \ncomparaci\u00f3n de secuencias de nucle\u00f3tidos de los genes \nHN y F de once cepas de la ENC tres distintas l\u00edneas \nevolutivas se han identificado en la actualidad.  Siendo determinant e primario para la patogenicidad de la \nprote\u00edna F sitio de anclaje en la secuencia de amino\u00e1cidos y la habilidad de proteasas espec\u00edficas \npara unirse a la prote\u00edna F de diferentes patotipos; \nencontr\u00e1ndose amino\u00e1cidos dib\u00e1sicos rodeando a la \nglutamina en la  posici\u00f3n 114 de la prote\u00edna F en el sitio \nde anclaje de cepas mesog\u00e9nicas y velog\u00e9nicas, \nmientras las cepas lentog\u00e9nicas carecen de este sitio.  \n El objetivo del presente estudio fue determinar \nlas caracter\u00edsticas moleculares de algunos de los virus de la ENC aislados en M\u00e9xico entre los a\u00f1os de 1997 al \n2001 derivados de diferentes regiones geogr\u00e1ficas de \nnuestro pa\u00eds en diferentes per\u00edodos de tiempo y as\u00ed \npoder  revelar las relaciones epidemiol\u00f3gicas de los \nbrotes utilizando  la t\u00e9cnica de RT -PCR amplifica ndo \nel gen de la prote\u00edna F.  \n \nMATERIAL Y M\u00c9TODOS  \nVirus:   Se utilizaron 7 cepas de referencia: 5 \nvelog\u00e9nicas vicerotr\u00f3picas ( Ishii, Chimalhuacan, \nMiyadera, Quer\u00e9taro, y Torre\u00f3n), 2 lentog\u00e9nicas (La Sota y Queensland V4)  y  19 aislamientos de la ENC \nse obt uvieron de casos remitidos al Departamento de \nProducci\u00f3n Animal: Aves, de la Facultad de Medicina Veterinaria y Zootecnia de la UNAM.  Los virus de la \nENC se replicaron en embriones de 9 d\u00edas de edad y los l\u00edquidos alantoideos se almacenaron a  - 85\u00ba C hast a su \nutilizaci\u00f3n.  \nTranscriptasa reversa (RT):   Este procedimiento \nha sido descrito por Wehmann et al (1997) y se realiz\u00f3 \nsin modificaci\u00f3n alguna.  \nReacci\u00f3n en cadena de la polimerasa (PCR):  Para \nel an\u00e1lisis de restricci\u00f3n del gen F un producto de 1349 \npb s e sintetizo (del nucle\u00f3tido, nt 334 al 1682) \nutilizando los iniciadores 1aa 5\u2019 -TGA- ITC-WAT -\nYCG -IAR-GAI-ACA- AGR -KTC -TG-3\u2019 (del \nnucle\u00f3tido 334 al 362) y 4aa  5\u2019 -ATC -TGR -YCI-ACT -\nGTR -TTA -TTC -CCA -AGC -CA-3\u2019 (del nucle\u00f3tido \n1654 al 1682).  La amplificaci\u00f3n se lle vo a cabo en un \ntermociclador utilizando 5 ciclos de 94 \u00b0 C durante 45 \nsegundos, 55\u00b0  C durante 30 segundos, 72\u00b0  C durante \nun minuto y 30 ciclos de 94\u00b0  C durante 45 segundos, \n48\u00b0 C durante un minuto, 72 \u00b0 C durante 3 minutos y \nfinalmente 72 \u00b0 C durante 7 minut os\n7.An\u00e1lisis de \nrestricci\u00f3n: El fragmento de 1349 pb de cada una de las \ncepas fueron digeridos utilizando 3 enzimas de restricci\u00f3n ( BstoI, HinfI y RsaI)  separando los \nfragmentos digeridos por tama\u00f1o en geles de agarosa al \n3% para la determinaci\u00f3n de los PE s. \n \nRESULTADOS  \nSiguiendo la t\u00e9cnica de RT -PCR utilizando el \ngenoma viral de RNA como templado para la \namplificaci\u00f3n de un fragmento de 1349 pb de los 19 \nasilamientos se obtuvieron los siguientes resultados: \nTorre\u00f3n 6/19 (31.5%);  Chimalhuacan 1/19 (5%) y L a \nSota 4/19 (21.5%).  Sin embargo, 8/19 (31.5%) tuvieron PEs distintos a los de las cepas de referencia  \n  \n79 utilizados.  Un an\u00e1lisis de secuenciaci\u00f3n es necesario \npara determinar si estas cepas se encuentran \nrelacionadas con otras cepas conocidas o bien para \ndeterminar si son cepas nuevas.  \n \nREFERENCIAS  \n1. Salvador Solis. Situaci\u00f3n de la campa\u00f1a \nnacional contra la enfermedad de Newcastle.  \nMemorias del Curso \u201cEnfermedades emergentes: \nEnfermedad de Newcastle\u201d; 2000 julio 14; M\u00e9xico, \nD.F. M\u00e9xico (D.F.): Asociaci\u00f3n Nacional de \nEspecialistas en Ciencias Av\u00edcolas de M\u00e9xico A.C; \n2000: 20- 22. \n2. Tamas Feh\u00e9rv\u00e1ri. Estrategias y control de la \nenfermedad de Newcastle en otros pa\u00edses. Memorias \ndel Curso \u201cEnfermedades emergentes: Enfermedad de \nNewcastle\u201d; 2000 julio 14; M\u00e9xico, D.F . M\u00e9xico \n(D.F.): Asociaci\u00f3n Nacional de Especialistas en Ciencias Av\u00edcolas de M\u00e9xico A.C; 2000: 1 -7. \n3. Jorge Francisco Monrroy L\u00f3pez.  \nEpidemiolog\u00eda de la Enfermedad de Newcastle \nvelog\u00e9nica viscerotr\u00f3pica. Memorias del Curso \n\u201cEnfermedades emergentes: Enfermedad de \nNewcastle\u201d; 2000 julio 14; M\u00e9xico, D.F. M\u00e9xico \n(D.F.): Asociaci\u00f3n Nacional de Especialistas en \nCiencias Av\u00edcolas de M\u00e9xico A.C; 2000: 12 -15. \n4. Examen general de calidad profesional para \nMedicina Veterinaria.  Material de estudios Area: Aves. Editor: I sidro Castro Mendoza. Primera \nreimpresi\u00f3n 1997. M\u00e9xico. UNAM. SUA. CENNEVAL.  \n5. Carlos S\u00e1nchez Widman. Memorias del \nCurso \u201cEnfermedades emergentes: Enfermedad de \nNewcastle\u201d; 2000 julio 14; M\u00e9xico, D.F. M\u00e9xico (D.F.): Asociaci\u00f3n Nacional de Especialistas en Ciencias Av\u00edcolas de M\u00e9xico A.C; 2000: 16 -19. \n6. Seal BS, King DJ and Meinersmann.  \nMolecular evolution of the Newcastle disease virus \nmatrix protein gene and phylogenetic relationships \namong the paramyxoviridea.  Virus Research 2000; 66: \n1-11. \n7. Ballagi- Pord\u00e1ny A, Wehmann E, Herczeg J, \nBel\u00e1k and Lomniczi B.  Identification and grouping of \nNewcastle disease virus strains by restriction site \nanalysis of region from the F gene. Arch Virol 1996; \n141: 243- 261. \n8. Lomniczi B, Wehmann E, Herczeg J, \nBallagi- Pord\u00e1ny A, Kalet a EF, Werner O, Moulemans \nG, Jorgensen PH, Mant\u00e9 AP, Gielkens ALJ, Capua I \nand Damoser J.  Newcastle disease outbreaks in recent \nyears in Western Europe were caused by an old (VI) \nand novel genotype (VII).  Arc Virol 1998; 143: 49- 54. \n9. Allan WH, Lancaster J E and T\u00f3th B.  \nVacunas contra la enfermedad de Newcastle.  Roma \n(Italia).  Organizaci\u00f3n de las Naciones Unidas para la \nAgricultura y la Alimentaci\u00f3n (FAO). 1980.  \n10. Calnek BW, Alexander DJ.  Newcastle \ndisease and other paramyxovirus infections. In: Calnek \nBW,  Barnes HJ, Berad CW, Reid MW, Yoder WH.  \nDiseases of poultry, 9\nth ed. Ames (Iowa): Iowa State \nUniversity Press, 1991: 496- 519. \n11.   M\u00e9ndez HJA. Caracter\u00edsticas diferenciales \nde algunas cepas del virus de la enfermedad de Newcastle (tesis de licenciatura). M\u00e9xico (D.F.) Facultad de Qu\u00edmica. IPN, 1995.  \n  Reed LJ and Muench.  A simple method for \nestimating fifty percent endpoints.  AmJ Hyg 1938; 27: \n493-497.\n \nCARACTERIZACI\u00d3N BIOL\u00d3GICA DE CUATRO CEPAS \nVELOG\u00c9NICAS Y UNA LENTOG\u00c9NICA DEL VIRUS  \nDE LA ENFERMEDAD DE NE WCASTLE  \n \nBIOLOGICAL CHARACTERIZATIOHN OF ONE LENTOGENIC AND FOUR \nVELOGENIC STRAINS OF NEWCASTLE DISEASE VIRUS  \n \nMireya Ju\u00e1rez 1, V\u00edctor M. Petrone 1, Tamas Fehervari1  \n   \n1Departamento de Producci\u00f3n Animal: Aves, Facultad de Medicina Veterinaria y Zootecnia, UNAM  \n \nSUMMARY  \nNewcastle disease has been a serious problem for \nthe poultry industry in Mexico and the world. In \nMexico the Doyle presentation is represented by \nMexican strains like Ixtapalapa, Quer\u00e9taro and \nChimalhuac\u00e1n strains. The purpose of this stud y was to \nbiologically characterize one lentogenic and four \nvelogenic strains of Newcastle disease virus, as well as to perform a comparison of their biological properties, \ngiven their pathogenicity. Results showed differences \nbetween hemagglutinating units   ( UIH), chicken \nembryo mortality rates ( RMEP ), and chicken embryo \nlethal dose 50% (DLEP 50%).  \n \n \n  \n  \n80 RESUMEN  \nLa enfermedad de Newcastle (ENC) ha sido un \nserio problema para la avicultura mexicana y mundial, \nen M\u00e9xico la presentaci\u00f3n Doyle esta representada po r \ncepas mexicanas como  Ixtapalapa, Quer\u00e9taro y \nChimalhuac\u00e1n. El presente estudio tuvo como objetivo \nrealizar la caracterizaci\u00f3n biol\u00f3gica de cuatro cepas \nvelog\u00e9nicas y una lentog\u00e9nica del virus de la \nenfermedad de Newcastle, as\u00ed como realizar una \ncomparaci \u00f3n entre sus propiedades biol\u00f3gicas dada su \npatogenicidad. Los resultados mostraron diferencias \nentre las unidades hemoaglutinantes (UHA), rango de \nmortalidad en embri\u00f3n de pollo (RMEP) y dosis letal embri\u00f3n de pollo 50% (DLEP 50%).  \n \nINTRODUCCI\u00d3N  \nLas prime ras descripciones de la enfermedad de \nNewcastle Velog\u00e9nica Vicerotr\u00f3pica (ENVV) en M\u00e9xico datan de 1946 cuando Camargo y T\u00e9llez Gir\u00f3n \nen un brote que fue confundido con c\u00f3lera aviar logran \nreconocer y diagnosticar la enfermedad. Olvera en \n1948 registr\u00f3 la muerte de 300, 000 gallinas en el \nDistrito Federal, describi\u00f3 una enfermedad con \ninfecci\u00f3n de tipo agudo, donde los animales muestran decaimiento, anorexia, plumas erizadas, diarrea y otros \nsignos caracter\u00edsticos de una septicemia. Los animales \nten\u00edan cian osis, edema de la cabeza, del cuello, del \ntorax, de los parpados y de la cresta. Algunos animales \nmor\u00edan en esta etapa, mientras que los que sobreviv\u00edan \npresentaban signolog\u00eda nerviosa: tort\u00edcolis, opist\u00f3tonos, epist\u00f3tonos, tics entre otros.  \nLa enfermedad de Newcastle (ENC) ha sido un \nserio problema para la avicultura mexicana, ya que su desarrollo se ha visto frenado por las diversas formas de presentaci\u00f3n de la enfermedad.  \nEn M\u00e9xico existen los cuatro tipos de \npresentaci\u00f3n de la ENC registrados por Hanson : el tipo \nHitchner, Beaudette, Beach y Doyle es ultim\u00f3 es una \nforma aguda y letal para aves de cualquier edad, en este \ntipo de presentaci\u00f3n se encuentran a las cepas mexicanas de la ENC Ixtapalapa, Quer\u00e9taro y \nChimalhuac\u00e1n.  \nLa ENC es m\u00e1s frecuente en aquel las \u00e1reas con \nalta densidad de poblaci\u00f3n av\u00edcola como Monterrey, Saltillo, Torre\u00f3n, Guadalajara, Tehuacan, en las que el \ntipo de presentaci\u00f3n en velog\u00e9nico vicerotr\u00f3pico.  \nA partir de 1991 se ha notado a nivel mundial, un \naumento de la incidencia de brotes  de la enfermedad. \nEn los \u00faltimos a\u00f1os en Australia, Honduras, Italia, \nJap\u00f3n y M\u00e9xico entre otros han informado brotes de la \nenfermedad. A nivel nacional durante 1998 se \nregistraron 30 focos de ENVV, 20 en 1999 y mas de 41 \nfocos en el 2000 a ra\u00edz del brote  en la comarca \nLagunera, en donde fueron sacrificadas mas de 13, 610, \n008 aves de 93 granjas afectadas, las cuales fueron \ndespobladas.  Las cepas mexicanas del virus de la enfermedad \nde Newcastle velog\u00e9nica vicerotr\u00f3pica (VENVV) estudiadas hasta la fecha ha n mostrado algunas \ndiferencias en su \u00edndice de neuropatogenicidad en \npollitos de 1 d\u00eda de edad, tiempo medio de mortalidad y \nsu compartamiento frente a gl\u00f3bulos rojos de diferentes \nespecies animales.  \nEl presente estudio tuvo como objetivo realizar la \ncaracterizaci\u00f3n biol\u00f3gica de cuatro cepas velog\u00e9nicas y \nuna lentog\u00e9nica del virus de la enfermedad de \nNewcastle, as\u00ed como realizar una comparaci\u00f3n entre sus propiedades biol\u00f3gicas dada su patogenicidad.  \n \nMATERIAL Y MET\u00d3DOS  \nSe utilizaron cuatro cepas vel\u00f3genica s donadas \npor el Dr. Tamas Fehervari las cuales estaban \nconservadas a \u2013 85\noC, estas cepas correspond\u00edan a la \ncepa Chimalhuac\u00e1n y Quer\u00e9taro aisladas en M\u00e9xico \nentre los a\u00f1os 50\u2019s y 60\u2019s las cuales son usadas como \ncepas de desaf\u00edo en pruebas de constataci\u00f3n en el \nDepartamento de Producci\u00f3n Animal: Aves, adem\u00e1s de \nutilizar 2 cepas aisladas en el Laboratorio de \ndiagn\u00f3stico del mismo departamento en el a\u00f1o 2000 \nprovenientes una de la delegaci\u00f3n Tlalpan del Distrito \nFederal y otra del estado de Torre\u00f3n; las cuales  \nproven\u00edan de gallos de pelea y pollo de engorda \nrespectivamente, adem\u00e1s de la cepa La Sota.  \n Para la caracterizaci\u00f3n de estas cepas se \nrealizaron las siguientes pruebas:  \nHemoaglutinaci\u00f3n (HA):  La capacidad del virus \nde la enfermedad de Newcastle (VEN) par a aglutinar \nc\u00e9lulas rojas sangu\u00edneas se debe a la fijaci\u00f3n de la prote\u00edna HN a los receptores de superficie de los \neritrocitos. Para esta prueba se utilizo una suspensi\u00f3n de eritrocitos de ave al 2% y sobre una placa de acr\u00edlico \nse colocaron 100\u00b5l de liqui do alantoideo y 100\u00b5l de la \nsuspensi\u00f3n de eritrocitos de ave al 2%.  \nTiempo de elusi\u00f3n (TEL) o actividad \nneuraminidasa:  La enzima neuraminidasa es tambi\u00e9n \npartede la mol\u00e9cula HN del VEN, el TEL e un \u00edndice \nque se utiliza para agrupar de manera amplio los aislamientos de VENC  como en agentes de elusi\u00f3n \nr\u00e1pidos o lentos. Una vez que se hizo evidente la \nhemoaglutinaci\u00f3n se tomo el tiempo en que se provoco \nel efecto de elusi\u00f3n.  \nTermoestabilidad (TES): es una prueba basada \nen la actividad de hemoaglutinaci\u00f3n del  virus despu\u00e9s \nde ser sometido a tratamiento t\u00e9rmico. Las cinco cepas \nfueron sometidas a una temperatura de 56\noC y se \ntomaron 100\u00b5l de cada uno de los liquidos alantoideos \na los 0, 5, 10, 15, 30 y 60 minutos para determinar que aun hemoaglutinaban.  \nDetermi naci\u00f3n de unidades hemoaglutinantes \n(UHA):  dada la capacidad del virus de hemoaglutinar \ngl\u00f3bulos rojos de ave se puede titular el virus y as\u00ed \ndeterminar la cantidad de UHA que tiene. Para esto se  \n  \n81 emplearon placas para IH y se realizaron diluciones del \nvirus en logaritmo base 2 y despu\u00e9s del 30 minutos de \nincubaci\u00f3n se determino el t\u00edtulo del virus en unidades \nhemoaglutinantes.  \nInhibici\u00f3n de la hemoaglutinaci\u00f3n (IH):  Dado \nque la actividad hemoaglutinante puede deberse a \ncualquiera de los 9 serotipos de param ixovirus aviares \no a cualquiera de los subtipos de hemoaglutinina tipo A \nde influenza. La demostraci\u00f3n de que el virus es de un \nserotipo espec\u00edfico puede llevarse a cabo por la prueba \nde IH con antisueros espec\u00edficos. Esta prueba fue \nrealizada  por el m\u00e9to do \u03b1 (suero constante -virus \ndiluido).  \nDosis letal embri\u00f3n de pollo 50%(DLEP50%):  \nes una prueba utilizada para determinar la diluci\u00f3n de \nvirus en la cual mueren el 50% de los embriones de \npollo inoculados. La DLEP50% fue determinada \nmediante el m\u00e9todo de R eed and Muench.  \nRango de mortalidad en embri\u00f3n de \npollo(RMEP): dadas las caracter\u00edsticas biol\u00f3gicas del \nVEN este ha sido clasificado como velog\u00e9nico, \nmesog\u00e9nico y lentog\u00e9nico, clasificaci\u00f3n realizada en \nbase al tiempo que tarda en matar al embri\u00f3n de poll o.  \nCada una de estas pruebas se llevo a cabo \nconforme a lo descrito en el A Laboratory manual for \nthe isolation and identification of avian pathogens.  \n \nRESULTADOS  \nEn la prueba de HA las 5 cepas empleadas \nhemoaglutinaron gl\u00f3bulos rojos de ave al 2%.El TEL para las cepas Chimalhuac\u00e1n, Quer\u00e9taro, Tlalpan y Torre\u00f3n fue en promedio de 14 minutos y para la cepa \nLa Sota de 26. La TES para todas las cepas fue de 5 \nminutos a 56\noC, en cuanto a las UHA las cepas \nChimalhuac\u00e1n, Quer\u00e9taro y La Sota tuvieron 4096 UHA, la  cepa Tlalpan 2048 y la Torre\u00f3n de 512. Para \nla prueba de IH las 5 cepas se inhibieron con antisuero \npara el VEN. La DLE50% fue de 10\n6.7 para la cepa \nChimalhuac\u00e1n, 106.3 para Quer\u00e9taro, 109.07 para \nTlalpan,  108.3 para Torre\u00f3n y 107.8 La Sota. El RMEP \nfue de 36 a 48 horas para las cepas Chimalhuac\u00e1n, \nQuer\u00e9taro, Tlalpan y Torre\u00f3n, mientras que para la cepa La Sota fue de 96 -140 horas.  \n  \nCONCLUSIONES Y DISCUSI\u00d3N  \nLos datos mas relevantes de este estudio \ncorreponden a el TEL ya que las 4 cepas v\u00e9logenicas fuero n clasificadas como de elusi\u00f3n intermedia y la \ncepa La Sota se comporto como de elusi\u00f3n lenta dato \nque corresponde con lo mencionado por King and Seal \n(1997). Para la termoestabilidad las 5 cepas evaluadas \nno mostraton actividad hemoaglutinante despu\u00e9s de ser \ntratadas a 56\noC por 10 minutos. Estos datos difieren \ncon los resultados obtenidos por Lara (1960) y Vel\u00e1zquez (1964) ya que mencionan que  la cepa Queretaro es estable a 56\noC por 120 minutos. En \ncuanto a los t\u00edtulos de UHA y DLEP50% se observan \nclaras diferencias entre cada una de las cepas. A pesar \nde que en este trabajo se describen propiedades de \ncepas que se usan como de desaf\u00edo es importante \nmencionar que no se cuentan con datos para establecer \nuna comparaci\u00f3n entre las cepas trabajadas para poder decir que estas han aumentado o disminuido su \npatogenicidad por lo que con esto se pretende poder \ncontar con datos de referencia para posteriores trabajos.  \n \nREFERENCIAS  \n1. Alexander D.J. Enfermedad de Newcastle y \notras infecciones por paramixovirus  In: Enfer medades \nde las aves, Calnek, B.W. Barnes, H.J. Beard, C.W. \nReid, W.M. Yorder, Jr. H.W. eds. Iowa State \nUniversity Press, Ames, Iowa, USA. pp 386 -439. 2000  \n2. Benjam\u00edn L.M. Panorama de la enfermedad \nde Newcastle en M\u00e9xico. Vet. Mex. pp. 30 -34. 1976.  \n3. King D.J.  and Seal B.S. Biological and \nMolecular Characterization of Newcastle Disease Virus Isolates Surveillance of live bird markets in the \nNortheastern United States. Avian Dis. 41:683 -689. \n1997.  \n4. Lara, F.A.M. Estudio de algunas \ncaracter\u00edsticas del virus de la enfermedad de Newcastle. Memorias del simposium de la Enfermedad \nde Newcastle, 1960. M\u00e9xico (DF) pp 14- 20.1960.  \n5. Senne D.A. Virus propagation in \nEmbryonating eggs. In: A laboratory manual  for the isolation and identification of avian pathogens, D.E. \nSwayne,  J.R. Glisson, M.W. Jackwood, J.E. Pearson, \nW.M. Reed, eds. Kendall/Hunt Publishing Company, \nPennsylvania. pp 235 -240. 1998.  \n6. Thayer S.G. and Beard C.W. Serologic \nProcedures. In: A laboratory manual  for the isolation and identification of avian pathogens, D.E. Swayne, \nJ.R. Glisson, M.W. Jackwood, J.E. Pearson, W.M. \nReed, eds. Kendall/Hunt Publishing Company, Pennsylvania. pp 255 -266. 1998.  \n7. Vel\u00e1zquez, E.A. Aceves, F.A. Temblador, \nA.S. Garc\u00eda M.A. Simroth, L.H. Hern\u00e1ndez, S.R. \nGonz\u00e1lez, G.R. Caracter\u00edsticas d e algunas cepas del \nvirus de la enfermedad de Newcastle aisladas en \nM\u00e9xico. Memorias del simposium de las enfermedades respiratorias de las aves, 1964. M\u00e9xico (DF) pp 103-\n109. 1964.  \n8. Villegas P. Titration of biological \nsuspensions. In: A laboratory manual  for the isolation \nand identification of avian pathogens, D.E. Swayne, \nJ.R. Glisson, M.W. Jackwood, J.E. Pearson, W.M. Reed, eds. Kendall/Hunt Publishing Company, \nPennsylvania. pp 248 -254 1998.  \n \n  \n  \n82 AISLAMIENTO E IDENTI FICACI\u00d3N DE PASTEURELLA \nHAEMOLYTICA AVIAR  \n \nISOLATION AND IDENTIFICATION OF PASTEURELLA HAEMOLYTICA \nAVIAR  \n \nV\u00e1zquez M.E., Campogarrido M.R., Gonz\u00e1lez C.P. y Sivanandan V.  \n \nBoehringer Ingelheim Vetmedica S.A. de C.V. Departamento de Investigaci\u00f3n y Desarrollo.  \nCalle 30 No. 2614. Zona Industrial. Gu adalajara, Jalisco M\u00e9xico. Email: evazquez@gua.boehringer -ingelheim.com  \n \nSUMMARY  \nEvidence of Pasteurella haemolytica  prevalence \nin poultry is scarce. (1,2). This germ has been \nfrequently isolated from birds with respiratory and \nreproductive problems. Fiel d prevalence of P. \nhaemolytica needs to be known in order to understand \nits roll in pathological conditions. Identification methodology for this pathogen was implemented. P. \nhaemolytica  was isolated from several breeder, layer, \nand broiler organs. In Mexic o 5 different P. \nhaemolytica  biogroups prevail, i.e: 1, 2, 4, 7, and U. \nTheir roll in respiratory and reproductive conditions should be analyzed.  \n \nRESUMEN  \nLas evidencias de la prevalencia de Pasteurella \nhaemolytica  en aves son pocas (1,2), y en M\u00e9xico su \naislamiento ha sido frecuente en aves con problemas \nrespiratorios y reproductivos.  \nCon el fin de conocer el rol de P. haemolytica , es \nnecesario establecer la prevalencia del microorganismo en campo,  para ello se implement\u00f3 \nuna metodolog\u00eda  para su identifi caci\u00f3n. Este \nmicroorganismo fue aislado en aves reproductoras, ponedoras y pollo de engorda a partir de diversos \u00f3rganos. En M\u00e9xico prevalecen cinco diferentes \nbiogrupos de P. haemolytica : 1, 2, 4, 7 y U.  Su papel \nen cuadros respiratorio y reproductivos debe de \nanalizarse.  \n \nINTRODUCCION.  \nPasteurella haemolytica  aviar es cocob\u00e1cilo \ngram -negativo, peque\u00f1o, no m\u00f3vil, encapsulado con \nligero pleomorfismo y que algunas veces presenta \ntinci\u00f3n bipolar, es \u00df -hemol\u00edtico presentando zonas de \nhem\u00f3lisis m\u00e1s grandes com paradas con P. haemolytica \nde origen bovino; algunas cepas pueden ser de \nnaturaleza seca mientras que otras son suaves y cremosas.  \nSon pocos los estudios encaminados a obtener la \nidentificaci\u00f3n y diferenciaci\u00f3n de P. haemolytica aviar \npor lo que su clasif icaci\u00f3n esta basada en los estudios \nrealizados para P. haemolytica en rumiantes, esta clasificaci\u00f3n antiguamente estaba regida por la fermentaci\u00f3n de dos az\u00facares la cual  agrupaba  los aislamientos en dos biotipos; el biotipo A (cepas que fermentan arabin osa pero no trealosa) y el biotipo T \n(todas las cepas fermentan trehalosa) (4).  A pesar de que el empleo de pruebas de fermentaci\u00f3n de az\u00facares \npara la determinaci\u00f3n de biogrupos y variantes es \ncomplicada a\u00fan continua realizandose, solo que ahora \ncon un m ayor grupo de az\u00facares en combinaci\u00f3n con \npruebas enzim\u00e1ticas, convirtiendose en una \nmetodolog\u00eda a\u00fan mas compleja (3). No obstante a las \nmodificiaciones que se han hecho para la identificaci\u00f3n \nde estos microorganismos no productores de indol y \nureasa negat ivos se sigue presentando una gran \nheterogeneidad bioqu\u00edmica.  Considerando todos  estos \nfactores, varios investigadores han tratado de poner en \nevidencia el porque de la existencia de tantas variantes \npor lo que han tenido que desarrollar estudios con \npruebas m\u00e1s sofisticadas como ribotipificaci\u00f3n, \nsecuenciaci\u00f3n de rDNA 16S y  hibridaci\u00f3n de DNA -\nDNA (5). De esta forma  P. haemolytica esta tendiendo \na ser reclasificada considerando a las cepas trealosa (+) \ny arabinosa ( -) como Pasteurella trehalosi, mientra s \nque las cepas que son ya sea arabinosa (+) o arabinosa \n(-) pero trealosa ( -) entrarian a formar parte del genero \nMannhemmia, el cual esta formado por las siguientes especies: haemolytica , glucosida, varigena, \ngranulomatis, ruminalis (5, 6).  \nEl objetivo d el presente trabajo fue conocer la \nprevalencia de P. haemolytica en diferentes regiones de M\u00e9xico mediante su aislamiento e identificaci\u00f3n  a partir de brotes de campo.  \n \nMATERIAL Y METODOS  \nMonitoreo. La mec\u00e1nica del estudio fue el obtener \nlos aislamientos a partir de aves enfermas que \npresentaran signolog\u00eda caracter\u00edstica a una infecci\u00f3n \npor P. haemolytica, para esto se recopilar\u00f3n muestras \nen todas las zonas av\u00edcolas de la rep\u00fablica o en su defecto nuestro equipo tom\u00f3 las muestras en el lugar \ndel problema.  Las muestras que se tomaron fueron de \nhendidura palatina, senos nasales, tr\u00e1quea, coraz\u00f3n, \nh\u00edgado, pulmones y g\u00f3nadas.   \n  \n83 Aislamiento. Las muestras fueron colocadas en \ntubos con caldo triptosa e incubadas durante 24h a \n37\u00baC. Partes de 20 \u00b5l se sembraron en cajas de agar \nsangre de ovino utilizando la t\u00e9cnica de aislamiento por \nestria, las placas se incubaron de 24 -48 h a 37\u00baC. Las \ncolonias que se consideraron como sospechosas presentaron  \u00df -hem\u00f3lisis, convexas bajas de 0.5 a 1.0 \nmm de di\u00e1metro, brillosas y cristalinas adem\u00e1s de ser \ncatalasa y oxidasa positivas.  \nIdentificaci\u00f3n.   Para la determinaci\u00f3n de \nbiogrupo se utiliz\u00f3 una modificaci\u00f3n de la t\u00e9cnica descrita por Jaworski et al. (3).  \n \nRESULTADOS  \n Los aislamientos (n=117) se recuperaron a partir \nde senos nas ales, hendidura palatina, tr\u00e1quea, h\u00edgado, \ncoraz\u00f3n, pulm\u00f3n y ovario. El 47% de los aislamientos fueron obtenidos en el estado de Puebla, el 26% de \nYucatan, 7% de Jalisco, 6% de Veracruz, 5% de Queretaro, 3% de Nuevo Le\u00f3n, 3% de Sinaloa y 3% \ndel Edo. de M\u00e9x ico.  Los biogrupos de P. haemolyica  \nencontrados en este estudio fueron el 1, 2, 4, 7 y U, \ncorrespondiendo el 78% para el biogrupo 4 ( P. \ntrehalosi), 9% para el biogrupo 2 ( P. trehalosi) ,  9% \npara el biogrupo 1 ( Manhemmia haemolytica), 3% para \nel biogrupo U  (sin clasificaci\u00f3n) y 1% para el biogrupo \n7 (sin clasificaci\u00f3n).  \n Por su parte el 78% de los aislamientos fueron \nrecuperados de gallina de postura cuyo rango de edad \noscil\u00f3 entre las 20 y 40 semanas, encontrandose la \npresencia de los 5 biogrupos antes men cionados. En \nreproductoras de 40 a 60 semanas de edad el 12 % de \nlos aislamientos estuvieron comprendidos por los \nbiogrupos 1,2 y 4; mientras que el 10% restante fue \nobtenido a partir de pollo de engorda de 7 a 8 semanas \nsemanas de edad , estando involucra dos los biogrupos \n2, 4 y U.  \n De los 117 aislamientos estudiados se econtr\u00f3 la \npresencia de 27 biovariantes siendo las m\u00e1s prevalentes las variantes 4\nBCDGSX (n=43) y 4CDGSX (n=26).  \n      \nCONCLUSIONES Y DISCUSION  \nPara poder entender cual es el papel que \nrealmente desempe\u00f1a la P. haemolytica aviar primero \nes necesario conocer y entender que tipos de bacterias se encuentran involucradas en las diferentes funciones \nzootecnicas de las aves. Para nuestro equipo de trabajo el principal paso era el desarrollar una m etodolog\u00eda que \nnos permitiera diferenciarlos con precisi\u00f3n ya que la \nmetodolog\u00eda de serotipificaci\u00f3n desarrollada para \nbovinos arroj\u00f3 datos muy variables con un mismo tipo \nde bacteria (datos no mostrados). La metodolog\u00eda \nempleada por Jaworski et al (3), pe rmiti\u00f3 obtener datos \nconfiables y repetitivos entre varias pruebas con un \nmismo aislamieto.  De acuerdo a los nuevos sistemas de clasificaci\u00f3n \nP. trehalosi  (bacterias trealosa positivas biogrupos 2 y \n4), estuvo involucrada en la mayoria de los casos tanto  \nde gallina de postura, reproductoras y pollo de engorda. Se ha reportado que P. trehalosi  coloniza las amigdalas \nde ovinos en espera de alg\u00fan tipo de estr\u00e9s como puede ser el transporte, cambios en el reg\u00edmen alimenticio, \nhumedad etc., considerandose este tipo de infecci\u00f3n \nm\u00e1s raro que la provocada por Mannhemia haemolytica \n(biogrupo 1), lo cual se contrapone con nuestros \nresultados; al mismo tiempo en gallina de postura el \ndesarrollo de la enfermedad fue en el per\u00edodo en que el ave sufre un stress hormona l muy fuerte lo que pudiera \ndesencadenar la infecci\u00f3n de las aves con esta bacteria.  \nAunque la infecci\u00f3n con P. haemolytica  esta m\u00e1s \nfrecuente relacionada en gallina de postura, tambien puede ser encontrada en pollo de engroda y en \nreproductoras, lo cual nos sugiere que es importante reforzar los estudios en estos campos a fin de tener un \nconocimiento m\u00e1s amplio de lo que realmente esta \nsucediendo.  \nLos resultados mostraron que los estados con \nmayor incidencia de estos problemas son Puebla y \nYucat\u00e1n tal ve z debido a que son zonas que manejan \nuna alta densidad de aves y que son lugares en donde existen condiciones clim\u00e1ticas extremas como son frio, \ncalor y humedad.  \nEste estudio nos da una perspectiva m\u00e1s clara del \npapel de P. haemoliyica en campo, de cuales  son los \ntipos de bacterias que se encuentran ocasionando este \ntipo de infecciones y sobretodo reafirma la teoria de \nque este agente bajo ciertas condiciones puede \nconvertirse en un primario, al mismo tiempo se ha \nmanejado que esta bacteria es flora normal  del tracto \nrespiratorio superior de las aves sin embargo al \nmonitorear aves sanas sin ning\u00fan tipo de signo cl\u00ednico que pudiera sugerir enfermedad no fue posible el \naislamiento de P. haemolytica. De esta manera \nconsideramos  es sumamente importante que se \ncontinue con este tipo de estudios a fin de comprobar y determinar cual es realmente el papel de P. \nhaemolytica en aves.  \n   \nREFERENCIAS  \n1. Hacking C.W & Pettit J.R. Pasteurella \nhaemolytica in pullet and laying hens. Avian diseases. \n18(3): 483- 486. 1974.  \n2. V\u00e1zqu ez M.E., Campogarrido M.R., \nCubillas C.A., Coss J., Gonz\u00e1lez C.P. y Sivanandan V. \nReporte de un caso de Pasteurella haemolytica en \ngallina de postura (Babcock) en teh\u00faacan Puebla.  \nMemorias del XXVI convencion anual ANECA, \nAcapulco, Guerrero. M\u00e9xico. P\u00e1g: 3 17-319.  \n3. Jaworski  M.D., L. Hunter, A. C. S. Ward. \nBiovariants of isolates of Pasteurella from domestic \nand wild ruminants. J. Vet. Invest. 10:49 -55. 1988.   \n  \n84 4. Adlam C.  y  J.M. Rutter. The structure, \nfunction and properties of cellular and extracellular \ncomponents of Pasteurella haemolytica.  Chapter 4. \nPasteurella and Pasteurellosis. Academic Press \nLimited. Pag: 75 -92. 1989.  \n5. Angen Oysten, Mutters Reinier, Caugant \nD.A., Olsen J.E and Bisgaard Magne. Taxonomix relationships of the [ Pasteurella ] haemolytica  compl ex \nas evaluated by DNA -DNA hybridizations ann 16S \nrRNA sequencing with proposal of Mannheimia haemolytica  gen. nov., comb. nov., Mannheimia \ngranulomatis comb. nov., Mannheimia glucosida sp. \nnov., Mannheimia ruminalis sp. nov. and Mannheimia \nvarigena sp. n ov. International Journal of Systematic \nBacteriology. 49: 67- 86. 1999.  \n6. Angen Oysten, Quirie Malcolm, Donachie \nWillie, Bisgaard Magne. Investigations on the species specificity of Mannheimia (Pasteurella) haemolytica \nserotyping. Veterinary Microbiology. 65:  283-290. \n1999.\n \nIMPACTO DE LA PASTEURELLA HAEMOLYTICA  \nEN PARVADAS COMERCIALES  \n \nTHE IMPACT OF PASTERUELLA HAEMOLYTICA ON  \nCOMMERCIAL FLOCKS  \n \nCampogarrido M.R.,V\u00e1zquez M.E.,  Gonzalez C.P. y Sivanandan V.  \n \nBoehringer Ingelheim Vetmedica S.A. de C.V. Departa mento de Investigaci\u00f3n y Desarrollo.  \nCalle 30 No. 2614. Zona Industrial. Guadalajara, Jalisco M\u00e9xico. Email: rcampoga@gua.boehringer -ingelheim.com  \n \nSUMMARY  \nWith the participation of poultry producers and \nfield practitioners, information from commercial la yer \nand broiler flocks was gathered. P. haemolytica  was \nidentified as the causative agent of respiratory and reproductive  conditions, with a 6- 20% decrease in egg \nproduction, and varying mortality rates. Information \nabout control measures with antimicrobials was also \nobtained. Some alternatives to prevent this particular disease in commercial flocks are discussed.  \n \nRESUMEN  \nCon la ayuda y participaci\u00f3n de avicultores y \ncl\u00ednicos de campo se recopil\u00f3 informaci\u00f3n de parvadas de postura comercial y de pollo de engorda en donde  P. haemolytica  se identific\u00f3 como el agente causal de \nprocesos de tipo respiratorio y reproductivo en donde \nexiste una  reducci\u00f3n de la producci\u00f3n que oscil\u00f3 entre \nun 6 a 20 % con unos porcentajes de mortalidad \nvariables. Adem\u00e1s se obtuv\u00f3  informaci\u00f3n acerca de las \nmedidas de control de los problemas a trav\u00e9s del uso de antimicrobianos y por \u00faltimo se mencionan algunas alternativas para prevenir esta enfermedad en las \nparvadas comerciales.  \n   \nINTRODUCCION  \nPasteurella haemolytica  aviar es un  cocob\u00e1cilo \ngram -negativo, peque\u00f1o, no m\u00f3vil, encapsulado con \nligero pleomorfismo y que algunas veces presenta tinci\u00f3n bipolar, es \u00df -hemolitico. Durante mucho tiempo \nel rol de la Pasteurella haemolytica  en las parvadas \ncomerciales fue considerado como circunstancial e incluso solo se le atribu\u00eda su participaci\u00f3n como un \nagente secundario; es en el a\u00f1o de 1974 cuando aparece \nuna publicaci\u00f3n cient\u00edfica que involucra a  P. \nhaemolytica  como un agente primario en cuadros \npatol\u00f3gicos en gallinas de postura (1). S in embargo, en \nM\u00e9xico en a\u00f1os recientes han sido cada vez m\u00e1s los cl\u00ednicos en campo y los laboratorios de diagn\u00f3stico que \nhan encontrado a este agente como causal de cuadros \nrespiratorios y reproductivos en aves que merman la \nactividad productiva y por ende ocasiona un impacto econ\u00f3mico en la industria av\u00edcola.  \nAnteriormente el lograr el aislamiento de P. \nhaemolytica  en las aves a partir de muestras de \nhendidura palatina y de tracto respiratorio superior en general era visto como algo habitual ya que se \nconsideraba a este agente como un habitante \u201cnormal\u201d \nen esos tejidos, pero actualmente el aislamiento de esta \nbacteria es cada d\u00eda m\u00e1s frecuente y adem\u00e1s a partir de \notros \u00f3rganos internos y no relacionados con el tracto \nrespiratorio; este patr\u00f3n se repet\u00eda en diferentes \nparvadas en donde se presentaban cuadros cl\u00ednicos similares con comportamiento parecidos y donde el \ncom\u00fan denominador de nuevo era el aislamiento de P. \nhaemolytica .   \nEl objetivo del presente trabajo es exponer los \ndatos que durante m\u00e1s de un a\u00f1o se han recabado con referencia a problemas productivos en donde se ha identificado a P. haemolytica  como responsable de los \nprocesos patol\u00f3gicos en diversas regiones de M\u00e9xico como ser\u00edan los estados de Nuevo Le\u00f3n, Sinaloa, \nJalisco, Quer\u00e9taro, Edo. De M\u00e9xico, Puebla, Veracruz \ny Yucat\u00e1n.   \n  \n85 MATERIAL Y METODOS  \nToda la informaci\u00f3n proviene de los seguimientos \nque Boehringer Ingelheim Vetmedica a realizado con \ndiferentes clientes en varias zonas de la Rep\u00fablica \nMexicana, por lo que los datos presentados son un  \nresumen de todas las histor\u00edas cl\u00ednicas levantadas para cada caso con la colaboraci\u00f3n de los M\u00e9dicos \nencargados de las parvadas correspondientes as\u00ed como \nlos resultados de laboratorio que se obtuvieron en su \noportunidad, los cuales se muestran en el Cuadr o No.1  \nPara hacer un poco m\u00e1s comprensible la \ninformaci\u00f3n, \u00e9sta se dividir\u00e1 en dos grupos 1) Gallina \nde postura y 2) Pollo de Engorda.  \n \nRESULTADOS  \n1) Gallina de Postura.  \nEn este caso se cont\u00f3 con informaci\u00f3n referente a \nla zona centro y sur del pa\u00eds en donde  se afectar\u00f3n \nparvadas comerciales en la etapa de producci\u00f3n donde \nse encontr\u00f3 que  entre 22 y 24 semanas de edad fueron \nla m\u00e1s afectadas, aunque tambi\u00e9n se obtuvieron datos \nde parvadas con 40 semanas de edad. Las parvadas \nafectadas se manejaron con un sis tema tradicional o \ncon equipo automatizado y en casetas elevadas con \npoco uso de personal para su atenci\u00f3n.  \nEl cuadro cl\u00ednico inici\u00f3 con un problema \nrespiratorio ligero con secreci\u00f3n nasal, edema periorbital, deshidrataci\u00f3n, diarrea de color variable \n(blan quecina y verdosa), disminuci\u00f3n en el consumo de \nalimento, ca\u00edda de crestas con un cambio de coloraci\u00f3n \n(cian\u00f3ticas), la producci\u00f3n se detuvo por 3 a 4 d\u00edas, \ndespu\u00e9s de una semana las aves mostraron una p\u00e9rdida \nde peso severa.  \nAl realizar la necropsia de l as aves afectadas se \nobserv\u00e1n las siguiente lesiones: Hepatomegalia, bazo \ninflamado y con un color como de \u201cuva\u201d , hemorragias en grasa abdominal, hemorragias en cavidad tor\u00e1cica, \nhemorragias en la superficie del proventr\u00edculo, \nhemorragias en coraz\u00f3n, ovar ios en regresi\u00f3n o \natrofiados, foliculos ovaricos deformes y algunos con \nlicuefacci\u00f3n en su contenido, l\u00edquido en cavidad \nabdominal, hemorragias en oviducto y adem\u00e1s es no \nfuncional.(2).  \nEl aislamiento bacteriano fue exitoso a trav\u00e9s de \nhendidura palatina,  tr\u00e1quea, l\u00edquido peritoneal, h\u00edgado, \nproventr\u00edculo, ovario y oviducto.  \nPor otro lado los tratamientos que se le \nadministraron a las parvadas tuvieron resultados variables, encontrandos\u00e9 situaciones en donde una \nmedicaci\u00f3n con Sulfas y Trimetoprim fueron e fectivas \npara controlar el problema, as\u00ed como casos en donde \ntratamientos con diferentes principios activos y rutas de \naplicaci\u00f3n no surtieron ning\u00fan efecto en las aves. En este caso al igual que en el pollo de engorda se ha \nintentado el controlar la infec ci\u00f3n por P. haemolytica  a trav\u00e9s de la vacunaci\u00f3n a diferentes edades de las aves \ncon resultados muy alentadores.  \nLa mortalidad no tiene un incremento muy \nsubstancial aunque s\u00ed se presenta; pero el verdadero \nproblema, en la parvada es el estancamiento de la \nproducci\u00f3n de huevo y el tama\u00f1o del mismo, ya que las \naves afectadas algunas regresan a la producci\u00f3n pero el tama\u00f1o del huevo se ve disminuido.     \n2) Pollo de Engorda  \nEn este caso se dispone de informaci\u00f3n \nprocedente de la zona centro del pa\u00eds y de los e stados \nde Jalisco, Nuevo Le\u00f3n  y  de Sinaloa. Las parvadas de engorda se criaron en condiciones convencionales; esto es, en piso con comederos manuales tipo tolva, \nbebederos autom\u00e1ticos de campana tipo Plasson, la \nventilaci\u00f3n podr\u00eda ser natural a trav\u00e9s de cortinas o \nforzada con ayuda de extractores y ventiladores.  \nEl cuadro cl\u00ednico inicia alrededor de la 5a. y 6a. \nsemana de edad como un proceso respiratorio agudo \nobservandos\u00e9 cabezas inflamadas, estornudos, pollo \nca\u00eddo, depresi\u00f3n, las aves dejan de consumi r alimento, \nbaja uniformidad de la parvada y un aumento en la \nmortalidad que puede ir de un 3 a 8 % en el transcurso \nde una sola semana.  \nAl realizar la necropsia de los animales se \nencontraron las siguientes lesiones: tr\u00e1quea \ncongestionada y con hemorragia s en su porci\u00f3n \nsuperior, hemorragias en coraz\u00f3n, hemorragias en la \ncara interna de la cavidad tor\u00e1cica, hepatomegalia, \nbazo inflamado y hemorragico, hemorragias en \nm\u00fasculo (pierna y/o pechuga), hemorr\u00e1gias en grasa abdominal y aerosaculitis.  \nPara tratar d e controlar el cuadro las parvadas \nfueron sometidas a tratamientos diversos como ser\u00edan la aplicaci\u00f3n de Iodo y \u00e1cidos org\u00e1nicos por aspersi\u00f3n, aplicaci\u00f3n de antibioticos como la Fosfomicina, \nClortetraciclinas, Eritromicina, Sulfas por mencionar \nalgunos pe ro los resultados obtenidos son muy \nirregulares e incluso en ciertos casos la resistencia del microorganismo es muy alta a cas\u00ed todas los principios \nactivos. Por otro lado en algunas ocasiones se ha \nintentado el control del microorganismo en parvadas poste riores a trav\u00e9s de la vacunaci\u00f3n de las aves con \nresultados alentadores.  \nEl cuadro inicial en su fase aguda con el tiempo \npuede cambiar a un panorama de franca complicaci\u00f3n \ncon exudados caseosos observandose una colibacilosis \nque invade por completo al ave . \nEl aislamiento del agente fue exitoso a partir de \nhendidura palatina, traquea, h\u00edgado  \nLa pigmentaci\u00f3n de las aves no se ve afectada de \nmanera significativa pero si su peso y conversi\u00f3n \nalimenticia.  \n       \n  \n86 CONCLUSIONES Y DISCUSION  \nLos cuadros cl\u00ednicos oca sionados por  P. \nhaemolytica  en las parvadas comerciales tienen algunas \ndiferencias notables si comparamos las aves de engorda \ny las gallinas de postura; ya que en los primeros, el \nefecto negativo en las parvadas es basicamente debido \na la mortalidad que o casiona en las aves, la \ndisminuci\u00f3n en la ganancia de peso y la postraci\u00f3n de animales que termina con producir una parvada muy \ndispareja que muchas ocasiones es castigada en su \nprecio de venta. Con esta informaci\u00f3n es f\u00e1cil el \ndeducir el impacto econ\u00f3mico  que induce un problema \nde P. haemolytica en las parvadas de engorda de \nmanera directa. Por otro lado debemos de considerar dentro del impacto econ\u00f3mico todos aquellos gastos \nocasionados por el tratamiento de las aves como ser\u00edan: \ncosto del antibi\u00f3tico, co sto de la aplicaci\u00f3n y la mano \nde obra que se necesita para controlar los brotes en campo.  \nEn el caso de las parvadas de gallina de postura el \nimpacto de P. haemolytica  no es en gran medida \ndebido a la mortalidad ya que aunque existe un ligero \naumento de l a misma esta no es significativa, por otro \nlado hay otros parametros productivos que si son \nafectados dramaticamente como son la postura y la \nperdida de peso ya que esto implica una merma \nconsiderable en la producci\u00f3n de huevo y adem\u00e1s un \nretraso de la par vada que nunca se podr\u00e1 recuperar y se \ntendra que tratar de amortizar la p\u00e9rdida por el resto del ciclo productivo que le quede a la parvada.  \nEn cuanto a las opciones que se tienen para poder \ncontrolar los problemas por P. haemolytica  en la granja \npodemos mencionar como el No. 1 a el manejo integral \nadecuado de la parvada que comprometa la Bioseguridad y el uso de antibi\u00f3ticos de una manera razonada y mesuarada; ya que al emplear \nindiscriminadamente los antibi\u00f3ticos a manera de \nrutina o de un programa previ amente establecido \nacarrea problemas de resistencia bacteriana y que no \nsolo tiene que estar ligada a P. haemolytica  sino a todas \nlas bacterias  que en su momento pueden aparecer en la \nindustria av\u00edcola; esto origina problemas que ya estan \ncada d\u00eda siendo m\u00e1s frecuentes en el campo debido a \nque en algunas ocasiones no es posible el detener un \ncuadro septicemico con la ayuda de antibi\u00f3ticos, lo que \nprovoca que la  bacteria sea practicamente resistente a \ntodos los principios activos con los que se cuenta para  \nafrontar estos problemas.  \nLa opci\u00f3n No. 2 con la que se podr\u00eda contar es la \nvacunaci\u00f3n de las aves tanto para P. haemolytica  como \npara el resto de los agentes infecciosos. Aunque ya es posible el poder demostrar el rol primario de la P. \nhaemolytica  en la s aves eso no quiere decir que puedan \nexistir complicaciones virales o bacterianas que por consecuencia agraven el problema y sus p\u00e9rdidas \necon\u00f3micas.  \n \nREFERENCIAS  \n1. Hacking C.W & Pettit J.R. Pasteurella \nhaemolytica in pullet and laying hens. Avian diseases.  \n18(3): 483- 486. 1974.  \n2. V\u00e1zquez M.E., Campogarrido M.R., \nCubillas C.A., Coss J., Gonz\u00e1lez C.P. y Sivanandan V. \nReporte de un caso de Pasteurella haemolytica en \ngallina de postura (Babcock) en teh\u00faacan Puebla.  \nMemorias del XXVI convencion anual ANECA, \nAcapul co, Guerrero. M\u00e9xico. P\u00e1g: 317 -319. \n  \nCuadro  1.  \nGranja \nNo. Origen  Funci\u00f3n \nZootecnica  Edad (sem)  Aves en Granja  \n1 Yucat\u00e1n  Postura  22/4 300,000  \n2 Yucat\u00e1n  Postura  56/3 170,000  \n3 Puebla  Postura  20/6 595,000  \n4 Puebla  Postura  68/0 58,000  \n5 Puebla  Postura  41/0 115,000  \n6 Puebla  Postura  22/0 355,000  \n7 Jalisco  Engorda  2/0 36,000  \n8 Jalisco  Engorda  6/4 52,000  \n9 Sinaloa  Engorda  6/0 130,000  \n10 Morelos  Engorda  6/0 36,000  \n11 Morelos  Engorda  7/0 36,000  \n   \n  \n87 PATRONES DE RESISTENCIA ANTIBI\u00d3TICA EN PASTEURELLA \nHAEMO LYTICA AVIAR  \n \nANTIBIOTIC RESISTENCE PATTERN OF AVIAN PASTEURELLA \nHAEMOLYTICA  \n \nGonz\u00e1lez C. P., V\u00e1zquez M.E., Campogarrido M.R. y Sivanandan V.  \n \nBoehringer Ingelheim Vetmedica S.A. de C.V. Departamento de Investigaci\u00f3n y Desarrollo.  \nCalle 30 No. 2614. Zona Industrial. Guadalajara, Jalisco M\u00e9xico. Email: cgonzalez@gua.boehringer -ingelheim.com  \n \nSUMMARY  \nPasteurella haemolytica  was isolated from \nbroilers, layers, and breeders with \nrespiratory/reproduct ive conditions in hot/humid, \nregions of Mexico with high poultry concentrations. These conditions might have enhanced the incidence of \nthe problem. P. haemolytica was suggested as being \nthe causative agent in all these cases. Antibiotic in vitro \nsensitivit y to was investigated. A certain degree of \nresistance was found.  It is important to prevent \nantibiotic abuse for the control of these clinical \nconditions.  \n \nRESUMEN  \nPasteurella haemolytica  fue aislada de cuadros \nrespiratorios/reproductivos en pollo de engorda, gallina \nde postura y reproductoras localizadas en diferentes \nregiones de M\u00e9xico, donde se sugiri\u00f3 su participacion \ncomo agente causal. Se investig\u00f3 la sensibilidad in vitro  a antibi\u00f3ticos y los resultados mostraron un alto \ngrado de resistencia.  \nLos pr oblemas con P. haemolytica  se presentaron \nen regiones con una densidad de poblaci\u00f3n alta y \ncondiciones clim\u00e1ticas con calor y humedad;  factores \nque pueden favorecer a que el problema se presente. Es importante cuidar el no abusar del empleo de \nantibi\u00f3tic os para el control de estos cuadros cl\u00ednicos.  \n \nINTRODUCCION  \nP. haemolytica es un b\u00e1cilo pleomorfico gram -\nnegativo que generalmente ha sido considerado como \nun pat\u00f3geno secundario sin que todav\u00eda pueda comprobarse lo contrario, sin embargo los resportes de  \naislamientos de este microorganismo en el campo \ncontinuan presentandose proncipalmente en gallinas de \npostura que estan iniciando sus procesos productivos \nen donde se ha reportado una apreciable baja en la \nproducci\u00f3n de huevo sin que la calidad del mismo se vea afectado (1, 2).  \nEl uso de antimicrobianos en la industria av\u00edcola \nse esta convirtiendo en una pr\u00e1ctica com\u00fan no solo con el objetivo de solucionar infecciones de tipo bacteriano sino que algunos productores emplean estos compuestos como promotores de crecimiento a concentraciones bajas. El mal uso de estas drogas puede afectar el microambiente que se encuentra en los ecosistemas de las casetas de tal manera que se pueda \ninducir el nacimiento de nuevos microorganismos \naltamente resistentes y por cons ecuencia muy dificiles \nde combatir. Actualmente no se tiene conocimiento del \ncomportamiento de P. haemolytica aviar ante los \ndiversos antimicrobianos, por lo que el objetivo del presente trabajo fue determinar dichos patrones en \naislamientos de esta bacter ia obtenidos en el campo.  \n \nMATERIAL Y METODOS  \nMuestras. 67 aislamientos de P. haemolytica \nfueron obtenidos a partir de problemas de campo \nlocalizados en los estados de Puebla, Yucat\u00e1n, Jalisco, \nEdo. de M\u00e9xico, Quer\u00e9taro, Nuevo Le\u00f3n y Sinaloa. Las \naves afectadas fueron tanto gallina de postura, \nreproductoras y pollo de engorda. Los sitios de donde \nse obtuvieron los aislamientos de P. haemolytica  \nfueron hendidura palatina, senos nasales, h\u00edgado, \novario, tr\u00e1quea, coraz\u00f3n y pulm\u00f3n. Los aislamientos \nfueron puri ficados y se biotipificaron de acuerdo a la \nmetodolog\u00eda descrita por Jaworski et al (3). Para su \nconservaci\u00f3n las bacterias se propagaron en caldo \ncerebro coraz\u00f3n (BHI) el cual fue suplementado con \n15% de glicerol est\u00e9ril para ser almacenados a \u2013 70\u00baC.  \nAntibiogramas. La t\u00e9cnica empleada fue una \nmodificaci\u00f3n de la de Bauer -Kirby, en donde los \naislamientos se propagaron en cajas de agar sangre de ovino (BBL -220150) durante 24 horas a 37\u00baC. Tubos \ncon caldo triptosa (Difco 0062- 17-6) se inocularon con \nuna coloni a de aislada del cultivo en agar sangre, los \ntubos fueron incubados a 37\u00baC. Despu\u00e9s de 5 horas de \ncultivo las bacterias fueron crecidas en placas de agar \nsangre. Las drogas antimicrobianas incluidas en este \nestudio fueron Cefalotina (CF), Penicilina (PE), \nEnoxacina (ENX), Netilmicina (NET), Ceftriaxona \n(CRO), Trimetropin/sulfametoxazol (SXT), Ampicilina (AM), Eritromicina (E), Cloranfenicol (CL), \nDicloxacilina (DC), Amikacina (AK) y  Gentamicina \n(GE).  \n  \n  \n88 RESULTADOS  \nLos 67 aislamientos estudiados correspondier on a \n7 estados de la rep\u00fablica y estuvieron  distribuidos en \nla siguiente forma: Casos 1 y 2 (n=26, Puebla), caso 3 \n(n=3, Jalisco),  caso 4 (n=4, Edo. de M\u00e9xico), caso 5 \n(n=4, Quer\u00e9taro), caso 6 (n=2, Nuevo Le\u00f3n), caso 7 \n(n=24, caso Yucat\u00e1n), caso 8 (n=4, Sinaloa).  Como se observa en el cuadro 1, P. haemolytica present\u00f3 una \nalta resistencia a la penicilina, enoxacina, trimetropin -\nsufametoxazol, eritromicina y dicloxacilina. Sin \nembargo tambien es importante resaltar los resultados obtenidos para el cloranf enicol (casos 4, 5 y 6) ya que \npresentan un nivel de resistencia considerable. Los \ncasos 3, 5 y 6 fueron los que presentaron un mayor \npatron de resistencia para los 12 antimicrobianos \nutilizados. Al comparar los patrones de resistencia en \nbase al sitio de aislamiento se encontr\u00f3 que los \naislamientos obtenidos de hendidura palatina mostraron \ntener patrones de resistencia arriba de un 43%, \nmientras que los provenientes de otros organos \npresentaron un 53% .  \n \nCONCLUSIONES  \n  Los antibi\u00f3ticos m\u00e1s usados en la ind ustria \navicola para el tratamiento de infecciones con \nproblemas bacterianos resultaron ser los menos \neficaces , mientras que los antibi\u00f3ticos usados con m\u00e1s baja frecuencia fueron los m\u00e1s efectivos para el \ntratamiento de  P. haemolytica.  \n  Los patrones de re sistencia que mostraron los \naislamientos de P. haemolytica  obtenidos tanto de \n\u00f3rganos respiaratorios como sist\u00e9micos fueron \nigualmente susceptibles a los antibi\u00f3ticos probados.  \n  El mal uso de los antibi\u00f3ticos empleados para el \ntratamiento de infecciones de tipo bacteriano cada d\u00eda es mas frecuente y puede provocar cambios en la \nparticipaci\u00f3n de P. haemolytica. en estos problemas, \nademas que el someter a esta bacteria a una presi\u00f3n de \nresistencia a antibi\u00f3ticos puede favorece a que actue \ncomo un pat\u00f3geno pr imario.  \n \nREFERENCIAS  \n1. V\u00e1zquez M.E., Campogarrido M.R., \nCubillas C.A., Coss J., Gonz\u00e1lez C.P. y Sivanandan V. \nReporte de un caso de Pasteurella haemolytica en \ngallina de postura (Babcock) en teh\u00faacan Puebla.  \nMemorias del XXVI convencion anual ANECA, Acapulco, Guerrero. M\u00e9xico. P\u00e1g: 317 -319.  \n2. Hacking C.W & Pettit J.R. Pasteurella \nhaemolytica in pullet and laying hens. Avian diseases. \n18(3): 483- 486. 1974.  \n3. Jaworski  M.D., L. Hunter, A. C. S. Ward. \nBiovariants of isolates of Pasteurella from domestic \nand wild r uminants. J. Vet. Invest. 10:49 -55. 1988.  \n \nCuadro 1.  \nAntibi\u00f3tico  % de Resistencia de acuerdo al No. de Caso  \n1 2 3 4 5 6 7 8 \nCefalotina  62.5 5.6 100 0 0 0 0 0 \nPenicilina  100 83.3 100 100 100 100 95.8 100 \nEnoxacina  62.5 100 100 75 100 100 100 100 \nNetilmicina  12.5 0 0 0 0 0 4.2 0 \nCeftriaxona  0 5.6 0 0 0 0 0 0 \nTrimetropin -\nsulfametoxazol  100 94.4 100 100 100 100 12.5 100 \nAmpicilina  87.5 50 100 25 100 100 4.2 0 \nEritromicina  100 77.8 100 100 100 100 95.8 100 \nCloranfenicol  37.5 27.8 0 75 50 50 20.8 0 \nDicloxacilina  100 100 100 100 100 100 100 100 \nAmikacina  25 11.1 100 0 0 0 0 0 \nGentamicina  12.5 5.6 33.3 0 0 0 4.2 0 \n \n \n \n   \n  \n  \n89 LA VACUNACI\u00d3N COMO UN M\u00c9TODO DE CONTROL \nPASTEURELLA HAEMOLYTICA EN AVES  \n \nVACCINATION AS A CONTROL METHOD OF PASTEURELLA \nHAEMOLYTICA IN POULTRY  \n \nSivanandan V., Campogarrido R.M, V\u00e1zquez M.E y Gonz\u00e1lez C.P.  \n \nBoehringer Ingelheim Vetmedica S.A. de C.V. Departamento de Investigaci\u00f3n y Desarrollo.  \nCalle 30 No. 2614. Zona Industrial. Guadalajara, Jalisco M\u00e9xico. Email: vsivanan@gua.boehrin ger-ingelheim.com  \n \nSUMMARY  \nOne alternative for the control of Pasteurella \nhaemolytica -associated problems in the poultry \nindustry is prophylactic vaccination. With the \ndevelopment of a vaccine it is necessary to support \nvaccine safety and efficacy through  I) an experimental \nmodel establishing the conditions to reproduce the \nclinical condition, and the parameters to be evaluated, \nII) Vaccination with oil -adjuvanted vaccines prepared \nwith the most antigenic bio -groups of Pasteurella \nhaemolytica , and III) Con trolled, experimental \nchallenge trials to evaluate vaccine performance. Controlled vaccination trial results confirm vaccine the \nefficacy as an aid to reduce economic losses in \nsusceptible flocks.  \n \nRESUMEN  \n     Una de las alternativas para el control de lo s \nproblemas ocasionados por Pasteurella haemolytica  en \nla industria av\u00edcola es su profilaxis a trav\u00e9s de la \nvacunaci\u00f3n.  Con el desarrollo de una vacuna es \nnecesario el soportar la seguridad y eficacia de la \nmisma a trav\u00e9s de un  \nI. Modelo experimental en donde se \nestablezcan las condiciones para la reproducci\u00f3n del cuadro cl\u00ednico y los par\u00e1metros a evaluar.  \nII. Vacunaci\u00f3n a trav\u00e9s de biol\u00f3gicos en \nadyuvante oleoso conteniendo los biogrupos de Pasteurella haemolytica  m\u00e1s antig\u00e9nicos.  \nIII. Pruebas experimentales en condi ciones \ncontroladas en donde a trav\u00e9s de un desaf\u00edo experimental se evalue el desempe\u00f1o de las vacunas.  \n     Los resultados obtenidos con la vacunaci\u00f3n en \npruebas bajo condiciones controladas confirman la \neficacia y la ayuda brindada por el biol\u00f3gico para \ndisminuir las p\u00e9rdidas econ\u00f3micas en las parvada \nsusceptibles.  \n \nINTRODUCCION  \nEl uso de biol\u00f3gicos para la prevencion y control \nde infecciones causadas por P. haemolytica esta  comprobada en rumiantes (1), sin embargo el conocimiento de esta pr\u00e1ctica en avic ultura es desconocida, aunque se en ciertas regiones del pa\u00eds utilizan esta herramienta como una medida de control, en donde se ha visto un desempe\u00f1o exitoso del biol\u00f3gico empleado mediante la disminuci\u00f3n \nconsiderable de sus perdidas econ\u00f3micas.    El \ndesarrollo de vacunas eficaces no es una tarea f\u00e1cil ya \nque se tienen que considerar un sin n\u00famero de factores \nque juegan un papel importante a fin de que un \nbiol\u00f3gico funcione exitosamente, de tal manera que el tipo de cepas que utilizan como antigenos, el tipo de \nadyuvante a emplear y hasta el n\u00famero de \ninmunizaciones necesarias para levantar una respuesta \ninmune protectiva juegan un papel decisivo.  \nEn base al anterior el objetivo del presente trabajo \nfue el conocer el desempe\u00f1o de una vacuna experimental de P. haemolytica ante un desaf\u00edo bajo \ncondiciones controladas.  \n  \nMATERIAL Y METODOS  \nAves. En el estudio se emplearon un total de 60 \naves SPF de dos semanas de edad, las cuales se \nmantuvieron desde su nacimiento y durante todo su \ndesarrollo en unidades de ais lamiento. A todas las aves \nse les proporcionar\u00f3n agua y alimento  ad libitum.  \nVacunaci\u00f3n. La vacuna se elabor\u00f3 con los \nbiogrupos de 2 y 4 de P. haemolytica (P. trehalosi)  \ncombinando las dos cepas en un adyuvante oleoso \n(w/o) .  Las aves se inmunizaron a las  2, 5 y 9 semanas \nde edad v\u00eda subcutanea con una d\u00f3sis de 0.5 ml por \nave. Los grupos de estudio estuvieron formados por 20 \naves vacunadas y 30 aves que se mantuvieron como controles (20 positivos y 10 negativos ).  \nDesaf\u00edo. Las aves se desafiaron a las 13 s emanas \nde edad administrando 0.2 ml de cada in\u00f3culo v\u00eda \nintravenosa, de tal manera que se desafiaron 20 aves \nvacunadas y 10 no vacunadas por in\u00f3culo dejando 10 \naves sin  vacunar y sin desafiar como controles \nnegativos. Las aves se observaron durante tres d \u00edas \npara el registro de mortalidad y morbilidad. Todas las aves sobrevivientes se sacrificaron al tercer d\u00eda post -\ndesaf\u00edo para efectuar el reaislamiento bacteriano a partir de \u00f3rganos as\u00ed como obtener el registro de las \nlesiones presentadas.   \n  \n90 Reaislamiento.  De cada una de las aves \nsacrificadas se tomaron muestras de h\u00edgado y de \ng\u00f3nadas. Estas muestras se sembraron en tubos con 20 \nml de caldo triptosa los cuales se incubaron durante 24 \nh a 37\u00baC. Muestras de los tubos que presentaron \ncrecimiento se resembraron  en cajas de ajar sangre de \novino utilizando la t\u00e9cnica de aislamiento por estria a \nfin de identificar colonias caracter\u00edsticas a P. \nhaemolytica  y despu\u00e9s obtener su indentificaci\u00f3n \nbioqu\u00edmica (2).  \n  \nRESULTADOS  \nEvaluacion cl\u00ednica. Las aves no presentaron \nning\u00fan tipo de reacciones adversas despu\u00e9s de la \nvacunaci\u00f3n siempre se mantuvieron con un aspecto \nsaludable despu\u00e9s de cada una de sus tres aplicaciones. \nDespu\u00e9s del desaf\u00edo algunas de las aves vacunadas \npresentaron depresi\u00f3n o somnolencia desaparenciendo \nestos sintomas despu\u00e9s de 36 h post -desaf\u00edo mientras \nque las aves control si presentaron la sintomatolog\u00eda \ncaracter\u00edstica a una infecci\u00f3n ocasionada por P. \nhaemolytica. Las aves que se mantuvieron como \ncontroles negativos no presentaron  signos clinicos y e l \nreaislamiento fue negativo para todos los organos \nmuestreados.  En el cuadro no. 1 se describe la protecci\u00f3n que confiere el  bi\u00f3logico ante el desaf\u00edo \ncon las dos cepas que contenia la vacuna mientras que las aves control no vacunadas se vieron afectadas por el \ndesaf\u00edo.  \n \nCONCLUSIONES  \n En este estudio se comprob\u00f3 que el empleo de \nbacterinas P. haemolytica  puede evitar el desarrollo de \nuna infecci\u00f3n en aves sanas y aunque el conocimiento \ndel desempe\u00f1o de estas bacterinas esta en proceso de \nevaluaci\u00f3n en e l campo en donde intervienen un gran \nnumero de factores,  esta pr\u00e1ctica puede ser una \nherramienta para  la prevenci\u00f3n y control de \ninfecciones ocasionadas por este microorganismo.  \n Es importante enfatizar que se debe continuar \ncon el desarrollo de este tip o de estudios con el fin de \nclarificar la eficacia de estos productos en condiciones \nde campo.  \n \nREFERENCIAS  \n1. Confer W. A., Montelongo M., Brown M. J., \nFergen B. J., Clement J.C. Onset of Serum Antibodies \nto Pasteurella (Mannheimia) haemolytica  following \nvaccination with five commercial vaccines. The Bovine \nPracititioner. 35(2): 141 -148. 2001.  \n2. Jaworski  M.D., L. Hunter, A. C. S. Ward. \nBiovariants of isolates of Pasteurella from domestic \nand wild ruminants. J. Vet. Invest. 10:49 -55. 1988.  \n                    \n Cuadro No. 1.  \nGrupos de Prueba  Inoculo de desaf\u00edo  Mortalidad y \nReaislamiento (%)  Protecci\u00f3n (%)  \nControl Negativo  Sin desaf\u00edo  0 N/A \nControl Positivo  Biogrupo 4  77 23 \nControl Positivo  Biogrupo 2  54 46 \nVacunado  Biogrupo 4  0 100 \nVacunado  Biogrupo 2  5 95 \n \nORNITHOBACTERIUM RHI NOTRACHEALE: ITS SURVIVAL OVER \nTIME AND TEMPERATURE IN POULTRY LITTER \n \nORNITHOBACTERIUM RHINOTRACHAELS (ORT): SU SUPERVIVENCIA \nANTE EL TIEMPO Y LA TEMPERATURA EN LA CAMA AV\u00cdCOLA  \n \nLopes, Vanessa C., Velayudhan, B., Halvorson, D. A., and Nagaraja, K. V.  \n \nDepartment of Veterinary PathoBiology, College of Veterinary Medicine, University of Minnesota,  \nSaint Paul, MN 55108.  \n \nRESUMEN  \nORT  se ha considerado como un pat\u00f3geno \nrespiratorio de nuevo surgimiento en aves. Causa \np\u00e9rdidas econ\u00f3micas  por aumento en las tasas de \ndecomisos en el rastro, principalmente durante los meses del invierno. No se ha descrito la supervivencia \nde este germen en el medio ambiente, por lo que \nestudiamos su capacidad de permanecer viable en la \ncama de las aves ante diferentes temperatura y a lo \nlargo del tiempo. Los resultados indican que ORT   \n  \n91 sobrevive cuando menos 150 d\u00edas a temperaturas bajas \nen la cama, lo cual sugiere que puede persistir en el \nmedio ambiente y contribuir al aumento en la \nincidencia de la infecci\u00f3 n durante los meses del verano.  \n \nOrnithobacterium rhinotracheale  (ORT) has been \nconsidered an emerging respiratory pathogen in \npoultry.  ORT causes economic losses, including \nincreased condemnation rates at the slaughterhouse \nespecially during winter month s.  No report on the \nsurvival of ORT in the environment has been described.  The ability of ORT to remain viable in the \npoultry litter was studied at different temperatures over \ntime. Results indicate that ORT survives for at least \n150 days at low tempera tures in litter, suggesting that \nits survival may cause the pathogen to persist in the \nenvironment and contribute to the higher incidence of \nORT infection during winter months.   \n \n(The full -length of this paper was submitted to Avian \nDiseases for publicatio n). \n \nAN UNUSUAL CASE OF MYCOPLASMA SYNOVIAE INFECTION  \nIN BROILER CHICKENS  \n \nUN CASO INUSUAL DE INFECCI\u00d3N CON MYCOPLASMA SYNOVIAE  (MS) EN \nPOLLO DE ENGORDA \n \nGabriel Senties -Cue, H.L. Shivaprasad and R.P. Chin.  \n \nCalifornia Animal Health and Food Safety Laboratory System, Fresno Branch  \nUniversity of California, Davis, 2789 S. Orange Ave., Fresno CA 93725  \n \nRESUMEN  \nInformamos sobre un caso inusual de infecci\u00f3n \npor MS en pollo de engorda con lesiones septic\u00e9micas. El involucramiento de varios \u00f3rganos como el h\u00edgado, \nel bazo, el m\u00fasculo esquel\u00e9tico, el enc\u00e9falo, los nervios \ny la bolsa de la quilla, asociado con vasculitis y \naislamiento de MS a partir del h\u00edgado y la bolsa de la \nquilla, hacen de \u00e9ste un caso inusitado. La cepa de MS \nfue diferente a la WVU 1853 y a otras cepas de MS aisladas de reproductoras pesadas de la misma \nempresa, pero pareci\u00f3 tener un patr\u00f3n de ADN similar \nal de otros MS aislados de pavos en la regi\u00f3n central de \nCalifornia.  \n Mycoplasma synoviae  (MS) infection is a \ncommon disease of chickens an d turkeys, affecting the \nair sacs and joints (2,4,5). However, MS isolates vary \nin their pathogenicity (5). There are strains that may \nproduce a subclinical infection, and strains that, in addition to the airsacculitis and synovitis, produce \ntenovaginitis,  and other less common septicemic \nlesions, including keel bursitis, hepatomegaly, \nsplenomegaly, nephromegaly, myocarditis, and \nencephalitis (1,3,4).  We report an unusual case of MS \ninfection in broiler chickens, with septicemic lesions.  \nSixty- one live an d 16 processed carcasses, \nranging in ages from 33 to 47 -days, were submitted for \nlaboratory evaluation to the California Animal Health \n& Food Safety Laboratory System, Fresno Branch, \nwith a clinical history of respiratory signs, keel bursitis, \nleg problems , increased mortality, unevenness, and high condemnation rate at processing. The breeders of the broiler chickens were infected with MS.    \nSignificant gross lesions found at necropsy \nincluded moderate to severe thickening of the keel bursa with accumulation of fibrinous to caseous \nexudate and petechial hemorrhages. The livers were \nmild to moderately enlarged, congested, and green, and some had small white foci. The spleens were moderate to severely enlarged, congested, and mottled white. \nThere were mild to  moderately swollen hocks with \naccumulation of fibrinous to caseous exudate. Other \nlesions included mild to severe accumulation of \nfibrinous to caseous exudate in the air sacs, congestion of the lungs, accumulation of fibrinous exudate in \npericardium, mode rate to severe atrophy of bursas of \nFabricius and thymuses, kidneys were moderately \nenlarged and pale, proventricular walls were \nmoderately thickened and there was moderate excess \nmucus in tracheas.  \nMicroscopically, lesions were characterized by \nlymphocyt ic infiltration in and around blood vessels of \nthe liver, spleen, keel bursa, skeletal muscle, brain, and \nnerves. In addition, there was mild to severe infiltration \nof lymphocytes in the mucosa of the tracheas, air sacs, \ninterstitium of the lungs, kidneys,  myocardium, \nglandular portions of the proventriculus, and keel \nbursas.  Fibrinoheterophilic infiltration was present in \nthe air sac, pericardium and keel bursa. In the bursas of \nFabricius and thymuses there was moderate lymphoid \ndepletion.   \n  \n92 Escherichia col i was isolated from air sac, heart \nsac, trachea and liver. Ornithobacterium \nrhinotracheale  was isolated from heart sac and trachea. \nPasteurella haemolytica -like/Actinobacillus \nsalpingitidis  group was isolated from trachea. \nStaphylococcus sp.  was isolated f rom liver. Bordetella \navium  was isolated from trachea. The role of these \nbacterial infections probably was secondary.  \nSera were positive for MS by the plate \nagglutination, hemagglutination- inhibition, and ELISA \ntests.  \nMycoplasma synoviae  was isolated from the air \nsac, keel bursa, trachea and liver. By random \namplification of polymorphic DNA, the MS isolated \nwas determined to be different from the MS strain \nWVU 1853 and another MS isolated from broiler -\nbreeders of the same company, but appeared to have \nsimil ar DNA pattern to another MS isolated from \nturkeys in Central California.  \nInvolvement of various organs, such as liver, \nspleen, skeletal muscle, brain, nerves, and keel bursa, \nassociated with vasculitis, and the isolation of MS from \nliver and keel bursa m ake this MS infection in broiler \nchickens unusual.  \n (The full -length article will be published in Avian \nDiseases ). \n \nREFERENCES  \n1. Chin, R. P., C.U. Meteyer, R. Yamamoto, \nH.L. Shivaprasad, and P.N. Klein. Isolation of Mycoplasma synoviae  from the brains of co mmercial \nmeat turkeys with meningeal vasculitis. Avian Dis. 35: \n631-637. 1991.  \n2. Kawakubo, Y., K. Kume and M. Yoshioka. \nHisto -and immuno -pathological studies on \nexperimental Mycoplasma synoviae  infection of the \nchicken. J. Comp. Pathol. 90:457 -467. 1980.   \n3. Kerr, M. K., and N.O. Olson. Pathology of \nchickens inoculated experimentally or contact -infected \nwith Mycoplasma synoviae . Avian Dis. 14:291- 320. \n1970.  \n4. King, D.D., S.H. Kleven, D.M. Wenger and \nD.P Anderson.  Field studies with Mycoplasma synoviae . Avian Dis . 17: 722- 726.1973.  \n5. Kleven S.H.  Mycoplasma synoviae  \ninfection. In: Diseases of poultry, 10\nth ed.  Calnek \nB.W., H.J. Barnes, C.W. Beard, L.R. McDougald, and Y.M. Saif, eds. Iowa State University Press, Ames, \nIowa. p 220- 228. 1997.  \n \nPRODUCTIVIDAD Y RESP UES TA SEROL\u00d3GICA DE \nREPRODUCTORAS CON EXPOSICIONES VACUNALES  Y/O DE \nCAMPO A MYCOPLASMA GALLISEPTICUM Y  \nMYCOPLASMA SYNOVIAE  \n \nPRODUCTIVITY AND SEROLOGICAL RESPONSE OF BROILER BREEDERS \nAFTER FIELD AND/OR VACCINE EXPOSURE TO MYCOPLASMA \nGALLISEPTICUM (MG) AND MYCOPLASMA SYNOVIAE (MS)  \n \nJuan Carlos Valladares*, Edmundo Angulo, Benjam\u00edn Barrientos, Daniel Ju\u00e1rez y Alfonso Lara.  \n \nLaboratorio de Control de Calidad y Patolog\u00eda Aviar, Productora de Alimentos Pecuarios de Nuevo Le\u00f3n, S.A. de \nC.V. Ju\u00e1rez y Arista s/n, Sali nas Victoria, N.L., M\u00e9xico. CP 65500. juancv@papsa.mexis.com  \n \nSUMMARY  \nFour commercial broiler breeder flocks with MG \nand MS vaccine and/or field infections were analyzed. \nSerological response was periodically evaluated using \nplate agglutination (PA) tests , and immunoassays \n(ELISA), in both the hens and their offspring. Breeder productive parameters were recorded. Seroconversion \nafter field or vaccine infection was first detected by \nPA, and later by ELISA. Seroconversion to MS was \nfaster and more constant t han that to MG. PA detected \nmaterial antibodies (Mab\u2019s) more uniformly than \nELISA. Treatments of breeders with anti -mycoplasma \ndrugs modified seroconversion indexes both in the breeders and in their progeny. Live MS/MG \nvaccinations resulted in increased nu mbers of chicks \nhatched per hen housed.  \n \nRESUMEN  \nSe analizaron 4 parvadas de gallinas \nreproductoras pesadas comerciales con infecciones vacunales y/o de campo con M gallisepticum  (MG)  y \nM synoviae  (MS). La respuesta serol\u00f3gica se evalu\u00f3 \nperi\u00f3dicamente con las t\u00e9cnicas de aglutinaci\u00f3n en \nplaca (AP) y de ensayo inmunoenzim\u00e1tico (ELISA) en \nlas gallinas y en su progenie; tambi\u00e9n se registraron los par\u00e1metros productivos de las reproductoras. La  \n  \n93 seroconversi\u00f3n tras las infecciones de campo o \nvacunales se detect\u00f3   primero por AP y posteriormente \npor ELISA. La seroconversi\u00f3n hacia MS fue m\u00e1s \nr\u00e1pida y constante que hacia MG. La prueba de AP \ndetect\u00f3 anticuerpos (Ac) maternos mas uniformemente \nque la prueba de ELISA. Los tratamientos con \nantimicoplasmicos en las repro ductoras modificaron \nsus \u00edndices de seroconversi\u00f3n  y lo de su progenie. La \nvacunaci\u00f3n con vacunas vivas de MG y de MS \nincrement\u00f3 el n\u00famero de pollos nacidos vivos por ave \nencasetada.  \nLos micoplasmas son los pat\u00f3genos primarios \nm\u00e1s importantes del aparato respiratorio de las aves dom\u00e9sticas, Mycoplasma gallisepticum (MG) y \nMycoplasma synoviae (MS) producen infecciones \ncr\u00f3nicas y aunque son relativamente poco pat\u00f3genos, \nda\u00f1an las c\u00e9lulas del epitelio ocasionando una mayor \nsusceptibilidad a los efectos de otr os pat\u00f3genos \nrespiratorios\n2,5,6.El objetivo del presente estudio fue \nanalizar la respuesta serol\u00f3gica de las gallinas reproductoras, la transmisi\u00f3n de Ac maternos a la \nprogenie y la productividad de las gallinas procedentes \nde parvadas con exposici\u00f3n vacun al y/o de campo \nhacia M gallisepticum y M synoviae.  \n \nMATERIAL Y METODOS  \nSe analizaron 4 parvadas de gallinas \nreproductoras pesadas comerciales con diferentes combinaciones de infecciones vacunales y de campo \ncon M gallisepticum  (MG)  y M synoviae  (MS). Toda s \nlas parvadas fueron de la misma estirpe, del mismo \norigen  y procedieron de parvadas de progenitoras \nlibres de infecci\u00f3n por MG y MS. Las condiciones de \nalojamiento, alimentaci\u00f3n y manejo fueron similares. \nLos huevos procedentes de cada parvada fueron manejados de manera similar y fueron procesados en la \nmisma Planta Incubadora.  \nLas infecciones de campo fueron detectadas por \nsignolog\u00eda y/o seroconversi\u00f3n y confirmadas por la detecci\u00f3n de sondas de DNA con la reacci\u00f3n en cadena \nde polimerasa \u00f3 PCR\n3 a parti r de hisopos traqueales.  \nSe evalu\u00f3 la respuestas serol\u00f3gica hacia MG y MS con las t\u00e9cnicas de AP\n4 y de ELISA7 cada 8 -10 semanas en las reproductoras y semanalmente en la progenie reci\u00e9n \nnacida. Se registr\u00f3 la producci\u00f3n total de huevo, \nproducci\u00f3n de huevo  incubable, producci\u00f3n de pollo \nnacido vivo, % de huevo inf\u00e9rtil - mortalidad \nembrionaria temprana, % de mortalidad embrionaria \ntard\u00eda - embri\u00f3n picado no nacido y mortalidad en \nhembras y machos.  \n \nRESULTADOS Y DISCUSION \nDe acuerdo al tipo de exposici\u00f3n hacia \nMycoplasma de campo y/o vacunal y a los tratamientos \nrecibidos se encontraron los siguientes casos:  \nParvada 1:MG libre, MS de campo a la 36\u00aa  \nsemana. Tratamiento 3,4 isovaleril tilosina 1x3 sem hasta 36\u00aa semana; tilosina constante  de la 36\u00aa  a la 63\u00aa \nsemana.  \nParvada 2: MG de campo a las 24\u00aa semana, MS: \nvacunal a la 18\u00aa  semana. Tratamiento: tilosina \npermanente de las 24\u00aa las 63\u00aa  semanas  \nParvada 3: MG vacunal a las 18\u00aa semana, MS de \ncampo a las 8\u00aa semana. Tratamiento: enrofloxacina de \nla 8\u00aa a la 10\u00aa sem ana \nParvada 4: MG: Vacunal a la 7\u00aa semana, MS: \nvacunal a la 5\u00aa semana. Sin tratamiento con \nantimicopl\u00e1smicos  \nLa seroconversi\u00f3n tras las infecciones de campo o \nvacunales se detect\u00f3 primero por AP y posteriormente por ELISA. La seroconversi\u00f3n hacia MS fue m\u00e1 s \nr\u00e1pida y constante que hacia MG. La prueba de AP detect\u00f3 Ac maternos mas uniformemente que la prueba de ELISA, con un comportamiento similar a lo descrito \npreviamente\n1,5,8. Los tratamientos con \nantimicoplasmicos en las reproductoras modificaron \nlos \u00edndic es de seroconversi\u00f3n en las gallinas y en su \nprogenie reci\u00e9n nacida, efecto tambi\u00e9n descrito previamente\n2,5. Las infecciones vacunales y/o de \ncampo con MG y MS tuvieron efectos variables sobre \nlos par\u00e1metros productivos de las reproductoras \nanalizados (Cuadro 1). La vacunaci\u00f3n con vacunas \nvivas de MG y de MS incremento el n\u00famero de pollos nacidos vivos por ave encasetada sugiriendo un efecto \nprotector de la vacunaci\u00f3n sobre la producci\u00f3n total de \npollitos por hembra reproductora.  \n  \n \n  \n \n \n \n   \n \n  \n  \n94 Cuadro 1 .- Par\u00e1metros productivos1 de 4 parvadas con exposici\u00f3n de campo y/o vacunal a MG y/o MS  \nEstado en \nrelaci\u00f3n a \nMycoplasma2 No. de huevos \ntotales por ave \nencasetada No. de huevos \nincubables por \nave encasetada  No. de pollos \nnacidos por ave \nencasetada  Mortalidad \nde las \nHembras  Mortalidad \nde los \nMachos  \nMG libre,  \nMS campo 36s  155.11  141.9  93.91  17.29%  31.27%  \nMG campo 24s  \nMS vac 18 s  149.89  131.2  98.43  13.41%  41.38%  \nMG vac 18s  \nMS campo 8s  142.03  131.3  76.70  15.80%  65.0%  \nMG vac 7s  \nMS vac 5s  145.98  135.2  103.13  16.69 % 45.81%  \nEst\u00e1ndar de la \nestirpe  155.6  152.5  132.8  - - \n1 Par\u00e1metros para el per\u00edodo de 26.3 semanas a 60.3 semanas  \n2 Edad a la infecci\u00f3n (campo) o a la vacunaci\u00f3n (vac)  \n \nREFERENCIAS  \n1. Contreras, M. y Fern\u00e1ndez, R. Mycoplasma \ngallisepticum  y Mycoplasma synoviae , interpretaci\u00f3n \nde pruebas serol\u00f3gicas y uso de vacunas. VII \nSimposium Av\u00edcola, Secci\u00f3n Nacional de Progenitores \nde Aves de la Uni\u00f3n Nacional de Avicultores, \nZacartecas, Zacatecas pp 129 -135. 2000.  \n2. Glison, J.: Funcionamiento y enfermedades \ndel aparato  respiratorio de los pollos. Conferencia de \nEnfermedades Respiratorias Aviares, Curso Pre \nCongreso ELANCO en XXV Convenci\u00f3n Nacional \nANECA 2000, Canc\u00fan, Q. Roo, M\u00e9xico pp 13- 16. \n2000.  \n3. IDEXX Laboratories, Inc. FlockCheck DNA \nPROBE Test Kits. Technical Manual, Westbrook, \nMaine, USA.  \n4. Intervet International B.V., Boxmeer \nHolland.  5. Kleven, S. Mycoplasma synoviae  infections, \nIn Diseases of Poultry, 10th ed. B. Calnek, H. Barnes, \nC. Beard, L. McDougald and Y. Saif eds. Iowa State Press, Ames, Iowa, pp. 220 -232. 1997.  \n6. Kleven, S. And Yoder,H.  Mycoplasmosis, \nin A Laboratory Manual for the Isolation and Identification of Avian Pathogens, pp.57- 623th ed, H. \nPurchase,  L. Arp, C. Domermuth and J. Pearson eds. American Association of Avian Pathologist, Kennett Square, PA.  Kendall Hunt Publishing Company, \nDubuque, Iowa pp 57- 62. 1989.  \n7. KPL Kirkegaard & Perry Laboratories, \nProFLOCK, Technical Manual, Gaithersburg, \nMaryland, 1999.  \n8. Ley, D. And Joder, H. Mycoplasma \ngallisepticum infections, In Diseases of Poultry, 10th \ned. B. Ca lnek, H. Barnes, C. Beard, L. McDougald and \nY. Saif eds. Iowa State Press, Ames, Iowa, pp. 194 -\n205. 1997.  \n \n \n \n   \n \n   \n \n   \n  \n95 COMPARACI\u00d3N DEL USO DE UN INMUNOESTIMULANTE Y DE \nUN COMPUESTO ANTIEST R\u00c9S EN LA RESPUESTA \nINMUNOL\u00d3GICA CONTRA LA ENFERMEDAD DE NEW CASTLE \nEN POLLO DE ENGORDA Y SU EFECTO SOBRE LA \nPRODUCTIVIDAD DE LA PARVADA  \n \nCOMPARISON OF ONE IMMUNOSTIMULANT AND ONE ANTI-STRESS \nCOMPOUND ON THE IMMUNE RSPONSE TO NEWCASTLE DISEASE, AND \nTHEIR EFFECT ON BROILER PRODUCTIVITY  \n \nMVZ MC Mar\u00eda Elena Rubio Garc\u00eda PROTE CO, S.C., MVZ MC N\u00e9stor Ledesma Mart\u00ednez FMVZ -UNAM,  \nMVZ MC Ezequiel S\u00e1nchez Ram\u00edrez CEIEPA \u2013  UNAM, MVZ MC Elizabeth Posadas CEIEPA -  UNAM  \n \nSUMMARY  \nKnowing that vaccine application is a stressor for \nbirds, one immunostimulant (LEV\uf6da) was compared \nwith an anti -stress compound (VsEs3 -C\uf6da) on the \nimmune response after vaccination with newcastle \ndisease virus, and their effects on productive \nparameters in broilers. Feed intake, feed conversion \nrate, morality rate, and productivity index were significantly better in VsEs3 -C-treated birds. The \nadministration of VsEs3 -C and LEV had no effect \nwhatsoever on the average level of antibodies. Even though, increased in vitro heterophil phagocytic \nactivity was observed. Increased bursal follicular \ndiameter with different de grees of lymphoid depletion \nnon-suggestive of infection was also observed.  \n \nRESUMEN  \nSabiendo que la aplicaci\u00f3n de vacunas es un \nfactor estresante para las aves, se compar\u00f3 el uso de un \ninmunoestimulante (LEV\n\uf6da) y un producto \nantiestr\u00e9s(VsEs3 -C\uf6da) en la  res puesta inmunol\u00f3gica \npos-vacunal  contra el virus de ENC en pollo y su \nefecto sobre par\u00e1metros productivos. El Consumo de \nalimento, Conversi\u00f3n alimenticia, % de Mortalidad e \n\u00cdndice de Productividad fueron significativamente \nmejores en aquellos que recibiero n VsEs3 -C. La \nadministraci\u00f3n de VsEs3 -C y LEV no present\u00f3 efecto \nalguno sobre el nivel de anticuerpos promedio en los grupos; sin embargo si incrementaron la actividad \nfagoc\u00edtica de los heter\u00f3filos in vitro  y  presentaron \nmayor di\u00e1metro folicular en la bol sa de Fabricio, con \ndiversos grados de depleci\u00f3n linfoide no sugestivos de \ninfecci\u00f3n.   \n \nINTRODUCCI\u00d3N  \nLa ENC contin\u00faa siendo un riesgo importante \npara la avicultura mexicana, la aplicaci\u00f3n de vacunas ha sido considerada hasta ahora el mejor medio de preven ci\u00f3n, teniendo como objetivo principal el desarrollo de anticuerpos que protejan contra la \ninfecci\u00f3n del virus velog\u00e9nico vicerotr\u00f3pico.\n13 La \nimportancia del adecuado desarrollo de la inmunidad \nactiva contra esta enfermedad ha provocado que d\u00eda a \nd\u00eda se bu squen alternativas que permitan favorecer o \npotenciar la respuesta posvacunal2 y reducir al m\u00e1ximo \nlos efectos negativos sobre la parvada durante el manejo  de la vacunaci\u00f3n.   \nDiversos  investigadores  han  reportado el uso de \nsustancias como el levamisol (LEV), \u00e1cido \nacetoxibenzoico (AAB) y \u00e1c. asc\u00f3rbico (AA) como \ncoadyuvantes en la respuesta inmunol\u00f3gica.\n1,3,4,5,7,12,13 \nBarbosa (1981) y Chakraborty (1998)  reportaron que \naves vacunadas contra ENC y medicadas con LEV en \nel agua de bebida obtuvieron una media geom\u00e9trica \nmayor de anticuerpos hemaglutinantes comparado con \npollos \u00fanicamente vacunados.3,7 El  uso del LEV como \nestimulante de la respuesta inmune es realizado con el \nobjetivo de incrementar la producci\u00f3n  de anticuerpos, \ndiversos estudios han encontrando que el uso de LEV \nv\u00eda agua de bebida favorece la respuesta posvacunal a  diferentes agentes como la ENC, Viruela aviar y \nGumboro (IBF)  entre otros.\n1,3,8 Aves vacunadas contra \nla IBF y tratadas con LEV, vitamina E y  AA, solos y \ncombinados  al ser comparadas con el grupo solamente \nvacunado presentaron una mejor respuesta inmune, \nsugiriendo as\u00ed un efecto inmunomodulatorio ben\u00e9fico \nen los programas de vacunaci\u00f3n.7,12   \nBendich (1990) report\u00f3 que la adici\u00f3n de AA en \ndietas de pollo de engorda favorece l a fagocitosis y \ndestrucci\u00f3n de organismos infecciosos y menciona, que durante una infecci\u00f3n por virus o bacterias se presenta una disminuci\u00f3n en el AA circulante seguido de  \ninmunosupresi\u00f3n.\n5  Gross (1990) adicion\u00f3 AA en la \ndieta de pollos de engorda y enc ontr\u00f3 un efecto lineal \nen la reducci\u00f3n del efecto estresante del calor conforme se aumentaba la cantidad de AA en la dieta. Se ha \nreportado que la mortalidad asociada con infecciones respiratorias posteriores a la exposici\u00f3n de un virus  \n  \n96 vacunal de ENC cepa B1 y por presencia de \nMicoplasma gallisepticum  es menor en animales \nalimentados con dietas suplementadas de AA.9 Por otra \nparte la literatura reporta que la adici\u00f3n de AAB \ntambi\u00e9n favorece la fagocitosis y la actividad \nmicrobicida de los polimorfonucleare s en animales y \nplantas, mejorando con esto la respuesta inmunol\u00f3gica, \nde igual forma el AAB tambi\u00e9n tiene la capacidad de \ninhibir el malestar y/o dolor por su efecto inhibitorio \nsobre las prostaglandinas o mediadores qu\u00edmicos del \ndolor a trav\u00e9s de la cicl ooxigenasa 4,14 \nSabiendo que la aplicaci\u00f3n de vacunas es un \nfactor estresante para las aves, se busco comparar el \nuso de un inmunoestimulante (LEV\uf6da) y un producto \nantiestr\u00e9s(VsEs3 -C\uf6da) en la  respuesta inmunol\u00f3gica \npos-vacunal  contra el virus de la ENC en pollo de \nengorda y su efecto sobre los par\u00e1metros productivos.  \n \nMATERIAL Y M\u00c9TODOS  \nSe llevaron a cabo dos pruebas, una en el  Centro \nde Ense\u00f1anza Investigaci\u00f3n y Extensi\u00f3n en Producci\u00f3n \nAv\u00edcola de la Facultad de Medicina Veterinaria y Zootecnia de la UNAM,  y la otra en la Unidad \nExperimental Proteco en Tlaquepaque , Jal., para tal \nefecto se utilizaron 480 (Prueba 1) y 300 (Prueba 2) \npollos de engorda de un d\u00eda de edad, de la estirpe Ross, \nasignados aleatoriamente en los siguientes \ntratamientos.\n\uf6da Marca Regis trada  \nLa Prueba 1 cont\u00f3 con 4 tratamientos: a) T -  (No \nvacunado -No medicado), b) T + (vacunado -No \nmedicado), c) Tratamiento Y (Vacunado + VsEs3 -C\uf6da) \ny Tratamiento Z (Vacunado + LEV\uf6da). La Prueba 2 solo \ncont\u00f3 con los tratamiento Y y Z. En ambas pruebas  se \nutilizaron las dosis recomendadas por el laboratorio. En \nla Prueba 1 la medicaci\u00f3n se realiz\u00f3  durante 7 d\u00edas, \niniciando 3 d\u00edas antes de la vacunaci\u00f3n, durante y 3 \nd\u00edas despu\u00e9s de \u00e9sta,  en la Prueba 2 las aves se medicaron durante 5 d\u00edas, iniciando 1 d\u00eda an tes de la \nvacunaci\u00f3n, el agua medicada se administr\u00f3 a libre acceso y como \u00fanica fuente de bebida  \nLas aves fueron vacunadas contra la ENC v\u00eda \nocular y subcut\u00e1nea a los 8 -10 d\u00edas, revacunando v\u00eda \nagua de bebida a los 25 \u2013 24 d\u00edas, de igual forma \nrecibieron agua y alimento a libre acceso a lo largo de \nla prueba. Los par\u00e1metros evaluados fueron: \nMortalidad semanal, Peso promedio por semana, \nConsumo acumulado de alimento, Conversi\u00f3n alimenticia, Ganancia diaria de peso, Viabilidad, \u00cdndice \nde productividad, Serolog\u00eda HI -ENC, Actividad \nFagoc\u00edtica de Heter\u00f3filos e Histopatolog\u00eda (Di\u00e1metro folicular de la bolsa de Fabricio y Relaci\u00f3n: Corteza -\nM\u00e9dula en timo )  \nAn\u00e1lisis Estad\u00edstico: Los resultados obtenidos se \nsometieron a un ANOVA y la diferencia entre media se obtuv o mediante la prueba de Tukey. Previamente el \nporcentaje de mortalidad y los resultados serol\u00f3gicos se sometieron a una transformaci\u00f3n por ra\u00edz cuadrada del \nArcoseno y logar\u00edtmica respectivamente.  \n \nRESULTADOS  \nLa ganancia de peso semanal a pesar de no \npresentar diferencia estad\u00edstica significativa (P \u22640.05) \nen ninguna de las dos pruebas, presento diferencia \nnum\u00e9rica importante sobre todo en las aves tratadas \ncon VsEs3 -C ya que obtuvieron 117g mas de peso que \nlas aves T+. En la prueba 2  las aves medicadas con  \nVsEs3 -C presentaron pesos promedio mayores a todo \nlo largo del ciclo productivo a\u00fan cuando estos no son significativamente diferentes. En el Consumo de alimento y Conversi\u00f3n alimenticia se report\u00f3 \nsignificancia estad\u00edstica  (P \u22640.05) entre el T - y el resto  \nde los grupos, siendo el grupo medicado con VsEs3 -C \nel que present\u00f3 menor consumo de alimento y mejor \nconversi\u00f3n alimenticia en ambas pruebas.  En lo \nreferente al Porcentaje de mortalidad, no se encontr\u00f3 \ndiferencia (P \u22650.05) entre tratamientos en ninguna d e \nlas pruebas. Las aves medicadas con VsEs3 -C \npresentaron menor Consumo Semanal Acumulado de \nAlimento, Conversi\u00f3n Alimenticia y mejor \u00cdndice de \nProductividad en las dos pruebas.  \nLa respuesta serol\u00f3gica report\u00f3 un logaritmo m\u00e1s \ncon la prueba de Inhibici\u00f3n de la Hemoaglutinaci\u00f3n para la ENC en las aves medicadas con LEV en la \nPrueba 1  (P\u22640.05), no as\u00ed en la Prueba 2. En ambos \ncasos la administraci\u00f3n de VsEs3 -C y LEV no \npresentaron efecto alguno sobre el nivel de anticuerpos \npromedio en los grupos.  \nEn lo refe rente a la actividad fagoc\u00edtica de los \nheter\u00f3filos, esta fue significativamente mayor  (P \u22640.05) \nen los grupos que fueron medicados con LEV  y \nVsEs3 -C. \nLas mediciones del di\u00e1metro folicular reportaron \ndiferencia estad\u00edstica  (P \u22640.05) a partir de los 18 d\u00edas  \nde edad, encontrando mayor di\u00e1metro folicular en el \ngrupo T -, posteriormente a los 28 d\u00edas (despu\u00e9s de las \ndos medicaciones)  el di\u00e1metro folicular de la bolsa de Fabricio en los diferentes tratamientos se recupera, los \ngrupos T - y T+ a los 35 d\u00edas son si gnificativamente \n(P\u22640.05) menores que los grupos medicados  \nEn la relaci\u00f3n corteza: m\u00e9dula, a\u00fan cuando no se \nencontr\u00f3 significancia estad\u00edstica despu\u00e9s de los \ntratamientos, esta se vio num\u00e9ricamente  mas  afectada  \nen  el  T -,  reportando un valor considera do como \natrofia severa, mientras que el resto de los grupos \npresentaron una clasificaci\u00f3n de moderada.   \n \nDISCUSIONES  \nLos par\u00e1metros productivos no se vieron \nafectados por el uso de estas sustancias; sin embargo es \nnotorio que las aves no vacunadas present aron menor \nconsumo de alimento, mejor conversi\u00f3n alimenticia y  \n  \n97 menor porcentaje de mortalidad. El grupo vacunado \nresulto mas afectado en estos par\u00e1metros que el resto \nde los tratamientos, debido quiz\u00e1 a la aplicaci\u00f3n de una \nvacuna a virus vivo, ya que esta s por lo general al \ncausar viremia dejan a las aves mas susceptibles a otras \ninfecciones, por lo cual la mortalidad fue mayor en este \ngrupo afectando por consiguiente el resto de los par\u00e1metros, cabe hacer notar que este efecto negativo \nno fue tan notorio en los grupos tratados con VsEs3 -C \ny LEV probablemente debido a la acci\u00f3n \ninmunomodulatoria\n1,3,5 y antipir\u00e9tica9 de los \ncomponentes. Shadaksharappa y colaboradores en un \ntrabajo realizado con sustancias inmunomoduladoras \ncomo la vitamina C, vitamina E y  L EV afirman que el \nuso de este tipo de tratamientos preventivos en \nconjunto con los programas de vacunaci\u00f3n tienen un \nefecto ben\u00e9fico.10   \nPor otra parte, a pesar de que la respuesta \nserol\u00f3gica se incremento en un logaritmo en las aves \nque recibieron LEV en  el agua de bebida antes y \ndespu\u00e9s de la vacunaci\u00f3n, estos resultados no fueron \nrepetitivos en la Prueba 2, Barbosa y otros \ninvestigadores mencionan que pollos de engorda \nmedicados con un inmunomodulador v\u00eda agua de \nbebida despu\u00e9s de la vacunaci\u00f3n contra l a ENC si \npresentan un incremento estad\u00edsticamente significativo \nen los t\u00edtulos de HI -ENC comparados con el grupo \ntestigo.3, 7  \nLa actividad fagoc\u00edtica de los heter\u00f3filos contra \nbacterias in vitro  fue mayor cuando se medico con \nVsEs3 -C y LEV, esto no presen to efecto alguno sobre \nla respuesta serol\u00f3gica en la vacuna de ENC, pero de alguna manera forma parte de la respuesta \ninmunol\u00f3gica y por lo tanto de la resistencia de las aves hacia otras enfermedades reduciendo as\u00ed el \nporcentaje de mortalidad.\n4,9,12 Estud ios en medicina \nhumana  mencionan que la terapia con LEV en \npacientes con leucemia linfobl\u00e1stica aguda ayuda a \nrestaurar la respuesta inmune por un incremento de la \nactividad fagoc\u00edtica. 6   \nDiversos reportes de la acci\u00f3n del virus de ENC \nsobre la bolsa de Fabricio indican que este ocasiona marcada degeneraci\u00f3n de la bolsa as\u00ed como destrucci\u00f3n \nde linfocitos en bazo y timo.\n2 Las aves que recibieron \nVsEs3 -C y LEV presentaron mayor di\u00e1metro folicular, \nsin embargo en todos los tratamientos se observo \ndepleci\u00f3n l infoide en diversos grados, sin ser \nsugestivos de infecci\u00f3n de la bolsa de Fabricio.  \nEn timos normales  se espera una relaci\u00f3n \ncorteza:m\u00e9dula de 2:1* cosa que no sucedi\u00f3 en este estudio; lo que s\u00ed se observo es que el  T -   desarroll\u00f3 \natrofia severa mas r\u00e1pidamente.  \n CONCLUSIONES  \na) Los par\u00e1metros productivos al manejo por \nvacunaci\u00f3n, son mejores cuando las aves son tratadas \npreventivamente con VsEs3 -C \nb) La respuesta serol\u00f3gica no se incrementa \nsignificativamente de manera constante con el uso de \nLEV  y VsEs3 -C cuando las aves son vacunadas contra \nla ENC  \nc) El uso de VsEs3 -C y LEV de manera \npreventiva incrementan la actividad fagoc\u00edtica de los heter\u00f3filos; no obstante se recomienda hacer mas \nestudios a este respecto para evaluar su papel en la \nresistencia de las av es. \n \nREFERENCIAS  \n1. Aguilar, P. C. El levamisol como \ninmunomodulador en la vacunaci\u00f3n de Gumboro. Tesis \nde Licenciatura. FES -Cuautitlan. UNAM. 1985.  \n2. Alexander, D. J. Newcastle diseases and \nother paramyxovirus infection . In: Diseases of  \nPoultry. 9\nth ed. Iowa  State University Press, ed. Calnek \nand cols. USA. pp. 1991.  \n3. Barbosa, E. J. Acci\u00f3n del levamisol como \ninmunoestimulante despu\u00e9s de la vacunaci\u00f3n y desaf\u00edo con virus de la enfermedad de Newcastle en pollos de engorda. Tesis de Licenciatura. FMVZ -UNAM. 1981.  \n4. Bas, A. L. Traas, B., Elams, M., Keskin, E. \nand Yazar, E. The effect of acetylsalicylic acid on the phagocytic function on bovine neutrophils in vitro. \n(ABSTRAC) Revue de Medicine Veterinaire 148:  857 \n\u2013 862. 1998.  \n5. Bendich, A. Ascorbic Acid and Immune \nFunctions (Review). Proc. 2\nnd Symposium. Kartause \nIttingen, Switzerland. Pp. 408 \u2013 420. 1990  \n6. Boguslawska, J. J. Chybicka, A. and \nPisarek, J. The study of T lymphocytes, granulocyte\u2019s \nphagocytic activity and adherent cells in patients with acute lynphoblastic  leukemia during levamisole \ntherapy. Imm. of the immunoproliferative dis. 855 -858. \n1978.  \n7. Chakraborty, D and  Chatterjee, A.  Studies \non immodulatory effect of levamisole in Newcastle disease vaccinated chicks. Indian Jour. in Comp. \nMicrobiology,  85 \u2013  87. 1998.  \n8. Gokce, G.; Irmak, K.; Sural, E and Ozlu, E. \nClinical observation on the therapeutic and \nprophylactic effects of immunomodulators in sheep pox. I. (ABSTRACT) Kafkas Universitesi Veteriner \nFakultesi Dergisi Turkey.  211- 215. 1997.  \n9. Gross, B. Effect of ascorbic acid on \nresistance of chickens to disease. Proc. 2\nnd Symposium. \nKartause Ittingen, Switzerland. 429 \u2013 436. 1990.  \n10. Guy, E. R. El levamisole y la \ninmunoregulaci\u00f3n. Vet. Argentina. 660- 674. 1988.  \n11. Hern\u00e1ndez V.J. Efectos del levamisol en \ndosis subterap e\u00faticas para pollo de engorda  \n  \n98 administrado en el agua de bebida. Tesis de \nLicenciatura. FMVZ -UNAM. 1981.  \n12. Shadaksharappa, H. L. , Gowda, R. N. and \nVijayasarathi, S. K. Effects  of levamisole hydrocloride, vitamin E and C on bursa body weight \n(B:B) index on infectious bursal disease virus (IBDV) \nvaccination in broilers. Indian Jour. in Vet. Path.  109 \u2013  \n112. 1997.  \n13. Solis, S. Situaci\u00f3n de la campa\u00f1a nacional \ncontra la enfermedad de Newcastle. Memorias Curso enfermedades emergentes: Enfermedad de Newcastle,  \nANE CA, M\u00e9xico. 20 -28. 2000.   \n14. 14. Yeo, W. H., Kim, Y. H., Park, E. K. and \nKim, S. S. Physico -chemical characteristics and \nantiviral activity of acetylsalicylic acid, an antibiotic  produced by actinomycetes B25. (ABSTRAC) Korean \nJour. of Plant Path.    13: 1 - 3. 1997.  \n \n(Comunicaci\u00f3n personal Dr. N\u00e9stor Ledesma).  \n \nEVALUACION DE PROTECCION CONTRA LA ENFERMEDAD DE \nNEWCASTLE ANTE UN DESAFIO, UTILIZANDO DIFERENTES \nCALENDARIOS DE VACUNACION \n \nPROTECTION AGAINST CHALLENGE USING DIFFERENT NEWCASTLE \nDISEASE VACCINATION PROGRAMS  \n \nMu\u00f1oz P. Patricia, Toscano C. Arnulfo, Chapa B. Joaqu\u00edn.; Lucio D. Eduardo  \n \nLaboratorio de Biolog\u00eda.  Investigaci\u00f3n Aplicada S.A. de C.V., Tehuac\u00e1n, Puebla, MEXICO 75700  \n \nSUMMARY  \nIn Mexico, Newcastle disease is controlled \nthrough biosecurity me asures, as well as through the \nadministration of live or killed virus vaccines, using \ndifferent vaccination schedules. The efficacy of four different vaccination programs was evaluated against \npathogenic challenge. For this purpose, a \npotency/challenge tes t was performed under controlled \nlaboratory conditions. Results showed that all four \nprograms protected the birds against challenge. \nProtection was 100% with 3 programs, and 90% with the other program.  \n \nRESUMEN  \n La Enfermedad de Newcastle (ENC), se control a \na trav\u00e9s de medidas de bioseguridad y aplicaci\u00f3n de \nvacunas a virus activo e inactivado, mediante \ndiferentes calendarios de vacunaci\u00f3n utilizados en \nM\u00e9xico. Se evaluaron cuatro diferentes calendarios de \nvacunaci\u00f3n para verificar su eficiencia ante un vir us \npat\u00f3geno, esto se realiz\u00f3 mediante una prueba de potencia -desaf\u00edo en condiciones controladas de \nlaboratorio. De acuerdo a los resultados obtenidos los cuatro programas de vacunaci\u00f3n protegieron a las aves \ncontra el desaf\u00edo de la ENC. Tres programas protegieron en un 100%; y otro en un 90%.  \n \nINTRODUCCION  \n  La Enfermedad de Newcastle (ENC), es causada \npor un paramyxovirus.  Entre los virus de la ENC, encontramos una gran variaci\u00f3n en cuanto a su virulencia, existen cepas que producen infecci\u00f3n sin presentar signos cl\u00ednicos de enfermedad, algunas otras \nproducen  enfermedad y mortalidad de hasta un 100%. \nS\u00f3lo se conoce un serotipo de virus el cu\u00e1l se puede \nclasificar de acuerdo a su virulencia en tres cepas: lentog\u00e9nicas (suaves), mesog\u00e9nicas (medias) y \nvel\u00f3genicas (virulentas)  (5). Tambi\u00e9n se pueden \nclasificar de acuerdo a la signolog\u00eda cl\u00ednica que \npresenten las aves, como son las cepas neurotr\u00f3picas, \nque provocan signos cl\u00ednicos de tipo nervioso y las \ncepas viscerotr\u00f3picas que provocan hemorragias severas e n las v\u00edsceras, sin la presentaci\u00f3n de signos de \ntipo nervioso; Estas diferencias permiten la \nidentificaci\u00f3n del virus de la ENC como cepa  \nneurotr\u00f3pica \u00f3 cepa viscerotr\u00f3pica (2).  \n  La prueba de Inhibici\u00f3n de la Hemoaglutinaci\u00f3n \n(HI), tiene una gran aplica ci\u00f3n pr\u00e1ctica en la \nprevenci\u00f3n y control de la ENC, ya que las aves que han sido expuestas a este virus (de campo \u00f3 vacunal), \ndesarrollan anticuerpos inhibidores de la \nhemoaglutinaci\u00f3n. Lo anterior permite que los calendarios de vacunaci\u00f3n empleados sean e valuados \nen una forma peri\u00f3dica, r\u00e1pida y econ\u00f3mica, lo cu\u00e1l es de gran ayuda para el m\u00e9dico de campo para la pronta toma de decisiones (2).  Sin embargo es recomendable \nque cuando haya un cambio en el calendario de \nvacunaci\u00f3n \u00f3 el tipo de vacuna se eval\u00fae por medio de \nuna prueba de potencia de desaf\u00edo controlada.  \n \nMATERIAL Y METODOS  \nDise\u00f1o experimental.  Se formaron cuatro \ngrupos de aves de pollo de engorda (35 pollos por \ngrupo), denomin\u00e1ndolos Programa 1, 2 , 3 y 4;  \n  \n99 provistos de agua y alimento ad libitum .     Se \nutilizaron cuatro diferentes calendarios de vacunaci\u00f3n \nque a continuaci\u00f3n se detallan:    \nPrograma 1: Al d\u00eda 1 de edad se aplic\u00f3 vacuna \nde Newcastle (NC) inactivada hiperconcentrada v\u00eda subcut\u00e1nea a raz\u00f3n de 0.2 ml/ave; y vacuna NC cepa \nB1B1 virus  vivo (vv), v\u00eda aspersi\u00f3n. Al d\u00eda 10 de edad \nse aplic\u00f3 vacuna combinada NC/BI cepas B1B1, Mass, \nConn,  v\u00eda aspersi\u00f3n. Al d\u00eda 36 de edad, se desaf\u00edo con \nun virus pat\u00f3geno contra la enfermedad de Newcastle \n(VPENC), cepa chimalhuacan con una dosis de 10\n4 \nDIE 50/ml, v\u00eda intramuscular, a  raz\u00f3n de 0.2 ml/ave. Al \nd\u00eda 54 de edad se sacrificaron las aves para ver lesiones a la necropsia.  \nPrograma 2: Al d\u00eda 1 de edad se aplic\u00f3 vacuna \nde NC inactivada hiperconcentrada v\u00eda subcut\u00e1nea a raz\u00f3n de 0.2 ml/ave; y vacuna NC  cepa B1B1 vv, v\u00eda \naspersi\u00f3n.  Al d\u00eda 10 de edad se aplic\u00f3 vacuna combinada NC/BI cepas B1B1, Mass, Conn, v\u00eda \naspersi\u00f3n. Al d\u00eda 25 de edad, se aplic\u00f3 vacuna NC cepa \nB1B1 vv, v\u00eda aspersi\u00f3n. Al d\u00eda 40 de edad se desafi\u00f3 \ncon VPENC, cepa chimalhuacan con una d osis de 10\n4  \nDIE 50  / ml, v\u00eda intramuscular a raz\u00f3n de 0.2 ml/ave.  Al \nd\u00eda 54 de edad se sacrificaron las aves para ver lesiones \na la necropsia.    \nPrograma 3: Al d\u00eda 1 de edad se aplic\u00f3 vacuna \nde NC inactivada hiperconcentrada v\u00eda subcut\u00e1nea a raz\u00f3n de 0.2  ml/ave; Y vacuna NC cepa B1B1  vv, v\u00eda \naspersi\u00f3n.  Al d\u00eda 10 de edad se aplic\u00f3 vacuna \ncombinada NC/ BI  cepas La Sota, Mass, Con, v.v., v\u00eda \naspersi\u00f3n.. Al d\u00eda 36 de edad se desafi\u00f3 con VPENC, cepa chimalhuacan con una dosis de 10\n4  DIE 50  / ml, \nv\u00eda intram uscular a raz\u00f3n de 0.2 ml/ave.  Al d\u00eda 50 de \nedad se sacrificaron las aves para ver lesiones a la necropsia. \n  \nPrograma 4: Al d\u00eda 1 de edad se aplic\u00f3 vacuna \nde NC inactivada hiperconcentrada v\u00eda subcut\u00e1nea a raz\u00f3n de 0.2 ml/ave; y vacuna NC cepa B1B1  vv, v \u00eda \naspersi\u00f3n.  Al d\u00eda 10 de edad se aplic\u00f3 vacuna combinada NC /BI cepas La Sota, Mass, Conn, v.v., \nv\u00eda aspersi\u00f3n.  Al d\u00eda 25 de edad,  se aplic\u00f3 vacuna NC \ncepa B1B1 vv, v\u00eda aspersi\u00f3n. Al d\u00eda 40 de edad se desafi\u00f3 con VPENC, cepa chimalhuacan con una dosis  \nde 10\n4  DIE 50  / ml, v\u00eda intramuscular a raz\u00f3n de 0.2 \nml/ave.  Al d\u00eda 54 de edad se sacrificaron las aves para \nver lesiones a la necropsia.          \nSe realizaron monitoreos serol\u00f3gicos  a los 9, 17, \n24, 31 y 39 d\u00edas de edad para los cuatro programas, para esto se utiliz\u00f3 la prueba de Inhibici\u00f3n de la \nHemoaglutinaci\u00f3n (HI), con 10 UHA, m\u00e9todo beta (suero diluido, virus constante), de acuerdo a la Norma Oficial.\n   \nSe colocaron 5 pollos de engorda  sin vacunar en \ncada uno de los cuatro programas, de la misma edad en \nla que fueron desafiados cada uno, para tomarlos en \ncuenta como controles positivos.  Cada una de las vacunaciones  por v\u00eda aspersi\u00f3n \nse realiz\u00f3 con un atomizador manual y al momento de \nla aplicaci\u00f3n, se apag\u00f3 el motor el\u00e9ctrico de la unidad \nde ais lamiento por un tiempo de 20 minutos, para que \nel aerosol de la vacuna  no se escapara a trav\u00e9s del \nsistema de aire filtrado.  \nEn cada uno de los monitoreos serol\u00f3gicos se \ntomaron de a 5 pollos de cada programa y se iban eliminando. Esto se realiz\u00f3 para no sangrar varias  \nveces a los mismos pollos y as\u00ed evitar \ninmunodeprimirlos, ya que este en un factor  \nimportante en este tipo de pruebas.  \n \nRESULTADOS  \nEntre el 4\u00ba y  6\u00ba  d\u00eda post -desaf\u00edo (PD), los 5 \npollos no vacunados de cada programa (controles positivos) m urieron, al igual que al 6\u00ba. d\u00eda PD, muri\u00f3 \nun pollo vacunado del programa 2,  presentando a la \nnecropsia lesiones caracter\u00edsticas de la ENC cepa \nviscerotr\u00f3pica, consistentes en hemorragias severas en \nproventr\u00edculo, tonsilas cecales y placas de Peyer.  \nDel 1 \u00ba a los 14 d\u00edas PD, los 10 pollos de engorda \nvacunados restantes, de los programas 1,3 y 4 y los 9 \npollos restantes del programa 2, no presentaron ning\u00fan \nsigno cl\u00ednico, caracter\u00edstico de NC.  \nEn los programas 1,3 y 4 los pollos de engorda \nvacunados mostraro n un  100% de protecci\u00f3n al \ndesaf\u00edo.  \nEn el programa 2 los pollos vacunados mostraron \nun 90% de protecci\u00f3n al desaf\u00edo.   \nLos  porcentajes  de protecci\u00f3n al desaf\u00edo, \nconferidos a las aves en los cuatro calendarios de \nvacunaci\u00f3n se consideran SATISFACTORIOS, ya que \nlos requisitos m\u00ednimos que marca la SAGARPA, son \nde un 80% de protecci\u00f3n al desaf\u00edo para que una \nvacuna sea considerada como efectiva.  \nEn las gr\u00e1ficas 1 y 2 se analizan el \ncomportamiento serol\u00f3gico de cada uno de los 4 \nprogramas de vacunaci\u00f3n, duran te el desarrollo de la \nprueba.  \n \nCONCLUSIONES  \nTodos los programas de vacunaci\u00f3n contra la \nenfermedad de NC tienen como objetivos disminuir la \nincidencia, evitar p\u00e9rdidas econ\u00f3micas por mortalidad, \nproblemas respiratorios y secuelas ante un desaf\u00edo de campo.  \nExisten diversos programas de vacunaci\u00f3n contra \nla  enfermedad de NC y en cada uno de ellos se espera \nuna respuesta inmune diferente. Por esto es importante \nque al modificar \u00f3 renovar los calendarios de \nvacunaci\u00f3n sean puestos a prueba, mediante las prueb as de potencia desaf\u00edo en condiciones controladas \nen  Unidades de Aislamiento.  \nEn cuanto al nivel de anticuerpos es necesario \nrecordar que aunque estos sean un buen reflejo de la  \n  \n100 protecci\u00f3n del ave contra la enfermedad de NC, existen \notros factores de resi stencia, as\u00ed como de inmunidad \nlocal y celular y fen\u00f3menos de interferencia viral que \ncoadyuvan en este proceso.  Aves con t\u00edtulos bajos \npueden resistir a un desaf\u00edo y aves con t\u00edtulos elevados \npueden sucumbir a este (5).  \nEn estudios realizados para conocer el grado de \nprotecci\u00f3n conferido a las aves con diferentes t\u00edtulos de anticuerpos, se determin\u00f3 que las aves est\u00e1n protegidas \ncontra la muerte cuando tienen un t\u00edtulo  m\u00ednimo de 5 \nlog2 (5),  pero esto no indica que las aves no ser\u00e1n \ninfectadas por el vir us de campo, en cuyo caso el virus \npuede replicarse, producir secuelas respiratorias y ser \neliminado por el organismo en diferentes grados \ndependiendo del t\u00edtulo de anticuerpos circulantes \nprevios a la infecci\u00f3n.  \nEs conveniente que tanto el m\u00e9dico de campo  \ncomo el avicultor se den cuenta de la  gran importancia \nde llevar muestreos peri\u00f3dicos en sus parvadas no s\u00f3lo para el caso de la enfermedad de NC, ya que adem\u00e1s de \notros beneficios, pueden llegar a comprobar \neventualmente la calidad de los productos util izados en \nsu granja (4).  \nPor \u00faltimo cabe destacar que adem\u00e1s de un \nprograma de vacunaci\u00f3n eficaz, es necesario considerar las  pr\u00e1cticas de buen manejo, bioseguridad y buena \nhigiene en las granjas (1).  \n \nREFERENCIAS  \n1. B.W. Calnek, \u201c Enfermedades de las aves \u201c  \nManual moderno, 2\u00aa. Edici\u00f3n, M\u00e9xico, D.F. -Santaf\u00e9 de \nBogot\u00e1  2000.   P.  574.  \n2. Intervet, \u201c Las enfermedades m\u00e1s \nimportantes de las aves \u201c 4\u00aa. Edici\u00f3n, M\u00e9xico, D.F. \n1999.   P.   14.  \n3. J.L. , Garc\u00eda; G.D., Merino; J.Cabriales; \nM.A., M\u00e1rquez. Boehringer Ingelheim Vetm\u00e9dica, \nS.A. de C.V.  \u201c Aspectos b\u00e1sicos de programas de \nvacunaci\u00f3n contra la enfermedad de Newcastle \u201c \nMemorias de la XXVI convenci\u00f3n anual de ANECA, \nAcapulco, Gro.  2001. P. 117.  \n4. Lozano D., Bernardo; Morf\u00edn F., Rogelio; \nLozano D., Jorge.  \u201cComporta miento en el campo de \nlas vacunas emulsionadas comerciales contra la \nenfermedad de Newcastle en pollos de engorda\u201d.       \nSarfati M., David,; Lucio M.,  Benjam\u00edn; Lozano D., \nBernardo; Soto P., Ernesto. \u201c Aplicaci\u00f3n de la \nInhibici\u00f3n de la Hemoaglutinaci\u00f3n e n el control de la \nEnfermedad de Newcastle \u201c.   \u201c Curso de actualizaci\u00f3n  \nANECA\u201d,  Monterrey, N.L. 1985.p. 59,60 y 61.\n \n \n  Graficia 1           Graficia 2  \n \n \n   \n \n  HI-ENC\n0123456789\nMonitoreo serol\u00f3gico ( E dad en d\u00edas )Media geom\u00e9trica \n( log 2 )\nPROGRA MA  3 3 4 6 8 8\nPROGRA MA  4 3 4 7 7 89 17 24 31 39HI-ENC\n0123456789\nMonitoreo serol\u00f3gico ( E dad en d\u00edas )Media geom\u00e9trica \n( log 2 )\nPROGRA MA  1 3 7 6 8 7\nPROGRA MA  2 5 5 6 6 89 17 24 31 39 \n  \n101 SAFETY AND EFFICACY OF A NOVEL NEWCASTLE DISEASE \nVACCINE ADMINISTERED IN OVO TO SPF AND COMM ERCIAL \nBROILER BIRDS  \n \nSEGURIDAD Y EFICACIA DE UNA NUEVA VACUNA CONTRA LA \nENFERMEDAD DE NEWCASTLE ADMINISTRADA IN OVO A AVES SPF Y A \nPOLLOS DE ENGORDA COMERCIALES \n \nEid E. HaddadA, Craig E. WhitfillA, Alan P. AvakianA, Donald B. LinkB, and Patricia S. WakenellB \n \nAEMBREX Inc., P.O. Box 13989, Research Triangle Park, North Carolina 27709.  \nBDepartment of Population Health and Reproduction, University of California, Davis, California, 95616  \n \nRESUMEN  \nSe desarroll\u00f3 una nueva vacuna contra la \nenfermedad de Newcastl e para administraci\u00f3n in ovo,  \nformulada mezclando cantidades apropiadas de las \ncepas B1 y LaSota, y de sus anticuerpos neutralizantes. \nLos virus y los anticuerpos se obtuvieron \ncomercialmente. En experimentos separados la vacuna \nse administr\u00f3 in ovo a los 18 d\u00edas del desarrollo, ya sea \na embriones libres de pat\u00f3genos espec\u00edficos ( SPF) o de \npollo de engorda. Los par\u00e1metros usados para evaluar \nla seguridad fueron la incubabilidad y la mortalidad, \nmientras que para la eficacia se evalu\u00f3 la protecci\u00f3n \ncontra el  desaf\u00edo est\u00e1ndar con la cepa GB de Texas. \nLos resultados de estos experimentos sugirieron que la \nvacuna es completamente segura y eficaz cuando se \nadministra in ovo a los embriones ya sea SPF  o de \npollo de engorda con inmunidad pasiva contra dicho \nvirus.  \n \nSUMMARY  \nA novel in ovo Newcastle Disease (ND) vaccine \nhas been developed. The vaccine was formulated by \nmixing the appropriate amount of NDV B1/La Sota \nwith the appropriate amount of its neutralizing \nantibodies. The ND virus and the antibodies were \nobtain ed commercially. In separate experiments, the \nvaccine was administered in ovo on day 18 of \nembryonic development to either Specific Pathogen \nFree (SPF) or broiler embryos. Safety and efficacy parameters were evaluated. Safety parameters included \nhatchabili ty and mortality, while efficacy parameters \nincluded protection against a standard Texas GB \nchallenge. Results of these experiments suggested that \nthe vaccine was fully safe and efficacious when \nadministered in ovo to either SPF or commercial \nbroiler chick ens with passive immunity to NDV.  \n \nINTRODUCTION  \nNewcastle disease is a highly contagious \nrespiratory disease of chickens as well as other avian species. The disease continues to be a major problem with a substantial economic impact on the poultry \nindustry throughout the world. Good vaccination as \nwell as sanitary veterinary measures are required to \ncontrol the disease. Current ND vaccination practices \nare based on multiple vaccinations against the disease either through spray or drinking water during the li fe of \nthe bird. The increasing problems associated with the control of the disease worldwide have emphasized the need for a better vaccine that would be easily applied \nand have a significant degree of effectiveness.  \nIn recent years and due to the availabil ity of an \nautomated mass egg injection system, the poultry \nindustry has adopted the use of the in ovo route of \nadministration to administer vaccines and biologicals \nto broilers at the time of transfer around day 18 of \nembryonic development (5). Currently, vaccines that \ncan be used in ovo include Marek =s disease (MD) and \nInfectious Bursal Disease Virus (IBDV) vaccines (3, 5, \n10). (Commercial in ovo vaccines against Pox virus \nhave also been approved in some countries of the \nworld.) There have been several attempts at developing \nin ovo vaccines against Ne wcastle Disease Virus \n(NDV) (1 -2, 6), Infectious Bronchitis Virus (IBV) (8 -\n9), bacteria, and coccidiosis vaccines (reviewed in 5).  \nWe have previously reported the successful \ndevelopment of an IBDV vaccine for post -hatch \ndelivery (3, 10) which also can be d elivered in ovo. \nHerein, we report on the successful application of the same concept towards the development of a ND \nvaccine that can be administered in ovo. The objective of this work was to evaluate the safety and efficacy of \nthis novel ND vaccine in bot h SPF and commercial \nbroilers with variable levels of maternal ND immunity.  \n \nMATERIALS AND METHODS  \nVaccine preparation.  The novel NDV vaccine \nwas prepared as described previously (10). Briefly, the appropriate amount of NDA was mixed with the \nappropriate a mount of NDV strain La Sota Type B1  \n  \n102 (NDV - NDA complex vaccine), added virus stabilizer, \ndispensed into glass vials at 1000 doses/vial, then \nlyophilized. Virus titer (7) and anti ND activity in \nNDA (4) were determined prior to mixing. The vaccine \nwas re -hydrated using commercially available MD \ndiluent and injected at 1 dose/embryo/100 \u00b5l on day 18 \nof embryonic development.  \nChallenge virus.  The NDV standard challenge \nvirus (Texas GB strain of NDV; Lot #92- 1, 109.6 \nEID 50/ml) was used at 104.7 EID 50/challenge dose, \nadministered intramuscularly (IM) into the breast \nmuscle.  \nVaccine evaluation criteria.  Safety was \nevaluated based on hatchability and post hatch \nmortality using SPF embryos. The vaccine was \nconsidered safe if the above parameters were within the \nvalues of the Vehicle (MD diluent alone) control \nvalues. Efficacy was evaluated by protection against the standard NDV challenge, administered according to \nthe established guidelines.  \nExperimental design.  Safety/Efficacy \nExperiment in SPF Birds.  In this exper iment, three \ngroups were included; Group 1 receiving MD diluent, \nGroup 2 receiving a 1X dose of the vaccine, and Group 3 receiving a 10X dose of the vaccine. Hatchability, \npost-hatch mortality (all groups) and day 21 of age \nprotection against the Texas GB (Groups 1 & 2) were \nall evaluated. The efficacy part of this experiment was \nrepeated to confirm the obtained results.  \nEfficacy Experiment in Commercial Broilers . In \nthis experiment, two groups were included; Group 1 \nreceiving MD diluent and serving as Vehi cle Controls, \nand Group 2 receiving a 1X dose of the vaccine. \nProtection against weekly Texas GB challenge was \nevaluated. Weekly serology using a commercially \navailable Enzyme -Linked Immunosorbent Assay \n(ELISA) kit (IDEXX, Inc.,) was also determined. \nAddit ionally, Hemagglutination -Inhibition (HI) tests \n(HA=8) were conducted on serum samples collected on \nday 1 of age.  \nStatistical analysis.  Descriptive statistics were \nused wherever appropriate. Titer values are presented \nas Geometric Mean Titer (GMT). HI titers are presented as Log\n2 values.  \n \nRESULTS AND DISCUSSION \nResults from Experiment 1 showed that overall \nhatchability was 95%, 91%, and 98% for the Vehicle Control Group 1, Group 2 (1X dose group), and Group \n3 (10X dose group), respectively. Overall post -hatch \nmortality was within acceptable levels as stated in \nUSDA 9CFR Guidelines. Vaccinated birds were fully \nprotected (> 90% protected) against the standard Texas \nGB when administered on day 21 of age. These results clearly demonstrate that the vaccine was fu lly safe and \nefficacious in SPF birds.  In Experiment 2, birds (30 birds/challenge) were \nchallenged on a weekly basis starting on day 7 of age. \nFull protection (>90% of the challenged birds) was \nobserved as early as day 14 of age and continued \nthrough the l ife of the bird (day 42 of age). Level of \npassive immunity was variable but substantial. Birds were able to produce substantial levels of anti NDV antibodies as measured by ELISA.  \nIn conclusion, the new NDV - NDA complex \nvaccine was shown to be both safe an d efficacious in \nboth SPF and commercial broilers with variable levels \nof passive NDV immunity. This novel vaccine offers \nthe advantages over conventional commercial ND vaccines by being administered in ovo as the only ND \nvaccine, thus replacing the need f or multiple ND \nhatchery and field vaccinations. The compatibility of this novel vaccine with other in ovo  vaccines is \ncurrently under investigation. Preliminary data suggest that this vaccine will be compatible with other \ncommercially licensed in ovo  vacci nes. The \nperformance of this novel vaccine under field \nconditions is also under investigation. Normal field \nperformance is expected based on our daily \nobservations of the mentioned broiler study.  \n \nREFERENCES  \n1. Ahmad, J and J. M. Sharma. Evaluation of a \nmodif ied live virus vaccine administrated in ovo to \nprotect chickens against Newcastle disease. Am. J. Vet. Res. 53:1999- 2004, 1992.  \n2. Ahmad, J., and J. M. Sharma. Protection \nagainst hemorrhagic enteritis and Newcastle disease in \nturkeys by embryo vaccination wit h monovalent and \nbivalent vaccines. Avian Dis. 37:485 -491, 1993.  \n3. Haddad, E. E., C. E. Whitfill, A. P. Avakian, \nC. A. Ricks, P. D. Andrews,  J. A. Thoma, and P. S. \nWakenell. Efficacy of a novel Infectious Bursal disease virus immune complex vaccine in broil er chickens. \nAvian Dis. 41:882- 889,1997.  \n4. Haddad, E. E., C. E. Whitfill, C. A. Ricks, \nT. Fredericksen, D. Rowe, L. Owen, A. Baldridge, L. \nMurray, and J. A. Thoma. Adaptation of the MTT (3 -\n[4,5-dimethylthiazol -2-yl]-2,5-diphenyl tetrazolium \nbromide) assay for the determination of virus -\nneutralizing antibodies using the virus -neutralization \nassay. Avian Dis. 38:755- 761. 1994.  \n5. Ricks, C. A., A. Avakian, T. Bryan, R. \nGidersleeve, E. Haddad, R. Ilich, S. King, L. Murray, \nP. Phelps, R. Poston, C. Whitfill, and C. W illiams. In \novo vaccination technology. Adv. Vet. Med. 41:495-\n515, 1999.  \n6. Stone, H. D. In ovo vaccination of chicken \nembryos with experimental Newcastle disease and avian influenza oil -emulsion vaccines.  Avian Dis. \n41:856- 863, 1997.   \n  \n103 7. Villegas, P. Titration of biological \nsuspensions. In: A laboratory manual for the isolation \nand identification of avian pathogens, 4th ed. D. E. \nSwayne, J. R. Glisson, M. W. Jackwood, J. E. Pearson, \nand W. M. Reed, eds.University of Pennsylvania, PA . \npp 248- 253. 1998.  \n8. Wakenell,  P. S., and J. M. Sharma. Chicken \nembryonal vaccination with avian infectious bronchitis virus. Am. J. Vet. Res. 47:933 -938, 1986.  \n9. Wakenell, P. S., J. M. Sharma, R. F. \nSlocombe. Embryo vaccination of chickens with infectious bronchitis virus: Histologic an d \nultrastructural lesion response and immunologic response to vaccination. Avian dis. 39:752- 765, 1995  \n10. Whitfill, C. E., E. E. Haddad, C. A. Ricks, J. \nK. Skeeles, L. A. Newberry, J. N. Beasley, P. D. Andrews, J. A. Thoma, and  P. S. Wakenell. \nDetermination of optimal formulation of a novel \ninfectious bursal disease virus (IBDV) vaccine \nconstructed by mixing bursal disease antisera with \nIBDV. Avian Dis. 39:687- 699. 1995.  \n \nEXPERIENCES WITH KILLED OIL EMULSION NEWCASTLE \nDISEASE VIRUS VACCINE ON DAY OLD TURKEY POULTS IN \nTHE MIDWEST (U.S.A.)  \n \nEXPERIENCIAS CON UNA VACUNA INACTIVADA Y EMULSIONADA EN \nACEITE, ELABORADA CON EL VIRUS DE LA ENFERMEDAD DE \nNEWCASTLE PARA USO EN PAVIPOLLOS DE UN D\u00cdA EN EL MEDIO \nOESTE ESTADOUNIDENSE  \n \nHugo A. Medina  \n \nJennie -O Turkey Store, I nc. P.O. Box 778, Willmar, Minnesota 55201  \n \nRESUMEN  \nEn algunos pa\u00edses ha sido dif\u00edcil erradicar al virus \nde la enfermedad de Newcastle ( NDV ) mediante \nprocedimientos de bioseguridad, limpieza y \ndesinfecci\u00f3n. En consecuencia, dichos pa\u00edses se han \nvisto obligados a usar la vacunaci\u00f3n como m\u00e9todo de \ncontrol. Las vacunas a virus activo se aplican \ncom\u00fanmente por aspersi\u00f3n, nebulizaci\u00f3n, en el agua de bebida, por instilaci\u00f3n ocular, intranasal o aspersi\u00f3n \nsobre el alimento. Llevamos a cabo pruebas en \nMinnesota co n una vacuna inactivada del virus de la \nenfermedad de Newcastle, inyectada al d\u00eda de edad. Disertaremos sobre las comparaciones y las \nobservaciones realizadas en los pavos vacunados al d\u00eda \nde edad.  \n \nNewcastle Disease Virus (NDV) is a worldwide \ndisease prob lem. NDV signs, symptoms and effects \nhave been described elsewhere. NDV is a worldwide problem that infects a wide range of wild and domestic \nfowl. It has been pointed out that about half of the bird \nspecies are susceptible to NDV. The main objective of \ninternational, national, local or farm methods of control \nhas as objective either prevent susceptible birds to \nbecome infected or to reduce the number of susceptible \nbirds through vaccination. In general NDV has been \nvery difficult to eradicate from some cou ntries through \nbiosecurity and sanitation procedures, as a consequence they have been forced to vaccinate as method of control.  \nOver the years the poultry industry in the U.S.A \nhas being exposed to the three pathotypes of the disease (Lentogenic, Mesogeni c and Velogenic \nstrains), which have been isolated from time to time. In general commercial fowl (layers, broilers, turkeys and all their parent and grand parent stocks) have been \nprotected to the disease by vaccination. The most common isolates of NDV pre sent in the U.S.A. belong \nto the Lentogenic pathotype group.  \nIdeally, vaccination against NDV would result in \nimmunity against infection and replication of the virus; but in reality, vaccination would reduce more serious effects of the disease, although vi rus replication and \nshedding may still occur but at a lower degree.  \nVaccination against NDV is widely used in the \npoultry industry. In the U.S.A. the most common \nmethods of vaccination with live virus vaccines are \nspray, fogging, water, intra -ocular, intra nasal, spray on \nfeed or a combination of them. Live NDV vaccines \nused for these purpose have been isolates under the \nLentogenic category; in particular virus strain most \nwidely used have been B1, B1 and B1 La Sota and \nClone 30 strains. Any of these methods  of vaccination \nhave been used on broilers, commercial layers, turkeys \nand their parent stocks.   \n  \n104 In Minnesota and the Midwest NDV has been \npresent for few decades. Apparently mass NDV \nvaccination in turkeys in Minnesota has been practiced \nsince the early 1 970\u2019s, up to the present time.  \nNDV inactivated vaccines has been in used since \nthe 1970\u2019s. These vaccines have been manufactured \nusing a Lentogenic or Mesogenic type of viruses. Other killed virus vaccines have been in use with other \nviruses or even in com bination with bacterins. At the \npresent time killed oil base emulsion vaccines have \nbeen manufacture with different oil base combinations; \nsuch as oil; water -in-oil and water -in-oil-in-water \nemulsion. The objective of these emulsions in \ncombination with ND V and / or other antigens has \nbeen to provide a longer lasting and higher immune \nresponse.  \nOil base killed vaccines are primarily provided by \ninjection. Sites of injection have been subcutaneously \n(neck), intramuscularly (leg, breast or tail).  \nTurkey floc ks can be, and in reality are, exposed \nto \u201cfield NDV challenges\u201d. These field challenges do \nnot necessarily induce respiratory problems or  \nsecondary infections (primarily by E. coli). Flocks in \nthe field can be exposed to NDV and as consequence \nrespond im munologically to various levels of antibody \ntiters (HI or ELISA tests) depending on the NDV \nexposure, degree of field challenge and/or \ncomplications due to that challenge.  \nThere is an assumption that the constant use of \nlive field NDV virus vaccines over t he years has \n\u201cseeded\u201d the wild bird population, production farms and barns.  \nDay old or younger than ten days subcutaneous \nNDV killed oil emulsion vaccination has been in use for several years in Latin America, the Far East, and \nthe Middle East to aid in th e control and prevention of \nthe disease. Day old killed NDV oil emulsion in the \nU.S.A. is a new concept. Although this is new, it \nappears to have a potential benefit in the turkey \nindustry. Continual NDV field vaccination had induced \na series of side effec ts, primarily respiratory problems. \nThis procedure reduces the number of NDV field \nvaccinations and reduces respiratory problems.  \nDay old vaccination in poultry is not a new \nprocedure. Day old subcutaneous vaccines have been \nused in chicken broilers and la yer replacements \n(Marek\u2019s Disease) since the 1970\u2019s. NDV day old vaccination also has been in use for some time in \nchickens, pullet replacements and in turkey poults. \nLive NDV vaccines have been used in chickens and \nturkeys. In turkeys NDV recombinant live  vaccines \nhave been used during the 1990\u2019s. In the Midwest and \nin Minnesota in particular these day old vaccines have \nbeen in use. Field immune response to these vaccines has been variable in effectiveness.  Day old injected vaccination has been practice in  \npoultry with the aid of single injectable machines. These machines handled by hatchery personnel \nvaccinate each bird individually. A new type (Nova -\nTech, Inc.) of injector machine vaccinates \nsubcutaneously 4 turkey poults at one time.  \nThe Nova -Tech injector machine can vaccinate 4 \nchicks or poults at a time. This machine can inject different dosages (0.2; 0.3 or 0.5 ml./bird) with easy \nadjustments; also eliminates the potential of self -\ninjection (finger). Another advantage of this procedure \nis the improve d injection accuracy, correct injected \nbird counts, consistency on the site of injection, and the \nfacility to visualize the site of injection.  \nKilled NDV oil base emulsion vaccines have been \nprovided at different ages in chickens and turkeys. In Minnesota NDV was tested (day old) in 1988, but no \nmass vaccination was implemented at that time due to potential self -inflected injection by the hatchery \npersonnel. In 1999 selected flocks were given oil killed Avian Pneumovirus and NDV vaccines at 4 weeks of \nage. The practice of this vaccination at 4 weeks of age \nincreased stress on the birds, increased biosecurity \nproblems (vaccination crews) on the presence of outside personnel, had low accuracy (about 60% of \nbirds vaccinated), and increased the cost of \nvaccinati on. \nDay old NDV live vaccination was used on some \nfarms, followed by a live water -administered NDV \nfield booster vaccination schedule. There are some \nkilled NDV commercially available oil emulsion \nvaccines. Most of the turkey poults that received NDV \nat da y old were vaccinated with a commercially \navailable product.  \nA number of poults were vaccinated in a \nSeptember 2000 trial, but mass vaccination was not \ninitiated until February 2001. NDV day old vaccination \nhas been provided to millions of turkey hens and toms \nsince that date.  \nThe following topics will be discussed: 1) A \ncomparison between NDV killed day old vaccination \nwith 0.1 and 0.2 ml./poults; 2) serologic profile post -\nNDV water field vaccination and response differences \nbetween HI and ELISA titers; 3)  observations on the \nnumber of weeks that it takes the oil vaccine to be \nabsorbed from the injection site; 4) possible side effects of NDV killed oil emulsion day old vaccination; \nand 5) benefits of NDV day old vaccination in turkeys.  \n \nREFERENCES  \n1. Calnek, B.W.Diseases of Poultry. Iowa State \nUniversity Press, Ames, Iowa, USA. 10\nth Edition 2000.  \n2. Fukanoki, S., Iwakura, T., and others. Safety \nand efficiency of water -in-oil-in-water emulsion \nvaccines containing Newcastle disease virus  \n  \n105 haemagglutinin -neuraminidas e glycoprotein. Avian \nPathology 30, 509- 516, 2001.  \n3. Kumar, M.C. Turkey World May- June \n1988.  \n4. Purchase, H.G., Arp, L.H., Domermuth, \nC.H. and Pearson, J.E. A Laboratory Manual for the \nIsolation and Identification of Avian Pathogens. American Association of Avian Pathologists. Third \nEdition 1989.  5. Samina, I., Khinich, Y., Gutter, B., Michael, \nA. & Peleg, B.A. Day -old vaccination with live -in-oil \nvaccines: Newcastle disease (ND) and infectious bursal \ndisease (IBD) in chickens and ND in turkey poults. \nAvian Patholo gy 28, 73- 78 1999.  \n6. Wesbury, Harvey. Newcastle disease virus: \nan evolving pathogen? Avian Pathology 30, 5- 11. \n2001.\n \nTHE ISOLATION AND CHARACTERIZATION OF AN AVIAN \nPNEUMOVIRUS ISOLATE FROM CANADA GEESE  \n \nR. S. Bennett, M. K. Njenga, K.V. Nagaraja and D. A. H alvorson  \n \nDepartment of Veterinary Pathobiology, College of Veterinary Medicine, University of Minnesota,  \n1971 Commonwealth Avenue, St. Paul, Minnesota  55108  \n \nINTRODUCTION  \nAvian pneumovirus (APV) infection in turkeys in \nthe United States was first diagno sed in 1997 \nassociated with a respiratory condition that first appeared in Colorado in 1996.  It was subsequently \ndiagnosed in Minnesota in 1997 (5).  Avian \nPneumovirus is a member of the metapneumovirus \ngenus of the Pneumovirinae subfamily of the \nParamyxo viridae family (2).  \nThe epidemiology of APV infection is not well \nunderstood.  The virus has been detected in some wild bird species (3), but their role as a vector of APV for \nturkeys has not been determined. Other \nparamyxoviruses have been isolated from w aterfowl \n(1) leading us to consider the possibility that wild \nwaterfowl could harbor APV.  Experimental studies \nhave shown that Peking ducks are susceptible to experimental infection with APV (4) and that the virus \ncould be detected in sentinel Mallard ducks ( Anas \nplatyrhynchos ) by reverse transcription polymerase \nchain reaction (RT -PCR) (3).  The purpose of this \nstudy was to determine if an APV from Canada geese is pathogenic to turkeys.  \n \nMATERIALS AND METHODS  \nSampling .  The University of Minnesota College  \nof Natural Resources and Minnesota Department of \nNatural Resources conducts an annual Canada goose \nroundup to remove nuisance geese from the \nMinneapolis/St. Paul metropolitan area during the \nperiod when the adult birds molt and before the \njuveniles (the c urrent year's hatchlings) are fledged. \nThe geese are captured and transferred to holding pens. \nChoanal celft swab sampling is conducted as the geese \nare being loaded from the holding pens onto transport \ntrucks.  Sample handling .  All samples were pooled 10  \nper tube in minimal essential medium (MEM) \ncontaining 200 units/ml penicillin G sodium, 200 \n\u00b5g/ml streptomycin sulfate, 0.75 \u00b5g/ml amphotericin B, \nand 150 \u00b5 g/ml gentamicin. The tubes were placed on \nice for transport to the laboratory. All samples were \ninoculated onto tissue culture immediately after arrival \nat the laboratory, but only samples that were APV \npositive by RT -PCR were continued for further \npassages.   \nVirus isolation . Choanal swab samples were \ninoculated onto chicken embryo fibroblasts (CEF) and  \nQT-35\n cells for one hour, removed, and replaced with \nMEM containing 1% fetal bovine serum, 100 units/ml \npenicillin G sodium, 100 \u00b5g/ml streptomycin sulfate, \n150 \u00b5g/ml gentamicin, 0.292 mg/ml L -glutamine, \n0.1moles MEM non- essential amino acids. The third \npassages of CEF and QT -35 were analyzed for APV \nRNA by RT -PCR.  The RT -PCR positive tissue \ncultures were continued until passage five, inoculated \ninto Vero cells and monitored daily for cytopathic \neffect (CPE) consisting of patches of dead, sloughing cells a nd syncytia (multinucleated cells).  \nDesign . Two groups of antibody -free male \nturkeys (14 and 15 birds) were reared in isolation. One \ngroup was inoculated with 200 \u00b5l of non -infectious \ntissue culture fluid via oculonasal route and the second \ngroup was inoculated with 200 \u00b5l of \nAPV/Minnesota/goose/15A/01. Birds were observed \ndaily for clinical signs; open mouth breathing, nasal discharge, watery or foamy eyes, and overall \ndepression. Nasal turbinates, tracheas, and lungs, were \ncollected periodically for RT -PCR and \nimmunohistochemical staining specific for APV. At 14 \ndays post inoculation serum was collected from all \nbirds and submitted to the Veterinary Diagnostic  \n  \n106 laboratory at the University of Minnesota, College of \nVeterinary Medicine for testing by ELISA sp ecific for \nAPV.  \n \nRESULTS  \nVirus isolation . Virus isolation was successful in \nfive choanal swab pools collected from juvenile Canada geese from the fifth passage of CEF. The five \nisolates from CEF were inoculated onto Vero cells, \nonly four viruses adapted to Vero cell culture. Two of \nthe Vero cell adapted isolates from Canada geese show \nCPE, including syncytia, the other two isolates \nreplicate in cell culture without CPE. The presence of APV in these four tissue cultures were confirmed by \nRT-PCR.  \nClinical signs . The Canada geese the isolate was \nmade from were not showing any clinical signs typical of an APV infection. For the turkeys infected with the \nCanada goose isolate, neither the control group or infected group showed any clinical signs during the14 \ndays of the experiment.  \nGross examination and IHC . No gross \nexamination was done on the Canada geese. No gross lesions were seen in either experimental group. The \nnasal turbinates of birds in the infected group were IHC \npositive for APV.  \nRT-PCR. Choanal swab samples from the control \ngroup were negative, but the choanal swabs from the infected group were positive.  \nSerology. At 14 DPI, all control birds were \nnegative for APV antibodies, but the infected group was antibody positive.  \n  \n DISCUSSION  \nThe isolation o f APV from wild Canada geese is \nevidence that this species may be a natural reservoir for \nAPV. The geese sampled in this study were from a \nmetropolitan area, far removed from domestic turkeys --\nthe only other species from which APV has been isolated in the U.S.  \nThe infected group did not show clinical signs but \nhad detectable antibodies for APV. APV isolated from \nCanada geese appears to be infectious, but non -\npathogenic to turkeys and may be useful as a vaccine \nfor APV.  \n \nREFERENCES  \n1. Kelleher, D. J., D. A. Hal vorson, J. A. \nNewman, and D. A.  Senne. Isolation of avian \nparamyxoviruses from sentinel ducks and turkeys in \nMinnesota. Avian Diseases. 29:400- 407. 1984.  \n2. Pringle, C.R. Virus Taxonomy.  Arch. Virol. \n144:421- 429. 1999.  \n3. Shin, H., M. K.  Njenga, B. McComb, D. A.  \nHalvorson, and K. V. Nagaraja. Avian Pneumovirus (APV) RNA from wild and Sentinel Bird in the United \nStates Has Genetic Homology with RNA from APV Isolates from Domestic Turkeys. Journal of Clinical \nMicrobiology November. Vol. 38, 11:4282- 4284. \n2000.  \n4. Shin, J., M. K. Njenga, D. A. Halvorson, D. \nP. Shaw, and K. V. Nagaraja. Susceptibility of ducks to \navian pneumovirus of turkey origin. AJVR. July. Vol. 62, 7: 991- 994. 2001.  \n5. Senne, D. A., and R. K. Edson. Avian \nPneumovirus Update.  Proceedings of the Annu al \nConvention of the American veterinary Medical \nAssociation. Reno, Nevada, July 1997.  \n \nWILD BIRDS AND THEIR ROLE IN THE EPIDEMIOLOGY OF \nAVIAN PNEUMOVIRUS (APV) INFECTION IN DOMESTIC BIRDS  \n \nLAS AVES SILVESTRES Y SUS PAPEL EN LA EPIZOOTIOLOG\u00cdA DE LA \nINFECCI\u00d3N CON EL NEUMOVIRUS AVIAR (APV) EN AVES DOM\u00c9STICAS  \n \nB. T. Velayudhan*, H. J. Shin, V. C. Lopes, D. A. Halvorson, and K. V. Nagaraja. \n \nDepartment of Veterinary PathoBiology, College of Veterinary Medicine,  \nUniversity of Minnesota, St. Paul, Minnesota  \n \nRESUMEN  \nVarias especies de aves silvestres se sometieron a \npruebas generales de escrutinio para detectar la \npresencia del genoma del APV.  Se analizaron los \nhomogeneizados de cornetes nasales mediante la reacci\u00f3n en  cadena con polimerasa y transcriptasa \ninversa ( RT-PCR ) para la detecci\u00f3n del ARN  viral. El \u00e1cido nucleico del virus se detect\u00f3 en las muestras tomadas de gorriones, gansos, estorninos, golondrinas, \npatos mallard y gaviotas. La comparaci\u00f3n de los nucle\u00f3tidos y de las secuencias predichas de \namino\u00e1 cidos del gene M de los APV aislados de estas \naves, revel\u00f3 un alto nivel de identidad (m\u00e1s del 96%) \ncon los aislamientos estadounidenses del APV de  \n  \n107 pavos dom\u00e9sticos. Este hallazgo sugiere el posible apel \nde las aves silvestres en la transmisi\u00f3n de este vir us a \nlas aves dom\u00e9sticas.  \n \nINTRODUCTION  \nAvian pneumovirus causes an acute respiratory \ndisease in turkeys. It is an enveloped, negative -sense, \nsingle -stranded RNA virus classified under the genus \nMetapneumovirus of the family Paramyxoviridae  (7). \nAPV was f irst reported from South Africa in 1978, and \nlater it was diagnosed in the United Kingdom, France, \nSpain, Germany, Italy, Netherlands, Israel and other \nAsian countries (1). In United States, the disease first appeared in 1996 in Colorado and later in Minne sota in \n1997. It is also reported from North and South Dakota \n(6). The US isolates of APV were reported to be \ndifferent from the European isolates (8). The disease is \ncharacterized by coughing, nasal discharge, tracheal \nrales, foamy conjunctivitis, and sin usitis in young \npoults. The diagnostic tests include RT -PCR (14), in \nsitu hybridization, immunohistochemistry (6), virus \nisolation and ELISA (2). The acute phase of APV infection lasts for about a week post -inoculation (4).  \nThe virus can survive a tempera ture of \u2013 70\u00baC and \u2013\n20\u00baC for over 26 wk, 4\u00baC for less than 12 wk, 20\u00baC for \nless than 4 wk, 37\u00baC for less than 48 hr and 50\u00baC for \nless than 6 hr (16). A seasonal pattern was observed in \nthe APV outbreaks in Minnesota with most of the outbreaks occurring in t wo periods, March through \nMay and October through November (15). The role of wild birds in the transmission of APV is highly speculated. In order to pursue this speculation further, \nwe initiated the screening of wild birds to see whether \nthey harbor APV.  \n \nMATERIALS AND METHODS  \nAnimals: Wild birds were collected from the Wild \nLife Rehabilitation center, Saint Paul, Minnesota. They \nwere the birds brought to the center from all over the \nstate. They included sparrows, geese, swallows, \nstarlings, owls, crows, A merican gold finches, \nAmerican robin, warblers, rock doves etc. The seagulls \nthat found dead in the vicinity of a turkey farm were \nalso included in the study. A total of 385 birds of \ndifferent species were screened.  \nSamples: Nasal turbinate was collected f rom each \nbird. A 20% homogenate was prepared in minimum essential medium (GIBCO BRL) with penicillin \n1000units/ml, streptomycin sulphate 1000\u00b5 g/ml, \namphotericin B 25\u00b5 g/ml and gentamicin 150 \u00b5g/ml. \nThe homogenate was then centrifuged at 3000 rpm for \n10 min; the supernatant was collected and stored at \u2013\n70\u00b0C for further use. This was used for the preparation \nof RNA.  \nRT-PCR: The RNA from the homogenate of nasal \nturbinates was extracted using a commercial viral RNA extraction kit (Qiagen, Valencia, CA). RT -PCR wa s \nperformed using the one step RT -PCR kit (Qiagen). \nThe primers used in this assay for the detection of APV \ngenome were those designed based on the matrix (M) \ngene of APV (Gene Bank). The forward primer used \nwas 5\u2019 -ACAGTGTGTGAGTTAAAAG -3\u2019 (M1), \nstarting fro m base number 335 and the reverse primer \nwas 5\u2019 - TGACTTCAGGACATATCTC -3\u2019 (M2), \nstarting from base number 754 of the US isolate of \nAPV. These primers would result in a PCR product of \n438 bp. The RT -PCR was set with reverse transcription \nat 50\u00b0C for 30min, an  initial denaturation at 94 \u00b0C for \n10min, followed by 35 cycles of annealing at 51\u00b0 C for \n1min, extension at 72 \u00b0C for 2min and denaturation at \n94\u00b0C for 1min and a final extension at 72 \u00b0C for 10min. \nThe products of RT -PCR amplification were run on a \n1.2 % aga rose gel stained with ethidium bromide and \nexamined using Eagle Eye II (Stratagene) apparatus.  \nControls: APV infected Vero cells were used as \nthe positive control and APV uninfected Vero cells \nwere used as the negative control in all the RT -PCR \nreactions.  \nVirus isolation: The samples which were positive \nfor RT -PCR were thrown onto a 70 % confluent \nmonolayer of human nasal septal sarcoma cells (RPMI -\n2650, ATCC). Five blind passages were made in this cell line followed by five blind passages in vero cells.  \nSequence comparison: The samples which \nshowed amplification with the above mentioned set of primers were subjected to the isolation of M gene. For \nthis purpose forward primer (M3) starting from the base number 14 (5\u2019 -ATGGAGTCCTATCTAGTAG -\n3\u2019) and the reverse  primer (M4) starting from base \nnumber 823 (5\u2019 - CTAAATAATATCAAGCTAGG -3\u2019) \nof the M gene of US isolate of APV were used. The \nconditions for RT -PCR were the same as mentioned \nabove. The expected size of the amplification product \nwas 825 bp. The M genes isolat ed from different wild \nbirds were subcloned into pGEMT EASY vector and sequenced. Their predicted amino acid sequences were \ncompared with the M gene of APV isolated from \ndomestic turkeys (APV/Minnesota 2A).  \n \nRESULTS  \nRT-PCR: Of the 385 samples tested, 6 sa mples \nfrom sparrows, 2 from starlings, 2 from geese, 1 from \nswallows, 1 from mallard duck and I from seagull were \npositive for APV RNA. The RT -PCR amplified a DNA \nproduct of 438 bp, which was the expected size of the \namplification product when the primers M1 -M2 were \nused.  \nVirus isolation: The virus isolation attempts from \nsamples positive for APV RNA are being continued.  \nSequence comparison: The M gene of sparrow, \ngeese, and seagull were sequenced. Their predicted amino acid sequences were compared with th at of APV  \n  \n108 M gene isolated from domestic turkeys. This sequence \ncomparison showed a sequence identity of more than \n96 % with the APV/Minnesota 2A isolates from \ndomestic turkeys (Gene Bank accession numbers \nAF26673, AF26674, and AF26675).  \n \nDISCUSSION  \nIn the present study nasal turbinate samples from \nvarious wild birds collected from the Wild Life \nRehabilitation Center, St. Paul, Minnesota and also \nfrom the vicinity of turkey farms were screened for the \npresence of APV genome. For the amplification of the \nnucleic acid and for sequence analysis primers were \ndesigned based on the published M gene sequence of \nAPV (Gene Bank). The M gene is reported to be \nconserved among the US isolates of APV (11, 12, 15). \nAPV genome was detected in the samples collected \nfrom spar rows, starlings, geese, swallows, mallard \nduck, and seagull. There are various reports on the \nisolation of other paramyxoviruses from wild birds (4, \n7, 13). The virus isolation from the samples is being \ncontinued.  Virus isolation is thought to be \ncumberso me and rarely successful (1). In the detection \nof APV, RT -PCR is shown to be more sensitive and \nrapid compared to virus isolation (9). The nucleotide \nand predicted amino acid sequence comparison of the \nM gene isolated from wild birds revealed over 96 % \nidentity with that of the APV isolates from domestic \nturkeys. This strongly suggests the role of wild birds in \nthe transmission of APV among domestic birds. The \nseasonal trend in the disease pattern in Minnesota also favors this observation.  \n \nREFERENCES  \n1. Alexa nder, D.J.  Newcastle disease and \nother Paramyxoviridae  infections. In: Diseases of \npoultry, 10th ed. B.W. Barnes, H.J. Beard, C.W. \nMcDougald, and L. Saif, Jr, eds. Iowa State University \nPress, Ames, IA. pp.541 -569. 1997.  \n2. Chiang S, A. M. Dar, S. M. Goyal, M. A. \nSheikh, J. C. Pedersen, B. Panigrahy,  D. Senne, D. A.  \nHalvorson, K. V. Nagaraja, and V. Kapur. A modified \nenzyme -linked immunosorbent assay for the detection \nof avian pneumovirus antibodies . J Vet Diagn Invest \n12(4): 381- 384. 2000.  \n3. Goyal, S. M., Sh u-Ju Chiang, A. M. Dar, K. \nV. Nagaraja, D. P. Shaw, D. A. Halvorson and V. \nKapur. Isolation of avian pneumovirus from an \noutbreak of respiratory illness in Minnesota turkeys. J \nVet Diagn Invest. 12: 166- 168. 2000.  \n4. Graham, D. A., A. German, D. Abernerthy, \nS. J. McCullough, R. J. Manvell, and A. J. Alexander. Isolation of ortho - and paramyxoviruses from wild \nbirds in Northern Ireland during the 1997 epizootic. \nVet Rec. 145: 20- 21. 1999.  5. Jirjis, F. F., S. L. Noll, D. A. Halvorson, K. \nV. Nagaraja, E. L. Townsend, A.M. Sheikh, and D.P. Shaw. Avian pneumovirus infection in Minnesota \nturkeys: Experimental Reproduction of the disease. \nAvian Dis. 44: 222- 226. 2000.  \n6. Jirjis, F. F., S. L. Noll, K. V. Nagaraja, D. A. \nHalvorson, and D. P. Shaw. Immunohistochemical detection of avian pneumovirus infection in formalin \nfixed tissues . J Vet Diagn Invest. 13: 13- 16. 2000.  \n7. Kelleher, C. J., D. A. Halvorson, J. A. \nNewman, and D. A. Senne. Isolation of avian paramyxoviruses from sentinel ducks and turkeys in \nMinnesota. Avian Dis.  29: 400- 407. 1984.  \n8. Kleven, S.H. Report of the committee on \ntransmissible diseases of poultry and other avian \nspecies.  Proceedings of the 101st Annual Meeting of \nthe U.S Animal Health Association, Richmond, VA. \n1997.  \n9. Pederson, J. C., D. A. Senne, B. Pan igrahy, \nand D. L. Reynolds. Detectiopn of avian pneumovirus \nin tissues and swab specimens from infected turkeys. \nAvian Dis. 45: 581- 592. 2001.  \n10. Pringle, C.R. Virus taxonomy. A bulletin \nfrom the Xth International Congress of Virology in \nJerusalem. Arch. Viro l. 141:2251- 2256. 2000.  \n11. Seal, B. S. Matrix protein gene nucleotide \nand predicted amino acid sequence demonstrate that the first US avian pneumovirus isolate is distinct from European strains. Virus Res. 58: 45- 52. 1998.  \n12. Seal, B. S., H. S. Sellers, and R. J . \nMeinersman. Fusion protein predicted amino acid sequence of the first US avian pneumovirus isolate and \nlack of heterogeneity among other US isolates. Virus \nRes. 66: 139- 147. 2000.  \n13. Shihmanter, E., Y. Weisman, R. Manvell, D. \nAlexander, and M. Lipkind. Mixe d paramyxovirus \ninfection of wild and domestic birds in Israel. Vet  Microbiol. 58: 73- 78. 1997.  \n14. Shin, H. J., G. Rajashekara, K. V. Nagaraja, \nF. F. Jirjis, D. P. Shaw, S. M. Goyal, D. A. Halvorson, and K. V. Nagaraja. Specific detection of avian pneumovirus (APV) US isolates by RT -PCR. Arch \nVirol. 145: 1239- 1246. 2000.  \n15. Shin, H. J., M. K. Njenga, B. McComb, D. \nA. Halvorson, and K. V. Nagaraja. Avian pneumovirus \n(APV) RNA from wild birds and sentinel birds in the \nUnited States has genetic homology with RNA fr om \nAPV isolates from domestic turkeys. J Clin Microbiol. \n38(11): 4282- 4284. 2000.  \n16. Townsend, E., D. A. Halvorson, K. V. \nNagaraja, and D. P. Shaw. Susceptibility of an avian pneumovirus isolated from Minnesota turkeys to \nphysical and chemical agents. Avian D is. 44:336- 342. \n2000.    \n  \n109 ACKNOWLEDGEMENTS  \nWe acknowledge the support of Minnesota \nTurkey Research and Promotion Council and the co -operation of the Wild Life Rehabilitation Center, St. \nPaul, Minnesota.  \n \nRECENT DEVELOPMENTS IN MYCOPLASMA DIAGNOSIS  \nAND CONTROL  \n \nDESARROLLOS RECIENTES EN EL DIAGN\u00d3STICO DE MYCOPLASMA Y SU \nCONTROL  \n \nS. H. Kleven  \n \nUniversity of Georgia, Department of Avian Medicine, Athens, Georgia 30602 -4875  \n \nRESUMEN  \nA pesar de las mejoras en la tecnolog\u00eda para su \ndiagn\u00f3stico y control, los mic oplasmas que afectan a \nlas aves contin\u00faan siendo un problema. Las grandes poblaciones av\u00edcolas concentradas en \u00e1reas peque\u00f1as y la producci\u00f3n en sitios con edades m\u00faltiples hacen del \ncontrol una tarea sumamente dif\u00edcil. Los m\u00e9todos \nmejorados de diagn\u00f3stico incluyen la prueba de ELISA  \ny la reacci\u00f3n en cadena con polimerasa ( PCR ) para la \ndetecci\u00f3n r\u00e1pida del ADN del germen, y contamos \nadem\u00e1s con m\u00e9todos mejorados para detectar la \u201chuella \ndigital\u201d de las cepas. Tenemos vacunas vivas e \ninactivadas que se pueden  usar en las situaciones \napropiadas cuando no es posible el control de la \ninfecci\u00f3n mediante aislamiento y bioseguridad. Las \ncepas vivas presentan algunas variaciones en sus \ncaracter\u00edsticas pero todas ellas son valiosas si se usan \ncorrectamente.  \n \nEfforts i n the United States to control \nMycoplasma gallisepticum  (MG) began in the 1960\u2019s, \nprimarily as a response to high condemnations from airsacculitis after the initiation of USDA post mortem \ninspection of poultry. Somewhat later, M. synoviae  \n(MS) and M. melea gridis  (MM) were added to the \nprogram. Since then, significant progress has been \nmade in controlling Mycoplasma infections in turkey \nand chicken breeding stocks. Voluntary MG control programs in the U. S. are administered under the \nNational Poultry Improve ment Plan; testing provisions \nand protocols are provided in their official publication \n(1). The majority of poultry production in the U. S. is \nmycoplasma -free; however, MG and MS infection are \ncommon in commercial egg production flocks. \nUnfortunately, in s pite of increased efforts at control, \noutbreaks continue to occur.  \nThere have been changes which have resulted in \nan evolving situation in MG control, both in the United \nStates and world -wide. These include changes in the \npoultry industry itself, improved detection methods, better understanding of the agent and its pathogenesis, \nand improved control methods.  \n \nCHANGES IN THE OF TH E POULTRY \nINDUSTRY WHICH AFFECT MYCOPLASMA \nCONTROL  \nIn most modern poultry producing areas of the \nworld, the emphasis on the contr ol of Mycoplasma \ninfections has been centered around maintenance of \nMycoplasma -free breeding stock and keeping parent \nand production flocks free of infection by utilizing single -age, all -in all -out farms with good biosecurity. \nIn many parts of the world, t his has been very \nsuccessful, and the majority of broiler, turkey and egg \nproduction is free of infection. In contrast, areas with \nless-developed poultry industries tend to have high \nlevels of contamination with MG and MS; this poses special problems for c ompanies attempting to institute \nmodern production methods.  \nWith the rapid growth of poultry production \nworld -wide, there has been concentration of large \nnumbers of birds into small areas, leading to increased risk of exposure to pathogenic Mycoplasmas. In  some \nareas, poultry production is so concentrated that from an epidemiological point of view, it is almost like a very large multi -age farm. Also, general improvements \nin disease control have sometimes resulted in decreased \nefforts in biosecurity, thus enhancing the possibilities \nfor the spread of Mycoplasma infections.  \nThere has been a tendency to drift away from all -\nin all -out production and to concentrate production on \nmulti -age sites. This has been especially true for \ncommercial egg production \u2013  the ma jority of egg \nproduction in the U.S. is now on multi -age sites, and \nthis trend is developing around the world. Such multi -\nage production sites are mostly MS -positive, and many \nare also MG positive (21), even though grandparent \nand parent stocks are general ly MG and MS -free. \nIn many locations, multi -age management of \nbroiler breeders or broilers may occur. In turkey  \n  \n110 production, multi -stage production farms, on which 2 \nor even 3 different ages are maintained, are becoming \nquite common.  \nTherefore, in spite of sometimes heroic efforts at \nbiosecurity and improved understanding of the survival of Mycoplasmas outside the host, Mycoplasma \noutbreaks continue to occur.  \n \nIMPROVEMENTS IN DETE CTION METHODS  \nThe basis for control programs has centered \naround serological methods such as agglutination and \nhemagglutination -inhibition, with reactors often \nconfirmed by isolation of the organism. More recently, \ncommercial ELISA kits have become available \n(IDEXX Laboratories, Westbrook, Maine, USA; \nKirkegaard and Perry Laboratories, Gaithersburg, \nMaryland, USA) and are becoming widely used. Such \nkits have excellent sensitivity and specificity, but non -\nspecific reactions may still occur. Potential \nimprovements in ELISA specificity may result from \nthe utilization of highly purified a ntigens, or the use of \na blocking ELISA utilizing a specific monoclonal \nantibody.  \nMG strains of low virulence typically produce a \npoor antibody response, and isolation from clinical \nspecimens may be difficult (26). This may be \nespecially true if the antige nic makeup of the MG \nstrain involved is not a good match with the strains \nused to produce test antigens. Variability in strains and \nclinical responses have also been noted for MS. We \nhave encountered situations where flocks have exhibited a low -level serological response with a low \npercentage of PCR reactions. Such flocks have been \nculture negative. It has been possible to transfer such \nreactivity by placing SPF chickens in contact with the \nprincipals. These observations suggest that there may \nbe atypical s trains which have been undetectable with \ntraditional diagnostic methods.  \nPolymerase chain reaction represents a rapid and \nsensitive alternative to traditional culture methods, which require specialized media and reagents and are time consuming. At least on e company (IDEXX \nLaboratories, Westbrook, Maine, USA) produces \ncommercial PCR kits, which are being widely used. A \nPCR procedure developed by Dr. Lauerman at Auburn University (15) is also in wide use.  \nSuch improvements in serological methods and \nrapid det ection by PCR have done much to facilitate \nthe rapid and accurate diagnosis of MG infection.  \n \nVARIABILITY AMONG AND WITHIN STRAINS \nOF M. GALLISEPTICUM AND M. SYNOVIAE  \nMG and MS strains are known to vary in \npathogenicity and antigenicity (11, 13). Variability in pathogenicity among strains of MG has been \nrecognized for some time (26). Significant antigenic variability among MG strains also exists (13), which \ncould affect the sensitivity of serological tests, \ndepending on the strain infecting the flock and the \nstrain used to prepare antigen. There are also \nsignificant differences in virulence among strains of \nMS. Recently, a strain of MS was encountered in \nturkeys which did not induce an antibody response even though birds were culture positive in the upper \nrespiratory tract (14). Although this has not been well \nstudied, this is also likely true for MM and M. iowae  \nstrains.  \nRestriction Length Polymorphism (RFLP) of \nwhole -cell DNA has been shown to be useful for \ndifferentiating MG strains (13). However, the RFLP  \nprocedure is time -consuming and laborious, making \nidentification of specific strains a tedious procedure. \nMore recently, Random Amplified Polymorphic DNA \n(RAPD) has been developed for identifying specific \nstrains (6, 7, 17). This procedure is very simple and \nrapid, and has provided a routine procedure for the \nrapid identification of MG strains. This has proven to \nbe very useful for epidemiological studies and for \nidentification of specific MG strains in field outbreaks. \nMore recently, we have utilized a PC R for the PvpA \n(19), mgc1 (gapA) (8, 10) and lipoprotein (22) genes, \nfollowed by RFLP or sequencing of the PCR product to \nidentify specific MG strains. Using this method we \nhave been able to more closely pinpoint the identity of \nfield and vaccine strains.  \nStudies utilizing Western blots and monoclonal \nantibodies have shown a high degree of variability in expression of surface antigens among strains of MG; \nmany of these proteins are variably expressed (2, 20). \nThis has led to a large effort in characterizing  the \nvariable expression of surface antigens have shown that phase variation also occurs in vivo. Similar variability of surface antigen expression has now also been shown \nto occur among strains of MS. For example, clones of \nMS which are hemagglutinin nega tive are less virulent \nthan clones which are hemagglutinin positive. The \nsignificance of such variability in the expression of \nsurface antigens is not well understood; however, it \nseems logical that it would play a role in pathogenesis, \nserological respons es, and evasion of the immune \nsystem of the host.  \n \nM. GALLISEPTICUM  VACCINATION  \nWith the advent of multi -age commercial layer \ncomplexes, control by vaccination became desirable.  \nThe first commercially available MG vaccines \nwere oil -emulsion bacterins (9).  Bacterins protect well \nagainst airsacculitis and egg production losses, but \nprovide little protection against colonization by field strains of MG, thus providing little value in eradication \nprograms. Major disadvantages of bacterins are the  \n  \n111 need for 2 dos es for optimal protection and the cost of \nadministration.  \nLive MG vaccines include F strain (3), which has \nbeen available for some time through several \nmanufacturers, strain 6/85 from Intervet America, \nMillsboro, Delaware (4, 5), and strain ts -11, develope d \nand widely used in Australia and licensed in the U.S. \nby Select Laboratories, Gainesville, Georgia (24, 25).  \nF strain exhibits moderate virulence in chickens \n(it is virulent for turkeys), colonizes the upper respiratory tract efficiently, spreads relativ ely slowly \nfrom flock to flock, and offers protection against losses in egg production. It provides excellent protection against colonization by challenge strains, and displaces \nthe wild -type field strains present in multi -age \ncommercial egg operations. Un fortunately, F strain has \nbeen implicated in field infections in commercial turkeys (16).  \nStrains 6/85 and ts -11 offer significant advantages \nover F strain. They both offer protection against challenge, but are avirulent and have very limited \npotential to spread from bird to bird (18), thus \npresenting less risk to neighboring poultry flocks. F \nstrain has better ability to displace challenge strains in \npen trial studies than does 6/85 or ts -11 (12), but field \nexperience in a commercial layer operation sugges ts \nthat strain ts -11 may be able to displace F strain in \nmulti -age commercial layers. After ts -11 vaccination \nwas discontinued, the flock has remained MG -free \n(23). Similar data with the 6/85 strain is not available, but there are complexes which have used  6/85 which \nnow are seronegative, suggesting that displacement of \nwild type strains is also possible with 6/85. If the wild -\ntype strains are highly virulent, it may be necessary to \nvaccinate with F strain for 1 or more production cycles \nand then switch ove r to either 6/85 or ts -11. \nOne major concern about live MG vaccines is \nsafety. There have been numerous instances of clinical \nrespiratory disease caused by \u201cescaped\u201d F strain \nvaccine; this strain should probably not be used if there \nis potential danger of spread to turkeys, even though it is the most efficacious strain in chickens. The 6/85 \nstrain has been shown to be very safe in chickens, and \nhas never been detected in unvaccinated chicken \nflocks, to the knowledge of this author. However, there have been several instances of isolation of 6/85 -like \nMG strains from turkeys showing clinical disease. In some cases there was a history of vaccination of nearby \nchickens or turkeys. The ts -11 strain has been detected \non at least two occasions in unvaccinated chick en \nflocks. In both instances there is a history of possible \nuse of contaminated vaccination equipment and in one \nof the instances, subsequent spread to neighboring \nbroiler breeders. We also know that ts -11 can spread \nfrom vaccinated spike males to unvaccin ated breeder \nfemales. These experiences suggest that even though the newer vaccines are very safe, they do have the \npotential for spread, and their safety should be very \ncarefully before a decision is made to vaccinate. An \nimportant rule for consideration in the use of these \nvaccines, is that high titered vaccine should be used \nand administered properly in order to give the vaccine \nstrain little opportunity to spread from bird to bird. Table 1 summarizes the author\u2019s experience with the \ncharacteristics of t he various vaccine strains.  \nMG vaccines have had less use in turkeys. The F \nstrain is too pathogenic for consideration in turkeys, but 6/85 or ts -11 strains may have potential use under \nvery limited circumstances. In one vaccination trial \nconducted by us, administration of 6/85 or ts -11 did not \nresult in respiratory signs or lesions in turkeys. There \nwas little or no measurable resistance against \nairsacculitis after heavy aerosol challenge, but there \nwas some protection detected against lesions in the \nupper  respiratory tract. The ts -11 strain appears to have \nlimited ability to infect turkeys.  \nField experiences utilizing live vaccines have \nbeen very favorable in commercial layers, and field \nexperiences in multi -age broiler breeders has also been \nfavorable. Th ese experiences suggest that live vaccines \nmay be viable tools for the eradication of MG infection on multi -age commercial poultry farms.  \nThere has been relatively little work on MS \nvaccines. There has been one MS bacterin licensed in the U.S., but it appa rently has had little field use. A \ntemperature sensitive MS strain has been licensed for \nuse in Australia, and is widely used there. It has been \nlicensed in Mexico and some other countries, but is not \navailable in the U.S.  \n \nREFERENCES\n \n1. Anonymous, National P oultry Improvement \nPlan and Auxiliary Provision. Vol. APHIS 91 -55-054. \n2000, Washington, DC: USDA.  \n2. Boguslavsky, S., D. Menaker, I. \nLysnyansky, T. Liu, S. Levisohn, R. Rosengarten, M. \nGarcia, and D. Yogev. Molecular characterization of \nthe Mycoplasma galli septicum pvpA gene which \nencodes a putative variable cytadhesin protein. Infect \nImmun. 68:3956- 3964. 2000.  \n3. Carpenter, T. E., E. T. Mallinson, K. F. \nMiller, R. F. Gentry, and L. D. Schwartz. Vaccination \nwith F -strain Mycoplasma gallisepticum to reduce \nprodu ction losses in layer chickens. Avian Diseases. \n25:404- 409. 1981.  \n4. Evans, R. D., and Y. S. Hafez. Evaluation of \na Mycoplasma gallisepticum strain exhibiting reduced \nvirulence for prevention and control of poultry \nmycoplasmosis. Avian Diseases. 36:197- 201. 1 992. \n5. Evans, R. D., Y. S. Hafez, and C. S. \nSchreurs. Demonstration of the genetic stability of a  \n  \n112 Mycoplasma gallisepticum strain following in vivo \npassage. Avian Diseases. 36:554 -560. 1992.  \n6. Fan, H. H., S. H. Kleven, and M. W. \nJackwood. Application of polyme rase chain reaction \nwith arbitrary primers to strain identification of \nMycoplasma gallisepticum. Avian Dis. 39:729 -735. \n1995.  \n7. Geary, S. J., M. H. Forsyth, S. A. Saoud, G. \nWang, D. E. Berg, and C. M. Berg. Mycoplasma \ngallisepticum strain differentiation by arbitrary primer \nPCR (RAPD) fingerprinting. Molec. Cell. Probes. \n8:311- 316. 1994.  \n8. Goh, M. S., T. S. Gorton, M. H. Forsyth, K. \nE. Troy, and S. J. Geary. Molecular and biochemical analysis\n \n9. of a 105 kDa Mycoplasma gallisepticum \ncytadhesin (GapA). Microbiol. 1 44:2971- 2978. 1998.  \n10. Hildebrand, D. G., D. E. Page, and J. R. \nBerg. Mycoplasma gallisepticum (MG) \u2014  laboratory \nand field studies evaluating the safety and efficacy of \nan inactivated MG bacterin. Avian Dis. 27:792 -802. \n1983.  \n11. Keeler Jr., C. L., L. L. Hnatow, P. L. \nWhetzel, and J. E. Dohms. Cloning and \ncharacterization of a putative cytadhesin gene (mgc1) \nfrom Mycoplasma gallisepticum. Infect. Immun. \n64:1541- 1547. 1996.  \n12.  Kleven, S. H., O. J. Fletcher, and R. B. \nDavis. Variation of pathogenicity of isolates of \nMycoplasma synoviae with respect to development of \nairsacculitis and synovitis in broilers. Am J Vet Res. \n163:1196- 1196. 1973.  \n13. Kleven, S. H., M. I. Khan, and R. \nYamamoto. Fingerprinting of Mycoplasma gallisepticum strains isolated from multiple -age layers \nvaccinated with live F strain. Avian Diseases. 34:984 -\n990. 1990.  \n14. Kleven, S. H., C. J. Morrow, and K. G. \nWhithear. Comparison of Mycoplasma gallisepticum strains by hemagglutination -inhibition and restriction \nendonuclease analysis. Avian Dis. 32:731 -741. 1988.  \n15. \n Kleven, S. H., G. N. Rowland, and M. C. \nKumar. Poor serological response to upper respiratory \ninfection with Mycoplasma synoviae in turkeys. Avian \nDis. In press. 2001.  \n16.  Lauerman, L. H. Mycoplasma PCR Assays. \nIn: Nucleic Amplification Assays for Diagnos is of \nAnimal Diseases, ed. L. H. Lauerman, eds. American \nAssociation of Veterinary Laboratory Diagnosticians, \nAuburn, AL. pp. 41- 52. 1998.  \n17. Ley, D. H., A. P. Avakian, and J. E. \nBerkhoff. Clinical Mycoplasma gallisepticum infection in multiplier breeder and meat turkeys caused by F \nStrain: Identification by sodium dodecyl sulfate -\npolyacrylamide gel electrophoresis, restriction \nendonuclease analysis, and the polymerase chain \nreaction. Avian Dis. 37:854 -862. 1993.  \n18. Ley, D. H., J. E. Berkhoff, and S. Levisohn. \nMolecular epidemiological investigations of \nMycoplasma gallisepticum conjunctivitis in songbirds \nby random amplified polymorphic DNA analysis. \nEmerging Inf. Dis. 3:375- 380. 1997.  \n19. Ley, D. H., J. M. McLaren, A. M. Miles, H. \nJ. Barnes, S. H. Miller, and G. Fran z. Transmissibility \nof live Mycoplasma gallisepticum vaccine strains ts -11 \nand 6/85 from vaccinated layer pullets to sentinel \npoultry. Avian Dis. 41:187- 194. 1997.  \n20. Liu, T., M. Garcia, S. Levisohn, D. Yogev, \nand S. H. Kleven. Molecular Variability of the \nAdhesin -Encoding Gene pvpA among Mycoplasma \ngallisepticum Strains and Its Application in Diagnosis. J Clin Microbiol. 39:1882- 1888. 2001.  \n21. Markham, P. F., M. D. Glew, J. E. Sykes, T. \nR. Bowden, T. D. Pollocks, G. F. Browning, K. G. Whithear, and I. D. Walker.  The organisation of the \nmultigene family which encodes the major cell -surface \nprotein, pMGA, of Mycoplasma gallisepticum. FEMS Microbiol. Lett. 352:347- 352. 1994.  \n22. Mohammed, H. O., T. E. Carpenter, and R. \nYamamoto. Evaluation of factors associated with \ninfection of commercial layers with Mycoplasma \ngallisepticum and Mycoplasma synoviae. Avian Dis. 31:470- 476. 1987.  \n23. Nascimento, E. R., R. Yamamoto, K. R. \nHerrick, and R. C. Tait. Polymerase chain reaction for \ndetection of Mycoplasma gallisepticum. Avian Dis. \n35:62- 69. 1991.  \n24. Turner, K. S., and S. H. Kleven. Eradication \nof live F strain Mycoplasma gallisepticum vaccine using live ts -11 on a multiage commercial layer farm. \nAvian Dis. 42:404- 407. 1998.  \n25. Whithear, K. G., Soeripto, K. E. Harrigan, \nand E. Ghiocas. Immu nogenicity of a temperature \nsensitive mutant Mycoplasma gallisepticum vaccine. \nAust Vet J. 67:168 -174. 1990.  \n26. Whithear, K. G., Soeripto, K. E. Harrigan, \nand E. Ghiocas. Safety of temperature sensitive mutant \nMycoplasma gallisepticum vaccine. Aust Vet J. \n67:159-165. 1990.  \n27. Yoder Jr., H. W. A historical account of the \ndiagnosis and characterization of strains of \nMycoplasma gallisepticum of low virulence. Avian \nDis. 30:510- 518. 1986.  \n \n  \n  \n113 Table 1.  Comparison of live MG vaccine strains . \n F Strain  6/85 Ts-11 \nForm  Lyophilized  Lyophilized  Frozen  \nRoute  Various  Spray  Eye Drop  \nVirulence  Moderate  None  None  \nPersistence  Excellent  ??? Good  \nAntibody  Moderate  None  Weak  \nTransmission  Moderate  Poor  Poor  \nDisplacement  Excellent  ??? Good  \n \nANIMAL WELFARE AND RELATED ISSUES  \n \nEL BIENESTAR DE LOS ANIMALES Y ASPECTOS RELACIONADOS  \n \nRichard Reynnells  \n \nNational Program Leader, Animal Production Systems, US Department of Agriculture, Cooperative State Research, \nEducation and Extension Service, 800 9th Street, SW, Room 3130 Waterfront C entre, Washington, DC 20250- 2220  \nTelephone number: 202.401.5352; Fax number: 202.401.6156, email: rreynnells@reeusda.gov \n \nRESUMEN  \nLas discusiones sobre el bienestar de los animales \nsuelen girar alrededor de las condiciones de los \nmismos, pero el bienestar  es m\u00e1s complejo que \ndeterminar su presencia o ausencia con base en diversos criterios. Las determinaciones del bienestar \nimpactan nuestra opini\u00f3n sobre los sistemas de manejo. \nNuestro deseo de contar con alimentos econ\u00f3micos \nafecta la capacidad de los granjeros de competir y su \nnecesidad de incrementar la eficiencia y los vol\u00famenes \nde producci\u00f3n. Las filosof\u00edas de los derechos de los animales pueden estar basadas, cuando menos en parte, \nen doctrinas religiosas y son diferentes de los objetivos \ndel bienesta r. Los ciudadanos est\u00e1n convencidos de la \nnecesidad de los derechos de los animales mediante \nargumentos de su bienestar. Los lineamientos del \nmanejo y los programas de certificaci\u00f3n obedecen a las \npreocupaciones de la sociedad respecto al bienestar animal.  El terrorismo agropecuario es un problema de \ndicho bienestar.  \n \nBACKGROUND  \nAnimal welfare is a complex set of issues, whose \npresence or absence is based on current scientific \nopinion, special interest ideology, and societal \nperceptions.  These issues invol ve many factors that are \noften not considered as impacting animal welfare and \nsociety\u2019s interpretation of ethical behavior toward \nanimals.  By segregating these components, and \nmaking a less than holistic appraisal of the situation, \nmanipulation of welfare  issues to benefit select entities \nis possible.  Rather than add more to the stockpile of \nopinions related to management\u2019s influence on animal \nwell-being, this paper will focus on some of these \ncollateral interactions.  There is considerable misunderstandin g regarding \nthe connection between having plentiful, inexpensive, \nhigh quality, and convenient food available to all \nAmericans and for export, and the farming system that provides this bounty.  A similar lack of appreciation by \ncitizens exists regarding th eir role in how individual \npurchases affect the structure of rural society and \nanimal production practices.  Over time, these practices \nmaterialized into highly efficient intensive confinement \nfarming systems, which are perceived to influence animal welfar e.  Some say the overall effect is an \nimprovement, or at least no harm, and some say it is the devil incarnate.  Most consumers have no idea how \nanimals are raised and do not care.  However, times are \nchanging and activists are convincing youth and \ncitizen s that radical changes are necessary, in addition \nto those demanded by the marketplace.  These converts \nmay become public decision makers, legislators, and \nprobably voters.  By agriculturalists piously \nrecognizing their economic and nutrient contributions \nto our society and global markets as a basic truism, and \nby urbanites and politicians unthinking acceptance of \nthis reality, this disconnect between food production and animal well -being becomes a non -issue and is not \neffectively addressed.  Except by acti vists attempting \nto change society.  We apparently can not appreciate how simultaneously robust and fragile the agricultural \nsystem in America is today, so do not adequately \naddress potential causes of our (de)evolution, or visualize the long term consequences.  It would be \nbeneficial if all concerned parties took a closer look at \nthe broad array of issues related to food production and marketing, and long term food security issues.  Animal \nwelfare and well -being is an important component of  \n  \n114 these discussio ns, as is the supporting Land Grant \nUniversity system, as discussed by Smith (8).  \nEven though animal welfare issues are not \nconfined to farm animals, many are.  Therefore, it is \nimportant to remember that farmers are the original \nanimal welfarists, environ mentalists, and food safety \nadvocates.  Most retain that role today, even though the \nmantle of truth is given to activists, many of whom \nmay have never met financial and other obligations \nsimilar to those of farmers.  Society requires advocates \nfor agricul ture to remind its members of reality.  To be \nan effective advocate, one must be able to honestly and objectively evaluate current situations against an ideal, and be willing to express concern if we do not meet \nthose high standards of achievement.  Advoca cy should \nbe a mentoring role, supportive of our agricultural \nsystem\u2019s capacity to improve the environment, safety \nand security of products, and enhance animal welfare.  \nOur agricultural future requires mutual respect of competing entities and a search for  truth, versus \npandering to special or personal interests and agendas.  \nBecause the former does not appear to be our current \nreality, does not mean we can not move in that \ndirection.  \nCheap food policy, as demanded by consumers, \nenhanced by grocers, and ree nforced by politicians for \ndecades has created efficiencies of production and \nprocessing that result in food safety and security levels unheard of in history.  These efficiencies have brought \nwith them many hidden costs to society.  Through their \neconomic decisions to obtain cheap food at any cost \n(e.g., purchases of \u201cthe best buy\u201d) consumers fostered a \nsituation that helped \u201ccreate the monster\u201d of highly \nconcentrated intensive confinement animal production.  \nSome consider intensive confinement animal \nprodu ction to negatively impact animal welfare and our \nsocial fabric.  Also, the infrastructure of rural \ncommunities, agriculture, and supporting Land Grant \nUniversities has changed.  Now many do not want to \nlive with that decision because of religious, health,  \nsocial, or other reasons.  They do not understand that \nonce an infrastructure is compromised, compensatory \naction is not an easy or automatic event.  \n \nRIGHTS VERSUS WELFARE AND WELL-\nBEING  \nAnimal welfare and well -being can not be \neffectively discussed in th e absence of rights.  The \nconcept of animal rights (legal standing equivalent to \nhumans; a \u201cright\u201d to not be abused) continues to be \nconfused with animal well -being (a holistic approach to \ndefining welfare) or welfare (more geared to health and \nproduction relationships).  In all cases of animal rights \nversus welfare/well -being, semantics should be \nemphasized, but in other cases (welfare versus  well-\nbeing) probably at a practical level, merely add to the mystique or perception of intellectual enlightenment o f \nspeakers/writers by the general public.  The question of \nrights and the philosophical and religious basis for this \nconcept must not be confused with well -being.  Some \nextreme rights activists have openly stated animals are \nbetter off dead or to not exist  than to be exploited (used \nas food, fur, research models, or as a pet ---now \nmodified to \u201ccompanion animal\u201d).  Other rights activists willingly accept the realities of animal use.  \nThe extremist opinion is followed through on by \nactivists who release mink,  rabbits or other animals that \nhave no knowledge of life outside the farm environment, and therefore have little ability to fend \nfor themselves, or avoid hazards such as traffic.  And \ndie.  To many, these actions are despicable due to the \nabsence of respect for law abiding citizens, the capacity \nof activists to \u201cplay God\u201d by deciding who can or can \nnot raise animals in what manner.  And to release \nanimals that then are likely to die.  Years of research \nbased on hundreds or thousands of animals is often \ndestroyed.  Also, by intimidating farmers, researchers \nand others through threats to their family, their \nproperty, or themselves, extreme rights activists force \ntheir views on others.  Careers or livelihoods are destroyed by activists.  Quality of life or life -saving \ndiscoveries that impact humans and animals are lost.  \nThis may be intellectual specieism at its finest.  \nAnimal welfare, well -being and rights is a \ncomplicated set of interdependent issues.  Philosophies \nregarding animal rights and animal well -being \nrepresent a continuum of potential beliefs.  And \nbecause we are human, there may be inconsistencies.  \nPossibly the most troublesome aspect of understanding \nthis situation are persons who use real, fictitious, or \nexaggerated problems to manipulate the genu ine \nconcern and goodwill of the public to achieve their \nultimate goals of animal rights.  Conversely, the animal \nindustries often sell products from intensively raised \nanimals as if they were from extensive (old -fashioned) \nfacilities, or may not define how  the animals are \nmanaged.  Cartoons, sit -coms, comics, and other media \npresent animal rights concepts to indoctrinate the child \nand influence the adult.  These almost subliminal or \nperhaps grossly overt manipulations of events to \nmodify society according t o the hidden agendas and \nincremental goals of animal rights activists, and \npossibly even some welfare activists, also suggests \nintellectual specieism or perhaps cultural imperialism.  \nIt is important, especially for industry members \nand university faculty t o be conversant with a range of \nanimal use philosophies, and to be able to recognize inconsistencies between public statements, actions and \ngoals of organizations.  In this way they can take any necessary corrective action and inform society and \ngovernment  decision makers of the basis for, and \nalternative interpretations of, the realities proposed by  \n  \n115 rights activist\u2019s or some animal welfarist\u2019s.  Many \nfuture leaders (young people in society) and legislators \nhear the messages of moderation created and delivered \nby professional and articulate activists and take heed.  \nThe base comments of the radical groups are nothing \nnew to many in agriculture.  However, listening to \nwhat activists say may provide the direction in which these organizations are going.  Moderation in talk.  \nIncrementalism in action.  Is the true goal elimination \nof animal use, or merely enhanced treatment of animals \nin production and processing?  Moderates \u201conly \nconcerned about the well being of animals\u201d get laws \npassed.  It is important to note that not all animal welfare or similar groups are the enemy of agriculture, \nand may only disagree with using intensive production \nsystems.  Therefore, many of these groups respect the \nright of farmers and citizens to use animals for food \nand other functi ons.  Do animal rights activists respect \nhuman rights?  Or are human\u2019s rights to use (not abuse) \nanimals a transitory condition determined by the group \nwith the best lawyers and ability to change laws and \nregulations?  \nThere are many participants in the ani mal rights, \nwelfare, and well -being controversy, not just activists \nwho clamor for change.  Major animal welfare issues \neach tend to have a related activist group in a \nleadership position ---many of which are not supportive \nof animal rights doctrine.  Alber t Schweitzer is often \nquoted regarding respect for animals (7).  The Animal \nWelfare Institute sponsors an annual award in honor of \nAlbert Schweitzer, which recognizes exceptional work in the area of animal welfare.  Most farmers have \nrespect for their anim als, even though these animals are \nraised for food or fur and are eventually killed to \nbenefit humans.  Most scientists have respect for the \nanimals they use for research and teaching.  Native \nAmerican religious teachings, taught respect for animals and na ture even though the result of their \nactivities was consumptive.  For example, Chief Seattle \nhas been quoted as saying: \u201cWhat is man without \nbeasts?  If all the beasts were gone, men would die from great loneliness of spirit.  For whatever happens \nto the b easts...soon happens to man.  All things are \nconnected.\u201d  Posewitz expressed the opinions of \ntoday\u2019s hunters (and those who fish) who show respect for animals and nature by following bag limits, taking \nshots having a high probability of a clean kill, and t rack \nand find a wounded animal (5).  Anti -poaching \nprograms exist in wildlife organizations ---but would \nanimal welfare/protection groups join with a \nwildlife/conservation organization to more effectively address poaching issues?  Which is more important, \nperception and membership numbers ( i.e., profit) or \nsolving problems and helping animals?  Is this \npositional bargaining to promote egocentric or \norganizational goals, or the abandonment of a well-being opportunity?  Respect and the illusion of respect \ncome s in many forms.  \nEven if there is scientific evidence (dependent on \nwhat is measured) that shows an intensive practice is \nacceptable relative to the result of a stressor, society \nmay not accept it on anthropomorphic or emotional \ngrounds.  Can industry withstand the crucible of common decency in dealings with animals?  Some \nactivists equate poor management, insensitivity, and \ncruelty to biblical \u201cdominion\u201d issues and use this as \none ploy to accuse the animal industries of cruelty.  \nNotwithstanding sacrificia l commands, nowhere is \nanimal abuse condoned or promoted in the Bible (2).  \nGood animal husbandry is the biblical command related to mankind having dominion over animals.  \nDominion is a  stewardship situation, and relates to \nbeing a manager of resources, n ot an owner, and \nhaving responsibility to preserve these resources for the next generation.  \nConfusion is intentionally created to downplay \nthe actual goals of animal rights activists.  Concern for \nan animal\u2019s welfare, not their rights, is the public \nmanta of many rights activists.  The mandatory \nconversion of society to their religious or philosophical \nviews may be via legislation very possibly created \nbecause of, or under the guise of, concern for animal \nwell-being/welfare.  There is also crossover of \nterminology, such as an animal\u2019s \u201cright\u201d to not be \ntortured or abused.  This misnomer is pervasive in \nindustry, academia and society.  It is a bridge of respectability between rights and welfare that blends all \nphilosophies into a product having broad acceptan ce, \nand is a huge problem.  Society forgets that good \nfarmers respect nature and the needs of their animals, \nand provide as optimal an environment as is \neconomically feasible.  This capacity is influenced by societal and individual decisions at the marketp lace, \nand by most farmer\u2019s desire to provide this high level \nof care.  \nSome animal rights groups may even be \nconsidered a secular religion, and have been claimed to \nbe so by one major activist group.  As a secular \nreligion, one must ask the basis for these religious \nteachings.  The same question must be asked if the \nrights or even welfare group\u2019s doctrine uses a \nphilosophical approach.  If such a movement is based on a religion is it not camouflage for conversion to that \nreligion?  Can animal rights dogma be  promoted to \nsociety as originally conceived and eventually intended \nby the activist groups ( e.g., legal standing and rights \nequivalent to humans, where any use of animals is \nexploitation), or must it be sold on welfare or a watered \ndown version of \u201crights \u201d?  Should your family\u2019s \nconversion to another religion or guiding philosophy be \na personal decision, or the equivalent mandated via \nanimal rights based legislation?   \n  \n116 CERTIFICATION AND SPECIALTY \nPRODUCTION  \nHow much of the activist\u2019s clamoring for \ncertificat ion is a facade for ultimate goals and how \nmuch is reality?  Does the public understand the issues \nover which activists protest?   Is public concern \ngenuine, and supported by their market dollars, or a \nmirage supported by regulations or market protection \ncertification programs?  If the latter situation, \nwidespread public support for change does not exist and should not be presented as if it does to legislators \nand agency decision makers.  Alternatively, many \npeople believe support for specialty markets based on extensive production principles has been a non -issue \nfor Land Grant Universities and government agencies, \nwhich has inhibited their ability to compete.  Are \ncertification programs warranted to satisfy a niche \nmarket, or are they a politically expedien t and self -\nprotecting gimmick or convenience by food marketing organizations?  \nAs stimulated by the late Henry Spira and other \nactivists, there are now demands by chain restaurants and others for animal products to be produced using \nprescriptive production practices (certification/guidelines), but no apparent intention to \nconsistently and adequately compensate the farmer for \nextra expenses.  This will further remove the smaller \nfarmer from the capacity to market their products in \nthis outlet.  Single or mini mal source purchases by \nchain food outlets and others also reduce or eliminate \nthe capacity for small farmers to supply these markets.  \nCompanies will need to become increasingly efficient, \nwithin the confines of the certification contract, which \nmay be de trimental to societal concerns of some \nactivists and other citizens.  Specialty programs may provide marketing incentives to producers through voluntary standards.  Also to be considered (as seen in \nEngland), a significant amount of the niche market \nprice differential may go to distributors and grocery \nchains rather than the farmer who makes the \ninvestment of land and labor and takes most of the \nrisks.  This situation is related to a historical concern of \nsome activists and others regarding intensive/contra ct \nproduction that the farmer will become a serf on his/her \nown property (4).  Certification programs provide \nspecialized products which answer the concerns of a portion of society, but will result in significant \nconversion and other costs to farmers.  Sho uld not \nthese costs be passed along to consumers rather than \nabsorbed using the farmer\u2019s equity?  \nThe Animal Welfare Institute has a certification \nprogram provided to swine producers at no charge, \nwhile others such as the American Humane \nAssociation provide  certification for a fee.  Chain \nrestaurants now are involved in mandating production \nand slaughter criteria, as well as on -farm ammonia levels.  Certification programs and guidelines are also \nprovided through commodity, allied industry and \nprofessional or ganizations.  We have gone from \nessentially no certification programs for animal well -\nbeing and environmental concerns to the potential for layered programs that promote environmental \nprotection, food safety, animal well -being or address \nmultiple concerns.   It would be beneficial to have an \nevaluation of animal well -being, and the cost:benefit \nsituation for farmers before and after these conversions.  \nDevelopment of niche markets has been a long \nstruggle, with limited acceptance due to many factors.  Those who claim small flock extensive production is \nsuperior regarding animal welfare must minimize \ninhibitory factors in the marketing system to see \ngreater use of this system.  Niche market extensive confinement producers may have increased costs or \nmarketing potential versus  intensive confinement \nenterprises having a corporate structure.  Society should recall that for small or large farmers, activist \norganizations, professional organizations or individuals \nthe profit motive is exactly the same.  It must exist.  \nFew of us can work for free.  Low volume farmers \nrequire higher profit margins to survive.  Another inhibiting situation is that as the market demand \nincreases for specialty markets, larger firms will enter \nthe market and create the same competitive sit uation \n(low prices, high volume) that eliminated small farmers \nin the first place.  Consumers need to decide if animal \nwell-being is a primary concern or a combination of \nwell-being and rural structure issues.  Society must also \nsupport enterprises that pe rpetuate the genetic diversity \nof our base stock of farm animals, many of which are rare or threatened with extinction (1).  This situation also relates to the question of intensive versus \nextensive production, genetics related well -being \nissues, and capacity to transfer specific traits to current \nstock to address welfare issues.  \nWhat is animal agriculture doing to convince \nsociety that animal production practices, for which \nscientific evidence may indicate are not as severe as \nthey seem, are necessary and properly conducted? \nRegardless of the source of public relations/educational packages and supporting scientific evidence, does society see some of these practices as morally wrong?  \nIf so, what will the industry do to address these issues?  \nDecades of econ omic considerations and societal \nexpectations have created the food production and \ntechnical assistance system of today (6, 8).  The \nproduction and supply system can not readily be converted to meet the whims or concerns of any entity, \nexcept by force, par ticularly if all economic factors are \nnot considered.  Market demands may effectively drive \nproduction changes if so allowed.    \n  \n117 Major animal welfare issues related to marketing \ninclude \u201cdowner\u201d animals and slaughter practices.   \nActivists such as Eisnitz  (3) bring in labor union and \nhuman well -being issues in addition to claiming \nskinning and dismemberment of conscious livestock.  \nThe latter is repeated in the press and other books, and \nwhile an instance was formally documented, it appeared to have been a labor versus management \nproblem.  If true, there is zero excuse, with all parties \nculpable.  In other cases, reflex activity may be \nhonestly confused with viability.  Better training, \nattention to detail and respect for animals as sentient \nbeings seems app ropriate.  \n \nAGRO -TERRORISM/EMERGING DISEASE \nCHALLENGE  \nI have worked in this area since about 1995, when \nasked by a government agency to evaluate a shipment of feedstuffs/equipment to a Middle Eastern country, assisted by Bob Norton (Auburn University; \n334.844.2604) and others.  After the September 11 \nattack, USDA no longer uses the term bio -terrorism, \nwhich was replaced by agro -terrorism, biological \nthreat, or some other term which elicits less emotional \nresponses and fear.  There will be one high level USD A spokesperson in this area.  I agree with this \npolicy due to the highly emotional nature and capacity for creating rumors based on comments by \u201ca government official\u201d that detract from teamwork and \ngetting the job done.  I can report in my distribution \nlists, etc. what others are doing, but can not and will not have a public opinion in this area.  \nNorton, et al. , have been working for several \nyears to have government and industry take a comprehensive approach to protecting crop and animal \nagriculture.  They suggest government agencies, \nuniversities and industries develop a comprehensive \nprevention, and effective early detection and treatment \nsystem.  This systematic approach would include \neffective bio -security measures to minimize potential \ndisease spread and help address related diminished \nfood security capabilities.  They suggest: collaboration \nbetween Cooperative Extension System and local \nagricultural organizations, secure communications \nto/from state and federal personnel, and training for farmers and o ther local communication channels ( e.g., \nFarm Bureau, local veterinarians, consultants).  Complete disease prevention is impossible, but \nstopping the spread of a food security challenge is \npossible, as is minimizing the effect of agro -terrorism, \nand thus t he preferred course of action.  Some in \nindustry believe placing breeder stock in distant and \nprotected areas is the preferred approach.  This is good, \nbut one can only hide so many breeding stock, and the risk still exists they can be contaminated and die , or have to be destroyed.  This threat is obviously a huge \nanimal welfare issue.  \nIt is interesting that animal rights activists that act \nas a conduit for publicity for the Animal Liberation \nFront have been relatively quiet since September 11.  \nNote that t he ALF has been determined by the US \nFederal Bureau of Investigation to have committed acts \nof terrorism.  Also, bin Laden said in a statement when \nhe denied involvement in the September 11 attack, said \nthat he \u201cdid not do it but could certainly understand \nwhy someone would\u201d.  Sound familiar?  \n \nRESOURCES TO ADDRESS ANIMAL \nWELFARE ISSUES  \nA. USDA/CSREES/PAS will develop a national \nsymposium on Animal Well -Being: Swine Housing \nand Management, and related training material for use with producers and in train -the-trainer programs.  This \nsymposium uses a portion of funds earmarked for USDA that are to be used to address animal well -being \nissues.  \nB. The electronic newsletter, Farmed \nAnimalWatch contains summaries of current articles \nprimarily related to animal well -being and \nenvironmental issues from industry and activist \npublications, and numerous other sources.  To \nsubscribe or for more information, send a message to \nInfo@FarmedAnimal.net.  \nC. Americans for Medical Progress produces an \nelectronic newsletter, AMP Ne ws Service, for the \nresearch community.  Summarized are animal welfare \nissues and activist actions.  Contact AMP at \namp@amprogres.org, or access \nhtp://www.amprogress.org.  \nD. The Animal\u2019s Agenda newspaper is an \nexceptional activist publication that provides  detailed \ndescriptions of national and international animal well -\nbeing campaigns and news items.  Subscribe by \ncontacting: Merritt Clifton, PO Box 960, Clinton, WA \n98236- 0960; anmlpepl@whidbey.com; \nwww.animalpeoplenews.org.  \nE. The Animal Welfare Issues Com pendium was \nedited by R. Reynnells and B. Eastwood, CSREES, and \npublished through the USDA National Agriculture \nLibrary, Animal Welfare Information Center, and is \navailable on their Internet site (http://www.nal.usda.gov/awic).  The document \ncontains 14 fa ct sheets which contain extensive \nreferences.  \nF. Future Trends in Animal Agriculture workshop \nis being revived.  This annual workshop allows all sides to  openly discussed animal well -being and rights \nissues.  This is an attempt to reestablish dialogue and  \ncreate opportunities to identify areas of mutual concern that translate into progress in animal well -being.   \n  \n118 G. USDA/ARS and CSREES held a Stakeholders \nMeeting based on the Food Animal Integrated \nResearch 2002 recommendations, to ascertain if USDA \nwas meet ing these goals.  Progress toward meeting \nGoal 6, \u201cPromote Animal Well -Being\u201d, was evaluated \nand recommendations made to how better meet this \ngoal.  Summary  recommendations include: A.  Measures to Assess Well -Being (multi -disciplinary \nteam to develop an index of animal well -being; \nscientific basis for measuring pain, stress and distress and a baseline of care; develop and evaluate various \nproduction systems); B. Determine Impact of Systems \n(expand funding to address shortage of trained personnel, and research partnerships); C. Ethics \n(communication; database on animal welfare -ethics \nincluding international studies; social and \npsychological basis for animal well -being; animal \nwelfare component in research; assess consumer attitudes and expectations; CSREES leadership).  \nH. Western Region Coordinating Committee 204, \nAnimal Bioethics, is a multi -state research committee.  \nPurposes include:  bring researchers from all commodity areas and philosophers together to discuss \npoints of contention, and to define common  ground; \npromote a greater understanding by everyone of current \nwell-being, rights  issues and the basis for standard \npractices and concerns.  Industry communication and understanding is encouraged.  \n \nWHAT TO DO?  \nA few items to consider include:  \n\u2022 Demand ac countability.  From activists.  From  \nindustry.  From everyone in the food production, \nprocessing and distribution system. From \nyourself.  \n\u2022 Recognize where activists are correct.  Make changes in your professional and commodity area as appropriate.  Activis ts must reciprocate.  \nUnderstanding and honest communications can \ncreate mutual respect.  \n\u2022 Educate consumers, youth, and government \ndecision makers using objective, science -based \ninformation and reduce the emotional and \npoliticized arguments to win battles . \n\u2022 Buy from farmers raising food animals under \norganic or extensive systems if you support these \nconcepts.  \n\u2022 Refrain from displays of concern over how terrible it is that small businesses and farmers just \ncan not survive...unless there is some personal \nfollow through.  \n\u2022 Explain to your children where the cartoons, sit -\ncoms, etc. are a facade for religious or philosophical proselytization, and how they (may) differ from your belief system.  \u2022 Support anti -terrorist legislation.  Many good \nresearchers have qu it, changed areas of emphasis \nor lost years of  research destroyed by terrorist \nactivities such as arson.  The situation is similar \nfor some farmers.  \n\u2022 Professional organizations and industries must cooperate.  Do not allow egos or rights groups to divide and conquer agriculture.  Even small farms \nwill be eliminated by rights groups, but promoted \nby welfare groups.  \n\u2022 Recognize welfare activist\u2019s differences with \nindustry may be merely disagreement about how \nto raise animals.  \n\u2022 D.V.M.\u2019s, Ph.D.\u2019s and others s hould be \nconsidered equals in the animal well -being, public \nhealth, and environmental issues fields.  We must work as a team to address these often intertwined \nissues. Prevention or amelioration of the effect of \nagro-terrorism is an example of the need for  this \ntype collaboration.  \u2022 County agents, local D.V.M.\u2019s and farm \norganizations through to Federal and state agency \npersonnel must create a seamless system to \neffectively and rapidly address bio- security \nchallenges.  \n \nREFERENCES  \n1. American Livestock Breeds Conservancy, \nBox 477, Pittsboro, NC 27312.  \n2. Bible, King James Version.  Example well -\nbeing/dominion references: Matthew 10:29 -31; Luke \n13:15; 14:5; 15:4 -  7; I Corinthians 7:31; 9:9; I \nTimothy 5:18; Deuteronomy 22:6; Genesis 1:26 -  30, \nand 2:15; Hebrews 2:6 - 8; Psalms 8:6 -  8. \n3. Eisnitz, G. A.  Slaughterhouse; The \nShocking Story of Greed, Neglect, and Inhumane Treatment Inside the U.S. Meat Industry.  Prometheus \nBooks, Amherst, New York.  1997.  \n4. Halweil, B.  Where Have All the Farmers \nGone?  In:  World Watch, September/October Issue, \npp. 12- 28.  2000.  \n5. Posewitz, J.  Beyond Fair Chase; The Ethic \nand Tradition of Hunting.  Falcon Press Publishing Co. \nInc., Helena and Billings, MT.  1994.  \n6. Schlosser, E.  Fast Food Nation: The Dark \nSide of the American Meal.  Houghto n Mifflin Co.  \n2001.  \n7. Schweitzer, A.  Reverence for Life.  \nSermons of Albert Schweitzer.  Translated by Reginald Fuller.  New York: Harper and Row.  1969.  \n8. Smith, P.  Killing the Spirit: Higher \nEducation in America.  Published by Penguin Group, \n375 Hudson St reet, New York, New York 10014.  \n1990.\n  \n  \n119 IN OVO ADMINISTRATION OF MAREK\u2019S DISEASE VACCINE: \nIMPORTANCE OF VACCINE DEPOSITION SITE IN THE  \nFERTILE EGG  \n \nADMINISTRACI\u00d3N IN OVO DE LA VACUNA CONTRA LA ENFERMEDAD \nDE MAREK: IMPORTANCIA DEL SITIO DONDE QUEDA DEPOSI TADA  \nLAVACUNA EN EL HUEVO F\u00c9RTIL  \n \nAlan P. AvakianA, Patricia S. WakenellB, Thomas BryanA, Jon L. SchaefferA, Christopher J. WilliamsA \nand Craig WhitfillA \n \nAEmbrex, Inc., P.O. Box 13989, RTP, NC, 27709  \nBDepartment of Population Health and Reproduction, Univ ersity of California -Davis, Davis, CA, 95616  \n \nRESUMEN  \nSe encontr\u00f3 que el sitio de dep\u00f3sito de la vacuna \ncontra la enfermedad de Marek in ovo afecta la eficacia \nde la misma, pues cuando qued\u00f3 en la c\u00e1mara de aire o \nen el l\u00edquido alantoideo gener\u00f3 una prote cci\u00f3n \ndeficiente, mientras que su dep\u00f3sito en el l\u00edquido \namni\u00f3tico o en el cuerpo del embri\u00f3n proporcion\u00f3 una \nexcelente protecci\u00f3n. Se observ\u00f3 que a los 18 d\u00edas de incubaci\u00f3n, la m\u00e1quina comercial de inyecci\u00f3n in ovo \n(sistema Inovoject\n\u00ae) deposita un colora nte ya sea en el \nl\u00edquido amni\u00f3tico o en el cuerpo del embri\u00f3n entre el \n98.4 y el 100.0% de las inyecciones. Estos datos \nindican que la m\u00e1quina de inyecci\u00f3n in ovo usada en \nestos estudios realiz\u00f3 un trabajo excelente pues \nproporcion\u00f3 una vacunaci\u00f3n efectiva contra la \nenfermedad de Marek, en los sitios correctos, a los 18 d\u00edas de incubaci\u00f3n.  \n \nIn the last decade the most obvious change in \nhatchery operations around the world has been the \ninitiation of in ovo (in the egg) vaccination. The initial \nresearch that led to this change was conducted in the early 1980\u2019s (5,6). These studies and more recent ones have shown that administration of MD vaccines HVT \n(5,6), SB1 (6) and CVI988 (8) to the late -stage chicken \nembryo is safe and induces earlier immunity than post -\nhatch MD vaccine administration. The concept of in \novo MD vaccination was moved from the laboratory to \nthe field by the development of an automated in ovo injection machine (4). Commercial in ovo vaccination \nbegan in the United States in late 1992 and today  is \noccurring in hatcheries in more than 30 countries.  \nEfficacy of MD vaccine may depend upon the in \novo site in which the vaccine is delivered. The normal \nfertile egg on day 18 of incubation has five sites that are large enough to be accessed by the needl e of the \ncommonly used in ovo injection machine and manual \nin ovo injection using a syringe and needle. These \ncompartments are the air cell, allantois, amniotic fluid surrounding the embryo, the embryo body and the yolk sac. The effect of delivering MD vaccine to different \nsites in ovo and the frequency of injections into these \ndifferent sites by the in ovo injection machine will be \npresented.  \n \nMATERIALS AND METHODS  \nInfluence of in ovo site of injection on MD \nvaccine efficacy: Studies 1 and 2 were done wit h SPF \neggs (Hy Vac Inc) and study 3 with broiler eggs \n(Cobb/Cobb). Eighteen- day-old embryonating eggs \nwere candled and inoculated as described (7). Briefly, \nan entrance hole was punched with an 18 -gauge needle. \nA 1 ml syringe with a 20 gauge needle was use d to \ninoculate eggs with 0.1 ml MD vaccine HVT/SB1 \n(Merial Select). The technique for exclusive and \nreliable manual delivery to each embryonic \ncompartment (air cell, allantoic fluid, amniotic fluid, \nbody of embryo) was developed using dye \ninoculations. Dur ing technique development, injection \nonto the air cell membrane was confirmed by finding \ndye only on the top surface of the air cell membrane. \nInjection into the allantoic fluid was substantiated by \nfinding dye located below the air cell membrane, but \nnot in contact with the embryo. Injection into the \namniotic fluid was confirmed by seeing dye on the \nembryo, while injection into the embryo was confirmed \nby seeing dye in the body of the embryo. For each of studies 1 -3, a 10% sample of eggs/treatment was \ninjected with dye and site of injection determined by \negg examination. A 100% accuracy of placement was confirmed for the air cell, allantoic and amniotic sites. Embryo placement was at 97% accuracy. Chicks \nvaccinated at hatch were given 0.1 ml of the MD \nvacci ne subcutaneously in the back of the neck.  \nThe challenge virus used was the RB1B strain of \nMDV at passage level 9 in chick kidney cells. On day 5 of age, chicks were challenged by intra- abdominal \ninjection of 500 pfu RB1B. Chicks were grown to 54  \n  \n120 days of a ge. Gross lesions of MD including tumors, \nand/or nerve yellowing, loss of striations and \nenlargement were recorded (3).  \nDetermination of injection site by an in ovo  \ninjection machine: The in ovo  injection machine \n(Inovoject \uf6da system, Embrex, Inc.) was opera ted as \nrecommended by the manufacturer and dye was \ninjected rather than vaccine. Eggs were injected at \nincubation ages 18 days and 0 hours, 18 days and 12 \nhours and 19 days and 0 hours. Normal fertile eggs were carefully examined for dye localization as \ndescribed above. Upside down eggs, upside down \nembryos and malformed embryos were excluded from \nthe analysis because they are unlikely to result in normal hatched chicks. Cobb/Cobb, Ross/Hubbard and \nRoss/Arbor Acres broiler eggs from different \ncommercial sou rces were used to determine site of dye \ninjection. A total of 3,983 broiler eggs in \napproximately equal proportions from breeder flocks of 32, 36, 46, 48, 58, and 66 weeks of age were examined.  \nEfficacy of MD vaccine delivered at 18 days and \n3 hours of inc ubation via an in ovo  injection machine : \nBroiler eggs of five different breeder flocks were incubated and hatched in commercial hatcheries. \nBreeder flock matched broilers were vaccinated using \neither a commercially operating in ovo injection \nmachine (Inovo ject\uf6da system, Embrex, Inc.) or manual \nsubcutaneous injection at hatch using a 1 ml syringe \nand 23 gauge needle. Bivalent HVT/SB1 (Merial \nSelect) was administered at a dose of 4500 pfu HVT \nand 2500 pfu SB1. Unvaccinated chicks were included in each study. M DV RB1B challenges and \nexaminations were as described above. Chicks were raised in isolation floor pens to 54 days of age.  \nProtective index (PI) was calculated for MD \nchallenges using the formula: % MD positive in unvaccinated chickens minus the % MD posit ive in \nvaccinated chicks divided by the % MD positive in \nunvaccinated chicks and multiplied by 100 (5).  \n \nRESULTS  \nThe effect of day 18 of incubation in ovo  site of \ninjection on MD vaccine efficacy is shown in Table 1. \nOverall, administration of MD vaccine to the air cell \nresulted in a PI of 0, administration to the allantois resulted in a PI of 28.3, while administration to either \nthe amniotic fluid, embryo body or at hatch gave PI of  \n94.4, 93.9 and 95.2, respectively.  \nThe frequency of injection into either the \namniotic fluid or the embryo body by an automated in ovo injection machine was 98.4% at 18 days and 0 \nhours of incubation, 99.6% at 18 days and 12 hours of \nincubation and 100.0% at 19 days and 0 hours of \nincubation. The frequency of injection into t he embryo \nbody were 4.3% at 18 days and 0 hours of incubation, 21.7% at 18 days and 12 hours of incubation and \n67.2% at 19 days and 0 hours of incubation.  \nIn MDV challenged broilers HVT/SB1 delivered \nat 18 days and 3 hours of incubation via an in ovo  \ninjec tion machine resulted in PI of 86.5, 90.0, 100.0, \n93.3 and 95.4 verses PI of manual at hatch MD \nvaccinates of 88.7, 68.2, 85.7, 100.0 and 86.0, respectively. Unvaccinated challenged controls had \nMD positive rates of 28% to 62%, depending on the \nstudy.  \n \nDISCUSSION  \nResults of studies 1 -3 indicate that in ovo site of \ninjection is important. There was no protective \nimmunity when MD vaccine was administered into the \nair cell and this confirmed earlier unpublished studies. \nDay 18 of incubation in ovo administration into the \nallantoic fluid was shown to provide an average PI of 28.3. In comparison, day 18 of incubation in ovo  \nadministration into the amniotic fluid or the embryo body resulted in PI of 94.4 and 93.9, respectively. \nThese data indicate that air cell and allantoic fluid \nadministration of  MD vaccine is to be avoided, while \ninjection into either the amniotic fluid or the embryo body is desirable and equivalent with laboratory post -\nhatch administration.  \nThe in ovo injection machine injected dye into the \ntwo in ovo  sites shown to be effective for MD vaccine \nadministration (amniotic fluid and body of embryo) at a very high rate. This finding was demonstrated using a large number of eggs from young, mid and old breeder \nflocks representing three common breed crosses. The \nrate of amniotic fluid and embryo injections increased \nas injection age increased from 98.4% at 18 days and 0 \nhours of incubation to 100.0% at 19 days and 0 hours \nof incubation. Injections into the body of the embryo increased from 4.3% to 67.2% during the 24 hour \nperiod that constituted day 18 of incubation. The \nincreasing size of the embryo during day 18 of \nincubation (2) is thought to be the primary reason for the increasing frequency of embryo injections.  \nIt was recently reported (1) that \u201ce xtra-\nembryonic\u201d in ovo administration of MD vaccine is \nless effective than injection into the body of the \nembryo. These authors did not distinguish the amniotic \nfluid from the allantoic fluid. They may have preferentially injected MD vaccine into the allan tois \nwhile manipulating the manual injection to miss the body of the embryo. In a series of MD vaccine efficacy \nstudies using commercially operating in ovo injection \nmachines, broiler eggs vaccinated at 18 days and 3 \nhours of incubation were found to have good protection \n(PI = 86.5 to 100.0) against an RB1B challenge. Data reported herein indicate that at 18 days and 3 hours of \nincubation one would expect less than 10% of \ninjections to hit the embryo body when using the in ovo  \n  \n121 injection machine. These data indicate that MD vaccine \nneed not be administered into the body of the embryo \nfor in ovo vaccination to induce good protective \nimmunity. This conclusion is supported by the \ncommercial success of in ovo  MD vaccination that \noften occurs early on day 18 of in cubation.  \nThe commercial success of in ovo vaccination has \nrecently been accompanied by a significant amount of \nexperimental in ovo research. Much of this research is \nconducted using manual injection techniques. These \ntechniques appear to differ from labor atory to \nlaboratory and are sometimes manipulated to test certain hypothesis and therefore may not mimic the in \novo injection machine. This type of research is always \nproductive and informative, but cannot always be \ndirectly related to commercial in ovo vaccination.  \nSimilarly, one cannot extrapolate results from the \ncommercial in ovo injection machine used in these \nstudies to other in ovo injection machines because of \nnumerous and significant design differences between the machines.  \n  \nREFERENCES  \n1. Islam, A.F .M.F., Walkden -Brown, S.W., \nWong, C.W., P.J. Groves, Burgess, S.K., K. E. Arzey \nand P.L. Young. Influence of vaccine deposition site on \npost-vaccinal viraemia and vaccine efficacy in broiler \nchickens following in ovo vaccination against Marek\u2019s \ndisease. Av ian Path. 30:525- 533. 2001.  2. Romanoff, A. The Avian Embryo. Structure \nand Functional Development. New York, McMillian \nInc. 1960.  \n3. Payne, L.N., Frazier, J.A., and P.C. Powell. \nPathogenesis of Marek\u2019s disease. Int. Rev. Exp. Pathol. \n16:59- 154. 1976.  \n4. Sarma, G.,  Greer, W., Gildersleeve, R.P., \nMurray, D.L., and A.M. Miles.  Field safety and efficacy of in ovo administration of HVT and SB -1 \nbivalent Marek\u2019s disease vaccine in commercial \nbroilers.  Avian Dis.  39:211- 217.  1995.  \n5. Sharma, J. M., and B. R. Burmester.  \nResistance to Marek\u2019s disease at hatching in chickens \nvaccinated as embryos with turkey herpesvirus.  Avian \nDis.  26:134- 149. 1982.  \n6. Sharma, J.M., and R.L. Witter.  Embryo \nvaccination against Marek\u2019s disease with serotypes 1, 2, and 3 vaccines administered singly or in \ncombination.  Avian Dis.  27:453- 463. 1983.  \n7. Wakenell, P.S., Bryan, T., Schaeffer, J., \nAvakian, A., Williams, C. and C. Whitfill. Effect of in \novo vaccine delivery route on HVT/SB1 efficacy and \nviremia. Avian Dis. 46: in press. 2002.  \n8. 8. Zhang, Y. and J. M. Sharma. Early \nposthatch protection against Marek\u2019s disease in \nchickens vaccinated in ovo with a CVI988 serotype 1 \nvaccine. Avian Dis. 45:639 -645. 2001.  \n \nTable 1:  Susceptibility of Chickens to a Marek\u2019s Disease strain RB1B challenge when vacci nated with MD vaccine \nHVT/SB1 in ovo on day 18 of incubation in different embryonic sites or subcutaneous at hatch.  \nMD \nVaccine  \nRoute   \n \nSite of injection   \nMDV \nChallenge  No. Positive for MD lesions/No. Challenged  \nStudy 1  \nSPF  Study 2  \nSPF  Study 3 \nBroiler   Total Studies 1 -3 \n(Protective Index)1 \nNone  None  No 0/50a 0/43a 0/50a 0/143      (NA)  \nNone  None  Yes 46/48d 40/42c  40/50d  126/140   (NA)  \nIn ovo  Air cell  Yes 45/49d NT NT 45/49       (0.0)  \nIn ovo  Allantoic fluid  Yes 39/49c 23/43b 29/49c 91/141     (28 .3) \nIn ovo  Amniotic fluid  Yes 2/48b 1/42a 4/49b 7/139       (94.4)  \nIn ovo  Embryo body  Yes NT 2/43a 3/48b 5/91         (93.9)  \nAt hatch  Neck  Yes NT 1/42a 3/50b 4/92         (95.2)  \n a,b,c,d Within study (columns), frequencies with the same superscript letter are not significantly different using chi -\nsquare analysis (p \u2264  0.05).  \n1 Number positive for MD lesions/number challenged totaled by site of injection for studies 1- 3. Protective index for \ntotaled frequencies by site of injection.  \nSPF = specific pathogen free, NT = not tested, NA = not applicable \n \n \n \n  \n  \n  \n122 THE ROLE OF MAREK\u2019S DISEASE VIRAL IL -8 IN VIRAL \nPATHOGENESIS  \n \nEL PAPEL DE LA INTERLEUCINA 8 DEL VIRUS DE LA ENFERMEDAD DE \nMAREK EN LA PATOGENIA DE LA ENFERMEDAD  \n \nPortia Cortes1 and Carol Cardona2 \n \n1Microbi ology Graduate Group, University of California, Davis  \n2Veterinary Medicine Extension, Surge III, Rm. 1383, University of California, Davis, Davis, CA  95616  \n \nRESUMEN  \nEn el genoma del virus de la enfermedad de \nMarek se encuentra codificado un hom\u00f3logo de l a \ninterleucina 8 (IL -8). Para determinar sus efectos en la \npatogenia de la enfermedad inoculamos un grupo de \naves de la l\u00ednea P (susceptibles a la enfermedad de \nMarek) y un grupo de aves de la l\u00ednea N (resistentes a \ndicha enfermedad) ya sea con la cepa RB1 B o con la \ncepa RB1B vIL -8\u2206smGFP (que es la RB1B pero \ncarece de la IL -8). La patolog\u00eda macrosc\u00f3pica y el \nensayo en placa indica que esta \u00faltima cepa no se replica in vivo,  sino a niveles inferiores en comparaci\u00f3n \ncon la RB1B. Nuestra hip\u00f3tesis es que la IL -8\u2206smGFP \nviral puede ser cr\u00edtica para la multiplicaci\u00f3n del virus y para su transferencia de c\u00e9lula a c\u00e9lula durante las fases iniciales de la patogenia de la enfermedad de Marek.  \n A homologue of interleukin- 8 (IL -8) is encoded \nin the Marek\u2019s disease virus (MDV) genome (1).  To \ndetermine the effects of viral interleukin -8 (vIL8) on \nthe pathogenesis of Marek\u2019s Disease (MD), we \ninoculated a group of P -line birds (MDV susceptible) \nand N -line birds (MDV resistant) with either the RB1B \nstrain of MDV or RB1B vIL -8\u2206smGFP (2) (RB1B \nlacking vIL8).  Two separate experiments were done \nand necropsies were performed at various time points starting at 3 days post -infection (dpi) and ending at 35 \ndpi, to follow the 4 phases of Marek\u2019s Disease.  One \nhundred percent of the P -line birds given RB1B had  \ntumors in two replicate experiments while only 6% of \nP-line birds given RB1B vIL -8\u2206smGFP and N -line \nbirds given RB1B had grossly detectable tumors. No \ntumors were observed in N -line birds given RB1B vIL -8\u2206smGFP.  P -line birds inoculated with RB1B had a \nlogarithmic rise in virus titer from 65 pfu (plaque \nforming units) at 5 dpi to 400,000 pfu at 21 dpi. Virus \nwas isolated from N -line birds given RB1B although \nvirus titers only reached a peak of only 8,500 pfu at 14 \ndpi and dropped to 30 pfu at 21 dpi. We is olated RB1B \nvIL-8\u2206smGFP virus from both P -line and N -line \ngroups of birds. In the N -line birds given RB1B vIL -\n8\u2206smGFP, titers did not exceed 100 pfu and virus \ncould not be isolated beyond 14 dpi. Viral titers \nremained low in P -line birds given RB1B vIL -\n8\u2206smGFP but the virus was isolated up to 28 dpi.  In \nsummary, these results indicate that RB1B vIL -\n8\u2206smGFP does replicate in vivo  but at a much lower \nlevel compared to the RB1B.  This limited capacity to \ngrow was observed during the early cytolytic phase of \nMD leading us to believe that vIL8 may be critical in \nviral replication and cell to cell transfer during the \ninitial phases of MD pathogenesis.  \n \nREFERENCES  \n1. Liu, J. - L., S. - F. Lin, L. Xia, P. Brunovskis, \nD. Li, I. Davidson, L. F. Lee, H. - J. Kung. Meq and v -\nIL8: Cellular genes in disguise?. Acta Virol. 43:94 -\n101. 1999.  \n2. Parcels, M. S., S. -F. Lin, R. L. Dienglewicz, \nV. Majerciak, D. R. Robinson, H. -C. Chen, Z. Wu, G. \nR. Rubyak, P. Brunovskis, H. D. Hunt, L. F. Lee, and H.-J. Kung. Marek\u2019s disease virus (MDV) encodes an \ninterleukin -8 homolog (vIL8): Characterization of the \nvIL-8 protein and a vIL -8 deletion mutant MDV.  J. \nVirol.  75: 5159- 5173. 2001.  \n \n \n  \n \n   \n  \n123 REDEFINING A LATENCY  MODEL FOR MAREK\u2019S DI SEASE \nVIRUS (MDV)  \n \nREDEFINICI\u00d3N DE UN MODELO DE LATENCIA PARA EL VIRUS DE LA \nENFERMEDAD DE MAREK  \n \nArumugaswami, Vaitilingaraja, Vjollca Konjufca, Robert L. Dienglewicz, and Mark S. Parcells  \n \nCenter of Excellence for Poultry Science, University of Arkansas, Fayetteville AR 72701  \n \nRESUMEN  \nLa enfermedad de Marek es un c\u00e1ncer de c\u00e9lulas \nT de los pollos causado por el virus del mismo nombre. \nLa transformaci\u00f3n de las c\u00e9lulas T por dicho virus est\u00e1 asociada con una infecci\u00f3n latente. El estudio de los \ngenes asociados con la latencia ha sido dif\u00edcil en \npollos. Nosotros utiliz amos una l\u00ednea de c\u00e9lulas T (la \nl\u00ednea RECC -CU91) para el estudio de la infecci\u00f3n \nlatente con el virus de la enfermedad de Marek, toda vez que estas c\u00e9lulas adquieren al virus a partir de fibroblastos de embri\u00f3n de pollo infectados en forma \nl\u00edtica. La laten cia del virus de la enfermedad de Marek \nestablecida en las c\u00e9lulas CU91 es indistinguible de la \nque se encuentra en las l\u00edneas celulares transformadas \npor el virus de la enfermedad de Marek en lo referente \nal estado del genoma, el patr\u00f3n de metilaci\u00f3n, la expresi\u00f3n de MEQ  y la reactivaci\u00f3n. Por lo tanto, este \nmodelo permitir\u00e1 el estudio de la latencia del virus que \nnos ocupa en ausencia de infecci\u00f3n in vivo.  \n \nINTRODUCTION  \nMarek\u2019s disease is a T -cell cancer of chickens \ncaused by an alphaherpesvirus, Marek\u2019s disease virus \n(MDV).  The transformation of T -cells by MDV is \nassociated with MDV latent infection (2, 13).  The \nstudy of genes associated with the transformation \nmechanism of MDV has been difficult as viruses \nlacking these genes fail to establish substant ial latent \ninfections in chickens.  We have re -examined the use \nof a REV -transformed T -cell line, RECC -CU91, for the \nstudy of MDV latent infection, as these cells take up MDV from lytically -infected chicken embryo \nfibroblasts (CEF) (9,12).  This method provides a \npowerful model for the study of MDV latent infection \nin the absence of MDV -induced transformation.  To \nbetter characterize this model, we have generated a number of MDV -harboring CU91- based cell lines \n(termed RE/MDCC for REV -transformed, MDV -\nharbor ing cell culture).  \n   \nRESULTS SUMMARY  \nRE/MDCC cell lines were established using \nRB1B (11) and RB1BvIL8\u2206 smGFP, a recently \ndescribed recombinant MDV having a deletion of the MDV IL -8 homolog (vIL8) and the insertion of a \nsoluble -modified green fluorescent pr otein (smGFP) \nexpression cassette (7).   \nWe have characterized the latency established in \nthese cell lines, RE/MDCC -UA30 (RB1B) and \nRE/MDCC -UA28 (RB1BvIL8 \u2206smGFP) according to:  \n1) the genome state of the MDV genome (integrated vs episomal),  \n2) methylation status  of the MDV genome,  \n3) the growth rate of CU91 cells and RE/MD cell lines,  \n4) the resistance of CU91s and RE/MD cell lines to apoptosis induced by serum starvation,  \n5) overall MDV genome expression,  \n6) inducible MDV genome expression,  \n7) Marek\u2019s EcoRI -Q (Meq) gene expre ssion, and  \n8)  the ability to reactivate MDV from this model \nfor latency.  \nUsing these cell lines, we have determined that:  \n1) The MDV genome is taken up by CU91 cells \nfrom MDV -infected fibroblasts within 24 hrs \nand is     integrated into the chicken cellular \ngenome within these cells.  \n2) Expression of MDV lytic genes is repressed in these cell lines in a manner indistinguishable \nfrom MDV -transformed, latently -infected \ncells. This repression is not based on \nmethylation of MDV DNA sequences.  \n3) Uptake of the MDV genome by CU91 cells, \ndecreases their doubling time (i.e., increases their growth rate).  \n4) Uptake of the MDV genome by CU91 cells also confers resistance to apoptosis induced by serum starvation.  \n5) Using probes spanning the entire MDV genome, the latency established in CU91 cells is comparable to that of MDV -transformed \ncell lines.  \n6) The pattern of meq expression (both sense and antisense) is indistinguishable in both forms of latency.  \n7) MDV early antigen pp38 and late antigen \nglycoprotein B are induced by treatment of \nthese cell lines with bromodeoxyuridine.   \n  \n124 8) Finally, the MDV genome can be rescued \nfrom the CU91 -based cell lines via co -\ncultivation on CEF.  The virus plaques \ninduced on CEF monolayers are somewhat \nsmaller than those caused by co -cultivation \nwith MDV -transform ed cell lines, but upon \npassage, show increases in virus titer indicating comparable virus yield per plaque.  \nThe initially small plaques induced on CEF \nmonolayers upon reactivation from CU91 \ncells are likely due to the expression of IFN -II \n(g) by CU91 cel ls  (6) and its effect on MDV \nlytic infection (15).  \n \nDISCUSSION  \nOur results really re -define what was previously \ndisregarded as a model for Marek\u2019s disease virus \nlatency.  The major reason why this model has not been \nexploited lay in the initial cell line  established using \nthis method, CU210.  The CU210 cell line harbors the \nMDV genome, but is a non- producer cell line that \ncannot be induced to express virus lytic antigens or reactivate virus (9).  In our examination of the CU210 \ncell line in comparison to the cell lines that we \nestablished, we found that the CU210s contain an insertion into the Meq gene, and perhaps other \nmutations that affect the latency established in these \ncells.  The mutation observed in the Meq gene, is nearly identical to one describe d for the vaccine virus \nCVI-988 (5), and previously described for another non-\nproducer MDV -transformed T -cell line, MKT -1 (8,14).  \nInterestingly, this mutation is an insertion of 177 nt in -\nframe with the Meq oncoprotein resulting in the \nreiteration of a pr oline -rich domain of Meq believed to \nbe involved in transcriptional repression(10).  The fact that this mutation has been observed in several, \nindependently- isolated MDV genomes, suggests a \nfunctional significance to this reiteration.  Perhaps this \nform of  Meq functions as a \u201csuper -repressor\u201d in \nblocking the expression and reactivation of the MDV \ngenome.  Previously, Pratt et al.,  were able to induce \nMDV genome expression in CU210 cells after \ntransfection of these cells with the BamHI -A region of \nthe genome  (9), a region encoding the ICP4 gene (a \nmajor immediate -early regulatory protein) (1).  Still, \nthe model seemed flawed, as the CU210s did not spontaneously reactivate virus in a manner similar to \nmost MDV -transformed cell lines.   \nOur re -examination of th is model has \ndemonstrated that the CU210 example is an exception, rather than the rule.  We have demonstrated that the CU91 cells rapidly take -up the MDV genome with the \nconsequence that the CU91s grow more rapidly and are more resistant to apoptosis.  The re appears, therefore, \nto be a positive selection for the uptake of the MDV \ngenome.  Moreover, the MDV genome immediately assumes a posture essentially identical to that seen in \nMDV- transformed cell lines.  The MDV genome is \nlargely shut down, with the not able exception of the \nlatency - and transformation- associated  regions, and \nthe virus is integrated.  Our results therefore confirm the observations of Delecluse and Hammerschmidt, \nthat the MDV genome is integrated in tumors and in \ncell lines (3,4).  What w e have also determined, \nhowever, is that the \u201cepisomal -form\u201d of the MDV \ngenome described for the CU25 cell line, is more likely to be a replicative intermediate and not a true episome.  \nThis \u201ccircular\u201d form was only found in cell lines from \nwhich virus could be reactivated and which also contained numerous linear fragments of the genome.  \nInclusion of lytically -infected fibroblasts in this study, \ndemonstrates that this \u201cepisomal\u201d form is present \nduring lytic infection.  Consequently, it is not likely an \nepisomal form, but a circular intermediate present \nduring \u201crolling circle\u201d replication of the herpesvirus genome.  Another interesting aside is that the MDV \ngenome appears to also integrate into the chicken \nchromosome during lytic infection.  \nThe induction of MDV gene expression and \nreactivation in this model are very important, as this \ndemonstrates a clear method for studying aspects of \nMDV latency in the absence of immune selection.  \nOstensibly, MDVs having mutations affecting lytic, \nlatent or transforming in fections would be very \ndifficult to study during in vivo  replication.  Even in \nbirds infected with very virulent MDVs, the number of latently -infected cells is relatively small, making study \nof this important virus -cell interaction likewise very \ndifficult.   Our results, therefore, clearly outline the \nutility of this model for the study of MDV latency.  \n \nREFERENCES  \n1. Anderson, A. S., A. Francesconi and R. W. \nMorgan.  Complete nucleotide sequence of the Marek's \ndisease virus ICP4 gene.  Virology  189:657- 67.  1992.  \n2. Calnek, B. W., K. A. Schat, L. J. Ross, W. \nR. Shek and C. L. Chen.  Further characterization of \nMarek's disease virus -infected lymphocytes. I. In vivo \ninfection.  Int J Cancer  33:389 -98.  1984.  \n3. Delecluse, H. J. and W. Hammerschmidt.  \nStatus of Marek's disease virus in established \nlymphoma cell lines: herpesvirus integration is \ncommon.  J Virol  67:82- 92.  1993.  \n4. Delecluse, H. J., S. Schuller and W. \nHammerschmidt.  Latent Marek's disease virus can be \nactivated from its chromosomally integrated state in \nherpesvirus -transformed lymphoma cells.  Embo J  \n12:3277- 86.  1993.  \n5. Lee, S. I., M. Takagi, K. Ohashi, C. \nSugimoto and M. Onuma.  Difference in the meq gene \nbetween oncogenic and attenuated strains of Marek's  \n  \n125 disease virus serotype 1.  J Vet Med Sci  62:287- 92.  \n2000.  \n6. Lowenthal, J. W., M. R. Digby and J. J. \nYork.  Production of interferon -gamma by chicken T \ncells.  J Interferon Cytokine Res  15:933 -8.  1995.  \n7. Parcells, M. S., S. F. Lin, R. L. Dienglewicz, \nV. Majerciak, D. R. Robinson, H. C. Chen, Z. Wu, G. \nR. Dubyak, P. Brunovskis, H. D. Hunt, L. F. Lee and \nH. J. Kung.  Marek's disease virus (MDV) encodes an \ninterleukin -8 homolog (vIL -8): characterization of the \nvIL-8 protein and a vIL -8 deletion mutant MDV.  J \nVirol  75:5159- 73.  2001.  \n8. Peng, Q. and Y. Shirazi.  Characterization of \nthe protein product encoded by a splicing variant of the \nMarek's disease virus Eco -Q gene (Meq).  Virology  \n226:77- 82.  1996.  \n9. Pratt, W. D., R. W. Morgan and K. A. Schat.  \nCharacterization of reticuloendothe liosis virus -\ntransformed avian T - lymphoblastoid cell lines infected \nwith Marek's disease virus.  J Virol  66:7239- 44.  1992.  \n10. Qian, Z., P. Brunovskis, F. Rauscher, 3rd, L. \nLee and H. J. Kung.  Transactivation activity of Meq, a \nMarek's disease herpesvi rus bZIP protein persistently expressed in latently infected transformed T cells.  J \nVirol  69:4037- 44.  1995.  \n11. Schat, K. A., B. W. Calnek and J. Fabricant.  \nCharacterization of two highly oncogenic strains of \nMarek's disease virus.  Avian Pathol.  11:5 93-605.  \n1982.  \n12. Schat, K. A., W. D. Pratt, R. Morgan, D. \nWeinstock and B. W. Calnek.  Stable transfection of \nreticuloendotheliosis virus -transformed lymphoblastoid \ncell lines.  Avian Dis  36:432 -9.  1992.  \n13. Shek, W. R., B. W. Calnek, K. A. Schat and \nC. H. Chen.  Characterization of Marek's disease virus -\ninfected lymphocytes: discrimination between \ncytolytically and latently infected cells.  J Natl Cancer Inst  70:485- 91.  1983.  \n14. Sugaya, K., G. Bradley, M. Nonoyama and \nA. Tanaka.  Latent transcripts of Marek's disease virus are clustered in the short and long repeat regions.  J \nVirol  64:5773- 82.  1990.  \n15. Xing, Z. and K. A. Schat.  Inhibitory effects \nof nitric oxide and gamma interferon on in vitro and in \nvivo replication of Marek's disease virus.  J Virol  \n74:3605- 12.  2000.  \n \nCHARACTERIZATION OF THE MAREK\u2019S DISEASE VIRUS \nPHOSPHOPROTEIN 38 (pp38) GENE FAMILY  \n \nCARACTERIZACI\u00d3N DE LA FAMILIA DEL GENE DE LA FOSFOPROTE\u00cdNA \n38 (pp38) DEL VIRUS DE LA ENFERMEDAD DE MAREK  \n \nPrigge, Jon T1 and Mark Parcells1 \n \nCenter of Excellence for Poultry Science, University of Arkansas, Fayetteville, AR 72701  \n \nRESUMEN  \nLa enfermedad de Marek es causada por un virus \nherpes alfa conocido como virus de la enfermedad de Marek. El c\u00f3digo gen\u00e9tico de este virus incluye una \nfamilia  altamente expresada de fosfoprote\u00ednas \n(pp24/pp38) cuya funci\u00f3n es desconocida. Al construir \nvirus de esta enfermedad recombinantes que presentan \nmutaciones en la regi\u00f3n que codifica para la pp38, \nidentificamos genes adicionales que pueden afectar su replicaci\u00f3n in vivo.  Adyacentes al ORF  pp38 se \nencuentran dos ORF  putativas denominadas HEP  y \nMys2. Utilizando la 3\u2019 RACE  (amplificaci\u00f3n r\u00e1pida de \nlos extremos del cADN) identificamos los factores de \ntranscripci\u00f3n que codifican para cada una de estas \nORF.  Actua lmente estamos construyendo l\u00edneas \ncelulares que expresan estas ORF  para determinar el \npapel que desempe\u00f1an en la infecci\u00f3n con el virus de la \nenfermedad de Marek y su evasi\u00f3n del aparato \ninmunocompetente.  \n Marek\u2019s Disease (MD) is caused by Marek\u2019s \nDisease  Virus (MDV), a highly cell -associated \u03b1 -\nherpesvirus (reviewed in 3).  MD is primarily characterized by lymphocyte infiltration of the nerves, and the development of lymphomas in visceral organs, \nmuscle, and skin. Since the 1970\u2019s, MD has been \neffectively controlled through an extensive vacci nation \nprogram using serotypically -related, apathogenic \nherpesviruses.  Despite expensive  vaccination \nprograms, MD continues to remain of considerable \neconomic importance due to condemnation losses at \nprocessing, the cost of continued vaccination programs,  \ndecreased production of immunosuppressed birds, and \ncontinually evolving hyper -virulent strains.  It becomes \napparent that a better understanding of the regulatory \nmechanisms of MDV is critical.  \nMDV\u2019s are comprised of three antigenically -\nrelated viruses ( serotypes 1, 2, and 3, or herpesvirus of \nturkeys [HVT]), of which MDV serotype 1 (MDV -1) is \noncogenic.  MDV serotypes 2 and 3 were initially  \n  \n126 isolated from healthy chickens (8) and turkeys (10), \nrespectively, and today are used as vaccines.  MDV -1 \nis unique  in that it is the only acute -transforming \nalphaherpesvirus that causes tumors in its host.   \nThe MDV -1 genome is approximately 178kbp \nand is organized similar to other alphaherpesviruses (9).  MDV has two regions of unique sequence, the unique -long (U\nL) and unique -short (U s) regions, which \nare flanked by regions of internal and terminal repeat -\nshort (IR s and TR s, respectively).  Among the \nserotypes of MDV, the greatest divergence is seen in \nthe repeated sequence flanking the U L (IR L and TR L).  \nEncoded at t he junctions of the repeats flanking the U L \nregion of MDV are a family of highly- expressed \nphosphoproteins 24 (pp24) and 38 (pp38), respectively. \nThese proteins were initially identified as tumor -\nassociated antigens, but are now known to be \nassociated with  reactivation from latency (1,7) and \nlytic infection.  The expression of pp38, albeit at a low level, in transformed cell lines appears to be important \nin the maintenance of the transformed phenotype, \nalthough the mechanism remains uncharacterized (11). \nTo date, the function(s) of pp38 and pp24 remain \nenigmatic.  \nTranscription mapping of the pp38 region has \ndemonstrated that pp38 may be encoded by a 1.8kb \nunspliced RNA transcript, (2,4,5) with minor \ntranscripts of 0.67, 0.8, 3.1, and 3.8kb, also reported from MDV -1 infected fibroblasts. (2,4) Possibly \nencoded by the pp38 1.8kb RNA are also two other putative ORFs that we have designated as HEP (BamHI -H Encoded Protein) and Mys2 (Mystery 2), \nwith yet uncharacterized functions.  The HEP and Mys2 correspond to R -LORF13a and LORF10, \nrespectively (6).  All three serotypes of MDV have the HEP -like and Mys2 ORFs present in the viral genome, \nfurther suggesting that the HEP and Mys2 ORFs are \nnot an artifact within the GA strain of MDV, although \nHEP is truncated in MDV -2 and HVT (Table 1).  The \nopen reading frames of HEP and Mys2 are highly basic \n(pI=12) and acidic (pI=~4), respectively, and have no \nknown homologs.  We currently have no clear data \nregarding the cellular localization of HEP and Mys2 \nduring infection, although fusion of GFP to HEP \nindicates that HEP may be localized to the nuclear \nmembrane.  Interestingly, HEP has a nuclear localization signal, thus further supporting the \nlocalization of GFP to the nucleus.  Oddly, both HEP \nand pp38 are quite divergent among the serotypes in \nterms of size, homology, and charge.  \nIn order to better understand the transcriptional \nexpression of pp38, HEP, and Mys2 in MDV infection, \ntranscriptional mapping analysis was performed on the \nBamHI -H/D region.  The HEP and Mys2 ORFs ma y be \nencoded by the pp38 1.8kb RNA transcript and/or may \nbe encoded by an RNA transcript other than the pp38 1.8kb RNA transcript.  To determine if HEP and Mys2 \nare encoded by a transcript other than the 1.8kb pp38 \nRNA transcript, the pp38 region (including the HEP \nand Mys2 ORF) was transcriptionally mapped using 3\u2019 \nRACE (Rapid Amplification of cDNA Ends).  The \nRACE products included the 1.8kb RNA transcript \nreported by Cui et al., (5) alternatively spliced transcripts that encoded for the full -length ORFs of \nHEP and Mys2, Mys2 alone, and non- spliced \ntranscripts that encoded for HEP.  Currently, cell lines of HEP, pp38, Mys2, and the RACE products are being \ndeveloped to study cell growth and reactivation from \nlatency.   \n \nREFERENCES  \n1. Baigent, S. J., L. J. R oss, and T. F. Davison. \nDifferential susceptibility to Marek's disease is \nassociated with differences in number, but not \nphenotype or location, of pp38+ lymphocytes. J. Gen. \nVirology 79: 2795- 2802. 1998.  \n2. Bradley, G., M. Hayashi, G. Lancz, A. \nTanaka, and  M. Nonoyama. Structure of the Marek's \ndisease virus BamHI -H gene family: genes of putative \nimportance for tumor induction. J. Virology 63: 2534-\n2542. 1989.  \n3. Calnek, B. W., and R. L. Witter. Marek's \ndisease. In:  Disease of poultry, 10 th ed.  B.W. Calnek , \ned. Iowa State University Press, Ames. pp. 369 -413. \n1997.  \n4. Chen, X. B., and L. F. Velicer. Multiple \nbidirectional initiations and terminations of transcription in the Marek's disease virus long repeat \nregions. J. Virology 65: 2445- 2451. 1991.  \n5. Cui, Z . Z., L. F. Lee, J. L. Liu, and H. J. \nKung. Structural analysis and transcriptional mapping of the Marek's disease virus gene encoding pp38, an \nantigen associated with transformed cells. J. Virology \n65:6509- 6515. 1991.  \n6. Lee, L. F., P. Wu, D. Sui, D. Ren,  J. Kamil, \nH. J. Kung, and R. L. Witter. The complete unique long sequence and the overall genomic organization of \nthe GA strain of Marek's disease virus. Proc. Natl. \nAcad. Sciences 97: 6091- 6096.  2000.  \n7. Parcells, M. S., R. L. Dienglewicz, A. S. \nAnderso n, and R. W. Morgan. Recombinant Marek's \ndisease virus (MDV) -derived lymphoblastoid cell lines: \nregulation of a marker gene within the context of the \nMDV genome. J Virology 73:1362- 1373. 1999.  \n8. Schat, K. A., and B. W. Calnek.  \nCharacterization of an apparently nononcogenic \nMarek's disease virus. J. Natl. Cancer Institute 60: \n1075- 1082. 1978.  \n9. Tulman, E. R., C. L. Afonso, Z. Lu, L. Zsak, \nD. L. Rock, and G. F. Kutish. The genome of a very virulent Marek's disease virus. J. Virology 74: 7980-\n7988. 2000.   \n  \n127 10.  Witter, R. L, K. Nazerian, H. G. Purchase, \nand G. H. Burgoyne. Isolation from turkeys of a cell -\nassociated herpesvirus antigenically related to Marek's \ndisease virus. Am. J. Vet. Research 31: 525 -538. 1970.  11.  Xie, Q., A. S. Anderson, and R. W. Morgan. \nMarek's disease virus (MDV) ICP4, pp38, and meq \ngenes are involved in the maintenance of \ntransformation of MDCC -MSB1 MDV -transformed \nlymphoblastoid cells. J. Virology 70: 1125- 1131. 1996.  \n \nTable 1 . Comparison of open reading frames at the junction of the IR L and U L sequences of MDV -1 (GA and MD -\n5), MDV- 2 and HVT serotypes.   \n \n Protein    MDV- 1(GA)   MDV- 1(MD -S)  MDV- 2   HVT  \n    aa    125    125      77     79 \nHEP    pI     12.0    12.0      11.8     12.6  \n    m.w.    14.0    14.0       8.3     9.6 \n \n         aa    290    290      221     8.4 \npp38    pI     4.75    4.79      5.58    11.7  \n            m.w.    31.1    31.2      23.4     8.6 \n \n    aa    126    127      129      130  \nMys2  pI     3.73    3.73      4.0       4.14 \n    m.w.    13.9    13.9      14.5      13.8  \n \n \nSUSCEP TIBILITY OF ADULT CHICKENS TO MAREK\u2019S DISEASE  \n \nSUSCEPTIBILIDAD DE LOS POLLOS ADULTOS A LA ENFERMEDAD  \nDE MAREK  \n \nR. L. Witter \n \nUSDA, Agricultural Research Service, Avian Disease and Oncology Laboratory, East Lansing, MI  \n \nRESUMEN  \nLa enfermedad de Marek se presenta en parvadas de \nponedoras o reproductoras adultas, pero no est\u00e1 claro si \n\u00e9ste es el resultado de la infecci\u00f3n reciente con cepas \nde alta virulencia, o bien de una infecci\u00f3n temprana exacerbada por la inmunodepresi\u00f3n resultante del \nestr\u00e9s, u otros f actores. Nosotros desafiamos a nuestras \naves a las 18 \u00f3 90 semanas de edad con un virus \naltamente virulento de la enfermedad de Marek y \nmedimos las respuestas de lesiones y la transmisi\u00f3n \nhorizontal. Los pollos libres de pat\u00f3genos espec\u00edficos \nfueron suscep tibles a par\u00e1lisis transitoria y tumores, y \ndiseminaron al virus horizontalmente; sin embargo, los \npollos previamente vacunados o expuestos resultaron \naltamente refractarios al desaf\u00edo cuando adultos. Esto \nsugiere que no es probable que los brotes tard\u00edos se \ndeban a infecciones recientes.  \n \nINTRODUCTION  \nAge of the chicken at the time of exposure to \nMarek\u2019s disease virus (MDV) is known to influence \nthe response to infection but only in chickens of \ngenetically resistant lines (2).  Virulence of the challenge virus is also important, since highly virulent strains can induce high rates of lymphomas in \nnonvaccinated na\u00efve older chickens (6).  The effect of \nage has most frequently been evaluated by \nmeasurement of lymphoma responses.  However, \nvirologic responses ar e also influenced.  Recent studies \nshowed that in older chickens cytolytic infections were resolved more rapidly (1) and virus load is somewhat \nlower (3).  However, little information is available on \nthe influence of age on induction of transient paralysis . \nOutbreaks of Marek\u2019s disease (MD) lymphomas \nin older layer flocks have been reported (5).  Some \noutbreaks have occurred subsequent to molting, in \npreparation for a second laying cycle.  However, the factors responsible for of these \u201clate breaks\u201d are poor ly \nunderstood.  One theory (new infection) suggests that old flocks are susceptible to de novo infection with highly virulent strains, which break through existing \nlevels of immunity and cause lymphomas (4).  An \nalternate theory (old infection) suggests th at outbreaks \nare caused by virus strains long resident in the flock but exacerbated by an environmental factor, perhaps \nthrough an immunosuppressive mechanism (8).  Since  \n  \n128 chickens usually become infected early with MDV, and \nthe virus remains present in the  latent state for life, it is \nnot easy to discriminate between these possibilities.  \nThese studies are designed to examine the \nsusceptibility of adult chickens to MD exposure.  Both \nspecific -pathogen -free (SPF) and previously vaccinated \nand exposed (VE) chi ckens of susceptible laboratory \nstrains or commercial leghorn lines were used.  Exposed chickens were evaluated for clinical signs of \ntransient paralysis (TP) and for lymphoma \ndevelopment.  In one trial, transmission of virus from \ninoculated older chickens  to uninoculated contact birds \nwas measured.  Five trials were conducted.  \n \nRESULTS  \nIn trial 1, 18wk SPF chickens of the susceptible \nADOL line 15x7 were highly susceptible to both TP and MD lymphoma development when inoculated with \nor exposed by contact to 6 highly virulent strains of the vv or vv+ pathotypes.  Responses approached 100% \nand median time to lymphoma mortality was 32 -35 \ndays post exposure (vv+ only).  However, a \ncomparable VE group vaccinated with HVT at hatch \nand exposed to the JM strain of MD V (v pathotype) at \n5 weeks was very resistant to contact challenge at 18 \nwk.  No TP was observed and only 1 of 109 birds had \nMD lesions.  \nSimilar exposures of 18wk SPF birds in trial 2 \nwith 5 additional MDV strains confirmed the high \nsusceptibility to a vv+  strain (584A).  In contrast, 4 \nstrains of lesser virulence induced lesser responses.  \nNone induced TP and only one strain (JM) induced \nhigh rates of MD lesions.  This suggested that TP and \nMD responses of 18wk SPF chickens were influenced \nby viral pathoty pe. \nTrial 3 included laboratory (15x7) chickens and 3 \ndifferent commercial layer strains that were hatched in the laboratory and reared under SPF conditions in \nisolators.  Comparable VE groups were vaccinated \nwith HVT at hatch and exposed to JM at 5wk.  \nExposure was by inoculation with a vv+ strain (648A) \nat 18wk.  The 15x7 chickens responded as in previous \ntrials.  The commercial SPF lines were resistant to TP \nand fairly resistant to MD lymphomas (21 -33%).  All \nlines previously vaccinated and exposed devel oped no \nTP or MD subsequent to MDV challenge at 18wk.  \nTrials 4 and 5 utilized spent hens (60 -90wk) from \nthe laboratory flock (line 7\n1).  Most were SPF stock, \nbut VE hens were included in trial 5 from a comparable flock vaccinated at hatch with HVT and agai n at 18wk \nwith serotype 1 and 2 vaccines.  In Trial 4, challenge of \nSPF hens with 648A induced high rates of acute TP and few birds survived.  Challenge with JM or Md5 \nstrains induced no or minimal TP responses, and the \nsurvivors developed low rates of MD lymphomas.  In \nTrial 5, SPF hens challenged with 648A again developed very high rates of acute TP (accompanied by \ndeath), which prevented measurement of lymphoma \nresponses.  However, SPF hens apparently shed virus \nprior to death as indicated by the appearance of acute \nTP in SPF contacts.  Once again, VE hens were \nrefractory to TP, developed no MD lymphomas and, \nwith one exception, did not transmit virus to SPF contacts.  \n \nDISCUSSION AND CONCLUSION  \nIn conclusion, SPF birds at 18wk or older are \nhighly suscepti ble to TP, including the acute form.  The \nresponse depends on the MDV strain, with strains capable of inducing high rates of TP in young chicks \nalso able to induce high rates in old birds.  SPF birds \n18wks or older are susceptible to MD lymphomas \nwhen expo sed to highly virulent strains, providing the \nexposure does not kill too many birds from acute TP.  MDVs of lesser virulence induce only low rates of MD lymphomas in SPF birds.  Commercial strains raised \nunder SPF conditions are relatively resistant to MD \nlymphomas.  Following challenge, old SPF hens also \ntransmitted virus to SPF contacts.  \nIn contrast, VE birds at 18wk or older were \nvirtually refractory to TP or MD lymphomas when challenged with highly virulent MDV strains by \ninoculation or by contact.  Fur thermore, in 1 trial, VE \nchickens transmitted virus to SPF contacts with very \nlow efficiency, suggesting that replication of the \nchallenge virus in the feather follicle epithelium was \nlimited.  These results suggest that \u201clate breaks\u201d do not likely result from de novo infection of previously \nvaccinated and exposed adult chickens, even with highly virulent strains, and suggest that other factors are probably involved.  Some immunosuppressive and \nstress factors that interfere with MD immunity are \nalready know n (7) but specific factors associated with \n\u201clate breaks\u201d have not yet been identified.  \n \nREFERENCES  \n1. Buscaglia, C., B.W. Calnek, and K.A. Schat.   \nEffect of immunocompetence on the establishment and \nmaintenance of latency with Marek's disease \nherpesvirus.   J. Gen. Virol.  69:1067- 1077.  1988.  \n2. Calnek, B.W.  Pathogenesis of Marek's \ndisease virus infection. In:  Current Topics in \nMicrobiology and Immunology. K. Hirai, ed.  \nSpringer -Verlag,  Berlin. pp. 25 -56. 2001.  \n3. Davison, T.F., S.J. Baigent, M. Rennie, and \nN. Bumstead.   Age- and strain -related differences in \nthe quantity of Marek's disease virus in different sub -\npopulations of lymphocytes.   Avian Pathol.  27:S88-\nS88. 1998.  \n4. Kreager, K.  Marek's Disease: Clinical \nAspects and Current Field Problems in Layer \nChic kens. In:  Diagnosis and control of neoplastic  \n  \n129 diseases of poultry. A.M. Fadly, K.A. Schat and J.L. \nSpencer, eds.  American Association of Avian \nPathologists,  Kennett Square, PA. pp. 23- 26. 1997.  \n5. Lucio -Martinez, B.  Impact of vv Marek's \ndisease on mortali ty and production in a multiple -age \nfarm. In:  Proceedings of the 48th Western Poultry \nDisease Conference. pp. 55 -56. 1999.  \n6. Rosenberger, J.K., S. S. Cloud, and N. \nOlmeda -Miro.  Epizootiology and adult transmission of \nMarek's disease. In:  Diagnosis and con trol of neoplastic diseases of poultry. A.M. Fadly, K.A. Schat \nand J.L. Spencer, eds.  American Association of Avian \nPathologists,  Kennett Square. pp. 30- 32. 1996.  \n7. Schat, K.A.   Marek's Vaccination Breaks.   \nVineland Update  February:1 -4.  1992.  \n8. Witter, R .L.  Protective efficacy of Marek's \ndisease vaccines. In:  Current Topics in Microbiology and Immunology. K. Hirai, ed.  Springer -Verlag,  \nBerlin. pp. 58 -90. 2001.  \n \nINFLUENCE OF MAREK\u2019S  DISEASE VACCINES ON THE \nRESPONSE OF COMMERCI AL BROILER BREEDER CHICKE NS \nTO INFECTION WITH SUBGROUP J AVIAN LEUKOSIS VIRUS  \n \nINFLUENCIA DE LAS VACUNAS CONTRA LA ENFERMEDAD DE MAREK \nSOBRE LA RESPUESTA DE LAS REPRODUCTORAS PESADAS A LA \nINFECCI\u00d3N CON EL VIRUS DE LA LEUCOSIS AVIAR, SUBGRUPO J  \n \nAly M. FadlyA, Jody K. DybingA and A run K. PandiriB \n \nAUSDA -Agricultural Research Service, Avian Disease and Oncology Laboratory, East Lansing, Michigan  \nBDepartment of Pathobiology and Diagnostic Investigation, Michigan State University, East Lansing, Michigan \n \nRESUMEN  \nSe inocularon l\u00edneas d e reproductoras pesadas y \nl\u00edneas experimentales con la cepa ADOL -Hc1 del virus \nde la leucosis aviar, subgrupo J (ALV -J) al nacer, y \ntambi\u00e9n se vacunaron contra la enfermedad de Marek usando los serotipos 1, 2 \u00f3 3. A las 32 semanas de edad, la incidencia de viremia con el ALV -J en los \npollos vacunados con virus herpes de pavo ( HVT ) vari\u00f3 \nde 0 a 100%, dependiendo de la l\u00ednea gen\u00e9tica. Dicha incidencia, en los pollos de una l\u00ednea comercial fue \nsignificativamente mayor en los grupos vacunados con \nuna vacuna del  serotipo 1 del virus de la enfermedad de \nMarek que en los que recibieron el HVT  o vacunas \nbivalentes que conten\u00edan el serotipo 2. La incidencia de \ntumores causados por el ALV -J en los pollos de una de \nlas tres l\u00edneas comerciales probadas fue \nsignificativa mente mayor en los grupos vacunados con \nel serotipo 1 del virus de la enfermedad de Marek que en los otros tratamientos.  \n \nABSTRACT  \nChickens of three commercial broiler breeder \nlines and two experimental lines were inoculated with \nstrain ADOL -Hc1 of subgrou p J avian leukosis virus \n(ALV -J) at hatch; chickens were also vaccinated with serotype 1, 2 or 3 Marek\u2019s disease (MD) vaccines. \nVaccinated and unvaccinated, ALV -J-infected chickens \nwere monitored for ALV -J induced infection and \ntumors through 32 weeks of a ge. At 32 weeks of age, \nthe incidence of ALV -J viremia in chickens vaccinated \nwith herpesvirus of turkeys (HVT), a serotype 3 MD \nvaccine virus varied from 0% to 100%, depending on \nline of chickens. Whereas, the incidence of ALV -J \nviremia in chickens of one  commercial line was \nsignificantly higher in groups vaccinated with a serotype 1 MD vaccine virus than those vaccinated \nwith HVT or bivalent vaccines containing serotype 2 \nMD virus.  \nAlso, the incidence of ALV -J tumors in chickens \nof 1 of 3 commercial line s tested, was significantly \nhigher in groups vaccinated with serotype 1 MD \nvaccine virus than in unvaccinated groups or groups \nvaccinated with HVT or bivalent vaccines. Results suggest that MDV vaccines may influence ALV -J \ninfection and tumors, but only in certain lines of \nchickens.  \n \n(The full -length article will be submitted for \npublication in Avian Diseases)  \n \n \n \n  \n  \n130 CAPTURA DE ANT\u00cdGENO CONTRA EL VIRUS DE LEUCOSIS \nAVIAR EN DISTINTOS \u00d3RGANOS DE POLLO DE ENGORDA  \n \nANTIGEN CAPTURE AGAINST AVIAN LEUKOSIS VIRUS IN DIFFERENT \nBROILER ORGANS  \n \nMireya Ju\u00e1rez 1,V\u00edctor M. Petrone 1, Ruben Merino1 , Tamas Fehervari1  \n   \n1Departamento de Producci\u00f3n Animal: Aves, Facultad de Medicina Veterinaria y Zootecnia, UNAM  \n \nSUMMARY  \nAvian leukosis (LA) is retrovirus -caused disease \nthat affects adult or sexually mature domestic birds. \nThe most important viral subgroups are A, B, C, D, J \nand E. The purpose of this study was to determine the organ in which p27 antigen of LA virus is most \nfrequently detected, using an antigen -capture ELISA \nkit in 1 -7-week -old broilers. Results showed that the \norgan with the most frequent detection was the bursa of Fabricius, followed by the intestine and the spleen.  \n \nRESUMEN  \nLa Leucosis aviar (LA) es una enfermedad viral \nque afecta a aves adultas o sexualmen te maduras, esta \nenfermedad es ocacionada por un retrovirus en aves \ndomesticas los subgrupos mas importantes son el \nA,B,C,D,J y E. El presente estudio tuvo como objetivo \ndeterminar el \u00f3rgano en que con mayor frecuencia se \ndetecta el ant\u00edgeno p27 de LA, med iante el uso de un \nKit ELISA de captura de ant\u00edgeno, en pollos de \nengorda de 1 -7 semanas de edad. Los resultados \nmostraron que el \u00f3rgano donde se tuvo mayor \nporcentaje de detecci\u00f3n fue la Bolsa de Fabricio \nseguido de intestino y bazo.  \n \nINTRODUCCI\u00d3N  \nLa Leuc osis Linfoide (LL)es descrita como una \nenfermedad neopl\u00e1sica, que se manifiesta en aves semi \nadultas o sexualmente maduras La LL es una enfermedad producida por un virus de la subfamilia \noncoviridae perteneciente a la familia retroviridae, que \nha sido clas ificado en 6 subgrupos A,B,C,D,J y E que \nson los causantes de las principales neoplasias en aves. \nEl virus esta presente en la saliva, heces, semen y alb\u00famina de los huevos de las aves, los cuales son una \nfuente de infecci\u00f3n que puede ser aprovechada por \nalgunos fomit\u00e9s, como los artr\u00f3podos, para diseminar \nla infecci\u00f3n en otras \u00e1reas. En los animales infectados \ncon LL se observa una disminuci\u00f3n en la producci\u00f3n \nde huevos, disminuci\u00f3n en la calidad del semen e incremento de la mortalidad no especifica. Los s ignos \nexteriores de la enfermedad no son espec\u00edficos; la \ncresta puede estar descolorida, arrugada y \nocasionalmente cian\u00f3tica. La inapetencia y el cansancio ocurren frecuentemente, el abdomen por lo general se encuentra expandido y las plumas a veces \nest\u00e1n punteadas con uratos o pigmentos biliares. El \ncrecimiento del h\u00edgado, la bolsa de Fabricio y los \nri\u00f1ones casi siempre puede detectarse por palpaci\u00f3n.  La muerte del ave generalmente sobreviene por el \ncrecimiento progresivo de las neoformaciones e infeccion es bacterianas secundarias, toxemias, \nhemorragias o difusi\u00f3n de un \u00f3rgano afectado por el \ntumor. La alteraci\u00f3n mas caracter\u00edstica es un agrandamiento difuso del h\u00edgado, bazo y en menor \ngrado de los ri\u00f1ones. Los tumores se observan \ngeneralmente en el h\u00edgado , bazo, bolsa de Fabricio y a \nveces en los ri\u00f1ones, g\u00f3nadas y mesenterio; debido a \nuna multiplicaci\u00f3n anormal y migraci\u00f3n de linfoblastos \na estos \u00f3rganos. Generalmente las aves retrasadas son \ninmunol\u00f3gicamente deficientes y potenciales focos de \ninfecci\u00f3n; el subgrupo J del virus de la Leucosis aviar \n(LA) ha coincidido con el incremento de este tipo de \npollos  en granjas y se le atribuye a este virus  ser el \ncausante  del problema. No obstante, es tambi\u00e9n \nposible que este problema sea originado por otras causas, principalmente fallas de manejo. El objetivo de \neste estudio fue determinar el \u00f3rgano en que con mayor frecuencia se detecta el ant\u00edgeno p27 de LA, mediante \nel uso de un Kit ELISA de captura de ant\u00edgeno.  \n \nMATERIAL Y M\u00c9TODOS  \nLas muestras utilizadas fueron tomadas de pollos \nde engorda de 1 -7 semanas de edad, correspondientes a \ncasos aislados. Los \u00f3rganos evaluados fueron h\u00edgado, \nbazo, bolsa de Fabricio, timo, medula \u00f3sea e intestino; estos \u00f3rganos fueron macerados y diluidos con \nsoluci\u00f3n amortiguadora de  fosfatos (diluci\u00f3n 1:10 \npeso:volumen) y mantenidos en congelaci\u00f3n por 24 \nhoras a \u2013 4\noC. El sobrenadante fue utilizado para la \ndetecci\u00f3n de la p27 mediante el uso de un Kit ELISA de captura de ant\u00edgeno para LA (Synbiotics \nCorporation). Adem\u00e1s se analizaron los sueros de aves \nde la misma edad para la determinaci\u00f3n de anticuerpos contra el subgrupo J de LA .Estos Kits comerciales de \nELISA cuentan con placas de microtitulaci\u00f3n \nrevestidas con anticuerpos antip27. La prueba ELISA \nse llev\u00f3 a cabo como se describe:   del sobrenadante de  \n  \n131 los macerados de los \u00f3rganos diluidos 1:10, se \ntransfirieron 50\u00b5l de cada muestra a la placa ELISA, \ndonde se coloco previamente 50\u00b5l de soluci\u00f3n buffer \nen cada micropozo Despu\u00e9s de 30 minutos de \nincubaci\u00f3n y un proceso de lavado, se a \u00f1adieron 100\u00b5l \nde conjugado a cada micropozo. Despu\u00e9s de 30 minutos de incubaci\u00f3n y otro proceso de lavado, se colocaron 100\u00b5l de crom\u00f3geno substrato a cada \nmicropozo. Despu\u00e9s de 15 minutos se agregaron 100\u00b5l \nde soluci\u00f3n inhibidora para detener el desarrol lo de \ncolor. La intensidad de color desarrollado se relaciona \ndirectamente con el nivel de ant\u00edgeno presente en la \nmuestra. Las placas ELISA se leyeron a 405nm con un lector ELISA Dynathec MR650. Los valores de \ndensidad optica (DO) se convirtieron en t\u00edtul os ELISA \ncon el software ProFILE para windows\u00ae (Synbiotics \nCorporation).  Para la determinaci\u00f3n de anticuerpos los \nsueros fueron diluidos 1:50 y el mecanismo de las \nprueba fue el descrito previamente.  \n \nRESULTADOS  \nLos  resultados fueron expresados solo como  \npositivos y negativos, en la semana 1 se analizaron 15 \nsueros de los cuales 1/15 resulto positivo, para esta \nsemana se detecto la p27 de bazo (2/4), bolsa de \nFabricio(6/14 )y m\u00e9dula \u00f3sea (2/4). En la semana 2 se \nanalizaron 8 sueros y 2/8 fueron positivos,  la captura \nde ant\u00edgeno fue positiva para bolsa de Fabricio (2/4) y \nm\u00e9dula \u00f3sea (1/4). Semana 3 se evaluaron 2 sueros los \ncuales resultaron negativos, para captura de ant\u00edgeno \nfue positiva para: bazo (1/3), h\u00edgado (1/3), bolsa de Fabricio (1/3), timo (1/3)  e intestino (2/3). Semana 4 se \nanalizaron 3 sueros los cuales resultaron negativos, \npara captura de ant\u00edgeno los \u00f3rganos positivos fueron: \nbazo (2/3), h\u00edgado (1/3), bolsa de Fabricio (1/3), timo \n(1/3) e intestino (1/3). De la semana 5 a la 7 los \nresultado s de ELISA tanto para detecci\u00f3n de \nanticuerpos como para captura de ant\u00edgeno fueron \nnegativos. En esta evaluaci\u00f3n fueron analizadas un \ntotal de 50 bolsas de Fabricio de las cuales 14 fueron \npositivas para la captura de ant\u00edgeno representando este el 28%, de 40 bazos 7 fueron positivos representando \nel 17.5%, de 8 m\u00e9dulas \u00f3seas 3 fueron positivas \nrepresentando 37.5%, de 30 h\u00edgados 5 fueron positivos representando el 16.6% y de 30 muestras de intestino 7 \nfueron positivas representando el 23.3%.  De 188 \nmuestr as de \u00f3rganos el 7.4% de positivos \ncorrespondieron a bolsa de Fabricio, el 3.7% a bazo, 3.7% a intestino, 2.6% a timo, 2.6%  a h\u00edgado  y 1.5% \na m\u00e9dula \u00f3sea.  \n \nCONCLUSIONES Y DISCUSI\u00d3N  \nLos resultados obtenidos indican los \u00f3rganos \ndonde se detecto en mayor porcentaje el ant\u00edgeno p27 \nfueron: bolsa de Fabricio, intestino, bazo. Sin embargo \nm\u00e9dula \u00f3sea fue el \u00f3rgano en el que se observo mayor \nporcentaje de captura, aunque solo se analizaron 8 \nmuestras de las cuales 3 fueron positivas representando \nel 37.5%. En cu anto a los resultados obtenidos de la \nsemana 5 a la 7 de edad no se puede concluir si el virus \nde Leucosis aviar fue eliminado de las aves por el \nsistema inmune, ya que estos datos corresponden a \naves de distintas casetas y granjas. Sin embargo estos \ndatos  pueden dar pie a la realizaci\u00f3n de una \ninvestigaci\u00f3n controlada en donde se valore la \nrespuesta inmune contra el virus de leucosis aviar y se \ncorrelacionen los t\u00edtulos de anticuerpos obtenidos con \nlos resultados de captura de ant\u00edgeno.  \n \nREFERENCIAS  \n1. Fadly , A.M. and Witter R.L. \nOncornaviruses: Leukosis/Sarcoma and \nReticuloendotheliosis. In: A laboratory manual for the \nisolation and identification of avian pathogens, D.E. Swayne, J.R. Glisson, M.W. Jackwood, J.E. Pearson, \nW.M. Reed, eds. Kendall/Hunt Publish ing Company, \nPennsylvania. pp 185 -196. 1998.  \n2. Payne L.N. and Purchase H.G. \nLeukosis/Sarcoma Group. In: Diseases of Poultry, \nCalnek, B.W. Barnes, H.J. Beard, C.W. Reid, W.M. Yorder, Jr. H.W. eds. Iowa State University Press, \nAmes, Iowa, USA. pp 386- 439. 2000  \n3. Thayer S.G. and Beard C.W. Serologic \nProcedures. In: A laboratory manual  for the isolation \nand identification of avian pathogens, D.E. Swayne, \nJ.R. Glisson, M.W. Jackwood, J.E. Pearson, W.M. \nReed, eds. Kendall/Hunt Publishing Company, \nPennsylvania. pp 2 55-266. 1998.  \n \n \n \n \n \n \n    \n  \n132 MONITOREO DE SALUD G ASTRO -INTESTINAL  \n EN EL POLLO DE ENGOR DA \n \nMONITORING THE GASTROINTESTINAL (GI) HEALTH IN BROILERS  \n \nCarlos A. Vega Salda\u00f1a, MVZ, MAS, MSA, EPAA.  \n \nAlpharma. Av. Lazaro Cardenas 3478, Col. Jardines de los Arcos, Guadalajara, Jalisco. C.P. 44500. Mexico.  \ncarlos.vega@alpharma.com  \n \nSUMMARY  \nAny agents able to alter the normal function in the \ndigestive system will result in poor nutrient utilization. \nA method to monitor t he GI health has been developed \nby Alpharma in order to evaluate and resolve birds\u2019 GI \ntact problems. The method uses bird necropsies as the \nbasis to grossly observe GI organ traits, as well as the \nuse of the Mc Master technique for Eimeria spp. oocyst \ndetection. The methodology described herein allows us \nto provide information for the decision -making process \nwithin poultry companies.  \n \nRESUMEN  \n Cualquier  agente que altere la funci\u00f3n normal \ndel sistema digestivo traera como consecuencia final \nuna mala utilizaci\u00f3n de nutrientes. El monitoreo de \nsalud gastro -intestinal ha sido desarrollado por \nAlpharma para evaluar y dar soluciones a problemas \ndel tracto gastro -ent\u00e9rico de las aves.  El m\u00e9todo tiene \ncomo base la necropsia de las aves observando \ncaracter\u00edsticas  macrosc\u00f3picas de los organos del \nsistema gastro -intestinal y el uso de la t\u00e9cnica de Mc \nMaster para la detecci\u00f3n de oocistos de Eimeria spp. \nLa metodolog\u00eda aqu\u00ed descrita nos permite aportar informaci\u00f3n al proceso de toma de decisiones en las \nempresas av\u00edc olas.  \n \nINTRODUCCI\u00d3N  \nLos insumos de mayor costo en la producci\u00f3n del \npollo de engorda entran por el aparato digestivo. Ah\u00ed \nlos nutrientes son preparados para ser absorbidos y \nposteriormente integrados a las necesidades de \nmantenimiento y producci\u00f3n de las a ves. El sistema \ndigestivo del pollo esta constantemente siendo desafiado por diversas etiologias. El organismo responde a estos agentes tratando de lograr un \nequilibrio sin alterar las funciones normales de este \nsistema.  \nExisten una gran diversidad de age ntes pat\u00f3genos \nque causan que se modifique el estado de homeostasis \nexistente en el tracto gastro -intestinal del pollo de \nengorda. Cualquier  agente infeccioso o no infeccioso \nque altere la funci\u00f3n del sistema digestivo traera como \nconsecuencia final una m ala utilizaci\u00f3n del principal \ninsumo usado en la producci\u00f3n av\u00edcola.  La salud aviar de las parvadas se eval\u00faa en visitas \nrutinarias a granjas, sin embargo las observaciones \nrutinarias carecen de una metodolog\u00eda de evaluaci\u00f3n  e \ninterpretaci\u00f3n teniendo como  consecuencia final la \nfalta de registro del evento observado.  \nDesde 1993 se ha utilizado en M\u00e9xico un sistema \nde monitoreo de la salud de la parvada (Necropsy \nInformation Management System o NIMS). Este \nmonitoreo tiene como m\u00e9todo el ave indicadora \naleat oria, escore de lesiones macrosc\u00f3picas y t\u00e9cnica \nde Mc Master para detecci\u00f3n de oocistos de Eimeria \nspp. En  1996 se ha comenz\u00f3 a utilizar en M\u00e9xico el \nSistema de Monitoreo de Salud Aviar (SMS) como una herramienta para monitorear las tendencias de salud \naviar y como una ayuda en el proceso de toma de \ndecisiones.  \nEn las visitas de campo que se realizan a gerentes \nde producci\u00f3n de las empresas av\u00edcolas ha surgido la \nnecesidad de establecer una base de datos para \nmonitorear la salud gastro -intestinal de las p arvadas \nutilizando el m\u00e9todo de necropsias como una herramienta de campo para analizar de manera r\u00e1pida y \nefectiva la presencia de agentes da\u00f1inos en el sistema \ndigestivo de las aves.  \nEl monitoreo de salud gastro -intestinal ha sido \ndesarrollado por Alpharm a a partir del SMS para \nevaluar y dar soluciones a problemas del tracto gastro -\nent\u00e9rico de las aves.  \nEl objetivo del presente trabajo es el de ofrecer \nuna metodolog\u00eda para evaluar y dar seguimiento a situaciones anormales en el tracto gastro -intestinal del \npollo de engorda.  \n \nMATERIAL Y M\u00c9TODOS  \nGranjas: Junto con los gerentes de producci\u00f3n y \nt\u00e9cnicos se realiza una selecci\u00f3n de granjas a evaluar.  \nAnimales: Las edades de evaluaci\u00f3n comienzan \ndesde los 14 d\u00edas hasta aves que esten por salir a rastro. \nSe seleccionan de 6 a 10 aves sanas por caseta a \nevaluar. Se evita tomar aves enfermas o remolachas debido a que estas no son una muestra representativa \ndel estado de salud de la parvada. El sacrificio de las \naves se realiza por sangrado y se procede a la \nidentific aci\u00f3n de las aves.   \n  \n133 Necropsias: Se retira desde es\u00f3fago hasta recto \ncolocando la muestra en agua. Se procede a tomar una \nmuestra de contenido intestinal de recto y de sacos \nciegos. Esta muestra se guarda individualmente en \nbolsas de pl\u00e1stico previamente ide ntificadas. Una vez \ntomadas las muestras de contenido intestinal se almacenan en temperatura de refrigeraci\u00f3n hasta su proceso.  \nSe realiza observaci\u00f3n de cavidad oral, \nproventr\u00edculo, intestino anterior, intestino posterior, sacos ciegos e h\u00edgado.  Es recom endable utilizar una \nlupa o vidrio de aumento para facilitar la exploraci\u00f3n.  \nPara la evaluaci\u00f3n de Eimeria spp  se utiliza el \nm\u00e9todo descrito por Johnson y Reid (1970).  \nUna vez realizadas las necropsias se procede a \nevaluar las muestras individuales de cont enido \nintestinal con la t\u00e9cnica de Mc Master para realizar \nconteos de oocistos de Eimeria spp . \nPreparaci\u00f3n de la muestra de contenido intestinal: \nSe toman 2 gramos de contenido intestinal y cecal. Esto se coloca en el recipiente Mc Master identificado \npara la ave en evaluaci\u00f3n. Al recipiente Mc Master se \nle adiciona soluci\u00f3n salina saturada para evitar que los \noocistos se destruyan. Se tapa el frasco y se agita \nsuavemente. La muestra se deja reposar por 3 a 5 minutos, transcurrido este tiempo se coloca una gasa en \nel interior del recipiente para que se filtre el material que no permite analizar adecuadamente su lectura. Con un gotero se toma la parte superior del recipiente \nl\u00edquido que ser\u00e1 vaciado en la c\u00e1mara de Mc Master.  \nEvaluaci\u00f3n microsc\u00f3pica: Se procede al recuento \nde oocistos por medio de un microscopio \u00f3ptico con el \nobjetivo de 10X. Los conteos son registrados en la hoja \nde captura de datos.  \nHoja de captura de datos: Los datos de necropsias  \nson capturados junto con los datos generales de la \ngranja c omo son fecha de visita, nombre de la empresa, \noperaci\u00f3n productiva, nombre o n\u00famero de granja, hora \nde visita, identificaci\u00f3n de la caseta, edad y sexo de las \naves. En esta hoja se vac\u00edan los datos observados a \npartir de lesiones macrosc\u00f3picas y de los re sultados del \nMc Master. Adem\u00e1s se registran comentarios generales \nde lo obsevado durante la visita a las casetas evaluadas. \nSe registran muestras en caso de haber obtenido \nmuestras o alimento para laboratorio.  \nEsta t\u00e9cnica se hace abarcando varias edades y  el \nseguimiento adecuado es cada 30 d\u00edas. Las necropsias y la colecci\u00f3n de datos pueden ser realizadas en la \ngranja en observaci\u00f3n o bien en un laboratorio al que \nson transportadas las aves.  \nEs recomendable el integrar la mayor cantidad de \ndatos de producc i\u00f3n y sanitarios de las parvadas \nevaluadas.  \nSoftware: La base de datos funciona a base de \nExcel 97 (Ambiente Windows) debido a que es un programa f\u00e1cil de usar y que nos permie realizar tablas \ny gr\u00e1ficos de manera r\u00e1pida.  \n \nINTERPRETACI\u00d3N DE RESULTADOS  \nLeng ua negra: 0= negativo, 1= positivo  \nLesiones orales: 0= negativo, 1= positivo.  \nConsumo de Cama: 0= <25% de cama en molleja, \n1= > del 25% de cama.  \nErosiones de molleja: 0=normal, 1= 25% erosi\u00f3n, \n2= 50% erosi\u00f3n, 3= 75% erosi\u00f3n, 4= lesiones en capa \nmuscular.  \nProventr\u00edculo: 0= normal, 1= gl\u00e1ndulas inflamadas, \n2= gl\u00e1ndulas inflamadas y alargadas, 3= gl\u00e1ndulas muy alargadas y fl\u00e1cidas.  \nIntestino: 0= normal, 1= enteritis ligera en parte \nanterior, 2= enteritis moderada hasta parte media, 3= enteritis severa hasta parte posterior.  \nContenido mucoide: 0=negativo, 1= exceso de \nmoco en intestino.  \nContenido acuoso: 0= negativo, 1= positivo.  \nAlimento sin digerir: 0= negativo, 1= positivo \n(alimento sin digerir en recto).  \nCicatrices intestinales: 0=negativo, 1= positivo.  \nLesiones Macrosc\u00f3picas de Eimeria spp : \nE. acervulina : 0= normal, 1= <5 esquizontes por \ncm\n2, 2= >5 esquizontes por cm2, 3= esquizontes \ncoalescentes, 4= esquizontes coalescentes y mucosa muy afectada.  \nE. tenella : 0= normal, 1= petequias en sacos ciegos \nsin sangr e en contenido, 2= sangre en contenido cecal, \n3= sangre en contenido cecal + tiflitis, 4= sangre + \nmaterial caseoso en contenido cecal + tiflitis.  \nE. maxima : 0= normal, 1= enteritis + poco material \namarillento en intestino, 2= enteritis + material \namarille nto en intestino + petequias, 3= enteritis + \ncontenido naranja + moco y petequias, 4= enteritis + contenido naranja en mayor cantidad + moco + \npetequias.  \nValores en conteo de oocistos en Mc Master \nindividual (oocistos por gramo de heces): 0 \u2013  2,000 = \nBuen control de coccidia, >2,000 \u2013 20,000 = Infecci\u00f3n \n+,  >20,000 \u2013  50,000= infecci\u00f2n ++, >50,000 \u2013  \n100,000= infecci\u00f2n +++ y > 100,000= infecci\u00f2n ++++.  \nSoftware: La aplicaci\u00f2n en Excel realiza los \nc\u00e1lculos estad\u00edsticos y reporta tablas de resultados por \ngranja examinada. Se pueden obtener gr\u00e1ficos de \nmanera inmediata.  \n \nCONCLUSION  \nEl monitoreo de Salud -gastrointestinal debe de \nser una una de las actividades prioritarias de cada \nempresa productora de pollo de engorda. La correcta \nevaluaci\u00f3n de lo observado con est a t\u00e9cnica nos \nayudara a evaluar da\u00f1os al sistema digestivo con \nconsecuencias en desempe\u00f1o productivo. La \nmetodolog\u00eda aqu\u00ed descrita nos permite aportar  \n  \n134 informaci\u00f3n al proceso de toma de decisiones en las \nempresas av\u00edcolas. Se recomienda incluir esta \nmetodol ogi\u00e1 en los procesos de capacitaci\u00f3n y \nentrenamiento de personal involucrado en producci\u00f3n \nde pollo de engorda.  \n \nREFERENCIAS  \n1. Acevedo, H. A.; Romero, C.E. y Quintero, \nM.M. Manual de pr\u00e1cticas de parasitolog\u00eda y \nenfermedades parasitarias. F.M.V.Z. -  U.N.A.M.  1990.  \n2. Braunius, W.W. Monitoring the biological \nperformance in broilers, with special regard to \nsubclinical Coccidiosis. Arc. Gef. 44: 183- 187. 1980.  \n3. Braunius, W.W. Management strategy and \nmonitoring. World Poultry. Coccidiosis (2):11 -12. \n1996.  \n4. Conway, D. Effects of different levels of \noocyst inocula of Eimeria cervulina , E. maxima  and E. \ntenella  on plasma constituents, packed cell volume, \nlesion scores and performance in chickens. Av Dis. 37: \n118-123. 1993.  5. Long, P. and Reid, M. A guide for the \ndiagnosis o f Coccidiosis in chickens. University of \nGeorgia. Research report 404: 1 -17. 1982.  \n6. Payne, A.M., Ring, A.W., Watkings, K.L., \nLouw, P.J., Trites, J.D., Rings, B.S., Stayer, P.A. and Rossi, A.R. The use of computer managed databases to \nmonitor enteric health trends in the U.S. broiler industry. Proc. 39\nth AAAP Annual meeting. Luoisville, \nKY. 9 -10. 1996.  \n7. Vega, S.C.A. The use of a database for \npoultry health monitoring in Mexico. Proceedings WPDC. 11 -12. 1998.  \n8. Vega, S.C.A. Una metodolog\u00eda para el \nmonitoreo en c ampo de las especies de Eimeria spp  \nque afectan al pollo de engorda. XVII Congreso \nLatinoamericano de Avicultura. 2001.  \n9. Voeten, A.C. and Braunius, W.W. \nSubclinical coccidiosis in broilers: A comparative \ninvestigation of detection methods. Archiv f Geflugel k. \n45: 189- 193. 1981.  \n10. Williams, R.B. The epidemiology of \nCoccidiosis in chickens. World Poultry. Coccidiosis \n(2):9 -10. 1996.  \n \nCOMPORTAMIENTO DE LA ELIMINACI\u00d3N DE OOQUI STES \nCOMO HERRAMIENTA EN LA EVALUACI\u00d3N DE UNA VACUNA \nCONTRA LA COCCIDIOSI S AVIAR \nEN AVES  REPRODUCTORAS  \n \nOOCYST SHEDDING AS A TOOL IN THE EVALUATION OF A COCCIDIAL \nVACCINE IN BREEDERS  \n \nJos\u00e9 Jes\u00fas Cabriales Jim\u00e9nez  \n \nDepartamento T\u00e9cnico. Boehringer Ingelheim Vetmedica, Calle 30 N\u00b0 2614 Zona Industrial, Guadalajara Jalisco. \n44940, E -mail: jcabrial@gua.boehringer -ingelheim.com  \n \nSUMMARY  \nFresh feces and litter samples from breeders \nvaccinated against coccidiosis in the hatchery were \nobtained. Vaccination was orally given using a gel \ncontaining viable Eimeria  spp. oocysts. Oocyst \nshedding in fresh f eces peaked by the 3 rd week, and it \ndecreased in subsequent samplings. Oocyst counts in litter did not show a consistent pattern as that observed in the feces. Oocyst counts together with productive \nperformance of the birds can be used as an aid to \npredict  whether immunity exists against different \nEimeria  species, and whether the flock is protected \nagainst coccidiosis.  \n RES\u00daMEN  \nSe tomaron muestras de heces frescas y cama de \naves reproductoras vacunadas contra la coccidiosis en la incubadora. La vacunaci\u00f3n f ue via oral con un gel \nque conten\u00eda ooquistes viables de Eimeria spp . El nivel \nm\u00e1ximo de eliminaci\u00f3n de ooquistes en heces frescas fue alrededor de la tercer semana y disminuy\u00f3 en \nsubsecuentes muestreos. Los conteos de ooquistes en \ncama no mostraron un pat r\u00f3n constante como el \nobservado en heces frescas. Estos conteos, junto con el \ncomportamiento productivo de las aves, pueden ayudar \na predecir si existe inmunidad contra las diferentes \nEimerias y la parvada est\u00e1 protegida contra esta enfermedad.  \n  \n  \n135 INTRODUCCI \u00d3N \nLa coccidiosis aviar es la enfermedad parasitaria \nm\u00e1s importante a nivel mundial debido a las p\u00e9rdidas \necon\u00f3micas que ocasiona a la industria av\u00edcola. Estas \np\u00e9rdidas son atribuibles a los altos costos de \nmedicaci\u00f3n, al pobre desarrollo de las aves y a l a \nmortalidad resultante de la enfermedad.  \nA trav\u00e9s de los a\u00f1os ha surgido un gran inter\u00e9s \nsobre la respuesta inmune de las aves hacia las \ncoccidias y con base en esto se ha desarrollado el uso \nde vacunas con ooquistes vivos. El objetivo de estas \nvacunas es  inducir inmunidad protectora durante la \nvida productiva del ave y el principio de la vacunaci\u00f3n \nse basa en la administraci\u00f3n de peque\u00f1as cantidades de \nooquistes a las aves, con el objeto de estimular al \nsistema inmune. En el estudio de esta enfermedad, no  \nse cuenta con las herramientas comercialmente \ndisponibles para evaluar el grado de inmunidad \nconferida por la exposici\u00f3n de campo o por la \nvacunaci\u00f3n. Las t\u00e9cnicas utilizadas para estudiar la \ninmunidad de las aves contra la coccidiosis demandan \nequipo y r activos muy costosos que son utilizados con \nfines de investigaci\u00f3n. Debido a que no se cuenta con \nuna prueba de diagn\u00f3stico que indique el grado de inmunidad de las aves contra la coccidiosis, en el \npresente estudio se evalu\u00f3 el comportamiento de la \nelimin aci\u00f3n de ooquistes en parvadas de aves \nreproductoras vacunadas al dia de edad con una vacuna \ncomercial. Esto con el objetivo de establecer un patr\u00f3n \nque sugiera que las aves vacunadas desarrollan inmunidad contra la enfermedad.  \n \nMATERIAL Y M\u00c9TODOS  \nSe colect\u00f3 la informaci\u00f3n necesaria para evaluar \nla inmunidad conferida por una vacuna comercial [Immucox -Reproductoras (Vetech Laboratories Inc.)] \nen diferentes parvadas de aves reproductoras criadas en \ndistintas regiones de M\u00e9xico. La vacuna contiene las \nsiguien tes especies de coccidia: Eimeria acervulina, E. \nbrunetti, E. maxima, E. necatrix  y E. tenella.  Para el \nseguimiento de dichas parvadas se procedi\u00f3 a colectar \nmuestras de heces frescas a los 5, 6, 7, 12, 13, 14, 19, \n20,  21, 29, 35 y 42 dias post -vacunaci\u00f3n . Tambi\u00e9n se \ncolectaron muestras de cama a los 12, 13, 14, 19, 20,  \n21, 29, 35 y 42  dias post -vacunaci\u00f3n.  \nEstas muestras se tomaron directamente de las \naves ejerciendo ligera presi\u00f3n en la regi\u00f3n abdominal cerca de la cloaca o bien, se colectaron heces recien \nevacuadas. Tambi\u00e9n se tomaron muestras de heces \nacumuladas en la cama en los tiempos que se \nmencionaron.  \nLas muestras se recolectaron en recipientes o \nfrascos limpios y fueron conservadas en soluci\u00f3n de Dicromato de Potasio al 2% en una relaci\u00f3n de 1: 5 \ncomo m\u00ednimo; es decir, una parte de muestra de heces \nmas cinco partes de soluci\u00f3n de Dicromato de Potasio.  AN\u00c1LISIS DE LAS MUES TRAS  \nEstas se enviaron a diferentes laboratorios de \ndiagn\u00f3stico para realizar la detecci\u00f3n y conteo de ooquistes de las heces r ecolectadas a trav\u00e9s de la \nprueba de McMaster.  \n \nRESULTADOS  \nLos resultados emitidos por el laboratorio fueron \nprocesado para su presentaci\u00f3n gr\u00e1fica y se muestran en la figura 1. El gr\u00e1fico muestra la cantidad de \nooquiste detectados por gramo de muestra eva luada \ntanto en heces frescas como en las acumuladas en la \ncama en las diferentes edades en que se colectaron.  \n \nDISCUSI\u00d3N  \nAl administrar peque\u00f1as cantidades de ooquistes \nesporulados a las aves, se estimula al sistema inmune \npara montar la protecci\u00f3n ante un  desaf\u00edo en campo. A \nnivel experimental se han llevado a cabo trabajos donde se administran peque\u00f1as dosis de ooquistes de \nEimeria spp  que afectan a las aves, y se sabe que cada \nespecie solo estimula la respuesta inmune contra la \ncual se ha inoculado, es d ecir: La respuesta montada \ncontra E. acervulina  solo proteger\u00e1 ante desaf\u00edos contra \nla misma especie y no contra E. tenella, maxima, \nnecatrix  o brunetti . Por esta raz\u00f3n es importante \nestimular la inmunidad contra las especies de coccidia \nque afectan com\u00fanm ente a las aves.  \nEn lo que se refiere a este trabajo, el \ncomportamiento observado en la eliminaci\u00f3n de los \nooquistes en las diferentes parvadas, se observa un incremento en la eliminaci\u00f3n de este par\u00e1sito conforme \na la edad de las aves. Lo anterior hace ev idente que los \npar\u00e1sitos vacunales tienen la capacidad de replicarse y \nllevar a cabo su ciclo de vida y estimular al sistema \ninmune del ave. El pico de eliminaci\u00f3n de ooquistes se \ndetect\u00f3 alrededor de la tercer de edad (20 dias) y \ndisminuy\u00f3 en el subsecuen te muestreo (29 d\u00edas de \nedad). Esto nos indica que la replicaci\u00f3n de las coccidias vacunales estimulan la respuesta inmune de \nlas aves que limita al par\u00e1sito en su replicaci\u00f3n dentro \ndel hospedero.  \nCon base en este comportamiento de la \neliminaci\u00f3n de ooqu istes y en la informaci\u00f3n \nanteriormente mencionada, podemos esperar que:  \nLas aves esten inmunes a posteriores desafios por \neste par\u00e1sito.  \nLas cepas vacunales de Eimeria spp  presentes en \nla vacuna esten constantemente estimulando la \ninmunidad de las aves co ntra este parasito.  \nQue estas mismas cepas sustituyan a la poblacion \nde coccidias presentes en la granja, es decir, cambiar la \npoblacion nativa por cepas de baja patogenicidad que \nson sensibles a los anticoccidianos.  \n  \n  \n136 REFERENCIAS  \n1. Arakawa, A. and Xie, M. Q.  Control of \ncoccidiosis in chickens. J. Protozool. Res. 3 : 31  39. \n1993.  \n2. Chapman, H.D. Biochemical, genetic and \napplied aspects of drug resistance in Eimeria  parasites \nof the fowl. Avian Path. 26: 221  244. 1997.  \n3. Danforth, H.D.: Use of live oocyst vaccines \nin the control of avian coccidiosis: experimental studies \nand field trials. International Journal for Parasitology \n28: 1099- 1109. 1998.  \n4. Lillehoj, H.S. and Lillehoj, E.P. Avian \nCoccidiosis: a review of acquired Intestinal Immunity and vaccination strategi es. Avian Dis. 44 : 408 -  425. \n2000.  5. Long, P.L.; Johnson, J.; McKenzie, M.E.; \nPerry, E.; Crane, M. ST. J. y Murray, P.K.: \nImmunization of young broiler chickens with low level \ninfections of Eimeria tenella, E. acervulina or E. \nmaxima. Avian Path. 15: 271 -  278.  (1986).  \n6. McDougald, R.L. and Reid, M.W.: \nCoccidiosis. In Diseases of Poultry. Edited by Calnek, B.W. Barnes, H.J.; Berd, C.W.; Reid, M.W. and Yoder \nJr., H.W. 10 th edition. 865 -  883. Iowa State University \nPress . Ames Iowa. U.S.A. 1997.  \n7. Nakai, Y.; Uchi da, T. y Kanazawa, K.: \nImmunization of young chickens by trickle infection \nwith Eimeria tenella. Avian Dis. 36: 1034 -  1036. 1992.\n \n \n \n   \n \n  \n \n   \n 250 100 65017850\n1595025450\n335037700\n348005460088800112200\n5150061900\n19650\n350040200\n7750\n24004850\n020000400006000080000100000120000N\u00ba de ooquistes reportados\n5 6 7 12 13 14 19 20 21 29 35 42\nEdad de las aves / Dias Post-Vacunaci\u00f3nFigura N\u00b01.- Eliminaci\u00f3n de ooquistes en aves vacunadas contra la coccidiosis aviar.\nN\u00ba de ooquistes en heces\nN\u00ba de ooquistes en cama \n  \n137 EVALUACI\u00d3N DE MORTAL IDAD, LESIONES ENT\u00c9RICAS Y \nCOCCIDIOSIS EN POLLOS DE ENGORDA TRATADOS CON \nEXCLUSI\u00d3N COMPETI TIVA Y TOLTRAZURIL  \n \nEVALUATION OF MORTALITY, ENTERIC LESIONS, AND COCCIDIOSIS IN \nCHICKENS TREATED WITH COMPETITIVE EXCLUSION AND \nTOLTRAZUR  \n \nJes\u00fas CoronaA, Jos\u00e9 Buitr\u00f3nA, Juan Carlos RojasBV\u00edctor M. PetroneB. \n \nA Bayer de M\u00e9xico SA de CV  \nB Facultad de Medici na Veterinaria y Zootecnia UNAM. 04510 M\u00e9xico DF.  \n \nSUMMARY  \nCompetitive exclusion using complete intestinal \nmicroflora in coccidia -vaccinated broilers at 1 day of \nage, together with toltrazuril, decreased coccidial \nnumbers, and did not result in detrimenta l effects on \nthe immune response. In addition, enteric lymphocyte infiltration in competitive exclusion -treated chickens \nsuggests a higher level of protection against coccidia \nand other enteric pathogens like Escherichia coli,  in the \nvaccinated chickens. B oth the enteric immune response \nand the lower amount of coccidia resulted in lower \nmortality and a lesser use of antimicrobials in 7 -week -\nold broilers.  \n \nRESUMEN  \nEl uso de Exclusi\u00f3n Competitiva con microflora \nintestinal completa en pollo de engorda y vacunado \ncontra coccidia al d\u00eda de edad, junto con el uso de \nToltrazuril disminuyo las coccidias sin detrimento de la \nrespuesta vacunal. Adem\u00e1s la infiltraci\u00f3n linfoc\u00edtica \nent\u00e9rica de los pollos con EC sugiere, una mayor \nprotecci\u00f3n contra coccidia en pollos vacu nados y \ncontra otros pat\u00f3genos ent\u00e9ricos como Echerichia coli. La respuesta inmune ent\u00e9rica, y la menor cantidad de \ncoccidias dio como resultado menor mortalidad y \nmenor uso de antimicrobianos en pollos de engorda de \nsiete semanas de edad.  \n \nINTRODUCCI\u00d3N  \nLa exclusi\u00f3n competitiva (EC) es la incapacidad \nde una poblaci\u00f3n de bacterias pat\u00f3genas para \nestablecerse en el intestino del ave debido a la \npresencia de microflora natural normal, esta microflora forma un ecosistema balanceado y din\u00e1mico (bacterias, \nsecreciones y peristaltismo) y esta formado \nprincipalmente por bacterias anaerobias. En los \nsistemas modernos de producci\u00f3n av\u00edcola es muy \ndif\u00edcil desarrollar una microflora natural debido a la \nfalta de contacto entre el pollito y la gallina madre, por lo tanto la colocaci\u00f3n de pollitos en instalaciones limpias y desinfectadas poco tiempo despu\u00e9s de nacer brinda las condiciones para que las aves tengan poca \noportunidad de adquirir la microflora intestinal que las \nproteger\u00eda de una infecci\u00f3n por enterobacterias \npat\u00f3genas como Salmonella spp (Nurmi & Rantala, \n1973), el uso de la EC a base de microflora completa, \nes el \u00fanico procedimiento basado en principios \nmicrobiol\u00f3gicos b\u00e1sicos que juega un papel integral en \nlos programas de control, que es aceptado internaciona lmente. Aun cuando el concepto se dise\u00f1\u00f3 \noriginalmente para controlar las infecciones por Salmonella spp, los experimentos han demostrado que \nlos tratamientos de EC, con microflora completa, \ntambi\u00e9n protege a los pollos de engorde, reproductores \ny pavos, c ontra cepas pat\u00f3genas de Escherichia coli, \nYersinia,  y Campylobacter spp.  Tambi\u00e9n se ha \ndemostrado que disminuye la mortalidad atribuible a enteritis necr\u00f3tica y a hepatitis, reduciendo los conteos de Clostridium perfringens . \nActualmente se destinan millon es de d\u00f3lares para \nel control de una de las enfermedades que resulta ser de las m\u00e1s importantes para la industria av\u00edcola como es el caso de la coccidiosis aviar, por lo que es de vital \nimportancia evaluar nuevos m\u00e9todos profil\u00e1cticos \ncomo la vacuna contra coccidiosis para ayudar al \ncontrol de este problema, un problema frecuente al que se enfrentan los usuarios de estas vacunas son las \nreacciones postvacunales y su repercusi\u00f3n  en la \ninmunidad conferida al ave. El toltrazuril  (TZ) es un \npotente coccidicid a que se ha usado para tratar \ncoccidiosis en pollo de engorda, ponedoras con crianza \nen piso, reproductoras y progenitoras , tambi\u00e9n se  utiliza el  TZ en programas para controlar las \nreacciones postvacunales, para cortar r\u00e1pido el brote , el efecto del pr oducto se fundamenta en la destrucci\u00f3n \nde todas las fases intracelulares del par\u00e1sito, sin \nembargo existe tambi\u00e9n la preocupaci\u00f3n err\u00f3nea por \nparte del proveedor de la vacuna de que si acepta que se use TZ en reacciones postvacunales la vacuna sea \ntotalmen te destruida provocando una subexposici\u00f3n y  \n  \n138 con ello una protecci\u00f3n incompleta, seg\u00fan Sosa 1996 el \nmecanismo por el cual el TZ destruye todas las fases \nintracelulares es afectando la cadena respiratoria y a las \nenzimas involucradas en la s\u00edntesis de la pir imidina, sin \nmodificar la estructura antig\u00e9nica de las Eimerias . La \nexposici\u00f3n antig\u00e9nica ante el sistema inmune se realiza \ny la protecci\u00f3n se establece, por otro lado las fases extracelulares no se ven afectadas y pueden infectar a \nla c\u00e9lula del epitelio intestinal en cuanto el TZ ha sido \nya eliminado permitiendo el refuerzo de la inmunidad  \nEl objetivo del presente trabajo es evaluar el \nefecto de la EC y TZ sobre la mortalidad, conteo de \nooquistes en heces e intracelulares, as\u00ed como infiltraci\u00f3n linfocita ria enterica en pollos de engorda \nvacunados contra coccidia \n \nMATERIAL Y M\u00c9TODOS  \nSe realiz\u00f3 un experimento de campo en una \nexplotaci\u00f3n comercial de pollo de engorda, con una \nduraci\u00f3n de siete semanas. Los tratamientos fueron la \naplicaci\u00f3n de EC al d\u00eda de ed ad en recepci\u00f3n asperjado \ncon gota gruesa, aplicaci\u00f3n de TZ   y Amprolio en agua \nde bebida a partir del 12o. d\u00eda de vida,  el experimento \nabarc\u00f3 del d\u00eda de edad a las siete semanas d edad de los \npollos  \nInstalaciones. Se utilizaron 6 casetas de ambiente \nnatural de 10 x 140  m de una granja de crianza de pollo \nde engorda ubicada en el altiplano mexicano.  \nPollos de engorda para la investigaci\u00f3n. El \nexperimento incluy\u00f3 84,800 pollos de estirpe Ross, vacunados contra coccidias en la incubadora v\u00eda aspersi\u00f3n. Los pollos se dividieron en las 6 casetas.  \nIn\u00f3culos. (EC). Flora intestinal completa \nproveniente de aves libres de pat\u00f3genos espec\u00edficos (Aviguard\u00ae. Bayer de M\u00e9xico SA de CV, M\u00e9xico DF) \nse utiliz\u00f3  6.25 mg por pollo (media dosis recomendada \npor el fabricante) . La flora de la EC se mezcl\u00f3 al 3% en \nagua potable libre de desinfectantes y se asperj\u00f3 1 litro \npara 4000 pollos. El Toltrazuril (Baycox\u00ae. Bayer de \nM\u00e9xico SA de CV, M\u00e9xico DF) se aplic\u00f3 diariamente \n7 mg/kg de peso vivo disuelto en el agua de bebida por dos d\u00edas. Amprolio  al 2.5% 1 lt./1000 lt de agua de \nbebida durante 4 d\u00edas. Sulfas con  trimetropim (ST)  180 \ng/1000 lt de agua durante tres d\u00edas.   \nDise\u00f1o de tratamientos.  Los se dividieron en dos \ngrupos 1 y 2, de 42,600 pollos repartidos en tres \ncasetas por grupo. Los se trataron de la siguiente \nmanera. 1) EC al primer d\u00eda de edad y TZ al d\u00eda 12 de edad. 2)  Amprolio y  ST a los 12 y 21 d\u00edas de edad \nrespectivamente.  \nRecolecci\u00f3n del dato de mortalidad y toma de \nmuestras. Semanalmente se registro mortalidad y se  \ntom\u00f3 excretas para parasitolog\u00eda, as\u00ed como \u00f3rganos en \nformalina al 10% amortiguada a Ph 7.4. Los \u00f3rganos tomados fueron secciones de parte media del asa \nproximal del duodeno, otra secci\u00f3n a un cm antes del divert\u00edculo de Meckel y otra secci\u00f3n a dos cm ant es del \nextremo de un ciego.  Tambi\u00e9n se hicieron un muestreo \nde la parte media transversal de la bolsa de cloacal \n(bolsa de Fabricio),  el pen\u00faltimo l\u00f3bulo distal del \ntimo, parte media trasversal del l\u00f3bulo derecho \nhep\u00e1tico y del l\u00f3bulo craneal renal.  \nParasitolog\u00eda. Las muestras de excretas se \nevaluaron  por medio de la t\u00e9cnica de Mac Master  \nHistolog\u00eda. Para la evaluaci\u00f3n intestinal se \ndividieron los hallazgos en mucosas en: presencia de \ncoccidias y infiltrado linfoc\u00edtico. La presencia de \ncoccidias se reali z\u00f3 el conteo del n\u00famero de estructuras \nparasitarias presentes en el epitelio, subepitelio, \ngl\u00e1ndulas y submucosa. De acuerdo al porcentaje de da\u00f1o del tejido se asigno una calificaci\u00f3n de 0 -3, \nposteriormente se obtuvo el promedio de lesiones. Para \nla calif icaci\u00f3n final si esta se encontraba entre 0.1 -1 el \ngrado de da\u00f1o era leve, de 1.1 a 2 moderado a, de 2.1 a 3 severo.  \nAn\u00e1lisis estad\u00edstico. La cantidad de aves muertas \nse evalu\u00f3 por medio de la prueba de Xi cuadrada.  La \ncomparaci\u00f3n de medias de la cantidad de coccidias en \ncama por medio de la prueba de T de Student. A los \nhallazgos histol\u00f3gicos se les aplico la prueba U de Mann Whitney.  La significancia estad\u00edstica se fij\u00f3 con \nP<0.05.  \n \nRESULTADOS  \nMortalidad.  La mortalidad a las 7 semanas de \nedad, fue sig nificativamente mayor (P<0.05) en el \ngrupo 2 con 6.54.%, ya que en el grupo 1 fue de 5.34%.  \nParasitolog\u00eda. El conteo de ooquistes en \nexcremento mostr\u00f3 mayor cantidad (P>0.05) en el \ngrupo 2 en las semanas 2, 3, 6 y 7.  \nHistolog\u00eda.  Presencia de Eimerias intr acelulares . \nEn duodeno, en el grupo 2 fue mayor solo en la semana 4 de edad. En yeyuno, el grupo 1 tuvo mayor cantidad \nde Eimerias intracelulares en la semana 1 de edad; sin \nembargo, el grupo 2 en las semanas 3 y 4. En la \nsemana 4 del grupo 2 se observaron  Eimerias \nintracelulares dentro de las gl\u00e1ndulas del yeyuno.  En \nciego, el grupo 1 solo present\u00f3 escasa cantidad de \nEimerias intracelulares en la semana 1. El grupo 2  \npresent\u00f3 Eimerias intracelulares de la semana 4 a la 7, \ncon cantidad significativa (p<0. 05) en las semanas 4 y  \n6. \nInfiltrado linfocitario . En duodeno, en el grupo 1, \nse encontr\u00f3 mayor cantidad (p<0.05) de infiltrado en la \nsemana 1, mientras que en el grupo 2 se present\u00f3 \nmayor infiltrado (P<0.05) en la semana 4. En yeyuno, \nen el grupo 1, se e ncontr\u00f3 infiltrado desde la semana 2 \nde edad; sin embargo, en la semana 4 el grupo 2 present\u00f3 mayor cantidad (P<0.05) que el grupo 1. En ciego, el grupo 1 mostr\u00f3 infiltrado linfocitario desde la \nsemana 1 de edad, siendo significativamente mayor en \nlas sema nas 1, 2  y 5; mientras que el grupo 2 exhibi\u00f3  \n  \n139 infiltrado desde la semana 3 de edad, presentando \nmayor cantidad (p<0.05) en la semana 6.  \n \nDISCUSI\u00d3N Y CONCLUSIONES  \nLa diferencia en la mortalidad entre los grupos  \nparece ser consecuencia del tratamiento apli cado al \ngrupo 1. donde la combinaci\u00f3n de la EC y TZ  jugaron un papel importante en la protecci\u00f3n del epitelio \nintestinal, la estimulaci\u00f3n antig\u00e9nica y la disminuci\u00f3n \nde poblaci\u00f3n de coccidias sobre todo en yeyuno y \nciegos a partir de la tercera semana coi ncidiendo con \nFeeding Times 1997.  \nEl conteo de ooquistes en excremento en el grupo \n1 fue menor que en el grupo 2, en la mayor\u00eda de las \nsemanas, con excepci\u00f3n de la semana 1. La escasa \ncantidad de ooquistes encontrada en el grupo 1 en la \nsemana 1 favorece l a inmunidad producida por la \nvacuna anticoccidial; sin embargo, a partir de la segunda semana se encontraron conteos bajos de ooquistes en el grupo 1, estos hallazgos son \nconsecuencia del tratamiento con TZ; mientras que en \nel grupo 2 se observa conteo alt o de ooquistes para \npollos de tres semanas de edad, por consecuencia este \ngrupo adem\u00e1s de ser tratado con amprol  recibi\u00f3 un \ntratamiento adicional con ST en la tercer semana para \ndisminuir la poblaci\u00f3n coccidial esperada en pollos de \nengorda vacunados cont ra coccidia, con lo que se logro \ntener cantidades de coccidias similares en excremento \nal grupo 1 en la semana 4.  \nEn la cantidad de Eimerias intracelulares  \nobservadas en el an\u00e1lisis histol\u00f3gico, en duodeno del grupo 1 solo se observaron Eimerias intracelu lares  en \nla quinta semana, mientras que en el grupo 2 se \nobserv\u00f3 en la cuarta y quinta. En yeyuno y ciego del \ngrupo 1 se observaron Eimerias intracelulares  en la \nprimera semana, mientras que en el grupo 2 no se encontraron Eimerias intracelulares , esto sug iere que la \ninmunidad contra Eimeria maxima y E. tenella  se \nfavoreci\u00f3 en los pollos tratados con EC; ya que despu\u00e9s \nde la semana 2 solo se encontr\u00f3 en el grupo 1 Eimerias \nintracelulares  en la semana 5 en yeyuno, sin que \nhubiera diferencias significativas con las encontradas \nen el grupo 2; mientras que en el grupo 2 se \nencontraron Eimerias intracelulares  en yeyuno de la \nsemana 3 a la semana 5 y en ciego desde la semana 4 \nhasta el final del experimento. Adem\u00e1s en el grupo 2 en \nyeyuno en la semana 4 se encontr aron E. maxima  \ninvadiendo gl\u00e1ndulas. La escasa presencia de Eimerias intracelulares  ent\u00e9ricas en el grupo 1 se puede explicar \npor la inmunidad producida por la vacuna y por el \ntratamiento de EC con TZ, aparentemente la EC favoreci\u00f3 la respuesta vacunal la primera semana, \nmientras que el TZ disminuyo la poblaci\u00f3n de \ncoccidias tanto en heces como intracelulares no afect\u00f3 \nnegativamente a la inmunidad en las semanas \nposteriores. Tambi\u00e9n en el an\u00e1lisis histol\u00f3gico se \nencontr\u00f3 infiltrado linfocitario en duodeno, las dos \nprimeras semanas en el grupo 1, lo que corresponde a una respuesta inmune vacunal ayudada por la EC, \ndespu\u00e9s de la tercera semana no hay diferencia en \ninfiltrado entre ambos grupos. El infiltrado linfocitario \nen yeyuno en el grupo 1 apareci\u00f3 desde la segunda \nsemana, mientras que en el grupo 2 inicio en la tercera \nsemana. Este infiltrado en yeyuno en la semana 3 y 4 \nfue significativamente mayor en el grupo 2 comparado \ncon el grupo 1, este hallazgo se debe a la invasi\u00f3n \ncoccidiana intracelular que en la semana 4 incluso \nllego a afectar las gl\u00e1ndulas de la mucosa del yeyuno, \nla invasi\u00f3n intracelular de coccidias en ciego se \nobservo en grupo 1 desde la primera semana siendo su \nmaxima cantidad en la semana 5. Esta gran cantidad de \ncoccidias intracelulares  cecales en la semana 5 del \ngrupo 1 se observa con ausencia de coccidias lo que \nsugiere que es debido a l tratamiento con EC. en este \nhecho la EC pareci\u00f3 jugar un papel importante para la nula colonizaci\u00f3n de coccidias en ciego.  \nMientras que en el grupo 2 a pesar de los \ntratamientos anticoccidiales se observaron coccidias de la semana 4 a la 7 en ciego, y en la semana 6 se \nencontr\u00f3 mayor infiltrado linfocitario en ciego lo que \nparece corresponder a la mayor cantidad de coccidias cecales y no a una respuesta vacunal.  \n \nREFERENCIAS  \n1. Nurmi, E. and M. Rantala. New aspects of \nSalmonella infection in broiler production.  Nature \n241:210- 211. 1973.  \n2. Sosa, J. J.,  R. Espinosa y M..A. Rebollo. \nEfecto de Toltrazuril sobre la protecci\u00f3n contra \ncoccidiosis en gallinas repro ductoras pesadas: prueba \nde campo. 45 th World Poultry Disease Conference; \n1996 3- 6 mayo; Canc\u00fan. M\u00e9xico. Asociaci\u00f3n Nacional \nde Especialistas en Ciencias Av\u00edcolas y World Poultry Disease Conference. pp.  438 -440, 1996.  \n3. Victoria G., E. Pavon, M. Rebollo, C .A. de \nTorres y R. Vazquez. Efecto del toltrazuril como tratamiento postvacunal de coccidiosis aviar en pollo de engorda en comparaci\u00f3n con amprolio, y su \nconsecuencia sobre la inmunidad. 45th Western Poultry \nDisease Conference; 1996 3 -6 mayo; Canc\u00fan. M\u00e9xi co. \nAsociaci\u00f3n Nacional de Especialistas en Ciencias Av\u00edcolas y WPDC. pp. 112- 115. 1996.  \n \n \n \n \n  \n  \n140 Cuadro 1.  Media de ooquistes de Eimeria  spp en heces e intracelulares entericas, asi como infiltrado linfocitario en \nmucosa ent\u00e9rica de pollos de engorda tratado s con exclusi\u00f3n competitiva, toltrazuril, amprolio y Sulfas con \ntrimetoprim.  \n Ooquistes en  \nHeces  Eimerias spp intracelulares  \nEnt\u00e9ricas  Infiltrado linfocitario  \n En mucosa ent\u00e9rica  \nSemana 1   Duodeno  Yeyuno  Ciego  Duodeno  Yeyuno  Ciego  \nEC1 y TZ2 200 0 0.2\u00aa 0.16 0.3\u00aa 0 0.4 \nAP3 y ST4 200 0 0b 0 0b 0 0 \nSemana 2  \nEC1 y TZ2 617\u00aa 0 0 0 0.1\u00aa 0.5\u00aa 0.5\u00aa \nAP3 y ST4 3767b  0 0 0 0a 0b 0b \nSemana 3  \nEC1 y TZ2 983\u00aa 0 0a 0 0.5 0.2\u00aa 0.5 \nAP3 y ST4 8800b  0 0.15b  0 0.4 0.9b 0.7 \nSemana 4  \nEC1 y TZ2 7400  0 0.05\u00aa  0a 0.5\u00aa 0.4\u00aa 0.8 \nAP3 y ST4 7083  0.3 0.83b  1b 0.8b 0.7b 0.6 \nSemana 5  \nEC1 y TZ2 2350  0.15 0.6 0 0.8 0.9\u00aa 2\u00aa \nAP3 y ST4 3966  0.1 0.42 0.16 0.8 1.3b 0.6b \nSemana 6  \nEC1 y TZ2 263 0 0 0a 0.7 1 0.8\u00aa \nAP3 y ST4 400 0 0 1.5b 0.7 0.7 1.3b \nSemana 7  \nEC1 y TZ2 33\u00aa 0 0 0a 0.5 0.6 0.5\u00aa \nAP3 y ST4 267b  0 0 0.5b 0.7 0.8 0.9b \nLiterales distintas dentro de la misma semana y columna indican diferencia estad\u00edsticamente significativa \n(p<0.05). 1 Exclusi\u00f3n competitiva. 2 Toltrazuril. 3 Amprolio. 4 Sulfas con Trimetropin.  \n \nUSE OF DICLA ZURIL FOR THE PREVENTION OF COCCIDIOSIS \nIN TURKEYS  \n \nEL USO DEL DICLAZURIL PARA LA PREVENCI\u00d3N DE LA COCCIDIOSIS \nEN PAVOS  \n \nLanny M. Howell  \n \nSchering -Plough Animal Health, 77 Kensington Dr., Bella Vista, AR. 72714  \n \nRESUMEN  \nEl diclazuril es un potente compues to sint\u00e9tico \nque produce un efecto coccidicida sobre las especies de \nEimeria.  Recientemente se aprob\u00f3 su uso en pavos en \nEstados Unidos bajo el nombre comercial Clinacox*. \nLos resultados de las pruebas realizadas en bater\u00eda y de \nlos trabajos confirmatorios , demostraron que el diclazuril a raz\u00f3n de 1 ppm en el campo es efectivo contra infecciones sencillas o mixtas de especies de Eimeria  en pavos. Los estudios de seguridad \ndemostraron que los pavos cuya raci\u00f3n estaba \nmedicada continuamente con 25 ppm de dicl azuril \ndurante 16 semanas, o con 100 ppm durante 7 d\u00edas \nconsecutivos, no mostraron signos anormales ni efectos  \n  \n141 colaterales. En las especies para las cuales no est\u00e1 \ndise\u00f1ado el producto (patos, caballos, conejos, bovinos \ny perros) los estudios de tolerancia  con diclazuril a \ndosis de 1 ppm o m\u00e1s no revelaron efectos adversos.  \nRecently Clinacox\uf6db was approved in the United \nStates for the prevention of coccidiosis in growing turkeys caused by Eimeria  adenoeides, E. \ngallopavonis, and E. meleagrimitis .  The active  \ningredient of Clinacox is diclazuril, which is a potent synthetic compound that produces a cidal effect on the \nEimeria species.  \n \nEFFICACY  \nNineteen battery trials were conducted in two \ngeographic locations to evaluate the efficacy of diclazuril in turkeys against single and mixed \ninfections of three Eimeria specie.  Two -week -old \nturkey poults were fed diets containing 0.0 ppm, 0.5 \nppm, 1.0 ppm or 1.5 ppm diclazuril.  Each treatment \nwas replicated at least four times and contained 10 birds per treatment grou p.  Birds were experimentally \ninfected with the appropriate Eimeria species and \nnecropsied six days later.  Variables evaluated to \ndetermine anticoccidial efficacy were reduction in fecal scores, weight gains, feed consumption, and \ncoccidiosis mortality.  A subjective scoring system to \nevaluate the litter fecal consistency which assigned a \nscore of 1 when being normal, 2 when being slightly \nwatery, 3 when being moderately water and 4 when \nbeing severely watery were used to score fecal \ndroppings.  \nThe results  from these trials demostrated that \ndiclazuril is effective at 0.5 ppm, 1.0 ppm and 1.5 ppm \nagainst single or mixed infections of Eimeria spp in \nturkeys.  The lowest dose to provide optimal \nanticoccidial efficacy is 1.0 ppm.  \nTwo floor pen trials were condu cted to confirm \nthe efficacy of 1.0 ppm diclazuril against mixed Eimeria species under simulated commercial \nconditions.  In each trial, turkeys were infected with \ndifferent field isolates of E. adenoeides, E. \ngallopavonis  and E. meleagrimitis  at 14 or 21 days of \nage.  Turkeys were fed non -medicated diets until the \ndays of challenge, and then 0 or 1.0 ppm diclazuril were administered in their diets until market weight \nwas reached.  \nIn both trials the fecal scores of diclazuril -\nmedicated group were statistical ly lower(P \u2264.001) than \nscores in the non -medicated group.  Weight gain was \ncalculated from the time of inoculation to seven days \npost infection.  Weight gains were significantly \nimproved in both trials when birds were medicated \nwith diclazuril over the non -medicated group.  The \ndiclazuril treated birds exhibited no mortality due to \ncoccidiosis, while the birds in the non -medicated \ngroups exhibited an average mortality due to coccidiosis of 14.75% and 17.6% at the locations \nrespectively.  \nTwo studies were cond ucted to confirm the safety \nand efficacy of diclazuril under commerical conditions.  \nIn the first trial, approximately 57,000 mixed- sex \n(29,000 toms and 28,000 hens) were divided between two brooder houses.  At 5 weeks of age they were \nmoved to four growout houses.  One -half of the turkeys \nwere fed 1.0 ppm diclazuril from day one of age until \nslaughter.  The other half received the standard \nanticoccidial and growth promotion feed medication \nprogram used at the site.  Hens were slaughtered at 14 weeks and to ms were slaughtered at 20 weeks of age.  \nIn the second trial approximately 11,200 tom turkeys were involved and were marketed at 18 weeks of age.  \nIn both trials, mortality, average market weight, \nnet weight marketed and feed conversion were \nimproved in the  diclazuril treated birds in spite of the \npresence of a growth promotant in the control ration.  \nNo adverse reactions or evidence of coccidiosis were \nobserved in any of the groups.  \n \nSAFETY  \nAn experiment was conducted to evaluate the \ntolerance and safety of  diclazuril in growing males and \nfemale turkeys under simulated field conditions.  \nDiclazuril was administered in the feed at 1.0 ppm, \n12.5 ppm, and 25 ppm for 16 week commercial \ngrowing period.  Turkeys treated with diclazuril were \ncompared to untreated control birds.  Tolerance and safety were evaluated and based upon: clinical \nobservations, mortality, hematology, serum \nbiochemistry and histopathology.  No significant drug-\nrelated adverse effects were observed in any of the \ntreatment groups.  \nIn another st udy, 30 turkeys were divided into 3 \ngroups of 10 birds each, and dosed in the feed at 0 ppm, 10 ppm or 100 ppm for 7 consecutive day.  Prior \nto, during and after the treatment period, no abnormal \nsigns or side -effects were observed in any of the birds.  \nAdditional studies performed in broiler breeders \nand broiler chickens demostrated diclazuril to be safe.  In non -target species tolerance studies were conducted \nin ducks, horses, rabbits, cattle, and dogs at use level \nand higher.  In all the studies it was co ncluded that \ndiclazuril caused  no adverse effects.  \n \nCONCLUSIONS  \nBased on the results of the battery and \nconfirmatory studies, it is concluded that diclazuril at the 1.0 ppm level administered in the feed is highly \neffective in preventing coccidiosis in turkeys.  In addition, the results from the safety studies in turkeys \nas well as non -target species demostrate that diclazuril \nis highly safe.   \n  \n142 CONTROL OF HISTOMONIASIS IN CHICKENS AND TURKEYS  \n \nCONTROL DE LA HISTOMONIASIS EN POLLOS Y PAVOS  \n \nL. R. McDougald  \n \nDepartment of Poultry Science, University of Georgia, Athens GA 30602 USA  \n \nRESUMEN  \nParece que el resurgimiento reciente de brotes de \ncabeza negra en pollos y pavos no se debe a un cambio \nen la virulencia de Histomonas  ni a un aumento en la \nexposici\u00f3n al v eh\u00edculo biol\u00f3gico (gusano cecal). La \nvirulencia para el pollo se exacerba mediante la \nexposici\u00f3n concurrente a dosis bajas de coccidia cecal. \nNo existen vacunas ni tratamientos efectivos contra la \ncabeza negra. Una prueba realizada con los antibi\u00f3ticos \ny los anticoccidianos disponibles mostr\u00f3 poco valor \ncontra esta enfermedad en pollos, o bien su valor fue \nnulo. Los programas de restricci\u00f3n alimenticia en \nreproductoras contribuyen a diseminar la infecci\u00f3n en \ntoda la parvada debido a una modificaci\u00f3n en el p H del \nbuche y la molleja, permitiendo la transmisi\u00f3n directa de ave a ave.  \n \nBlackhead disease, caused by Histomonas \nmeleagridis , is a common parasite of chickens, turkeys, \nand pet birds in the Americas, and to a lesser extent, in \nother countries.  Until re cently, the disease was held \nunder control by a combination of management, separation of chicken and turkey flocks, and highly \neffective medications available for treatment.  In the \nmid-late 1990s, clinical outbreaks of blackhead became \ncommon in chickens,  particularly broiler -breeder \npullets and layer pullets.  More recently, devastating outbreaks were reported in growing turkeys and turkey breeder hens.  The reasons for these outbreaks remain \nunclear, but have prompted renewed research to \naddress the caus es and to look for possible remedies.  \nSeveral possible causes of increased outbreaks were \nconsidered:  \nIncreased virulence of Histomonas Isolates?   \nSeveral isolates of H. meleagridis  were obtained from \nfield outbreaks in Georgia in breeder pullets and layer pullets, cultured in vitro , and tested by rectal \ninoculation of 2 -wk-old broiler chicks or turkey poults.  \nThese isolates behaved as expected:  Turkeys died of \ninfection after 2 -3 weeks, with severe cecal and liver \nlesions.  Chicks developed severe cecal  lesions, but \nonly occasional mild liver lesions.  At this point, there \nis no evidence for a change in virulence.  \nIncreased exposure to Heterakis worm eggs?  \nThe cecal worm is widespread and common in facilities used for rearing broiler breeder pullets and  \nlayer pullets, as reported by other workers (2).  There is no reason to think that this situation has changed in the last 30 or so years.  Turkeys are typically kept free of \nblackhead by eliminating exposure to carriers of cecal \nworms (chickens).  Thus, o utbreaks have been rare and \ninvolved only a small number of birds.  Recent \noutbreaks, wherein blackhead disease spread \nexplosively through flocks of turkeys resulting in \nextremely high mortality, suggest that unknown factors \nare influencing the horizontal spread of infection once introduced into a flock.  Some have suggested that \npreviously unreported, non -cecal worm, carriers might \nbe involved, because it is difficult or impossible to \nisolate Heterakis  worms from turkey flocks suffering \nblackhead disease, but experimental efforts have thus \nfar been unsuccessful (5).  \nInteraction with other diseases:   The marked \nincreased in clinical outbreaks in breeder pullets came \nat a time when the industry was being ravaged by other \ndiseases known to affect immune compet ence.  At this \ntime, we do not have any experimental results to support this supposition.  However, a considerable body of research indicates that H. meleagridis  needs \ncertain microflora for full virulence (1,6).  On this \nbasis, there is every reason to su spect that other \nintestinal diseases which disrupt the normal microflora \nmay somehow aid H. meleagridis  in colonization or in \nspread to the liver.  Recent work in our laboratory \ndemonstrated that small doses (1000 oocysts) of the \ncecal coccidium, Eimeria tenella , when given to young \nchicks concurrently with exposure to cultured H. \nmeleagridis  , increased the number and severity of liver \nlesions, and the % of birds showing liver lesions.  We \nused this interaction as a model for subsequent studies, \nfor induct ion of liver lesions in chickens (4).  The \nreason for this interaction was unclear, as treatment \nwith highly effective anticoccidials to prevent \ndevelopment of the coccidia beyond the sporozoite stage was generally ineffective in preventing this \ninteractio n (Table 1).  The possible interaction of \nblackhead with coccidia in turkeys has not been \nreported, but these studies are underway in our \nlaboratory.  \nManagement:  On the surface, it would seem like \na long shot, but there have actually been changes in manag ement of broiler breeder pullets in recent years \nwhich could contribute to susceptibility to blackhead.  \nA research report by Lund (3) examined the potential  \n  \n143 for bird -to-bird spread of blackhead disease in chickens \nand turkeys.  He found that oral administ ration of \ndroppings from diseased birds rarely initiated disease.  \nThe trophozoites of H. meleagridis  present in \ndroppings are fragile, and easily destroyed in the crop \nor gizzard.  The only way disease could be transmitted \nin this way was to starve the bi rds for several hours \nprior to inoculation, totally altering the pH of the crop \nand gizzard.  He concluded that bird -to-bird \ntransmission in this way was unlikely as long as birds \nwere well -fed and cared for.  Obviously, Lund did not \nconsider the (future) use of feed restriction or skip -a-\nday feeding as a management program for breeder \npullets.  Research is underway in our lab to measure \nthe potential for these practices to contribute to the \nbird-to-bird spread of blackhead disease in young \nchickens and tur keys.  The reliance on feed deprivation \nas a management tool in breeder pullets for both \nchickens and turkeys, and the lack of drugs to treat these infections, does not bode well for future control \nof blackhead in these birds.  \nTreatment:   At present there are no effective \nproducts available for treatment of clinical outbreaks of blackhead in chickens or turkeys.  Histostat (nitarsone \nor 4 -nitrophenylarsonic acid) is still available and \nworks well as a preventive.  Attempts to use 3- Nitro \n(roxarsone or 3 nit rophenylarsonic acid) are not \nfounded on scientific evidence.  In fact, Dr. Neal Morehouse, the discoverer and developer of arsenical \ncompounds at Salsbury Laboratories wrote in 1955 \n(report to the Iowa Academy of Sciences) that while 4 -\nNitro was a highly effective preventive for blackhead, \n3-Nitro had no demonstrable activity.  Recent tests in \nour laboratory confirm this finding (Table 1).  \nPossible Treatment with Existing Products:  \nWe recently conducted a series of tests to determine \nwhether any commonly a vailable feed or water \nadditives offered any protection against blackhead \ndisease in chickens.  We tested several feed and water \npreparations of antibiotics, as well as representative \ntypes of anticoccidials, in the feed.  The model described above was use d, wherein concurrent \ninoculations with the cecal coccidium E. tenella was \ngiven with H. meleagridis  to induce liver lesions in \nchickens.  The antibiotics tested were bacitracin, virginiamycin, sarafloxacin, penicillin, \nchlortetracycline, tylosin, and apramycin.  \nAnticoccidials tested were salinomycin, roxarsone, \nlasalocid, nicarbazin, and diclazuril.  The results are \nsummarized in Table 1.  None of the products had any \nappreciable or consistent effect on cecal lesions due to histomoniasis, and most had little or no effect on liver \nlesions or weight gains.  Bacitracin and nicarbazin, for \nreasons that were not clear, had a small but consistent effect on liver lesions, but were not curative.  Previous \nstudies had shown that apramycin, an antibiotic used mostly  in swine, at high levels had strong preventive \neffects on experimental histomoniasis in turkey poults, \nbut here did not protect chickens.  Carbadox, a product \nused mostly for growth promotion in swine, had \nsignificant antihistomonal activity in vitro , but  did not \nprotect chickens from blackhead.  \nOther experimental chemotherapy:  New \nproducts are needed for control of blackhead disease in \nchickens and turkeys.  Toward this end, we are testing \ncompounds reported in the literature as having \nantiprotozoal activity, particularly against Entamoeba \nand Trichomonas .  Most of these compounds, some of \nwhich are currently used in human medicine, also \npossess antihistomonal activity in vitro .  Tests are \nunderway to characterize these compounds in vivo , but \nunless comme rcial sponsors are attracted, they are \nunlikely to be available for use in food -producing \nanimals.   \nSummary and Conclusions:  \n1. The recent outbreaks of blackhead disease in \nchickens and turkeys do not appear to be caused by a \nchange in virulence of H. meleag ridis or of a change in \nexposure to the carrier Heterakis gallinarum.  \n2. Virulence of H. meleagridis  is enhanced by \nthe concurrent light infection with other organisms, \nsuch as cecal coccidia ( Eimeria tenella ), possibly by \naltering cecal microflora, or disrup tion of the mucosa.  \n3. There are no approved drugs for treatments \nof outbreaks in chickens or turkeys, and vaccination is \nnot possible for H. meleagridis . \n4. Tests with roxarsone failed to show any \nbeneficial effects on blackhead in chickens.  \n5. Tests with 5 repres entative anticoccidials \nand 7 antibiotics administered in feed or water failed to \nshow any important benefits on blackhead in chickens, \nwith the possible exception of bacitracin when used at high levels (100 -300 g/ton in feed).  \n6. Feed restriction programs in  broiler breeder \npullets and turkey hens may contribute to the susceptibility of these birds to blackhead disease, and may contribute to spread of disease through a flock.  \n \nREFERENCES  \n1. Bradley, R.E., and W.M. Reid. Histomonas \nmeleagridis and several bacteri a as agents of infectious \nenterohepatitis in gnotobiotic turkeys.  Exp. Parasitol. 19: 91- 101. 1962.  \n2. Hegngi, F.N., J. Doerr, T.S. Cumings, R.D. \nSchwartz, G. Saunders, A. Zajac, C.T. Larsen and F.W. \nPierson. The effectiveness of benzimidazole \nderivatives fo r the treatment and prevention of \nhistomoniasis (blackhead) in turkeys.  Vet. Parasitol. 81: 29- 37. 1999.  \n3. Lund E.E. Oral transmission of Histomonas \nin turkeys.  Poultry Sci 34: 900 -904.  1956.   \n  \n144 4. McDougald, L.R. and J. Hu. Blackhead \ndisease (Histomonas meleag ridis) aggravated in broiler \nchickens by concurrent infection with cecal coccidiosis \n(Eimeria tenella).  Avian Dis. 45:  307 -312. 2001.  \n5. Norton, R.A., F.D. Clark, and J.N. Beasley. \nAn outbreak of histomoniasis in turkeys infected with a moderate level of As caridia dissimilis but no Heterakis \ngallinarum.  Avian Dis 43: 342- 348. 1999.  \n6. Springer, W. T., J. Johnson, and W. M. \nReid.  Histomoniasis in gnotobiotic chickens and \nturkeys:  Biological aspects of the role of bacteria in \nthe etiology.  Exp. Parasitol. 28: 383-392. 1970.  \n \nTable 1.   Test of anticoccidials and antibiotics against Histomonas meleagridis  in chickens* \n_______________________________________________________________________  \n Treatment A \nProduct        Route   Level(ppm)  InfectionB       Wt Gain(g)  Liver ScoreC Cecal ScoreD \n_______________________________________________________________________________  \nUnmed            -       -             -  749   0  0 \nUnmed            -       -    His  + Coc    616   0.93   3.66 \nBacitracin    Feed         50    His  + Coc   604   0.51  3.44     \n        \"       100       His  + Coc    622   0.34 *  3.76 \n         \"       200    His  + Coc    647   0.31 *  3.71 \n         \"       300   His  + Coc    636   0.44 *  3.69   \nUnmed           -         -            -     858      0  0 \nUnmed          -         -    His  + Coc    770   1.37  3.74 \nApramycin   Water     75   His  + Coc    703   0.77  3.63 \n         \"       150  His  + Coc    787   1.18  3.56 \n          \"       300    His + Coc    701   0.47 *  3.40 \nUnmed          -            -                            -                     721   0  0 \nUnmed          -            -   His + Coc    588   0.93  3.64 \nCarbadox     Water   100   His + Coc    602   0.50 *  3.67 \nUnmed           -         -         -    716   0  0 \nUnmed           -         -   His    609   0.58  3.67 \nUnmed           -         -   His + Coc    587   0.82  3.63 \nPenicillin       Water  100   His + Coc    649 *    0.78  3.44 \nChlortetracycline      100   His + Coc    618 *    1.14  3.68 \nTylosin          Water  110   His + Coc    658 *    0.91  3.90 \nSarafloxacin   Water   40   His + Coc    656 *    1.06  3.21    \nUnmed           -          -        -    702   0  0 \nUnmed           -          -   His      641   0.18  3.59 \nUnmed           -          -    His + Coc    617   0.84  3.63 \nDiclazuril       Feed       1   His + Coc    557   0.78  3.74 \nSalinomycin   Feed     66   His + Coc    514   0.54  3.78 \nRoxarsone      Feed     50   His + Coc    577   0.61  3.43 \nLasalocid        Feed   100   His + Coc    594   0.68  3.86 \nNicarbazin      Feed   125   His + Coc    524   0.48 *  3.52 \n_______________ ________________________________________________________________  \n* Means with asterisk indicate significant improvement in comparison with mean from control group in the \nsame column.  \nA  Treatments were given in the feed or water from 2 days pre- exposure to  termination 14 days post -exposure.  \nB  Infections consisted of 1x103 sporulated oocysts of  Eimeria tenella  and/or 1x105 cultured cells of H. \nmeleagridis  given when birds were 14 days old.  \nC  Liver lesions caused by H. meleagridis  were graded on a subjecti ve scale of 0 -4, where 1=1 or few small \nlesions, 2=several small -mid sized lesions, 3=moderate number of mid -sized lesions, and 4=many lesions of all sizes \nmottling the organ.  \nD  Cecal lesions caused by H. meleagridis  were graded on a subjective scale of 0 -4, where 1= some thickening \nof the mucosa with scattered petechial foci, 2= moderate thickening of cecal mucosa, with pronounced reddening and sometimes blood, 3= pronounced thickening of mucosa, with sloughing of mucosa, and formation of a caseous \ncore, and 4= ceca enlarged and engorged with a caseous core made up of sloughed mucosa and serous exudates.  \nThese lesions are accompanied by dark red inflamation of the mesenteries around the intestine.\n \n \n \n  \n  \n145 PRIMER HALLAZGO EN M\u00c9XICO DEL \u00c1CARO  \nTERYGOCRUSOLICHUS CHANAYI EN GUAJOLOTES DE M\u00c9XICO  \n \nFIRST REPORT IN MEXICO OF THE MITE PTERYGOCRUSOLICHUS \nCHANAYI  IN TURKEYS  \n \nMa.Teresa Quintero M.  \n \nDepartamento de Parasitolog\u00eda, Facultad de Medicina Veterinaria y Zootecnia, U.N.A.M. Coyoac\u00e1n, C.P. 04510 \nM\u00e9xico D.F.  \n \nSUMM ARY  \nThis paper reports the presence of mites \ncharacterized as Pterygocrusolichus chanayi  \n(Trouessart ), family Pterolichidae, in turkey feathers . \nMites were found in turkeys in Palizada, Campeche, \nMexico, suffering feather loss. Mites were fixed using \nHoyer \u2019s fluid, to be further analyzed under the light \nmicroscope. This particular mite has been isolated \nelsewhere from both domestic and wild turkeys. Nevertheless, this is the first report of its presence in \nMexican turkeys.  \n \nRESUMEN  \nEn el presente trabajo se comunica la presencia de \n\u00e1caros en plumas de guajolotes, a los que se determin\u00f2 \ncomo Pterygocrusolichus chanayi  (Trouessart)  \npertencientes a la familia Pterolichidae, los \u00e1caros  \nfueron  encontrados en guajolotes de Palizada, \nCampeche, M\u00e8xico, que presen taban caida de plumas, \ncon los \u00e1caros encontrados se realizaron preparaciones empleando l\u00edquido de Hoyer y m\u00e1s tarde se observaron al microscopio compuesto. estos \u00e0caros, han sido \naislados de guajolotes dom\u00e9sticos y silvestres sin \nembargo  esta la primera vez que se comunica \npresencia en guajolotes de M\u00e8xico  \n \nINTRODUCCI\u00d3N  \nLos \u00e1caros de las plumas de guajolotes \nconstituyen  una gama de diversos g\u00e9neros y especies \npertenecientes a diversas  familias, entre las que se \nencuentra la familia Pterolichidae en la q ue se incluyen \nal g\u00e9nero Pterolichus  entre otros. En el presente trabajo \nse comunica la presencia de \u00e1caros en plumas de guajolotes a los que se determin\u00f3 como \nPterygocrusolichus chanayi  \n  \nMATERIAL Y METODOS  \nEl material consisti\u00f3 en plumas separadas de \nguajolotes criados en Palizada, Campeche, los \nguajolotes mostraban ca\u00edda de plumas, dichas plumas fueron transportadas al laboratorio a donde se les examin\u00f3 bajo el microscopio,estereosc\u00f3pico, de las plumas positivas a \u00e1caros se fueron separando \u00e9stos y se les mont\u00f3 entre porta y cubreobjetos empleando \nl\u00edquido de Hoyer  \n \nRESULTADOS  \n Al realizar la observaci\u00f3n de las preparaciones \nobtenidas, bajo el microscopio compuesto, se lleg\u00f3 a la \nconclusi\u00f3n de que se trataba de \u00e1caros de la familia \nPterolichidae y se les  identific\u00f3 como \nPterygocrusolichus chanayi  (Trouessart  and Megnin) \nse encontraron \u00e1caros en todas sus fases evolutivas. Seg\u00fan  Gaud y Atyeo, 1996 estos \u00e1caros se caracterizan  por presentar ep\u00edmeros libres no \narticulados, asimismo presentan un par de sed as \nverticales; una caracter\u00edstica sobresaliente en el macho \nes que presentan los f\u00e9mures de las patas I Y II \nexpandidos,  as\u00ed como que las patas posteriores  son \nsublaterales, estos \u00e1caros han sido encontrados en guajolotes dom\u00e9sticos y en silvestres.\n \n \nDISCUSION Y CONCLUSIONES  \nLa importancia de esta comunicaci\u00f3n, radica en el \nhecho de que estos \u00e1caros pudieran estar provocando la \nca\u00edda de plumas; los \u00e1caros encontrados se \ncaracterizan.   Al parecer esta es la primera vez que se identifica a este \u00e1caro en M\u00e9xico por lo que deber\u00e1 \nponerse atenci\u00f3n sobre el diagn\u00f3stico de estos \u00e1caros a \nfin de no confundirlos con\n otros muy cercanos como \nson los del g\u00e9nero Pterolichus  y asimismo establecer el \nda\u00f1o que estos organismos causen en las plumas de \nguajolotes.  \n \nREFEREN CIAS  \n1.  Gaud, J.and Atyeo W. Feather mites on the \nworld (Acarina, Astigmata) Ann Zoologische Wetenschappen 277:100 1996.  \n \n  \n  \n146 USING GEOGRAPHIC INFORMATION SYSTEM (GIS) \nTECHNOLOGY TO DETERMINE THE LOCATION OF \nCOMMERCIAL POULTRY FLOCKS, SUPPORT INDUSTRY AND \nLIVE BIRD MARKET SYSTEM COMPANIES, DEALERS AND \nMARKETS IN PENNSYLVANIA  \n \nUSO DE LA TECNOLOG\u00cdA DEL SISTEMA DE INFORMACI\u00d3N \nGEOGR\u00c1FICA (GIS ) PARA DETERMINAR LA UBICACI\u00d3N DE LAS \nPARVADAS COMERCIALES Y APOYAR A LA INDUSTRIA, LAS \nCOMPA\u00d1\u00cdAS, LOS DISTRIBUIDORES Y LOS MERCADOS DE AVES VIVAS \nEN PENNSYLVANIA \n \nSherrill Davison, Robert J. Eckroade, Susan W. Casavant, Stephen Gallo  \n  \nUniversity of Pennsylvania, School of Veterinary Medicine, Laboratory of Avian Medicine and Pathology, New \nBolton Center, 382 West Street Roa d, Kennett Square, PA  19348  \n \nRESUMEN  \nLa tecnolog\u00eda GIS  es una herramienta \ncomputarizada para el mapeo y an\u00e1lisis de datos que \npermite ayudar a predecir los resultados y a planear estrategias de control. Hist\u00f3ricamente se han \npresentado brotes de enfermed ades capaces de afectar a \nnumerosas parvadas en toda un \u00e1rea geogr\u00e1fica. Para \ndeterminar el \u00e1rea potencial de diseminaci\u00f3n de una \nenfermedad, antes era necesario que una persona \nlocalizara las granjas cercanas a las parvadas infectadas recorriendo el \u00e1rea en autom\u00f3vil y detect\u00e1ndolas \nvisualmente. El uso de la tecnolog\u00eda GIS  permite el \nacceso m\u00e1s f\u00e1cil y r\u00e1pido para localizar e identificar las \ninstalaciones av\u00edcolas circundantes, pudiendo crear con \nfacilidad las zonas de acci\u00f3n preventiva alrededor de \nlas pa rvadas para prop\u00f3sitos cuarentenarios. Esta \ninformaci\u00f3n permitir\u00e1 obtener una respuesta m\u00e1s \nr\u00e1pida en los esfuerzos de control.  \n \nGeographic Information System (GIS) \nTechnology is a computer -based tool for mapping and \nanalyzing data to assist in predicting outcomes and \nplanning control strategies.  This technology has been \nused not only in city and county governments but also in farming, public safety, marketing, and \ntelecommunication companies.  Parameters such as soil \ntypes, crime patterns, and customer sales have been tracked and analyzed.  \nHistorically, the Pennsylvania poultry industry \nhas experienced outbreaks of diseases such as avian influenza, Mycoplasma gallisepticum,  and infectious \nbronchitis.  These outbreaks have affected many flocks throughout a  wide geographical area.  To determine the \npotential area spread of a disease in the past a person \nneeded to locate poultry flocks near infected flocks by driving in the area and visually locating poultry \nfacilities.  The use of GIS technology allows for e asier \nand quicker access to the location and identification of \nsurrounding poultry facilities. This information will \nallow a more rapid response in control efforts for avian \ninfluenza or other diseases.\n  Buffer zones around \ninfected flocks for quarantine p urposes are easily \ncreated.  In addition, this system will allow for the \nanalysis of data such as the type of bird affected or the \ncompanies involved.  Trucking routes for feed, bird and egg trucks, and schedules of service personnel may \nbe integrated into  the program. This data analysis is \nessential to understanding whether spread of disease is \nmechanical in nature (i.e. personnel or vehicles).    \nGIS technology also graphically presents features \nthat may either be beneficial or detrimental to disease control.  The relational mapping of physical barriers \nsuch as rivers, mountains or highways can show limitations to disease spread.  On the other hand, during the most recent outbreak of avian influenza, wind was a factor in the transmission of disease to \nneighboring poultry premises.  Wind direction can be \nincluded as part of an epidemiological study.  \nTemperature and humidity data may also be useful \nparameters in the analysis of spread of disease.  \nThis is a unique application of GIS technology.  \nWe are aware of only a few other states that have used \nthis for the control of poultry diseases.   Other \napplications of GIS related to poultry have included the \nuse of GIS in making management decisions regarding \npoultry facility housing design and placement when \ncompared with the regional temperature humidity \nindex (4).  Additionally, GIS was used to understand the outcome of broiler litter application to land in an \nagricultural watershed (8).   \n  \n147 There have been limited applications of GIS to \nother animal species such as pigs, cows and horses.  \nThe majority of epidemiological work involves vector -\nborne diseases such as Lyme disease (6) and West Nile \n(WN) encephalitis (1). The variables that influence the \nepidemiology of cattle disease in Africa caused by a \nprotozoal par asite were assessed using a GIS (5). Other \napplications included predicting forest songbird habitat \nand tracking an urban rodent control program (3, 7).  \nThe 1997 -  1998 outbreak of nonpathogenic avian \ninfluenza H7N2 was estimated to cost the industry approximately 3.5 million dollars (2).  Several costs \nrelated to the outbreak were not calculated.  These costs included state personnel who visually located \nfarms and questioned companies about similarities \nbetween farms and subsequently analyzed the data \nwithout the use of a computer -based database.  GIS \ntechnology saves money and effort by decreasing the number of hours spent in determining the flocks at the highest risk of infection in addition to protecting a \nsegment of our food supply.  \nThe recent outbreaks  of Foot and Mouth disease \nand Bovine Spongiform Encephalopathy (Mad Cow disease) in other parts of the world, emphasize the \ngrowing need for GIS technology implementation in the agricultural community to control disease, limit \neconomic losses, and protect  elements of our food \nsupply.  The beef cattle, dairy cows, swine, and sheep \nindustries are all prime candidates for GIS technology.  \n  \n REFERENCES  \n1. Conrad, E.R., Tracking Diseases with GIS. \nArcUser, July \u2013  September 2001.  \n2. Davison, S., D. Galligan, T.E. Ecke rt, A.F. \nZiegler, and R.J. Eckroade.  Economic analysis of an outbreak of avian influenza, 1997 \u2013 1998. JAVMA \n214:1164 \u2013 1167, 1999.  \n3. Dettmers, R. and J. Bart. A GIS modeling \napplied to predicting songbird habitat.  Ecological \nApplications 9:152- 163, 1999.  \n4. Gates, R.S., H. Zhang, D.G. Colliver, and \nD.G. Overhults. Regional variation in temperature \nhumidity index for poultry housing. Transactions of the ASAE 38:197 \u2013 205, 1995.  \n5. Lessard, P., R. L\u2019Eplattenier, R.A.I. Norval, \nK. Kundert, T.T. Dolan, H. Croze, J.B . Walker, A.D. \nIrvin, and B.D. Perry. Geographical information \nsystems for studying the epidemiology of cattle \ndiseases caused by Theileria parva. Vet Record \n126:255- 262, 1990.  \n6. Nicholson, M.C. and T.N. Mather. Methods \nfor evaluating Lyme disease risks using geographical information systems and geospatial analysis. J. of Med. \nEntomology 33:711- 720, 1996.  \n7. Von Wahlde, M. and B.A. Colvin. Using \ngeographical information systems for tracking an urban \nrodent control program. Proceedings of the Vertebrate \nPest Conf erence, pp. 327 \u2013  334, 1994.  \n8. 8. Xu, F., T. Prato, and C. Fulcher. Broiler \nlitter application to land in an agricultural watershed: A GIS approach.  Water and Science Technology 28:111 -\n118, 1993.  \n \nSTRATEGIES FOR THE CONTROL OF  \nAVIAN INFLUENZA IN ITALY  \n \nIlaria CapuaA, Stefano MarangonB, Giovanni CattoliA and Calogero TerreginoA \n \nANational Reference Laboratory for Newcastle Disease and Avian Influenza,  \n B Centro Regionale per l\u2019Epidemiologia Veterinaria, Istituto Zooprofilattico Sperimentale delle Venezie, Via \nRomea 14/A, 35020 Legnaro, (PD), Italy.  \n \nSUMMARY  \n The present paper describes the control measures \napplied during the 1999- 2001 Italian avian influenza \nepidemic. The epidemic was caused by a low pathogenicity avian influenza virus of the H7N1 \nsubtype t hat mutated into a highly pathogenic avian \ninfluenza virus, after circulating in the industrial \npoultry population for approximately nine months. Following the emergence of the HPAI virus, that \ncaused death or culling of over 13 000 000 birds, and \nthe impl ementation of the measures indicated in \nDirective 92/40/CE, the LPAI virus re -emerged twice.  In order to control the re -emergence of LPAI \nvirus and to develop a novel control strategy, a \u201cDIVA\u201d (Differentiating Vaccinated from Infected Animals) strategy w as developed and combined to a \nstrict territorial control programme. The \u201cDIVA\u201d strategy was based on the use of an inactivated oil \nemulsion vaccine containing the same haemagglutinin \n(H) subtype as the field virus, but a different \nneuraminidase (N). The p ossibility of using the diverse \nN group, to differentiate between vaccinated and \nnaturally infected birds, was achieved through the \ndevelopment of an \u201c ad hoc \u201d serological test based on \nthe detection of specific anti - N1 antibodies.   \n  \n148 The control of the field  situation was ensured \nthrough an intensive sero -surveillance programme \naiming at detecting the circulation of the LPAI virus, \nthrough the regular testing of vaccinated and \nunvaccinated flocks, the latter located both inside and \noutside the vaccination area. In addition, the efficacy of \nthe vaccination schemes was evaluated in the field through regular testing of selected flocks.  \nAfter the first year of vaccination, the \nepidemiological data collected, indicating that the H7N1 virus was not circulating in t he vaccinated \npoultry, was considered to be sufficient by the EU Commission to lift the marketing restrictions on meat obtained from vaccinated poultry.  \n The experience gained during the Italian 1999 -\n2001 AI epidemic, suggest that the combination of a \u201cDIV A\u201d control strategy with a territorial monitoring \nsystem under official control can represent an effective tool for the control of avian influenza infections in poultry. In addition, the application of a \u201cDIVA\u201d \nvaccination policy, as opposed to a conventional policy \nenabled veterinary public health organisations to \nestablish that infection was not circulating any longer, \nand ultimately resulted in the possibility of marketing \nmeat obtained from animals vaccinated against an OIE List A disease.  \n \nINTRODUCTION  \nHighly pathogenic avian influenza (HPAI) is a \nviral disease of poultry included in OIE List A, and in the European Union its control is imposed by EU Directive 92/40/EEC (4). The disease may have \ndevastating effects on the poultry industry particularly \nwhen it affects industrial poultry rearing systems, and \nits presence in a given territory results in restrictions on animal movements, marketing and trade of poultry and \npoultry products. Similar restrictions are enforced if vaccination for HPAI is implement ed in a given \nterritory.  \n \nTHE ITALIAN 1999 -2001 H7N1 EPIDEMIC  \n During 1999 and 2000 north -eastern Italy has \nbeen affected by a devastating epidemic of HPAI, \ncaused by a type A influenza virus of the H7N1 \nsubtype that originated from the mutation of a low pathogenicity avian influenza (LPAI) virus of the same \nsubtype (1). The HPAI epidemic caused directly or indirectly the death or culling of over 13 million birds \nthat inevitably determined the disruption of the \nmarketing system and great economic losses to the \npoultry industry and to the social community. Following depopulation and restocking of the HPAI \ninfected areas, LPAI re- emerged twice, thus \ndetermining the poultry industry to request, through the \nItalian veterinary authorities, and obtain vaccination \nagainst avian influenza of the H7 subtype.  VACCINATION POLICY  \nFollowing the second LPAI epidemic wave, a \nvaccination policy against avian influenza was, \nstrongly requested by the farmers and by the poultry \nindustry. However, document Sanco/B3/AH/R17/2000 \nof the EU Scientific committee on animal health and \nanimal welfare, stated that a vaccination programme \ncould be approved provided that the vaccine \nadministered was a non genetically modified vaccine, \nand that it could be possible to discriminate vaccinated  \nfrom infected birds.  \nThe strategy proposed by the Italian reference \nlaboratory was that of using an inactivated oil emulsion \nvaccine containing a strain with a homologous \nhaemagglutinin (H) group and a heterologous \nneuraminidase (N) group. The reason for  this is the \npossibility of using it as a natural \u201cmarker\u201d vaccine, or \nmore correctly a DIVA [Differentiating Infected from \nVaccinated Animals] vaccine. In fact it is well known \nthe neutralizing antibodies to influenza A viruses are \ninduced primarily by the haemagglutinin molecule (4) \nand that vaccination with a vaccine containing a \nhomologous H group also reduces the amount of \ninfectious virus shed in the environment (4). Therefore the use of a vaccine containing the H7 antigen would \nensure protection agai nst clinical signs and, in case of \ninfection the reduction of virus shedding. The presence \nof a different neuraminidase (N) subtype, which \ninduces the production of specific antibodies, would \nenable official veterinary authorities, with the aid of an \u201cad hoc\u201d  diagnostic test, to discriminate between \ninfected and vaccinated flocks, and to monitor and \nfollow the evolution of the situation.  \nFollowing the satisfactory results of cross -\nprotection studies against the Italian H7N1 virus, \n(Capua, unpublished) the vaccine that has been used in \nthe field has been prepared from an inactivated H7N3 \nvirus (A/CK/Pakistan/95/H7N3). The discrimination \nbetween infected (N1 positive) and vaccinated (N1 \nnegative) birds was achieved by an indirect immunofluorescence test (iIFAT ), based on a \nrecombinant N1 protein expressed in a baculovirus vector (3).  \nA control strategy based on the combination of a \ncomplex field monitoring system, and on the application of strict vaccination protocols complying to those evaluated in the laborat ory and on the \nimplementation of the \u201cDIVA\u201d strategy was drawn up and approved by the, EU commission (2000/721/EC).  \nThe vaccination program began on November \n15\nth 2000 and will last until May 2002. Approximately \n12 000 000 birds [only meat type birds and t able-egg \nlayers (that apply the all -in all -out system)] raised in a \nrestricted zone (1156 km2) south of Verona will be \ninvolved in the vaccination programme. The vaccine is \nbeing marketed only under strict official control, and  \n  \n149 until November 30th, 2001 no vaccinated live birds or \npoultry products that originated from the vaccination \nzones were authorised for intra- community trade.  \n \nTERRITORIAL STRATEGY  \n The territorial strategy was drawn in order to \nconstantly monitor the situation in the field through \nofficial controls and voluntary notification. Briefly, the \nidentification of any LPAI infected farms relied on the \nnotification of suspected cases by farmers and field \nveterinarians. In addition, official veterinarians carried \nout regular serological testing  of poultry flocks at risk \nof infection. Once an infected flock was identified, an \nepidemiological investigation was carried out in the \naffected farms by means of a standardized \nquestionnaire to establish the possible origin of the \ninfection and to identif y flocks directly or indirectly at \nrisk of infection. In case of the identification of an outbreak, although no compulsory eradication or compensation for LPAI is provided for in EU \nlegislation, the Italian Ministry of Health opted for \neradication. This wa s achieved by stamping out or by \ncontrolled marketing of slaughterbirds, on infected \nfarms. In addition, the prohibition of restocking of \npoultry farms, and the enforcement of restriction \nmeasures on the movement of live poultry, vehicles \nand staff were im posed in the areas at risk.  \nOfficial monitoring of the areas at risk was \nimplemented with the aim of identifying undiagnosed \noutbreaks and to evaluate the efficacy of the \nvaccination program in the field.  \nThe control of the vaccinated farms was achieved \nboth through regular testing of sentinel birds and \nthrough the application of the N1 -N3 discriminatory \ntest. In fact, each vaccinated flock contained at least 1% of unvaccinated birds, that were appropriately \nidentified to distinguish them from vaccinated animals. In vaccinated flocks at least 10 sentinel birds (95% \nprobability to identify at least one positive bird if the \nprevalence of seropositive animals is \u2265  30%) were \nserologically tested every 45 days. Alternatively 10 \nserum samples were collected from  each shed and \nprocessed for the N1 -N3discriminatory test.  \nIn addition, a monitoring program to evaluate the \nefficacy of the vaccination protocols in the field was \nalso carried out, with the regular serological testing of \n20 vaccinated animals in at least 30 randomly selected vaccinated farms (95% probability of identifying at \nleast one non- immunized flock if their frequency is \u2265 \n10%). In order to adhere to the vaccination campaign, \nfarmers had to comply with strict biosecurity measures, \nand undergo regular  inspections under official control.  \n \nRESULTS  \nFollowing the implementation of the vaccination \npolicy, the third LPAI epidemic wave was detected in a non-vaccinated meat -type turkey farm located in the \nvaccination area. A total of 23 outbreaks (22 meat -type \nturkey and 1 layer farms) were identified and the last \naffected flock was stamped out on the 26\nth of March \n2001. During this epidemic wave, only 3 meat -type \nturkey farms were infected inside the vaccination area \nand among these, only one vaccinated flock  was \naffected. The presence of infection was promptly \nidentified through the laboratory investigations \nperformed on the sentinel birds. The farm was located \nin close proximity (200 m) to an unvaccinated farm and the infection did not spread further to neig hboring (0.8 \n- 1 km) vaccinated farms  \nThe intensive sero -surveillance programme, \napplied to poultry farms located outside the vaccination \narea in the Veneto region, following the eradication of \nthe last LPAI outbreak, determined the sampling and \nprocessing  of over 35.000 blood samples with negative \nresults.  \nThe N1 -N3 discriminatory test was also used to \nassess whether serological positivity to the HI test \ndetected in sentinel birds was truly determined by \ninfection or was due to sampling of vaccinated birds  \ninstead of sentinels. All samples were tested with negative results.  \nThe data obtained from the intensive monitoring \nprogram were considered sufficient by the EU Member \nStates, to demonstrate that the LPAI virus was not \ncirculating any longer in the na\u00efve  or in the vaccinated \npoultry population. The application with negative results, of the N1 -N3 discriminatory test, was \nconsidered as an additional guarantee for Member \nStates, and on 30\nth November 2001, commission \ndecision 2001/847/CE, authorized the marke ting of \nmeat obtained from vaccinated birds for intra-\ncommunity trade.  \n \nDISCUSSION  \nWith reference to control of avian influenza \ninfections, the data presented herein indicate that the \nstrategy implemented in Italy, i.e., the association \nbetween a territori al strategy under official control, \nstrict biosecurity measures including restriction on \nanimal movements and a \u201cDIVA\u201d vaccination program \ncan be successful in controlling LPAI. In addition, the \nemergence of a HPAI strain was avoided.  \nThe comparison betwee n the rates of spread \nobserved during the 1999- 2000 H7N1 LPAI epidemics, \nwhich occurred prior to the enforcement of this control \nstrategy, and the limited LPAI spread observed in the \nvaccinated area supports the association between \nrestriction, bio -securit y, surveillance and vaccination as \neffective tools for the control of LPAI.  \nCritical points for the application of this strategy \nappear to be, firstly, the development and validation of \na tailored discriminatory test (in this case N1 - N3) that  \n  \n150 enables the differentiation between infected and \nvaccinated birds, in a relatively short period of time. \nSecondly, the great amount of work on public officials \nthat is required in order to develop a complex territorial \napproach, market and distribute the vaccine, coll ect \nblood samples for monitoring programs, inspect farms on a regular basis, perform laboratory tests and collect and analyze data must be carefully organized and \nplanned for.  \nIn addition, prompt diagnosis and the \nimplementation of a stamping out or a controlled marketing policy on affected farms are fundamental to \nthe eradication of LPAI infections.  \nIn our opinion it is imperative that the results \nobtained from the territorial control strategy are made \navailable to support decision -making and this can onl y \nbe achieved if there is extensive collaboration between \nfarmers, official and field veterinarians, poultry \nindustry, the diagnostic laboratories, the epidemiology units and the central and local governments. Only in \nthis way it will be possible to establish a network of \ncollaboration able to make the best of the data and tools available in the effort to control avian influenza \ninfections in poultry.  \n \nREFERENCES  \n1. Capua I., and S. Marangon. Avian influenza \nin Italy (1999- 2000) a review. Avian Pathol. 29: 289 -\n294. 2000.  \n2. Cattoli\n G., C. Terregino, V. Brasola, J.F. \nRodriguez, and I. Capua. Development and preliminary \nvalidation of an \u201c ad hoc \u201d N1 -N3 discriminatory test for \nthe control of avian influenza in Italy. In: Proc. 5th \nInternational Symposium on Avian Inf luenza Georgia. \nCenter for Continuing Education, The University of \nGeorgia, Athens Georgia USA. In press.  \n3. CEC. Council Directive 92/40/EEC of 19 \nMay 1992 introducing Community measures for the \ncontrol of avian influenza. Official Journal of the \nEuropean Co mmission, L167: 1- 15. 1992.  \n4.  Swayne, D. E., J. R. Beck, M. Garcia and \nH. D. Stone. Influence of virus strain and antigen mass \non the efficacy of H5 avian influenza inactivated \nvaccines. Avian Pathol. 28: 245 -255. 1999.  \n \nCAMBIOS HEMATOL\u00d3GICOS EN AVES LEGHORN INFECTADAS \nCON EL VIRUS H5N2 DE INFLUENZA AVIAR DE ALTA \nPATOGENICIDAD \n \nHEMATOLOGICAL CHANGES IN LEGHORN BIRDS INFECTED WITH \nHIGHLY PATHOGENIC H5N2 AVIAN INFLUENZA VIRUS  \n \nRam\u00edrez D\u00edaz Guadalupe1, Calder\u00f3n Apodaca Norma2, Fehervari Tamas2, Fortoul Van De r Goes Teresa3 \n \n1Departamento de Patolog\u00eda, Facultad de Medicina Veterinaria y Zootecnia, UNAM. Tel. 56 22 58 78. Email: \nramirezd  servidor.unam.mx.  \n2Departamento de producci\u00f3n animal:Aves, Facultad de Medicina Veterinaria y Zootecnia, UNAM. Tel. 56 22 58 \n67. Email: nlca  servidor.unam.mx  \n 3Facultad de Medicina, UNAM. Tel. 56 23 23 60  \n \nSUMMARY  \nSome avian influenza viral strains cause \nlymphoid tissue and blood lymphocyte destruction.  \nThe purpose of this research was to determine \nhematological changes in 4 -week -old birds of both \nsexes, challenged with A/CK/Quer\u00e9taro/14588- 19/95 \n(H5N2) strain. Changes observed after comparison \nwith the controls included anemia starting at 36 hours \npost inoculation (hpi), leukocytosis, heterophilia, \nlymphopenia, monocytosis, a nd basophilia, starting at \n24 hpi. Hematological findings demonstrate the presence of the virus in challenged animals.  \n \nRESUMEN  \nLa influenza aviar es una enfermedad viral, \nalgunas cepas causan destrucci\u00f3n de tejido linfoide y   \nde linfocitos en sangre. El objetivo de este trabajo es \ndeterminar los cambios hematol\u00f3gicos en aves de 4 \nsemanas de edad, de ambos sexos, desafiadas con la \ncepa A/CK/Quer\u00e9taro/14588 -19/95 (H5N2). Los \ncambios que se presentaron con respecto al grupo \ntestigo fueron anemia a partir de las 36 hpi; \nleucocitosis, heterofilia, linfopenia, monocitosis y \nbasofilia a partir de las 24 hpi, los hallazgos \nhematol\u00f3gicos demuestran la presencia del virus en los \nanimales desafiados.  \nLa influenza aviar es una enfermedad  viral de \ngran importancia en las granjas de producci\u00f3n av\u00edcola \npor las perdidas econ\u00f3micas producidas por cepas \naltamente pat\u00f3genas, ya que afecta a aves de todas las \nedades y principalmente a aquellas que no han tenido  \n  \n151 exposici\u00f3n al virus.1,2,3 Los estudios hematol\u00f3gicos \nrealizados en la enfermedad de influenza aviar son \npocos, en los cuales se describe  que aves infectadas \ncon la  cepa H5N9 presentan destrucci\u00f3n de tejido \nlinfoide y de linfocitos en sangre.4 Otros estudios \nmencionan que puede existir la proliferaci\u00f3n e \nhiperplasia de  la c\u00e9lulas  hematopoy\u00e9ticas en pollos \ninfectados experimentalmente a los 3 y 4 d\u00edas post -\ninfecci\u00f3n (dpi) sin embargo estos hallazgos no \ncorrelacionaron con cambios hematol\u00f3gicos 5; ning\u00fan \nestudio describe los cambios presentes en  diferentes \nper\u00edodos del curso de la enfermedad que pueda aportar \ninformaci\u00f3n para el estudio de la enfermedad. El presente estudio tiene como objetivo determinar los \ncambios patol\u00f3gicos en sangre de pollos infectados con \nla cepa viral A/CK/Queretaro/14588 -19/95 (H5N2) de \nalta pat ogenicidad.  \n \nMETODOLOG\u00cdA  \nSe utilizaron 51 aves leghorn, libres de pat\u00f3genos \nespec\u00edfico (SpF) de 4 semanas de edad, de ambos sexos. Se constat\u00f3 la ausencia de anticuerpos \nsangu\u00edneos contra la el virus de la Influenza aviar \nmediante prueba serol\u00f3gica espec\u00ed fica de inhibici\u00f3n de \nla hemoaglutinaci\u00f3n, los animales fueron divididos en \ndos grupos, uno de ellos constituido de 42 animales, \nque se inocularon v\u00eda oral con la cepa de influenza \naviar A/CK/Queretaro/14588 -19/95 (H5N2) de alta \npatogenicidad (t\u00edtulo 10\n6 DLEP 50/0.2ml), al que se le \ndenomino grupo A y el otro constituido de 9 aves testigo el grupo B. Las aves infectadas y testigo se \nalojaron en diferentes unidades de aislamiento del \nInstituto Nacional de Investigaciones Forestales y \nPecuarias (INIFAP) bajo condiciones controladas y \nrecibieron alimento comercial y agua de bebida a libre \nacceso.  \nPara obtener la muestra sangu\u00ednea se realiz\u00f3 una \npunci\u00f3n v\u00eda yugular de un grupo de 6 aves cada 12 \nhoras post inoculaci\u00f3n (hpi) hasta las 96 hpi . Se \nrealizaron muestr eos de las aves testigo a las 24, 60 y 96 hpi, se extrajo de cada ave 1ml de sangre y se coloc\u00f3 en microtainers que conten\u00edan sales de \netilendiaminotetrac\u00e9tico (EDTA) en proporci\u00f3n de 1:10 \n(0.1 ml por cada ml de sangre) para la realizaci\u00f3n del \nhemograma. L as t\u00e9cnicas hematol\u00f3gicas empleadas fue \ncon base a lo descrito por Campbell.\n6 Se realiz\u00f3 el \ndiferencial de los gl\u00f3bulos blancos evaluando los frotis sangu\u00edneos y posteriormente se determinaran las cifras \nabsolutas.  \n \nRESULTADOS  \nLos cambios observados en el hematocrito se \npresentaron a partir de las 36 hpi con una disminuci\u00f3n \ndel 12.5% con base al grupo testigo y que llego hasta el \n18.7% a las 84 hpi.  \nPara la hemoglobina se presentaron cambios \ndesde las 24 hpi, donde se observ\u00f3 una disminuci\u00f3n de l2.01% y que  llego hasta el 36.68% a las 96 hpi.  \nEn los gl\u00f3bulos rojos se observa una ligera \ndisminuci\u00f3n a partir de las 48 hpi del 12.05% y llego hasta el 30.80 a las 84 hpi.  \nEn las prote\u00ednas totales se observ\u00f3 una \ndisminuci\u00f3n del 2.86% a partir de las 48 hpi, y que llego hasta el 24.77% a las 72 hpi.  \nCambios leucocitarios, se present\u00f3 leucocitosis en \nla mayor\u00eda de los grupos desafiados y fue muy \nfluctuante, por ejemplo a las 24 hpi se present\u00f3 un \nincremento del 13.64% y para las 36 hpi se observ\u00f3 un incremento del 17 6.26%, que vari\u00f3 para las 96 hpi a \n101.23%, gr\u00e1fica No. 1. Fue evidente la heterofilia en los diferentes grupos, que para las 24 hpi fue de 56.71% y con fluctuaciones entre las diferentes tomas, \nllegando hasta el 353.68% a las 96hpi. La linfopenia \nfue evid ente a partir de las 24 hpi con una disminuci\u00f3n \ndel 23.23% y que llego hasta el 42.03% a las 96 hpi. Se observ\u00f3 monocitosis a partir delas 24 hpi con un \nincremento del 304.34% y que llego hasta el 1039% a las 96 hpi.  \nSe observ\u00f3 basofilia del 18.51% para la s  24, 36 y \n60 hpi.  \n \nGrafica No.1, primera barra a la izquierda corresponde al grupo testigo.  \n0510152025X109/L\n24364860728496\nHPIPROMEDIO DE LEUCOCITOS EN AVES \nINFECTADAS CON INFLUENZA AVIAR \nALTAMENTE PATOGENA\n  \n  \n152 DISCUSI\u00d3N  \nLa disminuci\u00f3n del hematocrito, la hemoglobina \ny los eritrocitos, que se define como una anemia, en \nalgunos grupos con re specto al grupo testigo, puede \nestarse presentando por las hemorragias que reporta la \nliteratura y que se presentaron en aves inoculadas con \ncepas altamente pat\u00f3genas; indirectamente estas perdidas sangu\u00edneas pueden estar involucradas con la \nhipoproteinemi a de algunos grupos. \n2 \nLa linfopenia en los grupos que la presentan se \natribuye a linfotoxicidad por destrucci\u00f3n directa del tejido linfoide y de los linfocitos circulantes, la cual se \nrelaciona a la alta patogenicidad de la cepa H5N2 de influenza aviar ut ilizada en el experimento, aunque la \nliteratura informa que la linfopenia no se presenta en \nlos animales inoculados con todas las cepas altamente \npat\u00f3genas de influenza aviar.\n4 La  heterofilia que se \nobserv\u00f3 con respecto a los testigos no supera el 14.7 x 10\n9/L , lo que no descarta que algunos animales hayan \npresentado conteos superiores a 25 x 109/L, lo que nos \nrefiere un estado de estr\u00e9s de las aves por la presencia \nde la enfermedad y que hace constatar la presencia de \nla misma; la literatura considera heterofilia conteos \nmayores a 15 x 109/L y conteos mayores a 25 x 109/L, \nlos relaciona a la liberaci\u00f3n de catecolaminas y corticosteroides.\n6 La monocitosis se asocia a necrosis \ntisular y la basofilia al proceso inflamatorio, este cambio ser\u00e1 verificado al realizar el estudio histol\u00f3gico \nde los diferentes \u00f3rganos.\n6 \nLos cambios hematol\u00f3gicos observados \ncorroboran la presencia del virus y es una muestra de que en animales inoculados con cepas altamente pat\u00f3genas pueden llegar a presentar alteraciones \nhematol\u00f3gic as.  \nCONCLUSI\u00d3N  \nLos cambios hematol\u00f3gicos observados en los \ngrupos desafiados con respecto al testigo fueron \nnotorios y de relevancia lo que hace constatar la \npresencia y severidad del virus. Se observ\u00f3 anemia a partir de las 36 hpi e hipoproteinemia alas 48 hpi. Los \ncambios en el leucograma m\u00e1s evidentes fueron \nheterofilias  asociadas a la patogenicidad del virus y \nlinfopenias por linfotoxicidad a partir de las 24 hpi.  \n \nREFERENCIAS  \n1. The american association of avian \npathologist. Avian diseases manual. 3\nrd ed. \nPhiladelphia: Kendall/Hunt Publishing Company, 1979: 16- 20. \n2. Calnek BW. Diseases of poultry. 9 ed. USA: \nIowa State University Press, 1991: 532 -551. \n3. Capua I, Marangon S. The avian influenza \nepidemic in Italy, 1999- 2000: a review. Avian \nPathology 2000; 29:  289-294. \n4. Campen VA, Easterday CB, Hinshaw SV. \nVirulent avian influenza a viruses:Their Effect on Avian Lymphocytes and macrophages in vivo and in vitro. J.gen.Virol. 1989; 70:2887- 2895.  \n5. Barnes JH. Hemic system. In:The american \nassociation of avian patholo gists. Avian \nhistopathology. 2d ed. Canada. American Association \nof Avian Pathologists, 1999:1- 17.  \n6. Campbell WT. Avian hematology and \ncitology.2d ed. USA: Iowa State University Press, \n1995:3- 19.\n \nISOLATION OF LOW PATHOGENICITY AVIAN INFLUENZA \nVIRUS (H6N2) FROM CHICKENS IN CALIFORNIA, 2000 -2001  \n \nAISLAMIENTO DE UN VIRUS DE LA INFLUENZA AVIAR DE BAJA \nPATOGENICIDAD (H6N2) DE POLLOS EN CALIFORNIA, 2000-2001  \n \nWoolcock, P. R.A, Suarez, D. L.B and Kuney, D.C \n \nACalifornia Animal Health and Food Safety Laboratory Sys tem, University of California, Davis, Fresno Branch, \n2789 S Orange Ave., Fresno, CA 93725  \nB Southeast Poultry Research Laboratory, 934 College Station Rd., Athens, GA 30605  \nC Department of Animal Sciences, Cooperative Extension, University of California, R iverside, 21150 Box Springs \nRoad, Moreno Valley, CA 92557  \n \nRESUMEN  \nSe aisl\u00f3 un virus de la influenza aviar de pollos en \n10 diferentes lugares de California. Los aislamientos se \ntipificaron como H6N2 y se determin\u00f3 que eran de baja \npatogenicidad para el po llo. Siete de los aislamientos \nproced\u00edan de parvadas de postura comercial y tres de instalaciones mixtas donde exist\u00edan otras especies de \naves. Estos aislamientos se agruparon en forma \nseparada de otros virus de la influenza con base en los \ndatos de secuen cia de los genes de la H6, la \nneuraminidasa (N2) y la matriz (MA). El an\u00e1lisis de la \nsecuencia del gene no estructural ( NS) indic\u00f3  \n  \n153 introducciones de dos or\u00edgenes separados. Los genes \nN2, MA y NS  est\u00e1n relacionados con los aislamientos \nnorteamericanos, pero  el gene H6 est\u00e1 relacionado con \nun aislamiento de Eurasia.  \n \nReports of avian influenza virus (AIV) isolations \nfrom chickens have been relatively rare when compared to the number of reports from domestic \nturkeys and ducks (1). In the 1990\u2019s there were no \nisolations reported of high pathogenic avian influenza \n(HPAI) virus in chickens in North America and the \nnumber of reported isolations of low pathogenic AIV \nwas low; an H10 subtype was isolated in 1992, H 5N2 and H6 subtypes were isolated in 1993 and an H7N 2 \nsubtype in both 1995 and 1996 (4). No isolations were \nreported in 1997 or 1998 other than from live bird \nmarkets (2,3).  \n In California, the first and only AIV isolated \nfrom chickens in the 1990\u2019s was in 1999 from layers; it was an H10N7 subtype (5). Duri ng 2000- 2001, 10 \nseparate incidences of AIV infections occurred in \nchickens. All the AIVs isolated were identified as \nsubtyped H6N2. This number of isolations from \nseveral locations was unusual. It has provided an \nopportunity to relate the clinical and epi demiological \nobservations from these outbreaks to some of the \ngenetic characteristics of these virus isolates.  \nThe layer flocks from which virus isolations were \nmade were located in an area approximately 40 x 20 \nmiles in Southern California; the remaining birds from \nwhich viruses were isolated were elsewhere in the state of California. In the layers, the main clinical signs \nobserved were a slight drop in egg production and mild \nrespiratory distress.  \nIn terms of time, 3 separate outbreaks appear to \nhave occu rred, the first was in February/March 2000 (4 \ncases), the second in January/February 2001 (2 cases), \nand the most recent in June to September 2001 (4 \ncases). The first 4 cases occurred within 6 weeks of \neach other; 3 were in closely located layer flocks bu t \none isolate was from a rooster in a backyard flock of 20 \nbirds located near the Pacific coast in Los Angeles \nCounty, about 60 miles away. In January/February \n2001 2 cases occurred more than 300 miles apart; one \nin a mixed flock where other species were also present, the other in Southern California layers, close to the \noutbreaks of the previous year. The outbreaks later in \n2001 occurred over a 10- week period. In June, the first \ncase occurred in San Diego County, more than 80 miles from the concentration o f commercial layer \noperations. This was at a mixed operation where ducks were also present. The remaining 3 cases were \ngeographically more closely linked but still 10 to 30 \nmiles apart from each other.  \nFour different genes from the H6N2 isolates from \nall ten outbreaks were sequenced and compared.  This included the HA1 gene sequence from all ten isolates, \nand the full coding sequence from the neuraminidase \n(N2), nonstructural (NS), and matrix (MA) gene \nsegments. For the H6, N2 and MA gene segments, all \nthe isolates clustered as a unique group separate from \nother influenza viruses. The NS gene had two \ncompletely separate groups, with 5 isolates belonging to NS subtype (group) A, and 5 isolates belonging to \nsubtype (group) B.  The NS gene difference was \nintere sting in that the isolates did not completely \nseparate based on the year of isolation.  The NS subtype B isolates included all the 2000 isolates but \nalso one of the 2001 isolates.  \nPhylogenetic analysis as well as pair wise \nsequence analysis with the index  case, CK/CA/431/00, \nshowed that the N2, MA and NS gene clusters were \nmore closely related to other North American isolates.  The H6 was more closely related to a Eurasian isolate; \nhowever, few H6 sequences are available to \ndefinitively prove the origins o f the H6 gene.  \n \nREFERENCES  \n1. Alexander, D. J. A review of avian influenza \nin different bird species. Vet. Microbiol. 74:3 -13. 2000.  \n2. Committee on Transmissible Diseases of \nPoultry. Avian Influenza. Proceedings of the 102nd \nAnnual Meeting of USAHA. Minneapolis , MN. p. 618. \n1998.  \n3. Committee on Transmissible Diseases of \nPoultry and other Avian Species. Avian Influenza. \nProceedings of the 101st Annual Meeting of USAHA. \nLouisville, KY. pp. 497- 498. 1997.  \n4. Pearson, J. E., D. A. Senne, and B. \nPanigrahy. Avian Influenz a in the Western Hemisphere \nincluding the Pacific Basin 1992 -1996. Fourth \nInternational Symposium on Avian Influenza. R. D. Slemons, ed. Athens, GA. pp. 14 -17. 1997.  \n5. Woolcock, P. R., M. D. McFarland, S. Lai, \nand R. P. Chin. Enhanced recovery of avian influenza \nvirus isolates using a combination of chicken embryo \ninoculation methods. Avian Dis. 45: 1030- 1035. 2002.  \n \n \n  \n  \n  \n154 USO DEL ENSAYO ELISA PARA DETECTAR ANTICUERPOS \nCONTRA SALMONELLA ENTERITID IS EN YEMA DE HUEVO Y \nESTABLECER EL ESTADO DE INFECCION  \n EN GALLI NAS DE POSTURA  \n \nTHE USE OF ELISA TO DETECT SALMONELLA ENTERITIDIS  (Se) \nANTIBODIES IN THE YOLK SAC, AND TO ESTABLISH INFECTION STATUS \nIN LAYING HENS  \n \nEsmeralda Ch\u00e1pero, Rub\u00e9n Merino y Odette Urquiza  \n \nDepartamento de Producci\u00f3n Animal: Aves, FMVZ, UNAM, M\u00e9xi co, D. F., 04510  \n \nSUMMARY  \nThe purpose of this research was to rule out the \npresence of Se in table eggs, and to detect Se \nantibodies in the yolk sac using the ELISA, plate \nagglutination, and microagglutination tests.  Bacterial isolations from both intern al and external sampling of \n180 eggs were negative to Se in all groups. The ELISA \ntest showed a range of 3.3 -  20 positive yolks. \nMicroagglutination yielded 0 -3.3% positive results. All \nsamples were negative to the plate agglutination test.  \n \nRESUMEN  \nEl  ob jetivo de este trabajo fue descartar la \npresencia de Salmonella enteritidis  en huevos para \nconsumo humano, as\u00ed como detectar anticuerpos contra \n\u00e9sta en la yema del huevo, con las pruebas ELISA, \nAglutinaci\u00f3n en Placa y Microaglutinaci\u00f3n. El aislamiento bacteriano a partir del muestreo externo e \ninterno de 180  huevos para el aislamiento de Se fue \nnegativo a  Se en todos los grupos. Se evalu\u00f3 la yema \npor AP, MA y ELISA. Por ELISA se encontraron yemas positivas entre 3.3% y 20%; en la MA los \nresultados positiv os fueron del 0% al 3.3%. Todas las \nmuestras fueron negativas por AP.  \n \nINTRODUCCI\u00d3N  \nLa avicultura es un ejemplo de eficiencia \nproductiva, alcanzar las metas productivas ha requerido \nforzar el organismo de las aves de una manera \nconstante, lo que implica la  predisposici\u00f3n a \nenfermedades diversas, como el s\u00edndrome asc\u00edtico, salmonelosis, etc. (falta referencia)  \n La salmonelosis aviar ha tenido grandes \nrepercusiones econ\u00f3micas en avicultura, debido principalmente ha que los medios de publicidad han \ndivulgado la  posible asociaci\u00f3n de Salmonella \nenteritidis  (Se) y la revelaci\u00f3n de que algunos \nfagotipos de esta pueden transmitirse a trav\u00e9s de huevos al humano (6). La contaminaci\u00f3n de productos \nav\u00edcolas con salmonela (carne y huevo), ha provocado que la legislaci\u00f3n nacional e internacional realicen \nconstantes monitoreos en las aves. El procedimiento de \nrutina es el aislamiento bacteriano, sin embargo, el \nEnsayo Inmunoabsorbente de Enzima ligada (ELISA) se usa para detectar dichas infecciones, debido a que es \npr\u00e1ctica, sensible a la detecci\u00f3n de anticuerpos (1,2).  \nEl objetivo de este trabajo fue descartar la \npresencia de Se en huevos para consumo humano, as\u00ed \ncomo, la detecci\u00f3n de anticuerpos contra \u00e9sta en \nmuestras de yema de huevo por medio de las pruebas ELISA, Aglut inaci\u00f3n en Placa y Microaglutinaci\u00f3n.  \n \nMATERIAL Y M\u00c9TODOS  \nSe obtuvieron 180 huevos, de 6 procedencias, 30 \nhuevos por procedencia, 150 fueron comprados en la Central de Abastos de la Ciudad de M\u00e9xico y 30 adquiridos en el mercado de Chalco Estado de M\u00e9xico.  \nAislamiento Bacteriano.  \nMuestreo externo:  Cada huevo se identific\u00f3 \nindividualmente. Cada uno fue colocado individualmente en bolsas de pl\u00e1stico est\u00e9riles, \nempleando guantes para evitar contaminar el cascar\u00f3n \ncon las manos. La b\u00fasqueda de Salmonella sp se \nrealiz\u00f3 de acuerdo con la t\u00e9cnica descrita por Gentry, \n1972.  \nMuestreo interno:  El cascar\u00f3n se sec\u00f3 y se \nlimpi\u00f3 con alcohol al 70%, cada huevo se abri\u00f3 con \ntijeras est\u00e9riles (NOM -005-ZOO- 1993), de cada uno se \ntom\u00f3 1ml de yema, la cu\u00e1l fue depositada en tubo s con \n10ml de Caldo tetrationeto (CT), se homogeneizaron y \nse incubaron durante 24 horas a 37\u00b0C, sembrando \nposteriormente 1 asada de CT en agar de Mac Conkey (McC) con el mismo m\u00e9todo que en el muestreo externo (Gentry, 1972).  \nAl tiempo de tomar la yema pa ra muestreo \ninterno, se obtuvo 1/2ml de yema para la prueba \nELISA y otro 1/2ml para la prueba de \nmicroaglutinaci\u00f3n, cada muestra se mezcl\u00f3 con 1/2ml \nde PBS, las muestras fueron mantenidas bajo congelaci\u00f3n y refrigeraci\u00f3n respectivamente.   \n  \n155 ELISA: Durante la toma de muestras, las yemas \nfueron diluidas 1:2, con PBS. Posteriormente de la \ndiluci\u00f3n 1:2, se agreg\u00f3 0.2ml de yema a un tubo que \nconten\u00eda 1.8ml de PBS para obtener una diluci\u00f3n final \nde 1 en 20.  \nSe utiliz\u00f3 un kit comercial de acuerdo con las \ninstruccione s del fabricante.  Las muestras se diluyeron \n1/400 y se incubaron en las placas absorbidas con \nant\u00edgeno Lipopolisacarido (LPS) de Se, despu\u00e9s de un \nper\u00edodo de incubaci\u00f3n, las placas fueron lavadas y se \nles agreg\u00f3 el conjugado, por \u00faltimo se agrego la \nsoluci \u00f3n STOP, y se ley\u00f3 a 405nm en el \nespectrofot\u00f3metro,  (MR 650, DINATECH Laboratories, \nInc). T\u00edtulos de 0 fueron considerados negativos, de \n750 a 1795 sospechosos y t\u00edtulos mayores a 1796 \npositivos.  \nAglutinaci\u00f3n en Placa (AP):  En una placa se \ncoloco 0.1ml de cada muestra de yema diluida \npreviamente 1:2, a \u00e9stas se les agrego una gota de ant\u00edgeno de Salmonella, \nVINELAND, ( Laboratories of \ninmunogenetics, Inc. Afiliate of 461). Se incub\u00f3 a \ntemperatura ambiente durante 2 minutos, en espera de \nobservar reacci\u00f3n de aglutinaci\u00f3n durante ese tiempo.  \nMicroaglutinaci\u00f3n (MA): Las muestras diluidas \n1:2 fueron posteriormente diluidas en forma serial (1: a 1:64) en microplacas de titulaci\u00f3n de fondo en \"U\". Se \ncolocaron 100\u00b5l de ant\u00edgeno (de elaboraci\u00f3n local) en \ncada pozo. Las placas se incubaron en c\u00e1mara h\u00fameda a 37\u00b0C durante 24 horas. Las muestras se consideraron \npositivas cuando tuvieron t\u00edtulo de microaglutinaci\u00f3n \nsuperior a 1:20.  \n \nRESULTADOS  \nEl aislamiento bacteriano demostr\u00f3 la ausencia de \nSe en todos los grupos. La prueba de AP result\u00f3 \nnegativa para todas las muestras de todos los grupos. \nLa figura 1 muestra la reacci\u00f3n porcentual de casos positivos, negativos y sospechosos, identificados por \nlas pruebas ELISA y MA. Por ELISA se encontraron \npositivos que fluctuaron entre 3.3% y 20%, los \nnegativos variaron del 63.3% al 90%, mientras que los \nsospechosos estuvieron en el rango del 6.7% al 20%. \nEn la MA los resultados positivos fueron del 0% al \n3.3%, los negativos del 56.7 al 100% y los sospechosos \ndel 0 al 40%.  \n \nDISCUSI\u00d3N  \nEn el presente trabajo no se aisl\u00f3 Se, sin embargo, \nse aislaron E.coli y Enterobacter cloacae en la mayor\u00eda \nde los grupos, bacterias que muy probablemente \nprovienen del medio ambiente, estos resultados \ncoinciden con los de Padr\u00f3n (1992) quien en un estudi o \nde campo realizado en granjas comerciales, encontr\u00f3 \nque el 12% de los huevos limpios puestos en nidos \nfueron penetrados y contaminados por diferentes \nbacterias.  Durante los \u00faltimos a\u00f1os se han hecho progresos \nen la detecci\u00f3n de anticuerpos Se, Salmonella  \ntyphimurium,  incluso S. arizonae, S. berta, S. \ngallinarum  y S. pullorum (1), sin embargo, los \nresultados dependen de la calidad del ant\u00edgeno as\u00ed \ncomo del manejo que se le da  (Gast, 1997).  \nLos resultados de este trabajo, donde la AP de \ntodas las muestras fue negativa, mientras que por \nELISA y MA se encontraron tanto muestras \nsospechosa como positivas, estas \u00faltimas en baja \nproporci\u00f3n. Lo anterior coincide a los resultados de \notros investigadores , quienes encontraron diferencias \nentre los resultados obtenid os por AP y  aquellos \nobtenidos con ELISA en muestras de suero de una parvada infectada con Se. Estas diferencias \nconsistieron en que de algunas muestras que no \naglutinaron, al realizar la ELISA se obtuvieron valores \nde Densidad Optica (DO) relativamente altos, mientras que sueros que aglutinaron tuvieron DO bajas (1). Lo \nanterior puede deberse a reacciones falso positivas o \nreacciones cruzadas, las cu\u00e1les se deben al uso de \nmuestras muy diluidas, a una mala elecci\u00f3n en el kit \u00f3 \npor la misma muestra de yema, la cu\u00e1l contiene grasa que puede interferir con los resultados (1,2).  \nLo anterior sugiere que es necesario conocer la \nhistoria cl\u00ednica de la parvada, calendario de \nvacunaci\u00f3n, % de postura y manifestaciones cl\u00ednicas de enfermedad, para descartar salmonel osis por \naislamiento bacteriano y/o por serolog\u00eda, y recordar que Se puede ocasionar infecciones subcl\u00ednicas y si la parvada tiene buen manejo no habr\u00e1 eliminaci\u00f3n de \nsalmonela (5).  \n \nREFERENCIAS  \n1. Barrow, P.A.: The paratyphoid salmonellae. \nRev. sci. tech. o ff. Int. Epiz, 19 (2): 351- 375 (2000)  \n2. Barrow, P.A.: Use of ELISAs for \nmonitoring Salmonella in poultry. Vet. Rec., 22:99 \n(1994)  \n3. Garc\u00eda Meneses, A., T\u00e9llez- Isaias, G., \nGarc\u00eda- Espinoza, G., Valladares -de la Cruz, J.C. y \nUrquiza -Bravo, O.: Determinaci\u00f3n de la existencia de \nSalmonella enteritidis  serotipo enteritidis de 95 \naislamientos de cepas de campo de Salmonella  en aves \ndom\u00e9sticas. Vet. M\u00e9x. 27: 343 -345 (1996).  \n4. Gast, R.K and Holt, P.S.: Experimental \nhorizontal transmission of Salmonella enteritidis  \nstrains  (Phage 4,8, and 13A) in chicks. Avian Dis., 43: \n774-778 (1999).  \n5. Gast, R.K, Porter, R.E, JR., and Holt, P.S.: \nAssessing the sensitivity of egg yolk antibody testing \nfor detecting Salmonella enteritidis  infections in laying \nhens. Poultry sci., 76: 798- 801 ( 1997)  \n6. Gentry, R.F., y Quarles, C.L.: The \nmeasurement of bacterial contamination in egg shell. \nPoultry sci. 51:930- 933 (1972).   \n  \n156 0.00%20.00%40.00%60.00%80.00%100.00%\n%\nGRUPOSFigura 1. Relaci\u00f3n porcentual de los casos positivos, negativos y \nsospechosos en las pruebas ELISA y MA\n%(+) ELISA 3.30% 16.70 0% 3.30% 20% 3.30%\n% (+) MA 0.00% 0.00% 3.3% 0.00% 0% 0.00%\n%(-) ELISA 80% 63.30 83.30 90% 63.30 90%\n 1 2 3 4 5 6\n \n \nASPECTOS RELEVANTES DEL PROCESO DE COAGULACI\u00d3N  \nEN LAS AVES  \n \nRELEVANT ASPECTS OF THE BLOOD CLOTTING PROCESS IN BIRDS  \n \nM.V.Z. Esp. Mar\u00eda de la Luz Vilma Charles Noriega.  \n \nDepartamento de Producci\u00f3n animal: Aves  F.M.V.Z.   U.N.A.M. (E -mail: madelaluzch@yahoo.com.mx)  \n \nSUMMARY  \nHemostasis in birds has important differences \nwhen compared with that in mammal s and man. The \nimportance of thrombocytes in the formation of the \nhemostatic clot and their phagocytic activity have been \nrecognized. Thrombocyte counts can show alterations \nin blood clotting process, septicemic/toxic processes, and bone marrow hipoplasia.  During the biochemical \nstage the production of tissue thromboplastin and prothrombin is more efficacious. Prothrombin has \nshown to be the most sensitive parameter in the \ndetection of hemostasis alterations resulting from \nmycotoxin (i.e. aflatoxin, fumonis in) toxicity.  \n \nRES\u00daMEN  \nLa hemostasis aviar presenta diferencias \nsignificativas con respecto a los mam\u00edferos y el hombre.  \nEs reconocida la acci\u00f3n de los trombocitos para la \nformaci\u00f3n del tap\u00f3n hemost\u00e1tico, as\u00ed como su actividad fagocitaria. El conteo de tro mbocitos indica \nalteraciones en el proceso coagulativo y as\u00edmismo procesos septic\u00e9micos, t\u00f3xicos o de hipoplasia \nmedular. En la etapa bioqu\u00edmica es m\u00e1s eficaz la \nproducci\u00f3n de tromboplastina tisular y protrombina.  \nEsta \u00faltima ha demostrado ser el par\u00e1metr o m\u00e1s \nsensible para detectar alteraciones de la hemostasis que \npueden presentarse durante la intoxicaci\u00f3n con \nmicotoxinas como aflatoxinas y fumonisina.  \nAlgunos estudios sobre la coagulaci\u00f3n sangu\u00ednea \nde las aves se han publicado hace muchos a\u00f1os.  En 1934 se public\u00f3 un trabajo sobre la di\u00e1tesis \nhemorr\u00e1gica de los pollos.  Desde entonces los conocimientos acerca de la vitamina K y su metabolismo, comenzaron a cobrar mayor importancia, \nno s\u00f3lo en las aves sino tambi\u00e9n, en los mam\u00edferos y el \nhombre.  \nWartelle,  en 1957, estudi\u00f3 las diferencias \nexistentes en el proceso de coagulaci\u00f3n en las aves, encotrando que la generac\u00ed\u00f3n extr\u00ednseca de la tromboplastina tisular es m\u00e1s importante que la de \ntromboplastina intr\u00ednseca (plasm\u00e1tica).  \nDe hecho, la presencia de peque\u00f1 as cantidades de \njugos tisulares en contacto con el plasma, afectan de  \n  \n157 manera muy importante los tiempos de coagulaci\u00f3n en \nlas aves.  \nEste sistema depende de la mezcla de los jugos \ntisulares con la sangre y no as\u00ed de las superficies de contacto.  \nEl hemat\u00f3lo go que trabaje con la sangre de aves, \ndebe pensar que \u00e9stas poseen una temperatura corporal de 41 grados C y un sistema tegumentario distinto en el \nque las plumas constituyen una barrera temporal que \ninteract\u00faa con la sangre coagulada. (Archer, 1965).  \nEl f en\u00f3meno de la coagulaci\u00f3n se realiza \nmediante la interacci\u00f3n del tejido de los vasos \nsangu\u00edneos, los trombocitos y ciertas prote\u00ednas del plasma (factores de la coagulaci\u00f3n).  \nEtapas de la hemostasis:  \na) Primaria o celular  \nb) Secundaria o bioqu\u00edmica.  \n \nHEMOST ASIS PRIMARIA  \nEn esta etapa, intervienen principalmente las \nplaquetas, en los mam\u00edferos y los trombocitos en las \naves.   \nEl papel de los trombocitos de las aves en el \nproceso de coagulaci\u00f3n, es incierto. Estos se \ncaracterizan por ser c\u00e9lulas ovales, nucleadas, con uno \no dos gr\u00e1nulos azur\u00f3filos a uno y otro polo del n\u00facleo \nde la c\u00e9lula y citoplasma claro, ligeramente vacuolado.  \nEstas c\u00e9lulas tienen pseud\u00f3podos y funci\u00f3n \nfagoc\u00edtica.  Usualmente, se encuentran de uno a dos \ntrombocitos por campo con el objetivo seco fuerte y en \ntotal hay aproximadamente de 20 000 a 30 000/ul.  \nEstas c\u00e9lulas, despu\u00e9s de la exposici\u00f3n del \nsubendotelio y la vasoconstricci\u00f3n durante el da\u00f1o vascular, se encargan de formar el tap\u00f3n hemost\u00e1tico \ngracias a la acci\u00f3n de la prote\u00edna de Von  Willebrand \nque favorece la adherencia plaquetaria.  \n \nHEMOSTASIS SECUNDARIA  \nPor la interacci\u00f3n con el factor III  trombocitario, \nse activan los factores bioqu\u00edmicos de la coagulaci\u00f3n, que son prote\u00ednas que se producen en el h\u00edgado, con excepci\u00f3n del Calcio (Factor IV).  \nEsta consta de la v\u00eda intr\u00ednseca y de la v\u00eda \nextr\u00ednseca y su finalidad principal es formar la malla de fibrina. La v\u00eda intr\u00ednseca se llama as\u00ed por llevarse a cabo a partir de elementos que se encuentran en la \nsangre solamente a diferencia de l a v\u00eda extr\u00ednseca, en la \nque act\u00faa la tromboplastina tisular.  \nEl objetivo final de la v\u00eda intr\u00ednseca, es la \nformaci\u00f3n de la trombopastina plasm\u00e1tica, en la que \nact\u00faan  en forma consecutiva los factores XII, XI, IX.,VIII, IV( CA++), V y X.  \nEsta etapa en las aves, se realiza de manera muy \nr\u00e1pida y de hecho, se sabe que \u00e9stas poseen cantidades m\u00ednimas de factores XII, IX, (Sturkie y Butler, 1983)  \nV, VII y X. (Doerr y Hamilton, 1974). La interacci\u00f3n de todos estos factores se v\u00e9 favorecida por su adhesi\u00f3n \nal Factor 3 trombocitario  y tisular.  \nEn el hombre y los mam\u00edferos act\u00faan de manera \nigualmente importante los 12 Factores bioqu\u00edmicos, \nque se producen en el h\u00edgado, con excepci\u00f3n del IV \n(Ca++).  \nEn las aves, la v\u00eda extr\u00ednseca es la m\u00e1s \nimportante. La finalidad  de \u00e9sta es la formaci\u00f3n de la \ntromboplastina tisular (Factor III), en la que act\u00faan los \nfactores II,( fibrin\u00f3geno) V, VII y X (Stuart), que son \ndependientes de la vitamina K.  \nLa vitamina K se encuentra en el hepatocito de \nmanera que es indispnsable para q ue se agregen los \ngrupos carboxiglut\u00e1micos de \u00e9sta a la mol\u00e9cula de los \nfactores dependientes gracias a lo cu\u00e1l estos adquieren \ncarga el\u00e9ctrica negativa para adherirse a los \ntrombocitos por medio de las cargas el\u00e9ctricas positivas \nde los iones de Ca++ y po der interactuar con otros \nfactores de la coagulaci\u00f3n.  \nEsto explica por qu\u00e9 cualquier cirucunstancia en \nque exista deficiencia de vitamina K produce sangrados \nanormales.  \nValoraci\u00f3n de la hemostasis primaria:  \nEn las aves, la cuenta de trombocitos, descrita p or \nCampbell (1988).  La cantidad normal de trombocitos \noscila de 20 000 a 30 000/ul.  \nSu cantidad aumenta durante enfermedades \nt\u00f3xicas y septic\u00e9micas y disminuye cuando hay enfermedades virales graves,  procesos leuc\u00e9micos y \ntoxemias.  \nTiempo de sangrado:  \nEsta prueba se realiza para valorar la cantidad y \ncalidad de los trombocitos, as\u00ed como la integridad de el endotelio vascular,  una posible deficiencia hep\u00e1tica, \nprocesos t\u00f3xicos o presencia de anticoagulantes.  \nEl tiempo de sangrado en aves es \naproximadament e de 5 min . (Ju\u00e1rez y cols. (1997).  \nValoraci\u00f3n de la hemostasis secundaria:  \nTiene por objeto detectar alteraciones en las v\u00edas \nintr\u00ednseca, extr\u00ednseca y com\u00fan de la coagulaci\u00f3n a \npartir de plasma citratado (con el calcio precipitado e \ninactivo, que lo vuel ve incoagulable) en un tubo de \nensayo y en determinadas condiciones para medir \ncu\u00e1nto tiempo tarda en producir fibrina.  \nEn este fen\u00f3meno, como es bien sabido, \nintervienen los doce factores de la coagulaci\u00f3n, que en \nsu mayor\u00eda, con excepci\u00f3n del factor IV ( calcio) se \nproducen en el h\u00edgado.  \nLa v\u00eda intr\u00ednseca  tiene por objeto producir la \ntromboplastina plasm\u00e1tica, mediante la activaci\u00f3n de los factores XII, XI, IX, VIII, X y V en orden \nsecuencial.  \n Este proceso es de menor relevancia en las aves. \nDidisheim (1 959) reporta que esta etapa es \n\u201cineficiente\u201d al ser comparada con los est\u00e1ndares \naplicados para los mam\u00edferos, puesto que en aves,  \n  \n158 existen en muy poca cantidad los factores  V y VII, \npero sin embargo, Stopforth, (1970), confirm\u00f3 la \npresencia de factor X.  pero se puede utilizar la \nmedici\u00f3n del tiempo parcial de tromboplastina activada \npara explorar los factores XII, XI, IX, X, VIII y V. \n(Archer, 1965).  \nEl tiempo normal de tromboplastina parcial \nactivada es de 29 a 37 seg. En las aves se considera que es m\u00e1s  importante  la valoraci\u00f3n de la v\u00eda extr\u00ednseca, \npor medio de la prueba de el tiempo de \nprotrombina,(M\u00e9todo de Quick de un solo paso), que \ntrabaja con sangre citratada y tromboplastina hom\u00f3loga \n(Factor 3 tisular).  \nLa fibrina tarda en formarse de 12  a 14 seg \naproximadamente,  para \u00e9sto se requiere la presencia de \nlos factores dependientes de la vitamina K, (II,V,VII y \nX).  \nEn las aves, la deficiencia de vitamina K no es \ncom\u00fan puesto que se encuentra en los componentes de la dieta y adem\u00e1s, se sintetiza en el intestino pero se \npuede presentar por el uso inapropiado de antibi\u00f3ticos \nde amplio espectro, como sulfas, cefalosporinas y \nsalicilatos sin el apropiado aporte vitam\u00ednico, enteritis \ny malabsorci\u00f3n. As\u00edmismo, la dieta deficiente en \ngrasas, la deficiencia hep\u00e1tica y/o  colestasis, donde no \nhay suficiente aporte de sales biliares para la absorci\u00f3n \nde grasas, necesarias para el transporte de vitamina K.  \nPara realizar el tiempo de protrombina,  se \nrequiere de tromboplastina hom\u00f3loga, obtenida a partir \nde un ma cerado de cerebro de pollitos de menos de 3 \nsemanas de edad. ( Doerr y Hamilton, 1975).  \nEl tiempo de protrombina normal es de  9- 11seg. \n(Quick, 1938).  \nGrimminger (1970) indica que la nutrici\u00f3n con \nvitamina K influy\u00f3 en la actividad trombopl\u00e1stica del polvo de extracto de cerebro, dado que en la sangre \nremanente del cerebro de aves, contiene factores VII, \nIX y X en forma muy escasa.  \nEl tiempo de coagulaci\u00f3n , (M\u00e9todo de Lee-\nWhite modificada )  (Ju\u00e1rez y cols.1997)  permite diferenciar las alteraciones de tip o trombocitop\u00e9nico de \naqu\u00e9llas de or\u00edgen bioqu\u00edmico, puesto que en las \nprimeras, el tiempo de coagulaci\u00f3n es normal. Tambi\u00e9n \neval\u00faa en forma general la deficiencia de vitamina K, \nfibrin\u00f3geno, protrombina  y la presencia de anticoagulantes.   Seg\u00fan lo repor tado por Ju\u00e1rez y \ncols., el tiempo de coagulaci\u00f3n en aves se logra dentro de un intervalo de 3.60 a 6.40 min.  \nEspada, ( 1996) report\u00f3 que la micotoxicosis por \nFumonisina en pollos de engorde produce cambios en la concentraci\u00f3n de las prote\u00ednas plasm\u00e1ticas y en la \ncoagulaci\u00f3n con una dosis de 10 mg /kg.  Los pollos \nproblema comparados con los testigo, mostraron disminuci\u00f3n en el tiempo de protrombina. La protrombina result\u00f3 ser el elemento m\u00e1s sensible.  \nFern\u00e1ndez, en 1995, corrobora que la medici\u00f3n \ndel tiemp o de protrombina es un buen indicador la de \nla presencia de aflatoxicosis en las aves, demostrando que con la adici\u00f3n de 2.5 \u2013  5.0 ug/g de aflatoxina, hay \nincremento en el TP (de 13.2 seg en las aves control a \n15.7 seg en las aves intoxicadas con 5 ug /g d e \naflatoxina.), con disminuci\u00f3n de la alb\u00famina, alfa y \nbeta globulinas.  \nStopforth, en 1970, demostr\u00f3 que la inyecci\u00f3n \ncon warfarina a dosis de 10 mg/kg provoc\u00f3 un \nincremento notable en el tiempo de protrombina a las \n48 horas despu\u00e9s de la primera inyecci\u00f3n . \nSeg\u00fan Didisheim et al. ( 1959), hay ausencia o \ngran escas\u00e9s de factores VII y X y muy escaso factor IX en las aves.  La warfarina act\u00faa principalmente \nsobre el factor VII, explicando as\u00ed la gran cantidad de \nWarfarina requerida en las aves para prolongar el \ntiempo de protrombina.  Seg\u00fan el autor, las aves tienen el 5% de factor V comparado con el hormbre.  La \npresencia de factor X se confirma con la disminuci\u00f3n \ndel tiempo de protrombina tras la adici\u00f3n de plasma \nnormal a las aves despu\u00e9s de 48 horas de adi cionar \nwarfarina.  \n \nREFERENCIAS  \n1. Archer. R.K. Blood coagulation In: \nPhysiology and Biochemistry of the domestic Fowl.Academic Press, New York. 897 -911. 1971.  \n2. Campbell, T . Avian Hematology and \nCytology. Iowa State University Press/Ames.1:12. \n1988.  \n3. Doerr, J.A., Wyatt, R.D. and Hamilton, P.B. \nInvestigation and Standarization of prothrombin times \nin chickens. Poultry Science 54: 969 -980. 1975.  \n4. Doerr, J.A.; Hamilton, P.B.. Aflatoxicosis \nand intrinsec coagulation function in broiler chickens.  \nPoultry Science, 60:  1406- 1411. 1981.  \n5. Espada, Y., Ru\u00edz, G.R., et al. Fumonisin \nmycotoxicosis in broilers. Plasma proteins and \ncoagulation modifications. Avian diseases, 41: 73 -79. \n1997.  \n6. Grimminger, P.. Blood coagulation. In: \nSturkie, P.D. Avian Physiology. Cornell Univ. Press . \nN.Y. 21 -31. 1965.  \n7. Quick, A.JThe hemorragic diseases. Lea and \nFebiger, Philadelphia. 1957.  \n8. Stopforth, A. A study of coagulation \nmechanisms in domestic chickens. J. comp. path. \nvol.80. 1970.  \n9. Villanueva, J.V. Orientaci\u00f3n diagn\u00f3stica en \nlas hemorragias. Revi sta de posgrado de la c\u00e1tedra Via \nMedicina No. 106. 1- 7. 2001.  \n \n  \n  \n159 FEEDING EARLY MATURI NG COMMERCIAL LAYERS  \n \nALIMENTACI\u00d3N DE PONEDORAS COMERCIALES  \nDE MADUREZ TEMPRANA  \n \nBernie Beckman, DVM  \n \nHy-Line International, 2583 240th Street, P.O. Box 310, Dallas Cente r, IA  50063  \n \nRESUMEN  \nLa selecci\u00f3n gen\u00e9tica de las ponedoras tipo \nLeghorn se ha enfocado hacia la madurez sexual \ntemprana y ha mejorado la eficiencia alimenticia. Al \nmismo tiempo se ha incrementado en forma importante el n\u00famero y la masa de huevo. No obst ante, mientras se \nhan realizado todos estos cambios, el peso corporal del \nave ha permanecido sin cambios o incluso ha \ndisminuido. Para lograr el potencial de estos \nmejoramientos gen\u00e9ticos, es necesario definir los \nrequerimientos diarios de nutrimentos de e stas \nvariedades de aves. Presentaremos a discusi\u00f3n un \nresumen de las necesidades nutricionales de una estirpe \nLeghorn de madurez temprana utilizando como \nejemplo la Hy -Line W -98. Ilustraremos con casos de \ncampo la importancia de los niveles de calcio y f\u00f3s foro \npara evitar deformaciones esquel\u00e9ticas, fatiga de jaula \ny mala calidad del  cascar\u00f3n.  \n \nGenetic selection for earlier sexual maturity in \ncommercial pullets has occurred at the same time egg numbers and case weights have increased.  This \nchallenges the  nutritionist and producer to formulate \nfeeds that deliver the required nutrients within the \nconstraints of the actual flock feed consumption.  \nEarlier sexual maturity and lower feed intakes in these \nmodern varieties has made it difficult to formulate \nfeeds containing enough calcium, phosphorus, energy \nand protein to meet the hens\u2019 needs on a daily intake \nbasis.  High demand for eggshell formation in these \nlaying hens can lead to the progressive loss of \nstructural bone during the laying period leading to \nosteoporosis.  To be discussed will be the nutritional \nneeds for early maturing hens and field cases to \nillustrate the importance of calcium, phosphorus, and \nVitamin D\n3 in avoiding skeletal deformities, cage layer \nfatigue (CLF), and poor eggshell quality in layers.  See \nTable 1 for current W -98 nutritional recommendations.  \nInadequate intakes of Calcium, Phosphorus and \nVitamin D 3 can result in the following clinical signs:  \n1. Mortality  from soft bones, prolapse, or lung \ncongestion  \n2. Decreased rate of lay  with poor peak or a post \npeak dip.  3. Loss of shell quality  particularly late in lay.  \nEggshell quality usually declines only after many weeks of low calcium or phosphorus intake.  \n4. Erratic egg production  from birds that cycle in \nand out of production.  \n5. Cage layer fatigue  (CLF) (osteoporosis) starting \nat any time during the production period.  The \nsigns of CLF are crooked keels often in a \ncharacteristic S -shape.  Often the tip of the keel \nbone is bent or tipped.  A collapsed rib cage with \nbeaded ribs is another common find ing.  Soft, \nrubbery keel bones suggest the bird is presently in a negative calcium and phosphorus balance.  Deformed but firm bones and beaded ribs suggests \nthe condition occurred previously and is now \nrecovered.  \nReasons for an increase in CLF:  \n1. Genetic.   Selection for smaller body weight, \nhigh rate of lay and earlier sexual maturity has made it difficult to maximize bone mass prior to the onset of \negg production.  Selection for feed efficient birds \nhaving low feed intake has made it more difficult to \nformul ate feed with adequate calcium, phosphorus, \nenergy, and protein.  \n2. Environment and Behavior.   High -density \nhousing and lack of feeder space causes a 15 -20% \ndifference in feed intake among birds within a cage.  \nDecreased feed consumption during times of heat stress \nresults in marginal intakes of calcium and phosphorus.  High environmental temperatures causing birds to pant \nresults in decreased plasma carbonate available for \neggshell formation along with loss of phosphorus in the \nurine.  Lack of exercise for bi rds housed in cages has \nbeen shown to result in reduced bone mass and \nbreaking strength of long bones.  \n3. Nutrition.   Inadequate intake of calcium \nand phosphorus in the feed can occur at the onset of lay \nfor a number of reasons.  The flock feed consumption \ncan be slow to increase compared to requirements as egg production begins.  Incorrectly formulated feed, \nuse of poor quality feed ingredients, and mistakes in \nfeed formulation and mixing can also occur.  \n4. Low Feed consumption.   It is important to \nmonitor the a ctual flock feed consumption and make \nfrequent feed formulation adjustments based on actual feed consumption.  Feed consumption of a flock  \n  \n160 depends on many factors such as the house \ntemperature, feeder space, or the type of feeding \nsystem.  Seasonal heat st ress can lower feed intake.  \nEconomics of feeding for production cost alone can be \ncostly if not monitoring all the other factors that go into \nthe net return.  \n \nPREVENTION  \nA.   Nutrition.  \n1. Pullets grown to maximize frame \nsize to 12 weeks of age.  Use pullet feeding \nprograms that maximize the development of \nskeletal structure and lean body tissue.  Rations using excessive fat may result in onset of egg \nproduction before skeletal frame development is \ncompleted.  Use a prelay ration to build medullary \nbone when light stimulation or the first signs of \nsexual maturity occur (usually 3 weeks prior to \negg production).  \n2. Begin a Pre- peaking diet one week \nbefore egg production starts . \n3. Strain maturity differences  must be \nconsidered when programming prelay and peak \nformula s.  For example, Strain A may require \nPrelay ration at 16 weeks and a layer ration at 18 \nweeks, while Strain B requires Prelay at 17 weeks \nand a layer ration at 19 weeks because of later \nsexual maturity.  First step in preventing CLF is the proper programs  for this period.  \n4. Peaking diet.   Genetic progress has \nincreased egg mass output by 180 -190 \ngrams/hen/year.  This increase requires 15 -20 \nmore grams of calcium i.e. 50 mg calcium per Hen/Day, or 0.5% calcium in a formula based on 100 grams per bird feed con sumption (20 lb/100 \nbirds/day).  A ration that is consumed at 82 grams/bird/day (18 lbs/100 birds/day) providing 4 grams calcium/hen/day must contain 4.9% \ncalcium.  Large particle size of calcium ensures \nthe slow release of calcium during the night when \neggshell is formed.  Solubility of the calcium \nsource must also be considered.  \n5. Phosphorus Intake.  Bone contains \n18.5% phosphorus and 39% calcium.  Pullet rations must contain adequate phosphorus to build \nmaximum skeletal structure and for the \nremodeling of bone.  Intakes of phosphorus \nshould be 300- 500 mg/hen/day.  Younger hen\u2019s \nphosphorus requirement is higher.  Low \nphosphorus intake can occur when phosphorus \navailability of feed ingredients is overestimated.  \n6. Vitamin D and 25 OHD\n3.   Vitamin D \nis important  for the movement of feed calcium \nfrom intestine to the blood and the mobilization \nof calcium from the bones for shell formation.  \nD3 is an inexpensive feed ingredient and it is \nusual for a large safety factor of 8 to 12 times the actual requirement.  \nB. Envi ronment.  The cage design and feeder \nsystem management should provide adequate amounts of feed to all birds in a cage.  The evening feeding \nshould be within two hours of lights out.  Lower house \ntemperatures can be used to stimulate feed \nconsumption, 68\u00b0 -73\u00b0 F.  A midnight feeding of 1 hour \nmay increase feed consumption during hot weather by \n2 or 3 grams/bird/day.  \nC. Treatment of osteoporosis.  The incidence \nof osteoporosis can range from a small portion of the daily mortality to large numbers of hens with def ormed \nkeels and beaded ribs.  Flock problems can lead to low production or poor shell quality.  A problem with treatment is that hens are unable to reform cortical \nbone when in lay.  Research shows little benefit to \nincreasing dietary Ca, P and D\n3 levels w hen CLF is \ndiagnosed when measuring bone ash and calcium \ncontent.  \n \nCONCLUSION  \nOsteoporosis (CLF) causes economic loss to the \negg industry from increased mortality, reduced shell quality, loss of egg production (H/H eggs) and decreased fowl value.  The cond ition is preventable \nwith proper introduction of prelay and prepeak feeds.  \nFormulation of feeds based upon the actual feed intake \nof the flock is critical in accurately delivering the daily requirements of nutrients.  \n Table 1.   Current W -98 Ca and AvP Nutritional Recommendations  \n  \n Age Ca AvP   \n  Starter  0-6 weeks  1.0%     .50%  \n  Grower  6-8 weeks  1.0%     .48%  \n  Developer  8-16 weeks  1.0%     .46%  \n  Prelay  16-18 weeks (5%)  2.75%   .50%  \n  Prepeak  5-50% egg production 4.00%   .50%  \n  Peaking  50%-32 weeks  4.10 gm   .50 gm  \n  A 32-44 weeks  4.25 gm   .45 gm  \n  B 44-58 weeks  4.40 gm   .40 gm    \n  C >58 weeks  4.55 gm   .35 gm     \n  \n161 DIGESTIBILIDAD APARENTE ILEAL DE PROTEINA Y \nAMINOACIDOS EN POLLOS DE ENGORDA CON LA ADICION DE \nFITASA EN LA DIETA  \n \nAPPARENT ILEAL DIGESTIBILITY OF PROTEINS AND AMINOACIDS IN \nBROILERS AFTER ADDITION OF PHYTASE TO THE DIET  \n \nCortes Cuevas Arturo *1, Fuente MB1, Avila GE1, Mojica MC2, Alvarez M3  \n \n1Centro de Ense\u00f1anza, Investigaci\u00f3n y Extensi\u00f3n en Producci\u00f3n Av\u00edcola de la Facultad de Medicina Veterinaria y \nZootecnia de la UNAM, 2 Productos Roche S.A, 3 Degussa, M\u00e9xico S.A.  \n \nSUMMARY  \nPeniophora lycii -derived phytase was evaluated \nin low calcium/low phosphorus, sorghum -soybean \nbroiler diets. Treatment groups were: 1) Normal diet; \n2) same as 1 + 750 phytase uni ts/kg; 3) Low Ca/Low P \ndiet (0.1%); and 4) same as 3 + 750 phytase units/kg. \nWeight gain and feed conversion rate results after 19 \nshowed the effect of phytase (P<0.05). Feed intake and apparent ileal digestibility of both protein and amino \nacids were simi lar among treatment groups (P>0.05). \nThe use of phytase resulted in increased (P<0.15) apparent metabolizable energy increased.  \n \nRESUMEN  \nSe evalu\u00f3 una Fitasa a partir de ( Peniophora \nlycii) en dietas sorgo + soya bajas en calcio y f\u00f3sforo \npara pollos de eng orda.  Los tratamientos fueron : 1. - \nDieta normal , 2. -Como 1 + 750 unidades/kg de fitasa, \n3.- Dieta con menor contenido de calcio y f\u00f3sforo \n(0.1%) , y 4. - Como 3 + 750 unidades/Kg de fitasa. Los \nresultados en 19 dias para ganancia de peso y conversi\u00f3n ali menticia indicaron efecto a la fitasa  \n(P<0.05 ). El consumo y la digestibilidad aparente ileal \npara prote\u00edna y amino\u00e1cidos fueron similares entre tratamientos (P > 0.05). La energ\u00eda metabolizable \naparente  aument\u00f3 con la fitasa (P<0.15 ).  \n \nINTRODUCCI\u00d3N  \nLos ingredientes que en mayor porcentaje se \nemplean en alimentos balanceados para aves son de \norigen vegetal. Aproximadamente el 70% del f\u00f3sforo \nen estos ingredientes est\u00e1 presente como f\u00f3sforo f\u00edtico, \nel cual es deficientemente utilizado por las aves. La \nincapacidad para utilizar el f\u00f3sforo f\u00edtico origina \nproblemas de tipo econ\u00f3mico y medio ambientales; \ngrandes cantidades de f\u00f3sforo (P), se eliminan a trav\u00e9s \nde las excretas, lo que ocasiona contaminaci\u00f3n de lagos y r\u00edos. Otro aspecto relacionado, es que los  alimentos \nbalanceados se tienen que suplementar con fosfatos inorg\u00e1nicos, para poder cubrir el requerimiento de P del ave y esto resulta ser costoso. En base a lo anterior \nuna mejora en la utilizaci\u00f3n del f\u00f3sforo f\u00edtico por el animal, reducir\u00e1 los costos de producci\u00f3n y la \ncontaminaci\u00f3n por P.  \n \nMATERIAL Y M\u00c9TODOS  \nSe emplearon 160 pollos mixtos de un d\u00eda de edad \nalimentados con dieta sorgo + pasta de soya con y sin menor contenido de calcio y f\u00f3sforo inorg\u00e1nico (0.1%) \ny con y sin 750 unidades/Kg de fitasa, utilizando como \nmarcador al cromo.  Se utiliz\u00f3 un dise\u00f1o completamente al azar con un arreglo factorial 2x2; \ndonde un factor fue la dieta normal y con menor \ncontenido de calcio y f\u00f3sforo (0.1%), el otro factor fue \ncon y sin la adici\u00f3n de fitasa.  Los trata mientos fueron : \n1.- Dieta normal , 2. -Como 1 + 750 unidades/kg de \nfitasa, 3. - Dieta con menor contenido de calcio y \nf\u00f3sforo (0.1%) , y 4. - Como 3 + 750 unidades/Kg de \nfitasa. Se evalu\u00f3 adem\u00e1s la ganancia de peso, consumo de alimento y conversi\u00f3n alimenticia.  \n \nRESULTADOS  \nLos resultados obtenidos en 19 dias de \nexperimentaci\u00f3n para ganancia de peso (530.7\u00aa ,571.2b \n, 503.5\u00aa ,522b g) y conversi\u00f3n alimenticia (1.50\u00aa , \n1.41b, 1.56\u00aa, 1.46b) indicaron efecto a la adici\u00f3n de \nfitasa (P<0.05). El consumo de alimento (796.2 , 804.2 , 788.2  y 763.0 g) fue similar entre tratamientos ( P > 0.05). La energ\u00eda metabolizable aparente (2976\u00aa, 3058b \n, 2946\u00aa, y 3060b  Kcal/Kg )  aument\u00f3 con la adici\u00f3n de \nfitasa (P<0.15). Los resultados de la digestibilidad aparente ileal para p rote\u00edna y amino\u00e1cidos fueron \nsimilares entre tratamientos (P> 0.05).  \n \nCONCLUSIONES  \nDe los resultados obtenidos en el presente trabajo \nse puede inferir que la adici\u00f3n de 750 unidades/Kg de fitasa a partir de P. lycii en dietas a base de sorgo + \npasta de so ya, permite reducir el contenido de Ca y P \n(0.1%), adem\u00e1s se mejor\u00f3 la ganancia de peso y \nconversi\u00f3n alimenticia, debido a una mayor liberaci\u00f3n \nde energ\u00eda metabolizable aparente en las dietas.  \n(Este trabajo de investigaci\u00f3n posteriormente se \npublicar\u00e1 en l a revista Veterinaria M\u00e9xico ).  \n  \n162 EFECTO DE LA ADICI\u00d3N DE FITASA COMO FUENTE  DE \nF\u00d3SFORO INORG\u00c1NICO EN DIETAS PARA  \nGALLINAS DE POSTURA  \n \nTHE EFFECT OF PHYTASE ADDITION AS A SOURCE OF INORGANIC  \nPHOSPHOROUS IN LAYER DIETS  \n \nFuente MB, Cortes CA, Avila GE.  \n \nCentr o de Ense\u00f1anza Investigaci\u00f3n y Extensi\u00f3n en Producci\u00f3n Av\u00edcola.Facultad de Medicina Veterinaria y \nZootecnia de la UNAM.Correo electr\u00f3nico: bfuente@correo.unam.mx  \n \nSUMMARY  \nPeniophora lycii -derived phytase was evaluated \nusing low calcium (Ca)/low phosphorus  (P) sorghum -\nsoybean layer diets. A total of 288 45- week -old hens \nwere used. A 2x2 factorial design was applied. Factors \nwere the level of inorganic P supplemented as \ndicalcium phosphate in the diet, and the inclusion of \nphytase. The addition of a microbia l phytase was \nsufficient to alleviate deficiency signs in available P -\ndeficient diets.  \n \nRESUMEN  \nSe evalu\u00f3 una fitasa a partir de ( Peniophora lycii ) \nen dietas sorgo + soya bajas en calcio y f\u00f3sforo para gallinas de postura. Se emplearon un total de 288 \ngallinas de 45 semanas de edad al inicio de la prueba. \nSe us\u00f3 un dise\u00f1o factorial de 2 x 2 ; siendo un factor el \nnivel de f\u00f3sforo inorg\u00e1nico suplementado con fosfato \ndic\u00e1lcico, en la dieta, y la inclusi\u00f3n de fitasa. La \nadici\u00f3n de una fitasa microbian fue sufic iente para \naliviar los signos de deficiencia en dietas deficientes en \nf\u00f3sforo disponible.  \n \nINTRODUCCI\u00d3N  \nLa importancia del f\u00f3sforo en dietas para gallinas \n, radica en que este mineral es uno de los nutrimentos \nm\u00e1s caros, despu\u00e9s de la energ\u00eda y la prote\u00edna en la \nformulaci\u00f3n de raciones. Una causa de ello es que el f\u00f3sforo (P), en las plantas est\u00e1 unido en forma de fitatos y no es totalmente disponible para las aves. S\u00f3lo \nentre el 30 y el 40% del P total que consumen las aves \na trav\u00e9z de ingredientes de orig en vegetal es f\u00f3sforo \ndisponible (Pd) y el resto no se aprovecha. En el caso \nde las aves esto es un problema, debido a que no \ncuentan con fitasas para hidrolizar el \u00e1cido fitico haciendo disponible el f\u00f3sforo para el animal. Por lo \ntanto es necesario la ad ici\u00f3n de fuentes de f\u00f3sforo \ninorg\u00e1nico en las dietas para cubrir las necesidades de \nPd y obtener \u00f3ptimos comportamientos biol\u00f3gicos en \nlas aves. Las necesidades de Pd en las aves son un \nproblema de \u00edndole econ\u00f3mico y ecol\u00f3gico ya que una \ngran cantidad del f\u00f3sforo consumido por el animal es excretado en las heces y la orina, estos residuos animales se depositan en el suelo y son lavados y \ndrenados por acci\u00f3n del agua de lluvias contaminando \nestanques, arroyos, lagos, r\u00edos y oc\u00e9anos. Durante la \n\u00faltima d\u00e9cada los avances en biotecnolog\u00eda han \nresultado en la producci\u00f3n a gran escala de fitasas \nmicrobianas capaces de hidrolizar el \u00e1cido f\u00edtico y \nliberar el f\u00f3sforo ligado a los fitatos. Estudios \nrealizados en gallinas de postura han demostrado que la \nadici\u00f3n de en zimas fitasas ex\u00f3genas a las raciones \nmejoran la utilizaci\u00f3n del f\u00f3sforo por lo que puede \nreducirse el f\u00f3sforo que se adiciona a las raciones para gallinas de postura y por ende reducir la eliminaci\u00f3n \ndel f\u00f3sforo al medio ambiente. El objetivo del presente  \ntrabajo fue evaluar el comportamiento productivo y el grosor de cascar\u00f3n en gallinas de postura al \nsuplementar con una fitasa a partir de (Peniophora \nlycii) en dietas sorgo + pasta de soya, sin adici\u00f3n de una fuente concentrada de f\u00f3sforo inorg\u00e1nico.  \n \nMATERIALES Y M\u00c9TODOS  \nSe realiz\u00f3 en el Centro de Ense\u00f1anza \nInvestigaci\u00f3n y extensi\u00f3n en producci\u00f3n Av\u00edcola de la \nFacultad de Medicina veterinaria y Zootecnia de la UNAM. Se emplearon un total de 288 gallinas de la \nl\u00ednea Isa Babcock -B300 de 45 semanas de edad al \ninicio de la prueba. Las aves se distribuyeron al azar en \n4 tratamientos con 6 repetici\u00f3n de 12 gallinas cada una \n. Se emple\u00f3 una dieta basal sorgo + pasta de soya  \ndeficiente \u00fanicamente en Pd, a partir de la cual se \nhicieron los siguientes tratamientos : T1. - Dieta basal \nsorgo + pasta de soya sin adici\u00f3n de una fuente \nconcentrada de f\u00f3sforo inorg\u00e1nico; T2. - Como T1 + \n460 unidades/Kg de alimento; T3. - Dieta basal sorgo + \npasta de soya con 0.1% f\u00f3sforo inorg\u00e1nico y T4. - como \nT3 + 460 unidades/Kg de aliment o. En el Cuadro 1, se \nmuestra la composici\u00f3n de las dietas basales con base \nen sorgo + pasta de soya y en el an\u00e1lisis calculado se \nnota que la dieta sin fosfato dic\u00e1lcico adicionado \naport\u00f3 0.1 % de f\u00f3sforo inorg\u00e1nico y con fosfato \ndic\u00e1lcico 0.2 %. Se us\u00f3 u n dise\u00f1o factorial de 2 x 2 ; \nsiendo el primer factor el nivel de f\u00f3sforo inorg\u00e1nico  \n  \n163 suplementado con fosfato dic\u00e1lcico, en la dieta (0 y 0.1 \n% de f\u00f3sforo inorg\u00e1nico), el segundo la inclusi\u00f3n de \nfitasa (0 y 460 unidades/kg de alimento); cada \ntratamiento tu vo seis repeticiones. Se llevaron registros \nsemanales, durante las siete semanas, de los par\u00e1metros \nproductivos (porcentaje de postura, consumo de \nalimento, peso de huevo, conversi\u00f3n alimenticia y masa de huevo). Adem\u00e1s se midi\u00f3 el grosor de \ncascar\u00f3n al fi nal del experimento.  \n \nRESULTADOS  \nEl an\u00e1lisis estadist\u00edstico de los resultados \nobtenidos en 49 d\u00edas de experimentaci\u00f3n, mostr\u00f3 \ninteracci\u00f3n estad\u00edsticamente significativa (p<0.05)en el  \nporcentaje de postura, el cual se mejor\u00f3 al adicionar \nfitasa en la dieta  sin suplementaci\u00f3n de f\u00f3sforo \ninorg\u00e1nico (68.9\u00aa,80.3b,79.7b y 78.8b). Exsisti\u00f3 \ndiferencia estad\u00edstica significativa (p<0.05) en peso \npromedio del huevo (63.4g y 65.2), consumo de alimento por ave (107.3 y 111.9g) y masa de huevo \n(47.13 y 51.89 g) siendo m ejores los resultados con la \nsuplementaci\u00f3n de 0.1% de f\u00f3sforo inorg\u00e1nico (0.2% \nde f\u00f3sforo disponible) en la dieta. En porcentaje de \npostura, conversi\u00f3n alimenticia y grosor no se encontr\u00f3 \nefecto a el f\u00f3sforo o a la adici\u00f3n de la fitasa.  \n \nDISCUSI\u00d3N  \nLos res ultados de este experimento muestran que \naquellas dietas a las cuales fue adicionado 0.1% de f\u00f3sforo inorg\u00e1nico y la fitasa, fueron mejores en el \nporcentaje de postura y consumo de alimento, con \nrespecto a aquellas sin adici\u00f3n de f\u00f3sforo org\u00e1nico. \nEstos re sultados coinciden con trabajos publicados de \nVan der Klis et al. Quienes concluyeron que dietas que \nconten\u00edan 0.12% de f\u00f3sforo disponible no era \nsuficiente para mantener un \u00f3ptimo comportamiento productivo en gallinas de postura.La informaci\u00f3n \nobtenida in dica que la adici\u00f3n a dietas sorgo + pasta de \nsoya de una fuente de f\u00f3sforo inorg\u00e1nico o \nsuplementaci\u00f3n de una fitasa microbiana puede cubrir \nuna deficiencia de f\u00f3sforo en gallinas de postura; la \nadici\u00f3n de fitasa microbiana a dietas de gallinas de \npostura  puede sustituir un 0.1% del f\u00f3sforor inorg\u00e1nico \nde la raci\u00f3n debido a que esta enzima es capaz de \nliberar parte del f\u00f3sforo presente en forma de \u00e1cido \nf\u00edtico de los ingredientes.  \n \nCONCLUSI\u00d3N  \nLa adici\u00f3n de una fitasa microbiana a partir de \n(Peniophora lyc ii) 460 unidades/Kg de alimento, fue \nsuficiente para aliviar los signos de deficiencia (disminuci\u00f3n de consumo de alimento, del porcentaje \nde postura) en dietas deficientes en f\u00f3sforo disponible (0.1% de la dieta). La mejora pudo deberse no solo al \nincreme nto en la disponibilidad de f\u00f3sforo sino de \notros nutrimentos como energ\u00eda y otros minerales como \ncalcio, lo cual no fue determinado.  \n \nCuadro 1. Composici\u00f3n y aportes nutricionales de las dietas basales   \nIngredientes (%)  Dieta  con 0% de Pi  Dieta con 0.1 % de Pi  \nSorgo  70.79  71.09  \nPasta de soya  18.40  18.35  \nCarbonato de calcio  8.87 8.63 \nAz\u00facar  0.54 0.05 \nAceite  0.50 0.50 \nFosfato dic\u00e1lcico  0.00 0.49 \nOtros*  0.90 0.89 \nNutrimento  An\u00e1lisis calculado  \nProte\u00edna cruda %  15.0 15.0 \nEM Aves Kcal/kg  2800  2800  \nLisina  0.694  0.693  \nMetionina + Cistina  0.615  0.615  \nCalcio total %  3.500  3.500  \nF\u00f3sforo disponible  0.099  0.200  \n* Vitaminas y minerales por Kg. Vitamina A (4,000  MUI), Vitamina D3 (1,1000 MUI), Vitamina E (4,000 MUI), \nVitamina K 3(0.9 g), Vitamina B1 (0.5g ), Vitamina B2 (2.0g), Vitamina B6 (0.5 g), Vitamina B12 (4.0 mg), Acido \nF\u00f3lico (0.2g), Biotina (20.0mg), Ac. Pantot\u00e9nico (6.0g), Niacina (0.9g), Hierro (110g), Zinc(50g), Manganeso \n(110g), Cobre (12g), Yodo (0.30g), Selenio (100mg), Cobalto (0.20g) Antiox idante \n(10.0g).,sal,metionina,pigemto,cloruro de colina 60%,promotor de crecimiento, antioxidante.  \n Nota: Este trabajo de investigaci\u00f3n solo tiene resultados preliminares por lo que posteriormente se publicara en \nla Revista Veterinaria M\u00e9xico.  \n  \n  \n164 ASEGURAMIEN TO DE CALIDAD EN DETERMINAR EL NIVEL DE \nVITAMINA A EN ALIMENTOS BALANCEADOS  \n \nQUALITY ASSURANCE IN THE QUANTIFICATION OF VITAMIN A IN \nFINISHED FEEDS  \n \nMedina B. J.C., Lara A. J., Mu\u00f1oz S. J. y Altamirano C. M  \n. \nNUTEK S.A. de C.V. 7 Norte 416 Tehuac\u00e1n, Pue. 7 5700 M\u00e9xico nutek@grupoidisa.com  \n \nSUMMARY  \nPremix and balanced feed manufacaturers must \nguarantee that their products actually contain label -\ndeclared concentrations of nutrients and additives. In \nrecent years lack of agreement between vitamin A \nresults obtained in our laboratory and those specified \nby premix/feed suppliershas been repeatedly \nexperienced. In order to have international arbitrage, \nour laboratory entered the Association of American \nFeed Control Ofic ers\u2019s (AAFCO) result verification \nprogram. This paper describes the results obtained in this quality assurance program.  \n   \nRESUMEN  \nLos fabricantes de premezclas y alimentos \nbalanceados deben garantizar que sus productos \ncontienen las concentraciones de lo s nutrientes y \naditivos que especifican en sus etiquetas respectivas, \ndurante los \u00faltimos a\u00f1os se han presentado, en \ndiferentes ocasiones, la no concordancia entre los resultados de vitamina  A emitidos por este laboratorio contra los especificados por  lo s proveedores de \npremezclas y alimentos. Para tener un arbitraje internacional, este laboratorio se incorpor\u00f3 al programa \nde verificaci\u00f3n de resultados de la Association of \nAmerican Feed Control Officials (AAFCO). En este trabajo se presentan los resultado s obtenidos en este \nprograma de aseguramiento de calidad.    \n \nINTRODUCCI\u00d3N  \nHasta la fecha no existe ning\u00fan m\u00e9todo oficial, \npor cromatograf\u00eda de l\u00edquidos (HPLC), para la determinaci\u00f3n de vitamina A en premezclas y alimentos terminados, pero es la t\u00e9cnica de elecci\u00f3n en \npr\u00e1cticamente todos los laboratorios que analizan esta \nvitamina, lo que origina que se presenten diferencias \nimportantes cuando se realizan ensayos entre los \nlaboratorios de los productores y los de constataci\u00f3n. \nEl AOAC international s\u00f3lo ha publicado el m\u00e9todo 974.29 (1), que es colorim\u00e9trico. Esto significa que tanto  los fabricantes de vitaminas como los \nproductores de premezclas o alimentos  terminados no \nhan  considerado necesario establecer un m\u00e9todo que sea validado y sometido a un arbi traje internacional para que el de referencia. La determinaci\u00f3n de vitamina \nA en alimentos terminados es dif\u00edcil al grado tal que \nlos proveedores  han establecido variaciones anal\u00edticas del 50% al 30 % en alimentos  terminados, de 1000 a 5000 UI/t y de 5000 a 10000 UI/t respectivamente \n(Manz et al., (2).   \nAnte esta situaci\u00f3n nuestro laboratorio decidi\u00f3 \nparticipar en el programa de verificaci\u00f3n de resultados que es promovido por el AAFCO (Association of \nAmerican Feed Controls Oficials). Este programa consis te en el env\u00edo de una muestra mensual de \nalimento balanceado para que cada laboratorio realice \nlos ensayos proximales, macrominerales, \nmicrominerales, aditivos y vitaminas (AAFCO (3)). \nLos resultados obtenidos se remiten al AAFCO y \nposteriormente se recibe la evaluaci\u00f3n del trabajo \nrealizado.          \n \nMATERIAL Y M\u00c9TODOS  \nMuestras: 15 muestras de alimento balanceado y \npremezclas vitam\u00ednicas  para diferentes especies animales enviados por el AAFCO. El procedimiento anal\u00edtico fue reportado previamente en el AO AC \nInternational y en la FAO.   \nProcedimiento anal\u00edtico: La muestra se somete a \nmolienda, de modo tal que pase a trav\u00e9s de malla 20, se \npesan 10 g y se transfieren a un matraz volum\u00e9trico de \n100 mL, se adicionan 5 mL de agua destilada y se homogeniza, se adicionan 30 mL de la soluci\u00f3n  de \nextracci\u00f3n  (hexano -acetona -alcohol absoluto -tolueno \n(10:7:6:7)), se homogeniza, se deja en reposo por 30 \nminutos, se adicionan 10 mL de soluci\u00f3n de KOH (40 % en metanol),   se homogeniza y el matraz se lleva a \nun ba\u00f1o mar \u00eda, previamente calentado  a 55 \u00b0 C,  se \ncoloca un refrigerante en la boca del matraz, y se \nsaponifica por 20 minutos. Se retira del ba\u00f1o y se deja \nen reposo hasta que alcance la temperatura ambiente, \nse adicionan 30 ml de hexano, se afora con una \nsoluci\u00f3n acuosa al 10 % de sulfato de sodio. \nHomogeneizar y dejar en reposo por una hora. Se trasfiere una al\u00edcuota de 10 ml de la fase superior del extracto, se evapora, utilizando nitr\u00f3geno y se disuelve \nen un mL de soluci\u00f3n de la fase movil (metanol HPLC \n\u2013 agua HPLC (95:5)), se inyecta en el cromat\u00f3grafo de  \n  \n165 l\u00edquidos, que previamente se ha estabilizado con la fase \nm\u00f3vil y se ha calibrado con una soluci\u00f3n de referencia \nde vitamina A que contenga 30 UI/mL. La \nconcentraci\u00f3n de vitamina A es funci\u00f3n de la relaci\u00f3n \nde las \u00e1reas de las se\u00f1ales detectadas de la muestra \nsobre la del est\u00e1ndar, multiplicado por la concentraci\u00f3n de la soluci\u00f3n est\u00e1ndar y multiplicando por la relaci\u00f3n de la epifase (50 mL) sobre el peso de la muestra \n(Medina et al., (4), Mu\u00f1oz et al. (5)).  \n \nRESULTADOS  \nEn la tabla No. 1 se presenta la evaluaci\u00f3n del \nAAFCO de los ensayos de vitamina A realizados por \neste laboratorio, se especifica la calificaci\u00f3n otorgada \nen t\u00e9rminos de la desviaci\u00f3n estad\u00edstica Z. La norma \nISO 17025 acepta como v\u00e1lidos todos los  valores de \u00b1 \n2 Z. Tambi\u00e9n se incluye el rango de desviaciones \nlograda por todos los laboratorios participantes, en este \nprograma participan m\u00e1s de 200 laboratorios, pero menos de 20 analizan la vitamina A. Todos los ensayos \nfueron realizados por cromatogr af\u00eda de l\u00edquidos.  \n \nDISCUSI\u00d3N Y CONCLUSI \u00d3N \nEl m\u00e9todo oficial del AOAC International  para la \ndeterminaci\u00f3n de vitamina A es un procedimiento que  \nrequiere mucha manipulaci\u00f3n y tiempo, se suelen \npresentar interferencias. Esto ha obligado a cada \nlaboratorio a  desarrollar m\u00e9todos instrumentales, m\u00e1s \nr\u00e1pidos, precisos y exactos. Actualmente en la mayor\u00eda \nde los laboratorios se utiliza el procedimiento por \ncromatograf\u00eda de l\u00edquidos (HPLC), lo que falta por estandarizar es el procedimiento de preparaci\u00f3n de muestr as y el peso de muestra, tanto para alimentos \ncomo para premezclas. Todos los laboratorios certificados y de constataci\u00f3n, que ofrecen sus \nservicios de manera independiente deben contar con un \nprograma de aseguramiento de calidad, para cada \ndeterminaci\u00f3n anal\u00edtica, el programa que ofrece el \nAAFCO es el mejor de los que tenemos referencia, porque permite que cada laboratorio participe con todas \nlas determinaciones anal\u00edticas que pueda realizar. En el \ncaso de la vitamina A y de cualquier otro analito este \nprograma nos permite garantizar los resultados \nemitidos.  \n \nREFERENCIAS  \n1. AOAC International. Official Methods of \nAnalytical Chemist. Arlington VA. 2000.  \n2. Manz U. and Phillips K. Determination of \nvitamin A in complete feeds, premixes and vitamin concetrates with  HPLC. Analytical methods for \nvitamins and carotenoids in feed. Basle, Switzerland. 5-7. 1988.  \n 3.    AAFCO. Oficial Publication. 2001.  \n4.   Medina B., J.C.; Castillo E. Problemas en la \ncuantificaci\u00f3n de vitaminas liposolubles en premezclas y    alimentos terminados.  Documento de Campo No. \n16. Proyecto Aquila II. FAO. Santiago de Chile. 235-\n239. 1994  \n5. Mu\u00f1oz J.  and  Lara J. Analysis and \ndispertion of vitamin A in premix. 111\nth AOAC, \nInternational Annual Meeting. San Diego. CA. USA. \n88. 1997.  \n \nTabla No. 1. Concentraci\u00f3n de vitamina A en las muestras remitidas por el AAFCO de febrero del 2000 a diciembre \ndel 2001.  \nTipo de muestra  Calificaci\u00f3n para \nNUTEK , valor Z  Laboratorios \nparticipantes  Laboratorios con \nevaluaci\u00f3n aprobatoria  Z Intervalo de \nvariaci\u00f3n ent re \ntodos los \nlaboratorios.  \nPremix Vitaminas y \nminerals   Z = -0.5    19   18  5.19 a \u20131.72 \nDieta de primates  Z = -0.32    18   17  6.84  a   - 1.43 \nDieta para caballos  Z = 0.10     16   15 34.04 a   - 1.98 \nDieta  de iniciaci\u00f3n \nbovines  Z =  - 0.50   16   13    4.43 a   - 2.24  \nDieta  para borregos  Z =  -0.26   17   15 608 a \u20131.63 \nDieta para ganado \nde engorda  Z  = -1.20   18    16 3.59  a  - 1.55 \nDieta para cerdos  Z = -1.02  10    9 6.14  a  -1.32 \nDieta iniciaci\u00f3n \naves Z =  0.24   10      7 9.30   a  - 2.14 \nDieta finalizaci\u00f3n  \ncerdos  Z  =  0.36   12   11  12.14  a   1.67  \nDieta crecimiento \naves Z  =  - 0.46   11   10  5.19  a \u20131.72  \n  \n166 Dieta para becerras  Z = -0.77  17    17  2.0  a  - 1.43 \nDieta  para cerdos  Z = -0.51  9   7  48.96 a \u20130.85 \nDieta para perr os Z = -0.39  17  15  3.02 a \u2013 1.16 \nDieta para pollo \nfinalizador.  Z =  -0.42    11  10   1.46 a \u20134.01 \nDieta para ganado \nde engorda  Z = -0.8  20  19 12.51 a \u20131.49 \nPremix vitam\u00ednico  Z = -0.34 24 18 19-07 a \u20132.29 \n \nBENEFICIOS DE LA EXT RUSI\u00d3N Y LA MALTA SO BRE LOS \nPAR\u00c1METROS PRODUCTIVOS DE POLLOS DE ENGO RDA  \n \nBENEFITS OF EXTRUSION AND MALT ON BROILER PRODUCTIVE \nPARAMETERS  \n \nT. Quezada, 1 J. D. Figueroa,2 E. Rebollar, 3 A. Valdivia, 1 y G. Acero1 \n \nCentro de Ciencias Agropecuarias1 de la Universidad Aut\u00f3noma de A guascalientes . Tquezada@correo.uaa.mx \u00f3 \nteodulo_quezada@latinmail.com  Centro de Investigaciones Avanzadas Unidad Quer\u00e9taro (CINVESTAV - Qro.)2. \nEstudiante de maestr\u00eda del Programa Interinstitucional en Ciencias Pecuarias Universidad de Colima3. \n \nSUMMARY  \nWith the purpose of evaluating the benefit of both \nextrusion and the addition of malt to broiler diets to \nimprove productive parameters, four 7 -week \nexperiments including 1,400 Ross male broilers were carried out . Diets were: starter, 1 -4 weeks; finisher, 5 -7 \nweeks, in accordance with NRC requirements, with 22 and 19% protein, respectively, and 3,000 kcal/kg feed \nin both phases, with the exception of experiment 4, \nwhere the energy level was decreased to 2,800 kcal /kg. \nSome beneficial changes were observed in major broiler parameters.  \n \nRESUMEN  \nCon prop\u00f3sito de evaluar el beneficios del uso de \nla extrusi\u00f3n y la adici\u00f3n de malta a la dieta de pollos de \nengorda para mejorar los par\u00e1metros productivos, se \nrealizaron cu atro experimentos con 1400 pollos \nmachos Ross, alimentados durante siete semanas, \niniciaci\u00f3n (1 -4 semanas) y finalizaci\u00f3n (5 -7 semanas) \nde acuerdo a los requerimientos del NRC, con 22 y \n19% de prote\u00edna y 3000 kcal/kg de alimento en cada \netapa respectiva y con una disminuci\u00f3n de energ\u00eda \n(2800 kcal/kg de alimento) en el cuarto experimento. Se observaron algunos cambios ben\u00e9ficos en los \npar\u00e1metros principales de los pollos de engorda.  \n \nINTRODUCCI\u00d3N  \nProporcionar los nutrientes \u00f3ptimos al pollo de \nengorda en un ciclo de producci\u00f3n corto, es motivo de \nconstante investigaci\u00f3n, ya que se tienen \ncondicionantes adicionales que deben de tomarse en \ncuenta, como la baja disponibilidad y el alto costo de las fuentes de prote\u00ednas que obligan a utilizar en forma \u00f3ptima esto s recursos\n(1). Dentro de esta posibilidad se \nencuentra el uso de la extrusi\u00f3n y enzimas que tiendan \na mejorar los niveles de digestibilidad de las dietas y \nreducir los efectos detrimentales de factores \nantinutricionales presentes en diversos ingredientes(2, 4). \nFigueroa, (1985) describe el malteo como proceso \nf\u00edsico qu\u00edmico controlado, durante el cual los granos \ndesarrollan y activan sus sistemas enzim\u00e1ticos y \nmodifican suficientemente sus reservas alimenticias. La malta obtenida de granos como la cebada es  una \nfuente  barata de enzimas  \n\u03b2-amilasa,  \u03b1-amilasa, \u03b2-\nglucanasa, etc., que se pueden producir en granjas y aprovechar en alimentos balanceados para los animales \ndom\u00e9sticos\n(3). Las \u03b1-amilasas y las xilanasas \npotencializan la disponibilidad de nutrientes de las \nprincipales fuentes de energ\u00eda(8). La adici\u00f3n de enzimas \nen la fabricaci\u00f3n de alimentos para el ganado tiene \ncomo principal objetivo favorecer la digestibilidad y as\u00ed lograr la utilizaci\u00f3n \u00f3ptima de los nutrientes\n(9). El \nuso de la extrusi\u00f3n y la adi ci\u00f3n de enzimas a partir de \nla malta en los alimentos balanceados de los pollos de \nengorda, permiten suponer la mejora de la utilizaci\u00f3n y \noptimizaci\u00f3n de los nutrientes de los alimentos, \nmediante la evaluaci\u00f3n de los principales par\u00e1metros \nproductivos de las explotaciones de pollos de engorda.   \n \nMATERIALES Y M\u00c9TODOS  \nSe llevaron a cabo cuatro experimento, en cada \nuno se recibieron 7000 pollos sexados de un d\u00eda de \nedad y con un peso promedio de 40.0 g \u00b1 2.0 g, en la caseta de la Unidad de Pollos de engorda del Centro de \nCiencias Agropecuarias, se seleccionaron en forma  \n  \n167 aleatoria 1400 pollos machos, se pesaron y se \nrepartieron en 18 grupos en forma aleatoria, se \nasignaron seis tratamientos en dos etapas simultaneas; \nprimera etapa, dieta uno control (CTL), dieta dos con \nma\u00edz extrudido en la fase de iniciaci\u00f3n (MEI), dieta \ntres con ma\u00edz extrudido en la fase de iniciciaci\u00f3n y \nfinalizaci\u00f3n (MEIF), segunda etapa, dieta cuatro ma\u00edz extrudido solo en la fase de iniciaci\u00f3n m\u00e1s 2% de malta \nen la fase de iniciaci\u00f3n y fi nalizaci\u00f3n (MEI 2%), dieta \ncinco ma\u00edz extrudido solo en la fase de iniciaci\u00f3n m\u00e1s \n4% de malta en la fase de iniciaci\u00f3n y finalizaci\u00f3n \n(MEI 4%) y dieta seis ma\u00edz extrudido solo en la fase de \niniciaci\u00f3n m\u00e1s 6% de malta en la fase de iniciaci\u00f3n y finalizaci\u00f3n  (MEI 6%), con tres repeticiones cada uno, \nquedando un total de 79 aves por tratamiento y \nrepetici\u00f3n. Se recibieron con agua medicada con \nantibi\u00f3ticos y electrolitos por tres d\u00edas y vacunados de \nla incubadora contra Marek, Newcastle y Bronquitis. \nSe vacunaron en el agua de bebida contra Gumboro a los cuatro d\u00edas de edad, contra Newcastle en v\u00eda ocular \ny mixta Newcastle -Bronquitis subcut\u00e1nea a los 10 y 22 \nd\u00edas de edad y solamente contra Newcastle v\u00eda \nsubcut\u00e1nea a los 32 d\u00edas de edad. Se alimentaron ad \nlibitu m las aves con dietas en base a los requerimientos \ndel NRC\n(5), con un 22% de prote\u00edna y 3000 kcal/kg de \nalimento en la fase de iniciaci\u00f3n y 20% de prote\u00edna con \n3000 kcal/kg de alimento en la fase de finalizaci\u00f3n. La \ndiferencia con el cuarto experimento sol o fue la \ndisminuci\u00f3n de energ\u00eda a 2800 kcal/kg de alimento en \nla fase de iniciaci\u00f3n en todos los tratamientos a los que \nse les adiciono la malta. El agua de bebida fue administrada ad libitum . Se registro diariamente el \nconsumo de alimento, la mortalidad, se pesaron los pollos semanalmente. Se obtuvo el porcentaje de mortalidad y viabilidad, el consumo total de alimento \n(CTA), consumo de alimento diario por ave (CADA), \nganancia diaria de peso (GDP), los pesos promedio, los \u00edndices de conversi\u00f3n alimenticia (IC), los \u00edndices de \neficiencia (IE), la eficiencia alimentaria (EA),, los \n\u00edndices de productividad (IP)  y el punto de \ndesenvolvimiento (PD). Se organizaron los datos y se sometieron un an\u00e1lisis de varianza (ANOVA) y una \nprueba de medias de comparaci\u00f3n m\u00fa ltiples Tukey y \nKrhamer con un paquete computarizado de SAS\n(10) \n \nRESULTADOS  \n En los resultados de las ganancias diarias de peso \ncorrespondientes a los primeros tres experimentos con \nsus dos etapas respectivas se pudo apreciar una \ntendencia mayor de GDP par a los pollos que se \nalimentaron con cualquiera de los tratamientos de \nextrusi\u00f3n y de adici\u00f3n de enzimas a los tres niveles \nutilizados (2, 4 y 6 %). Por otra parte, en el \nexperimento No. 4, no se mostr\u00f3 esta tendencia como en los anteriores, esto fue debido probablemente a la disminuci\u00f3n de energ\u00eda que se realiz\u00f3 a las dietas en la \nfase de iniciaci\u00f3n.  \nLos pesos promedio finales que se registraron \npara cada uno de los primeros tres experimento en la \nprimera etapa las aves alimentadas con MEI y MEIF \nmuestran un mejor peso que los controles pero entre \nestos son muy similares por lo que sugiere que uno u \notro que se utilice tiene el mismo efecto en el peso, y \nen la segunda etapa se mostr\u00f3 la misma situaci\u00f3n con \nla caracter\u00edstica de que los animales m\u00e1s pesados en \nforma constante en los tres experimentos fueron los \nMEI 2%, MEI 4% y MEI 6% respectivamente. Para el \ncaso del cuarto experimento fue el mismo comportamiento con la ventaja de que este ultimo no \ncontaba con el mismo nivel de energ\u00eda de en los \nanteriores.  \n Los valores de los \u00edndices de conversi\u00f3n en la \nprimera etapa tambi\u00e9n fueron mejores para los MEI y \nMEIF con respecto a los CTL, sin embargo presentan \nuna tendencia a la mejora de la conversi\u00f3n alimenticia \npor parte de los pollos alimentados con el MEI que  con \nel MEIF. Para la segunda etapa en este par\u00e1metro se \nobservo que los animales alimentados con MEI 2%, \nMEI 4% y MEI 6% fueron mejores que los CTL, sin embargo tambi\u00e9n se marca una tendencia de menor a \nmayor \u00edndice de conversi\u00f3n de la siguiente manera 6% , \n4% y 2% respectivamente, esto indica la probabilidad \nde usar o recomendar una concentraci\u00f3n de malta al \n6% para obtener un mayor beneficio. El cuarto \nexperimento tambi\u00e9n mostr\u00f3 la misma tendencia aunque de menor grado que en los anteriores.  \n La eficienci a alimentaria para la primera etapa de \nlos experimentos 1, 2, 3 y 4 se mostraron con un valor mayor para todos con respecto al CTL, y con una tendencia de que el MEI es mejor que el MEIF por \nconsecuencia produce una mayor cantidad de kg de carne por tonelada de alimento consumido. Mientras \nque, en la segunda etapa de los mismos cuatro \nexperimentos en general los MEI 2%, MEI 4% Y MEI \n6% mostraron ser mejores que los CTL y en particular el MEI 6% presenta una tendencia de ser el mejor \ntratamiento recomendado para la alimentaci\u00f3n de los \npollos.  \n El \u00edndice de eficiencia durante la primera etapa \nde todos los experimentos incluyendo el cuarto, fueron mayores para todos los tratamientos con respecto al CTL, no encontr\u00e1ndose una tendencia clara entre los \nMEI y MEIF indicando de esta manera que uno u otro \nque se utilice da el mismo resultado. Mientras que, para \nla segunda etapa de los experimentos 1, 2, y 3 se \ndetecta una clara tendencia a que cualquier tratamiento \nes mejor que el CTL e igualmente esta tendencia se \nmanifiesta en que el MEI 2% y MEI 6% son las \nmejores e inclusive en el cuarto experimento se \nobserva la misma situaci\u00f3n. Cabe mencionar que los \nvalores obtenidos de los \u00edndices de eficiencia en  \n  \n168 nuestros experimentos se clasifican de buenos a \nexcelentes por s u rango de 130 a 140.  \n Con el \u00edndice de productividad  se puede \ncomentar que todos los valores obtenidos de ambas etapas (1\u00aa y 2\u00aa) est\u00e1n clasificados entre buenos y \nexcelentes con  rangos de 250 a 350.  \nEL punto de desenvolvimiento mostrado en los \ncuatro ex perimentos durante la primera y segunda \netapa fue que en todos los tratamientos se manifestaron \ncon un mejor rango con respecto a los CTL. Su \nclasificaci\u00f3n corresponde a una categor\u00eda de regular a \nbueno obteniendo valores entre un rango de 350 a 400 \npuntos , mientras que los CTL registraron rangos \ninferiores a 300 puntos.  \n \nREFERENCIAS  \n1. Arce, M. J., C. C. L\u00f3pez y G. E. Avila. \nSistemas de alimentaci\u00f3n en pollo de engorda. Tecnolog\u00eda Avipecuaria. A\u00f1o 14, No. 166. pp 6- 10. \n2001  \n2. Dur\u00e1n, D. C. La extrusi\u00f3n alcalina  una \ntecnolog\u00eda \u00fatil para procesar granos. Industria Alimentaria.  Vol. 18 No. 6 Nov -  Dic. pp. 20- 32. 1996  \n3. Figueroa, C. J. D. M\u00e9todos para evaluar la \ncalidad maltera en cebada. Secretaria de Agricultura y \nRecursos Hidr\u00e1ulicos. Tema did\u00e1ctico. No. 17. M\u00e9xi co. \n1995  \n4. G\u00f3mez, A. C. A. Efectos del procesamiento \nde extrusi\u00f3n CINVESTAV sobre los componentes Qu\u00edmicos y caracter\u00edsticas nutricionales de harinas \ninstant\u00e1neas de ma\u00edz para la elaboraci\u00f3n de tortillas. \nTesis de maestr\u00eda Universidad Aut\u00f3noma de Sinaloa. \nM\u00e9xico. 1995  \n5. National Research Council. Nutrient \nRequeriments of Poultry, Eight revised edition, \nNational Research Council. Washington, D.C. 1984  \n6. Ortiz, M. A., H. F. Ingalls, P. F. Alonso y G. \nJ. Nu\u00f1ez. Indices de productividad en pollo de engorda. \nTecnolog \u00eda Avipecuaria en Latinoam\u00e9rica. 10; 118: 3 -  \n8. 1997  \n7. Quintana, L. A. Avitecnia, manejo de las \naves m\u00e1s comunes. Ed. Trillas. 3ra edici\u00f3n. M\u00e9xico, D. \nF. 1999  \n8. Rob, F. B. and R. M. Ronald. Las enzimas \nen alimentos balanceados: Pasado, Presente y Futuro. \nTema s de actualidad para la Industria de alimentos \nbalanceados. Ed. Midia Relaciones S.A. de C. V. M\u00e9xico pp. 152 \u2013  156. 1997  \n9. Sears, A., G. Walsh y G. Hoyos. Enzimas: \nGeneralidades acerca de las Aplicaciones, clasificaci\u00f3n \nmecanismos de acci\u00f3n y resultados en nutrici\u00f3n \nanimal. Temas de actualidad para la industria de \nalimentos  balanceados. Ed. Midia Relaciones S.A. DE C.V. M\u00e9xico, D.F. pp. 158 -  166. 1997  \n10. 10. Statistical Analysis System (SAS). SAS \nUser's guide. Version 6 edition the Institute Cary   NC. 1997.\n     \nUNIFORMIDAD EN ALIMENTOS BALANCEADOS  \n \nBALANCED FEED UNIFORMITY  \n \nJoel Mu\u00f1oz*, Rub\u00e9n P\u00e9rez, Alicia Bringas y Juan Carlos Medina.  \n \nNutek S.A. de C.V. 7 Norte 416. Tehuac\u00e1n, Pue. E -mail: nutek@grupoidisa.com  \n \nSUMMARY  \nBirds need various nutrients like pr otein, fat, \ncarbohydrates, minerals, and vitamins. Nutrient requirements are proportional to expected performance. \nDifferent factors affect the uniformity of balanced \nfeeds\n4. This study evaluated the quality of layer feeds. \nTen samples from different produ ction batches were \nobtained under normal working conditions, and both \nzinc and manganese levels were determined y atomic absorption. Protein, fat, calcium, and phosphorus \nvariations in feeds manufactured by a feed mill during \nthe second half of 2001 are al so reported.  \n  \nRESUMEN  \nLas aves necesitan varios nutrientes como \nprote\u00ednas, grasa, carbohidratos, minerales y vitaminas, \nla demanda de los cuales est\u00e1 en proporci\u00f3n con el rendimiento esperado. Diversos factores afectan la \nuniformidad de los alimentos term inados(4). En este \ntrabajo se evalu\u00f3 la calidad de mezclado de alimentos de postura.  Se tomaron  10 muestras de diferentes lotes \nde producci\u00f3n, en condiciones normales de trabajo y se \ncuantific\u00f3 el  zinc y manganeso por la t\u00e9cnica de \nabsorci\u00f3n at\u00f3mica. Tambi\u00e9n se reporta la variaci\u00f3n en \nel contenido de  prote\u00edna, grasa, calcio y f\u00f3sforo en alimentos elaborados en una empresa durante el \nsegundo  semestre del 2001.   \n \nINTRODUCCI\u00d3N  \nLos programas de control de calidad en una planta \nde alimentos pueden generar una amplia cantidad de \ndatos, que si no se usan adecuadamente para mejorar la \nproducci\u00f3n, el tiempo y los recursos gastados para \nobtener esta informaci\u00f3n son desperdiciados.  Un  \n  \n169 programa de calidad puede ser complejo y muy \nextensivo o relativamente simple e inextenso, \ndependiendo de nuestras necesidades. Pero por simple \nque sea un programa de calidad, aavances tecnol\u00f3gicos \ncomo es la automatizaci\u00f3n de las plantas de alimentos, \nla adici\u00f3n de  ingredientes en forma l\u00edquida, el n\u00famero \nde ingredientes que se in corporan a la dieta y las \ndistintas fases de alimento que se elaboran lo hacen \ncomplejo.  \nLa base para el establecimiento de un programa \nde calidad son las especificaciones requeridas tanto de las materias primas como de los alimentos terminados. \nLas especi ficaciones nutricionales de los ingredientes \nse establecen de acuerdo a la propia naturaleza del \nproducto, el precio y la disponibilidad en el mercado; \npor otro lado, las especificaciones de los alimentos son \nlas que corresponden a la etapa de la vida de l os \nanimales y se dise\u00f1an para cumplir requerimientos espec\u00edficos.  La formulaci\u00f3n de un alimento se realiza con el prop\u00f3sito de que contenga  los requerimientos \nnutricionales de las aves. Por lo tanto se debe tener la \nseguridad de que los alimentos est\u00e9n perfectamente \nhomogeneizados.  Se acepta como criterio de \nuniformidad el 10 % del coeficiente de variaci\u00f3n. En \ncondiciones \u00f3ptimas, cada muestra que se analice debe \nser id\u00e9ntica en contenido de atributos a cualquier otra \nmuestra del mismo lote.  \nSe consider a que un alimento no esta bien \nhomogeneizado  cuando uno o m\u00e1s ingredientes, no \nest\u00e1n presentes en el mismo porcentaje o relaci\u00f3n, en \nque estaban antes de efectuar el proceso de mezclado. Los alimentos mal procesados, a menudo pueden ser \ncorregidas por aju ste de las mezcladoras, o por \nreemplazo de los componentes que se han desgastado. \nLa secuencia de adici\u00f3n de los ingredientes y aditivos  \nen la mezcladora, afecta el proceso de  mezclado. \nAumentar los tiempos de mezclado no siempre mejora la uniformidad de  un alimento en particular.  Entre las  \ncausas de la obtenci\u00f3n de un alimento fuera de \nespecificaciones, son  la realizaci\u00f3n de una pesada \nincorrecta o  fallas en alguna operaci\u00f3n de la cadena de producci\u00f3n,  como el no haber agregado las cantidades \ncorrectas de alg\u00fan ingrediente. Cuando el an\u00e1lisis de \nuna muestra de alimento indica que no cumple las \nespecificaciones, la investigaci\u00f3n inicial para descubrir la causa deber\u00eda incluir una revisi\u00f3n sobre la exactitud  \no mal funcionamiento de los equipos de pesa da y del \nsistema de bombeo de los ingredientes l\u00edquidos.  \n \nMETODOLOG\u00cdA  \n Se evaluaron dos par\u00e1metros: el primero fue para \ndeterminar la uniformidad del mezclado, con tiempo preestablecido de homogenizaci\u00f3n, este proceso se \nllev\u00f3 acabo 10 veces, en un period o de tiempo de dos \nmeses  y el segundo fue para determinar la variaci\u00f3n de los lotes de alimento para aves de postura, durante un \nsemestre.  \nSe seleccionaron 10 puntos de muestreo en la \nmezcladora, una vez terminado el proceso de \nmezclado. El peso de cada m uestra fue de un kg. Las \nmuestras fueron sometidas a un proceso de reducci\u00f3n de tama\u00f1o, por cuarteo y molienda. En cada muestra se cuantific\u00f3 el contenido de zinc y de manganeso, por \nabsorci\u00f3n at\u00f3mica (2). Al final se calcul\u00f3 el coeficiente \nde  variaci\u00f3n d e cada lote analizado.  \nLos an\u00e1lisis de prote\u00edna cruda, grasa cruda, calcio \ny f\u00f3sforo se efectuaron en 152 muestras, de alimento \npostura elaborado durante el segundo semestre del \n2001. Los ensayos se realizaron de acuerdo con los \nm\u00e9todos oficiales del AOAC  Internacional, (2).  \n \nRESULTADOS Y DISCUSI\u00d3N \nEl cuadro 1 presenta los resultados \ncorrespondientes a la variaci\u00f3n en el contenido de prote\u00edna, grasa, calcio y f\u00f3sforo en las muestras \nanalizadas. Se observa que los par\u00e1metros analizados \nen donde hubo mayor v ariaci\u00f3n es el contenido de \ngrasa y calcio. Probablemente debido a variaciones en \nlas fuentes de grasa y calcio durante el periodo considerado, por lo que se considera importante, incluir \nen el programa de aseguramiento de calidad, los \nan\u00e1lisis de los prin cipales ingredientes incluidos en la \nraci\u00f3n.  \nCon lo que respecta a las pruebas de mezclado la \nmedia de las medias de los 10 lotes ensayados es de 65 \nppm de manganeso con un coeficiente de variaci\u00f3n \nglobal del 13.5 %.  En el caso del zinc, la gran media \nfue de 115 ppm  con un coeficiente de variaci\u00f3n del \n19.7 %. Ambos coeficientes est\u00e1n fuera de la variaci\u00f3n \nrecomendada. Podemos suponer que la \nhomogenizaci\u00f3n de los minerales es dif\u00edcil y por lo tanto es com\u00fan encontrar estos niveles de coeficiente \nde variaci\u00f3n, en nuestra experiencia los coeficientes de \nvariaci\u00f3n que se obtienen con amino \u00e1cidos en soluci\u00f3n \nvar\u00edan desde 5.0 hasta 35.0 %, y la variaci\u00f3n es atribuible a todo el proceso desde la adici\u00f3n hasta el \nmezclado final.  \n \nCONCLUSI\u00d3N  \n1. No se puede evaluar l a calidad de mezclado \nanalizando un solo par\u00e1metro, ya que se estar\u00e1 \nevaluando solamente la homogenizaci\u00f3n del mismo.  \n2. La concentraci\u00f3n de cada uno de los nutrientes \npuede variar de lote a lote y provocar que en algunos \ncasos se obtengan par\u00e1metros  fuera d el rango \npermitido  \n3. En los sistemas de introducci\u00f3n de ingredientes \nl\u00edquidos se debe verificar continuamente el volumen \nbombeado y la homogenizaci\u00f3n de estos ingredientes.  \n4. Se considera como aceptable las variaciones \nanal\u00edticas que espec\u00edfica el AAFCO (Association  \n  \n170 American of  Feed Control Official)(1) para la \nevaluaci\u00f3n de los principales par\u00e1metros con los que \nformulan los alimentos balanceados para animales. \nSolo que para efectuar los c\u00e1lculos es necesario \nconocer los valores te\u00f3ricos de formulaci\u00f3n, situaci\u00f3n \nque no es com\u00fan para un laboratorio certificado que \ntrabaja de manera independiente.  \n \nREFERENCIAS  \n1. AAFCO. Official Publication. 2001  2. AOAC International. Official Methods of \nAnalytical Chemist. Arlington VA. 2000   \n3. R. A. Mccoy, K. C. Behnke, J. D. Hanc ock, \nand R. R. Mcellhiney. Effect of Mixing Uniformity on Broiler Chick Performance. Poultry Science. 73:443 \u2013  \n451. 1994  \n4. Wicker, D.L. and D.L. Poole. 1991. How is \nYour Mixer Performing. Feed Management, 42 (9) 40, \n43.\n \nCuadro 1.  Promedio de resultados de prote\u00edna, grasa, calcio y f\u00f3sforo  \nIdentificaci\u00f3n  n % de prote\u00edna  % de grasa cruda  % de calcio  % de f\u00f3sforo  \nmed D. E.  C. V.  med D. E.  C. V.  med D. E.  C. V.  Med D. E.  C. V.  \nFase A  23 20.4 2.4 11.8 6.0 1.55 25.8 1.45 0.23 15.9 0.71 0.068  9.6 \nFase B  51 19.4 1.05 5.4 6.6 0.79 12.0 4.0 0.42 10.5 0.54 0.044  8.1 \nFase C  62 17.4 1.40 8.0 4.5 0.76 16.9 4.3 0.79 18.4 0.51 0.042  8.2 \nFase D  16 17.0 0.93 5.5 4.0 0.93 5.5 4.0 0.91 22.8 0.54 0.051  9.4 \n \nDIETAS FORMULADAS A PROTE\u00cdNA IDEAL Y RES TRICCI\u00d3N \nALIMENTICIA, SOB RE LA HIPERPLASIA E HIPERTROFIA DEL \nTEJIDO GRASO ABDOMINAL EN POLLOS DE ENGO RDA  \n \nEFFECT OF IDEAL PROTEIN-FORMULATED DIETS AND FEED \nRESTRICTION ON FAT PAD HYPERPLASIA AND HYPERTROPHY IN \nBROILERS  \n \nCamacho -Fern\u00e1ndez D.1; Chagoya de S\u00e1nchez V.2; \u00c1vila G. E.3; L\u00f3pez C. C.1; V\u00e1squez P. C.4; Cuar\u00f3n I. J.5 \n \n1 Departamento de Producci\u00f3n Animal Aves; FMVZ -UNAM;  C.U., M\u00e9xico, D.F., 04510. Tel: (01 55) 56225867; \nFax: 56225868; e -mail: camachofernandez@yahoo.com.mx , 2 Laboratorio de Biolog\u00eda Celular (305- sur) del \nInstituto de Fisiolog\u00eda Celular, UNAM ; C.U., M\u00e9xico, D.F., 04510. Tel: (01 55) 56225614, 3 Centro de Ense\u00f1anza, \nInvestigaci\u00f3n y Extensi\u00f3n  en  Producci\u00f3n Av\u00edcola (CEIEPA) ; UNAM; Salvador D\u00edaz Mir\u00f3n s/n Zapoti tl\u00e1n, \nM\u00e9xico, D.F., 13209. Tel: (01 55) 58450029; Fax: 58451530, 4 Secretar\u00eda de Investigaci\u00f3n; Divisi\u00f3n de Estudios de \nPosgrado e Investigaci\u00f3n; FMVZ -UNAM;  C.U., M\u00e9xico, D.F., 04510. Tel: (01 55) 56225852 al 57; Fax: 56162342  \n5 Centro Nacional de Investig aci\u00f3n en Fisiolog\u00eda y Mejoramiento Animal (INIFAP), Ajuchitl\u00e1n, Qro., Tel: (01 442) \n2920249; Fax: 2920033  \n \nSUMMARY  \nBroiler diets were studied regarding total \nlysine/crude protein: 5.0 (treatment 1; T1) and 5.6 \n(treatment 2; T2); diets were formulated following the \nideal protein concept; a feed restriction program (T3) was also evaluated. Performance parameters i.e.: \ncarcass yield, lipid profile, and abdominal fat pad \nhyperplasia/hypertrophy were evaluated. Females \ndeposited more lipids than males. Higher b reast yield \nwas observed with T1. A better body weight was obtained with T2. Feed restriction results in reduced incidence of ascites syndrome, and increased lipid \ndeposition.  RESUMEN  \nEn pollos de engorda se estudiaron dietas con \nrelaci\u00f3n a lisina total/pr ote\u00edna cruda: 5.0 (tratamiento \n1; T1) y 5.6 (tratamiento 2; T2); formuladas sobre \nprote\u00edna ideal; y un programa de restricci\u00f3n alimenticia \n(T3). Se evaluaron variables zoot\u00e9cnicas, rendimiento \nen canal, perfil de l\u00edpidos, hiperplasia e hipertrofia del \ntejido graso abdominal. La mayor acumulaci\u00f3n de \nl\u00edpidos es para hembras sobre los machos. Se encontr\u00f3 \nun mayor rendimiento de pechuga con el T1 y un mejor peso corporal con el T2. Al aplicar una restricci\u00f3n \nalimenticia. se disminuye el s\u00edndrome asc\u00edtico, \nmejor ando la conversi\u00f3n alimenticia y se tiende a \nacumular m\u00e1s l\u00edpidos.\n    \n  \n171 Se estudiaron dos dietas diferentes en la relaci\u00f3n \nlisina total/prote\u00edna cruda (LT/PC), formuladas en base a \nprote\u00edna ideal para las fases alimenticias de crecimiento \ny finalizaci\u00f3n, y en un programa de restricci\u00f3n \nalimenticia en pollos de engorda, evaluando las variables \nzoot\u00e9cnicas, el rendimiento en canal, el perfil de l\u00edpidos \nen sangre y la acumulaci\u00f3n, hiperplasia e hipertrofia del tejido graso abdominal. Se utilizaron 792 pollos de \nengorda de un d\u00eda de edad (396 machos y 396 hembras), \ndistribuidos aleatoriamente en 24 lotes experimentales \nde 33 aves cada uno y mantenidos en producci\u00f3n hasta \nel d\u00eda 49 de edad. El dise\u00f1o experimental fue un arreglo \nfactorial 3 X 2, con tres tratamientos  alimenticios por \nsexo y con cuatro repeticiones por tratamiento. En la \nfase de iniciaci\u00f3n (0 -21 d\u00edas), todos los pollos recibieron \nla misma dieta formulada con base en el perfil de \namino\u00e1cidos digestibles (23% PC; 3,100 kcal/kg de \nEM); para las fases de crecimiento (22 -35 d\u00edas) y \nfinalizaci\u00f3n (36 -49 d\u00edas), las dietas fueron formuladas \ncon base a los amino\u00e1cidos azufrados digestibles con porcentajes de 0.72 y 0.68 respectivamente; de estos, se \nobtuvieron los valores de lisina digestible, lisina total y \nprote\u00edna cruda, obteniendo de esta forma, los \ntratamientos: T1) LT/PC= 5.0, consumo a libre acceso; T2) LT/PC= 5.6, consumo a libre acceso; T3) LT/PC= 5.0, programa de restricci\u00f3n alimenticia con acceso al \nalimento por 8 horas diarias del d\u00eda 15 al 35. Todos l os \ntratamientos fueron isocal\u00f3ricos, siendo para la fase de \ncrecimiento 3,100 kcal/kg de EM y para la fase de \nfinalizaci\u00f3n 3,200 kcal/kg de EM. Los resultados indican \nque el cambio en la relaci\u00f3n LT/PC de 5.0 a 5.6 bajo el concepto de prote\u00edna ideal y apli car un programa de \nrestricci\u00f3n alimenticia, se modifican las curvas de \ncrecimiento, que bien las representa un modelo \ncuadr\u00e1tico con un coeficiente de determinaci\u00f3n alto \n(R\n2=0.9965). La restricci\u00f3n alimenticia disminuye \n(p<0.05) el consumo de alimento, la mortalidad total \n(MT) y la causada por s\u00edndrome asc\u00edtico (SA), \nmejorando la conversi\u00f3n alimenticia, sin lograr un \ncrecimiento compensatorio a los 49 d\u00edas de edad. El consumo de alimento acumulado es mayor (p<0.05) en \nel T2; obteniendo el mayor peso corpora l sin llegar a ser \nestad\u00edsticamente significativo del T1, pero s\u00ed del T3. Las \nhembras del T2 obtuvieron el mayor ingreso neto en \nan\u00e1lisis econ\u00f3mico; no ocurriendo esto, en los machos \ndel mismo tratamiento, debido al alto costo de los amino\u00e1cidos sint\u00e9ticos  y al obtener la mayor MT y por \nSA. Los machos obtienen mayor peso de la canal (p<0.05) que las hembras, los valores de las piezas con relaci\u00f3n a la canal (g/100g), para pechuga resultaron mayores en las hembras, favoreci\u00e9ndose este valor en el \nT1; y para piernas, los valores de machos fueron \nmayores, siendo mejor el obtenido en el T3, \nencontr\u00e1ndose intermedio el valor del T2 para ambos \nsexos en las dos piezas. Las hembras acumulan m\u00e1s \ngrasa abdominal (p<0.05) en relaci\u00f3n a los machos \npara cada tratamiento,  los valores del T2 resultan ser \nlos mayores y los del T1 los m\u00e1s bajos. En  el perfil de \nl\u00edpidos en sangre, s\u00f3lo se encontraron diferencias (p<0.05) de los triglic\u00e9ridos (TGC) al d\u00eda 35 y de las \nlipoprote\u00ednas de alta densidad (LAD) al d\u00eda 49; \nespec\u00edficamen te los TGC son mayores al d\u00eda 35 para el \nT3 en ambos sexos, pero al d\u00eda 49, se observ\u00f3 que los \nTGC y las LAD fueron m\u00e1s elevados en las hembras. \nLos valores de l\u00edpidos por gramo de tejido seco, son \nmayores en el T3 para ambos sexos, desde la quinta a la \ns\u00e9ptima semana, presentando los coeficientes semanales \nm\u00e1s altos en las ecuaciones de regresi\u00f3n. El ADN por gramo de tejido seco, alcanza su valor m\u00e1s alto a la \nsegunda semana de edad (machos 622.67 \uf06dg y hembras \n657.67 \uf06d\ng), disminuyen      \nhembras desde la tercera semana, menor en relaci\u00f3n a los machos. A trav\u00e9s del c\u00e1lculo de la relaci\u00f3n \nADN/peso vivo en las condiciones experimentales empleadas, no se obtuvo una respuesta clara de la \nhiperplasia del tejido graso abdominal; sin embargo, en \nla relaci\u00f3n l\u00edpidos/ADN, se observ\u00f3 una clara respuesta \nsobre la hipertrofia de este tejido, iniciando en machos en promedio a los 11.1 d\u00edas y para las hembras a los \n10.8; siendo mayor, desde la quinta hasta la s\u00e9ptima \nsemana para machos y hembras del T3. Se concluye, que \nel T1 y el T2 no presentaron diferencias en la \nacumulaci\u00f3n de l\u00edpidos y cantidad de ADN por gramo \nde tejido graso abdominal seco, ni para la hipertrofia de \n\u00e9ste tejido; encontrando mayor rendimiento de pechuga con el T1 y un mejor peso cor poral con el T2. Es \neficiente el uso de la restricci\u00f3n alimenticia como \npaliativo para disminuir el SA y por ende la MT, \nmejorando a la vez la conversi\u00f3n alimenticia, m\u00e1s sin \nembargo, tanto hembras como machos no alcanzaron el \ncrecimiento compensatorio a l os 49 d\u00edas de edad y \npresentaron mayor acumulaci\u00f3n de l\u00edpidos por gramo de \ntejido graso abdominal seco y una mayor hipertrofia \nmedida por la relaci\u00f3n l\u00edpidos/ADN.   \n \n(El art\u00edculo completo se enviar\u00e1 a una revista con \narbitraje que est\u00e1 por definirse).  \n \n \n  \n  \n  \n172 CASE REPORT: DEFECTI VE DOWN IN A COMMERCIAL  \nBROILER FLOCK \n \nPLUM\u00d3N DEFECTUOSO EN UNA PARVADA COMERCIAL \nDE POLLO DE ENGORDA  \n \nNeil S. Ambrose  \n \nCanadian Poultry Consultants, 30325 Canary Court, Abbotsford BC, V4X 2N4, Canada  \n  \nRESUMEN  \nInforme de un caso de s \u00edndrome de plum\u00f3n \ndefectuoso en una parvada de 15,000 pollos de engorda \nHubbard HI -Y, procedente de un lote conocido de \nreproductoras que hab\u00eda presentado deficiencias en los \npar\u00e1metros de producci\u00f3n desde el principio del ciclo \nde postura. La elevada mort alidad que se observ\u00f3 desde \nlos primeros d\u00edas en la granja de engorda requiri\u00f3 una \nvisita de campo y una serie de trabajos diagn\u00f3sticos \nque no revelaron ninguna patolog\u00eda significativa. Una revisi\u00f3n met\u00f3dica de las medidas zoot\u00e9cnicas, del \nambiente de la caseta y de la dieta de las reproductoras \nrevel\u00f3 un error en los niveles de inclusi\u00f3n de \nmicroingredientes que, una vez rectificados, hicieron \nque cesara por completo el problema de plum\u00f3n \ndefectuoso en los nacimientos subsecuentes.  \n \nDefective down syndrome  in newly hatched \nbroiler chicks has occurred sporadically in the Fraser \nValley of British Columbia since 1987.  This syndrome \nhas also been termed \"clubbed down syndrome\" in the field but, the literature associates this specifically with riboflavin deficiency and this has not been conclusively \nproven in British Columbia (1).  In this syndrome there \ncan be a range of down abnormalities from a complete \nabsence of down on ventral parts to down takes on the \nappearance of grains of wheat with pointed ends (2).  \nOften, other physical abnormalities are noted at hatch \nsuch as deformed limbs, red hocks, and yolk sacs that are not absorbed.  As a result, defective down has \ncaused significant economic losses to the chicken \nindustry at all levels.  Many theories have b een \ndiscussed in the field with respect to an etiology and \nnone have been proven conclusively.  This report \ndescribes a case where practical epidemiology and \napplication of basic flock husbandry principles led to \npositive conclusion.  \n \nCASE HISTORY  \nIn the fall of 2001, a Hubbard X Hubbard 32wk \nold broiler breeder flock was encountering below \nstandard egg production and proportionally, small egg \nsize.  Birds were laying at 72% as against an expected \npeak of 83% for their age.  Average egg weight from a rando m sample of 180 eggs was 53gms when it should \nhave been 59gms (3).  Eggs that had been set in the \nincubators three weeks previously from this particular breeder flock hatched at 65% and the chick cull rate on the grading line was 20% for defective down and  other \nabnormalities.  Breakout of hatch residue presented an \noverall fertility rate of 94% however, there were early \ndeads of 7% and late deads of 9%.  10% of fertile eggs \ncontained full term chicks that had pipped the shell but \nnot hatched.   The average  chick weight form a sample \nof 30 was 36g.  \nFrom 25200 eggs set 16257 non -sexed chicks \nwere delivered to a local broiler producer and placed in \none triple decker barn with similar layout on each \nfloor.  \nA farm visit on the second day of placement \nfound chic ks to be generally lethargic.  Few chicks \ncould be seen actively eating or drinking and most \nhuddled in large groups under the brooders.  Attempts \nmade to stir the chicks had little effect.  Close physical \nexamination of the chicks found many to be display ing \ndefective down on their ventral or dorsal body surfaces.  \nSeveral had red or swollen hocks making ambulation \ndifficult.  Other chicks were missing an eye, had \ncrossed beaks, abnormal limb anatomy, or improperly \nhealed navels.  A general trend was small  chick size.  A \nsample of 50 chicks had an average weight of 39g that \nmay have been exacerbated by dehydration and lack of feed intake.  Mortality at this point was normal.  Gross \nnecropsy revealed no infectious process and diagnostic \ntesting of selected t issues was negative.  \nA second visit to the same flock at one week of \nage found the birds to be much more active.  Poor \nuniformity was readily apparent with an inordinate number of small chicks.  Mortality at seven days was \n7%, which included a culling rat e of 1%.  The flock \nwas subsequently shipped to the processing plant at 36 \ndays with a livability of 86.6%.  Average bird weight \nwas 1.63kgs with a condemnation rate of 2.6%.  \nCondemnation categories were unremarkable.  Feed conversion was 1.92.  These production parameters \nwould be considered below industry standards for the \nFraser Valley.  An average bird weight for 36 days \nwould be 1.75 -  1.90kgs.   \n  \n173 During the broiler production cycle an \ninvestigation of the source breeder flock was made.  It \nwas found tha t the pullets were moved from a light \ntight grow barn to a non -light tight lay house at 17 \nweeks during a time of rapidly increasing natural day length and light intensity.  The birds controlled day \nlength and intensity were not increased until 23 weeks of age.  Additionally, pullets were housed at an average \nbody weight of 1540g, 90g below target for age.  \nUniformity for the flock was 60%, which is very poor.  \nAlthough barn environment was adequate there were \nconcerns over water quality on the farm as bell  drinkers \nwere heavily stained despite regular cleaning.  A water \ntreatment system had been previously installed with an \nemphasis on the removal of iron.  However, a water \nsample taken that day indicated that iron was still \nabove acceptable levels for poul try at 0.3mg/l.  High \niron can cause bacterial growth, bad taste, precipitate and can be toxic to poultry (4).  \nPerhaps most significantly, it appeared that \nnutrient specifications as set out by the primary breeder \ncompany were not being followed for the gi ven age of \nbird.  In essence birds were under fed at a time of \nrapidly progressing sexual maturity and onset of egg \nproduction.  As this topic was being investigated it came to light that the inclusion level of vitamin B12 \nhad been only 10% of required for  the previous eight \nweeks.  B12 is involved in nucleic acid synthesis and \ncarbohydrate and fat metabolism.  It is an important \nenzyme in metabolic pathways and so with a \ndeficiency such pathways would fail.  Signs of deficiency include reduced egg size and  hatchability, \nmyelin degeneration, and increased late embryonic \nmortality (1).  \nThere was a major review of diet being fed \nfollowing this field call.  The ration was switched from \na wheat based diet to a corn based diet, amino acid levels were increased, and vitamin B12 levels were \nrectified plus an additional 20% for all micro -\ningredients was added.  Within ten days the flock had \nincreased egg production to within 2% of standard, egg size was markedly increased, and birds were gaining \nweight on less feed being fed.  Hatching eggs produced \nfrom this time period produced defective down chicks \nof only 0.5% and an overall hatchability of 86%.  It appeared that the defective down syndrome had been \nresolved in progeny form this breeder flock.  DISCUSSION  \nIn this authors opinion, this case of defective \ndown would appear to have a multi -factorial etiology. \nAlthough the mistake in diet formulation would be of \nsignificance in the overall nutritional status of the \nflock, other physical and husbandry factors in all \nprobability contributed to the clinical syndrome of defective down in the broiler chicks.  It is common \npractice in British Columbia to move pullets at 16wks \nof age, and in some cases, as early as 14wks, to the lay \nhouse.  In most instances the birds go from a  light tight \ngrowing barn to a non -light tight lay house.  The birds \nare usually kept on a growing ration until coordinated light stimulation at 23wks.  In this case, underweight \nbirds were moved into an environment that could have \nprematurely stimulated t hem both physically and \nreproductively.  As the birds aged there nutritional \ndemands may not have been met and the birds came \ninto production at much cost to their ability to produce \ngood quality hatching eggs.  Defective down was the \nclinical manifestatio n of a poor quality chick that was \nunderweight and without the required ability to survive \nin the competitive environment of a commercial broiler \nbarn.  \nThis case of defective down emphasizes the \ncritical importance of following the primary breeding \ncompany  recommendations for nutrition and \nmanagement of the broiler breeder to ensure that the \ncommercial broiler chick produced carries the physical \nand metabolic requirements necessary to realize their genetic potential.             \n             \nREFERENCES  \n1. Aust ic, R.E., and M.L. Scott. Nutritional \nDiseases. In: Diseases of poultry, 10 th ed. B.W. \nCalnek, H.J. Barnes, C.W. Beard, L.R. McDougald, \nand Y.M.Saif, eds. Iowa State University Press, Ames, \nIA. Pp. 56 -62. 1997.  \n2. Whitehead, C.C., J.S. Rennie, J.S. \nMcCormack,  and P.M. Hocking. Defective down \nsyndrome in chicks is not caused by riboflavin \ndeficiency in breeders. Br. Poult. Sci. 3:619 -623. 1993.  \n3. Hubbard HI -Y Breeder management guide. \nHubbard ISA.  \n4. Weltzein, E. Water quality for poultry. \nPoultry Industry Council. Fact sheet 111.  \n \n \n \n    \n  \n174 HEXAMITA MELEAGRIDIS  INFECTION IN CHUKAR \nPARTRIDGES ASSOCIATED WITH HIGH MORTALITY  \n AND INTRACELLULAR TROPHOZOITES  \n \nINFECCI\u00d3N CON HEXAMITA MELEAGRIDIS EN PERDICES CHUKAR, \nASOCIADA CON ALTA MORTALIDAD Y TROFOZO\u00cdTOS \nINTRACELULARES  \n \nG.L. Cooper, B.R. Charlton, A.A. Bickford and R. Nordhausen \n \nCalifornia Animal Health and Food Safety Laboratory System, Turlock Branch Laboratory,  \nUniversity of California, Davis, P.O. Box 1552, Turlock CA 95381 \n \nRESUMEN  \nSe present\u00f3 un brote de hexamitiasi s o enteritis \ncatarral debida a Hexamita meleagridis  (Spironucleus ) \nen una parvada de perdices chukar en California. La \nenfermedad comenz\u00f3 en el verano y afect\u00f3 a las aves j\u00f3venes, principalmente de 5 a 6 semanas de edad. Las \nheces de los animales afectado s eran h\u00famedas y \nsueltas, y los animales mostraron depresi\u00f3n y \nacinamiento. En las etapas terminales de la enfermedad \nmuchas aves presentaron coma. Las tasas de \nmortalidad fueron inusitadamente elevadas, alcanzando el 50 a 60% en algunas casetas.  \n \nAn outbr eak of hexamitiasis, or infectious \ncatarrhal enteritis, due to Hexamita meleagridis  \n(Spironucleus ) occurred in a flock of chukar partridges \nin California.  The disease began in the summer, and \naffected young birds between the ages of five and six weeks pri marily.  Affected birds had loose wet \ndroppings, and appeared listless and huddled.  Many birds became comatose in the terminal stages of the disease.  Mortality rates were unusually high, \napproaching 50- 60% in some houses.   \nThe affected ranch is a well -managed operation, \nlocated in the central valley of California, where \nsummers are hot and dry, and temperatures routinely \nexceed 100 F.  The grower is an experienced producer \nof game birds, and raises about 30,000 birds per year \nfor hunting clubs (primarily  chukar partridges, quail, \nand pheasants).  The birds are housed in 30 X 60 foot \nwood- framed sheds, which have been divided into 6 \nseparate pens.  Each pen is enclosed by wire, and is \nraised off the ground with wire flooring to reduce fecal \ncontamination.  The houses are generally clean and \nwell ventilated, however some fecal contamination of \nthe open feeder pans and drinkers used in brooding the \nyoung birds was evident, as well as fecal contamination \nof the surface of the cross beams that support the wire \nfloor.  The most obvious lesions noted on post -mortem \nexamination were catarrhal enteritis and dermatitis.  \nThe skin around the face and eyes and the corners of \nthe mouth was thickened, dry, and scaly, possibly as a \nresult of mal -absorption or vitamin defic iency.  The \nskin on the bottoms of the feet were thickened and \ncracked as well.  The upper 2/3 of the GI tract was \ndistended with fluid, and gas bubbles, and numerous \nsmall (8 -10um) flagellated protozoan parasites were \nseen in the jejunum and duodenum.  The parasites \nappeared very active in fresh wet mount preparations, \nand darted across the field in a rapid manner.  Other \npotential disease problems noted in individual birds \nincluded tapeworms, intestinal cryptosporidia, and \nrotavirus -like virus particles f ound in pooled gut \nsamples.  These were individual bird findings, \nhowever, and were not present consistently as were the \nflagellated protozoans.   \nOn scanning and transmission \nelectronmicrographs the parasite appears as a small (8 -\n12um) flagellated protozoan with a slender elongated \nbody.  It has 8 flagella, and 2 prominent nuclei, which are characteristic of the genus Hexamita (3).  The \nparasites can be found free in the lumen of the intestine, and clustered in the intestinal crypts.  On \nscanning EM\u2019s para sites can be found partially \nburrowed between enterocytes, or in some cases fully \nenveloped within host cells (enterocytes, or possibly \npaneth cells).  Affected cells appear discolored, and an apparent trail of tissue damage was seen along the path \nof migr ation.  Over the years there have been a number \nof reports of intracellular trophozoites of various \nspecies of Hexamita (5,7,2). An intracellular \nschizogonous reproductive cycle has even been suggested for Hexamita salmonis  and Hexamita \nmeleagridis (5).  T he reports have been disputed, \nhowever, and the observations dismissed as \nphagocytosis by paneth cells in the intestinal crypts (3).  \nMore recently, intracellular trophozoites were reported \nin laboratory rodents infected with Hexamita muris (2).   \n  \n175 The paras ites were reportedly not associated with \ndigestive vacuoles, and apparent disruption of \nepithelial cells was observed along the path of \ninvasion.  \nInfectious catarrhal enteritis was once a very \ncommon disease problem in turkeys in the US and \nCanada (4,6), and has had a significant economical impact on turkey production.  USDA estimates from \n1954 showed an annual loss of $667,000 from \nhexamitiasis in turkeys from 1942 to 1951 (4).  Since \nthen, however, the incidence of the disease has dropped \noff dramatically .  Figures for 1980 showed only 10 \ncases in the entire United States (4), although an \napparent upsurge in cases has been occurring in recent \nyears since the banning of furazolidone from poultry \nfeeds in the late 1980\u2019s (1).  During those early years, \nturke y growers noted a tendency for outbreaks of \ninfectious catarrhal enteritis to occur in birds even when raised on wire (6).  Given the many unanswered questions surrounding this disease in poultry, including \nthe lack of significant lesions to explain the se verity of \nsymptoms and the high mortality, perhaps we should \nexamine this disease more closely, and consider the \npossibility of tissue invasion by Hexamita meleagridis .  \n REFERENCES  \n1. Charlton, B.R., C.R. Gustafson, A.A. \nBickford, G.L. Cooper, and E.M. Johns on.  \nHexamitiasis:  Reappearance of an old disease?  \nProceedings 45\nth Western Poultry Disease Conference. \nCancun, Mexico.  209 -210.  1996.  \n2. Flatt, R.E., J.A. Halvorsen, and R.L. Russell.  \nHexamitiasis in a laboratory mouse colony.  Lab \nanimal Sci.  28:1.  6 3-65.  1978.  \n3. Kulda, J., and E. Nohynkova.  Flagellates of \nthe human intestine and of intestines of other species.  In:  Parasitic Protozoa, Vol II.  Julius P.  Kreier, ed.  \nAcademic Press, New York.  36 -38.  1978.       \n4. Reid, M.W., P.L. Long, and L.R. McDougal.  \nProtozoa.  In:   Diseases              of Poultry, 8\nth ed.  H. \nJohn Barns, B.W. Calnek, W.M. Reid and H.W. Yoder, Jr., eds.  Iowa State University Press, Ames, Iowa.  725-726.  1984.  \n5.   Slavin, D., and J.E. Wilson.  Hexamita \nmeleagridis.  Nature.  172:1179. 1953.  \n6. Vance, H.N., and C.H. Bigland.  \nHexamitiasis:  a report of cases in  Alberta turkey flocks.  Canadian J. Comp. Med. and Vet. Sci.  20:337-\n341.  1956.  \n7. Wilson, J.E., and D. Slavin.  Hexamitiasis of \nturkeys.  Vet. Record.   67:236- 242. 1955.  \n \nHIGH MORTALITY IN LAYERS  \nAS A RESULT OF CLOSTRIDIAL ENTERITIS  \n \nA. Singh Dhillon; L. H. Lauerman; Parimal Roy;  \nDennis Schaberg; Daina Bandli and Sylvia Weber  \n \nAvian Health Laboratory, Washington State University -Puyallup 7613 Pioneer Way East,  Puyallup, WA 98371-\n4998 E -mail: asdhillon@wsu.edu  \n \nHigh mortality was present in a new high- rise lay \nfarm, with a capacity of 180,000 birds per house. The \ngross and histopathologic lesions were consistent with \nclostridial enteritis. Clostridium perfringens  was \nisolated from the affected intestine. In addition, Escherichia coli , and on occasion Pasteurella \nhemolytica , was isolated from the liver and peritoneal \nsurfaces. Mild coccidiosis infection was also present. Five houses were affected but mortality was high in one house. The four -week mortality was 6.56 percent \nwith a loss of 10,898 chickens. The four -week \nmortality rate in the other houses ranged from a low of 0.237 percent to a high of 1.107 percent. The affe cted \nhouses were treated with amprolium for coccidiosis, and household bleach was added to water at a dilution of one part of bleach to 1,040 parts of water to \neliminate bacterial infection.  \nThe fly population was out  of    control and C. perfringens  was isolated from the \nalcohol -washed macerated flies caught from the \naffected poultry house. Dead flies were often seen in the feed troughs. The chickens consumed the dead flies \nalong with feed resulting in ingestion of C. perfringens . \nThe serum samples of aff ected birds and the macerated \nalcohol -washed and clarified fly extract caused illness, \nparalysis and death in the inoculated mouse. The C. perfringens  isolated from the chicken and flies was \nidentified as Clostridium perfringens  type A by PCR. \nThe disease was brought under control after straw was \nadded and mixed in with litter. As a result, the litter \ntemperature increased causing fly population to \ndecrease. This study suggests that flies in the poultry -\nhouses may not act solely as mechanical transmitters o f \nC. perfringens  to chickens but may cause the disease \nby ingestion of the bacteria within the body of flies.  \n  \n  \n176 VENEREAL COLIBACILLOSIS  (ACUTE VAGINITIS) IN  \nTURKEY BREEDER HENS  \n \nCOLIBACILOSIS VEN\u00c9REA (VAGINITIS AGUDA) EN PAVAS \nREPRODUCTORAS  \n \nPeter Gazdzin skiA and John BarnesB \n \nACuddy Farms,.Strathroy, Ontario, Canada, B College of Veterinary Medicine, NCSU. USA  \n \nRESUMEN  \nLas pavas reproductoras tienen un gran peso \ncorporal al principio de la producci\u00f3n de huevos, por lo \nque el manejo adecuado en esta \u00e9poca resulta crucial \npara lograr los mejores niveles de producci\u00f3n y \nfertilidad. El grado de madurez sexual es muy importante al momento de la primera inseminaci\u00f3n \nartificial. Este trabajo describe dos parvadas afectadas \npor colibacilosis ven\u00e9rea (vaginitis ag uda) causada por \nla inseminaci\u00f3n de pavas inmaduras con el himen intacto. La punci\u00f3n de esta membrana con la pajilla de inseminaci\u00f3n produjo severas lesiones en la vagina y la \ncloaca lo cual caus\u00f3 postura abdominal y peritonitis. \nDurante las primeras 5 sem anas de postura muri\u00f3 el 3% \nde estas hembras y fue necesario desechar a un 3 \u00f3 4% \nadicional.  \n \nSUMMARY  \nAs turkey breeder hens are heavier at the start of \negg production, proper management at this time becomes critical to achieve the best egg production and \nfertility. The degree of sexual maturity is very \nimportant at first artificial insemination (AI). This \npaper describes two flocks affected by venereal \ncolibacillosis (acute vaginitis) caused by insemination \nof immature hens with intact hymens. Puncturing o f the \nhymen membrane with insemination straw caused severe lesions in the vagina and cloaca leading to \ninternal laying and peritonitis. In the first 5 weeks of lay, 3% of hens died and another 3- 4% had to be \nculled.  \nIncreased early mortality due to perito nitis and a \nhigh number of cull hens was observed in two flocks of turkey breeder hens. The affected flocks had approximately 16,000 hens each. Each was lit for egg \nproduction in March and April at the age of 30 weeks \nand artificial insemination (AI) started at 32 weeks. Each flock was inseminated 3 times in the 10 -day \nperiod. At the third and fourth AI (33 weeks of age) increased mortality and hen culling was observed. In the first 5 weeks of lay, 3% mortality was recorded and \n3-4% of hens had to be culled. In non- affected flocks \nthe mortality in the same period is normally 1 \u20131.3%. \nThere were mainly three categories of culled and dead hens. The first and most significant category of hens \nhad cheesy core protruding from the cloaca and vagina. \nThe second had hens with partial prolapse of cloaca \n(pasty vents - vent gleet), while the third category \n(minority) were hens with prolapse of intestines. In \naffected flocks the peak of egg production was very \npoor - 60 % in fourth week vs. 72% in normal flocks. \nIn the fi rst week of egg production, the number of cull \neggs increased up to 27% vs. 15% in normal flocks. The increased number of cull eggs was due to small eggs (below 72 g).  \nPost-mortem examination of hens with cheesy \ncore in the cloaca showed that those hens had fibrinous pseudomembranes in the vagina and cloaca adherent to \nmucosa. The thickness of these membranes was so \ngreat that they obstructed the lumen of the vagina and thus inhibited the passage of eggs. All affected hens \nhad one or two eggs present in the  oviduct and many \novules in the abdominal cavity causing development of \nperitonitis.  \nMicroscopically, the upper reproductive tract \n(magnum) was normal whereas the vagina and cloacal areas were acutely inflamed. Earliest lesions consisted \nof mucosal thicken ing due to edema, fibrin and \nheterophils in the submucosa. There was no visible \netiologic agent in acutely inflamed tissues. In the more \nadvanced lesions, the mucosal surface was ulcerated \nand had been replaced by a diphteritic caseous necrotic membrane. N umerous bacterial colonies, \nmorphologically consistent with E.coli, were present in \nthe necrotic membranes.  \nNumerous swabs were taken from lesions in the \ncloaca and vagina and upper parts of the oviduct. The \nmedia were incubated in aerobic and anaerobic \nconditions. Swabs from the vagina and cloaca \nproduced numerous colonies of E.coli whereas swabs taken from upper parts of the oviduct did not produce \nany colonies. E.coli isolates tested from the two farms \nwere found sensitive to all tested antibiotics (Ampi cillin, Cephalothin, Enrofloxacin, Gentamicin, \nNeomycin, Spectinomycin, Sulfisoxazole, Tetracycline \nand Trimethoprim -Sulfa). Both isolates were also \ntested for virulence factors by a panel of PCR tests at \nPurdue University, West Lafayette, IN. These tests  \n  \n177 showed no presence of any of 8 virulent genes (F18, \n987P, F41, LT, STb, Sta, Stx2e, and eae).   \nA pair of blood samples taken from affected \nflocks was tested for PMV -2, PMV -3, PMV -6, PMV -7 \n(by HI test), Newcastle, Pasteurella, Bordetella, \nHemorrhagic enter itis (HE) and Influenza (by ELISA \ntest). All sera were positive for Newcastle, Pasteurella, \nHE and PMV \u20133 as a result of vaccination. PMV -2, \nPMV -6, PMV -7 and Influenza tests gave negative \nresults.  \nFurther investigations of the cause of this unusual \nvaginit is showed that insemination crews on these two \nfarms were mistakenly inseminating all hens that they were able to crack. Consequently, hens with the \npresence of hymen were inseminated like those \nwithout, by breaking the membrane with insemination \nstraw. Th e number of hens with the presence of hymen \nat first AI was found to correspond to the number of cull and dead hens with vaginitis and peritonitis. When the same AI crews inseminated the other flock and left the hens with intact hymen for the next AI, mort ality \nand the number of cull hens decreased dramatically. Also the number of partial prolapses of the cloaca were \nreduced.  \nBased on the above finding one can suggest the \nfollowing pathogenesis. As a result of breaking hymen \nin immature turkey hens a wound was created that \nbecame infected with E.coli bacteria. The \ninflammatory process developed diphteritic pseudo-\nmembranes obstructing the lumen of the vagina. Eggs \nformed in oviduct were therefore unable to pass \nthrough the vagina which lead to internal layin g and \nperitonitis. The degree of maturity of turkey breeder \nhens seems to be very important for the first insemination. Since the body size of turkey breeders is \nbigger each year, it is much easier to crack even \nimmature hens. If an AI crew doesn\u2019t pay att ention to \nthe presence of hymen it is possible to create vaginitis leading to high mortality and culling rate in the \nbeginning of egg production.  \n  \nPROVEN TRICULITIS/PO OR FEED CONVERSION:  \nA CASE STUDY  \n \nSharon Heins Miller, DVM, Diplomate ACPV  \n \nMerial Sel ect, PO Drawer 2497, Gainesville, GA 30503  \n \nA top performing integrated poultry company in \nthe Southeast United States slipped from number four \nin Agristats\u00ae to below 50%.  The primary performance \nproblem was poor feed conversion.  Their primary complaint  in the field based on clinical and gross \nnecropsy findings was feed passage and enlarged \nproventriculi.  Reovirus was suspected to be the root of \ntheir problems. This case study will concentrate on the malabsorption syndrome of reovirus.   \nReovirus is fou nd worldwide.  The virus can be \nfound in clinically normal chickens and turkeys.  Even in the presence of birds with clinical signs, isolation of \nreovirus may not be significant unless it can be proven \nto be causing the disease syndrome.  The most \ncommonly  recognized disease syndromes are viral \narthritis and malabsorption syndrome. The common \nclinical signs of the malabsorption syndrome are \nstunted growth, pale pigment of the feet, skin, and beak, broken or abnormally shaped feathers, feed \npassage, and poor  feed conversion.   Necropsy lesions \nmay reveal: enlarged proventriculus, small atonic \ngizzard, orange mucus in the intestinal tract, swollen \nfriable intestines, and poorly digested feed in the \nintestines.    \nCASE STUDY \u2013  HISTORY  \n\u2022 Two years of chronic probl ems throughout the company complex  \n\u2022 Performance declined from top 4 of Agristats\u00ae to below 50% on Agristats\u00ae  \n\u2022 Feed conversion was off by 10 points (1.88 on \n4.15 lb. in February 2001)  \n\u2022 Clinical signs in birds -  pale in color  \n\u2022 Post-mortem lesions -  enlarged \nproventriculus, moderate to severe feed \npassage; variable sized bursae  \nCauses of proventriculitis  \n\u2022 Reovirus  \n\u2022 Mycotoxin in the feed  \n\u2022 Infectious Bursal Disease  \n\u2022 Unknown  \nCase Investigation  \n\u2022 Vaccination Program  \n\uf0a7 Breeders - Lack of reovirus live priming in \nthe breeder p rogram;  inactivated reovirus \nvaccination given  \n\uf0a7 Broilers \u2013 Mareks/IBD standard & variant at \none day of age, \u00bc dose; IBD standard vaccine via the water  \n\u2022 Diagnostic Work -up \n\uf0a7 Serology \u2013 breeder reovirus titers were very \nhigh \n\uf0a7 Histology \u2013 some proventriculi lesio ns  \n  \n178 suggested viral challenge, some did not \nsuggest viral challenge; some bursae \nlesions suggested challenge between 20 \nand 30 days  \n\uf0a7 Virus isolation \u2013  reovirus isolated by two \nuniversity laboratories  \n\uf0a7 Challenge work \u2013 virus fed back to birds did \nnot re -create the proventriculus  \n\u2022 Feed  \n\uf0a7 Poor quality fat source  \n\uf0a7 Undercooking the soybean meal resulting in \nlow urease (0.01 -0.03)  \n\uf0a7 High free fatty acids (10 -15%)  \n\uf0a7 High peroxides (>10%)  \nRecommendations/Changes  \n\u2022 Vaccination  \n\uf0a7 Breeders - live reovirus priming - \nrecommendation n ot taken  \n\uf0a7 Broilers - one-day-old reovirus vaccination - \nrecommendation followed week on/week off \n- Mareks/IBD vaccination \u2013  stay on day -\nold IBD -  recommendation followed every \nweek  \n\u2022 Feed  \n\uf0a7 Poor grade fat changed to pet grade fat \n(decreased peroxides to under 10%)  \n\uf0a7 Fat tank in feed mill cleaned out  \n\uf0a7 Increased the urease levels to 0.05 -0.07 \uf0a7 Decreased free fatty acids to 2.5%  \nImprovements  \n\u2022 Proventriculus size and thickness decreased to \nnormal appearance  \n\u2022 Bursae size and health improved  \n\u2022 Mild or no feed passage noted w ith changes \nnoted above  \n\u2022 Feed conversion improved by 12 points from \nthe beginning of the investigation in August \n2001 (1.82 on 4.17 lb. one year comparison to \nabove February 2002)  \n \nSUMMARY/CONCLUSIONS  \nRecently, several United States poultry \nintegrators have  experienced performance issues and \nclinical signs suggestive of reovirus infection and challenge.  Once those companies started exchanging \ninformation, everyone assumed they had the same \nproblems.  When we first started investigating the \nperformance probl ems of this complex, we thought \nreovirus was the primary agent.  As the questions were asked and the operation evaluated, we realized there \nwas more to this situation than originally thought.  \nAdjustments in the quality and handling of the feed \ningredients  played a major role in improving the \nperformance in this company.  This case study reminds \nus that there may be more to a problem than initially \nperceived.\n \nMAGNESIUM INTOXICATI ON IN BROILER BREEDE R CHICKS  \n \nINTOXICACI\u00d3N CON MAGNESIO EN POLLAS REPRODUCTORA S \nPESADAS  \n \nZiv RavivA, Shmuel BerenhimeB, Henrike Borohovichc, Noam WinklerA, Nurit SapirA, Yochi RulfA  \n \nAY. Brown and Sons Ltd., P.O.Box 23 Hod -Hasharon, Israel, B Alonim Poultry Farm, Kibbutz Alonim, Israel.  \ncAfula Poultry Disease Laboratory, Afula, Isr ael  \n \n \nRESUMEN  \nRecibimos el informe de una parvada de \nreproductoras Cobb 500 de 10 d\u00edas de edad que presentaba severos problemas de patas y anormalidades \nen la deambulaci\u00f3n. El examen cl\u00ednico de la parvada \nrevel\u00f3 depresi\u00f3n del crecimiento, diuresis, rechazo a \ncaminar y consistencia ahulada en el tarso, el metatarso \ny el pico. El diagn\u00f3stico fue raquitismo. El tratamiento \nincluy\u00f3 el cambio inmediato de la raci\u00f3n y la \nadministraci\u00f3n de f\u00f3sforo y vitaminas en el agua de \nbebida. El an\u00e1lisis del alimento mostr\u00f3  un elevado \ncontenido de cenizas (8.8%) con niveles adecuados de calcio, f\u00f3sforo y vitamina D, adem\u00e1s de 16,000 ppm de magnesio. La parvada respondi\u00f3 bien al tratamiento. Las investigaciones en la planta de alimentos revelaron \nque se hab\u00eda agregado por err or \u00f3xido de magnesio a la \nraci\u00f3n.  \n \nSUMMARY  \n A ten day -old Cobb 500 parent flock was \nreported as suffering from severe leg problems and gait abnormalities. Clinical examination of the flock \nrevealed growth depression and a reluctance to move, and when force d to do so the birds walked with a shaky \ngait (walking on hot coals). The litter was very wet for \na flock of this age, and water consumption was five  \n  \n179 times greater then normal. Mortality was within the \nnormal range. Clinical examination of individual birds  \nrevealed rubbery tarsometatarsal bones and beaks. On \npostmortem examination of sacrificed birds the only \nabnormality seen was enlargement of the costo -\nverterbral articulation. An immediate diagnosis was made of rickets. Lesions were examined histopatholog ically and the feed was sent for analysis. \nRecommendations for treatment included an immediate \nreplacement of the ration and phosphorus and vitamin \nsupplementation in the drinking water. The feed \nanalysis showed a high ash level of 8.8%, with \nadequate levels of calcium, phosphorus and vitamin D, but 16,000ppm magnesium. Histopathological findings \nwere inconclusive with a normal growth plate adjacent \nto fibrotic areas. A feeding trial was initiated with a \nhundred, one day -old chicks using the suspected ration. \nThe feeding trial yielded identical clinical signs within one week of its initiation. The flock responded well to the new feed and supplements, and its recovery was \nuneventful and rapid. Investigations at the feed mill \nrevealed that magnesium oxide was added by mistake \nto the breeder chick ration. This case demonstrates: a. \nthe sensitivity of rapidly growing broilers to high \nmagnesium levels in the ration, b. high magnesium \nlevels should be included in the differential diagnosis \nof rickets.  \n \nINTRODUCTION  \nThe detrimental effect on growth and egg \nproduction of high magnesium (Mg) levels in poultry \nfeed is well documented, (Buckner 1932; Milby 1934; \nChicco 1967; McWard 1967; Lee 1980\n5,6). In the last \ncouple of decades, however, there were very few any \nreport s of this syndrome. The main source of high Mg \nlevels in poultry diets is a contaminated mineral supplement. The usual culprit is dolomitic limestone that can contain up to 13% Mg (McWard 1967), while \nrock phosphate and animal by -products can also \ncontain high levels of Mg (Lee 1980). The exclusion \nfrom poultry diets of raw materials with high Mg levels \nmade Mg toxicity an uncommon occurrence.  \nThis report describes a unique accidental feed -\nborn Mg intoxication in a very young broiler breeder \nflock.  \n \nCASE REPORT  \nCase History. On May 25, 2001, the owner of a \nbroiler breeder pullet farm reported many birds with \nleg problems in a ten days old Cobb 500 parents flock \nof 16,500 females and 2350 males. He noticed red \nblisters on the hocks of both sexes, presumably  a result \nof a hard hatch. He also mentioned that the flock was \ntreated with Baytril\nR for three days, but its condition \ncontinued to deteriorate. A visit to the farm revealed a \nretarded flock that was reluctant to move, and when disturbed they walked with a shaky gait (walking on \nhot coals). The litter was very wet for such a young \nflock. It transpired that the amount of drinking water \nused for the BaytrilR medication (200- 250ml/bird/day), \nwas five times higher than normally consumed by a \none-week -old flock . In the first week female chick \nlosses were 0.2% mortality and 0.3% culls, and the \nmale losses were 0.9% mortality and 1.1% culls. A \nclinical examination of individual birds revealed \nrubbery tarsometatarsal bones and beaks. The clinical \ndiagnosis was made  of rickets.   \nNecropsy. In an examination of sacrificed birds, \nrubbery femurs, tarsometatarsal bones and beaks were presented. The visceral organs were normal, and the \nonly skeletal abnormality was enlargement of the \ncosto -vertebral articulation.          \nBiological assay. In order to try and reproduce the \nsyndrome with the suspected ration we set up a feeding \ntrail with a hundred one day -old males (out of 7,000) \nthat were housed in another unit on the same farm. \nThese were fed with the suspect ration whil e the hatch \nmates received a normal commercial ration. The males \ndeveloped the pathological signs within one week, \nwhile the rest of the flock remained normal.   \nFeed analysis. A sample of feed was sent for \nanalysis and the initial result was a high ash le vel of  \n8.8% (the normal level is 6.0 -7.0%). The levels of the \nother nutrients: protein (20.7%), calcium (1.18%), \nphosphorus (0.66%), sodium (0.18%), chloride \n(0.25%), potassium (1.0%), manganese (116ppm), fat \n(3.4%), fiber (3.56%), moisture (10.5%), vitam in A \n(12500U) and vitamin D (3400U) were within normal \nlimits. In an attempt to solve the ash level enigma a \nration Mg analysis was requested. This yielded 16,000 ppm (the minimum requirement is 600 ppm, and the \nnormal range is 1000- 2000 ppm). An inquiry a t the \nfeed mill revealed that magnesium oxide was added by \nmistake to the breeder chick ration.  \nTreatment. Based on the clinical diagnosis of \nrickets, the initial recommendations for treatment included an immediate replacement of the feed and vitamin suppl ementation in the drinking water. \nFollowing the high ash values we assumed that the \nration calcium level was adequate or high, and \navailable phosphorus was added in the drinking water. There was an obvious improvement in the flock \ncondition within 48 hours  of treatment, and it took a \nfurther 2 -3 weeks for most of the flock to recover fully. \nApproximately 3.5% of the females and 4.0% of the \nmales did not recover a normal gait or growth and had \nto be culled out.  \nHistopathology. The femur and tarsometatarsal \nbones were removed, cut sagittally, and fixed in 10% buffered formalin. The pathological findings of a normal growth plate adjacent to fibrotic areas and a  \n  \n180 bone cortex without clear calcification were \ninconclusive.  \n \nDISCUSSION  \nRickets from all causes is q uite a rare occurrence \nin feed -restricted broiler breeder flocks in Israel. High \nMg levels in the ration is even rarer mainly because other products now replace magnesium -containing \nlimestone in poultry diets. Since there is hardly any \ninformation on this condition, this case report is a \nreminder of the sensitivity of the modern broiler \nbreeder, and presumably, its broiler progeny to high \nMg levels in the diet. The dual appearance of gait abnormality, rubbery long bones and beak with wet \nlitter and diuresis  are features of the uniqueness of this \npresentation. With regard to treatment, on receipt of the \nhigh ash result we added phosphorus to the diet. The \npositive effect of the treatment including the \nphosphorus supplementation, is supported by an early publi cation indicating the curative effect of dietary \nphosphorus and chloride on excessive dietary Mg (Lee \net al.,1980).  \n REFERENCES  \n1. Buckner, G. D., Martin, J. H. & Insko, W. \nM. Jr. The effect of magnesium carbonate when added to diets of growing chicks. Poult. Sci. 11: 58- 62. 1932.  \n2. Milby, T. T. Factors influencing the \nmalformation of the leg bones of growing chickens. \nIowa Agr. Exp. Sta. Res. Bull. 172. 1934.    \n3. Chicco, C. F., Ammerman, C. B., Van \nWalleghem, P. A., Waldroup, P. W. & Harms, R. H. \nEffect of vary ing dietary ratios of magnesium, calcium \nand phosphorus in growing chicks. Poult. Sci. 46: 368-\n373. 1967.  \n4. McWard, G. W., Magnesium tolerance of \nthe growing and laying chicken. Poult. Sci. 46: 91 -99. \n1967.  \n5. Lee, S. R., Britton, W. M. & Rowland, G. N. \nMagnesi um toxicity: bone lesions. Poult. Sci. 59: 2403-\n2411. 1980.    \n6. Lee, S. R. & Walter, M. B. Magnesium \ntoxicity: effect on phosphorus utilization by broiler \nchicks. Poult. Sci. 59: 1989- 1994. 1980.   \n \nACKNOWLEDGMENTS  \nWe thank Professor Martin Malkinson for hi s \nhelp to edit this article.  \n \nGASTRIC INTUSSUSCEPTION IN LAYING HENS  \n \nINTUSUSCEPCI\u00d3N EN PONEDORAS  \n \nNancy Reimers and H. John Barnes  \n \nCollege of Veterinary Medicine, North Carolina State University, Raleigh, NC 27606  \n \nRESUMEN  \nSe realizaron necropsias cada semana en toda la \nmortalidad de una caseta de postura, durante un a\u00f1o \nentero. Cinco de las 789 gallinas sometidas a necropsia \npresentaron una intususcepci\u00f3n g\u00e1strica resultante de la  introducci\u00f3n del proventr\u00edculo en el ventr\u00edculo, a la manera de un tele scopio. La intususcepci\u00f3n cre\u00f3 una \nconstricci\u00f3n del lumen del tracto gastrointestinal y, consecuentemente, estas aves estaban anovulatorias y severamente emaciadas. La edad de las aves afectadas \nvari\u00f3 de 110 a 121 semanas, al momento de la \nnecropsia. El ex amen macro y microsc\u00f3pico de los \ntejidos no logr\u00f3 sugerir la etiolog\u00eda en esta ocasi\u00f3n.  \n \nIntussusception is the invagination of one portion \nof the gastrointestinal tract into the adjacent portion.  \nIntestinal intussusception has been noted as a cause of \nmortality in both ratites and gallinaceous birds (1 -3).  \nPredisposing conditions include coccidiosis and \ngastrointestinal impaction, particularly in young birds.  \nAlthough less common, idiopathic gastric intussusceptions have been seen in both peafowl and \nchickens (4, 5).  Intussusceptions in most species are \nassociated with an alteration of normal peristaltic activity.  \nWeekly post mortem examinations were \nconducted on all mortality from a house of laying hens \nfor the period of a year.  In five of the seven hundred \neighty- nine birds necropsied, the proventriculus \ntelescoped into the ventriculus to form a gastric \nintussusception.  The intussusception created a \nconstriction of the lumen of the gastrointestinal tract consequently the hens were anovulatory and se verely \nemaciated.  Affected birds ranged from one hundred \nten to one hundred twenty -one weeks of age at the time \nof examination.  Gross and histologic examinations of \nthe tissues have failed to suggest an etiology for the \ncondition at this time.  \n \n(A full -length article will be submitted for review and \nconsideration for publication in Avian Diseases ). \n  \n  \n181 REFERENCES  \n1. Mushi, E., J.M. Kamau, J.W. Isa, M.G. \nBinta, and L. Modisa, Intussusception in the small \nintestine of a farmed ostrich (Struthio camelus) chick \nin Botswana.  Trop Anim Health Prod, 1998. 30(5): p. \n325-6. \n2. Frasca, S., Jr. and M.I. Khan, Multiple \nintussusceptions in a juvenile rhea (Rhea americana) \nwith proventricular impaction.  Avian Dis, 1997. 41(2): \np. 475- 80. 3. Bandyopadhyay, A.C. and S.K. Jain, A case  \nof intussusception in a fowl.  Indian Vet J, 1967. 44(2): \np. 117- 9. \n4. Rao, A.T. and L.N. Acharjyo, \nIntussusception of proventriculus in a common pea fowl (Pavo cristatus).  Vet Rec, 1979. 104(4): p. 76.  \n5. Sharma, U.K., Intussusception of the \nproventriculus of c hickens.  Avian Dis, 1972. 16(2): p. \n453-7.\n \nAN OUTBREAK OF INCLUSION BODY HEPATITIS IN  \nBROILER CHICKENS  \n \nUN BROTE DE HEPATITIS CON CUERPOS DE INCLUSI\u00d3N EN POLLO DE \nENGORDA  \n \nH. L. Shivaprasad, G. Senties -Cue, P. R. Woolcock, and R. P. Chin  \n \nCalifornia Anim al Health and Food Safety Laboratory System, Fresno Branch, University of California, Davis, 2789 \nSouth Orange Avenue, Fresno, CA  93725  \n \nRESUMEN  \nSe diagnostic\u00f3 hepatitis con cuerpos de inclusi\u00f3n \nen pollo de engorda  de 19 a 26 d\u00edas de edad con base \nen la  patolog\u00eda, la microscop\u00eda electr\u00f3nica y el \naislamiento del virus. El cuadro cl\u00ednico se caracteriz\u00f3 por aumento en la mortalidad, signos respiratorios y \nfalta de uniformidad en el tama\u00f1o de las aves. \nPresentaremos informaci\u00f3n sobre la historia de la \nvacuna ci\u00f3n de las reproductoras y de su progenie, los \nsignos cl\u00ednicos, la mortalidad, la serolog\u00eda, la \nbacteriolog\u00eda, la patolog\u00eda, el aislamiento del virus y la \ncaracterizaci\u00f3n del adenovirus aislado.  \n \nDuring the summer of 2001, an outbreak of \ninclusion body he patitis (IBH) due to adenovirus group \nI occurred in commercial broiler chickens.  Clinical signs included unevenness in the flock, respiratory \nsigns, and increased mortality of 0.5 to 1% per day for \nseveral days.  Total mortality of 8.15% was observed in \nsome flocks by the time the chickens were marketed at \naround 47 days of age.  The chickens had been vaccinated for Marek\u2019s disease at 1 day of age and for Newcastle disease (ND) and infectious bronchitis (IB) \nat 12 days of age and for infectious bursal dise ase \n(IBD) at 18 days of age. The chickens had not been \nvaccinated for chicken infectious anemia (CIA).  \nA total of 37 broiler chickens between the ages of \n19 and 26 days were submitted for laboratory evaluation.  Significant gross lesions included mild to \nmoderately enlarged pale livers with a reticular pattern \n(5 birds), enlarged livers with petechiae (3 birds), and \nlivers with tan to brown or greenish discoloration (5 birds).  Five birds had increased pericardial fluid and 14 birds had enlarged pale kidney s.  Bursa of Fabricius \nand thymus were mildly to severely atrophied in most of the birds examined.  One bird had pale bone marrow.  Other significant findings included fibrinous \nexudate in the pericardium, air sac, on the capsule of \nthe liver, and pleura, and increased mucus in the \ntrachea.\n \nMicroscopic lesions included acute multifocal \ncoagulation necrosis of hepatocytes with mild \ninflammation, and many hepatocytes contained \nbasophilic intranuclear inclusion bodies.  There was \nmild to moderate infiltration of lymphocytes in the \ninterstitium of the kidney and many tubules were \ndilated and some contained eosinophilic material \nwithin their lumens.  Bursa and thymus had mild to severe lymphoid depletion.  Other changes included \nmild to severe fibrinosuppurative inflammation of the \nair sacs, capsule of the liver, pericardium, and pleura.  \nProventriculi in a few birds had mild to moderate \ninfiltration of lymphocytes in the interstitium of the \nglandular portions.  Adenovirus, alone or in combination with adeno assoc iated viruses were \nisolated from the liver, kidney, trachea/lung and bursa \nof Fabricius from several birds. Thin section electron \nmicroscopy of the liver revealed typical hexagonal \nviral particles, ranging in size from 70 and 90 nm in the \nnucleus of hepato cytes consistent with the morphology \nof adenovirus.  \nE. coli was cultured from organs that had \nfibrinosuppurative inflammation including air sac, pericardium, capsule of the liver, and trachea.   \n  \n182 Bordetella avium  was isolated from the trachea of a \nfew birds .  The birds cultured for Mycoplasma \ngallisepticum, Mycoplasma synoviae , and salmonella \nwere negative.  Serologically, all the birds were \nnegative for MG, MS, reovirus, IB, and most were \nnegative for ND and IBD.  Only two sera out of 28 sera \nexamined were positive for CIAV.  \nThe broiler chickens originated from the same \nbreeder flock that was about 37 weeks of age.  Egg \nproduction in the broiler flock was excellent.  The \nbreeders had been vaccinated for Marek\u2019s disease, ND, IB, IBD, infectious laryngotrachei tis and cholera.  The \nbreeders had not been vaccinated for CIA, but the CIAV titers of the breeders at 11 and 18 weeks were \nadequate.  IBDV titers in the breeders were adequate at \n25, 29 and 35 weeks of age. The progeny of these \nbreeder chickens were house d in 80 houses, only 5 \nhouses broke with IBH.  However, a lack of uniformity \nin the size of the birds was observed in almost all the \nhouses.  \nAdenoviruses isolated from the broiler chickens \nare being further characterized.  \n \nCASE REPORT:  ZYGOMY COSIS IN LAYER PULLETS AND \nCOCKERELS  \n \nZIGOMICOSIS EN POLLAS PARA POSTURA Y GALLOS J\u00d3VENES  \n \nSara Throne Steinlage, J. E. Sander, T. P. Brown, A. Martinez \n \nRESUMEN  \nUn caso de pollas para postura y machos de 8 \nsemanas de edad presentados al laboratorio de \ndiagn\u00f3stico co n historia de aumento en la mortalidad, \nplumaje erizado, problemas de patas y vacunaci\u00f3n reciente. A la necropsia se encontraron grandes \ngranulomas multifocales en diversos tejidos. Al cultivo \nbacteriol\u00f3gico se observ\u00f3 s\u00f3lo un ligero crecimiento. \nLa histop atolog\u00eda revel\u00f3 una poblaci\u00f3n mixta de \nhongos como zigomicetos y Aspergillus,  siendo los \nprimeros mucho m\u00e1s numerosos. No se logr\u00f3 obtener \nel cultivo puro de los zigomicetos debido a la \ncoinfecci\u00f3n con Aspergillus  y Penicillium.  No se logr\u00f3 \naclarar la fuen te de origen de los hongos zigomicetos. \nSe realizaron pruebas serol\u00f3gicas para evaluar el estado inmunol\u00f3gico de la parvada.  \n A case of eight week old layer pullets and \ncockerels presented to the diagnostic lab with a history of increased mortality, ruffle d feathers, leg problems, \nand recent vaccination.  At necropsy the birds had large, multifocal granulomas in multiple tissues.  Only light bacterial growth was seen on culture.  On \nhistopathology, a mixed population of fungi was seen \nincluding Zygomycete a nd Aspergillus, with the \nzygomycetes being much more numerous.  Pure culture \nof the zygomycetes was unsuccessful due to the co -\ninfection with Aspergillus and Penicillium.  The source \nof the zygomycete fungi remains unknown.  Serology \nwas performed to evalu ate the flock\u2019s immune status.   \n \n(A full report of this study will be submitted for \npublication in Avian Diseases ). \nESTUDIO DE UNA SERIE DE CASOS  DE CUADRO DE  \nCOMPLEJO RESPIRATORIO TEMPRANO EN  \nPOLLOS DE ENGORDA  \n \nSTUDY OF A SERIES OF CASES OF EARLY RESPIRATORY  \nCOMPLEX IN BROILERS  \n \nMariano Salem, A. Ziegler, J. Rosenberger, S. Cloud, J. Gelb, M. Troeber, C. Pope, B. Sample  \n                                     \nAnimal and Food Science, University of Delaware, Georgetown, DE, 19947  \n \nSUMMARY  \nA series of mor e than 33 cases of respiratory \ncomplex in 8 -25 day -old broilers is reported. Infectious \nbursal disease virus (IBDV) was not a consistent \nfinding. Histopathology of the bursa of Fabricius, thymus, and other organs was non conclusive. Polymerase chain reacti on (PCR) showed a small \nnumber of thymuses positive to chicken anemia virus (CAV). Many chickens showed packed cell volumes <27, and they were serologically negative to CAV.  \n  \n183 CAV was isolated in 22% of the cases. \nPrimary/predisposing etiological agents could not be \nclearly defined.  \n \nRESUMEN  \nSe reporta una serie de m\u00e1s de 33 casos de cuadro \nde complejo respiratorio en pollos de engorda de 8 a 25 \nd\u00edas de edad . No se encontr\u00f3 presencia constante de \ncepas del virus de la Infecci\u00f3n de la Bolsa de \nFabricio(VIBF) , la histopatolog\u00eda de la Bolsa de \nFabricio, timo y otros \u00f3rganos, no fue concluyente. Un \nreducido n\u00famero de timos resultaron PCR positivos \npara el virus de la Anemia Infecciosa de los Pollos (VAIP) . Hubo muchos pollos con valores de \nhematocrito menor que  27 y con serolog\u00eda negative \npara VAIP. Se aisl\u00f3 VAIP en 22% de los casos . No se \npudo definir claramente la etiolog\u00eda inicial o \npredisponente.  \n \nINTRODUCCI\u00d3N  \n   El complejo respiratorio de las aves (CRA) es \nde las enfermedades mas diagnosticadas en el mund o \nav\u00edcola.generalmente es de etiolog\u00eda m\u00faltiple pero el cuadro cl\u00ednico es similar. En las aves afectadas se \nobserva perihepatitis, pericarditis ,peritonitis y \naerosaculitis fibrinopurulenta. Adem\u00e1s se pueden ver \nlesions exudativas en articulaciones asi com o procesos \ninfecciosos subcutaneous en diferentes partes de \ncuerpo.  \n   Entre las etiolog\u00edas virales iniciadoras se \nencuentran  el virus de la Bronquitis Infecciosa( VBI), el de la Enfermedad de Newcastle (VEN)de campo o \nvacunal, pneumovirus, virus de la La ringotraqueitis \nInfecciosa(VLTI) etc. Entre las etiolog\u00edas \npredisponentes virales se encuentran sobretodo las \ncausantes de inmunodeficiencias . De \u00e9stas \u00faltimas las \nm\u00e1s communes son las causantes de la Infecci\u00f3n de la Bolsa de Fabricio( IBF), la de la Anem ia Infecciosa de \nlos Pollos ( AIP) , la reovirosis, la Enfermedad de \nMarek (EM) y la Leucosis Aviar ( LA). Las \nenfermedades predisponentes bacterianas mas communes son Micoplamosis gallisepticum ( Mg) y \nMicoplasmosis sinoviae ( Ms) y  Ornitobacteriosis \nrhinotraqueale .  \n   Para determinar las etiolog\u00edas involucradas \ncuando se presenta una serie de casos es necesario \nintentar el aislamiento del /los agentes iniciadores y \npredisponentes  o determinar la infecci\u00f3n por estos \nagentes por serolog\u00eda o pruebas molec ulares.  \n \nREPORTE DE LA SERIE DE CASOS  \n Durante el a\u00f1o 2001 se presentaron mas de 33 \ncasos de pollos de engorda de entre 8 y 25 d\u00edas de edad  \nsiendo la mayor\u00eda de entre 10 y 13 d\u00edas de edad, con cuadros t\u00edpicos de CRA. Todos los casos fueron del \nmismo compl ejo av\u00edcola y se registraron de febrero a Mayo del a\u00f1o 2001. Las lesions observadas en todos \nlos casos fueron las t\u00edpicas del complejo respiratorio \nincluyendo: pericarditis, perihepatitis, peritonitis, \naerosaculitis  y en algunos casos lesions articulares . \nLos cultivos bacteriol\u00f3gicoas mostraron crecimiento de \nla bacteria Escherichia coli (E.coli) en todos los casos  \ny solamente se encontr\u00f3 la presencia de A. fumigatus en uno y la de E. fecalis en otro caso. Se compararon \nlos patrones de antibiograma adem\u00e1 s de hacer pruebas \nde patogenicidad de las cepas de E.coli aisladas para \ninvestigar la possible existencia  de un mismo tipo de \ncepa involucrada. No se encontr\u00f3 evidencia que \nindicara que alguna cepa de E. coli predominara en los \naislamientos. Se observ\u00f3 h ipoplasia del timo en 26 / 33 \ncasos  e hipoplasia de la Bolsa de Fabricio en 16/33 de \nlos casos. No se observ\u00f3 palidez de la m\u00e9dula osea o \nhemorragias subcut\u00e1neas.  \n \nHISTOPATOLOG\u00cdA  \nAunque se enviaron muestras de organos en 24/33 \nde los casos, solamente se v ieron lesiones semejantes \npero no id\u00e9nticas a las producidas por VAIP en timo en \n6/23 casos.. En 15/ 23 de los casos se observ\u00f3 \nhipoplasia del timo y en 14 /23 se observ\u00f3 hipoplasia de la Bolsa de Fabricio. Por otro lado se se report\u00f3 \nhiperplasia de la m\u00e9d ula osea en 14/14 muestras \nenviadas.  \n \nSEROLOG\u00cdA  \nUna observaci\u00f3n interesante es que cuando se \nprobaron los sueros contra VAIP mediante el m\u00e9todo de Elisa se encontr\u00f3 que solamente 11/ 67muestras ( \n16.4%) , del total de 13 parvadas probadas dieron \nresultados  positivos. Es decir 83.5 % de las muestras \nno ten\u00edan niveles detectables de anticuerpos contra VAIP.No se encontraron  muestras positivas a las pruebas de aglutinacion en placa o de Elisa contra \nMicoplasma gallisepticum ( Mg) o Micoplasma \nsinoviae ( Ms).  \n \nVALORES DE HEMATOCRI TO \nMuestras de sangre de 16/33 de los casos fueron \nsometidas a la prueba de hematocrito.  De 72 muestras totales se encontr\u00f3 que 37/72 dieron lecturas de menos \nde 27. Indicando que el 51 % de las aves muestreadas \nten\u00edan niveles indicati vos de anemia.  \n \nPRUEBAS DE CAPTURA DE ANT\u00cdGENO CON  \nANTICUERPOS MONOCLONALES (PCAAM) \nCONTRA EL VIBF  \nCon el prop\u00f3sito de determinar si el VIBF estaba \npresente y por consecuencia ser factor predisponente en \nesta serie de casos, se probaron Bolsa de Fabricio de 21/33 de los casos utilizando la prueba de captura de \nant\u00edgeno por anticuerpos  monoclonales . Result\u00f3 que \n20 / 21 casos fueron negativos a la presencia ant\u00edgenos  \n  \n184 del VIBF y en un s\u00f3lo caso de detect\u00f3 la presencia de \nla cepa RS -593 del VIBF.  \n                                                                                      \nAISLAMIENTO VIRAL  \nSe intent\u00f3 aislamiento viral de muestras de timo y \npulm\u00f3n de 17 /33 casos y se obtuvieron   11/17 resultados positivos para el  VBI,y 3/17 para el VENC, todos los aislamientos fueron obtenidos al primero o \nsegundo pase en embri\u00f3n . Adem\u00e1s , 22% de los casos \nmuestreados fueron positivos para el aislamiento del \nVAIP( 1) .  Uno de los aislamiento de del VBI fue \nsecuenciado y mostr\u00f3 ser del tipo Ark DPI, igual al de \nla vacuna empleada contra VBI al d\u00eda de edad.  \n \nPRUEBAS DE LA REACCI \u00d3N EN CADENA DE \nLA POLIMERASA  ( PCR) PARA VAIP  \nSe investig\u00f3 la presencia del VAIP por el m\u00e9todo \nde PCR  en timos de 10 /33 de los casos . Se encontr\u00f3 que 8/ 10 ( 80%) fueron negativos. Solame nte 2/10 \nfueron positivos a esta prueba..  \n \nCONCLUSIONES  \n  A pesar de el gran n\u00famero de pruebas \ndiagn\u00f3sticas hechas  para determinar la etiolog\u00eda/ s \ncausante en esta serie de casos de CR temprano, no se \npudo con certeza determinarlas.  \n  La mayor\u00eda de las av es no mostraron tener \nniveles detectables contra VAIP, lo que puede indicar \nuna falta de protecci\u00f3n adecuada contra la  AIP.    Por los resultados obtenidos en las PCAAM se \npuede concluir que el VIBF no parece estar presente  en las Bolsas de Fabricio de av es afectadas.  \n  Los aislamientos del VBI y el de ENC son muy \nprobablemente de origen vacunal.  \n  El porcentaje alto de aislamiento de VAIP unido \na los niveles bajos de anticuerpos  y  el porcentaje alto \nde aves con muetras de anemia  pueden  indicar que la \ninfecci\u00f3n por este virus pudiera tener un papel \nimportante en esta serie de casos. Por otro lado, en \nninguno de los casos cl\u00ednicos se presentaron  las \nlesiones t\u00edpicas de la infecci\u00f3n por VAIP cuando la \ninfecci\u00f3n ocurre por trasmisi\u00f3n vertical del virus. E s \ndecir , no hubo casos de \u201cala azul o dermatitis \ngangrenosa\u201d, no se observaron casos de palidez obvia \nen la m\u00e9dula osea  o en otros \u00f3rganos. Adem\u00e1s no se \nobserv\u00f3 correlaci\u00f3n entre las lesiones histopatol\u00f3gicas \ny las pruebas de PCR con los aislamientos vir ales. \n \nREFERENCIAS  \n1. G.Donald Ritter.Unusual Colisepticemia in \nYoung Broilers. Proceedings of the 36\nth National \nMeeting on Poultry Health and Processing. Pp. 124,126. 2001  \n   \nAGRADECIMIENTO  \nLa Sra. Stephanie Mengel -Wheareat, Kathy \nHamilton,y los Sres. Colby Smith y Joshua Litten \nhicieron el magn\u00edfico trabajo t\u00e9cnico en esta serie de \ncasos, por lo cual les estoy profundamente agradecido.  \n \nA STUDY OF PSEUDOMONAS AERUGINOSA  CONTAMINATION IN \nA COMMERCIAL POULTRY HATCHERY  \n \nESTUDIO DE CONTAMINACI\u00d3N CON PSEUDOMONAS  AERUGINOSA EN \nUNA INCUBADORA COMERCIAL  \n \nJean E. Sander  \n \nRESUMEN  \nLa contaminaci\u00f3n de la incubadora con \nPseudomonas  puede tener un impacto adverso sobre la \ncalidad de la salud del pollo reci\u00e9n nacido y, debido a \nla resistencia t\u00edpica de esta bacteria, la contaminaci\u00f3n \nno se elimina con facilidad. Se inocularon cinco \naislamientos de P. aeruginosa a pollos de un d\u00eda de \nedad, encontrando grandes variaciones en la virulencia. \nEl n\u00famero de bacterias en el saco vitelino fue bajo pero \nla severidad de la enfermedad  fue extrema. Todos los \naislamientos fueron resistentes a los antibi\u00f3ticos, excepci\u00f3n hecha de la gentamicina. A una \nconcentraci\u00f3n de 10\n9, todos los aislamientos fueron \nresistentes a los desinfectantes a base de amonio \ncuaternario o de fenol. La dosis de l as bacterias y la adici\u00f3n de EDTA -Tris,  estuvo fuertemente asociada \ncon la eficacia de los desinfectantes.  \nContamination of a hatchery by Pseudomonas can \nhave an adverse impact on chick quality and health and \ndue to the typical resistance and hardiness of this bacterium, contamination is not easily alleviated.  Five \nisolates of P. aeruginosa were inoculated into 1 -day \nold chicks, with a large variation in virulence.  The \nnumber of bacteria in the yolk sac was low, and severity of disease extreme.  All isolates were resistant \nto antibiotics with the exception of gentamycin.  All \nisolates at 10\n9 were resistant to quaternary ammonium \nand phenolic disinfectants.  Bacterial dose and the addition of EDTA -Tris was strongly associated with \ndisinfectant efficacy.   \n  \n185  (Full-length article will be published in Avian \nDiseases ).\n \nMORTALITY PROBLEMS I N HATCHERIES: HAVE T HEY \nDISAPPEARED DUE TO M ODERN TECHNOLOGY?  \n \nPROBLEMAS DE MORTALIDAD EN LA INCUBADORA: \u00bfHAN \nDESAPARECIDO GRACIAS A LA TECNOLOG\u00cdA MODERNA?  \n \nFranz Sommer, Bruce C harlton  \n \nCAHFS, Turlock Branch, 1550 N. Soderquist Ave, Turlock, Ca, 95380  \n \nRESUMEN  \nSe encontr\u00f3 que diferentes bacterias son agentes \ncausales de mortalidad en las plantas de incubaci\u00f3n, \ncausando p\u00e9rdidas dram\u00e1ticas ( Enterobacter cloacae, \nProteus  sp., Esch erichia coli). Despu\u00e9s de medio a\u00f1o \nde haber experimentado mortalidad en el pollo reci\u00e9n nacido, se volvi\u00f3 a presentar un caso similar. Se determin\u00f3 que las bacterias ( P. aeruginosa y E.  coli) \nhab\u00edan sido las causantes de las p\u00e9rdidas en este caso \ntambi\u00e9n . El hallazgo com\u00fan a los dos problemas fue la \ntasa comparable de mortalidad y la falta de aplicaci\u00f3n \nde un antibi\u00f3tico in ovo.  Los hallazgos postmortem  y \nlos resultados bacteriol\u00f3gicos fueron diferentes.  \n Due to modern technology, hatchery -related \naccessi ons are not a frequent type of case in the \nCAHFS system. Consequently, when they occur, they are not only challenging, but offer an excellent \nopportunity for learning.  \nIn late fall, 2000, live and dead day -old chickens \nwere submitted from a broiler hatcher y to the \ndiagnostic laboratory along with 60 unhatched eggs. On the previous day, a different ventilation regimen \nwas being tested for the first time and it was noticed \nthat hatchery mortality had increased. When the increased mortality extended into the 2\nnd day, \nsubmission of samples was made. The total mortality in \nthese two days was excessive.  \nPostmortem examination found all chicks had \nswollen yolk sacs, containing greenish or reddish contents, and additional fluid in the abdominal cavity. \nThe eggs cont ained dead in shells with a massive \nomphalitis and hernias. Bacteriology findings in the \nlive and dead chickens included various degrees of \nmixed flora, Enterobacter cloacae , Escherichia (E.) \ncoli and Providencia sp.  out of livers and yolk sacs. In \nthe sub mitted eggs or dead in shells, mainly Proteus \nsp., Enterobacter cloacae  and Klebsiella oxytoca  were \nfound. Similar results with the addition of \nPseudomonas sp.  were present in the livers. \nHistopathological examination found slight inflammatory reactions in  livers (necrotic foci, \nmicrothrombosis) and yolk sacs.  \nIn late spring of 2001, an additional case was \nreceived from the same hatchery. Dead chicks and \ncracked and uncracked eggs were submitted. Again, the \ncase history included problems with high mortality  and \nunhatched eggs.  \nIn these chicks, either hatched or dead in shells, \nlarge, edematous yolk sacs were found. The navels \nwere not closed, so parts of the yolk sacs were still \nextra corporal. Bacteriology findings included various \ndegrees of mixed flora, Enterococcus sp. , Escherichia \ncoli and Proteus sp.  out of livers and yolk sacs, but the \npredominant bacteria found was Pseudomonas (P.) \naeruginosa, even out of the brain. Histopathological \nexamination found inflammatory reactions in livers and \nyolk sacs.  \nIn case one, hatchery protocols revealed that in \nboth days the mortality was found in hatchers opened at the end of the day. Routine procedures had been \nperformed as usual. Parameters like parent stock or egg \nstorage seemed uninvolved. Bacteriological \nexam ination of different samples of vaccines, diluents \nand vials containing a competitive exclusion product that had been administered in the hatchery did not show any unexpected growth.  \nA common factor related to both days\u2019 mortality \nappeared to be one group of machines used for in ovo vaccination. So one possible explanation is that the machine may have run out of disinfectant solution used \nto disinfect each injector between eggs and thus \ncontaminated serial trays of eggs.  \nP. aeruginosa was the leading bacter iological \nfinding in case two. Although contamination of a vaccine with P. aeruginosa  has been described by \nMireles and Alvarez (2) as a cause of high mortality, in \nthis case the same batch of vaccine was used on other \neggs without any signs of increased m ortality. \nTemperature recordings of the hatchers did not show any abnormality and there were affected and unaffected \nhatchers in the same row of hatchers. One connection  \n  \n186 between the affected hatchers seemed to be a delivery \nof hatching eggs, but eggs from another origin had also \nbeen affected.  \nAlthough it was not possible to determine a \nsource for the intake of P. aeruginosa into these \nhatchers, improper temperature conditions during egg \ntransport could have been an underlying problem. Generally, nest clea n eggs that have 500 or fewer \nbacteria on the shell are not considered a severe \ncontamination risk, unless they sweat. Unfortunately, it \nis common for moisture to form on the shells after eggs \nare removed from a cool egg storage room, creating a \nserious ha zard (3). And, in distinction to case one, \nneither a competitive exclusion product nor an \nantibiotic was used during the vaccination.  \nCommon finding in these two cases was the \ncomparable mortality rate and the absence of an in ovo application of an antibio tic. Postmortem findings and \nbacteriology results were slightly different. In the first \ncase, mainly Enterobacter  and E. coli  were the \npredominant bacteria, while in the second case, the \nleading bacteriological finding was P. aeruginosa.  \nSince mortality s eemed to be related to the \nvaccination process during egg transfer, egg surface \ncontamination could have been the predominant factor \nin both cases. In case one, a competitive exclusion \nproduct was used, while in case two neither a \ncompetitive exclusion pro duct nor an antibiotic product \nwas used. Obviously, in case one the competitive \nexclusion product was not able to suppress bacterial \ngrowth to a satisfactory degree. In case two, it appears that high numbers of bacteria on the eggshells, without \nbeing inhi bited either by an antibiotic or a competitive \nexclusion product, resulted in embryo contamination \nand subsequently mortality.  \nBecause of a hole punched into the eggshell \nduring the in ovo vaccination process, they are more susceptible to infection. Realizing this, the company \nleasing in ovo vaccination equipment requires that \nparticipating hatcheries have an excellent sanitation \nprogram (4).  \nIn ovo  application of antibiotics is an opportunity \nto control contamination problems. Research has \ndemonstrated t hat there are competitive exclusion \nproducts available that appear to have the potential to \ncontrol many enteritic pathogens in poultry when \nadministered in ovo singly or in combination with an \nantibiotic (1). The worldwide movement to reduce \nantibiotic us e in poultry due to microbial resistance \nperceptions to antibiotics, these types of hatchery \nproblems may become more and more important.  \nAlthough modern technology has reduced the \nlikelihood of hatchery mortality, it has also created \nsome pitfalls.  \n \nREFER ENCES  \n1. Edens, F.W., Parkhurst, C.R., Casas, I.A., \nand Dobrogosz, W.J.: Principles of Ex Ovo \nCompetitive Exclusion and In Ovo  Administration of \nLactobacillus reuteri. Poultry Sci. 76, pp 179- 196. \n1997.  \n2. Mireles, V., C. Alvarez, C.: Pseudomonas \naeruginosa infe ction due to contaminated vaccination \nequipment. Proc. 28\nth West. Poult. Dis. Conf. and 13th \nPHS, Sacramento, California, pp. 55 -57. 1979.  \n3. Mauldin, J.M.: Maintaining Hatching Egg \nQuality. In: Bell, D.D., Weaver, W.D.: Commercial \nChicken Meat and Egg Produc tion, 5th ed., Kluwer, pp \n707-725. 2002.  \n4. Mauldin, J.M.: Operating the Hatchery. In: \nBell, D.D., Weaver, W.D.: Commercial Chicken Meat and Egg Production, 5\nth ed., Kluwer, pp 775- 800. 2002.  \n \n \n   \n \n   \n \n  \n  \n  \n187 EL EFECTO DE HUMEDAD INCUBATORIA EN LOS \nPAR\u00c1METROS PRODUCTIVOS DEL POLLO          \n \nTHE EFFECT OF INCUBATION HUMIDITY ON HATCHABILITY AND \nEMBRYO MORTALITY, AND ON MAJOR BROILER PRODUCTIVE \nPARAMETERS  \n \nPrado -Rebolledo OF1, Ju\u00e1rez- Estrada MA2., Arce -Menocal J3., Cabrera- Due\u00f1asJ4 \n \n1 Facultad de Medicina Veterinar ia y Zootecnia. Universidad de Colima. Autopista Colima -Manzanillo Km. 40. \nCrucero de Tecom\u00e1n Col. CP 28100 E -mail: omarpr@ucol.mx , 2 Departamento de Producci\u00f3n Animal: Aves, \nFacultad de Medicina Veterinaria y Zootecn ia. Universidad Nacional Aut\u00f3noma de M\u00e9xico, 3 Facultad de Medicina \nVeterinaria y Zootecnia. UMSNH. Ecuador 120. Frac. Am\u00e9rica. CP. 58270. Morelia Michoac\u00e1n, M\u00e9xico.  \n4 Majahual SPRL de CV. Prolongaci\u00f3n Hidalgo # 940. Arboledas del Carmen. Villa de \u00c1lvarez,  Colima. CP. 28978  \n \nSUMMARY  \nThe purpose of this research was to determine the \neffect of  relative humidity during incubation on \nhatchability, embryuo mortality, and broiler productive \nparameters in summer. One thousand four hundred and sixty four eggs lai d by 38- week -old Ross x Ross \nbreeders. Eggs were incubated in two setters at the \nfollowing temperatures: 37.5 \u00b1  0.5 \u00b0C dry bulb. 28.3 \u00b1  \n0.5 \u00b0C y 30 \u00b1  0.5 \u00b0C wet bulb, respectively. Data sere \nsubjected to Variance Analysis. Results suggest that at \n28.5 \u00b1 0.5\u00b0C more moisture is lost, with no statistical \nsignificance on the parameters evaluated.  \n \nEl objetivo fue determinar el efecto de la \nhumedad relativa durante la  incubaci\u00f3n y par\u00e1metros \nproductivos del pollo en \u00e9poca de verano. Se utilizaron 1 464 huevos de la estirpe Ross x Ross con 38 semanas de edad. Se incubaron en dos m\u00e1quinas incubadoras \ncon temperatura de 37.5 \u00b1  0.5 \u00b0C bulbo seco. 28.3 \u00b1  \n0.5 \u00b0C y 30 \u00b1 0.5 \u00b0C bulbo h\u00famedo respectivamente. \nLos datos se sometieron a un An\u00e1lisis de Varianza. Los resulta dos sugieren que a 28.5 \u00b1  0.5 \u00b0C se obtiene una \nmayor p\u00e9rdida de humedad sin observarse significancia \nen las diferentes variables medidas.  \n \n(El trabajo completo se pretende publicar en la revista \nVeterinaria M\u00e9xico ). \n \n \n \n \n \nIMPACT OF POULTRY HO USE AIR QUALI TY ON  \nHUMAN HEALTH \n \nIMPACTO DE LA CALIDAD DEL AIRE EN LAS CASETAS AV\u00cdCOLAS \nSOBRE LA SALUD HUMANA  \n \nTrisha Marsh Johnson  \n \nJones -Hamilton Co., 1 Plaza East, Suite 702, Salisbury, MD 21801  \n \nRESUMEN  \nLa calidad del aire en las casetas av\u00edcolas es \nsumamente def iciente. Los niveles de polvo, \nendotoxinas y amon\u00edaco son superiores a los valores \nl\u00edmite del umbral para el humano, y son mucho m\u00e1s \nelevados que en cualquier otra instalaci\u00f3n pecuaria. Subsecuentemente, los trabajadores de la industria \nav\u00edcola sufren m\u00e1s da\u00f1o respiratorio que cualesquier \notros trabajadores a cargo de animales. Disertaremos \nsobre los problemas respiratorios m\u00e1s comunes y sobre c\u00f3mo seleccionar el equipo apropiado de protecci\u00f3n \npersonal.  \n \nMuch attention has been paid to the air quality of \npoultry housing in regards to its impact on poultry \nhealth and performance.  However, little thought within \nthe industry has been focused on how air quality affects the health of poultry workers.  The only notable exception is the absolute wealth of data generated \nwithin the former Soviet Bloc countries but only  \n  \n188 available in Russian.  The data that does exist is quite \nclear and unequivocal.  Air quality within poultry \nhousing is poorer than in confinement facilities for any \nother species.  Subsequently, poul try workers suffer \nfrom more respiratory damage than any other workers \nin animal agriculture.  Because much of the damage is \ninsidious in nature and/or delayed in onset, its connection to occupational exposure is often \noverlooked.   \nThe most common respiratory disorders \nencountered in poultry workers are Hypersensitivity Pneumonitis (HP), Organic Dust Toxicity Syndrome \n(ODTS), occupational asthmas, and acute or chronic bronchitis.  Mucous Membrane Irritation syndrome and \nnon-specific, nion -asthmatic chronic airflow \nobstructions also occur with relative frequency but are \nless well -defined syndromes.  Dust, endotoxin, and \nammonia (NH\n3) exposure all contribute to theses \nsyndromes.  \nHP is the only of the respiratory symptoms \nencountered in animal agriculture almo st exclusively in \npoultry workers.  HP is caused by the sensitization to \nand repeated inhalation of organic antigens, in this \ncase, poultry feathers and fecal material.  The most well known type of HP is Farmer\u2019s lung, which is \ncaused by exposure to moldy hay.  Approximately 5 -\n15% of individuals exposed to poultry will develop HP \nand it is more common in non -smokers than smokers \n(Gudmundsson,2001).  This suggests the host immune response is a large factor in the development of the disease.  Lung changes are the result of cellular \ninfiltration into the alveoli and small airways followed \nby granuloma formation.  Cytokine release is important \nin the pathogenesis of the disease.  In acute HP, symptoms develop approximately 4 -6 hours after \nexposure and consist of  a combination of dyspnea, \ncough, chills, fever, headache, and malaise.  Symptoms last for 12 -24 hours and usually resolve spontaneously.   \nAcute episodes are often written off as viral \u201cflu -like\u201d \nevents. With continuing exposure, chronic disease may devel op resulting in changes consistent with other \ninterstitial lung disease.  Breathlessness, dyspnea upon exertion, and cough are common.  Fatigue, poor \nappetite, and weight loss are also seen.  The only \ntreatment is avoidance of the antigen and the lung \ndama ge is usually irreversible.  \nODTS also occurs frequently and presents much \nlike HP causing it to be written off as a \u201ctouch of the \nflu.\u201d  ODTS is a delayed hypersensitivity reaction to \nthe high levels of endotoxin present in poultry house \ndust.  Headache, d izziness, nausea, and breathlessness \noccur 3 -8 hours after exposure.  In more severe, acute \nepisodes fever and vomiting can occur.  Full recovery, \nespecially from the fatigue and malaise, can take 48 -72 \nhours.  Repeated episodes of ODTS can result in \nperma nent lung damage and fibrosis.  ODTS can occur on the first exposure or it may take ten years of \nexposure to become sensitized(Bar -Sela et al. 1984).  \nOccupational asthma most often occurs in poultry \nworkers who already exhibit allergic symptoms.  However, many farmers still develop occupational \nasthma without previously known allergies.  The prevalence rate is around 10% of all animal workers.  Mild allergic reactions include sneezing, runny nose, \nand skin hives.  As many as 50% of the workers who \nexhibit t hese mild symptoms will go on to develop the \ncoughing, wheezing, and tightening of the chest most \noften associated with asthma.  Symptoms can occur \nalmost immediately or be delayed for up to 8 hours \n(NIOSH, 1998).  In poultry workers, the asthma symptoms t end to persist even after the workers have \nleft the poultry facilities (Bar -Sela et al. 1984).  \nHigh levels of dust and NH\n3 in poultry facilities \nalso cause chronic respiratory irritation.  The Threshold Limit Value (TLV) for ammonia is 25 ppm, which is almost always exceeded in modern confinement \nfacilities.  This chronic exposure results in chronic \nbronchitis, bronchial reactivity, and/or bronchiolitis \nobliterans as well as generalized mucous membrane \nirritation.  Because the ability to smell ammonia is \ndramatically reduced even after minimal exposure, the \nnose should never be relied upon as an appropriate \nmonitoring tool.  \nThe development of modern confinement and \nanimal handling systems has greatly reduced the \nmajority of occupational injuries in animal ag riculture.  \nUnfortunately, this progress ahs come at the expense of \nincreased exposure to and concentration of respiratory \nhazards.  The levels of these hazards are higher in \npoultry buildings than in facilities in any other sector of \nanimal agriculture.  Louhelainen et al. (1987) \ncompared the TLV of organic dust (5mg/m\n3) with the \nactual dust concentration on 20 Finnish farms, four of \nwhich raised poultry.  The mean concentration of dust \nexceeded the TLV in all farm buildings with the \nhighest concentrations  recorded in the poultry houses at \n12.8 mg/m3.  Dust concentrations in a wide variety of \npoultry houses ranged from 0.02- 81.33 mg/m3 in a \nseparate study with the lowest dust concentrations \noccurring in the cage layer facilities (Ellen, 2000).  In \nturkey gr ow out houses, dust levels averaged 9.3 \nmg/m3 and NH 3 levels averaged 35ppm in the human \nbreathing zone.  During tilling of the litter, the NH 3 \nconcentration often exceeded 100ppm (Mulhasen, 1987).  While the levels of NH\n3, dust, and endotoxin \nreported in poultry houses vary widely in the literature, they always exceed the human TLVs by significant \namounts and are often 5 -10 fold higher than in other \nanimal facilities (Golbabaei, 2000; Dutkiewicz, 1978; \nHartung, 1998; Iverson, 2000).  \nThe increased respirato ry hazards documented in \npoultry housing are also clearly demonstrated in its  \n  \n189 effect on poultry workers.  Poultry workers have \nsignificantly higher prevalence of chronic cough, \nchronic phlegm, chronic bronchitis, and chest tightness \nthan non -exposed controls.  FVC, FEV1, and FEF25 \nwere significantly lower in poultry workers than \npredicted normal values.  Workers exposed for ten \nyears or more had even lower respiratory capacity test results than workers with shorter exposures (Zuskin, \n1995).  Significant dos e-response relationships \nbetween exposure and a decrease in pulmonary \nfunction over a work shift have also been documented.  \nThe following exposure levels resulted in a decrease of \nrespiratory function:  2.4 mg/m3 total dust, 0.16 mg/m3 respirable dust, 614 EU/m3 endotoxin and 12 ppm \nNH3 (Donham, 2000).  As noted in the earlier \nmentioned studies, conditions in poultry housing far \nexceed these levels.  The available literature \nconsistently documents respiratory damage in poultry \nworkers whether it is through increased incidence of \ndisease or decreased respiratory function tests \n(Danuser, 1988; Nielsen, 1995; Tudor, 1985; and \nThelin, 1984).  \nThe key to preventing respiratory illness is the \nselection and usage of appropriate personal protection \nequipment (PPE) c apable of mitigating the exposure to \nboth dust and ammonia.  Single strap nuisance dust \nmasks provide no protection and should never be used \nin poultry facilities.  Either disposable or reusable air purifying respirators equipped with NH3/methylamine \ncartridges should be worn.  The selection of a half or \nfull-face mask is up to the wearer.  A full -face mask \nwill also protect the eyes from ensure the proper fit and \nto conduct regular maintenance of the respirator.  \nOtherwise, a false sense of security may de velop.  The \nfollowing checklist of rules should always be used (Murphy, 1993):  \n\u2022 Always inspect and test fit with new \ncartridges.  Do not use a respirator that has \nbeen sitting around since     last season.  \n\u2022 Clean the respirator daily according to \nmanufacturer\u2019s instructions.  To extend \ncartridge life, store the      respirators and \ncartridges in an airtight bag.  \n\u2022 Store the respirator in a sealable plastic bag away from contaminants, not in a machine \nshop or livestock confinement building.  The \ncartridges in th e respirator continue to absorb \nthe gases in the storage area until the charcoal; \nhas reached its absorption capacity.  \n\u2022 Follow the test fit instructions.  \n\u2022 Do not use respirators with beards or other facial hair that pass between the sealing flange \nof the res pirator and the face.  \nThe nature of poultry housing lends itself to poor \nair quality that can negatively impact human health.  Often there is a dose response relationship between the levels of dust, endotoxin, and NH3 and the level of \nrespiratory dysfuncti on present.  The usage of \nappropriate PPE can mitigate the damage caused by \nrespiratory hazards.  \n \nREFERENCES  \n1. Danuser, B., Wyss, C. Hauser, R., von \nPlanta, U., and D. Folsch.  Lung Function and \nsymptoms in employees of poultry farms. Soz \nPraventivmed 33 (6) : 286 -91. 1988.  \n2. Donham, K.J., Cumro, D., Reynolds, S.J., \nand J.A. Merchant.  Dose -Response relationships \nbetween occupational aerosol exposures and cross -shift \ndeclines in poultry workers:  recommendations for \nexposure limits.  J Occup Environ Med Mar; 42( 3): \n260-9. 2000.  \n3. Dutkiewicz, J.  Exposure to dust -borne \nbacteria in agriculture. I. Environmental Studies.  Arch \nEnviron Health Sep -Oct; 33(5): 250- 9. 1978.  \n4. Ellen, H.H., Bottcher R.W., von Wachenfelt \nE., and H. Takai.  Dust levels and control methods in \npoultry houses. J Agric Saf Health Nov; 6(4): 275 -82. \n2000.  \n5. Golbabaei, F. and F. Islami.  Evaluation of \nworkers\u2019 exposure to dust, ammonia and endotoxin in \npoultry industries at the province of Isfahan, Iran.  Ind \nHealth Jan;38(1): 41 -6. 2000.  \n6. Gudmundsson, G . and J. Wilson.  \nPulmonary Core Curriculum: Hypersensitivity \nPneumonitis (farmer\u2019s lung disease). Virtual Hosp.org, 2001.  \n7. Hartung, J. Nature and amount of aerial \npollutants from livestock buildings.  Dtsch Tierarztl Wochenschr Jun;105(6):213- 6. 1998.  \n8. Iversen, M., Kirychuk, S., Drost, H., and L. \nJacobson.  Human health effects of dust exposure in animal confinement buildings. J Agric Saf Health \nNov;6(4): 283- 8. 2000.  \n9. Louhelainen, K., Kangas, J., Husman, K., \nand E.O. Terho. Total concentrations of dust in th e air \nduring farm work.  Eur J Respir Dis Suppl152:73- 9. \n1987.  \n10. Mulhausen, J.R., McJilton, C.E., Redig, \nP.T., and K.A. Janni. Aspergillus and other human respiratory disease agents in turkey confinement \nhouses. Am Ind Hyg Assoc J Nov;48(11):894- 9. 2987.  \n11. Nielsen, B.H., and N.O. Breum. Exposure to \nair contaminants in chicken catching. Am Ind Hyg Assoc J Aug;56(8):804- 8. 1995.  \n12. Preventing Asthma in Animal Handlers. \nNIOSH Publication No. 97 -116. Jan 1998.  \n13. Thelin, A., Tegler, O., and R. Rylander. \nLung reactions du ring poultry handling related to dust \nand bacterial endotoxin levels. Eur J Respir Dis \nMay;65(4):266- 71. 1984.   \n  \n190 14. Tudor, A., Racoveanu, C., Gheorghiu, M., \nGeorgescu M., and C. Pecec. Study of respiratory and \nimmunologic changes in the workers of a poultry far m.  \nMed Interne Apr -Jun; 23(2):129- 34. 1985.  15. Zuskin, E., Mustajbegovic, J., Schachter, \nE.N., Kern, J., Rienzi, N., Goswami, S., Marom, Z., \nand S. Manyani. Respiratory function in poultry \nworkers and pharmacological characterization of \npoultry dust extract.  Environ Res. Jul;70(1):11- 9. 1995.  \n \nMANEJO PARA LA PONEDORA COMERCIAL  \n \nMANAGING THE COMMERCIAL LAYER  \n \nM.V.Z Sergio G. Mata Lecourtois  \n \nIncubadora Mexicana S.A. de C.V., 7 Norte # 416 Tehuac\u00e1n Pue. Tel (238) 3 -11-40,  \nE-Mail -incumex@grupoidisa.com  \n \nSUMMA RY \nFor the egg industry to be truly profitable, \nefficiency is a must. For this purpose we should pursue the guidelines issued by the different genetic \ncompanies. All of them agree that, in order to obtain \nexcellent results, the application of major managem ent \npractices (cleaning, disinfection, good house conditions at bird placement, good temperature management, and \nproper beak trimming) during both the rearing and the \nproduction periods is essential.  \n \nRESUMEN  \nActualmente para que en la industria av\u00edcola del \nhuevo se obtengan verdaderas ganancias es primordial \nque se sea lo bastante eficaz y eficiente, para esto nos \ndebemos abocar sobre lo que nos marcan los \nlineamientos de las diversas l\u00edneas gen\u00e9ticas aviares; en donde todas coinciden que para lograr excel entes \nresultados es necesario la aplicaci\u00f3n de los principales \nmanejos tanto en crianza como en producci\u00f3n, tales \ncomo limpieza, desinfecci\u00f3n, buenas condiciones de \nlas casetas para la recepci\u00f3n de las aves, con un buen \nmanejo de las temperaturas. y la realizaci\u00f3n de un \nadecuado despique   \nINTRODUCCION  \nLos principales manejos que deben tener las \nponedoras son:  \nI. CRIANZA  \n1) Limpieza y desinfecci\u00f3n: Las unidades de \ncrianza deber\u00e1n previamente estar en buenas \ncondiciones, lavadas y desinfectadas, revisadas que se \nencuentran en buen funcionamiento las instalaciones y \nequipo.  \n2) Recepci\u00f3n.   Es importante adem\u00e1s del \nmanejo correcto de las temperaturas, suministrar \nalimento durante los primeros cuatro d\u00edas en el interior \nde la jaula. (cuando se trate de crianzas en jaula).     \n3) Despique.  Se recomienda revisar este \nmanejo, para lograr uniformidad en la realizaci\u00f3n, recomendamos realizarlo a partir de los 21 d\u00edas  en \ndonde se hace un s\u00f3lo corte de precisi\u00f3n. Y en las operaciones en donde se realizan dos despiques, \nefectuar el primer corte o despunte a los 7 -10 d\u00edas de \nedad y el segundo corte de pico a las 8 semanas de \nedad.\n \nA continuaci\u00f3n se describen los puntos b\u00e1sicos:  \nALIMENTO       Prote\u00edna  E.M. Kcal/Kg.  Calcio min -max F\u00f3sforo min -max \nIniciaci\u00f3n       21.5 %           2950          1.1- 1.2 %             .48- .50 %  \nCrecimiento1       17.5 %         2900          1.1- 1.2 %             .48- .51  %  \nCrecimiento 2       16.5 %         2800          1.1- 1.2 %             .45- .48  %  \n    \n4)   Pesos corporals.  Durante el crecimiento, se \nnecesita hacer en forma precisa el monitoreo semanal \ndel peso corporal y uniformidad, para poder realizar los \ncambios de f\u00f3rmula, as\u00ed como tener el peso adecuado \npara el inicio de postura. ( Se recomienda pesar 100 aves en jaula o bien 100 %  aves atrapadas en piso por \ncaseta). La obtenci\u00f3n de los pesos meta semana a semana y conjuntamente con la uniformidad va a ser un indicativo de manejo y a la vez un reflejo de lo que la parvada va a ser en su etapa de postura que es el punto \nm\u00e1s important e en el manejo de las pollas comerciales \npara lograr todos los objetivos productivos.  \n5) Tipos de Alojamiento y Requerimientos \nde Espacio para la Pollita Comercial.  \n5.1 Espacio: Ofrezca  una distribuci\u00f3n adecuada \nde agua, alimento y espacio de piso. Ya que dar  \n  \n191 cantidades deficientes de estos durante el per\u00edodo de \ncrecimiento afecta adversamente tanto a la taza de \ncrecimiento como a la uniformidad.  \n6) Temperaturas en Crianza.  \n7) Programa de vacunaci\u00f3n . \n8) Programa de Luz en Crianza para \nPonedora Comercial Ba bcock B -300. \n8.1 Intensidad. Se recomienda en casetas abiertas  \nde 20 a 40 Lux, con luz  artificial en crianza.  \nIntensidades de luz mayores a las recomendadas, \nprovocan que las aves se muestren m\u00e1s nerviosas  \n8.2 Color. El color de luz recomendado es \namar illo, anaranjado, rojo; esto puede ser \nproporcionado por focos incandescentes o \nfluorescentes.  \n9)     Selecci\u00f3n de aves    \nLa selecci\u00f3n de aves retrasadas es una buena \nmedida para lograr pesos y uniformidad de la parvada , \nya que reduce la competencia de es pacio y comida. \nTodas las aves que se encuentran todav\u00eda en \ncondiciones f\u00edsicas pueden ser seleccionadas hasta con \nun 25% abajo del peso meta. Aves con problemas de \nlocomoci\u00f3n deben ser sacrificadas. Esta medida debe \nser implementada tanto en crianza como en postura.  \n9.1 La estimulaci\u00f3n.  La estimulaci\u00f3n del \nconsumo de alimento es de gran beneficio para \nincrementar el consumo y por ende para lograr los \npesos meta, esto se puede realizar despu\u00e9s de un despique, reacci\u00f3n postvacunal, \u00e9pocas de calor, \ntraslado  o cuando el peso se encuentra abajo del \nest\u00e1ndar y se puede realizar conjuntamente con la \nadici\u00f3n de un suplemento vitam\u00ednico.  \n10) Transferencia de aves de crianza a \nunidades de producci\u00f3n.  Es de suma importancia que \nel traslado  sea a las 16 semanas de edad.  Un mal \ntraslado de aves ser\u00e1 responsable de un 80 % del total \nde la mortalidad en las primeras 6 -8 semanas de \nproducci\u00f3n. Esto ocurre sobre todo cuando las \nparvadas se encuentran en m\u00e1s de un 2 -10% de \nproducci\u00f3n diaria antes de ser transferidas. Caus ado en \nun 70% por la ruptura interna de los fol\u00edculos ov\u00e1ricos \no huevos en ponedoras al instalarse, ocasionando una \ninfecci\u00f3n por E. Coli, peritonitis y muerte  \nUn 30% en ponedoras bajo estr\u00e9s de producci\u00f3n \nes incapaces de adaptarse a una nueva jaula y de  \nencontrar agua a tiempo consecuentemente hay \nmortalidad por deshidrataci\u00f3n. Un mal trato a las aves \nal momento del traslado, nos ocasiona tambi\u00e9n alta \nmortalidad.  \n \nRECOMENDACIONES DE MANEJO PARA LA \nPONEDORAS II.  POSTURA \n1) Limpieza y Desinfecci\u00f3n:  \nLas uni dades de producci\u00f3n  deber\u00e1n previamente \nestar en buenas condiciones, lavadas y desinfectadas, revisadas que se encuentran en buen funcionamiento las instalaciones y equipo.  \n2) Recepci\u00f3n. Es importante adem\u00e1s del \nmanejo correcto, suministrar tipo de alime nto y \ncantidad adecuadas para que el ave identifique donde se encuentra el alimento, as\u00ed como para  que disponga \nde una cantidad suficiente de alimento y recuperar el peso perdido durante el traslado. Poner atenci\u00f3n para \nque el ave pueda disponer de el agu a en el bebedero \n(estimular el consumo de agua, picando copa) durante \nlos primeros 15 d\u00edas de recepci\u00f3n.      \n3) Alimentaci\u00f3n.  \n3.1 Utilizaci\u00f3n de alimentos. Actualmente \nrecomendamos realizar los cambios de formulaci\u00f3n de \nla siguiente manera.  \na. Postura (B ooster) de 16- 1 semanas a 40 \nsemanas de edad (hasta que la producci\u00f3n baja del 90 %).  \nb. Postura fase 1, de 41 semanas a 60 semanas \nde edad ( abajo del 80 % de producci\u00f3n .  \nc. Postura fase 2, de 61 semanas a 70 semanas \nde edad.  \nd. Postura fase 3, de 71 sem anas hasta la venta.  \n3.2  Pesos Huevo. Se recomienda pesar \nsemanalmente una muestra de 100 huevos por lote para identificar las ganancias de peso as\u00ed como para detectar \ncualquier problema que se presente.  \nPesos corporales. Durante el crecimiento, se \nnecesi ta hacer en forma precisa el monitoreo semanal \ndel peso corporal y uniformidad, para poder realizar los \ncambios de f\u00f3rmula, as\u00ed como tener el peso adecuado \npara el inicio de postura. ( Se recomienda pesar 100 \naves en jaula por caseta) .  \n4) Programa de vac unaci\u00f3n.  \n5) Programa Preventivo para Ectopar\u00e1sitos.  \n6) Programa de Luz en Producci\u00f3n para \nPonedora Comercial Babcock B -300. \n7.1 Intensidad. Se recomienda en producci\u00f3n de 2 \na 10 Lux, con luz artificial. Intensidades de luz \nmayores a las recomendadas, provo can en las aves \nmayor nerviosismo.      \n7.2 Color. El color de luz recomendado es \namarillo, anaranjado, rojo; esto puede ser \nproporcionado por focos incandescentes o \nfluorescentes.  \n7) Elaboraci\u00f3n e Interpretaci\u00f3n de la \ninformaci\u00f3n obtenida en granja.  \n1. Registro y Gr\u00e1ficas.  \nA) Pesos Corporales y uniformidades.  \nB) % Mortalidad.  \nC) Consumo de Alimento.  \nD) Peso de huevo.  \nE) No. de Huevos Acumulados.  \nF) Masa de huevo Acumulado.  \nG) Indice de Producci\u00f3n  \nH) Programa de Luz.   \n  \n192 I) Programa de Vacunaci\u00f3n.  \nJ) Tratamien tos. \n \nREFERENCIAS  \n1. Mata Lecourtois Sergio G. Comportamiento \nde las reproductoras. Seminario Babcock, Teh. Pue. \n2001 CD.  \n2. Mata Lecourtois Sergio G. Control de la \nviabilidad en las ponedoras Babcock.  Seminario \nBabcock, Teh. Pue. 1999 19- 22. \n3. Mata Leco urtois Sergio G. Controlando la \nmortalidad mediante dos despiques y par\u00e1metros \nproductivos. Seminario Babcock, M\u00e9xico, D.F.. 1997  37-45. \n4. Leeson Steve Dr. Programa de alimentaci\u00f3n \nde la ponedora. Seminario Babcock Tehuac\u00e1n, Pue. 2001 5- 9 5. Clive Board Dr. Nutrici\u00f3n y manejo de la \nBabcock. Seminario Babcock  Tehuac\u00e1n, Pue.  1995  41-50. \n6. Macf O.North Manual de producci\u00f3n \nAv\u00edcola, manejo de crianza 223 -350 3\u00aa. Edici\u00f3n.  \n7. Gu\u00eda de manejo Babcock requerimientos de \nespacio, jaula, piso etc. 2002.  \n8. Adjano hum Ephrem Dr. Manejo de las \ncaracter\u00edsticas de la luz en ponderas y su adaptaci\u00f3n \npara la Babcock B300, Seminario Babcock Tehuac\u00e1n, \nPue,   1999  85- 89 \n9. Summers, J.D. la importancia del peso \ncorporal y la edad de la madurez sexual, influenciada por progr amas de alimentaci\u00f3n y manejo adecuado de \nla producci\u00f3n de una ponedora redituable. Curso de \nactualizaci\u00f3n en el manejo de aves de postura, \nANECA, Tepatitl\u00e1n, Jal.   1994  30 -44. \n \nEFECTO DE LA TEMPERATURA DE CRIANZA SOBRE EL \nEMPLUME DE POLLOS DE ENGORDA M ACHOS Y HEMBRAS  \n \nTHE EFFECT OF BROODING TEMPERATURE ON FEATHER \nDEVELOPMENT IN MALE AND FEMALE BROILERS  \n \nJos\u00e9 Arce Menocal1, Carlos L\u00f3pez Coello2, Eduardo  Guti\u00e9rrez Valdespinos3, Ernesto Avila Gonz\u00e1lez4 \n \n1INIFAP Campo Morelia, Ecuador 120, Morelia, Mich, M \u00e9xico arce@unimedia.net.mx. 2DPA:A, FMVZ, UNAM. \nM\u00e9xico 04510 D.F. M\u00e9xico. 3UMSNH, Morelia, Mich. M\u00e9xico. 4CEIEPA, FMVZ, UNAM, M\u00e9xico 04510 D.F.  \n \nSUMMARY  \nLength of the 3rd. primary feather was evaluated \nas a variable in response to sex and environmental temperature, at 1, 3, 5, 7, 14, 21, and 28 days of age. \nFeather length growth up to 7 days was significantly \n(P<0.01) higher in the females. This situation prevailed \n(P<0.05) up to day 21. No difference (p>0.05) was observed between both sexes on day 28. As far as the \neffect of the first -week temperature is concerned, \nfeather length was greater under the most adverse conditions, but starting on day 14 longer feathers were \nobserved with the best environment.  \n \nRESUMEN  \nSe evalu\u00f3 el largo de la tercera pluma prim aria \ncomo variable de respuesta a sexo y temperatura ambiental al d\u00eda 1, 3, 5, 7, 14, 21 y 28 de edad, \nencontrando hasta los 7 d\u00edas un crecimiento mayor \n(p<0.01) en hembras, continuando (p<0.05) , hasta el \nd\u00eda 21, sin diferencias (p>0.05) entre sexos al d\u00eda  28. \nPara el efecto de temperatura durante la primera semana, la longitud fue mayor en condiciones \nambientales mas adversas, obteniendo desde el d\u00eda 14 \nplumas mas largas en el mejor ambiente.  \n INTRODUCCI\u00d3N  \nEl lento desarrollo del emplume en los pollos de \nengorda, particularmente en los machos de las l\u00edneas autosexables se han presentado con bastante frecuencia \nen las parvadas comerciales, ocasionando severas \nperdidas econ\u00f3micas principalmente por el da\u00f1o que \nocurre en la calidad del producto terminado. Las  \nplumas tienen funciones importantes (mantenimiento de la temperatura corporal y la protecci\u00f3n de la piel entre otras),  tradicionalmente poca atenci\u00f3n se le ha \ndado a este tejido, quiz\u00e1 debido a que el emplume no se \nmide en los t\u00e9rminos cl\u00e1sicos del desar rollo del ave, \ncomo lo demuestra la escasa  informaci\u00f3n publicada.  \nEntre los aspectos que han sido transformados, y \nque est\u00e1n involucrados en la conformaci\u00f3n, cantidad, \npatr\u00f3n y crecimiento  del emplume se encuentran el \ndesarrollo de las l\u00edneas autosexable s,  la r\u00e1pida \nvelocidad de crecimiento corporal,  la existencia de una \nmayor superficie debido al incremento del desarrollo muscular y una eficiente conversi\u00f3n alimenticia.  \nLos genetistas han podido incluir en las l\u00edneas \nautosexables un gen ligado al sexo (K) el cual \ndetermina un emplume lento en los machos de la \nprogenie; por ser las hembras portadoras del gen \nrecesivo, se facilita de una manera r\u00e1pida y precisa  la  \n  \n193 identificaci\u00f3n del sexo al nacimiento mediante la \nobservaci\u00f3n, distribuci\u00f3n y forma de las plumas \nremigeas. Tambi\u00e9n se ha logrado una r\u00e1pida velocidad \nde crecimiento corporal  aunado al incremento de la \nsuperficie por el desarrollo de las masas musculares, \nsin que el periodo de formaci\u00f3n de la pluma se haya \nacelerado para cubrir esa mayor \u00e1rea;  por lo que hoy \nen d\u00eda, los pollos tienen en proporci\u00f3n al peso corporal \nmenor peso de plumas,  lo que da como consecuencia \nun \u201cfaltante de plumas\u201d.  \nSin lugar a dudas la alta densidad de poblaci\u00f3n, el \nlimitado espacio de comedero y bebedero/ave, el \nestado d e la cama y las condiciones ambientales que \nincluyen temperatura, humedad, ventilaci\u00f3n e \nintensidad de la luz influyen sobre la calidad y cantidad \nde las plumas. Se ha mencionado que la crianza a \ntemperatura elevada predispone los problemas de lento \nemplum e, para conocer este efecto se realiz\u00f3 un estudio \nen pollos de engorda durante 28 d\u00edas, manteni\u00e9ndolos \nbajo condiciones ambientales arriba de los 30 oC, la \nganancia de peso y mortalidad se vieron afectados, \npero no fue posible reproducir alguna alteraci\u00f3n en el \nemplume (L\u00f3pez Coello, datos no publicados), la \ninvestigaci\u00f3n de Coper y Washburn (1998), demostr\u00f3 \nque el porcentaje del peso de la pluma : peso corporal \nen pollos de engorda machos de 51 d\u00edas de edad \ncuando fueron evaluados bajo condiciones de estad os \nde tensi\u00f3n por alta temperatura (32 oC versus 21oC), \nresult\u00f3 significativamente mayor  al mantener a las \naves  a 21 oC  (6.22%) en comparaci\u00f3n con la zona de \ncalor (5.03%), sin estar correlacionados con los par\u00e1metros productivos. Yalcin et al., (1997a) , \nevaluaron el emplume en 3 l\u00edneas gen\u00e9ticas de pollo de \nengorda (dos de lento y una de r\u00e1pido emplume) en Turqu\u00eda durante el verano (28 \noC) y oto\u00f1o (18 oC), no \nexistiendo diferencias a las 4, 5 y 6 semanas de edad al clasificar el dorso y muslos como comp letamente \ncubierto o pobre emplume. Los machos de lento \nemplume presentaron un menor score de emplume  a \nlas 4 5 y 6 semanas de edad en las dos estaciones. Todas las aves tuvieron el plumaje completo a las 7 \nsemanas de edad; donde determinaron el porcentaj e \nrelativo a peso corporal (verano 5.11, 5.06 y 5.07%, \noto\u00f1o 5.05, 4.28, 4.72%), siendo mayor en hembras \n(5.36 y  4.92%) que en machos (4.80 y 4.45%) en las \ndos estaciones. El emplume no estuvo asociado con la estaci\u00f3n del a\u00f1o o peso corporal; este autor ( 1997b) \nmenciona que las gallinas de cuello desnudo tienen un peso de la pluma cerca de 20% inferior (4.36%) que las \naves de emplume normal (5.57%) , \nindependientemente del clima, sexo o edad. Petras y \ncolaboradores en 1989 criaron pollos de engorda durante  los primeros 21 d\u00edas de edad  a temperaturas \nbajas (27.9 \noC y 19.7 oC con  humedad relativa de 61.7 \na 79.5% , obteniendo un peso corporal promedio a las 8 \nsemanas de 1757 y 1686 g, sin existir diferencias en el peso y largo de las plumas. Sharma et al., ( 1995) \ndeterminaron en pollos de 3 estirpes comerciales la \ncantidad de plumas en 2 diferentes \u00e9pocas del a\u00f1o \ncaliente / h\u00fameda y  \nfr\u00eda / seca) a las 6, 8 y 10 semanas de edad, \nencontrando diferencias significativas entre las tres \nestirpes solamente en la es taci\u00f3n fr\u00eda / seca a las 8 \nsemanas de edad. Herremans et al., (1989) demostraron \nque la producci\u00f3n de calor corporal se incrementa \ncuando la temperatura ambiental es baja, o al existir un \nmal emplume.  \nPara conocer  el efecto de diferentes temperaturas \nde crianza sobre la velocidad de emplume se realiz\u00f3 un estudio con 3000 pollitos sexados (1500 hembras y \n1500 machos) distribuidos mediante un dise\u00f1o \ncompletamente al azar, con un arreglo factorial 2 x 3  \ncon 5 r\u00e9plicas de 100 aves cada uno. Siendo los \nfactores el sexo (hembra y macho), y tres diferentes \nmanejos de calor artificial en los primeros 28 d\u00edas de \nedad de acuerdo al esquema siguiente por semana (1, 2, \n3 y 4), considerando la temperatura \noC promedio, \nm\u00ednima, m\u00e1xima y rango de temperatura):  T1. - 22.1,  \n18.7, 18.3, 19.4 (promedio), 13.8, 6.95, 6.05, 9.80 \n(m\u00ednima), 36.1, 35.1, 34.4, 32.1 (m\u00e1xima), 22.2, 28.2, \n28.3, 22.3 (rango) . T2. -  (22.6, 19.9, 19.0, 20.3 \n(promedio), 15.0, 7.92, 7.12, 10.4 (m\u00ednima), 37.5, 36.3, \n35.1,32.9 (m\u00e1xima), 22.4, 28.4, 28.0,22. 4 (rango ) T3. - \n23.5, 21.5, 21.8, 2.8 (promedio), 15.4, 9.67, 13.0, 15.5 \n(m\u00ednima), 37.8, 33.8, 33.0, 31.9 (m\u00e1xima), 22.4, 24.2, 19.9, 16.3 (rango). La caseta fue dividida totalmente en \n3 secciones, con una cortina pl\u00e1stica de grueso calibre, \nen cada uno de los compartimentos se colocaron 3 \nterm\u00f3metros electr\u00f3nicos que registraron la \ntemperatura cada hora. El alimento fue en forma de \nmigaja, teniendo las aves libre acceso al agua y \nalimento  \nAl d\u00eda de edad se seleccionaron e identificaron \ncon bandas met\u00e1licas en el ala a 50 aves de cada sexo y \nse midi\u00f3 el largo de la tercera pluma primaria del ala \nderecha con un Vernier (expresando los valores \nregistrados en cm. .  Los datos se sometieron a un \nan\u00e1lisis de varianza de doble v\u00eda \nLos resultados al primer d\u00eda de ed ad mostraron \nsignificancia estad\u00edstica ( (p<0.01) entre sexos, siendo \nmayor en las hembras (1.17) , con respecto a los machos (0.71),  en la segunda lectura que ocurri\u00f3 al \ntercer d\u00eda de edad, continu\u00f3 la mayor longitud de la \npluma (p<0.01)  en hembras (2.62) que en machos (1.78). La misma respuesta persisti\u00f3 al quinto d\u00eda de \nedad (p<0.01), observando valores de 3.56  para las \nhembras y de 2.08 en los machos). A la primera semana de edad el efecto de sexo continu\u00f3 , \nobteni\u00e9ndose valores de 4.07 y 2.58 respect ivamente. \n(El diferencial en esta periodo es marcado entre sexos, \nlo que indica un patr\u00f3n de emplume muy distinto entre \nellos), al realizar la medici\u00f3n al d\u00eda 14 se encontr\u00f3 un  \n  \n194 diferencial menor ya que fue a una significancia de \n(p<0.05), (hembras 6.68 y m achos 5.32)), A los 21 d\u00edas \nla diferencia estad\u00edstica tambi\u00e9n fue a favor de las \nhembras (8.47 contra 7.80); en la ultima lectura que se \nrealiz\u00f3 al d\u00eda 28 ya no se presentaron diferencias entre \nsexos, siendo los valores similares para hembras y \nmachos (9.9 2 contra 9.86).  \nCon respecto a la temperatura ambiental, para los \nprimeros 3 periodos de lectura ( 3, 5 y 7 d\u00edas de edad), \nlas aves del T1 obtuvieron estad\u00edsticamente mejor \nemplume (2.32\u00aa, 3.14\u00aa, 3.59\u00aa), siendo altamente \nsignificativo (p<0.01) con respecto a los animales del \nT2  (2.06b, 2.52c, 2.91c)  que estuvieron alojados con \nuna temperatura media, m\u00ednima y m\u00e1xima mayor), y solamente al d\u00eda cinco con respecto al T3 (2.22\nab, 2.79b, \n3.48\u00aa) donde se utilizaron las mejores temperaturas.  \nA los catorce d\u00edas de edad, el T3 (6.24\u00aa) mostr\u00f3 \nsignificancia  (p<0.01) con relaci\u00f3n al T2 (5.63b), pero \nno hacia T1 (6.13ab)., situaci\u00f3n que continu\u00f3 a los 21 \nd\u00edas ( T1 8.15ab, T2 7.88b, T3 8.39\u00aa) . Para la \nevaluaci\u00f3n realizada a los 28 d\u00edas de edad, la \nsignificancia se pres ent\u00f3 entre T3 (10.27\u00aa  con respecto \na T1 (9.69b y T2 (9.71b). \n \nCONCLUSIONES  \nEn la primera semana de edad (1, 3, 5 y 7 d\u00edas de \nedad) el efecto de la velocidad de crecimiento de la \ntercera pluma primaria es mas marcado entre sexos, \nsiendo mayor en las hembra s (p<0.01) , situaci\u00f3n que \ndisminuye con la edad entre los d\u00edas 14 y 21 (p<0.05) , \nno mostrando significancia estad\u00edstica a los 28 d\u00edas de edad, sin embargo debido a la mayor velocidad de \ncrecimiento de los machos, la cobertura es menor.  \nCon respecto a la temperatura ambiental durante \nla crianza, se obtuvo el mayor largo de la pluma en el \ntratamiento donde estas fueron mas desfavorables (T1), situaci\u00f3n que no persisti\u00f3 a partir del d\u00eda 14, donde la pluma result\u00f3 mas larga en los pollos ubicados en el \ntratamie nto con mejores condiciones ambientales (T3)  \nEl largo de la pluma primaria como variable de \nrespuesta hacia el emplume tiene la ventaja de ser un m\u00e9todo r\u00e1pido, preciso y econ\u00f3mico,; sin embargo, no \nrefleja en su totalidad el patr\u00f3n de emplume del animal y por si solo no considera aspectos de calidad y \ncantidad de plumas.  \n \nREFERENCIAS  \n1. Coper, M.A, and Washburn K.W. The \nrelationship of body temperature to weight gain, feed consumption, and feed utilization in broilers under heat \nstress. Poultry Science. 1998.  77:2, 237- 242.  \n2. Herremans M., Decuypere E., and Siau O. \nEffects of feather wear and temperature on prediction of food intake and residual food consumption. British \nPoultry Science. 1989. 30:1, 15- 22. \n3. Pietras M., Herbut E., and Wezyk S. Effect \nof thermal conditions in cages on metabolic rate, \nfeather growth and fattening performance of broiler \nchickens. Zootechniczna. 1989. 104:4, 51- 63. \n4. Sharma D., Tyagi P.K. and Shukla R.P. \nCarcass characteristics of broiler chicken as influenced by age, strain and season.  Indian Journal of Veterinary \nResearch. 1995. 4:1, 36- 43. \n5. Yalcin, S., Settar P., Ozkan S., and Cahaner \nA. Compararative evaluation of three commercial \nbroiler stocks in hot versus temperate climates. Poultry \nScience 1997a. 76:7, 921- 929. \n6. Yalcin S., Testik A., Ozkan S., Settar P., \nCelen F., and Cahaner A. Performance of naked and \nnormal broilers in hot, warm, and temperate climates. \nPoultry Science. 1997b, 76:7, 930- 937. \n \nDETECCI\u00d3N DE LA MIOP AT\u00cdA PECTORAL PROFUNDA BAJO \nDOS SISTEMAS DE MANE JO DE CARGA Y EMBA RQUE EN \nPOLLO DE ENGORDA  \n \nDEEP PECTORAL MYOPATHY (DPM) IN BROILERS USING TWO \nCATCHING/SHIPPING SYSTEMS  \n \nJuan C. Valladares1Gerardo del Bosque1, Benjam\u00edn S\u00e1nchez2 y Armando Antill\u00f3n3 \n \n1Laboratorio de Control de Calidad y Patolog\u00eda Aviar, Productora de Alime ntos Pecuarios de Nuevo Le\u00f3n, S.A. de \nC.V. Ju\u00e1rez y Arista s/n, Salinas Victoria, N.L., M\u00e9xico. CP 65500. juancv@papsa.mexis.com  \n2 Elanco Animal Health, 3 Nutrifarm, S.A. de C.V.  \n \nSUMMARY  \nThe effect of two catching, loading, and shipping \nsystems on the pr evalence of DPM and other traumatic \nlesions detected in the processing plant, as well as in fresh carcass retail shops was evaluated using two \nshipments of 4,800 broiler males weighing 3.4 kg as an \naverage. A traditional, per -group, hand catching system \nwas compared with an individual hand catching/rail  \n  \n195 system. Lesion detection was made by gross \nobservation in the processing line, and carcasses were \nobserved again in 10 public fresh carcass retail  shops. \nResults with the traditional loading system were: DP M, \n10%; foot traumatic lesions (FTL), 5% and traumatic \nbreast bursitis (TBB) 0.3%. Results with the rail-\ncatching system were DPM <0.01%, FTL, 0.1%, and TBB, 0.3%.  \n  \nRESUMEN  \nSe analiz\u00f3 el efecto de dos sistemas de manejo de \ncaptura, carga y embarque de po llo de engorda en la \nprevalencia de Miopat\u00eda Pectoral Profunda (MPP) y de otras lesiones traum\u00e1ticas detectadas a nivel de Rastro \ny en expendios al p\u00fablico de pollo fresco en dos \nembarques de 4,800 pollos machos con un peso \npromedio de 3.4 kg. Se comparo u n sistema de captura \ntradicional manual en grupo y un sistema de captura manual individual con rieles.. La detecci\u00f3n de lesiones se realiz\u00f3 por observaci\u00f3n macrosc\u00f3pica en la l\u00ednea de \nfaenamiento y las canales fueron observadas \nposteriormente en 10 expendi os p\u00fablicos de pollo \nfresco reci\u00e9n procesado. Con el sistema de carga \ntradicional se estim\u00f3 una prevalencia de MPP del 10%; \nde lesiones traum\u00e1ticas en patas (LTP) del 5% y de \nbursitis traum\u00e1tica de la quilla (BTQ) en 0.3% mientras \nque en sistema de captura con rieles se estim\u00f3 una \nprevalencia de MPP menor al 0.01%, de LTP del 0.1% \ny de BTQ del 0.3%.  \nLa Miopat\u00eda Pectoral Profunda (MPP) tambi\u00e9n \nconocida como enfermedad del m\u00fasculo de Oregon o enfermedad del m\u00fasculo verde, es un padecimiento \ncaracterizado por hemorragias, edema y necrosis del \nm\u00fasculo pectoral profundo ( m supracoracoideus )\n 2,4,6 y \nfue originalmente descrita en pavos en 19683. La MPP \nes la consecuencia de un movimiento s\u00fabito y brusco \nde aleteo que ocasiona tumefacci\u00f3n y aumento de \ntama\u00f1o del m\u00fas culo supracoracoides, el cual se \naprisiona dentro de su fascia inel\u00e1stica hasta generar \nisquemia y necrosis por falta de un riego sangu\u00edneo suficiente\n3,4,6; experimentalmente se ha demostrado que \nun aleteo violento de tan solo 30 segundos puede \nproducir la  MPP4. La MPP es m\u00e1s frecuente en aves de \npeso elevado y aparentemente es mas frecuente en los \nmachos en \u00e9poca de invierno, no esta relacionada con \naportes de ning\u00fan nutriente espec\u00edfico pero la adici\u00f3n \nde vitamina E y selenio (sobre todo en su forma org\u00e1nica) puede motivar un efecto protector leve; se \npuede presentar en cualquier estirpe pero las estirpes de \nr\u00e1pido crecimiento son las m\u00e1s afectadas\n5. La necrosis \nresultante del m\u00fasculo afectado puede al principio \ntener un aspecto hemorr\u00e1gico en las primeras  horas tras \nsu generaci\u00f3n, y evolucionar a un aspecto reseco y verdoso algunos d\u00edas despu\u00e9s de su desarrollo, pero es asintom\u00e1tica\n4,6. El manejo brusco que motiva la \npresentaci\u00f3n de la MPP y de otras lesiones traum\u00e1ticas observadas en el rastro, como las l esiones traum\u00e1ticas \nen las patas (LTP), incluyendo las hemorragias en \narticulaciones de tarsos y muslos, el dislocamiento del \nf\u00e9mur y la ruptura del tend\u00f3n tarsal,  as\u00ed como la \nbursitis traum\u00e1tica de la quilla (BTQ) puede ser \nocasionado en el momento en el  que las aves son \ncapturadas antes de ser cargadas, en el enjaulado, la \ncarga, el transporte, la descarga o en el manejo inmediato previo al sacrificio;  y en cada una de estas \netapas se pueden generar lesiones que demeriten la \ncalidad de las canales\n1,5,. \n El objetivo del presente estudio fue analizar s\u00ed el \nsistema de captura y carga de pollo de engorda previo al sacrificio modifica la incidencia de MPP, LTP y \nBTQ detectados a nivel de rastro o expendio de pollo \nfresco.  \n \nMATERIAL Y METODOS  \nSe analizaron dos  embarques de pollos de \nengorda, machos, de 4,800 aves con un peso promedio \nde 3.4 kg., sin dietar, procedentes de la misma caseta \nde producci\u00f3n, con dos sistemas de atrapamiento y \nenjaulado de las aves antes de su transporte al rastro, \ndenominados arbitra riamente como Sistema \nConvencional de Captura (SCC) y Sistema Nuevo de \nCaptura (SNC).  \nEn el SCC el cami\u00f3n se localiz\u00f3 afuera de la \ncaseta y las jaulas vac\u00edas se subieron al cami\u00f3n acomod\u00e1ndolas por niveles. Dentro de la caseta los \ncargadores atraparon de f orma manual 4 aves en cada \nmano, tom\u00e1ndolas de una pata. Los cargadores sacaron \na las aves de la caseta caminando un trayecto de entre \n20 y 30 m.; afuera de la caseta y en la orilla de la \nplataforma del cami\u00f3n, pasaron las 8 aves a un segundo \ncargador que las introdujo a las jaulas vac\u00edas. \nConforme las jaulas de un nivel se fueron llenando, se \ncoloc\u00f3 otro nivel de jaulas hasta completar 10 niveles.  \nEn el SNC el cami\u00f3n se localiz\u00f3 afuera de la \ncaseta y se le coloc\u00f3 una rampa hecha con dos tubos de PVC de 2 pulgadas, desde la plataforma hasta la \nentrada de la caseta. La caseta fue dividida en corrales \nde aprox. 6 metros cuadrados, utilizando jaulas vac\u00edas \ncomo barrera. Cada cargador captur\u00f3 a las aves, una \npor una, tom\u00e1ndola con ambas manos sobre el dorso a \nla altura de las alas, introduci\u00e9ndolas individualmente a \nlas jaulas. Una vez cargadas, las jaulas fueron sacadas \nde la caseta con la ayuda de dos tubos de PVC de 2 pulgadas colocados en el piso a manera de rieles de ferrocarril, sobre los cuales se empujaro n las jaulas \nllenas una detr\u00e1s de otra hasta llegar a la puerta de la caseta, donde fueron tambi\u00e9n empujadas sobre la rampa hasta la plataforma del cami\u00f3n, una vez arriba \nlas jaulas se apilaron en 10 niveles como en el Sistema \nConvencional.  \nEl transporte u lterior, la descarga, el sacrificio y \nel procesamiento de las canales se realiz\u00f3 en forma  \n  \n196 convencional y fue similar en ambas observaciones. El \nrecorrido entre la granja y el sitio de sacrificio fue de \naproximadamente 1,000 km. y el tiempo de traslado \nfue entre 15 y 17 horas. Brevemente el proceso de \nfaenamiento consisti\u00f3 en la descarga de las jaulas en \nforma manual, posteriormente las aves fueron sacadas \nde las jaulas tom\u00e1ndolas de las patas y fueron colgadas de ambas patas en una l\u00ednea met\u00e1lica, posterior mente \nfueron desensibilizadas con un choque el\u00e9ctrico con la \ncabeza sumergida en agua por 5 seg., sacrificadas por \ncorte de la vena yugular y desangradas por gravedad; \nfueron sumergidas en un caldero con agua caliente \ndurante 1 -2 min. y fueron desplumadas con una \nm\u00e1quina el\u00e9ctrica para finalmente pasar a un \ndesplumado final en forma manual.  \nLa detecci\u00f3n de lesiones externas se realiz\u00f3 por \nobservaci\u00f3n macrosc\u00f3pica en la l\u00ednea de faenamiento. La detecci\u00f3n de la MPP se realiz\u00f3 por palpaci\u00f3n de la \nparte lateral  anterior de la pechuga  y en los casos \nsospechosos se incidiendo la masa muscular pectoral \npara observar el m\u00fasculo supracoracoides. Debido a \nque los pollos procesados en el Rastro no se evisceran \nni se cortan se procedi\u00f3 a dar seguimiento a los mismos \nen 10 expendios de pollo fresco diferentes, solicitando \nla evaluaci\u00f3n de las pechugas por los expendedores y \nprocediendo al corte de las mismas en casos \nsospechosos. Se colectaron selectivamente 5 muestras \nde pechugas afectadas con MPP para realizar estudios  \nde histopatolog\u00eda y bacteriolog\u00eda de los m\u00fasculos \nafectados.  \n \nRESULTADOS Y DISCUSI\u00d3N \nCon el Sistema Convencional de Captura la carga \nde las 4,800 aves con una cuadrilla de 12 cargadores se \nrealiz\u00f3 en dos horas. Se estim\u00f3 una incidencia de \nMiopat\u00eda Pectoral Profunda del 10%; de Lesiones \nTraum\u00e1ticas en Patas del 5% y de Bursitis Traum\u00e1tica de la Quilla en 0.3% mientras que en Sistema Nuevo de \nCaptura la carga de las 4,800 aves se realiz\u00f3 con una \ncuadrilla de 14 personas en dos horas con treinta \nminutos. No s e detectaron lesiones compatibles con \nMPP, se observ\u00f3 aproximadamente un  0.05%, de \nLesiones Traum\u00e1ticas en Patas y un 0.31% y de \nBursitis Traum\u00e1tica de la Quilla.  \nLas lesiones detectadas en los casos de MPP \nincluyeron edema y hemorragias entre los m\u00fasculo s \npectorales superficial y profundo, tumefacci\u00f3n del \nm\u00fasculo supracoracoides con  consistencia suave y \nfriable, color blanquecino o amarillento y aspecto similar a carne de pescado; similar a lo descrito previamente por otros autores\n2,4,6; microsc\u00f3picament e \nse observ\u00f3 necrosis coagulativa masiva con \nhialinizaci\u00f3n y p\u00e9rdida de estr\u00edas, sin presencia de \nn\u00facleos ni infiltrado inflamatorio; el estudio \nbacteriol\u00f3gico fue negativo al aislamiento de bacterias \naerobias y anaerobias.  \nLas Lesiones Traum\u00e1ticas de las Patas \nconsistieron primordialmente en hemorragias en la cara \ninterna del muslo, desarticulaci\u00f3n de la articulaci\u00f3n \ncoxofemoral, con desprendimiento del cart\u00edlago \narticular y hemorragias periarticulares, ruptura parcial \no completa del tend\u00f3n gastrocn\u00e9mio co n hemorragias \nen la articulaci\u00f3n tarsal y fractura de los tarsos. Las lesiones traum\u00e1ticas de la Quilla consistieron en \nhemorragias subcut\u00e1neas severas a nivel pectoral.  \nLa utilizaci\u00f3n del Sistema Nuevo de Captura \naparente redujo la incidencia de MPP y de LTP \ndetectadas a nivel de rastro, aunque la proporci\u00f3n de \nBTQ fue similar, la utilizaci\u00f3n de m\u00e9todos de \natrapamiento de las aves que eviten el movimiento \nbrusco de estas antes de ser enjauladas puede \nincrementar la calidad de las canales y reducir el \nn\u00famer o de decomisos que se observan en el Rastro, \ncomo ha sido estudiado en Brasil, en Europa y en el sureste de Asia\n1. \n \nREFERENCIAS  \n1. Bakker, W. La carga de pollos y su \ntransporte a la procesadora. Tecnolog\u00eda Avipecuaria en Latinoam\u00e9rica 167: 16- 22. 2001.  \n2. Bilgili, S., J. Hess, R. Lien and K. Downs. \nDeep Pectoral Myopathy in brioler chikens. Abstracts XXI World Poultry Congress, Montreal, Canada. 2000.  \n3. Dickinson, E., J. Stephens and D. Helfer. A \ndegenerative myopathy in turkeys. Proc. 17th Western Poultry Dis. Co nf., Davis, CA. pp 17. 968.  \n4. Jones, M. Miopat\u00eda degenerativa en m\u00fasculo \npectoral de pollo. S\u00edntesis Ac\u00edcola, pp 34- 38, abril \n1989.  \n5. Owens, C. Situaci\u00f3n actual y tendencias \nglobales en el procesamiento de aves. Tecnolog\u00eda Avipecuaria en Latioamerica 158: 3 -6. 2001.  \n6. Ridell, C. Developmental, Metabolic, and \nother noninfectious Disorders., in Diseases of Poultry, 10th ed. B. Calnek, H. Barnes, C. Beard, L. McDougald and Y. Saif eds. Iowa State Press, Ames, \nIowa, pp. 923- 924. 1997.  \n \n \n \n \n   \n  \n197 INTERACCI\u00d3N GENOTIPO- AMBI ENTE EN UNA LINEA DE AVES \nPRODUCTORA DE HUEVO COMERCIAL  \n \nGENOTYPE: ENVIRONMENT INTERACTION IN A COMMERCIAL  \nLAYER STRAIN \n \n1MVZ. Juan Antonio Serratos Vidrio; 2Ph.D. Benito L\u00f3pez Ba\u00f1os;  3Ph.D. Ariel Ortiz Mu\u00f1iz  \n \n1Hy Line de Mexico S.A. DE C.V; Avenida Porci cultores # 50 Tepatitl\u00e1n Jal.  \nE \u2013 Mail: jserrato@vitep.com.mx  \n2, 3,  Facultad de Estudios Superiores Cuahutitlan; UNAM \n  \nSUMMARY  \nThis paper evaluates the effects of the \ngenotype:environment interaction ( IGA) in light -weight \nlaying hens from different breeder flocks of different \nages and seasons, in several farms located in Mexico\u2019s \nJalisco state highlands. The genetic level of the flocks included the year of production (1, 2, 3), season \n(spring -summer, PV; or fal l-winter, OI), and breeder \nage (young, J ; production peak, PP ; or old, V) at the \nend of the laying cycle, as categorization variables.  \n \nRESUMEN  \nEl presente  trabajo eval\u00faa los  efectos de la \ninteracci\u00f3n genotipo - ambiente (IGA) en parvadas de \ngallinas lig eras procedentes de diferentes lotes de \nreproductoras con distintas edades y \u00e9pocas \nestacionales en varias granjas de la zona de los Altos \nde Jalisco, M\u00e9xico. Se consider\u00f3 el nivel gen\u00e9tico de \nlas parvadas como el a\u00f1o de producci\u00f3n (1,2,3,), la \u00e9poca estacional Primavera \u2013 Verano (PV) y Oto\u00f1o \u2013 \nInvierno (OI), la edad de las reproductoras J\u00f3venes (J) aves en el pico de producci\u00f3n y Viejas (V), al final del ciclo de producci\u00f3n como variables de clasificaci\u00f3n.  \nPALABRAS CLAVES:  interacci\u00f3n genotipo -  \nambiente,  en una l\u00ednea de ponedoras ligeras.  \n \nPLANTEAMIENTO DEL PROBLEMA  \nEtapa ed desarrollo:  \nEn los resultados de los desarrollos (0- 18 \nsemanas) de las pollas blancas variedad W36 en la \nzona de los Altos de Jalisco, M\u00e9xico se  observa que un \ngran numero de parvada s no alcanzan los par\u00e1metros \nproductivos se\u00f1alados \u00f3ptimamente en la gu\u00eda de \nmanejo respectiva, viabilidad, peso corporal. (1,2)  \nEtapa de produccion:  \nEn los resultados de las primeras 10 semanas de \nproducci\u00f3n (20- 30 semanas) de las gallinas blancas \nvariedad W36 en la zona de los Altos de Jalisco, \nM\u00e9xico se observa que un gran numero de parvadas no \nalcanzan los par\u00e1metros productivos se\u00f1alados \n\u00f3ptimamente en la gu\u00eda de manejo respectiva, numero de huevos producidos, masa total, conversi\u00f3n, viabilidad, peso c orporal. (,4,5,6,7,8,10)  \n            \nMATERIAL  \nEl material utilizado en el presente trabajo es el \ncomportamiento productivo de las parvadas  \nobservadas durante los a\u00f1os 1998,1999, y 2000, de \ngallinas blancas Hy Line Variedad W36 procedentes de diferentes lo tes de reproductoras con distintas edades y \n\u00e9pocas estacionales en varias granjas de la  zona Alte\u00f1a \nJaliciense.  \n \nMETODO  \nDentro de la metodolog\u00eda del presente estudio, se \nconsider\u00f3 el nivel gen\u00e9tico de las parvadas como el a\u00f1o \nde producci\u00f3n (1998, 1999 y 2000), la \u00e9poca estacional \nen que nacieron las pollitas Primavera \u2013  Verano (PV) y \nOto\u00f1o \u2013 Invierno (OI), la edad de las reproductoras \n(J\u00f3venes (J) aves en el pico de producci\u00f3n y Viejas (V), al final del ciclo de producci\u00f3n) como variables de \nclasificaci\u00f3n . Y como covariables: El peso corporal de \nlas reproductoras, peso promedio del huevo que da \norigen al lote de pollitas comerciales y el peso \npromedio de las pollitas al nacimiento. Los porcentajes de mortalidad a las 18 semanas y el porcentaje de \nproducci\u00f3n de las aves comerciales en las semanas 20, \n21, 22, 23, 24, 25, 26, 27, 28,  se utilizaron como \nvariables respuesta, mismas que fueron  transformadas a valores Arcosenos para su an\u00e1lisis estad\u00edstico (9) \nmediante el Modelo siguiente:  \n \n      Y\nijkl =  \uf06d + Gi + E j + C k +  I ij + I  ik + B 1 X1 + B 2 \nX2 + B 3 X3 + E l    \n \nDonde:    Y ijkl es % de mortalidad a las 18 semanas de \nlas pollas comerciales o % de producci\u00f3n de las \nsemanas 20 a 28.  \n\uf06d\uf06d\uf06d es una media general  \nGi es el nivel gen\u00e9tico de las reproductoras.  \nEj es \u00e9poca de nacimiento de las pollitas.  \nCk es la clasificaci\u00f3n de edad de las reproductoras.  \nIij es la interacci\u00f3n genotipo - \u00e9poca de nacimiento.   \n  \n198 Iik es la interacci\u00f3n genotipo - edad de las \nreproductoras.  \nX1, X 2, X 3 son,  Peso corporal y Peso del huevo de las \nreproductoras, Peso al nacimiento de la pollita \ncomercial respectivamente mismas que se utilizan \ncomo covariables.  \nB1, B 2 y B 3 son par\u00e1metros de ajuste del modelo.  \nEl es, el error aleatorio.  \n     Tambi\u00e9n se estim\u00f3 las medias de m\u00ednimos \ncuadrados y el error  est\u00e1ndar de todas las variables \nrespuesta, utilizando la orden GLM del programa SAS (Versi\u00f3n 6.12).  \n \nRESULTADOS Y DISCUSI\u00d3N \nEl cuadro 1 muestra las medias de m\u00ednimos \ncuadrados para los porcentajes de mortalidad a las 18 \nsemanas y los porcentajes de producci\u00f3n de huevo de las semanas 20 a 28 para las gallinas blancas l\u00ednea  W \n36, en el podemos notar que para porcentaje de \nmortalidad a las 18 semanas los efectos principales por \ngrupo gen\u00e9tico 1, 2 y 3  fue de 2.0, 2.8 y 1.6 \nrespectivamente, mismos que denota n diferencias \nestad\u00edsticas significativas entre el nivel gen\u00e9tico 2 y 3 \n(p<0.05). Esto puede deberse a problemas de tipo \npatol\u00f3gico durante el a\u00f1o de desarrollo de las parvadas del nivel  gen\u00e9tico 2 que es el que presenta mayor \nmortalidad, mas que a una di ferencia gen\u00e9tica entre \ngrupos. Los porcentajes de mortalidad estimados por \n\u00e9poca oto\u00f1o -  invierno y primavera -  verano fueron de \n2.5 y 1.8 respectivamente mismos que no denotan diferencia significativa (p>0.1). Esto mismo se observa en los porcentajes de mortalidad para pollas \nprovenientes de madres j\u00f3venes o viejas, mismas que \npresentaron porcentajes de mortalidad de 3.2 y 1.1 \nrespectivamente y sin diferencia significativa (p>0.1).  \nEn este mismo cuadro podemos observar los \nefectos principales para el inicio de la postura a las 20 semanas de edad expresado en porcentajes, donde \npodemos notar que los niveles gen\u00e9ticos 1 y 2 inician \nsu postura con 2.2%, mientras que el nivel 3 inicia la \npostura con un 11.8% diferencia que resulta ser \nsignificativa (p<0.05) mi sma que se mantiene hasta la \nsemana 23 donde alcanza un porcentaje de 64.5, \nmientras que los grupos 1 y 2 llevan un 51.2 y 48.5 \nrespectivamente. Sin embargo de la semana 24 a la 28 no se detectaron diferencias significativas entre los niveles gen\u00e9ticos alcanzando en esta \u00faltima semana \n89.4, 90.5 y 89.5 % para los grupos gen\u00e9ticos 1, 2 y 3 \nrespectivamente. Respecto al efecto principal de la \n\u00e9poca de inicio de la producci\u00f3n de las aves \ncomerciales podemos notar en este mismo cuadro que \nel comportamiento de la  producci\u00f3n es parecido al \ncomportamiento de los grupos gen\u00e9ticos ya que las \naves que inician postura en oto\u00f1o -  invierno tienen 1.6 \nmientras que las de primavera - verano tienen 9.1%             \nDiferencia significativa (p< 0.05). Y mantienen \nesta diferen cia hasta la semana 23 donde las parvadas \nde OI alcanzan 43.9 y las de PV 65.6% . A partir de la semana 24 a la 28 no se detectan diferencias significativas (p> 0.1) alcanzando en esta \u00faltima \nsemana 89.0 y 90.6 % respectivamente. Sin embargo \nno se detectar on diferencias significativas entre aves \nprovenientes de madres j\u00f3venes y viejas, quienes \ninician la postura con 4.1 y 6.7 %  y alcanzan a las 28 \nsemanas 90.8 y 88.9 % respectivamente.  \nEn el cuadro 2 se muestran los porcentajes de \nmortalidad expresados en medias de m\u00ednimos \ncuadrados que denotan los efectos de IGA entre nivel \ngen\u00e9tico y \u00e9poca, en este podemos observar  que de los \n6 arreglos formados, el arreglo 2, 5 y 6 denotan diferencias significativamente menores a los arreglos 1, \n3 y 4, con porcentajes d e mortalidad de 1.2, 1.6 y 1.7 \ncontra 2.8, 3 y 2.5 respectivamente, representado el \narreglo 2, por el nivel gen\u00e9tico 1 y \u00e9poca PV, el arreglo \n5 por el nivel gen\u00e9tico 3 y \u00e9poca OI, el arreglo 6 por el \nnivel gen\u00e9tico 3 y \u00e9poca PV. El significado no solamente  biol\u00f3gico sino tambi\u00e9n econ\u00f3mico de la \ndiferencia encontrada de un punto porcentual  puede \nrepresentar la rentabilidad de la empresa.  \nDe lo anteriormente descrito podemos inferir que \nel arreglo formado entre el grupo gen\u00e9tico 3 y la \ncondici\u00f3n de viejas, tienden a romper postura con \npromedios m\u00e1s altos en las primeras 4 semanas de \nproducci\u00f3n, pero que a partir de la quinta semana ya no \nse observan diferencias significativas entre estos 6 \narreglos. Esto plantea la necesidad de evaluar como impacta los efect os de IGA en el ciclo completo de \npostura y masa de huevo, de tal manera que se puedan elegir aquellas parvadas que tengan un mejor \ncomportamiento productivo en ambientes  \ndeterminados.\n \n \n \n \n \n \n  \n \n  \n  \n199 Cuadro 1 . Medias de m\u00ednimos cuadrados para porcentajes de mo rtalidad y  producci\u00f3n de huevo para las semanas \n20 a 28 en gallinas de postura Hy - Line.  \n Nivel Gen\u00e9tico  Epoca  Edad  \n1 2 3 OI PV J\u00f3venes  Viejas  \nMort. 18 Semanas  2.0a 2.8ab 1.6ac 2.5a 1.8\u00aa 3.2 a 1.1 a \nProd. 20  Semanas  2.2 a 2.2 a 11.8b 1.6 a 9.1 b 4.1 a 6.7 a \nProd. 21 Semanas  9.4 a 9.9 a 26.8 b 6.2 a 24.5 b 9.4 a 21.3 a \nProd. 22 Semanas  26.3a 25.9 a 46.4 b 19.3 a 46.5 b 8.0 a 57.8 a \nProd. 23 Semanas  51.2a 48.5 a 64.5 b 43.9 a 65.6 b 1.0 a 100.0 a \nProd. 24  Semanas  71.8a 67.8 a 78.8 a 67.5 a 78.1 a 20.6 a 100.0 a \nProd. 25 Semanas  80.7a 80.0 a 79.0 a 75.7 a 84.1 a 57.7 a 100.0 a \nProd. 26  Semanas  86.4a 86.7 a 85.1 a 82.6 a 89.5 a 61.7 a 100.0 a \nProd. 27  Semanas  88.8a 90.4 a 89.7 a 87.7 a 91.6 a 63.6 a 100.0 a \nProd. 28 Semanas  89.4a 90.5 a 89.5 a 89.0 a 90.6 a 90.8 a 88.9 a \nNota. Letras diferentes entre grupos de clasificaci\u00f3n denotan diferencia significativa (p<0.05)  \n \nCuadro 2 . Porcentaje de mortalidad a las 18 semanas expresada en  medias de m\u00ednimos cuadrados  que denota  \nefectos de interacci\u00f3n g enotipo - \u00e9poca en gallinas de postura Hy - Line.  \nNivel Gen\u00e9tico  Epoca  Edad  \n OI PV J\u00f3venes  Viejas  \n1 2.8a 1.2bc 3.0 a 1.0 a \n2 3.0 a 2.5 a 3.9 a 1.7 a \n3 1.6ac 1.7bc 2.7 a 0.6 a \nNota. Letras diferentes entre grupos de clasificaci\u00f3n denotan diferencia signi ficativa (p<0.05)  \n \nCONCLUSI\u00d3N  \nSe denotan los efectos de IGA entre nivel \ngen\u00e9tico y \u00e9poca, para mortalidad a las 18 semanas de \nedad, as\u00ed como,  para el inicio de la postura. Tambi\u00e9n \nse detecta efectos de IGA entre nivel gen\u00e9tico y edad \nde las reproductoras  en lo referente a porcentaje de \npostura de la semana 20 a 23 (p< 0.05).  \n \nREFERENCIAS  \n1. Gutierrez Mill\u00e1n, L.E, et al. 1991 \nInteracci\u00f3n del genotipo -ambiente en las caracter\u00edsticas \nproductivas de tres l\u00edneas de pollo de engorda comercial. T\u00e9cnica Pecuaria en M\u00e9xico. 27: 3, 137-\n145. \n2. Hy Line, 1999. Gu\u00eda de Manejo para \nPonedoras Hy Line Variedad W36 Hy Line International Des Moines  E.U.A.  \n3. L\u00f3pez B. B., 1999. Evaluaci\u00f3n de la \nProducci\u00f3n L\u00e1ctea de un Reba\u00f1o Caprino \nConsiderando los Efectos de Interacci\u00f3n Genotipo \nAmbiente. Tesis Doctoral, FMVZ, Universidad de \nColima.  \n4. Ludrovsky, F., et al. 1986. Genotype and \nenviroment interaction in broiler production of commercial and naked line. 7\nth European Poultry \nConference, Paris, Volume 1, 196- 199. \n5. North, M. O., y D. D. Bell , 1993. Manual de \nProducci\u00f3n Av\u00edcola. Tercera Edici\u00f3n. Editorial El Manual Moderno. M\u00e9xico.  \n6. Oakes, M.W. 1967. The effect of different \nlevels of managment on the assessment of differences between variety of chickens. Anim. Prod. 9: 121.  \n7. Quintana L., J. A., 1999. Avit\u00e9cnia. Manejo \nde las aves dom\u00e9sticas m\u00e1s comunes.  \n8. Editorial Trillas. M\u00e9xico. 384 p.  \n9. Rauen, H.W., et al.1986. Significance of the \ngenes for reduced feathering and naked neck (NA) in relation to the ability of laying hens to adapt to the \nstress of  permanently high temperatures. Archv fur \nGeflugelkunde. 50(6): 235- 245 \n10. SAS. 1193. SAS/SAT. Guide for personal \nComputers. Version 6.3. Edition SAS Institute, North \nCarolina, USA.  \n11. Sergeev, V.A. and Sobolev, E.A. 1989. \nGenotype -enviroment interaction for ab dominal fat \ndeposition in broilers.  CAB: Animal Breeding \nAbstracts\n.\n \n  \n  \n200 REDUCCI\u00d3N DE LA INTO XICACI\u00d3N ALIMENTARIA CON \nAFLATOXINA B 1 EN POLLO DE ENGORDA ME DIANTE N -\nACETILCISTE\u00cdNA  \n \nDECREASED DIETARY AFLATOXIN B 1 (AFB 1) TOXICITY USING N -\nACETYL-CYSTEINE (NAC) IN BROILERS \n \nA. G. Valdivia,1 A. Mart\u00ednez,1 F. J. Dami\u00e1n,1 T. Quezada,1 R. Ortiz,1 y J. L. Reyes 2 \n \n1 Centro de Ciencias Agropecuarias, A. P. No. 3, Jes\u00fas Mar\u00eda, Aguascalientes, 20900 , avaldiv@correo.uaa.mx ; y 2 \nDepartamento de Fisiolog\u00eda y Biof\u00edsica, Centro de Investigaci\u00f3n y Estudios Avanzados - Instituto Polit\u00e9cnico \nNacional, A. P. No. 14 -740, D. F. 07000, M\u00e9xico.  \n \nSUMMARY  \nFour 30- broiler groups were used to evaluate the \nability of NAC to reduce the toxicity e ffects of AFB 1 \nin the feed. Birds were divided into the following \ntreatment groups: A) Control; B) Purified AFB 1 (3 \nmg/kg feed) for 21 days; C) NAC (800 mg/kg body \nweight daily); and D) AFB 1 + NAC at the same \nconcentrations used in groups B and D. AFB 1 + NAC- \ntreated animals showed to be partially protected against \nAFB 1 effects on perfor mance, liver, and kidney \ndamage, as well as against bi ochemical alterations.  \n \nRESUMEN  \nCon el prop\u00f3sito de evaluar la capacidad de la N -\nacetilciste\u00edna (NAC) para disminuir lo s efectos de la \nintoxicaci\u00f3n alimentaria por aflatoxina B 1 (AFB 1), se \nsometieron cuatro grupos de 30 pollos de engorda a los \ntratamientos diet\u00e9ticos siguientes: A) control; B) AFB 1 \npurificada (3 mg/kg de alimento) durante 21 d\u00edas; C) NAC (800 mg/kg peso corporal, diariamente); D) \nAFB\n1 m\u00e1s NAC a las mismas dosis que los grupos B y \nC. Los an imales tratados con AFB 1 m\u00e1s NAC \nmostraron estar protegidos parcialmente contra los \nefectos de la toxina sobre el rendimiento, da\u00f1os \nhep\u00e1ticos y renales as\u00ed como con las alteraciones \nbioqu\u00edmicas.  \n \nINTRODUCCI\u00d3N  \nLa N -acetilciste\u00edna (NAC) es una variante \nacetilada del amino\u00e1cido L -ciste\u00edna que ha sido \nampliamente prescrita en humanos y utilizada en otros mam\u00edferos como un ant\u00eddoto contra varios t\u00f3xicos as\u00ed \ncomo tambi\u00e9n contra  algunos agentes carcinog\u00e9nicos, \nentre los que se incluye la aflatoxina B\n1 (AFB 1). NAC \nes una fuente excelente de grupos sulfhidrilos, es capaz \nde estimular la s\u00edntesis de glutati\u00f3n reducido (GSH), \nbloquear la activaci\u00f3n de AFB 1, prom over la \ndestoxificaci\u00f3 n y actuar directamente como un \natrapador de radicales libres (3, 6).  \nLa AFB 1 es la micotoxina natural m\u00e1s potente, es \nextremadamente t\u00f3xica y carcinog\u00e9nica por lo que representa un riego serio para la salud de las \npoblaciones humanas (7, 13). Adicionalme nte, la AFB 1 \nprovoca severas alteraciones sanitarias y productivas \nen los pollos a partir de cantidades m\u00ednimas en el \nalimento (10 \u00b5g / kg) (11, 12). Se ha demostrado que \nhasta un nivel variable, la AFB 1 se inactiva mediante \nsu conjugaci\u00f3n con GSH, un trip \u00e9ptido hep\u00e1tico que \nact\u00faa mediado por la actividad de un grupo de enzimas \ndenominado glutati\u00f3n S -tranferasa (GST) y que \nfinalmente se excreta como un complejo formado por \nNAC ligada a AFB 1 (1, 10, 18).  \nPor lo que pudiera suponerse que el nivel \nfisiol\u00f3gico  de protecci\u00f3n pudiera mejorarse aportando \nprecursores de GSH, sobre todo en las aves que lo \nutilizan extensamente para la formaci\u00f3n muscular y del plumaje. El prop\u00f3sito de este estudio fue evaluar la \ncapacidad de NAC para disminuir los efectos de la \nintox icaci\u00f3n ocasionada por la ingesti\u00f3n de AFB\n1 en \npollos de engor da. \n \nMATERIALES Y M\u00c9TODOS  \nCon un dise\u00f1o completamente al azar y utilizando \nlos procedimientos descritos (9, 17), se formaron cuatro \ngrupos de 30 pollos cada uno, sexo macho, Hubbard, de un d\u00eda d e edad y se les suministraron, dentro de una \ndieta est\u00e1ndar sin contaminaci\u00f3n aparente de micotoxinas, los tratamientos siguientes: A) grupo control; B) AFB\n1 purificada (3 mg/kg de alimento) \ndurante 21 d; C) NAC (800 mg/kg P. C., diariamente); D) AFB\n1 m\u00e1s NAC a las mismas dosis que los gr upos \nB y C.  \nLas aves fueron alojadas en jaulas y el peso \ncorporal y la ingesti\u00f3n de alimento fue registrada \ndiariamente. En el d\u00eda 21 de edad, se obtuvieron \nmuestras sangu\u00edneas, hep\u00e1ticas y renales y se estimaron \nactividad es enzim\u00e1ticas espec\u00edficas de alanina \naminotransferasa, aspartato aminotransferasa y GST; se calcul\u00f3 la concentraci\u00f3n hep\u00e1tica de GSH y de \nprote\u00ednas totales en plasma e h\u00edgado y tambi\u00e9n se \nrealizaron cortes histol\u00f3gicos de h\u00edgado y ri\u00f1\u00f3n con la \ntinci\u00f3n del \u00e1cido pery\u00f3dico de Schift.   \n  \n201 RESULTADOS Y DISCUSI\u00d3N \nEn nuestro estudio se observ\u00f3 el efecto negativo \nde la ingesti\u00f3n de AFB 1 sobre el rendimiento de los \npollos y sobre la alteraci\u00f3n de par\u00e1metros bioqu\u00edmicos \ny presencia de alteraciones patol\u00f3gicas en h\u00edgado  y \nri\u00f1\u00f3n, por lo cual estos resultados coinciden con reportes previos \n(2, 8, 15).  \nLos cambios inducidos por la AFB 1 fueron \nestad\u00edsticamente significativos al compararlos contra \nlos pollos que consumieron la dieta control. Cuando los \npollos consumieron una  dieta contaminada con AFB 1 \npero adicionada con NAC se apreciaron diferencias \nestad\u00edsticamente significativas contra el grupo que \nsolamente consumi\u00f3 esta micotoxina, alcanzando a protegerse del efecto negativo en las proporciones \nsiguientes: Peso corporal (57.8 %), ganancia diaria de \npeso corporal (49.1 %), \u00edndice de conversi\u00f3n \nalimenticia (21.4 %), concentraci\u00f3n de pr ote\u00ednas totales \nen plasma e h\u00edgado (45.2, 66.7 %), actividad de alanina aminotransferasa en plasma (67.4 %), glutati\u00f3n -S-\ntransferasa hep\u00e1tica (18.8 %) y concentr aci\u00f3n de \nglutati\u00f3n reducido en h\u00edgado (75.0 %).  \nAdem\u00e1s, el grupo AFB\n1 + NAC mostr\u00f3 menores \ncambios morfol\u00f3gicos en la decoloraci\u00f3n hep\u00e1tica, textura friable, esteatosis microvesicular e inflamaci\u00f3n \nde la membrana basal del glom \u00e9rulo.  \nLos pollos que consumieron la dieta adicionada \nsolamente con NAC no presentaron alteraciones del consumo de alimento, incremento de peso y conversi\u00f3n \nalimenticia, ni tampoco se alteraron los par\u00e1metros qu\u00edmicos sangu\u00edneos y hep\u00e1ticos ni tampoco indujo \ncamb ios mo rfol\u00f3gicos en h\u00edgado y ri\u00f1\u00f3n.  \nEste estudio se muestra que la administraci\u00f3n de \nNAC en la dieta disminuye significativamente los efectos negativos provocados por el consumo de AFB\n1 \nsobre la ganancia de peso corporal, conversi\u00f3n \nalimenticia, GSH hep\u00e1tico prote\u00ednas en plasma e h\u00edgado adem\u00e1s de que disminuye la severidad de las \nlesiones histol\u00f3gicas inducidas por esta micotoxina.  \nSe puede considerar que NAC es inocuo para el \nconsumidor final, ya que se metaboliza r\u00e1pidamente en \nlos pollos para formar cis te\u00edna y GSH y los residuos \ndel compuesto \u00edntegro desaparecen en cuesti\u00f3n de \nhoras de los tejidos; en los humanos se utiliza en dosis \ndiarias tan altas como 500 mg/kg de peso co rporal \n(5, \n14).  \nOtros estudios (2, 4, 16) han mostrado que otras \nsustancias com o los aluminosilicatos y los amino\u00e1cidos \nazufrados de la dieta son, al igual que NAC, agentes \nquimioprotectores capaces de disminuir los efectos \nt\u00f3xicos de las micotoxinas, los cuales pudieran ser utilizados conjuntamente para evitar la absorci\u00f3n de las \ntoxinas y elevar el nivel de resistencia de las aves, \nadem\u00e1s de complementarse con el empleo de \nestrategias que eviten la contaminaci\u00f3n de los alimentos o que permitan su descontaminaci\u00f3n o \nremedi aci\u00f3n.  \n \nREFERENCIAS  \n1. Adav, S. S., and S. P. Govindwar. Effects of \naflatoxin B\n1 on liver microsomal enzymes in different \nstrains of chickens. Comp. Biochem. Physiol . \n118C:185- 189. 1997.  \n2. Bailey, R. H., L. F. Kubena, R. B. Harvey, \nS. A. Buckley, and G. E. Rottinghaus. Efficacy of \nvarious inorganic sorbents to reduce the toxicity of \naflatoxin and T -2 toxin in broiler chickens. Poult Sci . \n77:1623- 1630. 1998.  \n3. Banner, W., M. Koch, S. B. Hopf, D. M. \nCapin, S. Chang, and T. G. Tong. Experimental \nchelation therapy in chromium, lead and boron \nintoxication with N -acetylcysteine an d other \ncompounds. Toxicol. Appl. Pharmacol. 83:142- 147. \n1986.  \n4. Beers, K. W., H. Nejad, and W. G. Bottje. \nAflatoxin and glutathione in domestic fowl (Gallus domesticus) I. Glutathione elevation and attenuation by \nhigh dietary methionine. Comp. Biochem. Physiol. \n101:239- 44. 1992.  \n5. De Caro L., A. Ghizzi, R. Costa, A. Longo, \nG. P. Ventresca, and E. Lodola. Pharmacokinetics and \nbioavailability of oral acetylcysteine in healthy \nvolunteers. Arzneim -Forsch/Drug Res. 39:382- 386. \n1989.  \n6. De Flora, S., C. Bennicelli, A . Camoirano, \nD. Serra, M. Romano, G. A. Rossi, A. Morelli, and A. De Flora. In vivo effects of N -acetylcysteine on \nglutathione metabolism and on the biotransformation \nof carcinogenic and/or mutagenic compounds. Carcin ogenesis, 6:1735- 45, 1985.  \n7. Eaton, D. L., and E. P. Gallagher. \nMechanism of aflatoxin carcinogenesis. Ann. Rev. Pharmacol. Toxicol. 34:135- 172. 1994.  \n8. Espada, Y, M. Domingo, J. G\u00f3mez, and M. \nA. Calvo. Pathological lesions following an experimental intoxication with aflatoxin B\n1 in broiler \nchicke ns. Res. Vet. Sci. 53:275- 279. 1992.  \n9. Federation of Animal Science Societies. \nGuideline for poultry husbandry. In: Guide for the care and use of agricultural animals in agricultural research and teaching. Savoy IL, USA. pp 55 -66. 1999.  \n10. Gawai, K. R., J. K. V odela, P. S. Dalvi, and \nR. R. Dalvi. Comparative assessment of the effect of aflatoxin B\n1 on hepatic dysfunction in some \nmammalian and avian species. Comp. Biochem. Physiol. 101C:415- 418. 1992.  \n11. Giambrone, J. J., U. L. Diener, N. D. Davis, \nV. S. Panangala,  and F. J. Hoerr. Effects of purified \naflatoxin on broiler chickens. Poultry Sci. 64:852 -858. \n1985.   \n  \n202 12. Hamilton, P. B. Determining safe levels of \nmycotoxins. J. Food Prot. 47:570- 575, 1984.  \n13. International Agency for Research on \nCancer, World Health Organizati on. Aflatoxins. In: \nSome Naturally Occurring Substances: Food Items and \nConstituents, Heterocyclic Aromatic Amines and \nMycoto xins. IARC Monographs on the Evaluation of \nCarcin ogenic Risk to Humans 56, Lyon, France, pp \n245-395. 1993.  \n14. Kelly, G. S. Clinical ap plications of N -\nacetylcysteine. Alternative Medicine Review 3:114 -\n127. 1998.  \n15. Mollenhauer, H. H., D. E. Corrier, W. E. \nHuff, L. F. Kubena, R. B. Harvey, and R. E. Droleskey. Ultraestructure of hepatic and renal lesions in chickens \nfed aflatoxin. Am. J. Vet.  Res. 50:771- 777. 1989.  16. Richardson, K. E., L. A. Nelson, and P. B. \nHamilton. Interaction of dietary protein level on dose \nresponse relationships during aflatoxicosis in young \nchickens. Poultry Sci. 66:969- 976. 1987.  \n17. Valdivia, A. G., A. Mart\u00ednez, F. J. Dami \u00e1n, \nT. Quezada, R. Ortiz, C. Mart\u00ednez, J. Llamas, M. L. \nRodr\u00edguez, L. Yamamoto, F. Jaramillo, M. G. Loarca-Pi\u00f1a,  and J. L. Reyes Efficacy of N -acetylcysteine to \nreduce the effects of aflatoxin B\n1 intoxication in broiler \nchickens, Poultri Sci. 80:727 -734. 2000.  \n18. Wang, S, W. G. Bottje, D. Cawthon, C. \nEvenson, K. Beers, and R. McNew. Hepatic export of \nglutathione and uptake of constituent amino acids, \nglutamate and cysteine, in broilers in vivo. Poultry Sci. \n77:1556- 1564. 1998.  \n \nEVALUACI\u00d3N  IN VIVO  DE LA CAPA CIDAD INHIBITORIA DE  LAS \nMICOTOXICOSIS EN AVE S ALIMENTADAS CON DI ETAS \nCONTAMINADAS CON AFL ATOXINAS, OCRATOXINA  A Y  TOXINA \nT-2 CON LA ADICI\u00d3N DE  LEVADURAS  SACCHAROMYCES \nCEREVEISIAE Y CON MANANGLUCANOLI GOSACARIDOS \n(SAFMANNAN MR) \n \nIN VITRO EVALUATION OF THE MYCOTIXICOSIS INHIBITORY ACTIVITY \nOF THE ADDITION OF SACCHAROMYCES CEREVE ISIAE  YEAST AND \nMANNAN OLIGOSACCHARIDES (SAFMANNANTM) IN BIRDS FED \nAFLATOXIN-, OCHRATOXIN A-, AND T-2 TOXIN- CONTAMINATED FEEDS  \n \nRen\u00e9 M\u00e1rquez M\u00e1rquez.1*, Enrique Vera Guti\u00e9rrez1 y  Dante Gonz\u00e1lez Salazar2 \n \n1Laboratorio. de Micotoxinas  y 2Laboratorio de Diagnostico  del Cenid -Microbiolog\u00eda, INIFAP, SAGARPA. \nCarretera M\u00e9xico -Toluca, Km. 15.5,  Cuajimalpa, D.F. C.P. O5110  \n \nSUMMARY  \nSixty chickens were divided into 4 15 -bird \ngroups. One  treatment per group was given: Negative \nControls, no mycotoxins; positive controls, a diet containing 282 \u03bcg/kg aflatoxin, 290 \u03bcg/kg ochratoxin \nA, and 6,300 \u03bcg/kg T -2 toxin; yeast group, 2 g/kg + \nmycotoxins, and; Safmannan group, 1 g/kg + \nmycotoxins. The experiment lasted for 4 weeks. \nWeight gains were: negative controls 592 g (100%), \npositive controls 314 g ( 57%); yeast group 533 g \n(90%), and; Safmannan group 599 g (101%). Severe \nliver, intestine, proventriculus, thymus, bursa, tongue, \nand oral mucosa lesions were observed in the positive \ncontrols. In the yeast and the Safmannan groups milder \nlesions were obse rved. Severe hipoplasia in the \nlymphoid organs and low Newcastle disease antibody \ntiters were observed in the positive controls. This effect \nwas lower in both the yeast and the Safmannan groups.  RES\u00daMEN  \nSe utilizaron 60 pollos  en 4 tratamientos:  \nControl,   Testigo Positivo dieta con 282\u00b5g/Kg \nAflatoxinas, 290 \u00b5g/Kg   Ocratoxina -A y 6,300 \u00b5g/Kg \nT-2,   Levaduras  2g/Kg + micotoxinas, Safmannan \n1g/Kg + micotoxinas, 15 aves por tratamiento, durante \n4 semanas. Las ganancias de peso  fueron: 592g  \nControl (100%),   Testigo Positivo  314g (57%),  con \nLevaduras 533g (90%) y con Safmannan 599g (101%). \nHubo severas lesiones en  h\u00edgado, intestinos, \nproventr\u00edculo, timo, bursa, lengua y mucosa  oral en los \nTestigos positivos,  con la adici\u00f3n de Levaduras  o   \nSafmannan  e l grado de lesiones disminuy\u00f3. Los \n\u00f3rganos linfoides en el Testigo Positivo  presentaron \nuna severa  hipoplasia,   con bajos t\u00edtulos    de \nanticuerpos contra  Newcastle. Este efecto  fue menor \nen las aves de los tratamientos   con Levaduras  y  \nSafmannan.   \n  \n203 Se realiz\u00f3 un dise\u00f1o factorial 4 X 5 X 3 donde los \nfactores fueron: 4 Tratamientos, 5 aves por tratamiento \ny 3 repeticiones. Se utilizaron pollos de la estirpe  Ross \nde un d\u00eda de edad, se alojaron en una criadora \nPetersime con control el\u00e9ctrico de temperatura y se \nalimentaron con una dieta comercial de iniciaci\u00f3n y \nagua potable a libre acceso, durante una semana.  Las aves se alimentaron durante 4 semanas con una dieta   \nlibre de micotoxinas para el Tratamiento 1,  para el \nTratamiento 2  con una dieta cont aminada \nexperimentalmente:  282\u00b5g/Kg Aflatoxinas, 290 \u00b5g/Kg   \nOcratoxina -A y 6,300 \u00b5g/Kg T -2,   para el Tratamiento \n3 se utiliz\u00f3 la mezcla de micotoxinas +l  Levaduras  \n2g/Kg  y para el Tratamiento 4 la mezcal de \nmicotoxinas + Safmannan 1g/Kg . Se evalu\u00f3 l a \nganancia de peso semanal, t\u00edtulos de anticuerpos contra \nla Enfermedad del Newcastle (EN) y se realiz\u00f3 la \nnecropsia de los animales para su estudio \nhistopatol\u00f3gico.  \n Los efectos de la toxicidad acumulativa de las \nmicotoxinas, se observ\u00f3 a partir de la 2\u00aa  semana de \nalimentaci\u00f3n de las aves con la dietas  contaminadas y sin la adici\u00f3n de levaduras o mananglucanos, a partir \nde ese per\u00edodo presentaron una ganancia de peso \nsignificativamante menor al resto  de los tratamientos,  aparecieron las primeras lesion es ulcerativas  en \npaladar y  la necrosis  en la base de la lengua  en la mayor\u00eda de las aves de dicho grupo. Los resultados  de la ganancia de peso, indican que los niveles de \ncontaminaci\u00f3n de micotoxinas utilizados  ocasionaron \nuna disminuci\u00f3n de m\u00e1s del  40% en los animales del \ntratamiento  testigo positivo, mientras que al adicionar \na las dietas contaminadas  una dosis de 2g/Kg de \nLevaduras las aves obtuvieron una ganancia de peso \nfinal del 90.2% respecto la ganancia del control negativo y del 101% con l a adici\u00f3n de Safmannan, lo \nque representa un efecto importante de protecci\u00f3n a la micotoxicosis. La necropsia de las aves revel\u00f3 que a \npesar de que el peso corporal de los animales con \ndietas conteniendo levaduras o glucanmananos era \nsimilar al grupo contr ol negativo, se presentaron \nalgunas lesiones ulcerosas en el paladar, zonas de \nnecrosis en la lengua, \u00falceras en proventr\u00edculo, ri\u00f1ones \ncongestionados e h\u00edgados grasos, lesiones que variaban \nampliamente entre los grupos e incluso entre las aves \ndel mismo g rupo. El an\u00e1lisis microsc\u00f3pico de los \ntejidos confirm\u00f3 que las lesiones m\u00e1s severas se obtuvieron en las aves que consumieron la dieta contaminada y sin secuestrante de micotoxinas, \nmientras que en el grupo control negativo \npr\u00e1cticamente no  se presentaron   alteraciones \nhistopat\u00f3logicas,  y en las aves del tratamiento con \nlevaduras se observaron lesiones en diversos tejidos \nque se clasificaron como moderadas, es importante \nse\u00f1alar que la magnitud de las lesiones disminuyeron \nconsiderablemente con la adici\u00f3n  de mananglucanos a \nlas dietas contaminadas. Los \u00f3rganos linfoides que se \nanalizaron microscopicamente  (Timo y bursa de \nFabricio) presentaron una severa  deplesi\u00f3n  en las aves del tratamiento testigo positivo, aunado a que \npresentaron los t\u00edtulos   m\u00e1s b ajos de anticuerpos \ncontra la Enfermedad del Newcasle, lo que significa \nuna inmunodepresi\u00f3n tanto celular como humoral. Este \nefecto se vio significativamante disminuido en las aves \nde los tratamientos  adicionados  con levaduras  y mananglucanos, presentan do el mejor efecto inhibitorio \nde la  inmunosupresi\u00f3n   por micotoxicosis en las aves \nque se les adicion\u00f3 a la dieta 1.0 g/Kg de \nMananglucanos (Safmannan).  \n \nTratamientos     Semana 0  \n  X      \u00b1     D.E.          Semana  1  \n  X       \u00b1   D.E.       Semana  2  \nX        \u00b1      D.E.     Semana 3  \n X        \u00b1    D.E.      \nGanancia  \n    Total  \n1 Control ( -) 139.28\u00aa   10.81  322.66\u00aa      29.8  499.2\u00aa      52.70  731.06 \u00aa    65.03  591.78\u00aa  \n2 Testigo (+)  151.70\u00aa   13.15  315.03\u00aa     38.82  385.17b      63.86  492.29b     97.06  340.59b \n3  Levaduras  149.50\u00aa  16.24  311.57\u00aa     36.42  446.80 a,c     61.24  683.25\u00aa    95.75  533.75\u00aa \n4 Safmannan  145.42\u00aa   14.87  300.23\u00aa     47.94  509.00\u00aa      76.61  745.00\u00aa   100.70  599.58\u00aa  \nLiterales diferentes en las columnas indican significancia estad\u00ed stica entre los Tratamientos (p<0.05) ANDEVA.  \n \nREFERENCIAS  \n1. Brake J., P.B. Hamilton, and R.S. Kittrell. \nEffects of the Trichotheecene Mycotoxin \nDiacetoxyscirpenol on Feed Consumption, Body \nWeight, and Oral Lesions of Broiler Breeders. Poultry Science 79:85 6-863. 2000  \n2. Chorvatoricov\u00e1 D., Machova E., Sandula J., \nKogan G. Protective effect of the Yeast glucomannan \nagainst cyclophosphamide -induced mutageeenicity. \nMut. Res. 444:117- 122. 1999.  3. Ma. Y., Vemura K., Oka S., Kezutsumi Y., \nKawasaki T. Antitumor activity  of mannan -binding \nprotein in vivo as releated by a virus expression \nsystem: mannan -binding protein dependent cell -\nmediated cytotoxicity. Proc. Natl. Acad. Sci. U.S.A. \n96: 371- 375. 1999  \n4. Osborne D., Huff W., Hamilton P., \nBurtmeister H. Comparison of ochrato xin aflatoxin and \nT-2 toxin for their effects on selected parameters \nrelated to digestion and evidence for specific  \n  \n204 metabolism of carotenoides in chickens.Poult. Sci. \n61:1646- 1652. 1982  \n5. Stanley V., Ojo R., Woldesenbet S., \nHuitchinson D. The use of Saccharo myces cerevisiae \nto supress the effects of aflatoxicosis in broiler chicks. \nPoult. Sci. 72:1867- 1872.1993  6. Wagnerova J., Liskova A., Navarova J., \nKristofova A., Trnovec T., Ferencik M. The effect of \ntwo glucan carboxymethyl derivates with vasrious \nsubstitut ion degrees on cyclophosphamide \nimmunosupression in mice. Immunopharmacol. \nImmunotoxicol. 15:227- 242.  1993.  \n \nEFECTO DE OCRATOXINA A, UREA Y AMPROLIO SOBRE LA \nPIGMENTACI\u00d3N EN POLLO DE ENGORDA  \n \nEFFECT OF OCHRATOXIN A (OA), UREA, AND AMPROLIUM ON SKIN \nPIGMENTATION IN BROILERS  \n \nGarc\u00eda MAR 1, Petrone GV2, Ju\u00e1rez RM2 \n \n1Ceiepa, FMVZ -UNAM; 2DPA:Aves, FMVZ -UNAM  \n \nSUMMARY  \nThe effect of OA, urea, and amprolium on the \nabsorption and deposition of synthetic carotenoid \npigment in 4 -7-week -old broilers was studied.  \nMeasurements were performed in plasma, intestine (3 \nportions), and feces. Skin pigmentation was also measured. Birds with OA showed pale skins, and \nreduced carotenoid plasma/intestine (all three sections) \nconcentrations. No difference was observed in skin pigmentation of the birds treated with amprolium or \nurea when compared with the controls; even though \ncarotenoid plasma level differences were observed. \nAccording with the results, the poor skin pigmentation \nof OA -treated birds does not seem to be related wit h \npigment density in the intestine.  \n \nRESUMEN  \nSe estudi\u00f3 el efecto de ocratoxina A (OA), urea y \namprolio sobre la absorci\u00f3n y deposici\u00f3n de pigmento \ncarotenoide sint\u00e9tico en aves de 4 a 7 semanas. Las \nmediciones se hicieron en plasma, tres porciones de \nintestino y heces, adem\u00e1s de la pigmentaci\u00f3n cut\u00e1nea. \nCon OA, las aves mostraron palidez en piel, y \nreducci\u00f3n de carotenoides en plasma e intestino en sus \ntres porciones. No se observ\u00f3 diferencia en la \npigmentaci\u00f3n cut\u00e1nea de las aves tratadas con amprolio y urea respecto al testigo, aunque s\u00ed en los carotenoides \nplasm\u00e1ticos respecto al testigo. Por los resultados, la \nmala pigmentaci\u00f3n en las aves tratadas con OA no \nparece tener relaci\u00f3n con la reducci\u00f3n de la densidad \ndel contenido intestinal.  \n \nINTRODUCCI\u00d3N  \nLa pigmentaci\u00f3n amarillo -naranja del pollo de \nengorda ha sido considerada como una caracter\u00edstica comercial deseable, y es, de alguna manera, indicador \ndel estado de salud en que el pollo fue criado, dado que un pollo mal pigmentado en la mayor\u00eda de los cas os \ntuvo alg\u00fan padecimiento que alter\u00f3 la absorci\u00f3n y \ndeposici\u00f3n del pigmento. Entre los diversos factores \nque provocan  mala pigmentaci\u00f3n del pollo, se \nencuentra la ocratoxina A (OA),  que produce \ndisminuci\u00f3n del crecimiento, inmunosupresi\u00f3n y una \nreducci\u00f3 n en la concentraci\u00f3n de pigmentos \ncarotenoides en plasma. En algunas observaciones de \ncampo se ha mencionado la posibilidad de una \nasociaci\u00f3n entre mala pigmentaci\u00f3n y exceso de \nhumedad en las heces, como durante ocratoxicosis o \npor inclusi\u00f3n de urea en d ietas como fuente de \nnitr\u00f3geno no proteico. Se ha informado que los \nanticoccidianos mejoran la pigmentaci\u00f3n por un mecanismo indirecto. Sin embargo, observaciones de \ncampo mencionan la posible asociaci\u00f3n entre el uso de \namprolio por tiempos prolongados y m ala \npigmentaci\u00f3n, sin que se hayan corroborado \u00e9stas observaciones. Por \u00e9ste motivo, el objetivo de \u00e9ste \ntrabajo fue el  estudiar los efectos de OA y urea, \nconocidos por producir diuresis, y un anticoccidiano sobre la absorci\u00f3n y deposici\u00f3n del pigmento en  pollos \nde engorda de 4 semanas.  \n \nMATERIAL Y M\u00c9TODOS  \nSe utilizaron 76 aves Ross x Ross de 4 semanas \nde edad, alimentados con dietas a base sorgo -soya con \n45 ppm de pigmento sint\u00e9tico (Lucant\u00edn amarillo). Las \naves fueron aleatoriamente asignadas a cada uno de \ncuatro tratamientos: T1: testigo; T2 igual que T1 con \n60 ppm de amprolio en el agua de bebida; T3: igual \nque T1 + 1.5 ppm de OA en el alimento; T4: igual que \nT1 + 5 % urea en el alimento. Cada tratamiento incluy\u00f3 3 r\u00e9plicas de 6 pollos. La pigmentaci\u00f3n cut\u00e1nea fue \nmedida a los 28, 38 y 48 d\u00edas de edad en todas las aves, \nmediante el color\u00edmetro de reflectancia MINOLTA \n(CIELab System). Se realizaron 3 muestreos de  \n  \n205 acuerdo con el siguiente calendario: 29 d\u00edas toma basal \nde 4 aves por tratamiento;  39 y 49 d\u00edas: 7 aves por \ntratamiento. Las aves fueron alimentadas despu\u00e9s de un \nayuno de 12 h, las muestras de sangre e intestino se \ntomaron 90 minutos despu\u00e9s de haber recibido \nalimento. En cada toma se midi\u00f3 pigmento plasm\u00e1tico \ny en tres diferentes secciones de i ntestino: hacia el final \ndel asa duodenal, yeyuno anterior y posterior al \ndivert\u00edculo de Meckel, adem\u00e1s de heces. Estas \nmediciones se realizaron en un espectrofot\u00f3metro con \nlongitud de onda de 480 nm. Mediante una curva \npatr\u00f3n de carotenoides, los resultad os fueron \ntransformados a \u00b5g de carotenoides/g de muestra. Por \notro lado, la humedad de las heces fue medida seg\u00fan la \nmetodolog\u00eda descrita en el an\u00e1lisis proximal.  \n \nRESULTADOS  \nSe encontr\u00f3 una reducci\u00f3n significativa en los \nvalores de amarillamiento en piel en las aves tratadas \ncon OA, visible desde el d\u00eda 38, y se mantuvo hasta el final del estudio (1.49 \u00b1 .28). No se observ\u00f3 diferencia entre las aves tratadas con amprolio (11.72 \u00b1 .96) y \nurea (11.55 \u00b1 .82) respecto al testigo (13.88 \u00b1 1.52) al \nfinal del es tudio. En plasma se encontr\u00f3 diferencia \nestad\u00edstica entre las aves tratadas con amprolio y urea \n(.245 \u00b1 .01 y .268 \u00b1 .025) y el testigo, en las aves tratadas con OA (.0213 \u00b1 .005) respecto al resto de los \ngrupos. En las aves tratadas con OA, se observ\u00f3 una  \nmenor concentraci\u00f3n de carotenoides en los tres \nsegmentos de intestino. En aves tratadas con urea, la \nconcentraci\u00f3n de carotenoides fue menor en duodeno a los 49 d\u00edas, pero se mantuvo sin diferencias en los otros \nsegmentos, tanto a los 39 como a los 49 di as. No se \nencontr\u00f3 diferencia en las aves que recibieron amprolio \nrespecto al testigo. En heces, no se observ\u00f3 una \ndiferencia en el valor de carotenoides en alguno de los \ntratamientos a los 38 d\u00edas, aunque si se observ\u00f3 diferencia a los 49 d\u00edas, en que la menor concentraci\u00f3n \nse encontr\u00f3 en las aves del grupo testigo. La humedad \nde las heces en los tratamientos 3 y 4 (81.18 \u00b1 1.82 y \n84.56 \u00b1 .86) fue significativamente mayor que en el grupo testigo (76.22 \u00b1 1.83).  \n \nDISCUSI\u00d3N  \nLa reducci\u00f3n en los carotenoides en los tres \nniveles intestinales en aves alimentadas con OA muestra que \u00e9stos no fueron absorbidos, lo cual se corrobora cuando se observan los carotenoides del \nplasma. La mayor cantidad de carotenoides en \u00e9stas \naves se encontr\u00f3 en las heces, y esto finalme nte \nrepercuti\u00f3 en la pigmentaci\u00f3n cut\u00e1nea. El efecto \nobservado podr\u00eda explicarse por una probable \npresentaci\u00f3n de varios factores como: consumo de \nalimento reducido, incremento de l\u00edquidos en intestino por flujo de orina hacia el intestino en aves con \ndiuresis, por lo cual observamos heces m\u00e1s h\u00famedas, o una disminuci\u00f3n de la capacidad de los enterocitos de captar el pigmento para poder absorberlo \nposteriormente. La reducci\u00f3n de la densidad del \ncontenido intestinal por incremento de l\u00edquidos en \nintestino es  un factor que podr\u00eda alterar la absorci\u00f3n del \npigmento, como se ha discutido en otros informes, dado que el pigmento se absorbe por difusi\u00f3n pasiva.  \nEn aves alimentadas con urea se observ\u00f3 una reducci\u00f3n \nen los carotenoides del plasma a los 38 d\u00edas, lo cu al es \nconsistente con el incremento en la humedad de las \nheces. Es conocido que la urea incrementa el consumo \ny excreci\u00f3n de agua, la cual es eliminada en la orina. \nSe ha mencionado que la orina tiene un flujo normal de \nla cloaca hacia el recto, los ciegos , e inclusive intestino \ndelgado. Si esto ocurre, el contenido del intestino se \nhace menos denso, lo cual tendr\u00eda un efecto sobre la \nabsorci\u00f3n del pigmento. Este efecto probablemente \nafect\u00f3 la absorci\u00f3n del pigmento, y en plasma se \nobserv\u00f3 una reducci\u00f3n de la concentraci\u00f3n de \ncarotenoides en plasma. Sin embargo,  no se afect\u00f3 la \npigmentaci\u00f3n cut\u00e1nea.   Probablemente, la reducci\u00f3n \nen los carotenoides del plasma no fue lo \nsuficientemente significativa para afectar \nnegativamente la pigmentaci\u00f3n en piel.  \nAunque  en el plasma de las aves tratadas con \namprolio se observ\u00f3 disminuida la concentraci\u00f3n de \ncarotenoides a los 10 d\u00edas del inicio de su uso (d\u00eda 38), \nno se encontr\u00f3 que  la pigmentaci\u00f3n en piel fuera \ndiferente respecto al testigo. Se ha mencionado que el \namprolio, como lo hacen la mayor\u00eda de los \ncoccidiostatos, mejora la pigmentaci\u00f3n cut\u00e1nea del \npollo por una reducci\u00f3n en la poblaci\u00f3n de coccidias \nintestinales. Sin embargo, no se observ\u00f3 tal efecto en \n\u00e9ste estudio, en el que las aves estuvieron libres de \ncoccidias.  \n Por lo tanto, de los factores aqu\u00ed probados, s\u00f3lo \nOA afect\u00f3 significativamente la pigmentaci\u00f3n. Urea afect\u00f3 la concentraci\u00f3n de carotenoides en plasma, \npero a un nivel que no repercuti\u00f3 negativamente en la \npigmentaci\u00f3n de piel, mientras amprolio n o afect\u00f3 la \npigmentaci\u00f3n.  \n \nREFERENCIAS  \n1. Schaeffer JL, Tyczkowski JK, and Hamilton \nP. Alterations in carotenoid metabolism during ochratoxicosis in young broiler chickens. Pou. Sci 1987;66:318- 324 \n2. Osborne DJ, Huff WE, Hamilton PB, and \nBurmeister HR. Comparis on of ochratoxin, aflatoxin \nand T -2 toxin for their effects on selected parameters \nrelated to digestion and evidence for specific \nmetabolism of carotenoids in chickens. Pou. Sci. \n1982;61:1646- 1652.  \n3. Petrone VM, Ju\u00e1rez RM, Tejeda R y Garc\u00eda \nA. Hallazgos macr osc\u00f3picos e histol\u00f3gicos \ngastrointestinales en pollos con mala pigmentaci\u00f3n  \n  \n206 intoxicados con ocratoxina A. Memorias del X \naniversario de la Sociedad Mexicana de Pat\u00f3logos \nveterinarios: 2001 junio 14- 17; Puerto Vallarta \n(Jalisco) M\u00e9xico. M\u00e9xico (DF): Sociedad Mexicana de \nPat\u00f3logos Veterinarios, AC,  2001.  4. Tyczkowski JK and Hamilton P.  Altered \nmetabolism of carotenoids during pale bird syndrome in chickens infected with Eimeria acervulina. Pou. Sci \n1991;70:2074- 2081.\n \nMETODOLOG\u00cdA PARA EVALUAR EXCRETAS DE POLL O \n \nMETHODOLOGY FOR FECAL EVALUATION  \n \nCarlos L\u00f3pez Coello1, Jos\u00e9 Arce Menocal2 y Ernesto Avila Gonz\u00e1lez3 \n \n1Departamento de Producci\u00f3n Animal:Aves, FMVZ, UNAM. M\u00e9xico 04510, D.F. coelloca@servidor.unam.mx.  \n2INIFAP, Morelia, Michoac\u00e1n, M\u00e9xico, 3 FMVZ, UNAM.  \n \nSUMMARY  \nThe evaluation of scouring conditions in broilers \nare typically done in a subjective manner. This limits \nresult interpretation. Given the need for more reliable \nquantitative and qualitative information, an in -house \nsampling methodology was developed as a diagnostic \ntool. This methodology takes into account the different \nsampling points in different areas within the house, and the identification of feces types. Results are then \ninterpreted.  \n \nRESUMEN  \nLa evaluaci\u00f3n de los cuadros diarreicos en pollos  \nde engorda, generalmente se realizan de una manera \nsubjetiva que limitan su interpretaci\u00f3n, as\u00ed como el \ntranscurso de los mismos, ante la necesidad de contar \ncon informaci\u00f3n cualitativa y cuantitativa mas \nconfiable, se desarrollo una metodolog\u00eda de muestr eo \nen la caseta como una herramienta de diagn\u00f3stico, \nconsiderando los puntos de muestreo en las diferentes \nzonas de la caseta, identificando el tipo de excretas y \nrealizando una interpretaci\u00f3n de los resultados \nobtenidos.  \n \nINTRODUCCI\u00d3N  \n Hoy en d\u00eda las afecciones del sistema digestivo \nson cada vez mas frecuentes a pesar de las avances en \nlas t\u00e9cnicas anal\u00edticas para el control de calidad de las materias primas, la inclusi\u00f3n de secuestrantes de \nmicotoxinas  as\u00ed como de los procesos de fabricaci\u00f3n \nde alimentos  balanceados con ingredientes de alta \ncalidad y el mantenimiento de un tejido sano para la \ndigesti\u00f3n y absorci\u00f3n, posiblemente en parte atribuidas \na los sistemas intensos de producci\u00f3n, y a las regulaciones referentes a la restricci\u00f3n de la inclusi\u00f3n \nde pr omotores como promotores de crecimiento.  \n La recuperaci\u00f3n de los nutrientes de la ingesta, \nrepresenta uno de los principales objetivos del \nintestino, por ello es uno de los factores que se deben \ncuidar para alcanzar el m\u00e1ximo comportamiento productivo en l os pollos de engorda, consecuentemente \nun sistema digestivo sano desde un punto de vista \nanat\u00f3mico y fisiol\u00f3gico es fundamental.  \nLos cuadros que se observan (infecciosos y no \ninfecciosos) com\u00fanmente bajo condiciones comerciales de producci\u00f3n generalmente tienen un origen \nmultifactorial donde se encuentran involucrados todos \nlos componentes de la producci\u00f3n animal (nutricional, \nsanitario y manejo), siendo menos frecuentes los de \netiolog\u00eda simple. Los signos y lesiones macrosc\u00f2picas \ny microsc\u00f3picas que se describen, son poco espec\u00edficos y en general dif\u00edcil de diferenciar, ya que el ave \nresponde en general de una manera similar ante esas \ncircunstancias, debido a que se activan los mismos \npatrones fisiopatol\u00f2gicos; siendo necesario describir \ncon mayor precisi\u00f3 n las lesiones de acuerdo a tama\u00f1o, \ncolor, consistencia ya cantidad (Goodwin, 1998). \nCualquier modificaci\u00f3n de origen f\u00edsico, qu\u00edmico, \nbiol\u00f3gico o neuronal  puede manifestarse como un \nproblema ent\u00e9rico.  \nLa diarrea  en las aves es uno de los signos mas \nfrecuentes de los trastornos ent\u00e9r\u00eccos, existiendo \ndiversos procesos que la producen.  \n     1. Hipermotilidad intestinal. Se refiere a un \nincremento en la intensidad, frecuencia y ciclo del peristaltismo, ocasionando una mayor velocidad de \npaso del alimento a t rav\u00e9s del intestino, puede ser \ngenerada por una inadecuada granulometr\u00eda de los \ningredientes, exceso del porcentaje de fibra cruda o desequilibrio de la flora intestinal, as\u00ed como por las \ntoxinas de bacterias como E. coli, clostridium u otros \nanaerobios. L os insecticidas y  pesticidas tambi\u00e9n \npueden favorecer este proceso.  \n     2. Alteraci\u00f3n en la permeabilidad de la pared \nintestinal. Los cuadros de enteritis cursan con un proceso inflamatorio en la mucosa intestinal, donde se modifica el tama\u00f1o de los poros intercelulares \nafectando la permeabilidad. Esto se produce en todos \nlos casos de enteritis, ya que por definici\u00f3n siempre \nhay inflamaci\u00f3n.   \n  \n207      3. Hipersecreci\u00f3n. En los procesos donde se \npierde el balance entre absorci\u00f3n y secreci\u00f3n de \nelectrolitos, el resultado es la acumulaci\u00f3n de agua en \nel lumen intestinal, y con ello la diarrea (pudiendo o no \nexistir da\u00f1o en la estructura de la mucosa). La \nhipersecreci\u00f3n participa en la patofisiolog\u00eda de varios \nprocesos infecciosos debido a la estimulaci\u00f3n de la secreci\u00f3n intestinal por la inflamaci\u00f3n, irritaci\u00f3n  y \nrespuesta inmunol\u00f3gica. Cuando hay producci\u00f3n de \nenterotoxinas, se puede presentar un cuadro de enteritis \nmucoide caracterizado por que  aumenta la capacidad \nsecretora del intestino. En la parte distal de  las \nvellosidades se encuentran las c\u00e9lulas responsable de la \nabsorci\u00f3n  de los nutrientes, en cambio en las criptas \nestas mismas c\u00e9lulas en periodo juvenil son las \nresponsables de la secreci\u00f3n, por lo que una perdida de \nlas c\u00e9lulas maduras se reflejar\u00e1 en  menor absorci\u00f3n. \nestimulando la formaci\u00f3n de nuevas c\u00e9lulas j\u00f3venes secretoras, pudiendo ser una de las causas de diarrea.  \n    4. Cuadro de \"mala absorci\u00f3n\". Debido a la \nenteritis, aumenta la descamaci\u00f3n de enterocitos y hay \ndeterioro de las vellosidades intestinales, produciendo \nuna menor capacidad de absorci\u00f3n, pudiendo encontrar \nmaterial no digerido en las excretas.  \n    5. Aumento de la presi\u00f3n osm\u00f3tica \nintraluminar. Debido a la retenci\u00f3n del agua ingerida, \nadem\u00e1s de los exudados y detritus del proceso \ninflamatorio, se acelera la velocidad del  transito intestinal. Este proceso puede estar asociado con una \nfermentaci\u00f3n y proliferaci\u00f3n  bacteriana, as\u00ed como de \nnutrientes no digeridos, produciendo cambios en el pH y desequilibrio \u00e1cido -base.  \n   6. Existen  evidencias de la participaci\u00f3n del \nsistema neuroendocrino/paraneural en la presencia de diarreas. Las secreciones gastrointestinales \nnormalmente son estimuladas por las hormonas \ndigestivas como la gastrina y la secretina, as\u00ed como por la estimulaci\u00f3n del nervio vago \nLos cuadros de diarrea se pueden complicar con \ndeshidrataci\u00f3n, hipoglucemia, perdidas de fluidos corporales, hipovolemia, hipertensi\u00f3n arterial, vaso constricci\u00f3n perif\u00e9rica e isquemia, hiperpotasemia, \nalteraci\u00f3n de la funci\u00f3n cardiaca y en cas os mas \navanzados acidosis metab\u00f3lica (Mart\u00ednez, 2001).  \n La anamnesis, y una mejor informaci\u00f3n referente \na los signos cl\u00ednicos y lesiones seguramente van a contribuir, no solamente para mejor diagnostico sino \ntambi\u00e9n  como pronostico, teniendo el riesgo de \nconfundir el cuadro cl\u00ednico al no utilizar las t\u00e9cnicas de \ndiagn\u00f3stico adecuadas, independientemente que los \nprocesos pueden corregirse o complicarse cuando hay cambios en la dieta, poblaci\u00f3n animal, manejo, clima \netc. (L\u00f3pez Coello, 2001)  \nLa metodolog\u00eda de diagnostico puede incluir \nt\u00e9cnicas sofisticadas, costosas y tardadas como es el \ncaso de la determinaci\u00f3n de la flora intestinal, que incluye ensayos moleculares para la identificaci\u00f3n de \nmicroorganismos que por cierto  no han sido del todo \nconocidos, ya que con los estudios actuales se estima \nque solamente se ha podido determinar el 16% de las bacterias intestinales y que ejercen  una gran \nparticipaci\u00f3n para obtener el \"confort intestinal\".  \nEs curioso la poca atenci\u00f3n que se le ha dado a la \ncalidad de las  excretas cuando se presenta un problema, \ngeneralmente se realiza una descripci\u00f3n muy subjetiva \nsin bases, y frecuentemente se cae en el error de un \ninadecuado abuso de los signos cl\u00ednicos para integrar el \ndiagn\u00f3stico, ya que solamente con  la signolog\u00eda  no es \nposible determinar la patog\u00e9nia de la alteraci\u00f3n y mucho menos la etiolog\u00eda, complicando con ello la \nemisi\u00f3n del diagn\u00f3stico. Mediante los estudios \nhistopatol\u00f3gicos tampoco es posible determinar todas \nlas causas que afectan al sistema digestivo y men os aun \nmicrosc\u00f3picamente (En la escala de diagn\u00f3stico es importante incluir los aspectos metab\u00f3licos y \nneuronales, para su  integraci\u00f3n).  \nCon la intenci\u00f3n de contribuir para la definici\u00f3n e \ninterpretaci\u00f3n de la calidad de las excretas se dise\u00f1o una metodol og\u00eda de medici\u00f3n que incluye aspectos \ncualitativos y cuantitativos, Es importante considerar \nque los pollos de engorda realizan de 7 a 15 \nevacuaciones diarias y que las mismas provienen del \nsistema urinario, de los ciegos o del intestino y que de \nalguna ma nera pueden estar combinadas entre s\u00ed. En \nuna caseta con 20,000 aves, se tendr\u00edan entre 140,000 a 280,000 evacuaciones por d\u00eda, correspondiendo a un ciclo de 50 d\u00edas a un total de 7 a 14 millones de \nexcretas, siendo posible encontrar cualquier tipo entre \ntodas ellas, independientemente de que por la misma \ndensidad de las aves, solamente se van a poder \nindentificar aquellas frescas.  \nOtro aspecto que es necesario establecer es el \nconcepto de muestreo que se aplica constantemente en \nla avicultura, ya que gener almente se trabaja sobre la \npoblaci\u00f3n como ocurre en las muestras de serolog\u00eda, \nan\u00e1lisis de alimento, peso corporal etc., pero por alguna raz\u00f3n que todav\u00eda no queda clara ante los problemas \ndigestivos, da la impresi\u00f3n que se busca en la cama las \nexcretas q ue se quieren identificar y esto sin lugar a \ndudas distorsiona la realidad de lo que acontece.  \nLa metodolog\u00eda que se expone a continuaci\u00f3n es \nmuy sencilla y f\u00e1cil de aplicar, se recomienda en un principio hacerla constantemente cada semana sobre \ntodo para uniformar criterios e identificar las variables \nen los distintos puntos de la caseta como es la \norientaci\u00f3n de la caseta (entrada del sol), ubicaci\u00f3n de \nbebederos principalmente, \u00e1reas de crianza (recepci\u00f3n \nde pollitos), material de cama, traspaso de cama etc.  \nTambi\u00e9n se recomienda tener evaluaciones previas y posteriores ante un problema espec\u00edfico, ya que esto \nser\u00e1 de utilidad para conocer el proceso del mismo y \nemitir un pron\u00f3stico o bien la aplicaci\u00f3n de medidas  \n  \n208 para su control. Este concepto ya se est a aplicando en \nalgunas empresas, dando resultados satisfactorios  \n1. Identificar dentro de la caseta 15 sitios de \nmuestreo (5 en cada uno de los pasillos laterales y uno \nen la regi\u00f3n central), por ejemplo si la caseta mide 120 \nmetros de largo por 12 de anch o, el lugar de muestreo \ncorresponder\u00e1 a una distancia de 1 metro de cada \npasillo hacia el interior de la caseta, teniendo una \ndistancia lateral de 20 metros entre cada sitio; en el \ncaso de los lugares centrales ser\u00e1 en la parte central de \nla caseta (6 metr os del pasillo).  \n2. Cada lugar de muestreo corresponder\u00e1 a 1 m 2.  3. En el interior del \u00e1rea definida, se contara el \ntotal de excretas frescas, clasific\u00e1ndolas en 5 categor\u00edas.  \n4. Las categor\u00edas son: 1) Heces normales, 2) \nHeces acuosas, 3) Heces de color anormal \n(principalmente verdosas)  4) Heces con presencia de \nmoco, 5) Heces con presencia de alimento sin digerir  \n5. En una matriz se coloca la informaci\u00f3n \nobtenida y se expresan los resultados como porcentaje.  \n6. La interpretaci\u00f3n se realiza en base a los \nporcentajes obtenidos y en los antecedentes de las \nlecturas anteriores.  \n \nEJEMPLO DE EVALUACION EN PARAVADA DE 4 SEMANAS DE EDAD  \nVARIABLE  TOTAL  PASILLO ZONA ORIENTE  PASILLO ZONA CENTRAL  PASILLO ZONA PONIENTE  \n total  (%) 1 2 3 4 5 total  (%) 1 2 3 4 5 total  (%) 1 2 3 4 5 total  (%) \nNormales  91 53.8 7 5 4 5 3 24 45.3 6 7 6 5 4 28 54.9 8 9 7 8 7 39 60.0 \nAcuosas  46 27.2 4 3 4 3 1 15 28.3 3 4 2 3 2 14 27.4 4 3 5 2 3 17 26.1 \nVerdosas   2   1.2 1 0 0 0 0  1  1.9 0 0 0 1 0  1  2.0 0 0 0 0 0  0   0.0 \nMoco   4   2.4 0 0 0 1 0  1  1.9 0 0 0 1 0  1  2.0 0 0 2 0 0  2   3.1 \nAlimento  26 15.4 3 2 4 2 1 12 22.6 2 2 0 2 1  7 13.7 2 0 2 3 0  7 10.8 \nTotal  169  15 10 12 11 5 53  11 13 8 12 7 51  14 12 16 13 10 65  \n(%) 100 100       100       100       100 \nEjemplo de interpr etaci\u00f3n  \n1.- Debido a que el \u00e1rea de crianza estaba en el punto 1 hab\u00eda mayor numero de aves y por ello hay un mayor \nnumero de excretas en los puntos 1 Y 2.  \n2.- En el pasillo oriente entraba la luz solar en la ma\u00f1ana y las aves se ubicaban en esa zona, prov ocando \nmayor densidad de poblaci\u00f3n y excretas, promoviendo la humedad en la cama.  \n3.- La definici\u00f3n del cuadro cl\u00ednico se centraliza a heces acuosas (27,2%) con presencia de alimento sin digerir \n(15.4%) con poca presencia de moco (2.4%).  \n \nREFERENCIAS  \n1. Goodwin, M.A. Patofisiolog\u00eda dl aparato \ndigestivo de las aves :una revisi\u00f3n. Memorias Curso de enfermedades digestivas de las aves. ANECA, M\u00e9xico, \nD.F. pp 23- 37. 1998.  \n2. Mart\u00ednez R.A.S. Enfermedades ent\u00e9ricas de \nlas aves. Memorias Ciclo de conferencias SIPESA -\nTROUW. Guadalajara, M\u00e9xico, 2001.  3. L\u00f3pez C.C., Arce M.J., Avila G.E. Factores \ninvolucrados en la nutrici\u00f3n y alimentaci\u00f3n de pollos de engorda que afectan la integridad del intestino. \nMemorias 10. encontro Alpharma de enteropatias em \nfrangos de corte, Campi\u00f1 as, Brasil pp31 -47. 2001.\n \nCuadro 1.  \nTratamientos  \n Duodeno* \n Yeyuno \nanterior a \nMeckel*  Yeyuno \nposterior a \nMeckel*  Heces*  \n Plasma**  \n Humedad en \nheces  Amarillamiento \nen piel  \n39 d\u00edas  \nTestigo  69 \u00b1 28.6a  67.9 \u00b1 \n26.8a  80.56 \u00b1 \n24.7ab  96.43 \u00b1 44.9a  0.36 \u00b1 .033 a 76.23 \u00b1 1.83a  9.89 \u00b1 .88a  \nAmprolio  55.62 \u00b1 \n15.2a  54.2 \u00b1 \n11.8a  47.3 \u00b1 8.3bc  279.18 \u00b1 20.7a  0.24 \u00b1 .017b  78.07 \u00b1 .94ab  9.5 \u00b1 .65a  \nOcratoxina A  8.32 \u00b1 .7b  7 \u00b1 1.7b  10.53 \u00b1 2.1c  67.17 \u00b1 15.2a  0.021 \u00b1 \n.005c  81.18 \u00b1 1.82b  2.21 \u00b1 .33b  \nUrea  45.46 \u00b1 \n10.3ab  57.41 \u00b1 \n20.6a  84.8 \u00b1 26.5a  277.4 \u00b1 15a  0.267 \u00b1 \n.025b  84.57 \u00b1 .86c  8.79 \u00b1 .79a  \n49 d\u00edas  \nTestigo  82.32 \u00b1 \n7.13a  80.37 \n\u00b113.04ab  134.34 \n\u00b132.6a  75.877 \u00b1 12.5b  0.27 \u00b1 0.04a  71.25 \u00b1 2.22a  12.45 \u00b1 1.53a   \n  \n209 Amprolio  83.46 \u00b1 \n21.18ab  114.957 \u00b1 \n15.6a  106 \u00b1 \n25.16a  231.94 \u00b1 \n46.26a  0.24 \u00b1 .02a  65.64 \u00b1 2.35a  11.72 \u00b1 .96a  \nOcratoxina A  14.39 \u00b1 \n6.89c  9.74 \u00b1 2.5c  7.47 \u00b1 2b  213 \u00b1 30.06ab  0.02 \u00b1 .01b  77.03 \u00b1 1.75b  \n1.54 \u00b1 .27b  \nUrea  46.266 \u00b1 \n11.4b  74.290 \u00b1 \n12.8b  80.185 \u00b1 \n20.02a  189.44 \u00b1 \n70.36b  0.18 \u00b1 0.03a  79.58 \u00b1 2.25b  \n10.36 \u00b1 .75a  \nValores con distinta literal indican diferencia significativa (p<0.05)  \nMedia \u00b1 Error Est\u00e1ndar de la Media \n*Valores en \u00b5g de carotenoides/g muestra  \n**Valores de absorbancia \n \nEVALUACI\u00d3N DE LA CALIDAD DE ABSORENTES AMONIACOS  \n \nQUALITY EVALUATION OF AMMONIA ABSORBENTS  \n \nIrlanda Garc\u00eda, Lourdes Guevara y Javier Lara.  \n \nNUTEK S.A. DE C.V. 7 norte 416. Tehuac\u00e1n, Pue. 75700 M\u00e9xico. E -mail: jlara@grupoidisa.com  \n \nSUMMARY  \nAmmonia production causes \nhealth/environmental proble ms. Thus, the use of \nammonia absorbents is desirable. This paper presents \none method to measure the ammonia -absorption ability \nof different materials. The method consists of passing a \nnitrogen stream in a vessel containing both an \nammonium hydroxide soluti on and the test material. \nAmmonia drawn by nitrogen is quantified using an \nassessment. Mineral - and plant -origin materials were \nevaluated. Results ranged from 3% to 90% retention \nrates.  \n \nRESUMEN  \nLa emisi\u00f3n de amoniaco es un problema con \nrepercusiones a la salud y al medio ambiente, por lo que el uso de absorbentes de amoniaco es deseable. En \neste trabajo se presenta un m\u00e9todo para medir la \ncapacidad de absorci\u00f3n de amoniaco de diferentes \nmateriales. El m\u00e9todo consiste en hacer pasar una \ncorriente de nitr\u00f3ge no en un recipiente que contiene \nuna soluci\u00f3n de hidr\u00f3xido de amonio y el material a \nevaluar. El amoniaco arrastrado por el nitr\u00f3geno se \ncuantifica por una valoraci\u00f3n. Se evaluaron materiales \nde origen mineral y vegetal con resultados que variaron \ndel 3% a l 90% de retenci\u00f3n.  \n \nINTRODUCCI\u00d3N  \nEn el \u00e1mbito mundial, la emisi\u00f3n de amoniaco \n(NH3) por las explotaciones pecuarias constituye un \nproblema importante tanto para la salud, animal y humana, como para el medio ambiente. En el caso \nparticular de M\u00e9xico, el p roblema de salud es \nfrecuentemente considerado de bajo impacto pues normalmente las casetas son ventiladas, por lo que el aspecto ecol\u00f3gico retoma un primer plano. A esto se \ndebe que el uso de aditivos que evitan la volatilizaci\u00f3n \ndel amoniaco no es com\u00fan,  sin embargo en algunas \nempresas, concientes de la importancia del aspecto \necol\u00f3gico y de proporcionar un mejor confort a los \nanimales y a los trabajadores, se empiezan a usar estos \naditivos. Adem\u00e1s se ha demostrado que al controlar la \nemisi\u00f3n del amoniaco  se mejora la productividad.  \nEn las explotaciones pecuarias el amoniaco se \nforma principalmente por la descomposici\u00f3n del \u00e1cido \u00farico o de la urea y su emisi\u00f3n al medio ambiente \ndepende de muchos factores relacionados tanto con las \ninstalaciones como con l a nutrici\u00f3n animal (1), pero de \nuna manera general depende de las condiciones del \nesti\u00e9rcol.  \nLa emisi\u00f3n de amoniaco puede ser controlada \nmediante tres clases de materiales, el primero es a \ntrav\u00e9s de materiales que tienen la capacidad de \ncombinarse con el amonio o el amoniaco, el segundo es \na trav\u00e9s de materiales que disminuyen el  pH del desecho y el tercero a trav\u00e9s de materiales que act\u00faan \nmicrobiol\u00f3gicamente ya sea inhibiendo la funci\u00f3n de la \nenzima ureasa o el crecimiento de ciertos \nmicroorganismos que  favorecen la descomposici\u00f3n del \n\u00e1cido \u00farico. Entre los materiales que han sido \nempleados para el control de la emisi\u00f3n del amoniaco se pueden mencionar a las zeolitas, los fosfatos, el \n\u00e1cido fosf\u00f3rico, el sulfato ferroso, los extractos de \nyuca, algunos \u00e1c idos org\u00e1nicos y paraformaldeh\u00eddo (2).  \nEn la literatura se han reportado algunos estudios \npara evaluar la capacidad de absorci\u00f3n de amoniaco. \n\u00c9stos se han realizado ya sea mediante pruebas de \nfermentaci\u00f3n de semanas de duraci\u00f3n (2), o mediante \nevaluaciones  donde se mide la disminuci\u00f3n del amonio \nlibre en soluci\u00f3n (3,4). En el primer caso la duraci\u00f3n de \nla prueba impide su uso para control de calidad y en el  \n  \n210 segundo no se tiene una medida directa de la \ndisminuci\u00f3n de la volatilizaci\u00f3n del amoniaco. Por \nconsi guiente, se requiere un m\u00e9todo r\u00e1pido y que mida \ndirectamente la volatilizaci\u00f3n del amoniaco.  \nEn este trabajo se propone un m\u00e9todo r\u00e1pido para \nmedir directamente la volatilizaci\u00f3n del amoniaco y se \nevaluaron varios aditivos qu\u00edmicos que pueden ser utilizad os para el control de la emisi\u00f3n del amoniaco. \nNo se consideran materiales del tipo microbiol\u00f3gico.  \n \nMATERIAL Y M\u00c9TODO  \nSe seleccionaron varios materiales que son o que \npueden ser utilizados para el control de la emisi\u00f3n de amoniaco. Estos materiales se pue den clasificar en dos \ngrupos, los que funcionan a trav\u00e9s de una reducci\u00f3n del \npH y los que se combinan con el amonio. Del primer \ngrupo se utilizaron: Cloruro F\u00e9rrico hexahidratado, \nSulfato Ferroso monohidratado, Ortofosfato de Calcio \nal 18% de F\u00f3sforo y \u00c1c ido Fosf\u00f3rico. Del segundo \ngrupo se usaron 2 zeolitas de origen natural en polvo \nfino identificadas como ZM y ZC, 1 zeolita granulada \ndel mismo origen que la ZM, 1 aluminosilicato, 1 \nbentonita s\u00f3dica, 1 extracto de Yuca en forma l\u00edquida y \ns\u00f3lida. En este c aso se incluy\u00f3 un aluminosilicato \nporque este material es usado con frecuencia en los \nalimentos como adsorbente de micotoxinas y no se ha \nhecho \u00e9nfasis en su propiedad de absorci\u00f3n de \namoniaco. Tambi\u00e9n se incluy\u00f3 una bentonita s\u00f3dica pues este material al igual que las zeolitas (5) tienen \nuna alta afinidad  por el amonio.  \nEl m\u00e9todo consiste en colocar en un matraz 1 g o \n1 mL del material a evaluar y adicionar 10 mL de una \nsoluci\u00f3n valorada de Hidr\u00f3xido de Amonio al 0.5 N. El \nmatraz se cierra con un tap\u00f3n de hule el cual tiene dos \nperforaciones, una para la entrada de una corriente de Nitr\u00f3geno y la otra para la salida de este gas que \narrastra el amoniaco que se volatiliza de la soluci\u00f3n. Se utiliza Nitr\u00f3geno pues el aire adem\u00e1s del di\u00f3xido de \ncarbono puede c ontener trazas de amoniaco que har\u00eda \nnecesario lavarlo para eliminar estas interferencias \ncomplicando el m\u00e9todo. El flujo de Nitr\u00f3geno se fija a 100 mL/min y se hace circular por 30 minutos. La \nsalida est\u00e1 conectada a un matraz que contiene una \nsoluci\u00f3n va lorada de \u00c1cido Clorh\u00eddrico donde se \nretiene el amoniaco que se arrastr\u00f3 con el nitr\u00f3geno. \nEste \u00e1cido se valora y mediante un c\u00e1lculo \nestequiom\u00e9trico se obtiene la cantidad de amoniaco que \nse volatiliza. Antes de evaluar los materiales se realiza \nuna prueb a blanco que permite calcular cuanto \namoniaco se volatiliza sin la presencia de ning\u00fan \naditivo. El resultado se reporta como porcentaje del amoniaco que se retiene con respecto al amoniaco que \nse volatiliza sin el uso del aditivo. Cada material fue \nanalizado por duplicado y en el caso de los materiales que tienden a aglomerarse se tuvo el cuidado de \ndispersarlos bien.  Otra variable tambi\u00e9n controlada fue la temperatura, la cual se mantuvo a 24  1 oC mediante \nla inmersi\u00f3n del matraz en un ba\u00f1o de agua.  \n \nRES ULTADOS Y DISCUSI\u00d3N \nLa evaluaci\u00f3n de 6 repeticiones del blanco dio un \npromedio de 0.978 milimoles de amoniaco (16.6 mg)  \nvolatilizados que corresponden a 0% de retenci\u00f3n.  El \ncoeficiente de variaci\u00f3n fue de 5.6%. Los resultados de \nla reducci\u00f3n de la volati lizaci\u00f3n del amoniaco por los \nmateriales utilizados se presentan de manera resumida \nen el cuadro 1. En este cuadro se observa que los \nvalores de reducci\u00f3n de emisi\u00f3n del amoniaco \ndependen del tipo de material utilizado y del principio \nde funcionamiento. As \u00ed se observa que los que retienen \nel mayor porcentaje de amoniaco son aquellos que \nfuncionan sobre el principio de la disminuci\u00f3n del pH, \ncomo son el \u00e1cido fosf\u00f3rico, el cloruro f\u00e9rrico, el \nsulfato ferroso y en menor grado el ortofosfato. Estos resultados coinciden con los reportados en la literatura \n(2) donde se llega a la conclusi\u00f3n que la reducci\u00f3n del amoniaco es mejor cuando se utiliza \u00e1cido fosf\u00f3rico y \nsulfatos de fierro y de aluminio, que cuando se utiliza \nun silicato recubierto con \u00e1cido. En ese mis mo estudio \nse favorece el uso del cloruro f\u00e9rrico al del sulfato \nferroso por la toxicidad que puede ocasionar un exceso \ndel fierro biodisponible del sulfato y se cuestiona el uso \nde los materiales que contienen F\u00f3sforo por su efecto de eutroficaci\u00f3n de las  aguas. Esto resulta muy \ninteresante considerando que en la actualidad se pueden usar algunos \u00e1cidos org\u00e1nicos, como el ad\u00edpico \n(6) u otros, en los alimentos que tienden a acidificar los \ndesechos lo que puede disminuir la emisi\u00f3n de \namoniaco. Adem\u00e1s estos \u00e1cidos org\u00e1nicos pueden tener \nuna influencia favorable en el tracto intestinal.  \nRespecto a las zeolitas se observa de los \nresultados de la zeolita ZM que el tama\u00f1o de part\u00edcula \nno tuvo una influencia muy grande en el resultado. Sin \nembargo el origen de la zeolita puede ser importante, \npues se observa una diferencia de m\u00e1s del 10% de la reducci\u00f3n usando la zeolita ZM con respecto a la zeolita ZC.  En el caso del extracto de Yuca se tiene \npr\u00e1cticamente el mismo valor de reducci\u00f3n en s\u00f3lido \nque en l\u00edquido.  Es  importante remarcar que este \nextracto de yuca no tuvo la reducci\u00f3n de amoniaco que era esperada, pues la cantidad adicionada en el \nexperimento represent\u00f3 el 10% del volumen de la soluci\u00f3n de amonio con valores de retenci\u00f3n solamente \ndel orden del 22%. Est o implica un nivel alto de \ninclusi\u00f3n como absorbente de amoniaco, lo cual ya ha \nsido reportado en la literatura (4). Probablemente el funcionamiento de los extractos de yuca sea mas por \nprincipio microbiol\u00f3gico que por absorci\u00f3n.  \nLa reducci\u00f3n de amoniaco obtenida con el \naluminosilicato resulta de inter\u00e9s, pues se tiene un porcentaje del orden del 17% y al ser este material \nempleado con frecuencia en los alimentos para  \n  \n211 controlar la micotoxicosis se tiene un beneficio \nadicional, pues puede contribuir a reducir la emisi\u00f3n de \namoniaco.  Por otra parte, en este estudio la bentonita \ns\u00f3dica utilizada tuvo un bajo nivel de reducci\u00f3n, lo \ncual aunado a su car\u00e1cter s\u00f3dico que puede contribuir a \naumentar la salinidad de los desechos, la hace un \nmaterial con pocas posib ilidades de uso. Es claro que \nno todas las bentonitas van a tener el mismo \ncomportamiento.  \n \nCONCLUSI\u00d3N  \nEl m\u00e9todo presentado permite evaluar de manera \nr\u00e1pida la capacidad de absorci\u00f3n de amoniaco de varios \nmateriales. Este m\u00e9todo no tiene validez para los \nmateriales que act\u00faan microbiol\u00f3gicamente. La rapidez \ndel m\u00e9todo permite que pueda ser utilizado para el \ncontrol de calidad de los absorbentes de amoniaco. En \ncuanto a la evaluaci\u00f3n se llega a la conclusi\u00f3n que los \nmateriales que tienden a reducir el pH de los desechos retienen mayor cantidad de amoniaco que aquellos que \nse combinan con el amoniaco. Finalmente la decisi\u00f3n \nde usar o no un absorbente de amoniaco y que tipo va a \ndepender del aspecto econ\u00f3mico ya que el problema \ndel amoniaco debe estudiarse desd e varios aspectos, \nque incluyen las instalaciones, la nutrici\u00f3n y el manejo \nde los desechos.  REFERENCIAS  \n1. Canh, T.T., A.J.A. Aarnink, M.W.A. \nVerstegen y J.W. Schrama. Influence of dietary factors \non the pH and ammonia emission of slurry from \ngrowing -finishing pigs. J. Anim. Sci. 76, 1123- 1130, \n1998.  \n2. Moore, P.A., T.C. Daniel, D.R. Edwards y \nD.M. Miller. Evaluation of chemical amendments to \nreduce ammonia volatilization from poultry litter. \nPoultry Sci. 75, 315- 320, 1996.  \n3. Headon, D.R., K. Buggle, A. N elson y G. \nKilleen. Glycofractions of the yucca plant and their \nrole in ammonia control. P 95 -108. En T.P. Lyons (ed), \nBiotechnology in the feed industry. Alltech, Inc. \nNicholasville, Ky. 1991.  \n4. Wallace, R.J., L. Arthaud y C.J. Newbold. \nInfluence of yucc a shidigera extract on ruminal \nammonia concentration and ruminal microorganism. \nAppl. Environ. Microbiol. 60, 1762- 1767. 1994.  \n5. Theophilou, N. Clinoptilolite may help \nreduce ammonia. Feed Mix 8, 14 -16, 2000.  \n6.    Van Kempen, T.A.T.G. Dietary adipic acid  \nreduces ammonia emission from swine excreta. J. Anim. Sci. 79, 2412- 2417, 2001.  \n \nCuadro 1.  Reducci\u00f3n de la volatilizaci\u00f3n de amoniaco por diversos aditivos. El valor representa la media de dos \nevaluaciones.  \n \nMATERIAL  REDUCCI\u00d3N DE \nVOLATILIZACI\u00d3N DE \nAMONI ACO  \n(%) \n\u00c1CIDO FOSF\u00d3RICO  90.7 \nCLORURO F\u00c9RRICO H  82.0 \nSULFATO FERROSO  70.6 \nORTOFOSFATO  63.6 \nE. YUCA POLVO  24.4 \nE. YUCA L\u00cdQUIDO  22.9 \nALUMINOSILICATO  17.3 \nZEOLITA ZM POLVO  14.7 \nZEOLITA ZM GRANO  14.0 \nBENTONITA SODICA  7.0 \nZEOLITA ZC  3.5 \n \n \n \n  \n  \n212 EFICACIA DEL 3 -ACETIL 4\u201d -ISOVALERIL TARTRATO DE \nTILOSINA EN EL TRATA MIENTO DE LA ENFERMEDAD \nRESPIRATORIA CR\u00d3NICA  (MYCOPLASMA ALLISEPTI CUM ) \n \nEFFICACY OF 3-ACETYL, 4\u201d-ISOVALERYL TYLOSINE TARTRATE (AIV) IN \nTHE TREATMENT OF CHRONIC RESPIRATORY DISEASE  \n(MYCOPLASMA GALLISEPTICUM)  \n \nCerd\u00e1, Ra\u00fal 1, 2; Piscopo, Miguel 2; Unzaga, Florencia 2; Marino, Fernando 2; Petruccelli, Miguel 2 \n \n1ECO Animal Health, UK.  2Facultad de Ciencias Veterinarias, Universidad Nacional de La Plata. CC 296  \n(B1900 AVW) La Plata, Rep\u00fablica Argentina.  \n \nSUMMARY  \nThe purpose of this research was to evaluate the \ntherapeutic efficacy of AIV alone or in combination \nwith bromexine (BRO), in an experimental model to reproduce chronic respiratory disease (CRD) caused by \nM. gallisepticum . Four 2 -day-old 15- chick groups were \ninoculated with M. gallisepticum  K781 strain given by \nby spray. Significant differences were found regarding lesion scores and weight gains between the controls \nand the AIV - and AIV+BRO -treated groups. A marked \ndelay in seroconversion was al so observed en these \ngroups.  \n \nRESUMEN  \nEl objetivo del estudio fue evaluar la eficacia \nterap\u00e9utica del 3 -acetil 4\u201d -isovaleril tartrato de tilosina \n(AIV), solo y asociado a bromexina (BRO) en un \nmodelo de reproducci\u00f3n experimental de la \nenfermedad respirator ia cr\u00f3nica (ERC) por \nMycoplasma gallisepticum  . Se inocularon 4 grupos de \n15 pollos de 2 d\u00edas de vida  con la cepa de M. gallisepticum   K781 mediante aerosol. Se observaron \ndiferencias significativas en cuanto a lesiones y \nganancia de peso entre los grupos  medicados con AIV \ny AIV asociado a BRO con el grupo control como as\u00ed \ntambi\u00e9n un marcado retraso en la seroconversi\u00f3n en \ndichos grupos.  \n  \nINTRODUCCI\u00d3N  \nLa infecci\u00f3n por M. gallisepticum  y la signolog\u00eda \ncl\u00ednico -patol\u00f3gica por ella producida, conocida como \nERC, se caracteriza en pollos parrilleros, por estertores \nrespiratorios, tos y secreciones nasales. Estos signos, en ciertos casos, se ven exacerbados por la presencia de \notros agentes, como bacterias ( Escherichia coli ) y virus \n(Bronquitis infecciosa). La relevancia de esta \nsignolog\u00eda cl\u00ednica se desprende de las cuantiosas \np\u00e9rdidas econ\u00f3micas que ocasionan en la industria \nav\u00edcola, debido b\u00e1sicamente al aumento del \u00edndice de conversi\u00f3n alimenticia y a la depreciaci\u00f3n del valor de la canal, y sobre todo, al cos to de los medicamentos \npara paliar los efectos antes mencionados. Esta \nenfermedad obliga a establecer programas de control y \nprevenci\u00f3n temprana. Para implementar estos \nprogramas se hace necesario comprender la aparici\u00f3n secuencial de estos signos cl\u00ednicos  que afectan el \nnormal comportamiento del ave.  \nLos mucol\u00edticos, como la BRO , son una de las \narmas terap\u00e9uticas con que cuenta la industria av\u00edcola para paliar o reducir las p\u00e9rdidas econ\u00f3micas \nproducidas por los cuadros mencionados, mediante su \nacci\u00f3n flu idificante del mucus traqueobronquial \n(Takeda, 1983) (Sumano, 1995). El uso de antibi\u00f3ticos \nes otro de los elementos que la industria posee para \ncombatir la ERC. Dentro de \u00e9stos se encuentra el AIV derivado de la tilosina de reciente uso en el mercado \n(Skelly, 1986). Por otra parte se ha reportado un \naumento de la eficacia terap\u00e9utica en afecciones \nrespiratorias mediante la asociaci\u00f3n de estas dos clases \nde drogas (Sumano, 1995).  \nEl objetivo del presente estudio fue evaluar la \neficacia del AIV y la BRO , individualmente y \nasociados, en un modelo experimental de ERC por M. \ngallisepticum , en base al an\u00e1lisis de las lesiones \nrespiratorias macrosc\u00f3picas, ganancia de peso y \nseroconversi\u00f3n.  \n \nMATERIALES Y M\u00c9TODOS  \nPara este estudio se utilizaron 65 pollitos \nreproduc tores de engorda de un d\u00eda de vida, \nprovenientes de una granja comercial libre de \nmicoplasmas y salmonellas. Los mismos fueron divididos en cuatro grupos: A) grupo control inoculado \ncon M. gallisepticum   (20 animales), B) grupo \ninoculado con  M. gallisepticum   y medicado con \nmucol\u00edtico (15 animales), C) grupo inoculado con M. \ngallisepticum  y medicado con antibi\u00f3tico (15 animales) \ny D) grupo inoculado con M. gallisepticum  y medicado \ncon mucol\u00edtico y antibi\u00f3tico (15 animales).   \n  \n213 Los animales de los cuatro grupos fueron \ninoculados con una cepa pat\u00f3gena de M. gallisepticum   \n(ver in\u00f3culo) el segundo d\u00eda de vida. Previamente se \ntomaron muestras de sangre de 10 animales para \nconfirmar serolog\u00eda negativa a M. gallisepticum   y \nMycoplasma sinoviae . \nCuando se comenzaron a observar los primeros \nsignos cl\u00ednicos respiratorios (6 d\u00edas posinoculaci\u00f3n), se \ncomenzaron los tratamientos en el agua de bebida y \ndurante 5 d\u00edas. El grupo B comenz\u00f3 a recibir BRO  a las \ndosis indicadas por el fabricante, 0,8 mg / kg peso vivo.  \nEl grupo C comenz\u00f3 a recibir AIV a la dosis de 20 mg \n/kg peso vivo . As\u00ed mismo el grupo D recibi\u00f3 la \ncombinaci\u00f3n de las dos drogas arriba mencionadas.  \nIn\u00f3culo . Para el desarrollo de la infecci\u00f3n \nexperimental se emple\u00f3 una cepa de referencia de M. gallisepticum   (K -781). Dicha cepa fue adaptada al \nmedio de cultivo l\u00edquido de Frey con 12% de suero porcino (Frey, 1968) mediante la realizaci\u00f3n de pasajes de 0,2 ml de cultivo inoculado en 2 ml de medio fresco, \nhasta la obtenci\u00f3n de crecimiento en fase logar\u00edtmica \n(crecimi ento en 24 hs por cambio de color del \nindicador de pH del p\u00farpura al amarillo -naranja). En \nese momento se obtuvo un in\u00f3culo con una \nconcentraci\u00f3n de 10\n10UFC/ml. La descarga del in\u00f3culo \nen los pollitos se realiz\u00f3 v\u00eda aerosol mediante el \nempleo de un nebuliz ador de medicina humana. La \ncopita pl\u00e1stica se carg\u00f3 con 5 ml del cultivo y se coloc\u00f3 \nen forma vertical dentro de una caja de cart\u00f3n \nconteniendo los animales a inocular (10 por vez). El \ntiempo de exposici\u00f3n fue de aproximadamente 3 minutos a fin de asegura rse una correcta descarga.  \nMuestreo. Se sacrificaron 5 animales por lote a \nlos 5, 10 y 15 d\u00edas post tratamiento (PT). Los animales fueron pesados, sangrados y sacrificados a los efectos de realizar los distintos estudios. Los estudios \nserol\u00f3gicos se llevar on a cabo mediante la prueba de \naglutinaci\u00f3n r\u00e1pida en placa (ARP) con ant\u00edgeno de \nIntervet.\n (Intervet International B.V. Boxmeer -\nHolland).  \nAn\u00e1lisis estad\u00edstico . Para el an\u00e1lisis estad\u00edstico \nde la ganancia de peso se aplic\u00f3 el an\u00e1lisis de varianza \n(prueba  de Fisher) con un nivel de significancia de \n0.05.  \n \nRESULTADOS  \nLos resultados de ganancia de peso, lesiones en \nsacos a\u00e9reos y serolog\u00eda se detallan en la tabla adjunta. En el grupo control murieron 3 animales entre los 2 y 3 \nd\u00edas PT con severas lesiones en  los sacos a\u00e9reos.  \n \nDISCUSI\u00d3N  \nA diferencia de la mayor\u00eda de los estudios de \neficacia en los que la medicaci\u00f3n se inicia antes o \nconjuntamente con la inoculaci\u00f3n experimental, en el \npresente ensayo se busc\u00f3 determinar la eficacia terap\u00e9utica del AIV solo y asociado a BRO luego que \nse presentaran los signos cl\u00ednicos de la enfermedad. \nTeniendo en cuenta que una vez establecida la \nenfermedad la efectividad de los tratamientos en la \nERC es muy baja, consideramos de sumo valor los \nresultados obtenidos en el prese nte estudio en donde se \npueden observar diferencias significativas ( P < 0.0001) \nen la ganancia de peso entre los grupos tratados con AIV y los restantes como as\u00ed tambi\u00e9n un menor \nn\u00famero de animales con lesiones en los grupos tratados. Si bien no se observa ron diferencias \nsignificativas entre los grupos C y D a diferencia de los \ntrabajos de otros investigadores (Sumano, 1995), \nprobablemente por el escaso n\u00famero de muestras, si pueden observarse diferencias entre el grupo B y el \ngrupo control en la ganancia d e peso y lesiones \nrespiratorias como as\u00ed tambi\u00e9n en la mortalidad, lo cual \nhabla de una cierta actividad del mucol\u00edtico en las aves \ntratadas. Pero tal vez el punto de mayor inter\u00e9s sea el \nreferente a la seroconversi\u00f3n en donde se puede \nobservar un importan te retraso en la misma en cada \nmuestreo, llegando inclusive a m\u00e1s de 25 d\u00edas post \ninoculaci\u00f3n en un animal del grupo D, cuando \nnormalmente la positividad es detectada antes de los 10 \nd\u00edas post infecci\u00f3n mediante la prueba de ARP (Opitz, 1983), como ocurri\u00f3 en los grupos A y B.  \n  A partir del presente estudio podemos concluir \nque el AIV presenta una alta efectividad en el \ntratamiento de la ERC por M. gallisepticum  \nconfirmando los resultados obtenidos por Skelly y \ncolaboradores (1986). No obstante es necesar io realizar \nun estudio m\u00e1s amplio a fin de conocer \nfehacientemente la interacci\u00f3n entre el AIV y la BRO \nfrente a esta enfermedad.  \n \nREFERENCIAS  \n1. Frey, M., R. Hanson and D. Anderson. A \nmedium for the isolation of  avian Mycoplasmas. Am. \nJ. Vet. Res. 29: 2164- 2171. 1968.  \n2. Nunoya, T., M. Tajima, T. Yagihashi and S. \nSannai. Evaluation of Respiratory Lesions in Chickens \nInduced by Mycoplasma gallisepticum . Jpn. J. Vet. Sci. \n49: 621- 629. 1987.  \n3. Opitz, H., J. Duplessis and M. Cyr. Indirect \nmicro enzyme -linked immunosorbent assay for the \ndetection of antibodies to Mycoplasma synoviae and \nMycoplasma gallisepticum . Avian Dis 27, 3 : 773- 786. \n1983.  \n4. Skelly, B., D. Andersen, M. Pruss, and R. \nPellegrino. Prophylactic efficacy of 3 -Acetil -4\u201d-\nIsovaleryl Tylosin in a Mycoplasma gallisepticum -\nInduced Airsacculitis Infection. Avian Dis 3: 505 -509. \n1986.  \n5. Sumano, H., I. Gracia, A. Capistran, A. \nMeade, G. Rivero and L. Ruiz -Ramirez. Use of \nambroxol and bromhexine as mucolytics for enhanced  \n  \n214 diffusion of furaltadone into tracheobronchia l \nsecretions in broilers. British Poultry Science. 36: 503 -\n507. 1995.  6. Takeda, H, M. Misawa, and S. Yanaura. A \nRole of Lysosomal Enzymes in the Mechanism of \nMucolytic action of Bromhexine. Japan. J. Pharmacol. \n33: 455- 461. 1983.  \n \nCuadro 1:  Lesiones, seroco nversi\u00f3n y ganancia de peso de los distintos grupos a distintos intervalos de tiempo.  \n   \n5 d\u00edas PT    \n10 d\u00edas PT    \n15 d\u00edas PT  \n \nTratamientos   \n Lesiones   \nARP  \nLesiones   \nARP   \n Lesiones   \nARP   \nPeso promedio  \na los 28 d\u00edas (g.)  \nA) Control  5/5 2/5 5/5 5/5 5/5 5/5 1.010c \nB) BRO  4/5 2/5 4/5 5/5 5/5 5/5 1.089a \nC) AIV  1/5 0/5 1/5 1/5 2/5 5/5 1.187b \nD) AIV+BRO  0/5 0/5 3/5 1/5 3/5 4/5 1.207b \nMedias de pesos con letras distintas son significativamente diferentes ( P < 0.05)  \n \nDETERIMINACI\u00d3N DE LA  SENSIBILIDAD A ANTIB I\u00d3TICOS DE \nDIFERENTES CEPAS DE ESCHERICHIA  COLI  \n \nDETERMINATION OF ANTIBIOTIC SENSITIVITY OF DIFFERENT \nESCHERICHIA COLI STRAINS  \n \nRosario CC1, T\u00e9llez Isa\u00edas1, Eslava CC2. \n \n1Departamento de Producci\u00f3n Animal: Aves, Facultad de Medicina Veterinaria y Zootecni a, UNAM. Circuito \nExterior 04510, Cuidad Universitaria, M\u00e9xico, D.F. 2Departamento de Salud P\u00fablica, Facultad de Medicina, \nUNAM. rosario@servidor.unam.mx  Tel  (52) 55 56 22 58 67  Fax (52) 55 56 22 58 68  \n \nSUMMARY  \nSeventy- six E. coli strains were isolated from \nfertile eggs and chicks with yolk sac infection.  These \nstrains were subjected to antimicrobial sensitivity tests. \nAll strains were found to be sensitive to antibiotics like \nAmikacin, aztreonan, cefoxym e, ceftizoxyme and \nimipenem. Nevertheless, nearly 50% of the strains \nwere found to be resistant to ampicillin, \nsulfa/trimethoprim, and ciprofloxacin. Minimum inhibitory concentrations of both gentamicin and  \nkanamycin showed very low levels of resistance.  \n \nRESUMEN  \nSe aislaron 76 cepas de Escherichia coli  a partir \nde muestras de huevo f\u00e9rtil y aves con infecci\u00f3n del \nsaco vitelino. Las cepas obtenidas fueron sometidas a \npruebas de sensiblidad a antimicrobianos. Se encontr\u00f3 \nque todas las cepas fueron sensibles  a antibi\u00f3ticos \ncomo amikacina, aztreonan, cefoxime, ceftizoxime e imipenem, sin embargo en el caso de amicilina, \nsulfa/trimetoprim y ciporfloxacina  se encontr\u00f3 que \ncasi el 50% de las cepas eran resistentes a dichos \nantibi\u00f3ticos.  En el caso de la gentamicina y la \nkanamicina hubo un grado muy bajo de resistencia en \nla prueba de concentraci\u00f3n m\u00ednima inhibitoria.  INTRODUCCI\u00d3N  \nA diferencia de otras bacterias que s\u00f3lo pueden \nproducir un tipo de enfermedad,  E. coli  es    capaz de \nocasionar una gran variedad de padecimientos. En las \naves se le ha relacionado con infecciones respiratorias, \ndermatitis, infecci\u00f3n del saco vitelino y onfalitis (4).  \nEn a\u00f1os recientes, con el objeto de prevenir las \nenfermedades aviares, se ha optado por la administraci\u00f3n  de nivele s subterap\u00e9uticos de agentes \nantimicrobianos a las aves en el alimento y el agua (2).  \nEn el a\u00f1o de 1995 y 1996 se aprobaron la sarafloxacina y la enrofloxacina para uso en animales en los Estados \nUnidos, para su uso en el control de la mortalidad y la \nmorbilidad ocasionada por E. coli (7). A pesar del \noptimismo inicial, la resistencia a las fluoroquinolonas \nentre las bacterias se ha incrementado \nsignificativamente desde su introducci\u00f3n (1).  \nDe igual manera la introducci\u00f3n de cefalosporinas \nde amplio espect ro, tales como cefotaxime, ceftriaxona \ny ceftazidime se ha visto acompa\u00f1ada de la aparici\u00f3n de cepas multiresistentes (5).  \n \nMATERIAL Y M\u00c9TODOS  \nCepas Bacterianas .  Las cepas que se utilizar\u00e1n \nen el presente estudio fueron aisladas a partir de granja  \n  \n215 de repr oductoras, incubadora y pollo de engorda, e \nidentificadas como E. coli.  Para realizar la \ncaracterizaci\u00f3n, las cepas de E. coli  se sembraron \npreviamente en placas de agar sangre y agar  \nMacConkey con lactosa, con el fin de establecer la \npureza de las misma s, despu\u00e9s de lo cual, se incubaron \na 37\u00ba C por 24 horas.  \nPerfil de sensibilidad a antimicrobianos. Las 76 \ncepas aisladas se sometieron a una prueba de \ndeterminaci\u00f3n de la sensibilidad microbiana utilizando \nel sistema VITEK para bacilos gram -negativos \naerobios y/o anaer\u00f3bicos facultativos de crecimiento \nr\u00e1pido. En ella se eval\u00faa la sensibilidad hacia: amikacina, ampicilina, aztroenan, cefazolina, \ncefotaxima, cefoxitina, ceftazidima, ciprofloxacina, \ngentamicina, imipenem, nitrofurantoina, piperaciclina, \nticarcilina/\u00e1cido clavul\u00e1nico, tobramicina, trimetoprim/ \nsulfametoxazol. El sistema se basa en la t\u00e9cnica est\u00e1ndar de microdiluci\u00f3n para CMI. Para su realizaci\u00f3n se siguieron las indicaciones del fabricante.  \nDeterminaci\u00f3n de la concentraci\u00f3n m\u00ednima \ninhibitoria (CMI) en Escherichia coli . En la prueba \nde Concentraci\u00f3n M\u00ednima Inhibitoria (CMI) realizada a \nlas cepas en estudio se utilizaron sales puras de tres \nantibi\u00f3ticos: Gentamicina, Kanamicina y Tetraciclina . \nSe utiliz\u00f3 la t\u00e9cnica en placa, para lo cual se \nprepararon placas de agar Mueller Hinton con \ndiferentes concentraciones de los antibi\u00f3ticos utilizados. En el caso de la gentamicina la \nconcentraci\u00f3n m\u00e1s elevada fue de 100 g/ml a partir de \nla cual se realizaron diluciones d\u00e9cuples seriadas hasta una concentr aci\u00f3n de 1.6 g/ml. En el caso de  los otros \ndos antibi\u00f3ticos la concentraci\u00f3n m\u00e1xima utilizada fue \nde 50 g/ml y la  m\u00ednima de 1.6 g/ml.  \nLas cepas de E. coli  fueron sembradas en caldo \nnutritivo e incubadas 18 horas a 37\u00ba C. Los in\u00f3culos se \najustaron a una concentraci\u00f3n de 0.5 con el nefel\u00f3metro de McFarland, posteriormente se \nsembraron 20 cepas por placa en las diferentes \ndiluciones del antibi\u00f3tico. Las placas se incubaron 24 \nhoras a 37\u00ba C despu\u00e9s de lo cual se procedi\u00f3 al an\u00e1lisis de los resultados obtenidos.  \n \nRESULTADOS  \nPerfil de sensibilidad a antimicrobianos  \nLos resultados de la prueba de sensibilidad a \nantibi\u00f3ticos, se muestran en el Cuadro 1. En el caso de algunos antibi\u00f3ticos todas las cepas resultaron \nsensibles, como en el caso de la amikacina, aztreo nam \ne imipenem. Aunque en algunos antibi\u00f3ticos como \ncefoxitin y gentamicina se encontraron algunas cepas resistentes, la mayor\u00eda eran sensibles. Sin embargo, en \nel caso de algunos antibi\u00f3ticos como la ampicilina, la \ncombinaci\u00f3n sulfa trimetoprim, hubo un porcentaje elevado de resistencia. En el caso de la ciprofloxacina \ntambi\u00e9n  se encontr\u00f3 que las cepas en estudio presentaron un elevado porcentaje de resistencia \n(47%). En el caso de la gentamicina se encontraron 4 \ncepas resistentes.  \nSe encontraron 11 cepas  resistentes a ampicilina, \nciprofloxacina, piperacilina y sulfa/trimetoprim, los \ncuales fueron los antibiotimicrobiamos que presentaron \nel mayor porcentaje de resistencia.  \nDeterminaci\u00f3n de la concentraci\u00f3n m\u00ednima \ninhibitoria (CMI) en Escherichia coli  \nAdem\u00e1 s de la gentamicina, se incluyeron en el \nensayo de CMI kanamicina y tetraciclina, ya que estos \nson dos de los antibi\u00f3ticos m\u00e1s usados en la avicultura.  \nLos resultados de la sensibilidad a la gentamicina \ncoinciden en la prueba automatizada de VITEK y en la  \nprueba de CMI a excepci\u00f3n de una cepa que fue \nresistente en el VITEK y sensible en la prueba de CMI.  \nEn el caso de la kanamicina un gran porcentaje \n(73.6%) de las cepas fue sensible a bajas \nconcentraciones del antibi\u00f3tico a pesar de que se utiliza \ncom\u00fanm ente en la avicultura. Sin embargo, en el caso \nde la tetraciclina 67 cepas (88.1%)  fueron resistentes a \nconcentraciones mayores a 50 g/ ml.  \n \nDISCUSI\u00d3N  \nProbablemente la alta incidencia de cepas \nresistentes a ciprofloxacina es causada por una resistencia cr uzada entre las fluoroquinolonas, ya que a \npesar de que no se use directamente este \nantimicrobiano en aves, la enrofloxacina es \nparcialmente metabolizada en h\u00edgado a ciprofloxacina (Intorre, 1997). El hallazgo de cepas resistentes a \nfluoroquinolonas en gra njas donde no se usaba tales \nquimioterap\u00e9uticos ya hab\u00eda sido reportada \npreviamente, sin embargo, se trataba de quinolonas de \nuso veterinario que posiblemente fueron llevadas de \nuna granja a otra por un inadecuado programa de bioseguridad (3).  \nSe ha observ ado que el uso indiscriminado de \nagentes antimicrobianos en la medicina, ha acelerado la diseminaci\u00f3n de elementos gen\u00e9ticos que codifican para resistencia.  \nEn el caso de Salmonella typhimurium , se \nconsideraba que el principal reservorio de cepas \nmultires istentes eran los bovinos, sin embargo a partir \nde 1993 esta cepa ha sido ampliamente aislada de aves, \ny esto se ha relacionado con un incremento en la aparici\u00f3n de cepas resistentes a ciprofloxacina en \nhumanos  (6).  \nEs importante considerar estos resultad os, ya que \nla resistencia en animales puede tener un gran impacto \nen salud p\u00fablica, debido a que se ha sugerido que \nexiste una relaci\u00f3n entre el uso de antimicrobianos en \nla avicultura y la aparici\u00f3n de pat\u00f3genos con una sensibilidad disminuida o completa resistencia a ciertos \nagentes utilizados para el tratamiento de infecciones en \nhumanos.   \n  \n216 REFERENCIAS  \n1. Everett, M.J., Fang, J.Y., Ricci, V., Piddock, \nL.J.V. Contributions of individual mechanism to \nfluoroquinolones resistance in 36 Escherichia coli \nstrain s isolated from humans and animals. Antimicrob \nAgents Chemother 40:2380 -2386. 1996  \n2. Geornaras, I., Hastings, J.W., Holy, A.V. \nGenotypic analysis of Escherichia coli  strains from \npoultry carcasses and their susceptibilities to \nantimicrobial agents. Appl E nviron Microbiol 67:1940-\n1944. 2001.  \n3. Hofacre, C.L., Cotret, A.R.D., Maurer, J.J., \nGarritty, A., Thayer, S.G. Presence of fluoroquinolone -\nresistant coliforms in poultry litter. Avian Dis 44:963 -\n967. 2000.  \n4.  Mosqueda, T.A. y Lucio, M.B. \nEnfermedades com unes de las aves dom\u00e9sticas. M\u00e9xico: Universidad Nacional Aut\u00f3noma de M\u00e9xico, \n1985.  \n5. Shen, D., Biedenbach, D.J., Winokur, P.L., \nPfaller, M.A., Jones, R.N. Phenotypic and genotypic characterization of Chinese strains of Escherichia coli  \nproducing extended -spectrum lactamase. Diagn \nMicrobiol Infect Dis 34:159- 164. 1999.  \n6. Threlfall, E.J., Cheasty, T., Graham, A., \nRowe, B. High -level resitance to ciprofloxacin in \nEscherichia coli . Lancet 349:403. 1997.  \nWhite, D.G., Piddock, L.J., Maurer, J.J., Zhao, S., \nRicci, V., Thayer, S.G. Characterization of \nfluoroquinolone resistance among veterinary isolates of avian Escherichia coli. Antimicrob Agents Chemother \n44:2897- 2899. 2000.  \n \nCuadro 1.  Sensibilidad a diferentes antibi\u00f3ticos de 76 cepas de E. coli aisladas a p artir de huevo f\u00e9rtil y aves con \ninfecci\u00f3n del saco vitelino utilizando el sistema VITEK.   \n PATRON DE SENSIBILIDAD (no. de cepas)  \nANTIBIOTICO  Sensible  Intermedio  Resistente  \n    \nAMIKACINA  76   \nAMPICILINA  27  49 \nAZTREONAM  76   \nCEFAZOLIN  64 1 11 \nCEFOT AXIME  76   \nCEFOXITIN  74 1 1 \nCEFTAZIDIME  69 2 5 \nCEFTIZOXIME  76   \nCIPROFLOXACINA  40  36 \nGENTAMICINA  71 1 4 \nIMIPENEM  76   \nNITROFURANTOINA  66 2 8 \nPIPERACILINA  33 13 30 \nTICARCILLIN/CA  52 24  \nTOBRAMICINA  75 1  \nTRIMETOPRIM/SULFA  21  55 \n \n \n   \n \n   \n  \n  \n217 EVALUACION COMPARATIVA INVITRO DE DOS \nANTIMICROBIANOS A BASE DE FOSFOMICINA UTILIZANDO LA \nTECNICA DE MIC CONTRA DIVERSAS ESPECIES BACTERIANAS  \n \nIN VITRO COMPARISON OF TWO FOSFOMYCIN-BASED \nANTIMICROBIALS USING THE MINIMUM INHIBITORY CONCENTRATION \n(MIC) TECHNIQUE AGAINST DIFFERENT BACTERIAL SPECIES  \n \nLopez,F., Morales,C., Sosa,A.  \n \nSUMMARY  \nThe effects of pathogenic bacteria like \nEscherichia coli, Haemophilus paragallinarum,  or \nPasteurella haemolytica, in association with \nMycoplasma spp. render birds susceptible of \ndeveloping the symptoms typical of complicated, chronic respiratory complex. Therefore we have been \nlooking for new antibiotic combinations that are more effective against these new challenges faced by the \npoultry industry. The purpose of this study was to  \nevaluate the in vitro  antimicrobial activity of two \ncommercial products, one prepared with fosfomycin, and the other with fosfomycin plus trimethoprim. \nBacteria evaluated were: Salmonella gallinarum, S. typhimurium, S. pullorum, S. enteritidis, Pasteurella \nhaemolytica, Pasteurella multocida, Pseudomonas \naeruginosa, E. coli, and  Staphylococcus aureus.  \n \nRESUMEN  \nLos efectos de pat\u00f3genos bacterianos como \nEscherichia coli, Hemophillus paragallinarum, \nPasteurella hemolitica, asociados con Mycoplasmas \nhacen a las  aves  susceptibles de adquirir los s\u00edntomas \nde la enfermedad del complejo respiratorio cr\u00f3nico \ncomplicado; es por ello que nos hemos dado a la tarea \nde generar nuevas combinaciones de antibi\u00f3ticos \ncapaces de ser m\u00e1s efectivos contra estos nuevos retos de la avicultura.  El objetivo del presente es evaluar la \nactividad microbiana invitro de dos productos \ncomerciales, uno  a base de fosfomicina y otro \ncompuesto de fosfomicina m\u00e1s trimetroprim.    \nLas bacterias evaluadas  fueron: Salmonella \ngallinarum, Salmonella tifimurium, Salmonella \npullorum, Salmonella enteritidis, Pasteurella \nhemolytica, Pasteurella multocida, Pseudomona \naureoginosa, E. coli, y Staphilococcus aureus.  \n \nINTRODUCCI\u00d3N  \nEn los \u00faltimos a\u00f1os se han encontrado en el \ncampo un alto porcentaje de cepas bacterianas \nresistentes contra una amplia gama de antibi\u00f3ticos, \ncausando problemas relacionados con la efectividad de los tratamientos para solucionar problemas infecciosos \nde las aves.       \nEl uso de antibi\u00f3ticos para el control de \nenfermedades en la avicultura moderna es una actividad com\u00fan en las granjas. Tan com\u00fan que las \nbacterias que anteriormente eran eficazmente \ncontroladas se han vuelto altamente resistentes a estos. \nPor esta raz\u00f3n los laboratorios dedican esfuerzos y \nrecursos a la generaci\u00f3n d e nuevas alternativas para el \ncontrol de las patolog\u00edas bacterianas aviares. Al \nescasear las mol\u00e9culas nuevas otra alternativa de los \nlaboratorios ha sido el buscar combinaciones sin\u00e9rgicas \naltamente eficaces; es por ello que en este trabajo hemos realizad o un estudio comparativo para revisar la \neficacia invitro de la fosfomicina en contra de una combinaci\u00f3n de fosfomicina mas trimetroprim con la \nfinalidad de desafiar ambos antibi\u00f3ticos en contra de \nlas principales bacterias pat\u00f3genas de las aves.  \n \nMATERIAL Y M\u00c9TODOS  \nSe realiz\u00f3 la evaluaci\u00f3n en la secci\u00f3n de \nbacteriolog\u00eda del laboratorio de diagnostico de \nInvestigaci\u00f3n Aplicada S.A. de C.V. ubicado en la \nciudad de Tehuac\u00e1n Puebla, utilizando diferentes \nmedios de cultivo para las diferentes especies bacterian as  (1), micro placas de 96 pocillos, pipetas, \npuntas, cultivos estandarizados de las siguientes especies bacterianas: Salmonella tiphimurium, \nSalmonella enteritidis, Salmonella pullorum \nSalmonella gallinarum, Pasteurella haemolytica, \nPasteurella multocida , Pseudomona aureoginosa, E. \ncoli, y Staphilococcus aureus. Dos antibi\u00f3ticos \ncomerciales (uno a base de fosfomicina al 10% y otro a \nbase de fosfomicina al 10% mas trimetroprim al 2.5%).  \nPara la evaluaci\u00f3n se utilizo la t\u00e9cnica de M\u00ednima \nConcentraci\u00f3n Inhib itoria (MIC), iniciando con la \nconcentraci\u00f3n de ambos productos comerciales (10 mg \nen 100 ml de fosfomicina en uno y en el otro 10 mg en 100 ml de fosfomicina mas 2.5 mg en 100 ml de \ntrimetroprim) y a partir de estas se fueron haciendo \ndiluciones dobles ha sta determinar la concentraci\u00f3n \nm\u00ednima inhibitoria, seg\u00fan refiere el m\u00e9todo de Kir  \nVawer modificado.   \n  \n218 RESULTADOS  \nLos valores de MIC despu\u00e9s de las evaluaciones \nen cada una de las especies bacterianas referidas \nresultaron menores para la combinaci\u00f3n de fosf omicina \n- trimetroprim que para la fosfomicina sola seg\u00fan se \nrefiere en la tabla y gr\u00e1fica 1.  \n \nCONCLUSIONES Y DISCUSI\u00d3N  \nLos valores de MIC resultaron menores para la \ncombinaci\u00f3n de fosfomicina m\u00e1s trimetroprim que para \nla fosfomicina sola en la mayor\u00eda de las bacterias \nutilizadas.  \nLa combinaci\u00f3n de fosfomicina mas trimetroprim \nresulto mejor que la fosfomicina sola para inhibir el crecimiento de las bacterias invitro.  \nLa Fosfomicina es un antibi\u00f3tico aislado a partir \nde cepas de Streptomices sp,  cuyo mecanis mo de \nacci\u00f3n act\u00faa mediante el bloqueo de la transferaza que \nincorpora el fosfoenol piruvato del p\u00e9ptido nucle\u00f3tido \nmuramil. Inhibe la formaci\u00f3n de pared bacteriana en su \nprimera etapa, por lo tanto tiene acci\u00f3n bactericida. Si \nsumamos este efecto al del t rimetroprim el cual radica \nen la acci\u00f3n sobre dos pasos de la v\u00eda enzim\u00e1tica para \nla s\u00edntesis del \u00e1cido tetrahidof\u00f3lico, ya que es un potente inhibidor de la enzima dihidrofolato reductasa \ny que posee gran actividad y eficacia terap\u00e9utica en las \nprimeras e tapas de la infecci\u00f3n bacteriana aguda ya que \nen esta etapa se re\u00fanen las siguientes caracter\u00edsticas: \nbacterias con alto nivel metab\u00f3lico, hu\u00e9sped con \nsistema ret\u00edculo endoterial capaz de fagocitar los \nagentes pat\u00f3genos, velocidad para evitar que el proces o inflamatorio produzca barreras que impidan la difusi\u00f3n de los medicamentos, y que el trimetroprim, eficaz aun \nen infecciones cr\u00f3nicas; entonces podemos observar un \nefecto aditivo en ambos antibi\u00f3ticos que potencialisa la \nefectividad en contra de estos pat\u00f3genos.  \n \nREFERENCIAS  \n1. Campbell, T.W.; Coles, EH. Patolog\u00eda \nCl\u00ednica en Aves. In: Diagn\u00f3stico y Patolog\u00eda \nVeterinaria, 4\nth ed. M\u00e9xico, Editorial Interamericana, \n1989, pp 285- 308. \n2. Colusi, A. Resultados sobre el uso de la \nfosfomicina en terap\u00e9utica aviara en i n vivo e in vitro. \n10 Congreso Latinoamericano de Avicultura 1987.  \n3. Colusi, A.D.; Colusi, M. Respuesta \nexperimental in vivo de la fosfomicina frente a \nSalmonella gallinarum. CAPIA Informa 2000, 189: 3-\n7. \n4. Coneman, W. Elmer. Diagnostico \nMicrobiologico, Allen D. Stephen, Dowell B.R., \nSommers M.  Prueba de sucepribilidad a los \nantimicrobianos, Capitulo II Editorial Panamericana. \nPaginas 393  a la 396, a\u00f1o 1989.  \n5. Fern\u00e1ndez, A.; Lara, C; Puyuelo, R.; Ramos, \nJ.J.; Loste, A.; Marca, M.C.; Verde, M.T.  Efficacy of \nphosphomycin in the control of Escherichia coli \ninfection of broiler chickens. Res. Vet. Sci. 1998; 65: \n201-204. \n6. Merchant, I.; Packer, A.  Veterinary \nBacteriology and Virology. Ed. The Iowa State University Press. 7ed. 1967.  \n \nRESULTADOS DE MINIMA CONCENTRACI ON INHIBITORIA Y BACTERICIDA  \nFosfomicina + Trimetroprim y Fosfomicina Sola   \n \n MIC   \nFosfomicina +Trimetroprim  Fosfomicina  \nmcg/ml  Log.  mcg/ml  Log.  \nCEPA      \nSalmonella  typhimurium  0.0000762  1.3 0.00244  1.11 \nSalmonella  enteritidis*  0.00244  1.1 0.00976 1.04 \nSalmonella  gallinarum*  0.0000762  1.3 0.00488  1.08 \nSalmonella  pullorum**  0.00488  1.1 0.00488  1.08 \nPasteurella haemolytica  0.00122  1.2 0.00488  1.08 \nPasteurella multocida  0.00488  1.1 0.6103  0.7 \nPasteurella multocida  0.00122  1.2 0.6103  0.7 \nPseudomona  aureoginosa  1.25 0.6 1.25 0.6 \nEscherichia coli  O35  0.625  0.7 1.25 0.6 \nStaphylococcus aureus***  1.25 0.6 5 0.3 \n \n*INDRE  \n**IPN  \n***ATCC 29737  \nMIC = Concentraci\u00f3n M\u00ednima Inhibitoria                                                                         (Tabla 1)  \n  \n  \n219 THE USE OF FEED ADDITIVES IN BROILER CHICKENS  \nIN THE USA  \n \nUSO DE ADITIVOS ALIMENTICIOS EN POLLO DE ENGORDA EN EE.UU.  \n \nH. D. Chapman  \n \nDepartment of Poultry Science, University of Arkansas, Fayetteville, AR 72701  \n \nRESUMEN  \nEntre 1995 y 2000 el uso de antibi\u00f3ticos en los \nalimentos av\u00edcolas disminuy\u00f3 progresivamente. La \nbacitracina fue el m\u00e1s frecuente en las raciones de \niniciaci\u00f3n y crecimiento mientras que la virginiamicina \nlo fue en las dietas de retiro. En la mayor\u00eda de las \nunidades de  producci\u00f3n se usaron dos antibi\u00f3ticos \ndiferentes por parvada, principalmente bacitracina \nseguida de virginiamicina o bambermicinas, aunque en algunos casos se us\u00f3 un solo antibi\u00f3tico. La inclusi\u00f3n \nde roxarsona no cambi\u00f3 en el per\u00edodo estudiado pero el \nuso de la combinaci\u00f3n ion\u00f3foro -roxarsona -antibi\u00f3tico \ndisminuy\u00f3 y, al mismo tiempo, se increment\u00f3 el uso de \nuna combinaci\u00f3n ion\u00f3foro -roxarsona.  \n \nINTRODUCTION  \nIn recent years there have been major changes in the use of feed additives for growth promotion and di sease \ncontrol in broilers in the USA but these changes have \nnot been documented in the scientific literature.  \nQuantitative documentation of many aspects of poultry \nproduction has provided the poultry industry with \ncomprehensive, accurate, and frequent dat a that can be \nutilized to compare performance of individual broiler production units and thereby improve profitability of poultry production (AGRI STATS, Inc. 5001 U.S. \nHighway 30 West, Suite A, Fort Wayne, IN 46818).  \nThe database developed by AGRI STATS provides \nmonthly information on the usage of feed additives in \nbroiler feeds by more than 95% of broiler production \nunits (poultry plants) throughout the U.S.A.  Furthermore, information is provided on indices of performance such as calorie conversion, % m ortality, \nand the number of days taken to grow a flock to 2.27 Kg.  This database has been used to examine overall trends in the use of feed additives (anticoccidial drugs \nand growth promoters) during the last 5 -6 years \n(Chapman, 2001; Chapman and Johnson,  In Press).  \nThe anticoccidial drugs studied include the ionophores \n(ionophorous antibiotics -  lasalocid, monensin, narasin, \nsalinomycin, and semduramicin) and the synthetic \ndrugs (?chemicals? -  halofuginone, nicarbazin, \nrobenidine, and zoalene).  Growth p romoters include \nthe arsenical drug roxarsone, and the antibiotics \nbacitracin,  bambermycins, lincomycin, tylosin, and virginiamycin.  In this report quantitative trends in the \nuse of growth promoters during the years 1995- 2000 \nare presented.  Types of pro grams employed are \ncorrelated with performance of the birds.  \n \nMETHODS  \nThe methods used to analyze the data have been \ndescribed (Chapman, 2001; Chapman and Johnson, In \nPress).  \n \nRESULTS  \nTrends in drug use . There was a progressive \ndecrease in the overall use of antibiotics (ANT) from \n1995 to 2000 in starter, grower and withdrawal rations.  \nFor example, 95% and 98% of production units used an \nANT in the starter and grower feeds in 1995 but by \n2000 this had decreased to 65% and 67% respectively.  \nOverall ANT use  was similar at different times of year.  \nIn 1995 roxarsone (ROX) was used by 70% and 74% \nof production units in the starter and grower feeds but \nthis did not change thereafter.  There were differences \nin the usage of individual antibiotics.  Thus bacitrac in \nwas most frequently used in the starter and grower feed \nwhereas virginiamycin was used most often in the withdrawal ration.  Bambermycins and lincomycin \nwere mainly used in grower feeds and tylosin was \noccasionally used in withdrawal rations.  Most \nproduction units (69%) used two different ANT \n(mainly bacitracin followed by virginiamycin or \nbambermycins) during a single flock but 22% used just one ANT and 8% three ANT.  (For example bacitracin \nin the starter, bambermycins in the grower and \nvirginiamycin in the withdrawal ration).  Twenty one \ndifferent permutations of ANT were reported during this period!  \nCombinations of different types of drugs, for \nexample an ionophore (ION) for coccidiosis control plus ROX and an ANT in different feeds was also \nreported .  There was a decrease in the use of an \nION+ROX+ANT combination in the starter and \ngrower feeds (from 44% to 32% and 70% to 47% \nrespectively, but an ION plus ROX combination \nshowed an increase in use.  Use of synthetic drugs in combination with ROX+ANT al so decreased.  Most \nproduction units used bacitracin at 55 ppm in the starter  \n  \n220 and grower feeds but there was an increase in the \npercentage of units using a lower concentration (27.5 \nppm) in the grower during the period of the study.  \nROX was mainly used at  50 ppm but some units \nemployed lower concentrations.  \nPerformance. There were no significant \ndifferences in calorie conversion whether an \nION+ROX+ANT, ION+ ROX or ION+ANT was used \nbut the number of days to rear birds to 2.27 Kg was \nsignificantly greater fo r those units using just \nION+ROX.  However, units that employed an \nION+ROX had a significantly lower mortality.  \nCosts of medication . There was a decline in the \ncost of providing an ION+ROX+ANT during the period of investigation.  \n \nDISCUSSION  \nThe results ind icate the extent to which antibiotics \nand roxarsone are still used to promote the growth of \nbroilers in the USA.  The most popular programs \ninvolve the use of bacitracin in the starter and grower, \nand virginiamycin in the withdrawal.  These drugs are \noften  used in combination with roxarsone and an \nanticoccidial (ionophore) drug.  Nevertheless, a significant decrease in the use of antibiotics has \noccurred in broiler feeds (particularly in the withdrawal feed) in recent years.  It is possible that producers \nconsider these drugs not as effective as in the past but a \nprincipal explanation is that producers desire to save \nmoney by reducing the costs of medication.  The cost \nof medication has actually decreased but this has not \nprevented a reduction in antibiotic usage.  It is \ninteresting to speculate whether the decline in drug \nusage has resulted in impaired performance of broiler \nflocks.  Differences in performance were evident in this \nstudy.  Production units that did not use an ANT took \nlonger to rear birds to a specific weight and units that \ndid not use ROX had a higher mortality.  \n \nACKNOWLEDGMENTS  \nI thank M. Donohue and Agri Stats for kindly \ngiving permission to utilize the AGRI STATS \ndatabase.  \n \nREFERENCES  \n1. Chapman, H.D.  Use of anticoccidial drugs \nin broiler ch ickens in the USA: analysis for the years \n1995 to 1999.  Poultry Science 80:572- 580, 2001.  \n2. Chapman, H.D. and Z.B. Johnson.  Use of \nantibiotics and roxarsone in broiler chickens in the USA: analysis for the years 1995- 2000.  Poultry \nScience (In Press).  \n \nINCIDENCE OF PATHOLOGICAL CONDITIONS IN CLINICALLY \nNORMAL BROILERS FROM DIFFERENT REGIONS OF THE USA  \n \nHector M. Cervantes  \n \nPhibro Animal Health, 1031 Westchester Court, Watkinsville, GA 30677- 2171  \n \nData collected during a 13 -month period from \nroutine broile r chicken health surveys from 3 \ngeographical regions of the United States was averaged \nby region and the incidence of pathological conditions compared to determine if significant differences \nexisted between regions.   Region 1 averages included \n3 companies  from the southeastern United States, \nregion 2 averages included 3 companies from the \nnortheastern United States and region 3 included 2 \ncompanies from the western United States.  Abnormal \nconditions or subclinical diseases normally recorded \nduring our broiler chicken health surveys included the \nfollowing:  \n1. Undersized birds, if a bird size is 75% or less \nthan that of its group.  \n2.  Bursa score, the bursa of Fabricius of each \nbird is exposed and measured with a Bursameter.  The \nscores can range from 1 -8 depending on the size of the \nbursa, the larger the bursa, the higher the score.  3. Active IBD, if the bursa of Fabricius of a bird \nis firm and/or turgid and covered with a transparent \ngolden yellow gelatinous exudate.  \n4.  Foot pad lesions (pododermatitis), if a bird has \none or more lesion(s) that has/have ulcerated through the keratinized skin on one or both feet.  \n5.  Oral lesions, typical lesions ranging from \nerosions to necrotizing ulcers are found at the base of \nthe tongue, the roof of the mouth or the cr anial \nesophagus.  Scoring is based on the number and depth \nof the lesions.  Erosions of the epithelium are recorded \nas mild lesions.  Erosions and shallow ulcers are recorded as moderate lesions.  Deep ulcerations filled \nwith necrotic debris in the mouth o r in the esophagus \nextending through the mucosa, muscle layer and serosa \ncreating a perforation are recorded as severe lesions.  \n6.  Tracheitis, this condition is graded according \nto its severity and recorded as mild, moderate or severe.  A trachea having o ne or more of the following \nchanges, serosal or mucosal hyperemia, a few mucosal \npetechia, or clear non -occlusive  intralumenal mucous  \n  \n221 accumulation, would be recorded as mild tracheitis. A \ntrachea having numerous petechiae, echymotic \nhemorrhages, purulent intralumenal mucous, and \nirregular to slight flattening of cartilaginous rings \nwould be recorded as moderate tracheitis.   A trachea \nwith hemorrhagic intralumenal mucous, diphtheritic \nmembranes, a caseous mucous plug, and severe or total collapse of tracheal ring would be recorded as severe \ntracheitis.  \n7.  Dehydration, when the subcutaneous tissue \nand musculature of the breast and thighs have a darker, red to purple color, appears drier and the skin is less \npliable and separates from the musculature with g reater \ndifficulty than normal. Internally the organs and \nvessels are darker in color and urates are seen in the \nureters, kidneys, and often in other organs and joints.  \nThe eyes are often recessed deeper into the orbit and \nthe oral mucous is very sticky.  \n8.  Inflammatory Process (IP), there are different \nstages and severity of this condition but any of the following would be recorded as IP; subcutaneous \nedema with golden to serosanguinous fluid which \nprogresses to form dry plastic -like yellow plaques \nunder the skin located over the hips or under the sides \nor ventral abdomen.  \n9.  Tibial Dyschondroplasia (TD), an excessive or \nirregular shaped cartilaginous core that is observed by slicing off the medial surface of the proximal metaphysis and epiphysis of the t ibia tarsus bone.  \n10.  Ricketts, if a bird has a wider growth plate \nwhen the proximal end of its tibia is examined.  No attempt is made to grade the severity of this \nabnormality.  \n11.  Synovitis, if when the capsule of the tibia \ntarsus and metatarsus or the  femoral -tibia tarsus joint is \nincised exposing the intra -article joint space and an \nexcessive amount of synovial fluid that is \nserosanguinous or purulent is found.\n  \n12.  Femoral head necrosis (FHN), if when \ndisarticulating a bird\u2019s hip the proximal end of  the \nfemur breaks off.  If the cap of the femoral head \nseparates during the disarticulation of the hip and stays \nwith the acetabulum, this is not recorded as an \nabnormality.  \n13.  Sudsy airsacs, if a small amount of tiny \nbubbles are present on the air sacs of a bird.  \n14.  Airsacculitis, this condition is graded \naccording to its severity and recorded as mild, \nmoderate or severe.  If a bird has slight cloudiness and \nvascularization of its air sacs and the presence of small \namounts of fluid or yellowish exudate  on its airsacs, it \nwould be recorded as a mild airsacculitis. If a bird\u2019s \nairsacs are thickened and larger amounts of fluid or \nyellowish exudate are on them, it would be recorded as \nmoderate airsacculitis.  If a bird\u2019s airsacs are very \nthickened and conta in even larger accumulations of exudate, and/or if large accumulations of caseous \nmaterial are found in its body cavity, it would be \nrecorded as severe airsacculitis.  \n15.  Colisepticemia, if the examination of the \ninternal organs of a bird reveals the pres ence of a \ndiffuse fibrino -purulent exudate around the heart \n(pericarditis), and/or the liver (perihepatitis), and/or  \npolyserositis.  \n16.  Ascitis, if the examination of the internal \ncavity of a bird reveals the presence of excessive amounts of a serogelati nous or serosanguinous fluid \nand/or hepatomegaly and cardiomegaly.  \n17.  Retained yolk sac, when the yolk sac remains \nattached to the jejunum in birds 7 days old or older.  \n18.  Proventriculitis, if the size of the \nproventriculus is at least one half the siz e of the gizzard \nand when examination of its internal surface reveals a \nloss of the normal architecture of the secretory duct \npapillae with or without hemorrhaging and thickening  or thinning of the cross -section of the proventricular \nwall. No attempt is m ade to differentiate between \nproventriculitis and proventriculosis or any other proventriculopathy.  \n19.  Litter eater, when a bird\u2019s gizzard is incised \nand 50% or more of its contents consist of litter.  \n20.  Gizzard erosion, if an ulcer is found on the \nlining of the ventriculus.  A mild score is given if one \nor more erosions are seen in the kaolin layer of the ventriculus giving the lining a rough appearance.  A \nmoderate score is given if the ulceration goes through \nthe kaolin layer and exposes the underlyi ng muscle.  A \nsevere score is given if the ulcer extends through the \nkaolin layer and erodes into the underlying muscle.  \n21.  Coccidiosis, when a bird\u2019s intestinal tract is \nexamined externally and internally for the presence of \ngross coccidial lesions and  one or more lesions of one \nor more species of Eimeria  parasites are found, the \nlesions are recorded individually and the bird is \ncounted as positive for coccidiosis.  Typical gross \ncoccidial lesions consist of uneven villus thickening or \natrophy with white/tan spots or streaks in the duodenum, petechia, villus atrophy, thinning of the \nintestine, uneven mucosal surface in the jejunum or a \nrange of changes in the ceca consisting of slight \nmucosal thickening, hyperemia and thin watery contents to severe thick ening and contraction with \nfrank hemorrhage and bloody caseous cores.  \n22.  Enteritis, when the internal contents of a \nbird\u2019s intestinal tract are examined and evidence of \nenteritis is found, regardless of the type. This condition \nis graded according to its  severity as mild, moderate or \nsevere.   \n23.  Intestinal debris, when the internal contents \nof a bird\u2019s intestinal tract are examined and large amounts of a dry orangey mucous is found.   \n  \n222 24.  Worms, when the internal contents of a bird\u2019s \nintestinal tract ar e examined and tapeworms or round \nworms are encountered, the type of worm found is \nrecorded individually and the bird is counted as \npositive for worms.  \n25.  Feed passage, when excessive amounts of \nfeed particles are found at the distal end of a bird\u2019s ileum, this finding is recorded under this category.  No \nattempt is made to categorize this finding as malabsorption and/or maldigestion.  \n26.  Others, this category is used to include \nconditions not previously described but that may be \nprevalent at a particul ar location.  \n \nTable 1.  The table shown below summarizes our necropsy findings by region:  \nPathological condition(s)  \n      Region 1   Region 2   Region 3  \nAverage bird age (days)   30.30   33.96   28.57  \nUndersized     2.50   1.67   1.11 \nActive IBD     0.25   0   0 \nFoot pad lesions    38.38   34.55   6.31     \nOral lesions     36   8.15   9.13 \nTracheitis      6.51   2.95   2.17 \nDehydrated     0   0   0 \nIP      0.48   0.52   0 \nTD      6.01   3.23   3.85 \nRickets      0   0   0 \nSynovitis      0.55   0   0.85 \nFHN       0.42   0   0.85 \nSudsy air sacs     2.88   4.51   3.80 \nAirsacculitis     7.19   12.32   1.55 \nColisepticemia     0.55   1.18   1.30 \nAscitis      1.88   1.57   1.96 \nRetained yolk sac    12.55   11.83   11.66  \nProventriculitis     5.52   9.70   3.83 \nLitter eater     1.80   1.55   2.43 \nGizzard erosion     11.54   20.81   10.96  \nCoccidiosis     30.05   25.44   21.29  \nEnteritis      18.87   27.41   18.42  \nIntestinal debris     4.74   6.25   12.56  \nRoundworms     0   0   0 \nTapeworms     3.43   0   0 \nFeed passage     4.93   2.51   9.15 \nBursa scores     4.06   4.15   4.44 \n \nSignificant observations made from the data \ncollected and reported here, can be summarized as \nfollows:  \n1.  The incidence of undersized, active IBD, \nsynovitis, femoral head necrosis, sudsy air sacs, \ncolisepticemia, ascitis, retained yolk sacs, litter eaters, \nand bursa scores, was approximately within 1% from each other for all regions.  \n2.  No birds with signs of dehydration, rickets or \nroundworms were found from any region.  \n3.  The incidence of footpad lesions \n(pododermatitis) was noticeab ly higher in birds from \nthe southeastern and northeastern regions.  No particular reason for this difference is apparent.  \n4.  The incidence of oral lesions was similar in \nbirds from the northeastern and western regions but much higher in birds from the southeastern region.  Source of cereal grains used in feed formulation, cereal \nand feed storage conditions and differences in \ngeographical environmental conditions may be at least \npartly responsible for the variation found between regions.  \n5.  The incidence o f tracheitis was similar in birds \nfrom the northeastern and western regions but more \nthan double in birds from the southeastern region.  No \nparticular difference for this difference was apparent.  \n6.   The incidence of TD was similar in birds from \nthe northeastern and western regions but nearly twice as high in birds from the southeastern region.  No \nparticular difference for this difference was apparent.  \n7.  The incidence of airsacculitis was highest in \nbirds from the northeastern region, intermediate in  \n  \n223 birds from the southeastern region and lowest in birds \nfrom the western region.  \n8.  The incidence of proventriculitis was highest \nin birds from the northeastern region, intermediate in \nbirds from the southeastern region and lowest in birds \nfrom the western r egion.  \n9.  The incidence of gizzard erosions was similar \nin birds from the southeastern and western region and nearly twice as high in birds from the northeastern \nregion.  \n10.  The incidence of coccidiosis was highest in \nbirds from the southeastern region, intermediate in \nbirds from the northeastern region and lowest in birds from the western region.  \n11.  The incidence of enteritis was similar in birds \nfrom the southeastern and western regions and higher in birds from the northeastern region.  12.  The Incide nce of intestinal debris was highest \nin birds from the western region, intermediate in birds from the northeastern region and lowest in birds from \nthe southeastern region.  \n13.   Tapeworms were found only in birds from \nthe southeastern region.  \n14.  The west ern region had the highest incidence \nof birds with signs suggestive of maldigestion and/or \nmalabsorption, the incidence in birds from the \nsoutheastern region was intermediate and in birds from \nthe northeastern region was lowest.  \n \nACKNOWLEDGEMENTS  \nThe author wishes to recognize the assistance of \nDr. Brett Hopkins with the description of the necropsy \nlesions.\n \nDIAGNOSTIC PATHOLOGY AND ULTRASTRUCTURE OF  \nAVIAN DISEASES  \n \nFerenc Ratz1, Ma. Teresa Casaubon2,  Tamas Fehervari2, Jos\u00e9 A. Quintana2 \n \n1Department of H istopathology and Electonmicroscopy, Central Veterinary Institute. 1149 Budapest XIV  \nT\u00e1bornok u. 2 Hungary \n2Department of Animal Production: Poultry, Faculty of Veterinary Medicine and Zootechnique, National \nAutonomous University of Mexico, Av Universidad  3000 Mexico City, Mexico 04510  \n \nSUMMARY  \nThe use of electron microscope in diagnostic \npathology is discussed. The negative staining method versus positive block method are compared and the \nadvantage of the use of light microscopic examination guided elect ron microscopic survey is also \ndemonstrated in case of some important virus diseases as reticuloendotheliosis, EDS76, infectious \nlaryngotracheitis, inclusion body hepatitis.  \nThe electron microscope (EM) was invented by \nthe German researchers E. Ruska and M. Knoll in 1931 \nbut its use in biological research began only twenty \nyears later. However, further ten years were needed to \nlay down the ultra structure of the animal and plant \ntissues and cells. The knowledge of normal ultra \nstructure opened the gate for  the study of pathological \nchanges occurred inside the cell giving opportunity for the interpretation of infection procedure in molecular \nlevel.  \nThe EM can be used not only in research but as a \ntool for diagnostic purpose. In this case efficacy and \npromptn ess are very important factors to provide \ndiagnosis as soon as possible. These properties however are not always typical for the electron microscopic study because the preparation, selection of \nright part of the sample usually requires a quite long \nperiod.  To reduce the preparation time and to get higher efficacy samples have to be fixed with a reagent \nsuitable for both, light and electron microscopic study \nand lesions should be selected first in histological \nslides (\u201cselection\u201d) and evaluate through light \nmicroscope (\u201cguidance\u201d). The method is known as \nlight microscopic (LM) examination guided electron \nmicroscopic survey. It makes possible that only those parts of the damaged tissue section or cell will be \nsubmitted for EM study where previous LM \nexaminatio n suggests the presence of ultra structural \nlesion or viruses, bacteria. In technical term, \nelectrically slightly frozen then cut, stained and \nevaluated tissue sample is laid down again on the original sample where the histological cut came from \nand for el ectron microscopic study only the desired \npart is selected under stereo microscope.  \nTissue samples can be studied in ultra thin slides \ncalled positive staining (block) method or in \nsuspension called negative staining method. The last one gives the possibi lity to analyze the form, \nmorphology and structure of bacteria, viruses or fungi. Cells of tissue culture and bacteria obtained from cultures can be excellently studied by the sedimentative \ncentrifugation followed by fixation and embedding in \nagar because the jellified agar allows handling samples like any conventional histological preparation.   \n  \n224 In a diagnostic work, the EM is used mainly for \ntwo purposes:  \n1. Demonstration of presence or absence of \ninfectious agent,  \n2. Determination of the structure and analysis of \ninclusion bodies (IB).  \nThe first purpose can be reached by using either \nnegative staining or block methods. Both of them \nrequires a relatively high (minimum 10 6) virus \nconcentration in the sample. Since in case of natural \ninfections, high virus  concentration cannot be often \nfound in the organs the method should be more \nefficient if it is combined with virus isolation either in \nchicken embryo or in cell culture where virus \nconcentration often exceeds 10 6.  \nNegative staining method is the most com mon to \ndetect any avian virus. In case of negative staining, \nvirus or other microorganism, mainly originated from \nculture samples, is sedimentated by centrifugation and the sediment (pellet) is used for EM analysis. The \nimmune electron microscopic preparat ion is also a \nuseful method when pellet is mixed with specific \nhyperimmune serum then analyzed by EM. This \nmethod is often used to detect adeno viruses, e.g. \nEDS\u201976 virus. The block method requires cells from \norgan tissue or from cell culture and cell degeneration, virus replication can be found in infected cells. The \nblock method is used to detect retroviruses, amongst \nothers REV.  \nThe study of inclusion bodies by EM is a very \nimportant method for determining if IB is related to \nvirus infection or not. In this case only one or two cells are investigated therefore the use of LM examination \nguided EM survey is recommended. This method is \napplied in case of infectious laryngotracheitis, \ninclusion body hepatitis and avian pox infection.  \n \nANALISIS DE LA SITUACI \u00d3N DE LA AVICULTURA MEXICANA Y \nNORTEAMERICANA PRODUCTORA DE CARNE DE AVE EN EL \nPERIODO 1990 -1999  \n \nANALYSIS OF THE MEXICAN AND THE US BROILER INDUSTRIES: 1990-1999  \n \nTrueta S.R, Alonso P.F. Y Garc\u00eda B.G.  \n \nDepartamento de Administraci\u00f3n y Econom\u00eda. Facultad d e medicina Veterinaria y Zootecnia. Universidad Nacional \nAut\u00f3noma de M\u00e9xico. Ciudad Universitaria, Coyoac\u00e1n. C.P. 04510, M\u00e9xico, D.F. Tel\u00e9fono 56 -22-59-05.  \nFax 56 -22-59-05. \n \nSUMMARY  \nThis paper analyses some discrepancies between \nthe Mexican and the US po ultry industries between \n1990 and 1999. In 1998 broiler meat production in the US was equivalent to 7.93 times that of Mexico. In \n1990 per -kilo production cost for Mexican integrations \nwas 27% higher than that in the US. US per - capita  \nconsumption was 2.01 times that of Mexico. It is \nconcluded that the decision of entering NAFTA in the \npoultry sector was wrong, and nothing has been done \nto alleviate the problems caused by these disparities.  \n \nRESUMEN  \nEl trabajo analiz\u00f3 algunas asimetr\u00edas entre la \navicultura mexicana y norteamericana en 1990 y 1999.  \nEn 1998 la producci\u00f3n de carne de pollo en EUA fue 7.93 veces mayor a la mexicana.  En 1990 el costo de \nproducci\u00f3n de un Kg de carne de pollo para avicultores \nintegrados nacionales fue 27% superior a los estadouni denses.   El consumo de carne de pollo per \nc\u00e1pita en EUA fue 2.01 veces m\u00e1s que en M\u00e9xico.   Se concluye que la decisi\u00f3n de entrar al TLCAN en avicultura fue inadecuada y no se ha hecho nada por paliar los problemas por asimetr\u00edas.  \n \nINTRODUCCI\u00d3N  \nLa desregu laci\u00f3n y privatizaci\u00f3n, la competencia \ninternacional y la apertura comercial, han sido algunos \nfactores significativos de la pol\u00edtica econ\u00f3mica \nmexicana que han obligado a la reestructuraci\u00f3n del aparato productivo nacional, incluyendo al av\u00edcola. En \ncuant o a la pol\u00edtica agropecuaria nacional se han hecho \nimportantes esfuerzos para dejar de apoyar a los \nconsumidores v\u00eda precios de mercado, eliminando \nprecios oficiales tope de la mayor\u00eda de bienes de la \ncanasta b\u00e1sica, incluyendo al huevo; y por el lado del productor, eliminando subsidios a insumos estrat\u00e9gicos \ncomo el sorgo.  \nPor otro lado, el comercio av\u00edcola mundial ha \nsufrido modificaciones sustanciales tanto en su \ncompetitividad como en sus valores agregados que han \nimpactado en los procesos productivos de las \neconom\u00edas agr\u00edcolas, donde las relaciones  del sector \npecuario con el sector industrial y de servicios son cada  \n  \n225 vez m\u00e1s intensas a trav\u00e9s de integraciones horizontales \ny verticales, colocando a nivel de anaquel productos \nav\u00edcolas con alto valor agregado. Este alto valor \nagregado exige, entre otros aspectos, alta calidad \nhigi\u00e9nica, siendo esto un reto  para pa\u00edses emergentes \ncomo M\u00e9xico que se resolver\u00e1 estableciendo normas \nsanitarias.  \nLa avicultura nacional productora de carne de \npollo es la activida d del subsector pecuario que \npresenta una mayor expansi\u00f3n productiva, ya que de 1990 a 1999 la Tasa Media de Crecimiento Anual fue \nde 9.7%. Los ciclos cortos de producci\u00f3n, el \naprovechamiento de la infraestructura productiva av\u00edcola ociosa, la conformaci\u00f3n  de grandes consorcios \nav\u00edcolas en donde no ten\u00edan presencia y un aumento de \ndemanda por carnes blancas, fueron algunos de los \nfactores que permitieron esa T.M.C.A tan alta.  \nLa avicultura estadounidense , la m\u00e1s poderosa \ndel mundo, productora de carne de pollo; produjo en 1998 la cantidad de 12.7 millones de ton., es decir, el \n28% de la producci\u00f3n mundial. Asimismo, y a ra\u00edz de \nla firma del Tratado de Libre comercio de Am\u00e9rica del \nNorte (T.L.C.A.N.) con Estados Unidos de Am\u00e9rica \n(E.U.A.), la avicultura mexi cana ( permeada de capital \nfor\u00e1neo) enfrenta retos muy fuertes en el \u00e1mbito de \ncomercio internacional con los Estados Unidos de \nAm\u00e9rica, entre algunos de estos retos est\u00e1n: la \ndiferencia a favor de los estadounidenses en la provisi\u00f3n y calidad de los recur sos naturales, humanos, \nde capital y financieros; mayores rendimientos de granos forrajeros que los obtenidos en M\u00e9xico con \u00edndices pluviom\u00e9tricos menores y los cuantiosos \napoyos directos e indirectos que reciben los avicultores \nestadounidenses que les per miten vender m\u00e1s barato  \nAsimismo, y en el marco internacional, el \ngobierno norteamericano considera que las \nnegociaciones en el comercio internacional agropecuario son m\u00e1s importantes al interior de la \nOrganizaci\u00f3n Mundial de Comercio (O.M.C.) que en el \nT.L.C.A.N. Adem\u00e1s, la pol\u00edtica de comercio  exterior \nde E.U.A.  funciona subordinada a la pol\u00edtica \nagropecuaria interna y esta \u00faltima a partir de pol\u00edticas \nde largo plazo. Por otro lado, la producci\u00f3n de carne de \npollo en U.S.A y en M\u00e9xico, se llevan a cabo en \ncondiciones t\u00e9cnicas, econ\u00f3micas, sociales, pol\u00edticas y jur\u00eddicas diferentes; configurando fuertes asimetr\u00edas \nentre ambas.  \nAnte este panorama general, se analizan algunos \naspectos productivos -econ\u00f3micos de la aviculturas \nmexicana y norteamericana productoras de carne de \nave en el periodo1990- 1999.  \n  \nMATERIAL Y M\u00c9TODOS  \nSe obtuvo informaci\u00f3n de fuentes secundarias, \nlibros, revistas, y anuarios estad\u00edsticos. Parte de la \ninformaci\u00f3n se proces\u00f3 mediante la f\u00f3rmula:  Donde T.M.C.A es la Tasa Media de Crecimient o \nAnual, V.F es el valor final, V.I. el valor inicial y n el \nn\u00famero de a\u00f1os en estudio.  \n                                                                                                      \n                                                                                                     \n               1/n  \nT.M.C.A =  n  VF     -1 * 100     \u00f3    T.M.C.A =   VF       - 1 * 100 \n             VI                                                  VI  \n \nDESARROLLO  \nEn 1993 la producci\u00f3n mundial de carne de pollo \nfue de 28.4 millones de ton., en ese mismo a\u00f1o los \nEstados Unidos de Am\u00e9rica produjeron 9.9 millones de \nton., es decir, el 34.85% del total mundial; mientras que M\u00e9xico produjo en ese a\u00f1o 1.04 millones de ton., \nel 3.66% de la oferta mundial. Visto desde ot ra \nperspectiva, la producci\u00f3n de carne de pollo  de \nM\u00e9xico fue del 10.10% con respecto a la producci\u00f3n de \nlo Estados Unidos.  \nEn 1993 la producci\u00f3n de carne de pollo de \nEstados Unidos fue  de 9.52 veces superior a la \nproducci\u00f3n nacional.  \nPara 1998 la produc ci\u00f3n mundial de carne de ave \nse ubic\u00f3 en 37.7 millones de ton., en ese mismo a\u00f1o, Estados Unidos pridujo12.7 millones de ton. de la \noferta mundial de carne (un tercio de las existencias mundiales), para ese a\u00f1o, M\u00e9xico produjo 1.6 millones de ton., aportan do el 4.24% de las disponibilidades \nmundiales. En ese a\u00f1o (1998) la producci\u00f3n \nestadounidense fue 7.93 veces mayor a la mexicana, \nacort\u00e1ndose la diferencia con respecto a 1993.  \nDe 1988 a1998 la T.M.C.A de la producci\u00f3n de \ncarne de ave en los Estados Unidos  fue del 3.27%, en \nM\u00e9xico, en ese mismo periodo fue de 7.07%, esto \nexplica la reducci\u00f3n en el n\u00famero de veces superior en \nel volumen de producci\u00f3n de carne de pollo de Estados \nUnidos en relaci\u00f3n con M\u00e9xico. Adem\u00e1s, la dif\u00edcil \nsituaci\u00f3n vivida por M\u00e9xico du rante la d\u00e9cada de los \n80\u2019s y 90\u2019s determinaron que los consumidores \nmodificaran en cierta medida su consumo a favor de \ncarne de pollo sacrificando sobre todo, el consumo de \ncarne de cerdo y res.  \nEn 1999 el 93.4% de las empresa av\u00edcolas \nnorteamericanas co ntaban con plantas de \nprocesamiento adicional (tercera fase de producci\u00f3n \nque aporta un mayor valor agregado) en tanto que en \nM\u00e9xico solo tres empresas contaban con ese proceso \nrepresentando un porcentaje muy bajo.  \nEsta diferencia no es evidencia de una menor \ncompetitividad de los productores nacionales, son de un patr\u00f3n de demanda radicalmente diferente; mientras \nen Estados Unidos la demanda de productos con \nprocesamiento adicional (\u201c nuggets\u201d, budines de pollo, \npechuga rellenas de jam\u00f3n y queso, alimentos  \npreparados, etc.) ha crecido vertiginosamente; en \nM\u00e9xico, aunque en los \u00faltimos a\u00f1os se ha  \n  \n226 incrementado notablemente el consumo de estos \nproductos av\u00edcolas con un importante valor agregado, \nel 60% de la producci\u00f3n de pollo se comercializ\u00f3 en la \npresentaci \u00f3n de procesado en mercado p\u00fablico (42% \npresentaci\u00f3n pollo vivo y 18% presentaci\u00f3n mercado \np\u00fablico) y solamente el 9% presentaci\u00f3n \nsupermercado.  \nLa capacidad total de sacrificio de pollo en \nM\u00e9xico en 1998 fue de 881.1 millones de aves; en \nEstados Unidos la  capacidad total comparable fue de \n8,641.6 millones de pollos, es decir, 9.8 veces la \nnacional.  \nEn el periodo de 1990- 1999 el uso de la \ncapacidad instalada en M\u00e9xico fue de 91.5% en promedio. En Estados Unidos este indicador se situ\u00f3 en \n1999 en 96%. Este c omportamiento se explic\u00f3 \nfundamentalmente por el aumento de la demanda en \nesta actividad tanto en M\u00e9xico como en Estados \nUnidos.  \n En 1990 la capacidad instalada (productiva) \nociosa de Estados Unidos represent\u00f3 m\u00e1s de la mitad \nde la capacidad total instalad a en M\u00e9xico.  \nEn 1990 el costo de producci\u00f3n de un kg. de \ncarne de pollo en M\u00e9xico, para productores que \nfabrican su alimento, fue 27% superior  al \ncorrespondiente a los Estados Unidos. Para el caso de \nproductores nacionales  con compra de alimento \nbalanceado en el mercado, el diferencial fue del 37%. El diferencial fundamental se debe a los costos de \nalimentaci\u00f3n.  \nEl consumo de carne de pollo por habitante en los \nEstados Unidos en 1990 fue 2.5 veces superior al de \nM\u00e9xico en 1990 el consumo en Estados Unidos fue de \n30 kg. por persona, en M\u00e9xico de 12 kg. por habitante. \nEn 1998 la diferencia disminuy\u00f3 a 2.01 veces el \nConsumo Nacional Aparente de carne de ave en \nEstados Unidos fue de 38.1 kg. por persona, en M\u00e9xico de 18.92 kg. en ambos pa\u00edses se registr\u00f3 una tendencia \ncreciente en el periodo de 1990- 1998 ya que la \nT.M.C.A en Estados Unidos  fue (3.03%) y en M\u00e9xico \nde (5.85%) de ah\u00ed se explica que el n\u00famero de veces se haya reducido de 2.5 a2.01. El dinamismo en el \nconsumo de carne de pollo tanto en Estados Uni dos \ncomo en M\u00e9xico se explica por el cambio en las \npreferencias de lo consumidores, los cuales, vienen sustituyendo carne roja por blanca. Adem\u00e1s por el \nincremento en la participaci\u00f3n de carne de pollo en los \nmercados de alimentos preparados \u201cfast food\u201d y por la \ndisminuci\u00f3n en el precio relativo del pollo, como \nresultado de un incremento en la eficiencia productiva \ndel sector y por la crisis econ\u00f3mica.  \nEn cuanto al \u00edndice de conversi\u00f3n, se observ\u00f3 que \nen M\u00e9xico se requiri\u00f3 en 1999 de 2.2 kg. de alimento para producir 1 kg. de carne de ave, esto en las \nempresas integradas, mientras que en Estados Unidos se requirieron solamente de 2.0 kg., es decir, se utiliz\u00f3 \nen M\u00e9xico un 1.0% m\u00e1s de alimento y un 20% m\u00e1s \npara los productores no integrados. Otro indicador \nt\u00e9cnico relativo a productividad es el n\u00famero de ciclos \nproductivos por a\u00f1o. Mientras que en M\u00e9xico la \nproducci\u00f3n de pollo tuvo como promedio en 1998 5 \nciclos, en Estados Unidos el n\u00famero de ciclos por a\u00f1o \nfue de 6.4 .  \n \nCONCLUSIONES  \nAnte las fuertes asimetr\u00ed as entre las dos \naviculturas con grandes ventajas comparativas \nestadounidenses es necesario que la avicultura nacional \nse esfuerce para elevar su nivel de productividad, hacer \nmucho m\u00e1s eficientes sus canales de distribuci\u00f3n ,  \ncumplir con est\u00e1ndares ambientales, mejorar la \norganizaci\u00f3n interna de la actividad, lo que exigir\u00e1 de \nfuertes inversiones, que hasta ahora se han frenado por \nescasos y selectivos recursos   financieros y adem\u00e1s a \nun alto costo y un amplio margen de intermediaci\u00f3n \nfinanciera. Por otr a parte, el Estado mexicano debe \nadoptar una pol\u00edtica que impulse la competitividad \nav\u00edcola. As\u00ed mismo, manejarse con una visi\u00f3n en \ncadena, donde las  interrelaciones entre sector primario, \nsecundario y terciario no solamente se den entre los \ngrandes conso rcios av\u00edcolas, adem\u00e1s con la \norganizaci\u00f3n de peque\u00f1os y medianos avicultores.  \nLa decisi\u00f3n de entrar e avicultura al T.L.C.A.N. \nfue inadecuada y no se ha hecho nada para paliar los \nproblemas que representan las asimetr\u00edas.  \n \nREFERENCIAS  \n1. Alonso, P.F. La avic ultura en M\u00e9xico 1975 -\n1998. Centro Mexicano de Estudios Sociales \u2013 Debate-  \nPropuesta A.C. 2000.  \n2. Estudio de la Posici\u00f3n del Sector Av\u00edcola \npara la Negociaci\u00f3n del Acuerdo de Libre Comercio \nM\u00e9xico \u2013 Estados Unidos. Grupo de Economistas y \nAsociados. Uni\u00f3n Naci onal de Avicultores. 1991.  \n3. Situaci\u00f3n Actual y Perspectivas de la \nProducci\u00f3n de Carnes en M\u00e9xico 1990 \u20132000. Centro \nde Estad\u00edstica Agropecuaria. Secretar\u00eda de Agricultura, \nGanader\u00eda, Desarrollo Rural, Pesca y Alimentaci\u00f3n. \n2001.  \n4. Situaci\u00f3n Actual y Perspectivas de la \nProducci\u00f3n de Pollo En M\u00e9xico 2000. Centro de Estad\u00edstica Agropecuaria. Secretar\u00eda de Agricultura, \nGanader\u00eda, Desarrollo Rural, Pesca y Alimentaci\u00f3n. \n2001.  \n   \n  \n227 EL COMPORTAMIENTO DE LAS IMPORTACIONES DE CARNE \nDE POLLO EN EL PERIODO 1994 -1999 EN EL MARCO  \nDEL TLCAN  \n \nBROILER MEAT IMPORTS WITHIN THE NORTH AMERICAN FREE TRADE \nAGREEMENT (NAFTA): 1994 -1999  \n \nAlonso, P.F.; Garc\u00eda, B.G.  \n \nDepartamento de Administraci\u00f3n y Econom\u00eda. Facultad de Medicina Veterinaria y Zootecnia.  Universidad Nacional \nAut\u00f3nom a de M\u00e9xico.  Ciudad Universitaria, Coyoac\u00e1n.  C.P. 04510, M\u00e9xico, D.F.  Tel. 56 22 59 36.  \nFax 56 22 59 37  \n \nSUMMARY  \nThis paper analyses the behavior of broiler meat \nimports to Mexico during the 1994- 1999 period, within \nthe NAFTA framework. Results indica te that \ngrandparent stock imports showed a yearly mean \ngrowth rate ( TMCA ) of 3.5%. Broilers grew 9.52%. \nMeat imports grew at a 10.79% TMCA . From 1994 to \n1999 broiler/turkey meat paste imports grew at a 17.12% TMCA . Salty meat and cuts grew 5.82% during \nthe period. It is discussed that high paste import rates \nhave affected the Mexican swine industry.  \n \nRESUMEN  \nEl trabajo estudi\u00f3 el comportamiento de las \nimportaciones de carne de ave en M\u00e9xico durante \n1994- 1999 en el marco del TLCAN.  Los resultados \nindican que durante el periodo las importaciones para aves progenitoras fueron a una TMCA del 3.5%; en \naves de abasto 9.52%.  Las importaciones de carne \ncrecieron a una TMCA del 10.79%.   De 1994 a 1999 \nlas importaciones de pasta de carne de pollo y pavo \ncrecieron a una TMCA del 17.12%.  Los trozos y carne \nsalados crecieron en el periodo en 5.82%.  Se discute \nque las altas importaciones de pastas han afectado a la \nporcicultura nacional.  \n \nINTRODUCCI\u00d3N  \nDe 1994 a 1999, la avicultura productora de carne \nfue la actividad de la ganader\u00eda que expendio en mayor \nmedida su oferta.   Los ciclos cortos de producci\u00f3n, el \naprovechamiento de la infraestructura productiva ociosa y la conformaci\u00f3n de grandes consorcios \nav\u00edcolas que se expandieron hacia entidades en donde \nno ten\u00edan pre sencia, han sido algunos de los factores \nque permitieron que la producci\u00f3n de carne de pollo \ncreciera en un 53.77% en el periodo antes referido, \npasando de 1.1 millones de ton a 1.7 millones de ton, expresando una Tasa Media de Crecimiento Anual \n(TMCA) de 8.98%.  Este fuerte crecimiento productivo \nse canalizo pr\u00e1cticamente hacia el mercado interno.  A ra\u00edz de la firma del Tratado de Libre Comercio \nde Am\u00e9rica del Norte (TLCAN) con Estados Unidos de \nAm\u00e9rica (EUA), la avicultura nacional, permeada de \ncapital fo r\u00e1neo, enfrenta retos fuertes como establecer \nuna relaci\u00f3n comercial diferente con el pa\u00eds (EUA) m\u00e1s poderoso en avicultura de carne siendo que su \nproductividad es m\u00e1s alta que la productividad av\u00edcola mexicana.  Asimismo la avicultura norteamericana \nprese nta otras ventajas como son: diferencial a favor de \nellos en provisi\u00f3n y calidad de recursos naturales, \nhumanos y de capital, \u00edndices pluviom\u00e9tricos que en \namplias regiones estadounidenses son del 100%, \napoyos directos e indirectos que reciben los aviculto res \nestadounidenses, as\u00ed como integraciones verticales y \nhorizontales hacia las cadenas de abastecimiento de \ninsumos y en la comercializaci\u00f3n con alto valor \nagregado de la mercanc\u00eda a nivel de detalle.  \n La desaparici\u00f3n de cuotas y aranceles en enero \nde 200 3, adem\u00e1s de fortalecer la ya ancestral balanza \ncomercial deficitaria av\u00edcola, es probable que acelere \nlas acumulaciones y concentraciones de capital en la \nrama av\u00edcola reproduci\u00e9ndolo y ampli\u00e1ndolo.  \n Ante este planteamiento se estudiara el \ncomportamiento de las importaciones de carne de ave \nhechas por M\u00e9xico en el periodo 1994 \u2013  1999 en el \nmarco del TLCAN.  \n \nMATERIAL Y METODOS  \nSe obtuvo informaci\u00f3n de fuentes secundarias de \nlibros, revistas y anuarios estad\u00edsticos.  Parte de la \ninformaci\u00f3n obtenida se proce so mediante la f\u00f3rmula:  \nDonde TMCA es la Tasa Media de Crecimiento \nAnual, VF es el Valor Final, VI el Valor Inicial y n \nn\u00famero de a\u00f1os de estudio.  \n \nDESARROLLO  \nLas compras de aves en el mercado internacional \ndurante 1999, y con respecto a 1998, mostraron una baja importante, es as\u00ed que con referencia a aves para \nabasto directo o previa engorda, las importaciones \nbajaron de 6.7 a 2.4 millones de aves, es decir una  \n  \n228 disminuci\u00f3n del 64.17%.  Con referencia a las \nimportaciones de pie de cr\u00eda (progenitoras), el v olumen \nse desplomo de las 778 mil cabezas en 1998 a 555 mil \ncabezas en 1999 en s\u00ed una baja del 29%.  Estas \ndisminuciones en las importaciones se explica por una \ncontracci\u00f3n del mercado nacional, al haberse eliminado \no disminuido el efecto negativo de algun as \nenfermedades, como la Leucosis aviar, que afecta la \nproductividad interna y obviamente la producci\u00f3n \ninterna.  \nCabe mencionar que la participaci\u00f3n de las aves \nimportadas para abasto en raz\u00f3n a la producci\u00f3n \nnacional de carne de pollo es muy peque\u00f1a repre sentando menos del 1%, equivaliendo a 11,700 y \n4,000 ton de carne en canal, respectivamente para 1998 \ny 1999.  \nSi se hace un an\u00e1lisis del periodo (1994 \u2013  1999) \nla TMCA para aves progenitoras fue del 3.55% \npasando de 466 mil a 555 mil, en lo referente a aves  \npara abasto la TMCA en el periodo fue de 9.52%, ya \nque en 1994 se importaron 1.5 millones de aves, para \n1999 las compras al exterior fueron 2.4 millones.  \nPor otro lado, las importaciones de carne (que \nincluyen canales y trozos de ave, ya sean refrigeradas , \ncongeladas, salados o en salmuera y las pastas de pavo \ny pollo) crecen en el periodo (1994 \u2013  1999) a una \nTMCA del 10.79%, pasando de 119 mil ton a 199 mil \nton.  En 1999 las 199 mil ton importadas se distribuyeron en 48.5% en canales y trozos de ave, ya \nsean refrigerados, congelados o en salmuera y el 51.5% \npor pastas de carne de pollo y pavo.  Al interior del \n48.5%, se observa que \u00fanicamente el 1.4% \ncorrespondi\u00f3 a aves enteras o canales y el 47.1% a \ntrozos, contemplando en este porcentaje las \nimportacione s de carne salada o en salmuera.  \nEstudiando la informaci\u00f3n por componentes de \n1994 a 1999 se aprecia que la TMCA de pastas fue 17.12%, ya que se paso de 47 mil ton importadas en \n1994 a 103 mil ton en 1999.  Mientras que la de trozos \ny carne salados o en salmuera fue de 5.82%, en 1994 \nlas importaciones fueron 73 mil ton en 1999 de 97 mil ton. \nSe observa que las pastas de ave presentan el \nmayor dinamismo, obedeciendo a la necesidad de adquisici\u00f3n de productos particulares para la industria empacadora, cuya pr oducci\u00f3n al interior del pa\u00eds es baja.  Por otro lado la autorizaci\u00f3n del incremento de \nlas cuotas de estas pastas se viene dando con el fin de \natender la demanda de la planta elaboradora de \nembutidos y carnes fr\u00edas.  \n \nDISCUSION  \nAun cuando la avicultura nac ional productora de \ncarne de pollo es la actividad del subsector pecuario \nque m\u00e1s ha crecido, que su oferta de 1.7 millones de \nton en 1999 se colocaron en el mercado interno y que \nlas importaciones totales representaron en 1999 el \n11.50% de la oferta nacio nal, no deja de preocupar la \ndin\u00e1mica de importaciones de canales y trozos de ave \nque han crecido a una TMCA del 10.79% en el periodo de estudio, por eso la importancia de una pol\u00edtica \nprudente en la asignaci\u00f3n de cupos para importaci\u00f3n.  \nA la fecha las imp ortaciones de pie de cr\u00eda \npresentan un tama\u00f1o suficiente para abastecer el \nproceso de engorda.  \nEn el 2000 el total de importaciones ascendi\u00f3 a \n210 mil ton, 3% superior a lo reportado en 1999, con lo \nque su participaci\u00f3n en el componente del Consumo \nNacional Aparente fue del 10%.  \nCon respecto a la Balanza Comercial av\u00edcola para \nel 2000 se presenta altamente deficitaria en 206, 000 ton.  El hecho que haya importado (210 000 ton) \nmucho m\u00e1s que lo que se export\u00f3 (4,000 ton) implica \nque se dejan de crear empleos  directos e indirectos, as\u00ed \ncomo efectos multiplicadores al interior de la actividad av\u00edcola y de la rama porcina ya que las importaciones de pastas han afectado a esa rama.  \n \nREFERENCIAS  \n1. Alonso, P.F. La avicultura en M\u00e9xico 1975 \n\u2013 1998.  Centro Mexicano de  Estudios Sociales \u2013 \nReflexi\u00f3n \u2013 Debate \u2013 Propuesta  A.C. 2000.  \n2. Situaci\u00f3n Actual y Perspectivas de la \nProducci\u00f3n de Carnes en M\u00e9xico 1990 \u2013  2000.  Centro \nde Estad\u00edstica Agropecuaria.  Secretar\u00eda de Agricultura, Ganader\u00eda, Desarrollo Rural, Pesca y Alimentaci\u00f3n. 2001.  \n3. Situaci\u00f3n Actual y Perspectivas de la \nProducci\u00f3n de Pollo en M\u00e9xico 2000.  Centro de \nEstad\u00edstica Agropecuaria.  Secretar\u00eda de Agricultura, \nGanader\u00eda, Desarrollo Rural, Pesca y Alimentaci\u00f3n. \n2001.\n \n \n \n \n    \n  \n229 NEW TECHNOLOGY FOR T HE POULTRY INDUSTRY -  \nTHE ESSENTIAL COMPON ENTS OF SCIENCE AND ECONOMICS  \n \nNUEVA TECNOLOG\u00cdA PARA LA INDUSTRIA AV\u00cdCOLA \u2013 LOS \nCOMPONENTES ESENCIALES DE LA CIENCIA Y LA ECONOM\u00cdA  \n \nDonald Bell \n \nCooperative Extension, University of California, Highlander Hall, Riverside, CA 92521  \n \nRESUMEN  \nLa industria av\u00edcola ha sido punta de lanza en \navances tecnol\u00f3gicos desde que, en sus albores, se \nadoptaron los principios cient\u00edficos del cruzamiento \n(gen\u00e9tica), el establecimiento de las especificaciones bien definidas de las necesidades alimentici as \n(nutrici\u00f3n), y el uso de computadoras desde un principio para formular raciones de alta eficiencia y \nelevado valor nutricional, adem\u00e1s de facilitar la \nselecci\u00f3n de las estirpes de aves capaces de alcanzar niveles incre\u00edblemente altos de eficiencia para \ntransformar los ingredientes del alimento en productos \npara el consumidor, tanto huevo como carne, a raz\u00f3n \nde menos de 2 Kg de alimento por 1 Kg de producto. \nDetr\u00e1s de estos resultados est\u00e1n los esfuerzos de \ncientos de cient\u00edficos que han dedicado su vida a \ncomprender y mejorar la industria av\u00edcola mundial. \nGracias a sus esfuerzos, las aves y sus productos son \nsiempre altamente preferidos por los consumidores en \ntodos los pa\u00edses.  \n \nABSTRACT  \nThe poultry industry has been at the forefront of \ntechnological adva ncements since the early adoption of \nscientific breeding principles (genetics), the establishment of highly defined nutritional requirement \nspecifications (nutrition), and the early use of \ncomputers to formulate highly efficient and nutritious \nfeeds and to  facilitate the selection of strains of \nchickens capable of unbelievably high conversion of \nfeedstuffs to consumer products - both eggs and meat \nat less than 2 pounds of feed per 1 pound of product.  \nBehind these results are the efforts of hundreds of scientists who have dedicated their lives to the \nunderstanding and betterment of the poultry industry of the world.  Through their efforts, poultry and poultry \nproducts are consumed at all -time high levels by \nconsumers in all countries.  \n \nINTRODUCTION  \nJust what  is science?  Traditionally, science was \nthought to include physics, chemistry and biology.  Through the years, additional disciplines were added \nuntil today, we include subjects such as computer science, social science, engineering science and yes, \neven p oultry science among a long list of others.  Of \nthe many definitions found in different dictionaries and \nencyclopedias, the one that attracted me most was: \u201cThe search for knowledge and understanding \u201d. \n As you can see, the emphasis is on the process \nand no t necessarily the discipline.  \nAssociated with the word science, is the concept \n\u201cScientific method\u201d.  This is an equally important \nsubject to the discussion to follow.  Webster defines it \nas \u201cthe principles and procedures for the systematic \npursuit of knowl edge involving: the recognition and \nformulation of a problem, the collection of data \nthrough observation and experiment, and  the \nformulation and testing of hypotheses\u201d.  \nThe discussion that follows will emphasize 1) the \nneed and the search for knowledge, 2 ) the research \ncommunity, 3) research methods, 4) sources of \ninformation, 5) information transfer, 6) adoption by the \nultimate user, 7) evaluation of its worth, and 8) \nscientific tools for the future.  \n \nTHE NEED AND THE SEARCH FOR \nKNOWLEDGE  \nNew technology m ust result in higher flock \nperformance, greater efficiencies in converting feed to eggs and meat, better working conditions for \nemployees, improvements in the health and well -being \nof flocks, higher quality and safe egg and meat \nproducts, fewer environment al problems for neighbors \nand finally, a reasonable economic return for the \nfarmer\u2019s efforts.  These are the measures that must be applied to the results of making change.  \nSignificance of New Technology . \u201cSignificance\u201d \nof this new technology implies:  \n1. Scientific significance - are the observed results \nsimply a chance happening and can they be repeated? \n2. Social significance -  how is society \naffected by the adoption of the new practice? \n3. Economic significance -  have all economic \nconsequences been properly considered and is the net effect still favorable?  \n \n  \n  \n230 THE RESEARCH COMMUNITY  \nTraditionally, research has been the responsibility \nof the educational and research universities in our \nsociety.  In recent years, though, commercial industry \nand even farmers h ave discovered a role for themselves \nin pursuing new basic and applied knowledge.  Many agricultural companies have multi -million dollar \nresearch programs with large staffs and excellent facilities.   \nIn general, university research is more of a basic \nnature with emphasis on the fundamental processes.  \nThrough their Extension Services, applied, problem -\nsolving research is emphasized.  \nIndustrial research is usually product -oriented and \nis commonly protected by patents and copyrights.  The \nemphasis is on the production of unique salable \nproducts.  \nAt the production and/or processing sites, new \nideas and products must be evaluated using acceptable \nscientific procedures.  A casual observation that \nsomething works better than something else is not \nsufficient evide nce to adopt the concept.  True research \nrequires repeated examination of relationships under \nrandom and controlled conditions, hopefully comparable to the conditions under which it will be \napplied.  \nThe researcher or developer should always be \nconcerned wi th the possibility of interacting factors \nwhich may change the outcome of the research.  Will \nthe concept succeed with different strains and breeds?  Will it work as effectively under high and low \ntemperature conditions?  Will it have a comparable \nadvantage when applied to different nutritional \nprograms?  \nThe scientist or developer must examine all \nrelevant performance traits in determining the merits of a new concept.  It\u2019s not enough to measure rates of egg \nproduction, egg size, mortality and feed consumpt ion if \neggshell quality is significantly affected by the \ntreatment.  Total mortality may not measure the net effects of mortality if different \u201cpatterns\u201d of mortality \nexist.  \nAnd, finally, improvements in performance traits \nmay not result in improvement in economic results.  Nutritionists would not be needed if maximum \nperformance was the goal.  Once a good ration was developed, it should last for all times.  The \nnutritionist\u2019s role, though, is to develop the most \neconomic feeding program under varying condi tions \nand to do this, some elements of performance may \nhave to be sacrificed, ingredients may have to be \naltered, and new values used.  \nEgg production rates could be improved easily by \nincreasing cages space allowances but this may result in less total farm  profits.  Single cycle egg production \nis associated with higher egg production rates and improved feed efficiency, but replacement costs are higher.  Increasing the \u201cbottom line\u201d must be the \nobjective of adopting new technology.  \n \nRESEARCH METHODS  \nAll scie ntists (researchers) approach problems \nand the development of solutions in a similar manner.  \nIt is through this methodology that new knowledge and \nsolutions for problems are obtained.  Listed below are \nsome of the problem -solving techniques used by the \nscientific community.  \nHypothesis: a tentative idea as to how facts are \ninterpreted and explained  \nExperiment:    a research tool used to discover \nsomething unknown or to test a principle or hypothesis  \nRandomization: treatments are given an equal \n(unbiased) cha nce to be in a given house (row, deck, \nlocation)  \nReplication: a treatment is repeated two or more \ntimes to provide a measure of variation.  \nVariation: differences in results due to either a \ntreatment difference or natural differences between \napparently simi lar individuals (flocks, houses, etc.).  \nNormal variation within an \u201cuntreated\u201d population must be measured in order to understand the differences observed in the treated population.  When \ngraphed, most biological data fit a mathematically \ndefined curve called the normal frequency \n(distribution) curve.  \nAnalysis of Variation: a test comparing the \nvariability within samples (replicates) of a common treatment versus the variability of replicates between \ntreatments .   \nProbability: a comparison of the observed \nfrequency with the amount expected purely by chance.  \nIn flipping a coin there would be a probability of 0.50 \n(half the times) that heads would come up.  In scientific \nresearch, a probability of 0.05 would indicate that \nresults of the nature observed would be expected by \nchance (not due to treatment) five times out of one -\nhundred.  In other words, there would be a strong indication that the results were the result of the \ntreatment studied (feed, strain of birds, or other \nvariable).  \nCorrelation: is defined as  the degree of \nrelationship between two or more items.  For example \nhow is the price of eggs affected by the volume of \nproduction.  A related term is the R 2 of a regression \nline \u201cfit\u201d.  A perfect fit is 1.0, a good fit might be .85, \nor a poor fit might be only .35.  It is a measure of the \ndegree of variability which can be attributed to the item being studied . \nRegression (linear, curvilinear): an additional \nunit of input will yield an increasing (positive) or decreasing (negative) production of output in a \nproportional manner (linear) or changing manner  \n  \n231 (various curvilinear shapes).  An example would be an \nincrease in body weight gain as temperature decreases \nwithin a mid -range of normal temperatures - this would \nbe a linear curve.  If extremely cold and hot  \ntemperatures were included, body weight gain would eventually drop at both extremes and the resulting \nregression curve would be curvilinear or U -shaped . \nRepeatability: a measure of the likelihood that \nresults will come out in the same direction and/or \nmagnitude when a \u201ctest\u201d is repeated.  \nInteraction: results are not of the same \nmagnitude or direction when two or more factors are \ninvolved at a time.  For example, Strain A reacts positively to fewer birds per cage while Strain B reacts \nnegatively.  \nSurveys - yield frequencies of individual \nmeasurements within a population , various averages can be calculated.  Large data bases from commercial \nfarms can be assembled and relationships between factors can be determined.  This is a very effective \nsubstitute for sm aller highly controlled experiments on \nuniversity farms.  \nSeparation of Means (averages): statistical \nprocedures which separate individual statistically \nsignificant different results within a ranked set of \nresults.  \nComparison: in the simplest form, this is how \nfarmers usually \u201ctest\u201d methods and products.  Regardless of the size of the house or flock, two houses \nor flocks will differ by chance and no real reliable \ndetermination of treatment differences can be assumed.  \nComparison results, though, can be stren gthened \nby the use of repetition.  Repeatable results in the same \ndirection can be used to evaluate treatments.  \nLaboratory Research: carefully controlled \nexperiments where all variables other than the one \nbeing tested are held alike as possible.  Laborator y \nexperiments usually involve smaller groups with \nreplication of treatments and controls, but sophisticated \nmeasurements of physiological change, micro -nutrients \nconcentrations, and bird behavior.  The birds and/or \nenvironment may be instrumented for conti nuous \nrecording of temperatures, relative humidity, gases and \nlight patterns.   Ingredients and finished diets may be \nexhaustively tested along with feed consumption levels to determine the precise intake level of all nutrients.  \nVideo cameras may be emplo yed to record the effects \nof a treatment on bird reactions.  \nPublication of Research Results : a key element \nof any research is to publish the results in a \u201crefereed\u201d \npublication reviewed by one or more scientists within the same discipline field.  This proc edure results in a \ncritical review of experimental design, procedures and results.  It also assures that the experiment was conducted within the context of other similar studies.  \n SOURCES OF INFORMATION \nBasic flock management programs should be \npattered af ter the recommendations of the poultry \nbreeder wherever possible.  These guidelines are tailored to the unique requirements of the strain \ninvolved and have been developed after years of \nresearch and experience.  In some cases, though, local conditions  (di sease, economics, environment) may \njustify departing from the breeder\u2019s recommendations.  \nThis should only be done after consulting with other \nreputable advisors.  \nEach breeder has developed performance \nstandards for their birds which provides the user with  a \nvery useful comparison tool.  Flock performance which \ndiffers from these standards should be studied for \npossible correction.  Performance standards for feed \nconsumption and egg size are usually not too useful \nsince few breeders attempt to make adjustme nts for \nseasonal effects, thus making comparisons difficult..  \nOther sources of information include books, \nmagazines, university publications, professional \njournals and newsletters.  Hundreds of such \npublications exist and are available in a wide \nassortment  of different languages.  \nElectronic communications and information \nretrieval in today\u2019s poultry industry . E-Mail is a \nconcept that none of us could have imagined just a few years ago.  Who would have thought we could sit in \nour offices and have instantaneo us communications \nback and forth with someone on the other side of the \nglobe at essentially no cost?  That\u2019s what e -mail has \ngiven us.  \nWeb -sites, on the other hand, have given us \naccess to thousands of information sources directly \napplicable to our specialized interests.  A feature on the \nInternet is the \u201cbookmark\u201d which allows on to select favorite sites with hundreds of sites with usable \ninformation on poultry.  Each of these sites, in turn, \nhave multiple \u201clinks\u201d with other sites which multiply \nyour connections to additional sources of poultry information.  \nSites are available from all major universities, \nprivate companies, government, trade associations, and \nprofessional societies - to name just a few.  The \nUniversity of California Cooperative Extension s ite\u2019s \naddress is:  \nanimalscience.ucdavis.edu/extension/avian \n(Reference #1: Bell, 2000)  \n \nINFORMATION TRANSFER  \nThe transfer of knowledge is defined as \u201cthe \nconveyance of information or goods from individuals, \ncompanies, or nations that have possession of suc h \nknowledge to other parties who may benefit from \nreceiving it\u201d.  This may be as simple as exchanging \nideas between neighbors to ones that require complex  \n  \n232 international agreements.  It involves many cultural \nand economic considerations which may facilitate or \nimpede the transfer.  \nToday, ideas are more available than at any time \nin the past.  We live in a global business where \nproducers and suppliers have almost instantaneous \naccess to what people are doing elsewhere.  At no time in the past has there been s o many management options \nto consider -  multiple products and solutions for every \nproblem.  The key word is \u201cproblem\u201d - does a problem \nactually exist?  \nBefore transfer is accomplished, the recipient \nmust decide whether or not he is in the market for new technology.  This can only be assessed by knowing \nwhere the company is today.  If the communicator\u2019s \nconcepts are said to be superior to those in use, the \ncustomer must be very critical in accepting them at \n\u201cface value\u201d.   Results with referrals of successful  \ncommercial applications should be required.   \nThe rate of transfer is governed by the nature of \nthe advantages associated with the idea or product.  \nUsers have their own pace for accepting new concepts.  \nAutomatic feeders have been in existence for 50 or \nmore years, but recent surveys in the US have shown \nthat 16% of egg production farms still prefer to use \nhand feeding systems.  Belt egg collection systems \nhave also been in use for 50 years, but approximately \n1/3 of all eggs are still gathered by hand. (R eference \n#2:  Anonymous, 2000).  \nTechnological \u201cbreak -throughs\u201d are not common \nbut, when they solve widely recognized problems at relatively low cost, changes are fast and as a result, we \nhave temporary disruption in our industries.  An \nexample of this is w hen a vaccine became available for \nMarek\u2019s Disease.   Producers had to make immediate adjustments in flock size in order to compensate for the \nlower mortality rates; otherwise, chronic over -\nproduction would have resulted.  \nOther examples of sudden change include: \nshifting to brown- egg layers almost over -night in parts \nof the world, changing egg size definitions and number of size classes, and the mandating of egg handling \nprocedures beyond the capacity of our refrigeration \nsystems.  \nThe industry is faced with  another sudden change \nwhen laws requiring modified, or the elimination of \ncage systems, are activated.  With increasing space \nallowances and changing specifications, all of a sudden \nextremely efficient systems will no longer be allowed \nto operate.  Even t hough enormous welfare and \neconomic advantages can be demonstrated \nscientifically, public perceptions will be allowed to \ndictate management systems which have been proven \nover decades of use.  \nImpediments to the transfer of technology \ninclude:  1. Man\u2019s norm al reluctance to change.  \n2. Certain technology has no place in some \nregions of the world.  It\u2019s just not an economic practice \nunder different conditions of prices and costs.  \n3. Nation\u2019s often protect their own industries by \nnot allowing the import of techn ology.  For example, \nthe latest breeding stock from overseas is not allowed \nin. \n4. Private or national funds are simply not \navailable  \n(Reference #3:  Filmer and Anderson, 1984)  \nThe most important technology is almost always \navailable except for the constraints listed above.   \nPublic research is readily available through \nmembership in professional genetic, nutrition, health, \nengineering and food processing societies.  A relatively \nsmall investment can gain a company almost \ninstantaneous access to every publi c institution\u2019s \nresearch papers.   Private information or products are generally available through purchase except for \ncompanies that develop their own procedures and \ntechnologies and use these to establish an advantage \nover their competitors.  \nThe applicat ion of new technology involves three \nor more parties:  \n1. The researcher or individual who develops and \ntests a concept  \n2. The communicator who recognizes the merits \nof the concept and can effectively describe its potential.  \n3. The ultimate user who must ve rify its use \nwithin his company.  \nThe developer of a new idea or product must \nhave a \u201ctrack record\u201d of successful experiences if \npotential users are going to listen.  This applies both to \nprofessional researchers and to private enterprises.  The \ndeveloper m ust have a thorough understanding of all \nfactors which may affect the idea.  This requires:  \n1. A knowledge of proper evaluation procedures  \n2. An awareness of interacting inputs which may \naffect its successful implementation.  \n3.  A thoroughness of investiga tion \n4.  A concern for economics.  \nAn understanding of the factors surrounding a \n\u201cnew concept\u201d requires a total familiarity with how \nthings were done in the past and the various options \navailable in the present.  This includes the options in use today in di fferent regions of the world.  \nRecommendation can and should draw from an international pool of experiences.  \nThe second participant in the transfer of \nknowledge is the communicator .  This includes: 1). \nthe friend in another region who\u2019s also in the poultry business, 2). the sales person who communicates his observations collected during the past week of farm \nvisits, 3). the poultry magazine editor who is always \nlooking for new concepts, 4). The University Extension  \n  \n233 poultry specialist who\u2019s charged with revi ewing what\u2019s \nnew and promising for the poultry industry.  \nCommunicators are most effective when they \noperate on a one -to-one basis with people who they\u2019ve \nhad successful relationships with in the past.  This \nrelationship allows for a clear understanding of the \nneeds of the poultry producer by the communicator through past contacts.  Needs can be directed to \nmutually recognized problem areas.  \nThe transfer of knowledge is very successfully \naccomplished by the popular poultry press.  Producers rely on trusted e ditors to sort out the \u201cwheat from the \nchaff\u201d of new technology.  Readers must also look for \nrecognizable authors for the various articles.  Some \njournals leave the listing of authorship to the end of the \narticle, as if an after -though; authorship should be \nlisted at the front so that readers will know the source.  \nA third major way of transferring knowledge is \nthrough meetings, workshops,  and seminars.  Even \nthough notable speakers may be on the program, the \naudience must take extreme care with the information \nif they plan to apply it under local conditions without \ncareful study.  Just because its interesting, doesn\u2019t \nmean it has a local application.  \nToday\u2019s communication techniques are so rapid \nand all -encompassing that users may find themselves \n\u201clistening \u201d to persons with a platform (Internet) but \nwith no credentials (experience).  The Internet has \nopened the door for the rapid transfer of both \nscientifically evaluated and anecdotal experiences.\n The user must be cautioned to apply the same \nrules to this so urce of information as to the other \nsources previously discussed (Reference #4:  Bell, \n1988, Reference #5:  Broekhuizen, 1988)  \nThe third and final participant in the transfer of \nknowledge is the ultimate user who must make the \ndecision that the information  is worthy of use and has \nan economic potential.  This individual must have an \naccurate awareness of his/her present position relative \nto the new concept and a willingness to accept the \nproposal that improvement may be possible.  \nSome producers are completely closed to new \nideas - what\u2019s apparently worked well for years, does \nnot need changing.  Others are willing to try new ideas on a small scale with careful evaluation.  And then, some want to try every idea that comes along resulting \nin a high degree of f ailure.  Obviously, the intermediate \napproach is best.  \n \nADOPTION BY THE ULTIMATE USER  \nAdding new technology to an established \nbusiness requires a number of basic steps:  \n1.  Introduction of the concept  \n2.  Gather information and analysis  \n3. Small scale adop tion \n4.  Large scale adoption  5.  Continuous evaluation and comparison \nWhat steps should be taken to implement a new \nprogram?  \n1.  Develop program guidelines  \n2.  Prepare a detailed written description  \n3. Monitor its applications (quality control)  \n4.  Measur e and evaluate results  \nHow can you evaluate products or ideas? \n1.  Repeated comparison  \n2.  Well designed tests in your own test \nhouse  \n3.  Sponsorship of research \n4.  Use of knowledgeable consultants  \nDivision managers must document, monitor and \ndefend pract ices to higher levels of management.  \nApplication of New Technology . Once an idea \nor product is applied, the user must continually monitor \nits application.  Are results consistent?  Does the user \napply the concept exactly as the developer \nrecommends?   Does  the product continue to improve \nover time e.g., strains of chickens?  Are other options \ncontinuously considered?  \nTechnology is not a static issue.  If this were so, \negg production standards would not have increased by \n2 eggs per hen per year.  Mortality r ates would still be \nin excess of 1% per month compared to less than one -\nhalf of that today.   It would still take 8 weeks to grow a 4 pound broiler.  \n \nEVALUATION OF ITS WORTH  \nThe performance of laying flocks is commonly \nevaluated by a variety of measurement s.  These usually \ninclude hen- day egg production, hen- housed egg \nnumbers and mortality.  More careful evaluators \ninclude egg weight, feed consumption and various \nmeasures of egg quality.  \nEmphasis on only one or a few measurements can \noften lead to the inco rrect evaluation of a strain , a \nprogram or a product being tested.  Oftentimes, one positive trait is partially or totally offset by an accompanying negative trait.  For example, high peaks \nof egg production may be associated with lower egg \nproduction rat es further on in the egg production cycle \nLarge eggs may be associated with an excessively high \nfeed consumption level.  High mortality totals may \nhave a more or less significant impact because of when the birds die.  \nSimilar examples can be illustrated for  the \nselection of programs.  High house temperatures result \nin extremely good feed efficiencies, but may adversely \naffect average egg values because of lower egg \nweights.  Crowding may reduce egg numbers and \nincrease mortality on a percentage basis, but economic returns may be enhanced.  Flock recycling may reduce \negg production rates and house utilization, but overall \nreturns for the facility may be higher.  The issue is \u201care  \n  \n234 you placing the proper emphasis on various \nperformance traits or are you emphasizing traits which \nonly \u201cappear\u201d to be beneficial? \nTraditional approaches for analyzing flock \nperformance, one trait at a time, must make way for more complex techniques which bring the economics \nof the issue into proper focus.  Researchers as well as egg pr oducers must evaluate multiple traits and this can \nbe done only with representative economic values.  \nOver -emphasis on one performance trait over others \ncan and does often lead to erroneous conclusions \nregarding strain selection, recommendations followed, \nand products purchased.  Today\u2019s low margin industry can not live with errors of interpretation of this type.  \nImportant relationships relative to products and \nmanagement practices should be re- examined from \ntime to time under new price and cost combination s to \nbe sure that good technology is not lost to the industry because \u201cat one time it was not a sound economic practice.\u201d   Likewise, the economic circumstances in \none region or in one country may not justify the use of \ntechnology that is widely accepted i n other regions or \ncountries.  Sound economic analyses are required to \nmake sure that our  use of technology is justified.  \nTechnology which may have been discarded for \neconomic reasons sometime in the past, should be re-\nevaluated for their current economic  justification when \nprices and costs have changed.  Costs of labor and \nequipment alternatives need to be re- evaluated as costs \nchange.  Replacement programs should be re- visited as \nreplacement and feed costs increase and as egg prices change.  Cage densiti es may have to be adjusted as \nbuyers become more involved with the management of \nthe flocks from which they purchase eggs.  \n \nSCIENTIFIC TOOLS FOR THE FUTURE  \nDr. W.B. Roush, Department of Poultry Science \nat Pennsylvania State University, has recently reviewed \na number  of existing decision -making systems which \nare currently being used or will be so in the near future \nby forward -thinking businessmen.  Those in limited \ncurrent use include: statistical analysis (see above), \nlinear and non -linear programming, inte ger \nprogramming, multiple objective (goal) programming, \ndecision analysis, waiting line (queuing) models, dynamic programming, and the Markov analysis.   In \nthe not -too-distant future, neural network computing, \ngenetic algorithms, fuzzy set theory and exper t systems \nwill be in common use.  Roush concludes by saying \n\u201cOperations research is a fundamental discipline \nencompassing familiar (e.g., linear programming) and new technologies (e.g., neural networks and genetic \nalgorithms) for defining management decisi ons. \n(Reference #6, Roush, 2001).  \n ISSUES WHICH AFFECT RESEARCH \nDIRECTIONS  \nNew ideas and products are commonly issue -\ndriven, especially when systems are mandated by \nregulations.  For example, today we see a series of \nissues that face all poultry producers and \u201cnew\u201d \nanswers are actively being sought:  \n1. Environmental - waste handling, equipment, \nodor.  \n2. Welfare -  space allowances, changing cage \ndesigns, beak trimming, molting.  \n3. Food Safety - elimination of problem \nsources, processing.  \n4. Cost and efficien cy competitiveness.  \n5. Government intervention.  \nNew legislation regarding cage space and the \neventual abolishment of traditional cages has driven \nmanufacturers to a frenzy of new designs which they \nhope will satisfy the legislators.  If past history is any  \nguide, new regulations could easily be adopted to make the new designs unacceptable in the future. Concepts \nwhich address current concerns may prove \nunsatisfactory later on.  Meanwhile, the industry must \ngo on and hopefully not get mired down with regulat ions which are not science - based.  \nFood safety is the latest issue to call for mandated \nprocedures in the poultry industry.  Even though most quality assurance programs are voluntary, new \nlegislation has dictated handling procedures for eggs to \ncontrol the ir temperature at the processing plant, during \ntransportation and at the retail store.  Other legislation \nrequires code dating, nutrition and safety warnings on \negg cartons.  More and more practices are being \nspelled out by the regulators in our society so me good \nand others not well thought -out. \n \nSUMMARY  \nScience provides the basis for everything we do.  \nA major problem is the frequent escalation of requirements beyond that which is built upon scientific research. A significant element in our society believe s \nthat \u201cIf a little is good, more must be better\u201d.  If resources are to be utilized efficiently, it\u2019s imperative \nthat standards of management be established and \nadhered to and that ranges of acceptability be allowed.  \nSuch standards must allow for differen t \ngeographically -related systems, different types of birds, \ndifferent management styles and different economic factors.  \nManagement methods should not be dictated by \nanyone other than the owner of the operation - not the \ngovernment nor special interest grou ps.  The manager \nof owner is responsible for the selection of sound management programs.  The procedures discussed in \nthis paper can help the manager with the selection of \nsuch programs.   \n  \n235 REFERENCES  \n1. Bell, D.D., 2000. Electronic Communication \nand Information  Retrieval in Today\u2019s Poultry Industry, \nCalifornia Poultry Letter, Jan -Feb. \n2. Anonymous, 2000.  Part II: Reference of \n1999 Table Egg Layer Management in the U.S., USDA \nAnimal and Plant Health Inspection Service.  \n3. Filmer, W.W., and A. Andersen, 1984. The \nLegislation Affecting the Economic  Results of Broiler \nand Egg Laying Farms.  Pages 79- 83 in: Proceedings \nof the World\u2019s Poultry Congress, Helsinki, Finland.  4. Bell, D.D., 1988, Information Gathering and \nUse.  Pages 142 -145 in: Proceedings of the World\u2019s \nPoultry  Congress, Nagoya, Japan.  \n5. Broekuizen,  H.B., 1988.  Poultry Education \nand Extension in the Netherlands.  Pages 151 -155 in: \nProceedings of the World\u2019s Poultry Congress, Nagoya, Japan.  \n6. Roush, W., 2001.  An Operations Research \nApproach to Leveraging New Techn ology \nOpportunities.  J. Appl. Poult. Res. 10:293- 302. \n \nCIN\u00c9TICA DE LA ABSOR CI\u00d3N, TRANSPORTE Y DEPOSICI\u00d3N DE \nPIGMENTO CAROTENOIDE  EN POLLO DE ENGORDA  \n \nKINETICS OF CAROTEOIND PIGMENT ABSORPTIO N, TRANSPORTATION, \nAND DEPOSITION IN BROILERS  \n \nAceves AMG1, Garc \u00eda MAR1, Ju\u00e1rez RM2, Petrone VM2, , Fuente MB1. \n \n1CEIEPA, FMVZ -UNAM; 2 DPA: Aves, FMVZ -UNAM  \n \nSUMMARY  \nCarotenoid pigment was measured in plasma, \nduodenum, jejunum, and feces of 21- to-49 day -old \nbroilers fed 80 ppm natural pigment, in order to determine the absorption site and fate of such pigment. \nThe highest pigment concentration was found in the \njejunum, just next to Meckel\u2019s diverticulum. \nCarotenoid plasma concentration was increased from \n0.36 g/ml (3rd week) to 23.07 g/ml (5th week, 200 \nmin.).  A large amount of pigment was excreted in the feces, particularly at 40 minutes (1393.06 g/g) at week \n3. These results are useful in understanding the \nabsorption kinetics of carotenoid pigments.  \n \nRESUMEN  \nPara determinar el sitio de absorci\u00f3n y destino del \npigmento  carotenoide, \u00e9ste se midi\u00f3 en plasma, \nduodeno, yeyuno y heces en aves de 21 a 49 d\u00edas alimentadas con 80 ppm de pigmento natural. La \nmayor concentraci\u00f3n se encontr\u00f3 en el yeyuno anterior al divert\u00edculo de Meckel. La concentraci\u00f3n de \ncarotenoides plasm\u00e1ticos se increment\u00f3 de 0.36 g/ml (3\u00aa semana) hasta 23.07 g/ml (5\u00aa semana, 200 min.).  \nUna alta cantidad de pigmento fue eliminada por las \nheces, especialmente a los 40 minutos (1393.06 g/g) en \nla 3\u00aa semana. En intestino se observ\u00f3 la mayor concentraci\u00f3n de carotenoides en yeyuno anterior al \ndivert\u00edculo de Meckel. Estos resultados son de utilidad \npara entender la cin\u00e9tica de absorci\u00f3n del pigmento \ncarotenoide.  \n INTRODUCCI\u00d3N  \nLa pigmentaci\u00f3n del pollo de engorda reviste \nespecial importancia para el consumidor en el \nmomento de la compra. El  color amarillo naranja de la \npiel  del pollo se ha convertido en un indicador de \ncalidad y en ciertos casos, del estado de salud del pollo. \nPara conseguir \u00e9sta coloraci\u00f3n, se recurre al uso de \npigmentos naturales o sint\u00e9ticos, adicionados a \ndiferentes concentraciones. El pigmento natural amarillo, por ejemplo, se utiliza de 60 a 80 ppm en el \nalimento. La eficiencia en la utilizaci\u00f3n del pigmento \ndepende de varios procesos fisiol\u00f3gicos de absorci\u00f3n, \ntransporte y deposici\u00f3n que no han sido estudiados \ncompletamente, y por lo tanto, la informaci\u00f3n acerca \nde la metodolog\u00eda de evaluaci\u00f3n es limitada. La \u00fanica \nt\u00e9cnica objetiva es  la colorimetr\u00eda de reflectancia, con \nque se mide la pigmentaci\u00f3n en piel. Sin embargo, no se ha desarrollad o  una metodolog\u00eda de acuerdo con la \ncin\u00e9tica del pigmento para medirlo antes de que ocurra \nla deposici\u00f3n en piel. La medici\u00f3n en plasma es \u00fatil \npara detectar problemas de mala absorci\u00f3n del pigmento por alteraci\u00f3n en intestino y poder corregirlos antes de que se presente mala pigmentaci\u00f3n cut\u00e1nea. \nTampoco se ha evaluado como ocurre la absorci\u00f3n del pigmento a lo largo del intestino y de acuerdo con el tiempo en que ocurre la digesti\u00f3n del alimento, lo cual \nser\u00eda de utilidad para entender c\u00f3mo se afecta la \npigmentaci\u00f3n en presencia de diferentes especies de coccidia que afectan regiones espec\u00edficas del tracto \nintestinal.. Con \u00e9stos antecedentes, la finalidad de \u00e9ste \ntrabajo fue evaluar la absorci\u00f3n ent\u00e9rica, transporte  \n  \n236 plasm\u00e1tico y la absorci\u00f3n cut\u00e1nea del p igmento de flor \nde cempas\u00fachitl.  \n \nMATERIAL Y M\u00c9TODOS  \n Se utilizaron 234 aves de 21 d\u00edas, criadas en \nbater\u00eda, alimentadas con dietas a base sorgo -soya sin \ncoccidiostato, con 80 ppm de pigmento natural. Las \naves fueron pesadas semanalmente. La medici\u00f3n del \npigmento cut\u00e1neo se realiz\u00f3 mediante el color\u00edmetro de \nreflectancia MINOLTA (CIELab System) a los d\u00edas 20, \n27, 34, 41 y 48, en la zona apter\u00edlica costal derecha, en \n40 aves por toma. Previo a la toma de muestras, los \nd\u00edas 21, 28, 35, 42 y 49, las aves fueron alimentadas a libre acceso despu\u00e9s de 14 h de ayuno, para garantizar \nque las aves consumieran alimento  A partir de ocho \naves por cada intervalo de tiempo: 0, 40, 80, 120, 160 y \n200 min., se tomaron 2 ml de sangre con EDTA, 3 cm \nde intestino en tres dife renttes porciones: hacia el final \ndel asa duodenal, yeyuno anterior y posterior al \ndivert\u00edculo de Meckel, y heces. Las muestras de \nintestino y heces fueron pesadas y refrigeradas. De \ncada muestra de intestino y heces,  se extrajo el \npigmento carotenoide con 20 ml de soluci\u00f3n de \nhexano:etanol:acetona:tolueno (10:6:6:7) durante toda \nla noche, en refrigeraci\u00f3n y oscuridad. De las muestras \nde sangre se obtuvieron 0.5 ml de plasma, que se \nmezclaron con 4.5 ml de acetona para la extracci\u00f3n de \nlos carotenoides. En  ambos casos, se ley\u00f3 la \nabsorbancia de las muestras en un espectrofot\u00f3metro \najustado a 478 nm de longitud de onda. Los valores \nfueron convertidos a g de carotenoides/g de muestra para intestinos y heces, y en g de carotenoides /ml en \nplasma, mediante una curva patr\u00f3n de carotenoides.  \n \nRESULTADOS Y DISCUSI\u00d3N \nLos resultados se presentan en el cuadro 1. En \nplasma, a los 21 d\u00edas, la mayor concentraci\u00f3n de \npigmento se alcanz\u00f3 a los 200 min., y mostr\u00f3 una \ntendencia ascendente. A los 28 d\u00edas, la concentraci\u00f3n \nde carotenoides se increment\u00f3 hasta 20.7 g/ml, y 23.07 \ng/ml en el d\u00eda 35 a los 200 minutos. A partir de \u00e9ste \npunto, la concentraci\u00f3n de pigmentos carotenoides \nmostr\u00f3 una tendencia descendente.  A los 42 d\u00edas se \nencontr\u00f3 entre 20 y 22 g/ml, manteni\u00e9ndose const ante \nen todos los intervalos de tiempo. Para los 49 d\u00edas se mantuvo entre 17 y 20 g/g. En intestino, la \nconcentraci\u00f3n de carotenoides en duodeno a los 21 d\u00edas \nfue de 50.37 g/g a los 40 min., mostrando una \ntendencia ascendente conforme transcurri\u00f3 el tiempo  \ndespu\u00e9s del suministro del alimento. En heces se \nencontr\u00f3 la mayor concentraci\u00f3n de carotenoides a los \n40 min (1393 g/g) la cual fue disminuyendo hacia los 200 min.(207.54 g/g). Se observ\u00f3 una mayor \nconcentraci\u00f3n en yeyuno anterior a Meckel a los 40 y \n80 min. (87.72 g/g ), la cual fue disminuyendo hacia \nlos 200 min, mientras que en yeyuno posterior a \nMeckel la tendencia fue a la inversa.  \nEstos resultados indican que la m\u00e1xima \nconcentraci\u00f3n en duodeno despu\u00e9s de ingerir alimento se alcanza a los 160 min. La  mayor concentraci\u00f3n de \ncarotenoides en intestino se encuentra en yeyuno \nanterior al divert\u00edculo de Meckel. La mayor \neliminaci\u00f3n del pigmento en heces se observ\u00f3 a los 40 \nmin. (1393.06 g/ml). En aves que consumen alimento \ncon pigmento en forma continua, la  concentraci\u00f3n de \ncarotenoides en plasma permanece constante sin \nimportar el tiempo transcurrido desde que el ave inici\u00f3 \nsu consumo de alimento.  \n \nREFERENCIAS  \n1. Fern\u00e1ndez S. Pigmentaci\u00f3n en avicultura. \nMemorias del 1er. Diplomado en Producci\u00f3n Av\u00edcola; \n2000 febrero -marzo; M\u00e9xico (DF): Facultad de \nMedicina Veterinaria y Zootecnia, UNAM, 2000:94 -\n96. \n2. Herrick GM. Repletion and depletion  of \npigmentation in broiler skin and shank. Poult Sc \n1971;1467- 1475.  \n3. Janky DM. The use of the Minolta \nReflectance Chro mameter II TM for pigmentation \nevaluation of broiler shanks. Pou Sci 1986;65:491- 496. \n4. North MO. Comercial chicken production \nmanual. 3a ed., The Avi Publishing Company Inc., WestPort Connecticut,  USA, 1984.  \n5. Vicente SJ. Aspectos b\u00e1sicos sobre la \npigm entaci\u00f3n en la Industria Av\u00edcola. Memorias del \n1er.   Diplomado en Producci\u00f3n Av\u00edcola; 2000 febrero-\nmarzo; M\u00e9xico (DF): Facultad de Medicina Veterinaria \ny Zootecnia, UNAM, 2000:94 -96. \n \n \n \n \n \n \n \n  \n \n  \n  \n237 Cuadro 1.  Valores de amarillamiento en piel y carotenoides en intestino, heces y plasma  \nMedia \u00b1 Error est\u00e1ndar de la media.  \n \n \nEdad   \n \nAmarillamiento  \nen piel   \nEVALUACI\u00d3N DE CAROTENOIDES EN INTESTINO ( \u00b5g carotenoides/g muestra) Y \nPLASMA ( \u00b5g/ml)  \n \nMinutos  Duodeno  Yeyuno anterior  \na Meckel  Yeyuno posterior  \na Meckel  Heces Plasma  3\u00aa \nsemana  \n \n \n2.46 \u00b1 .21  \n \n \n 40 50.37 \u00b1 5.68  87.82 \u00b1 7.85  77.04 \u00b1 10.25  1393.06 \u00b1 \n525.275  0.36 \u00b1 .13  \n80 62.28 \u00b1 10.39  103.25 \u00b1 15.48  89.25 \u00b1 8.643  2354.67 \u00b1 \n1430.79  0.35 \u00b1 .13  \n120 93.68 \u00b1 7.9  137.76 \u00b1 8.09  122.81 \u00b1 15.99  693.56 \u00b1 203.99  0.67 \u00b1 .13  \n160 199.41 \u00b1 97.7  122.62 \u00b1 16.82  148.28 \u00b1 24.33  476.83 \u00b1 171.26  0.89 \u00b1 .11  \n200 103.38 \u00b1 10.82  131.33 \u00b1 17.21  566.64 \u00b1 450.93  207.54 \u00b1 50.72  0.91 \u00b1 .17  \n      4\u00aa \n semana  \n \n \n \n \n10.22 \u00b1 .31  \n       \n40 58.15 \u00b1 8.12  111.36 \u00b1 20.61  114.81 \u00b1 16 .51 202.07 \u00b1 34.27  13.31 \u00b1 .91  \n80 65.99 \u00b1 13.20  110.49 \u00b1 7.25  111.04 \u00b1 15.48  439.18 \u00b1 116.65  13.93 \u00b1 .9  \n120 77.93 \u00b1 13.73  130.36 \u00b1 16.01  140.31 \u00b1 21.5  129.53 \u00b1 17.82  13.42 \u00b1 .84  \n160 110.66 \u00b1 34.98  177.17 \u00b1 35.08  216.68 \u00b1 22.84  191.47 \u00b1 49.73  12.62  \u00b1 1.36  \n200 92.88 \u00b1 28.13  121.51 \u00b1 12.63  172.70 \u00b1 21.44  133.37 \u00b1 22.85  14.72 \u00b1 1.09  \n      5\u00aa \nsemana  \n \n \n \n13.4 \u00b1 .36  \n       \n40 114.36 \u00b1 9.57  301.70 \u00b1 55.46  234.87 \u00b1 32.47  425.94 \u00b1 179.04  21.30 \u00b1 1.5  \n80 166.99 \u00b1 29.58  338.27 \u00b1 43.79  294.55 \u00b1 87.4 3 535.92 \u00b1 132.45  20.03 \u00b1  1.95  \n120 145.12 \u00b1 15.19  296.26 \u00b1 21.26  258.82 \u00b1 42.10  253.71 \u00b1 64.66  20.31 \u00b1 1.51  \n160 162.67 \u00b1 15.14  333.21 \u00b1 58.58  211.78 \u00b1 48.29  109.65 \u00b1 29.11  21.31 \u00b1 1.53  \n200 152.71 \u00b1 15.9  346.99 \u00b1 48.94  188.45 \u00b1 27.99  118.13 \u00b1 26.7 6 23.07 \u00b1 .65  \n      6\u00aa  \nsemana  \n \n \n \n15.59 \u00b1 .66  \n       \n40 157.08 \u00b1 20.44  343.92 \u00b1 44.1  502.07 \u00b1 60.35  1462.52 \u00b1 838.78  22.29 \u00b1 1.52  \n80 135.03 \u00b1 25.11  281.63 \u00b1 49.71  404.89 \u00b1 41.16  482.92 \u00b1 54.25  21.47 \u00b1 1.04  \n120 156.34 \u00b1 10.82  312.20 \u00b1 30.17  477.59 \u00b1 55.36  213.45 \u00b1 44.16  20.62 \u00b1 1.13  \n160 202.03 \u00b1 28.4  354.53 \u00b1 31.45  735.31 \u00b1 97.6  275.49 \u00b1 93.91  20.14 \u00b1 1.49  \n200 149.53 \u00b1 13.53  228.22 \u00b1 20.56  425.11 \u00b1 28.9  400.04 \u00b1 99.98  22.73 \u00b1 0.78  \n      7\u00aa. \nsemana  \n \n \n \n20.44 \u00b1 .54        \n40 120.42 \u00b1 12.53  282.63 \u00b1 42.81  335.81 \u00b1 71.79  375.52\u00b146.48  17.95 \u00b1 .84  \n80 132.89 \u00b1 13.65  328.99 \u00b1 51.15  379.81 \u00b1 70.78  419.69\u00b159.22  20.17 \u00b1 1.26  \n120 162.80 \u00b1 19.11  321.49 \u00b1 49.92  315.79 \u00b1 56.16  380.32\u00b161.04  19.13 \u00b1 1.48  \n160 190.60 \u00b1 20.13  403.45 \u00b1 36.8  499.08 \u00b1 71.63  628.68\u00b1128.78  18.44 \u00b1 1.31  \n200 163.04 \u00b1 11.46  269.58 \u00b1 27.6  388.05 \u00b1 84.49  240.69\u00b148.05  19.31 \u00b1 1.28  \n \n  \n  \n238 MECANISMOS DE PATOGE NICIDAD DE ESCHERICHIA COLI  \nAVIAR COMO L\u00cdNEA DE INVESTIGACI\u00d3N: ADHERENCIA A \nPROTE\u00cdNAS DE LA MATRIZ EXTRACELULAR  \n \nPATHOGENICITY MECHANISMS OF AVIAN ESCHERICHIA COLI AS A \nRESEARCH LINE: ADHESION TO EXTRACELLULAR MATRIX PROTEINS  \n \nS\u00e1nchez Villanueva C, Almanza M\u00e1rquez Y, Ram\u00edrez -Santoyo RM.  \n \nDepartamento de Enfermedades Infecciosas. Unidad de Biolog\u00eda Experimental. Universid ad Aut\u00f3noma de \nZacatecas. Calzada de la Revoluci\u00f3n Mexicana s/n. Col Tierra y Libertad. Guadalupe Zac. Apartado Postal 12 Tel y \nFax (492) 921- 13-26. E - mail: rmrs20@hotmail.com. y colv21@hotmail.com  \n \nSUMMARY  \nColibacillosis is a major cause of economic los ses \nfor the poultry industry. It is caused by pathogenic E. \ncoli strains that carry diverse virulence factors, some of \nwhich possibly allow the bacterium to adhere to host \ntissues. This research analyzed the adhesion ability of \npathogenic avian E . coli  to  extracellular matrix \ncomponents: type IV collagen, and fibronectin. Results \nshowed more adherence to type IV collagen but not so \nto fibronectin when pathogenic E. coli strains were \ncompared with strains of the normal flora.  \n \nRESUMEN  \nLa colibacilosis aviar  es una de las principales \ncausas de p\u00e9rdidas econ\u00f3micas en la industria av\u00edcola, \ny es producida por cepas pat\u00f3genas de E. coli  que \nportan diversos factores de virulencia, algunos de los cuales posiblemente le permiten adherirse a los tejidos \ndel hu\u00e9sped. En este trabajo se analiz\u00f3 la capacidad de \nadherencia de E . coli pat\u00f3gena aviar al c\u00f3lageno tipo \nIV y a la fibronectina, ambos componentes de la matriz \nextracelular. Los resultados mostraron m\u00e1s adherencia \nal col\u00e1geno tipo IV pero no a la fibronectina cuan do se \ncompararon cepas de E. coli  pat\u00f3gena y cepas de flora \nnormal.  \nLa colibacilosis aviar es un problema de salud \nanimal y econ\u00f3mico que afecta principalmente  a la \nindustria del pollo de engorda. Es causada por cepas \npat\u00f3genas de Escherichia coli  (APEC).  Entre los \ns\u00edndromes que produce destacan la enfermedad respiratoria y la septicemia (1,2)  \nA partir de la d\u00e9cada pasada se empez\u00f3 a analizar \nla capacidad de adherencia de los pat\u00f3genos \nbacterianos a la matriz extracelular. Con la finalidad de \nelucidar s\u00ed la capacidad de adherencia  de las cepas \npat\u00f3genas al col\u00e1geno tipo IV y/o a la fibronectina \ncelular son un posible mecanismo de patogenicidad, se realiz\u00f3 el presente trabajo.  \n MATERIAL Y M\u00c9TODOS  \nSe utilizaron cuatro cepas de APEC aisladas de \ncasos cl\u00ednicos  de septicemia aviar que fueron ColV \npositivos, para los estudios comparativos se utilizaron \ncuatro cepas de E. coli   aisladas de aves cl\u00ednicamente \nsanas que mostraron ser fimbria tipo 1 negativas y \nColV  negativas.  \nEnsayos de adherencia a prote\u00ednas de mat riz \nextracelular inmovilizadas: Se realizaron en cajas de cultivo de 24 pozos que conten\u00edan cubreobjetos a los \ncuales previamente se agreg\u00f3 col\u00e1geno tipo IV (Sigma) \na una concentraci\u00f3n de 8g/cm 2, as\u00ed mismo otros \ncubreobjetos fueron preparados con 3 pmol de  \nfibronectina celular (Sigma). Se colocaron in\u00f3culos de \n107 UFC/ml de cada una de las cepas de E. coli  y se \nincubaron 90 minutos a 37\u00baC, 5% de CO 2 y 85% de \nhumedad. Los cubreobjetos se lavaron, se ti\u00f1ieron con \nGiemsa y se observaron al microscopio contand o diez \ncampos visuales. Cada ensayo se repiti\u00f3 dos veces. Los resultados fueron sometidos a un ANDEVA.  \n \nRESULTADOS  \nSe encontr\u00f3 una mayor capacidad de adherencia \nal col\u00e1geno tipo IV en las cepas APEC en comparaci\u00f3n \ncon las cepas ind\u00edgenas de E . coli (p<0.05); en \ncontraste no se encontraron diferencias significativas \nen la adherencia a la fibronectina celular al comparar \nlos dos grupos de bacterias.  \n \nDISCUSI\u00d3N  \nLos resultados sugieren que la adherencia al \ncol\u00e1geno tipo IV puede ser un mecanismo de \npatogenicida d de las cepas APEC.  \n \nREFERENCIAS  \n1. Blanco, M., Blanco, J. E., Mora, A., Blanco, \nJ. Escherichia coli  septic\u00e9micos aviares: serotipos, \nfactores de virulencia, resistencia a antibi\u00f3ticos y \ndesarrollo de vacunas. Med. Vet. 13:  525 -535. 1996   \n  \n239 2. Dho Moulin, M .,Fairbroteher, M. Avian \npathogenic  Escherichia coli  (APEC) Vet. Res. 30: \n299-316. 1999.   \n(Financiamiento: Proyecto CONACYT 30593- B). \n \nEFECTO DE LA EDAD EN  LA MINERALIZACI\u00d3N DE L \nCASCAR\u00d3N DE HUEVOS D E GALLINAS CRIOLLAS GEN \nCUELLO DESNUDO (NA) HETEROCIGOTAS (NANA) Y SU \nCOMPARACI\u00d3N CON LA E STIRPE COMERCIAL BAB COCK B -\n380, DURANTE EL PRIM ER CICLO  DE POSTURA  \n \nEFFECT OF AGE ON EGG SHELL MINERALIZATION OF NATIVE, NAKED \nNECK (Na GENE), HETEROCYGOUS (Nana), AND BABCOCK B-380 HEN \nEGGS DURING THE FIRST LAYING CYCLE  \n \nAlvarez,  RMT.1,3,Solorio G. F.,2  Tato P.4,  T\u00e9llez G.3 \n \n1 Laboratorio de Parasitolog\u00eda, Facultad de Biolog\u00eda, Universidad Michoacana de San Nicol\u00e1s de \nHidalgo, Michoac\u00e1n  (UMSNH), 2 Instituto de Investigaciones Metal\u00fargicas. UMSNH.  Morelia Michoac\u00e1n  \n3 Departamento de Producci\u00f3n Animal: Aves, Facultad de Medicina Veterinaria y Zootecnia,  \nUniversidad Nacional Aut\u00f3noma de M\u00e9xico, M\u00e9xico D.F., 4 Departamento de Microbiolog\u00eda y Parasitolog\u00eda, \nFacultad de Medicina, Universidad Nacional, Aut\u00f3noma de M\u00e9xico, M\u00e9xico, D.F.  \n \nSUMMARY  \nThe eggshell contents of several chemical \nelements was determined during the first laying cycle. \nSamples were subjected to X -ray microanalysis. \nResults showed that during production peak, elements (C, O, N, Mg, Mn, Al, P, S, Ca, K, et c.) remain \nconstant. As hen age progresses chemical levels decline, and calcium carbonate crystal cementing \nprotein levels decrease, thus a more evident eggshell \ndemineralization and pore size increase occur. The \ncomparison showed that native hens experience a \nsmaller decrease (P<0.05) in the amounts of chemical elements.  \n \nRES\u00daMEN  \nSe determin\u00f3 la presencia de elementos qu\u00edmicos \nconstituyentes del cascar\u00f3n, durante el primer ciclo de \npostura. Las muestras se somet\u00edan a microan\u00e1lisis de \nrayos X. Los resultado s mostraron que durante el pico \nde postura se mantienen constante los elementos \nqu\u00edmicos, (Carbono, Oxigeno, Nitr\u00f3geno, Magnesio, \nManganeso Aluminio,  F\u00f3sforo, Azufre, Calcio, \nPotasio etc. conforme avanza la edad, disminuye estos.  \nAl reducir las concentraciones, disminuyen las \nprote\u00ednas cementantes de cristales de carbonato de Calcio, observ\u00e1ndose mayor desmineralizaci\u00f3n del \ncascar\u00f3n y abertura de poros. La comparaci\u00f3n mostr\u00f3 \nque las gallinas criollas disminuye menos las cantidad \nde elementos qu\u00edmicos  P < 0.05.  El objetivo de este trabajo fue, determinar la \nvariaci\u00f3n en  la distribuci\u00f3n de la cut\u00edcula, en las diferentes zonas, del cascar\u00f3n de huevos de gallinas \ncriollas gen cuello desnudo (Na) heterocigotas (Nana) \ncomparadas con la gallinas comerciales B -380. La \nmetodolog\u00eda  consisti\u00f3 en cortar 5 pedazos de  3x3 mm \nde cascar\u00f3n con un microdisco de diamante, en zonas \npolares, ecuatoriales medio -ecuatorial -polar,  se \nmetalizaron (S150A sputter coater)  con cobre, las \nmuestras de cascar\u00f3n cada 8 semana, a part ir del la \nsemana 4\u00b0 de postura, en un microscopio electr\u00f3nico de \nbarrido (Jeol JSM.6400), a una acelaci\u00f3n de electrones \nde 10,000 voltios  se localizaba la regi\u00f3n m\u00e1s \nrepresentativa y se tomaba fotograf\u00eda a 700X, 1500X y 4000X  de magnificencias. Los resul tados mostraron  \nque existe diferencias de distribuci\u00f3n  de la cut\u00edcula  en \nlas diferentes zonas del  cascar\u00f3n, y adem\u00e1s varia entre \nlas gallinas criollas y las gallinas B -380. Conforme \navanza la edad, diminuye su cantidad y  distribuci\u00f3n, \ntambi\u00e9n existi\u00f3 un diferencia entre las dos  gallinas.  \nConclusiones: La distribuci\u00f3n de la cut\u00edcula no es \nhomog\u00e9nea  en todo el cascar\u00f3n, var\u00eda su concentraci\u00f3n \ndependiendo de la zona. As\u00ed como tambi\u00e9n  se observ\u00f3 \nen las  fotograf\u00edas, que le afecta considerablemente la edad de la gallina conforme avanza el ciclo productivo, \naunque las dos gallinas se ve afectada en su cut\u00edcula por la edad, sin embargo las gallinas criollas mantienen  \nlas zonas ecuatorial muy protegidas en todo el ciclo , \ncomparadas con las  B -380. \n  \n  \n240 A MODEL FOR THE HORIZONTA L TRANSFER OF \nCAMPYLOBACTER JEJUNI  IN POULTRY  \n \nUN MODELO PARA LA TRANSFERENCIA HORIZONTAL DE \nCAMPYLOBACTER JEJUNI EN AVES  \n \nK. Amoako, S. Gomis, A. Potter, and B. Allan  \n \nVeterinary Infectious Disease Organization, 120 Veterinary Road, Saskatoon, Saskatchewan, Canada S7N 5E3.  \n \nRESUMEN  \nEl prop\u00f3sito de este trabajo fue desarrollar un \nmodelo para la colonizaci\u00f3n del pollo con C. jejuni.  \nDesarrollamos un modelo para la transferencia \nhorizontal de la bacteria en un grupo de aves. Se \nobtuvieron  improntas cloacales de aves individuales y \nse cultivaron en agar de Karmali, medio sumamente \nselectivo para este g\u00e9nero bacteriano. Al tercer d\u00eda el \n40% de las aves mostraba ya colonizaci\u00f3n y esto fue \nv\u00e1lido tambi\u00e9n para el 85% de las aves al quinto d\u00eda. El \ns\u00e9ptimo d\u00eda todas las aves del grupo eran positivas a C. \njejuni.  Los pollos desafiados inicialmente continuaron \ncolonizados a todo lo largo del experimento.  \n \nThe purpose of this work was to develop a model \nfor the colonization of chickens by Campylobact er \njejuni.   Day-old chicks are not normally colonized by \nC. jejuni.  Around two weeks of age colonization of \nbirds is first detected. By the time of slaughter, \nhowever, between 30 and 100% of flocks will be colonized. It is assumed that a few birds are col onized. \nThe bacteria are shed in the feces and spread to other \nbirds. We have developed a model for the horizontal \ntransfer of C. jejuni within a group of birds. At day of \nage 20 percent of the birds were challenged with 10\n8 \nCFU\u2019s of C. jejuni NCTC11186.  This is the strain of \nC. jejuni that has been sequenced. The bacteria were grown for 18 hours under reduced oxygen conditions \non Mueller -Hinton agar. For use in the challenge the \nbacterial cells were resuspended in normal saline and \ndiluted to the appropri ate concentration. Cloacal swabs \nwere obtained from individual birds and cultured on \nKarmali agar, a medium that is very selective for Campylobacter, to monitor the spread of colonization. \nBy day three 40% of the birds were colonized and by \nday five 85% of  the birds were colonized. On day 7 all \nbirds in the group were positive for C. jejuni.  The birds \nthat were initially challenged remained colonized throughout the experiment.  \nWe have also shown that it is possible to colonize \nolder birds by horizontal tra nsfer. Broilers that were \nfour weeks old were tested to confirm that they were not shedding C. jejuni. Forty broilers were housed \ntogether and 25 % of the birds were given an oral challenge of 5 X 10\n6 colony forming units of C. jejuni. \nThe bacteria were gr own as previously described. By \nday five 75% of the birds, including all those \nchallenged had positive cloacal swabs for C. jejuni and \nby day seven all birds were shedding C. jejuni.  \nThese models mimic the situation that occurs \nwhen a flock is initially c olonized. It will be useful in \nthe study of the effect of vaccination on the \ncolonization of poultry by C. jejuni.  \n  \n \n \n  \n \n   \n \n  \n  \n241 CARACTERIZACI\u00d3N HIST OPATOLOGICA EN ENC\u00c9F ALOS DE \nPOLLOS LIBRES DE PAT\u00d3GENOS ESPEC\u00cdFICOS \nEXPERIMENTALMENTE IN FECTADOS CON EL VIRUS  DE LA \nENFERMEDAD DE NEWCAS TLE CEPA CHIMALHUAC\u00c1N  \n \nBRAIN HISTOPATHOLOGICAL CHARACTERIZATION OF SPECIFIC \nPATHOGEN FREE (SPF) CHICKENS EXPERIMENTALLY INFECTED WITH \nNEWCASTLE DISEASE VIRUS, CHIMALHUAC\u00c1N STRAIN  \n \nMVZ Adriana Barri1, MVZ MC Nestor Ledesma1, MVZ PhD. Guillermo T\u00e9llez Isa\u00edas1 , \nMVZ PhD. David Caldwell2. \n \n1Unversidad Nacional Aut\u00f3noma de M\u00e9xico, Departamento de Producci\u00f3n Animal:Aves  \n2Texas A&M University, Poultry Science Department  \n \nSUMMARY  \nLesions found in the central nervous system of 36 \nSPF chi ckens were histopathologically characterized. \nBirds were inoculated with Newcastle disease virus, \nChimalhuac\u00e1n strain. Five cross sections per brain were obtained. The following lesions were found: \ngliosis, 97%; focal necrosis, 69%; demyelination, 58%; \nperipheral chromatolysis, 55.5%; and vascular \ndegeneration, 53%. The most affected regions of the \nbrain were as follows: Telencephalon and cranial/ \ncaudal diencephalon: the neostriatum and the hiperestriatum. Mesencephalon: the optic chiasma. \nCerebellum: the pyramidal cells. These results differ \nfrom those published by other authors regarding \ndifferent newcastle disease virus strains. Further \nstudies comparing different strains are required.  \n \nRESUMEN  \nFueron caracterizadas histopatologicamente las \nlesiones en sistema nervioso central de 36 pollos SPF \ninoculados con la cepa Chimalhuacan del virus de \nENC, se estudiaron 5 cortes coronales por cada \nencefalo, encontrandose como lesiones mas frecuentes: gliosis 97%, necrosis focal 69%, desmielinizaci\u00f3n 58%, cromatoli sis periferica 55.5% y degeneracion \nfibrinoide 53%. Los sitios mas afectados fueron en telencefalo, diencefalo rostral y caudal, el neostriato e hiperestriato, en mesencefalo el quiasma optico y en \ncerebelo las celulas piramidales. Estos resultados \ndifiere n con lo reportado para otras cepas del virus de \nENC. Se requieren mas estudios para comparar las \nlesiones producidas por otras cepas.  \n \nABSTRACT  \nA histopathological characterization of lesions \nfound in the central nervous system of 36 SPF chickens was mad e. The birds were inoculated with the \nNewcastle disease virus Chimalhuacan strain. Five transversal cuts per brain were made, finding as \nfrequent lesions: gliosis 97%, focal necrosis 69%, \ndemyelination 58%, peripheral chromatolisis 55.5%, \nand vascular dege neration 53%. The most affected \nregions of the telencephalon, rostral and caudal diencephalon were the neostriatum and hiperestriatum, of the mesencephalon the optic chiasm, and of the \ncerebellum the pyramidal cells. These results differ \nfrom other reports  made for other NDV strains. Further \nstudies making comparisons among different strains \nare required.  \n \nINTRODUCCI\u00d3N  \nEl enc\u00e9falo de un ave esta dividido en 5 \ndivisiones para su mejor estudio; el telenc\u00e9falo, \ndienc\u00e9falo, mesenc\u00e9falo, metenc\u00e9falo y mielenc\u00e9falo. \nDe cada subdivisi\u00f3n existen subregiones, y cada una de \nestas divisiones y subdivisiones constituye un elemento de suma importancia para el buen funcionamiento del \nencefalo y por ende del ave. Las lesiones provocadas \npor el virus de la enfermedad de New castle (V -ENC) \nen el sistema nervioso central (SNC) de pollos \ninfectados con cepas velog\u00e9nicas (V V -ENC), no han \nsido debidamente caracterizadas. Aunque en distintos pa\u00edses se han descrito las lesiones provocadas por \nalgunas cepas mesog\u00e9nicas, mesog\u00e9nicas neuroadaptadas, velog\u00e9nicas viscerotr\u00f3picas y \nvelog\u00e9nicas neurotr\u00f3picas,\n no existen estudios en \nnuestro pa\u00eds sobre las lesiones producidas por la cepa \nChimalhuacan V V -ENC en el enc\u00e9falo de las aves. \nAdem\u00e1s, la mayor\u00eda de los informes \u00fanicamente \ndescriben encefalitis no supurativa sin especificar el \nsitio anat\u00f3mico de la lesi\u00f3n, su distribuci\u00f3n ni su grado, \npor lo que podr\u00edan existir diferencias con respecto a las \ncepas de las cuales s\u00ed existen informes, as\u00ed como \nexisten diferencias en los signos cl\u00ednicos o bservados. \nAl tener identificadas las lesiones y la ubicaci\u00f3n \nneuroanat\u00f3mica de aquellas provocadas por el V V - \n  \n242 ENC, se puede tener un diagn\u00f3stico m\u00e1s certero. El \nprop\u00f3sito de este estudio fue identificar y caracterizar \nlas lesiones en SNC en aves libres de  pat\u00f3genos \nespec\u00edficos (LPE) que fueron inoculadas \nexperimentalmente con la cepa Chimalhuacan V V -\nENC. Se utilizaron 54 aves las cuales fueron separadas en dos grupos. Grupo 1) 36 aves fueron inoculadas I.M. con 0.2 ml de 10\n6 DIE 50 de V V- ENC. Grupo 2) \n18 aves inoculadas I.M. con PBS est\u00e9ril y fueron \nutilizadas como grupo testigo negativo. A las 24, 36 y \n48 horas posinoculacion (PI) fueron sacrificados 2 \npollos del grupo infectado y uno del testigo negativo \ncon el fin de obtener el encefalo de estas, \nposter iormente se obtuvieron de la misma forma las \nmuestras a intervalos 4 horas entre cada muestreo. \nCada enc\u00e9falo se fij\u00f3 en formalina al 10% amortiguada \na un pH de 7 para su posterior proceso por la t\u00e9cnica de \ninclusi\u00f3n en parafina y tinci\u00f3n H y E. Se hiciero n 5 \ncortes por enc\u00e9falo (telenc\u00e9falo, dienc\u00e9falo rostral, dienc\u00e9falo caudal, mesenc\u00e9falo y cerebelo) y se \nregistraron las lesiones y la frecuencia en cada regi\u00f3n \nanat\u00f3mica. No hubo mortalidad ni signolog\u00eda \nobservada en el grupo 2, mientras que en el grupo 1, \ninoculado con la V V -ENC, se encontraron signos \nrespiratorios (estornudos, secreci\u00f3n nasal), digestivos (diarrea color verde esmeralda), y nerviosos \n(incoordinaci\u00f3n, tort\u00edcolis, tics, tremor) a partir de la \nhora 36 PI. La mortalidad empez\u00f3 a las 72 hora s PI. \nCerca del 80% de las aves presentaron signos nerviosos. Se observ\u00f3 que la mayor\u00eda de las aves que \nmostraron signos cl\u00ednicos nerviosos, presentaron \nlesiones a la histolog\u00eda, aunque en algunos casos se \npudieron observar lesiones sin que los animales \npresentaran la signolog\u00eda nerviosa correspondiente. Las regiones que presentaron cambios histol\u00f3gicos de \nmanera m\u00e1s importante y constante fueron: telenc\u00e9falo \n(neostriato e hiperestriato particularmente); \nmesenc\u00e9falo (sobre todo en la subregi\u00f3n del quiasma \n\u00f3ptico); y en el cerebelo (particularmente en la capa de \nc\u00e9lulas piramidales). En la evaluaci\u00f3n de estas regiones, las lesiones histol\u00f3gicas consistieron  en: \n97% focos de gliosis, 89% focos de necrosis; 69% \nfocos de desmielinizaci\u00f3n leves, 58% cromatolisis \nperif\u00e9rica; 55.5% degeneraci\u00f3n fibrinoide de vasos \nsangu\u00edneos, 53% edema perivascular, 53% \nneuronofagia, 33% infiltraci\u00f3n linfoc\u00edtica perivascular \n(manguito perivascular) leve, 28% hemorragias y 19% meningitis no supurativa leve. Estos resultados, \ndifieren  con lo descrito en cepas mesog\u00e9nicas y \nlentog\u00e9nicas en donde se ha observado encefalitis \ndifusa no supurativa caracterizada por infiltraci\u00f3n \nlinfoc\u00edtica perivascular, malacia, vasculitis proliferativa \ny desmielinizaci\u00f3n. Se requieren m\u00e1s estudios en \ndonde  sean comparados los sitios de lesi\u00f3n de otras \ncepas velog\u00e9nicas viscerotr\u00f3picas y neurotr\u00f3picas de la \nenfermedad de Newcastle para poder saber si existen \ndiferencias entre las diferentes cepas. Es de suma \nimportancia realizar, para cualquier estudio \nhisto patologico (sin importar la enfermedad que se este \ndiagnosticando) de encefalo, los 5 cortes usados en este \nestudio, con el fin de abarcar la mayor area posible del \nencefalo y evitar omitir areas que presenten lesiones importantes que nos puedan dar indici o de la presencia \ndel virus.  \n (El articulo completo sera publicado en el Avian \nPathology ).\n \nDEMONSTRATION OF AVIAN PNEUMOVIRUS INFECTION IN \nCHICKENS IN RUSSIA  \n \nDEMOSTRACI\u00d3N DE LA INFECCI\u00d3N DE POLLOS  \nCON EL NEUMOVIRUS AVIAR (APV ) EN RUSIA  \n \nY.A. Bochkov, E.V . Ovchinnikova, A.V. Borisov, V.N. Irza, V.V. Borisov, G.V. Batchenko, T.B. Manin, L.O. \nScherbakova, V.V. Drygin  \n \nAll-Russian Research Institute for Animal Health, 600901, Vladimir, Russia  \n \nRESUMEN  \nLa infecci\u00f3n causada por el neumovirus aviar \n(APVI) antes  conocida como rinotraque\u00edtis infecciosa \ndel pavo ( TRT) es causada por un APV  que pertenece al \ng\u00e9nero Metapneumovirus,  familia Paramyxoviridae.  La \ninformaci\u00f3n serol\u00f3gica obtenida con un kit de ELISA \ncomercial detect\u00f3 anticuerpos contra el APV \naproximadamen te en el 50% de las muestras de suero obtenidas de pollos de 150 d\u00edas de edad o m\u00e1s, en \ngranjas en Rusia y pa\u00edses CIS en el 2001. Los \nresultados de los estudios moleculares, biol\u00f3gicos y \nserol\u00f3gicos sugirieron la presencia de una infecci\u00f3n por APV  en poll os, en los pa\u00edses citados.  \n \nAvian pneumovirus infection (APVI), earlier \nknown as infectious turkey rhinotracheitis (TRT), is  \n  \n243 caused by an avian pneumovirus (APV), which belongs \nto genus Metapneumovirus, family Paramyxoviridae. \nThe disease is an upper resp iratory infection of turkeys \nand in chickens the role of APV as a primary pathogen \nis less clearly defined, but it is commonly associated \nwith swollen head syndrome in breeder chickens. For \nthe first time TRT was described in turkeys in Southern Africa in the late 1970s and then in France, UK and \nother countries. According to the serological data using \ncommercial ELISA kit (Biochek, USA) antibodies to \nAPV were detected in approximately 50 % of the \nserum samples obtained from chickens at the age of \n150 days and elder from poultry farms of Russia and CIS-countries in 2001 that specifies a wide prevalence \nof the disease. By the use of RT -PCR with primers designed by Cavanagh et al. [1999], which flanks a part \nof G gene of APV, 49 samples of pathological materia l \n(lungs, tracheas and guts) were tested. The primers \nallow to differentiate 2 pneumovirus genotypes - A and \n?. In four samples APV genome of genotype A was \nidentified. In three samples genome of IBV field \nisolates together with a pneumovirus was detected.  A \npneumovirus of genotype B was not identified. Rather \nlow percentage of positive samples can possibly be \ncaused by circulation of  pneumoviruses of other \ngenotypes, which could not be detected by the given \nprimers. Thus, the results of molecular -biologica l and \nserological studies suggested the presence of a \npneumovirus infection in chickens on territory of Russia and countries of CIS.  \n \nSTUDIES ON PREDOMINANT DISEASES IN POULTRY  \nBACKYARD FLOCKS IN MOROCCO (KHENIFRA REGION)  \n \nESTUDIOS SOBRE LAS ENFERMEDADES PREDOMINANTES  \nEN LAS PARVADAS DE TRASPATIO EN MARRUECOS  \n(REGI\u00d3N DE KENIFRA)  \n \nK. Bouzoubaa, B. Atifi and M. El Houadfi  \n \nInstitut Agronomique et V\u00e9t\u00e9rinaire Hassan II, D\u00e9partement de Pathologie Aviaire  \nBP 6202  Rabat -Instituts   Morocco  \n  \nRESUMEN  \nEl objetiv o de estos estudios fue determinar las \nenfermedades predominantes en la avicultura de traspatio de tres peque\u00f1os poblados de la provincia de \nKenifra, encontrando que \u00e9stas son de origen \ninfeccioso y parasitario. Esta \u00faltima categor\u00eda fue masiva y, adem\u00e1s, se encontr\u00f3 seroprevalencia variable \nrespecto a enfermedad de Newcastle, infecci\u00f3n de la \nbolsa de Fabricio, bronquitis infecciosa, Mycoplasma gallisepticum  y M. synoviae.  El 5.6% de las improntas \ncloacales permiti\u00f3 el crecimiento de Salmonella \nenteritidis.  \n \nABSTRACT  \nThe main objective of these studies is to \ndetermine predominant diseases of backyard poultry in \nthree villages located in the rural district of 'Lehri', in \nthe province of Kenifra. An inquiry on medical aspect \nwas carried out. Predominant diseas es were determined \non the basis of observations of sick poultry, necropsy \nexaminations, and mainly laboratory analyses. One \nhundred eighty blood samples were collected at \ndifferent intervals : D\n1, D 15 and D 45. Different \nserological tests were carried out i n order to detect \nantibodies against the following diseases : newcastle disease by IH and ELISA, infectious bursal disease and \ninfectious Bronchitis by ELISA, Mycoplasma \ngallisepticum and Mycoplasma synoviae  by plate \nagglutination test. One hundred eighty cloacal swab \nsamples were used for the isolation and identification \nof Salmonella. These studies showed that predominant diseases of backyard poultry in the area are of \ninfectious and parasitic origin. The examinations and \nobservations of the sick animals revealed a predominance of diseases with respiratory signs. In the \npost mortem examinations, internal and external \nparasites were identified; a massive parasitic \ninfestation of chickens in the area of study was shown.  \nUsing some serological tests, a high p revalence of \nall the diseases investigated in the three villages was found. Seroprevalence between 10% and 70% was \nfound for the Newcastle diseases by IH test. The \nELISA  revealed a seropositivity of 80% for Newcastle \ndisease, Infectious Bursal Disease, an d Infectious  \nBronchitis. The plate agglutination showed a \nseropositivity between 27% to 37% for Mycoplasma \ngallisepticum, and a seropositivity between 3% to 17% \nfor Mycoplasma synoviae.  Bacteriological examination \nshowed 5.6% of all 180 cloacal swab sampl es were \ncontaminated by Salmonella enteritidis . \n  \n  \n244 SITUACI\u00d3N Y OPORTUNIDAD DE LA PRODUCCI\u00d3N DE HUEVO \nORGANICO EN UN SISTEMA RURAL DE LA SIERRA NORTE DE \nPUEBLA  \n \nSTATUS AND OPPORTUNITIES OF ORGANIC EGG PRODUCTION IN A \nRURAL SYSTEM IN THE NORTHERN SIERRA OF PUEBLA \n \n1Mar\u00eda Cano -Basave, 1Carlos L\u00f3pez -D\u00edaz y 2Marco Antonio Ju\u00e1rez- Estrada.  \n \n1Departamento de Econom\u00eda y Administraci\u00f3n. 2Departamento de Producci\u00f3n Animal: Aves.  Facultad de Medicina \nVeterinaria y Zootecnia,  Universidad Nacional Aut\u00f3noma de M\u00e9xico. Av enida Universidad 3000.  \nCiudad Universitaria 04510 M\u00e9xico, D.F.  \n \nSUMMARY  \nThis study determined the feasibility of \nproduction and commercialization of organic eggs in a \ncommon -land community, in the Mexican state of \nPuebla. A survey was performed among the  urban \npopulation to determine the acceptability of this type of \nproducts. Under the social/economic conditions observed in Ixtacamaxtitl\u00e1n, it was determined that the \nproduction of organic eggs is feasible using semi -heavy \nand native hens. Probing showed that the product can \nbe well accepted i among the urban population, since consumers appreciate organic eggs, and typify them as \n\u201cranch eggs\u201d. This type of eggs was preferred over regular farm eggs.  \n \nRESUMEN  \nEl presente estudio determin\u00f3 factibilidad de \nproducci\u00f3n y comercializaci\u00f3n de huevo org\u00e1nico en \nuna comunidad ejidal de Puebla. Se efect\u00fao un sondeo urbano para determinar la aceptaci\u00f3n de este tipo de \nproductos. Bajo las condiciones sociales y econ\u00f3micas \nobservadas en la comunidad de Ixtacamaxtitl\u00e1n se  \ndetermin\u00f3 que es factible la producci\u00f3n de huevo \norg\u00e1nico mediante la explotaci\u00f3n de gallinas \nsemiligeras y criollas. El sondeo efectuado en un medio \nurbano fue aceptable, ya que el consumidor aprecia el \nconsumo de huevo \u201corg\u00e1nico\u201d tipificado como \u201chuevo \nranchero\u201d y lo prefiere al consumo de huevo de granja.  \n \nINTRODUCCI\u00d3N  \nLa industria del huevo para plato cubre \naparentemente toda la gama de necesidades y \nrequerimientos del consumidor en cuanto a precio y \ncalidad 1. Sin embargo, actualmente existe un inter\u00e9s  \ncreciente por el consumo de productos de origen \nnetamente org\u00e1nicos o bien enriquecidos con aceites \ninsaturados (Omega 3 y Omega 6). Como ya se sabe, la \nproducci\u00f3n conocida como \u201corg\u00e1nica\u201d viene a \nsatisfacer la necesidad de la poblaci\u00f3n de mejorar su calidad de vida y prolongar en tiempo la esperanza de \nla misma, al consumir alimentos m\u00e1s sanos producidos a partir del cuidado de los recursos naturales y de la \nmenor utilizaci\u00f3n de sustancias potencialmente nocivas \n(antibi\u00f3ticos, sudanes, conservadores, etc. )2. Los \nalimentos que proporcionan los sistemas productivos \n\u201corg\u00e1nicos\u201d son inocuos para la salud humana, ya que no contienen residuos qu\u00edmicos potencialmente \npeligrosos ni contaminan el  medio ambiente 2. \nAdem\u00e1s, mediante el sistema extensivo de producci\u00f3n  \nse puede lograr una producci\u00f3n autosostenible que \npuede llegar a satisfacer la demanda de alimentos de la \npoblaci\u00f3n, manejar los recursos naturales y humanos, \nal igual que los financieros y f\u00edsicos, para aumentar la \nriqueza y bienestar a largo plazo que n o impliquen un \ncrecimiento real del costo social. 2,3 En el presente \ntrabajo se estudio la factibilidad de producci\u00f3n y \nconsumo del \u201chuevo de rancho\u201d (caracterizado como \n\u201corg\u00e1nico\u201d debido a la falta de legislaci\u00f3n al respecto \nen nuestro pa\u00eds) producido en l a comunidad de \nIxtacamaxtitl\u00e1n en la sierra norte de Puebla.  \n \nMATERIAL Y M\u00c9TODOS  \nSe estudi\u00f3 la situaci\u00f3n de la explotaci\u00f3n aviar en \n22 familias de la comunidad del ejido Almeya en el municipio de Ixtacamaxtitl\u00e1n en la sierra Norte del Estado de Puebla. Ut iliz\u00e1ndose cuestionarios abiertos y \ncerrados para la obtenci\u00f3n de informaci\u00f3n t\u00e9cnica, \nsanitaria y socioecon\u00f3mica a partir de las 22 familias \ncensadas. Para la recopilaci\u00f3n de la informaci\u00f3n a nivel \nde preferencia de consumo se aplicaron 100 \ncuestionarios cerrados en el consumidor urbano de \nestrato medio de la ciudad de M\u00e9xico, Distrito Federal. \nLa informaci\u00f3n fue capturada en computadora y \nprocesada a trav\u00e9s de los paquetes computacionales \nSPSS y la hoja de c\u00e1lculo Excel (Microsoft Office 2000 \u00ae). Los resu ltados se expresan en porcentajes.  \n \nRESULTADOS  \nEl censo av\u00edcola de las 22 familias reporto un \ntotal de 466 aves, de las cuales 18.66% eran pollitos, \n14.8% pollonas de reemplazo, 4.29% eran gallos y  \n  \n245 10.51% pollos para consumo, otras aves observadas \nfueron 9 .87% de guajolotes y 0.21% de patos. De las \ngallinas en postura se observ\u00f3 que 30.90% del total de \nlas gallinas estaban en postura, 10.72% en descanso y \nel resto eran aves no productoras. Durante las dos \nsemanas en las cuales se verific\u00f3 la tasa de ovoposi ci\u00f3n \nla mayor cantidad de huevos registrados fue en la \nfamilia 20 con 10.18% de la producci\u00f3n total que fue \nde 737 huevos y en la familia 2 con 9.50%. La mayor\u00eda \nde las familias reportaron cada una aproximadamente \nun 4% de la producci\u00f3n total y son pocas l as que \ntuvieron un porcentaje menor al 1 por ciento, como la familia identificada con la clave 15 que registro \u00fanicamente 0.81% de la producci\u00f3n total. En las \ngallinas de la familia 9 no se registr\u00f3 ovoposici\u00f3n \ndurante toda la duraci\u00f3n del estudio. El tipo  de \nexplotaci\u00f3n es extensivo, las aves pastorean libremente \ndurante el d\u00eda y en la noche son encerradas en un \ngallinero. En el gallinero se les proporciona \u00fanicamente ma\u00edz que es cultivado en la misma \ncomunidad, adem\u00e1s de desperdicios de cocina y masa, \nel alimento comercial s\u00f3lo se utiliza para \ncomplementar la dieta de los pollitos en el 42.8% de \nlos casos. En la comunidad la mayor\u00eda de los habitantes \nno utiliza medicina preventiva ni profilaxis para tratar a \nsus gallinas debido a falta de informaci\u00f3n ya qu e \ndesconocen el manejo que se les da en una granja comercial. La comercializaci\u00f3n en la comunidad se efect\u00faa para usarlo como huevo f\u00e9rtil y reproducir a sus \ngallinas as\u00ed como para consumo pagando a un peso \n(Moneda Nacional, mes de julio del 2001) la pieza de \nhuevo. De los cuestionarios aplicados a las familias de \nclase media de la ciudad de M\u00e9xico para conocer la \npreferencia que existe por este tipo de huevo se \nencontr\u00f3 que el 74% de los consumidores conoce al \nhuevo \u201corg\u00e1nico\u201d (definido espec\u00edficamente as\u00ed  de \nacuerdo a  las caracter\u00edsticas de producci\u00f3n y \ncomposici\u00f3n referidas para las producciones av\u00edcolas \nde este tipo en Europa) como huevo de rancho, el 18% \ncomo huevo de gallinero, el 5% como huevo de \ntraspatio y el  3% como otro tipo de huevo.  Ninguno de los consumidores se refiri\u00f3 a \u00e9l como huevo \n\u201corg\u00e1nico\u201d. El 85% de los consumidores ha probado el \nhuevo de rancho alguna vez en su vida , de ellos el \n20% lo ha probado una o dos veces por mes, el 2% lo ha consumido 3 a 6 veces por a\u00f1o, el 28% una o dos \nveces por a\u00f1o y finalmente el 34% menos de una vez \npor a\u00f1o. El 80% de los consumidores considera que el huevo de rancho tiene un sabor diferente al huevo que \nnormalmente se vende en tiendas de autoservicio. La \nmayor parte de los consumidores (62%) cree que e l \nhuevo de rancho es mas saludable que el huevo de \ngranja, 7% considera que es menos saludable y 31% \ncree que es igual de saludable que el huevo de granja. Con respecto al colesterol, el 23% de los consumidores \ncree que tiene mas colesterol que el huevo de granja, 23% cree que tiene menor cantidad y 54% considera \nque el huevo tiene la misma cantidad de colesterol que \nel huevo de granja. El 70.4% de los consumidores cree \nque el huevo de rancho es mas sabroso que el huevo de \ngranja, el 25.5% piensa que es igu al de sabroso y \n\u00fanicamente el 4% considera que es menos sabroso en comparaci\u00f3n con el huevo de granja. De acuerdo al valor nutritivo el 59%  de los consumidores considera \nque el huevo de rancho es mas nutritivo que el huevo \nde granja, 7% cree que es menos nutritivo y 34% \nconsidera que es igual de nutritivo que el huevo de \ngranja.  \n \nDISCUSI\u00d3N  \nBajo las condiciones sociales y econ\u00f3micas \nobservadas en la comunidad de Ixtacamaxtitl\u00e1n se \ndetermin\u00f3 que es factible la producci\u00f3n de huevo \norg\u00e1nico mediante la explota ci\u00f3n de gallinas \nsemiligeras y criollas. Siempre y cuando se establezcan las condiciones de medicina preventiva, pr\u00e1cticas de \nmanejo, crianza y alimentaci\u00f3n adecuadas con la \nfinalidad de eficientizar la producci\u00f3n. Se requiere el \nestudio de un modelo para determinar un proceso de \ncomercializaci\u00f3n m\u00e1s eficiente de los huevos producidos en este tipo de explotaciones de acuerdo a \nlos lineamientos de producci\u00f3n y comercializaci\u00f3n \nestudiados por Lampkin y Padel 3, Mendoza y \nRam\u00edrez 4, y G\u00f3mez et al 5. Se requiere el estudio de \nun modelo econ\u00f3mico -social para eficientizar el \nestablecimiento y funcionalidad de un criadero de \ngallinas ecol\u00f3gicas bajo el esquema de producci\u00f3n \ncomunal mexicano, de acuerdo a las sugerencias \nestablecidas para regiones de recursos econ\u00f3micos escasos conforme al marco socioecon\u00f3mico de \ndesarrollo sustentable estudiado por Lampkin y Padel 3. \nEn el pa\u00eds no existe a\u00fan  legislaci\u00f3n respecto a las \npr\u00e1cticas de producci\u00f3n, comercializaci\u00f3n y sanidad \ndel \u201chuevo org\u00e1nico\u201d, por lo cual se requiere est udiar  \nla formulaci\u00f3n de una propuesta de ley de este tipo. En \nel presente estudio se observ\u00f3 ampliamente que el consumidor aprecia y prefiere el consumo de huevo \n\u201corg\u00e1nico\u201d tipificado como \u201chuevo ranchero\u201d. Adem\u00e1s \nse constat\u00f3 que existe una inquietud creciente por el \nconsumo de productos av\u00edcolas clasificados como \n\u201corg\u00e1nicos\u201d.  \n \nREFERENCIAS  \n1. Situaci\u00f3n actual y perspectivas de huevo \npara plato en M\u00e9xico 1990 -2000. SAGARPA -CEA. \nM\u00e9xico, D.F. 2001.  \n2. Torres, T.F., y Tr\u00e1faga, D.Y.  La agricultura \nOrg\u00e1nica. Institut o de Investigaciones Econ\u00f3micas -\nUNAM. M\u00e9xico D.F. 1997.   \n  \n246 3. Lampkin, N.H. and Padel, S. The economics \nof organic farming: an international perspective. Cab. \nInternational. United Kingdom. 1994.  \n4. Mendoza Z. J. A., Ram\u00edrez F. L.  El \npotencial econ\u00f3mico de los Pro ductos Agropecuarios Comercialmente No Tradicionales.  Memoria de la Primera Exposici\u00f3n Nacional. 1997.  \n5. G\u00f3mez C. A., G\u00f3mez T. L., Schwentesius R. \nR., Rend\u00f3n M. R. Perspectivas de la Agricultura \nOrg\u00e1nica de M\u00e9xico. Ponencia. PIAI -CIESTAAM. \n2001.\n \nNEUROPATHOLOGY ASSOCIATED WITH HAEMOPROTEUS \nLOPHORTYX INFECTION IN BOBWHIT E QUAIL  \n \nNEUROPATOLOG\u00cdA ASOCIADA CON LA INFECCI\u00d3N POR \nHAEMOPROTEUS LOPHORTYX EN CODORNICES BOBWHITE  \n \nCarol Cardona1, Arthur Bickford2 \n \n1Veterinary Medicine Extension, Surge III, Rm. 1383, Univ ersity of California, Davis, Davis, CA  95616  \n2California Animal Health and Food Safety Laboratory, Turlock, PO Box 1522 Turlock, CA  95381  \n \nRESUMEN  \nLas parvadas de codornices Bobwhite con \nfrecuencia experimentan durante el verano \u00edndices de \nmortalidad qu e llegan al 20 \u00f3 30%, debidas a \nHaemoproteus lophortyx  en California. Las aves \ninfectadas se rehusan a moverse, presentan plumaje erizado, esplenomegalia y emaciaci\u00f3n. \nAproximadamente el 10% de los animales infectados tambi\u00e9n presenta signos neurol\u00f3gicos c omo \nincapacidad para caminar o ponerse de pie, aun cuando \ntodas las aves (excepto las moribundas) pueden volar. \nMuestran tambi\u00e9n sacudimientos de la cabeza, temblor y pataleo. Los cortes seriados de enc\u00e9falo de aves \nafectadas mostraron numerosas \u00e1reas de \nencefalomalacia, infiltraci\u00f3n linfocitaria perivascular y \nestrechamiento de la luz de los vasos sangu\u00edneos. \nNuestra propuesta es que H. lophortyx  penetra en las \nc\u00e9lulas endoteliales del cerebro y produce oclusi\u00f3n del \nflujo sangu\u00edneo y encefalomalacia en las  \u00e1reas irrigadas \npor los vasos afectados.  \n Commercial bobwhite quail flocks repeatedly \nexperience summertime mortality reaching 20 -30% \n(normal mortality is 2 -6%) due to Haemoproteus \nlophortyx  in California.  In addition to the devastating \neconomic losses t o commercial quail producers, this \nparasite has hindered efforts to raise native California \nand other Western species of quail for release into the \nwild (1,3).  We have studied H. lophortyx on one \ncommercial bobwhite quail operation in Oroville, CA \nextensi vely (2).  Mortality increases in May and drops \nprecipitously once cold weather begins (November).  \nInfected birds are reluctant to move, have ruffled \nfeathers, and exhibit splenomegaly, emaciation and \nmuscle wasting, with obvious hemorrhagic streaks in skeletal muscle. Muscle forms of the parasite are \nconsistent with schizonts of H. lophortyx , and \ngametocytes in the red blood cells are diagnostic for H. lophortyx .   \nAn estimated 10% of infected bobwhite quail also \nexhibit the clinical signs of neurologic d isease.  These \nsigns include imbalance manifest by an inability to walk or stand although all but moribund birds can fly.  \nHead shaking, tremors, and paddling have all been \nobserved.  In order to explore the cause of these disease \nsymptoms, we collected th e brains of quail with one or \nmore clinical signs of neurologic disease.  Serial \nsections were stained with hematoxylin and eosin and \nexamined histologically.  Numerous areas of encephalomalacia were observed, as were perivascular \ncuffs with narrowed vesse l lumens.  We propose that \nH. lophortyx  enters endothelial cells in the brain \nresulting blood flow occlusion and consequent foci of encephalomalacia in areas supplied by affected vessels.    \n \nREFERENCES  \n1. Campbell, H., and L. Lee. Studies on quail \nmalaria in  New Mexico and notes on other aspects of \nquail populations. New Mexico Dept. Game and Fish. \nRestor. Proj. W -41-R. 1953.  \n2. Cardona, C.J., A. Ihejirika, and L. \nMcClellan.  Haemoproteus lophortyx  infection in \nbobwhite quail, Avian Dis. In press.  \n3. O\u2019Roke, E. C. The morphology, \ntransmission and life -history of  Haemoproteus \nlophortyx  O\u2019Roke, a blood parasite of the California \nvalley quail. Univ. California Pub. Zool., University of \nCalifornia Press, Berkeley, CA.  36:1 -50. 1930\n. \n  \n  \n247 AMPLIFICATION OF THE  IL-2 GENE OF TOTAL CHICKEN \nSPLEEN CELLS IN A SALMONELLA GALLINARU M INFECTION  \n \nAMPLIFICATION OF THE IL-2 GENE OF TOTAL CHICKEN SPLEEN CELLS \nIN A SALMONELLA GALLINARUM INFECTION  \n \nCastellanos L1, Ledesma N1, Ortega D1, T\u00e9llez G1,  Caldwell D2 \n \n1 D.P.A.:AVES F.M.V.Z. U.N.A .M., 2 Departments of Veterinary Pathobiology and  \n Poultry Science Texas A&M University  \n \nSUMMARY  \nOne of the most important cytokines in a \nSalmonella infection is IL -2. The amplification of this \ngene was attempted in neonatal chickens challenged \nwith Salmonella gallinarum . IL-2 mRNA amplification \nwas not observed using reverse transcriptase -\npolymerase chain reaction (RT -PCR). Nevertheless, the \namplification of the gene by internal PCR was observed starting on day 1. IL -2 mRNA amplification \nobtained from B300 bird spleen cells is 95.7% \nhomologous to the sequence published in 1999. No \nevidence was found of IL -2 as being the main cytokine \nin the immune response to S. gallinarum in neonatal \nchickens.  \nINTRODUCCION  \nLa IL -2 es una de las mol\u00e9culas centrales de la \nrespuesta inmune celular y es una de las citocinas que \nse expresan por una infecci\u00f3n de Salmonella. 1,2 Se han  \nrealizado estudios para buscar diferencias moleculares en la IL -2 de diferentes l\u00edneas de pollo para encontrar \nalguna relaci\u00f3n entre la susceptibi lidad de estas l\u00edneas \npara algunas enfermedades. 3   En el presente trabajo \nse estableci\u00f3 la t\u00e9cnica para amplificar el gen de la IL -\n2 para determinar su expresi\u00f3n en aves neonatas ante \nun desaf\u00edo por Salmonella . \n \nDESARROLLO  \nSe estableci\u00f3 la  t\u00e9cnica de RT -PCR y de PCR \ninterna  para la amplificaci\u00f3n del RNAm de IL -2 a \npartir  de esplenocitos totales estimulados con \nConcanavalina A. Se verific\u00f3 la amplificaci\u00f3n obtenida \npor medio de cortes con enzimas de restricci\u00f3n, as\u00ed \ncomo por secuenciaci\u00f3n.  Una vez obtenida la \namplificaci\u00f3n se evalu\u00f3  la expresi\u00f3n de dicho gen a partir de esplenocitos totales de aves ligeras B -300  \nALPES de 1 d\u00eda de edad desafiados con 1X10 8 UFC \nde Salmonella gallinarum .  La evaluaci\u00f3n de la \nexpresi\u00f3n de dicho gen se llev\u00f3 a cabo los d\u00eda s 1,2,3,4, \n5, 6,7 y 10 postdesaf\u00edo.   \nRESULTADOS  \nSe observaron lesiones y signos causados por la \nSalmonella gallinarum  durante el desarrollo de la enfermedad. A partir del s\u00e9ptimo d\u00eda postinfecci\u00f3n \ndichas lesiones disminuyeron considerablemente \nobserv\u00e1ndos e mejor\u00eda evidente de las aves enfermas, \nmientras las aves del grupo control no presentaron \nning\u00fan signo o lesi\u00f3n. Se logr\u00f3 el reaislamiento de \nSalmonella a partir de bazo. No se observ\u00f3  la \namplificaci\u00f3n del RNAm de IL -2 tanto en animales \ndesafiados como en no desafiados, por lo tanto se hizo \nPCR interna y se observ\u00f3 amplificaci\u00f3n de IL -2 desde \nel primer d\u00eda postinoculaci\u00f3n tanto en animales desafiados como en animales control.  \n \nDISCUSION  \nGarrity P 4 menciona que para realizarse la \ntranscripci\u00f3n de la IL -2 se debe de llevar acabo la \nactivaci\u00f3n de todo un complejo de prote\u00ednas, las cuales \nno se ha demostrado est\u00e9n presentes en el pollo \nneonato. Los resultados del presente estudio muestran \nque el RNAm se encuentra presente desde el primer d\u00eda \nde edad del pol lo, pero no en cantidades suficientes \npara ser detectadas por RT -PCR, y que tiene un \ncomportamiento similar en aves con y sin desaf\u00edo por \nSalmonella lo que sugiere que la IL -2 no es la citocna \nprincipal en la resistencia a infecciones por Salmonella. \nPor o tra parte, es importante considerar que Shaw J et \nal. 5 demuestran que la vida media  del RNAm de IL -2 \nes de 1 a 2 horas y que declina  de 4 a 6 horas despu\u00e9s.  Se requieren mas estudios en los que se determinen los \npapeles que desempe\u00f1an otras citocinas ante \ninfecciones por Salmonella.  \n \nREFERENCIAS  \n1. Sirard, J.C., Niedergang, F., Kraehenbuhl, \nJ.P. Live attenuated Salmonella: a paradigm of mucosal \nvaccines. Immunol. Reviews 171:5- 26. 1999.  \n2. Finlay, B.B., Brumell, J.H. Salmonella  \ninteractions with host cells: in vitro to in vivo . Phibs. \nTrans. R. Soc. Lond. B. Biol. Sci. 355:623- 631. 2000.  \n3. Kaiser, P., Mariani, P. Promoter sequence, \nexon:intron structure, and synteny of genetic location show that  a chicken cytokine with T -cell proliferative \nactivity is IL2 and  not IL15. Immunogenetics 49:26- 35. \n1999.   \n  \n248 4. Garrity, P., Chen, D., Rothenberg E., Wold, \nB. Interlukin- 2 transcription is regulated in vivo at \nlevel of coordinated binding of both constitutive and \nregulated factors. Mol. Cell. Biol. 14:2159 -2169. \n19994.  5. Shaw , J., Meerovitch, K., Bleackley, C., \nPaetkau, V. Mechanisms regulating the level of IL -\n2mRNA in T lymphocytes.J.Immunol140:2243-2248.1988.\n \nAPLICACI\u00d3N DE UNA CUT\u00cdCULA ARTIFICIAL EN HUEVOS \nINCUBADOS DE AVESTRUZ  \n \nAPPLICATION OF AN ARTIFICIAL CUTICLE  TO OSTRICH  \nHATCHING EGGS  \n \nMarco A. Ju\u00e1rez- EstradaA, Ra\u00fal Cervantes -S\u00e1nchezA, Jos\u00e9 A. Quintana -L\u00f3pezA,Ernesto \u00c1vila -Gonz\u00e1lezA \n \nA Departamento de Producci\u00f3n Animal: Aves,  Facultad de Medicina Veterinaria y Zootecnia,  Universidad \nNacional Aut\u00f3noma de M\u00e9xico. Aven ida Universidad 3000. Ciudad Universitaria 04510 M\u00e9xico, D.F.  \nE-mail:   britoco@servidor.unam.mx \n \nSUMMARY  \nThe effect of an artificial cuticle on moisture loss \nand hatchability was determined using 11 eggs from 6 \nAfrican Black female ostriches, from August  to \nNovember, 2000. The artificial cuticle was prepared \nusing chicken egg albumin. The cuticle was analyzed \nby blocking the genetics of each female over moisture \nloss from each egg. Differences were observed between all 6 females. Treatment with the cuticl e \n(moisture loss: 20.8%) was different to the treatment \nwith no cuticle (average: 22.4%). The artificial cuticle \nhelps decreasing moisture loss without affecting \nembryo livability.  \n \nRESUMEN  \nSe determin\u00f3 el efecto de una cut\u00edcula artificial \nsobre p\u00e9rdida de  humedad e incubabilidad de 112 \nhuevos de seis hembras African black de agosto a \nnoviembre del 2000. La cut\u00edcula artificial se elabor\u00f3 \ncon ovoalb\u00famina de gallina. La cut\u00edcula se analiz\u00f3 bloqueando la gen\u00e9tica de cada hembra sobre la p\u00e9rdida de humedad de c ada huevo. Se observaron \ndiferencias entre las seis hembras. El tratamiento con la cut\u00edcula (p\u00e9rdida de humedad: 20.8%) fue diferente al tratamiento sin ella (promedio: 22.4%). La cut\u00edcula \nartificial ayuda a disminuir la p\u00e9rdida de humedad sin \nafectar la v iabilidad del embri\u00f3n.  \n \nINTRODUCCI\u00d3N  \nEn la actualidad se requiere aumentar la eficiencia \nen la producci\u00f3n de avestruces por lo cual la \nincubaci\u00f3n artificial ayuda a eficientizarla, sin \nembargo; se debe monitorear cuidadosamente durante \nla incubaci\u00f3n la p\u00e9 rdida de humedad de cada huevo. Se \nsabe que una gran cantidad de huevos de hembras \nj\u00f3venes, viejas y algunos muy porosos tienen una excesiva p\u00e9rdida de humedad durante la incubaci\u00f3n. \nEsta exagerada p\u00e9rdida de humedad compromete la \nviabilidad del embri\u00f3n, \u00e9 sta p\u00e9rdida es regulada por el \nintercambio gaseoso del embri\u00f3n vivo, la cantidad y \ntama\u00f1o de los poros que tiene el cascar\u00f3n, adem\u00e1s de la \nhumedad de la incubadora, por lo cual \u00e9sta \u00faltima es la \n\u00fanica que t\u00e9cnicamente es posible modificar. Se dice que para obtener una adecuada tasa de natalidad se \nrequiere que el huevo pierda aproximadamente el 15% de su peso en forma de vapor de agua. Uno de los \nelementos presentes en el cascar\u00f3n del huevo es la \ncut\u00edcula, la cual proporciona una barrera que evita el \npaso de agentes pat\u00f3genos hacia el interior del huevo, amortigua la diferencia de temperaturas entre el interior \ny el exterior del huevo, regula el intercambio gaseoso \nal principio de la incubaci\u00f3n e impide una excesiva \np\u00e9rdida de humedad.  \nSe ha observado que e n algunas explotaciones de \navestruces a gran altitud sobre el nivel del mar se \npresenta un alto porcentaje de mortalidad embrionaria tard\u00eda principalmente en huevos picados no nacidos \nposiblemente debida a la exagerada p\u00e9rdida de \nhumedad, se decidi\u00f3 determ inar por lo tanto el efecto \nque tiene sobre la p\u00e9rdida de humedad e incubabilidad \nla aplicaci\u00f3n de una cut\u00edcula artificial sobre huevos de \navestruz aptos para incubar.   \nMATERIAL Y M\u00c9TODOS  \nHuevos para incubaci\u00f3n. - Se utilizaron los \nhuevos provenientes de s eis hembras de avestruz \nAfrican black (identificadas como 1, 5, 7, 21, 79 y 93) las cuales estuvieron en parejas con machos de la misma raza de febrero a noviembre del 2000. Para este \nestudio se utilizaron 112 huevos ovopositados de julio \na octubre del a\u00f1o  2000.   \n  \n249 Recolecci\u00f3n de los huevos y desinfecci\u00f3n. - Los \nhuevos se recolectaron a partir del nido con guantes de \nhule, se procedi\u00f3 a limpiarlos de polvo con una franela \nlimpia, posteriormente se asperjaron con una soluci\u00f3n \ndesinfectante con base a \u00e1cidos org\u00e1nicos. La cut\u00edcula \nartificial se elabor\u00f3 a partir de un compuesto de \novoalb\u00famina de gallina contenida en un buffer est\u00e1ndar. \u00c9sta se aplic\u00f3 con un atomizador de gota \nmediana a una distancia de 15 cm de 56 huevos puestos \nen serie por cada una de las hembras  evaluadas, dando \nel tratamiento de cut\u00edcula a un huevo s\u00ed y a los 56 \nsiguientes \u00fanicamente se les desinfect\u00f3 de manera \nrutinaria. Los huevos se almacenaron en el cuarto fr\u00edo por un periodo de  tres a cinco d\u00edas a una temperatura \nde 18\u00baC con una humedad re lativa de 70 -80%, despu\u00e9s \nse les proporcion\u00f3 una etapa de precalentamiento \ndurante seis horas a una temperatura de 20 a 22\u00baC  y \nposteriormente se metieron a la incubadora \nIncubaci\u00f3n de los huevos. - Los huevos se \nincubaron durante treinta y nueve d\u00edas en un a m\u00e1quina \nincubadora IAMEX tipo gabinete para noventa huevos \nde avestruz, a una temperatura de 97.5\u00baF y 30% de \nhumedad relativa. Para la eclosi\u00f3n se mantuvieron tres \nd\u00edas m\u00e1s en una nacedora IAMEX tipo gabinete a una \ntemperatura de 96\u00baF y 50% de humedad re lativa.  \nMetodolog\u00eda de estudio. - La metodolog\u00eda \nconsisti\u00f3 en registrar el peso de cada huevo al momento de ingresar al cuarto fr\u00edo y al momento de su traslado a la nacedora (treinta y nueve d\u00edas de \ndesarrollo embrionario, el porcentaje de p\u00e9rdida de \nhumed ad se obtuvo de restar del peso inicial de entrada \nal cuarto fr\u00edo el peso a los treinta y nueve d\u00edas de \nincubaci\u00f3n. La fertilidad de los huevos se determin\u00f3 \ncon base en un ovoscopiado realizado a los quince y \nveinti\u00fan d\u00edas de incubaci\u00f3n. La incubabilidad s e \nobtuvo tomando en cuenta los avestripollos nacidos a partir del 100% del total de huevos diagnosticados como f\u00e9rtiles.  \nAn\u00e1lisis estad\u00edstico. - Para determinar el efecto del \ntratamiento de la cut\u00edcula sobre la p\u00e9rdida de humedad se realiz\u00f3 un an\u00e1lisis de v arianza a trav\u00e9s de un modelo \nlineal generalizado empleando bloques incompletos, se \nbloqueo el efecto que tiene el aspecto gen\u00e9tico de cada \nhembra sobre la p\u00e9rdida de humedad de cada huevo \novopositado por la misma hembra.  \n \nRESULTADOS  \nSe observ\u00f3 que existen  grandes diferencias entre \nlas seis hembras evaluadas ya que los huevos de \nalgunas pierden m\u00e1s humedad que los de otras, por \nejemplo se observ\u00f3 que la hembra 1 perdi\u00f3 en promedio 18.25% de humedad mientras que la hembra \n79 perdi\u00f3 hasta 27.24% de humedad. L os huevos de la \nhembra 1, 5, 7, 21, 79 y 93 con cut\u00edcula artificial \nperdieron 18.13%, 19.54%, 20.95% 19.29%, 26.22% y \n20.65% de humedad respectivamente. Mientras que sin cut\u00edcula artificial los huevos de la hembra 1, 5, 7, 21, \n79 y 93 perdieron 18.38%, 22. 25%, 23.49%, 20.95%, \n28.27% y 21.54% de humedad respectivamente. Al \nevaluar el modelo con bloqueo del factor gen\u00e9tico se \ndetermin\u00f3 que el tratamiento con la cut\u00edcula (promedio: \n20.8%) fue diferente (P<0.0001) al tratamiento sin ella \n(promedio: 22.4%). El porcentaje de incubabilidad de los huevos tratados con cut\u00edcula fue de 50.0% y el de \nlos no tratados fue de 35.7%.  \n \nDISCUSI\u00d3N  \nEl utilizar alg\u00fan tipo de sustancia no apta para \nreemplazar la cut\u00edcula natural con la finalidad de \ndisminuir la p\u00e9rdida de humedad a niveles que se \npueden considerar normales (15%), a la altura sobre el \nnivel del mar que se esta incubando en este tipo de \nexplotaci\u00f3n, probablemente pondr\u00eda en riesgo la \nviabilidad del embri\u00f3n, debido a que al taponar todos \nlos poros y no permitir un adecuado intercambio de \nox\u00edgeno el embri\u00f3n muere disminuyendo por lo tanto la \ntasa de incubabilidad. A pesar de lo reportado por \nChristensen et al (1996)\n1 quien indica que la estructura \ndel poro del avestruz es de mayor complejidad que la \ndel huevo de la gal lina dom\u00e9stica, la cut\u00edcula se puede \nver afectada por diversos factores de manejo como son \ncuando la cut\u00edcula natural es removida debido a que el \nhuevo fue puesto en la tierra o el piso y tuvo que \nlimpiarse con una lija, un trapo, o bien tuvo que ser lavad o, asperjado con l\u00edquido desinfectante o haber \nsido fumigado con exceso de formaldeh\u00eddo y permanganato de potasio. El empleo de la cut\u00edcula probada en este trabajo puede llegar a ser muy \u00fatil para \nrescatar embriones valiosos provenientes de huevos \novoposit ados por hembras viejas o embriones \nprovenientes de huevos ovopositados que pierden demasiada humedad  la cual probablemente es debida a \nun gran tama\u00f1o del poro o a bien a un adelgazamiento del cascar\u00f3n. Se observ\u00f3 que en algunas hembras \n(Hembra 5) la cut\u00ed cula artificial ayuda a disminuir m\u00e1s \neficientemente la p\u00e9rdida de humedad de los huevos \nque lo observado en otras hembras (Hembra 1), lo cual indica que existen condiciones particulares de la \nestructura del cascar\u00f3n descritas ya por Christensen et \nal (1996)\n1 de cada una de las hembras estudiadas aqu\u00ed, \nque se encuentran afectadas en mayor grado por la \nutilizaci\u00f3n de la cut\u00edcula artificial influyendo \ndirectamente con el grado de intercambio gaseoso y por lo tanto con la p\u00e9rdida de vapor de agua.  \nEl utilizar una cut\u00edcula artificial disminuye la \np\u00e9rdida de humedad durante la incubaci\u00f3n, por lo cual se observa que la utilizaci\u00f3n de una cut\u00edcula de este \ntipo ayuda a disminuir una exagerada p\u00e9rdida de \nhumedad, sin embargo, se deben considerar algunos \nfactores como  el reportado por Enguilo (1994)\n2 donde \nal utilizar una cut\u00edcula artificial elaborada con \novoalb\u00famina de gallina dom\u00e9stica asperjada sobre  \n  \n250 huevos de reproductoras pesadas viejas, observ\u00f3 al \nigual que en el presente estudio, que se aumentaba \nsignificativame nte la incubabilidad y disminu\u00eda la \np\u00e9rdida de humedad durante la incubaci\u00f3n, sin \nembargo, report\u00f3 adem\u00e1s un menor peso en los pollitos \nnacidos, lo cual posiblemente podr\u00eda repercutir \ndirectamente sobre la calidad de los mismos. Esta \u00faltima caracter\u00edstica no se evalu\u00f3 en el presente \nestudio. Se requieren mas investigaciones acerca de la \n\u00f3ptima composici\u00f3n de esta cut\u00edcula en la incubaci\u00f3n \nde huevos de avestruz y otras especies aviares que \npresenten problemas de incubaci\u00f3n por exagerada p\u00e9rdida de humedad o bien p\u00e9rdida de la cut\u00edcula natural.  \n \nREFERENCIAS  \n1. Christensen, V.L. Davis, G.S., and Lucore \nL.A. Eggshell conductance and other functional \nqualities of ostrich eggs. Poultry Sci. 75: 1404- 1410. \n1996.  \n2. Enguilo, M. B. L. Efecto de la aplicaci\u00f3n de \nuna cut\u00edcul a artificial a base de alb\u00famina, sobre el \ncascar\u00f3n en la incubabilidad de huevos de gallinas de \n58 semanas de edad. tesina de licenciatura. Universidad \nNacional Aut\u00f3noma de M\u00e9xico, M\u00e9xico. 1994.  \n \nDETERMINACI\u00d3N DEL PESO \u00d3PTIMO DE INCUBACI\u00d3N EN \nHUEVOS DE AV ESTRUZ \n \nDETERMINATION OF OPTIMUM EGG WEIGHT IN OSTRICH  \nHATCHING EGGS  \n \nMarco A. Ju\u00e1rez- Estrada1; Ra\u00fal Cervantes -S\u00e1nchez1; Jos\u00e9 A. Quintana -L\u00f3pez1; Ernesto \u00c1vila -Gonz\u00e1lez1 \n \n1Departamento de Producci\u00f3n Animal: Aves,  Facultad de Medicina Veterinaria y Zootecn ia,  Universidad Nacional \nAut\u00f3noma de M\u00e9xico. Avenida Universidad 3000. Ciudad Universitaria 04510 M\u00e9xico, D.F.  \nE-mail:   britoco@servidor.unam.mx \n \nSUMMARY  \nThe optimum weight of eggs yielding a successful \nhatch, and that of non hatched eggs were determined. The average weight of hatched eggs prior to incubation \nwas 1.53 Kg, and 1.54 Kg for the eggs of the first and \nsecond cycles, respectively. Non -hatched egg weights \nwere 1.59 Kg, and 1.64 Kg for the first and second \ncycles, respectively. On day 39 hatched  egg weights \nwere 1.26 Kg, and 1.25 Kg for the first and second \ncycles, respectively, The weights of non -hatched eggs \nwere 1.24 Kg, and 1.28 Kg for the first and second cycles, respectively. Moisture loss rates of hatched eggs were 17.33%, and 18.21%, for the first and \nsecond cycles, respectively. Moisture loss rates of non -\nhatched eggs were 22.08%, and 21.9%, for the first and second cycles, respectively.  \n \nRESUMEN  \nSe determin\u00f3 peso \u00f3ptimo de huevos que \neclosionaron exitosamente y los que no. El promedio \nde huevos nacidos antes de incubar del primer ciclo fue \n1.53 Kg, del segundo 1.54 Kg. Los no nacidos del \nprimer ciclo fue 1.59 Kg, del segundo 1.64 Kg.  Al d\u00eda \n39 los huevos  eclosionados del primer ciclo fue 1.26 \nKg, del segundo 1.25 Kg, Los no eclosionados  del \nprimer ciclo fue 1.24 Kg, del segundo 1.28 Kg. La \np\u00e9rdida de humedad de los nacidos en el primer ciclo fue 17.33%, del segundo 18.21%. Los no nacidos del \nprimer ciclo fue 22.08%, del segundo 21.9%.  \n \nINTRODUCCI\u00d3N  \nActualmente la selecci\u00f3n gen\u00e9tica efec tuada en \nlas avestruces, principalmente en la \u00fanica raza \nexistente ( African black ) se ha concentrado m\u00e1s en la \ncalidad de los productos, como las plumas o bien en la \ncantidad de huevos, que en la calidad de la \nreproducci\u00f3n. La pr\u00e1cticamente nula selecci\u00f3n gen\u00e9tica efectuada en la crianza del avestruz no ha permitido \nobtener a\u00fan huevos uniformes a partir de las aves \nreproductoras. Este proceso se vislumbra a plazo muy largo, principalmente por el tiempo y dinero \nrequerido.\n1 Por lo tanto y con base a la ausen cia de \nselecci\u00f3n gen\u00e9tica, los par\u00e1metros de incubaci\u00f3n deben \nser v\u00e1lidos para una amplia banda media, no obstante \ndebe buscarse la m\u00e1xima uniformidad en los huevos puestos y seleccionados para la incubaci\u00f3n. Se ha \nobservado que la mayor parte de los huevos incubados \nen una explotaci\u00f3n ubicada en el altiplano mexicano pierden m\u00e1s humedad de la requerida mostrando ser \nuno de los principales problemas que afectan la \nincubabilidad y factibilidad econ\u00f3mica de la explotaci\u00f3n.\n2 En el presente estudio se eval\u00faa el  peso \n\u00f3ptimo de incubaci\u00f3n de huevos eclosionados favorablemente durante dos ciclos de producci\u00f3n. Los \nhallazgos de este an\u00e1lisis son discutidos con relaci\u00f3n a  \n  \n251 las implicaciones requeridas para mejorar la \nincubabilidad de los huevos de avestruz.  \n \nMATERIAL Y M\u00c9TODOS  \nSitio del estudio. - El presente estudio se realiz\u00f3 en \nel criadero de avestruces de la Facultad de Medicina Veterinaria y Zootecnia de la Universidad Nacional Aut\u00f3noma de M\u00e9xico ubicado en Zapotitl\u00e1n, Tl\u00e1huac, \nM\u00e9xico, D.F  ubicado a una altitud de 2,250 m. s. n. m.  \nHuevos para incubaci\u00f3n. - Se utilizaron 535 \nhuevos incubados provenientes de 11 hembras de avestruz African black  durante el ciclo de reproducci\u00f3n \nde 1999 y 486 huevos incubados provenientes de 9 \nhembras durante el ciclo de reproducci\u00f3n de l 2000. Las \nhembras estuvieron en parejas con machos de la misma \nraza de febrero a noviembre de cada ciclo de \nproducci\u00f3n.       \nIncubaci\u00f3n de los huevos. - Los huevos del primer \nciclo (1999) se incubaron durante treinta y nueve d\u00edas en una m\u00e1quina incubadora  Jamesway tipo AVN\u00ae. Las \ndel segundo ciclo (2000) en una incubadora IAMEX \ntipo gabinete para noventa huevos de avestruz, a una \ntemperatura de 97.5\u00baF y 30% de humedad relativa. Para \nla eclosi\u00f3n de los avestripollos durante los dos ciclos se \nmantuvieron tres  d\u00edas m\u00e1s en una nacedora IAMEX \ntipo gabinete a una temperatura de 96\u00baF y 40 -50% de \nhumedad relativa.  \nMetodolog\u00eda de estudio. - La metodolog\u00eda \nconsisti\u00f3 en registrar el peso de cada huevo al \nmomento de ingresar al cuarto fr\u00edo y al momento de su \ntraslado a la nacedora (a los treinta y nueve d\u00edas), obteniendo el porcentaje de p\u00e9rdida de humedad \nrestando la diferencia existente entre el peso a los \ntreinta y nueve d\u00edas de incubaci\u00f3n del peso inicial de \nentrada al cuarto fr\u00edo. La fertilidad de los huevos se \ndetermin\u00f3 con base en un ovoscopiado realizado a los \nquince y veinti\u00fan d\u00edas de incubaci\u00f3n. La nacencia se \nobtuvo tomando en cuenta a los avestripollos nacidos a \npartir del 100% del total de huevos determinados como \nf\u00e9rtiles.  \nAn\u00e1lisis estad\u00edstico. - Se consider aron \ndescriptivamente los promedios de peso de los huevos eclosionados durante el primer y segundo ciclo antes \nde incubar y al momento de la transferencia. Adem\u00e1s \nde los promedios de peso de los huevos no eclosionados durante el primer y segundo ciclo antes \nde incubar y al momento de la transferencia. Se \ndetermin\u00f3 el porcentaje de p\u00e9rdida de humedad de los \nhuevos eclosionados en el primer y segundo ciclo. A su \nvez se determin\u00f3 el porcentaje de p\u00e9rdida de humedad \nde los huevos no eclosionados del primer y se gundo \nciclo de producci\u00f3n.  \n \nRESULTADOS  \nEl promedio de peso de los huevos nacidos antes \nde incubar (Cuarto Fr\u00edo) durante el primer ciclo (1999) fue de 1.53 Kg  y al d\u00eda 39 de incubaci\u00f3n momento de \nla transferencia fue de 1.26 Kg. En los huevos no \nnacidos el promedio antes de incubar fue de 1.59 Kg y \nal d\u00eda 39 de 1.24 Kg. El promedio de peso de los \nhuevos nacidos antes de incubar durante el segundo \nciclo (2000) fue de 1.54 Kg  y al d\u00eda 39 de incubaci\u00f3n \nfue de 1.25 Kg. En los huevos no nacidos el promedio antes de incubar fue de 1.64 Kg y al d\u00eda 39 de 1.28 Kg. \nEl porcentaje de p\u00e9rdida de humedad en los 56 huevos \neclosionados del ciclo 1999 fue de 17.33%, mientras \nque de los 79 huevos f\u00e9rtiles no eclosionados la p\u00e9rdida \nde humedad fue de 22.08%. El porcentaje de p\u00e9rdida \nde humedad en los 52 huevos eclosionados del ciclo \n2000 fue de 18.21%, mientras que de los 141 huevos \nf\u00e9rtiles no eclosionados la p\u00e9rdida de humedad fue de \n21.9%.  \n \nDISCUSI\u00d3N  \nLo que se observa es que el peso promedio de los \nhuevos eclosionados dur ante los dos ciclos antes de \nincubar (1.535 Kg.) tiende a ser m\u00e1s bajo que el promedio de los huevos no eclosionados (1.615 Kg). \nLo cual indica de acuerdo a diferentes autores\n,1,2,3,4,5  \nque los huevos demasiado grandes presentan \nproblemas de incubabilidad. El peso promedio ideal \n(1.40 Kg) propuesto por diferentes autores2,3,4,5 sugiere \nque es necesario contar con hembras que ovopositen \nhuevos con esta caracter\u00edstica. El peso promedio al momento de la transferencia (39 d\u00edas) de los huevos \neclosionados favor ablemente durante los dos ciclos \n(1.255 Kg) es semejante al promedio de los huevos no eclosionados durante los dos ciclos evaluados (1.260 \nKg) lo cual indica que existe una mayor p\u00e9rdida de \npeso durante el proceso de incubaci\u00f3n de los huevos no eclosionado s, posiblemente esta causa es la m\u00e1s \nimportante y que hace que estos huevos no logren eclosionar. Factiblemente la causa es que ya no pueden aprovechar la energ\u00eda del saco vitelino, y por lo tanto \nno pueden romper la c\u00e1mara anterior y mucho menos \nromper el  cascar\u00f3n al momento de la eclosi\u00f3n, por lo \ncual muchos de estos embriones est\u00e1n muriendo \nposiblemente de asfixia.  Algunos autores\n,3,4 sugieren \ncomo pertinente una p\u00e9rdida de peso del huevo durante \nla incubaci\u00f3n del 15 % por lo cual indican como ideal \nal d\u00eda 39 un peso promedio de 1.19 Kg. Deeming et al3 \ntrabajando con un lote de 96 huevos f\u00e9rtiles \nencontraron que el peso antes de la incubaci\u00f3n de 82 \nhuevos eclosionados fue de 1.456 Kg  y de 14 huevos  \nno eclosionados fue de 1.424 Kg. No existe una \ndiferen cia significativa entre estos pesos que justifique \nel que exista un factor que explique el porque no \neclosionaron esos 14 huevos. Al contrario de lo observado en la presente investigaci\u00f3n donde el promedio de los huevos no eclosionados (1.615 Kg)  \nfue mucho mayor al promedio de los huevos que si lo \nhicieron. (1.535 Kg). Los huevos estudiados por  \n  \n252 Deeming et al3 proven\u00edan de un criadero comercial en \nNamibia lo cual sugiere que posiblemente las hembras \nque ovopositaron esos huevos presentaban mayor \nhomogeneida d entre ellas, o bien los huevos proven\u00edan \nde tan s\u00f3lo 3 o 4 hembras. El  porcentaje promedio de \np\u00e9rdida de peso (12.39%) en los huevos eclosionados \nestudiados por Deeming et al3 fue menor al observado \nen los huevos no eclosionados (14.85%). Lo cual \naunque  fue menor a los promedios de p\u00e9rdida de peso \nde los huevos analizados en el presente estudio \nmuestran claramente que los huevos no eclosionados \npierden mucha m\u00e1s humedad que los no eclosionados. \nAdem\u00e1s Deeming et al3 indica que la p\u00e9rdida de peso \nde los h uevos incubados en su estudio fue menor a la \nrequerida (15%). Una falla para perder suficiente peso \ndurante la incubaci\u00f3n puede conducir a una retenci\u00f3n \nde agua por el embri\u00f3n de avestripollo lo cual puede \nreducir a su vez la incubabilidad. Una baja p\u00e9rdid a de \nvapor de agua durante la incubaci\u00f3n puede indicar \ntambi\u00e9n que existe una baja permeabilidad en la \nconductancia de vapor de agua y gases a trav\u00e9s del \ncascar\u00f3n. Si la permeabilidad del cascar\u00f3n es muy baja, \nlos problemas de abastecimiento de ox\u00edgeno y \nremoci\u00f3n de bi\u00f3xido de carbono pueden complicar la \nsobrevivencia de los embriones que presentan un \ndesarrollo avanzado. Lo cual posiblemente explica en \ncierto grado lo que sucedi\u00f3 con los huevos incubados \npor Deeming et al3 , pero no explica lo sucedido con  \nlos huevos analizados en el presente estudio. Sin \nembargo, algunos investigadores 1,2,3,4,5  mencionan que \nmuchos de los huevos que mueren antes de eclosionar \ntienen  grandes p\u00e9rdidas de humedad a pesar de haber \nsido incubados con humedades relativas alta s. \nIndicando que esta situaci\u00f3n posiblemente se deba a \nuna alta porosidad del cascar\u00f3n. Factiblemente \u00e9sta es \nla causa de que todos los huevos analizados en el \npresente estudio, a\u00fan los eclosionados pierdan un porcentaje de humedad superior (promedio de los dos \nciclos: 17.77%) al recomendado (15%). Esto posiblemente explica la alta mortalidad observada \ndurante el primer mes de vida, como consecuencia de \nla obtenci\u00f3n de avestripollos (Clasificados como de \nsegunda calidad) afectados por este exceso de p\u00e9rdida  \nde humedad durante el proceso de incubaci\u00f3n. Algunos \nautores\n,2,3,5  han sugerido que muchos huevos se \nsalvar\u00edan de esta exagerada p\u00e9rdida de humedad si la \nporosidad del cascar\u00f3n se pudiera reducir \nartificialmente taponeando los poros temporalmente o \nbien sellando una parte de ellos. Otro factor importante \nque posiblemente incide sobre este aumento de p\u00e9rdida \nde humedad ya mencionado por Ju\u00e1rez et al2 es la \naltura del sitio de incubaci\u00f3n. Lo que se concluye en el \npresente estudio es que los huevos analizado s presentan \nuna alteraci\u00f3n en la conductancia de vapor de agua a \ntrav\u00e9s del cascar\u00f3n que esta relacionada directamente \ncon la porosidad del mismo.  \n \nREFERENCIAS  \n1. Stewart, J.S. Manejo del huevo de avestruz y \nde la incubaci\u00f3n. American Ostrich 11: 22. 1995.  \n2. Ju\u00e1rez, E.M.A. Alfaro, C.J.C. Esquivel, P.J, \ny \u00c1vila G. E. Determinaci\u00f3n de la p\u00e9rdida de humedad \nen huevos f\u00e9rtiles de avestruz \u201cAfrican Black\u201d \nincubados en el Distrito Federal durante el periodo de reproducci\u00f3n de 1999. Memorias de la XXV \nConvenci\u00f3n anual ANECA.  Canc\u00fan , Quintana Roo, \nM\u00e9xico. pp. 138-142. 2000.   \n3. Deeming, D.C. Ayres, L., and Ayres, F.J. \nObservations on the commercial production of ostrich (Struthio camelus) in the United Kingdom: incubation. Vet. Rec. 132: 602- 607. 1993.  \n4. Christensen, V.L. Da vis, G.S., and Lucore, \nL.A. Eggshell conductance and other functional qualities of ostrich eggs. Poult .Sci. 75: 1404 -1410. \n1996.  \n5. Gonzalez, A. Satterlee, D.G. Moharer, F., \nand Cadd, G.G. Factors affecting ostrich egg \nhatchability. Poult. Sci. 78: 1257 -1262. 1999.  \n \nHALLAZGOS MACROSC\u00d3PICOS Y MICROSCOPICOS EN AVES \nCON PROBLEMAS DE DESPIGMENTACION TRABAJO \nEXPERIMENTAL  \n \nGROSS AND MICROSCOPIC FINDINGS IN POULTRY WITH POOR \nPIGMENTATION - EXPERIMENTAL WORK  \n \nChapa B., J., Rodr\u00edguez G., E. \n \nInvestigaci\u00f3n Aplicada S. A. de C.V.  Tehuac\u00e1n, Puebla, M\u00e9xico.  \n \nSUMMARY  \nThe purpose of this experiment was to reproduce \n\u2013under controlled conditions \u2013 the clinical picture observed in broilers, and to demonstrate the possible \ncauses for the poor skin pigmentation of these birds, including the influence of the feed. Dietary carotene  \n  \n253 and xanthophyll levels could have been the most \nimportant cause. Other findings like poor gizzard \nmuscle development, and proventriculus lesions could \nalso have exerted an influence. The cause of these \nlesions was not clear. Test feed texture/composition \ncould also have had a major influence.  \n \nRESUMEN  \nEl objetivo del trabajo fue reproducir en \ncondiciones controladas el cuadro cl\u00ednico observado en pollos de engorde y demostrar las posibles causas de la \nmala pigmentaci\u00f3n de estas aves, incluyendo la \ninfluencia del alimento. El contenido de carotenos y \nxantofilas en el alimento pudo ser la causa m\u00e1s \nimportante y,  otros hallazgos como el pobre desarrollo \nmuscular de la molleja y lesiones en el proventr\u00edculo \npudieron influir en la presentaci\u00f3n del problema. No se \ndemostr\u00f3 la causa de estas lesiones; la composici\u00f3n y textura del alimento de prueba pudieron influir de manera importante.   \n  \nINTRODUCCION  \nLa pigmentaci\u00f3n de la piel de las aves y de la \nyema del huevo es una caracter\u00edstica que influye en la demanda de estos productos por parte del consumidor. \nLos problemas de mala pigmentaci\u00f3n en las aves \npueden tener diversas causas entre las que se incluyen \nla composici\u00f3n del alimento, deficiencias nutricionales, parasitosis y lesiones en el tracto digestivo por \ninfecciones virales o bacterianas. Estas causas pueden ocurrir en forma independiente o en combinaci\u00f3n con otras y tener un efecto negativo en  el grado de \npigmentaci\u00f3n deseado. Con la finalidad de reproducir  \nel cuadro cl\u00ednico observado en varias granjas de pollo \nde engorde y tratar de demostrar las posibles causas de \nla mala pigmentaci\u00f3n en las aves, incluyendo la \ninfluencia del alimento, se realiz\u00f3 un trabajo experimental en condiciones controladas.  \n \nMATERIA LES Y METODOS  \nAves . Se utilizaron 40 pollos de engorde de 1 d\u00eda \nde edad que fueron separados en 4 grupos de 10 aves \ncada uno y alojados en unidades de aislamiento.  \nAlimento. Dos grupos de aves (grupos 3 y 4) se \nalimentaron a libre acceso con el mismo tipo de \nalimento (alimento de prueba) que hab\u00eda sido \nsuministrado a las aves en las granjas. A los otros dos \ngrupos de aves (grupos 1 y 2) se les suministr\u00f3 un \nalimento comercial para pollo de engorde elaborado en \notra planta de alimentos.  \nDise\u00f1o experimental . Un macerado de intestinos \nobtenidos de aves representativas del problema en las \ngranjas, fue preparado previamente en una proporci\u00f3n \nde 1:10 en soluci\u00f3n salina fisiol\u00f3gica, filtrado y mezclado en el agua de bebida de los grupos 2 y 4 de \naves al d\u00eda de edad; a las aves de los grupos 1 y 3 no se les proporcion\u00f3 este macerado. Las aves se pesaron \nsemanalmente hasta la sexta semana de edad y, al \nt\u00e9rmino de la prueba, se realizo la necropsia y se \nobtuvieron \u00f3rganos que se fijaron en una soluci\u00f3n de \nformol neutr o al 10 %, se procesaron y ti\u00f1eron con \nhematoxilina y eosina por m\u00e9todos convencionales  para el examen histopatol\u00f3gico (4). Muestras de alimento fueron enviadas para el an\u00e1lisis qu\u00edmico \nproximal, la determinaci\u00f3n de carotenos y xantofilas al \nlaboratorio de qu\u00edmica la empresa NUTEK S.A. en \nTehuac\u00e1n, Puebla.  \n \nRESULTADOS  \nGanancia de peso . No se observaron diferencias \nsignificativas en el peso de las aves comparando los \ngrupos por la prueba de comparaci\u00f3n de medias \n(P>0.05).  \nAn\u00e1lisis del alimento. Los resulta dos del an\u00e1lisis \nal alimento de prueba fueron los siguientes: grasa cruda \n(7 %), fibra cruda (3.3 %), prote\u00edna cruda (22.8 %), \nextracto libre de nitr\u00f3geno (52.3 %), carotenos (4 ppm) \ny xantofilas (11 ppm). Los resultados del an\u00e1lisis al \nalimento comercial:  grasa cruda (5.6 %), fibra cruda \n(2.9 %), prote\u00edna cruda (21.9 %), extracto libre de \nnitr\u00f3geno (54.5 %), carotenos (7 ppm) y xantofilas (25 \nppm). Esto demuestra importantes diferencias en la \ncantidad de carotenos y xantofilas, que fueron mayores \nen el ali mento comercial. La cantidad de grasa, fibra y \nprote\u00edna, fueron ligeramente mas altos en el alimento de prueba.  \nNecropsia . Una menor pigmentaci\u00f3n de la piel y \nde la grasa corporal fue observada en las aves de los \ndos grupos 3 y 4 que consumieron el aliment o de \nprueba en comparaci\u00f3n con la pigmentaci\u00f3n de las aves \nde los grupos 1 y 2 que consumieron el alimento \ncomercial. Los proventr\u00edculos de las aves de los grupos 3 y 4 se observaron de mayor tama\u00f1o que los de las \naves de los grupos 1 y 2. Tambi\u00e9n, una mar cada \ndiferencia en el tama\u00f1o de las mollejas de las aves de \nlos grupos 3 y 4, que se observaron notablemente peque\u00f1as en comparaci\u00f3n con las mollejas de las aves \nde los grupos 1 y 2.  \nHistopatolog\u00eda . Las lesiones microsc\u00f3picas \nsignificativas fueron las sigu ientes:  \nGrupo 1 . Moderada a notable infiltraci\u00f3n \nlinfocitica multifocal o difusa en la capa glandular del \nproventr\u00edculo.  \nGrupo 2 . Moderada infiltraci\u00f3n multifocal de \nlinfocitos y presencia de fol\u00edculos linfoides dispersos \nen la capa glandular del provent r\u00edculo; disminuci\u00f3n de \nla poblaci\u00f3n linfoide en la corteza del timo de dos aves; \ny lesiones de fase cr\u00f3nica de Infecci\u00f3n de la Bolsa de \nFabricio, caracterizadas por la disminuci\u00f3n de la poblaci\u00f3n linfoide y regeneraci\u00f3n de fol\u00edculos en las \nmuestras de cuat ro aves, y atrofia de los fol\u00edculos en \nuna muestra.   \n  \n254 Grupo 3 . Moderada a marcada infiltraci\u00f3n \nmultifocal de linfocitos, fibrosis y necrosis de c\u00e9lulas \nglandulares del proventr\u00edculo.  \nGrupo 4 . Discreta infiltraci\u00f3n linfocitica con \npresencia de fol\u00edculos linf oides en la t\u00fanica glandular \ndel proventr\u00edculo; disminuci\u00f3n de la poblaci\u00f3n linfoide \nen la corteza del timo en tres muestras; y atrofia de fol\u00edculos en una  Bolsa de Fabricio.  \n \nDISCUSION  \nLas xantofilas son los compuestos responsables \nde la pigmentaci\u00f3n de la piel m\u00e1s importantes en la alimentaci\u00f3n de las aves (1); es f\u00e1cil,  por lo tanto, concluir que la deficiente pigmentaci\u00f3n en dos grupos \nde aves se debi\u00f3 a la menor concentraci\u00f3n de carotenos \ny xantofilas en el alimento, comparada con la \nconcentraci\u00f3n de estos compuestos en el alimento \ncomercial y es muy probable que esta haya sido la causa m\u00e1s importante del problema en las granjas.  \nEl hallazgo m\u00e1s notable en la necropsia fue el \npobre desarrollo de la musculatura de la molleja y el \nmayor tama\u00f1o del prov entr\u00edculo en las aves de prueba. \nSe ha reportado que el pobre desarrollo de la \nmusculatura de la molleja es por lo general el resultado \nde una dieta finamente molida carente en fibra, y la dilataci\u00f3n del proventr\u00edculo es secundaria (5). Las \npropiedades de la textura del alimento como el \ncontenido de fibra y el tama\u00f1o e integridad de las part\u00edculas son importantes para una apropiada \nmusculatura y motilidad de la molleja (2). Los \nhallazgos en la necropsia difieren de lo anterior ya que el alimento de prueba t en\u00eda un mayor contenido de \nfibra que el alimento comercial, pero concuerdan en el \naspecto de la textura, ya que el alimento de prueba era \nen forma de harina y el comercial en forma granular. \nDe acuerdo a las lesiones microsc\u00f3picas, no se pudo \nasociar el gr ado de lesi\u00f3n al hecho de que hayan consumido el macerado de intestinos de aves afectadas \nen la granja, sin embargo un hallazgo interesante \nfueron las lesiones similares y menos severas en las \naves que consumieron el macerado de intestino (grupos \n2 y 4) qu e en las aves que no lo consumieron (grupos 1 \ny 3), independientemente del tipo de alimento. Solo en el grupo de aves que consumieron el alimento de prueba las lesiones fueron m\u00e1s severas y contribuyeron \nposiblemente al problema de despigmentaci\u00f3n, ya que \nlas lesiones en proventr\u00edculo pueden ser la causa del \npaso de alimento no digerido y las consecuencias como \nla mala absorci\u00f3n de nutrientes, pobre conversi\u00f3n, \npalidez, etc. (3)  \n \nREFERENCIAS  \n1. Casta\u00f1eda, S.,  Hirschler, E., Sams, A.: \nEvaluaci\u00f3n del color de la piel en pollo de engorda \nutilizando pigmentos naturales y sint\u00e9ticos en la dieta. \nMemorias de la XXVI Convecci\u00f3n de ANECA. Ed. \nAsociaci\u00f3n Nacional de Especialistas en Ciencias \nAv\u00edcolas, Acapulco. Guerrero. M\u00e9xico (2001).  \n2. Ferket, P.: La nutrici\u00f3n de pavo s y \nreproductoras comerciales. Memorias de la XVI Congreso latinoamericano de avicultura. Ed. Asociaci\u00f3n Peruana de Avicultura, Lima, Per\u00fa (1999).  \n3. Goodwin, M., Hafner, S., Bounous, D., \nLatimer, K., Player, C., Niagro, F., Campagnoli, R., Brown, J.: Viral p roventriculitis in chickens. Memorias \nde la XXI Convecci\u00f3n de ANECA. Ed. Asociaci\u00f3n Nacional de Especialistas en Ciencias Av\u00edcolas, Canc\u00fan, Q. Roo, M\u00e9xico (1996).  \n4. Luna, L.G.: Manual of histological staining \nmethods of the armed forced institute of pathology, 3\nrd \ned. Blackiston Div.,  Mcgraw -Hill, New York, 1968.  \n5. Ridell, C. The influence of fiber in the diet \non the dilatation (hypertrophy) of the proventriculus in chickens. Avian Dis. 20: 442- 445. 1976.  \n \nNEISSERIA SP.  - A NOVEL BACTERIUM OF POULTRY  \n \nR.P. Ch in \n \nCalifornia Animal Health & Food Safety Laboratory System, Fresno  \n2789 S. Orange Ave., Fresno, CA 93725, rpchin@ucdavis.edu  \n \nRESUMEN  \n Una bacteria no identificada anteriormente, \nperteneciente a la famila Neiss eriaceae, se aisl\u00f3 de \npollos y pavos con enfermedad respiratoria. Setenta y \nseis cepas de esta bacteria han sido aislados durante los \n\u00faltimos 5 a\u00f1os. La secuencia del 16S rRNA ha demostrado que esta bacteria es una nueva especie \ndentro del g\u00e9nero Neisseria . \n In October 1995, an unidentified bacterium was \nsubmitted to the California Animal Health and Food \nSafety (CAHFS) Laboratory System, Fresno lab, for \nidentification. After extensive testing, this isolate was \nonly identified as a nonfermentative, gram -nega tive \n(NFGN), rod -shaped bacterium. Four months later, this \nsame bacterium was isolated in pure cultures from the \nlungs of turkeys with severe pneumonia. Since then, 38 cases were identified from which 76 strains of the \nNFGN was isolated from the respirator y system of  \n  \n255 turkeys and chickens with respiratory disease. Cases \nwere submitted from various parts of the country.  \nMost cases reported a history of respiratory \ndistress and/or increased flock mortality. Lesions seen in infected birds included tracheitis an d pneumonia, \nwhich correlate with the sites of isolation. Sixty -one \npercent of the isolations were made from the trachea and 25% from the lung. Occasional isolations were also \nmade from the infraorbital sinuses, heart sac and air \nsacs. Age of infected bird s ranged from 35 to 315 days \nin turkeys, and 53 days to 3 years in chickens. Other \nbacteria, such as Escherichia coli , Ornithobacterium \nrhinotracheale , Mycoplasma gallisepticum , M. \nsynoviae , M. meleagridis , Bordetella avium  and \nPasteurella multocida  were also isolated from affected \nsites in 90% of the cases. In addition, Newcastle \ndisease, pneumovirus infection and infectious \nlaryngotracheitis were seen in some of the affected \nbirds.  Preliminary assessment of phenotypic \ncharacteristics indicated this bacter ium was different \nfrom common pathogenic or opportunistic bacteria \nisolated from the avian respiratory tract. The colonies \nappear small, grey, slightly raised with entire edges. \nAll isolates were gram -negative, rod -shaped, positive \nfor catalase and oxidase s, and grew at 25C, 35C and \n42C. The API 20NE system resulted in biocodes of 0000044 (95%) or 0000045 (5%). Fatty acid analysis \ndemonstrated that the bacterium belonged to the family \nNeisseriaceae. Comparative 16S rRNA gene \nsequencing analysis demonstrated  that the bacterium is \na new species within the genus Neisseria . The \nsignificance of this organism in respiratory disease in birds is unknown, though a preliminary study found it \nto produce pneumonia in turkeys.  \n \n(A full -length article will be published in  Avian \nDiseases ).\n \nDISK- DIFFUSION TESTING OF  REFERENCE AND POULTR Y \nVETERINARY BACTERIAL  ISOLATES FOR SUSCEPTIBILITY TO \nAUREOMYCIN \uf8e8 (CHLORTETRACYCLINE)  \n \nPRUEBA DE DIFUSI\u00d3N EN DISCO PARA DETERMINAR LA \nSUSCEPTIBILIDAD A LA AUREOMICINA\u00ae (CLORTETRACICLINA) DE \nAISLAMIENTOS BACTERIANOS DE REFERENCIA Y DE CASOS AV\u00cdCOLAS  \n \nSteven R. Clark, James Skinner, Jeremy J. Mathers  \n \nAlpharma Inc., Animal Pharmaceuticals, P.O. Box 1399, Fort Lee, NJ 07024 USA  \n \nRESUMEN  \nSe realiz\u00f3 un estudio para evaluar la actividad \nantibacteri ana in vitro  de la clortetraciclina contra \ncepas de Escherichia coli, Salmonella typhimurium  y \nPasteurella multocida.  Se probaron las siguientes \ncepas: E. coli ATCC (Colecci\u00f3n Americana de Cultivos \nTipo) 25922, S. typhimurium  ATCC 14028 y P. \nmultocida  ATCC 12945. Para la evaluaci\u00f3n se \nobtuvieron aislamientos de pavo y de pollo de E. coli  \n(n = 21), P. multocida  (n = 19) y S. typhimurium  (n = \n8) de seis laboratorios veterinarios de diagn\u00f3stico \nav\u00edcola. El procedimiento de an\u00e1lisis fue congruente \ncon los linea mientos del NCCLS , realizando la \nincubaci\u00f3n a 35\u00b0C en agar Mueller -Hinton. La \nsusceptibilidad de los aislamientos se prob\u00f3 usando \ndiscos comerciales de aureomicina (A -30) y los \nresultados mostraron actividad antibacteriana contra E. \ncoli, S. typhimurium  y P. multocida.  \n SUMMARY  \nA study was conducted to assess the in vitro  \nantimicrobial activity chlortetracycline against strains of Escherichia coli, Salmonella typhimurium  and \nPasteurella multocida . Isolates were tested for \nsusceptibility using commercially p repared disks \ncontaining chlortetracycline (Aureomycin). E. coli,  S. \ntyphimurium  and P. multocida were all inhibited by \nchlortetracycline.  \n \nMATERIALS AND METHODS  \nStrain E. coli ATCC 25922 were included for \nquality control, along with reference strain S. typhimurium  ATCC 14028 and P. multocida  ATCC \n12945. Turkey and chicken isolates of E. coli (n=21), \nP. multocida (n=19) and S. typhimurium  (n=8) were \nobtained from 6 poultry veterinary diagnostic \nlaboratories and evaluated. The testing procedure was \nconsiste nt with NCCLS guidelines, incubated at 35 \ndegrees Celsius on Mueller -Hinton agar. Isolates were \ntested for susceptibility using commercially prepared  \n  \n256 Aureomycin test disks (A -30) that are 6.4 mm filter \npaper disks impregnated with 30 mcg of \nchlortetracycli ne. Twenty selected strains were \nadditionally tested with standard commercial \ntetracycline disks (Te -30). \n \nRESULTS AND DISCUSSION \nAgainst the tested reference strains, both \nAureomycin chlortetracycline and tetracycline were \nantimicrobially active.  Disk di ffusion assays of ATCC \nstrains indicate that chlortetracycline is antimicrobially \nactive against E. coli with zone diameters of 18.0 -19.3 \nmm, S. typhimurium  (17.0- 18.6 mm) and P. multocida  \n(33.7- 34.7 mm).  \nThe listed interpretative tetracycline (Te -30) \nranges for Enterobacteriaceae are <=14 mm, resistant; \n15-18 mm, intermediate; and >=19 mm, susceptible. \nUsing the Te -30 interpretive criteria as a general \nguideline for Aureomycin (A -30) disks, 6/21 (29%) E. \ncoli, 17/19 (89%) P. multocida , and 1/8 (13%) S. \ntyphimurium  strains had a susceptible or intermediate \nresponse. Note that official AST breakpoints have not \nbeen established by NCCLS for Aureomycin \nchlortetracycline (A -30) disks and they are intended for research purposes only; use the Te- 30 interpretive \ncriteria as a general guideline for A -30 disks.  \nSeven of the S. typhimurium  isolates tested were \nnon-susceptible to the A -30 disks.  Five of eight \nisolates were from the same poultry company but different farms in one region.  These isolates could be \nsimila r serotypes having similar tetracycline patterns, \nand may not be representative of overall S. \ntyphimurium  response.   \nThe results from ATCC strains were used as a \nreference to compare the field isolates, reporting the number (%) of isolates with measured zone diameters \nequal to or larger than the respective ATCC strain. Of \nthe E. coli and P. multocida  field isolates tested, 19% \nand 16%, respectively, had zones larger than ATCC \nstrains.  \nThe chlortetracycline (A -30) results were similar \n(13 of 20; 65%) to te tracycline (Te- 30) for most \nstrains. Seven of 20 (35%) were not susceptible to \neither drug and 6 (30%) isolates had significantly \nsmaller chlortetracycline zone diameters.  \nWithin this trial, all of the microorganisms had \nadequate growth under the test cond itions. The results \nshow that Aureomycin had antibacterial activity against the tested poultry pathogens.  \n \nEFECTO DE LA VACUNA CONTRA COCCIDIOSIS AVIAR, \nNOBLIS COX ATM \u00ae, EN GRADO DE PIGMENTACION Y \nPARAMETROS PRODUCTIVOS EN POLLO DE ENGORDA  \n \nTHE EFFECT OF NOBILIS COX ATM\u00ae, AVIAN COCCIDIOSIS VACCINE, ON SKIN \nPIGMENTATION AND PRODUCTIVE PARAMETERS IN BROILERS  \n \n1Ver\u00f3nica D\u00e1vila -Ram\u00edrez , 1Marco A. Ju\u00e1rez- Estrada, 2Guillermo Gonz\u00e1lez Herrera, 2Francisco R\u00edos 1Gerardo \nNava -Morales, 1Ernesto \u00c1vila -Gonz\u00e1lez  \n \n1Depar tamento de Producci\u00f3n Animal: Aves,  Facultad de Medicina Veterinaria y Zootecnia,  Universidad Nacional \nAut\u00f3noma de M\u00e9xico. Avenida Universidad 3000. Ciudad Universitaria CP. 04510 M\u00e9xico, D.F.  \n2Intervet M\u00e9xico. Av. Paseo de los Frailes 22 Parque Industri al Santiago Tianguistenco CP. 52600 Edo. de M\u00e9xico \nE-mail: vdavilav@yahoo.com    &  britoco@servidor.unam.mx \n \nSUMMARY  \nThe purpose of this research was to evaluate the \neffect of the vaccine Nobilis Cox ATM\u00ae, by measuring pigmentation and major productive \nparameters in broilers challenged with pathogenic \ncoccidia. Four groups were used: A) vaccinated -\nchallenged, B) vaccinated -non challenged, C) \nchallenged -non vaccinated, and D) non vaccinated -non \nchallenged. Vaccine was applied at 5 days of age. \nChallenge was given at 28 days of age. At 35 days of \nage lesions were scored. The best final pigmentation was obtained in the vaccinated groups. Group B was \nthe best group.  INTRODUCCI\u00d3N  \nEn M\u00e9xico la marcada tendencia a preferir \nproductos av\u00edcolas fuertemente pigmentad os, es por \nuna creencia com\u00fan que las aves con una tonalidad \namarilla o amarilla -naranja son las m\u00e1s sanas, mejor \nalimentadas y por lo tanto m\u00e1s nutritivas \n1. Existen \nvarios factores que afectan la pigmentaci\u00f3n en el pollo \nde engorda. Estos pueden ser raza, sexo, manejo, \nalimentaci\u00f3n y principalmente enfermedades \ngastrointestinales. La coccidiosis es la enfermedad \nparasitaria m\u00e1s importante de la producci\u00f3n av\u00edcola. \nLos par\u00e1sitos protozoarios del g\u00e9nero Eimeria  se \nmultiplican en el tracto digestivo, ocasion ando da\u00f1o  \n  \n257 tisular con interrupci\u00f3n del proceso digestivo \n(absorci\u00f3n de nutrientes) y aumento en la \nsusceptibilidad a otros pat\u00f3genos infecciosos2. En la \nactualidad ante el problema de disminuci\u00f3n de \nsensibilidad de las drogas anticoccidianas empleadas rutinariamente en el control de la coccidiosis, se est\u00e1 \nimplementando la pr\u00e1ctica de vacunar al pollo de engorda contra coccidiosis. La estrategia que se \npersigue es producir un brote controlado de la \nenfermedad con un in\u00f3culo coccidiano conocido con la \nfinali dad de inducir inmunidad y proteger a las aves  \nante un brote cl\u00ednico ocasionado por cepas de campo\n3,4 \n. En el presente estudio se eval\u00faa el impacto que tiene \nuna vacuna (Nobilis Cox ATM\u00ae) contra coccidia sobre \nel peso, lesiones intestinales, eliminaci\u00f3n d e oocistos, \ngrado de pigmentaci\u00f3n y conversi\u00f3n alimenticia \ndespu\u00e9s de un desaf\u00edo efectuado con un aislado de \ncepas pat\u00f3genas de campo.  \n \nMATERIAL Y M\u00c9TODOS  \nAnimales de experimentaci\u00f3n. - Se utilizaron 480 \npollos de engorda (Ross x Ross) sexados mitad \nhembras  y mitad machos, de un d\u00eda de edad. Alojados \nde forma mixta en una caseta de ambiente natural del \nCEIEPA de la U.N.A.M. Separando los corrales con rodetes de l\u00e1mina galvanizada para evitar \ncontaminaci\u00f3n cruzada, como material de cama se \nutiliz\u00f3 50% de viru ta y 50% de paja de avena. Al d\u00eda 8 \nde edad se vacunaron contra Newcastle v\u00eda ocular \n(cepa B1 0.03 ml) y subcut\u00e1nea (cepa La sota 0.5 ml).  \nVacuna. - La vacuna Nobilis Cox ATM (Intervet \nInternational B.V. Booxmeer -Holanda)  contiene cuatro \ncepas de oocistos vivos esporulados, estas cepas vacunales se reproducen a\u00fan en presencia de ciertos \nanticoccidianos del tipo ion\u00f3foro, su composici\u00f3n por \ncada 5 ml (agua de bebida) es de 500 ooquistes \nesporulados de Eimeria acervulina , 100 ooquistes \nesporulados de Eimeria tenella , 50 ooquistes \nesporulados de Eimeria maxima cepa ACM  y 50 \nooquistes esporulados de Eimeria maxima cepa ACVM.  \nLa vacunaci\u00f3n se efectu\u00f3 al d\u00eda cinco de edad a trav\u00e9s del agua de bebida a una diluci\u00f3n 1:100 de acuerdo a \nlas recomendaciones del fabricante. Se constat\u00f3 que los \npollitos consumieran aproximadamente los 5 ml \nrecomendados por el fabricante,  ya que hab\u00edan sido \npreviamente privados del agua de bebida por treinta \nminutos . \nInoculo de desaf\u00edo. - Se utiliz\u00f3 un inoculo \nparasitario aislado y tipifica do en el Departamento de \nProducci\u00f3n Animal: Aves por el MVZ Marco A. Ju\u00e1rez \nEstrada, el inoculo consisti\u00f3 en proporcionar directamente al d\u00eda 28 de edad con una c\u00e1nula pl\u00e1stica \ndirectamente al divert\u00edculo esof\u00e1gico de cada ave \ndesafiada 2.0 x 10\n4 de E. ace rvulina ; 1.0 x 103 de E. \nm\u00e1xima y 1.0 x 104 de E. tenella  oocistos esporulados \npor ave.  Dise\u00f1o experimental. - Las aves fueron divididas \nen cuatro grupos mixtos de tratamiento cada uno con \ntres repeticiones de 40 aves distribuidas aleatoriamente.  \nGrupo A: V acunado y desafiado; B: Vacunado y no \ndesafiado; C: Desafiado y no vacunado y D: No vacunado y no desafiado.  Al d\u00eda 28, los grupos A y C \nfueron desafiados. Se suministr\u00f3 agua y alimento ad \nlibitum ,  con una dieta est\u00e1ndar con base a sorgo y \npasta de soya. Se adicion\u00f3 pigmento amarillo de origen \nvegetal en la etapa de finalizaci\u00f3n a una concentraci\u00f3n \nde 80 ppm , sin adicionar ning\u00fan tipo de anticoccidiano \nen cualquiera de las dos etapas de alimentaci\u00f3n.  \nEvaluaci\u00f3n del experimento. - Con la finalidad de \ndeterm inar las lesiones por coccidia de acuerdo a la \nescala de Johnson y Reid (1970)\n5 siete d\u00edas \npostinoculaci\u00f3n (pi) se sacrificaron 5 aves de cada repetici\u00f3n. Durante los 49 d\u00edas de evaluaci\u00f3n, se \nregistraron de forma semanal el peso y la conversi\u00f3n \nalimenticia. El grado de pigmentaci\u00f3n se tom\u00f3 a nivel de la vena de la grasa en la piel de la pechuga izquierda \na los 42 y 49 d\u00edas de edad, utilizando un color\u00edmetro de \nreflectancia Minolta CR -300 (Minolta Ltd. Japan), con \nel sistema CIELab de brillantez (L), intens idad de \nenrojecimiento (a), e intensidad de amarillamiento (b). \nAl d\u00eda 49 se realizaron dos mediciones, la primera en la granja antes de salir a rastro y la segunda saliendo de la \nl\u00ednea de procesamiento del rastro. Semanalmente se \nhicieron muestreos con 5 g de heces conservadas en \ndicromato de potasio al 2.5%. La cuantificaci\u00f3n de \noocistos se efect\u00fao en el Departamento de Producci\u00f3n \nAnimal: Aves de la U.N.A.M.  \nAn\u00e1lisis estad\u00edstico. - Los par\u00e1metros productivos \ny el n\u00famero total de la excreci\u00f3n de oocistos se  \nevaluaron a trav\u00e9s de la prueba de an\u00e1lisis de varianza (ANDEVA). Conforme a un arreglo factorial 2x2, un \nfactor fue vacunaci\u00f3n y el otro fue desaf\u00edo. El \u00edndice de \nlesiones se evalu\u00f3 con la prueba no param\u00e9trica de Kruskall -Wallis. Las diferencias se dete rminaron a un \nnivel de significancia de P<0.05.  \n \nRESULTADOS  \nLa vacuna Nobilis Cox ATM \uf6da  no afect\u00f3 el peso \nfinal de las aves, los pesos no variaron entre los grupos a los 35, 42 \u00f3 49 d\u00edas de edad. Al d\u00eda 14 de edad el grupo A mostr\u00f3 una mayor eliminaci\u00f3n de oocistos \n(142,080a\n , n\u00famero total por gramo de heces) \ndifiriendo (P<0.05) respecto a los grupos B, C y D \n(43,947b , 1,636b ,569b.) Al d\u00eda 21 de edad el grupo C \nelimin\u00f3 la mayor cantidad de oocistos (21,973a) que \nfue diferente (P<0.05) al grupo A (6,116b) , el grupo B \njunto con el grupo D no difirieron respecto a ning\u00fan \ngrupo. Al d\u00eda 28 no hubo diferencias entre grupos (A: \n2,560a; B: 2,631a; C:924a; C:640a). A los 35 d\u00edas de \nedad el grupo D present\u00f3 la menor cantidad de oocistos \ny el grupo C la mayor cantid ad. Se observ\u00f3 diferencia \nentre los grupos desafiados y sin desafiar, estos \u00faltimos  \n  \n258 (B y D) mostraron la mejor conversi\u00f3n alimenticia \n(2.07b).  \nLas lesiones  m\u00e1s severas por E. avervulina  fueron \nen los grupos A y C ( 1.94\u00b1  0.48 y 2.42\u00b1  0.53) . La \nvariable desaf\u00edo mostr\u00f3 tener efecto P=0.009. \nObserv\u00e1ndose diferencia entre los grupos desafiados \n(2.18a) y sin desafiar (0.99b), donde los grupos menos lesionados fueron los no desafiados. En las lesiones \ninducidas por E. maxima el grupo C fue el m\u00e1s \nafectado ( 1.81 \u00b1 0.312.) Los grupos menos lesionados \nfueron los grupos B y D  (0\u00b10 y 0.45\u00b1  0.793.) Con \nvalor intermedio se observ\u00f3 al grupo A ( 1.16\u00b1 1.011). \nLos promedios de los grupos desafiados (1.49a) \nmostraron diferencia (P<0.05) respecto a  los grupos \nmenos lesionados q ue fueron los no desafiados (0.22b). \nEn la evaluaci\u00f3n del \u00edndice de lesiones para E. tenella,  \nambas variables (vacuna y desaf\u00edo) mostraron efecto P<0.05. Los grupos menos lesionados fueron los vacunados (0.22b) seguidos por los grupos no \ndesafiados (0.27b) .  \nRespecto a la pigmentaci\u00f3n a los 42 d\u00edas de edad, \nel factor vacuna present\u00f3 efecto positivo P=0.0001, \ndonde los grupos con mayor amarillamiento fueron los \nvacunados (15.73a) respecto a los no vacunados (12.65b). En el grado de enrojecimiento el grupo A fue \nel de menor valor, obteniendo el mayor valor de enrojecimiento el grupo C y el grupo D. S\u00f3lo la \nvacunaci\u00f3n presenta efecto sobre la pigmentaci\u00f3n de \nrojos (P<0.001) donde los grupos vacunados presentan \nel menor valor (0.64b) y los no vacunados el mayor (1.03a). A los 49 d\u00edas de edad en la medici\u00f3n efectuada \nen la granja, el efecto vacuna mostr\u00f3 aumento sobre el \ngrado de pigmentaci\u00f3n amarillo presentando el mayor \nvalor los grupos vacunados (18.26a) respecto a los no \nvacunados (15.51b). El grupo B mostr\u00f3 e l valor m\u00e1s \nalto y el D el menor valor. En la medici\u00f3n de \nenrojecimiento no existi\u00f3 interacci\u00f3n de la vacuna con \nel desaf\u00edo, como tampoco efectos principales, el grupo \nde mayor valor fue el D y el menor el B. Saliendo de la \nl\u00ednea de rastro a los 49 d\u00edas de edad, se observ\u00f3 efecto \nde interacci\u00f3n en el grado de amarillamiento, donde el \ngrupo mejor pigmentado fue el B ( 41.46\u00b14.961a ) que \ndifiri\u00f3 (P<0.05) al resto de los grupos. El peor grupo fue el D ( 33.96\u00b1 4.343c)  que fue semejante al grupo C y \ndifiri\u00f3 (P<0.05) con relaci\u00f3n al grupo A. Observando \nque la vacuna tuvo efecto para obtener una mayor \npigmentaci\u00f3n, donde el mayor promedio lo presentan \nlo grupos vacunados ( 39.6). La variable vacuna tuvo el \nmayor efecto (P<0.0003), mostrando en los promedios \nque los grupos vacunados obtuvieron el mayor valor de \namarillamiento (39.6a) en comparaci\u00f3n a los grupos no \nvacunados (34.87b). No se encontraron diferencias en \nel enrojecimiento.  \n \n DISCUSI\u00d3N  \nLas aves vacunadas mostraron crecimiento \ncompensatorio como lo han menciona do varios \nautores\n3,4 dando como resultado que no haya habido \ndiferencia estad\u00edstica en pesos al d\u00eda 49 de edad.  La \nmucosa intestinal del grupo B no sufri\u00f3 da\u00f1os severos facilitando una mejor absorci\u00f3n de los nutrientes\n6,7. La \nvacunaci\u00f3n aparentemente no ti ene efecto sobre el peso \nfinal, sin embargo, ante un desaf\u00edo de campo Schetters8 \nmenciona que la vacuna Nobilis Cox ATM mejora la conversi\u00f3n alimenticia. En el presente estudio se observ\u00f3 que aunque la conversi\u00f3n alimenticia de los \ngrupos vacunados no mues tra diferencia estad\u00edstica \nrespecto a los no vacunados, si se observa una tendencia a ser menor. El factor que tuvo efecto sobre \nlas lesiones causadas por E  acervulina y E maxima  fue \nel desaf\u00edo, favoreciendo a los no desafiados, mostrando \nque la vacuna presento un efecto protectivo de las \nmucosas intestinales en el grupo A respecto al grupo C \nque fue el m\u00e1s afectado por no contar con la vacuna. \nEn los grupos no vacunados se observ\u00f3 la \ncontaminaci\u00f3n por cepas vacunales comenzando con el \ngrupo C y D a los 14 d\u00edas de edad, mostrando un pico a \nlos 21 d\u00edas y posteriormente declinando al d\u00eda 28, lo \ncual indica que la cepa contaminante, posiblemente fue E. acervulina   debido a la alta inmunidad generada en \nmenos de tres semanas, mientras que los grupos \nvacunados mo straron una tasa de replicaci\u00f3n \nhomog\u00e9nea y sostenida. Schetters\n8 y colaboradores \nobservaron una reducci\u00f3n del 80% en la eliminaci\u00f3n de \noocistos a los 21 d\u00edas de edad en los grupos vacunados \nreducci\u00f3n semejante (89%) a la obtenida en esta \nprueba. La pigmen taci\u00f3n medida en la granja a los 42 \nd\u00edas de edad, mostr\u00f3 que la vacuna no interfiri\u00f3 en la \nabsorci\u00f3n de pigmentos, manteniendo una buena \nintegridad f\u00edsica de la mucosa intestinal, para continuar con sus procesos de absorci\u00f3n normales, como lo \nmenciona Cort \u00e9s\n9,10, mostrando por lo tanto un mayor \nvalor de amarillamiento en la pigmentaci\u00f3n. Esto \ndebido al menor da\u00f1o temprano de la mucosa intestinal \nproporcionado por una buena inmunidad temprana3. A \nlos 49 d\u00edas se observ\u00f3  que el amarillamiento no se vio \nafectado por las variables del experimento en ambas \nlecturas (granja y rastro). El mayor valor lo obtuvo el \ngrupo vacunado y no desafiado al mostrar diferencias \nrespecto al resto de los grupos, mostrando que los \ngrupos vacunados fueron los mejor pigmentados en \ngeneral, por lo que se puede deducir que la vacuna no \ninterfiere negativamente en la pigmentaci\u00f3n. Schetters8 \nmenciona como una ventaja importante de la vacunaci\u00f3n, el proveer mayor flexibilidad en el tiempo en el cual las aves podr\u00edan ser sacrificadas, dad o que no \nexiste necesidad de periodos de retiro de droga anticoccidiana. Adem\u00e1s de que las vacunas no \npresentan resistencia por parte de las coccidias \npat\u00f3genas de campo como sucede con los productos  \n  \n259 qu\u00edmico -sint\u00e9ticos11. Sin embargo lo que si se tiene que  \nconsiderar son los estudios de protecci\u00f3n cruzada \ncontra diferentes aislamientos de Eimeria sp \nprovenientes de diferentes regiones geogr\u00e1ficas del \npa\u00eds. \n \nCONCLUSIONES  \nEl uso de la vacuna Nobilis Cox ATM\uf6da es \nrecomendable, ya que el grupo que fue vacunado y  no \ndesafiado result\u00f3 ser el grupo con menor \u00edndice de lesiones, el menor en conversi\u00f3n alimenticia y el mejor \npigmentado adem\u00e1s de no haberse visto alterado el \npeso final.  \n \nREFERENCIAS  \n1. Multon, J.L. Aditivos y auxiliares de \nfabricaci\u00f3n en las industrias agroalimentarias, ed. \nEspa\u00f1a :Acribia,1988.  \n2. Calnek, B.W. Enfermedades de las aves. ed. \nM\u00e9xico: Manual Moderno, 1995.  \n3. Ju\u00e1rez, E.M.A. T\u00e9llez, I.G. La inmunidad \ncelular en la inmunoprofilaxis de la coccidiosis aviar. \nMemorias del curso de Inmunoparasitolog\u00eda y  biolog\u00eda \nmolecular. M\u00e9xico, Distrito Federal. pp. 18- 28. 2000.   \n4. Suls, L. The continuing battle against \ncoccidiosis. World Poultry -Misset Coccidiosis Special \nSupplement. 4 -8, 1999.  5. Johnson, J. Reid, W.M. Anticoccidial drugs: \nlesion scoring techniques in battery and floor -pen \nexperiments with chickens. Experimental Parasitol. 28: 30-36. 1970.  \n6. Mu\u00f1oz, B.L. Las coccidiosis de las \nporciones anterior y media del intestino delgado del \npollo y sus efectos. Medicina Veterinaria.; 15: 212 -\n217. 1998.  \n7. Chapman, H.D., and Cherry, T.E. Eye spray \nvaccination: infectivity and development of inmunity to Eimeria acervulina and Eimeria tenella. Journal of \nApplied Poultry Research.  6: 274- 278. 1997.  \n8. Schetters, P. M. Janssen, A. J. M., and \nVermeulen, A. N. A new vaccination con cept against \ncoccidiosis in poultry. World Poultry -Misset \nCoccidiosis Special Supplement. 26 -27. 1999.  \n9. Cortes, C.R., and Cabriales, J..J. Efecto de la \ncoccidiosis subcl\u00ednica en la absorci\u00f3n de xant\u00f3filas de marigold por el pollo de engorda. VII Jornadas M\u00e9 dico \nAv\u00edcolas 1998 marzo 81- 84. ANECA .  \n10. Cortes, C.R. Efectos de la coccidiosis sobre \nla pigmentaci\u00f3n del pollo de engorda: revisi\u00f3n \nbibliogr\u00e1fica.  Memorias de la VII Jornadas M\u00e9dico \nAv\u00edcolas. M\u00e9xico, Distrito Federal. pp.  814 -914. 1998.  \n11. Solis, J. Control de la coccidiosis aviar. \nAcontecer Av\u00edcola. 3: 45:50. 1995.  \n \nTRANSFER OF FOOD BORNE BACTERIAL PATHOGENS: \nINVESTIGATING POTENTIAL MODES OF INFECTION IN \nTURKEYS  \n \nTRANSFERENCIA DE BACTERIAS PAT\u00d3GENAS DE ORIGEN \nALIMENTARIO: INVESTIGACI\u00d3N DE LOS MODOS POTENCIALES DE \nINFECCI\u00d3N EN PAVOS  \n \nD. J. DonoghueA, N. A. CoxB, C.R. CisarC, Y. K. KirbyC, P. J. BloreA, H. L. NicholsA,  \nB. M. HargisA, and A. M. DonoghueC \n \nA Poultry Science Department, University of Arkansas, Fayetteville, AR 72701; B Nelson A. Cox, Poultry \nMicrobiological Safety Research Unit, ARS, USDA, Russell Research Center, Athens GA 30605; C Poultry \nProduction and Product Safety Research Unit, ARS, USDA Fayetteville, AR 72701  \n \nRESUMEN  \nCampylobacter  se puede transferir a las pavas \nadultas mediante la inse minaci\u00f3n artificial. Debido a \nque el semen en las granjas meleagr\u00edcolas comerciales \nse mezcla y luego se utiliza para inseminar a m\u00faltiples \npavas, es muy factible que el semen contaminado \npueda diseminar al Campylobacter  en toda la parvada. \nLos objetivos de este trabajo fueron: 1) Evaluar el \nsemen de pavo recolectado al azar en granjas \ncomerciales y determinar cu\u00e1les bacterias estaban presentes en \u00e9l; y 2) Evaluar el efecto de los diluentes para semen disponibles comercialmente sobre el  \ncrecimiento bacteri ano. Las bacterias identificadas en \nel semen del pavo fueron Pseudomonas aeruginosa, \nEscherichia coli, E.  hermannii, Staphylococcus lentus, \nS. sciuri  o S. capitis, Salmonella y Campylobacter.  Los \ndiluentes para semen que contienen antibi\u00f3ticos reducen s\u00f3lo  en forma limitada la carga bacteriana en \nel semen del pavo.  \n  \n  \n260 Vertical transmission of Campylobacter  between \nbroiler breeder flocks and commercial broiler flocks \nhas recently been demonstrated by molecular \ncharacterization of clonal isolates (1).  How \nCamp ylobacter is transferred between broiler breeder \nflocks and progeny is unknown due to the inability to culture Campylobacter from eggs or hatcheries. \nCampylobacter  may be transferred to hens via artificial \ninsemination. Because semen on commercial turkey \nfarms is pooled and then used to inseminate multiple \nhens, contaminated semen could easily spread \nCampylobacter  throughout entire flocks.  Semen \ncollection by nature of the tom\u2019s anatomy is \npredisposed to fecal contamination.  Because vertical \ntransmission has only recently been reported (1), the \nlikelihood for Campylobacter  transfer in semen has not \nbeen evaluated.  The objectives of this study were to: 1) evaluate turkey semen collected randomly from \ncommercial turkey farms and determine which bacteria were present in the semen; and 2) evaluate the effect of \ncommercially available semen extenders on bacterial \ngrowth.  \n \nMETHODS  \nSix turkey flocks were evaluated for the presence \nof bacteria over a 7 week period.  Semen containing \nrandomized pool of ejaculates from 10 -30 toms/farm \nwas evaluated for bacterial load.  Bacterial load was \nassessed using standard bacteriological methods.  \nBriefly, 100ul semen was added to 9.9ml of \nButterfield=s phosphate diluent, 10 fold serial dilutions were performed and then 100ul of each dilution was \nplated on tryptic soy agar plates.  Additionally, 10ul of \nraw semen was plated on Campy -cefex plates \n(containing the following antibiotics: cefoperazone, 20mg/L; vancomycin, 20mg/L; trimethoprim 20mg/L; \nand natamycin 25 mg/L) and grown overnight at 42C \nin a microaerophilic environment.   DNA was extracted \nfrom semen samples for use in PCR using two different \ntechniques.  The first method was a very crude prep \nconsisting of 100ul of raw semen diluted in 400ul dH\n2O, boiled for 10 min at 100C and then placed on \nice.  The second method followed the sample \nenrichment protocol described previously (2).  PCR \nreactions were performed as described by Soumet et \nal., (3) and Vanniasinkam et al., (4) except the \nannealing temperature used was 63C.  T o determine \nbacterial counts after exposure to commercially available semen extenders containing antibiotics, 10 ul \nof bacteria isolated from semen (kept frozen after \ncollection) was placed into 10 ml of TBS and grown \novernight.  Equal portions (0.25 ml) of bacterial culture and 4 different treatment groups, 3 replicates each, \nwere combined and incubated for 15, 30, and 60 min at \nroom temperature.  The four semen extenders \ntreatments were 1) without antibiotic; 2) with 200 ug/ml of gentamicin  (Field Ready Turkey Extenders \nGreen and Blue, respectively); 3) with 2.5 ug/ml \ngentamicin and 8.8 ug/ml tylosin (Ovodyl); and 4) with \nenrofloxacin (TSS Medium).  All extenders were \nprovided by IMV Inc., Minneapolis, MN.  \n  \nRESULTS AND DISCUSSI ON \nPseudomona aeruginosa, Escherichia coli  and \nhermannii, Staphylococcus lentus , and  either  sciuri  or \ncapitis , Salmonella and Campylobacter  were identified \nin turkey semen.   One of the flocks tracked for seven \nweeks (August -September) consistently tested positive \nfor Campylobacter , which has been further identified \nas C. coli  using genus and species specific primers in \nPCR (2, 4). Salmonella enteritidis  was also identified \nby PCR (using genus species specific primers, (3)) in two of the flocks tracked.  All extenders containing \nantibiotics resulted in a log or greater reduction in \nbacterial count compared to the extender without antibiotics at the 15 min time point.  At the 30 min time \npoint only the treatment 2 extender caused a log \nreduction compared to control and no difference in  \nbacterial counts was noted at the 60 min time point.  \nBecause turkey semen has not been considered a \nsource for pathogenic bacteria, antibacterial diluents for these pathogens have not been developed or tested \nfor efficacy against human food borne pathoge ns.  It \nappears semen extenders containing antibiotics produce \na limited reduction in bacterial load in turkey semen.  \nWe are currently evaluating the efficacy of antibiotic \ncontaining semen extenders against Salmonella and \nCampylobacter.  \n \nREFERENCES  \n1. Cox, N., N.J. Stern, K. Hiett, and M. \nBerrang, 1999. Transmission of Campylobacter jejuni  \nfrom breeders to commercial broiler chickens.   Tenth Internat. Workshop on Campylobacter , Heliobacter  \nand Related Organisms H.L.T. Mobley, I. Nachamkin, \nD. Mcgee, eds.  B altimore, MD. Pg 61.  \n2. Gonzalez, I., K. A. Grant, P. T. Richardson, \nS. F. Park and M. D. Collins. 1997.  Specific \nidentification of the enteropathogens Campylobacter \njejuni and Campylobacter coli  by using a PCR test \nbased on the ceuE  gene encoding a putative virulence \ndeterminant.  J. Clinical Microbiology 35:759 -763. \n3. Soumet, C., G. Ermel, V. Rose, N. Rose, P. \nDrouin, G. Salvat, and  P. Colin.  1999. Identification \nby a multiplex PCR -based assay of Salmonella \ntyphimurium  and Salmonella enteritidis  strains from  \nenvironmental swabs of poultry houses. Letters in \nApplied Microbiology 29: 1- 6 \n4. Vanniasinkam, T., J. A. Lanser and M. D. \nBarton. 1999. PCR for the detection of Campylobacter  \nspp . in clinical specimens.  Letters in Applied \nMicrobiology 28: 52- 56.  \n  \n261 EL VIRUS  DE INFLUENZA AVIAR. \u00bfPOTENCIAL PAND\u00c9MICO? \n(REVISI\u00d3N BIBLIOGR\u00c1F ICA)  \n \nAVIAN INFLUENZA VIRUS:  PANDEMIC POTENTIAL? (A BIBLIOGRAPHIC \nREVIEW)  \n \nEscorcia, M.  \n \nDepartamento de Producci\u00f3n Animal Aves. magdaescorcia@yahoo.com  \n \nSUMMARY  \nThree papers are summarized d emonstrating that \ndirect bird -to-human avian influenza virus transmission \nhardly occurs in mother nature. Beare et al., found that \nhumans are refractory to the infection with avian \nviruses. Scholtissek, Banks, Claas, Kida and Ito, \npropose swine as the species where dual infections can \noccur (avian influenza, human influenza), thus \nallowing events of genetic re -arrangement, resulting in \nprogeny capable of infecting humans. Castrucci and Claas identified influenza viruses with genetic re-\narrangements from bot h poultry and humans (H3N2) in \npigs.  \n \nRESUMEN  \nSe resumen tres trabajos del \u00e1rea de influenza \naviar donde se demuestra que la transmisi\u00f3n directa del \nvirus de ave a humano es dif\u00edcil en la naturaleza.  \nBeare y col., encontraron que los humanos son \nrefractari os a la infecci\u00f3n con virus aviares.  \nScholtissek, Banks, Claas, Kida e Ito, proponen a \nlos cerdos como la especie animal donde se dan \ninfecciones duales (influenza aviar, influenza humana) \npermitiendo  eventos de rearreglo gen\u00e9tico dando \nprogenie capaz de infectar a humanos.  \nCastrucci y Claas identificaron virus influenza \ncon rearreglos gen\u00e9ticos de aves y humanos (H3N2) en \ncerdos.  \n  \n \n INTRODUCCI\u00d3N  \nLa transmisi\u00f3n directa de virus de influenza aviar \n(H5N1) a 18 humanos en Hong Kong en 1997 con 6 muertos esta bleci\u00f3 que estos virus pueden transmitirse \naparentemente de forma directa al humano y causarles \nuna infecci\u00f3n letal.  \nSe ha propuesto un posible mecanismo:  \n- Los virus aviares pueden transmitirse sin \nrearreglo gen\u00e9tico pero deben primero adaptarse a las \nc\u00e9lul as humanas en otras especies animales.  \n \nREFERENCIAS  \n1. Beare, A. S., and R. G. Webster. 1991 \nReplication of avian influenza virus in humans. Arch. \nVirol. 119: 37- 42. \n2. Banks, J., Speidel, E., and Alexander, D. J. \n1998 Characterisation of an avian influenza A vi rus \nisolated from a human \u2013  is an intermediate host \nnecessary for the emergence of pandemic influenza \nviruses? Arch. Vorol. 143: 781- 787 \n3. Ito, T., Couceiro, N. S: S:, Kelm, S., Baum, \nL. G., Krauss, S., Castrucci, M. R., Donatelli, I., Kida, H., Paulson, J. C., Webster, R. G. and Kawaoka, Y. \n1998. Molecular basis for the generation in pigs of \ninfluenza A viruses with pandemic potential. J Virol \n72: 7367- 7373.  \n4. Shaw, M., Cooper, L., Xu, X., Thompson, \nW., Krauss, S., Guan, Y., Zhou, N., Klimow, A., Cox, N., Webs ter, R., Lim, W., Shortridge, K., Subbarao, K. \n2002. Molecular changes associated with the \ntransmission of avian influenza a H5N1 and H9N2 \nviruses to humans. J Med Virol 66: 107- 114. \n \n \n \n  \n \n    \n  \n262 SEXADO DE AVESRUCES  \n \nSEX DETERMINATION IN OSTRICHES  \n \nEsquivel  PJ1, S\u00e1nchez RE1, J\u00ednez MT1, Avila GE1, Flores DJL2 \n \n1Centro de Ense\u00f1anza, Investigaci\u00f3n y Extensi\u00f3n en Producci\u00f3n Av\u00edcola de la FMVZ -UNAM  \n2Secretar\u00eda de Producci\u00f3n Animal de LA FMVZ -UNAM  \n \nSUMMARY  \nSex determination is an important management \nprocedure in the integration of breeder couples or trios, \nor for the sale of sexed individuals. This procedure can \nbe performed either visually or by palpation.  This \nresearch evaluated 30 ostriches, i.e.: 5 birds of each of \nthe following ages: 4 days, 1 month, 4 month s, 6 \nmonths, 8 months, and 14 months. Birds were identified in accordance with hatch consecutive \nnumbers. From 0 to 4 months an error rate of 26.6% \nwas made. From 6 to 14 months no errors were made. \nIn conclusion, sexing errors can be made in ostriches \nyounger than 4 months.  \n \nRESUMEN  \nEl sexado es un  manejo importante, para formar \npares, tr\u00edos reproductores o bien para comercializarlos. \nEste se realiza mediante un examen visual o palpaci\u00f3n:  \nEn este trabajo s\u00e9  evaluaron 30 avestruces: 5 pollos de \ncuatro d\u00ed as de edad, 5 de un mes, 5 de cuatro meses, 5 \nde seis meses, 5 de ocho meses y 5 de catorce meses. \nSe identificaron  de acuerdo al n\u00famero progresivo de \nnacimientos. Resultados fueron del 26.6% de error,  de cero a cuatro meses, y de seis a catorce meses no  \nexisti\u00f3 error. Esto indica  un porcentaje de error en animales menores a 4 meses.  \n \nINTRODUCCION  \nEl sexado en avestruces antes de la pubertad \nrepresenta un manejo importante para su comercializaci\u00f3n, ya que existen compradores que se \ninteresan en adquirir avestruces peque\u00f1os por ser estos \nde bajo costos interes\u00e1ndose m\u00e1s en adquirir hembras \nque en machos para formar pares o tr\u00edos reproductores \no con la finalidad de llevarlo al mercado. El sexado se \nlleva a cabo mediante un examen visual o palpaci\u00f3n: a la cu arta semana de edad, se presiona la porci\u00f3n m\u00e1s \nbaja de la pared de la cloaca dando un giro con un \nmovimiento circular horizontal y ventral de esta \nmanera se aprecia el cl\u00edtoris o pene del ave. En \nanimales de cuatro meses se introduce el dedo \u00edndice \nen el piso de la cloaca y haciendo tracci\u00f3n para \nexteriorizar el pene o cl\u00edtoris. El pene es m\u00e1s largo, c\u00f3nico, ligeramente curvado hacia el lado izquierdo. El \ncl\u00edtoris es m\u00e1s peque\u00f1o y de un color ligeramente m\u00e1s \np\u00e1lido. En avestruces mayores de cinco meses se puede \ndiferenciar el sexo observando el pene del macho que \nemerge con el paso de la orina o cuando defeca. En las aves adultas el color es la clave m\u00e1s visible a partir de \nlos 14 meses de edad, ya que estas empiezan a cambiar \nde coloraci\u00f3n de las plumas, en el caso del macho es de \ncolor negro y el de la hembra de color gris.  \n \nMATERIAL Y METODOS  \nEl siguiente trabajo se  realizaci\u00f3n en el \nC.E.I.E.P.A. de la  FMVZ. UNAM donde se  utilizaron \n30 avestruces con las siguientes edades,  grupo 1 con, 5 \npollos de cua tro d\u00edas de edad.  Grupo  dos 5 pollos  de \nun mes. Grupo tres 5 pollos de cuatro meses.  Grupo \ncuatro 5 pollos de seis meses.  Grupo cinco, 5 \navestruces de ocho meses de edad y  grupo seis con 5 avestruces  de catorce meses de edad. Los animales se \nidentif icaron con aretes de acuerdo al n\u00famero \nprogresivo de nacimientos.  \n \nRESULTADOS  \nLos resultados obtenidos en los animales sexados \nfueron del 26.6% de error, los de cero a cuatro meses \nde edad y de seis a catorce meses no existi\u00f3 error al \nsexado. Estos resulta dos indican que hay un porcentaje \nde error en animales menores a 4 meses.  \n \n \n \n   \n  \n  \n263 IDENTIFICACI\u00d3N DE VI RUS DE LA ENFERMEDAD DE \nGUMBORO EN EL PER\u00da P OR ELISA DE CAPTURA DE \nANT\u00cdGENO  \n \nIDENTIFICATION OF INFECTIOUS BURSAL DISEASE VIRUS IN PERU \nUSING ANTIGEN CAPTURE ELISA  \n \nEliana IcocheaB, M\u00f3nica AlbaB, Rosa GonzalezB, Manuel Contrerasc, Elmer D\u00e1vilac y Stephanie Mengel -WhereatA \n \nCollege of Veterinary Medicine, San Marcos University, Lima Per\u00faB Department of Animal and Food Sciences, \nUniversity of Delaware, Delawar e USAA, Merial Laboratoriesc \n \nSUMMARY  \nThe study was conducted to determine the \npresence of the variants strains of Infectious bursal \ndisease virus (IBDV) in commercial poultry farms in \nPer\u00fa. Eighty- five bursas from fifteen broiler farms \nwere evaluated by antigen -capture enzyme \nimmunoassays (Ac -ELISA). The monoclonal antibody \n(Mab) B29 was used to detect IBDV where twenty \nsamples were positives, seventeen suspicious and forty -\neight negatives. The Mab AVS was used as a control. \nA panel of Mabs: B29, B69, R63, BK9, 67, 57 and 10 \nwas used for antigenic characterization in order to \nidentify variant strains among the positives and \nsuspicious samples. Only 29 samples showed reaction, 14 of them (48%) were clasical strains, 6 (21%) were \nDelaware strains and 9 (31%)  were not identified.  \n \nRESUMEN  \nEl presente estudio (SE) tuvo como finalidad \nidentificar la presencia de cepas variantes de virus de la \nenfermedad infecciosa de la bursa (VEIB) en granjas \ncomerciales en Per\u00fa. Un total de 85 bursas  de fabricio \nprocedentes d e  15 granjas de pollos de carne fueron \nevaluadas por la T\u00e9cnica de ELISA de Captura de \nAnt\u00edgeno. El anticuerpo monoclonal (Mab) B29 fue usado para detectar presencia de virus de Gumboro obteni\u00e9ndose 20 muestras positivas, 17 sospechosas y \n48 negativas. El  anticuerpo monoclonal para el virus de \nla Enfermedad de newcastle (ENC), AVS fu\u00e9 usado \ncomo control negativo. Las muestras positivas y sospechosas fueron enfrentadas a un panel de  \nanticuerpos  monoclonales contra el  VEIB: B29, B69, \nR63, BK9, 67, 57 y 10, para identificar cepas variantes. \nSolo 29 muestras mostraron reacci\u00f3n, 14 de ellas \n(48%) fueron calificadas como  de tipo cl\u00e1sico, 6 \n(21%) como Delaware y 9 (31%) no pudieron ser identificadas.  \nLa Infecci\u00f3n bursal es una enfermedad  altamente \ncontagiosa  de pollos j\u00f3venes ocasionada por un virus \nde la familia Birnaviridae que se caracteriza por \nproducir dos formas de infecci\u00f3n,  una forma \nsubcl\u00ednica  en aves de 1 a 3 semanas y una forma cl\u00ednica en aves de 21  a 65 d\u00edas de edad. La c\u00e9lula blanco es el linfocito B inmaduro, por tanto el virus \nproduce lesiones en Bursa de Fabricio ocasionando \ninmunosupresi\u00f3n en aves j\u00f3venes.  El cuadro cl\u00ednico se \ncaracteriza por tener un corto periodo de incubaci\u00f3n, 2 \na 3 d\u00edas, 100% de morbilidad,  20 a 30% de m ortalidad, \ndiarrea acuosa blanquecina, depresi\u00f3n y erizamiento de \nplumas. (1)  \nExisten dos serotipos de virus 1 y 2,  el serotipo 1 \naislado en pollos y pavos, es pat\u00f3geno solo en pollos, \ndentro de este serotipo son reconocidos 6 subtipos \nantig\u00e9nicos que incluyen   cepas cl\u00e1sicas y cepas \nvariantes. El serotipo 2 es un virus no pat\u00f3geno aislado \nde pavos. (2)  \nPara  la detecci\u00f3n de anticuerpos espec\u00edficos son \nusadas pruebas de Virus neutralizaci\u00f3n y  ELISA y \npara la detecci\u00f3n del  virus, Inmunofluorescencia \ndirecta e inoculaci\u00f3n en huevos embrionados de 11 d\u00edas. Durante los \u00faltimos a\u00f1os con la necesidad de \nidentificar la naturaleza patog\u00e9nica o antig\u00e9nica de \nnuevas cepas, las t\u00e9cnicas de ELISA de Captura  de \nAnt\u00edgeno (3) y RT/PCR vienen siendo empleadas (4,5). \nLa t\u00e9cnica de ELISA de captura de ant\u00edgeno aprovecha \nla tecnolog\u00eda  de los Mabs y tiene la ventaja de detectar \nel virus directamente del tejido bursal. Con un panel de \nMabs conocidos es posible identificar cepas virales,  \nsin embargo esta t\u00e9cnica est\u00e1 limitada a los Mabs \nusados,  Anticuerpos adicionales son necesarios par a \nidentificar nuevas cepas. (3,6).  \nDurante la \u00faltima d\u00e9cada han sido reportadas en \nmuchos pa\u00edses variantes antig\u00e9nicas del serotipo 1 (3, \n5,7). En e l Per\u00fa en zonas av\u00edcolas densamente pobladas \nse observan algunas veces cuadros compatibles con \nprocesos inmunosupresivos sin embargo no existen \nestudios que indiquen si estos est\u00e1n o no relacionados a  cepas variantes del virus.  \nEl presente estudio tuvo co mo objetivo  detectar \nsi en las granjas comerciales del Per\u00fa adem\u00e1s de las \ncepas cl\u00e1sicas est\u00e1n  presentes tambi\u00e9n cepas variantes \ndel virus de Gumboro  \n \n  \n  \n264 MATERIAL Y METODOS   \nLugar de estudio.  Laboratorio de Patolog\u00eda \nAviar de la Facultad de Medicina V eterinaria de la \nUniversidad Nacional Mayor de San marcos, Lima -\nPer\u00fa.  \nBursas de Fabricio.  Fueron colectadas 85 bursas \nde Fabricio de pollos de carne entre  09 y 35 d\u00edas de \nedad procedentes de 15 granjas ubicadas en una zona \nav\u00edcola densamente poblada. Las muestras proced\u00edan \nde aves que  hab\u00edan recibido una dos vacunaciones con \nvacunas conteniendo cepas intermedias, la \u00faltima de ellas por lo menos 9 d\u00edas antes de la fecha de muestreo.  \nELISA de captura de ant\u00edgeno.  La prueba fue \nhecha siguiendo la t\u00e9cnica p reviamente descrita (3).  \nPlacas de ELISA de 96 celdas (Costar Corp., \nCambridge, MA) fueron cubiertas con una soluci\u00f3n de \n1 mg de Staph aureus proteina A / ml de agua \ndestilada, luego diluidas 1/500 en buffer bicarbonato / \ncarbonato y mantenidas a 4 \no C en  c\u00e1mara h\u00fameda \ndurante toda la noche. Fue removida la proteina A y \na\u00f1adidos los anticuerpos de captura (Mab) diluidos \n1:100 en PBS -tween y 2% de nonfat dry milk (NFDM) \nluego incubados a 4 o C toda la noche.  La placa fue \nbloqueada con una soluci\u00f3n de 2% de  NFDM por 1 \nhora a temperatura de ambiente. Removida la leche y \nadicionadas las bursas homogenizadas en tres \nvol\u00famenes de soluci\u00f3n salina fosfatada (PBS) \nconteniendo 0.05% de una soluci\u00f3n de Tween- 20 e \nincubadas por 2 horas a 39 o C. Las placas fueron \nlavadas tres veces con la soluci\u00f3n buffer de lavado y \nluego a\u00f1adidos  anticuerpos secundarios policlonales \nde pollo contra VEIB diluidos 1:500 en buffer IBEIA y \n0.5% de inmunoglobulina G humana (IgGH) e \nincubados por 1 hora a 39 o C. Las placas fueron \nnuevamen te lavadas tres veces y adicionado el \nconjugado ( Goat anti -chicken peroxidasa) diluido en \nuna soluci\u00f3n buffer IBEIA mas IgGH (KPL), incubadas por 1 hora a 39 \no C y nuevamente lavadas. \nFue a\u00f1adido el substrato peroxidasa (ABTS - KPL #50-\n66-00) y cuando fue alcanzada una D.O. de 1,000, fue \na\u00f1adida una soluci\u00f3n de dodecyl sulfato de sodio al 5% \npara paralizar la reacci\u00f3n. La lectura se hizo en un \nlector de ELISA usando un filtro de una longitud de \nonda de 405 nm.  \nAnticuerpos monoclonales: Un panel de 8 Mabs \ndel virus de Infecci\u00f3n bursal  proporcionados por el Dr. \nJohn Rosenberger de la Universidad de Delaware, \nUSA. fueron usados para la identificaci\u00f3n viral: B29, B69, R63, Bk9, 67, 57, 10, AVS; este \u00faltimo es un \nanticuerpo monoclonal del virus de la Enfermedad  de \nnewcastle (ENC) y fue usado como control negativo. \nLas cepas de campo fueron clasificadas de acuerdo a su \nreactividad frente a los anticuerpos monoclonales.  \n \nRESULTADOS  \nLa evaluaci\u00f3n de 85 Bursas de Fabricio de pollos \nde carne procedentes de 15 granjas  av\u00edcolas, analizadas \npor la t\u00e9cnica de ELISA de captura de ant\u00edgeno frente al Mab B29  que es usado para detectar presencia de \nvirus de Gumboro  dio como resultado 20 muestras \npositivas (24%), 17 sospechosas (20%) y 48 negativas (56%). Las muestras positi vas y sospechosas \nenfrentadas a los anticuerpos  monoclonales B69, R63, \nBk9, 67, 57 y 10, para  identificar cepas variantes \nmostraron reacci\u00f3n en 29 muestras, 14 de ellas (48%) \nfueron calificadas como  de tipo cl\u00e1sico, 6 (21%) como \nDelaware y 9 (31%) no pu dieron ser identificadas.   \nLos resultados de la prueba por granjas son \nmostrados en la tabla 1.  \n \nDISCUSION  \nTrabajos hechos por el Dr. Snyder y col, usando  anticuerpos monoclonales  permitieron detectar cambios progresivos de epitopes de neutralizaci\u00f3n vi ral \nen las cepas cl\u00e1sicas y es as\u00ed como  variantes Delaware del serotipo I del VEIB fueron  identificadas desde mediados de la d\u00e9cada de los 80 en  \u00e1reas av\u00edcolas en \nDelmarva (1, 7). Posteriormente  tambi\u00e9n han sido \nreportadas en Costa Rica, El Salvador, G uatemala, \nM\u00e9xico, Puerto Rico, Venezuela (8) y \u00faltimamente en \nBrasil (9). El presente trabajo tuvo como objetivo \ndeterminar si en nuestro pa\u00eds adem\u00e1s de las cepas cl\u00e1sicas est\u00e1n presentes cepas variantes del virus,  con \nese fin fueron examinadas bursas de Fabricio de pollos \nde carne procedentes de 15 granjas comerciales ubicadas en la costa norte de la capital habi\u00e9ndose \ndetectado presencia del VEIB cl\u00e1sico en 9 de las 15 y, \nvariantes Delaware en solo dos de ellas. La prevenci\u00f3n \nde la enfermedad se realiza mediante  medidas de \nbioseguridad y  la aplicaci\u00f3n de vacunas.  Para lograr \nuna optima protecci\u00f3n mediante esto \u00faltimo es \nnecesario que las cepas vacunales tengan similar \ncomposici\u00f3n antig\u00e9nica con las cepas de campo, de ah\u00ed la importancia de determinar  la naturaleza de los virus \ndesafiantes presentes en las  explotaciones av\u00edcolas (1).  \n \n \n  \n \n  \n  \n  \n265 Tabla 1.  Resultados de la prueba de ELISA de captura de ant\u00edgeno para detectar cepas variantes del virus de EIB en \n15 granjas de pollos de carne.  \nGranja  Edad (D\u00edas ) Resultado  Tipo  \n1 30  + Cl\u00e1sico  \n2 25 + Delaware  \n3 14 - - \n4 09 - - \n5 15 - - \n6 26 - - \n7 18 - - \n8 35 - - \n9 25 + Delaware  \n10 30 + Cl\u00e1sico  \n11 30 + Cl\u00e1sico  \n12 35 + Cl\u00e1sico  \n13 31 + Cl\u00e1sico  \n14 25 + Cl\u00e1sico  \n15 23 + Cl\u00e1sico  \n \n \nREFERENCIAS  \n1. Lukert, P.D., B. W. Calnek, H. John Barnes, C. W. Beard, L. R. Mcdougald, and Y. M. Saif, Infectious \nBursal Disease. In:  Diseases of poultry, 10th ed. Iowa State University Press, Ames, IA. pp 721 -738. 1997.  \n2. Jackwood, D. J. , Saif, Y. M. And Moorhead, P. D., Inmunogenicity of Infectious bursal disease virus \nserotypes I an II in chickens. Avian Dis. 29: 1184 -1194. 1985.  \n3. Snyder, D. B., D. P. Lana, B. R. Cho, and W. W. Marquardt. Group and strain -specific neutralizaci\u00f3n \nsites of infectious bursal disease virus defined with monoclonal antibodies. Avian Dis. 32: 527- 534. 1988.  \n4. Jackwood, D.J., and R., J. Jackwood. Infectious bursal diseases viruses: Molecular diferentiation of \nantigenic subtypes among serotype I and II in 75 Ohio chickens flocks. Avian Dis 38:531- 537.1994  \n5. Sellers, H. S.;Villegas, P. N.,Seal, B. S. and Daral Jackwood. Antigenic and Molecular Characterization \nof three Infectious Bursal Disease Virus Field Isolates. Avian Dis. 43: 198 -206. 1999.  \n6. Mengel, S. Department of Animal and Food Sciences,  Univ ersity of Delaware, Delaware USA. \nComunicaci\u00f3n personal. 2000.  \n7. Rosenberger, J. K., and S.S. Cloud. Isolation and characterization of variant infectious bursal disease \nviruses. J..Am. Vet. Med.Assoc. 189 -357. 1986.  \n8. Fernandez, R., E. Montiel, C. Jaramillo, Y. Ramos, D. Jackwood, J. Quesada y N. Master. \nCaracterizaci\u00f3n de las Cepas del Virus de la Enfermedad de Gumboro en Aves de Engorde en Latinoam\u00e9rica, utilizando la t\u00e9cnica de Reacci\u00f3n en Cadena de la Polimerasa. Memorias del XV Congreso Latinoamericano de Avicultura, Canc\u00fan, M\u00e9xico. (del 23 al 26 de Setiembre), 119- 121. 1997.  \n9. Ikuta, Nilo. Diagnostico Molecular do Virus da Doenca de Gumboro. II Simposio da Doenca de \nGumboro. Campinas, SP. Brasil  (del 21al 22 de noviembre del 2001). pp 93- 101. \n \n \n  \n \n  \n  \n 266  \n  \n  EFECTO DE UNA VACUNA COMERCIAL DE COCCIDIA SOBRE \nEL TIPO DE ESPECIE PRESENTE DESPU\u00c9S DE UN DESAF\u00cdO \nPAT\u00d3GENO EN POLLOS DE ENGORDA  \n \nEFFECT OF A COCCIDIAL COMMERCIAL VACCINE ON THE EIMERIA \nSPECIES PRESENT AFTER A PATHOGENIC CHALLENGE IN BROILERS  \n \nMarco A. Ju\u00e1rez- Estrada, Ana. I. Fern\u00e1ndez- Cort\u00e9s, Gerardo M. Nava- Morales, Rub\u00e9n Merino -Guzm\u00e1n, Nestor \nLedesma -Mart\u00ednez, y Guillermo T\u00e9llez Isa\u00edas  \n \nDepartamento de Producci\u00f3n Animal: Aves,  Facultad de Medicina Veterinaria y Zootecnia,  Universidad Nacional \nAut\u00f3noma de M\u00e9xico. Avenida Universidad 3000. Ciudad Universitaria 04510 M\u00e9xico, D.F.  \nE-mail:   britoco@servidor.unam.mx \n \nSUMMARY  \nA coccidial vaccine was evaluated regarding both \nproduction parameters and the species of Eimeria  \npresent after challenge. Groups were: 1) non \nvaccinated; 2) non vaccinated/challenged (day 21); 3) \nvaccinated/challenged; and 4) vaccinated/non \nchallenged. At day 28, groups 1, 2, 3, and 4 weighed 923.30 + 126.24\n\u00aa; 775.05 +  99.05b; 731.47  + 120.58b; \nand 726.16 +  130.67b, respectively. At 7 days p.i. E. \nacervulina  was found in 87%, 54%, and 21% in groups \n1, 2, and 3, respectively. Groups 2 and 3 showed  22%, \nand 41% E. maxima , respectively. Groups 1, 2, and 3, \nshowed 13%, 24%,  and 28% E. tenella , respectively.  \n \nRESUMEN  \nSe eval\u00fao una vacuna de coccidia sobre \npar\u00e1metros productivos y tipos de especies de coccidia presentes despu\u00e9s de un desaf\u00edo. Los grupos fueron 1) \nSin vacuna; 2) Sin vacuna y desaf\u00edo (d\u00eda 21); 3) \nVacunado y desafiado; 4) Vacunado sin desaf\u00edo. Al d\u00eda \n28 los grupos 1,2,3, y 4 pesaron  923.30\u00b1126.24\na; \n775.05\u00b199.05b; 731.47\u00b1120.58b y 726.16\u00b1130.67b. \nSiete d\u00edas p.i., el grupo uno present\u00f3 87% el dos 54% y el tres 21% de E. acervulina . El grupo dos 22%, el \ngrupo tres 41% de E. m\u00e1xima . El grupo uno 13%, el \ndos 24% y el tres  38% de E. tenel la.       \n \nINTRODUCCI\u00d3N  \nPara el control de la coccidiosis aviar se han \nempleado desde 1950 compuestos qu\u00edmicos y de fermentaci\u00f3n biol\u00f3gica. Estos compuestos utilizados \ncuidadosamente en los programas anticoccidiales son \neficientes para el control de la enf ermedad. Sin \nembargo, el inevitable desarrollo de resistencia anticoccidiana por cepas de campo ha dado como \nresultado la formulaci\u00f3n de otro tipo de estrategias para \nel control de la coccidiosis, las vacunas basadas en la \nutilizaci\u00f3n de oocistos vivos es una de ellas. La \nvacunaci\u00f3n contra la coccidiosis no es un concepto \nnuevo, las vacunas se han utilizado en la industria av\u00edcola desde la d\u00e9cada de 1950. Las cinco vacunas m\u00e1s representativas en el sector comercial (marcas \nregistradas como \u201cCoccivac\u201d, \u201cImmu cox\u201d, \u201cNobilis -\nCox\u201d\u201cLivacox\u201d y \u201cParacox\u201d) incorporan en su \ncomposici\u00f3n algunas de las siete especies de Eimeria \nque m\u00e1s afectan a las aves. Cuando se aplican bajo \nbuenas pr\u00e1cticas de crianza todas estas vacunas \nproporcionan inmunidad s\u00f3lida contra la infec ci\u00f3n por \ncoccidias. Sin embargo, a pesar de que otorgan una \nbuena protecci\u00f3n contra la enfermedad principalmente en pollonas de reemplazo y aves reproductoras, estas \nvacunas se han utilizado menos frecuentemente en el \npollo de engorda. El principal motivo para este bajo empleo es que el rendimiento obtenido en el pollo de \nengorda registrado como ganancia de peso, eficiencia \nalimenticia y pigmentaci\u00f3n, no siempre es igual al que se observa en los pollos medicados profil\u00e1cticamente. \nAunque algunos de los aspe ctos relacionados con una \neficiente vacunaci\u00f3n tienen que ver directamente con el \ntipo o sistema empleado para la vacunaci\u00f3n, existen \nreportes de respuesta inmune pobre a E. tenella , \nadem\u00e1s de variabilidad antig\u00e9nica de las cepas de E. \nm\u00e1xima , mostrando fr ecuentemente que la vacunaci\u00f3n \ncon oocistos vivos no siempre es efectiva en proteger \ncontra cepas de campo de diferentes sitios geogr\u00e1ficos. \nEn el presente estudio se eval\u00faa el impacto que tiene \nuna vacuna contra la coccidiosis sobre el peso, \ncalificaci\u00f3n de lesiones, eliminaci\u00f3n de oocistos y tipos \nde especies de coccidia presentes despu\u00e9s de un desaf\u00edo \nefectuado con un aislado de cepas pat\u00f3genas de campo.  \n \nMATERIAL Y M\u00c9TODOS  \nAnimales de experimentaci\u00f3n. - Todas las aves \nfueron criadas en piso en corrales d e 100 x 120 cm en \nuna unidad de aislamiento de la Facultad de Medicina Veterinaria y Zootecnia de la Universidad Nacional \nAut\u00f3noma de M\u00e9xico. Consumieron una dieta est\u00e1ndar \npara pollo de engorda isoprote\u00edca e isocal\u00f3rica, con \nbase sorgo -soya y sin ning\u00fan t ipo de droga \nanticoccidiana.   \n 267  \n  \n  Vacuna. - Se utiliz\u00f3 una vacuna comercial para \npollo de engorda que conten\u00eda una dosis est\u00e1ndar para \nmil pollos con oocistos esporulados de E. acervulina, \nE. m\u00e1xima y E. tenella.  Se aplico al d\u00eda de edad por \naspersi\u00f3n en una cabina especialmente dise\u00f1ada de acuerdo a las recomendaciones del fabricante.  \nInoculo de desaf\u00edo. - Se utiliz\u00f3 un inoculo \nparasitario aislado y tipificado en el Departamento de Producci\u00f3n Animal: Aves por el MVZ Marco A. Ju\u00e1rez \nEstrada, el inoculo consiti\u00f3 e n proporcionar \ndirectamente con una canula pl\u00e1stica directamente al \ndiverticulo esof\u00e1gico 6.0 x 10\n4 de E. acervulina ; 5.0 x \n103 de E. m\u00e1xima y 4.0 x 104 de E. tenella  oocistos \nesporulados por ave.  \nDise\u00f1o Experimental. - Cada grupo experimental \nconsisti\u00f3 de veinte pollos de engorda (Ross x Ross) y \nse dividi\u00f3 en cuatro grupos experimentales. 1) Testigo \nnegativo sin vacuna; 2) Testigo positivo sin vacuna y \ncon desaf\u00edo; 3) Vacunado y desafiado; 4) Vacunado sin desaf\u00edo. Los grupos vacunados recibieron la vacuna por \naspersi\u00f3n al d\u00eda de edad como ya se ha descrito. Los \ngrupos 2 y 3 fueron desafiados a los 21 d\u00edas de edad, \nlos grupos 1 y 4 solo recibieron soluci\u00f3n tamponada \npor la misma v\u00eda y con el mismo manejo. \nSemanalmente las aves fueron pesadas y los oocistos en heces fueron cuantificados. Se verific\u00f3 el porcentaje \nde incremento de peso del d\u00eda 21 al d\u00eda 28 de edad. Al d\u00eda 28 de edad (7 d\u00edas postinoculaci\u00f3n (p.i.)) todas las aves de cada grupo se evaluaron para calificar lesiones \nde acuerdo a la escala establecid a por Johnson y Reid \n(1970) y los oocistos recuperados p.i. fueron determinados cualitativamente de acuerdo a lo descrito \npor Long et al (1976).  \nAn\u00e1lisis estad\u00edstico. - Los efectos registrados en \nlos par\u00e1metros por grupo fueron determinados por \nan\u00e1lisis de  varianza de un solo factor. Las diferencias \nentre las medias de los grupos fueron determinadas a \ntrav\u00e9s de la comparaci\u00f3n m\u00faltiple de medias de Tukey \ncon una significancia para alfa preestablecida de \nacuerdo a Fisher de P<0.05.  \n \nRESULTADOS  \nAl d\u00eda 7 el gru po uno peso 133.10\u00b118.31\na, el \ngrupo dos 125.70\u00b114.66a, el grupo tres 127.10\u00b118.31a \ny el cuatro 122.44\u00b120.0a; Al d\u00eda 14 los grupos 1,2,3, y \n4 pesaron 321.80\u00b154.59a; 313.40\u00b151.57a; \n309.55\u00b153.10a y 292.44\u00b142.70a; respectivamente. Al \nd\u00eda 21 los grupos 1, 2, 3,  y 4 pesaron 615.65\u00b1100.10a; \n622.00\u00b172.67a; 544.83\u00b1105.88b y 504.94\u00b188.49a; \nrespectivamente. Al d\u00eda 28 los grupos 1,2,3, y 4 \npesaron 923.30\u00b1126.24a; 775.05\u00b199.05b; \n731.47\u00b1120.58b y 726.16\u00b1130.67b; respectivamente. El \nporcentaje de incremento de peso del d\u00ed a 21 al d\u00eda 28 \nen el grupo uno fue de 50.13%, en el grupo dos fue de \n24.59%, en el grupo tres de 34.46% y en el grupo \ncuatro de 44.09%.  La calificaci\u00f3n de lesiones para E. acervulina  de los grupos 1, 2, 3 y 4 fue 0.87\u00b10.76b, \n2.35\u00b10.49a, 0.94\u00b10.43b y 0.27\u00b1 0.46c respectivamente. \nPara E. maxima  los grupos 1,2,3 y 4 presentaron \n0.05\u00b10.22c, 1.75\u00b10.64a, 1.17\u00b10.73b y 0.11\u00b10.32c \nrespectivamente. Para E. tenella  los grupos 1,2,3 y 4 \npresentaron 0.05\u00b10.22b, 0.25\u00b10.55a, 0.70\u00b10.89a y \n0.11\u00b10.32b respectivamente. El con teo de oocistos al \nd\u00eda 7 de edad de los grupos 1,2,3 y 4 fue de  0\u00b10 b, 0\u00b10b  \n, 626.2\u00b1750.5a y 421.48\u00b1512.45a oocistos \nrespectivamente. A los 14 d\u00edas los grupos 1,2,3 y 4 \nexcretaron 0\u00b10c, 0\u00b10c , 49,600.0\u00b11,995.5b y \n260,000\u00b131,450.84a oocistos respectivame nte. A los 21 \nd\u00edas de edad los grupos 1,2,3 y 4 excretaron 0\u00b10c, 0\u00b10c, \n1,598,666.6+837,835.5a y 718,666.6+104,126.4b \noocistos respectivamente. A los 28 d\u00edas de edad los \ngrupos 1,2,3 y 4 excretaron 406,000.0+35,071.9c, \n3,626,666.6+828,985.9a, 2,280,000.0+573,860.2b y \n62,666.6+10,927.4c oocistos respectivamente. Al \nefectuar el an\u00e1lisis cualitativo de oocistos a los 21 d\u00edas \nse determin\u00f3 que el grupo uno present\u00f3 0% de Eimeria \nsp.. El grupo dos 0% de Eimeria sp.. El grupo tres 80% \nde E. acervulina , 8% de E. ma xima  y 12% de E. \ntenella . El grupo cuatro 83% de E. acervulina , 2% de \nE. maxima  y 15% de E. tenella . A los 28 d\u00edas de edad 7 \nd\u00edas p.i. se determin\u00f3 que el grupo uno present\u00f3 87% \nde E. acervulina  y 13% de E. tenella . El grupo dos \n54% de E. acervulina , 22% de E. maxima  y 24% de E. \ntenella . El grupo tres 21% de E. acervulina , 41% de E. \nmaxima  y 38% de E. tenella . El grupo cuatro 84% de \nE. acervulina , 4% de E. maxima  y 12% de E. tenella .  \n \nDISCUSI\u00d3N  \nLo que se determin\u00f3 en el presente estudio es que \nla protecci\u00f3 n de la vacuna evaluada aqu\u00ed contra E. \nacervulina  fue eficiente al proteger al grupo vacunado \ny desafiado mostrando una afecci\u00f3n del peso no \nsignificante. El grupo control positivo mostr\u00f3 un mayor da\u00f1o intestinal que el resto de los grupos, la \nrecuperaci\u00f3n  de peso una semana despu\u00e9s del desaf\u00edo \nfue menor con relaci\u00f3n al grupo 3. La ganancia en peso \nde los grupos 1 y 2 se redujo durante la fase aguda dela \ninfecci\u00f3n pero se increment\u00f3 durante la fase de \nrecuperaci\u00f3n de acuerdo a lo observado por Adams et \nal (1996). Siete d\u00edas postinoculaci\u00f3n las aves de los \ngrupos vacunados desafiados y sin desafiar, no \nmostraron diferencias significativas de peso entre s\u00ed; \npero en calificaci\u00f3n de lesiones y eliminaci\u00f3n de \noocistos el grupo 2 fue diferente al grupo 1. Si bien la \nvacuna comercial protege contra un desaf\u00edo de campo, \nesta protecci\u00f3n no fue del 100% como se observa en el \ncuadro 1 donde el grupo vacunado y desafiado aunque \nmuestra una menor reducci\u00f3n en la ganancia de peso \nrespecto al grupo testigo positivo, esta ga nancia de \npeso es menor al grupo vacunado no desafiado y al \ngrupo testigo negativo que no recibi\u00f3 el desaf\u00edo. El \ngrupo vacunado y no desafiado muestra una menor  \n 268  \n  \n  ganancia de peso en relaci\u00f3n a la observada en el grupo \ntestigo negativo  (cuadro 1), posibleme nte debido a que \nlas especies vacunales se siguen replicando a esta edad \ny por lo tanto afectan la ganancia de peso, sin embargo, \nposteriormente este peso lo recuperan \ncompensatoriamente dos semanas m\u00e1s tarde mostrando \nuna menor conversi\u00f3n alimenticia de acuerdo a lo reportado por D\u00e1vila (2000). En el presente estudio la \ninmunidad humoral no tuvo un efecto importante en los \ngrupos desafiados, aunque, Girard et al (1997) al \nutilizar un ensayo de cultivo in vitro  de tejido intestinal \ndurante 21 d\u00edas despu\u00e9s del desaf\u00edo con E. acervulina  y \nE. tenella ,  anticuerpos espec\u00edficos de IgA e IgG se \nincrementaban \u00fanicamente despu\u00e9s de la segunda \nsemana postdesaf\u00edo. Por lo cual posiblemente en este \nestudio no se determino ninguna diferencia despu\u00e9s de \nsolo siete d\u00edas po stdesaf\u00edo. Las investigaciones que \nmuestran variabilidad antig\u00e9nica por parte de E. maxima  y pobre inmunidad por parte de E. tenella  \nindican que la vacunaci\u00f3n con una suspensi\u00f3n de \noocistos vivos no puede llegar a ser tan eficiente en \nproteger contra desaf \u00edos de campo por cepas \nprovenientes de diferentes localizaciones geogr\u00e1ficas. \nPor lo cual las cepas de Eimeria  sp presentes en las \nvacunas comerciales no siempre proporcionan \nsuficiente inmunidad a los desaf\u00edos con cepas \nheter\u00f3logas de campo de estas mismas especies. \nAunque la vacuna comercial utilizada en el presente estudio protege contra un desaf\u00edo de campo, esta \nprotecci\u00f3n no fue del 100% ya que como ya se a \ndescrito existe una mayor proporci\u00f3n de E. maxima  en \nel grupo vacunado desafiado que en el grupo vacunado \ny no desafiado. La falta de protecci\u00f3n cruzada entre \ncepas heter\u00f3logas de E. maxima  se ha mencionado ya \ndesde la publicaci\u00f3n de Long en 1976; sin embargo no se hab\u00eda caracterizado adecuadamente esta falta de \nprotecci\u00f3n entre cepas de diferente or igen geogr\u00e1fico \nhasta los recientes estudios hechos por Danforth (1998) \nquien ha mostrado que existe una enorme \ninmunovariaci\u00f3n entre cinco cepas de E. maxima  \nobtenidas de diferentes \u00e1reas en Norteam\u00e9rica. Lo \ninteresante es que en M\u00e9xico se han introducido  \nrecientemente vacunas comerciales para pollo de \nengorda que contienen cepas vivas de E. maxima  sin \nefectuar los estudios previos de inmunoprotecci\u00f3n \ndesafiando con cepas nativas. El presente estudio \ndemuestra que la protecci\u00f3n cruzada es importante a \nconsiderar en la protecci\u00f3n conferida por una vacuna \ncomercial y su probable \u00e9xito en proteger \nadecuadamente las parvadas de aves de diferentes \nlocalidades geogr\u00e1ficas del pa\u00eds. A pesar de que E. maxima  se ha reportado como una especie muy \ninmun\u00f3gena, en el pr esente estudio la vacuna de origen \nextranjero no protegi\u00f3 contra el aislado de origen \nmexicano, repercutiendo m\u00e1s esta falta de iprotecci\u00f3n \ncruzada sobre los par\u00e1metros productivos que el efecto \n\u00fanico de aplicar la vacuna sin desafiar. Ante el desaf\u00edo \ncontra E. tenella  el grupo vacunado present\u00f3 una \nprotecci\u00f3n d\u00e9bil debido en parte a la mala generaci\u00f3n de inmunidad de \u00e9sta especie en particular y \nposiblemente al igual que en el caso de E. maxima  a la \nbaja inmunidad cruzada de la vacuna con las cepas del \naislado mexicano. Es importante considerar la \ncaracterizaci\u00f3n molecular de las cepas nativas de \nEimeria  sp en M\u00e9xico para comprender la relaci\u00f3n que \ntienen en la protecci\u00f3n conferida por cepas comerciales \ncon la finalidad de determinar posibles variaciones \nantig\u00e9nicas. Se requiere efectuar m\u00e1s investigaci\u00f3n en \nel pa\u00eds respecto a la inmunidad cruzada contra E. maxima  antes de utilizar vacunas de manera \nindiscriminada.  \n \nREFERENCIAS  \n1. Johnson, J., and Reid, W.M. Anticoccidial \ndrugs: lesion scoring techniques in bat tery and floor -\npen experiments with chickens. Experimental Parasitol. \n28: 30- 36. 1970.  \n2. Long, P.L. Millard, B.J. Joyner, L.P., and  \nNorton, C.C. A guide to laboratory techniques used in the study and diagnosis of avian coccidiosis. Folia Vet. \nLatina 6: 200- 217. 1976.  \n3. Adams, C. Vahl, H.A., and Veldman, A. \nInteraction between nutrition and Eimeria acervulina  \ninfection in broiler chickens: development of an experimental infection model. British J. of Nutr. 75: \n867-873. 1996.  \n4. D\u00e1vila, R.V. Efecto de la vacuna No bilis \nCox ATM\n\uf8e8 contra la coccidiosis aviar sobre el grado \nde pigmentaci\u00f3n y principales par\u00e1metros productivos en pollos de engorda. tesina de licenciatura. \nUniversidad Nacional Aut\u00f3noma de M\u00e9xico, M\u00e9xico. \n2001.  \n5. Girard, F. Fort, G. Yvor\u00e9, P., and Qu\u00e9r\u00e9, P . \nKinetics of specific inmunoglobulin A, M and G production in the duodenal and caecal mucosa of chicken infected with Eimeria acervulina  or Eimeria \ntenella . Int. J. Parasitol.27:803 -809. 1997.  \n6. Danforth, H.D. Use of live oocyst vaccines \nin the control of a vian coccidiosis: experimental studies \nand field trials. Int. J. Parasitol. 28: 1099 -1109. 1998.  \n  \n 269  \n  \n  COMPATABILIDAD DE UN ADSORBENTE \nORGANOALUMINOSILICATO DE MICOTOXINAS CON \nADITIVOS QUIMICOS  \n \nCOMPATIBILITY OF A MYCOTOXIN ADSORBING ORGANIC ALUMINUM \nSILICATE WITH CHEMICAL ADDITIVES  \n \nFierro, J. A.,  y  Medina, J. C. \n \nNutek, S.A. de C.V. 7 norte 416, Tehuacan, Puebla. M\u00e9xico. nutek@grupoidisa.com.mx  \n  \nSUMMARY  \nThis paper describes the compatibility results of a \norganic mycotoxin adsorbant and chemical fungicidal  \nand actericidal additives ised in the manufacturing of \nbalanced feeds(3). The inclusion of these additives is \nextremely important for the adequate protection against \nthe contamination by different organisms during \nstorage(2,5). In order to manage this pro blem, \nchemically -treated mycotoxin adsorbents have been \ndeveloped for the control of non- polar mycotoxines \nlike zearalenone. Even though, chemical reactions of \naluminum silicates with fungicidal and bactericidal \ncompoundes have not been documented.  \n \nRESUM EN \nEl trabajo describe los resultados de \ncompatibilidad de un adsorbente de micotoxinas, con \ntratamiento org\u00e1nico, contra aditivos qu\u00edmicos: \nfunguicidas y bactericidas, que se utilizan en la elaboraci\u00f3n de alimentos balanceados para animals (3). \nLa inclusi \u00f3n de estos aditivos es de gran importancia \npara una adecuada protecci\u00f3n contra la contaminaci\u00f3n \npor diferentes microorganismos durante su \nalmacenamiento (2,5). Para enfrentar este problema se \nhan desarrollado adsorbentes de micotoxinas con tratamiento org \u00e1nico para el control de las micotoxinas \nno polares como la zearalenona, sin embargo, no se cuenta con la documentaci\u00f3n de que los \norganoaluminosilicatos reaccionen qu\u00edmicamente con \nfunguicidas y bactericidas.  \nLos problemas de contaminaci\u00f3n con bacterias y \nhongos son de gran importancia para la industria  pecuaria. Algunos hongos, adem\u00e1s de disminuir la \ncalidad nutritiva de los alimentos, pueden producir \nmicotoxinas responsables de problemas en la industria \npecuaria debido a que reducen los par\u00e1metros \nproductivos. Algunas de ellas afectan el  sistema \ninmune y en casos muy severos puede presentarse la \nmuerte (2,3,4). El objetivo fue evaluar el efecto de \ncuatro aditivos qu\u00edmicos sobre un \norganoaluminosilicato comercial. Los aditivos a evaluar fueron los sigui entes: \u00c1cido propi\u00f3nico concentrado, diacetato de sodio Q.P:, formaldeh\u00eddo en soluci\u00f3n acuosa al 37 %, producto comercial patentado contra Salmonella sp. (formaldeh\u00eddo 30% -\u00e1cido \npropi\u00f3nico 10%, etc.). El tiempo de contacto fue de 20 minutos, 7, 14, 21 y 28 d\u00edas. Las mezclas se realizaron \npor duplicado con una semana de diferencia. Como medida  de la compatibilidad se consider\u00f3 la capacidad de adsorci\u00f3n de zearalenona por cromatograf\u00eda de \nl\u00edquidos de alta resoluci\u00f3n(1), dado que esta es una de \nlas micotoxina s de menor polaridad. Los resultados \nobtenidos fueron los siguientes: el adsorbente presento \ncompatibilidad en todos los tratamientos durante el \nperiodo de prueba, la adsorci\u00f3n fue del 100 % de \nzearalenona, solo en el d\u00eda 14 se presento una peque\u00f1a variaci \u00f3n con tres de los aditivos \u00e1cido propi\u00f3nico (98 \n%), formaldeh\u00eddo (97 %) y el producto comercial (98 %), la variaci\u00f3n se puede atribuir a la naturaleza del \nproducto. En conclusi\u00f3n, la inclusi\u00f3n de aditivos \nqu\u00edmicos en alimentos balanceados y materias primas \ntanto de origen vegetal como animal no presenta ning\u00fan problema con otros aditivos como el \norganoaluminosilicato, adsorbente de micotoxinas, \nestudiado.  \n \nREFERENCIAS  \n1. AOAC International. Official Methods of \nAnalysis. 16\nth edition pag. 24. cp 49 Internation al \nArlington, Va.  1995.  \n2. Christensen, C. M., y D. B. Sauer. Storage \nof cereal grains and their products. Amer. Assoc. of \nCereal Chemists, Inc. St. Paul, Minn. Pp 219 \u2013 240. \n1982.  \n3. Coelho, M.  B. Molds, mycotoxins and \npreservatives in feed industry. Ed. BASF pag. 129. 1992.  \n4. Micotoxinas.Tercera conferencia \ninternacional mixta FAO/OMS/PNUMA sobre \nmicotoxinas. T\u00fanez, T\u00fanez. 1999.  \n5. Torres, V. R..  Agentes transmitidos por \nalimentos. Universidad de Guadalajara.  Cap. 3 \u2013 16. \n1999.\n  \n 270  \n  \n   \nEFFECTS OF THE VACCINATION AND NORMAL AVIAN GUT \nFLORA (NAGF) APPLICATION ON SALMONELLA \nENTERITIDIS/GALLINARUM  CONTROL IN COMMERCIAL \nLAYERS IN ITALY \n \nEFECTOS DE LA VACUNACI\u00d3N Y DE LA APLICACI\u00d3N DE FLORA \nINTESTINAL AV\u00cdCOLA NORMAL (NAGF) SOBRE EL CONTROL DE \nSALMONELLA ENTERITIDIS/S. GALLINARUM EN PONEDORAS \nCOMERCIALES, EN ITALIA  \n \nGrilli G.A, Pisoni A. A, Ricci A.B, Meini A.C, Stonfer M.D, Tagliabue S.E, Gallazzi D. A \n \nA Dipartimento di Patologia Animale, Igiene e Sanit\u00e0 Pubblica Veterinaria, Universit\u00e0 degli Studi di Milano  \nvia Caloria 10, 20133 Milano \u2013  ITALY, B Lab. di Referenza Nazionale per le Salmonellosi, IZS Legnaro, Padova \u2013  \nItaly, C Intervet Italia s.r.l., via Walter Tobagi 7, 20068 Peschiera Borromeo (MI) \u2013  ITALY , D Bayer s.p.a. Sanit\u00e0 \nAnimale, viale Certosa 126, 20156 Milano \u2013  ITAL Y, EIstituto Zooprofilattico Sperimentale, via Bianchi 9,  \n25124 Brescia \u2013  ITALY  \n \nRESUMEN  \nDesde 1997 existe en Italia un programa \nvoluntario de control de S. enteritidis  y S. typhimurium  \nen ponedoras comerciales. Durante los \u00faltimos 3 a\u00f1os \nm\u00e1s de 50 mill ones de gallinas (60% de las parvadas \nitalianas) se vacunaron contra S. enteritidis  y/o S. \ngallinarum.  El 30% de las gallinas recibi\u00f3 el NAGF  ya \nsea en la incubadora o durante la primera semana de \nvida. La incidencia de tifoidea en las ponedoras y la prese ncia de S. enteritidis  en el huevo han disminuido. \nDisertaremos sobre los resultados y los analizaremos.  \n \nSUMMARY  \nSalmonella enteritidis  and S. gallinarum  \ninfections in Italy are not present in layer parents\u2019 \nflocks. In commercial layers fowl typhoid and S . \nEnteritidis infection sporadically occur  because of the \ndeficiency on biosecurity measures (mainly recycling \neggs packages) and because of the warm climate in \nSouth Italy.  The introduction of Salmonellae  in commercial \nlayers flocks through feeds does n ot represent an \nimportant vector, as in chicken or turkey.  \nSince 1997 in Italy is effective a voluntary S.  \nenteritidis  and S. typhimurium  control programme in \ncommercial layers. During the last 3 years more than 50 million hens (60% of Italian flocks) were  vaccinated \nagainst S. enteritidis  (inactivated vaccine) and/or S.  \ngallinarum  (live vaccine). NAGF at the hatchery level \nor during the first week of age was applied to 30% of \nhens. Fowl typhoid in layers as well as the presence of \nS. enteritidis  in eggs ha ve decreased in the field, but \nthe isolation of these organisms may occur again in live \npoultry/mammals or in avian meat products (Table 1). This situation is due to a reduced application of NAGF \nand of specific vaccines (only for economic reasons). \nAt the  same time there has been a decrease of \nsalmonellosis with clinical signs by S . enteritidis  \nand/or S. gallinarum . In order to control properly these \ninfections, prophylactic programmes and specific vaccinations must be applied continuously for more \nyears and biosecurity measures have be implemented.  \n \n \n \n  \n \n \n  \n \n   \n 271  \n  \n  Table 1 . Isolation of S.  Enteritidis  and S. Gallinarum  in animals and meat products from 1997 to  \n2000 in Italy.  \nYear  Chicken  Turkey  Other  \navian  \nspecies  Bovine  Pork  Meat products  Eggs  Feeds  Other  Total \nBovine/  \nPork  Poultry  \nS. Enteritidis  \n1997  128 2 4 11 2 4 40 28 - 40 259 \n1998  87 25 6 3 - 2 34 36 3 65 261 \n1999  78 10 8 - 2 7 24 25 1 40 195 \n2000  25 - 4 2 - 4 23 13 - 22 93 \nTotal  318 37 22 16 4 17 121 102 4 167 808 \nS. Gallinarum  \n1997  63 - - - - - - - - 3 66 \n1998  12 - 1 - - - - 2 - - 15 \n1999  27 - 44 - - - - 1 - 2 74 \n2000  10 - 3 - - - - - - 1 14 \nTotal  112 - 48 - - - - 3 - 6 169 \n \n \nEVALUACI\u00d3N DE LA CAP ACIDAD DE SECUESTRO IN VITRO  DE \nOCRATOXINA A POR DIF ERENTES SECUESTRANTES \nCOMERCIALES  UTILIZADOS EN M\u00c9XICO  \n \nEVALUATION OF THE IN VITRO EFFECTIVENESS ON OCHRATOXIN A \n(OA) OF DIFFERENT MYCOTOXIN BINDERS  USED IN MEXICO  \n \nGarc\u00eda MAR1, Rosiles MR2, Bautista OJ2. \n \n1 CEIEPA, Facultad de Medicina Veterinaria, UNAM.  \n2Laboratorio de Toxicolog\u00eda, Fac ultad de Medicina Veterinaria, UNA  \n \nSUMMARY  \nThe sequestering ability on OA of 10 commercial \nmycotoxin binders used in Mexico was measured in \nvitro, using high performance liquid chromatography \n(HPLC) on unbound mycotoxin. Three different OA extraction met hods were used. Similarly, OA -\ncontaminated wheat was used as a mycotoxin source in \none of the trials. Results showed wide variability \ndepending on the extraction method. Only one product remained constant in its binding ability in all three \ntrials. When OA -contaminated wheat was used as a \nsource of OA, variability was even higher. These \nresults demonstrate the little reliability of the in -vitro \nbinding challenge test for the evaluation of mycotoxin \nbinders.  \n \nRESUMEN  \nSe midi\u00f3 la capacidad de secuestro in vitro  de \nocratoxina A (OA) de 10 secuestrantes comerciales de \nmicotoxinas utilizados en M\u00e9xico, mediante \ncuantificaci\u00f3n por cromatograf\u00eda de l\u00edquidos de alta \nresoluci\u00f3n (HPLC) de la micotoxina no secuestrada, utilizando 3 diferentes m\u00e9todos de extracci\u00f3n de O A. \nAsimismo, se utiliz\u00f3 trigo contaminado con OA como \nfuente de micotoxina en uno de los ensayos. Los \nresultados mostraron una amplia variabilidad seg\u00fan el m\u00e9todo de extracci\u00f3n. Solo un producto se mantuvo \nconstante en su capacidad de secuestro en los tres  \nensayos realizados. Cuando se utiliz\u00f3 trigo \ncontaminado como fuente de OA, la variabilidad fue a\u00fan mayor. Estos resultados demuestran la poca \nconfiabilidad del desaf\u00edo de secuestro in vitro  para la \nevaluaci\u00f3n de un secuestrante de micotoxinas.  \n \nINTRODUCCI \u00d3N \nLas micotoxinas son metabolitos t\u00f3xicos  de \nhongos que afectan el grano y otras materias primas. Una de las m\u00e1s importantes y t\u00f3xicas para aves j\u00f3venes \nes la ocratoxina A (OA),  que produce disminuci\u00f3n de \nla ganancia de peso, inmunosupresi\u00f3n y mala \npigm entaci\u00f3n. Para combatir a las micotoxinas  se ha \nrecurrido al uso de secuestrantes, como los aluminosilicatos, consistentes b\u00e1sicamente en arcillas \ncompuestas de aluminio y silicio combinados con otros  \n 272  \n  \n  minerales en arreglos tridimensionales, que forman \nestructuras con amplia superficie de contacto y \nporosidad. Recientemente, nuevos productos a base de \nparedes celulares de levaduras han surgido en el \nmercado para tal fin. La eficacia de los secuestrantes se \nha comprobado s\u00f3lo para aflatoxinas en estudios in \nvitro  e in vivo.  Dada la presencia de otras micotoxinas, \ncomo OA, diversos productos han surgido en el \nmercado para su secuestro, y se hace necesario un \ncontrol de calidad. La evaluaci\u00f3n de secuestro in vitro  \nbusca simular las condiciones encontradas en el  tracto \ndigestivo del ave, tales como pH y el tiempo de \ncontacto entre secuestrante y micotoxina. Sin embargo, tal evaluaci\u00f3n no refleja el comportamiento del \nproducto en condiciones de campo. No obstante, es el \ntipo de evaluaci\u00f3n m\u00e1s frecuentemente utiliz ada por los \nfabricantes de secuestrantes, y en muchos casos, el \n\u00fanico sistema de evaluaci\u00f3n con que \u00e9stos productos \ncuentan antes de salir a la venta.   \nDada \u00e9sta situaci\u00f3n, el objetivo de la presente \ninvestigaci\u00f3n fue medir la capacidad de secuestro in \nvitro de OA de 10 secuestrantes comerciales de \nmicotoxinas, utilizando cromatograf\u00eda de l\u00edquidos de \nalta resoluci\u00f3n (HPLC) para cuantificar la micotoxina \nno secuestrada.  \n \nMATERIAL Y M\u00c9TODOS  \n Se evaluaron 10 secuestrantes comerciales, a los \ncuales se les determin\u00f3 el pH. Para el desaf\u00edo de \nsecuestro in vitro  se colocaron 20 ml de soluci\u00f3n de \npepsina en \u00e1cido clorh\u00eddrico 0.075N en tubos de \npolipropileno, y se mezclaron  500 mg de secuestrante \ny por un lado, 250 mg de trigo molido contaminado \ncon OA (ensayo I) y  por otra parte 2 \u00b5g de est\u00e1ndar de \nOA (ensayos II, III y IV). Los tubos fueron colocados \nen ba\u00f1o Mar\u00eda por 3 h a 37 C en oscuridad. De cada \nmuestra se tom\u00f3 una al\u00edcuota de donde la micotoxina libre (no secuestrada) fue extra\u00edda siguiendo 3 \ndiferentes meto dolog\u00edas: Nesheim para HPLC (ensayo \nI y III), Stoloff  (ensayo II), e igual que en ensayo I y \nIII sin filtraci\u00f3n de la muestra (Ensayo IV). Las muestras fueron inyectadas a un cromat\u00f3grafo de \nl\u00edquidos de alta resoluci\u00f3n. Se calcul\u00f3 la curva de \nregresi\u00f3n li neal para los est\u00e1ndares de OA y las \nmuestras problema. Para el c\u00e1lculo del porcentaje de \nsecuestro se cuantific\u00f3 la micotoxina presente en el \ntestigo negativo (tubo sin secuestrante) y se consider\u00f3 \u00e9sta como el cien por ciento de la micotoxina (cero por \nciento de secuestro). Los resultados de adsorci\u00f3n in \nvitro  fueron analizados mediante la prueba de \nestad\u00edstica no param\u00e9trica de Friedman, considerando \nel ensayo de adsorci\u00f3n como bloque, con una \nsignificancia de \u03b1 = 0.05.  \n RESULTADOS  \nEl porcentaje de adsor ci\u00f3n de OA result\u00f3 muy \nvariable seg\u00fan el m\u00e9todo de extracci\u00f3n y el tipo de \nproducto. Los porcentajes var\u00edan desde cero hasta \n98.36 (Ver Cuadro) En el ensayo I, los resultados \nfueron tambi\u00e9n variables, dado que en algunos casos la \nconcentraci\u00f3n de OA no sec uestrada fue mayor que en \nel testigo (Ver Cuadro). No es posible, por lo tanto, \nestablecer alguna comparaci\u00f3n entre las \nconcentraciones obtenidas en los diferentes casos. El \nsecuestrante que se mantiene constante en el secuestro \nde OA en los ensayos II a I V es el producto 5, siendo \nen promedio el de mayor porcentaje de secuestro in \nvitro .  \n \nDISCUSI\u00d3N  \nNo se encontr\u00f3 evidencia estad\u00edstica de que la \nadsorci\u00f3n de OA por parte de alguno de los \nsecuestrantes sea mejor. La diferencia fue num\u00e9rica, y \nen la mayor\u00eda de los casos no coincide con lo \nmencionado para cada secuestrante por parte de sus \nfabricantes. Por otra parte, dada la variabilidad de los \nresultados obtenidos por diferentes m\u00e9todos extracci\u00f3n \nde la muestra, la confiabilidad del ensayo in vitro  como \nm\u00e9to do de evaluaci\u00f3n de un secuestrante es \ncuestionable, lo cual ha sido mencionado por varios \nautores  respecto a las pruebas in vitro . Es importante \nconsiderar el uso de un testigo negativo, conteniendo la \nmisma soluci\u00f3n de contacto y micotoxina,  pero sin \nsecuestrante, que debe ser procesado y cuantificado \ncomo cualquiera de las muestras. De \u00e9sta manera, el \nvalor de la toxina recuperada en \u00e9ste testigo ser\u00e1 \nconsiderada el cien por ciento de micotoxina de la cual \npartimos, y los c\u00e1lculos para cada secuestrant e deben \nser realizados en base a dicho testigo. De no hacerlo as\u00ed, la micotoxina perdida durante el proceso de extracci\u00f3n ser\u00e1 considerada como secuestrada, lo cual \nnos arrojar\u00e1 un resultado falso.  \nEl secuestrante que num\u00e9ricamente present\u00f3 una \nmayor capacidad de secuestro in vitro  de OA fue el \nidentificado como producto 5, el cual es ampliamente recomendado por sus fabricantes para el secuestro de \nOA, situaci\u00f3n que, al menos bajo condiciones in vitro , \ncoincide con lo obtenido en \u00e9ste estudio. El resto de los \nsecuestrantes no presentaron una buena capacidad de \nsecuestro de OA, lo cual coincide con los estudios realizados al respecto para otras micotoxinas. Dado que \nno existe una metodolog\u00eda bien establecida para la \nrealizaci\u00f3n del ensayo de secuestro in vitro , existe \ncierta diversidad en los m\u00e9todos desarrollados por cada laboratorio. Los resultados observados en este estudio \ncuando se confrontaron los secuestrantes con trigo \ncontaminado con OA resultaron ampliamente variables, dado que la distribuci\u00f3n de cu alquier \nmicotoxina no es homog\u00e9nea en el grano, por lo que no \nes recomendable realizarlo de \u00e9sta manera, dado que  \n 273  \n  \n  puede producir un resultado falso. El utilizar est\u00e1ndar \nde OA es un procedimiento que garantiza la cantidad \nde micotoxina con la que se confro nta el secuestrante, \nlo cual resulta costoso y no es comparable con las \ncondiciones presentes en el ave.  \nFinalmente, es importante considerar que la \nevaluaci\u00f3n in vitro  es un sistema de evaluaci\u00f3n de \nsecuestrantes que trata de simular las condiciones \nprese ntes en el organismo del ave, pero si un \nsecuestrante presenta una buena adsorci\u00f3n in vitro  no \nimplica que suceder\u00e1 lo mismo in vivo . Por \u00e9sta raz\u00f3n, \nla prueba biol\u00f3gica de \u00e9stos productos se hace \nnecesaria para obtener un resultado m\u00e1s preciso y cercano a la realidad.  \n \nREFERENCIAS  \n1. Andrade OF. Efecto de los aluminosilicatos \ncomo secuestrantes de aflatoxina B1, evaluado por conversi\u00f3n alimenticia y concentraci\u00f3n de calcio, f\u00f3sforo, magnesio, fierro, cobre y zinc en pollo de \nengorda (tesis de licenciatura). M\u00e9xico (DF): FMVZ, \nUNAM, 1993.  \n2. Roland DA, Barnes DG and Laurent SM. \nInfluence of sodium aluminosilicate, hydroxy -sodalite, \ncarnegieite, aluminum sulfate and aluminum phosphate on performance of comercial Leghorns. Poultry \nScience 1991;70:805- 811. \n3. Osuna O. S oluciones pr\u00e1cticas para \ndisminuir el impacto de las micotoxinas en la \navicultura. Memorias del XVI Congreso \nCentroamericano y del Caribe de Avicultura; 2000 \nNoviembre 15- 17; Panam\u00e1 (Panam\u00e1): Asociaci\u00f3n \nCentroamericana de Avicultura, 2000:355 -361.  \n4. Medina JC, Mu\u00f1oz J, Lara J, Rivera L y \nFierro JA. Criterios de control de calidad de aluminosilicatos comercializados como adsorbentes de \nmicotoxinas. Memorias del XVI Congreso \nLatinoamericano de Avicultura;1999 septiembre 21- 24; \nLima (Per\u00fa). Per\u00fa: Asociaci\u00f3n Per uana de Avicultura, \n1999: 391- 393. \n5. Lechuga GD, Rosiles MR, Horta RJM. \nIdentificaci\u00f3n fisicoqu\u00edmica de algunos \naluminosilicatos y de su actividad adsorbente sobre \naflatoxina B\n1 in vitro . Veterinaria M\u00e9xico \n1995:26;129- 132. \n6. Scheideler SE. Effects of various types of \naluminosilicates and aflatoxin B1 on aflatoxin toxicity, chick performance and mineral status. Poultry  Science \n1993:72;282- 288.\n \nCuadro 1 . Resultados de adsorci\u00f3n de ocratoxina A por diferentes secuestrantes bajo diferentes m\u00e9todos de \nextracci\u00f3n de la micotoxina no secuestrada.  \nPRODUCTO  Ensayo I  \n \n(ppm de OA)  Ensayo II  \n% de \nsecuestro  Ensayo III  \n% de \nsecuestro  Ensayo IV  \n% de \nsecuestro  Promedio  \nControl  56.44  0.00a  0.00a  0.00a  0.00 \nProducto 1  24.84  78.98a  66.57a  41.78a  48.53  \nProducto 2  41.74  0.00a  0.00a  0.93a  0.31 \nProducto 3  37.00  56.66a  0.00a  7.77a  21.48  \nProducto 4  56.14  30.36a  54.36a  10.07a  31.60  \nProducto 5  68.13  93.07a  98.36a  63.31a  84.91  \nProducto 6  24.87  95.55a  43.54a  0.00a  43.26a  \nProducto 7  26.34  80.05a  62.73a  43.18a  61.99a  \nProducto 8  64.54 66.50a  0.00a  27.21a  31.24a  \nProducto 9  57.17  63.43a  0.00a  19.31a  27.58a  \nProducto 10  71.12  45.10a  10.94a  11.92a  31.33a  \nValores con diferente literal indican diferencia estad\u00edsticamente significativa (p<0.05)  \n \n   \n \n  \n 274  \n  \n  EVALUACI\u00d3N DE SECUES TRANTES DE MICOTOX INAS PARA \nREDUCIR LA TOXICIDAD EN DIETAS PARA  POLL O DE \nENGORDA CONTAMINADAS  CON CULTIVOS DE ASPERGILLUS \nOCHRACEUS Y FUSARIUM  TRICINCTUM  PRODUCTORES DE \nOCRATOXINA A Y TOXIN A T-2 \n \nEVALUATION OF MYCOTOXIN BINDERS TO DECREASE TOXICITY IN \nBROILER DIETS CONTAMI NATED WITH OCHRATOXIN A-/T-2 TOXIN-\nPRODUCING ASPERGILLUS OCHRACEUS  AND  \nFUSARIUM TRICINCTUM CULTURES  \n \nGarc\u00eda MAR1, Avila GE1, Rosiles MR2, Petrone GV3 \n \n1CEIEPA, Facultad de Medicina Veterinaria, UNAM; 2 Laboratorio de Toxicolog\u00eda, Facultad de Medicina \nVeterinaria, UNAM; 3 Departamento de Producci\u00f3n Animal: Aves, Facultad de Medicina Veterinaria, UNAM.  \n \nSUMMARY  \nThe effectiveness of 3 mycotoxin binders against \nthe toxicity caused by ochratoxin A (OA) and T -2 toxin \n(T-2) was tested in broilers. Treatment gro ups \nincluded: negative control; diets with binder and no \nmycotoxin; OA positive control; T -2 positive control; \nOA + T -2 positive control; and their combinations with \nbinders. Productive parameters, gross and microscopic \nlesions (liver, kidney, proventriculus, and bursa of \nFabricius), and blood chemistry parameters were \nmeasured. Results showed that the effects of OA were \nnot offset by any binder. T -2 effects were partially \noffset by two of the binders tested. Toxic effects were \nmore severe when both mycotoxins were given in \ncombination.  \nRESUMEN  \nSe prob\u00f3 la efectividad de 3 secuestrantes de \nmicotoxinas  contra la toxicidad de ocratoxina A (OA) \ny toxina T -2 (T -2) en pollo de engorda. Los \ntratamientos incluyeron: testigo negativo,  dietas con \nsecuestrante sin m icotoxina, testigo positivo de OA, T -\n2 y ambas, y  sus combinaciones con secuestrantes. Se \nevaluaron par\u00e1metros productivos, lesiones macro y \nmicrosc\u00f3picas en h\u00edgado, ri\u00f1\u00f3n, proventr\u00edculo y bolsa \nde Fabricio; y diferentes par\u00e1metros de bioqu\u00edmica \nsangu\u00ednea . Los resultados mostraron que los efectos de \nOA no fueron contrarrestados por alg\u00fan secuestrante. \nLos efectos por T -2 fueron parcialmente \ncontrarrestados por dos de los secuestrantes empleados. Los efectos t\u00f3xicos fueron m\u00e1s severos cuando se \ncombinaron a mbas micotoxinas.  \n \nINTRODUCCI\u00d3N  \nLas micotoxinas son metabolitos t\u00f3xicos producto \ndel desarrollo de hongos sobre el grano y otras materias \nprimas. Su presencia produce efectos detrimentales en los animales; en las aves se observa disminuci\u00f3n de la ganancia de peso, inmunodepresi\u00f3n y mala \npigmentaci\u00f3n. Debido a esto, se ha recurrido al uso de los secuestrantes de micotoxinas, entre los que se encuentran los aluminosilicatos. Estos productos se \nadicionan en el alimento y secuestran las micotoxinas \ncuando se en cuentran en el medio acuoso intestinal. Su \nefectividad ha sido comprobada para las aflatoxinas en \nexperimentos in vitro  e in vivo.  Sin embargo, en los \nalimentos es posible encontrar otras micotoxinas de \nimportancia cl\u00ednica y econ\u00f3mica e igualmente t\u00f3xicas \npara las aves, como la ocratoxina A (OA) y toxina T -2 \n(T-2), cuya toxicidad no ha podido ser reducida por \nalg\u00fan secuestrante. La evaluaci\u00f3n de un secuestrante \ndebe incluir experimentos in vitro  y pruebas in vivo  con \nevaluaci\u00f3n de lesiones macrosc\u00f3picas e h istol\u00f3gicas, \nadem\u00e1s de bioqu\u00edmica sangu\u00ednea, seg\u00fan la literatura. Las micotoxinas dif\u00edcilmente se encuentran solas en un \ningrediente, por lo que un secuestrante deber\u00eda actuar \ncontra varias micotoxinas as\u00ed como contra los \nmetabolitos fungales no identifica dos. Pocos estudios \nse han realizado utilizando cultivos de hongos \ntoxig\u00e9nicos, lo cual semeja m\u00e1s a la realidad observada \nen campo. Es importante, por lo tanto, la evaluaci\u00f3n de un secuestrante bajo \u00e9stas condiciones, por lo cual,  el \nobjetivo de \u00e9ste tra bajo fue la evaluaci\u00f3n de 3 \nsecuestrantes de micotoxinas expendidos en M\u00e9xico \nrecomendados para el secuestro de OA y T -2, cuando \n\u00e9stas se encuentran solas y en combinaci\u00f3n.  \n \nMATERIAL Y M\u00c9TODOS  \nSe utilizaron cepas de A.. ochraceus y F. \ntricinctum , para la p roducci\u00f3n de OA y T -2, \nrespectivamente. El grano contaminado fue \nesterilizado, molido y deshidratado, y se adicion\u00f3 a \ndietas a base sorgo -soya. OA y T -2 se cuantificaron en  \n 275  \n  \n  el alimento, mediante HPLC y ELISA, \nrespectivamente. Tres secuestrantes de micotoxi nas \nfueron adicionados a las dietas en las concentraciones \nrecomendadas por sus fabricantes. Los tratamientos \nfueron los siguientes:  \nT1: Testigo (aves alimentadas con dieta sin \nsecuestrante ni micotoxina).  \nT2: Secuestrante A  \nT3: Secuestrante B  \nT4: 567 ppb de OA  \nT5: 927 ppb de T -2  \nT6: 567 ppb de OA mas 927 ppb de T -2 \nT7: Como T4 + Secuestrante A  \nT8: Como T4 + Secuestrante B  \nT9: Como T5 + Secuestrante A  \nT10: Como T5 + Secuestrante B  \nT11: Como T6 + Secuestrante A  \nT12: Como T6 + Secuestrante B  \nT13: Como T4 + Secuestrante C  \nT14: Como T5 + Secuestrante C  \nSe utilizaron aves Ross x Ross de 1 d\u00eda de edad, \nalojadas en bater\u00edas de crianza. Las aves fueron \ndistribuidas aleatoriamente a cada tratamiento con 4 \nr\u00e9plicas de 6 aves, y fueron alimentadas durante 21 \nd\u00edas de acuerdo al tratamiento. Semanalmente se llev\u00f3 \nun registro de ganancia de peso, alimento consumido y \nmortalidad. A los 21 d\u00edas de edad se seleccionaron \naleatoriamente 5 aves por tratamiento, a partir de las cuales se realizaron las siguientes pruebas:  \nBioqu\u00edmica Sangu\u00ednea:  En la sangre de cada \nave, obtenida por punci\u00f3n cardiaca y tratada con heparina, se obtuvo el plasma y se midieron: prote\u00ednas \nplasm\u00e1ticas totales (PT), alb\u00famina (ALB), globulinas \n(GL), la enzima aspartato amino transferasa (AST) y \n\u00e1cido \u00fari co (AU).  \nPatolog\u00eda Macrosc\u00f3poca:  Se evaluaron lesiones \nmacrosc\u00f3picas en boca, lengua, es\u00f3fago, h\u00edgado, ri\u00f1\u00f3n, bolsa de Fabricio (BF), proventr\u00edculo (PV) y molleja \n(MLL) en 5 aves por tratamiento. Cada ave fue pesada \ne identificada, y el h\u00edgado, ri\u00f1\u00f3n izqu ierdo y bolsa de \nFabricio fueron pesados individualmente, para obtener \nlos pesos relativos.  Se midieron los di\u00e1metros de la \nmolleja y el proventr\u00edculo por su eje mayor, adem\u00e1s de \nla uni\u00f3n proventr\u00edculo -molleja. Para la evaluaci\u00f3n \nhistol\u00f3gica, se obtuviero n muestras de ri\u00f1\u00f3n, h\u00edgado, \nproventr\u00edculo, bolsa de Fabricio, de cada ave, y se \nfijaron con formalina al 10 %.  \nHistopatolog\u00eda:  Todos los cortes fueron te\u00f1idos \ncon hematoxilina -eosina. A partir de 5 ri\u00f1ones por \ntratamiento se obtuvo un porcentaje de c\u00e9lula s en \nnecrosis y una relaci\u00f3n ovillo/glom\u00e9rulo.  \nEn 5 proventr\u00edculos por tratamiento se \nseleccionaron 5 gl\u00e1ndulas adyacentes a la capa \nmuscular del \u00f3rgano, con presencia de conducto. Se midi\u00f3 el di\u00e1metro transversal de la gl\u00e1ndula, y el \ndi\u00e1metro de su condu cto,  adem\u00e1s del grosor del epitelio de recubrimiento del conducto glandular. En \nh\u00edgado, se determin\u00f3 un porcentaje de c\u00e9lulas \ntumefactas, c\u00e9lulas en necrosis y tejido de reparaci\u00f3n, \nadem\u00e1s del n\u00famero de conductos biliares por espacio \nporta. En bolsa de Fa bricio se determin\u00f3 un porcentaje \nde tejido linfoide da\u00f1ado.  \nAn\u00e1lisis  Estad\u00edstico: La ganancia de peso y \nconsumo de alimento se analizaron mediante una \nprueba multivariada denominada componentes \nprincipales. Los valores de bioqu\u00edmica cl\u00ednica se \nanalizaron  mediante an\u00e1lisis de varianza multivariado. \nLos resultados de histopatolog\u00eda se analizaron mediante la prueba de Kruskal -Wallis.  \n \nRESULTADOS  \nSe observ\u00f3 reducci\u00f3n significativa de la ganancia \nde peso y consumo de alimento en los tratamientos que \nincluyeron   OA (p<0.05) (Ver cuadro 1). Aves tratadas \ncon OA y secuestrantes no fueron diferentes al testigo positivo de OA. Con T -2, se observ\u00f3 una reducci\u00f3n \nsignificativa del peso y consumo de alimento en las \naves tratadas con T -2 + secuestrante A, que no fue \ndistinta del testigo positivo de T -2. En las aves \nalimentadas con T -2 + Sec B y T -2 + Sec C, el peso \ncorporal y consumo de alimento fueron \nsignificativamente distintos al grupo testigo, pero \ntambi\u00e9n diferentes al testigo positivo de T -2, por lo \ncual hubo una protecci\u00f3n parcial. Cuando se \ncombinaron ambas micotoxinas, hubo una reducci\u00f3n \nsignificativa en peso y consumo, y no se encontr\u00f3 diferencia entre los grupos tratados con ambas \nmicotoxinas con y sin secuestrantes.  Tambi\u00e9n se \nobserv\u00f3 una reducci\u00f3n significat iva de los valores de \nPT, ALB y GL en las aves tratadas con OA y T -2, sin \nimportar si fueron tratadas o no con secuestrantes. AU \naument\u00f3 significativamente en las aves tratadas con OA, con y sin secuestrantes. No se observ\u00f3 tal efecto \ncon T -2.  \nSe observ\u00f3 un aumento significativo en el PR de \nri\u00f1\u00f3n en las aves tratadas con OA, pero no con  T -2. \nBF se encontr\u00f3 significativamente afectada en aves tratadas con T -2 y OA, con o sin secuestrante. No se \nencontraron cambios en h\u00edgado ni en PV y MLL  \nEn las aves que r ecibieron OA se encontraron \nlesiones microsc\u00f3picas significativas en ri\u00f1\u00f3n (necrosis \nde c\u00e9lulas epiteliales tubulares) e h\u00edgado (tumefacci\u00f3n y necrosis de hepatocitos e hiperplasia de conductos \nbiliares). En las aves tratadas con T -2 se observaron \nlesiones  principalmente en h\u00edgado. Cabe se\u00f1alar que en \naves tratadas con 2 secuestrantes sin micotoxinas, se \nobservaron lesiones significativas de da\u00f1o hep\u00e1tico \n(hepatocitos con tumefacci\u00f3n).  \n \n \n \n  \n 276  \n  \n  DISCUSI\u00d3N  \nLos resultados coinciden con otros trabajos en los \nque lo s efectos t\u00f3xicos de OA no fueron \ncontrarrestados por secuestrantes. Algunos autores han \nmencionado que las evaluaciones in vivo  deben \nrealizarse con dosis elevadas de micotoxina, para determinar que un secuestrante es eficaz. Sin embargo, nosotros conside ramos que dichas dosis no se \npresentan con frecuencia en condiciones naturales. En \n\u00e9ste trabajo, utilizando una dosis de 567 ppb, que es la \nsexta parte de lo que se us\u00f3 en otras investigaciones, y \npuede ocurrir en condiciones naturales, encontramos \nefectos  significativos de OA. Existe una gran \ndivergencia entre los estudios conducidos bajo \u00e9sta \nmetodolog\u00eda y aquellos en que se emple\u00f3 grano \ncontaminado con el hongo productor de la micotoxina. \nEsta condici\u00f3n es lo m\u00e1s cercano a la realidad, dado \nque naturalme nte una micotoxina no se presenta sola, \ncomo sucede cuando se utiliza la micotoxina pura en la mayor\u00eda de las investigaciones, sino que se presentan \ndiversos metabolitos, la mayor\u00eda t\u00f3xicos y \ndesconocidos, e inclusive no identificables en \nlaboratorio, a\u00fan cuando la micotoxina principal sea la \nque se encuentre en mayor cantidad.  La reducci\u00f3n en \nla concentraci\u00f3n de PT, ALB y GL, as\u00ed como el \nincremento en AU en plasma, corrobora que los \nsecuestrantes no protegieron contra los efectos t\u00f3xicos \nde OA. Igualmente , las lesiones observadas en ri\u00f1\u00f3n e \nh\u00edgado confirman dicho resultado.  \nCon 927 ppb de T -2 observamos una reducci\u00f3n \nsignificativa de la ganancia de peso y del consumo de \nalimento, que fueron estad\u00edsticamente distintos del \ngrupo testigo, pero tambi\u00e9n del gru po con s\u00f3lo T -2 \n(p=0.09), lo cual implica que al menos dos de los \nproductos evaluados tuvieron un efecto parcialmente \nprotector. La presentaci\u00f3n de \u00falceras se ha considerado \ncaracter\u00edstica de toxina T -2, sin embargo, con la dosis y \nel tiempo de exposici\u00f3n,  las aves no desarrollaron \n\u00falceras. Su presentaci\u00f3n puede ser, por lo tanto, dependiente del tiempo de exposici\u00f3n y de la dosis en el alimento. Sin embargo, se ha mencionado que el \nprincipal efecto de T -2, la presentaci\u00f3n de \u00falceras, \nocurre por contacto. C uando \u00e9stas se presentan en boca \ny lengua, se reduce el consumo de alimento y por ende, la ganancia de peso. Estos efectos son dif\u00edciles de \ncontrarrestar por un secuestrante, dado que \u00e9stos pueden reducir los efectos sist\u00e9micos de las \nmicotoxinas al intera ctuar con ellas a nivel intestinal \ncuando ambos se encuentran en soluci\u00f3n. De ser as\u00ed, \nresultar\u00eda ampliamente dif\u00edcil contrarrestar los efectos ulcerativos de T -2, dado que antes de ser absorbida, \nact\u00faa por contacto en cavidad oral. Aunque hubo cierta protecci\u00f3n por los secuestrantes en contra de T -2, las \nlesiones microsc\u00f3picas de h\u00edgado revelaron que la \ntoxina fue parcialmente absorbida y tuvo efectos \nvisibles en microscop\u00eda. Dichas lesiones son \nconsistentes con la reducci\u00f3n en las concentraciones de \nPT, A LB y GL.  \nLa combinaci\u00f3n de ambas micotoxinas produjo \nmayor reducci\u00f3n de la ganancia de peso y del consumo \nde alimento. Ning\u00fan secuestrante fue capaz de \ncontrarrestar el efecto de ambas micotoxinas, lo cual \ncoincide con lo mencionado en informes previos. N o \nobservamos un efecto sin\u00e9rgico de ambas micotoxinas, \nsino un efecto aditivo. Los efectos sobre PT, GL y \nALB no fueron m\u00e1s marcados cuando ambas \nmicotoxinas se combinaron, pero s\u00ed lo fueron las \nlesiones microsc\u00f3picas, lo cual es consistente con el efecto aditivo observado sobre los par\u00e1metros \nproductivos.  \nPor los resultados mostrados en \u00e9ste estudio, \nhasta el momento ning\u00fan secuestrante es capaz de contrarrestar los efectos t\u00f3xicos de OA, mientras que la \ntoxicidad de T -2 fue contrarrestada parcialmente por  2 \nsecuestrantes, durante los 21 d\u00edas que dur\u00f3 la prueba.  \n \nREFERENCIAS  \nDisponible con el autor . \n \n   \n  \n \n  \n \n  \n \n  \n \n  \n  \n 277  \n  \n    Cuadro 1 . Peso ganado y consumo de alimento de las aves experimentales.  \nTratamiento  Peso ganado  Consumo de \nalimento  \nTestigo  665 \u00b1 4.7a  905 \u00b1 18.79a  \nSecuestrante A  669.25 \u00b1 10.2a  898.67 \u00b1 22.11a  \nSecuestrante B  662.25 \u00b1 18.81a  898  \u00b1 9.97a  \nOA 509.38 \u00b1 16.52d  745.63 \u00b1 21.86d  \nT-2 567.33 \u00b1 31.03c  768.91 \u00b1 36.13c  \nOA+T -2 486.46 \u00b1 25.91e  713.62 \u00b1 24.87e  \nOA+ secuestrante A  530.75 \u00b1 6.95d   779.35 \u00b1 21.49d  \nOA+ secuestrante B  500.58 \u00b1 15.02d  776.25 \u00b1 21.7d  \nT-2+ Sec A  574.50 \u00b1 27.19c  820.05 \u00b1 31.31d  \nT-2+ Sec B  641.38 \u00b1 18.53b  890.88 \u00b1 34.29d  \nOA + T -2+ Sec A  507.92 \u00b1 22.38e  683.75 \u00b1 28.38e  \nOA + T -2 + Sec B  445 \u00b1 17.6f  659.97\u00b1 29.76e  \nOA + Sec C  520 \u00b1  20.43d  740 \u00b1  31.62d  \nT-2+Sec C  636.25 \u00b1 13.6b  870 \u00b1 17.32b  \nValores con diferente literal indican diferencia significativa (p<0.05)  \n\u2022 Media \u00b1 Error Est\u00e1ndar  \n \nNEW VARIETY OF ORNITHOBACTERIUM RHI NOTRACHEALE  \n \nUNA NUEVA VARIEDAD DE ORNITHOBACTERIUM RHYNOTRACHEALE  \n \nR. G\u00fcnther 1, M. Ryll2, H. M. Hafez3 und K. -H. Hinz2 \n \n1 Veterinary Laboratory, Heidemark M\u00e4sterkreis GmbH, Industriestr. 12, 49681 Garrel, Germany  \n2 Poultry Clinic, Tier\u00e4rztlichen Hochschule Hannover, B\u00fcnteweg 17, 30 559 Hannover, Germany  \n3 Institute of Poultry Diseases, Free University Berlin, Koserstr. 21, 14195 Berlin, Germany  \n \nRESUMEN  \nOrnithobacterium rhynotracheale  pertenece a la \nnueva especie Ornithobacterium rhinotracheale  gen. \nnov., sp. nov., dentro de la superfamilia V del rARN. \nSe sabe que esta bacteria est\u00e1 difundida en todo el \nmundo y causa infecciones en el tracto respiratorio de pavos y pollos. Todos los aislamientos descritos \nmostraron una reacci\u00f3n positiva de citocromooxidasa. \nDescribiremos el primer aislamiento y la identific aci\u00f3n \nde una cepa de esta bacteria negativa a la \ncitocromooxidasa, obtenido a partir de pavos. De \nacuerdo con la historia del caso parece que la cepa \naislada es de alta virulencia.  \n \nCASE HISTORY  \nSudden death occurred in a flock of 20.000 toms \nat 19 weeks o f age. Mortality peaked after 5 -6 days at \n0.4% per day. Within two weeks till slaughter mortality reached 13%. The farm is geographically isolated and \nwent into production with an \u201call in \u2013  all out \u201c regimen \nthe year before.  METHODS  \nSamples where incubated under microaerophilic \nconditions on defibrinated sheepblood- agar at 37\u00b0C, \nstained with GRAM`s stain and identified by means of \nbiochemical and cytochemical  tests (Hinz, et al., 1994, \nVandamme et al., 1994, van Empel und Hafez, 1999). \nCytochromoxidase -activity was tested using chemicals \nby FLUKA (contains N,N,N`,N` -Tetramethyl -1,4-\nPhenlendiamin -D-hydrochlorid) and SIGMA (contains \nN-N-Dimethyl -P-Phenylenediamine Monohydrid) \nfollowing the method described by Mannheim et al. \n(1980). Additionally, the strains  where assayed in the \nbuffered single substrate -test (\u201ebss -test\u201c, Hinz et al, \n1998) as well as in the API Zym and API 20 NE \nsystem  (Bio -M\u00e9rieux, Montalieu -Vercieu, France). \nSubsequently, the results where compared with those from the O. rhinotracheale  type strain LMG 9086\nT \n(Vandamme et al., 1994). Serotyping was performed with the agar -gel-immunodiffusion- assay (AGID) \npublished by Hafez und Sting (1999).  \n  \n 278  \n  \n  RESULTS  \nPure cultures could be isolated in four out of five \nlung samples. On sheepblood -agar the isolates grew as \nsmall, gray -shining colonies without haemolysis. The \nbacteria stained as GRAM \u2013 negative, pleomorphic \nrods. The c ytochrome -oxidase reaction turned out to be \nnegative in all four isolates. Antibiograms where \nidentical. According to the additional biochemical and \ncytochemical investigations the isolate could be clearly \nidentified as O. rhinotracheale. Serotyping revealed \nserotyp A.  \n \nREFERENCES  \n1. Hafez, H.M. und R. Sting. Investigations on \ndifferent Ornithobacterium rhinotracheale  \u201dORT\u201d \nisolates. Avian Diseases 34: 1 \u20137. 1999.  \n2. Hinz, K. -H., C. Blome, and M. Ryll. Acute \nexudative pneumonia and aerosacculitis associated with Ornithobacteruim rhinotracheale  gen. nov, sp. \nnov. in turkeys. The Veterinary Record 135: 233- 234. \n1994.  3. Hinz, K. -H., M. Ryll, and B. K\u00f6hler. \nDetection of acid production from carbohydrates by \nRiemerella anatipestifer  and related organisms using \nthe buffered single substrate test. Veterinary \nMicrobiology 60: 277- 284. 1998.  \n4. Mannheim, W., S. Pohl and R. Holl\u00e4nder. \nDie Systematik von Act inobacillus, Heamophilus und \nPasteurella : Basenzusammensetztung der DNS, \nAtmungschinone und kulturell -biochemische \nEigenschaften repr\u00e4sentativer Sammlungsst\u00e4mme. Zentralbl. Bakteriol. Parasitenk. Infektionskr. Hyg. Abt 1 Orig. Reihe A 246: 512- 540. 1980.  \n5. Van Empel, P.C.M., H.M. Hafez. \nOrnithobacterium rhinotracheale : a review. Avian \nPathology 28: 217-227. 1999.  \n6. Vandamme, P., P. Segers, M. Vancanneyt, \nK. van Hove, R. Mutters, J. Hommez, F. Dewhirst, B. Paster, K. Kersters, E. Falsen, L.A. Devriese, M. \nBisgaa rd, K. -H. Hinz, and W. Mannheim.  \nOrnithobacteruim rhinotracheale  gen. nov, sp. nov. \nisolated from the avian respiratory tract.  International \nJournal of Systematic Bacteriology 44: 24- 37. 1994.  \n \nEVALUACI\u00d3N DE UNA VACUNA DE EIMERIA TENELLA,  \nE. ACERVULINA Y  E. MAXIMA EN POLLO DE ENGORDA  \n \nEVALUATION OF AN EIMERIA TENELLA/E. ACERVULINA/E. MAXIMA \nVACCINE IN BROILERS  \n \nHern\u00e1ndez VX, Escamilla R, Petrone VM.  \n \nDepto. Producci\u00f3n Animal: Aves, FMVZ. UNAM.  \n \nSUMMARY  \nGiven the growing incidence of resistance \ndevelopmen t among field coccidial strains, and the \ngrowing use of coccidial vaccines in broilers, and given \nfield results \u2013 not always satisfactory \u2013 the protective \nefficacy of an E. acervulina/E. maxima/E. tenella  \nvaccine administered to broilers by spray was \nevaluat ed. \n \nRES\u00daMEN  \nDebido a que cada vez es mayor el desarrollo de \nresistencia de cepas de coccidias en campo y al \ncreciente uso de diversos tipos de vacunas para el \ncontrol de Coccidiosis en pollo de engorda, as\u00ed como a \nlos resultados no siempre satisfactorios en campo se \nevalu\u00f3 la eficacia protectora de una vacuna contra E. acervulina, E. maxima y  E. tenella  que fue \nadministrada  a pollo de engorda por aspersi\u00f3n . \n MATERIAL Y M\u00c9TODOS  \nAves.  Se utilizaron pollitos de engorda de la \nestirpe Arbor Acres de un d\u00eda de e dad, provenientes de \nuna incubadora comercial que fueron alojados hasta la sexta semana de vida en corrales en unidades de aislamiento del Departamento de Producci\u00f3n Animal: \nAves (DPA: Aves) de la FMVZ de la UNAM  \nAlimento. Se administr\u00f3 agua y alimento  at \nlibitum , manejando dos fases de alimentaci\u00f3n: iniciador \ncon 21% de PC., 3100 kcal de E.M. y 40 ppm de \npigmento. El alimento finalizador se les proporcion\u00f3 del d\u00eda 22 de edad al final de la prueba, con 18% de \nPC., 3000 kcal de E.M. y 85 ppm de pigmento. Ambas \nfases fueron elaboradas sin coccidiostato y sin \npromotor de crecimiento. \u00danicamente las aves del \ngrupo IV recibieron alimento con coccidiostato (60 \nppm de salinomicina) durante toda la prueba.  \nVacuna. La titulaci\u00f3n de la vacuna se realiz\u00f3 \ncon una c\u00e1mara de Newbawer, y el diferencial por \nespecie se llev\u00f3 a cabo con la medici\u00f3n de 100 ooquistes esporulados. La vacuna conten\u00eda cepas de  \n 279  \n  \n  campo no atenuadas, en los  siguientes porcentajes: E. \nacervulina (27%) , E. maxima (18%) , E. tenella (58%). \nLa dosis por pollo fue de 1,000 ooquistes esporulados.  \nInoculo de desaf\u00edo.  Al d\u00eda 21 de edad las aves \nfueron desafiadas en el alimento con un inoculo mixto \nque contiene 200,000 ooquistes, con E. acervulina \n(23%) , E. maxima (27%) y  E. tenella (12%).  \nConteo de ooquistes en heces.  Para evaluar el \nn\u00famero de ooquistes eliminados en heces por grupo, \nas\u00ed como el porcentaje por especie, se colectaron \nmuestras de heces de las tres r\u00e9plicas de cada grupo al \nd\u00eda 7, 14, 21, 28, 35 y 42 de edad. El conteo de \nooquistes / g de heces (opgh) se realiz\u00f3 en la c\u00e1mara de McMaster, y se expres\u00f3 como promedio de las tres \nr\u00e9plicas.  \nSeveridad de las lesiones. Al d\u00eda 7 posdesaf\u00edo \n(28 de edad) las aves sobrevivientes de dos r\u00e9plicas de cada grupo fueron sacrificadas por dislocaci\u00f3n cervical \ne inme diatamente despu\u00e9s se les extrajo el intestino. \nLas lesiones sugestivas a coccidias fueron evaluadas de \nacuerdo a la escala de Johnson y Reid.  \nEvaluaci\u00f3n de pigmento cut\u00e1neo.  El pigmento \nse evalu\u00f3 con el color\u00edmetro de reflectancia Minolta CR-300 (Minolta , Co. Osaka, Jap\u00f3n).  \na los 42 d\u00edas de edad en la zona apterica pectoral \nlateral en10 pollos de cada grupo.  \n\u00cdndice anticoccidial. Se realiz\u00f3 tomando en \ncuenta el porcentaje de viabilidad, ganancia relativa de \npeso corporal entre el d\u00eda 21 y 28 de edad, \u00edndi ce de \nlesiones e \u00edndice de ooquistes al d\u00eda 28 de edad, y se clasific\u00f3 como bueno en valores de 180 a 200, moderado de 160 a 179, pobre menor a 160.  \nAn\u00e1lisis estad\u00edstico.  Los pesos y la \npigmentaci\u00f3n cut\u00e1nea fueron sometidos a una prueba estad\u00edstica de an \u00e1lisis de varianza y las diferencias \nentre las medias de los pesos entre grupos fueron evaluadas con la prueba de comparaci\u00f3n m\u00faltiple de medias de Tukey con una significancia de P <0.05.  \n \nDISE\u00d1O EXPERIMENTAL  \nLas aves fueron distribuidas en 6 grupos, cada \nuno con 3 replicas de 10 pollos. Se asign\u00f3 un \ntratamiento por grupo: los grupos I y II recibieron la \nvacuna por aspersi\u00f3n al d\u00eda de edad, y se revacun\u00f3 al \ngrupo II al d\u00eda 10 de edad. El grupo III \u00fanicamente fue desafiado. Al grupo IV se le administr\u00f3 la va cuna al d\u00eda \ntres de edad y recibi\u00f3 alimento con 60 partes por mill\u00f3n (ppm) de salinomicina durante todo el ciclo. El \ngrupo V no fue vacunado ni infectado. Mientras que al \ngrupo VI \u00fanicamente se administr\u00f3 la vacuna al d\u00eda 21 \nde edad, a dosis de 20X.  \n \nRESULTADOS  \nEl grupo V se mantuvo negativo a ooquistes en \nheces durante toda la prueba, as\u00ed como los grupos III y \nVI hasta siete d\u00edas despu\u00e9s del desaf\u00edo y de la vacunaci\u00f3n respectivamente. Las muestras de heces en \nlos grupos vacunados al d\u00eda de edad (grupos I y  II) \nfueron positivas a ooquistes a partir del d\u00eda 7 de edad y \nregistraron un pico m\u00e1ximo al d\u00eda 14 y 28 \nrespectivamente. En el grupo que recibi\u00f3 la vacuna v\u00eda \nagua de bebida (grupo VII), se detectaron coccidias en \nheces a partir del d\u00eda 7 de edad en canti dad menor a los \ngrupos I y II, y el n\u00famero m\u00e1ximo de ooquistes \nexcretados por gramo de heces fue 64,328 opgh al d\u00eda \n21 de edad, menor a los tratamientos I y II. En relaci\u00f3n \nal grupo III se observ\u00f3 un pico de eliminaci\u00f3n de \n478,780opgh, 7 d\u00edas posinfecci\u00f3n;   mientras que el \ngrupo VI elimin\u00f3 un m\u00e1ximo de 187,220 opgh 7 d\u00edas \nposvacunaci\u00f3n.  \nEl \u00edndice total de lesiones a los 7 d\u00edas posdesafio \nfue en los grupos vacunados desde 0 a 2.5, el grupo III \nque \u00fanicamente fue desafiado tuvo un \u00edndice de \nlesiones total de  5.16, mientras que en el grupo VI fue \nde 2.5. En el grupo V o testigo negativo no se observaron lesiones. La mortalidad atribuible a la \nvacunaci\u00f3n o infecci\u00f3n con coccidias, por la severidad \nde las lesiones halladas a la necropsia (E. tenella  grado \n4+) fu e mayor en los grupos I, IV y III \nrespectivamente.  \nAl d\u00eda 1 y 14 de edad no se observ\u00f3 diferencia de \npeso entre grupos. A partir del d\u00eda 28 de edad y m\u00e1s al final de la prueba se observ\u00f3 que el grupo III fue \nsignificativamente menor en comparaci\u00f3n con el r esto \nde los grupos, seguido por los grupos I, VI y IV. En cuanto a la ganancia relativa de peso entre el d\u00eda 21 y 28 de edad, se observ\u00f3 que de los grupos vacunados, el \nIV mostr\u00f3 una mejor ganancia relativa durante este \nperiodo, no as\u00ed el grupo VI que fue el m\u00e1s bajo. Los \npesos finales fueron de mayor a menor en los grupos II, \nV, IV, VI, III y I, y fue significativamente diferente en \ntodos los grupos.  \nEl \u00edndice anticoccidial tuvo una calificaci\u00f3n de \nbueno adem\u00e1s del grupo testigo (V), en el grupo IV; y \npobre en el resto de los grupos.  \n \nCONCLUSI\u00d3N  \nDe acuerdo a los resultados obtenidos en el \u00edndice \nanticoccidial se concluye que la vacuna utilizada en este estudio protegi\u00f3 solo parcialmente contra el \ndesaf\u00edo a los grupos I y II, y protegi\u00f3 mejor a las aves \ndel grupo IV que fueron vacunadas en agua al d\u00eda 3 de \nedad y al que adem\u00e1s se le suministr\u00f3 salinomicina en \nel alimento. La vacunaci\u00f3n en agua es menos \nhomog\u00e9nea que por aspersi\u00f3n, por lo que se sugiere \nque estos resultados muestran que la administraci\u00f3n de \n60 ppm de salinomicina en la dieta durante todo el \nciclo control\u00f3 mejor la replicaci\u00f3n de los ooquistes vacunales, as\u00ed como de las coccidias de desaf\u00edo, evitando lesiones en intestino. Sin embargo  tiene la \ngran desventaja de incrementar los costos de \nprodu cci\u00f3n al incluir un coccidiostato para controlar  \n 280  \n  \n  efectos indeseables de la vacuna. La vacuna utilizada \nen este estudio no fue seleccionada con cepas de baja \nvirulencia, hecho que se demuestra con los resultados \ndel grupo IX, adem\u00e1s una desventaja frecuente en este tipo de vacunas es la falta de estandarizaci\u00f3n del \nporcentaje de ooquistes esporulados por especie, en \nparticular esta vacuna conten\u00eda un alto porcentaje de E. \ntenella .\n  \nCuadro 1. Efecto de la vacunaci\u00f3n Eimeria tenella, E. acervulina y E. maxima  en pollo de engorda sobre la \nmortalidad, peso, pigmento cut\u00e1neo e \u00edndice anticoccidial  \n Edad en d\u00edas  % de \nmortalida*  \u00cd. L. Peso  \nfinal  Pigmento  I.A. Grupo  7 14 21 28 35 42 \nI 18350  109885  83709  32984  4800  562 12 2.25 1820 E  13.7 C  Pobre  \nII 12506  49824 76348  504464  10580  2768  0 2.5 1950 A  21.0 AB  Pobre  \nIII 0 0 0 478780  16400  1334  5 5.6 1473 F  10.9 C  Pobre  \nIV 3841  6600  64328  2480  13369  353 6 0 1898 C  22.4 A  Moderado  \nV 0 0 0 0 0 0 0 0 1914 B  20.2 AB  Bueno  \nVI 0 0 0 187220  96000  2280  0 2.5 1853 D  15.9 BC Pobre  \nI.L. = \u00cdndice de lesiones  \nI.A. =\u00cdndice anticoccidial  \nLiterales diferentes dentro de una misma columna denotan diferencia significativa P< 0.05.  \n*= % de mortalidad atribuible a coccidiosis, promedio de las tres r\u00e9plicas  \nREFERENCIAS  \n1. Chapman, H.D . (2000) Control of \ncoccidiosis in broilers: Role of drug programs and \nvaccines in the development of immunity.  2. Chapman, H.D. (2000) Practical use of \nvaccines for the control of coccidiosis in the chicken.  World\u2019s Poultry Science Journal 56: 7 -20. \n3. McDouga ld LR. Y Reid WM. Coccidiosis \nin: Calnek BW., Barnes HJ., Reid WM., Yoder H.W. Diseases of poultry 10\nth 1999.  \n \nCARACTERIZACI\u00d3N MOLECULAR DEL VIRUS BRONQUITIS \nINFECCIOSA  \n \nMOLECULAR CHARACTERIZATION OF INFECTIOUS BRONCHITIS VIRUS  \n \nHuerta L. B. J1,2, Merino R.1, 0rtiz N. M1, T\u00e9llez I. G1, Alonso M. R.2. \n \n1Departamento de Producci\u00f3n Animal: Aves, de la Facultad de Medicina Veterinaria y Zootecnia de la UNAM. Av. \nUniv. 3000, C.P. 04510. M\u00e9xico D.F. Tel\u00e9fono y Fax: 56225867.  \n2 Departamento de Gen\u00e9tica y Bioestad \u00edstica: Lab. de Gen\u00e9tica molecular,  de la Facultad de Medicina Veterinaria y \nZootecnia de la UNAM.  Av. Universidad 3000, C.P. 04510. M\u00e9xico D.F. Tel\u00e9fono: 56225902, Fax: 56 16 65 36. E -\nmail:belemhuerta@hotmail.com  \n \nSUMMARY  \nA study was performed on 23 viru s isolates as an \nattempt to implement a more specific diagnosis, and to distinguish between infectious bronchitis virus strains isolated in Mexico. RNA was purified from allantoic \nfluid, then used in the synthesis of cDNA to amplify \u2013\nusing reverse transcri optase -polymerase chain reaction \n(RT-PCR) \u2013 the S1 glycoprotein gene. Amplified \nfragments were digested with 3 restriction enzymes. Digestion patterns corresponded to the following strains: 7 to Mass, 5 to BL -56, and 3 to UNAM97. In \naddition, 2 digestion pa tterns did not correspond to any \nof those previously reported in Mexico.  \n RESUMEN  \nCon la finalidad de implementar un diagn\u00f3stico \nm\u00e1s espec\u00edfico y distinguir las cepas de Bronquitis \nInfecciosa (BI) aisladas en M\u00e9xico, se realiz\u00f3 un \nestudio con 23 muestras de aislamientos virales. El \nRNA se purific\u00f3 a partir de liquido alantoideo y fue \nutilizado en la s\u00edntesis cDNA para amplificar, por \nmedio de la t\u00e9cnica RT -PCR el gen de la glicoprote\u00edna \nS1. Los fragmentos amplificados fueron digeridos con tres enzimas de restricci\u00f3n. Los patrones de digesti\u00f3n \ncorrespondieron: 7 a la cepa Mass, 5 a BL -56, 3 a \nUNAM97 y se encontraron 2 patrones de digesti\u00f3n \ndiferentes a los previamente reportados en M\u00e9xico.  \n  \n 281  \nINTRODUCCION  \nLa bronquitis infecciosa aviar (BIA) es una \nenfermedad r espiratoria viral aguda, altamente \ncontagiosa de los pollos. En M\u00e9xico es una de las \nprincipales enfermedades respiratorias de gran \nimportancia econ\u00f3mica ya que causa disminuci\u00f3n en la \nproducci\u00f3n y calidad del huevo.  \nEsta enfermedad es producida por un vir us de \nRNA que pertenece a la familia C oronaviridae,  que \nincluye al g\u00e9nero Coronavirus. El virus de bronquitis infecciosa aviar (vBI) est\u00e1 conformado principalmente por tres prote\u00ednas espec\u00edficas: las glicoprote\u00ednas de \nesp\u00edcula (S), la glicoprote\u00edna de memb rana (M) y la \nprote\u00edna de la nucleoc\u00e1pside interna. La glicoprote\u00edna S esta compuesta por dos glicopolipeptidos S1 y S2. La \nglicoprote\u00edna S1, induce la inhibici\u00f3n de la \nhemoaglutinaci\u00f3n y ha sido considerada para inducir \ninmunidad, por tal motivo la clasif icaci\u00f3n de las cepas \nde vBI se basa principalmente en las caracter\u00edsticas de la prote\u00edna S1. Sin embargo, hay evidencias de que el \nvBI puede sufrir una recombinaci\u00f3n durante \ninfecciones mixtas originando variaci\u00f3n entre las \ncepas.  \nTradicionalmente, las cep as de vBI son \nidentificadas por la prueba de VN (virus -\nseroneutralizaci\u00f3n) o por la prueba HI (inhibici\u00f3n de la \nhemoaglutinaci\u00f3n).  En a\u00f1os recientes con el \nadvenimiento de las t\u00e9cnicas en Biolog\u00eda Molecular \ntales como RT -PCR (Transcriptasa Reversa -Reacci \u00f3n \nen Cadena de la Polimerasa), RFLP\u2019s (Polimorfismo en \nla Longitud de los Fragmentos de Restricci\u00f3n) y \nsecuenciaci\u00f3n del gen S1 es posible tener un \ndiagnostico m\u00e1s espec\u00edfico para identificaci\u00f3n de las \ncepas del vBI.  \nPor tal motivo se consider\u00f3 importante  \nimplementar un diagnostico por medio de la t\u00e9cnica de \nRT-PCR para caracterizar molecularmente la \nfrecuencia de las variantes del vBI en M\u00e9xico.  \n \nMATERIAL Y M\u00c9TODOS  \nSe utilizaron 23 muestras de vBI proporcionadas \npor el departamento de Aves de la Facultad de \nMedicina Veterinaria y Zootecnia de la UNAM. El \nRNA fue purificado a partir de liquido alantoideo. \nPosteriormente el RNA se utilizo para obtener el \ncDNA mediante la t\u00e9cnica de RT el cual sirvi\u00f3 como \nmolde en la reacci\u00f3n de PCR para amplificar un \nfragmen to de 1720 pb correspondiente al gen de la \nglicoprote\u00edna S1. Los fragmentos amplificados fueron \ndigeridos con tres enzimas de restricci\u00f3n BstYI, HaeIII y Xcm I que permiten identificar las diferentes cepas de \nvBI. Los fragmentos digeridos fueron separados de \nacuerdo a su tama\u00f1o por electroforesis en geles de \nagarosa al 3%.  \nLos patrones de digesti\u00f3n obtenidos se \ncompararon entre si para determinar a que patr\u00f3n de cepa corresponde con los previamente descritos en M\u00e9xico (Mass, BL56 y UNAM 97).  \n \nRESULTADOS  \nEn base a los patrones de digesti\u00f3n de las 23 \nmuestra de vBI, se encontraron 15 cepas previamente reportadas en M\u00e9xico las cuales correspondieron a: 7 cepas fueron clasificadas como Massachussets, 5 como \nBL-56 y 3 fueron UNAM97. Sin embargo, 8 cepas \nmostraron  2 nuevos patrones de restricci\u00f3n: 4 fueron \nclasificadas como UNAM2001 -1 y otras 4 se \nclasificaron como UNAM2001 -2. Estas \u00faltimas 8 cepas \ndeben ser sometidas a un an\u00e1lisis de secuenciaci\u00f3n para \ndeterminar si en realidad se trata de cepas nuevas cepas \nvaria ntes del vBI.  \n \nDISCUSI\u00d3N  \nEn este estudio se encontr\u00f3 que el 65.22% de las \nmuestra de vBI correspondieron a cepas previamente reportadas en M\u00e9xico como Massachussets (30.43%), \nBL56 (21.74%) y UNAM97 (13.04%). Algo relevante \nde este an\u00e1lisis fue que el 34.78 % de las cepas tuvieron \npatrones de digesti\u00f3n diferentes a los anteriores, estos \npatrones correspondieron a UNAM2001- 1 (17.4%) y \nUNAM2001- 2 (17.4%). Lo anterior podr\u00eda estar \nindicando que otras variantes distintas a las que ya han \nsido reportadas en M\u00e9xico  podr\u00edan estar causando la \nenfermedad de BIA. Sin embargo para corroborar si \nrealmente se trata de nuevas variantes de vBI es \nnecesario realizar otros estudios, como secuenciaci\u00f3n \nde nucle\u00f3tidos que permiten caracterizar mas \nextensamente estas variantes.  \nEste  trabajo es importante ya que proporciona \ninformaci\u00f3n acerca de la variaci\u00f3n gen\u00e9tica y la \nprevalec\u00eda de las distintas cepas del vBI en M\u00e9xico. El \nenfoque molecular  permite conocer los or\u00edgenes de los \nbrotes y rastrear los caminos de la infecci\u00f3n o la  \naparici\u00f3n de nuevas cepas mutantes; adem\u00e1s esta \ninformaci\u00f3n puede ser usada para desarrollar nuevas \nvacunas y modificar los programas de vacunaci\u00f3n en determinadas \u00e1reas geogr\u00e1ficas y as\u00ed proveer  mayor \nprotecci\u00f3n contra la enfermedad de Bronquitis \nInfecciosa Aviar.  \n \nREFERENCIAS  \n1. Calnek, B. W. (1997). Enfermedades de las \nAves. ED. Manual moderno  \n2. King, D. J., Hopkins, S. R. (1984). Rapid \nserotyping of infectious bronchitis virus isolates with \nthe hemaglutination -inhibition test. Avian Dis . 28:727-\n733. \n3. Koch, G., Hartog, A., Kant, A., Roozear, D. \nJ.(1990). Antigenic domains on the peplomer protein of \navian infectious bronchitis virus: Correlation with \nbiological functions. J. Gen Virol.  71:1929- 1935.   \n 282  \n4. Kwon, H. M., Jackwood, M. W., Gelb, J. \n(1993). Differentiatio n of Infectious Bronchitis Virus \nSerotypes Using Polymerase Chain Reaction and \nRestriction Fragment Length Polymorphism Analysis. \nAvian Dieseases .37:194- 202. 5. Wang, L., Junker D., Collisson, E.W. \n(1993). Evidence of natural recombination within S1 gene of i nfectious bronchitis virus. Virology . 192:710-\n716.\n \nTHE INFLUENCE OF BEHAVIOR AND ENVIRONMENTAL        \nENRICHMENT ON RESISTANCE OF TURKEYS TO  \nESCHERICHIA COLI RESPIRATORY INFECTION  \n \nINFLUENCIA DEL COMPORTAMIENTO Y DEL ENRIQUECIMIENTO DEL \nAMBIENTE SOBRE LA RESISTENCIA DE LOS PAVOS A LA INFECCI\u00d3N \nRESPIRATORIA POR ESCHERICHIA COLI  \n \nG.R. Huff, W.E. Huff, J.M. Balog, N.C. Rath, and A.M. Donoghue  \n \nUSDA/ARS Poultry Production and Product Safety Research, University of Arkansas, Fayetteville, AR 72701  \n \nRESUMEN  \nEl prop\u00f3sito de este trabajo fue determinar los \nefectos del enriquecimiento del medio ambiente al \nprincipio de la vida de las aves sobre su resistencia a \nlas enfermedades relacionadas con el estr\u00e9s, y desarrollar una manera conductual de predecir dicha \nresist encia. Se proporcionaron objetos novedosos a los \npavos durante las primeras dos semanas de vida. Los \nque cruzaron un laberinto \u201cT\u201d en 20 segundos o menos \nse designaron como r\u00e1pidos, mientras que los que \ntardaron m\u00e1s de 60 segundos se consideraron como lentos. Los resultados sugieren que las diferencias en la \nresistencia a las enfermedades relacionadas con el estr\u00e9s se puede predecir usando la prueba del laberinto \nen \u201cT\u201d y que el enriquecimiento del ambiente durante \nlas primeras dos semanas de vida puede ser  nocivo para \nlas aves que presentan una respuesta r\u00e1pida.  \n We have developed a stress model of turkey \nosteomyelitis complex that has led us to hypothesize \nthat a small proportion of male turkeys selected for fast \ngrowth is inherently susceptible to opportunistic \nbacterial infections leading to arthritis, synovitis, \nosteomyelitis, and soft tissue abscesses. Involvement of both the immune and hypothalamic -pituitary -adrenal \n(HPA) systems in the stress response has led us to question whether behavioral and psyc hological \nresponses demonstrated in mammalian stress models \nare applicable to turkeys and whether behavioral traits \nmay be useful for selecting turkeys better able to cope with the stressors of commercial production (1,2).  \nChicks that traverse a T -maze to  come into visual \ncontact with other chicks very quickly have been shown to have higher body weights (6), and decreased \nadrenocortical responses to a stressor than do very slow chicks (5). The T -maze test has been suggested as a  \nsimple, non- invasive selec tion criteria for commercial \nbreeding programs (4). We have previously reported \nthat the stress of handling turkeys once or twice daily for the first 10 days of life, while tending to increase \nbody weight, can also cause lasting changes in the \nimmune respo nse and result in decreased resistance in \nour model (1,2). It has been reported that increases in \nbody weight similar to those produced by handling \nchicks can be incurred by simply providing environmental stimulation for the first 10 days of life \n(3,7).  \n The purpose of this study is to attempt to \nmodulate disease resistance in later life by providing \nenvironmental stimulation for the first two weeks after \nhatch and to determine whether the performance of 2 -\nday-old pouts in a T -maze can predict later disease  \nresistance.  \n \nMETHODS  \nThree hundred male day -old commercial turkey \npoults were randomly assigned to 12 floor pens. Environmental enrichment was provided in 6 pens, for the first 14 d after hatch, by placing in the pens a \nvariety of commercially available i nfant toys, colored \nplastic balls, bells, mirrors,  and other objects with \ntextured surfaces. At 2 days of age each poult was \ntested for the time it took to reinstate contact with \nhatch mates using procedures described by Marin et al. (6).  Birds which com pleted the test within 20 seconds \nwere designated Fast. Those which took longer than 60 \nseconds were Slow.  At 5 weeks of age, half of the \nbirds were given three intramuscular injections of  2 \nmg  of dexamethasone (DEX)/kg body weight. On the \nday of the third DEX injection, all DEX -treated birds  \n 283  \nwere inoculated in the left cranial -thoracic air sac with \napproximately 10 cfu of a non -motile, lactose negative \nstrain of E. coli serotype O2. Birds were necropsied 2 \nweeks later. Data from mortalities and necropsi ed birds \nwere combined and analyzed using the GLM and least \nsquare means procedures of SAS.  \n \nRESULTS AND DISCUSSION \nBirds provided with environmental enrichment \nhad increased mean body weights ( P=0.02) and \nincidence of mortality ( P=0.001), and decreased total \nWBC counts ( P=0.0002).  Those birds designated as \nFast had increased mean airsac scores ( P=0.015). This \nwas due mainly to increased airsacculitis in the challenged Fast birds assigned to enriched pens \n(P=0.003). Challenged Fast birds from enriched pens  \nalso had increased mortality ( P=0.002) and decreased \nbody weights ( P=0.001) as compared to challenged \nSlow birds from enriched pens. In response to \nchallenge, the Slow birds from non -enriched pens had \nincreased total WBC counts ( P=(0.03) and \nheterophil/ly mphocyte ratio ( P=0.03) whereas there \nwas no change in enriched Slow birds or Fast birds \nfrom either enriched or non -enriched pens. These data \nsuggest that the rather moderate stressor of \nenvironmental enrichment can increase body weights \nas has been repor ted, however, a sub -population of \nenriched birds (Fast) may become more susceptible to \nstress -induced opportunistic respiratory infections \nperhaps due to an increased airsac inflammatory response.  \n REFERENCES  \n1. Huff, G.R., W.E. Huff, J.M. Balog, and N.C. \nRath. Effect of early handling of turkey poults on later \nresponses  \n2. to a dexamethasone -Escherichia  coli  \nchallenge. 1. Production values and physiological response. Poultry Sci. 80:1305 -1313. 2001.  \n3. Huff, G.R., W.E. Huff, J.M. Balog, and N.C. \nRath. Effect of early handling of turkey poults on later \nresponses to a dexamethasone -Escherichia coli  \nchallenge. Resistance to air sacculitis and turkey \nosteomyelitis complex.  Poultry Sci. 80:1314 -1322. \n2001.  \n4. Jones, R.B., S. Harvey, B.O. Hughes, and A. \nChadwick. Growth and the plasma concentrations of \ngrowth hormone and prolactin in chicks: effects of \n\u0391environmental enrichment \u2245, sex and strain. Br. Poult. \nSci. 21:457- 462. 1980.  \n5. Marin, R.H. and R.B. Jones, 1999. Latency \nto traverse a T -maze at 2 days of age and later \nadrenocortical responses to an acute stressor in \ndomestic chicks. Physiol. Behav. 66:809- 813. \n6.  Marin, R.H., R. B. Jones, D.A. Garcia, and \nA. Acre, 1999. Early T -maze behavior and subsequent \ngrowth in commercial broiler flocks. Br. Poult. Sci. 40:434- 438. \n7.  Nich ol, C.J. Effects of environmental \nenrichment and gentle handling on behavior and fear \nresponse of transported broilers. Appl. Anim. Behav. \nSci. 33:367- 380. 1992.  \nANALISIS DE LA RENTABILIDAD EN LA COMERCIALIZACION \nDE POLLO EN M\u00c9XICO  \n \nA PROFITABILITY ANALYS IS OF BROILER TRADE IN MEXICO  \n \nIngalls HFR, Ortiz, MA  \n \n1  Comit\u00e9 Cient\u00edfico de ANECA, Dr. Ernesto Soto, Chairman, reuni\u00f3n ANECA, WPDC.  \nAnexo  documento para memorias Congreso ANECA, WPDC.  \nAtentamente: MVZ Fernando Ingalls Herrera  Depto. Ciencias Sociales FES -C, UNAM.  \nTel: 56 23 18 32, e -mail: ingallsh@servidor.unam.mx  \n \nSUMMARY  \nThis research compares the profitability \nexperienced by traders in 3 different broiler meat \nselling points throughout Mexico during 2000. Data \npublished by Mexico\u2019s Poultry Producer s Union ( UNA ) \nregarding production costs and selling prices was used. \nEconomic analysis was performed by applying the \nIngalls -Ortiz profitability index ( IOR). From the results \nobtained it was concluded that the profit margin is \nhigher at retail shops (57.06% \u00b1 23.586) than at other selling points. Producer\u2019s margin is 27% lower than the \nmost profitable selling point.  \n \nRESUMEN  \nLa investigaci\u00f3n compara la rentabilidad que \ntuvieron los comercializadores en tres diferentes puntos \nde venta de la carne de pollo a nivel nacional durante el \na\u00f1o 2000. Utilizando los datos de la Uni\u00f3n Nacional de Avicultores (UNA), de los precios de producci\u00f3n y  \nventa. Se realizo un an\u00e1lisis econ\u00f3mico,  mediante la  \n 284  \naplicaci\u00f3n del \u00cdndice Ingalls -Ortiz de Rentabilidad \n(IOR). Con los re sultados obtenidos podemos concluir \nque el margen de rentabilidad, es mayor en la poller\u00eda \n(57.06%\u00b1 23.586) que en los otros  puntos de venta, \nteniendo el productor un margen inferior en un 27% \ncon respecto al  punto de venta m\u00e1s rentable.  \n \nOBJETIVO  \nEl ob jetivo de la investigaci\u00f3n es demostrar y \ncomparar la rentabilidad diferenciada promedio que \nobtuvieron los comercializadores finales, en tres \ndiferentes puntos de venta de carne de pollo a nivel \nnacional  durante el a\u00f1o 2000 en M\u00e9xico  \n \nINTRODUCCI\u00d3N  \nTomand o como referencia los reportes t\u00e9cnicos \ndel tema de comercializaci\u00f3n pecuaria, se conoce que \nel margen de rentabilidad de la etapa de \ncomercializaci\u00f3n al consumidor final, var\u00eda de acuerdo a la inversi\u00f3n, infraestructura y nicho de mercado. M\u00e1s \nsin embargo , queda claro que el margen de rentabilidad \nes mayor en la etapa de comercializaci\u00f3n, que en la \netapa de producci\u00f3n   \n \nMETODOLOG\u00cdA  \nUtilizando como base de datos los informes de la \nUni\u00f3n Nacional de Avicultores (UNA) referentes al \na\u00f1o 2000, de los precios de venta y de comercializaci\u00f3n, se realizo un an\u00e1lisis econ\u00f3mico, \nmediante la aplicaci\u00f3n del \u00cdndice Ingalls -Ortiz de \nRentabilidad (IOR), para obtener el margen de \nrentabilidad en tres puntos de venta final  al \nconsumidor de la carne de pollo y poder  determ inar su \ndiferenciaci\u00f3n.  \n \nRESULTADOS  \nLos resultados obtenidos  son los siguientes: \nprecio de venta Kg promedio en autoservicio $18.59 \u00b1  \n0.618, mercado p\u00fablico $18.68 \u00b1  0.681, poller\u00eda $ \n18.98\u00b1 0.738,  precio en pie $10.73 \u00b1  2.46, precio \nprocesado $12.35 \u00b1 1.99. La rentabilidad en la \ncomercializaci\u00f3n de pollo en pie fue de: autoservicio \n85.35% \u00b148.860, mercado p\u00fablico 82.67% \u00b1 41.624 y \npoller\u00eda 85.52% \u00b1 42.011. La rentabilidad en la \ncomercializaci\u00f3n del pollo procesado es de: autoservicio 54.76% \u00b1 29.158, mercado p\u00fablico 54.60% \n\u00b122.921 y poller\u00eda 57.06% \u00b1 23.586.   \n \nCONCLUSIONES  \nCon los resultados obtenidos podemos concluir \nque el margen de rentabilidad bruta es bastante bueno, \nen los diferentes puntos de venta siendo mayor en la \npoller\u00eda que en los otros estudiados, teniendo el productor un margen inferior, en promedio del 27%.  \n \nEVALUACI\u00d3N DE UNA CUT\u00cdCULA ARTIFICIAL SOBRE LA \nP\u00c9RDIDA DE HUMEDAD E INCUBABILIDAD EN HUEVOS DE \nAVES LEGHORN DE SEGUNDO CICLO  \n \nEVALUATION OF AN ARTIFICIAL CUTICLE ON MOISTURE AND \nHATCHABILI TY LOSS IN THE EGGS OF SECOND-CYCLE LEGHORN HENS  \n \nMarco A. Ju\u00e1rez- EstradaA, Ra\u00fal Cervantes -S\u00e1nchezA.Jos\u00e9 A. Quintana -L\u00f3pezA, Omar F. Prado -RebolledoB, Ernesto \n\u00c1vila -Gonz\u00e1lezA \n \nADepartamento de Producci\u00f3n Animal: Aves,  Facultad de Medicina Veterinaria y Zo otecnia,  Universidad Nacional \nAut\u00f3noma de M\u00e9xico. Avenida Universidad 3000. Ciudad Universitaria 04510 M\u00e9xico, D.F.  BFacultad de Medicina \nVeterinaria y Zootecnia -Universidad de Colima. Autopista Colima - Manzanillo km 40 Crucero de Tecom\u00e1n. \nTecom\u00e1n. Col. C.P. 28100, E -mail:   britoco@servidor.unam.mx  \n \nSUMMARY  \nThe effect of an artificial cuticle on hatchability \nwas evaluated using a 2x2 factorial arrangement, \nincluding 344 eggs per group. Group A (clean eggs \nwith cuticle), group B (clean eggs, no cuticle),  group C \n(dirty eggs with cuticle), and group D (dirty eggs, no \ncuticle). At 21 days no factor interaction occurred. \nOnly an effect  (P<0.05) of the cuticle on moisture loss \n(with cuticle18.46\u00b13.72b %; w/o cuticle 19.64\u00b12.64a %) was observed. No factor int eraction was found on \nhatchability, but the cleanness factor had a significant effect (clean 70.24\u00b114.05\na; dirty 60.71\u00b14.61b), and so \ndid the cuticle (with cuticle 70.68\u00b110.21a %; with no \ncuticle 60.27\u00b18.45b %). \n \nRESUMEN  \nSe evalu\u00f3 el efecto de una cut\u00edcula artificial sobre \nincubabilidad con un arreglo factorial 2x2, con 344  \n 285  \nhuevos por grupo. Grupo A (Huevo limpio con \ncut\u00edcula), Grupo B (Huevo limpio sin cut\u00edcula), Grupo \nC (Huevo sucio con cut\u00edcula) y Grupo D (Huevo sucio \nsin cut\u00edcula). A los 21 d\u00edas no hubo  interacci\u00f3n de \nfactores, solo efecto (P<0.05) de la cut\u00edcula en p\u00e9rdida \nde humedad (con 18.46\u00b13.72b %; sin 19.64\u00b12.64 a %). \nEn incubabilidad no hubo interacci\u00f3n de factores pero \nsi del factor limpio (limpio 70.24\u00b114.05a; no limpio \n60.71\u00b14.61b) y del facto r cut\u00edcula (con 70.68\u00b110.21a \n%; sin 60.27\u00b18.45b %).  \n \nINTRODUCCI\u00d3N  \n El hombre ha sustituido la incubaci\u00f3n natural por \nm\u00e9todos artificiales lo cual ha constituido un aspecto \nclave para el \u00e9xito actual de las explotaciones av\u00edcolas. \nAparte de la fertilidad d e una parvada la incubaci\u00f3n \ndepende directamente de la estructura del cascar\u00f3n de \nlos huevos, la cual puede verse afectada por la edad, \ntipo de alimentaci\u00f3n, salud y estirpe del ave; sin \ndescartar otros elementos que influyen directamente sobre la incubaci \u00f3n, tales como la altura sobre el nivel \ndel mar, disponibilidad de ox\u00edgeno, temperatura y humedad de la m\u00e1quina incubadora. Una de las \nestructuras que evitan la f\u00e1cil penetraci\u00f3n de bacterias \nal interior del huevo es la cut\u00edcula, la cual se distribuye irregularmente sobre la superficie del cascar\u00f3n y se \nencuentra adherida a la parte calcificada del mismo, se introduce en los poros y forma tapones que sellan temporalmente al huevo. La cut\u00edcula esta compuesta de \n85% de prote\u00edna (3% prote\u00ednas hidrosolubles) y de 13 a \n15% de l\u00edpidos y carbohidratos. Un factor que condiciona la p\u00e9rdida de humedad en los huevos \ndurante la incubaci\u00f3n es la cut\u00edcula. La ausencia de \n\u00e9sta facilita la contaminaci\u00f3n y altera el intercambio gaseoso,  poniendo en riesgo la vida del embri\u00f3 n; lo \ncual debe considerarse en la incubaci\u00f3n de huevos de segundo ciclo, ya que estos tienen en su estructura la misma cantidad de calcio y f\u00f3sforo, sin embargo son de \nmayor tama\u00f1o y por consiguiente presentan un \ncascar\u00f3n m\u00e1s delgado y con poros mas grand es, los \ncuales permiten una mayor p\u00e9rdida de peso durante la incubaci\u00f3n. Ante esta situaci\u00f3n se decidi\u00f3 evaluar una \ncut\u00edcula artificial compuesta por ovoalb\u00famina aviar \npara determinar el porcentaje de p\u00e9rdida de humedad e \nincubabilidad de huevos limpios y sucios de gallinas \nligeras de segundo ciclo.  \n \nMATERIAL Y M\u00c9TODOS  \nLugar de experimentaci\u00f3n. - El experimento se \ndesarroll\u00f3 en la planta incubadora del Centro de Ense\u00f1anza, Investigaci\u00f3n y Extensi\u00f3n en Producci\u00f3n Av\u00edcola perteneciente a la Facultad de Medicin a \nVeterinaria y Zootecnia de la Universidad Nacional Aut\u00f3noma de M\u00e9xico, ubicado en Salvador D\u00edaz Mir\u00f3n \ns/n, Col. Zapotitl\u00e1n, Del. Tlahuac en M\u00e9xico D.F., a \nuna altitud de 2,250 m.s.n.m. Con condiciones de clima templado h\u00famedo, siendo enero su mes mas fr\u00ed o y \nmayo el mas caluroso, presentando una precipitaci\u00f3n \npluvial de 747 mm.  \nHuevos para incubaci\u00f3n .- Los huevos incubados \nfueron de la estirpe Isa Babcock B -300, aves \nreproductoras que contaban con 9 semanas de \nproducci\u00f3n de segundo ciclo con relaci\u00f3n 1:9 \nmacho:hembra, se recolectaron 732 huevos limpios de \nnido  y 732 huevos sucios de piso, todos los huevos se \nrecolectaron con guantes de hule.  \nDise\u00f1o experimental. - Los huevos antes de \nincubar se dividieron en cuatro grupos de 366 huevos \ncada uno de acuerdo a un arreglo factorial 2 X 2 donde \nel primer factor fue la presencia de cut\u00edcula artificial o \nno, y el segundo factor si el huevo era limpio y \nproven\u00eda de nido o no. A cada huevo se le asigno un \nn\u00famero progresivo individual, el grupo A (Huevo \nlimpio con cu t\u00edcula) se le asperj\u00f3 \u00fanicamente la \ncut\u00edcula, el grupo B (Huevo limpio sin cut\u00edcula) se le \nasperjo una soluci\u00f3n desinfectante org\u00e1nica \u00fanicamente (Citrex 1.5%),  el grupo C (Huevo sucio con cut\u00edcula) \nse limpio con un trapo est\u00e9ril y Yodo al 2 % y \nposterior mente se asperj\u00f3 con la cut\u00edcula artificial, el \ngrupo D (Huevo sucio sin cut\u00edcula) fue limpiado de la \nmisma manera y posteriormente se le asperj\u00f3 \n\u00fanicamente una soluci\u00f3n desinfectante comecial \n(Acidos \u00f3rganicos al 1.5%).  \nCut\u00edcula artificial. - La cut\u00edcula a rtificial se \nelabor\u00f3 a partir de un liofilizado de alb\u00famina de huevo \nde gallina, que se hidrat\u00f3 antes de su utilizaci\u00f3n al 10% con soluci\u00f3n tamponada amortiguadora (PBS) y un \ndesinfectante org\u00e1nico (Concentrado de \u00e1cidos \n\u00f3rganicos al 1.5%).  \nAplicaci\u00f3n de l a cut\u00edcula artificial. - Se aplic\u00f3 \npor medio de un atomizador manual de gota mediana a \nuna distancia respecto a los alveolos de 15 cm aproximadamente.  \nMetodolog\u00eda experimental. - Se pesaron \nindividualmente, se les asperj\u00f3 aleatoriamente con la cut\u00edcula artif icial o bien soluci\u00f3n desinfectante de \nacuerdo al dise\u00f1o experimental planteado, se \nintrodujeron al cuarto fr\u00edo durante 3 d\u00edas a una \ntemperatura de 18 \u00b0C y una humedad relativa del 80%, \ndespu\u00e9s se precalentaron por un periodo de 6 horas a \nuna temperatura d e 22 \u00b0 C y una humedad relativa del \n60%. Posteriormente se incubaron. Al d\u00eda 18 de \nincubaci\u00f3n todos los huevos de cada tratamiento se \npesaron y trasladaron a la nacedora.  \nPesaje. - Para el pesado del huevo se utiliz\u00f3 una \nbalanza electr\u00f3nica (O -haus\u00ae) con ra ngos de un \ngramo.  \nM\u00e1quinas incubadoras y condiciones de \nincubaci\u00f3n .- Para el proceso de incubaci\u00f3n (18 d\u00edas) se \nutiliz\u00f3 una m\u00e1quina incubadora de una sola etapa \n(Jamesway tipo AVN), con una temperatura durante las \n24 hrs. de 99.8 \u00b0 F y una humedad relativa del 50%,  \n 286  \npara la eclosi\u00f3n los \u00faltimos tres d\u00edas de incubaci\u00f3n se \nemple\u00f3 una m\u00e1quina nacedora de una sola etapa \n(Jamesway tipo AVN) con una temperatura de 99.2 \u00b0F \ny una humedad relativa del 60%.  \nDeterminaci\u00f3n de p\u00e9rdida de humedad e \nincubabilidad. - El porce ntaje de p\u00e9rdida de humedad \nse obtuvo al restar del peso inicial del huevo incubado, \nel peso del mismo huevo obtenido al d\u00eda 18 de \nincubaci\u00f3n, fecha de su transferencia a la nacedora. El \nporcentaje de incubabilidad se obtuvo del total de \nhuevos que eclosio naron a partir del total de huevos \ndiagnosticados como f\u00e9rtiles al d\u00eda 18 de incubaci\u00f3n.  \nEvaluaci\u00f3n experimental. - Se determin\u00f3 una \nadecuada aleatorizaci\u00f3n de los huevos trav\u00e9s de su \npeso el d\u00eda de la recolecci\u00f3n, se determin\u00f3 el \nporcentaje de p\u00e9rdida de h umedad bajo las condiones \nexperimentales ya descritas, se determin\u00f3 el porcentaje \nde incubabilidad en cada uno de los grupos evaluados.  \nAn\u00e1lisis estad\u00edstico : Para el an\u00e1lisis de los \nporcentajes obtenidos estos se transformaron obteniendo el arcoseno de la ra\u00edz cuadrada de la \nproporci\u00f3n. Para determinar probables diferencias de \nlos datos se sometieron a un an\u00e1lisis factorial 2 X 2. \nCon interacci\u00f3n significativa las diferencias entre \ntratamientos fueron analizadas con la prueba de \ncomparaci\u00f3n m\u00faltiple de med ias de Duncan fij\u00e1ndose \nun nivel m\u00ednimo para alfa de P<0.05. Los an\u00e1lisis estad\u00edsticos se realizaron utilizando el paquete computacional Statistic Analysis Sistem  (SAS Institute \n\u00ae). \n \nRESULTADOS  \nA los 18 d\u00edas del experimento se observ\u00f3 que \nrespecto al porcentaje de p\u00e9rdida de humedad no hubo \ninteracci\u00f3n entre los factores, \u00fanicamente hubo efecto \n(P<0.001) de la cut\u00edcula sobre reducci\u00f3n del porcentaje \nde p\u00e9rdida de humedad (con cut\u00edcula 18.46 b %; sin \ncut\u00edcula 19.64 a %). En el porcentaje de incubabilidad \nno se observ\u00f3 interacci\u00f3n de los factores pero hubo \nefecto (P <0.03) del factor limpio, el cual aument\u00f3 la \nincubabilidad (limpio 70.24 a; no limpio 60.71 b) y del \nfactor cut\u00edcula (P <0.01) (con cut\u00edcula 70.68 a %; sin \ncut\u00edcula 60.27 b %). Los promedios de los g rupos est\u00e1n \nreportados en la Tabla 1.  \n \nDISCUSI\u00d3N  \nDesde 1983 Burton y Tullet, citados por Deeming \net al 1 han mencionado que muchos huevos f\u00e9rtiles \npodr\u00edan salvarse si la porosidad del cascar\u00f3n se \nredujer\u00e1 artificialmente a trav\u00e9s de la aplicaci\u00f3n de un \nbarniz especialmente dise\u00f1ado para sellar parcialmente \nlos poros, o bien tapando definitivamente una parte de \nla superficie del cascar\u00f3n con la finalidad de reducir \nuna excesiva p\u00e9rdida de peso, la cual se ha observado \nest\u00e1 relacionada directamente con una baja de \nincubabilidad. Sin embargo, existe poca investigaci\u00f3n sobre la utilizaci\u00f3n de \u201cBarnices especiales\u201d que \nauxilien a reducir la p\u00e9rdida de humedad sin \ncomprometer  el desarrollo del embri\u00f3n. En el presente \nestudio la utilizaci\u00f3n de la cut\u00edcula artificial fue muy \nfavorable en reducir la p\u00e9rdida de humedad, \nindependientemente si el huevo proven\u00eda de piso o de \nnido. Sin embargo, en cuanto a incubabilidad, aunque el promedio del factor cut\u00edcula fue mayor y diferente a \nla utilizaci\u00f3n \u00fanica del desinfectante y no se observ\u00f3 \ninteracci\u00f3n entre factores, el grupo de huevo sucio con \ncut\u00edcula no mostr\u00f3 una diferencia marcada respecto al \ngrupo limpio sin cut\u00edcula, aunque si fue mayor al grupo \nsucio sin cut\u00edcula. Por lo cual bajo el contexto de este resultado se requ iere investigar si bacteriol\u00f3gicamente \nexiste alguna circunstancia que explique esta aparente \ndiferencia. En un estudio efectuado por Enguilo\n2 \nutilizando una cut\u00edcula artificial con base a \novoalb\u00famina obtuvo resultados favorables al disminuir \nla p\u00e9rdida de  peso los primeros 18 d\u00edas de incubaci\u00f3n \nde huevos provenientes de reproductoras pesadas, \nreportando una p\u00e9rdida de humedad del 12.7% \naparentemente diferente al grupo que no empleo la \ncut\u00edcula artificial donde solo se utiliz\u00f3 la fumigaci\u00f3n \ncon permanganato  de potasio y gas formaldehido \n(14.1%). Las diferencias en p\u00e9rdida de humedad \nrespecto al presente trabajo que fueron m\u00e1s altas \n(promedio: 19.05%), posiblemente se deben a que \nEnguilo2 incub\u00f3 a baja altitud (Cuautla, Morelos, \nM\u00e9xico), en cambio en la presente investigaci\u00f3n esta \nincubaci\u00f3n se efect\u00fao a 2,250 m.s.n.m. En cuanto a \nincubabilidad Enguilo2 observ\u00f3 que en el grupo con \ncut\u00edcula artificial naci\u00f3 el 69.5% del total de huevos \ndiagnosticados como f\u00e9rtiles, en tanto que en el grupo \nsin cut\u00edcula se obser v\u00f3 un 51.3% de incubabilidad. \nEstos porcentajes aunque bajos debido posiblemente a \nque se trataba de reproductoras pesadas de 53 semanas \nde edad, reflejan un marcado efecto de la cut\u00edcula sobre un aumento de los huevos eclosionados, semejante a lo \nobservad o en el presente estudio donde los huevos \nlimpios con cut\u00edcula presentaron un 18.48% de p\u00e9rdida \nde humedad en tanto que en el grupo sin cut\u00edcula fue de 19.5%. Aunque la utilizaci\u00f3n de cut\u00edcula es favorable \nen la reducci\u00f3n de la p\u00e9rdida de humedad adem\u00e1s de  \naumentar el porcentaje de incubabilidad, Enguilo\n2 \nencontr\u00f3 que el peso de los embriones es menor con \nrelaci\u00f3n a la no utilizaci\u00f3n de cut\u00edcula, por lo cual esta \ncircunstancia la atribuyo a una alteraci\u00f3n en la \nconductividad del cascar\u00f3n, ya que de acuerdo a Peebles\n3 al inicio de la incubaci\u00f3n la tensi\u00f3n \naumentada de CO 2 en el interior del huevo es necesaria \npara la estimulaci\u00f3n del crecimiento pero despu\u00e9s del d\u00eda cuatro al establecerse el intercambio gaseoso de \nox\u00edgeno y CO\n2 , la cut\u00edcula podr\u00eda posiblemen te \nafectarlo. Sin embargo se requieren m\u00e1s investigaciones para determinar el tiempo en que tarda \nen desaparecer una cut\u00edcula artificial de este tipo,  \n 287  \nadem\u00e1s de la diluci\u00f3n \u00f3ptima a emplear, considerando \nadem\u00e1s medir el grado de conductancia de vapor de \nagua del cascar\u00f3n con cut\u00edcula y sin ella. Un punto \nimportante m\u00e1s por investigar es el impacto \nmicrobiol\u00f3gico que tiene el empleo de una cut\u00edcula \nartificial sobre los embriones y la calidad \nbacteriol\u00f3gica de los pollitos eclosionados.  \n \nREFERENCIAS  \n1. Deeming,  D.C. Ayres, L., and Ayres, F.J. \nObservations on the commercial production of ostrich (Struthio camelus) in the United Kingdom: incubation. \nVet. Rec. 132:602- 607. 1993.  \n2. Enguilo, M.B.L. Efecto de la aplicaci\u00f3n de \nuna cut\u00edcula artificial a base de alb\u00famina,  sobre el \ncascar\u00f3n en la incubabilidad de huevos de gallinas de 58 semanas de edad. tesina de licenciatura. Universidad \nNacional Aut\u00f3noma de M\u00e9xico, M\u00e9xico. 1994 . \n3. Peebles, E.D. Pansky, T. Doyle, S.M. Boyle, \nC.R. Smith, T.W. Latour, M.A., and Gerard, P.D. \nEffects of dietary fat and eggshell cuticle removal on \negg water loss and embryo growth in broiler hatching \neggs. Poultry Scien. 77: 1522- 1530. 1998.  \n \nTabla 1.  Porcentaje de p\u00e9rdida de humedad e incubabilidad durante la incubaci\u00f3n de huevos con y sin cut\u00edc ula \nartificial  \nPorcentaje de p\u00e9rdida de humedad al d\u00eda 18 de incubaci\u00f3n                                                                            \nCut\u00edcula  \n      \n      Limpio                                 ( + )                                                             ( - )                           Promedio  \n                ( + )                            18.48 \u00b1 4.80                                               19.51 \u00b1 2.39                       19.00 a*  \n                ( - )                             18.45 \u00b1 2.65                                               19.78 \u00b1 2.89                       19.11 a  \n            Promedio                           18.46 b                                                        19.64 a                                     \n                                                         Porcentaje de nacimientos al d\u00eda 21 de incubaci\u00f3n  \n                                                                                         Cut\u00edcula  \n              Limpio                                 ( + )                                                             ( -  )                           Promedio  \n                ( + )                            75.30 \u00b1 15.05                                              65.18 \u00b1 13.06                    7 0.24 a*  \n                ( - )                             66.07 \u00b1 5.37                                                55.36 \u00b1 3.85                      60.71 b  \n            Promedio                           70.68 a                                                        60.27 b         \n                          \n*Literales diferentes en el promedio de los factores son estad\u00edsticamente diferentes (P<0.05)  \n \nIMMUNE FUNCTION FOLL OWING VACCINATION WI TH AN \nINACTIVATED AVIAN PN EUMOVIRUS VACCINE  \n \nLA FUNCI\u00d3N INMUNE DESPU\u00c9S DE LA APLICACI\u00d3N DE UNA VACUNA \nINACTIVADA CONTRA EL NEUMOVIRUS AVIAR  \n \nDarrell R. Kapczynski and Terry M. Tumpey  \n \nSoutheast Poultry Research Laboratory, A.R.S., U.S.D.A., 934 College Station Rd, Athens, Ga 30605  \n \nRESUMEN  \nEl neumovirus aviar ( APV) recientemente \ncomenz\u00f3 a producir una enfermedad en los pavos, que \nest\u00e1 causando severas p\u00e9rdidas econ\u00f3micas a la industria meleagr\u00edcola. El principal objetivo de este \nestudio fue comparar los mecanismos de la inmunidad \ncelular con linfocitos de pavo purific ados, procedentes \nde aves vacunadas y testigos despu\u00e9s de un desaf\u00edo con el APV.  Los resultados indican diferencias en las \nrespuestas proliferativas entre los grupos vacunados y \nlos no vacunados.  \n Avian pneumovirus (APV) is a recently emerged \ninfectious di sease of turkeys causing severe economic \nlosses to the turkey industry.  The disease results in poor feed conversion, increased condemnations, and \nmortality associated with secondary bacterial \ninfections. Economic losses to APV are estimated at 15 \nmillion dollars annually by the turkey industry. APV \ninfections of poultry were exotic to the U.S. until 1996, when a new subtype of APV, type C (APV/C), was identified as the etiology of the disease.  Some delay in \ndiagnosis occurred until the virus could be isol ated, \nbecause diagnostic reagents to APV types A and B \npresent in other countries were ineffective in  \n 288  \nidentifying birds infected with type C virus.  The \nhistory of the disease in the U.S. contrasts that \nexperienced in other countries where the disease has \nbeen a serious problem since the mid -1980s. In those \ncountries, the disease spread rapidly throughout their \nturkey production industry and has affected chickens as \nwell as turkeys.   \nControl of APV has been performed by \nvaccination with live -attenuated, ce ll-culture adapted \nAPV strains.  Currently, APV type A vaccines protect against challenge from both type A and B viruses from \nEurope.  Research has also shown that live attenuated \nAPV vaccines may cause disease in young poults, which is apparently due to v irulent viral subpopulations \ncontained in vaccine preparations.  Vaccination of \nbirds with the U.S. virus reduces signs of disease \nfollowing challenge with the APV type A, but not from \nAPV type B.  Inactivated APV vaccines are \ncommercially available.  Howe ver, clinical trials \nexamining mammalian pneumovirus inactivated \nvaccines (human respiratory syncytial virus (RSV) or \nbovine RSV) resulted in enhanced pulmonary disease \nfollowing infection. Research generated in our \nlaboratory corroborate these findings.   \nThe main objective of this study was to compare \ncellular immune mechanisms of purified turkey \nlymphocytes from control and vaccinated birds \nfollowing APV challenge.  Peripheral blood lymphocytes were isolated and tested for proliferative \nresponse to APV a nd Concanavalin A (ConA).  The \nrelative percent of CD4+ lymphocytes following virus \nchallenge was measured by flow cytometry.  Also, the \neffect of APV infection on humoral immunity was \nexamined by comparing APV -specific serum \nantibodies following virus cha llenge.   \nThe results indicate differences in proliferative \nresponses between vaccinated and non -vaccinated \ngroups.  Birds not immunized prior to challenge, had \nhigher stimulation indexes (SI) to both APV and ConA \nthan immunized birds.  Interestingly, the SI to APV \nand ConA decreased throughout the experiment in the \nnon-vaccinated APV -challenged group, possibly \nindicating immunosuppression.  Groups that were not \nchallenged had higher SI to APV and ConA than \nimmunized -challenged groups.  No significant \ndiffe rences in CD4+ lymphocyte populations were \nobserved between vaccinated and non -vaccinated \nAPV -challenged groups following challenge.  Finally, \nAPV -specific antibodies increased in all challenged \ngroups as determined by ELISA.  However, only non-\nvaccinated groups had corresponding increases in \nvirus -neutralizing antibodies.  These results indicate \nvaccination with inactivated -APV does not induce \nprotective immunity, and APV challenge may result in \na suppressed response of lymphocytes to mitogen.  \n  \nVACCINE P OTENTIAL OF CORE LPS  OF AVIAN  \n ESCHERICHIA COLI  \n \nEL POTENCIAL DEL LIPOPOLISAC\u00c1RIDO (LPS ) CENTRAL DE \nESCHERICHIA COLI AVIAR COMO VACUNA  \n \nMargie D. LeeA, John J. MaurerB, Charles L. HofacreB \n \nADepartment of Medical Microbiology and Parasitology, BDepartment of Avian Medicine, College of Veterinary \nMedicine, The University of Georgia, Athens, GA 30602 -4875 \n \nRESUMEN  \nLas vacunas existentes contra E. coli en otras \nespecies animales se han enfocado hacia las toxinas y \nlos pili espec\u00edficos de la enfermedad que se desea \nprevenir. No se ha logrado la caracterizaci\u00f3n de los \naislamientos de origen aviar de acuerdo a  un factor de \nvirulencia, pues por lo general no son toxig\u00e9nicos, son poco invasivos y se ha encontrado que no comparten \nadhesinas comunes. Ser\u00eda deseable contar con un \nvacuna efectiva para el control de E. coli  pat\u00f3gena en \npollo de engorda. Nosotros empleamos un sistema de \ntipificaci\u00f3n mediante reacci\u00f3n en cadena con \npolimerasa para clasificar los tipos de oligosac\u00e1ridos (OS) centrales asociados con E. coli pat\u00f3gena de origen aviar. Casi todos los aislamientos recolectados a partir de sitios que normalmente son est\u00e9riles presentaron los OS centrales ya sea R -1 \u00f3 R -3. Nuestros hallazgos \nindican que la inmunidad contra los OS centrales R -1 y \nR-3 puede ser una manera efectiva de proteger a los \npollos contra un gran n\u00famero de enfermedades causadas por E. coli.  \n Avian E. coli infections have been fought with \nantibiotics primarily because development of a broadly \nprotective vaccine has been difficult due to the var iety \nof serotypes associated with poultry diseases. These \nisolates also do not have well characterized virulence factors that can be exploited in vaccine development.  \n 289  \nExisting E. coli vaccines for other animals have \nfocused on toxins and pili that are spec ific for the \ntargeted disease.  For example, bovine colibacillosis \nvaccines target the K99 pili which are found on \npathogenic isolates (5).  Poultry isolates have defied \ncharacterization by virulence factor because they are \ngenerally nontoxigenic, poorly i nvasive, and have not \nbeen found to have common adhesins (3).  The \ninfections are responsible for significant loses to the \npoultry industry because they cause disease in birds \nnear market age and the isolates are usually resistant to \nmany antibiotics (2,4) .  But due to the issues associated \nwith antimicrobial usage in food animals, effective \nantibiotics may not be available for future use.  \nAntibiotic resistance is increasing worldwide \ncausing a financial burden of $30 billion yearly and posing a great thre at to public health (7).  The use of \ncertain antibiotics to treat infections in animals has been linked to greater resistance to similar drugs used to fight human pathogens.  For example, a study \nevaluating resistance to quinolones among \nCampylobacter jejuni  isolates from Minnesota \nresidents from 1992 through 1998 revealed a \nsignificant increase in resistance after 1995, the year in \nwhich fluoroquinolones became approved in the United \nStates to treat poultry (6).  The concern about animal \nuse and increased resistance has resulted in FDA -\ninitiated procedures to re -evaluate approval of \nfluoroquinolones for animal use.  Unfortunately the \nfluoroquinolones are the only effective antibiotic for \nsome E. coli infections in poultry (2).  \nAn effective vaccine would be a useful tool for \ncontrol of avian pathogenic E. coli in broilers. O -\nantigen is very immunogenic and can be a useful antigen if a specific serotype is commonly found \nassociated with disease. These bacteria, however, \nproduce hundreds of O -antigen serotypes,  many of \nwhich can be found in avian isolates. However, E. coli  \npossesses few core oligosaccharide (OS) structures (1).  \nOne study determined that most isolates pathogenic to \nhumans only contained 2 different OS types (R -1 and \nR-3) and that these types wer e also common to canine \nblood or urinary tract isolates.  We used the PCR \ntyping system described by Amor et al. (1) to \ncharacterize the prevalence of core OS types associated with avian pathogenic E. coli.  We found that nearly all of the isolates collected from sites that are normally \nsterile (liver, lung, blood) possessed either R -1 or R -3 \ncore OS.  Isolates cultured from the trachea or skin, \nmost likely commensals, were less likely to be of these \ncore types suggesting that R -1 and R -3 core LPS may \nbe as sociated with pathogenicity. This suggests that \nthese two core OS types are prevalent in disease-causing avian E. coli.  These findings indicate that \nimmunity to R -1 and R -3 core OS may be an effective \nway to protect chickens from a great number of \ndisease s caused by E. coli.  A vaccine may be a good \nalternative to treating poultry infections for which the only current treatment is fluoroquinolones, antibiotics \nbelonging to the same class as those needed to treat \nhumans, which may soon be banned for animal use.  \n \nREFERENCES  \n1. Amor K., D. E. Heinrichs, E. Frirdich, K. \nZiebell, R. P. Johnson, and C. Whitfield. Distribution of Core Oligosaccharide Types in Lipopolysaccharides \nfrom Escherichia coli .  Infect. Immun. 3:1116- 1124, \n2000.   \n2. Bass L., C. A. Liebert, M. D. Lee, A. O. \nSummers, D. G. White, S. G Thayer, and J. J. Maurer. Incidence and Characterization of Integrons, Genetic \nElements Mediating Multiple -Drug Resistance, in \nAvian Escherichia coli .  Antimicrob. Agents \nChemother. 12: 2925- 2929, 1999.   \n3. Dho-Moulin M ., and J. M. Fairbrother. \nAvian pathogenic Escherichia coli  (APEC). Vet Res, \n30:299- 316, 1999.   \n4. Gross W. B.    Colibacillosis.  In: Diseases \nof Poultry, 9\nth ed. B. W. Calnek ed. Iowa State \nUniversity Press, Ames. pp. 138 -144. 1995.  \n5. Nagy, B. Vaccination of  cows with a K99 \nextract to protect newborn calves against experimental \nenterotoxic colibacillosis. Infect. Immun. 27:21 -24, \n1980.  \n6. Smith K. E., J. M. Besser, G.W. Hedberg, F. \nT. Leano, J. B. Bender, J.H. Wicklund, B.P. Johnson, K.A. Moore, M. T. Osterholm, and The Investigation \nTeam. Quinolone -resistant Campylobacter jejuni  \nInfections in Minnesota, 1992 -1998.  N. E. J. M., 20: \n1525- 1531, 1999.   \n7. Spake A. Losing the Battle.  U.S. News and \nWorld Report, 126(18): 52- 60, 1999.  \n \n \n \n \n    \n 290  \nCAMBIOS HEMATOLOGICOS EN AVES INFECTADAS CON LA \nCEPA 73688 ALTAMENTE PATOGENA DEL VIRUS DE \nINFECCION DE BOLSA DE FABRICIO \n \nHEMATOLOGICAL CHANGES IN BIRDS INFECTED WITH HIGHLY \nPATHOGENIC 73688 STRAIN, INFECTIOUS BURSAL DISEASE (IBF) VIRUS  \n \nLima, M.A1; Calderon, A.N2; Fehervari, B.T.2, Fortoul VDG. T. 3 \n \n 1Departamento de Patologia  Facultad de Medicina Veterinaria y Zootecnia, UNAM. Tel. 56 22 58 78.  \nEmail: melo@servidor.unam.mx , 2Departamento de Produccion Animal: Aves, Facultad de Medi cina Veterinaria y \nZootecnia, UNAM. Tel. 56 22 58 67. Email: nlca@servidor.unam.mx,  3Departamento de Microscopia Electronica, \nFacultad de Medicina. UNAM  \n \nSUMMARY  \nIBF results in lymphoid atrophy and depletion in \nthe bursa of Fabricius. The purpose of this experiment \nwas to determine hematological changes in 2 -week -old \nbirds challenged with IBF virus, 73688 strain. In Group \n1 samples, packed cell volume, hemoglobin, and red \nblood cells remained unchanged when co mpared with \ngroup 2, with the exception of 96- hour samples in \ngroup 1, where these parameters were decreased. \nLeukopenia was found 96 hours post -infection, and \nheteropenia was observed at 72, 84, and 96 hours.  \n \nINTRODUCCION  \nLa Infecci\u00f3n de la Bolsa de Fabr icio (IBF) es una \nenfermedad de origen viral, de aves j\u00f3venes de 3 a 6 \nsemanas de edad, es altamente contagiosa y ocasiona \natrofia de la Bolsa de Fabricio (BF). El agente \netiol\u00f3gico es un Birnavirus, que bajo condiciones naturales se transmite por v\u00eda oral , posteriormente se \nreplica en linfocitos y macr\u00f3fagos del intestino y por \nv\u00eda sangu\u00ednea se dirige a la BF donde se replica; 16 \nhoras postinfecci\u00f3n (hpi) existe viremia con replicaci\u00f3n \nsecundaria en otros \u00f3rganos como bazo, h\u00edgado, timo, ri\u00f1\u00f3n y tonsilas c ecales. La mortalidad es variable, pero \npuede ser hasta un 50% en aves Leghorn. El per\u00edodo de \nincubaci\u00f3n es de 2 -3 d\u00edas, animales en la fase aguda de \nla enfermedad presentan severa postraci\u00f3n, anorexia, \ndiarrea, depresi\u00f3n, plumas erizadas y sucias (1,2). Debido a la signolog\u00eda, los cambios importantes en un \nhemograma son eritrocitosis relativa que se asocia a p\u00e9rdida de l\u00edquidos en la diarrea, leucopenia y \nleucocitosis por heterofilia dos d\u00edas y 5 d\u00edas pi, \nrespectivamente. La linfopenia que se presenta pued e \nestar relacionada al incrementado n\u00famero de c\u00e9lulas \nque sufren apoptosis, espec\u00edficamente linfocitos B. Los \nefectos de inmunodepresi\u00f3n parecen ser m\u00e1s evidentes \nsi la exposici\u00f3n al virus es en 2 a 3 semanas de edad \n(2,3,4).  METODOLOGIA  \nSe utilizaron 29 a ves Leghorn, libres de \npat\u00f3genos espec\u00edficos (SPF) de 2 semanas de edad, las aves se dividieron en dos grupos; Grupo 1 formado por \n21 aves, a las cuales se les administr\u00f3 una dosis de 0.2 \nml de la cepa 73688 del virus de IBF, v\u00eda oral y Grupo \n2 formado por  8 aves, como testigos, a las cuales se les \nadministr\u00f3 0.2 ml de soluci\u00f3n salina v\u00eda oral. Las aves \ninfectadas, as\u00ed como las testigos se alojaron en \ndiferentes unidades de aislamiento del Departamento \nde Producci\u00f3n Animal: Aves de la Facultad de \nMedicina V eterinaria y Zootecnia (FMVZ), bajo \ncondiciones controladas, recibieron alimento comercial \ny agua de bebida a libre acceso. Posteriormente se \nhicieron 7 muestreos a las 24, 36, 48, 60, 72, 84 y 96 \nhoras hpi, del grupo 1 y de cada uno se tomaron \nmuestras de  sangre de 3 aves. Los muestreos en el \ngrupo 2 fueron \u00fanicamente a las 24, 60 y 96 horas y de cada grupo se tomaron muestras de sangre a 3, 2 y 3 aves, respectivamente. La cantidad de sangre de cada \nave fue de 0.8 ml, v\u00eda intracardiaca, utilizando \nmicrotainer con EDTA, como anticoagulante para la evaluaci\u00f3n del hemograma, el cual se realiz\u00f3 en el \nDepartamento de Patolog\u00eda secci\u00f3n Hematolog\u00eda, de la \nFMVZ.  \n \nRESULTADOS  \nDe los resultados obtenidos, en la l\u00ednea roja \ndurante los muestreos del grupo 1, se mantuvie ron \nconstantes el Hematocrito, Hemoglobina y Eritrocitos, \ncon respecto al grupo 2, excepto en el muestreo de las \n96 hrs del grupo 1, en el cual se observa una \ndisminuci\u00f3n del hematocrito en 17.7% y hemoglobina \n27.9%  con respecto al grupo testigo. En cuant o a los \neritrocitos se present\u00f3 una disminuci\u00f3n a las 84 y 96 hpi en 16.7% y 21.3%, respectivamente. En los valores \nde leucocitos, los cambios m\u00e1s importantes fueron a las \n72 y 96 hpi en donde disminuyeron en un 45.8% en los \ndos muestreos. Los heter\u00f3filos,  disminuyeron en un \n71.9%, 47% y 65.7% en los muestreos de las 72, 84 y  \n 291  \n96 hpi respectivamente (Gr\u00e1fica 1). Los linfocitos  y \nmonocitos no presentaron cambios importantes en el \ngrupo 1, mientras que en el grupo 2 se hace evidente una ligera linfopenia, a l as 24 hrs. Con respecto a los \nvalores de eosin\u00f3filos, bas\u00f3filos y prote\u00ednas \nplasm\u00e1ticas, no mostraron cambios relevantes.  \n \n \n \nDISCUSION  \nDentro de los hallazgos m\u00e1s importantes en el \nhemograma es eritrocitosis relativa asociada a \nhemoconcentraci\u00f3n (3), sin embargo en este estudio los \nvalores de hematocrito, hemoglobina y eritrocitos se \nencontraron sin cambios relevantes, debido \nposiblemente a que las aves no presentaron diarrea y \npor lo tanto no se suscit\u00f3 p\u00e9rdida de l\u00edquidos, que nos causara la presencia de esta eritrocitosis realtiva.  \nCepas altamente pat\u00f3genas inducen severa \ndepleci\u00f3n de c\u00e9lulas hematopoy\u00e9ticas en m\u00e9dula \u00f3sea, \nlo que hace suponer que las aves presentan cuadros de \nanemias, leucopenia y heteropenia (6), y como \npodem os observar existe una disminuci\u00f3n de la l\u00ednea \nroja en el grupo 1 a las 96 hpi, lo cual nos sugiere que \nel virus ha ocasionado lesiones a nivel de m\u00e9dula \u00f3sea, \nsin embargo estos cambios se van a correlacionar m\u00e1s adelante, con estudios histopatol\u00f3gicos.  \nEn el leucograma, en este estudio los valores de \nleucocitos en el grupo 1 se encontraron solo cambios \nen las 72 y 96 hpi, con respecto al grupo testigo, a lo que se le denomina leucopenia, las cuales fueron \nocasionadas por la heteropenia que se present\u00f3 a partir \nde las 72 hpi, lo cual es el resultado de una depleci\u00f3n \nde leucocitos circulantes y depleci\u00f3n o degeneraci\u00f3n de la leucopoyesis, estas leucopenias son causadas \nprimariamente por heteropenias y es consecuencia de \ninfecciones virales, esto es debido a q ue el virus afecta \nl\u00edneas progenitoras en m\u00e9dula \u00f3sea, ocasionando su \ndisminuci\u00f3n. Por otro lado, la presencia de linfopenia \nen el muestreo de las 24 hrs del grupo 2 es b\u00e1sicamente asociada a la liberaci\u00f3n de glucocorticosteroides \nend\u00f3genos que se liberan durante una respuesta inicial \nde estr\u00e9s.  La lisis de linfocitos es causada por necrosis y \napoptosis en aves j\u00f3venes infectadas con el virus de \nIBF, esta apoptosis tambi\u00e9n se ha observado en \nlinfocitos de sangre perif\u00e9rica in vitro , por lo tanto se \npuede su poner que las aves infectadas podr\u00edan \npresentar una linfopenia y esto es debido a que una de las causas importantes de linfopenia, se  asocia a enfermedades virales severas, sin embargo en los \nresultados obtenidos en todos los muestreos del grupo \n1 no se observaron cambios relevantes.  \n \nCONCLUSIONES  \nEs necesario realizar muestreos m\u00e1s prolongados \npara observar mejor el comportamiento celular tanto de \nl\u00ednea roja  y blanca, en esta enfermedad y as\u00ed poder \ndeterminar si despu\u00e9s de las 96 hpi se aprecia una \nanemi a evidente o existe recuperaci\u00f3n por parte del \nave. As\u00ed mismo, determinar si las heteropenias \nobservadas se vuelven m\u00e1s marcadas  o las aves se \nrecuperan.  \nTodos los hallazgos hematol\u00f3gicos se \ncorroborar\u00e1n con estudio histopatol\u00f3gico de m\u00e9dula \n\u00f3sea para determinar el da\u00f1o ocasionado por el virus de \nIBF, en todos los muestreos.  \n \nRESUMEN  \nLa Infecci\u00f3n de la Bolsa de Fabricio  (IBF), es \nuna enfermedad que causa atrofia y depleci\u00f3n linfoide \nbolsa de Fabricio. El objetivo es determinar cambios \nhematol\u00f3gicos en aves, de 2 semanas de edad, desafiadas con la cepa 73688 del virus de IBF. Durante \nlos muestreos del grupo 1 se mantuvieron constantes el \nHematocrito, Hemoglobina y Eritrocitos, con respecto al grupo 2, excepto en el muestreo de las 96 hrs del \ngrupo 1, en el  cual se observa una disminuci\u00f3n, con  \n 292  \nrespecto al grupo testigo. Se present\u00f3 leucopenia a las \n96 hrs posinfecci\u00f3n y heteropenia a las 72, 84 y 96 hrs \nrespectivamente.  \n \nREFERENCIAS  \n1. Tsukamoto, K., Tanimura, N., Mase, M. and \nImai, K. Comparison of virus repli cation efficiency in \nlimphoid tissues among three infectious bursal disease virus strains. 1995; 39:844- 852. \n2. Van den Berg, T.P. Agude infectious bursal \ndisease in poultry: A review. 2000; 29:175- 179. \n3. Okoye, J.O.A. Infectious bursal disease of \nchickens. 1984; 54:425- 436. \n4. Sharma, J.M., Dohms, J.E. and Metz, A.L. \nComparative Pathogenesis of serotype 1 and variant \nserotype 1 isolates of Infectious Bursal Disease virus \nand their effect on humoral and cellular immuni \ncompetence of Specific- Pathogen -Free Chickens.  \nAvian Diseases. 1989; 33:112 -124. 5. Craig, W.H., Brewer, R.N. and Allen, E. \nStudies on infections bursal disease in chickens. 2. \nScoring microscopic lesions in the bursa of fabricius, \nthymus, spleen, and kidney in gnotobiotic and battery \nreared white Leghor ns experimentally infected with \nInfectious Bursal Disease Virus. Poultry Science. 1980; 59:1006- 1017.  \n6. McFerran, J.B. and McNulty, M.S. Virus \nInfections of Birds. Elsevier Science Publishers B.V. \nAmsterdam 1993, (pp 213- 228).  \n7. Campbell, T.W. Avian Hematology  and \nCitology. Second edition. Iowa State University \nPress/Ames. 1995.  \n8. Inoue, M., Fujita, A. and Maeda, K. Lysis of \nmielocitos in chickens infected with Infectious Bursal \nDisease Virus. Vet. Pathol. 1999; 36:146- 151. \n9. Feldman, B.F., Zinkl, J.G. and Jain, N. C. \nSchalm\u00b4s. Veterinary Hematology. Fifth edition. \nLippincott Williams and Wilkins.  \n \nAPPLICATION OF THE PCR TO DETECT CHICKEN ANEMIA \nVIRUS GENOME  \n \nAPLICACI\u00d3N DE LA REACCI\u00d3N EN CADENA CON POLIMERASA (PCR) \nPARA DETECTAR EL GENOMA DEL VIRUS DE LA ANEMIA DEL POLLO  \n \nV. A. Lobanov, V. V. Borisov, M. A. Volkova, G.V. Batchenko, V. V. Drygin  \n \nAll-Russian Research Institute for Animal Health, Vladimir, Russia  \n \nRESUMEN  \nEl diagn\u00f3stico de la infecci\u00f3n con el virus de la \nanemia del pollo ( CAV ) se puede lograr mediante  \naislamiento viral o mediante la detecci\u00f3n de \nanticuerpos espec\u00edficos. El aislamiento del virus \nmediante las t\u00e9cnicas convencionales es un proceso bastante laborioso y tardado. Adem\u00e1s, algunas cepas de \neste virus no se han logrado reproducir en c\u00e9lulas \nMSB -1 ni en otras l\u00edneas celulares linfoblastoides. \nComo una alternativa diagn\u00f3stica se desarroll\u00f3 una \nprueba de reacci\u00f3n en cadena con polimerasa mediante \n\u201canidaci\u00f3n\u201d para detectar el genoma del virus de la \nanemia del pollo. Usando este sistema de an\u00e1lisis s e \ndetect\u00f3 el genoma de dicho virus en el 54.2% de las \npruebas. El an\u00e1lisis de la informaci\u00f3n revel\u00f3 que el \nvirus de la anemia del pollo con frecuencia est\u00e1 \nasociado con el s\u00edndrome de hidropericardio en Rusia. \nEstos hallazgos sugieren una amplia distribuci\u00f3n del \nvirus en las granjas rusas.  \n \nDiagnosis of chicken anemia virus (CAV) \ninfection can be made by virus isolation or the \ndetection of CAV specific antibodies. Isolation of CAV by conventional techniques is a cumbersome and time -consuming process which i mpairs the rapid and reliable \ndemonstration of virus in clinical samples. Further, some CAV strains have failed to replicate in MSB -1 or \nother lymphoblastoid cell lines.  \nAs an alternative diagnostic approach a \npolymerase chain reaction (\"nested\" -PCR) has b een \ndeveloped for detection of CAV genome. Using the test system samples of pathologic material obtained during 1999- 2001 years from 47 poultry farms in Russia, \nUkraine, and Belarus have been investigated. As a \nresult, CAV genome has been detected in 54.2%  of \ntests. The data analysis revealed that CAV is often \nassociated with hydropericardium syndrome outbreaks \nin Russia.  \nDel-Ros (USA) and Cuxhaven -1 (TAD, \nGermany) strain -specific fragments have been \namplified. The amplified 1453 bp fragments of the \nstrains  and three field isolates detected have been \ncloned in pGEM -T plasmid vector. The cloned 1453 bp \nfragment contains the major part of VP1 gene, coding single structural protein 51,6 K, and also more than a \nhalf of the length of ORF for VP2 (24 K) and VP3 or  \napoptin (13,6 K). The 1453 bp sequences have been \ndetermined on both strands using universal forward and  \n 293  \nreverse pUC/M13 primers and a set of specially \nsynthesized primers.  \nThe comparison of nucleotide sequences of \ncloned fragments of two CAV strains and three isolates \nwith similar sequences published by EMBL showed the possibility of differentiation of strains and isolates of \nCAV.  \nThe data obtained suggests a wide distribution of \nCAV in poultry farms in Russia.  \n \nEFECTO DE LA ESTIRPE GENETICA, SEXO Y ALGU NAS \nPRACTICAS DE MANEJO SOBRE LOS PARAMETROS DE \nPRODUCCION EN EL POLLO DE ENGORDA  \n \nEFFECT OF THE STRAIN, SEX, AND MANAGEMENT PRACTICES ON \nBROILER PRODUCTION PARAMETERS \n \n1L\u00f3pez, B.B., Ortiz, M.A. y T\u00e9llez, H.J.  \n \nFacultad de Estudios Superiores Cuautitl\u00e1n,  UNAM.   1  E-mail.  benitolb@servidor.unam.mx  \n \nSUMMARY  \nThe effect of the strain genetics and the sex was \nevaluated using three broiler strains under a 3x3 factorial model. Co -variables were day -one weight, \ngrow -out days, and population density. Daily weight \ngain, final weight, overall mortality rate, feed \nconversion rate, and productivity index, showed no \nstatistically significant differences between strains \n(P>0.1).  When these same variables were evaluated on a per -sex basis, average daily weight gain wa s \nsignificantly higher in males. Therefore, average final weight was also higher. Nevertheless, mortality rates, \nfeed conversion rates, and productivity index showed \nno statistically significant differences (P>0.1).  \n \nRESUMEN  \nEl efecto de la estirpe gen\u00e9tic a y sexo,  se evalu\u00f3 \nen tres estirpes de engorda en un modelo factorial 3x3 y como covariables el peso al primer d\u00eda, d\u00edas de \nengorda y densidad de poblaci\u00f3n.  Encontrando que para ganancia de peso diaria (GDP), peso final,   porcentaje de mortalidad gener al , conversi\u00f3n \nalimenticia e \u00edndice de productividad no presentaron \ndiferencias estad\u00edsticas significativas entre estirpes (p> \n0.1).  Al evaluar estas mismas variables por sexo, se encontr\u00f3 que en GDP los machos  tuvieron  promedios \nsignificativamente  m\u00e1 s altos  y que por ende en el peso \nfinal lograron tambi\u00e9n los promedios m\u00e1s altos, pero \nque en los porcentajes de mortalidad, conversi\u00f3n e IP \nno denotaron diferencias significativas (p> 0.1).  \nEl presente trabajo se realizo con el objeto de \nevaluar el efect o de la estirpe gen\u00e9tica, sexo,    peso al \nprimer d\u00eda,  d\u00edas de engorda y densidad de poblaci\u00f3n sobre los par\u00e1metros de producci\u00f3n: ganancia diaria de \npeso (GDP), conversi\u00f3n, peso final, porcentaje de \nmortalidad  e \u00cdndice de Productividad (IP). Para dicho fin se estudiaron  84 parvadas de engorda con un total \nde 1, 162, 803 aves, producidas durante al a\u00f1o 2000 en \nlas zonas  de Jalisco, Aguascalientes y Guanajuato.  \nLas estirpes que se evaluaron fueron  Arbor acress, Ross y Shaver en tres arreglos; lotes de machos, \nhembras y mixtos mismos que sirvieron como criterios \nde clasificaci\u00f3n para su evaluaci\u00f3n estad\u00edstica en un \nmodelo factorial 3x3 y como covariables el peso al \nprimer d\u00eda, d\u00edas de engorda y densidad de poblaci\u00f3n. \nEncontrando que para GDP el promedio general de las aves estudiadas fue de 45.01 gr diarios y que por \nestirpe fue 46,6, 44.9 y 44.4 para Arbor Acress, Ross y \nShaver respectivamente, mismas que no presentaron \ndiferencias estad\u00edsticas significativas entre ellas (p> \n0.1). Para la variable peso f inal el promedio general fue \nde 2.326 Kg mientras que el peso por estirpe fue de \n2.407, 2.320 y 2.288 en el mismo orden mencionado \nanteriormente y sin diferencias significativas. Este \nmismo fen\u00f3meno se observ\u00f3 en porcentaje de \nmortalidad, con  9.1 de morta lidad general 2.1 en \nconversi\u00f3n alimenticia y 202.2 de IP, sin diferencias significativas. Sin embargo al evaluar estas mismas variables por sexo, se encontr\u00f3 que en ganancia diaria \nde peso los machos  tuvieron  los promedios m\u00e1s altos \n47.1 gr y que por en de en el peso final lograron \ntambi\u00e9n los promedios m\u00e1s altos 2.420 Kg, pero que en \nlos porcentajes de mortalidad, conversi\u00f3n e IP no \ndenotaron diferencias significativas (p> 0.1). Tampoco \nse encontr\u00f3 efecto de interacci\u00f3n entre estirpe y sexo. \nFinalmente l as covariables peso al primer d\u00eda y d\u00edas de \nengorda  est\u00e1n correlacionadas positiva  y \nsignificativamente con las variables de producci\u00f3n ya \nmencionadas, no as\u00ed la variable densidad de poblaci\u00f3n \nque mostr\u00f3 una correlaci\u00f3n negativa significativa (p< \n0.05).\n  \n 294  \nENZYME -LINKED IMMUNOSORBENT ASSAY USING PEPTIDE \nSPECIFIC ANTIBODIES FOR DETECTION OF AVIAN \nINFECTIOUS BRONCHITIS VIRUS  \n \nENSAYO DE INMUNOABSORCI\u00d3N LIGADO A ENZIMAS USANDO \nANTICUERPOS ESPEC\u00cdFICOS CONTRA P\u00c9PTIDOS PARA LA DETECCI\u00d3N \nDEL VIRUS DE LA BRONQUITIS INFECCIOSA  \n \nN.N. Lougovskaia, A.A. Lougovskoi, N.S. Mudrak, V.V. Drygin, A.V. Borisov, V.V. Borisov, A.A. Gusev  \n \nAll-Russian Research Institute of Animal Health, Vladimir, 600900, Russia  \n \nRESUMEN  \nSe us\u00f3 un p\u00e9ptido de la regi\u00f3n inmunodominante \nconservada d e la terminal N de la prote\u00edna del \npepl\u00f3mero S2 del virus de la bronquitis infecciosa \n(IBV), para aislar los anticuerpos espec\u00edficos de sueros \npoliclonales hiperinmunes de pollo mediante \ncromatograf\u00eda de inmunoafinidad. Estos anticuerpos se \nutilizaron para  desarrollar un ensayo de \ninmunoabsorci\u00f3n indirecto de bloqueo en fase l\u00edquida \npara la detecci\u00f3n del ant\u00edgeno del virus de la bronquitis \ninfecciosa en muestras de l\u00edquido alantoideo de \nembriones de pollo despu\u00e9s de la propagaci\u00f3n de cepas vacunales de dich o virus.  \n A peptide VTNAPYVSYGKFAIKPOG deduced \nfrom the N -terminal conserved immunodominant \nregion of peplomeric S2 protein of avian infectious bronchitis virus (IBV) was used to isolate the specific antibodies from chicken hyperimmune polyclonal sera \nby immunoaffinity chromatography on BrCN -activated \nSepharose 4B. The antibodies were employed to \ndevelop an indirect liquid -phase blocking \nimmunosorbent assay for detection of  IBV antigen in \nsamples of allantoic fluid of chicken embryos after \npropagating of IB V vaccine strains. The choice of the \npeptide was based on the observation that the \nrespective fragment of S2 peplomeric glycoprotein of \nIBV bound wide range of monoclonal antibodies as \nwell as recognized specific immunoglobulins (IgG) in \nchicken polyclonal  serum samples (1).    \nIn our assay IBV coated ELISA plates were used \nto capture the excess of peptide- specific IgG after \npreincubation of them with test material. IgG bound to IBV antigen were in turn detected with anti -chicken horseradish peroxidase conju gate and chromogenic \nsubstrate. Signal to noise ratios (S/N) were calculated \nfrom the optical densities obtained in the assay and \ndiagnostic threshold was established from S/N ratio \nfrequency distribution of samples positive or negative \nfor IBV by virus ti tration or polymerase chain reaction. \nS/N ratios more than 0.8 were considered to be \nnegative, ratios less than 0.7 were found to be positive \nand ratios between 0.7 and 0.8 were considered to be \nsuspicious of IBV.  \nFor SPF- allantoic fluid of chicken embryo s S/N \nvalue obtained in the assay were above 0.85 while \nallantoic  fluids taken after propagation of IBV vaccine \nstrains H52, H120, M41, 4/91, D274, D1466 \ndemonstrated the S/N values in the range from 0.2 to \n0.6.  \nThe specificity of  the assay was confirmed by \ninvestigating the samples of allantoic fluid or tissue \nculture supernatants of heterologous viral antigens (Egg Drop Syndrome, Infectious Bursal Disease, \nNewcastle Disease, Reovirus) and Mycoplasma \ngallisepticum. The nonspecific reaction with \nheterologo us antigen was insignificant yielding the S/N \nvalues ranging from 0.8 to 0.95 for different test samples. Relative sensitivity of the assay ranged from 105 to 106 of  50% median egg infectious doses \n(EID50) and were examined by investigation of \nconsecutive two-fold dilutions of infectious allantoic \nfluid with known IB virus EID50 predetermined by \nvirus titration in SPF chicken embryos.  \n  \nREFERENCE  \n1. Kusters et al., J. Immunol. 143:2692. 1989.  \n \n \n \n \n  \n 295  \nCHARACTERIZATION OF ND VIRUS ISOLATE FROM RECENT \nOUTBREAK IN C ENTRAL REGION OF RUSSIA \n \nCARACTERIZACI\u00d3N DE UN AISLAMIENTO DEL VIRUS DE LA \nENFERMEDAD DE NEWCASTLE DE UN BROTE RECIENTE EN LA REGI\u00d3N \nCENTRAL DE RUSIA \n \nT.B. Manin, I.P. Pchelkina, Y.A. Bochkov, A.V. Borisov, L.O. Scherbakova, S.K. Starov, V.V. Drygin  \n \nAll-Russian Research Institute for Animal Health, 600901, Vladimir, Russia  \n \nRESUMEN  \nEl virus de la enfermedad de Newcastle aislado de \nun brote reciente en la regi\u00f3n Central de Rusia  fue \nidentificado mediante el an\u00e1lisis de la determinaci\u00f3n \nparcial de la secue ncia del gene de la prote\u00edna de fusi\u00f3n \n(F). Este aislamiento tiene la secuencia de amino\u00e1cidos \ndel sitio de separaci\u00f3n de la proteasa de la prote\u00edna FO (112R -R-Q-R-R-F117), un \u00edndice de patogenicidad \nintracerebral de \u2013  1,97 y un tiempo medio de muerte de \nlos embriones de 49 horas, como ocurre con las cepas \nvelog\u00e9nicas de este virus. Se sospech\u00f3 que los brotes \ncausados por el virus del genotipo VII constituyeron la \ncuarta panzootia de la enfermedad de Newcastle, misma que es distinta de la tercera panzootia causada \npor los \u201cvirus de pich\u00f3n PMV -1\u201d. \n \nThe ND virus isolated from recent outbreak in \nCentral region of Russia was identified by partial sequence analysis of the fusion (F) protein gene. The \nisolate has the amino acid sequence of protease \ncleavage site o f the F0 protein (112R -R-Q-R-R-F117), \nintracerebral pathogenicity index - 1,97 and mean \ndeath time on embryos - 49 hours like velogenic strains \nof NDV.   A phylogenetic tree based on sequences \nobtained showed that the isolate was similar to the \ngenotype VII b viruses. NDV isolates from southern \nAfrica, Bulgaria and Turkey were placed into this \ngroup. The group VIIb is a part of a larger genetic \ncluster VII that also includes NDV strains from the Far \nEast, East Asia, and some western European countries \n(VIIa).  It was suspected that outbreaks caused by VII \ngenotype have constituted the fourth panzootic of ND, \nwhich is distinct from the third panzootic caused by the \"pigeon PMV -1 viruses\".  \n \nEVALUACI\u00d3N DE LA APLICACI\u00d3N DE UNA VACUNA \nINACTIVADA CONTRA EL VIRUS DE LA BRONQUITIS \nINFECCIOSA POR ASPERSI\u00d3N EN UNA PARVADA DE  \nPOLLO DE ENGORDA  \n \nEVALUATION OF A SPRAY- GIVEN, KILLED, INFECTIOUS BRONCHITIS \nVIRUS (IBV) VACCINE IN A BROILER FLOCK  \n \nMVZ. Daniel Marrufo Villa, MVZ. Alejandro Sosa P\u00e9rezSandi, MVZ. Eduardo Lucio Decanini y MVZ. Enrique \nGonz\u00e1lez Escobar.  \n \nInvestigaci\u00f3n Aplicada S.A. de C.V., 7 Norte No. 416 Col. Centro, Tehuac\u00e1n Puebla, M\u00e9xico.  \nSecci\u00f3n T\u00e9cnica \u2013  Gerencia L\u00ednea Aves - Investigaci\u00f3n Aplicada S.A. de C.V.  \nTel. (2) 380- 38-05, 380- 38-08 y 380- 38-09. Fax. ( 238) 380- 38-06, Correo Electr\u00f3nico:  dmarrufo@grupoidisa.com  \n \nSUMMARY  \nA killed IBV vaccine was administered by fine spray to broilers at both 1 and 16 days of age. Birds showed no respiratory signs or IBV antibodies throughout the \nproduction cycle. In the  potency/challenge test 100% \ncontrols, and 10% vaccinates showed clinical signs of infectious bronchitis. Challenge IBV was re -isolated \nfrom 100% control embryos and 10% vaccinates. \nSpray -given killed vaccine confers 90% protection \nagainst challenge.  \n  \n 296  \nRESU MEN  \nSe realiz\u00f3 la aplicaci\u00f3n al 1 y 16 d\u00eda de edad de una \nvacuna inactivada por aspersi\u00f3n por gota fina contra el \nvirus de Bronquitis Infecciosa en una parvada de pollo \nde engorda. Durante el ciclo de producci\u00f3n las aves no \npresentaron signolog\u00eda respirato ria, ni anticuerpos \ncontra el VBI. En la prueba de potencia- desaf\u00edo el \n100% de aves testigo y el 10% del grupo vacunado presentaron signos cl\u00ednicos de BI. El 100% de \nembriones testigo y 10% del grupo vacunado se reaisl\u00f3 \nel VBI de desaf\u00edo. La Vacuna Inactiv ada por Aspersi\u00f3n \nconfiere protecci\u00f3n contra un desaf\u00edo del VBI del 90%.  \n \nRESULTADOS  \nLa Bronquitis Infecciosa (BIA) es considerada como el \nproblema respiratorio de mayor prevalencia en la \nindustria av\u00edcola mundial, en el caso del pollo de \nengorda se presen tan grandes p\u00e9rdidas econ\u00f3micas, \ndebido a la elevada mortalidad que se puede presentar en aves j\u00f3venes y por la interacci\u00f3n de agentes \nbacterianos secundarios ( E. Coli) . Inicialmente la \nforma de controlar a la Bronquitis Infecciosa era por \nmedio de la expo sici\u00f3n de virus no atenuados \nvirulentos, posteriormente la vacunaci\u00f3n con virus \natenuados, sin embargo estas formas de control \nacarrean otro tipo de problemas como los son las \nreacciones postvacunales severas, los brotes de campo \ninducidos por virus vacuna les y la aparici\u00f3n de cepas \nvariantes del virus de BIA; raz\u00f3n por la cual naci\u00f3 la necesidad de crear otra alternativa de control de la enfermedad, que consiste en la aplicaci\u00f3n del virus de \nBIA inactivado por aspersi\u00f3n con un adyuvante a base \nde toxinas b acterianas. Esta vacuna a su contacto con \nlas mucosas del tracto respiratorio estimula una fuerte \ninmunidad de tipo local la cual es requerida para lograr \nla protecci\u00f3n contra los desaf\u00edos de campo y la \ndisminuci\u00f3n casi absoluta de las lesiones producidas \npor el VBIA. El objetivo de prueba fue evaluar el nivel \nde protecci\u00f3n que confiere aplicaci\u00f3n de una vacuna \ninactivada por aspersi\u00f3n contra la BIA en una parvada de pollo de engorda mediante la valoraci\u00f3n de la \nrespuesta serol\u00f3gica y una prueba de potencia desaf\u00edo.  \nLa prueba se realiz\u00f3 en una granja de pollo de engorda \nlocalizada en el centro del pa\u00eds en donde se alojaron \n138,000 pollos de engorda de un d\u00eda de edad. La \nprueba consisti\u00f3 en la aplicaci\u00f3n de la vacuna inactivada por aspersi\u00f3n contra la BI al d\u00eda y al los 16 \nd\u00edas de edad (5 d\u00edas despu\u00e9s de la aplicaci\u00f3n de la \nvacuna a virus vivo de Newcastle). La vacuna fue \naplicada por medio de aspersi\u00f3n por gota fina a una \ndosis de 0.5 ml por ave. En la granja se realizaron las \npracticas de manejo, medidas de bioseguridad y \npracticas de alimentaci\u00f3n que normalmente se llevan a cabo en las parvadas comerciales. En la parvada se \nrealiz\u00f3 un seguimiento serol\u00f3gico tomando muestras a \nlos 16, 21, 28, 35, 42 y 48 d\u00edas de edad con la finalidad \nde determinar si las aves hab\u00edan sido expuestas al virus \nde la BI de campo mediante la t\u00e9cnica de ELISA y cual \nera la respuesta inmune a dicho desaf\u00edo, as\u00ed mismo \ncorrelacionarlo con el estado de salud de las aves y el nivel de protecci\u00f3n estimulada por la vacuna. A las 6 \nsemanas de edad se tomaron 14 pollos vacunados y 5 \naves ALPES de 7 semanas (grupo testigo) y fueron \ntrasladaron a las unidades de aislamiento del Laboratorio de Biolog\u00eda de IASA en donde se realiz\u00f3 \nuna prueba de Potencia -Desaf\u00edo con un virus pat\u00f3geno \nde BIA aplicando por v\u00eda intraocular 0.3 ml de virus BI \ncepa Mass (10 4 DIE50/ml). Al 5\u00b0 d\u00eda se tomaron \nmuestras de exudados traqu\u00e9ales de ambos grupos con \nhisopo, de cada muestra se inocularon 5 embriones \nLPE de 10 d\u00edas de edad para realizar el reaislamiento \ndel virus.   \nDurante el ciclo de producci\u00f3n las aves no presentaron \nsignolog\u00eda respiratoria atribuible al virus de BIA; con \nrespecto al seguimiento serol\u00f3gico solo a los 16 d\u00edas se \nobservaron t\u00edtulos de anticuerpos contra el VBI con un \nnivel bajo (anticuerpos materno s), durante el resto del \nciclo productivo no se detecto la presencia de anticuerpos, por lo tanto podemos asumir que no se presento un desaf\u00edo de campo. Con lo referente a la \nprueba de potencia- desaf\u00edo se encontr\u00f3 entre el 3\u00b0 y 5\u00b0 \nd\u00eda post -desaf\u00edo que el 1 00% de las aves ALPES y un \nave de grupo vacunado (10%) presentaron signos cl\u00ednicos de Bronquitis Infecciosa. Del aislamiento al 7\u00b0 \nd\u00eda post -inoculaci\u00f3n se evaluaron los embriones \nencontrando que todos los embriones del grupo ALPES \npresentaron lesiones caus adas por el VBI (25+/25) en \nel grupo de embriones de las aves vacunadas solo se \nencontraron 5+/50, dichas lesiones fueron \nencorvamiento, enanismo y falta de plumas, de las aves \ndel  grupo vacunado se realizo el reaislamiento del VBI de desaf\u00edo del 10% de l as aves y del grupo testigo se \nreaislo del 100% de pollos. Por lo tanto el 100% de las \naves testigo no presentaron protecci\u00f3n ante un desaf\u00edo \ny los pollos a los que se les aplic\u00f3 la vacuna inactivada \npor aspersi\u00f3n contra BI tuvieron un 90% de protecci\u00f3n, \npor tal motivo la prueba de Potencia- Desaf\u00edo se \nconsidera \u201cSatisfactoria\u201d, es decir, la vacuna si \nprotegi\u00f3 a las aves ante el desaf\u00edo con el VBI (Prueba \nrealizada seg\u00fan lo establecido por la SAGARPA).  \nDel presente estudio podemos concluir que la \nVacuna Inactivada por Aspersi\u00f3n confiere una fuerte protecci\u00f3n a las aves contra un posible desaf\u00edo de \ncampo con el virus de BI y adem\u00e1s que es inocua para \nlas aves.  \n \n  \n 297  \n\u201cEVALUACI\u00d3N DE PAR\u00c1M ETROS PRODUCTIVOS Y GRADO DE \nPIGMENTACI\u00d3N EN POLL OS DE ENGORDA VACUNADOS \nCONT RA COCCIDIOSIS (NOBI LIS COX ATM\u00ae) Y MEDI CADOS \nCON SALINOMICINA (SACOX \u00ae).\u201d  \n \nEVALUATION OF PRODUCTIVE PARAMETERS AND SKIN \nPIGMENTATION OF COCCIDIA-VACCINATED (NOBILIS COX \nATM\u00ae)/SALINOMYCIN-TREATED (SACOX  \u00ae)  BROILERS \n1Marco A. Ju\u00e1rez- Estrada, 1Jos\u00e9 F. Mart\u00ed nez-Bruno, 1Ver\u00f3nica D\u00e1vila -Ram\u00edrez,  2Guillermo Gonz\u00e1lez Herrera, \n2Francisco R\u00edos, 1Ernesto \u00c1vila -Gonz\u00e1lez.  \n \n1Departamento de Producci\u00f3n Animal: Aves,  Facultad de Medicina Veterinaria y Zootecnia,  Universidad Nacional \nAut\u00f3noma de M\u00e9xico. Avenida Univers idad 3000. Ciudad Universitaria CP. 04510 M\u00e9xico, D.F.  \n2Intervet M\u00e9xico. Av. Paseo de los Frailes 22 Parque Industrial Santiago Tianguistenco CP. 52600 Edo. de M\u00e9xico  \nE-mail: britoco@servidor.unam.mx  \n \nSUMMARY  \nThe vaccine Nobilis Cox ATM\u00ae was evaluated in \ncombination with salinomycine after coccidial \nchallenge. Groups were: A: challenge + vaccine  + \nsalinomycine; B: vaccine + salinomycine; C: challenge \n+ salinomycine, and D: salinomycine. On day 28 \ngroups A and C were challenged. On day 14 group D showed th e best body weight, followed by group B. \nGroup A showed the worst body weight. Group B showed the best feed conversion rate, followed by \nGroups A, C, and D. Yellowness on day 42 reached its \nhighest value in group B, while the lowest value was \nobserved in G roup D.  \n \nRESUMEN  \nSe estudi\u00f3 la vacuna Nobilis Cox ATM\u00ae con \nSalinomicina ante un desaf\u00edo coccidiano. Los grupos \nfueron (A: desaf\u00edo + vacuna  + salinomicina; B: vacuna \n+ salinomicina; C: desaf\u00edo + salinomicina y D: salinomicina). Al d\u00eda 28, A y C fueron desafiados. Al \nd\u00eda 14 el mejor grupo en peso fue el D, seguido del B y \nel menor fue el A. La conversi\u00f3n alimenticia  fue mejor \npara el grupo B, seguido del A, C y D. En amarillamiento al d\u00eda 42 el grupo B fue el m\u00e1s alto y el \nD el m\u00e1s bajo.  \n \nINTRODUCCI\u00d3N  \nUna infecci\u00f3n natural por coccidias induce una \nr\u00e1pida y s\u00f3lida inmunidad, indicando hasta ahora que \nlos par\u00e1sitos vivos son esenciales en los mecanismos inmunol\u00f3gicos de protecci\u00f3n inmune\n1. Se han \ndesarrollado varios tipos de vacunas con base a \noocistos vivos,  las cuales han mostrado \u00e9xito variable. \nSe recomienda  que para evitar cualquier efecto negativo de la inmunizaci\u00f3n la vacuna se administre a las aves lo m\u00e1s tempranamente posible; debido a que \nmuchas ocasiones algunas aves no reciben la dosis que inicIa la respuesta inmune primaria, o bien la reciben \nen demas\u00eda. Las aves que no reciben la cantidad suficientes de oocistos vivos van a recibirlos \n\u00fanicamente hasta despu\u00e9s de una o dos semanas \ncuando la dosis vacunal ya se replic\u00f3 y se encuentra en \nla cama\n1. Por lo cual durante el periodo de vacunaci\u00f3n \ncon oocistos vivos no se debe dar ning\u00fan tipo de \ntratamiento anticcocidiano que pueda factiblemente \nafectar la proliferaci\u00f3n de los oocistos vacunales. En mercados donde se utilizan adicionalmente algunos \nion\u00f3for os anticoccidianos como la Salinomicina para \nprevenir enteritis necr\u00f3tica (Se conoce que Clostridium  \nsp forma parte de aproximadamente el 30% de \nmicroflora regular que coloniza el tracto digestivo de \nlas aves dom\u00e9sticas) la utilizaci\u00f3n de vacunas vivas \npuede causar problemas al inducir el retiro de este \nf\u00e1rmaco\n1. La utilizaci\u00f3n de una vacuna viva que \ndesarrolle inmunidad a\u00fan en presencia de Salinomicina \nes un concepto novedoso en el control de la coccidiosis \naviar2. Se efectu\u00f3 un estudio con pollos de engor da \nalojados en piso con el objeto de evaluar la aplicaci\u00f3n \nde la vacuna Nobilis Cox ATM\u00ae junto con la \nadministraci\u00f3n de Salinomicina para observar la \nprotecci\u00f3n contra un desaf\u00edo de campo.  \n \nMATERIAL Y M\u00c9TODOS  \nAnimales de experimentaci\u00f3n. - Se utilizaron 32 0 \npollos de engorda (Ross x Ross) mitad hembras y \nmitad machos, de un d\u00eda de edad durante 49 d\u00edas de \nexperimentaci\u00f3n. Las aves se alojaron de manera mixta en una caseta de ambiente natural del CEIEPA de la \nU.N.A.M. Cada corral se separo con l\u00e1mina \ngalvaniz ada para evitar contaminaci\u00f3n cruzada, se \nutiliz\u00f3 cama mixta 50% viruta de madera y 50% paja \nde avena. Al d\u00eda 8 de edad se vacunaron contra \nNewcastle v\u00eda ocular (cepa B1 0.03 ml) y subcut\u00e1nea (cepa La sota 0.5 ml).   \n 298  \nVacuna. - La vacuna Nobilis Cox ATM (Intervet \nInternational B.V. Booxmeer -Holanda)  contiene cuatro \ncepas de oocistos vivos esporulados, estas cepas \nvacunales se reproducen a\u00fan en presencia de algunos \nanticoccidianos del tipo ion\u00f3foro como la \nSalinomicina, su composici\u00f3n por cada 5 ml (agua de \nbebida) es de 500 ooquistes esporulados de Eimeria \nacervulina , 100 ooquistes esporulados de Eimeria \ntenella , 50 ooquistes esporulados de Eimeria maxima \ncepa ACM  y 50 ooquistes esporulados de Eimeria \nmaxima cepa ACVM 2. La vacunaci\u00f3n se efectu\u00f3 al d\u00eda \ncinco de edad por agua de bebida a una diluci\u00f3n 1:100 \nde acuerdo a las recomendaciones del fabricante. Se verific\u00f3 que los pollitos previamente privados de agua \nde bebida por treinta minutos consumieran los 5 ml \nrecomendados por el fabricante.  \n Inoculo de desaf\u00edo. - Se utiliz\u00f3 un inoculo \nparasitario aislado y tipificado en el Departamento de \nProducci\u00f3n Animal: Aves por el MVZ Marco A. Ju\u00e1rez Estrada, el inoculo consisti\u00f3 en proporcionar \ndirectamente en el diverticulo esof\u00e1gico de cada ave \ndesafiada al d\u00eda 28 de edad  la cantidad de 2.0 x 10\n4 de \nE. acervulina ; 1.0 x 103 de E. m\u00e1xima y 1.0 x 104 de E. \ntenella  oocistos esporulados.  \nDise\u00f1o experimental. - Las aves fueron \ndistribuidas aleatoriamente en cuatro grupos de tratamiento cada uno con dos repeticiones de 40 aves \npor corral.  Grupo A: vacuna + desaf\u00edo + salinomicina; \nB: vacuna + no desaf\u00edo + salinomicina; C: No vacuna + desaf\u00edo + salinomicina y D: No vacuna + no desaf\u00edo + salinomicina.  Al d\u00eda 28, los grupos A y C fueron \ndesafiados con un inoculo de campo. Se suministr \u00f3 \nagua y alimento ad libitum ,  la dieta est\u00e1ndar se \nformul\u00f3 con base a sorgo y pasta de soya. Se adicionaron 60 ppm de Salinomicina (Sacox, \nHoechst\u00ae) y en la etapa de finalizaci\u00f3n se agreg\u00f3 \npigmento amarillo de origen vegetal a una \nconcentraci\u00f3n de 80 ppm .  \nEvaluaci\u00f3n del experimento. - A los siete d\u00edas \npostinoculaci\u00f3n (pi) se sacrificaron 5 aves de cada \nrepetici\u00f3n con la finalidad de calificar l as lesiones por \ncoccidia de acuerdo a la escala de Johnson y Reid (1970)\n3. Durante los 49 d\u00edas de evaluaci\u00f3n, se \nregistraron de forma semanal el peso y la conversi\u00f3n \nalimenticia. El grado de pigmentaci\u00f3n se efect\u00fao a \nnivel de la vena de la grasa en la piel de la pechuga \nizquierda a los 42 y 49 d\u00edas de edad, utilizando un \ncolor\u00edmetro de reflectancia Minolta CR -300 (Min olta \nLtd. Japan), con el sistema CIELab de brillantez (L), \nintensidad de enrojecimiento (a), e intensidad de \namarillamiento (b). Al d\u00eda 49 se realizaron dos \nmediciones, la primera en la granja antes de salir a \nrastro y la segunda saliendo de la l\u00ednea del r astro. \nSemanalmente se hicieron muestreos de 5 g de heces \nconservadas en dicromato de potasio al 2.5% por \nrepetici\u00f3n. La cuantificaci\u00f3n de oocistos se efect\u00fao con la T\u00e9cnica de McMaster.  \nAn\u00e1lisis estad\u00edstico. - Los par\u00e1metros productivos \ny el n\u00famero total de la excreci\u00f3n de oocistos se evaluaron a trav\u00e9s de la prueba de an\u00e1lisis de varianza \n(ANDEVA). Conforme a un arreglo factorial 2x2, un \nfactor fue vacunaci\u00f3n y el otro fue desaf\u00edo. El \u00edndice de \nlesiones se evalu\u00f3 con la prueba no param\u00e9trica de Kruskall -Wallis. Las diferencias se determinaron a un \nnivel de significancia de P<0.05.  \n \nRESULTADOS  \nAl d\u00eda 14 el peso del grupo D (374.5\u00b15.7a) \nmostr\u00f3 diferencia estad\u00edstica (P<0.05) respecto al \ngrupo A (340.12\u00b110.8c), grupo C (358.5\u00b11.6b), pero \nno respecto al grupo B (367.12\u00b111.1ab). Al d\u00eda 21 y \n28de edad no hubo diferencia estad\u00edstica entre los \npesos de los grupos. Al d\u00eda 35 hubo interacci\u00f3n \n(P<0.043) de los factores vacuna y desaf\u00edo donde los \ngrupos A (1.74\u00b10.03a), B (1.75\u00b10.007a) y C \n(1.72\u00b10.03a), fueron diferente s (P<0.05) al grupo D ( \n1.68\u00b10.007b) que  mostr\u00f3 el menor peso.  Al d\u00eda 42 y \n49 no hubo interacci\u00f3n de los factores, al d\u00eda 42 el \ngrupo D mostr\u00f3 el menor peso, los pesos fueron \nsimilares al d\u00eda 49 de edad. Al d\u00eda 14 de edad los \ngrupos A (1,173a), B (4,400a ) y C (6,187a) eliminaron \noocistos que no difirieron entre grupos (grupo D: 0.0a). \nAl d\u00eda 21 de edad los grupos que eliminaron oocistos \nno fueron diferentes (A: 5,547; B: 5,120; C: 6,293; D: 2,267). Al d\u00eda 28 de edad los grupos no mostraron \ndiferencias en la eliminaci\u00f3n de oocistos (A: 533; B: \n1,067; C: 853; D: 640).  A los 35 d\u00edas de edad los grupos no mostraron interacci\u00f3n de los factores en la \neliminaci\u00f3n de oocistos (A: 853; B: 853; C: 2,347; D: \n533). A los 42 d\u00edas de edad los grupos no mostraron \nintera cci\u00f3n de los factores en la eliminaci\u00f3n de \noocistos (A: 640; B: 427; C: 320; D: 320). A los 49 d\u00edas de edad los grupos no mostraron interacci\u00f3n de los factores en la eliminaci\u00f3n de oocistos (A: 213; B: 213; \nC: 320; D: 107). En la conversi\u00f3n alimenticia hubo \ninteracci\u00f3n entre vacuna y desaf\u00edo, el mejor grupo fue \nel B (2.05b), luego el C (2.06b), el A (2.1b) y el D (2.19a). El promedio de los grupos con vacuna fue de \n2.10 y sin vacuna 2.13. Hubo efecto de la vacuna y del \ndesaf\u00edo sobre el \u00edndice de lesiones pr oducidas por E. \nacervulina , el efecto de aplicaci\u00f3n de la vacuna (1.2 b) \ny sin vacuna (2.1 a).  E. maxima  presento interacci\u00f3n \nde las variables, el grupo A ( 0.6b), el grupo C (1.16a), \nno afect\u00f3 al grupo D y B. E. tenella  no produjo lesiones \nen los grupos A, B y D pero si en el C (0.6). El grado \nde amarillamiento y enrojecimiento en granja al d\u00eda 42 present\u00f3 interacci\u00f3n. El grupo D obtuvo la pigmentaci\u00f3n roja m\u00e1s alta y el grupo B la m\u00e1s baja. \nEn amarillos el grupo B fue el m\u00e1s alto (19.22a) y el D \nel m\u00e1s b ajo (16.12b). Al d\u00eda 49, el grado de \namarillamiento fue mejor en el grupo C (22.7) y B  \n 299  \n(20.0). El grado de amarillamiento y enrojecimiento en \nrastro no mostraron interacci\u00f3n.  \n \nDISCUSI\u00d3N  \nLos resultados de la prueba en piso desarrollada \ndurante 49 d\u00edas muest ran que la vacuna administrada al \nd\u00eda 5 de edad induce una respuesta ligera dos semanas despu\u00e9s, lo cual se pudo verificar por el n\u00famero de \noocistos cuantificados en heces y el peso, que \n\u00fanicamente se vio ligeramente afectado al d\u00eda 14 de \nedad. Esta baja d e peso fue r\u00e1pidamente compensada \nya que una semana m\u00e1s tarde no hubo diferencia significativa de los grupos vacunados respecto a los no vacunados. Esta recuperaci\u00f3n de peso en las aves es \nm\u00e1s tard\u00eda en trabajos experimentales donde se ha \nutilizado esta va cuna sin emplear ning\u00fan tipo de \nion\u00f3foro. La reacci\u00f3n postvacunal  estuvo asociada al \nestablecimiento de la infecci\u00f3n reflejada por ligeras \nlesiones observadas hasta tres semanas despu\u00e9s de la vacunaci\u00f3n en el grupo no desafiado. La vacuna es \nsegura para l as aves y no afecta negativamente el \nrendimiento. Lo cual demuestra que en presencia de \nSalinomicina se induce una inmunidad s\u00f3lida.  Cuando \nse desaf\u00edo con cepas de campo las aves vacunadas \ntuvieron significativamente un mejor rendimiento en \nconversi\u00f3n ali menticia y se ha reportado que con \ndesaf\u00edos altos previene significativamente la mortalidad. Schetters et al\n2 han mencionado que el \npeso es mucho mejor cuando las aves son vacunadas y \nreciben un desaf\u00edo de campo que cuando no reciben la \nvacuna y son desafi adas. La vacuna Nobilis COX ATM \n\u00ae induce una inmunidad efectiva en las aves que \nreciben Salinomicina. Adem\u00e1s garantiza una adecuada protecci\u00f3n contra cepas de campo durante las tres \nprimeras semanas postvacunaci\u00f3n antes de que se \ndesarrolle inmunidad efect iva. El administrar \nSalinomicina durante el periodo de desarrollo de inmunidad previene la infecci\u00f3n contra especies \ndiferentes a las presentes en la vacuna, proporciona \ntambi\u00e9n protecci\u00f3n contra un probable brote debido a \nClostridium perfringens .  La pr\u00e1c tica descrita en el \npresente estudio ayuda a preservar la utilizaci\u00f3n de las \ndrogas del tipo ion\u00f3foro, ya que al inducir inmunidad \nlas cepas vacunales desplazan  a las cepas de campo \nque pudieran en determinado momento socavar la \nefectividad de las drogas anticoccidiales. Schetters et al\n2 mencionan que la inmunidad con la vacuna Nobilis \nCOX ATM \u00ae se desarrolla efectivamente cuando han \nproporcionado Monensina a 100 ppm y Narasina a 60 \nppm. Reportando resultados similares a los del presente \nestudio donde se e mple\u00f3 Salinomicina a 60 ppm.  \n \nREFERENCIAS  \n1. Ju\u00e1rez, E.M.A. T\u00e9llez, I.G. La inmunidad \ncelular en la inmunoprofilaxis de la coccidiosis aviar. \nMemorias del curso de Inmunoparasitolog\u00eda y biolog\u00eda \nmolecular. M\u00e9xico, Distrito Federal. pp. 18- 28. 2000.   \n2. Schetters , P. M. Janssen, A. J. M., and \nVermeulen, A. N. A new vaccination concept against \ncoccidiosis in poultry. World Poultry -Misset \nCoccidiosis Special Supplement. 26- 27. 1999.  \n3. Johnson, J. Reid, W.M. Anticoccidial drugs: \nlesion scoring techniques in battery and  floor -pen \nexperiments with chickens. Experimental Parasitol. 28: \n30-36. 1970.  \n \nAN\u00c1LISIS COMPARATIVO  DE ANTIBIOGRAMAS REALIZADOS \nEN AISLAMIENTOS DE  ESCHERICHIA COLI  \nDURANTE EL PERIODO 1 996 \u2013 2001  \n \nCOMPATARIVE ANALYSIS OF SENSITIVITY TESTS USING Escherichia coli \nISOLATES: 1996 \u2013 2001  \n \nGraciela M\u00e9ndeza, Donaj\u00ed Garc\u00edab, Diana V\u00e1zqueza, Juan Garc\u00eda -Garc\u00edaa ,  \nDavid Sarfatib, Bernardo Lozanob y Ernesto Sotob \n \naDiagn\u00f3sticos Cl\u00ednicos Veterinarios SA de CV. M\u00e9xico. bLaboratorio Avimex SA de CV. M\u00e9xico.  \n \nSUMMARY  \nE. coli was isolated from the trachea, lung, and air \nsacs of birds from the Mexican states of Mexico, Morelos, and Hidalgo. The antimicrobial sensitivity \ntest was performed using a disc diffusion method \nknown as the Kirby -Bauer test(2). Strain colonies with  \nan inhibition zone of 8+ mm were considered as \nsensitive to the antibacterial. Annual sensitivity rates were considered as follows: 33% or less, low \nsensitivity; 33 -66% intermediate sensitivity; 66% or \nmore, high sensitivity. Important sensitivity variations were observed throughout the time period analyzed.  \n \nRESUMEN  \nSe obtuvieron aislamientos de Escherichia coli  a \npartir de tr\u00e1quea, pulm\u00f3n y sacos aereos de aves   \n 300  \nprovenientes de los estados de M\u00e9xico, Morelos e \nHidalgo. La prueba de susceptibilidad antimi crobiana \nse realiz\u00f3 por el m\u00e9todo de difusi\u00f3n con disco conocida \ncomo prueba de Kirby -Bauer (2). Se consider\u00f3 sensible \nal antimicrobiano a las cepas con un di\u00e1metro del halo inhibitorio de 8 mm en adelante (1). La sensibilidad \nanual se consider\u00f3 baja con m enos de 33%, media \nentre 33 y 66% y alta con m\u00e1s del 66%. Se observan \nvariaciones de sensibilidad importantes entre los a\u00f1os \nanalizados.\n \n % de sensibilidad antimicrobiana  ( > 33%)  con cepas de E. coli aisladas durante el periodo de 1996 a 2001.  \nAntimicr obiano  Concentraci\u00f3n \nen \u00b5g/disco  1996  \n140 cepas  1997  \n169 cepas  1998  \n160 cepas  1999  \n83 cepas  2000  \n90 cepas  2001  \n94 cepas  \nAcido nalidixico  30\u00b5g 4.8%  12.2%  6.2%  4.8%  0% 0 % \nEnrofloxacina  10\u00b5g 65.5%  60.3%  39.6%  43.3%  51.2%  54.2%  \nNorfloxacina  10\u00b5g 50.0%  53.8%  44.0%  39.7%  35.0%  55.4%  \nFosfomicina  50\u00b5g 75.0%  70.8%  62.5%  58.1%  62.5%  82.5%  \nMagnacina  30\u00b5g ND ND ND ND ND 91.0%  \nAmpicilina  10\u00b5g 48.0%  48.3%  18.3%  28.7%  0% 0% \nFuraltadona  300\u00b5 g 41.0%  43.6%  22.0%  30.1%  55.0%  60.0%  \nTetraciclina  30\u00b5g 39.2%  10.8%  14.0%   12.5%  8.5%  \nGentamicina + \n\u00e1cido nalid\u00edxico  10\u00b5g+ 30\u00b5g 25.0%  42.3%  15.8%  18.9%  75.0%  67.5%  \nNeomicina  30\u00b5g 40.1%  46.3%  23.3%  32.8%  80.0%  75.6%  \nND. No determinado.  \n \nDISCUSI\u00d3N  \nPara el \u00e1cido nalid\u00edxico  y la tetraciclina se \nobserva una sensibilidad baja en forma continua \ndurante los cinco a\u00f1os de estudio, mientras que para la \nneomicina, as\u00ed como para la combinaci\u00f3n \ngentamicina/\u00e1cido nalidixico se observa una alta \nsensibilidad durante los \u00faltimos dos a\u00f1os. Para la \nenrofloxacina y norfloxacina se observa una \nsensibilidad mediana. Para la magnacina* se observa \nuna fluctuaci\u00f3n de la sensibilidad entre media y alta, \nsimilar a la furaltadona que present\u00f3 una tendencia a \nelevarse en el ultimo a\u00f1o. La ampicilina present\u00f3 una sensibilidad media en los dos primeros a\u00f1os y baja en \nlos \u00faltimos a\u00f1os. Florfenicol fue probado \u00fanicamente \nen el \u00faltimo a\u00f1o, mostrando sensibilidad alta para las \ncepas de E. coli aisladas durante ese a\u00f1o.  \n \nCONCLUSI\u00d3N\n \n En el presente estudio se observa que para los \naislamientos de E. coli,  la fosf omicina fue el \u00fanico \nantimicrobiano que mostr\u00f3  sensibilidad media y alta \nde forma constante durante los cinco a\u00f1os de estudio. \nEl florfenicol, la fosfomicina, la neomicina y la combinaci\u00f3n gentamicina con \u00e1cido nalid\u00edxico fueron los \u00fanicos antimicrobianos  que mostraron alta \nsensibilidad durante el \u00faltimo a\u00f1o.     \n* Marca Registrada de Laboratorio Avi -Mex SA \nde CV. M\u00e9xico para una fosfomicina estabilizada y potenciada.  \n \nREFERENCIAS  \n1. Gail L. Woods & John A. Washington. \nAntimicrobial Susceptibility Tests: Dilu tion and Disk \nDiffusion Method. In Manual of Clinical Microbiology. Edited by Patrick R. Murray. 6\nth Ed. \n1995.  \n2. Jorgensen, J, H., Ferraro, M.J., Craig, W.A., \nDoren, G.V., Finegold, S.M., Fung -Tomc,J., Hansen, \nS.L., Hindler, J., Reller, L.B., Swenson, J.M., Tenover, F.C., Testa, R.T., & M.A. Wikler. Performance \nStandards for Antimicrobial Disk Susceptibility Tests. \nApproved Standart. M2- A6, Vol 17, No. 1. The \nNational Committee for Clinical Laboratory Standards. Approved by the American National Standards \nInstitute. 6 th edition. 1997.  \n \n \n  \n 301  \nESTUDIO SEROL\u00d3GICO Y MORFOL\u00d3GICO DE \nADENOCARCINOMAS ABDOMINALES EN GALLINAS \nREPRODUCTORAS SEMIPESADAS  \n \nSEROLOGICAL/MORPHOLOGICAL STUDY OF ABDOMINAL \nADENOCARCINOMAS IN SEMI-HEAVY BREEDERS  \n \nV\u00edctor M. Petrone 1, Mireya Ju\u00e1rez 1, Tamas Fehervari1 , Armando Garc\u00eda1 \n \n1Departamento de Producci\u00f3n Animal: Aves, Facultad de Medicina Veterinaria y Zootecnia, UNAM  \n \nSUMMARY  \nThe incidence of neoplasic diseases in birds is \nlow. Nevertheless, in breeders and commercial layers \nthe incidence of carcinomas and adenocarcinomas is \nrather high. The presentation of these tumors has been \nassociated with avian leukosis virusinfections. The \npurpose of this study was to perform the serological \nand morphological evaluation of abdominal adenocarcinomas i n semi -heavy breeder hens. \nSerological/morphological results of this study were consistent with an adenocarcinoma of pancreatic \norigin, associated with avian leukosis virus infection.   \n \nRESUMEN  \nLa incidencia de enfermedades ne\u00f3plasicas en \naves es baja, si n embargo en aves reproductoras o de \npostura comercial, la incidencia de carcinomas y adenocarcinomas es muy frecuente. Su presentaci\u00f3n se \nha asociado a infecciones por el virus de Leucosis aviar \n(LA). El objetivo de este estudio fue realizar la evaluaci\u00f3n  serol\u00f3gica y morfol\u00f3gica de un \nAdenocarcinoma abdominal en gallinas reproductoras \nsemipesadas. Los resultados serol\u00f3gicos y \nmorfol\u00f3gicos de este estudio fueron compatibles con \nun Adenocarcinoma de origen p\u00e1ncreatico asociado a \ninfecci\u00f3n con el virus de LA .  \n \nINTRODUCCI\u00d3N  \nEl estudio de las enfermedades neopl\u00e1sicas en las \naves, se ha atribuido a etiolog\u00edas de origen viral. La incidencia de neoplasias en pollos de engorda es muy \nbaja; sin embargo en aves reproductoras o de postura \ncomercial, la incidencia de neoplasias como carcinomas y adenocarcinomas es mas frecuente. \nDentro de los virus que producen neoplasias en aves, el \nvirus de la leucosis aviar perteneciente a  la subfamilia \noncoviridae y a la familia retroviridae, ha sido clasificado en 5 subgrupos A,B ,C,D,J y E de los cuales \nlos cinco primeros son los causantes de las principales \nneoplasias en aves. Dentro de las neoplasias epiteliales \nque originan estos virus son reconocidas las siguientes: \nnefroblastomas, nefromas, hepatocarcinoma, \nadenocarcinoma de p\u00e1ncreas, tenomas, carcinoma de c\u00e9lulas de la granulosa, carcinoma de c\u00e9lulas escamosas y seminomas. La leucosis linfoide es una enfermedad viral que se caracteriza por una \nmultiplicaci\u00f3n anormal de linfoblastos y aparici\u00f3n de \nlesiones tumorales en \u00f3rganos  como bazo, ri\u00f1\u00f3n, \nh\u00edgado, bolsa de Fabricio, p\u00e1ncreas y ovario. Esta enfermedad afecta a las aves desde el final de la recr\u00eda hasta mitad de puesta. La incidencia es muy variable \npuede observarse desde un 5 -50% de aves afectadas. \nLos signos cl\u00ednicos son i nespec\u00edficos ya que, puede \nhaber inapetencia, emaciaci\u00f3n, cresta p\u00e1lida o \ncian\u00f3tica, el abdomen esta agrandado y las plumas \ncercanas a la cloaca sucias de uratos. Las lesiones de esta enfermedad se presentan como infiltraciones \ndifusas o nodulares en los \u00f3rganos, a diferencia de la \nenfermedad de Marek no provoca neoplasias neurales, \nni lesiones oculares.  Para el diagn\u00f3stico de la \nenfermedad en la parvada es importante la realizaci\u00f3n \nde monitoreos serol\u00f3gicos tanto para detecci\u00f3n de anticuerpos contra el su bgrupo J de leucosis aviar \ncomo para captura del ant\u00edgeno p27 de leucosis aviar.   \nHistoria cl\u00ednica.  Se remitieron al Departamento \nde Producci\u00f3n Animal: Aves de la FMVZ 3 gallinas \nreproductoras semipesadas cuya signolog\u00eda era baja en \nla producci\u00f3n de huevo,  presencia de uratos alrededor \nde la cloaca y disminuci\u00f3n en el consumo de alimento.   \nHallazgos macrosc\u00f3picos. Durante la inspecci\u00f3n \nexterna se observo que las plumas presentes alrededor \nde la cloaca estaban h\u00famedas y presentaba abundante \nmaterial blanco de consistencia yesosa (uratos), una de \nlas tres aves presentaba abdomen abultado y fl\u00e1cido, \nadem\u00e1s de presentar dificultad para respirar. Al realizar la inspecci\u00f3n interna se observ\u00f3 en 1/3 aves la \npresencia de abundante liquido en la cavidad \nabdominal (a scitis), en 2/3 se encontraron diversos \nn\u00f3dulos que coalecian, de consistencia firme y de color \ngris-blanco. Estos n\u00f3dulos se encontraban en forma \nmasiva afectando las superficies serosas del h\u00edgado, p\u00e1ncreas, oviducto, mesenterio e intestinos. Las \nparedes  del intestino estaban adheridad y engrosadas. \nSe realiz\u00f3 la disecci\u00f3n de los tejidos afectados y se \ntomaron muestras para an\u00e1lisis histol\u00f3gico las cuales fueron conservadas en formol al 10%.   \n 302  \nHallazgos microsc\u00f3picos.  Se observaron al \nmicroscopio \u00f3ptico di versas secciones de tejido te\u00f1idas \ncon hematoxilina -eosina. En los cortes de p\u00e1ncreas, \nduodeno e h\u00edgado, se observo la presencia de \nabundante infiltrado inflamatorio constituido por \nlinfocitos y escasos heter\u00f3filos distribuidos \nmultifocalmente, adem\u00e1s de u na abundante cantidad de \nc\u00e9lulas epiteliales c\u00fabicas formando t\u00fabulos de aspecto \nglandular, rodeados por abundantes septos tejido \nfibroso. En la luz de estas estructuras tubulares se \nobservaba material eosinofilico  de apariencia \nhomog\u00e9nea.  \nPruebas complem entarias.   Se realizo prueba de \nELISA para detecci\u00f3n de anticuerpos contra el subgrupo J de leucosis aviar de las 3 aves, adem\u00e1s de \nELISA para captura de ant\u00edgeno para la detecci\u00f3n de la \np27 de leucosis aviar  a partir de h\u00edgado, intestino y \nm\u00e9dula \u00f3sea. L os resultados de estas pruebas fueron \npositivas tanto para la detecci\u00f3n de anticuerpos como \npara captura de ant\u00edgeno de h\u00edgado y m\u00e9dula \u00f3sea.  \n \nDISCUSI\u00d3N Y CONCLUSI \u00d3N \nCon base en los hallazgos macrosc\u00f3picos y \nmicrosc\u00f3picos, este tejido neopl\u00e1sico caracterizado por la presencia  de abundantes c\u00e9lulas epiteliales formando t\u00fabulos de aspecto gladular secretor y el \nabundante infiltrado inflamatorio, as\u00ed como en los \nresultados serol\u00f3gicos positivos tanto para detecci\u00f3n de anticuerpos y ant\u00edgeno para el virus de l eucosis aviar se \ndiagn\u00f3stico: una neoplasia de tipo secretora de estirpe epitelial; compatible con un Adenocarcinoma pancre\u00e1tico asociado a la infecci\u00f3n con el virus de \nleucosis aviar. Sin embargo es conveniente realizar \ninmunohistoquimica para diferenciar lo de un \nAdenocarcinoma de ovario. En el caso de las neoplasias de origen viral que afectan a las aves es de \ngran importancia establecer la etiolog\u00eda para determinar los m\u00e9todos de control mas eficientes. El \nvirus de leucosis aviar se transmite en forma vertical lo \nque provoca graves p\u00e9rdidas a la industria por \nproblemas de aves retrasadas que son \ninmunol\u00f3gicamente deficientes y potenciales focos de \ninfecci\u00f3n para el resto de la parvada. Recientemente el \nsubgrupo J del virus de la leucosis aviar se ha asoci ado \nel incremento de este tipo de pollos en las granjas. No \nobstante, es tambi\u00e9n posible que este problema sea \noriginado por otras causas, principalmente fallas de \nmanejo. Por lo que es importante realizar monitoreos \nserol\u00f3gicos de las parvadas para determ inar tanto el \nnivel del anticuerpos con los que llega el pollito, as\u00ed \ncomo realizar pruebas de captura de ant\u00edgeno para \ndeterminar si el virus se esta transmitiendo \nverticalmente. Para establecer programas de control a \nnivel de reproductoras.  \n \nREFERENCIAS  \n1.  Fadly, A.M. and Witter R.L. Oncornaviruses: \nLeukosis/Sarcoma and Reticuloendotheliosis. In: A \nlaboratory manual  for the isolation and identification \nof avian pathogens, D.E. Swayne, J.R. Glisson, M.W. \nJackwood, J.E. Pearson, W.M. Reed, eds. Kendall/Hu nt Publishing Company, Pennsylvania. pp \n185-196. 1998.  \n2.  Payne L.N. and Purchase H.G. \nLeukosis/Sarcoma Group. In: Diseases of Poultry, \nCalnek, B.W. Barnes, H.J. Beard, C.W. Reid, W.M. \nYorder, Jr. H.W. eds. Iowa State University Press, Ames, Iowa, USA. pp 38 6-439. 2000  \n3. Thayer S.G. and Beard C.W. Serologic \nProcedures. In: A laboratory manual  for the isolation and identification of avian pathogens, D.E. Swayne, J.R. Glisson, M.W. Jackwood, J.E. Pearson, W.M. \nReed, eds. Kendall/Hunt Publishing Company, Pennsyl vania. pp 255- 266 1998.  \n \nEPIZOOTIOLOG\u00cdA DE LA LEUCOSIS MIELOIDE SUBGRUPO \u201cJ\u201d \nEN AVES SEMILIGERAS Y CRIOLLAS DEL NORTE DE PUEBLA  \n \nEPIDEMIOLOGY OF MYELOID LEUKOSIS SUBGROUP \u201cJ\u201d IN SEMI-HEAVY \nAND NATIVE HENS IN NORTHERN PUEBLA \n \n1Marco A. Ju\u00e1rez- Estrada, 1Luis B Moncada, 1Rub\u00e9n Merino -Guzm\u00e1n, 2Mar\u00eda Cano -Basave, 2Carlos L\u00f3pez -D\u00edaz  \n \n1Departamento de Producci\u00f3n Animal: Aves.  2Departamento de Econom\u00eda y Administraci\u00f3n. Facultad de Medicina \nVeterinaria y Zootecnia,  Universidad Nacional Aut\u00f3noma de M\u00e9xico. Avenid a Universidad 3000. Ciudad \nUniversitaria 04510 M\u00e9xico, D.F.   \n \nSUMMARY  \nThe presence of myeloid leucosis, sub -group \u201cJ\u201d \nin backyard birds can represent an epidemiological hazard for the poultry industry.  In order to learn about the incidence of this probl em in Puebla\u2019s Northern \nSierra, a serological survey was performed. One hundred and fifty six serum samples were obtained from hens belonging to 21 rural families. ELISA test  \n 303  \nwas carried out using P26 group common antigen \nplates. Positive results were obta ined in 68.96% serum \nsamples. When sub -group \u201cJ\u201d was specifically tested \nfor using ELISA plates sensitive to sub -group \u201cJ\u201d \nspecific G85 antigen, more than 15% positive results \nwere obtained.  \n \nRESUMEN  \nLa presencia de Leucosis Mieloide subgrupo \u201cJ\u201d \nen aves d e traspatio llega a presentar una problem\u00e1tica \nepizootiol\u00f3gica para la avicultura industrial. Para conocer la incidencia en la sierra norte de Puebla, se \nefectu\u00f3 un estudio serol\u00f3gico, se tomaron 156 sueros sangu\u00edneos de gallinas provenientes de 21 familia s \ncampesinas. Se empleo ELISA con placas de ant\u00edgeno \ncom\u00fan de grupo P26, se observ\u00f3 68.96% de sueros \npositivos, se prob\u00f3 espec\u00edficamente al subgrupo \u201cJ\u201d \ncon placas de ELISA sensibles al ant\u00edgenos especifico \nel subgrupo \u201cJ\u201d G85 presentando positividad mayor  al \n15%.  \n \nINTRODUCCI\u00d3N  \nLa presencia permanente de una enfermedad \ninmunodepresora como la Leucosis Mieloide subgrupo \u201cJ\u201d puede llegar a ser problem\u00e1tica en zonas rurales o \nde traspatio, ya que adem\u00e1s de disminuir el abasto de \nprote\u00edna para la ingesta humana, las aves act\u00faan como \nreservorios potencialmente peligrosos para la industria av\u00edcola. Con la finalidad de conocer la incidencia que \ntiene esta enfermedad viral en la sierra norte de Puebla, \nse efectu\u00f3 un estudio serol\u00f3gico de las explotaciones av\u00edcolas d e traspatio ubicadas en el ejido urbano de \nAlmeya perteneciente al municipio de Ixtacamaxtitl\u00e1n \nque se encuentra en el estado de Puebla.  \n \n MATERIAL Y M\u00c9TODOS  \nSe tomaron 156 sueros sangu\u00edneos de gallinas \nsemiligeras y criollas provenientes de 21 familias \ncampesinas. En el laboratorio se corrieron los sueros a \ntrav\u00e9s de la prueba de inmunoabsorci\u00f3n enzim\u00e1tica \n(ELISA) con la finalidad de detectar anticuerpos \ncomunes de grupo con placas sensibilizadas al ant\u00edgeno P26, al obtenerse un porcentaje de positividad del \n68.96% y de acuerdo a la literatura que demarca un \nl\u00edmite de incidencia para los virus del grupo Leucosis \nLinfoide y Sarcoma menor al 15%, se determin\u00f3 probar \nla presencia espec\u00edfica del virus de Leucosis Mieloide \nsubgrupo \u201cJ\u201d en embriones de 18 d\u00edas y  en huevos \nreci\u00e9n ovopositados, a trav\u00e9s de ELISA utilizando \nplacas sensibilizadas para detectar la prote\u00edna G85 \nespec\u00edfica del virus de Leucosis Mieloide subgrupo \n\u201cJ\u201d.  \n \nRESULTADOS Y DISCUSI\u00d3N \nSe determin\u00f3 una presencia positiva del virus en \nesta zona rur al. Se conoce poco de la epizootiolog\u00eda de \nesta enfermedad en el pa\u00eds. Lo que se puede inferir es \nque ante los brotes recientes en los \u00faltimos a\u00f1os por el \nvirus de Leucosis Mieloide en la avicultura comercial, estos fueron controlados al eliminar a las pro genitoras \ninfectadas, sin embargo, este control no alcanzo a la \navicultura de traspatio, la cual al recibir aves \ncontaminadas con el virus y debido a las limitantes \necon\u00f3micas y de operaci\u00f3n para su eliminaci\u00f3n \npermiten que esta enfermedad  se perpet\u00fae den tro de \nestas parvadas, funcionando posteriormente como \nreservorios del virus convirtiendose en una amenaza \npara la avicultura comercial. Se requiere la \nimplementaci\u00f3n de nuevas estrategias de control para \nevitar que contin\u00fae la diseminaci\u00f3n del virus de \nLeucosis Mieloide subgrupo \u201cJ\u201d en el pa\u00eds.  \n \nEFECTO DEL 25 HIDROX ICOLECALCIFEROL (25 -(OH)D 3) EN \nLOS PAR\u00c1METROS PRODU CTIVOS E INMUNIDAD DE POLLOS \nDE ENGORDA  \n \nEFFECT OF 25 HYDROXY-CHOLE- CALCIFEROL (25-(OH)D 3) ON \nPRODUCTIVE PARAMETERS AND IMMUNITY OF BROILERS \n \n1Morales LR, 2G\u00f3mez VG, 1Servin GC, 1\u00c1vila GE.  \n \n1 Centro de Ense\u00f1anza, Investigaci\u00f3n y Extensi\u00f3n en Producci\u00f3n Av\u00edcola, FMVZ -UNAM.  \nE-mail: sep_rene@hotmail.com ., 2Depto. Producci\u00f3n Animal: Aves, FMVZ -UNAM.  \n \nSUM MARY  \nWith the purpose of evaluating if whether the \ndietary supplementation with 25 -(OH)D 3, improves \nbroiler productive performance and immunity, a 21- day \nexperiment was carried out using 1 -day-old broilers. Results showed that feed supplementation with 69 mg \n25-(OH) D 3 (equivalent to 2 million IU vitamin D3) \nper ton of feed, improved both cellular immune \nresponse and tibial calcium deposition. Therefore, this \nis a viable alternative to improve production.   \n 304  \nRESUMEN  \nCon el objetivo de evaluar si la adici\u00f3n de 25-  \nhidroxicolecalciferol  (25 -(OH)D 3), como suplemento \nen dietas para pollos de engorda mejoraba el \ncomportamiento productivo e inmunidad, se realiz\u00f3 un \nexperimento con pollos de engorda de 1 d\u00eda de edad, \ncon una duraci\u00f3n de 21 d\u00edas. Los resultados obteni dos, \nmostraron que la adici\u00f3n de 25 -hidroxicolecalciferol a \nraz\u00f3n de 69 mg por tonelada, lo equivalente a 2 \nmillones de UI de vitamina D 3 mejor\u00f3, la respuesta \ninmune celular y la deposici\u00f3n de calcio en las tibias de \nlas aves, resultando de esta manera una alternativa \nviable para mejorar la producci\u00f3n.  \n \nMATERIALES Y M\u00c9TODOS  \nSe emple\u00f3 un dise\u00f1o completamente al azar con \ncuatro tratamientos en base a dietas sorgo + pasta de soya: 1) dieta con 200,000 UIP/Ton, de vitamina D3 \n(NRC 1994), 2) dieta sin vitamina D\n3 + 69 mg de 25-\n(OH)D3/Ton, 3) dieta con vitamina D3 (2,000,000 \nUIP/Ton) similar a una premezcla comercial y 4) como \nT3 + 69 mg de 25- (OH)D 3/Ton; cada tratamiento cont\u00f3 \ncon 4 r\u00e9plicas de 10 pollos cada una. El agua y el \nalimento se suministraron a libre ac ceso.  \n RESULTADOS Y CONCLUS I\u00d3N  \nLos resultados obtenidos en 21 d\u00edas de \nexperimentaci\u00f3n para los par\u00e1metros productivos, \nmostraron que T3 y T4 que conten\u00edan un nivel de \nvitamina D 3 comercial sin y con adici\u00f3n de (25 -\n(OH)D 3), presentaron una mayor ganancia de peso (P < \n0.024 - 494.98B, 498.78B, 560.90A, 596.42Ag) y mejor \nconversi\u00f3n alimenticia (P < 0.008 -  1.37a, 1.30ab, \n1.20b,1.25b). Para la respuesta inmune, se observ\u00f3 un \nincremento en la respuesta inmune celular (P < 0.05 - \n0.0341b, 0.0637\u00aa, 0.0367b, 0.0647amm)en aquellos \ntratamientos T2 y T4 a los cuales fue adicionado  (25 -\n(OH)D 3). El contenido de calcio en las tibias de las \naves fue mayor (P < 0.038 -  10.70B, 11.62AB, 11.13B, \n12.61A)  en los tratamientos que conten\u00edan 25 -(OH)D 3. \nDe los resultados obtenidos  bajo las condiciones \nempleadas, se puede concluir que la adici\u00f3n de 25 -\nhidroxicolecalciferol a raz\u00f3n de 69 mg por tonelada, lo \nequivalente a 2 millones de UI de vitamina D 3 mejor\u00f3 \nen pollos de engorda de 1 a 21 d\u00edas de edad, la respuesta inmune celular y la deposici\u00f3n de calcio en \nlos huesos de las aves, resultando de esta manera una alternativa viable para mejorar la producci\u00f3n.  \n (El articulo completo ser\u00e1  posteriormente publicado en \nla Revista Veterinaria  M\u00e9xico).  \n \nLO QUE SE DEBE CONOC ER DE LAS EVALUA CIONES  \nDE ADSORBENTES DE MI COTOXINAS  \n \nWHAT WE SHOULD KNOW ABOUT MYCOTOXIN BINDERS  \n \nJoel Mu\u00f1oz*, Antonio Fierro y Juan Carlos Medina  \n \nNutek S.A. de C.V. 7 Norte 416. Tehuac\u00e1n, Pue. E -mail: nutek@grupoidisa.com  \n \nSUMMARY  \nA problem commonly found in many mycotoxin \nbinder (or toxin inhibitor) evaluations, is the lack of \nscientific support. Two ways of measuring binder efficiency exist: in vitro and in vivo. When the binding \nability evaluation of a product against one  particular \ntoxin is claimed, evaluation conditions, parameters evaluated, measuring procedures, numbers of animals \ntested, and innocuousness measuring methods are \nrarely described. Sometimes only the effects on weight gains and feed conversion rates are m entioned, but \nthese two parameters are not conclusive. The selection of a mycotoxin binder must be based on the access to all supportive technical information.  \n \nRESUMEN  \nUn problema encontrado con muchas \nevaluaciones de adsorbentes de toxinas o inhibidores \nde toxinas es la falta de un respaldo cient\u00edfico para confirmarlas, existen dos formas de comprobar la \neficiencia de los adsorbentes: \u201cIn Vitro\u201d e \u201cIn Vivo\u201d.   Cuando se menciona que se evalu\u00f3 la capacidad de \nadsorci\u00f3n de un adsorbente contra determinada t oxina, \nrara vez se dice bajo que condiciones fue evaluado,  los \npar\u00e1metros que se midieron, como se midieron, el \nn\u00famero de animales que se ocuparon o como se  midi\u00f3 \nla inocuidad. A veces solamente se menciona los \nefectos sobre la  ganancia de peso y conver si\u00f3n \nalimenticia, pero estos dos par\u00e1metros no son \ncontundentes. Para la selecci\u00f3n de un adsorbente debe \nestar sustentada por el acceso a la informaci\u00f3n t\u00e9cnica \nque lo respalde.  \n \nINTRODUCCI\u00d3N  \nEl uso de adsorbentes de micotoxinas es una \nalternativa de contr ol, pr\u00e1ctica y eficiente. Un \nadsorbente de micotoxinas es un material inerte, capaz de fijar a su superficie la micotoxina. De nuestra  \n 305  \nexperiencia reconocemos que algunos adsorbentes \ntienen gran capacidad de adsorber aflatoxinas pero muy \nbaja o nula afinid ad por otras toxinas.  Existe un gran \nrespaldo cient\u00edfico sobre la evaluaci\u00f3n de adsorbentes \nde aflatoxinas, obteni\u00e9ndose buenos resultados, pero no \nse puede globalizar que todos los adsorbentes van a \nfuncionar igual.  La investigaci\u00f3n sobre otras toxinas sin embargo no es tan amplia, debido  a que los \nestudios con micotoxinas es m\u00e1s complejo que por \nejemplo determinar los niveles t\u00f3xicos de alg\u00fan \npromotor de crecimiento.  Un n\u00famero determinado de \nexperimentos deben realizarse para confirmar los \nresultados y evaluar a diferentes niveles de micotoxinas \ny adsorbentes. Par\u00e1metros tradicionales  como la \nganancia de peso o la conversi\u00f3n alimenticia, \nprobablemente no son adecuados para una evaluaci\u00f3n \nsatisfactoria.  \n \nPLANTEAMIENTO  \nUna problem\u00e1tica que tenemos en M\u00e9xico para \nrealizar los estudios  \u201cIn Vivo\u201d de los adsorbentes es la \nadquisici\u00f3n de las micotoxinas, estas se deben \nimportar, generalmente de Estados Unidos, en donde la  \nventa de algunas toxinas  esta restringida, por lo que es \nnecesario entregar una serie de documentos que avalen \nel uso final. La otra alternativa es buscar alguna \ninstituci\u00f3n o laboratorio que pueda realizar estas \npruebas.  Este puede ser un  motivo por el cual algunos adsorbentes sean promovidos sin haber realizado \nestudios sobre su eficie ncia.  Las evaluaciones  \u201cIn \nVivo\u201d se pueden realizar con una sola toxina o con  mezcla de varias para simular  las condiciones de toxicidad  a las que est\u00e1n expuestas las aves en el \ncampo(1).  Por esta \u00faltima raz\u00f3n hoy en d\u00eda se \nrecomienda realizar  la ef iciencia de adsorci\u00f3n contra \nmezclas de  toxinas y a diferentes dosis de \nmicotoxinas.    Para  resultados r\u00e1pidos y m\u00e1s \necon\u00f3mico, se han desarrollado ensayos  \u201cIn Vitro\u201d. En algunos de estos se puede demostrar que el adsorbente \nno se va ligar a la toxina.  Si el producto no se une a la \nmicotoxina \u201cIn Vitro\u201d, probablemente no tenga \nactividad \u201cIn Vivo\u201d . La evaluaci\u00f3n \u201cIn Vitro\u201d es de \nenorme valor tanto al desarrollar un producto como \npara  monitorear la calidad lote a lote (4). Sin embargo \nlas pruebas \u201cin Vi tro\u201d nunca puede reproducir las \ncondiciones del tracto digestivo de los animales debido \na la actividad enzim\u00e1tica, fluctuaciones en el pH, la \ndistribuci\u00f3n del producto en el alimento, etc. Motivos \nsuficientes  para decir que no existe estudio m\u00e1s \ndefinitiv o que el que se realiza \u201cIn Vivo\u201d.  \n \nREFERENCIAS  \n1. Lara, J,; Mu\u00f1oz, J.; Rivera, L.; Medina, J.C.  \n2. Steve Leeson, John D. Summers y Gonzalo \nJ. Diaz. Nutrici\u00f3n aviar comercial. Primera edici\u00f3n. P\u00e1gina 86 y 94 \n3. Kubena, L.F.; W.E.  Huff, R.B. Harvey, \nA.G. Yersin, M .H. Elissalde, D.A. Witzel, L.E. Giroir, \nT.D. Phillips, and H.D. Petersen. 1991. Effects of a \nhydrated sodium calcium aluminosilicate on growing \nturkey poults during aflatoxicosis. Poultry Sci. 70:1823- 1830.  \n \nEXPERIENCIA DE TRES A\u00d1OS CON EL USO DE  UNA VACUNA \nTERMOSENSIBLE DE MYCOPLASMA  SYNOVIAE  \n \nTHREE- YEAR EXPERIENCE USING A TEMPERATURE-SENSITIVE \nMYCOPLASMA SYNOVIAE (MS) VACCINE  \n  \nErnesto Soto, Miguel \u00c1ngel Murillo*, Manuel M\u00e9ndez, David Montoya,  \nDavid Sarfati y Bernardo Lozano.  \n \nLaboratorio AVIMEX SA d e CV. M\u00e9xico.  \n \nSUMMARY  \nVAXSAFE* MS, a temperature- sensitive MS \nvaccine, strain MS -H, has been successfully used in \nMexico in the recovery of productive parameters of birds previously infected with MS. Medication with \nanti-mycoplasma drugs has been eliminated in \nbreeders. Also, culled bird numbers have been \ndecreased, and both fertility and total hatch have been \nincreased. Improved progeny livability due to lower \nrespiratory problems has been obtained. In commercial layers the severity of clinical signs has  been reduced, together with the lesions typically observed after bacterial infections like infectious coryza; in addition \nup to 6 extra eggs per hen housed have been obtained.  \n \nRESUMEN  \nEl uso de la vacuna termosensible de Mycoplasma \nsynoviae  cepa MS -H den ominada VAXSAFE* MS ha \nsido utilizada eficazmente en M\u00e9xico para recuperar los par\u00e1metros productivos afectados ante los \nproblemas infecciosos de las aves con este \nmicroorganismo. En aves reproductoras se ha   \n 306  \neliminado la medicaci\u00f3n con antimicopl\u00e1smicos, \ndisminuido las aves de desecho, mejorado la fertilidad \ny el nacimiento total. En la progenie se ha mejorado la \nviabilidad por menores problemas respiratorios. En las \ngallinas comerciales se ha disminuido la severidad de \nlos signos cl\u00ednicos y las lesiones no rmalmente \nobservadas en infecciones bacterianas como coriza \ninfecciosa y  recuperando hasta 6 huevos por ave \nencasetada.  \n \nINTRODUCCI\u00d3N  \nLa micoplasmosis es una de las infecciones \nbacterianas m\u00e1s importantes para la avicultura mundial \npor su efecto negativo en los par\u00e1metros productivos \nde las parvadas afectadas. Los efectos sobre los pollos \nde engorda, las reproductoras y gallinas de postura \nvar\u00edan de acuerdo a diferentes factores como son la \nvirulencia de la cepa, estado inmune de la parvada y las \ninfeccion es asociadas, pudiendo ser desde \nimperceptibles hasta causar serios problemas cl\u00ednicos \n(3). \nEntre los micoplasmas aviares , MS presenta la \ntasa m\u00e1s alta de invasividad y contaminaci\u00f3n horizontal, siendo tambi\u00e9n transmitido por  v\u00eda vertical. \nMS presenta uno  de los porcentajes de infecci\u00f3n m\u00e1s \naltos en la poblaci\u00f3n av\u00edcola del M\u00e9xico, en donde se \ntiene conocimiento de la infecci\u00f3n en \naproximadamente el 40% de las reproductoras pesadas, 75% de las gallinas comerciales y 70% del pollo de \nengorda (1).  \nEn los Est ados Unidos de Am\u00e9rica el \nMycoplasma  synoviae   (MS) es considerado un \npat\u00f3geno de poca importancia. Sin embargo, las cepas de MS han sido clasificadas como ligeramente \npat\u00f3genas, moderadamente pat\u00f3genas y pat\u00f3genas (2). \nEn M\u00e9xico y otros pa\u00edses de Latinoa m\u00e9rica existen \ngraves problemas de infecciones articulares y bajas de \npostura en gallinas comerciales y aves reproductoras \n(asoci\u00e1ndose a virus respiratorios y a cualquier \nproblema bacteriano), as\u00ed como problemas respiratorios \nseveros en el pollo de engorda, en donde el \u00fanico agente pat\u00f3geno demostrado ha sido el MS (3).  \nEl objetivo del presente trabajo es el de compartir \nlas experiencias de campo que se han adquirido durante los \u00faltimos tres a\u00f1os en m\u00e1s de cinco millones de aves inmunizadas anualmente con  la vacuna termosensible \nde Mycoplasma  synoviae  cepa MS -H (VAXSAFE* \nMS).  \n \nRESULTADOS  \nVAXSAFE* MS se aplica \u00fanicamente por v\u00eda \nocular una sola vez en la vida de las aves. La edad de \naplicaci\u00f3n sugerida es a partir de la segunda semana de \nedad, siempre y c uando se demuestre que son aves \nnegativas (por serolog\u00eda en aves j\u00f3venes y PCR en aves \nmayores de ocho semanas).  Es com\u00fan realizar pruebas serol\u00f3gicas luego de la \nvacunaci\u00f3n. Los resultados que se han obtenido son \nsimilares a los reportados con las vacunas  vivas \ntermosensibles de Mycoplasma gallisepticum  (MG). A \npartir de seis semanas postaplicaci\u00f3n se puede obtener \nentre 10 y 100% de seropositividad. Sin embargo, es \ncom\u00fan no detectar reacci\u00f3n alguna durante muchas semanas. Los niveles de anticuerpos detect ados son \ntotalmente variables por cualquier m\u00e9todo de prueba \nque se utilice (aglutinaci\u00f3n en placa por diluci\u00f3n, \nELISA, HI).  \nLa prueba de PCR ha sido utilizada con cierta \nfrecuencia. Los resultados de esta prueba han sido \npositivos en muestras traqueales o de hendidura \npalatina a partir de 4 semanas postvacunaci\u00f3n y hasta \nla salida de las aves al rastro (65 semanas de edad). \nTambi\u00e9n se han realizado pruebas de PCR en \nembriones picados no nacidos, provenientes de \nreproductoras inmunizadas con VAXSAFE* MS, con \nel fin de verificar que la inmunizaci\u00f3n de las madres \nevita la transmisi\u00f3n vertical a la progenie. Estas \npruebas se han realizado cuando las madres tienen 35, \n45, 55 y 65 semanas de edad, sin que hasta el momento \nse hubiera detectado alguna muestra posi tiva, mientras \nque de parvadas no inmunizadas e infectadas con cepas \nde campo si se han obtenido resultados positivos.  \nLa bacteriolog\u00eda ha sido utilizada como un apoyo \nen casos de duda, ya que a trav\u00e9s de la temperatura de cultivo a 33C se puede determinar la presencia de la \ncepa termosensible de MS ( \u226510\n6 log 2), misma que \ncrece defectivamente a temperaturas superiores a los 37.5C (\u226410\n2 log 2).   \nA nivel de campo se han obtenido los siguientes \nresultados:  \nA corto plazo, una disminuci\u00f3n considerable de \nlos co stos por medicaci\u00f3n con antimicopl\u00e1smicos en \nlas reproductoras vacunadas, de aproximadamente $ \n6.00 por ave; disminuci\u00f3n de aves de desecho por \nproblema de patas en reproductoras y pollitas comerciales principalmente (hasta en un 90% de reducci\u00f3n); prevenci\u00f3n en la transmisi\u00f3n vertical en el \n100%.  \nA mediano plazo, recuperaci\u00f3n de la fertilidad,  \nentre 0.3 y 1.8% anual; recuperaci\u00f3n del nacimiento \ntotal, entre 0.3 y 1.9% anual. Disminuci\u00f3n de la \nmagnitud de los signos cl\u00ednicos y de las lesiones \nnormalmente o bservadas en infecciones bacterianas \ncomo coriza infecciosa y pasterelosis en gallinas \ncomerciales.  \nA largo plazo, disminuci\u00f3n de costos por \nmedicaci\u00f3n en la progenie, hasta en un 30% (por disminuci\u00f3n de reacciones respiratorias posvacunales \nseveras), mejo ra la ganancia diaria de peso hasta en \n2.3g, y mejora hasta en 5 d\u00e9cimas la conversi\u00f3n \nalimenticia. En aves ponedoras comerciales \nrecuperaci\u00f3n de 6 huevos por gallina encasetada.   \n 307  \nCONCLUSI\u00d3N  \nVAXSAFE* MS es una herramienta eficaz en la \nprevenci\u00f3n y control de la transmisi\u00f3n vertical del MS  \nde campo. Su uso ha permitido la recuperaci\u00f3n de los \npar\u00e1metros productivos afectados por la presencia de \nMS pat\u00f3geno, en reproductoras y su progenie, as\u00ed como \nen las gallinas de postura comercial.  \n \nREFERENCIAS  \n1. Aneca, A.C . Situaci\u00f3n epidemiol\u00f3gica de las \nprincipales enfermedades de las aves en M\u00e9xico. \nMemorias de la XVIII Convenci\u00f3n Nacional  de \nANECA.362 -385. 1993.  2. Lockaby, S:B., Hoerr, F:J., Lauerman, L.H., \nSmith, B.F., Samayloc, A.M., Toivio -Kinnucan, M.A. \ny S.H. Kleven. Factors associated with virulence of \nMycoplasma synoviae.  Av. Dis. Vol 43. No.2: 251 \u2013  \n261. 1999.  \n3. Soto, E., Murillo, M.A., Murillo, J.J., \nG\u00f3mez, M. Camacho, E., V\u00e1zquez, D., Alvarado, C., \nMorales, A., Villarreal, A., Gonz\u00e1lez, J., Ca\u00f1a, F., \nBorrego, J. L., Alvarez, E. y  R. Bezares. Avances en el \ncontrol de Mycoplasma synoviae en M\u00e9xico.Memorias \ndel XII Curso de Actualizaci\u00f3n AVIMEX. M\u00e9xico.18 -\n29. 2000.  \n  \nSEROLOGIC RESPONSES AND RECOVERY OF MYCOPLASMA \nGALLISEPTICUM  IN SPF VACCINATED CHICKENS  \n \nNasciment o, E.R.1, P.A. Polo1, V.L.A. Pereira1, M.L. Barreto1, M.G.F. Nascimento2,   \nM.A.F. Zuanaze3, and H. Scanavini -Neto3. \n \n1Universidade Federal Fluminense -UFF, Niter\u00f3i, Rio de Janeiro,  \n 2Embrapa Agroind\u00fastria de Alimentos, Rio de Janeiro- RJ,  \n3Laborat\u00f3rio Bio Vet S/A, Vargem Grande Paulista, S\u00e3o Paulo, Brazil.  \n \nThe diagnosis of Mycoplasma gallisepticum  \n(MG) infection is becoming more difficult then in the past. False positive results can arise from antimicrobial treated flocks, and false positives from vaccinated \nchickens or from infection by MG low virulent strains, \nthat in both cases, could spread to non infected flocks (1, 2).  \nThe objective of the present study is to gain an \nunderstanding of host responses to live MG vaccines as to improve MG infection diagn osis and monitoring of \npoultry breeding hens. Six groups of chickens, \nrepresenting the MG vaccines (MG -F, TS- 11, and \n6/85), a field strain (MG -70), plus a control (not \nimmunized nor challenged), and challenge group (not \nimmunized, but challenged), each in an isolator unit, \nwere used. All strains were given to the chickens by mouth, dropping in 0.5 ml when they were 21 and 35 \ndays old, being the vaccine strains according to their \nmanufacturers. The MG -70 was measured to have \n10\n6.79 color change unit (CCU)/ml  and used as fresh \nculture. All groups except the control were challenged \ntwice with MG -R strain (titers of 101.5 and 104.5, \nrespectively), i.e., 49 days, and 63 days post 1st \nimmunization (P1stI). Monitoring was done weekly, \nsince day zero P1stI up to 12 weeks, by serology \n(Agglutination - RSA and ELISA), necropsies, and \nreisolation.  \nUnder RSA (Bio Vet antigen), all the chickens \nremained MG negative up to 35 days P1stI. The MG -F \ngroup yielded positive results (sera at 1:10 dilution) 42 \ndays P1stI or 21 day s P2ndI. The MG -70 group yielded positive results only 63 days P1stI (45 days P2stI, and \n14 days post challenge) although suspicious reactions \n(undiluted sera) could be seen at 42 days P1stI. The \ngroups immunized with TS -11 and 6/85 had identical \nRSA behav ior, by yielding suspicious results 49 days \nP1stI  (day of the 1st challenge) and positive reactions at \n77 days P1stI (14 days post 2nd challenge. The control \ngroup remained negative while the challenge group was positive 14 days post first challenge.  \nThe geometric mean ELISA (IDEXX \nLaboratories, Inc., S\u00e3o Paulo, SP, Brazil) titers for the challenged groups rose up beyond 21 days P1\nstI and \ncontinued increasing in such way that 56 days P1stI (1st \nchallenge day) the highest value was for MG -F (8.705), \nfollowe d by MG -70 (5.473), then TS -11 (1.701), and \nfinally, 6/85 (1.574), maintaining this pattern up to 77 \ndays P -1\u00aaI (21 days post 1st. challenge). As to the \nserologic patterns for the immunized groups, it was \nobserved that all them converted after the second \nimmunization (14 days P1stI), but the increase of MG -F \nand TS -11 groups was fast while for MG -70 and 6/85 it \nwas slower. A steady drop on the TS -11 group was \nseen 42 days P -1\u00aaI (28 days P -2\u00aaI), not followed by the \nothers, but all immunized groups dropped in  titer after \nthe first and/or second challenge, except MG -70. \nRegarding the coefficient of variation (CV), \nfluctuations were seen on all groups after immunization, stabilizing at 6 -7 weeks P -1\u00aaI, when the \nsmallest titters were yielded by MG -70 (20.7; 25.7) , \nfollowed by TS -11 (26.5; 30.8), MG -F (32,6; 27.5), \nand 6/85 (48.8; 36.6); even at the end of the trial the  \n 308  \nCV for MG -70 was small (11,30), but above that found \nfor 6/85 (2.2), which in turn, was more inconstant then \nthe others the week basis.  \nNo disease was seen in any of the groups, and the \nhistopathologic changes seen in tissues from necropsied chickens were compatible with antigenic \nstimulus, but on the challenge group tracheitis and airsacculitis were found. Moreover, by PCR -RAPD, all \nthe strains used  were found to be genetically different \namong themselves; the standard MGA5969 and MG -R \nbeing reisolation of MG accomplished during and at \nthe end of the trial.  \nIn conclusion, all strains used were genetically \ndifferent, and yielded serologic responses under SAR and ELISA that could be regarded as positive results, \nbut only the MG -F yielded positive results by RSA and ELISA before the challenge. After challenge, all \nreactions were intensified, but the seroconversion \npattern for MG -70 was more uniform then t he others, \nand always ascendant, up to the end of the trial.  \n \nREFERENCES  \n1. Nascimento, E.R. Micoplasmoses. In: \nDoen\u00e7as das Aves, 800p. A. Berchieri Jr., and C. \nMacari eds. FACTA, Campinas, S\u00e3o Paulo, Brazil, pp. \n217-224. 2000.  \n2. Nascimento, E.R., S.M. Ferrera- Neto, \nM.C.M, Galleti, M.G.F. Nascimento, G. B. Lignon, \nand G.A. Mendon\u00e7a. Chicken Mycoplasma \ngallisepticum  infection, diagnosed by agent detection, \nhemagglutination inhibition, but not agglutination. In: \nAVMA Conference/AAAP, New Orleans, USA. 1999.  \n \nPATO G\u00c9NESIS MOLECULAR DE INFECCIONES PROVENIENTES \nDE SALMONELLA SPP  \n \nMOLECULAR PATHOGENESIS OF SALMONELLA SPP INFECTIONS  \n \nOrtega Alvarez Daniel, Garc\u00eda Espinosa Gary, T\u00e9llez Isa\u00edas Guillermo  \n \nD.P.A.:AVES F.M.V.Z. U.N.A.M.  \n \nSUMMARY  \nSalmonella spp. are intracellular, facultative \nbacteria than can cause disease in a great varity of \nanimal species, including humans. Some Salmonella  \nserotypes are adapted to one specific host (i.e.: S. typhi  \ncan infect humans, S. gallinarum and S. pullorum infect \nmost avian species.) In contrast, other serotypes can infect a wide variety of hosts (i.e.: S. enteritidis.) The \nmolecular basis for which some specific serotypes are \nadapted to one single host are scarceley understood.  \n \nRESUMEN  \nSalmonella spp. es una bacteria intracelular  \nfacultativa capaz de causar enfermedad en una gran \nvariedad de especies animales, incluyendo los seres \nhumanos. Algunos serotipos de Salmonella est\u00e1n \nadaptados a un hu\u00e9sped espec\u00edfico (p.e., S. typhi  puede \ninfectar a los seres humanos, S. gallinarum  y S. pullorum  \na la mayor\u00eda de las aves). En contraste, otros serotipos \npueden infectar a una amplia variedad de hu\u00e9spedes (p.e., S. enteritidis ). Las bases moleculares por la que algunos \nserotipos espec\u00edficos est\u00e1n adaptados a un s\u00f3lo hu\u00e9sped, son comprendidas escasamente.  \n \nINTRODUCCI\u00d3N  \nEl estudio molecular en procariontes, ha facilitado \nla identificaci\u00f3n de los principales factores de \nvirulencia de S. typhimurium  y la caracterizaci\u00f3n de los mecanismos moleculares involucrados en la interacci\u00f3n \nhu\u00e9sped -bacteria (1).\n \n \nDETERMINANTES GEN\u00c9TICOS DE \nVIRULENCIA  \nLa mayor\u00eda de los genes de virulencia de S. \ntyphimurium  est\u00e1n agrupados y cada grupo distinto \nrecibe el nombre de isla de patogenicidad (IP). Las IP se encuentran tambi\u00e9n en varias enterobacterias \nincluyendo Yersinia enterocolitica , Shigella flexneri, y \nEscherichia coli  enteropatog\u00e9nica (EPEC, por sus \nsiglas en Ingl\u00e9s) (2), entre otras. La figura 1 ilustra la \ndistribuci\u00f3n de las IP de S. typhimurium  (IPS), as\u00ed \ncomo otros componentes esenciales de virulencia.   \nLas IPS-1 y IPS - 2 codifican un aparato de \nsecreci\u00f3n de tipo III, que permite la inyecci\u00f3n de prote\u00ednas efectoras dentro del citoplasma de la c\u00e9lula del \nhu\u00e9sped, a trav\u00e9s de un canal molecular especializado (3). El sistema de secreci\u00f3n tipo III, encontrado en  otras \nenterobacterias, es independiente de la ruta de secreci\u00f3n por sec (1). La maquinaria de IPS -1 inyecta dentro de \nc\u00e9lulas de mam\u00edfero prote\u00ednas efectoras, que inducen al acomodo de actina del citoesqueleto, dando como \nresultado, membranas onduladas e internaci\u00f3n de \nSalmonella (2).  \nLa IPS -1 efectora tambi\u00e9n participa en la reacci\u00f3n \ninflamatoria generada por la bacteria en la mucosa intestinal. La IPS -2 consiste en genes que controlan la \nmultiplicaci\u00f3n bacteriana en los compartimentos  \n 309  \nintracelulares de c\u00e9lulas epiteliales y fagoc\u00edticas (4). La \nIPS-3 es requerida para la sobrevivencia intracelular en \nmacr\u00f3fagos, debido a que provee productos esenciales \npara el crecimiento en condiciones limitadas de Mg (2,5). \nLa IPS -4 codifica un sistema de secreci\u00f3n de t ipo I \nmediante secreci\u00f3n de toxinas y puede llegar a participar en la adaptaci\u00f3n de Salmonella en el ambiente intracelular de los macr\u00f3fagos (6). Finalmente, la IPS -5 \ncodifica factores involucrados en la secreci\u00f3n de fluidos \ny la reacci\u00f3n inflamatoria en l a mucosa intestinal \nocasionados por Salmonella dublin  e invasi\u00f3n ocasionada \npor S. typhimurium , como SopB (SigD), una prote\u00edna \nefectora secretada por la SPI -1(7). En cuanto al papel de \nlas prote\u00ednas codificadas por los pl\u00e1smidos de \nSalmonella, \u00e9stos partic ipan en la lisis de los macr\u00f3fagos \n(8). \n  \nREFERENCIAS  \n1. Galan JE. Molecular and cellular bases of \nSalmonella entry into host cells. Curr Top Microbiol \nImmunol 1996;209:43- 60. \n2.  Groisman EA, Ochman H. Pathogenicity \nisland - bacterial evolution in quantum leaps . Cell \n1997;87:791- 794. 3. Hueck CJ. Type III protein secretion \nsystems in bacterial pathogens of animals and plants. \nMicrobiol Mol Biol Rev 1998;62:379- 433. \n4. Shea JE, Hensel M, Gleeson C, Holden DW. \nIdentification of a virulence locus encoding a second \ntype I II secretion system in Salmonella typhimurium . \nProc Natl Acad Sci USA 1996;93:2593- 2597.  \n5. Blanc -Potard AB, Solomon F, Kayser J, \nGroisman EA. The SPI -3 pathogenicity island of \nSalmonella enterica. J Bacteriol 1999;181:998- 1004.  \n6. Wong KK, McClelland M, Stillwe ll LC, \nSisk EC, Thurston SJ, Saffer JD.  Identification and \nsequence analysis of a 27 -kilobase chromosomal \nfragment containing a Salmonella pathogenicity island \nlocated at 92 minutes on the chromosome map of \nSalmonella enterica serovar typhimurium  LT2. Infe ct \nImmun 1998;66:3365- 3371.  \n7. Wood MW, Jones MA, Watson PR, Hedges \nS, Wallis TS, Galyov EE. Identification of a \npathogenicity island required for Salmonella \nenteropathogenicity. Mol Microbiol 1998;29:883- 891. \n8. Guilloteau LA, Wallis TS, Gautier AV, \nMaCintyre S , Platt DJ, Lax AJ. The Salmonella  \nvirulence plasmid enhances Salmonella- induced lyses \nof macrophages and influences inflamatory responses. Infect Immun 1996;64:3385- 3393.  \n \nBIENESTAR Y PRODUCTIVIDAD EN LA INDUSTRIA AV\u00cdCOLA  \n \nWELFARE AND PRODUCTIVITY IN THE POULTRY INDUSTRY  \n \nAriel Ortiz Mu\u00f1iz, Esther Buend\u00eda S\u00e1nchez y Fernando Ingalls Herrera \n \nFacultad de Estudios Superiores Cuautitl\u00e1n, UNAM.  \n \nSUMMARY  \nThe assembly of facilities and husbandry \nmanagement procedures used in poultry production to \nprovide the bi rds with conditions to enhance \nproductivity may not comply with the requirements demanded by animal welfare associations. Thus, as \npoultry producers and specialists we must take in \nconsideration such demands, but doing it under \nconditions that allow us to remain profitable, without \naffecting consummers prices. Otherwise, decreased consumption might result, since today poultry prices \nare affordable by the majority of the population.  \n \nRESUMEN  \nEl conjunto de instalaciones y manejos \nzoot\u00e9cnicos y sanitarios que  se implementan  en la \nproducci\u00f3n aviar para proporcionar las condiciones que favorezcan la productividad, pueden  no cumplir con \nlos requisitos   que demandan  las sociedades \nprotectoras de  animales,  por lo que como productores y especialistas hay que c onsiderar dichas demandas \npero en condiciones que nos permitan seguir produciendo en forma rentable y que no afecte los \nprecios al consumidor, ya que  podr\u00eda representar  una \nbaja en el consumo de estos productos que actualmente son accesibles para la mayo r parte de la poblaci\u00f3n.  \nCampa\u00f1as recientes dirigidas por  grupos de las \nsociedades protectoras de los animales piden a la industria av\u00edcola que descontinu\u00e9 practicas tales como el uso de jaulas, el despique y la pelcha forzada \nargumentando  que: \"Dichas p racticas condenan a las \naves a la inmovilidad y a la frustraci\u00f3n en un sistema \nen  que al nacer, a los polluelos se les aparta \nbrutalmente de sus madres para ser sometidos a un \nmanejo donde se les corta dolorosamente su sensible pico con un  cuchillo al ro jo vivo y que les provocara \nun dolor cr\u00f3nico de por vida\"(3). Muchas veces, las propuestas y normatividades, que en teor\u00eda van en \nmejora del bienestar animal, no tienen base cient\u00edfica y  \nencubren una simple operaci\u00f3n de imagen, como es el  \n 310  \ncaso de la caden a de alimentos McDonals que ahora \nrequiere garant\u00edas de que las gallinas sean tratadas de \nuna manera humanitaria a ra\u00edz de que ha sido acusada \nde fomentar las practicas de \"fabricas de huevo\"(2).  \nPor lo que hay una imperiosa  necesidad de \nestablecer  normatividades que mejoren las condiciones \nen que crecen y producen nuestras parvadas para evitar que se nos impongan medidas como la prohibici\u00f3n  de \nlas jaulas para la producci\u00f3n de huevo comercial que se \ndio en Europa.  \nEn relaci\u00f3n con la densidad de poblaci\u00f3n , \nprobablemente  se ha trabajado con densidades \nmayores a las \u00f3ptimas para el bienestar  tratando de obtener mayores utilidades por lo que es conveniente \npensar en utilizar densidades  menores, en donde \npodamos obtener  menores \u00edndices de mortalidad y \nmejo res conversiones que nos indiquen el punto en \ndonde convergen el bienestar de las aves y una productividad aceptable(4)  \n En Europa los sistemas que se han considerado \npara la producci\u00f3n de huevo comercial en piso tienen \ncomo mayor desventaja el incremento hasta en mas del \n100% de los costos de producci\u00f3n y en dichas \nsociedades quiz\u00e1 muchos estar\u00edan dispuestos ha pagar \nun precio m\u00e1s alto por tener una conciencia  tranquila, \naunque no se ha considerado la competencia externa y \nque tanto este dispuesto el p\u00fablico de la Comunidad \nEuropea en general a pagar un mayor precio o consumir productos av\u00edcolas importados producidos en \ncondiciones comerciales actuales, pero que se oferten a \nun precio m\u00e1s bajo(1). En los pa\u00edses en desarrollo este incremento en los precios tendr\u00eda una repercusi\u00f3n \nnegativa en los consumos de estos productos y por lo \ntanto en la nutrici\u00f3n y bienestar de la poblaci\u00f3n \nhumana. Adem\u00e1s dichos sistemas  aumentan la \nincidencia de infecciones parasitarias y  un mayor \nriesgo de agresi\u00f3n entre las aves.   \nDebemos pensar en sustituir las  pr\u00e1cticas \nactuales de restricci\u00f3n de alimento y agua para inducir la muda o pelecha forzada que han sido consideradas \ncomo tratamientos crueles e inhumanos con practicas \nmenos agresivas que ya se est\u00e1n implementando(2).  \nCon relaci\u00f3n al corte de pico es necesario publicar \ny  hacer hincapi\u00e9 de que el canibalismo y mortalidad \npudieran ser mayores en parvadas sin despicar, pero \ntambi\u00e9n pensar en cortes  menos severos, estirpes \nmenos agresivas y uso de analg\u00e9sicos en los d\u00edas \nposteriores a dicho manejo(1).   \n \nREFERENCIAS  \n1. Dunn Norman.; Jaulas para ponedoras: el \nmejor sistema a pesar de la critica. ;Avicultura \nProfesional. Vol.16.,No.2., A\u00f1o 1998.  \n2. Mart\u00ednez Abelardo. ; La campa\u00f1a de la UPC \ncontra la muda inducida. ;Correo Av\u00edcola.,  A\u00f1o XIII, \nNo.12, Diciembre 2000  \n3. Moster\u00edn Jes\u00fas.; \u00a1Vivan los animales!.; \nEditorial Debate, D.L.; Primera edici\u00f3n.; Madrid 1998.  \n4. Zuidhoff Mart\u00edn. ; Producci\u00f3n de pollo de \nengorda: una perspectiva europea. ;Correo Av\u00edcola., \nA\u00f1o XIV, No.4, Abril 2001.  \n \nSCREE NING BROILERS WITH HALOTHANE AND \nSUCCINYLCHOLINE TO IDENTIFY BIRDS PRONE TO \nDEVELOPING PALE, SOFT, EXUDATIVE (PSE) MEAT  \n \nAN\u00c1LISIS DEL POLLO DE ENGORDA CON HALOTANO Y \nSUCCINILCOLINA PARA IDENTIFICAR A LOS INDIVIDUOS \nSUSCEPTIBLES AL DESARROLLO DE CARNE P\u00c1LID A, SUAVE Y \nEXUDATIVA (PSE ) \n \nC. M. Owens, L. C. Cavitt and B. M. Hargis  \n \n Department of Poultry Science, University of Arkansas, Fayetteville, AR  72701  \n \nRESUMEN  \nLa industria av\u00edcola ha observado un dram\u00e1tico \nincremento en la incidencia de carne PSE,  similar a lo \nocurrido en la carne de cerdo. Este problema se ha \nasociado con factores gen\u00e9ticos y ambientales. La \nprueba general con halotano se ha usado en la industria \nporcina con gran \u00e9xito, pero los resultados en pavos \nson s\u00f3lo marginales. Tambi\u00e9n se ha ut ilizado la succinilcolina en combinaci\u00f3n con el halotano para la identificaci\u00f3n m\u00e1s precisa de los animales susceptibles \nal estr\u00e9s. Aun cuando es necesario comprender mejor la \nsituaci\u00f3n, la sensibilidad al halotano junto con el uso \nde succinilcolina no ha logrado identificar a los pollos \nde engorda susceptibles al desarrollo de carne PSE.   \n  \n 311  \nMeat that is PSE is paler in color, forms soft gels, \nand has lower water holding capacity.  The condition is \na problem in the poultry industry and has been \nassociated wi th genetic and environmental factors.  The \nuse halothane has been used in the swine industry and \nexperimentally in turkeys to identify animals prone to \ndeveloping PSE meat.  In addition, succinylcholine has been used with halothane in swine to more accurat ely \nidentify animals with the genetic mutation in the \nryanodine receptor, especially those that are \nheterozygotes for the defective gene.  The purpose of \nthis study was to determine if using halothane with \nsuccinylcholine to screen broilers could improve t he \nidentification of birds prone to developing PSE meat.  \nSuccinylcholine was used to serve a triggering agent \n(prior to slaughter) for the PSE condition.  At four wk \nof age, broilers (n=1000) were subjected to 3% \nhalothane gas and were evaluated for mus cle rigidity in \nthe legs.  If birds exhibited signs of muscle rigidity in the legs, they were classified as halothane positive and if not, birds were classified as halothane negative.  \nOverall, approximately 14% of the birds were \nclassified as HAL+.  All H AL+ birds and an equal \nnumber of HAL - birds were grown to 7 wk and were \ncommercially processed.  At time of processing, half of \nthe birds were injected intravenously with succinylcholine and were slaughtered at 0.25 h post -\ninjection.  Pectoralis samples we re collected at 0.25, 2, \n5, and 24 h PM for the evaluation of rigor development (muscle pH) and meat quality (L*value, moisture, and \ncook loss).  Halothane sensitivity had no consistent \neffect on rigor development, muscle color, or water holding capacity.  The halothane -succinylcholine \nscreening test was not successful in identifying birds \nprone to developing PSE meat.  \n \n(Present research will be published as a full -length \narticle in Poultry Science).  \n \nCHARACTERIZATION OF vv+MDVs HAVING MUTATIONS IN \nGLYCOP ROTEIN L (gL)  \n \nCARACTERIZACI\u00d3N DE LOS VIRUS MUY VIRULENTOS DE LA \nENFERMEDAD DE MAREK QUE PRESENTAN MUTACIONES EN LA \nGLUCOPROTE\u00cdNA L (gL)  \n \nParcells, Mark S.1, Elizabeth Santin2, Christine E. Shamblin3, and Robert L. Dienglewicz1 \n \n1 Center of Excellence for Poultry Science, University of Arkansas, Fayetteville, AR 72701;  \n2 Department de PatologiaVeterinaria, FCAV \u2013  UNESP, Jaboticabal, SP, Brasil  \n3 St. Jude Children\u2019s Research Hospital, Memphis, TN  38105 \n \nRESUMEN  \nLa enfermedad de Marek es un c\u00e1ncer de c\u00e9lulas \nT de los pollos causado por el virus de la enfermedad \nde Marek. Han evolucionado tres patotipos de este \nvirus: el virulento, el muy virulento y el muy virulento \nplus ( vMDV, vvMDV, vv+MDV , respectivamente), aun \ncuando se desconoce la base molecular de est as \ndiferencias en la virulencia. Nosotros detectamos cepas \ndel vv+MDV  que presentan una mutilaci\u00f3n en el gene \nde la gL y hemos generado la hip\u00f3tesis de que esta \nmutaci\u00f3n puede afectar la capacidad de estos virus de \ninteractuar con la cepa vacunal del virus  herpes del \npavo ( HVT ). Los resultados de un estudio in vivo  \nindicaron que esta mutaci\u00f3n no afecta la interacci\u00f3n \nentre el vv+MDV  y el HVT,  sino que sugiere que puede \nafectar la transmisi\u00f3n del vv+MDV  a aves de mayor \nedad.  \n \nField strains of Marek\u2019s disese virus (MDV) have \nincreased in virulence since the advent of high density \npoultry production during the late 1950s.  The most recent isolates of MDV fall into a hyper -virulent or \nvv+MDV pathotype and induce profound immune suppression, stunting and neurologic lesions (2).  \nAnother characteristic associated with some vv+MDVs has been a conference of rapid horizontal transmission \nto vaccine virus HVT (1).  We recently identified \nseveral vv+MDV strains that had mutations in \nglycoprotein L (gL), a glycoprotein i mportant to the \nproper processing and surface expression of \nglycoprotein H (gH).  The mutations in the gL coding \nregion mapped to the signal cleavage site and would \naffect its putative processing (3).  We theorized that \nthese mutations may have provided a molecular basis \nfor a complementation between MDV -1 and HVT \nstrains, via gL/gH interactions.  We have tested this hypothesis in vivo  via co -infection of SPF chickens \nwith vvMDV, vv+MDV (gLmut), vv+MDV (gL wild \ntype) with and without HVT co- inoculation.  We  have \nfound that co- infection of chickens with HVT did not \naffect: 1. viremias of MDV -1 or HVT, 2. mortality, 3. \ntumor incidence or 4. horizontal spread to day -old       \n      \n          \n      \n     \n 312  \ncontact chickens.  We did observe a slight increase in \nhorizontal transmission and associate d mortality in \ncontacts exposed at 2 and 6 weeks of age to \nvv+MDV(gLmut).  Our results suggest that although \nthe mutations in gL are not causative of the vv+ \nphenotype, these mutations may be one of several \nmechanisms affecting increased spread of these viruses, particularly to older birds.  \n \nREFERENCES  \n1. Rosenberger, J. K., S. S. Cloud and N. \nOlmeda -Miro.  Epizootiology and adult transmission of Marek's disease.  Avian Tumor Virus Symposium, \nReno, NV, 30 -32.  1997.  \n2. Witter, R. L.  Increased virulence of Marek' s \ndisease virus field isolates.  Avian Dis  41:149 -63.  \n1997.  \n3. Wu, P., W. M. Reed and L. F. Lee.  \nGlycoproteins H and L of Marek's disease virus form a \nhetero -oligomer essential for translocation and cell \nsurface expression.  Arch Virol  146:983 -92.  2001.  \n \nEFECTO DE EDAD DE LA REPRODUCTORA EN PESO DE \nHUEVO, P\u00c9RDIDA DE HUMEDAD, MORTALIDAD EMBRI\u00d3NICA, \nTIEMPO DE REPOSO, Y VIABILIDAD DE PROGENITURA \nDURANTE LA PRIMERA SEMANA DE VIDA  \n \nEFFECT OF BREEDER AGE ON EGG WEIGHT, MOISTURE LOSS, EMBRYO \nMORTALITY, RESTING TIME, AND FIRST WEEK BROILER LIVABILITY  \n \nPrado -Rebolledo OF1., Garc\u00eda- M\u00e1rquez LJ1., V\u00e1zquez \u2013 Garc\u00eda JL1., G\u00f3mez -Bucio JR1., Quintana -L\u00f3pez JA2 \n \n1 Facultad de Medicina Veterinaria y Zootecnia. Universidad de Colima. Autopista Colima- Manzanillo Km. 40. \nCruce ro de Tecom\u00e1n, Col. CP. 28100. e -mail: omarpr@ucol.mx  \n2 Facultad de Medicina Veterinaria y Zootecnia. Departamento de Producci\u00f3n Animal: Aves. UNAM  \n \nSUMMARY  \nThis research determined chick optimum resting \ntime, since this parameter has not been established  by  \nroutine hatchery practices. Two thousand two hundred \nand sixty nine eggs laid by Ross x Ross breeders of \nthree different ages: 1 (35); 2 (45) y 3 (55) weeks of \nage, with six treatments and 3 repetitions: 1 (4), 2 (8), 3 \n(12), 4 (16), 5 (20) and 6 (24)  resting hours, \nrespectively. Results showed that extended resting \nperiods in the hatchery affect broiler livability and \nweight gain at all three breeder ages.  \n Dentro de las pr\u00e1cticas de rutina de las plantas \nincubadoras  no se ha establecido el tiempo \u00f3ptimo de \nreposo de los pollos por lo que se determin\u00f3. Se \nutilizaron 2 269 huevos f\u00e9rtiles de la estirpe Ross x Ross de tres edades 1 (35); 2 (45) y 3 (55) con 6 \ntratamientos y 3 repeticiones de 1 (4), 2 (8), 3 (12), 4 \n(16), 5 (20) y 6 (24) horas de reposo respectivamente. \nLos datos mostraron que al prolongar el tiempo de \nreposo en la incubadora se afecta la viabilidad y \nganancia de peso, en las tres edades de reproductoras.  \n \n(El trabajo completo se pretende publicar en la revista \nde Veterinaria M\u00e9xico ). \n \n \n \n  \n \n    \n 313  \nEFECTO DE DOS R\u00c9GIMENES ALIMENTARIOS EN \nREPRODUCTORAS HUBBARD  \n \nEFFECT OF  TWO BROILER BREEDER FEEDING PROGRAMS (HUBBARD)  \n \nQuintana J.A.1, Avila E.2, Herrera J.3,  L\u00f3pez C.1, T\u00e9llez G.1, Ponce G.4, Saldivar S.4 \n \n1Departamento de Producci\u00f3n Animal:aves FMVZ Universidad Nacional Aut\u00f3noma de M\u00e9xico  \n2CEIEPA  FMVZ  Universidad Nacional Aut\u00f3noma de M\u00e9xico  \n3Colegio de Postgraduados, Montecillo M\u00e9xico, 4Grupo Av\u00edcola El Pe\u00f1\u00f3n M\u00e9xico  \n \nSUMMARY  \nTwo feed intake regimes were tested. Higher feed \nintake resulted in  higher production peak. Birds fed \nless feed had a lower peak, but their body weight \nincrease was similar to that of birds with a higher feed \nintake, probably because lower production diects feed to a higher body fat accretion.  \n \nEl objetivo del experiment o fue  evaluar el porcentaje \nde postura, peso corporal, pico de producci\u00f3n y \nporcentaje de mortalidad en gallinas reproductoras \npesadas que recibieron dos programas de alimentaci\u00f3n.  \n \nMATERIAL Y METODOS  \nEl experimento se realiz\u00f3 en una granja comercial \nubicada en el municipio de Yecapixtla al noreste del \nestado de  Morelos  a 1500 msnm. Con una temperatura promedio anual de 22\u00b0C, m\u00ednima de 5\u00b0C y m\u00e1xima de 35\u00b0C  con una precipitaci\u00f3n pluvial de \n150mm en la \u00e9poca de verano. Se utiliz\u00f3 una parvada \nde 6000 galli nas reproductoras pesadas de 25 semanas \nde edad con  peso corporal similar, de la estirpe \nHubbard, en dos casetas comerciales con tres \ndivisiones cada una,  para alojar a 1000 aves por \ndivisi\u00f3n.  \nA continuaci\u00f3n se describen  los dos tratamientos \nempleados, aleatorizados en un  dise\u00f1o en bloques \ncompletos al azar, cada uno con tres repeticiones:  \nTratamiento A: Alimentaci\u00f3n de gallinas con \n159.6 gramos de alimento/ave/d\u00eda  promedio durante todo el ciclo.  \u2022 Tratamiento B: Alimentaci\u00f3n de las gallinas \ncon 166.3 gr amos de alimento/ave/d\u00eda promedio, \ndurante todo el ciclo.  \nLas variables medidas fueron: Porcentaje de \nproducci\u00f3n gallina -d\u00eda,  porcentaje de mortalidad \ndurante  el ciclo de postura,  porcentaje del pico de \npostura, consumo diario de alimento y los pesos \ncorporales promedios de las aves a las 30, 40 y 50 \nsemanas de edad. La parvada se sacrific\u00f3 a las  50 \nsemanas de edad. Los resultados  promedio obtenidos se analizaron seg\u00fan  el dise\u00f1o mencionado, los \nporcentajes de mortalidad  se transformaron por el  \narcoseno de la raiz cuadrada,   de acuerdo a lo se\u00f1alado \npor Herrera  y col. (2000).  \n \nRESULTADOS  \nEl porcentaje de mortalidad present\u00f3 variaciones \nfuertes entre las repeticiones de cada tratamiento. Cabe \nse\u00f1alar que la parvada sufri\u00f3  leucosis aviar, \nocasionand o el 50 % de la mortalidad; sin embargo, en \nla repetici\u00f3n 1 del tratamiento A pr\u00e1cticamente el 60% \nde la mortalidad fue debido a  leucosis aviar. \nIndependiente  de la anterior, hubo una tendencia num\u00e9rica a presentar menor mortalidad, a mayor \nconsumo de al imento (P>0.05) entre tratamientos.  \nEl n\u00famero de huevos producidos por gallina en el \nciclo, fue mayor para la aves que consumieron mas \nalimento (Tratamiento B) (P< 0.09). El pico de \nproducci\u00f3n fue 10% mayor (P<0.05) para el  \ntratamiento B (Cuadro 1).  \n \nCuadro 1.  N\u00famero de huevos por gallina durante el ciclo de postura y porcentaje al  pico de postura en \ngallinas reproductoras Hubbard.  \nTratamiento  N\u00famero de huevos por \ngallina  Pico de postura  \n(%) \nA 111.5 a*  68.7 a  \nB 124.7 b*  78.3 b  \na*,b* y a, b, Medias co n la misma literal en columna son diferentes: P< 0.09 y  P<0.05 respectivamente  \n  \nEl peso corporal alcanzado a las30 semanas fue \nde 3.4Kg por gallina  y a las 50 semanas de edad de 4.1 \nKg; fue similar (P>0.05) para ambos tratamientos,  correspondiendo a u n 37% de aumento  con respecto al \npeso obtenido a  las 25 semanas de edad.   \n 314  \nDISCUSI\u00d3N  \nLa mortalidad ocurrida en una repetici\u00f3n fue muy \nalta, correspondiendo a las aves que consum\u00edan  6 \ngramos menos de alimento por gallina durante todo el \nciclo. Aunque no hubo diferencias estad\u00edsticas entre \ntratamientos, se hace notar que la parvada sufri\u00f3 la \nenfermedad de leucosis aviar y la mitad de las aves murieron por dicha enfermedad.  \nIndependientemente de la enfermedad, las \ngallinas del tratamiento A (6  gramos menos d e \nconsumo de alimento), tuvieron menor porcentaje al \npico de postura. Estos resultados son similares a los del \nExperimento 1, donde se encontr\u00f3 que con aves que consumen mas alimento tienen mayor  pico de postura.  \nEl incremento de peso de las 25 a las 50 semanas \nfue alrededor de 37%, el cual es similar al registrado en \nel Experimento 1. Es interesante observar como a\u00fan \nconsumiendo 6 gramos menos las aves del  el \ntratamiento A, alcanzaron el mismo peso  que las del \ntratamiento B. La causa posiblemente sea q ue las \ngallinas al no poner, almacenan los nutrientes, \ntransform\u00e1ndolos en grasa (Wilson, 1998).  \nEn este experimento, no fue posible medir la \nfertilidad, ya que  al ser gallinas reproductoras es \nimportante que adem\u00e1s de que la gallina produzca el \nmayor n\u00fam ero de huevos, estos tengan una mayor \nincubabilidad. Para poder medir la fertilidad, algunos \nautores (Goerzen y cols. 1996), han realizado estudios \nal respecto en gallinas reproductoras pesadas en jaula, \nen las cuales  es mas f\u00e1cil controlar las variables  \nincluyendo la fertilidad, (Tinch, 1996).   \nRecientemente se le est\u00e1 dando importancia al \nbienestar de las gallinas reproductoras pesadas en relaci\u00f3n a la restricci\u00f3n alimenticia, ya que Mench y Falcone (2000) mencionan que las gallinas reproductoras muest ran evidencias de estr\u00e9s \nfisiol\u00f3gico, porque se incrementan los \ncomportamientos anormales por  el \u201chambre cr\u00f3nica\u201d \nde las gallinas. Estos autores sugieren m\u00e9todos \nalternativos  para disminuir el consumo de  alimento  \ncomo es la restricci\u00f3n cualitativa de la dieta, y evitar que los controles del peso corporal  afecten el bienestar \nen las gallinas. Van Middelkoop y Van der Haar (2000) \nprobaron un comedero que proporciona el alimento \u201cal \nboleo\u201d sobre la cama y observaron que hab\u00eda menos uniformidad  en el peso  de la parvada, pero que las \ngallinas  tardaban mas tiempo comiendo, y se manten\u00edan m\u00e1s tranquilas.   \n \nREFERENCIAS  \n1. Goerzen, P.R., Julsrud, W. L.  and \nRobinson, F. E. (1996). Duration of fertility in Ad \nLibitum and feed -restricted caged broiler breeders. \nPoultry Science  \n2. Mench, J.A. and Falcone, C. (2000). \nWelfare concerns in feed restricted meat type poultry \nstocks. XXI Worlds Poultry Congress 20- 24, Montreal, \nCanada  \n3. Tinch, A.  (1996).  Novel methods in broiler \nbeeding. International Hatchery Practice, 11, 7 -9. \n4. Van Middelkoop, J.H. and Van der haar, \nJ.W. (2000). The application of scatter feeding in managing feed restriction during the rearing of broiler breeders. XXI World\u00b4s Poultry Congress 20- 24. \nMontreal Canada.  \n5. Wilson, J.L. (1998). Manejo en naves sin \nventanas de reproductores pesados mediante restricci\u00f3n \nde luz . Selecciones Av\u00edcolas, 3, 155 -163. \n  \nPRODUCTIVIDAD EN REPRODUCTORAS DE MAYOR CONSUMO \nDE COMIDA  \n \nPRODUCTIVITY OF BROILER BREEDERS WITH A HIGHER FEED INTAKE \n(AVIAN FARMS)  \n \nQuintana J.A.1, Avila E .2,  Herrera J.3, L\u00f3pez C.1, T\u00e9llez G.1, Rojas L.A.4, Le\u00f3n F.4 \n \n1Departamento de Producci\u00f3n Animal:aves FMVZ Universidad Nacional Aut\u00f3noma de M\u00e9xico  \n2CEIEPA  FMVZ  Universidad Nacional Aut\u00f3noma de M\u00e9xico,  \n3Colegio de Postgraduados, Montecillo M\u00e9xico, 4Reproductoras del Valle de M\u00e9xico  \n \nSUMMARY  \nTwo feed intake levels were compared during lay.  \nNo statistical differences in mortality rates were found. The highest production peak was oberved in hens with standard body weight fet 10 extra grams of feed; \nnever theless, heavier birds with this same feed intake \nshowed the lowest production peak. Birds require more feed to satisty apetite and production needs, but bory \nfat accretion must be prevented.  \nEl objetivo del experimento fue comparar el \ncomportamiento produ ctivo de gallinas reproductoras \nde raza pesada, cuando se les proporciona dos \ncantidades diferentes de alimento durante la postura.  \n  \n 315  \nMATERIAL Y METODOS  \n     Se realiz\u00f3 en una granja comercial localizada \nen el municipio de Amecameca al oriente del Estado de  \nM\u00e9xico  a 2470 msnm. Entre los paralelos 18\u00b0 49\u00b4 \nlatitud Norte  y 98\u00b0 57\u00b4 latitud Oeste. La zona presenta \nuna temperatura media anual de 14.4\u00b0C, m\u00ednima de \n0\u00b0C y m\u00e1xima de 29\u00b0C  con una precipitaci\u00f3n pluvial de 1001 mm en \u00e9poca de verano (Garc\u00eda, 1981). Se \nutiliz\u00f3 una parvada de 9000 gallinas reproductoras \nAvian Farm alojadas en tres casetas  de ambiente \nnatural con 6 lotes de 1500 aves cada uno, \nmanteniendo  una densidad  de  4 aves /m2.  \n     A las 25 semanas de edad se seleccionaron \ntodas las aves seg\u00fan el peso corporal y se uniformaron los lotes quedando 4 divisiones con aves de \naproximadamente 3.0 Kg  y dos divisiones con gallinas \nde 3.2 Kg. Estos dos \u00faltimos lotes quedaron como \ntratamiento control.  \n     Se llev\u00f3 a cabo un dise\u00f1o experimental \ncompletam ente al azar de tres tratamientos con dos \nr\u00e9plicas cada uno de la siguiente forma:  \nTratamiento A:  gallinas (ligeras) con el peso \nest\u00e1ndar  recomendado por el manual de la estirpe  al \ninicio de postura, A estas aves se les aliment\u00f3 con un \nm\u00e1ximo de  195 g de alimento/ave/d\u00eda (556 Kcal de \nEM/ave/d\u00eda).  \nTratamiento B: gallinas (ligeras) con  el peso \nest\u00e1ndar al inicio de postura. A estas aves se les \naliment\u00f3  con un m\u00e1ximo 205 g de alimento/ave/d\u00eda, \n(10 gramos m\u00e1s que el tratamiento A) (584 kcal de EM/ave/d\u00eda ).  \nTratamiento C: Gallinas (pesadas)  con 5% de \nsobrepeso, con respecto al est\u00e1ndar de la estirpe, alimentadas con 205 g /alimento/ave/d\u00eda (584 kcal de \nEM/ave/d\u00eda)  \nA toda las gallinas se les administr\u00f3 la cantidad \narriba se\u00f1alada hasta el pico de producci \u00f3n. \nDespu\u00e9s del pico de postura, se  retir\u00f3 el alimento \nsobrante, en raz\u00f3n de la hora del d\u00eda a la cual se \nterminaba; procurando 5 horas diarias de consumo, a excepci\u00f3n de un lote del tratamiento C en el cual se les \ndej\u00f3 una hora m\u00e1s.  El alimento empleado fue para gallinas \nreproductoras pesadas con base en sorgo y soya.  La dieta consumida en los tres tratamientos conten\u00eda  2850 \nKcal de EM/Kg y 16.5 % de prote\u00edna cruda.  \nSe cuantific\u00f3 el huevo total e incubable por \ngallina, el pico de postura, edad al pico de postura, el \nporcentaje de mortalidad al ciclo y la clasificaci\u00f3n del huevo no incubable, asi como el peso corporal al pico y \nal final del experimento que fue hasta la 60 semanas de \nedad.  \nLos resultados se analizaron con el paquete \nestad\u00edstico SAS  para un dise\u00f1o completamente al azar \nutilizando ANDEVA. Las medias fueron comparadas \nmediante la prueba de Tukey (Herrera y Barreras, \n2000).  \n \nRESULTADOS  \nLa mortalidad durante el ciclo de producci\u00f3n en \nlas aves ligeras con menos alimento fue de 29.4%, en \nlas de mayor consumo 25.9% y en las aves pesadas con \nm\u00e1s alimento 23.4%. No existi\u00f3 diferencia significativa \n(p>0.05)ratamientos.  \nEl an\u00e1lisis estad\u00edstico de las variables de  \nrespuesta del pico de postura y edad al pico; mostr\u00f3  \ndiferencias  entre  tratamientos (P<0.01), el pico de postura present\u00f3 el mayor  porcentaje para el \ntratamiento B (aves ligeras con mayor consumo de \nalimento) y el menor porcentaje para el tratamiento C \n(las aves pesadas). La edad de las gallinas para llegar al \npico de postura fue similar  en los tres tratamientos \ncomo se puede observar  en el  Cuadro 1.  \nCon respecto al  n\u00famero de huevos no incubables: \nhuevos chicos menos de 50 gramos (4 a 6 /GE), huevo sucio, huevo roto y huevo de doble yema(1.3 a 1.9) por \ngallina encasetada. No existi\u00f3 dif erencia estad\u00edstica \np>0.05 entre tratamientos.        \nLos resultados globales de huevo incubable, as\u00ed \ncomo los de los huevos totales por gallina encasetada; \nmostraron diferencias estad\u00edsticas, siendo  similares \npara las aves ligeras y pesadas con mayor con sumo de \nalimento  con mas de diez huevos por gallina (P<0.05), que las aves ligeras con menor consumo de alimento (Cuadro 1).  \n \nCuadro 1 .  Huevos incubables y no incubables y total de huevos producidos por gallina encasetada.(GE)  \nTrat.    % pic postura  Huevos \nIncubable/GE  Huevos No \nincubable/GE  Huevos \nTotales/GE  \n    \nA          83.0b  126.2b  7.3a 133.3b  \nB          85.8a  135.7a  8.7\u00aa 144.4\u00aa  \nC          80.6c  136.3a  8.8a 145.2\u00aa  \na,b,c,. Medias con diferente literal son estad\u00edsticamente diferente P<0.05  \n \nHubo diferencias (P<0.05) en el consumo total  de \nalimento por gallina en el ciclo, siendo similar para los tratamientos A y B (aves ligeras)  y alrededor de 5 Kg. \nmas para el tratamiento C  (aves pesadas), el promedio  \n 316  \nde consumo por ave/ d\u00eda durante todo el ciclo, fue de \nalrededor de 170 gramos  para los tratamientos A y B \n(484.5 Kcal/ave)y de 193 gramos para el tratamiento C \n(550 kcal/ave). El \u00edndice de conversi\u00f3n (gramos de \nalimento para obtener un huevo incubable)   y el peso \npromedio del huevo fue similar  (P>0.05)para los tres \ntratamientos  \nLas aves ligeras con menor consumo al pico de \nproducci\u00f3n tuvieron menos peso corporal, que las  aves \ncon mayor consumo (tratamientos B y C), resultado \nque se conserv\u00f3 hasta las 60 semanas de edad (P>0.05). \nEl incremento  de peso corporal de las 25 a las 60 \nsemanas fue de 31% para las aves ligeras con menos \nconsumo al pico  y de 37% para las  aves ligeras y \npesadas con mas consumo al pico.  \n \nDISCUSI\u00d3N  \nAunque se not\u00f3 en las aves una tendencia \nnum\u00e9rica a menor mortalidad cuan do consumen mas \nalimento, no hubo diferencias estad\u00edsticas significativas entre tratamientos, quiz\u00e1 por el reducido n\u00famero  de \nrepeticiones empleadas y debido al efecto que ejercen \nlos factores ambientales sobre este par\u00e1metro, seg\u00fan \nSeemann (1997). Estos resultados son similares a los \nreportados por Moye (1996) y Quintana y cols. (1998).  \nExistieron  diferencias significativas en el \nporcentaje del pico de producci\u00f3n, siendo el mayor en las aves con  peso est\u00e1ndar pero con  diez gramos extra de alimento. Sin  embargo las aves m\u00e1s pesadas  con \neste mismo consumo fueron las que peor pico de postura alcanzaron. Posiblemente, las aves  requieran un incremento en el consumo para satisfacer su apetito \ny completar los requerimientos para la postura pero sin \nque se en grasen, de acuerdo con  Brake y Peak  (1999).  \nNo existieron diferencias entre tratamientos en el \nn\u00famero de huevos  no incubable;  sin embargo, hubo \nuna fuerte tendencia a presentar diferencias  el caso de huevos con doble yema en las aves m\u00e1s pesadas con \nmayor consumo  de  alimento, datos similares a los de   \nYu y cols. (1992b).  \nLa producci\u00f3n total de huevo, incluyendo el \nincubable, fue menor para las  aves con el peso \nest\u00e1ndar que sugiere la l\u00ednea gen\u00e9tica  y que en \npromedio consumieron 10 gramos menos de  alimento \npor gallina, que el resto de las aves, esto corrobora \nhallazgos  anteriores de Quintana y cols. (1998).  \nSe not\u00f3 que el consumo de alimento total, fue \nid\u00e9ntico para los tratamientos A y B (aves ligeras), \ndurante todo el ciclo; a\u00fan cuando el segundo consumi\u00f3 \n10 gramos m\u00e1s hasta el pico. Posiblemente haya alguna \ncompensaci\u00f3n fisiol\u00f3gica para ajustar el consumo total del ave a lo largo del ciclo  productivo. Por otro lado \nlas aves mas pesadas  tienden a comer mas para \nmantener  su conformaci\u00f3n, independientemente que lleguen mas pesadas al final. La conversi\u00f3n de \nalimento fue mejor para el tratamiento B, debido a que produjo mas huevos, informaci\u00f3n que est\u00e1 de acuerdo \ncon Brake y cols. (1994).  \nSe pudo observar que las aves de los tratamientos \nB y C alc anzaron el mismo porcentaje de incremento \nde peso. Las aves que consumieron menor cantidad de alimento, alcanzaron seis por ciento menos del peso al \nfinal del ciclo. Sin embargo el porcentaje de aumento de este \u00faltimo corresponde a lo esperado por algunos \nautores  para mayor productividad y fertilidad (Brake y \nPeak,1999  y Wilson, 1998).  \nLien y Hess (1999) encuentran 5 huevos menos \npor gallina cuando se restringe en forma brusca el \nconsumo de alimento;  tambi\u00e9n observaron que el peso \ndel ovario y  el n\u00famero de fol\u00edculos fueron menores.  \nJensen (2000)  comenta que la productividad de \nuna parvada de gallinas reproductoras  pesadas depende del control del desarrollo folicular ov\u00e1rico , el \ncual   est\u00e1 directamente influenciado  por la mortalidad, \nla que aumenta s i el sistema metab\u00f3lico no es \ncontrolado adecuadamente . El mismo autor observ\u00f3 que cuando existe un sobrepeso  de 5% de las gallinas a \nlas 20 semanas de edad, mayor es el n\u00famero de pollitos \npor cada gallina reproductora.  Fancher (2000)  \nmenciona que las g allinas reproductoras alcanzan 3.9 \nKg. de peso al final del ciclo productivo. En el presente estudio las gallinas que produjeron mayor cantidad de \nhuevos , pesaron al final del ciclo  200 a 500 gramos \nmas que lo reportado por Fancher (2000).  \nResulta intere sante comentar que Leeson (2000), \nrecientemente afirm\u00f3 que con frecuencia se encuentra hasta un 20% de diferencia  mundial  en las \nespecificaciones de nutrientes en  las dietas y \ncantidades de alimento a consumir en hembras y \nmachos    y de todas maneras el pico de postura  \nconstantemente alcanza el 86% y la incubabilidad \noscila entre   84 y 85% durante toda la vida de la gallina.  \nEstudios realizados en pavos sugieren que \ndespu\u00e9s de una restricci\u00f3n  de alimento en el per\u00edodo de desarrollo debe seguir un r\u00e1 pido crecimiento por dos \nsemanas antes del inicio de la postura (Ferket, 2000). \nEsto podr\u00eda explicar porqu\u00e9 el lote B de gallinas ligeras \nprodujo  mas huevos.  \nLos resultados de este experimento coinciden con \nlos encontrados en 1995, por Wilson y cols., los  cuales \nencontraron que  cuando se incrementaba el consumo de alimento r\u00e1pidamente al inicio de postura y el  peso \ncorporal por arriba de lo recomendado, hab\u00eda mas \nhuevos f\u00e9rtiles y mas pollitos  por gallina  que cuando \nse alimentaba lentamente. Renema y cols. (2000) \ntambi\u00e9n observaron que las gallinas con un sobrepeso \nde 18% con respecto a los par\u00e1metros de la estirpe  al \ninicio de la madurez sexual   presentaron m\u00e1s fol\u00edculos   que en las gallina de bajo peso. Otros autores se\u00f1alan   \nla relaci\u00f3n que exist e entre la productividad y el \nest\u00edmulo de luz  cuando se realiza a las 22 semanas de  \n 317  \nedad, en comparaci\u00f3n a las 20 semanas  obteniendo \nhasta 30 huevos; de la misma manera cuando se \nconsumen 8.7 gramos menos al d\u00eda,  de alimento por \ngallina, se obtienen 15 huevos menos (Brown y cols. \n2000). En otro estudio Robinson y cols. (2000)  se\u00f1alan \nque el peso del ovario  fue 14.7% del peso vivo  en las \ngallinas alimentadas con las cantidades recomendadas por el manual de la estirpe  y de solamente 6.7% en las \ngallina s alimentadas con una reducci\u00f3n  8.7% del \nconsumo de la dieta.    \n \nREFERENCIAS  \n1. Brake, J.T. (1994, Marzo). El papel de la \nnutrici\u00f3n en la fertilidad. III Curso de actualizaci\u00f3n en \nmanejo de reproductoras e incubaci\u00f3n. ANECA.  24 -\n27, M\u00e9xico D.F.  \n2. Brake, J. an d Peak, S.D. (1999). Feeding \nprograms to maximize broilers breeder fertility. \nAbstracts. Concurrent Meeting Southern Poultry Science Society 20\nth annual  \n3. Brown B. Robinson, F.E., Renema, R.A. and \nHyatt, D. (2000). Effects of feeding profile and \nphotoestimul ation in age in female broiler breeder 2. \nReproductive performance and efficiency. Poultry \nScience Association. 89 Annual meeting abstracts, \nMontreal Canada.  1 63.  \n4. Fancher, B. I. (2000). Aplicaciones pr\u00e1cticas \nde los modelos de nutrici\u00f3n av\u00edcola. VII Simposium av\u00edcola. Universidad de Zacatecas. Seccion nacional de \nprogenitores de aves de la Uni\u00f3n Nacional de Avicultores. p 35 -50 \n5. Ferket, R.P. (2000). Nutrici\u00f3n de las \nreproductoras comerciales de pavos. Avicultura profesional.., 18, 5: 24- 27. \n6. Jensen, L.E. (2 000) Desarrollo ov\u00e1rico y \nproblemas asociados con el calcio en reproductoras pesadas. Tecnolog\u00eda avipecuaria en latinoam\u00e9rica. 13, \n147: 36- 40 7. Lien, R.J., and Hess, B.J. (1999). Effects of \npost-peak feed allotment decrease rate on egg \nproduction by broilers  breeder hens. Abstracts, \nConcurrent Meeting Southern Poultry Science Society \n20\nth annual meeting and Southern Conference on Avian \nDiseases Society 40th annual meeting 18 -19. Atlanta \nGa. S. 107  \n8. Moye, J. (1996). Broiler breeder hen feeding \nprograms to reduc e mortality. World Poultry Elsivier, \n12, 41- 42. \n9. Quintana, J.A., \u00c1vila, G.E., T\u00e9llez, G.I., \nL\u00f3pez, C.C., Herrera, H.J., Rojas, O.L.A. and Le\u00f3n, P.F. (1998b). Relationship between body weight and the hens at 20, 25 and 30 weeks -of-age. Abstracts  \nConcurrent Meeting Southern Poultry Science Society \nand Southern Conference on Avian Diseases 20 -21.  \nAtlanta Ga. S 139.  \n10. Renema, R.A. and Robinson, F.E.  (2000). \nReproductive implications of full feeding female meat \ntype poultry parent stocks. Poultry Science Associa tion \n89 th annual meeting abstracts. Montreal Canada. 18 -\n20, 163.  \n11. Robinson F.E., Renema RA,. Brown B. and \nHyatt, D. (2000). Effects of feeding profile and \nphotostimulation in age in female broiler breeder 3. Carcass characteristics at 64 wk of age. Poultry  Science  \nAssociation 89 th annual meeting abstracts. Montreal Canada 18 -20. 1 63  \n12. Seemann, G. (1997). Environmental \nmanagement. International Hatchery Practice, 11, 27 -\n29. \n13. Wilson, J.L. (1998). Manejo en naves sin \nventanas de reproductores pesados mediante restricci\u00f3n de luz . Selecciones Av\u00edcolas,  3, 155 -163. \n14. Yu, M.H.,  Robinson, F.E., Charles,  R.G., \nWeingardt, R. (1992b). Effect of feed  allowance during rearing and breeding on female broiler breeders. 2. Ovarian morphology and production.  Poultry \nScien ce, 71,  1750- 1761.  \n \n \n \n \n   \n \n    \n 318  \nDETECCI\u00d3N DE HORMONAS SEXUALES Y TIROIDEAS EN \nMUESTRAS DE SUERO IMPLEMENTANDO UN M\u00c9TODO RADIO \nIMMUNO AN\u00c1LISIS HUMANO \n \nDETECTION OF SEXUAL AND TYROID HORMONES IN BROILER \nBREEDER SERUM  USING HUMAN RADIO IMMUNO ASSAY \n \nQuintanaJ .A.1, Avila E.2, Herrera J.3,  L\u00f3pez C.1, T\u00e9llez G.1, Rojas L.A.4, Le\u00f3n F.4 Bravo L.M.5 \n \n1Departamento de Producci\u00f3n Animal:aves FMVZ Universidad Nacional Aut\u00f3noma de M\u00e9xico.  \n2CEIEPA  FMVZ  Universidad Nacional Aut\u00f3noma de M\u00e9xico, 3Colegio de Postgraduados ,  \nMontecillo M\u00e9xico, 4Reproductoras del Valle de M\u00e9xico, 5Laboratorio Cl\u00ednico Tlapan M\u00e9xico.  \n \nSUMMARY  \nThe purpose of this trial was to compare serum \nsexual and tyroid hormone levels in laying and non -\nlaying hens at the onset of sexual maturity, using a \nradio immuno assay. Total tiroxine (T4) levels increase \nas the age of pullets increases, and growth hormone (ST) decreases. Feed restriction results in increased ST and T4, while tri -iodine -tyronine (T3) decreases. On \nfeed days these hormones return to norm al levels, but \nT3 remains low. Laying hens had higher folicule -\nstimulating hormone (FSH), and estradiol levels than \nnon-laying hens. Average body weights at 25 weeks of \nage were also higher in layers. Prolactine and T3 \ntended to be higher in non -laying hens since this birds \nhad not reached sexual maturity.  \nEl objetivo del experimento fue comparar los \nniveles de hormonas sexuales y tiroideas en sangre de gallinas  ponedoras y no ponedoras al inicio de la madurez sexual utilizando el m\u00e9todo de Radio Inmuno An\u00e1lisis.  \n \nMATERIAL Y  METODOS  \nDe una parvada de gallinas reproductoras de \nestirpe Ross, a las 25 semanas de edad alojadas en una granja comercial localizada en el Estado de M\u00e9xico a 2470 msnm, se obtuvieron al azar 30  gallinas; las \ncuales se pesaron indivi dualmente, por sus \ncaracter\u00edsticas f\u00edsicas se determin\u00f3 si ya hab\u00edan \niniciado o no la postura  y se recolect\u00f3 una muestra de sangre sin anticoagulante de cada una de ellas. La \nsangre  se centrifug\u00f3 en la misma granja en un lapso \ninferior a 5 minutos para obtener el suero, los cuales  \nfueron  analizados por el m\u00e9todo de Radio Inmuno \nAn\u00e1lisis (RIA), para determinar las hormonas sexuales \ny tiroideas.  Se utiliz\u00f3 un contador gama  Cobra II  Packard de RIA en fase s\u00f3lida que emplea yodo -125 \ncomo trazador.  \nSe det erminaron las hormonas: Luteinizante \n(LH), fol\u00edculo estimulante (FSH),   prolactina (PRL), estradiol (E2), progesterona (P4), Testosterona (TT). Adem\u00e1s se midieron las hormonas tiroideas: \ntriyodotironina (T3) y Tiroxina total (T4).  \nLos resultados se anali zaron mediante un an\u00e1lisis \nde varianza para datos completamente al azar usando el \npaquete estad\u00edstico SAS (Herrera, 1997).  \n  \nRESULTADOS  \nLa hormona (LH) en suero de gallinas ponedoras \ny no ponedoras a las 25 semanas de edad, present\u00f3 una \ntendencia num\u00e9rica no estad\u00edstica de aumento en las \nponedoras (Cuadro 1); tambi\u00e9n se encontraron valores \npara la prolactina (PRL) en el suero de gallina no \nponedoras, con una alta variabilidad entre los \ntratamientos, lo que determin\u00f3 que no hubiera diferencia estad\u00edstica (p>0.05).  \nEn el Cuadro 1 se muestra la presencia de la \nhormona (FSH) en el suero, con diferencia altamente significativa (P<0.01) entre gallinas, siendo m\u00e1s alto el \nvalor en  las gallinas ponedoras. Tambi\u00e9n se resumen \nlos resultados de la presencia de la horm ona estradiol \n(E2) en el suero de gallinas ponedoras y no ponedoras al inicio de la madurez sexual, con una diferencia de \ncasi 3 veces (301 pg  / ml) mayor (P<0.003) en las \ngallinas ponedoras.  \nLos resultados de la cuantificaci\u00f3n de la \nhormona progesterona   (P4) se observan en el mismo \nCuadro 1, existiendo tendencia estad\u00edstica (P=0.08) entre aves,  siendo m\u00e1s alta en las gallinas ponedoras, se nota tambi\u00e9n diferencia altamente significativa \n(P<0.01) para TT en el suero de gallinas ponedoras con \nrespecto a las no ponedoras.  \nCuando se analiz\u00f3 las presencia de las ho0rmonas \ntiroideas T3 y T4 , no existi\u00f3 diferencia significativa (P>0.05) entre tratamientos de  gallinas ponedoras y no ponedoras.  \n Se pudo detectar que las gallinas ponedoras ten\u00edan un \npeso mayor  promedio de 235 gramos que las no \nponedoras (P<0.05).siendo las primeras con 3.16Kg y \nlas no ponedoras 2.93 Kg.  \n  \n 319  \nCuadro 1 . Cantidad de la hormona Luteinizante (LH),  Prolactina (PRL), Foliculo estimulante (FSH), Estradiol \n(E2), Progesterona(P4), Testoste rona (TT), Triyodotironina (T3), Tiroxina(T4), en suero de gallinas ponedoras y no \nponedoras a la edad de la madurez sexual.  \nPromedio  Ponedoras  No ponedoras  \n mU/ml  DE CV \n mU/ml  DE CV \nLH 6.59 2.86 43 5.43 3.6 66 \nPRL  ng/ml  Ng/ml  \n 4.45 0.66 148 7.57 0.96 127 \n   \n       \nFSH 4.2\u00aa 1.6 39 3.2b 1.7 51 \n \nE2 Pg. / ml  pg./ml  \n 301.2\u00aa  176 58 7.5b 3.5 50 \n   \n ng/ml  DE CV ng/ml  DE CV \nP4 0.18 a  0.14 80 0.4 b  0.01 13 \nTT 0.2 a*  0.05 26 0.16 b*  0.05 33 \na,b, medias con literales distintas son estad\u00edsticamente sig nificativas (P <0.01)  \n   \n ng/dl  DE CV  ng/dl  DE CV  \nT3 68.0 22.2 32 77.4 49.8 64 \n Micg/dl  Micg/dl  \nT4 2.0 0.5 27 1.8 0.3 18 \nNo se encontraron diferencias estad\u00edsticas (P>0.05)  \nDE= Desviaci\u00f3n est\u00e1ndar.   CV= Coeficiente de variaci\u00f3n.  \nNo se encontraron d iferencias significativas (P>0.05)  \n \nDISCUSION  \nBrugeman y cols. (1999 a y b) no encontraron \ndiferencias en los niveles de hormonas sexuales que \npudieran correlacionarse con el tipo de restricci\u00f3n \nalimenticia  empleado durante el desarrollo y sugieren \nque e l comportamiento reproductivo est\u00e1 influenciado \npor el tama\u00f1o de los \u00f3rganos sexuales y la edad de la \nmadurez sexual. Tampoco detectaron alguna \ncorrelaci\u00f3n entre la producci\u00f3n de huevos   y los niveles  de hormonas sexuales.  \nNo se encontraron diferencias estad\u00edsticas para las \nhormonas LH, PRL, T4, y T3 entre ponedoras y no \nponedoras. Los niveles observados para LH, se \nencuentran entre los valores basales reportados por \nBercovitz (1988) y por Lea y cols. (1996).  \nNoddegaard y cols. (2000) mencionan que al \nretardar la fotoestimulaci\u00f3n  no se produce un efecto \nsobre la LH. Estos investigadores observaron que al \nincrementar la LH en la sangre,  tambi\u00e9n  aumenta la producci\u00f3n de huevo. En el presente estudio, aunque la \nLH fue ligeramente mayor para las gallinas p onedoras \nno fue estad\u00edsticamente significativo.   \nEn el caso de la PRL los valores obtenidos \ntambi\u00e9n son similares a los reportados por Bedecarrats y cols. (1997). Los valores de T3  concuerdan con los \nniveles basales informados por Wingfield y Farner (1975) y Bercovitz y Sarver (1988).   \nConforme aumenta la edad  en las  pollas en \ndesarrollo, se incrementa la producci\u00f3n de T4 y decrece la hormona del crecimiento esto se observa \nprincipalmente en las pollas seleccionadas su gran peso \ncorporal. Cuando las pol las est\u00e1n sometidas a un \nprograma de restricci\u00f3n alimenticia se incrementan las \nhormonas del crecimiento  y T4, mientras que la T3 disminuye . En el  d\u00eda que comen las pollas estas hormonas retornan a los niveles normales, excepto la \nT3 que se mantiene en los mismos niveles (Nir y cols. \n1987). Dewil y cols. (1996), observaron que las \nestirpes sensibles al s\u00edndrome asc\u00edtico, ten\u00edan niveles mas bajos de las hormonas triyodotironina (T3) y \ntiroxina (T4).  \n Existi\u00f3 diferencia para la FSH siendo mayor en \nlas gal linas ponedoras que en las no ponedoras, los \nvalores son m\u00e1s altos que los reportados por Erb  y \ncols. (1982). Cuando la gallina pone el  primer huevo los niveles de LH y FSH son estables, independiente \ndel r\u00e9gimen alimenticio (Bruggeman  y cols. 1999 a y \nb). Sin embargo estos autores, no establecieron  \n 320  \nclaramente; como podr\u00edan afectar las concentraciones \nde LH  o FSH,  la cantidad de alimento consumido  o el  \ntiempo de restricci\u00f3n alimenticia.  \nEl estradiol fue mas alto en gallinas ponedoras, \nlos valores se  encuentran entre los rangos de las \nmujeres. Winfield  y Farner en 1975 reportan valores \nbasales con un rango de 74 a 108 pg/ml, en este estudio los datos fueron mas altos. Theriault  y cols. (2000) \nobservaron que al adicionar 30 gramos  extra de \nalimento al d\u00eda por gallina a las 20 semanas de edad  \nantes del  inicio de la producci\u00f3n,   los niveles de \nEstradiol E2 iban aumentando de  20 pg/ml hasta 135 \npg/ml a las 35 semanas de edad. Renema y cols. (2000) demostraron que al adicionar 30 gramos extra de \nalimento por gallina al d\u00eda al inicio de la madurez \nsexual, a los 7 d\u00edas posteriores a la fotoestimulaci\u00f3n,  \nlos niveles de estradiol se encontraron al doble que \ncuando no se sobrealimentaba a la gallina.   \nLos valores para progesterona, aunque con \ndiferencias  estad\u00edsticas entre tratamientos, son  \ninferiores a los reportados por Bercovitz  y Sarver \n(1988) de 1.18 a 1.65 ng/ml; igualmente en humanos  \nlos valores son mayores a 4 ng, posiblemente el \nm\u00e9todo de RIA no detecte los valores reales de \nprogesterona en las gallinas. Las diferencias \nobservadas en la testosterona, con valor m\u00e1s alto en las \nponedoras, coincide con valores para los humanos. Los \npesos corporales promedio de las gallinas ponedoras fueron m\u00e1s altos que en las no ponedoras a las 25 \nsemanas es posi ble que el menor peso corporal de las \ngallinas no ponedoras este relacionado a la falta de \nmadurez sexual, en  las gallinas no ponedoras con \nvalores de hormonas sexuales fueron m\u00e1s bajos. De la \nmisma forma las hormonas prolactina y T3 tienen una \ntendencia a valores m\u00e1s altos en las no ponedoras; \ngallinas que no han alcanzado la madurez sexual. Y estas hormonas se detectan en mayor niveles en aves que no han alcanzado la madurez sexual.  \n.Renema y Robinson (2000) mencionan que \ndebido a que el crecimiento y masa muscular de lo pollos de engorda  se ha incrementado  en las \u00faltimas d\u00e9cadas; se deber\u00e1 redefinir el consumo de alimento en \nlas gallinas reproductoras. Comentan que los \nprogramas de alimentaci\u00f3n ad libitum en las pollas \npueden provocar: obesidad, debili dad, lesiones del \naparato locomotor y menor producci\u00f3n de fol\u00edculos \nov\u00e1ricos; en estas aves se altera el metabolismo y sus \nhormonas reproductivas  debido al balance energ\u00e9tico \nsiempre positivo, cr\u00f3nico. En la actualidad se discute \nentre el apropiado manejo  del alimento y el bienestar \nde la gallina, contra la productividad de huevos \nincubables y pollitos. Los genetistas y fisi\u00f3logos est\u00e1n \ntrabajando para combinar e identificar los factores \nligados al crecimiento y reproducci\u00f3n y la capacidad de producir poll itos que crezcan r\u00e1pidamente sin la necesidad de una fuerte restricci\u00f3n de alimento o del \npeso corporal (Whitehead, 2000).   \nActualmente se est\u00e1 observando  la actividad \nhormonal de una prote\u00edna  llamada \u201dleptina\u201d     que \npodr\u00eda ayudar a regular el apetito  de las gallinas.  La \nleptina se ha encontrado en  el tejido graso e h\u00edgado de los pollos.  Se ha asociado con la obesidad, infertilidad y diabetes de humanos (Tarshis, 2000).  Ashwell  y  \nCzerwinski  (1999) han cuantificado los niveles \nexpresi\u00f3n de la hormon a leptina.  Denbow  y cols. \n(2000)  inyectaron  10 mcrg. de  leptina intracerebral \nen pollos de engorda y en pollas  Leghorn, (r\u00e1pido y \nlento crecimiento respectivamente), notaron que en \nambos casos se redujo el consumo de alimento, sin \nafectar el consumo de agua.  \nFinalmente Dridi y cols. (2000) vieron que la \ncantidad de leptina en las gallinas  no modifica el comportamiento frente al comedero, pero disminuye el \ntiempo que permanece la gallina comiendo. Se sugiere \nrealizar estudios utilizando la hormona lep tina  como \ninhibidor del apetito en gallinas reproductoras pesadas \ncomo m\u00e9todo alterno de restricci\u00f3n alimenticia para \nevitar el estr\u00e9s excesivo  del hambre y la competencia \npor el alimento.  \n \nREFERENCIAS  \n1. Ashwell, C.M. Czerwinski, S.M.(1999). \nHormonal regul ation of leptin expression in broiler \nchickens. American journal of physiology: regulatory, integrative and comparative physiology. 45: 1 226 .  \n2. Bedecarrats, G., Guemene, D. and Richard -\nYris, M.A. (1997). Effects of enviromental and social \nfactors on incub ation behavior, endocrinological \nparameters, and production traits in turkey hens \n(Meleagridis gallopavo). Poultry Science, 76, 1307 -\n1314.  \n3. Bercovitz A.B. and Sarver, P.L. (1988). \nComparative sex -related differences of excretory sex \nsteroids form day -old an dean condors (Vultur gryphus) \nand peregrine falcons (Falco peregrinus)  : non -invasive \nmonitoring of neonatal endocrinology. Zoo Biology, 7, \n147-153. Obtenido en la red mundial el 7 de Agosto de \n1999: http://www.agris.com  Bercovitz A.B. Mirsky, A. \nand Frye, F. Jr. (1985). Non -invasive assessment of \nendocrine differences in day -old chicks (Gallus \ndomesticus) by analysis of the immunoreactive \noestrogen excreted in the egg. Journal Reproduction \nFertility, 74, 681.  \n4. Bruggeman, V., Onagbesan, O., D`hondt, E., \nBuys, N., Safi, M., Vanmonfort, D., Berghman, L., \nVandesande, F. and Decuypere E. (1999 b) Feed \nrestriction in broiler pullets. Poultry Science  78, 10: \n144-154. \n5. Denbow, D.M., Meade, S., Robertson, A., \nMc Murtry, J.P., Richards, M. and Ashwell C, (2000).  \n 321  \nLeptin -induced decraese in food intake in chickens. \nPhysiology Behaviour,  69:3 359- 62.  \n6. Dewil, E., Buys, N., Albers, G.A. and \nDecuypere, E. (1996). Different characteristics in chick \nembrios of two broiler lines differing in  susceptibility \nto ascites. British Poultry Science 37, 1003 -1013.  \n7. Dridi, S., Raver, N., Gussakovsky, E.E., \nDerouet, M., Picard, M., Gertler, A., Taouls, M. \n(2000). Biological activities of recombinant chicken , \nleptin C4S analog compared with unmodified l eptins. \nAmerican Journal Endocrinology Metabolism.  279:1 \nE116- 23.  \n8. Erb, L., Lasley, B.L., Czekala, N.M. \nMonfort, S.L. and Bercovitz, A.B. (1982). A dual radioimmunoassay and cytosol receptor binding assay \nfor the measurement of estrogenic compounds applie d \nto urine, fecal and plasma samples. Steroids, 39, 1.  \n9. Lea, R.W., Richard -Yris, M.A., and Sharp, \nP.J. (1996). The effect of ovarioectomy on \nconcentrations of plasma prolactin and LH and parental \nbehavior in the domestic fowl.  Genetic and Comp \nEndocrinology, 101, 115- 121.  Nir, I., Harvey S., \nCherry, J.A., Dunnnington, E.A., Klandorf, H., Siegal, \nP.B. (1987) Growth- associated traits in parenteral and F1 population of chickens under different feeding programs. 4 growth and thyrord hormones. Poultry \nScience.  66, 32- 37. \n10. Noddegaard, E., Talbot, R.T., Sharp, \nP.J.(2000).  Effect of delayed step -up lighting on \nplasma luteinizing hormone and reproductive function in broiler breeders. Poultry Science, 79,5: 778- 83.  \n11. Renema, R.A. and Robinson, F.E.  (2000). \nReproduct ive implications of full feeding female meat \ntype poultry parent stocks. Poultry Science Association 89 th annual meeting abstracts. Montreal Canada. 18 -\n20, 163.  \n12. Tarshis, S. New technique to measure leptin \nactivity.(2000). Agricultural research 48, 5: 22 -12.  \n13. Theriault, C., Tremblay, N., Robinson, F.E., \nRenema, R.A. and Proudman, J.A. (2000, August) Changes in plasma estradiol concentration and plasma \nlipid level in broiler breeder pullets in response to \nbonus feeding during sexual maturation. Poultry \nScien ce Association 89\nth annual meeting 18 -20 \nabstracts. Montreal Canada. Whitehead, C.C. (2000) \nNutrition: the interrogative science. British Poultry \nScience. 41, 5 -15. \n \nPRIMER HALLAZGO EN M\u00c9XICO DEL \u00c1CARO  \nTERYGOCRUSOLICHUS CHANAYI EN GUAJOLOTES DE M\u00c9XICO  \n \nFIRST REPORT IN MEXICO OF THE MITE PTERYGOCRUSOLICHUS \nCHANAYI  IN TURKEYS  \n \nMa.Teresa Quintero M..  \n \nDepartamento de Parasitolog\u00eda, Facultad de Medicina Veterinaria y Zootecnia, U.N.A.M. Coyoac\u00e1n, C.P. 04510 \nM\u00e9xico D.F.  \n \nSUMMARY  \nThis paper reports the presen ce of mites \ncharacterized as Pterygocrusolichus chanayi  \n(Trouessart ), family Pterolichidae, in turkey feathers . \nMites were found in turkeys in Palizada, Campeche, \nMexico, suffering feather loss. Mites were fixed using \nHoyer\u2019s fluid, to be further analyzed under the light \nmicroscope. This particular mite has been isolated \nelsewhere from both domestic and wild turkeys. \nNevertheless, this is the first report of its presence in \nMexican turkeys.  \n \nRESUMEN  \nEn el presente trabajo se comunica la presencia de \n\u00e1caros en plumas de guajolotes, a los que se determin\u00f2 \ncomo Pterygocrusolichus chanayi  (Trouessart)  \npertencientes a la familia Pterolichidae, los \u00e1caros  \nfueron  encontrados en guajolotes de Palizada, Campeche, M\u00e8xico, que presentaban caida de plumas, \ncon los \u00e1caros encontrados se realizaron preparaciones \nempleando l\u00edquido de Hoyer y m\u00e1s tarde se observaron al microscopio compuesto. estos \u00e0caros, han sido \naislados de guajolotes dom\u00e9sticos y silvestres sin \nembargo  esta la primera vez que se comunica \npresencia en guajolotes de M\u00e8xico  \n \nINTRODUCCI\u00d3N  \nLos \u00e1caros de las plumas de guajolotes \nconstituyen  una gama de diversos g\u00e9neros y especies \npertenecientes a diversas  familias, entre las que se \nencuentra la familia Pterolichidae en la que se incluyen al g\u00e9nero Pterolic hus entre otros. En el presente trabajo \nse comunica la presencia de \u00e1caros en plumas de \nguajolotes a los que se determin\u00f3 como \nPterygocrusolichus chanayi  \n   \n 322  \n MATERIAL Y METODOS  \nEl material consisti\u00f3 en  plumas separadas de \nguajolotes criados en Palizada, Ca mpeche, los \nguajolotes mostraban ca\u00edda de plumas, dichas plumas \nfueron transportadas al laboratorio a donde se les \nexamin\u00f3 bajo el microscopio,estereosc\u00f3pico, de las \nplumas positivas a \u00e1caros se fueron separando \u00e9stos y se les mont\u00f3 entre porta y cubreobjetos empleando \nl\u00edquido de Hoyer  \n \nRESULTADOS  \n Al realizar la observaci\u00f3n de las preparaciones \nobtenidas, bajo el microscopio compuesto, se lleg\u00f3 a la \nconclusi\u00f3n de que se trataba de \u00e1caros de la familia \nPterolichidae y se les identific\u00f3 como \nPterygocrusolic hus chanayi  (Trouessart  and Megnin) \nse encontraron \u00e1caros en todas sus fases evolutivas. \nSeg\u00fan  Gaud y Atyeo, 1996 estos \u00e1caros se \ncaracterizan  por presentar ep\u00edmeros libres no \narticulados, asimismo presentan un par de sedas \nverticales; una caracter\u00edstica sobresaliente en el macho es que presentan los f\u00e9mures de las patas I Y II expandidos,  as\u00ed como que las patas posteriores  son \nsublaterales, estos \u00e1caros han sido encontrados en \nguajolotes dom\u00e9sticos y en silvestres.  \n \nDISCUSION Y CONCLUSIONES  \nLa importa ncia de esta comunicaci\u00f3n,  radica en \nel hecho de que estos \u00e1caros pudieran estar provocando \nla ca\u00edda de plumas; los \u00e1caros encontrados se \ncaracterizan.   Al parecer esta es la primera vez que se \nidentifica a este \u00e1caro en M\u00e9xico por lo que deber\u00e1 \nponerse atenci\u00f3n sobre el diagn\u00f3stico de estos \u00e1caros a \nfin de no confundirlos con otros muy cercanos como \nson los del g\u00e9nero Pterolichus  y asimismo establecer \nel da\u00f1o que estos organismos causen en las plumas de \nguajolotes.  \n \nREFERENCIAS  \n1. Gaud , J.and Atyeo W. Feather mites on the \nworld (Acarina, Astigmata) Ann Zoologische \nWetenschappen 277:100  1996.  \n  \nMODULATION OF PHAGOCYTE FUNCTION BY \nOVOTRANSFERRIN, A CHICKEN ACUTE PHASE PROTEIN  \n \nMODULACI\u00d3N DE LA FUNCI\u00d3N DE LOS FAGOCITOS POR LA \nOVOTRANSFERRINA, PROTE\u00cdNA DE FASE AGUDA EN EL POLLO  \n \nN. C. Rath, H. Xie, W. E. Huff, G. R. Huff, and J. M.  Balog, \n \n PPPSR, ARS, USDA, University of Arkansas, Fayetteville, AR 72701  \n \nRESUMEN  \nLas prote\u00ednas de fase aguda son prote\u00ednas \nplasm\u00e1ticas cuyas concentraciones s\u00e9ricas se elevan \ndurante los procesos de infecci\u00f3n e inflamaci\u00f3n. Una \nde ellas es la ovotransferrina en las aves. Para  \ncomprender el significado de la elevaci\u00f3n de sus \nniveles en la inflamaci\u00f3n estudiamos sus efectos in vitro  sobre una l\u00ednea celular de macr\u00f3fagos de pollo  \n(HD11) y sobre los heter\u00f3filos de la sangre perif\u00e9rica. \nLa ovotransferrina indujo la producci\u00f3n de \ninterleucina -6 y de metaloproteinasa de la matriz; \nadem\u00e1s, estimul\u00f3 las actividades de estallido \nrespiratorio en ambos tipos de c\u00e9lulas. S\u00f3lo las c\u00e9lulas \nHD11 produjeron nitrito bajo el est\u00edmulo con la \novotransferrina y \u00e9sta indujo la desgranulaci\u00f3n de los \nheter\u00f3filos. Estos resultados sugieren que la \novotransferrina tiene efectos inmunomoduladores sobre los macr\u00f3fagos y los heter\u00f3filos.  \n \nInflammation induce s many physiological \nchanges one of which is the increases in the levels of \nseveral serum proteins called acute phase proteins (APP).  The exact functions of APPs during \ninflammation is not clear but it is thought that these \nproteins may modulate immune re sponse and help \nrestore physiological homeostasis.  Serum transferrin is \na major APP in poultry [1, 2].  We recently showed \nthat it is the same protein as ovotransferrin, a major egg \nwhite protein [3]. The serum level of ovotransferrin \nincreases in respons e to inflammation and a variety of \nbacterial and viral infections [3].  To understand the \nrole of ovotransferrin during inflammation, we studied \nits effects on a chicken macrophage cell line HD11 and \nheterophils in culture.  We used ovotransferrin at concentrations 0,1,10,100, and 1000 \uf06d\ng/ml of culture \nmedium and measured the changes in the levels of interleukin -6 (IL -6), nitrite, and matrix \nmetalloproteinases (MMP) in the conditioned media after 24 h of culture, the respiratory burst activities within 2 h,  and the degranulation of heterophils \nbetween 6 -24 h. The methods used have been described \npreviously [3, 5, 6]. The results of these experiments are summarized in Table 1. Ovotransferrin at doses of \n100 \uf06dg/ml or above induced  Il-6 and MMP production  \n 323  \n in both cell types, stimulated nitrite production by \nHD11cells and potentiated phorbol myristate acetate \n(PMA) -induced respiratory burst in HD11 cells  \nmeasured by the oxidation of dichlorofluorescein \ndiacetate. On the other hand, heterophils did not \nproduce n itrite but exhibited an increase in respiratory \nburst activities with ovotransferrin alone. Like PMA, \novotransferrin induced loss of fluorescein \nisothiocyanate stained cytoplasmic granules in heterophils. Ovotransferrin was neither mitogenic nor cytotoxic to these cells. These results suggest that \novotransferrin can modulate macrophage and \nheterophil functions in chickens. The need for a high \nthreshold concentration of ovotransferrin by these cells \nimplies that regulation occurs only under emergency \nsituations such as inflammation or infection, because many of the APPs are normal constituents of blood.\n \nTable 1.   Effects of ovotransferrin on HD11 macrophage and heterophils.  \n \nCell type   \nIL-6  \nNitrite   \nMMP   \nRespiratory \nburst   \nDegranulation   \nViability  \n \nHD11   \n\uf06d  \n\uf06d  \n\uf06d  \n\uf06d  \nN/A  \n\uf06d \n \nHeterophils   \n\uf06d  \nN/A  \n\uf06d  \n\uf06d  \n\uf06d  \n\uf06d \n\uf06d = increased, \uf06d = no change, N/A= not applicable  \n \nREFERENCES  \n1. Hallquist, N. A. and K. C. Klasing. \nSerotransferrin, ovotransferrin and metallothionein \nlevels during an immune response in chickens. Comp.  \nBiochem. Physiol. 108B:375- 384, 1994.  \n2. 2. Chamanza, R, Toussaint, M. J. M,  van \nEderen, A. M,   van Veen, L., and  Hulskamp -Koch, C. \nA. preliminary investigation of using acute phase \nvariables to assess diseases in chickens.  Vet. Ouart. \n21: 158- 162. 1999.   \n3. Xie, H., G. R. Huff, W. E. Huff, J. M. \nBalog, P. Holt, and N. C. Rath. Identification of \novotransferrin as an acute phase protein in chickens.  \nPoultry Sci., 81: 112- 120. 2002 . 4. Xie, H., L. Newberry, D. C. Clark, W. E. \nHuff, G. R. Huff, J. M. Balog, N. C. Rath.  Changes in \nserum ovotransferrin levels in chickens with \nexperimentally -induced inflammation and diseases.  \nAvian Dis., in press, 2002.  \n5. Rath, N. C., G. R. Huff, J. M. Balog, W. E. \nHuff. Fluorescein isothiocynate staining and characterization of avia n  heterophils. Vet. Immunol. \nImmunopathol. 64: 83- 95.  1998.  \n6. Xie, H., N. C. Rath, G. R. Huff, J. M. Balog, \nW. E. Huff.  Inflammation -induced changes in serum \nmodulate chicken macrophage function. Vet. Immunol. \nImmunopathol. 80: 125-135. 2001.  \n \nENFERMEDAD  DE MAREK EN POLLO DE  ENGORDA  \nINFORME DE UN CASO  \n \nMAREK\u2019S DISEASE (MD) IN BROILERS: A CASE REPORT  \n \nRevelo SU1,  Ju\u00e1rez RM1, Petrone VM1 \n \n1  Departamento de Producci\u00f3n Animal: Aves, Facultad de Medicina Veterinaria y Zootecnia, Universidad Nacional \nAut\u00f3noma  de M\u00e9xico, 04510, M\u00e9xico, D.F.  \n \nSUMMARY  \nA case of MD in broilers is described. Prostration, \ngreen feces, paralysis of one or more extremities, and \nskin lesions were observed. Mortality was increased starting early in the cycle, and cumulative mortality a t \nthe end (56 days) was 25.4%. By the 8 th week \n(processing) signs were characterized by enlarged feather follicles in wings and legs, and around the vent.  Loss of iris pigmentation (iridocyclitis) was also \nobserved. Histological results showed lesions typical of \nMD. Nevertheless lesions in the thymus and bursa of \nFabricius suggest infections with other viruses like \ninfectious bursal disease virus, chicken anemia virus, \nor reovirus.  \n  \n 324  \n RESUMEN  \nSe describi\u00f3 un caso de la Enfermedad de Marek \nen pollo de engorda.  Se observaron pollos postrados, \nheces verdes, par\u00e1lisis de una o m\u00e1s de las \nextremidades adem\u00e1s de lesiones cut\u00e1neas. La \nmortalidad se incremento desde el inicio del ciclo y la \nmortalidad acumulada para el fin del ciclo (56 d\u00edas) fue \nde 25.4%. Para la 8\u00b0 semana cuando las aves salieron a \nrastro los signos se caracterizaron por el aumento de \ntama\u00f1o del fol\u00edculo de la pluma en extremidades \nsuperiores e inferiores y alrededor de la cloaca y se \nobserv\u00f3 despigmentaci\u00f3n del iris (iridociclitis). Los \nresultados d e la histolog\u00eda mostraron lesiones \ncaracter\u00edsticas con la Enfermedad de Marek, sin \nembargo las lesiones en timo y bolsa de Fabricio \nsugieren infecciones por otro virus como el de \nGumboro, Anemia Infecciosa o Reovirus.  \n \nINTRODUCCI\u00d3N  \nLa Enfermedad de Marek ( EM) es una \nenfermedad infecciosa, causada por un herpesvirus, \ncaracterizada por causar infiltrado linfoide neopl\u00e1sico. \nEl virus se replica en las c\u00e9lulas del fol\u00edculo de las \nplumas y \u00e9ste encuentra su v\u00eda de salida a trav\u00e9s de la piel mediante las descamaciones. La importancia de \nesta enfermedad es la inmunosupresi\u00f3n as\u00ed como en las \nperdidas econ\u00f3micas  por decomisos en rastro y \ndesechos de pollos retrasados. \u00daltimamente esta \nenfermedad se ha presentado en aves a\u00fan vacunadas, \naves adultas, y en lugares que ten\u00edan poca incidencia de \nesta. \nEl objetivo principal del trabajo es describir un \ncaso de la enfermedad de Marek, y la forma como se elaboro el diagn\u00f3stico.  \nHistoria cl\u00ednica. El caso se presento en una \nexplotaci\u00f3n de pollo de engorda, estirpe Ross, en el estado de M\u00e9xico. El calendario de vacunaci\u00f3n \nconsisti\u00f3 en:  al 1\u00b0 d\u00eda Marek, 8\u00b0 d\u00eda Gumboro Oral, \n12\u00b0 enfermedad de Newcastle (ENC) simult\u00e1nea y BI \nOcular, 21\u00b0 Gumboro oral. Las aves tuvieron un desarrollo inicial sin problemas cl\u00ednicos aparentes hasta \nla semana 5 donde se observ\u00f3 pollos postrados, heces \nverdes, par\u00e1lisis de una o m\u00e1s de las extremidades \nadem\u00e1s de lesiones cut\u00e1neas. A la semana 7 la \nmortalidad acumulada fue de 20.2%. La mortalidad se \nincremento desde el inicio del ciclo. La mortalidad acumu lada para el fin del ciclo (55 d\u00edas) fue de 25.4%. \nPara la 8\u00b0 semana cuando las aves salieron a rastro los signos se caracterizaron por el aumento  de tama\u00f1o del \nfol\u00edculo de la pluma que se observaron generalmente \nen extremidades superiores e inferiores y alrededor de \nla cloaca y se observ\u00f3 despigmentaci\u00f3n del iris \n(iridociclitis).  \nHallazgos macrosc\u00f3picos. En la inpecci\u00f3n externa \nse observaron costras distribuidad multifocalmente \nsobre la piel, ademas de \u00e1reas de hemorragias equimoticas. En la inspecci\u00f3n interna se observo hidropericardio, y en coraz\u00f3n se apreciaban n\u00f3dulos \nblancos. En la cavidad abdominal se observo ascitis, el \nh\u00edgado amarillo y  aumentado de tama\u00f1o, con bordes \nredondeados (cambio graso), disminuci\u00f3n moderada en \nel tama\u00f1o de la bolsa de Fab ricio y aumento de tama\u00f1o \ndel bazo con presencia de n\u00f3dulos blancos. Se \ncolectaron muestras de los \u00f3rganos afectados y fueron \nconservados en formol al 10%.  \nPruebas Complementarias. Adem\u00e1s se colectaron \nsueros para estudios de: ELISA de Reovirus y \nInhibici \u00f3n de la Hemoaglutinaci\u00f3n  (HI) de ENC e \nInfluenza Aviar (IA), as\u00ed como \u00f3rganos para aislamiento viral para la enfermedad de Newcastle y \nMarek, a partir de pulm\u00f3n, tr\u00e1quea, enc\u00e9falo y piel.  \nHallazgos microsc\u00f3picos. Se observo \npanofalmitis fibrinopurulenta severa, atrofia t\u00edmica \ncortical severa, infiltraci\u00f3n linfocitaria moderada en la \nmucosa del proventr\u00edculo, infiltraci\u00f3n linfocitaria leve \nen nervio ci\u00e1tico, depleci\u00f3n linfoide severa en bazo, \nduodenitis linfoc\u00edtica de moderada a severa, abundante \ninfiltrac i\u00f3n de linfocitos neopl\u00e1sicos en h\u00edgado, en \nbolsa de Fabricio se encontr\u00f3 bursitis cr\u00f3nica de leve a \nmoderada y atrofia de fol\u00edculos linfoides, y nefrosis de \nleve a moderada.  \nResultados de Serolog\u00eda.  Para la prueba de  \nELISA de reovirus 5/7 sueros resultaron con t\u00edtulos de \nanticuerpos para reovirosis. Sin embargo los resultados \nde aislamiento para el virus de Newcastle y Marek fueron negarivos, as\u00ed como los t\u00edtulos de HI tanto para \ninfluenza como para Newcastle.  \n \nDISCUSI\u00d3N Y CONCLUSI ONES  \nLas lesiones microc\u00f3picas  fueron caracter\u00edsticas \ncon la Enfermedad de Marek, sin embargo las lesiones \nen timo y bolsa de Fabricio sugieren infecciones por \notro virus como el de Gumboro, Anemia Infecciosa o \nReovirus. Las lesiones hep\u00e1ticas y renales sugieren una \nintoxicaci\u00f3n  ex\u00f3gena, mientras la enteritis linfoc\u00edtica \nsugiere un proceso t\u00f3xico o viral. El uso de antibi\u00f3ticos \nu otros f\u00e1rmacos pudieron producir lesiones similares \nen h\u00edgado y ri\u00f1\u00f3n. Los da\u00f1os linfoides sugieren inmudepresi\u00f3n.  \nLos resultados serol\u00f3gicos mostraron un \ncoeficiente de Variaci\u00f3n de 58% y resultado negativo de dos de siete sueros a la ELISA de reovirus, lo cual \nrepresenta un estado inmune diferente de los pollos. \nAunque el aislamiento del virus de Marek fue negativo las lesiones observadas fueron compati bles con Marek, \nse\u00f1alando la exposici\u00f3n  temprana del virus en concentraciones suficientes para provocar la enfermedad,  lo que hace hincapi\u00e9 en reforzar medidas \nde bioseguridad, as\u00ed como no permitir el alojamiento de \naves de diferentes edades. La limpieza  y desinfecci\u00f3n, \nas\u00ed como el descanso sanitario de las instalaciones \nreduce significativamente la exposici\u00f3n del virus de la  \n 325  \n enfermedad  de Marek y a otros agentes pat\u00f3genos que \ninteract\u00faan con el virus de esta enfermedad.  \nEl diagn\u00f3stico diferencial fue pr incipalmente con \nENC, y se descarto por el aislamiento y t\u00edtulos de HI negativos.  \nEvaluar la aplicaci\u00f3n eficaz de la vacuna, desde el \ntiempo en que \u00e9sta es preparada, temperatura de almacenamiento y t\u00edtulo, asegurar que este \nadecuadamente manejada y aplicada desde el tanque de \nNitr\u00f3geno hasta el contacto con el ave; as\u00ed como \ntambi\u00e9n evitar mezclar la vacuna con antibi\u00f3ticos que \ndisminuyan el t\u00edtulo.  \nLos par\u00e1metros productivos como la mortalidad, \nganancia de peso y por lo tanto el \u00edndice de productividad, ki los por metro cuadrado etc., no \nalcanzaron los valores estimados, la mortalidad se \nelev\u00f3 considerablemente y los decomisos en rastro \ncontribuyeron con las p\u00e9rdidas econ\u00f3micas.  \nOtro aspecto importante es implementar la \nevaluaci\u00f3n de la calidad que cada d\u00eda se vuelve una actividad de rutina que ayuda en muchos casos a detectar tempranamente posibles problemas; as\u00ed como realizar un monitoreo para Anemia Infecciosa Aviar, \nInfecci\u00f3n de la bolsa de Fabricio contra virus que \nafecten el sistema linfoide o procesos t\u00f3xicos. Todos  \naquellos factores que comprometan la integridad \nfisiol\u00f3gica del sistema inmunol\u00f3gico deben ser \nidentificados  e implementados los programas necesarios para su control.  \n \nREFERENCIAS  \n1. Calnek B. W. Diseases of Poultry. 9\u00b0 Ed.  \nEditorial Manu al Moderno. 1995. 1148 p\u00e1ginas.  \n2. Mu\u00f1oz Ricardo. Control  de Marek. \nIndustria Av\u00edcola, Diciembre 2000.  \n3. Petrone Garc\u00eda, Hern\u00e1ndez Velasco y T\u00e9llez \nIsa\u00edas. Enfermedad de Marek. Veterinaria M\u00e9xico 31 (4),  2000.  \n4. Petrone Garc\u00eda V. M., Salado Carvajal R. y \nT\u00e9llez Isa\u00edas G. Enfermedad de Marek. En: Sistemas \nde Producci\u00f3n Animal II Aves, Volumen 2, Sistema  de \nUniversidad Abierta. 1999.  \n \nMANEJO DE LOS DESECH OS EN LA INDUSTRIA AV\u00cdCOLA  \n(ESTUDIO RECAPITULAT IVO)  \n \nWASTE MANAGEMENT IN THE POULTRY INDSUTRY  \n(A SUMMARY REPORT)  \n \n1Gonzalo N. Salazar Matal\u00ed, 1Jos\u00e9 A. Quintana L\u00f3pez, 2Ren\u00e9 Rosiles Mart\u00ednez  \n \n1Departamento de Producci\u00f3n Animal: Aves. 2Departamento de Nutrici\u00f3n  \nFacultad de Medicina Veterinaria y Zootecnia Universidad Nacional Aut\u00f3noma de M\u00e9xico  \n \nSUMMARY  \nThe poultry industry is formed by high \ntechnology/high productivity complexes that generate large amounts of waste, i.e.: cadavers (either natural \nmortality or culled birds) and feces. Therefore, a waste \nmanagement program should exist. Major waste systems are  listed, described and discussed herein, \ntogether with some suggested guidelines\n. \n \nRESUMEN  \nLa industria av\u00edcola se integra por complejos \ntecnificados con alta productividad por lo que se \nproducen grandes cantidades de desechos entre los que \nse encuentran c ad\u00e1veres de las aves muertas o \nseleccionadas durante el ciclo y excretas de los \nanimales, por lo que se debe contar con un programa \nintegral de manejo de los desechos que se producen. Se enlista describe y discute en el texto las principales \nformas de mane jar los desechos y se acompa\u00f1a de una \nserie de lineamientos que se sugieren para el manejo \nadecuado de los mismos.  INTRODUCCI\u00d3N  \nLa industria av\u00edcola en los \u00faltimos 50 a\u00f1os ha \npasado de ser una actividad de traspatio a una industria consistente en complejos  altamente tecnificados y \nconcentrados, con el correspondiente incremento en los desechos producidos. El impacto del nitr\u00f3geno, f\u00f3sforo \ny agentes pat\u00f3genos en el medio ambiente ha forzado a \nla industria av\u00edcola a implementar medidas para el \nmanejo de desechos.  \n \nMANEJO DE LOS DESECH OS S\u00d3LIDOS \nEN LA INDUSTRIA AV\u00cdC OLA  \nAlgunas de las pr\u00e1cticas m\u00e1s comunes para \nmanejar desechos se discuten a continuaci\u00f3n:  \n1. Rellenos sanitarios. Pueden usarse para \neliminar desechos de incubadoras, cadaveres de las aves y decomisos en el rastro, su aplicaci\u00f3n se limita \npor: accesibilidad, costo y regulaciones ambientales.  \n2. Molienda. Se aplica para convertir los \ndesechos del proceso del pollo en un ingrediente \u00fatil  \n 326  \n para alimentaci\u00f3n animal. La ubicaci\u00f3n de la granja, \nfacilidad de trans porte, y costo pueden ser limitantes.  \n3. Extrusi\u00f3n. Consiste en forzar \nmec\u00e1nicamente el material a trav\u00e9s de un orificio peque\u00f1o, se puede utilizar para desechos de \nincubadoras y cad\u00e1veres.  \n4. Compostas. Este proceso reduce el volumen \nde los materiales, destruye  la mayor\u00eda de las bacterias \npat\u00f3genas, y estabiliza el material, para ser utilizado \ncomo fertilizante o ingrediente para alimentaci\u00f3n \nanimal, incluso de aves. En otros pa\u00edses se realiza de \nmanera comercial.  \n5. Pozos de desecho. Utilizados com\u00fanmente, \ny aprobados para el desecho de cad\u00e1veres en algunas \u00e1reas. Se deben construir de manera que se garantice su \nimpermeabilidad.  \n6. Lagunas y tanques cerrados. Se utilizan \ndesde la d\u00e9cada de 1960 para gallinas de postura y \notras explotaciones animales. Deben contar con recubrimientos adecuados.  \n7. Aplicaci\u00f3n a la tierra como fertilizante. Es \nuna pr\u00e1ctica muy antigua y a\u00fan aplicable. Se recomienda aplicar 9 toneladas de desechos por \nhect\u00e1rea en una sola aplicaci\u00f3n al a\u00f1o, y 14 toneladas \npor hect\u00e1rea si son m\u00faltiples las aplicaciones.  \n8. Los desechos se utilizan como ingrediente \npara la dieta de rumiantes, se agrega melaza, se debe separar la mortalidad de los desechos, para prevenir la \npresentaci\u00f3n de botulismo en los rumiantes. Es \nimportante controlar la cantidad de microminerales en \nlas excretas de las aves para evitar la presentaci\u00f3n de \ntoxicidad en rumiantes, tambi\u00e9n se debe observar la \nsusceptibilidad de las especies.  \n \nCONCLUSIONES  \nLas regulaciones ambientales tienden a hacerse \nm\u00e1s estrictas, lo que obliga a los productores pecuarios \na buscar mecanismos para dar valor agregado a los \ndesechos convirti\u00e9ndolos en subproductos. Los \nmercados potenciales para los desechos de las granjas \nav\u00edcolas se pueden agrupar de la siguiente forma: 1) \nfertilizantes para el suelo, 2) ingrediente  para el \nalimento de animales, y 3) fuente de energ\u00eda.  \nEl uso de desechos de aves para alimentar al \nganado bovino es exitoso bajo circunstancias \nadecuadas y buen manejo, igualmente la aplicaci\u00f3n de \nlos desechos como fertilizante, especialmente cuando \nlos s uelos son inf\u00e9rtiles por naturaleza y los desechos \nson aplicados de manera local, es decir que el costo por \ntransportaci\u00f3n no sea excesivo.  \n \nREFERENCIAS  \nDisponible con el autor.  \n \nCOMPARISON OF SURVEY DATA ON ANTIBIOTIC GROWTH \nPROMOTANTS AND RESPONSES TO A LTERNATIVES  \n \nCOMPARACI\u00d3N DE LOS DATOS DE UNA ENCUESTA SOBRE LOS \nPROMOTORES ANTIBI\u00d3TICOS DEL CRECIMIENTO Y LAS RESPUESTAS A \nOTRAS ALTERNATIVAS  \n \nA.E. (Ted) Sefton and Steve Collett  \n \nAlltech, Inc., 3031 Catnip Hill Pike, Nicholasville, KY 40356  \n \nRESUMEN  \nLos antibi\u00f3ticos promotores del crecimiento se \nhan convertido en un est\u00e1ndar de inclusi\u00f3n en las \nraciones para pollos de engorda y pavos. Este trabajo \nresume los estudios realizados para investigar la \nrespuesta sobre un suplemento alternativo (Bio- Mos\u00ae, \nAlltec h, Inc., Nicholasville, KY, EE.UU.) en dietas \nlibres de promotores del crecimiento u otras que \nconten\u00edan promotores antibi\u00f3ticos. Bio -Mos es un \noligosac\u00e1rido manano fosforilado, derivado del material de la pared celular de las levaduras. Estos \nreportes ind ican que,  cuando no se utiliza un \nantibi\u00f3tico promotor del crecimiento, la inclusi\u00f3n de \nBio-Mos representa una ventaja en el rendimiento de \nlas dietas para pollos de engorda y pavos. Bio- Mos se puede usar para sustituir a un antibi\u00f3tico promotor del \ncreci miento con la expectativa de obtener resultados \ncomparables de rendimiento.  \n \nINTRODUCTION  \nAntibiotic growth promotants have become a \nstandard inclusion in broiler and turkey rations. Rosen (1) reported improvement in gain and/or feed \nconversion in 72% of 12,153 studies of 14 \nantibacterials in poultry and swine tests. Recently, the \nAmerican Medical Association, House of Delegates \nurged the United States Food and Drug Administration \nto \u201cphase out all anti- microbials except under \nveterinary prescription for d efined therapeutic \npurposes\u201d (2).  This pressure is based on the perceived  \n 327  \n link between the agricultural use of antibiotics and the \npresence of antibiotic resistant bacteria found in human \ninfections (3). There has been consumer pressure to \nfind alternativ es to antibiotic growth promoters, which \nhas lead to a number of producers to evaluate \nalternative programs.  \nThis paper summarizes published and \nunpublished studies investigating the response to an \nalternative supplement (Bio -Mos\uf6da, Alltech, Inc., \nNicholasv ille, KY) in growth promoter -free diets and \nthose containing antibiotic growth promoters. Bio -Mos \nis a phosphorylated mannan oligosaccharide derived \nfrom yeast cell wall material. In all cases, the summary \nis broken down into published papers, abstracts of  \nmaterial presented at scientific meetings and non -\npublished commercial evaluations.   \n \nBIO-MOS RESPONSE IN ANTIBIOTIC -FREE \nPROGRAMS  \nBroilers.  Birds supplemented with Bio -Mos had \ngreater weight for age compared to those on antibiotic-free programs.  Diffe rences ranged from +0.54 to + \n4.81% in the seven papers. The overall improvement \nwith Bio -Mos was 2.72% average (each study given \nequal weight). The difference was +0.54% in published \npapers, +3.76% for papers published as abstracts and +2.75% for unpublis hed evaluations.  \nIn all seven studies, Bio -Mos fed birds had \nimproved feed conversion, compared to those on program not containing an antibiotic growth promotant .  \nThe difference ranged from \u2013 0.54 to \u2013 8.96%.  The \noverall average improvement was \u2013 3.17%.  T he \ndifference was 1.42% for the single published paper, \n6.10% for abstracts, and 2.35% for the unpublished \nreports.  \nThese reports indicate that broiler performance \nimproved when Bio- Mos was fed, both in terms of \ngrowth rate and feed efficiency, when compar ed to a \nprogram not containing a growth promotant antibiotic.  \nTurkeys.   The overall average improvement in \ngrowth rate was 1.49% in flocks fed Bio- Mos \ncompared to those given no antibiotic growth \npromotant. Of seven comparisons, Bio- Mos fed birds \nhad bett er weight for age in four (57%) of the \ncomparisons.  The difference ranged from \u2013 2.72 to \n+5.86%.  The difference was +2.63% for published \npapers, +5.86% for abstracts and 0.39% for unpublished reports.  \nOverall average improvement in feed conversion \nwas 1.9 9% in flocks fed Bio -Mos compared to those \ngiven an antibiotic growth promotant. Of the seven \ncomparisons, the Bio -Mos fed birds had the better -feed \nconversion in 6 (86%). The difference ranged from \u2013\n8.17 to +0.44%.  The average improvement was 0.39% for t he single published paper, 7.42% for the single \nabstract and 2.49% for unpublished reports.  Similar to the response in broilers, Bio -Mos \nimproved turkey performance both in terms of growth rate and feed efficiency when compared to a program \nnot containing a growth promotant antibiotic.  \n \nCOMPARISON OF BIO -MOS TO ANTIBIOTIC \nGROWTH PROMOTANT PROGRAMS  \nBroilers.   On average, growth rate was 1.34% \ngreater for flocks fed Bio -Mos than for those given an \nantibiotic growth promotant. In 10 of 16 (62%) \ncomparisons, t he market weight of broilers fed Bio -\nMos was greater than the antibiotic growth promotant fed birds.  The differences ranged from \u20132.91 to \n+8.34%.  Average difference was \u2013 2.12% in the single \npublished paper, - 2.91% in the single abstract and \n+1.89 in unpu blished reports.  \nFeed efficiency averaged 1.70% better for broiler \nflocks given Bio- Mos compared to the antibiotic -fed \nflocks.  Of the 16 comparisons, 10 (62%) favored Bio-\nMos.  The difference ranged from \u2013 13.37 to +4.41%.  \nThe single published study show ed Bio -Mos and the \nantibiotic growth promotant to give equal feed efficiency at market.  The single abstract showed a \n0.83% advantage for the antibiotic growth promotant, while the unpublished reports showed a 2.59 % \nadvantage for Bio -Mos.   \nThese studies indicate that Bio -Mos and antibiotic \ngrowth promotants will yield comparable response in terms of growth and feed efficiency.  \nTurkeys.   Growth rate was 0.66% better on \naverage when an antibiotic growth promotant was used compared to Bio- Mos.  Bio -Mos floc ks had greater \nmarket body weight than antibiotic growth promotant \nflocks in six of 10 comparisons.  In published papers \nthere was a 0.62% advantage to Bio- Mos, a 0.87% \nadvantage in the single abstract and a 1.27% \ndisadvantage in the unpublished reports.  \nFeed efficiency averaged 1.01% better in the Bio -\nMos fed flocks compared to those supplemented with antibiotic growth promotants.  In eight of the 10 comparisons, the Bio -Mos flocks showed an \nadvantage.  In published papers there was a 0.02% advantage for t he antibiotic growth promotant flocks, \nin the single abstract the advantage was 0.95% in favor \nof the Bio -Mos flocks, and in the unpublished reports \nthe advantage was 1.31% in favor of the Bio -Mos fed \nflocks.  \nThese reports would indicate that Bio -Mos and \ngrowth promotant antibiotics give comparable \nresponses.  \n \nCONCLUSIONS  \nOverall, these reports indicate that when an \nantibiotic growth promotant is not used, there is a performance advantage to including Bio- Mos in diets \nfed either broilers or turkeys.  They f urther indicate  \n 328  \n that Bio -Mos can be substituted for a growth promotant \nantibiotic with the expectation of comparable \nperformance results.  \n \nREFERENCES  \n1. Rosen, G. D., 1996. The Nutritional Effects \nof Tetracyclines in Broiler Feeds.  Proceedings of \nWorld\u2019s Pou ltry Congress Volume II, New Delhi, \nIndia, pg. 141- 146. 2. Anonymous, 2001. Antimicrobials Phase \nOut? World Poultry -Elsevier. 17(11): 6.  \n3. Salyers, A., 1999.  Agricultural Use of \nAntibiotics and Antibiotic Resistance in Human Pathogens: Is There a Link?  Biotechnology in the Feed \nIndustry.  Proceedings of Alltech\u2019s 15\nth Annual \nSymposium.  Eds T. P. Lyons and K. A. Jacques.  Pg. \n155-171. \n \n \nAISLAMIENTO Y CARACTERIZACION DE ORNITHOBACTERIUM \nRHINOTRACHEALE OBTENIDO DE PAVOS CON ENFERMEDAD \nCORIZOIDE  \n \nISOLATION AND C HARACTERIZATION OF ORNITHOBACTERIUM \nRHINOTRACHEALE  FROM TURKEYS WITH A CORYZA-LIKE INFECTION  \n \nSoriano VE1, Longinos GM2, y RP Fern\u00e1ndez2  \n \n 1Departamento de Investigaci\u00f3n y Desarrollo Av\u00edcola, Bios\u00edntesis Laboratorios SA. Toluca 50130, M\u00e9xico.  \n2Centro de Investigaci\u00f3n y Estudios Avanzados en Salud Animal, FMVZ -UAEM. Toluca 50000, M\u00e9xico.  \n \nSUMMARY  \nO. rhinotracheale was isolated from 6 -week -old \nturkeys with a coryza -like disease. Biochemical \nproperties (API 20NE system), and hemagglutinating \nactivity of the se turkey isolates were similar to those of \nchicken isolates. Isolates were genetically typified using the ERIC -PCR test.  \n \nRESUMEN  \n Se obtuvo el aislamiento de Ornithobacterium \nrhinotracheale a partir de pavos de 6 semanas de edad \ncon enfermedad coriozoide. Las propiedades \nbioqu\u00edmicas (sistema API 20NE) y actividad \nhemoaglutinante de los aislamientos fueron similares a \nlas observadas para aislamientos de pollo. Los aislamientos fueron tipificados gen\u00e9ticamente mediante \nla prueba de ERIC -PCR.  \n Pavos de 6 se manas de edad con enfermedad \nrespiratoria y una mortalidad registrada del 30% fueron \nremitidos al CIESA -FMVZ -UAEM. Se realiz\u00f3 el \naislamiento de Ornithobacterium rhinotracheale a partir de senos infraorbitarios y pulm\u00f3n. A la \nnecropsia, se observ\u00f3 congesti\u00f3n de pulm\u00f3n y de \nh\u00edgado, entre otras lesiones.  \n Las propiedades bioqu\u00edmicas de los aislamientos \nobtenidos fueron probadas mediante el sistema comercial API 20NE, registr\u00e1ndose el siguiente c\u00f3digo: \n0-2-2-0-0-0-4. Este mismo c\u00f3digo ha sido obtenido de \nforma uniforme a partir de aislamientos O. \nrhinotracheale  de pollo (2).   Los aislamientos obtenidos mostraron actividad \nhemoaglutinante empleando eritrocitos de pollo fijados \ncon glutaraldeh\u00eddo. Esta misma caracter\u00edstica ha sido \nobservada en aislamientos obtenid os de pollo (1, 2). \nLos aislamientos obtenidos fueron incluidos en pruebas \nde aglutinaci\u00f3n en placa e inhibici\u00f3n de la \nhemoaglutinaci\u00f3n empleando un antisuero preparado contra la cepa de referencia B -3263/91 (serovar A) (3), \nobteni\u00e9ndose resultados positiv os. \n Dos aislamientos fueron tipificados \ngen\u00e9ticamente mediante la prueba de ERIC -PCR, \nobserv\u00e1ndose el mismo patr\u00f3n de amplicones.  \n De acuerdo con otros autores, O. rhinotracheale \npuede ser un agente pat\u00f3geno importante en explotaciones de pavos.\n \n \nREFERENC IAS \n1. Fitzgerald, S. L., Greyling, J. M., Bragg, R. \nR. Correlation between ability of Ornithobacterium rhinotracheale to agglutinate red blood cells and \nsusceptibility to fosfomycin. Onderstepoort J. Vet. Res. \n65:317- 320. 1998.  \n2. Soriano, V. E., Longinos , G. M., Navarrete, \nG. M., and R. P. Fern\u00e1ndez. Characterization and \nadherence tests of Ornithobacterium rhinotracheale isolates from Mexico. Proc. 49th West. Poult. Dis. Conf. Sacramento, California. p. 50. 2000.  \n   \n  \n 329  \n 3.   Van Empel, P., Van Den  Bosh, H., Loeffen, \nP., and P. Storm. Identification and serotyping of \nOrnithobacterium rhinotracheale. J. Clin. Microbiol. \n35:418- 421. (Al art\u00edculo completo se publicar\u00e1 en Avian Diseases ). \n \n \nIN VITRO  EVALUATION OF VARIOUS ANTIBIOTIC \nAGAINST MYCOPLASMA SYNOVIAE  \n \nIN VITRO MICROBIOLOGICAL DETERMINATION OF THE \nSUSCEPTIBILITY OF MYCOPLASMA SYNOVIAE TO FIVE \nANTIMICROBIALS  \n \nErnesto Soto1, Richard Yamamoto2, Clemente Lemus1 y Ariel Ort\u00edz3 \n \n1Facultad de Agricultura, Universidad Aut\u00f3noma de Tepic, M\u00e9xico. 2University of Cal ifornia -Davis, USA.  \n3FES- Cuatitl\u00e1n, Universidad Nacional Aut\u00f3noma de M\u00e9xico, M\u00e9xico  \n \nSUMMARY  \nThe microdilution antimicrobial susceptibility test \nwas used to determine the minimum inhibitory \nconcentration (MIC) against WVU 1853 strain of M. \nsynoviae, in agreement with NCCLS. Eight replicates \nwere used in the trial. The test was concluded when a color change was observed in the positive control, \nmeaning bacterial growth. The lowest and highest MIC\u2019s were obtained with tylosin tartrate, and \nlincomycin hydroc hloride, respectively. Statistically \nsignificant differences (P<0.01) were found between \nboth drugs. No difference was observed between the \nMIC\u2019s for enrofloxacin HCl and chlortetracycline HCl, \nor any other way. No antimicrobial activity was determined wit h erythromycin estolate at the \nconcentrations tested.  \n RESUMEN  \nSe utiliz\u00f3 la prueba de susceptibilidad \nantimicrobiana con microdiluci\u00f3n, determinando la CIM hacia la cepa WVU 1853 de Mycoplasma synoviae  de acuerdo al NCCLS.  La prueba se dio por \nterminada cuando el grupo control positivo cambi\u00f3 el color indicando crecimiento bacteriano. Los resultados \nde la prueba realizada con ocho r\u00e9plicas indican que la \nmenor CIM fue obtenida con tartrato de tilosina y la mayor con clorhidrato de lincomicina, detect\u00e1ndose  \ndiferencias estad\u00edsticas significativas entre ellos ( P < \n0.01). No hubieron diferencias entre las CIMs para \nclorhidrato de enrofloxacina y clorhidrato de \nclortetraciclina, ni de cualquier otra forma. No se \ndetect\u00f3 actividad antimicrobiana hacia estolato d e \neritromicina en las diluciones probadas.   \n (The entire paper has been submitted to Avian \nPathology  for publication).  \n \n \n  \n \n  \n \n   \n  \n 330  \n EFECTO EN LA CANTIDA D DE PIGMENTO SINT\u00c9T ICO EN \nPLASMA DE POLLO DE ENGORDA DESPU\u00c9S DE  L A \nVACUNACI\u00d3N CONTRA EIMERIA ACERVULI NA, E. MAXIMA , E. \nMIVATI Y E. TENELLA  Y TRATADO  CON TOLTR AZURIL  \n \nSYNTHETIC PIGMENT PLASMA LEVELS IN BROILERS AFTER EIMERIA \nACERVULINA, E. MAXIMA, E. MIVATI, AND E. TENELLA VACCINATION \nAND TRETMENT WITH TOLTRAZURIL \n \nTejeda VR1, Petrone VM1, Hern\u00e1ndez VX1. \n1Departamento de Producci\u00f3n Animal: Aves, Facultad de Medicina Veterinaria y Zootecnia,  \nNacional Aut\u00f3noma de M\u00e9xico, M\u00e9xico, D.F.  \n \nSUMMARY  \nThis research evaluated synthetic pigment plasma \nlevels in broilers after vaccination against E, \nacervulina, E. max ima, E. mivati, and E. tenella , and \ntreatment with toltrazuril. At 24 days of age no synthetic pigment plasma difference was found \nbetween the vaccinates and the negative controls. At 31 \ndays of age the vaccinated group showed no difference \nwhen compared w ith the vaccinated/challenged group. \nAt 38 days of age the  \nvaccinated/challenged/toltrazuril- treated group showed \nno difference when compared with the negative \ncontrols. The vaccinated group, the \nvaccinated/challenged group, and the \nchallenged/toltrazuril- treated group showed no \ndifference when compared with the \nvaccinated/challenged/toltrazuril- treated group. At 45 \ndays of age all groups showed no difference with the \nnegative control group, since no coccidia was present \nin the intestine.  \n \nRESUMEN  \nSe evalu\u00f3  semanalmente a partir de la tercer \nsemana y hasta 45 d\u00edas de edad la cantidad de \npigmento sint\u00e9tico en plasma de pollo de engorda \ndespu\u00e9s de haber sido vacunados contra Eimeria \nacervulina, E. maxima, E. mivati  y E. tenella y tratados \ncon toltrazuril.  \nA los 24 d\u00edas de edad el grupo vacunado y el \ngrupo testigo negativo no mostraron diferencia en la cantidad de pigmento en plasma.  A los 31 d\u00edas de edad \nel grupo vacunado es igual al grupo vacunado y \ndesafiado. A los 38 d\u00edas de edad el grupo vacunado, \ndesafiado y tratado con toltrazuril es igual al grupo \ntestigo negativo. El grupo vacunado, el grupo vacunado \n/desafiado y el grupo desafiado /tratado con toltrazuril \nson iguales  al grupo que fue vacunado, desafiado y \ntratado con toltrazuril. A los 45 d\u00edas de eda d  todos los grupos fueron iguales al testigo negativo debido a la \nausencia de Eimeria  spp. en intestino.  \n \nINTRODUCCION  \nLa coccidiosis aviar (CA) es un parasitosis de \ndistribuci\u00f3n mundial y actualmente es la de mayor \nimportancia en el pollo de engorda afectando \nprincipalmente entre la tercera y sexta semana de edad. \nLa CA produce una mala absorci\u00f3n de nutrientes y \npigmentos, lo que ocasiona retraso en el crecimiento, \nalta conversi\u00f3n alimenticia, bajos niveles s\u00e9ricos  de carotenos en el plasma, mala pigment aci\u00f3n cut\u00e1nea, y \ngrandes perdidas al productor.  \nPara el control de la CA se puede usar el \ntoltrazuril es un coccidicida que pertenece al grupo qu\u00edmico de las triazinonas sim\u00e9tricas que ejerce un \nefecto perjudicial sobre la mitosis y las mitocondrias. \nProvo ca vacuolizaci\u00f3n del ret\u00edculo endopl\u00e1smico en \ntodos los estadios evolutivos intracelulares de la CA.  \nEl toltrazuril no tiene ninguna relaci\u00f3n con otros \nagentes anticoccidianos por lo que hasta la fecha no se han informado de Eimerias resistentes. Se usa en el \nagua de bebida y es efectivo para la reducci\u00f3n de \nlesiones intestinales producidas por  la CA, disminuye \nlas perdidas de peso y  mortalidad en la parvada, \nadem\u00e1s de que puede ser usado como terapia y \ntratamiento intermitente en infecciones por Eimeria s. \nEl objetivo de este trabajo fue evaluar la cantidad \nde pigmento sint\u00e9tico en plasma de pollo de engorda \ndespu\u00e9s de haber sido vacunados contra Eimeria \nacervulina, E. maxima, E. mivati  y E. tenella, y \ntratados con toltrazuril.  \n \nMATERIAL Y METODOS  \n Se ut ilizaron 210  de pollos de engorda sin sexar \nde un d\u00eda de edad. Los pollos fueron alojados en bater\u00eda \ncon calefacci\u00f3n el\u00e9ctrica y consumieron alimento comercial con 65 ppm de pigmento amarillo sint\u00e9tico \n\u00e9ster C30 (etil \u00e9ster del \u00e1cido  \u00df -apo-8\u2019-caroten\u00f3ico ) y  \n 331  \n agua a libre acceso. Se formaron dos grupos de aves. El \ngrupo \u201cA\u201d incluyo 120 pollos y el grupo \u201cB\u201d incluyo \n90 pollos hasta los 20 d\u00edas de edad.  \nEl grupo \u201cA\u201d recibi\u00f3 cuatro vacunaciones (t\u00edtulo \nde 426,000 ooquistes esporuados y viables/ml con 50% Eime ria acervulina, 11% E. maxima,15% E. mivati   y \n24% E. tenella) v\u00eda oral  con dosis ( 1x =1000 \nooquistes) 1x, 2x, 3x y 4x, los d\u00edas 5, 10, 15 y 20 de edad, respectivamente. El grupo \u201cB\u201d no recibi\u00f3 \nvacunaci\u00f3n.  \nA los 25 d\u00edas de edad  90 pollos del grupo \u201cA\u201d y  \n30 pollos del grupo \u201cB\u201d se desafiaron con dosis 80x. A \nlos 32 y 33 d\u00edas de edad 30 pollos del grupo \u201cA\u201d desafiados con 80x y 30 pollos desafiados con 80x del \ngrupo \u201cB\u201d fueron tratados v\u00eda oral con toltrazuril en \ndosis de 7 mg/kg de peso corporal.  \nA los  39 d\u00edas de edad se desafiaron con dosis \n160x  a 30 pollos del grupo \u201cA\u201d que fueron vacunados, \ndesafiados con 80x y tratados con toltrazuril; y 30 pollos del grupo \u201cA\u201d que fueron vacunados y \ndesafiados con 80x.  \nA los 39 d\u00edas de  edad se desafiaron con dos is de \n160x a 30 pollos del grupo \u201cB\u201d sin tratar y a 30 pollos que fueron desafiados con dosis de 80x y tratados con \ntoltrazuril. Los 30 pollos sobrantes del grupo \u201cB\u201d no \ntuvieron vacunaci\u00f3n, desaf\u00edo, ni tratamiento (testigo \nnegativo). (Cuadro)  \nA 10 pollos de cada grupo de manera aleatoria y \nsemanalmente a partir de los 24 d\u00edas de edad fueron \nsangradas    (1.5 ml) obteniendo una mezcla en \nproporci\u00f3n de 1:10 de EDTA:sangre de la vena radial y tres horas despu\u00e9s de haber iniciado a ingerir alimento. \nSe extrajo  0.5 ml de plasma de cada muestra y se \nmezclo con 4.5 ml de acetona por medio de un \nagitador. De cada muestra se midi\u00f3  la densidad \u00f3ptica \ncon una longitud de onda de 478 nm.(Allen,1987)  \n \nRESULTADOS  \nA los 24 d\u00edas de edad el grupo vacunado y el \ngrupo testigo negativo no mostraron diferencia en la \ncantidad de pigmento en plasma.  A los 31 d\u00edas de edad el grupo vacunado muestra absorbancia de 0.440 y es \nigual al grupo vacunado y desafiado con 80x con \nabsorbancia de 0.384. El grupo vacunado es igual al \ngrupo te stigo negativo con absorbancia de 0.532; el \ngrupo desafiado con 80x con absorbancia de 0.205 es \nmenor a los otros tres grupos. A los 38 d\u00edas de edad el \ngrupo vacunado, desafiado con 80x y tratado con \ntoltrazuril con absorbancia de 0.315 es igual al grupo \ntestigo negativo con absorbancia de 0.377. El grupo \nvacunado con absorbancia de 0.242,  el grupo \nvacunado y desafiado con 80x con absorbancia de 0.257 y el grupo desafiado con 80x y tratado con \ntoltrazuril con absorbancia de 0.257 son iguales  al \ngrupo vacu nado, desafiado con 80x y tratado con \ntoltrazuril con absorbancia de 0.315. A los 45 d\u00edas de edad  todos los grupos fueron iguales al testigo \nnegativo con absorbancia de 0.119 (Cuadro).  \n \nDISCUSION Y CONCLUSIONES\n \nA los 24  y 31 d\u00edas de edad los pollos vacun ados \ncon Eimeria  spp. la cantidad de pigmento en plasma es \nigual  a los pollos no vacunados (testigo negativo). A los 31 d\u00edas de edad, los grupos que fueron vacunados \npreviamente con Eimeria  spp la cantidad de pigmento \nen plasma es igual ante un desaf\u00edo; e n cambio un grupo \nque no fue vacunado y ante un desaf\u00edo de Eimeria  spp \nla cantidad de pigmento en plasma es menor.  \nA los 38 d\u00edas de edad los pollos que han sido \nvacunados con  Eimeria spp. son iguales a los pollos \nque presentaron un desaf\u00edo y que fueron tra tados con \ntoltrazuril. Los pollos que fueron vacunados, presentaron un desaf\u00edo y que fueron tratados con \ntoltrazuril la cantidad de pigmento en plasma es igual a \nlos pollos que no han tenido contacto con Eimerias. A \nlos 45 d\u00edas de edad los pollos vacunados  con Eimeria  \nspp., desafiados con Eimeria spp., tratados con \ntoltrazuril y nuevamente desafiados  con Eimeria spp. \nla cantidad de pigmento es igual a los pollos que no \nhan tenido contacto con Eimerias (testigo negativo) debido a que ya no existen ciclos re productivos de \nEimerias hay ausencia de estas en intestino y se permite la absorci\u00f3n de pigmento.  \n \nREFERENCIAS  \n1. Aramadan, K, El -Sooud A, El -Bahy MM, \nAnticoccidial efficacy of toltrazuril and halofuginone \nagainst Eimeria tenella  infection in broiler chickens  in \nEgypt. Research in Veterinary Science 1997;62:175-\n178. \n2. Allen CP. Physiological Responses of \nChicken Tissue to Coccidial Infection: Comparative Effects of Eimeria acervulina and Eimeria mitis  on \nMucosal Mass, Carotenoid Content, and Brush Border \nEnzyme Activity. Poultry Science 1987;66:1306- 1315.  \n3. Laczay P, Gabor V, Gabor S. Comparative \nstudies on the efficacy of Sulphachlorpyrazine and Toltrazuril for the treatment of cecal coccidiosis in \nchickens. International Journal for Parasitology  1995; 25 (6): 75 3-756 \n4. Pirac\u00e9s SF, Cort\u00e9s CR. Factores que afectan la \npigmentaci\u00f3n del pollo de carne. X Ciclo de Conferencias Internacionales sobre av\u00edcultura. AMENA 1991: 103- 127. \n \n \n \n  \n 332  \n Cuadro 1.  Media de la cantidad de pigmento plasm\u00e1tico medido por absorbancia de pol lo de engorda vacunados \ncontra Eimeria spp. y tratados con toltrazuril .  \nEdad en d\u00edas   \n24 31 38 45  \nVacunado  \n \n\u201cA\u201d 0.921a Vacunado/ \nDesaf\u00edo 80x  0.384 a Vacunado/Desaf\u00edo 80x  0.257 a Vacunados/Desaf\u00edo 80x  0.130 a \nVacunado/Desafio80x/  \nToltrazuril  0.315 ab Vacunados/Desaf\u00edo80x/  \nToltrazuril/  \nDesaf\u00edo 160x  0.162 a \nVacunado  0.440 ab Vacunado  0.242 a Vacuna/Desaf\u00edo 80x/  \nDesaf\u00edo 160x  0.182 a \nVacunados  0.154 a \nTestigo \nnegativo  \n \n\u201cB\u201d 0.905 a Testigo \nnegativo  0.532 b Testigo negativo  0.377 b Testigo nega tivo 0.119 a \nDesafio80x/Toltrazuril/ \nDesaf\u00edo 160x  0.115 a \nDesaf\u00edo 80x/ Toltrazuril  0.249 a \nDesaf\u00edo 80x  0.205 c Desaf\u00edo 160x  0.109 a \nLas diferentes literales indican diferencia estad\u00edstica significativa (p< 0.05).  \n \nCOMPLETE  VP1 NUCLEOTID E SEQUENCES OF FIELD GOOSE \nAND MUSCOVY DUCK PARVOVIRUS ISOLATES AND THEIR \nATTENUATED DERIVATIVES  \n \nSECUENCIAS COMPLETAS DE LOS NUCLE\u00d3TIDOS VP1 DE \nAISLAMIENTOS DE CAMPO DE PARVOVIRUS DE GANSOS Y PATOS \nRUSOS, Y SUS DERIVADOS ATENUADOS  \n \nH.J. Tsai*, C.H. Tseng , K. Mei Graduate Institute of Veterinary Medicine, National Taiwan University,  \n142 Chou -San Road, Taipei, Taiwan  \n \nRESUMEN  \nAnalizamos las secuencias completas de los \nnucle\u00f3tidos de la VP1 del parvovirus del ganso ( GPV ) \ny del parvovirus del pato ruso ( MDP V) aislados en \nTaiw\u00e1n, y estudiamos tambi\u00e9n sus derivados \natenuados. Descubrimos que las cepas del GPV  \ntaiwanesas y de otros pa\u00edses comparten del 96.2 al \n96.8% de homolog\u00eda en la secuencia de los nucle\u00f3tidos \nde la VP1, y que las  cepas del MDPV  comparten d el \n98.2 al 98.3% de homolog\u00eda. Al mismo tiempo, la \nhomolog\u00eda de las secuencias de los nucle\u00f3tidos de la \nVP1 entre las cepas del GPV  y las del MDPV  fue s\u00f3lo \ndel 78.3 al 79.7%. Asimismo, hubo s\u00f3lo \naproximadamente 5% de divergencia entre los \naislamientos de c ampo del GPV  y el MDPV  y sus \nderivados atenuados. Se concluye que el GPV  y el \nMDPV  son un grupo gen\u00e9tico distinto y que su \natenuaci\u00f3n produjo un cambio gen\u00e9tico de menor \nimportancia en la PV1.  \n \nTo understand the genetic relationships between \nthe goose and duck parvovirus and their attenuated derivatives, we analyzed the complete nucleotide \nsequences of viral structural protein (VP1) of a goose \nparvovirus (GPV) isolated in 1982 (1982F) and a \nMuscovy duck parvovirus (MDPV) isolated in 1990 \n(1990F) , their attenuated derivatives (1982V and 1990 \nV), and a goose parvovirus  isolated in 2001 (2001F). \nAfter comparing the nucleotide sequences of \nHungarian isolates obtained from GenBank , we \ndiscovered that Taiwanese and Hungarian GPV strain  \n(U25749) share 96.2% to 96.8% VP1 nucleotide \nsequence homology , and Taiwanese MDPV strains \nshare 98.2% to 98.3% homology with Hungarian MDPV (U22967) . VP1 nucleotide sequences  \nhomology between GPV  strains  and MDPV strains \nwere only 78.3% to 79.7%. T here w as only about 5% \ndivergence o n GPV and M DPV between field  isolates \nand their attenuated derivatives . It is concluded that \nGPV and MDPV are distinct genetic group and \nattenuation of the GPV and MDPV resulted in minor \ngenetic change in VP1.  \n \n  \n 333  \n \n \nFig. 1.  The homology and divergence of go ose and Muscovy duck parvovirus viral protein 1 nucleotide sequences \nof Taiwanese field isolates, their attenuate derivattives and Hungarian isolates.  \n \n \nFRECUENCIA EN EL DIAGN\u00d3STICO DE LAS ENFE RMEDADES \nAVIARES EN EL LABORATORIO DE DIAGN\u00d3STICOS CL\u00cdNICOS \nVETERINARIOS DURANTE LOS DOS \u00daLTIMOS A\u00d1OS . \n \nFREQUENCY OF POULTRY DISEASE DIAGNOSTICS IN DIAGN\u00d3STICOS \nCL\u00cdNICOS VETERINARIOS IN RECENT YEARS  \n \nDiana V\u00e1zquez1, Catalina Alvarado1, Graciela M\u00e9ndez1, Agust\u00edn Morales1, David Sarfati2,  \nBernardo Lozano2, Marco Rico1 , Juan Garc\u00eda- Garc\u00eda1 y Ernesto Soto2 \n \n1Diagn\u00f3sticos Cl\u00ednicos Veterinarios SA de CV. M\u00e9xico. 2Laboratorio Avimex SA de CV. M\u00e9xico.  \n \nSUMMARY  \nSamples from the states of Mexico, Morelos, and \nHidalgo are typically submitted to this laboratory, \nlocated in central Mexico. Results reported herein correspond to broiler and broiler breeder flocks. The \ndiseases/entities most frequently diagnosed in broilers \ninclude infectious bronchitis, colibacillosis, Salmonella \nenteritidis, Ornithobacterium rhinotracheale , \ninfectious bursal disease, Marek\u2019s disease, coccidiosis, \nand cryptosporidiosis. In broiler breeders the most \nfrequent diagnosis corresponded to Mycoplasma \nsynoviae  and S. enteritidis  \n RESUMEN  \nEl laboratorio se localiza en la regi\u00f3n centro de \nM\u00e9xico y principal mente recibe muestras de los \nestados de M\u00e9xico, Morelos e Hidalgo. Los resultados \ndel presente trabajo corresponden a casos de pollo de engorda y reproductora pesada. Las entidades \npatol\u00f3gicas diagnosticadas con mayor frecuencia en el \npollo de engorda fuer on la bronquitis infecciosa, \ncolibacilosis, S. enteritidis , O. rhinotracheale , \nGumboro, Marek, coccidiosis y criptosporidiosis.  En \nlas reproductoras pesadas fueron M. synoviae y  S. \nenteritidis .\n  \n  \n \n \n  \n \n \n  \n 334  \n Frecuencia de diagn\u00f3stico de la principales enferm edades de las aves (casos positivos sobre el total de muestras \nsospechosas).  \n\u00c1rea  Etiolog\u00eda o enfermedad  2000  2001  \n \n \nVirolog\u00eda  Enfermedad de Newcastle (ENC)  10 / 849  0 / 963  \nInfluenza aviar (IA)  0 / 849   1 / 963  \nBronquit\u00eds infecciosa (BI)  45 / 81   8 / 85 \nLaringotraque\u00edtis aviar (LTI)   0 / 10  0 / 10  \nViruela aviar (VA)  0 / 10  2 / 10  \n \n \nBacteriolog\u00eda  Haemophillus paragallinarum (Hpg)  3 / 20  1 / 12  \nSalmonella  65 / 1010  69 / 971  \nOrnithobacterium rhinotracheale  (Ort)  1 / 40  5 / 22  \nPasteurella multo cida (Pm)  2 / 16  3 / 11  \nEscherichia coli (Ec) 148 / 363  367 / 460  \n \n \nHistolog\u00eda  Infecci\u00f3n de la bolsa de Fabricio (IBF)  367 / 539  404 / 600  \nCriptosporidiosis  30 / 33  31 / 31  \nMicotoxinas  49 / 59  25 / 25  \nEnfermedad de Marek (EM)  66 / 88  60 / 67  \nHepatitis con cuerpos de inclusi\u00f3n (HCI)  8 / 10  2 / 10  \n \n \nSerolog\u00eda  Ornithobacterium rhinotracheale  (Ort)  129 / 218  340 / 496  \nPneumovirus (TRT)   68 / 618  46 / 165  \nLeucosis  mieloide J    29 / 1295  50 / 1148  \nLeucosis linfoide  8 / 462  52 / 914  \nPCR  Myc oplasma synoviae (Ms)  30 / 53  70 / 98  \nParasitolog\u00eda  Coccidiosis  432 / 537  309 / 403  \n \nDISCUSI\u00d3N  \nLos aislamientos de ENC corresponden a la  zona \nde La Laguna (norte de M\u00e9xico) durante el brote que se \npresent\u00f3 en los meses de marzo a mayo. El aislamiento \nde IA fue enviado a CPA para su identificaci\u00f3n. El \nreporte final indica que se trat\u00f3 de un virus de baja \npatogenicidad. Los aislamientos de BI fueron \nserotipificados. Durante el a\u00f1o 2000 se determin\u00f3 que 36 aislamientos fueron del serotipo Massachusetts \n(Mass),  1 cepa correspondi\u00f3 a Arkansas,  4 \naislamientos pertenecieron al serotipo BL 56 y  4 \naislamientos al serotipo DS57. Durante el a\u00f1o 2001 se \naislaron \u00fanicamente cepas del serotipo Mass. TRT se \ndetect\u00f3 por pruebas de ELISA con relativa frecuencia, \naumen tando su porcentaje de seropositvidad en el a\u00f1o \n2001.  \nLa detecci\u00f3n de positividad para leucosis linfoide \no leucosis mieloide tipo J en reprodructoras ha sido relativamente baja.  \nLos resultados de Salmonella corresponden en un \n100% a S. enteritidis . No se diagn\u00f3stico S. pullorum \u00f3  \n S. gallinarum  en ning\u00fan caso. El Ort ha sido aislado \npero tambi\u00e9n determinado por pruebas de ELISA.  \nEl diagn\u00f3stico de micotoxinas ha sido realizado \nprincipalmente por lesiones histol\u00f3gicas en h\u00edgado que sugieren este problema.  \nEl diagn\u00f3stico de criptosporidiosis fue realizado \nal analizar histol\u00f3gicamente las bolsa de Fabricio. El diagn\u00f3stico de coccidiosis fue determinado mediante \npruebas de Mc Master, detect\u00e1ndose principalmente E. \ntenella ,  E. m\u00e1xima  y E. acervulina . \n \nCONCLUSI \u00d3N \nLas principales enfermedades y agentes \netiol\u00f3gicos identificados en el pollo de engorda fueron \nla bronquitis infecciosa, el pneumovirus, la \ncolibacilosis, Ort  y Ms en problemas respiratorios.  \nLas principales enfermedades inmunol\u00f3gicas \ndetectadas fuero n Gumboro y Marek, mientras que la \ncoccidiosis y la criptosporidiosis se diagnosticaron como las enfermedades parasitarias m\u00e1s frecuentes.  \nPara las reproductoras pesadas, S. enteritidis  y  \nMs fueron las infecciones mayormente detectadas.  \n  \n 335  \n INDIRECT ENZYME -LINKED IMMUNOSORBENT ASSAY FOR \nTHE QUANTITATIVE DETECTION OF ANTIBODIES TO AVIAN \nADENOVIRUS GROUP 1 SEROTYPE 4  \n \nENSAYO DE INMUNOABSORCI\u00d3N LIGADO A ENZIMAS INDIRECTO PARA \nLA DETECCI\u00d3N  CUANTITATIVA DE ANTICUERPOS CONTRA EL \nADENOVIRUS AVIAR, SEROTIPO 4, GRUPO 1  \n \nM.A. Volkova, N.S. Mudrak, V.V. Drygin, V.V. Borisov, D.S. Surnev, A.A. Gusev  \n \nAll-Russian Research Institute of Animal Health, Vladimir, 600900, Russia  \n  \nRESUMEN  \nLos adenovirus aviares del serotipo 4, grupo 1 \n(AAV-4) se asocian con  brotes del s\u00edn drome de \nhidropericardio en pollos y causan alta mortalidad. El \nobjetivo de la presente investigaci\u00f3n fue desarrollar  \nuna t\u00e9cnica de ELISA  r\u00e1pida, sencilla y sensible para \ndetectar y cuantificar los anticuerpos contra el AAV-4 \nen suero de pollo. Los resul tados mostraron que dicha \nprueba de ELISA se puede usar para la evaluaci\u00f3n del \nestado inmunol\u00f3gico de las aves despu\u00e9s de la \nvacunaci\u00f3n, para el diagn\u00f3stico de laboratorio del \ns\u00edndrome de hidropericardio y para realizar pruebas de escrutinio en lotes de reproductoras y en parvadas \nlibres de pat\u00f3genos espec\u00edficos, en busca de la \npresencia de anticuerpos contra el adenovirus aviar del \nserotipo 4, grupo 1.  \n \nAvian adenovirus group 1 serotype 4 (AAV -4) \nare associated with hydropericardium syndrome (HPS) \noutbrea ks in chickens, causing high mortality. \nDiagnosis of HPS is done by either isolation of the \nvirus or serology using an agar gel precipitation (AGP) \nand serum neutralization test. But they have low \nsensitivity or are time consuming and expensive. The aim of  the present investigation was to develop a rapid, \nsimple, and sensitive ELISA to detect and quantitate \nantibodies to AAV -4 in chicken sera.  \nThis test utilizes purified 10%  liver suspension of \nchicken,  inoculated of AAV -4, as the coated antigen. A chicken serum against AAV -4 with ELISA titer 1:3200 \nwas used as positive control, normal SPF -chicken \nserum as negative control, and ABTS as a substrate. The absorbance values were read at 405 nm. Antibody \ntiter of chicken sera samples was detected in the single \nworking dilution from S/P   (sample to positive) ratio. \nThe equation for the calculated antibody titer was: \nlog10(T) = 2.8714*log10(S/P) + 3.611. The working \ndilution was established at 1:400; also the optimal \nabsorbance values of positive and negative contr ol sera \nand positive/negative threshold were established. The \nELISA results were characterized as: positive \n(T>1:900), doubtful (1:225<T>1:900) and negative \n(T<1:225). We observed low cross -reactivity with \nreference sera against different avian adenoviruses \ngroup 1.  \nThe results of testing by ELISA and AGP of 300 \nsera from vaccinated chicken and of positive and \nnegative reference sera have shown that the lowest \npositive AGP+ titer corresponded to an ELISA titer of 1:1600. Taking into consideration the above  results, an \nELISA kit was formulated for antibody detection against AAV -4 in chicken sera. The ELISA kit can be \nused for evaluating the immune status of poultry after \nvaccination, for laboratory diagnosis of HPS and for \nscreening breed and SPF - flocks for  the presence of \nantibodies to avian adenovirus group 1serotype 4.  \n \n \n \n \n  \n \n  \n 336  \n DEVELOPMENT OF LIQUID- PHASE BLOCKING ENZYME -\nLINKED IMMUNOSORBENT ASSAY FOR THE QUANTITATIVE \nDETECTION OF AVIAN ADENOVIRUS  GROUP 1 SEROTYPE 4  \n \nDESARROLLO DE UN ENSAYO DE INMUNOABSORCI\u00d3N LIGADO A \nENZIMAS DE BLOQUEO EN FASE L\u00cdQUIDA PARA LA DETECCI\u00d3N \nCUANTITATIVA DE ADENOVIRUS AVIAR SEROTIPO 4, GRUPO 1  \n \nM.A. Volkova, N.S. Mudrak, D.S. Surnev, V.A. Lobanov, G.W. Batchenko, V.V. Drygin, \nV.V. Borisov, A.A. Gusev  \n \nAll-Russian Research Inst itute of Animal Health, Vladimir, 600900, Russia  \n \nRESUMEN  \nEl objetivo de la presente investigaci\u00f3n fue \ndesarrollar una prueba de inmunoabsorci\u00f3n ligada a \nenzimas, de bloqueo, en fase l\u00edquida, r\u00e1pida, sencilla, \nsensible y espec\u00edfica ( LPB-ELISA ) para detect ar y \ncuantificar el adenovirus aviar serotipo 4, grupo 1 \n(AAV-4) directamente en homogeneizados de tejidos de \npollo. Encontramos que la LPB -ELISA  se puede \nemplear para valorar la concentraci\u00f3n del ant\u00edgeno del AAV-4 en materiales en bruto usados para produ cir \nvacunas y para detectar aislamientos de campo del \ncitado virus.  \n \nThe aim of present investigation was to develop a \nrapid, simple, sensitive, and specific liquid -  phase \nblocking enzyme -linked ELISA (LPB -ELISA) to \ndetect and quantitate  avian adenovirus group 1 serotype \n4 (AAV -4) directly in chicken tissue homogenates. \nCoated microplates AAV -4 antigen from purified 10% \nliver suspension of chicken, inoculated of AAV -4 were \nused to capture the excess of specific immunoglobulin \nafter pre- incubation of them i n liquid phase  with the \nsample under the test. A hyperimmune chicken serum against AAV -4 was used as blocking antibodies. \nBound immunoglobulins were detected by anti -chicken IgG peroxidase conjugate and substrate ABTS. The mixture of normal liver suspensio n pre -incubated with \nspecific IgG was used as negative control, none of immunoglobulins added to the wells as background \ncontrol. The working concentration of the antigen, the \nblocking serum and conjugate, and positive/negative threshold were established. The blocking percent in \nsamples was calculated using the formula: B(%) = 100 \n- (100(ODsample - ODbackground/ODneg.control - \nODbackground)), where OD = optical density.  \nThe LPB -ELISA results were characterized as: \npositive (B%>30), doubtful (20<B%>30) and negative \n(B%< 20). All samples were tested in twofold dilution \nmethod. Calculation of results was done from the end \npoint of titration. The highest dilution of the sample \ngiving B%>30 was taken as the virus titer.  \nWe haven\u2019t observed  cross -reactivity with  \nreference control avian adenoviruses group 1. There was a significant correlation between the results of \ntesting of 50 positive and negative reference and \ntissues samples by LPB -ELISA, PCR and AGP. LPB -\nELISA was 100 -200 times more sensitive than AGP. \nThus , LPB -ELISA  can be employed  to assess AAV -4 \nantigen concentration in raw materials used to produce \nvaccine and to detect field isolates AAV -4. \n  337  CRIOPRESERVACI\u00d3N Y EVALUACI\u00d3N FISIOL\u00d3GICA  \nDE LOS ESPERMATOZOIDES DE AVES \n \nCRYO-PRESERVATION AND PHYSIOLOGICAL EVALUATION OF \nPOULTRY SPERM CELLS \n \nJ. A. Herrera1, J. A. Quintana2, M. Betancourt1, R. Fierro1 \n \n1.- Departamento Ciencias de la Salud. D.C.B.S. U.A.M.-Iztapalapa. M\u00e9xico. \n2.- Departamento de Producci\u00f3n Animal: Aves. Facultad de Medicina Veterinaria y Zootecnia, U.N.A.M. M\u00e9xico. \n \nSUMMARY \nThe semen of domestic birds can be cryo-\npreserved in a liquid medium. This allows for the \ncreation of semen banks of commercial and wild \nspecies. There are only a few papers reporting the basic evaluation of the physiology and the fertilizing ability of sperm cells. Therefore, we propose to determine the effect of the cryo-protectors dimethyl sulfoxide (DMSO) and polyvinylpyrrolidone (PVP) among the indicators of the basic evaluation, as well as carbohydrate distribution on the membrane surface by fluorescence microscopy, and flow cytometry. \n \nRESUMEN \nEl semen de aves dom\u00e9sticas se puede conservar \nen medio l\u00edquido y criopreservado. Esto permite la creaci\u00f3n de bancos de semen para especies comerciales y silvestres. No existen suficientes trabajos que integren la evaluaci\u00f3n b\u00e1sica con la fisiolog\u00eda y capacidad fertilizante de los espermatozoides. Por esto, se propone determinar el efecto de los crioprotectores dimetilsulf\u00f3xido (DMSO) y  polivinilpirrolidona (PVP) en los indicadores de la evaluaci\u00f3n b\u00e1sica, as\u00ed como la distribuci\u00f3n de carbohidratos en la superficie membranal mediante microscop\u00eda de fluorescencia y citometr\u00eda de flujo. \n \nINTRODUCCI\u00d3N \nEn 1937 se describi\u00f3 un m\u00e9todo para obtener \nsemen de gallos, con el prop\u00f3sito de realizar inseminaci\u00f3n artificial (IA), conservaci\u00f3n y/o evaluaci\u00f3n seminal. La IA se ha utilizado como un m\u00e9todo para mantener y reproducir l\u00edneas puras de reproductores primarios y cuando la reproducci\u00f3n se interfiere por condiciones de clima adverso e incompatibilidad f\u00edsica. El almacenamiento del semen en medio l\u00edquido es una pr\u00e1ctica com\u00fan y se puede \nconservar con capacidad fertilizante hasta por 24 horas. \nPara esto, es necesario proporcionar ox\u00edgeno, mantener el pH en  intervalo de 6.0 a 8.8, osmolar idad entre 250 \na 460 mosmol/kg H\n2O y mantener a temperatura de 5-\n7\u00b0C (1). La criopreservaci\u00f3n esperm\u00e1tica se desarroll\u00f3 \nhace aproximadamente 50 a\u00f1os. Esta ha permitido la creaci\u00f3n de bancos de semen en la industria av\u00edcola y \nla conservaci\u00f3n de las c\u00e9lulas germinales de individuos \no especies que est\u00e1n en riesgo de extinguirse. A pesar de los esfuerzos realizados en el campo de la criopreservaci\u00f3n esperm\u00e1tica, pocas t\u00e9cnicas permiten supervivencias elevadas. Los crioprotectores conocidos se dividen en dos grupos: los que atraviesan la membrana celular tales como glicerol, eritreitol, adonitol, dimetilsulf\u00f3xido (DMSO) y dimetilacetamida (DMA), y los que act\u00faan desde el exterior, como la glucosa, fructosa, sacarosa, lactosa y polivinilpirrolidona (PVP). \nEn la IA, la evaluaci\u00f3n del semen proporciona \ninformaci\u00f3n de su calidad y de la concentraci\u00f3n esperm\u00e1tica en eyaculados posteriores. Se haincrementado el uso de t\u00e9cnicas in vitro para \ndeterminar el efecto de la conservaci\u00f3n como el da\u00f1o por criopreservaci\u00f3n, entre \u00e9stas est\u00e1n: la morfolog\u00eda por microscop\u00eda de luz y electr\u00f3nica, movilidad, prueba de resistencia osm\u00f3tica, tasa de utilizaci\u00f3n de ox\u00edgeno, niveles de ATP, peroxidaci\u00f3n de l\u00edpidos, integridad de membrana plasm\u00e1tica, viabilidad por tinci\u00f3n y uni\u00f3n (2) y penetraci\u00f3n in vitro de prote\u00ednas en la membrana \nperivitelina(3). \nNo existen suficientes trabajos que integren la \nevaluaci\u00f3n b\u00e1sica, con la fisiolog\u00eda y capacidad fertilizante de los espermatozoides reci\u00e9n eyaculados y/o criopreservados de aves dom\u00e9sticas y/o silvestres, por lo cual se propone investigar este tema mediante la siguiente metodolog\u00eda. \nEn espermatozoides de gallo ( Gallus dom\u00e9sticus ), \nfais\u00e1n de collar ( Phasianus colchicus ) y hocofais\u00e1nes  \n(Crax rubra ), se analizar\u00e1n dos crioprotectores, DMSO \ny PVP. Se determinar\u00e1n los indicadores de evaluaci\u00f3n b\u00e1sica. Evaluaci\u00f3n espec\u00edfica, mediante microscop\u00eda de \nfluorescencia y citometr\u00eda de flujo (4) para evaluar la \nviabilidad, con Rodamina, (R-123), y la distribuci\u00f3n de carbohidratos en la superficie membranal, con lectinas  338  conjugadas a isotiocionato de fluoresce\u00edna \n(FITC): Triticum vulgaris  aglutinina (WGA), que se \nune a residuos de N-acetilglucosamina y/o \u00e1cido si\u00e1lico; Ulex europaeus  aglutinina (UEA) a residuos \nde fucosa y Concanavalia ensiformis  aglutinina \n(Con-A), a residuos de manosa. La fertilidad se \nevaluar\u00e1 mediante IA de hembras de la misma \nespecie para determinar lo proporci\u00f3n de huevos f\u00e9rtiles mediante la incubaci\u00f3n artificial de \u00e9stos durante el periodo de IA (5).  \nREFERENCIAS \n1. Etches, J. R. (1996). Artificial insemination. \nEn Reproduction in poultry , pp. 234-262. Edited by \nINTERNATIONAL, C. Cambridge. 2. Donoghue, A. M. Wishart, G. J. (2000). \nStorage of poultry semen. Anim Reprod Sci  \n62:213-32. \n3. Barbato, G. F., Cramer, P. G. Hammerstedt, \nR. H. (1998). A practical in vitro sperm-egg binding assay that detects subfertile males. Biol Reprod  \n58:686-99. \n4. Fierro, R., Daniel, M., Foliguet, B., Bene, \nM. C., Barbarino-Monnier, P., Faure, G. C., Grignon, G. (1996). Acrosome reaction of human sperm: application of TEM/flow cytometry. Advances in \nContraceptive Deliver Systems  12:109-111. \n5.  Van Voorst, A. Leenstra, F.R. (1995). \nFertility rate of daily collected and cryopreserved fowl semen. Poult Sci 74: 136-40. \n \n \nEVALUACI\u00d3N DE VACUNAS INACTIVADAS CONTRA \nINFLUENZA AVIAR \n \nEVALUATION OF KILLED AVIAN INFLUENZA (IA) VACCINES \n \nM.V.Z. Eduardo Lucio Decanini,  M.V.Z. Daniel Marrufo Villa , M.V.Z. Enrique Gonz\u00e1lez Escobar.1 \n1 Investigaci\u00f3n Aplicada S.A. de C.V., 7 Norte No. 416 Col. Centro Tehuac\u00e1n, Pue, M\u00e9xico. \n  \nSUMMARY \nSeveral Newcastle disease/avian influenza \nvaccines, and vaccination programs were evaluated in a poultry company located in central Mexico. As a result of this field study, birds vaccinated at 7 days of age with the ENC+IA combination vaccine, but non vaccinated against infectious bronchitis (BI) or infectious bursal disease (IBF) showed a better \nperformance than those vaccinated against IA at 14 \ndays and also immunized against BI and IBF (intermediate plus) after challenge with a low pathogenicity IA virus. A better bird performance was also seen with high antibody levels against IA, as compared with those having low titers. \n \nRESUMEN \nEn una empresa av\u00edcola del centro de M\u00e9xico se \nevaluaron diferentes vacunas y calendarios de vacunaci\u00f3n contra la enfermedad de Newcastle e \nInfluenza aviar. Como resultado del estudio de campo \nse observ\u00f3 que las aves vacunadas a 7 d\u00edas de edad con la vacuna combinada ENC+IA y no vacunadas contra BI ni contra IBF cepa intermedia agresiva, tuvieron, despu\u00e9s de ser desafiadas con el virus IA de baja patogenicidad mejor comportamiento productivo que aquellas vacunadas contra IA a los 14 d\u00edas y tambi\u00e9n inmunizadas contra  BI e IBF cepa intermedia agresiva. Tambi\u00e9n se observ\u00f3 un mejor comportamiento de las   \n aves con niveles altos de anticuerpos contra IA comparado con aquellas que tuvieron t\u00edtulos bajos. \n \nINTRODUCCI\u00d3N \nLa presencia de un virus de influenza aviar (IA) \nfue reconocida oficialmente en M\u00e9xico el mes de Mayo de 1994. El virus fue clasificado como un virus H5N2 de baja patogenicidad. Para el fin de a\u00f1o se estaban \nreportando los primeros brotes de alta patogenicidad \ndebidos a la mutaci\u00f3n del virus. A partir de este momento, se autoriz\u00f3 el empleo de vacunas en contra de la IA en nuestro pa\u00eds, cuyo objetivo primordial estaba centrado en evitar la presentaci\u00f3n y las p\u00e9rdidas debidas a los brotes de IA de alta patogenicidad. El virus de alta patogenicidad fue erradicado de nuestro pa\u00eds para el a\u00f1o de 1995.  Sin embargo, prevaleci\u00f3 la presencia del virus de baja patogenicidad  dando como resultado bajas en la productividad y propensi\u00f3n de las aves a sufrir problemas respiratorios complicados.\n1  \nEl empleo de la vacunaci\u00f3n ha sido una \nherramienta en la Campa\u00f1a para el control y erradicaci\u00f3n de la IA en M\u00e9xico. Para ello, las autoridades sanitarias expidieron una normativa que especifica los criterios para la producci\u00f3n de las vacunas y la calidad que deben reunir.  Aunque la norma para el control y erradicaci\u00f3n se encuentra en revisi\u00f3n, el empleo de las vacunas se ha permitido  339  \u00fanicamente con la autorizaci\u00f3n de las autoridades \nsanitarias. \nLos criterios de calidad que se han establecido en \nnuestro pa\u00eds, as\u00ed como los modelos existentes a nivel mundial para la evaluaci\u00f3n de las vacunas contra la IA consisten en evaluar la capacidad de la vacuna para \nevitar la mortalidad causada por el virus de la IA, en el \ncaso de M\u00e9xico para el virus de alta patogenicidad. Los estudios realizados por las autoridades sanitarias han indicado el adecuado funcionamiento de todos los biol\u00f3gicos empleados para proteger a las aves desafiadas contra la mortalidad causada por el virus de alta patogenicidad. Sin embargo este virus no ha estado presente en M\u00e9xico desde 1995, mientras que el virus que ha estado involucrado en p\u00e9rdidas para los productores debidas a problemas respiratorios complicados ha sido el virus de baja patogenicidad.\n9 \nAunque existen trabajos que claramente establecen los \nbeneficios de inducir altos niveles de anticuerpos para \ndisminuir la reproducci\u00f3n viral y por ende el n\u00famero de part\u00edculas virales excretadas durante la infecci\u00f3n en el caso de vacunas inactivadas, no existe un modelo de evaluaci\u00f3n que claramente le indique al m\u00e9dico veterinario si existen diferencias apreciables en par\u00e1metros productivos con vacunas de diferentes calidades medidas por la cantidad de anticuerpos inducida.\n2,3,5 Por otra parte, algunas experiencias en el \nuso de vacunas contra la IA en M\u00e9xico incluye la detecci\u00f3n de problemas en algunos de los productos \ncomerciales en cuanto al balance de anticuerpos para \nlas fracciones de Newcastle e IA y en la consistencia de la respuesta serol\u00f3gica de lote a lote.\n1 \nEl virus vacunal de la bronquitis inf ecciosa ha \nsido empleado en el laboratorio en modelos que buscan la reproducci\u00f3n de un cuadro de enfermedad respiratoria cr\u00f3nica complicada, tal como se presenta en el campo. \nExisten en el mercado veterinario mexicano dos \ntipos de vacunas aprobadas contra la IA, siendo la mas utilizada la  vacuna emulsionada en aceite (H5N2) aplicada por v\u00eda subcut\u00e1nea, misma que toma alrededor \nde 3 a 4 semanas postvacunaci\u00f3n para producir los \nm\u00e1ximos niveles de anticuerpos. Tambi\u00e9n existe una vacuna recombinante  resultado de la inserci\u00f3n de material gen\u00e9tico del virus de la IA en un poxvirus de la Viruela Aviar, que le confiere la capacidad de expresar la hemoaglutinina del virus de la IA en su superficie.\n 1,6,7,8  \n \nOBJETIVO \nEstablecer un modelo de evaluaci\u00f3n de vacunas \ncontra la IA que permita medir diferencias en la calidad \nde las vacunas para evitar problemas respiratorios \nsecundarios, empleando una prueba de desaf\u00edo con un virus de baja patogenicidad  combinado con un virus vacunal de la bronquitis inf ecciosa y evaluar la respuesta serol\u00f3gica y de protecci\u00f3n al desaf\u00edo \nempleando el modelo descrito en aves que recibieron una vacuna combinada ENC-IA o emulsiones monovalentes para las fracciones. \n \nMATERIAL Y M\u00c9TODOS \nLas aves empleadas en el estudio se alojaron en \nuna granja de pollo de engorda ubicada en el centro del pa\u00eds bajo condiciones de explotaci\u00f3n comercial com\u00fan. Se seleccionaron cuatro casetas,  cada una de 15, 000 \npollos de engorda de un d\u00eda de edad, a los cuales se le aplic\u00f3 uno de tres calendarios de vacunaci\u00f3n diferentes con la finalidad de evaluar el nivel de anticuerpos y por lo tanto de protecci\u00f3n que confirieron las vacunas emulsionadas contra la ENC e IA unitarias y bivalentes y el papel que tienen sobre \u00e9stas la vacuna a virus vivo contra la Bronquitis Inf ecciosa (BI). Los calendarios de \ninmunizaci\u00f3n quedaron integrados como se describe en \nla gr\u00e1fica 1. \nA los grupos A C y D se les aplicaron vacunas \nemulsionadas producidas por el mismo laboratorio (Laboratorio I) a diferencia del grupo B que recibi\u00f3 vacunas de otro laboratorio (Laboratorio B). Las vacunas emulsionadas fueron aplicadas por v\u00eda subcut\u00e1nea en la parte posterior media del cuello. Los biol\u00f3gicos a virus vivo contra la ENC fueron cepa La Sota y para la BI cepa Massachusetts y se suministraron a las aves por instilaci\u00f3n ocular. Las vacunas contra la IBF fueron cepa tipo Lukert \nintermedia en el agua de bebida. A los 16 d\u00edas de edad \nse tomaron 10 pollos de cada grupo y se trasladaron al laboratorio para alojarlas en unidades de aislamiento tipo Horsfall-Bauer con aire filtrado a presi\u00f3n negativa. Los 4 grupos fueron desafiados a los 21 d\u00edas de edad  aplicando 0.03 ml de un virus de baja patogenicidad H5N2 del virus de IA (10\n4 DIE50/ml) por v\u00eda ocular. A \nlos 14, 21, 29 y 36 d\u00edas de edad se tomaron 10 muestras de sueros de las aves de cada grupo alojadas en las unidades de aislamiento, con la finalidad de evaluar el comportamiento de anticuerpos contra la IA y la ENC. A las muestras de sueros se les realiz\u00f3 la \nt\u00e9cnica de Inhibici\u00f3n de la Hemoaglutinaci\u00f3n (HI) para \nIA empleando la prueba oficial y 8 UHA para la prueba de HI contra la ENC. A los 29 d\u00edas de edad se tomaron los pesos corporales ( aves sobrevivientes al desaf\u00edo de todos los grupos), al igual que a las aves de los grupos A, B y C que fueron pesadas a los 45 d\u00edas de edad en la granja. A todas las aves se les realizaron las mismas pr\u00e1cticas de manejo de acuerdo a las que normalmente se llevan a cabo en la granja y se les proporcion\u00f3 alimento balanceado con iguales caracter\u00edsticas nutricionales y en la misma disponibilidad. \n \nRESULTADOS \nEn la gr\u00e1fica 1 se muestran los resultados \nserol\u00f3gicos de los t\u00edtulos de anticuerpos producidos por  340  la aplicaci\u00f3n de las vacunas emulsionadas y la \nrespuesta al desaf\u00edo, en donde podemos observar que en las aves a las que se les aplicaron las vacunas emulsionadas bivalentes (ENC-IA) a los 7 d\u00edas de edad presentaron las mayores curvas de anticuerpos (C y D), en el caso de las vacunas de ENC e IA aplicadas a los 7 \ny 14 d\u00edas de edad respectivamente (Grupos A y B) se \nencontraron curvas de anticuerpos mas bajas, siendo menor a\u00fan la cantidad de anticuerpos de la vacuna producida por el Laboratorio B (Grupo B), quien supera el nivel de 5 logaritmo base dos, una semana despu\u00e9s que los grupos A y D y dos despu\u00e9s del grupo C. Para la ENC se observaron curvas de anticuerpos con un comportamiento similar para los cuatro grupos. En el caso de la prueba de potencia-desaf\u00edo se encontr\u00f3 que las aves del grupo A presentaron un porcentaje de mortalidad del 26.7%, grupo B de 40%, grupo C de 26.4% y grupo D de 0%. Finalmente en relaci\u00f3n a los \npesos corporales a los 29 d\u00edas de edad los pollos \nsobrevivientes del grupo A presentaron un peso promedio de 1.051 Kg., las de grupo B 0.961 Kg., grupo C de 1.240 y 1.150 Kg. para el grupo D; los pesos corporales a los 45 d\u00edas de edad de aves en granja y sin desaf\u00edo aparente fueron de 2.066 Kg. para el grupo A (Laboratorio I), de 2.020 Kg. para el grupo B (Laboratorio B) y el Grupo C de 2.055 kg. (Laboratorio I). \n \nDISCUSI\u00d3N Y CONCLUSIONES \n\u2022 En este trabajo se observ\u00f3 que las aves \ninmunizadas con la vacuna (I) a la edad ideal (7 d\u00edas para esa zona) obtuvieron mayores niveles de anticuerpos y un comportamiento superior en cuanto a viabilidad y ganancia de peso comparado con las aves inmunizadas con la vacuna (B). Aunque hay reportes de protecci\u00f3n contra (IA) a\u00fan cuando se tienen bajos niveles de anticuerpos, este estudio muestra que las aves con niveles de anticuerpos superiores tuvieron mejor viabilidad y comportamiento productivo.  \n\u2022 Las curvas de anticuerpos para la ENC fueron \nsatisfactorios o protectivos ante un posible desaf\u00edo de campo y no se observaron diferencias entre la aplicaci\u00f3n de vacunas emulsionadas unitarias y bivalentes contra la ENC. \n\u2022 Se observ\u00f3 que las aves a las cuales se aplica la \nvacuna de (BI) a los 18 d\u00edas de edad tuvieron un comportamiento negativo. Esto nos confirma que en algunos casos la vacuna contra BI puede fungir como complicante de (IA). Tambi\u00e9n se observ\u00f3 en el estudio un deterioro en el comportamiento de las aves as\u00ed como de sus par\u00e1metros productivos \n(Grupos A, B y C). \n \n  REFERENCIAS  \n1. Arriola J. M. Experiencias de campo en el uso de \nvacunas contra Influenza Aviar. Simposio Internacional sobre Influenza Aviar, Sociedad Venezolana de Veterinarios Especialistas en Aves 4 y 5 noviembre 1999, Maracay Venezuela. \n2. Beard W. C. The role of vaccines and vaccination. \nMemorias del Third international symposium on Avian Influenza. Madison Wisconsin USA Mayo 27-29 1992. International Organizing Committee Avian Influenza. \n3. Brugh, M. Beard C. W., Stone H. D. Immunization \nof chickens and turkeys against avian influenza with monovalent and polyvaleni oil emulsion vaccines. Am. J. Vet Res. 40:165-169. 1979. \n4. Cowen B. S., Wilson R.A., Harris S. K., Hyde R. \nL., Pearson, J. E. Avian Influenza Vaccine (H5n2) Studies In light and heavy breeds of chickens. \nWestern Poyltry Disease Conference. Mayo, 1986. \n5. Donahoe, J.P., Inactivated  Avian Influenza Whole \nVirus Vaccines. Proc. Fourth International Symposium on Avian Influenza. May 1997. 228-236 \n6. Halvorson A. D. Experience With Avian Influenza \nControl In Minnesota. Extension Veterinarian-Avian Health Agricultural Extension Service University of Minnesota Western Poluty Deseas Conference Proceedings Marzo 1995. \n7. Stone, H.D. Efficacy of avian influenza oil-\nemulsion vaccines in chickens of various ages. \nAvian Dis. 31:483-490. 1987. \n8. Webster, R. G. Enfrentando al Virus de la \nInfluenza Aviar H5N2 Altamente Pat\u00f3geno. II Curso de Actualizaci\u00f3n sobre Influenza Aviar. ANECA M\u00e9xico D.F. Noviembre 1994.  36-47 \n9. Wood, J M., Kawaoka, Y., Newberry, L. A., \nBordwell E, Webster, R.G. Standardization of inactivated H5N2 influenza vaccine and efficacy against lethal A/Chicken/Pennsylvania/1370/83 infection. Avian Dis. 29 867-872 1985.  341 T\u00cdTULOS DE ANTICUERPOS CONTRA INFLUENZA AVIAR Y ENFERMEDAD DE \nNEWCASTLE (Expresados en Log 2). \nEDAD EN D\u00cdAS GRUPO\n5 7 14 16 21\nA IBF ENC emulsi\u00f3n, ENC virus vivo y BI virus vivo. IA emulsi\u00f3n IBF ENC virus vivo\nB IBF ENC emulsi\u00f3n, ENC virus vivo y BI virus vivo. IA emulsi\u00f3n IBF ENC virus vivo\nC IBF IA-ENC emulsi\u00f3n, ENC virus vivo  y BI virus vivo. ----- IBF ENC virus vivo\nD IBF IA-ENC emulsi\u00f3n y ENC virus vivo. ----- ----- ENC virus vivoCalen-\ndario \nde  \nVacun\naci\u00f3n 012345678910\n14 21 29 36T\u00edtulos de anticuerpos expresados Log2A-IA B-IA\nC-IA D-IA\nA-ENC B-ENC\nC-ENC D-ENC 342 ORGANIC CHICKEN PRODUCTION \n AVICULTURA ORGANICA \n \nJon Ratcliff \n \nChurch Farm Barn, Chapel Lane, Milton, Banbury, Oxon, UK \n \nRESUMEN \nUna serie de factores, en su mayor\u00eda relacionados \ncon la seguridad alimentaria (resistencia bacteriana a los antibi\u00f3ticos, encefalopat\u00eda esponjiforme del bovino, intoxicaci\u00f3n con dioxinas, etc.) ha hecho que peque\u00f1os pero poderosos segmentos de consumidores en pa\u00edses primermundistas, principalmente europeos, exijan a sus gobiernos la imposici\u00f3n de medidas tendientes a la producci\u00f3n pecuaria \u201corg\u00e1nica\u201d. Existe todav\u00eda mucha confusi\u00f3n sobre lo que significa este t\u00e9rmino, pero en \ngeneral es la oposici\u00f3n a la producci\u00f3n intensiva y la \nengorda de animales con raciones que llevan aditivos artificiales. Avicultura org\u00e1nica  es pues, la producci\u00f3n de pollos en pastoreo \u201clo que da a la carne mejor sabor y textura\u201d y, adem\u00e1s, su alimentaci\u00f3n es a base de matriales producidos org\u00e1nicamente y sin antibi\u00f3ticos promotores del crecimiento. El costo de producci\u00f3n m\u00e1s que duplica al de la avicultura intensiva.  \nPeople who have been in the European poultry \nindustry for more than 30 years are witnessing a return \nto systems of management that were common before \nintensification transformed the industry.  Legislation, particularly in the EU, has been unforgiving to the industry particularly in relation to welfare and feed additives.  This has led to a small sector of the industry returning to traditional chicken production to supply a high premium niche market.  Mainstream intensive production has also developed in response to consumer pressure resulting in a range of systems that although not true organic, are referred to as free range and drug or additive free. \nThe last ten years has seen a number of high \nprofile food scares in Europe which include Bovine \nSpongiform Encephalopathy (BSE), salmonella and dioxin poisoning.  The most recent of these scares, dioxin contaminated animal feed in Belgium, served to highlight the ineffectiveness of self regulation within the food industry and strengthen the deep distrust felt by most European consumers towards political efforts to regulate food safety.  Against this general distrust felt by most consumers towards commercial chicken production, a combination of factors has led to the growth of the organic and additive or drug free sectors.  \nFirstly, there are those consumers, mainly in Europe, \nthat have been against intensive chicken production, preferring instead the slower growing free range system that is claimed to produce a mature chicken with better flavour and texture.  Secondly, there has \nbeen the move away from in-feed antibiotic growth promoters and other additives due to concerns about human resistance to antibiotics.  Recent studies, such as DanMap from Denmark, have highlighted the decline in antibiotic resistance in Enterococcus faecium  \nfollowing the removal of antibiotic growth promoters in 1995.  Thirdly, a very small percent of consumers have supported the return to organic chicken production, free of any additives and only using \norganically produced feed materials. \nOrganic production in the UK is controlled by a \ngoverning body (UKROFS) which has to comply with the European standards for organic feeds and systems.  Until last year the requirements for organic chicken production were based on a free range system of production fed a ration derived from seventy percent organic raw materials, restrictions on the use of additives such as growth promoters but no restriction on flock sizes.  Last year, in an attempt to restrict la rge \nscale commercial production of organic chicken, the \nrules were significantly tightened.  Flock size was \nlimited to 4800, the minimum content of organic raw materials was raised to eighty percent and perhaps most alarming of all, synthetic amino acids were also banned.  This move has had serious welfare implications because of resulting vent pecking and cannibalism.  UKROFS has been widely criticized for the move to ban synthetic amino acids, but within Europe countries such as Germany support the move.  Needless to say these changes have effectively stopped any further expansion into the organic production.  The size of the market is less than 3 percent and has \npeaked.  In the UK a surplus of organic eggs and \nchicken has led to a significant fall in prices.  The cost of organic production is at least twice that of commercial broiler production and failure to recover these costs makes the venture financially unviable.  Supermarkets supply most of the organic products sold in Europe and retail prices are around five times that of normal commercial chicken. \nFrance has traditionally been the leader in free \nrange chicken production in Europe with the Label Rouge system.  Chickens are reared outdoors according \nto strict regulations that are audited by the French \nAgriculture department.  Although not true organic, it is a system that has been extremely successful, accounting for around thirty percent of the French  343 market.  Other countries have followed with similar \nsystems of production although market share elsewhere in Europe is not as great as in France.  Many consumers consider Label Rouge to be an affordable system that incorporates many of the ethics of organic production, but without the requirement to feed organic \nfeed materials, although it does require a diet that \nexcludes any animal protein. \nIntensive indoor chicken production has also \nadapted to the demand from consumers and supermarkets to end the reliance on antibiotic growth promoters (AGPs).  The EU ban on avoparcin in 1997 was a clear signal that politicians were beginning to take seriously consumer concerns surrounding the potential risk of the transfer of antibiotic resistant micro-organisms from animals to humans arising from the feeding of antibiotic growth promoters.  The ban was extended by the EU in 1998 to include tylosin \nphosphate, zinc bacitracin spiramycin and \nvirginiamycin, leaving only avilamycin and flavomycin as the two growth promoters currently registered for use in pigs and poultry.  The EU has signaled the likely ban on the remaining growth promoters within two years.  However, certain retailers, including the UK's largest and most influential supermarket group, Tesco, have taken their own lead in implementing a complete ban on AGPs in broiler feeds. This has come on the back of a number of significant developments within Europe within the past few years. \nSweden and Denmark implemented a voluntary \nban on AGPs in 1986 and 1997 respectively.  Their experience has been well documented and \ndemonstrated that the impact on animal performance and health has been less than expected.  Their strategy not only focused on alternative products but the type of in-feed coccidiostat used (ionophore or chemical), stocking density, ventilation, hygiene standards, chick \nquality and feed composition.  In October 1999, the \nUK's largest poultry company, Grampian Country Food Group, announced the removal of AGPs from all broiler and breeder feed. Although not the first company to do so, the impact from a volume perspective was very significant. Their decision came on the back of extensive trials with alternative products, under commercial conditions, over a two year period in conjunction with a review of management practices. Significantly, there were no reported detrimental effects with regard to bird health, suggesting there would be no greater use of therapeu tic \nantibiotics to treat flocks.  As a result, most other \nchicken producers in the UK now exclude all antibiotic growth promoters but use alternative products of which the most successful would be organic acids, essential oil extracts and mannan oligosaccharide. \nNot surprisingly, the consumer is often confused \nby the many different systems of production that are labeled organic or drug free.  Price, for many consumers, is the limiting factor and that is why the lower cost alternatives to organic have been more successful.  The policy of the commercial broiler \nindustry to remove antibiotic growth promoters has \nbeen widely applauded. \n \n ", "language": "PDF", "image": "PDF", "pagetype": "PDF", "links": "PDF"}